ASSAY_ID ASSAY PROJECT PLATE WELL WELL_TYPE RAW_VALUE_A BSUB_VALUE_A Z_SCORE_A COMPOSITE_Z REPRODUCIBILITY CHEMBANK_ID VIRTUAL_ID SMILES 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A01 compound treatment 1.0337 0.0337 0.66 0.6552 1.0 1953487 Maybridge1_002289 CC1CN=C(Nc2ccc(Cl)cc2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A02 compound treatment 1.0212 0.0212 0.41 0.4118 1.0 1953488 Maybridge1_002290 NNC(=O)[C@H]1C[C@@H]1C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A03 compound treatment 1.0463 0.0463 0.9 0.8987 1.0 1953489 Maybridge1_002291 Cc1ccc(NC2=NCC(C)(C)S2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A04 compound treatment 1.0073 0.00727 0.14 0.1412 1.0 1037854 Maybridge1_002292 Nc1ccc(O)c2C(=O)c3c(O)ccc(N)c3C(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A05 compound treatment 1.0519 0.0519 1.01 1.007 1.0 1953490 Maybridge1_002293 CCOC(=O)C(O)(c1ccc(N)c(OC)c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A06 compound treatment 0.9961 -0.00387 -0.08 -0.0752 -1.0 1953491 Maybridge1_002294 CN1C2CCC1CC(=NOC(=O)c3ccc(Cl)cc3)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A07 compound treatment 0.9961 -0.00387 -0.08 -0.0752 -1.0 1291574 Maybridge1_002295 Cn1c(Nc2ccccc2)cc(=O)n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A08 compound treatment 0.9836 -0.0164 -0.32 -0.3187 -1.0 1872890 Maybridge1_002296 Cc1ccc(OC(=O)c2ccc(cc2)[N+](=O)[O-])c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A09 compound treatment 0.9683 -0.0317 -0.62 -0.6164 -1.0 1953492 Maybridge1_002297 Nc1nc(ns1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A10 compound treatment 0.9794 -0.0206 -0.4 -0.3999 -1.0 1534164 Maybridge1_002298 COc1ccccc1N2CCN(Cc3ccccc3Cl)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A11 compound treatment 0.9787 -0.0213 -0.41 -0.4134 -1.0 1529433 Maybridge1_002299 COc1ccccc1C2CCN(CC2)C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A12 compound treatment 0.9717 -0.0283 -0.55 -0.5487 -1.0 1953493 Maybridge1_002300 O=C(CN1CCC(CC1)NC(=O)c2ccccc2)N(C3CCCCC3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A13 compound treatment 1.0247 0.0247 0.48 0.4794 1.0 1025920 Maybridge1_002301 Oc1ccc([N+](=O)[O-])c2C(=O)c3ccccc3C(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A14 compound treatment 0.9968 -0.00318 -0.06 -0.0617 -1.0 1371569 Maybridge1_002302 O=C(OCc1ccccc1)N2C3CC3NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A15 compound treatment 0.9906 -0.00945 -0.18 -0.1835 -1.0 1083848 Maybridge1_002303 CCCCC(NC(=O)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A16 compound treatment 0.9885 -0.0115 -0.22 -0.2241 -1.0 1020730 Maybridge1_002304 Clc1cc(Cl)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A17 compound treatment 1.0142 0.0142 0.28 0.2765 1.0 1953494 Maybridge1_002305 [O-][N+](=O)c1ccc(o1)c2nnc(S)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A18 compound treatment 0.9947 -0.00527 -0.1 -0.1023 -1.0 1953495 Maybridge1_002306 CCOC(=O)[C@@H]1[C@H]([C@H](C(=O)OCC)[C@](C)(O)CC1=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A19 compound treatment 0.9989 -0.00109 -0.02 -0.0211 -1.0 1953496 Maybridge1_002307 COc1ccc(CC2CCC(=NOC(=O)c3cccc(c3)C(F)(F)F)CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A20 compound treatment 0.9766 -0.0234 -0.45 -0.454 -1.0 1576383 Maybridge1_002308 CC(C)CCOC(=O)C1(CC2(C1)COC(OC2)c3ccccc3)C(=O)OCCC(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A21 compound treatment 1.0163 0.0163 0.32 0.3171 1.0 1953497 Maybridge1_002309 CCOC(=O)/C(=N/Nc1ccccc1C)/C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A22 compound treatment 1.0212 0.0212 0.41 0.4118 1.0 1953498 Maybridge1_002310 CCOC(=O)C(CCC(=O)O)(CCC(=O)O)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A23 mock treatment 0.9954 -0.00457 -0.09 -0.0888 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 A24 mock treatment 0.9947 -0.00527 -0.1 -0.1023 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B01 compound treatment 0.9683 -0.0317 -0.62 -0.6164 -1.0 1953499 Maybridge1_002311 O[C@H]1CC2CCC1N(Cc3ccccc3)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B02 compound treatment 1.1201 0.12 2.33 2.3327 1.0 1936533 Maybridge1_002312 CCOc1ccc(Br)cc1C=C2C(=O)NC(=S)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B03 compound treatment 1.0059 0.00588 0.11 0.1141 1.0 1953500 Maybridge1_002313 COc1ccc(cc1)/C(=N/O)/C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B04 compound treatment 1.0296 0.0296 0.57 0.5741 1.0 1577344 Maybridge1_002314 COc1cccc(NC(=S)NC2CC(C)CC(C)(C)C2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B05 compound treatment 1.008 0.00797 0.15 0.1547 1.0 1953501 Maybridge1_002315 ON=C1C/C=C\CC(=NO)C/C=C\C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B06 compound treatment 1.0567 0.0567 1.1 1.1017 1.0 1050941 Maybridge1_002316 Clc1ccc(C=C2C(=O)NC(=S)NC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B07 compound treatment 1.0059 0.00588 0.11 0.1141 1.0 1953502 Maybridge1_002317 Cc1ccc(cc1)S(=O)(=O)OCC2(CCC3CC2)C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B08 compound treatment 0.9975 -0.00248 -0.05 -0.0482 -1.0 1953503 Maybridge1_002318 Oc1c(Br)cc(Br)cc1/C=N/c2ccc(Cc3ccc(\N=C\c4cc(Br)cc(Br)c4O)cc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B09 compound treatment 0.9773 -0.0227 -0.44 -0.4405 -1.0 1068565 Maybridge1_002319 OC(=O)C1CCCC1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B10 compound treatment 0.9766 -0.0234 -0.45 -0.454 -1.0 1513655 Maybridge1_002320 CN(C)c1ccc(CC2C(=O)Nc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B11 compound treatment 1.0163 0.0163 0.32 0.3171 1.0 1953504 Maybridge1_002321 Brc1ccc2NC(=O)/C(=C\C(=O)c3ccc(cc3)c4ccccc4)/c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B12 compound treatment 0.9843 -0.0157 -0.31 -0.3052 -1.0 1953505 Maybridge1_002322 CSC1=C(C#N)C(=O)NC(S1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B13 compound treatment 0.985 -0.015 -0.29 -0.2917 -1.0 1953506 Maybridge1_002323 OC(=O)c1ccc(s1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B14 compound treatment 1.0205 0.0205 0.4 0.3982 1.0 1953507 Maybridge1_002324 Brc1ccc(CSc2nnc(SCc3ccc(Br)cc3)s2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B15 compound treatment 0.9606 -0.0394 -0.77 -0.7652 -1.0 1953508 Maybridge1_002325 OC(=O)c1csc(n1)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B16 compound treatment 1.0156 0.0156 0.3 0.3035 1.0 1071578 Maybridge1_002326 Clc1ccccc1C2Nc3ccccc3S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B17 compound treatment 1.017 0.017 0.33 0.3306 1.0 1953509 Maybridge1_002327 CCC(C)(C)C1CCC(=O)/C(=C\c2ccccc2)/C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B18 compound treatment 1.0128 0.0128 0.25 0.2494 1.0 1232551 Maybridge1_002328 COc1cc(cc(OC)c1OC)C(=O)c2c(C)c(C)c(C)c(C)c2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B19 compound treatment 0.9522 -0.0478 -0.93 -0.9275 -1.0 1953510 Maybridge1_002329 FC(F)(F)c1cccc(NC(=O)CC#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B20 compound treatment 0.9536 -0.0464 -0.9 -0.9004 -1.0 1953511 Maybridge1_002330 CN(C)c1ccc(cc1)C(=O)N/N=C/c2cc(Cl)cc(Cl)c2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B21 compound treatment 0.9989 -0.00109 -0.02 -0.0211 -1.0 1953512 Maybridge1_002331 COc1ccc(C=C2C(=O)NC(=S)NC2=O)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B22 compound treatment 1.0052 0.00518 0.1 0.1006 1.0 1953513 Maybridge1_002332 Cc1onc(c1C(=O)NN)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B23 mock treatment 1.0226 0.0226 0.44 0.4388 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 B24 mock treatment 1.0045 0.00448 0.09 0.0871 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C01 compound treatment 1.0519 0.0519 1.01 1.007 1.0 1953514 Maybridge1_002333 CC1CN=C(Nc2ccc(F)cc2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C02 compound treatment 0.9933 -0.00666 -0.13 -0.1294 -1.0 1013499 Maybridge1_002334 CC(C)(C)c1cc(cc(c1O)C(C)(C)C)c2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C03 compound treatment 1.0261 0.0261 0.51 0.5064 1.0 1953515 Maybridge1_002335 CC1(C)CN=C(Nc2ccc(Cl)cc2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C04 compound treatment 1.0101 0.0101 0.2 0.1953 1.0 1953516 Maybridge1_002336 CC1(C)N(O)C(=O)C(C)(C)N(O)C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C05 compound treatment 0.9829 -0.0171 -0.33 -0.3323 -1.0 1953517 Maybridge1_002337 FC(F)(F)c1nc2ccccc2[nH]c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C06 compound treatment 0.9808 -0.0192 -0.37 -0.3729 -1.0 1953518 Maybridge1_002338 CN1C2CCC1CC(=NOC(=O)c3ccc(cc3)[N+](=O)[O-])C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C07 compound treatment 1.0282 0.0282 0.55 0.547 1.0 1774966 Maybridge1_002339 [O-][N+](=O)c1ccc(/C=C/c2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C08 compound treatment 0.9495 -0.0505 -0.98 -0.9816 -1.0 1953519 Maybridge1_002340 Cc1ccc(OC(=O)c2ccc(Cl)cc2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C09 compound treatment 1.0045 0.00448 0.09 0.0871 1.0 1953520 Maybridge1_002341 CCNc1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C10 compound treatment 0.9195 -0.0805 -1.56 -1.5633 -1.0 1579020 Maybridge1_002342 COc1ccccc1N2CCN(Cc3ccc(Cl)c(Cl)c3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C11 compound treatment 0.9919 -0.00805 -0.16 -0.1564 -1.0 1039501 Maybridge1_002343 COc1ccc2[nH]c(C)cc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C12 compound treatment 0.9606 -0.0394 -0.77 -0.7652 -1.0 1953521 Maybridge1_002344 CC1(C)C(NCC(=O)N(C2CCCCC2)c3ccccc3)C4(C)CCC1C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C13 compound treatment 0.9717 -0.0283 -0.55 -0.5487 -1.0 1953522 Maybridge1_002345 Cc1cc(N)n(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C14 compound treatment 0.9606 -0.0394 -0.77 -0.7652 -1.0 1953523 Maybridge1_002346 Nc1nc(cc(n1)C(F)(F)F)c2ccc(cc2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C15 compound treatment 0.971 -0.029 -0.56 -0.5622 -1.0 1026 Maybridge1_002347 CC(=O)NC(Cc1ccccc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C16 compound treatment 0.9132 -0.0868 -1.69 -1.685 -1.0 1953524 Maybridge1_002348 CC(=O)c1cc(F)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C17 compound treatment 0.9745 -0.0255 -0.49 -0.4946 -1.0 1953525 Maybridge1_002349 CCCC(CCC)C(C(=O)O)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C18 compound treatment 0.9446 -0.0554 -1.08 -1.0763 -1.0 1010667 Maybridge1_002350 Nc1c(ccc2C(=O)c3ccccc3C(=O)c12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C19 compound treatment 1.0108 0.0108 0.21 0.2088 1.0 1953526 Maybridge1_002351 COc1ccc(CC2CCC(=NOC(=O)c3ccc(cc3)C(C)(C)C)CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C20 compound treatment 0.9745 -0.0255 -0.49 -0.4946 -1.0 1059445 Maybridge1_002352 CC(SCc1ccccc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C21 compound treatment 0.9738 -0.0262 -0.51 -0.5081 -1.0 1953527 Maybridge1_002353 CCOC(=O)/C(=N/Nc1ccccc1)/C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C22 compound treatment 0.9829 -0.0171 -0.33 -0.3323 -1.0 1953528 Maybridge1_002354 CC(C)(C)C#CC(O)(C#CC(C)(C)C)C#CC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C23 mock treatment 0.9683 -0.0317 -0.62 -0.6164 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 C24 mock treatment 0.9836 -0.0164 -0.32 -0.3187 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D01 compound treatment 1.0233 0.0233 0.45 0.4523 1.0 1953529 Maybridge1_002355 C1C2CC3CC1CC(C2)C3c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D02 compound treatment 1.0261 0.0261 0.51 0.5064 1.0 1953530 Maybridge1_002356 COc1cc(OC)c(C=C2C(=O)NC(=S)NC2=O)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D03 compound treatment 0.9752 -0.0248 -0.48 -0.4811 -1.0 1026485 Maybridge1_002357 Cc1ccc(cc1)S(=O)(=O)NCCCCCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D04 compound treatment 0.9808 -0.0192 -0.37 -0.3729 -1.0 1953531 Maybridge1_002358 CCCCNC(=S)Nc1cccc(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D05 compound treatment 0.9878 -0.0122 -0.24 -0.2376 -1.0 1039144 Maybridge1_002359 OC(=O)C1C(C2CC1C=C2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D06 compound treatment 0.9794 -0.0206 -0.4 -0.3999 -1.0 1953532 Maybridge1_002360 CC(C)(C)NC(=O)NCCc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D07 compound treatment 0.9808 -0.0192 -0.37 -0.3729 -1.0 1953533 Maybridge1_002361 BrC1(CC2CC3(Br)C1)CC(Br)(C2)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D08 compound treatment 0.9585 -0.0415 -0.81 -0.8057 -1.0 1913713 Maybridge1_002362 COc1ccc(/C=N/c2ccc(O)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D09 compound treatment 0.9843 -0.0157 -0.31 -0.3052 -1.0 1953534 Maybridge1_002363 COc1cc(/C=C/2\NC(=O)NC2=O)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D10 compound treatment 0.994 -0.00596 -0.12 -0.1158 -1.0 1164268 Maybridge1_002364 O=C1Nc2ccccc2C1Cc3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D11 compound treatment 1.0094 0.00936 0.18 0.1818 1.0 1953535 Maybridge1_002365 CC(=O)N1C(=O)/C(=N/Nc2ccc(cc2[N+](=O)[O-])[N+](=O)[O-])/c3cc(Br)ccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D12 compound treatment 0.969 -0.031 -0.6 -0.6028 -1.0 1209197 Maybridge1_002366 Nc1ccccc1C(=O)NCc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D13 compound treatment 0.9641 -0.0359 -0.7 -0.6975 -1.0 1012508 Maybridge1_002367 OC(=O)c1ccnc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D14 compound treatment 0.9947 -0.00527 -0.1 -0.1023 -1.0 1953536 Maybridge1_002368 Clc1ccccc1/C=N/NC(=S)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D15 compound treatment 0.9599 -0.0401 -0.78 -0.7787 -1.0 1945130 Maybridge1_002369 Cc1oc(cc1C(=O)O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D16 compound treatment 1.0101 0.0101 0.2 0.1953 1.0 1953537 Maybridge1_002370 [O-][N+](=O)c1ccc(cc1)C2Nc3ccccc3S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D17 compound treatment 1.0003 3.05E-4 0.01 0.0059 1.0 1087610 Maybridge1_002371 COc1ccc(C=C2C(=O)NC(=O)NC2=O)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D18 compound treatment 0.9857 -0.0143 -0.28 -0.2782 -1.0 1953538 Maybridge1_002372 Cc1c(C)c(C)c(CSCC(=O)N/N=C/C=C/c2ccccc2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D19 compound treatment 0.9627 -0.0373 -0.72 -0.7246 -1.0 1052222 Maybridge1_002373 O=C1NC(=O)C(=Cc2ccncc2)C(=O)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D20 compound treatment 0.9836 -0.0164 -0.32 -0.3187 -1.0 1953539 Maybridge1_002374 COc1cc(/C=N/NC(=O)c2ccc(cc2)N(C)C)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D21 compound treatment 1.0386 0.0386 0.75 0.7499 1.0 1953540 Maybridge1_002375 O=C1NC(=S)NC(=O)C1=C/C=C/c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D22 compound treatment 0.9293 -0.0707 -1.37 -1.3739 -1.0 1104953 Maybridge1_002376 COc1cc2COC(=O)Cc2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D23 mock treatment 0.9885 -0.0115 -0.22 -0.2241 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 D24 mock treatment 1.0358 0.0358 0.7 0.6958 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E01 compound treatment 1.0163 0.0163 0.32 0.3171 1.0 1953541 Maybridge1_002377 CC1CN=C(Nc2ccc(F)c(Cl)c2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E02 compound treatment 0.9989 -0.00109 -0.02 -0.0211 -1.0 1045555 Maybridge1_002378 N#CCc1cccc(CC#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E03 compound treatment 1.0066 0.00657 0.13 0.1277 1.0 1953542 Maybridge1_002379 CC1(C)CN=C(Nc2ccc(F)cc2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E04 compound treatment 1.0149 0.0149 0.29 0.29 1.0 1080378 Maybridge1_002380 CC1(CCC2(O)CC1)C(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E05 compound treatment 0.985 -0.015 -0.29 -0.2917 -1.0 1953543 Maybridge1_002381 O/N=C\1/CCCc2nonc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E06 compound treatment 1.0003 3.05E-4 0.01 0.0059 1.0 1706026 Maybridge1_002382 CC1(C)C(NS(=O)(=O)c2cc(Cl)c(Cl)cc2Cl)C3(C)CCC1C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E07 compound treatment 0.9801 -0.0199 -0.39 -0.3864 -1.0 1002835 Maybridge1_002383 CCOc1ccc(NC(=O)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E08 compound treatment 0.9989 -0.00109 -0.02 -0.0211 -1.0 1953544 Maybridge1_002384 Cc1ccc(OC(=O)c2cccs2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E09 compound treatment 1.0017 0.0017 0.03 0.033 1.0 1018520 Maybridge1_002385 NS(=O)(=O)c1ccc(cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E10 compound treatment 1.0491 0.0491 0.95 0.9529 1.0 1953545 Maybridge1_002386 COc1ccccc1N2CCN(Cc3cccc(c3)[N+](=O)[O-])CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E11 compound treatment 0.9996 -3.92E-4 -0.01 -0.0076 -1.0 1953546 Maybridge1_002387 Cc1[nH]c2ccccc2c1CCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E12 compound treatment 0.9724 -0.0276 -0.54 -0.5352 -1.0 1953547 Maybridge1_002388 [O-][N+](=O)c1ccc(cc1)C(=O)Oc2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E13 compound treatment 0.9648 -0.0352 -0.68 -0.684 -1.0 1953548 Maybridge1_002389 CC(=O)NC(CCCNC(=N)N)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E14 compound treatment 1.0323 0.0323 0.63 0.6282 1.0 1135193 Maybridge1_002390 CCc1cc2c(C)cc(=O)oc2cc1OCC(=O)Nc3cccc(C)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E15 compound treatment 1.0094 0.00936 0.18 0.1818 1.0 1953549 Maybridge1_002391 CC(=O)N[C@@H](Cc1ccccc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E16 compound treatment 0.9738 -0.0262 -0.51 -0.5081 -1.0 1953550 Maybridge1_002392 OC(=O)c1cc(F)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E17 compound treatment 1.0087 0.00866 0.17 0.1683 1.0 1953551 Maybridge1_002393 COc1cc(Br)c(OC)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E18 compound treatment 0.9286 -0.0714 -1.39 -1.3874 -1.0 1323862 Maybridge1_002394 c1ccc(cc1)c2nc(no2)c3noc(n3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E19 compound treatment 0.9919 -0.00805 -0.16 -0.1564 -1.0 1953552 Maybridge1_002395 COc1ccc(CC2CCC(=NOC(=O)c3ccc(cc3)[N+](=O)[O-])CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E20 compound treatment 0.969 -0.031 -0.6 -0.6028 -1.0 1953553 Maybridge1_002396 CCOC(=O)C(CCC(=O)O)(CCC(=O)O)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E21 compound treatment 1.0261 0.0261 0.51 0.5064 1.0 1638020 Maybridge1_002397 CN1C(=O)c2ccc(Oc3ccc(cc3)C(C)(C)c4ccc(Oc5ccc6C(=O)N(C)C(=O)c6c5)cc4)cc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E22 compound treatment 0.9599 -0.0401 -0.78 -0.7787 -1.0 1414356 Maybridge1_002398 OC1CCC2CC1CC2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E23 mock treatment 0.9752 -0.0248 -0.48 -0.4811 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 E24 mock treatment 0.9912 -0.00875 -0.17 -0.1699 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F01 compound treatment 0.9996 -3.92E-4 -0.01 -0.0076 -1.0 1666767 Maybridge1_002399 OC(=O)C1C2CC3CC(C2)C(=O)C1C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F02 compound treatment 1.0943 0.0943 1.83 1.8322 1.0 1953554 Maybridge1_002400 CC(C=C1C(=O)NC(=S)NC1=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F03 compound treatment 0.9425 -0.0575 -1.12 -1.1169 -1.0 1953555 Maybridge1_002401 Cc1ccc(cc1)S(=O)(=O)OCC2(CC3CC4CC(C3)C2)C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F04 compound treatment 1.0045 0.00448 0.09 0.0871 1.0 1953556 Maybridge1_002402 COc1cccc(NC(=S)Nc2ccc(Br)cc2Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F05 compound treatment 1.0059 0.00588 0.11 0.1141 1.0 1041551 Maybridge1_002403 OC(=O)C1C(C2c3ccccc3C1c4ccccc24)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F06 compound treatment 0.9787 -0.0213 -0.41 -0.4134 -1.0 1052223 Maybridge1_002404 O=C1NC(=O)C(=Cc2ccccn2)C(=O)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F07 compound treatment 0.9515 -0.0485 -0.94 -0.941 -1.0 1953557 Maybridge1_002405 COC(=O)c1ccc2c(C)cc(=O)oc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F08 compound treatment 1.0073 0.00727 0.14 0.1412 1.0 1953558 Maybridge1_002406 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccc(cc2)S(=O)(=O)c3ccc(\N=C\c4cc(Cl)cc(Cl)c4O)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F09 compound treatment 0.9662 -0.0338 -0.66 -0.6569 -1.0 1953559 Maybridge1_002407 Oc1ccc(/C=C/2\NC(=O)NC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F10 compound treatment 0.9773 -0.0227 -0.44 -0.4405 -1.0 1585399 Maybridge1_002408 Cc1cc(C)c(C(=O)O)c(CC(C)(C)C(=O)O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F11 compound treatment 0.9362 -0.0638 -1.24 -1.2386 -1.0 1583841 Maybridge1_002409 COc1ccc2nccc(C(OC(=O)C)C3CC4CCN3CC4C=C)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F12 compound treatment 0.9731 -0.0269 -0.52 -0.5217 -1.0 1953560 Maybridge1_002410 Nc1ccccc1C(=O)NCCCN2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F13 compound treatment 0.9926 -0.00736 -0.14 -0.1429 -1.0 1034432 Maybridge1_002411 OC(=O)c1cc2ccccc2cn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F14 compound treatment 0.9926 -0.00736 -0.14 -0.1429 -1.0 1680127 Maybridge1_002412 COc1ccc(cc1)C2Nc3ccccc3-n4cccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F15 compound treatment 0.9418 -0.0582 -1.13 -1.1304 -1.0 1953561 Maybridge1_002413 Cc1c(cnn1c2ccccc2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F16 compound treatment 0.9892 -0.0108 -0.21 -0.2105 -1.0 1953562 Maybridge1_002414 O=C(CC#N)NNC(=S)NC1CC2CC1C=C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F17 compound treatment 0.9369 -0.0631 -1.23 -1.2251 -1.0 1049246 Maybridge1_002415 O=C1NC(=O)C(=Cc2ccc3OCOc3c2)C(=O)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F18 compound treatment 0.9801 -0.0199 -0.39 -0.3864 -1.0 1953563 Maybridge1_002416 CC(O)c1c(C)c(C)c(C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F19 compound treatment 1.1389 0.139 2.7 2.6979 1.0 1926891 Maybridge1_002417 Oc1ccc(C=C2C(=O)NC(=O)NC2=O)cc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F20 compound treatment 1.0108 0.0108 0.21 0.2088 1.0 1953564 Maybridge1_002418 COc1cc(/C=N/NC(=O)c2ccc(cc2)N(C)C)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F21 compound treatment 0.978 -0.022 -0.43 -0.427 -1.0 1953565 Maybridge1_002419 Clc1ccc(C=C2C(=O)NC(=O)NC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F22 compound treatment 1.024 0.024 0.47 0.4659 1.0 1953566 Maybridge1_002420 Clc1cccc(Cl)c1CSC(=N)Nc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F23 mock treatment 0.9808 -0.0192 -0.37 -0.3729 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 F24 mock treatment 1.0149 0.0149 0.29 0.29 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G01 compound treatment 1.0609 0.0609 1.18 1.1828 1.0 1953567 Maybridge1_002421 CC1CN=C(Nc2cccc(c2)C(F)(F)F)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G02 compound treatment 0.9822 -0.0178 -0.35 -0.3458 -1.0 1004812 Maybridge1_002422 OCCc1c[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G03 compound treatment 1.0317 0.0317 0.61 0.6147 1.0 1953568 Maybridge1_002423 CC1(C)CN=C(Nc2cccc(c2)C(F)(F)F)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G04 compound treatment 1.0003 3.05E-4 0.01 0.0059 1.0 1953569 Maybridge1_002424 CC1(CC1C(=O)NN)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G05 compound treatment 0.9885 -0.0115 -0.22 -0.2241 -1.0 1953570 Maybridge1_002425 O/N=C\1/CCCc2c1nc(c3ccccc3)n2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G06 compound treatment 0.9564 -0.0436 -0.85 -0.8463 -1.0 1421027 Maybridge1_002426 Cc1cc(c(C)cc1Cl)S(=O)(=O)NC2C(C)(C)C3CCC2(C)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G07 compound treatment 1.0052 0.00518 0.1 0.1006 1.0 1050913 Maybridge1_002427 Brc1ccc-2c(c1)C(=O)c3cc(Br)ccc32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G08 compound treatment 1.0156 0.0156 0.3 0.3035 1.0 1953571 Maybridge1_002428 Cc1ccc(OS(=O)(=O)c2cc(C)c(Cl)cc2C)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G09 compound treatment 1.0115 0.0115 0.22 0.2224 1.0 1114550 Maybridge1_002429 COc1ccc(OC)c(NC(=O)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G10 compound treatment 0.9279 -0.0721 -1.4 -1.401 -1.0 1268749 Maybridge1_002430 COc1ccccc1N2CCN(Cc3ccc4ccccc4c3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G11 compound treatment 0.969 -0.031 -0.6 -0.6028 -1.0 2112 Maybridge1_002431 OC(=O)CCc1c[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G12 compound treatment 0.9773 -0.0227 -0.44 -0.4405 -1.0 1953572 Maybridge1_002432 Clc1ccc(cc1)S(=O)(=O)Oc2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G13 compound treatment 0.9822 -0.0178 -0.35 -0.3458 -1.0 1953573 Maybridge1_002433 CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G14 compound treatment 0.9578 -0.0422 -0.82 -0.8193 -1.0 1937246 Maybridge1_002434 FC(F)(F)c1cc(n[nH]1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G15 compound treatment 0.9606 -0.0394 -0.77 -0.7652 -1.0 1277912 Maybridge1_002435 CC(=O)NC(C(=O)O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G16 compound treatment 0.962 -0.038 -0.74 -0.7381 -1.0 1002852 Maybridge1_002436 Clc1cc(Cl)c(Cl)c(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G17 compound treatment 0.9439 -0.0561 -1.09 -1.0898 -1.0 1953574 Maybridge1_002437 C[C@]12CC(=O)C[C@]2(C)CC(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G18 compound treatment 0.9634 -0.0366 -0.71 -0.7111 -1.0 1953575 Maybridge1_002438 Cc1nc(no1)c2noc(C)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G19 compound treatment 0.9975 -0.00248 -0.05 -0.0482 -1.0 1953576 Maybridge1_002439 OC(=O)CNC1CCS(=O)(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G20 compound treatment 0.9801 -0.0199 -0.39 -0.3864 -1.0 1641870 Maybridge1_002440 OC1CC2CCC1C(C2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G21 compound treatment 0.9919 -0.00805 -0.16 -0.1564 -1.0 1123196 Maybridge1_002441 CC(C)(c1ccc(Oc2ccc(C(=O)O)c(c2)C(=O)O)cc1)c3ccc(Oc4ccc(C(=O)O)c(c4)C(=O)O)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G22 compound treatment 0.9522 -0.0478 -0.93 -0.9275 -1.0 1025330 Maybridge1_002442 O=C(CCCCCCCCC(=O)c1ccccc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G23 mock treatment 0.9989 -0.00109 -0.02 -0.0211 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 G24 mock treatment 1.0296 0.0296 0.57 0.5741 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H01 compound treatment 0.9738 -0.0262 -0.51 -0.5081 -1.0 1953577 Maybridge1_002443 CCOC(=O)C1(CCCC2CCC1)OC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H02 compound treatment 1.0512 0.0512 0.99 0.9934 1.0 1953578 Maybridge1_002444 CCOc1ccccc1C=C2C(=O)NC(=S)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H03 compound treatment 0.9613 -0.0387 -0.75 -0.7516 -1.0 1053130 Maybridge1_002445 BrC1(CC2CC3C1)CC(Br)(C2)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H04 compound treatment 1.0233 0.0233 0.45 0.4523 1.0 1953579 Maybridge1_002446 CC(=O)CSc1nsc(SCC(=O)C)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H05 compound treatment 1.086 0.086 1.67 1.6698 1.0 1953580 Maybridge1_002447 CC(C)(CC(=O)O)C(CCC(=O)O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H06 compound treatment 0.9947 -0.00527 -0.1 -0.1023 -1.0 1953581 Maybridge1_002448 COc1ccc(CC/N=C/c2ccccn2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H07 compound treatment 0.9759 -0.0241 -0.47 -0.4676 -1.0 1052017 Maybridge1_002449 O=C1CC(=O)N2C=CC=CC2=N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H08 compound treatment 0.9731 -0.0269 -0.52 -0.5217 -1.0 1953582 Maybridge1_002450 COc1ccccc1/C=C\2/C(=O)Nc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H09 compound treatment 0.978 -0.022 -0.43 -0.427 -1.0 1953583 Maybridge1_002451 CC(C)(CCCCC(C)(C)C(=O)O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H10 compound treatment 0.9912 -0.00875 -0.17 -0.1699 -1.0 1947495 Maybridge1_002452 COc1ccc(CCNC(=S)Nc2cccc(c2)C(F)(F)F)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H11 compound treatment 0.9808 -0.0192 -0.37 -0.3729 -1.0 1953584 Maybridge1_002453 Brc1ccc2nc(cc(C#N)c2c1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H12 compound treatment 0.9683 -0.0317 -0.62 -0.6164 -1.0 1953585 Maybridge1_002454 O=C(NNC(=S)NC1CC2CC1C=C2)c3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H13 compound treatment 0.994 -0.00596 -0.12 -0.1158 -1.0 1008402 Maybridge1_002455 OC(=O)c1cc2ccccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H14 compound treatment 1.0017 0.0017 0.03 0.033 1.0 1953586 Maybridge1_002456 Cc1nn(C(=O)c2ccccc2Cl)c(C)c1N=Nc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H15 compound treatment 0.9641 -0.0359 -0.7 -0.6975 -1.0 1953587 Maybridge1_002457 Cc1nn(nc1C(=O)O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H16 compound treatment 0.9724 -0.0276 -0.54 -0.5352 -1.0 1953588 Maybridge1_002458 Cc1csc(NC(=N)N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H17 compound treatment 0.9655 -0.0345 -0.67 -0.6705 -1.0 1953589 Maybridge1_002459 COc1cc(C=C2C(=O)NC(=O)NC2=O)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H18 compound treatment 0.985 -0.015 -0.29 -0.2917 -1.0 1953590 Maybridge1_002460 Cc1c(C)c(C)c(C(=O)c2ccc(cc2)[N+](=O)[O-])c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H19 compound treatment 0.9557 -0.0443 -0.86 -0.8599 -1.0 1052210 Maybridge1_002461 O=C1NC(=O)C(=Cc2ccco2)C(=O)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H20 compound treatment 1.0003 3.05E-4 0.01 0.0059 1.0 1953591 Maybridge1_002462 CC(OC(C)c1c(C)c(C)c(C)c(C)c1C)c2c(C)c(C)c(C)c(C)c2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H21 compound treatment 0.9961 -0.00387 -0.08 -0.0752 -1.0 1931378 Maybridge1_002463 COc1cccc(C=C2C(=O)NC(=S)NC2=O)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H22 compound treatment 1.0059 0.00588 0.11 0.1141 1.0 1953592 Maybridge1_002464 CC(C)c1ccc(NN=C(C(=O)C)C(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H23 mock treatment 0.985 -0.015 -0.29 -0.2917 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 H24 mock treatment 1.0393 0.0393 0.76 0.7635 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I01 compound treatment 0.9982 -0.00179 -0.03 -0.0347 -1.0 1953593 Maybridge1_002465 CC1CN=C(Nc2cccc(C)c2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I02 compound treatment 1.0247 0.0247 0.48 0.4794 1.0 1953594 Maybridge1_002466 OC(=O)[C@@H]1Cc2ccccc2N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I03 compound treatment 1.0128 0.0128 0.25 0.2494 1.0 1953595 Maybridge1_002467 Cc1cccc(NC2=NCC(C)(C)S2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I04 compound treatment 0.9676 -0.0324 -0.63 -0.6299 -1.0 1953596 Maybridge1_002468 O=C(NC(C(/N=C/c1ccccc1)c2ccccc2)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I05 compound treatment 1.0275 0.0275 0.53 0.5335 1.0 1953597 Maybridge1_002469 CCCCCCC(=O)c1ccc(Br)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I06 compound treatment 0.9996 -3.92E-4 -0.01 -0.0076 -1.0 1674947 Maybridge1_002470 CC1(C)C(NS(=O)(=O)c2ccc(C#N)cc2)C3(C)CCC1C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I07 compound treatment 0.9801 -0.0199 -0.39 -0.3864 -1.0 1953598 Maybridge1_002471 CCCCCc1ccc(CN)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I08 compound treatment 0.9404 -0.0596 -1.16 -1.1575 -1.0 1953599 Maybridge1_002472 Cc1ccc(OS(=O)(=O)c2ccc(Cl)cc2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I09 compound treatment 1.0059 0.00588 0.11 0.1141 1.0 1004835 Maybridge1_002473 CC(=O)CC(=O)Nc1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I10 compound treatment 1.0275 0.0275 0.53 0.5335 1.0 1256986 Maybridge1_002474 COc1ccccc1C2CCN(Cc3ccc(Cl)cc3Cl)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I11 compound treatment 0.9641 -0.0359 -0.7 -0.6975 -1.0 1914379 Maybridge1_002475 CCSc1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I12 compound treatment 0.9899 -0.0101 -0.2 -0.197 -1.0 1953600 Maybridge1_002476 O=S(=O)(Oc1ccc(Oc2ccccc2)cc1)c3ccc(C#N)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I13 compound treatment 1.031 0.031 0.6 0.6011 1.0 1081511 Maybridge1_002477 CC(=O)NC(CC(=O)N)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I14 compound treatment 0.9843 -0.0157 -0.31 -0.3052 -1.0 1238971 Maybridge1_002478 CC1(C)C(CCC1(C)C(=O)N2CCCCC2)C(=O)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I15 compound treatment 0.9766 -0.0234 -0.45 -0.454 -1.0 3115140 Maybridge1_002479 C[C@@H](N)C(=O)OCc1ccccc1.Cc1ccc(cc1)S(=O)(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I16 compound treatment 0.9627 -0.0373 -0.72 -0.7246 -1.0 1953602 Maybridge1_002480 Cc1c(Br)c(Br)c(Br)c(Br)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I17 compound treatment 0.9975 -0.00248 -0.05 -0.0482 -1.0 1953603 Maybridge1_002481 COc1cc(I)c(OC)cc1I 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I18 compound treatment 0.9341 -0.0659 -1.28 -1.2792 -1.0 1017720 Maybridge1_002482 OCC1CCCN2CCCCC12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I19 compound treatment 1.0108 0.0108 0.21 0.2088 1.0 1953604 Maybridge1_002483 ClC1=CCS(=O)(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I20 compound treatment 0.9752 -0.0248 -0.48 -0.4811 -1.0 1953605 Maybridge1_002484 COC1(C/C=C\CC(C/C=C\C1)(OC)OC)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I21 compound treatment 0.9655 -0.0345 -0.67 -0.6705 -1.0 1017948 Maybridge1_002485 OC1(CCCCC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I22 compound treatment 0.9592 -0.0408 -0.79 -0.7922 -1.0 1604709 Maybridge1_002486 OC1CC2CCC1N(Cc3ccccc3)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I23 mock treatment 1.0303 0.0303 0.59 0.5876 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 I24 mock treatment 1.0059 0.00588 0.11 0.1141 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J01 compound treatment 1.0282 0.0282 0.55 0.547 1.0 1016032 Maybridge1_002487 COC(=O)C1CC2(CC(CC(C(=O)OC)C2=O)(C(=O)OC)C1=O)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J02 compound treatment 0.9787 -0.0213 -0.41 -0.4134 -1.0 1953606 Maybridge1_002488 COc1ccc(OC)c(/C=C\2/C(=O)Nc3ccccc23)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J03 compound treatment 1.008 0.00797 0.15 0.1547 1.0 1100808 Maybridge1_002489 CCOC(=O)C1(CCC2(CC31SCCS3)C(=O)OCC)CC42SCCS4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J04 compound treatment 1.0163 0.0163 0.32 0.3171 1.0 1953607 Maybridge1_002490 COc1ccc(Br)cc1/C=C\2/C(=O)Nc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J05 compound treatment 0.9801 -0.0199 -0.39 -0.3864 -1.0 1953608 Maybridge1_002491 COC(=O)CCC(CCC(=O)OC)(C(=O)C)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J06 compound treatment 1.0156 0.0156 0.3 0.3035 1.0 1953609 Maybridge1_002492 Fc1cccc(F)c1C(=O)NCCCNC(=O)c2c(F)cccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J07 compound treatment 0.9968 -0.00318 -0.06 -0.0617 -1.0 1953610 Maybridge1_002493 CCCCCCCCCCCCCC#CC(O)C(N)CO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J08 compound treatment 0.9989 -0.00109 -0.02 -0.0211 -1.0 1953611 Maybridge1_002494 CN(CCC#N)c1ccc(C=C2C(=O)NC(=O)NC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J09 compound treatment 1.0031 0.00309 0.06 0.06 1.0 1322271 Maybridge1_002495 OC1(CC(=O)c2ccc3OCOc3c2)C(=O)Nc4ccc(Br)cc41 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J10 compound treatment 0.994 -0.00596 -0.12 -0.1158 -1.0 1953612 Maybridge1_002496 Cc1c(C)c(C)c(CNC(=O)c2ccccc2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J11 compound treatment 0.9738 -0.0262 -0.51 -0.5081 -1.0 1953613 Maybridge1_002497 OC(=O)c1ccc2OCCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J12 compound treatment 0.978 -0.022 -0.43 -0.427 -1.0 1953614 Maybridge1_002498 O=C(NNC(=S)NC1CC2CC1C=C2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J13 compound treatment 0.9488 -0.0512 -1.0 -0.9951 -1.0 1953615 Maybridge1_002499 Cc1cc(C(=O)O)c(C)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J14 compound treatment 0.978 -0.022 -0.43 -0.427 -1.0 1059435 Maybridge1_002500 COc1cc(CC(=O)O)c(cc1OC)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J15 compound treatment 0.9822 -0.0178 -0.35 -0.3458 -1.0 1452607 Maybridge1_002501 OC(=O)c1ccc2[nH]nnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J16 compound treatment 1.0045 0.00448 0.09 0.0871 1.0 1953616 Maybridge1_002502 COc1cc(cc(OC)c1OC)C(=O)NN(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J17 compound treatment 1.0017 0.0017 0.03 0.033 1.0 1953617 Maybridge1_002503 CCNC(=N)SCc1c(C)c(C)c(C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J18 compound treatment 1.0045 0.00448 0.09 0.0871 1.0 1953618 Maybridge1_002504 Oc1c(Cl)cc(Cl)cc1/C=N/NC(=S)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J19 compound treatment 0.9878 -0.0122 -0.24 -0.2376 -1.0 1953619 Maybridge1_002505 COc1ccc(Br)cc1C=C2C(=O)NC(=O)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J20 compound treatment 0.9899 -0.0101 -0.2 -0.197 -1.0 1060626 Maybridge1_002506 COc1ccc(cc1)C(=C)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J21 compound treatment 0.9313 -0.0687 -1.33 -1.3333 -1.0 1953620 Maybridge1_002507 CCOc1ccc(C=C2C(=O)NC(=S)NC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J22 compound treatment 1.0094 0.00936 0.18 0.1818 1.0 1953621 Maybridge1_002508 Fc1ccc(NC(=O)C2CCC2)cc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J23 mock treatment 0.9599 -0.0401 -0.78 -0.7787 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 J24 mock treatment 0.9697 -0.0303 -0.59 -0.5893 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K01 compound treatment 1.0881 0.0881 1.71 1.7104 1.0 1938018 Maybridge1_002509 CC1CN=C(Nc2ccccc2C)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K02 compound treatment 1.008 0.00797 0.15 0.1547 1.0 1168019 Maybridge1_002510 CC(=O)OC1CC2CCC1N(Cc3ccccc3)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K03 compound treatment 0.9933 -0.00666 -0.13 -0.1294 -1.0 1953622 Maybridge1_002511 CCOC(=O)C(O)(c1ccc(N)cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K04 compound treatment 0.9697 -0.0303 -0.59 -0.5893 -1.0 1953623 Maybridge1_002512 Clc1cc(Cl)c(cc1Cl)S(=O)(=O)Oc2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K05 compound treatment 1.001 0.001 0.02 0.0194 1.0 1278482 Maybridge1_002513 OC(=O)CCCc1ccc2OCCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K06 compound treatment 0.9829 -0.0171 -0.33 -0.3323 -1.0 1738476 Maybridge1_002514 CC1(C)C(NC(=O)c2cccs2)C3(C)CCC1C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K07 compound treatment 1.0323 0.0323 0.63 0.6282 1.0 1917345 Maybridge1_002515 CCN(c1ccccc1)S(=O)(=O)c2cc(ccc2N)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K08 compound treatment 1.0108 0.0108 0.21 0.2088 1.0 1953624 Maybridge1_002516 Cc1ccc(OS(=O)(=O)c2cc(Cl)c(Cl)cc2Cl)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K09 compound treatment 0.9885 -0.0115 -0.22 -0.2241 -1.0 1038041 Maybridge1_002517 CC(=O)CC(=O)NCc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K10 compound treatment 1.0094 0.00936 0.18 0.1818 1.0 1246691 Maybridge1_002518 COc1ccccc1C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K11 compound treatment 0.9627 -0.0373 -0.72 -0.7246 -1.0 1300359 Maybridge1_002519 O=C(CC(Nc1ccccc1)c2ccccc2)C3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K12 compound treatment 0.9369 -0.0631 -1.23 -1.2251 -1.0 1953625 Maybridge1_002520 Cc1cc(c(Cl)cc1Cl)S(=O)(=O)Oc2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K13 compound treatment 1.0038 0.00379 0.07 0.0736 1.0 1007394 Maybridge1_002521 CC(=O)NC(CCC(=O)O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K14 compound treatment 0.978 -0.022 -0.43 -0.427 -1.0 1953626 Maybridge1_002522 CC1(C)C/2CCC1(C)C(=O)\C2=C/c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K15 compound treatment 0.9822 -0.0178 -0.35 -0.3458 -1.0 1083802 Maybridge1_002523 Cc1ccc2nc(sc2c1S(=O)(=O)O)c3ccc(N)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K16 compound treatment 0.9313 -0.0687 -1.33 -1.3333 -1.0 1953627 Maybridge1_002524 FC(F)(F)c1n[nH]c2CCCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K17 compound treatment 0.9648 -0.0352 -0.68 -0.684 -1.0 1953628 Maybridge1_002525 CC(=CCC(CC=C(C)C)(C#N)C(=O)O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K18 compound treatment 0.9857 -0.0143 -0.28 -0.2782 -1.0 1633817 Maybridge1_002526 CCOC(=O)C1CC2CN(CC(C1)C2=O)S(=O)(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K19 compound treatment 0.9522 -0.0478 -0.93 -0.9275 -1.0 1420628 Maybridge1_002527 CS(=O)(=O)C1CS(=O)(=O)CC1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K20 compound treatment 0.9063 -0.0937 -1.82 -1.8203 -1.0 1057505 Maybridge1_002528 OC(=O)C1CC2CCC1CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K21 compound treatment 0.9467 -0.0533 -1.04 -1.0357 -1.0 1055897 Maybridge1_002529 O=C(N1CCC(=O)CC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K22 compound treatment 0.9836 -0.0164 -0.32 -0.3187 -1.0 1953629 Maybridge1_002530 COC(=O)CCC(CCC(=O)OC)(C(=O)OC)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K23 mock treatment 0.9843 -0.0157 -0.31 -0.3052 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 K24 mock treatment 1.0233 0.0233 0.45 0.4523 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L01 compound treatment 1.0616 0.0616 1.2 1.1964 1.0 1953630 Maybridge1_002531 O/N=C(\CNC(c1ccccc1)(c2ccccc2)c3ccccc3)/c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L02 compound treatment 0.9871 -0.0129 -0.25 -0.2511 -1.0 1378376 Maybridge1_002532 COc1cccc(NC(=S)Nc2ccc(O)cc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L03 compound treatment 1.0066 0.00657 0.13 0.1277 1.0 1077130 Maybridge1_002533 OC1CC2CCC1C2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L04 compound treatment 0.9564 -0.0436 -0.85 -0.8463 -1.0 1083326 Maybridge1_002534 CSC(=C(C#N)C#N)SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L05 compound treatment 1.0059 0.00588 0.11 0.1141 1.0 1953631 Maybridge1_002535 CC1(C)C2C1C3(CO)CCC2CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L06 compound treatment 1.017 0.017 0.33 0.3306 1.0 1953632 Maybridge1_002536 Clc1cc(Cl)cc(c1)N2C(=O)C=CC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L07 compound treatment 0.9244 -0.0756 -1.47 -1.4686 -1.0 1953633 Maybridge1_002537 O=C1OCC2(CCC3CC12)C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L08 compound treatment 0.9801 -0.0199 -0.39 -0.3864 -1.0 1953634 Maybridge1_002538 COc1cc(/C=N/CCCN2CCN(CCC\N=C\c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L09 compound treatment 0.9961 -0.00387 -0.08 -0.0752 -1.0 1953635 Maybridge1_002539 OC1(CC(=O)c2cccc(c2)[N+](=O)[O-])C(=O)Nc3ccc(Br)cc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L10 compound treatment 0.9655 -0.0345 -0.67 -0.6705 -1.0 1953636 Maybridge1_002540 CC(=O)/C(=N\O)/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L11 compound treatment 0.9843 -0.0157 -0.31 -0.3052 -1.0 1953637 Maybridge1_002541 Ic1ccc2OCCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L12 compound treatment 0.9794 -0.0206 -0.4 -0.3999 -1.0 1953638 Maybridge1_002542 O=C(NNC(=S)NC1CC2CC1C=C2)c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L13 compound treatment 0.9724 -0.0276 -0.54 -0.5352 -1.0 1953639 Maybridge1_002543 OC(=O)c1ccc2snnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L14 compound treatment 0.9906 -0.00945 -0.18 -0.1835 -1.0 1087077 Maybridge1_002544 COC(=O)Cc1cc(OC)c(OC)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L15 compound treatment 0.9773 -0.0227 -0.44 -0.4405 -1.0 1004346 Maybridge1_002545 Cc1c(C)c(C)c(Br)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L16 compound treatment 0.9885 -0.0115 -0.22 -0.2241 -1.0 1953640 Maybridge1_002546 CCOC(=O)CSCc1c(C)c(C)c(C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L17 compound treatment 0.9439 -0.0561 -1.09 -1.0898 -1.0 1953641 Maybridge1_002547 Cc1c(C)c(C)c(CSC(=N)Nc2ccccc2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L18 compound treatment 0.9495 -0.0505 -0.98 -0.9816 -1.0 1953642 Maybridge1_002548 S=C(N/N=C/C=C/c1ccccc1)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L19 compound treatment 0.9014 -0.0986 -1.92 -1.915 -1.0 1953643 Maybridge1_002549 N#Cc1ccc(CSC2=NCCCN2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L20 compound treatment 0.9662 -0.0338 -0.66 -0.6569 -1.0 1953644 Maybridge1_002550 Cc1c(C)c(C)c(C(=O)c2ccc(Cl)cc2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L21 compound treatment 1.031 0.031 0.6 0.6011 1.0 1953645 Maybridge1_002551 CC(=O)Nc1ccc(C=C2C(=O)NC(=S)NC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L22 compound treatment 0.9989 -0.00109 -0.02 -0.0211 -1.0 1953646 Maybridge1_002552 CC(C)c1ccc(NN=C2C(=O)NC(=O)NC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L23 mock treatment 1.001 0.001 0.02 0.0194 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 L24 mock treatment 1.0254 0.0254 0.49 0.4929 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M01 compound treatment 1.0477 0.0477 0.93 0.9258 1.0 1953647 Maybridge1_002553 CC1CN=C(NC2CCCCC2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M02 compound treatment 1.0073 0.00727 0.14 0.1412 1.0 1953648 Maybridge1_002554 Nc1cc(c(N)c2C(=O)c3ccccc3C(=O)c12)S(=O)(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M03 compound treatment 0.955 -0.045 -0.87 -0.8734 -1.0 1953649 Maybridge1_002555 CCOC(=O)C(O)(c1ccc(NC)cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M04 compound treatment 1.0226 0.0226 0.44 0.4388 1.0 1953650 Maybridge1_002556 Cc1cc(c(C)cc1Cl)S(=O)(=O)Oc2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M05 compound treatment 1.0442 0.0442 0.86 0.8582 1.0 1077614 Maybridge1_002557 NC(=O)c1cccc2C(=O)c3ccccc3-c21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M06 compound treatment 1.0066 0.00657 0.13 0.1277 1.0 1333748 Maybridge1_002558 CC1(C)C(NC(=O)c2ccc(Cl)cc2)C3(C)CCC1C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M07 compound treatment 1.017 0.017 0.33 0.3306 1.0 1281100 Maybridge1_002559 CCNc1cc(NC(=O)C)ccc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M08 compound treatment 0.9808 -0.0192 -0.37 -0.3729 -1.0 1953651 Maybridge1_002560 Cc1ccc(OS(=O)(=O)c2ccc(C#N)cc2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M09 compound treatment 0.9871 -0.0129 -0.25 -0.2511 -1.0 1561783 Maybridge1_002561 COc1ccccc1C2CCN(CC2)S(=O)(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M10 compound treatment 0.9759 -0.0241 -0.47 -0.4676 -1.0 1953652 Maybridge1_002562 COc1ccccc1C2CCN(Cc3cccc(c3)[N+](=O)[O-])CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M11 compound treatment 1.0804 0.0804 1.56 1.5616 1.0 1006159 Maybridge1_002563 ClC1=C(Cl)C(=O)c2ccccc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M12 compound treatment 0.985 -0.015 -0.29 -0.2917 -1.0 1953653 Maybridge1_002564 Clc1cccc(c1Cl)S(=O)(=O)Oc2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M13 compound treatment 0.9885 -0.0115 -0.22 -0.2241 -1.0 1231 Maybridge1_002565 CC(C)C[C@H](NC(=O)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M14 compound treatment 1.0003 3.05E-4 0.01 0.0059 1.0 1953654 Maybridge1_002566 Nc1nc(cc(n1)C(F)(F)F)c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M15 compound treatment 0.9857 -0.0143 -0.28 -0.2782 -1.0 1953655 Maybridge1_002567 Cc1cc(I)c(C)cc1I 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M16 compound treatment 0.9634 -0.0366 -0.71 -0.7111 -1.0 1953656 Maybridge1_002568 Nc1nc(c2CCCCc2n1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M17 compound treatment 0.9662 -0.0338 -0.66 -0.6569 -1.0 1953657 Maybridge1_002569 Clc1cccc(Cl)c1C(=O)O/N=C/2\CCCc3[nH]c4ccccc4c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M18 compound treatment 0.962 -0.038 -0.74 -0.7381 -1.0 1953658 Maybridge1_002570 CC(C)CC1(C/C(=N/NC(=O)N)/C)CCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M19 compound treatment 0.9634 -0.0366 -0.71 -0.7111 -1.0 362 Maybridge1_002571 CCN(CC)CC(=O)Nc1c(C)cccc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M20 compound treatment 0.9627 -0.0373 -0.72 -0.7246 -1.0 1953659 Maybridge1_002572 COC(=O)C1CCC(NC(=O)C)C(C1)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M21 compound treatment 0.9634 -0.0366 -0.71 -0.7111 -1.0 1953660 Maybridge1_002573 COC(=O)c1cnc(NNS(=O)(=O)c2ccccc2)nc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M22 compound treatment 0.9606 -0.0394 -0.77 -0.7652 -1.0 1189123 Maybridge1_002574 COC(=O)C1CCC(=C(C1)C(=O)OC)NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M23 mock treatment 0.9912 -0.00875 -0.17 -0.1699 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 M24 mock treatment 0.9947 -0.00527 -0.1 -0.1023 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N01 compound treatment 1.0498 0.0498 0.97 0.9664 1.0 1953661 Maybridge1_002575 CC1(C)CC2(CCCCC2)C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N02 compound treatment 1.0442 0.0442 0.86 0.8582 1.0 1953662 Maybridge1_002576 FC(F)(F)c1cccc(NC(=S)Nc2cccc(c2)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N03 compound treatment 0.9432 -0.0568 -1.1 -1.1034 -1.0 1196220 Maybridge1_002577 OC(=O)C1CC2(COC(OC2)c3ccccc3)C1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N04 compound treatment 1.0205 0.0205 0.4 0.3982 1.0 1054980 Maybridge1_002578 O=C1NC(=O)C(=Cc2cccs2)C(=O)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N05 compound treatment 0.9996 -3.92E-4 -0.01 -0.0076 -1.0 1195740 Maybridge1_002579 COC(=O)C1CCC(=C(C1)C(=O)OC)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N06 compound treatment 0.9989 -0.00109 -0.02 -0.0211 -1.0 1953663 Maybridge1_002580 Clc1cccc(Cl)c1OC(=O)/C=C/c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N07 compound treatment 0.9676 -0.0324 -0.63 -0.6299 -1.0 1953664 Maybridge1_002581 CCC1(CC2CC3CC(Br)(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N08 compound treatment 0.9766 -0.0234 -0.45 -0.454 -1.0 1335256 Maybridge1_002582 Clc1ccc(CC2C(=O)Nc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N09 compound treatment 0.969 -0.031 -0.6 -0.6028 -1.0 1316548 Maybridge1_002583 OC1(CC(=O)c2ccc(cc2)c3ccccc3)C(=O)Nc4ccc(Br)cc41 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N10 compound treatment 0.985 -0.015 -0.29 -0.2917 -1.0 1084499 Maybridge1_002584 O=C1N2CCCNC2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N11 compound treatment 0.9738 -0.0262 -0.51 -0.5081 -1.0 1223785 Maybridge1_002585 OC(=O)C1COc2ccccc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N12 compound treatment 0.9369 -0.0631 -1.23 -1.2251 -1.0 1953665 Maybridge1_002586 COc1ccccc1NC(=S)NNC(=S)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N13 compound treatment 0.9564 -0.0436 -0.85 -0.8463 -1.0 1953666 Maybridge1_002587 OC(=O)c1ccc2nonc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N14 compound treatment 0.9996 -3.92E-4 -0.01 -0.0076 -1.0 1517484 Maybridge1_002588 CCOC(=O)C1CCN(CC1)C(=S)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N15 compound treatment 0.9592 -0.0408 -0.79 -0.7922 -1.0 1062106 Maybridge1_002589 Cc1c(C)c(C)c(Cc2c(C)c(C)c(C)c(C)c2C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N16 compound treatment 0.9557 -0.0443 -0.86 -0.8599 -1.0 1953667 Maybridge1_002590 Cc1c(C)c(C)c(C(=O)c2ccccc2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N17 compound treatment 0.9557 -0.0443 -0.86 -0.8599 -1.0 1080236 Maybridge1_002591 CC1CCN(CC1)C(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N18 compound treatment 0.9752 -0.0248 -0.48 -0.4811 -1.0 1953668 Maybridge1_002592 COc1ccc(OCCC(=O)NNC(=S)Nc2cccc(OC)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N19 compound treatment 0.9446 -0.0554 -1.08 -1.0763 -1.0 1953669 Maybridge1_002593 O=C(CSc1nsc(SCC(=O)c2ccccc2)c1C#N)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N20 compound treatment 0.9759 -0.0241 -0.47 -0.4676 -1.0 1953670 Maybridge1_002594 CN(C)c1ccc(cc1)C(=O)NNC(=S)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N21 compound treatment 1.0365 0.0365 0.71 0.7094 1.0 1928357 Maybridge1_002595 Oc1ccc(C=C2C(=O)NC(=S)NC2=O)cc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N22 compound treatment 0.9829 -0.0171 -0.33 -0.3323 -1.0 1720569 Maybridge1_002596 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)Nc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N23 mock treatment 0.9878 -0.0122 -0.24 -0.2376 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 N24 mock treatment 0.9697 -0.0303 -0.59 -0.5893 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O01 compound treatment 1.0275 0.0275 0.53 0.5335 1.0 1953671 Maybridge1_002597 CC1(C)CN=C(Nc2ccccc2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O02 compound treatment 0.9669 -0.0331 -0.64 -0.6434 -1.0 1008471 Maybridge1_002598 C(N(Cc1ccccc1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O03 compound treatment 0.9585 -0.0415 -0.81 -0.8057 -1.0 1953672 Maybridge1_002599 CCOC(=O)C(O)(c1ccc(N)c(C)c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O04 compound treatment 0.985 -0.015 -0.29 -0.2917 -1.0 1953673 Maybridge1_002600 Fc1ccc(cc1)S(=O)(=O)Oc2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O05 compound treatment 1.0282 0.0282 0.55 0.547 1.0 1953674 Maybridge1_002601 CCCCCCCCCCOC(=O)c1cc(cc2/C(=N/O)/c3cc(ccc3-c21)[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O06 compound treatment 1.0108 0.0108 0.21 0.2088 1.0 1953675 Maybridge1_002602 Cc1ccc(OC(=O)c2ccc(cc2)C(C)(C)C)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O07 compound treatment 0.9738 -0.0262 -0.51 -0.5081 -1.0 1953676 Maybridge1_002603 CCOc1cc([N+](=O)[O-])c(OCC)cc1N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O08 compound treatment 0.9467 -0.0533 -1.04 -1.0357 -1.0 1953677 Maybridge1_002604 Cc1ccc(OS(=O)(=O)c2cccc(c2)C(F)(F)F)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O09 compound treatment 1.0296 0.0296 0.57 0.5741 1.0 1549404 Maybridge1_002605 COc1ccccc1C2CCN(CC2)C(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O10 compound treatment 0.9697 -0.0303 -0.59 -0.5893 -1.0 1128908 Maybridge1_002606 COc1ccccc1C2CCN(Cc3ccc4ccccc4c3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O11 compound treatment 0.9613 -0.0387 -0.75 -0.7516 -1.0 1004233 Maybridge1_002607 N=C(Nc1ccccc1)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O12 compound treatment 1.0052 0.00518 0.1 0.1006 1.0 1953678 Maybridge1_002608 C[C@@]1(C[C@]1(C)C(=O)NN)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O13 compound treatment 0.9808 -0.0192 -0.37 -0.3729 -1.0 1953679 Maybridge1_002609 CSCC[C@H](NC(=O)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O14 compound treatment 0.9529 -0.0471 -0.91 -0.914 -1.0 1953680 Maybridge1_002610 Nc1nc(cc(n1)C(F)(F)F)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O15 compound treatment 0.9536 -0.0464 -0.9 -0.9004 -1.0 1953681 Maybridge1_002611 OC(=O)c1cccc2Cc3cc(I)ccc3-c21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O16 compound treatment 0.9327 -0.0673 -1.31 -1.3063 -1.0 1408788 Maybridge1_002612 On1c(nc2C(=O)CCCc21)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O17 compound treatment 0.9787 -0.0213 -0.41 -0.4134 -1.0 1953682 Maybridge1_002613 Clc1ccc(C(=O)O/N=C/2\CCCc3[nH]c4ccccc4c23)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O18 compound treatment 0.9745 -0.0255 -0.49 -0.4946 -1.0 1004141 Maybridge1_002614 CCOC(=O)C(CCC#N)(CCC#N)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O19 compound treatment 1.024 0.024 0.47 0.4659 1.0 1200376 Maybridge1_002615 CC1CC(C)(C)N(CCO)c2cc(C)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O20 compound treatment 0.9878 -0.0122 -0.24 -0.2376 -1.0 1953683 Maybridge1_002616 COC1(CCC2CC1)CC2(O)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O21 compound treatment 0.9745 -0.0255 -0.49 -0.4946 -1.0 1066497 Maybridge1_002617 CC(C)(C)c1cc(c(Br)c(c1)C(C)(C)C)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O22 compound treatment 0.9564 -0.0436 -0.85 -0.8463 -1.0 1194846 Maybridge1_002618 N#CC1CC2CC1N(Cc3ccccc3)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O23 mock treatment 0.9627 -0.0373 -0.72 -0.7246 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 O24 mock treatment 1.0247 0.0247 0.48 0.4794 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P01 compound treatment 1.017 0.017 0.33 0.3306 1.0 1953684 Maybridge1_002619 COC(=O)C1CCCC(C(=O)OC)C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P02 compound treatment 1.0456 0.0456 0.89 0.8852 1.0 1276535 Maybridge1_002620 COc1cccc(NC(=S)Nc2cccc(O)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P03 compound treatment 1.017 0.017 0.33 0.3306 1.0 1953685 Maybridge1_002621 C=C1CC2CC(C1)CC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P04 compound treatment 1.0421 0.0421 0.82 0.8176 1.0 1953686 Maybridge1_002622 O=C1NC(=O)C(=Cc2c[nH]c3ccccc23)C(=O)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P05 compound treatment 0.9975 -0.00248 -0.05 -0.0482 -1.0 1953687 Maybridge1_002623 O/N=C(\C(=O)c1ccccc1)/c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P06 compound treatment 1.0003 3.05E-4 0.01 0.0059 1.0 1953688 Maybridge1_002624 CCCCN1C(=O)c2cccc3cc(cc(C1=O)c23)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P07 compound treatment 0.9843 -0.0157 -0.31 -0.3052 -1.0 1620380 Maybridge1_002625 CC(C)(O)C(C)(C)CN(Cc1ccccc1)Cc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P08 compound treatment 1.0296 0.0296 0.57 0.5741 1.0 1953689 Maybridge1_002626 COc1ccc(CCN2C(C(CCC2=O)C(=O)O)c3cc(OC)c(OC)c(OC)c3)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P09 compound treatment 0.9752 -0.0248 -0.48 -0.4811 -1.0 1303983 Maybridge1_002627 OC1(CC(=O)c2ccc(F)cc2)C(=O)Nc3ccc(Br)cc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P10 compound treatment 1.0003 3.05E-4 0.01 0.0059 1.0 1019365 Maybridge1_002628 COC1=CC(=O)C=C(OC)C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P11 compound treatment 0.9836 -0.0164 -0.32 -0.3187 -1.0 1002875 Maybridge1_002629 OCC1COc2ccccc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P12 compound treatment 1.0317 0.0317 0.61 0.6147 1.0 1953690 Maybridge1_002630 N#CCSc1nnc(SCC#N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P13 compound treatment 0.9655 -0.0345 -0.67 -0.6705 -1.0 1027517 Maybridge1_002631 OC(=O)c1cc2ccccc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P14 compound treatment 1.001 0.001 0.02 0.0194 1.0 1953691 Maybridge1_002632 S=C(NCC1CCCC1NC(=S)NC2CC3CC2C=C3)NC4CC5CC4C=C5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P15 compound treatment 1.001 0.001 0.02 0.0194 1.0 1953692 Maybridge1_002633 CC1CCCCN1Cc2c(C)c(C)c(C)c(C)c2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P16 compound treatment 1.0226 0.0226 0.44 0.4388 1.0 1953693 Maybridge1_002634 CCC(=O)c1c(C)c(C)c(C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P17 compound treatment 0.9975 -0.00248 -0.05 -0.0482 -1.0 1953694 Maybridge1_002635 Cc1cc(CSC(=N)Nc2ccccc2)c(C)cc1CSC(=N)Nc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P18 compound treatment 0.9773 -0.0227 -0.44 -0.4405 -1.0 1086332 Maybridge1_002636 CN(C)c1ccc(cc1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P19 compound treatment 0.9947 -0.00527 -0.1 -0.1023 -1.0 1953695 Maybridge1_002637 Cc1c(C)c(C)c(CSc2nsc(SCc3c(C)c(C)c(C)c(C)c3C)c2C#N)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P20 compound treatment 1.0421 0.0421 0.82 0.8176 1.0 1953696 Maybridge1_002638 CN(C)c1ccc(cc1)C(=O)N/N=C/c2cc(Br)cc(Br)c2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P21 compound treatment 1.0156 0.0156 0.3 0.3035 1.0 1953697 Maybridge1_002639 COc1cc(C=C2C(=O)NC(=S)NC2=O)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P22 compound treatment 1.0386 0.0386 0.75 0.7499 1.0 1953698 Maybridge1_002640 CC(=O)C(=NNc1ccc(Br)c(Cl)c1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P23 mock treatment 1.0128 0.0128 0.25 0.2494 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1231 P24 mock treatment 1.0484 0.0484 0.94 0.9393 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A01 compound treatment 1.0462 0.0462 0.9 0.8964 1.0 1953699 Maybridge1_002641 COc1cc(/C=N/NC(=O)CSCc2c(Cl)cccc2Cl)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A02 compound treatment 1.04 0.04 0.78 0.7763 1.0 1953700 Maybridge1_002642 CS/C(=N\S(=O)(=O)c1ccccc1)/N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A03 compound treatment 1.0372 0.0372 0.72 0.7229 1.0 1553954 Maybridge1_002643 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)N2CCC3N(C2)C(=O)c4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A04 compound treatment 1.0008 7.95E-4 0.02 0.0154 1.0 1953701 Maybridge1_002644 FC(F)(F)c1cc(NNc2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A05 compound treatment 1.0063 0.00629 0.12 0.1222 1.0 1953702 Maybridge1_002645 S=C(N/N=C/c1ccc2OCOc2c1)NC3CC4CCC3C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A06 compound treatment 1.0118 0.0118 0.23 0.229 1.0 1953703 Maybridge1_002646 FC(F)(F)c1cc(cc(c1)C(F)(F)F)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A07 compound treatment 1.0255 0.0255 0.5 0.496 1.0 1953704 Maybridge1_002647 Cc1c(C)c(C)c(COc2ccc(Cl)cc2Cl)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A08 compound treatment 0.941 -0.059 -1.15 -1.1459 -1.0 1602202 Maybridge1_002648 Cc1ccc-2c(NC(c3cccn32)c4cc(Cl)cc(Cl)c4O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A09 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 1953705 Maybridge1_002649 O=C(CC(=O)N1CCCC1)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A10 compound treatment 0.9712 -0.0288 -0.56 -0.5585 -1.0 1700909 Maybridge1_002650 Clc1cc(Cl)c2OC3(CCCCC3=Cc2c1)N4CCCC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A11 compound treatment 0.9829 -0.0171 -0.33 -0.3316 -1.0 1953706 Maybridge1_002651 COc1ccc(cc1CSc2ccc(Cl)cc2)C(=O)C[n+]3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A12 compound treatment 0.9602 -0.0398 -0.77 -0.7721 -1.0 1953707 Maybridge1_002652 Cc1c(cc2c(c1[N+](=O)[O-])C(C)(C)CC2(C)C)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A13 compound treatment 1.0152 0.0152 0.3 0.2958 1.0 1022227 Maybridge1_002653 CC(=O)Oc1ccccc1C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A14 compound treatment 1.0008 7.95E-4 0.02 0.0154 1.0 1953708 Maybridge1_002654 C(c1cccnc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A15 compound treatment 1.007 0.00698 0.14 0.1356 1.0 1953709 Maybridge1_002655 C/C(=N\NC(=S)N)/c1ccccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A16 compound treatment 0.9486 -0.0514 -1.0 -0.999 -1.0 1953710 Maybridge1_002656 CCOC(=O)C1=C(C)NC(=C(C1c2ccc(o2)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)C(=O)OCC)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A17 compound treatment 0.9809 -0.0191 -0.37 -0.3717 -1.0 1953711 Maybridge1_002657 FC(F)(F)c1cc(NC(=O)c2ccc(Cl)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A18 compound treatment 0.9747 -0.0253 -0.49 -0.4918 -1.0 1953712 Maybridge1_002658 Fc1cccc(F)c1NC(=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A19 compound treatment 1.1121 0.112 2.18 2.1779 1.0 1953713 Maybridge1_002659 COCCCNC(=S)N/N=C/c1cccc(OC)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A20 compound treatment 0.9864 -0.0136 -0.26 -0.2649 -1.0 1953714 Maybridge1_002660 FC(F)(F)c1cc(cc(c1)S(=O)(=O)NCCNS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A21 compound treatment 1.0173 0.0173 0.34 0.3358 1.0 1953715 Maybridge1_002661 OC1=NN=CC1CCCNC(=S)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A22 compound treatment 1.0022 0.00217 0.04 0.0421 1.0 1953716 Maybridge1_002662 COc1c(cc(cc1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A23 mock treatment 0.9836 -0.0164 -0.32 -0.3183 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 A24 mock treatment 1.0242 0.0242 0.47 0.4693 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B01 compound treatment 1.0084 0.00836 0.16 0.1623 1.0 1953717 Maybridge1_002663 Cc1c(nnn1c2cccc(c2)C(F)(F)F)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B02 compound treatment 1.0084 0.00836 0.16 0.1623 1.0 1953718 Maybridge1_002664 CN(C)C(=S)SCc1ccccc1C(=O)Oc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B03 compound treatment 0.9781 -0.0219 -0.43 -0.4251 -1.0 1953719 Maybridge1_002665 CC(=O)C(=NNc1c(F)cccc1F)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B04 compound treatment 0.9939 -0.00608 -0.12 -0.1181 -1.0 1953720 Maybridge1_002666 [O-][N+](=O)c1ccc(NCCc2ccccn2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B05 compound treatment 0.9664 -0.0336 -0.65 -0.652 -1.0 1953721 Maybridge1_002667 FC(F)(F)c1ccccc1NCN2C(=O)CCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B06 compound treatment 0.996 -0.00402 -0.08 -0.078 -1.0 1130340 Maybridge1_002668 COc1ccc(Oc2cccc(F)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B07 compound treatment 0.9843 -0.0157 -0.3 -0.3049 -1.0 1953722 Maybridge1_002669 COCCCNC1=NC(=O)C(CC(=O)Nc2cc(Cl)ccc2Cl)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B08 compound treatment 0.9685 -0.0315 -0.61 -0.6119 -1.0 1953723 Maybridge1_002670 CN(/N=C/c1cc(Cl)cc(Cl)c1O)c2ccc(cn2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B09 compound treatment 0.9994 -5.8E-4 -0.01 -0.0113 -1.0 1953724 Maybridge1_002671 CN(C)c1c(F)cc(cc1F)/C(=N/O)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B10 compound treatment 0.9678 -0.0322 -0.63 -0.6253 -1.0 1953725 Maybridge1_002672 Cc1nn(c(C)c1/C=N/O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B11 compound treatment 0.9417 -0.0583 -1.13 -1.1325 -1.0 1953726 Maybridge1_002673 Cc1onc(c1C(=O)OCC#C)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B12 compound treatment 0.9747 -0.0253 -0.49 -0.4918 -1.0 1953727 Maybridge1_002674 Cc1nn(C(=O)c2ccc(Cl)cc2)c(C)c1Cc3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B13 compound treatment 0.9362 -0.0638 -1.24 -1.2393 -1.0 1953728 Maybridge1_002675 Cc1nnsc1C(=O)NCc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B14 compound treatment 0.9541 -0.0459 -0.89 -0.8923 -1.0 1953729 Maybridge1_002676 CC(=O)C(Cc1ccc(cc1)[N+](=O)[O-])(Cc2c(F)cccc2Cl)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B15 compound treatment 0.9994 -5.8E-4 -0.01 -0.0113 -1.0 1531342 Maybridge1_002677 OC(=O)c1ccccc1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B16 compound treatment 0.9802 -0.0198 -0.39 -0.385 -1.0 1953730 Maybridge1_002678 Cc1onc(c1C(=O)NCCSCc2c(F)cccc2Cl)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B17 compound treatment 0.9554 -0.0446 -0.87 -0.8656 -1.0 1953731 Maybridge1_002679 Fc1cccc(N2CCCC2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B18 compound treatment 0.9781 -0.0219 -0.43 -0.4251 -1.0 1953732 Maybridge1_002680 O=C(N1CCSCC1)c2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B19 compound treatment 0.9815 -0.0185 -0.36 -0.3583 -1.0 1953733 Maybridge1_002681 ON(Cc1cccc(c1)C(F)(F)F)Cc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B20 compound treatment 0.9431 -0.0569 -1.11 -1.1058 -1.0 1953734 Maybridge1_002682 OCCOc1ccc(cn1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B21 compound treatment 1.0035 0.00354 0.07 0.0688 1.0 1953735 Maybridge1_002683 CS/C(=N\c1cccc(c1)C(F)(F)F)/N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B22 compound treatment 0.9637 -0.0363 -0.71 -0.7054 -1.0 1953736 Maybridge1_002684 Cc1c(nnn1c2ccc(F)c(Cl)c2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B23 mock treatment 0.9692 -0.0308 -0.6 -0.5986 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 B24 mock treatment 1.0194 0.0194 0.38 0.3758 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C01 compound treatment 1.0359 0.0359 0.7 0.6962 1.0 1953737 Maybridge1_002685 COc1cccc(NC(=S)NNC(=O)CSCc2c(Cl)cccc2Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C02 compound treatment 0.9602 -0.0398 -0.77 -0.7721 -1.0 1953738 Maybridge1_002686 FC(F)(F)c1cccc(Cc2cccc(c2)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C03 compound treatment 0.9857 -0.0143 -0.28 -0.2782 -1.0 1671582 Maybridge1_002687 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)Nc2ccc(CC#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C04 compound treatment 0.9829 -0.0171 -0.33 -0.3316 -1.0 1953739 Maybridge1_002688 Oc1c(Br)cc(Br)cc1/C=N/NC(=S)N[C@H]2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C05 compound treatment 0.974 -0.026 -0.51 -0.5052 -1.0 1953740 Maybridge1_002689 S=C(NC1CC2CC1C=C2)N3CCC(CCCC4CCN(CC4)C(=S)NC5CC6CC5C=C6)CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C06 compound treatment 0.9616 -0.0384 -0.75 -0.7454 -1.0 1210996 Maybridge1_002690 COc1cccc2CC3=C(CC(C)(C)CC3=O)Oc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C07 compound treatment 0.9836 -0.0164 -0.32 -0.3183 -1.0 1953741 Maybridge1_002691 Cc1c(C)c(C)c(COc2ccc(I)cc2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C08 compound treatment 0.9534 -0.0466 -0.91 -0.9056 -1.0 1953742 Maybridge1_002692 Clc1ccc(NC(=O)CSc2ccccn2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C09 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 1624927 Maybridge1_002693 Cc1onc(c1NC(=O)Nc2c(Cl)cccc2Cl)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C10 compound treatment 0.9431 -0.0569 -1.11 -1.1058 -1.0 1953743 Maybridge1_002694 N/C(=N\OC(=O)c1sc2ccccc2c1Cl)/c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C11 compound treatment 0.996 -0.00402 -0.08 -0.078 -1.0 1953744 Maybridge1_002695 COc1cc(ccc1CN2CCOCC2)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C12 compound treatment 0.9327 -0.0673 -1.31 -1.3061 -1.0 1385956 Maybridge1_002696 Cc1c(N)c2c(cc1NC(=S)Nc3ccc(Cl)c(Cl)c3)C(C)(C)CC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C13 compound treatment 1.0015 0.00148 0.03 0.0288 1.0 1953745 Maybridge1_002697 C/C(=N\OC(=O)c1c(C)onc1c2c(Cl)cccc2Cl)/c3ccccc3O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C14 compound treatment 0.9382 -0.0618 -1.2 -1.1993 -1.0 1020520 Maybridge1_002698 OC(=O)CSCc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C15 compound treatment 0.9829 -0.0171 -0.33 -0.3316 -1.0 1953746 Maybridge1_002699 COCCCNC1=C(C#N)C(=O)NC(S1)C2CCC=CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C16 compound treatment 0.9396 -0.0604 -1.17 -1.1726 -1.0 1953747 Maybridge1_002700 [O-][N+](=O)c1c(cc(cc1C(F)(F)F)C(F)(F)F)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C17 compound treatment 1.0022 0.00217 0.04 0.0421 1.0 1953748 Maybridge1_002701 Fc1ccc(cc1)C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C18 compound treatment 0.9678 -0.0322 -0.63 -0.6253 -1.0 1953749 Maybridge1_002702 Fc1cccc(F)c1NC(=S)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C19 compound treatment 0.9815 -0.0185 -0.36 -0.3583 -1.0 1953750 Maybridge1_002703 Oc1c(Cl)cc(Cl)cc1/C=N/CCCC2C=NNC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C20 compound treatment 0.9719 -0.0281 -0.55 -0.5452 -1.0 1953751 Maybridge1_002704 [O-][N+](=O)c1cc(c(Sc2ccccn2)cc1Sc3ccccn3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C21 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1953752 Maybridge1_002705 Cc1c(C)c(C)c(CSC(=N)CC#N)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C22 compound treatment 0.9596 -0.0404 -0.79 -0.7855 -1.0 1337004 Maybridge1_002706 CC(C)c1ccc(NCN2C(=O)CCC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C23 mock treatment 0.987 -0.013 -0.25 -0.2515 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 C24 mock treatment 0.9994 -5.8E-4 -0.01 -0.0113 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D01 compound treatment 1.0255 0.0255 0.5 0.496 1.0 1953753 Maybridge1_002707 Cc1c(nnn1c2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D02 compound treatment 1.0008 7.95E-4 0.02 0.0154 1.0 1953754 Maybridge1_002708 O=C(NCc1cccs1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D03 compound treatment 1.1575 0.158 3.06 3.0589 1.0 1953755 Maybridge1_002709 Fc1cccc(F)c1NN=C2C(=O)NC(=O)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D04 compound treatment 1.0345 0.0345 0.67 0.6695 1.0 1953756 Maybridge1_002710 COc1cc(NS(=O)(=O)c2c(C)c(C)c(C)c(C)c2C)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D05 compound treatment 1.0214 0.0214 0.42 0.4159 1.0 1722458 Maybridge1_002711 O=C1CCC(=O)N1CNc2ccccc2n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D06 compound treatment 0.9472 -0.0528 -1.03 -1.0257 -1.0 1953757 Maybridge1_002712 Clc1cccc(Oc2ccccc2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D07 compound treatment 1.0132 0.0132 0.26 0.2557 1.0 1953758 Maybridge1_002713 COCCCNC1=NC(=O)C(CC(=O)Nc2ccccc2Cl)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D08 compound treatment 0.9884 -0.0116 -0.22 -0.2248 -1.0 1313488 Maybridge1_002714 CC1CC(C)CN(C1)c2ccc(N)cc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D09 compound treatment 0.9733 -0.0267 -0.52 -0.5185 -1.0 1953759 Maybridge1_002715 C(Oc1ccccc1)C#CC#CCOc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D10 compound treatment 0.9781 -0.0219 -0.43 -0.4251 -1.0 1190260 Maybridge1_002716 Clc1cccc(Cl)c1C(=O)NCCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D11 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 1953760 Maybridge1_002717 FC(F)(F)c1ccc(Cl)c(N/C=N/c2cc(ccc2Cl)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D12 compound treatment 0.9939 -0.00608 -0.12 -0.1181 -1.0 1953761 Maybridge1_002718 Cc1nn(C(=O)c2c(Cl)cccc2Cl)c(C)c1Cc3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D13 compound treatment 0.9678 -0.0322 -0.63 -0.6253 -1.0 1953762 Maybridge1_002719 CN(C)CCCNS(=O)(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D14 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 1953763 Maybridge1_002720 FC(F)(F)c1cc(cc(c1)S(=O)(=O)Nc2ccc(cc2)n3cccc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D15 compound treatment 0.9884 -0.0116 -0.22 -0.2248 -1.0 1953764 Maybridge1_002721 Cc1nnsc1C(=O)Nc2c(C)cccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D16 compound treatment 0.9719 -0.0281 -0.55 -0.5452 -1.0 1497678 Maybridge1_002722 Cc1onc(c1NC(=O)N2CCSCC2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D17 compound treatment 0.974 -0.026 -0.51 -0.5052 -1.0 1953765 Maybridge1_002723 Fc1cccc(c1C#N)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D18 compound treatment 0.996 -0.00402 -0.08 -0.078 -1.0 1342287 Maybridge1_002724 Fc1ccc(NC2OC(=O)c3ccccc23)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D19 compound treatment 0.9623 -0.0377 -0.73 -0.7321 -1.0 1405030 Maybridge1_002725 ON(Cc1ccc(Cl)cc1)Cc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D20 compound treatment 0.9506 -0.0494 -0.96 -0.959 -1.0 1953766 Maybridge1_002726 Clc1cc(Cl)cc(OS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D21 compound treatment 0.9925 -0.00745 -0.14 -0.1447 -1.0 1953767 Maybridge1_002727 CS/C(=N\c1ccc(Cl)cc1)/NCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D22 compound treatment 1.0042 0.00423 0.08 0.0822 1.0 1953768 Maybridge1_002728 Brc1ccc(s1)c2ccn[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D23 mock treatment 0.9809 -0.0191 -0.37 -0.3717 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 D24 mock treatment 1.0084 0.00836 0.16 0.1623 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E01 compound treatment 1.0496 0.0496 0.96 0.9632 1.0 1953769 Maybridge1_002729 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)NNC(=O)c2cc(OC)c(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E02 compound treatment 1.0077 0.00767 0.15 0.1489 1.0 1953770 Maybridge1_002730 [O-][N+](=O)c1cc(Cc2cc(cc(c2)C(F)(F)F)[N+](=O)[O-])cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E03 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1227164 Maybridge1_002731 Clc1c(sc2ccccc12)C(=O)N3CCCN4C3c5ccccc5C4=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E04 compound treatment 0.9671 -0.0329 -0.64 -0.6386 -1.0 1953771 Maybridge1_002732 COc1ccc(NC(=S)NNC(=NS(=O)(=O)c2ccccc2)NNC(=S)Nc3ccc(OC)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E05 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 1192501 Maybridge1_002733 Cc1c(C)c(C)c(C(=O)c2c(Cl)c(Cl)c(Cl)c(Cl)c2C(=O)O)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E06 compound treatment 0.9602 -0.0398 -0.77 -0.7721 -1.0 1953772 Maybridge1_002734 [O-][N+](=O)c1ccccc1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E07 compound treatment 0.9932 -0.00677 -0.13 -0.1314 -1.0 1080021 Maybridge1_002735 OC(=O)C1C(C2CC1C=C2)C(=O)Nc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E08 compound treatment 0.9822 -0.0178 -0.34 -0.345 -1.0 1953773 Maybridge1_002736 Nc1cc(Cc2cc(N)cc(c2)C(F)(F)F)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E09 compound treatment 1.0008 7.95E-4 0.02 0.0154 1.0 1953774 Maybridge1_002737 FC(F)(F)c1cccc(c1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E10 compound treatment 0.963 -0.037 -0.72 -0.7187 -1.0 1953775 Maybridge1_002738 Nc1ccccc1Nc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E11 compound treatment 0.9932 -0.00677 -0.13 -0.1314 -1.0 1953776 Maybridge1_002739 OC(=O)c1cccc([N+](=O)[O-])c1C(=O)Nc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E12 compound treatment 0.9596 -0.0404 -0.79 -0.7855 -1.0 1953777 Maybridge1_002740 Clc1ccc(cc1)/C(=N/c2ccccc2)/c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E13 compound treatment 0.9767 -0.0233 -0.45 -0.4518 -1.0 1953778 Maybridge1_002741 COCCCNC(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E14 compound treatment 0.9809 -0.0191 -0.37 -0.3717 -1.0 1953779 Maybridge1_002742 CSC1=C(C#N)C(=O)NC(S1)c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E15 compound treatment 0.9898 -0.0102 -0.2 -0.1981 -1.0 1953780 Maybridge1_002743 N/C(=N\O)/CC(=O)N1CCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E16 compound treatment 0.9692 -0.0308 -0.6 -0.5986 -1.0 1953781 Maybridge1_002744 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1O/N=C/2\CSCc3ccccc23)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E17 compound treatment 0.9974 -0.00264 -0.05 -0.0513 -1.0 1953782 Maybridge1_002745 Oc1c(Cl)cc(Cl)cc1/C=N/c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E18 compound treatment 0.9596 -0.0404 -0.79 -0.7855 -1.0 1953783 Maybridge1_002746 [O-][N+](=O)c1cc(ccc1c2ccc(cc2[N+](=O)[O-])C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E19 compound treatment 0.9912 -0.00883 -0.17 -0.1714 -1.0 1953784 Maybridge1_002747 COc1cccc(/C=N/CCCC2C=NNC2=O)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E20 compound treatment 0.987 -0.013 -0.25 -0.2515 -1.0 1953785 Maybridge1_002748 Clc1ccc(NCN2C(=O)CCC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E21 compound treatment 0.9829 -0.0171 -0.33 -0.3316 -1.0 1953786 Maybridge1_002749 COc1cc(/C=C(\C#N)/C(=S)N)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E22 compound treatment 0.9685 -0.0315 -0.61 -0.6119 -1.0 1953787 Maybridge1_002750 FC(F)(F)c1cc(cc(c1)C(F)(F)F)n2nncc2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E23 mock treatment 1.0084 0.00836 0.16 0.1623 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 E24 mock treatment 0.9623 -0.0377 -0.73 -0.7321 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F01 compound treatment 1.0125 0.0125 0.24 0.2424 1.0 1159680 Maybridge1_002751 Cc1cccc(NCN2C(=O)CCC2=O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F02 compound treatment 0.9472 -0.0528 -1.03 -1.0257 -1.0 1689403 Maybridge1_002752 Clc1ccc(NCc2cccnc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F03 compound treatment 0.9898 -0.0102 -0.2 -0.1981 -1.0 1953788 Maybridge1_002753 Clc1cccc(NCN2C(=O)CCC2=O)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F04 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 1953789 Maybridge1_002754 Clc1ccc(cc1Cl)S(=O)(=O)NC(=N)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F05 compound treatment 0.9678 -0.0322 -0.63 -0.6253 -1.0 1953790 Maybridge1_002755 Oc1ccccc1/C=N/c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F06 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 1451316 Maybridge1_002756 Oc1ccccc1C(=O)Nc2ccc(F)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F07 compound treatment 0.9726 -0.0274 -0.53 -0.5319 -1.0 1953791 Maybridge1_002757 COc1ccc(NC(=O)C(Cl)Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F08 compound treatment 0.9651 -0.0349 -0.68 -0.6787 -1.0 1953792 Maybridge1_002758 CN(/N=C/c1cc(Cl)cc(Cl)c1O)c2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F09 compound treatment 1.0001 1.07E-4 0.0 0.0021 1.0 1953793 Maybridge1_002759 CC(=O)c1nnn(c1C)c2cccc(Cl)c2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F10 compound treatment 0.9719 -0.0281 -0.55 -0.5452 -1.0 1953794 Maybridge1_002760 [O-][N+](=O)c1ccc(OC(=O)c2c(Cl)cccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F11 compound treatment 0.9602 -0.0398 -0.77 -0.7721 -1.0 1953795 Maybridge1_002761 FC(F)(F)c1ccccc1N/C=N/c2ccccc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F12 compound treatment 0.9802 -0.0198 -0.39 -0.385 -1.0 1953796 Maybridge1_002762 Cc1nn(C(=O)C(C)(C)C)c(C)c1Cc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F13 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1953797 Maybridge1_002763 Fc1cccc(Cl)c1C(=O)Nc2ccccc2SCc3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F14 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 1953798 Maybridge1_002764 Cc1c(C)c(C)c(I)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F15 compound treatment 0.9472 -0.0528 -1.03 -1.0257 -1.0 1953799 Maybridge1_002765 Cc1onc(c1C(=O)NCc2c(F)cccc2Cl)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F16 compound treatment 0.9678 -0.0322 -0.63 -0.6253 -1.0 1468180 Maybridge1_002766 Clc1ccc(cc1)S(=O)(=O)N2CCSCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F17 compound treatment 0.9561 -0.0439 -0.85 -0.8522 -1.0 1953800 Maybridge1_002767 FC(F)(F)c1cc(Br)ccc1/C=C/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F18 compound treatment 0.9651 -0.0349 -0.68 -0.6787 -1.0 1158701 Maybridge1_002768 O=C(NC(=S)N1CCSCC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F19 compound treatment 1.0145 0.0145 0.28 0.2824 1.0 1354351 Maybridge1_002769 Fc1cccc(NC(=O)c2ccc(Cl)cc2Cl)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F20 compound treatment 0.9925 -0.00745 -0.14 -0.1447 -1.0 1953801 Maybridge1_002770 FC(F)(F)c1cc(cc(c1)S(=O)(=O)Oc2cc(Cl)cc(Cl)c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F21 compound treatment 0.9671 -0.0329 -0.64 -0.6386 -1.0 1953802 Maybridge1_002771 CS/C(=N\c1ccccc1F)/N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F22 compound treatment 1.0249 0.0249 0.48 0.4826 1.0 1293180 Maybridge1_002772 Clc1ccc(cc1Cl)S(=O)(=O)Nc2n[nH]c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F23 mock treatment 0.9912 -0.00883 -0.17 -0.1714 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 F24 mock treatment 1.0132 0.0132 0.26 0.2557 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G01 compound treatment 1.0654 0.0654 1.27 1.2702 1.0 1953803 Maybridge1_002773 Clc1cccc(Cl)c1CSCC(=O)NNC(=S)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G02 compound treatment 1.0235 0.0235 0.46 0.4559 1.0 1953804 Maybridge1_002774 CC1N=C(S)N2C(C)N=C(S)N12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G03 compound treatment 1.0022 0.00217 0.04 0.0421 1.0 1201564 Maybridge1_002775 NC(=O)Nc1ccc(CC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G04 compound treatment 0.9651 -0.0349 -0.68 -0.6787 -1.0 1953805 Maybridge1_002776 Fc1ccc(NC(=S)NNC(=NS(=O)(=O)c2ccccc2)NNC(=S)Nc3ccc(F)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G05 compound treatment 0.9616 -0.0384 -0.75 -0.7454 -1.0 1171659 Maybridge1_002777 Cc1cc(C(=O)c2ccccc2C(=O)O)c(C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G06 compound treatment 0.9836 -0.0164 -0.32 -0.3183 -1.0 1953806 Maybridge1_002778 FC(F)(F)c1cc(NC(=O)C(Cl)(Cl)Cl)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G07 compound treatment 0.9857 -0.0143 -0.28 -0.2782 -1.0 1953807 Maybridge1_002779 Cc1cc(OCc2c(C)c(C)c(C)c(C)c2C)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G08 compound treatment 0.9939 -0.00608 -0.12 -0.1181 -1.0 1953808 Maybridge1_002780 OC(=O)c1c(ccc([N+](=O)[O-])c1N2CCCCC2)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G09 compound treatment 1.0001 1.07E-4 0.0 0.0021 1.0 1953809 Maybridge1_002781 C/C(=N\OC(=O)Nc1c(C)onc1c2c(Cl)cccc2Cl)/c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G10 compound treatment 1.0049 0.00492 0.1 0.0955 1.0 1953810 Maybridge1_002782 CCCCNC(=S)Nc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G11 compound treatment 0.9754 -0.0246 -0.48 -0.4785 -1.0 1953811 Maybridge1_002783 COc1ccc(cc1CN2CCOCC2)/C(=N/O)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G12 compound treatment 0.9706 -0.0294 -0.57 -0.5719 -1.0 1953812 Maybridge1_002784 CC(=O)C(=NNc1cc2c(c([N+](=O)[O-])c1C)C(C)(C)CC2(C)C)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G13 compound treatment 0.9506 -0.0494 -0.96 -0.959 -1.0 1589549 Maybridge1_002785 NNC(=O)c1ccccc1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G14 compound treatment 0.9568 -0.0432 -0.84 -0.8389 -1.0 1953813 Maybridge1_002786 FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2ccc(C=C(C#N)C#N)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G15 compound treatment 0.9987 -0.00127 -0.02 -0.0246 -1.0 1113787 Maybridge1_002787 NC(=O)Nc1cc(Cl)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G16 compound treatment 0.9568 -0.0432 -0.84 -0.8389 -1.0 1065100 Maybridge1_002788 CC(=O)Nc1c(F)cccc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G17 compound treatment 0.9733 -0.0267 -0.52 -0.5185 -1.0 1953814 Maybridge1_002789 FC(F)(F)C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G18 compound treatment 0.9953 -0.0047 -0.09 -0.0914 -1.0 1953815 Maybridge1_002790 CC1(C)CC(=O)C(=NNc2ccc(cc2[N+](=O)[O-])C(F)(F)F)C(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G19 compound treatment 0.9994 -5.8E-4 -0.01 -0.0113 -1.0 1953816 Maybridge1_002791 Cc1c(C)c(C)c(CSc2nnc(/C(=C/c3c(Cl)cccc3Cl)/C#N)n2C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G20 compound treatment 0.952 -0.048 -0.93 -0.9323 -1.0 1231343 Maybridge1_002792 Cc1c2NC(Nc2c(C)c(C)c1C)c3cc(Cl)cc(Cl)c3O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G21 compound treatment 1.0042 0.00423 0.08 0.0822 1.0 1953817 Maybridge1_002793 N/C(=N\O)/Cc1nc(cs1)c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G22 compound treatment 1.009 0.00904 0.18 0.1756 1.0 1953818 Maybridge1_002794 COc1cc(OC)c(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G23 mock treatment 1.0139 0.0139 0.27 0.2691 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 G24 mock treatment 1.0235 0.0235 0.46 0.4559 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H01 compound treatment 1.0132 0.0132 0.26 0.2557 1.0 1284196 Maybridge1_002795 COc1cccc(NC(=O)c2c(C)cc(C)cc2CC(C)(C)C(=O)O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H02 compound treatment 0.9637 -0.0363 -0.71 -0.7054 -1.0 1953819 Maybridge1_002796 Clc1ccc(/C=N/c2cccnc2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H03 compound treatment 0.9857 -0.0143 -0.28 -0.2782 -1.0 1953820 Maybridge1_002797 CC(=O)c1ccccc1OC(=O)c2c(F)cccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H04 compound treatment 1.0214 0.0214 0.42 0.4159 1.0 1953821 Maybridge1_002798 FC(F)(F)c1cc(cc(c1)S(=O)(=O)NC(=N)c2cccnc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H05 compound treatment 0.9699 -0.0301 -0.59 -0.5852 -1.0 1953822 Maybridge1_002799 Fc1cccc(F)c1C(=O)C[n+]2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H06 compound treatment 0.9747 -0.0253 -0.49 -0.4918 -1.0 1608769 Maybridge1_002800 Oc1ccccc1C(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H07 compound treatment 0.9815 -0.0185 -0.36 -0.3583 -1.0 1953823 Maybridge1_002801 Fc1cccc(NC2=NC(=O)C(CC(=O)Nc3cc(Cl)ccc3Cl)S2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H08 compound treatment 0.9946 -0.00539 -0.1 -0.1047 -1.0 1953824 Maybridge1_002802 Fc1cccc(Cl)c1C=C(C#N)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H09 compound treatment 0.963 -0.037 -0.72 -0.7187 -1.0 1953825 Maybridge1_002803 O=C(CC#N)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H10 compound treatment 0.9685 -0.0315 -0.61 -0.6119 -1.0 1953826 Maybridge1_002804 [O-][N+](=O)c1cccnc1NCCCn2ccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H11 compound treatment 0.9987 -0.00127 -0.02 -0.0246 -1.0 1953827 Maybridge1_002805 CC1(C)OC(=O)C(=Cc2cccs2)C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H12 compound treatment 0.9664 -0.0336 -0.65 -0.652 -1.0 1953828 Maybridge1_002806 ON(Cc1c(F)cccc1Cl)Cc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H13 compound treatment 0.9451 -0.0549 -1.07 -1.0658 -1.0 1953829 Maybridge1_002807 [O-][N+](=O)c1ccc(OCc2c(F)cccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H14 compound treatment 1.0042 0.00423 0.08 0.0822 1.0 1055619 Maybridge1_002808 Cc1cc(C)c(C)c(I)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H15 compound treatment 0.9905 -0.00952 -0.18 -0.1848 -1.0 1420221 Maybridge1_002809 COc1ccc(OC)c(c1)S(=O)(=O)NCc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H16 compound treatment 0.9541 -0.0459 -0.89 -0.8923 -1.0 1953830 Maybridge1_002810 FC(F)(F)c1cc(cc(c1)S(=O)(=O)N2CCSCC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H17 compound treatment 0.9499 -0.0501 -0.97 -0.9724 -1.0 1953831 Maybridge1_002811 COC(=O)c1ccc(CS(=O)(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H18 compound treatment 0.9706 -0.0294 -0.57 -0.5719 -1.0 1953832 Maybridge1_002812 NC(=N)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H19 compound treatment 0.9554 -0.0446 -0.87 -0.8656 -1.0 1953833 Maybridge1_002813 Cc1c(C)c(sc1C#N)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H20 compound treatment 1.0049 0.00492 0.1 0.0955 1.0 1953834 Maybridge1_002814 Clc1ccc(cc1)S(=O)(=O)Oc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H21 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1953835 Maybridge1_002815 CS/C(=N\C(C)c1ccccc1)/Nc2ccc(Oc3ccc(Cl)cc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H22 compound treatment 0.9781 -0.0219 -0.43 -0.4251 -1.0 1953836 Maybridge1_002816 CC(=N)NCCc1ccncc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H23 mock treatment 0.9946 -0.00539 -0.1 -0.1047 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 H24 mock treatment 0.9836 -0.0164 -0.32 -0.3183 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I01 compound treatment 1.0365 0.0365 0.71 0.7096 1.0 1953837 Maybridge1_002817 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)NNC(=S)NCC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I02 compound treatment 0.9767 -0.0233 -0.45 -0.4518 -1.0 1953838 Maybridge1_002818 SC1=NC2(CCCCC2)NN1c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I03 compound treatment 1.0049 0.00492 0.1 0.0955 1.0 1953839 Maybridge1_002819 COc1ccc(OC)c(c1)C(=O)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I04 compound treatment 0.9795 -0.0205 -0.4 -0.3984 -1.0 1953840 Maybridge1_002820 FC(F)(F)c1cc(cc(c1)C(F)(F)F)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I05 compound treatment 0.9836 -0.0164 -0.32 -0.3183 -1.0 1953841 Maybridge1_002821 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)ON=C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I06 compound treatment 0.976 -0.024 -0.47 -0.4651 -1.0 1953842 Maybridge1_002822 OC(=O)/C=C/C(=O)Nc1ccccc1SCCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I07 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1953843 Maybridge1_002823 COc1cccc(NC(=S)N(CCC#N)CCC#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I08 compound treatment 0.9657 -0.0343 -0.67 -0.6653 -1.0 1953844 Maybridge1_002824 Clc1ccc(CSc2ccccc2n3cccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I09 compound treatment 1.0042 0.00423 0.08 0.0822 1.0 1953845 Maybridge1_002825 Cc1c(C)c(C)c(C(=O)Cc2ccccc2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I10 compound treatment 0.9747 -0.0253 -0.49 -0.4918 -1.0 1953846 Maybridge1_002826 CCCCNC(=S)Nc1ccc(cc1)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I11 compound treatment 1.0008 7.95E-4 0.02 0.0154 1.0 1953847 Maybridge1_002827 COc1ccc(cc1CSCC(=O)Nc2ccc(Cl)cc2)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I12 compound treatment 0.9451 -0.0549 -1.07 -1.0658 -1.0 1953848 Maybridge1_002828 FC(F)(F)c1cccc(NC(=S)Nc2ccc(Cl)c(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I13 compound treatment 0.9747 -0.0253 -0.49 -0.4918 -1.0 1953849 Maybridge1_002829 O=C(N/N=C/C=C/c1ccccc1)c2ccccc2n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I14 compound treatment 0.9925 -0.00745 -0.14 -0.1447 -1.0 1953850 Maybridge1_002830 NC(=S)/C(=C/c1ccc(o1)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I15 compound treatment 1.009 0.00904 0.18 0.1756 1.0 1953851 Maybridge1_002831 CCOc1ccc(/C=N/NC(=S)NCCCOC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I16 compound treatment 0.9671 -0.0329 -0.64 -0.6386 -1.0 1953852 Maybridge1_002832 FC(F)(F)c1cc(NCCC#N)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I17 compound treatment 1.0902 0.0902 1.75 1.7507 1.0 1953853 Maybridge1_002833 Clc1ccc(NC(=S)NNC(=O)CC#N)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I18 compound treatment 1.084 0.084 1.63 1.6306 1.0 1953854 Maybridge1_002834 [O-][N+](=O)c1cc(ccc1NN=C2C(=O)NC(=O)NC2=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I19 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 1953855 Maybridge1_002835 Cc1c(C)c(C)c(CSc2nnc(/C(=C/c3cccs3)/C#N)n2C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I20 compound treatment 0.9754 -0.0246 -0.48 -0.4785 -1.0 1953856 Maybridge1_002836 FC(F)(F)c1ccc(NCN2C(=O)CCC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I21 compound treatment 0.9479 -0.0521 -1.01 -1.0124 -1.0 1953857 Maybridge1_002837 COC(=O)c1c2CC(C)(C)C(=O)c2c(C)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I22 compound treatment 0.9609 -0.0391 -0.76 -0.7588 -1.0 1953858 Maybridge1_002838 CS(=O)(=O)c1ccc(cc1NNc2cc(ccc2S(=O)(=O)C)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I23 mock treatment 1.0159 0.0159 0.31 0.3091 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 I24 mock treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J01 compound treatment 1.0056 0.00561 0.11 0.1089 1.0 1953859 Maybridge1_002839 Clc1cc(Cl)c(NCN2C(=O)CCC2=O)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J02 compound treatment 0.9781 -0.0219 -0.43 -0.4251 -1.0 1953860 Maybridge1_002840 CCOC(=S)SCc1c(F)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J03 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1145147 Maybridge1_002841 Fc1cccc(F)c1C(=O)N2CCN(CC2)C(=O)c3c(F)cccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J04 compound treatment 0.9939 -0.00608 -0.12 -0.1181 -1.0 1953861 Maybridge1_002842 Fc1ccc(c(F)c1)n2c(S)nc3ccccc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J05 compound treatment 1.007 0.00698 0.14 0.1356 1.0 1675003 Maybridge1_002843 CCOC(=O)c1c(Cl)cc(C)cc1N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J06 compound treatment 0.9671 -0.0329 -0.64 -0.6386 -1.0 1953862 Maybridge1_002844 CSCCNC(=O)c1c(C)onc1c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J07 compound treatment 0.9754 -0.0246 -0.48 -0.4785 -1.0 1953863 Maybridge1_002845 FC(F)(F)c1cc(c2cccs2)n(n1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J08 compound treatment 0.9836 -0.0164 -0.32 -0.3183 -1.0 1506264 Maybridge1_002846 NCC(O)COc1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J09 compound treatment 0.9568 -0.0432 -0.84 -0.8389 -1.0 1953864 Maybridge1_002847 COc1ccc(Br)c(c1)C(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J10 compound treatment 0.976 -0.024 -0.47 -0.4651 -1.0 1953865 Maybridge1_002848 [O-][N+](=O)c1cccnc1Sc2ccccc2C3=NCCCN3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J11 compound treatment 0.9905 -0.00952 -0.18 -0.1848 -1.0 1953866 Maybridge1_002849 Fc1cccc(N2CCOCC2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J12 compound treatment 0.9568 -0.0432 -0.84 -0.8389 -1.0 1953867 Maybridge1_002850 CC(C)(C)n1cnnc1SCc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J13 compound treatment 0.9279 -0.0721 -1.4 -1.3995 -1.0 1953868 Maybridge1_002851 Fc1cccc(Cl)c1CNC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J14 compound treatment 1.0118 0.0118 0.23 0.229 1.0 1041480 Maybridge1_002852 Cc1cc(C)c(I)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J15 compound treatment 0.9451 -0.0549 -1.07 -1.0658 -1.0 1953869 Maybridge1_002853 FC(F)(F)c1cccc(CSc2ccccc2NC(=O)c3ccc(Cl)c(Cl)c3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J16 compound treatment 0.9348 -0.0652 -1.27 -1.266 -1.0 1713840 Maybridge1_002854 Clc1ccc(cc1Cl)S(=O)(=O)Nc2cccc(C#C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J17 compound treatment 0.9527 -0.0473 -0.92 -0.919 -1.0 1953870 Maybridge1_002855 Clc1cccc(N2CCCC2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J18 compound treatment 0.974 -0.026 -0.51 -0.5052 -1.0 1953871 Maybridge1_002856 FC(F)(F)c1cc(cc(c1)S(=O)(=O)NC(=N)c2ccc(Cl)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J19 compound treatment 0.9864 -0.0136 -0.26 -0.2649 -1.0 1953872 Maybridge1_002857 C(/N=C/c1cccs1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J20 compound treatment 0.9733 -0.0267 -0.52 -0.5185 -1.0 1953873 Maybridge1_002858 OCCOc1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J21 compound treatment 0.9596 -0.0404 -0.79 -0.7855 -1.0 1953874 Maybridge1_002859 COc1ccc(/N=C(\SC)/N2CCOCC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J22 compound treatment 0.974 -0.026 -0.51 -0.5052 -1.0 1953875 Maybridge1_002860 CC(=N)NCCCn1ccnc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J23 mock treatment 1.0001 1.07E-4 0.0 0.0021 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 J24 mock treatment 0.9898 -0.0102 -0.2 -0.1981 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K01 compound treatment 0.9781 -0.0219 -0.43 -0.4251 -1.0 1953876 Maybridge1_002861 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)N/N=C/C=C/c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K02 compound treatment 0.9747 -0.0253 -0.49 -0.4918 -1.0 1953877 Maybridge1_002862 Fc1ccc(cc1)C(=O)NNC(=NS(=O)(=O)c2ccccc2)NNC(=O)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K03 compound treatment 0.9946 -0.00539 -0.1 -0.1047 -1.0 1953878 Maybridge1_002863 COc1ccc(OC)c(c1)C(=O)c2cc(OC)c(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K04 compound treatment 0.9754 -0.0246 -0.48 -0.4785 -1.0 1953879 Maybridge1_002864 Clc1cc(Cl)c(Cl)c(c1Cl)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K05 compound treatment 0.9657 -0.0343 -0.67 -0.6653 -1.0 1953880 Maybridge1_002865 COc1ccc(cc1)/C(=N/OCc2c(Cl)cccc2Cl)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K06 compound treatment 1.0022 0.00217 0.04 0.0421 1.0 1953881 Maybridge1_002866 Nc1ccccc1SCc2cc(Cl)cc3COCOc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K07 compound treatment 1.0173 0.0173 0.34 0.3358 1.0 1677495 Maybridge1_002867 Cc1onc(c1NC(=O)Nc2cccc(Cl)c2Cl)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K08 compound treatment 0.9877 -0.0123 -0.24 -0.2382 -1.0 1330991 Maybridge1_002868 CCOC(=O)C(C(Nc1ccccc1)c2ccccn2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K09 compound treatment 1.0015 0.00148 0.03 0.0288 1.0 1953882 Maybridge1_002869 COc1ccc(cc1CSc2ccccn2)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K10 compound treatment 0.9671 -0.0329 -0.64 -0.6386 -1.0 1060483 Maybridge1_002870 Clc1ccc(cc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K11 compound treatment 0.9657 -0.0343 -0.67 -0.6653 -1.0 1660885 Maybridge1_002871 Clc1ccc(cc1)C(=O)Nc2ccccc2C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K12 compound treatment 0.9334 -0.0666 -1.29 -1.2927 -1.0 1953883 Maybridge1_002872 Cc1c(NN=C2C(=O)CC(C)(C)CC2=O)cc3c(c1[N+](=O)[O-])C(C)(C)CC3(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K13 compound treatment 1.0359 0.0359 0.7 0.6962 1.0 1953884 Maybridge1_002873 Clc1cccc(NC(=S)NNC(=O)c2ccccc2n3cccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K14 compound treatment 0.9534 -0.0466 -0.91 -0.9056 -1.0 1233497 Maybridge1_002874 C1CN(CCO1)C(N2CCOCC2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K15 compound treatment 0.9506 -0.0494 -0.96 -0.959 -1.0 1953885 Maybridge1_002875 COCCCNC(=S)N/N=C/c1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K16 compound treatment 0.9651 -0.0349 -0.68 -0.6787 -1.0 1953886 Maybridge1_002876 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1Sc2nc3ccccc3c(=O)n2c4ccc(F)cc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K17 compound treatment 0.976 -0.024 -0.47 -0.4651 -1.0 1953887 Maybridge1_002877 COc1ccccc1NC(=S)NNC(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K18 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 1953888 Maybridge1_002878 FC(F)(F)c1cc(cc(c1)S(=O)(=O)NC(=N)c2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K19 compound treatment 0.9596 -0.0404 -0.79 -0.7855 -1.0 1704769 Maybridge1_002879 CCc1cc2c(cc1c3csc(CC#N)n3)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K20 compound treatment 0.976 -0.024 -0.47 -0.4651 -1.0 1953889 Maybridge1_002880 Cc1nc2cc(Cl)c(Cl)cc2nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K21 compound treatment 1.0152 0.0152 0.3 0.2958 1.0 1953890 Maybridge1_002881 N/C(=N\O)/Cc1nc(cs1)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K22 compound treatment 0.996 -0.00402 -0.08 -0.078 -1.0 1408145 Maybridge1_002882 O=C1CCC(=O)N1CNc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K23 mock treatment 1.0118 0.0118 0.23 0.229 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 K24 mock treatment 0.9726 -0.0274 -0.53 -0.5319 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L01 compound treatment 0.9843 -0.0157 -0.3 -0.3049 -1.0 1149953 Maybridge1_002883 Cc1cc(C)c(C(=O)N2CCOCC2)c(CC(C)(C)C(=O)O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L02 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 1076994 Maybridge1_002884 O=c1cc(cc(o1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L03 compound treatment 0.9547 -0.0453 -0.88 -0.8789 -1.0 1953891 Maybridge1_002885 FC(F)(F)c1cc(cc(c1)C(F)(F)F)N2N=NC3C4CC(C5CCCC54)C32N6CCOCC6 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L04 compound treatment 0.976 -0.024 -0.47 -0.4651 -1.0 1953892 Maybridge1_002886 Cc1c(C)c(C)c(C(=O)c2cccs2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L05 compound treatment 1.0001 1.07E-4 0.0 0.0021 1.0 1953893 Maybridge1_002887 CC(C)(C)n1nc(cc1O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L06 compound treatment 0.9857 -0.0143 -0.28 -0.2782 -1.0 1953894 Maybridge1_002888 Fc1ccccc1C(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L07 compound treatment 0.9609 -0.0391 -0.76 -0.7588 -1.0 1953895 Maybridge1_002889 NC1=NC2(CS1)CSC(=N2)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L08 compound treatment 1.0159 0.0159 0.31 0.3091 1.0 1504767 Maybridge1_002890 Fc1ccc(NC(=O)CCN2CCOCC2)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L09 compound treatment 0.985 -0.015 -0.29 -0.2916 -1.0 1953896 Maybridge1_002891 FC(F)(F)c1cc(N/N=C(\C#N)/C(=O)c2ccco2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L10 compound treatment 1.0015 0.00148 0.03 0.0288 1.0 1953897 Maybridge1_002892 Clc1cc(Cl)cc(c1)C(=O)c2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L11 compound treatment 0.9451 -0.0549 -1.07 -1.0658 -1.0 1953898 Maybridge1_002893 OC(c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L12 compound treatment 0.9809 -0.0191 -0.37 -0.3717 -1.0 1953899 Maybridge1_002894 CC(C)(C)n1cnnc1SCc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L13 compound treatment 0.9472 -0.0528 -1.03 -1.0257 -1.0 1953900 Maybridge1_002895 CNc1nnc(s1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L14 compound treatment 0.9836 -0.0164 -0.32 -0.3183 -1.0 1511675 Maybridge1_002896 CSC1=C(C#N)C(=O)NC(C)(C)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L15 compound treatment 0.952 -0.048 -0.93 -0.9323 -1.0 1953901 Maybridge1_002897 Fc1cccc(Cl)c1CSc2ccccc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L16 compound treatment 0.9513 -0.0487 -0.95 -0.9457 -1.0 1953902 Maybridge1_002898 Cc1cc(Br)c(NC(=O)C(Cl)(Cl)Cl)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L17 compound treatment 0.9657 -0.0343 -0.67 -0.6653 -1.0 1953903 Maybridge1_002899 CN(C)CCCNc1cccc(Cl)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L18 compound treatment 1.0035 0.00354 0.07 0.0688 1.0 1021479 Maybridge1_002900 OCCOc1ccc(cc1[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L19 compound treatment 0.9314 -0.0686 -1.33 -1.3328 -1.0 1953904 Maybridge1_002901 Clc1cccc(Cl)c1OCC#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L20 compound treatment 1.0132 0.0132 0.26 0.2557 1.0 1465575 Maybridge1_002902 Cc1onc(c1C(=O)Oc2ccc(Cl)c(Cl)c2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L21 compound treatment 0.9767 -0.0233 -0.45 -0.4518 -1.0 1953905 Maybridge1_002903 Fc1ccc(c(F)c1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L22 compound treatment 0.9905 -0.00952 -0.18 -0.1848 -1.0 1046732 Maybridge1_002904 Ic1ccc(I)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L23 mock treatment 1.0132 0.0132 0.26 0.2557 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 L24 mock treatment 1.0448 0.0448 0.87 0.8697 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M01 compound treatment 1.042 0.042 0.82 0.8163 1.0 1361526 Maybridge1_002905 Cc1c(C)c(C)c(C(=O)c2ccccc2C(=O)O)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M02 compound treatment 0.9527 -0.0473 -0.92 -0.919 -1.0 1953906 Maybridge1_002906 CSC1=NC(C)N2N1C(C)N=C2SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M03 compound treatment 0.9602 -0.0398 -0.77 -0.7721 -1.0 1953907 Maybridge1_002907 COc1cc(/C=N/NC(=S)NC2CC3CCC2C3)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M04 compound treatment 0.9884 -0.0116 -0.22 -0.2248 -1.0 1953908 Maybridge1_002908 Clc1c(Cl)c(Cl)c(c(Cl)c1Cl)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M05 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1953909 Maybridge1_002909 C/C(=N\OC(=O)c1ccc(Cl)cc1)/c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M06 compound treatment 0.9575 -0.0425 -0.83 -0.8255 -1.0 1196063 Maybridge1_002910 COc1cccc(C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M07 compound treatment 0.9994 -5.8E-4 -0.01 -0.0113 -1.0 1953910 Maybridge1_002911 NC(=O)NC1(CCCCC1)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M08 compound treatment 0.9568 -0.0432 -0.84 -0.8389 -1.0 1953911 Maybridge1_002912 FC(F)(F)c1cccc(NC(=S)NN/C(=N\S(=O)(=O)c2ccccc2)/N3CCCC3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M09 compound treatment 0.9678 -0.0322 -0.63 -0.6253 -1.0 1953912 Maybridge1_002913 COc1ccc(cc1CSC#N)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M10 compound treatment 1.3369 0.337 6.54 6.5428 1.0 1953913 Maybridge1_002914 C/C(=N\NC(=S)Nc1cccc(c1)C(F)(F)F)/c2cc(Cl)cc(Cl)c2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M11 compound treatment 0.9266 -0.0734 -1.43 -1.4262 -1.0 1953914 Maybridge1_002915 Cc1onc(c1C(=O)ONC(=O)c2ccccc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M12 compound treatment 0.9767 -0.0233 -0.45 -0.4518 -1.0 1953915 Maybridge1_002916 Clc1cc(Cl)c(cc1Cl)S(=O)(=O)NNC(=O)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M13 compound treatment 0.9692 -0.0308 -0.6 -0.5986 -1.0 1953916 Maybridge1_002917 COc1cc(cc(OC)c1OC)C(=O)O/N=C(\N)/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M14 compound treatment 0.9589 -0.0411 -0.8 -0.7988 -1.0 1953917 Maybridge1_002918 FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2ccc(/C=N/NC(=O)CC#N)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M15 compound treatment 0.9747 -0.0253 -0.49 -0.4918 -1.0 1953918 Maybridge1_002919 Cc1c(C)c(C)c(CO)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M16 compound treatment 0.9547 -0.0453 -0.88 -0.8789 -1.0 1953919 Maybridge1_002920 Cc1cc(Br)ccc1n2c(Sc3c(cc(cc3[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])nc4ccccc4c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M17 compound treatment 1.0235 0.0235 0.46 0.4559 1.0 1953920 Maybridge1_002921 Clc1ccc(cc1)c2csc(CC#N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M18 compound treatment 0.952 -0.048 -0.93 -0.9323 -1.0 1953921 Maybridge1_002922 Nc1ccccc1SCC(=O)Nc2c(F)cccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M19 compound treatment 0.9499 -0.0501 -0.97 -0.9724 -1.0 1953922 Maybridge1_002923 COCCCNC(=S)N/N=C/c1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M20 compound treatment 1.0029 0.00286 0.06 0.0555 1.0 1953923 Maybridge1_002924 CS(=O)(=O)Cc1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M21 compound treatment 1.0008 7.95E-4 0.02 0.0154 1.0 1395529 Maybridge1_002925 NNC(=S)Nc1ccc(cc1)S(=O)(=O)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M22 compound treatment 0.9657 -0.0343 -0.67 -0.6653 -1.0 1060489 Maybridge1_002926 Ic1ccc(cc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M23 mock treatment 0.9884 -0.0116 -0.22 -0.2248 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 M24 mock treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N01 compound treatment 1.0166 0.0166 0.32 0.3224 1.0 1253244 Maybridge1_002927 O=C1CCC(=O)N1CN2CCC(CCCC3CCN(CN4C(=O)CCC4=O)CC3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N02 compound treatment 1.0035 0.00354 0.07 0.0688 1.0 1953924 Maybridge1_002928 Cc1c(C)c(C)c(c(C)c1C)S(=O)(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N03 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 1953925 Maybridge1_002929 S=C(NC1CC2CC1C=C2)N3CCN(CC3)C(=S)NC4CC5CC4C=C5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N04 compound treatment 1.0242 0.0242 0.47 0.4693 1.0 1953926 Maybridge1_002930 FC(F)(F)c1cc(cc(c1)S(=O)(=O)NC(=N)c2cccs2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N05 compound treatment 0.9829 -0.0171 -0.33 -0.3316 -1.0 1953927 Maybridge1_002931 Fc1ccccc1NC(=O)C(Cl)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N06 compound treatment 0.9836 -0.0164 -0.32 -0.3183 -1.0 1662233 Maybridge1_002932 Cc1onc(c1C(=O)NC2CCN(Cc3ccccc3)CC2)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N07 compound treatment 1.0297 0.0297 0.58 0.5761 1.0 1953928 Maybridge1_002933 COc1ccc(CCNC(=O)c2ccc(CSc3ccc(Cl)cc3)o2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N08 compound treatment 0.9692 -0.0308 -0.6 -0.5986 -1.0 1953929 Maybridge1_002934 Cc1nn(C(=O)c2c(C)onc2c3c(Cl)cccc3Cl)c(C)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N09 compound treatment 1.0132 0.0132 0.26 0.2557 1.0 1923332 Maybridge1_002935 Cc1onc(c1C(=O)N)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N10 compound treatment 0.9987 -0.00127 -0.02 -0.0246 -1.0 1953930 Maybridge1_002936 [O-][N+](=O)c1cccc(Cl)c1SCc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N11 compound treatment 0.9939 -0.00608 -0.12 -0.1181 -1.0 1953931 Maybridge1_002937 FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N12 compound treatment 0.9836 -0.0164 -0.32 -0.3183 -1.0 1953932 Maybridge1_002938 CC(C)(C)n1cnnc1Sc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N13 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1953933 Maybridge1_002939 Cc1onc(c1C(=O)NOC(=O)c2cccs2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N14 compound treatment 0.9513 -0.0487 -0.95 -0.9457 -1.0 1621185 Maybridge1_002940 OC1C(=O)Nc2ccc(Br)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N15 compound treatment 0.9719 -0.0281 -0.55 -0.5452 -1.0 1953934 Maybridge1_002941 CC1N=C(SCc2c(F)cccc2Cl)N3C(C)N=C(SCc4c(F)cccc4Cl)N13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N16 compound treatment 0.9637 -0.0363 -0.71 -0.7054 -1.0 1953935 Maybridge1_002942 Cc1cc(Br)c(NC(=O)c2ccc(Cl)cc2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N17 compound treatment 0.9458 -0.0542 -1.05 -1.0524 -1.0 1276809 Maybridge1_002943 Fc1cccc(NC2CCN(Cc3ccccc3)CC2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N18 compound treatment 1.0001 1.07E-4 0.0 0.0021 1.0 1953936 Maybridge1_002944 CCOC(=O)NN(C(=O)OCC)c1c(C)c(C)c(C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N19 compound treatment 0.9369 -0.0631 -1.23 -1.226 -1.0 1953937 Maybridge1_002945 CS/C(=N\C(C)(C)CO)/Nc1c(C)cccc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N20 compound treatment 0.9802 -0.0198 -0.39 -0.385 -1.0 1953938 Maybridge1_002946 Cc1onc(c1C(=O)OCCOc2ccc(cc2[N+](=O)[O-])C(F)(F)F)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N21 compound treatment 0.941 -0.059 -1.15 -1.1459 -1.0 1953939 Maybridge1_002947 Clc1cc(Cl)cc(c1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N22 compound treatment 0.9706 -0.0294 -0.57 -0.5719 -1.0 1953940 Maybridge1_002948 Cc1cc(cc(C)c1F)S(=O)(=O)Oc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N23 mock treatment 0.9706 -0.0294 -0.57 -0.5719 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 N24 mock treatment 1.0159 0.0159 0.31 0.3091 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O01 compound treatment 1.0345 0.0345 0.67 0.6695 1.0 1560876 Maybridge1_002949 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)Nc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O02 compound treatment 0.9809 -0.0191 -0.37 -0.3717 -1.0 1953941 Maybridge1_002950 CN(C)C(=S)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O03 compound treatment 0.9767 -0.0233 -0.45 -0.4518 -1.0 1339604 Maybridge1_002951 COc1ccc(OC)c(c1)C(=O)c2ccc(N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O04 compound treatment 1.0084 0.00836 0.16 0.1623 1.0 1953942 Maybridge1_002952 Cc1nnc(s1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O05 compound treatment 0.9974 -0.00264 -0.05 -0.0513 -1.0 1649462 Maybridge1_002953 Cc1cc(C)c(NC(=O)C2C(C3CC2C=C3)C(=O)O)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O06 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 1953943 Maybridge1_002954 COc1cc(cc(c1)C(F)(F)F)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O07 compound treatment 1.0228 0.0228 0.44 0.4426 1.0 1953944 Maybridge1_002955 Fc1ccc(cc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O08 compound treatment 0.9602 -0.0398 -0.77 -0.7721 -1.0 1232106 Maybridge1_002956 CCOC(=O)C(C(Nc1ccc(Cl)c(Cl)c1)c2ccccn2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O09 compound treatment 0.9967 -0.00333 -0.06 -0.0647 -1.0 1953945 Maybridge1_002957 CCN(CC)C(=S)Nc1cccc(SC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O10 compound treatment 0.9575 -0.0425 -0.83 -0.8255 -1.0 1953946 Maybridge1_002958 COc1ccc(cc1CC#N)/C(=N/Nc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O11 compound treatment 1.0194 0.0194 0.38 0.3758 1.0 1953947 Maybridge1_002959 Fc1ccc(NC(=S)NNC(=O)CC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O12 compound treatment 0.9651 -0.0349 -0.68 -0.6787 -1.0 1953948 Maybridge1_002960 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1Sc2ccc(Cl)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O13 compound treatment 0.9671 -0.0329 -0.64 -0.6386 -1.0 1953949 Maybridge1_002961 COCCCNC1=C(C#N)C(=O)NC(S1)c2ccc(O)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O14 compound treatment 0.9719 -0.0281 -0.55 -0.5452 -1.0 1953950 Maybridge1_002962 [O-][N+](=O)c1c(cc(cc1C(F)(F)F)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O15 compound treatment 0.9953 -0.0047 -0.09 -0.0914 -1.0 1953951 Maybridge1_002963 COC(=O)c1c(C)onc1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O16 compound treatment 0.9857 -0.0143 -0.28 -0.2782 -1.0 1249654 Maybridge1_002964 Fc1cccc(F)c1NC(=O)c2c(F)cccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O17 compound treatment 0.9802 -0.0198 -0.39 -0.385 -1.0 1953952 Maybridge1_002965 COCCCNC(=S)N/N=C/c1ccccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O18 compound treatment 0.9809 -0.0191 -0.37 -0.3717 -1.0 1953953 Maybridge1_002966 Fc1cccc(F)c1NC(=O)CSc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O19 compound treatment 1.0118 0.0118 0.23 0.229 1.0 1953954 Maybridge1_002967 COCCCNC(=S)N/N=C/c1ccc(cc1)N(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O20 compound treatment 0.9527 -0.0473 -0.92 -0.919 -1.0 1576501 Maybridge1_002968 CSc1cccc(NCN2C(=O)CCC2=O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O21 compound treatment 0.9864 -0.0136 -0.26 -0.2649 -1.0 1953955 Maybridge1_002969 COc1cc(NC(=O)c2c(C)onc2c3ccccc3Cl)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O22 compound treatment 0.9822 -0.0178 -0.34 -0.345 -1.0 1953956 Maybridge1_002970 Cc1onc(c1NC(=O)O/N=C(\N)/c2ccc(Cl)cc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O23 mock treatment 0.976 -0.024 -0.47 -0.4651 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 O24 mock treatment 1.0214 0.0214 0.42 0.4159 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P01 compound treatment 0.9616 -0.0384 -0.75 -0.7454 -1.0 1143543 Maybridge1_002971 Cc1cc(Cl)ccc1NCN2C(=O)CCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P02 compound treatment 1.0015 0.00148 0.03 0.0288 1.0 1468836 Maybridge1_002972 Cc1ccc2N(CCCc2c1)S(=O)(=O)c3c(C)c(C)c(C)c(C)c3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P03 compound treatment 1.0255 0.0255 0.5 0.496 1.0 1953957 Maybridge1_002973 FC(F)(F)c1cc(/C=C/C#N)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P04 compound treatment 1.0297 0.0297 0.58 0.5761 1.0 1953958 Maybridge1_002974 CC(=N)NS(=O)(=O)c1c(C)c(C)c(C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P05 compound treatment 1.0482 0.0482 0.94 0.9365 1.0 1953959 Maybridge1_002975 FC(F)(F)c1cc(/C=C/c2noc(CN3CCCC3)n2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P06 compound treatment 1.0029 0.00286 0.06 0.0555 1.0 1953960 Maybridge1_002976 CC(=O)c1ccccc1OC(=O)c2c(C)onc2c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P07 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 1953961 Maybridge1_002977 COc1ccc(OC)c(c1)S(=O)(=O)Oc2ccc(C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P08 compound treatment 1.0042 0.00423 0.08 0.0822 1.0 1299890 Maybridge1_002978 Clc1ccc(NC(=O)Nc2cccc(Cl)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P09 compound treatment 0.9815 -0.0185 -0.36 -0.3583 -1.0 1953962 Maybridge1_002979 CCN(CC)CCNC(=O)c1c(C)onc1c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P10 compound treatment 1.0077 0.00767 0.15 0.1489 1.0 1953963 Maybridge1_002980 Cc1nn(c(C)c1Cc2c(F)cccc2Cl)S(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P11 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1953964 Maybridge1_002981 Fc1cccc(Cl)c1CSCc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P12 compound treatment 0.9699 -0.0301 -0.59 -0.5852 -1.0 1953965 Maybridge1_002982 CN(C)/C=N/c1c(cc(cc1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P13 compound treatment 1.0097 0.00973 0.19 0.189 1.0 1953966 Maybridge1_002983 NNC(=O)c1snnc1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P14 compound treatment 1.0001 1.07E-4 0.0 0.0021 1.0 1953967 Maybridge1_002984 Nc1nnc(Sc2ncccc2[N+](=O)[O-])s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P15 compound treatment 0.9712 -0.0288 -0.56 -0.5585 -1.0 1953968 Maybridge1_002985 CC1N=C(SC(=O)c2c(C)onc2c3c(Cl)cccc3Cl)N4C(C)N=C(SC(=O)c5c(C)onc5c6c(Cl)cccc6Cl)N14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P16 compound treatment 0.9685 -0.0315 -0.61 -0.6119 -1.0 1953969 Maybridge1_002986 Cc1onc(c1C(=O)N2CCSCC2)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P17 compound treatment 1.1018 0.102 1.98 1.9777 1.0 1726756 Maybridge1_002987 Oc1cc(nn1CCC#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P18 compound treatment 0.9891 -0.0109 -0.21 -0.2115 -1.0 1953970 Maybridge1_002988 [O-][N+](=O)c1cc(C#N)ccc1Sc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P19 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 1466399 Maybridge1_002989 Clc1ccc(NCc2cccnc2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P20 compound treatment 1.0077 0.00767 0.15 0.1489 1.0 1953971 Maybridge1_002990 Cc1c(nnn1c2cc(Cl)cc(Cl)c2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P21 compound treatment 1.0063 0.00629 0.12 0.1222 1.0 1953972 Maybridge1_002991 NC(=N)NS(=O)(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P22 compound treatment 1.0111 0.0111 0.22 0.2157 1.0 1953973 Maybridge1_002992 CC(C)(C)SCCNC(=O)/C=C/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P23 mock treatment 1.0008 7.95E-4 0.02 0.0154 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1232 P24 mock treatment 1.0468 0.0468 0.91 0.9098 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A01 compound treatment 1.066 0.066 1.28 1.2813 1.0 1953974 Maybridge1_005457 Cc1c(sc2ccc(Cl)cc12)c3csc(n3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A02 compound treatment 1.0288 0.0288 0.56 0.5603 1.0 1117656 Maybridge1_005458 Oc1cc(=O)n(c2ccccc2)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A03 compound treatment 1.0231 0.0231 0.45 0.4493 1.0 1953975 Maybridge1_005459 FC(F)(F)COc1cccc(OCC(F)(F)F)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A04 compound treatment 1.026 0.026 0.5 0.5048 1.0 1248358 Maybridge1_005460 Oc1c(c2ccccc2)c(=O)[nH]c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A05 compound treatment 1.0481 0.0481 0.93 0.9346 1.0 1953976 Maybridge1_005461 COc1cccc(OCC(F)(F)F)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A06 compound treatment 1.0303 0.0303 0.59 0.588 1.0 1953977 Maybridge1_005462 c1cncc(c1)c2n[nH]c(n2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A07 compound treatment 1.0438 0.0438 0.85 0.8514 1.0 1698693 Maybridge1_005463 Fc1cccc(OCc2ccc(Cl)cc2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A08 compound treatment 1.0181 0.0181 0.35 0.3523 1.0 1953978 Maybridge1_005464 CCCCN1C(=O)/C(=N/Nc2ccc(C#N)cc2)/C(=C(C#N)C1=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A09 compound treatment 1.051 0.051 0.99 0.9901 1.0 1953979 Maybridge1_005465 FC(F)(F)c1cc(cc(c1)C23NCCN3C(=O)c4ccccc42)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A10 compound treatment 1.0103 0.0103 0.2 0.1997 1.0 1071329 Maybridge1_005466 CC(=O)OC1CCC2(C)C3CCC4(C)C(CCC4C3CC=C2C1)OC(=O)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A11 compound treatment 0.9924 -0.00756 -0.15 -0.1469 -1.0 1953980 Maybridge1_005467 OC(=O)c1ccc(COCOCc2ccc(o2)C(=O)O)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A12 compound treatment 1.0153 0.0153 0.3 0.2968 1.0 1953981 Maybridge1_005468 CC12CCC3C(CCc4cc(Oc5ccc(cc5)[N+](=O)[O-])ccc34)C2CC[C@@]1(O)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A13 compound treatment 1.0046 0.00457 0.09 0.0888 1.0 1953982 Maybridge1_005469 Fc1ccc(NC(=S)NCCCn2ccnc2)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A14 compound treatment 1.0089 0.00886 0.17 0.172 1.0 1011811 Maybridge1_005470 CC12CC(=O)C3C(CCC4=CC(=O)CCC34C)C2CCC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A15 compound treatment 1.0146 0.0146 0.28 0.2829 1.0 1633463 Maybridge1_005471 CC(C)(C)c1ccc(cc1)c2nc3cc(Cl)ccc3c(=O)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A16 compound treatment 1.0089 0.00886 0.17 0.172 1.0 1953983 Maybridge1_005472 CCSC(SCC)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@@H](OC(=O)C)[C@@H](COC(=O)C)OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A17 compound treatment 0.9753 -0.0247 -0.48 -0.4797 -1.0 384 Maybridge1_005473 O=c1[nH]c2ccccc2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A18 compound treatment 1.0096 0.00957 0.19 0.1859 1.0 1004231 Maybridge1_005474 CC1=CC(C)(C)NC(=S)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A19 compound treatment 1.0281 0.0281 0.55 0.5464 1.0 1953984 Maybridge1_005475 CN(C)c1ccc(cc1)C(=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A20 compound treatment 1.0139 0.0139 0.27 0.2691 1.0 1003531 Maybridge1_005476 OC(=O)c1ccccc1NC(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A21 compound treatment 1.041 0.041 0.8 0.796 1.0 1953985 Maybridge1_005477 CC(=O)c1c(C)nn(c1c2ccccc2[N+](=O)[O-])c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A22 compound treatment 1.0167 0.0167 0.32 0.3245 1.0 1953986 Maybridge1_005478 COC(=O)c1ccccc1SC(CC(=O)c2ccccc2)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A23 mock treatment 1.0353 0.0353 0.69 0.685 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 A24 mock treatment 1.0296 0.0296 0.57 0.5741 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B01 compound treatment 1.0581 0.0581 1.13 1.1287 1.0 1953987 Maybridge1_005479 NC(=S)NCc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B02 compound treatment 1.0388 0.0388 0.75 0.7544 1.0 1161665 Maybridge1_005480 Cn1c2NCN(CCc3ccccc3)Cc2c(=O)n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B03 compound treatment 1.0239 0.0239 0.46 0.4632 1.0 1953988 Maybridge1_005481 COc1cc(/C=C\2/N=C(OC2=O)c3ccccc3I)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B04 compound treatment 1.0303 0.0303 0.59 0.588 1.0 1614749 Maybridge1_005482 COc1ccc(cc1)C(=O)Cc2c(O)c3ccccc3oc2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B05 compound treatment 1.0103 0.0103 0.2 0.1997 1.0 1953989 Maybridge1_005483 OC(=O)CC(CC(=O)O)c1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B06 compound treatment 1.0217 0.0217 0.42 0.4216 1.0 1953990 Maybridge1_005484 CC(=O)Nc1ccc(/C=C(\C#N)/c2ccc(C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B07 compound treatment 1.0046 0.00457 0.09 0.0888 1.0 1953991 Maybridge1_005485 CCOC(=O)C1C(C(C(=O)OCC)C(O)(NC1(O)C(F)(F)F)C(F)(F)F)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B08 compound treatment 1.0274 0.0274 0.53 0.5325 1.0 1074669 Maybridge1_005486 O=c1c2cccc3cccc(c4nc5ccccc5n14)c32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B09 compound treatment 0.9981 -0.00185 -0.04 -0.036 -1.0 1953992 Maybridge1_005487 CN(C)C(=O)Nc1ccc(C)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B10 compound treatment 1.001 0.001 0.02 0.0195 1.0 1297284 Maybridge1_005488 CCOc1ccc(NC(C(=O)O)c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B11 compound treatment 1.0189 0.0189 0.37 0.3661 1.0 1953993 Maybridge1_005489 Fc1ccc(cc1)n2ncc3ccccc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B12 compound treatment 0.9917 -0.00828 -0.16 -0.1608 -1.0 1953994 Maybridge1_005490 CCOc1ccc(/C=C\2/N=C(OC2=O)c3cccc(c3)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B13 compound treatment 1.0139 0.0139 0.27 0.2691 1.0 1953995 Maybridge1_005491 O=c1n(CCc2ccccc2)ncc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B14 compound treatment 1.0067 0.00672 0.13 0.1304 1.0 1953996 Maybridge1_005492 CCOc1ccc(/C=C(\C#N)/c2nc3ccccc3[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B15 compound treatment 1.0024 0.00243 0.05 0.0472 1.0 1953997 Maybridge1_005493 Cc1ccc(cc1)N2N=C(CC2c3ccc4OCOc4c3)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B16 compound treatment 1.0103 0.0103 0.2 0.1997 1.0 1953998 Maybridge1_005494 COc1ccc(/C=C(\C#N)/c2ccc(cc2)[N+](=O)[O-])cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B17 compound treatment 1.0017 0.00172 0.03 0.0334 1.0 1953999 Maybridge1_005495 COc1ccc(/C=C/2\CCc3ccccc3C2=O)c(Cl)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B18 compound treatment 0.9746 -0.0254 -0.49 -0.4935 -1.0 1954000 Maybridge1_005496 CC(O)CN1C(=O)c2cccc3cccc(C1=O)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B19 compound treatment 0.981 -0.019 -0.37 -0.3687 -1.0 1587071 Maybridge1_005497 CC1=C(C)CC(C(C1)C(=O)O)C(=O)Nc2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B20 compound treatment 1.0053 0.00529 0.1 0.1027 1.0 1954001 Maybridge1_005498 Brc1ccc2C(=O)N(Cc3cccnc3)C(=O)c4cccc1c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B21 compound treatment 0.9967 -0.00328 -0.06 -0.0637 -1.0 1954002 Maybridge1_005499 OC(=O)c1ccccc1/C=C\2/SC(=S)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B22 compound treatment 0.9853 -0.0147 -0.29 -0.2855 -1.0 1954003 Maybridge1_005500 Clc1ccc(NCN2C(=O)c3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B23 mock treatment 0.9889 -0.0111 -0.22 -0.2162 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 B24 mock treatment 1.031 0.031 0.6 0.6018 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C01 compound treatment 1.0581 0.0581 1.13 1.1287 1.0 1954004 Maybridge1_005501 Cc1nc(cs1)c2sc3ccccc3c2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C02 compound treatment 1.0053 0.00529 0.1 0.1027 1.0 1210275 Maybridge1_005502 O=C1C(C(=O)N(C(=O)N1c2ccccc2)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C03 compound treatment 1.0239 0.0239 0.46 0.4632 1.0 1954005 Maybridge1_005503 Fc1cccc(OCC(F)(F)F)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C04 compound treatment 1.0146 0.0146 0.28 0.2829 1.0 1065642 Maybridge1_005504 Cc1ccc(cc1)S(=O)(=O)OCC2(CCC3CC2)CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C05 compound treatment 1.0146 0.0146 0.28 0.2829 1.0 1954006 Maybridge1_005505 CCOc1cccc(OCC(F)(F)F)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C06 compound treatment 1.0074 0.00743 0.14 0.1443 1.0 1954007 Maybridge1_005506 CC(C)c1cc(C(C)C)c([N+](=O)[O-])c(c1)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C07 compound treatment 0.9882 -0.0118 -0.23 -0.2301 -1.0 1954008 Maybridge1_005507 Cc1ccc(Sc2cccc(F)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C08 compound treatment 1.323 0.323 6.27 6.2728 1.0 1954009 Maybridge1_005508 COc1ccc(/C=C(\C#N)/c2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C09 compound treatment 0.9967 -0.00328 -0.06 -0.0637 -1.0 1954010 Maybridge1_005509 CCOC(=O)NC(=S)N1CCOCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C10 compound treatment 1.016 0.016 0.31 0.3107 1.0 1954011 Maybridge1_005510 C[C@]1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C11 compound treatment 0.9603 -0.0397 -0.77 -0.7708 -1.0 1954012 Maybridge1_005511 CCOC(=O)NC(=S)NCCC1CCNCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C12 compound treatment 1.0081 0.00814 0.16 0.1582 1.0 1954013 Maybridge1_005512 CC(=O)OC1CCC2(COC3CC4C5CCC(OC(=O)c6ccccc6)C5(C)CCC42)[C@]3(Br)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C13 compound treatment 0.986 -0.014 -0.27 -0.2717 -1.0 1954014 Maybridge1_005513 Cc1cc(Br)c(NC(=S)NN)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C14 compound treatment 0.9753 -0.0247 -0.48 -0.4797 -1.0 1954015 Maybridge1_005514 CC(=O)OC1CCC2C3CC[C@H]4CC(OC(=O)C)/C(=C/c5ccccc5)/CC4(C)C3CCC12C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C15 compound treatment 0.9932 -0.00685 -0.13 -0.133 -1.0 1954016 Maybridge1_005515 CCC(C#N)(c1ccccc1)c2ccc(/N=C/c3cc(Cl)cc(Cl)c3O)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C16 compound treatment 0.971 -0.029 -0.56 -0.5629 -1.0 1954017 Maybridge1_005516 Nc1nc2ccc(cc2s1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C17 compound treatment 0.9824 -0.0176 -0.34 -0.341 -1.0 1954018 Maybridge1_005517 OCc1cccc2cccc(I)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C18 compound treatment 1.1067 0.107 2.07 2.0716 1.0 1705887 Maybridge1_005518 Cn1c(=O)c(I)c(O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C19 compound treatment 0.9475 -0.0525 -1.02 -1.0204 -1.0 1954019 Maybridge1_005519 CC(C)(C)c1ccc(cc1[N+](=O)[O-])C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C20 compound treatment 0.9532 -0.0468 -0.91 -0.9095 -1.0 1954020 Maybridge1_005520 COc1ccc(/C=C(\C#N)/c2ccccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C21 compound treatment 1.026 0.026 0.5 0.5048 1.0 1954021 Maybridge1_005521 CC1=NN(C(=O)C1)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C22 compound treatment 1.0089 0.00886 0.17 0.172 1.0 1197943 Maybridge1_005522 COC(=O)c1ccccc1SC(CC(=O)c2cccnc2)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C23 mock treatment 0.9903 -0.00971 -0.19 -0.1885 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 C24 mock treatment 0.9575 -0.0425 -0.83 -0.8263 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D01 compound treatment 1.011 0.011 0.21 0.2136 1.0 1954022 Maybridge1_005523 OCCCCCCNC(=S)Nc1ccc(F)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D02 compound treatment 1.0217 0.0217 0.42 0.4216 1.0 1391290 Maybridge1_005524 OC(=O)COCC(=O)Nc1cccnc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D03 compound treatment 0.9996 -4.24E-4 -0.01 -0.0082 -1.0 1337707 Maybridge1_005525 OC(=O)C(Cc1ccccc1)NC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D04 compound treatment 1.0231 0.0231 0.45 0.4493 1.0 1143718 Maybridge1_005526 Cc1cc(C)cc(c1)N2C(=O)CC(Sc3ccccc3C(=O)O)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D05 compound treatment 0.9939 -0.00614 -0.12 -0.1192 -1.0 1623738 Maybridge1_005527 CC1=CCC2C(C1)C(=O)N(C2=O)c3ccc(I)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D06 compound treatment 1.0217 0.0217 0.42 0.4216 1.0 1954023 Maybridge1_005528 Cc1ccc(cc1)/C(=C/c2ccc3OCOc3c2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D07 compound treatment 1.0217 0.0217 0.42 0.4216 1.0 1954024 Maybridge1_005529 OC(=O)CC(CC(=O)Nc1ccc(I)cc1F)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D08 compound treatment 0.9724 -0.0276 -0.54 -0.5351 -1.0 1024809 Maybridge1_005530 O=C1Nc2ccccc2SC1c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D09 compound treatment 0.956 -0.044 -0.85 -0.854 -1.0 1954025 Maybridge1_005531 CN(C)C(=O)Nc1cccc(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D10 compound treatment 1.0324 0.0324 0.63 0.6296 1.0 1954026 Maybridge1_005532 COc1ccc(/C=C\2/N=C(C)OC2=O)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D11 compound treatment 1.0281 0.0281 0.55 0.5464 1.0 1954027 Maybridge1_005533 OC(=O)c1ccccc1/C=N/Nc2cc(Cl)ccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D12 compound treatment 1.0396 0.0396 0.77 0.7682 1.0 1008681 Maybridge1_005534 COc1cc(cc(OC)c1OC)C(=O)NCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D13 compound treatment 0.9882 -0.0118 -0.23 -0.2301 -1.0 1954028 Maybridge1_005535 C1Oc2ccc(cc2O1)C3CC(=Nc4ccccc4S3)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D14 compound treatment 1.0546 0.0546 1.06 1.0594 1.0 1954029 Maybridge1_005536 Clc1ccc(/C=C(\C#N)/c2nc3ccccc3[nH]2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D15 compound treatment 1.0024 0.00243 0.05 0.0472 1.0 1954030 Maybridge1_005537 O=C/1C2CCN(CC2)\C1=C\c3cccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D16 compound treatment 0.9874 -0.0126 -0.24 -0.2439 -1.0 1954031 Maybridge1_005538 O=C1N(CCCN2CCN(CCCN3C(=O)c4cccc5cccc(C3=O)c45)CC2)C(=O)c6cccc7cccc1c67 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D17 compound treatment 0.986 -0.014 -0.27 -0.2717 -1.0 1954032 Maybridge1_005539 O=C/1/C(=C/c2cccs2)/COC\C1=C/c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D18 compound treatment 1.0653 0.0653 1.27 1.2674 1.0 1954033 Maybridge1_005540 [O-][N+](=O)c1ccc2C(=O)N(Cc3ccco3)C(=O)c4cccc1c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D19 compound treatment 0.9632 -0.0368 -0.72 -0.7154 -1.0 1717190 Maybridge1_005541 OC(=O)C1c2ccccc2C(=O)N(C3CCCCC3)C41CCCCC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D20 compound treatment 0.981 -0.019 -0.37 -0.3687 -1.0 1954034 Maybridge1_005542 O=C1N(CCc2ccccn2)C(=O)c3ccc(Sc4ccccc4)c5cccc1c35 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D21 compound treatment 0.946 -0.054 -1.05 -1.0481 -1.0 1619211 Maybridge1_005543 COc1ccc(cc1)C2C(C(=O)O)c3ccccc3C(=O)N2C4CCN(Cc5ccccc5)CC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D22 compound treatment 1.0096 0.00957 0.19 0.1859 1.0 1954035 Maybridge1_005544 Clc1ccccc1NCN2C(=O)c3ccccc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D23 mock treatment 0.9575 -0.0425 -0.83 -0.8263 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 D24 mock treatment 0.9917 -0.00828 -0.16 -0.1608 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E01 compound treatment 1.0153 0.0153 0.3 0.2968 1.0 1528809 Maybridge1_005545 Cc1c(sc2ccccc12)c3csc(n3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E02 compound treatment 1.0217 0.0217 0.42 0.4216 1.0 1080143 Maybridge1_005546 CC(C)(O)C1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E03 compound treatment 1.096 0.096 1.86 1.8636 1.0 1954036 Maybridge1_005547 O=C/1ON=C(CSc2ccccc2)\C1=C\c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E04 compound treatment 1.0039 0.00386 0.07 0.075 1.0 1954037 Maybridge1_005548 Oc1c(c2ccccc2)c(=O)[nH]c3ccc(OC(F)(F)F)cc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E05 compound treatment 0.9946 -0.00542 -0.11 -0.1053 -1.0 1954038 Maybridge1_005549 CC(C)Oc1cccc(OCC(F)(F)F)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E06 compound treatment 1.0203 0.0203 0.39 0.3939 1.0 1954039 Maybridge1_005550 COc1ccc(Oc2ccc(cn2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E07 compound treatment 1.0388 0.0388 0.75 0.7544 1.0 1954040 Maybridge1_005551 CS/C(=N\S(=O)(=O)c1ccccc1)/Nc2cccc(SC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E08 compound treatment 1.0303 0.0303 0.59 0.588 1.0 1954041 Maybridge1_005552 COc1cc(ccc1N2CCCCC2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E09 compound treatment 1.0467 0.0467 0.91 0.9069 1.0 1954042 Maybridge1_005553 COc1ccc(OC)c(c1)S(=O)(=O)/N=C(\Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)/SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E10 compound treatment 1.0096 0.00957 0.19 0.1859 1.0 1954043 Maybridge1_005554 CC1CC2C3CC[C@H]4CC(O)CCC4(C)C3[C@H](O)CC2(C)[C@@]1(O)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E11 compound treatment 1.0274 0.0274 0.53 0.5325 1.0 1954044 Maybridge1_005555 CCOC(=O)NC(=S)NCc1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E12 compound treatment 0.9853 -0.0147 -0.29 -0.2855 -1.0 1954045 Maybridge1_005556 CC12CCC3C(CCC4=CCCCC34)C2CCC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E13 compound treatment 1.0131 0.0131 0.26 0.2552 1.0 1954046 Maybridge1_005557 CCOC(=O)NC(=S)N1CCSCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E14 compound treatment 0.9967 -0.00328 -0.06 -0.0637 -1.0 1954047 Maybridge1_005558 COc1cc(C)c2C3CCC4(C)C(CC[C@]4(C)O)C3CCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E15 compound treatment 1.036 0.036 0.7 0.6989 1.0 1126946 Maybridge1_005559 Nc1ccc(cc1)S(=O)(=O)Nc2nc(cc(n2)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E16 compound treatment 1.0281 0.0281 0.55 0.5464 1.0 1954048 Maybridge1_005560 C/C(=N\NC(=O)N)/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E17 compound treatment 0.9974 -0.00257 -0.05 -0.0498 -1.0 1954049 Maybridge1_005561 OCc1cccc2cccc(Br)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E18 compound treatment 0.9467 -0.0533 -1.03 -1.0343 -1.0 1954050 Maybridge1_005562 CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c3ccccc13)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E19 compound treatment 0.9682 -0.0318 -0.62 -0.6183 -1.0 1045906 Maybridge1_005563 COc1ccc(cc1)C(=O)c2ccc(OC)cc2OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E20 compound treatment 1.0096 0.00957 0.19 0.1859 1.0 1954051 Maybridge1_005564 N#C/C(=C\c1ccc2OCOc2c1)/c3ccccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E21 compound treatment 1.1195 0.12 2.32 2.3212 1.0 1034241 Maybridge1_005565 CN(C)c1ccc(C=C(C#N)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E22 compound treatment 0.9832 -0.0168 -0.33 -0.3271 -1.0 1954052 Maybridge1_005566 Fc1ccc(cc1)C2CC(=NN2c3ccccc3)c4ccc(F)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E23 mock treatment 0.9917 -0.00828 -0.16 -0.1608 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 E24 mock treatment 0.991 -0.00899 -0.17 -0.1746 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F01 compound treatment 1.0353 0.0353 0.69 0.685 1.0 1954053 Maybridge1_005567 OC(=O)c1cccnc1SC2CC(=O)N(C2=O)c3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F02 compound treatment 1.031 0.031 0.6 0.6018 1.0 1954054 Maybridge1_005568 COc1ccc([N+](=O)[O-])c(n1)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F03 compound treatment 1.0231 0.0231 0.45 0.4493 1.0 1236973 Maybridge1_005569 Cc1nc(NC(=O)c2cnccn2)ccc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F04 compound treatment 1.0017 0.00172 0.03 0.0334 1.0 1049203 Maybridge1_005570 OC(=O)c1onc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F05 compound treatment 1.0017 0.00172 0.03 0.0334 1.0 1252314 Maybridge1_005571 CC1=CCC2C(C1)C(=O)N(C2=O)c3ccc(F)cc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F06 compound treatment 1.0074 0.00743 0.14 0.1443 1.0 1954055 Maybridge1_005572 COc1ccc(cc1)/C(=C/c2ccc(OC)c(OC)c2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F07 compound treatment 0.9817 -0.0183 -0.35 -0.3549 -1.0 1954056 Maybridge1_005573 CSc1cccc(NC(=O)CC(CC(=O)O)c2ccc(cc2)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F08 compound treatment 1.0246 0.0246 0.48 0.4771 1.0 1333234 Maybridge1_005574 CCOc1ccc(NC(C(=O)Nc2ccc(OCC)cc2)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F09 compound treatment 1.0239 0.0239 0.46 0.4632 1.0 1417585 Maybridge1_005575 OC(=O)CSCC(=O)NC1CCN(Cc2ccccc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F10 compound treatment 0.9967 -0.00328 -0.06 -0.0637 -1.0 1954057 Maybridge1_005576 COc1ccc(/C=C(\C#N)/c2cccc(Cl)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F11 compound treatment 1.0367 0.0367 0.71 0.7128 1.0 1954058 Maybridge1_005577 COc1ccc(/C=C/2\CCc3ccccc3C2=O)cc1OCc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F12 compound treatment 0.9732 -0.0268 -0.52 -0.5213 -1.0 1954059 Maybridge1_005578 N#C/C(=C\c1ccccc1)/c2nc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F13 compound treatment 1.0053 0.00529 0.1 0.1027 1.0 1137115 Maybridge1_005579 CC1=C(C)CC(C(C1)C(=O)O)C(=O)NCc2csc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F14 compound treatment 1.0767 0.0767 1.49 1.4892 1.0 1954060 Maybridge1_005580 Clc1ccccc1/C=C(\C#N)/c2nc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F15 compound treatment 1.016 0.016 0.31 0.3107 1.0 1449572 Maybridge1_005581 Cc1cc(ccc1Br)N2C(SCC2=O)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F16 compound treatment 0.9703 -0.0297 -0.58 -0.5767 -1.0 1083206 Maybridge1_005582 O=C1N(CCCCCCCCN2C(=O)c3cccc4cccc(C2=O)c34)C(=O)c5cccc6cccc1c56 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F17 compound treatment 0.9689 -0.0311 -0.6 -0.6044 -1.0 1590174 Maybridge1_005583 O=C(NC(=S)Nc1ccc2CCCc2c1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F18 compound treatment 1.4265 0.427 8.28 8.2833 1.0 1924086 Maybridge1_005584 [O-][N+](=O)c1ccc2C(=O)N(Cc3cccnc3)C(=O)c4cccc1c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F19 compound treatment 0.9774 -0.0226 -0.44 -0.4381 -1.0 1464771 Maybridge1_005585 Cn1c2NCN(Cc3ccc4OCOc4c3)Cc2c(=O)n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F20 compound treatment 1.0146 0.0146 0.28 0.2829 1.0 1954061 Maybridge1_005586 OCCSc1ccc2C(=O)N(CCc3ccccn3)C(=O)c4cccc1c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F21 compound treatment 0.986 -0.014 -0.27 -0.2717 -1.0 1621297 Maybridge1_005587 NC(=O)C1CCN(CC1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F22 compound treatment 0.9689 -0.0311 -0.6 -0.6044 -1.0 1083101 Maybridge1_005588 Clc1cccc(NCN2C(=O)c3ccccc3C2=O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F23 mock treatment 0.9732 -0.0268 -0.52 -0.5213 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 F24 mock treatment 1.0174 0.0174 0.34 0.3384 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G01 compound treatment 1.0396 0.0396 0.77 0.7682 1.0 1679514 Maybridge1_005589 Cc1c(sc2ccccc12)C(=O)c3ccccc3C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G02 compound treatment 0.986 -0.014 -0.27 -0.2717 -1.0 1954062 Maybridge1_005590 OC(=O)C1(CC2CC3CC(Br)(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G03 compound treatment 1.0474 0.0474 0.92 0.9208 1.0 1954063 Maybridge1_005591 Clc1ccc(/C=C/2\C(=O)ON=C2CSc3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G04 compound treatment 1.0103 0.0103 0.2 0.1997 1.0 1080145 Maybridge1_005592 CCOC(=O)C1(CCC2(CC1=O)C(=O)OCC)CC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G05 compound treatment 1.0288 0.0288 0.56 0.5603 1.0 1512628 Maybridge1_005593 Fc1cccc(Oc2ccccc2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G06 compound treatment 1.0503 0.0503 0.98 0.9762 1.0 1038289 Maybridge1_005594 CC(=O)CCc1c[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G07 compound treatment 1.0346 0.0346 0.67 0.6712 1.0 1954064 Maybridge1_005595 Clc1cccc(N/C(=N\S(=O)(=O)c2ccccc2)/NCCc3ccccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G08 compound treatment 0.9796 -0.0204 -0.4 -0.3965 -1.0 1954065 Maybridge1_005596 CN(C1CCCCC1)c2ccc(cc2Cl)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G09 compound treatment 1.0174 0.0174 0.34 0.3384 1.0 1954066 Maybridge1_005597 COc1ccc(OC)c(c1)S(=O)(=O)/N=C(/NCC(C)C)\SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G10 compound treatment 0.9896 -0.0104 -0.2 -0.2023 -1.0 1954067 Maybridge1_005598 C[C@]1(O)CCC2C3CC[C@@]4(C)CC(=O)/C(=C/c5ccccc5)/CC4(C)C3CCC21C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G11 compound treatment 1.0024 0.00243 0.05 0.0472 1.0 1954068 Maybridge1_005599 CN(N)C(=S)NC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G12 compound treatment 1.0053 0.00529 0.1 0.1027 1.0 1954069 Maybridge1_005600 COc1ccc2C3C(C)CC4(C)C(CC[C@@]4(O)C#C)C3CCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G13 compound treatment 1.0346 0.0346 0.67 0.6712 1.0 1954070 Maybridge1_005601 [O-][N+](=O)c1ccc(CNCc2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G14 compound treatment 1.0103 0.0103 0.2 0.1997 1.0 1518209 Maybridge1_005602 O=C(Nc1ccncc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G15 compound treatment 1.0181 0.0181 0.35 0.3523 1.0 1954071 Maybridge1_005603 Nc1oc(c2ccco2)c(c1C#N)c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G16 compound treatment 1.1324 0.132 2.57 2.5707 1.0 1019776 Maybridge1_005604 NNC(=O)c1ccc(o1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G17 compound treatment 0.981 -0.019 -0.37 -0.3687 -1.0 1625004 Maybridge1_005605 OC(=O)Cc1ccccc1I 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G18 compound treatment 1.1024 0.102 1.99 1.9884 1.0 1954072 Maybridge1_005606 CN(C)/C=C/C=C\1/C(=O)c2cccc3cccc1c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G19 compound treatment 1.1938 0.194 3.76 3.7632 1.0 1954073 Maybridge1_005607 COc1cc(N=Nc2c(Cl)cc(cc2[N+](=O)[O-])[N+](=O)[O-])c(NC(=O)C)cc1N(CCO)CCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G20 compound treatment 0.9789 -0.0211 -0.41 -0.4103 -1.0 1954074 Maybridge1_005608 N#C/C(=C\c1ccc(C#N)cc1)/c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G21 compound treatment 1.0246 0.0246 0.48 0.4771 1.0 1954075 Maybridge1_005609 C/C(=C\c1ccc(Cl)cc1)/C(=N/O)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G22 compound treatment 0.9746 -0.0254 -0.49 -0.4935 -1.0 1954076 Maybridge1_005610 CN(C)/C=C/1\Cc2ccccc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G23 mock treatment 1.0203 0.0203 0.39 0.3939 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 G24 mock treatment 1.0074 0.00743 0.14 0.1443 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H01 compound treatment 1.0324 0.0324 0.63 0.6296 1.0 1223060 Maybridge1_005611 OC(=O)CC(CC(=O)Oc1ccccc1N2CCCC2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H02 compound treatment 1.0331 0.0331 0.64 0.6434 1.0 1602597 Maybridge1_005612 CCOC(=O)Cc1csc(NC(=O)CSCC(=O)O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H03 compound treatment 1.0167 0.0167 0.32 0.3245 1.0 1125333 Maybridge1_005613 CCOC(=O)Nc1cc(OC)c(OC)cc1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H04 compound treatment 1.0074 0.00743 0.14 0.1443 1.0 1954077 Maybridge1_005614 Cc1cc(C)c(NC(=O)N)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H05 compound treatment 1.0124 0.0124 0.24 0.2413 1.0 1183506 Maybridge1_005615 CC1=CCC2C(C1)C(=O)N(C2=O)c3ccc(Br)c(C)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H06 compound treatment 1.0524 0.0524 1.02 1.0178 1.0 1954078 Maybridge1_005616 Oc1ccc(/C=C(\C#N)/c2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H07 compound treatment 0.9682 -0.0318 -0.62 -0.6183 -1.0 1954079 Maybridge1_005617 OC(=O)CC(CC(=O)NCc1ccco1)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H08 compound treatment 0.976 -0.024 -0.47 -0.4658 -1.0 1954080 Maybridge1_005618 OCCN1C(=O)c2cccc3cc(cc(C1=O)c23)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H09 compound treatment 1.0053 0.00529 0.1 0.1027 1.0 1954081 Maybridge1_005619 OCC1(CO)CSC(=N1)Nc2ccc(I)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H10 compound treatment 1.0381 0.0381 0.74 0.7405 1.0 1954082 Maybridge1_005620 Clc1cccc(c1)/C(=C/c2ccccc2Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H11 compound treatment 1.0053 0.00529 0.1 0.1027 1.0 1604955 Maybridge1_005621 NS(=O)(=O)c1ccc(cc1)n2ncc3ccccc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H12 compound treatment 1.0446 0.0446 0.87 0.8653 1.0 1776302 Maybridge1_005622 N#C/C(=C\C=C\c1ccccc1)/c2nc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H13 compound treatment 0.9882 -0.0118 -0.23 -0.2301 -1.0 1954083 Maybridge1_005623 O=C1N(CN(CCSc2ccccc2)CN3C(=O)c4ccccc4C3=O)C(=O)c5ccccc15 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H14 compound treatment 1.0303 0.0303 0.59 0.588 1.0 1676681 Maybridge1_005624 Clc1cc(Cl)c2oc(=O)c(cc2c1)c3nc4ccccc4[nH]3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H15 compound treatment 0.9817 -0.0183 -0.35 -0.3549 -1.0 1954084 Maybridge1_005625 CCOC(=O)CSC(=S)NCc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H16 compound treatment 1.0281 0.0281 0.55 0.5464 1.0 1954085 Maybridge1_005626 O=C1N(CC2CCCO2)C(=O)c3cccc4cccc1c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H17 compound treatment 0.9839 -0.0161 -0.31 -0.3133 -1.0 1587112 Maybridge1_005627 COc1ccc(cc1)C2C(C(=O)O)c3ccccc3C(=O)N2Cc4ccc(F)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H18 compound treatment 1.0039 0.00386 0.07 0.075 1.0 1954086 Maybridge1_005628 [O-][N+](=O)c1cc2C(=O)N(CCc3ccccn3)C(=O)c4cccc(c1)c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H19 compound treatment 1.0067 0.00672 0.13 0.1304 1.0 1954087 Maybridge1_005629 CC(=O)Nc1cccc(OCCCN2CNc3c(C2)c(=O)n(C)c(=O)n3C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H20 compound treatment 0.9981 -0.00185 -0.04 -0.036 -1.0 1169131 Maybridge1_005630 CCSc1ccc2C(=O)N(NCCO)C(=O)c3cccc1c32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H21 compound treatment 1.0303 0.0303 0.59 0.588 1.0 1954088 Maybridge1_005631 COc1ccc(/C=C\2/N=C(OC2=O)c3ccccc3)cc1OC4CCCC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H22 compound treatment 0.9996 -4.24E-4 -0.01 -0.0082 -1.0 1954089 Maybridge1_005632 Clc1ccccc1CC2=NCCN2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H23 mock treatment 0.9932 -0.00685 -0.13 -0.133 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 H24 mock treatment 1.016 0.016 0.31 0.3107 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I01 compound treatment 1.031 0.031 0.6 0.6018 1.0 1323676 Maybridge1_005633 CCOC(=O)c1csc(n1)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I02 compound treatment 1.0231 0.0231 0.45 0.4493 1.0 1954090 Maybridge1_005634 OC(=O)C1(CC2CC3CC(Cl)(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I03 compound treatment 1.0067 0.00672 0.13 0.1304 1.0 1954091 Maybridge1_005635 CCCS(=O)(=O)c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I04 compound treatment 0.9653 -0.0347 -0.67 -0.6738 -1.0 1954092 Maybridge1_005636 C1C2CC3CC1CC(C2)(C3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I05 compound treatment 1.0131 0.0131 0.26 0.2552 1.0 1716781 Maybridge1_005637 Fc1ccc(Oc2cccc(F)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I06 compound treatment 1.0081 0.00814 0.16 0.1582 1.0 1954093 Maybridge1_005638 Cc1ccc(cc1)S(=O)(=O)Oc2cc(=O)n(C)c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I07 compound treatment 1.0546 0.0546 1.06 1.0594 1.0 1954094 Maybridge1_005639 COc1ccc(cc1CS/C(=N\S(=O)(=O)c2ccccc2)/Nc3cccc(Cl)c3Cl)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I08 compound treatment 1.031 0.031 0.6 0.6018 1.0 1954095 Maybridge1_005640 CC12CCC3C(CC4OCC53CCC(O)C[C@]45Br)C2CCC1OC(=O)c6ccccc6 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I09 compound treatment 0.9824 -0.0176 -0.34 -0.341 -1.0 1954096 Maybridge1_005641 COc1ccc(OC)c(c1)S(=O)(=O)Nc2ccc(C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I10 compound treatment 1.011 0.011 0.21 0.2136 1.0 1954097 Maybridge1_005642 C[C@]1(O)CCC2C3CC[C@H]4CC5(CCC4(C)C3CCC21C)OCCO5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I11 compound treatment 0.996 -0.00399 -0.08 -0.0776 -1.0 1954098 Maybridge1_005643 CCOC(=O)NC(=S)NCCc1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I12 compound treatment 1.0217 0.0217 0.42 0.4216 1.0 1588046 Maybridge1_005644 CC1CC2(C)C(O)CCC2C3CCc4cc(O)ccc4C13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I13 compound treatment 0.9889 -0.0111 -0.22 -0.2162 -1.0 1954099 Maybridge1_005645 CC(C)(C)c1ccc(NC(=O)CSCC(=O)NN)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I14 compound treatment 0.986 -0.014 -0.27 -0.2717 -1.0 1136690 Maybridge1_005646 Sc1nnc2nc3c4ccccc4c5ccccc5c3nn12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I15 compound treatment 1.6343 0.634 12.32 12.3182 1.0 1004303 Maybridge1_005647 CCOC(=O)C1=C(C)NC(=C(C1)C(=O)OCC)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I16 compound treatment 0.9403 -0.0597 -1.16 -1.1591 -1.0 1083242 Maybridge1_005648 CSC(=N)Nc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I17 compound treatment 0.9782 -0.0218 -0.42 -0.4242 -1.0 1954100 Maybridge1_005649 CC(=O)NCc1ccccc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I18 compound treatment 1.0224 0.0224 0.44 0.4355 1.0 1954101 Maybridge1_005650 O=C/1CCCC\C1=C/Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I19 compound treatment 1.016 0.016 0.31 0.3107 1.0 1050798 Maybridge1_005651 [O-][N+](=O)c1cnc2ccccn12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I20 compound treatment 0.9582 -0.0418 -0.81 -0.8124 -1.0 1954102 Maybridge1_005652 N#C/C(=C/c1cccs1)/c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I21 compound treatment 1.0424 0.0424 0.82 0.8237 1.0 1954103 Maybridge1_005653 COc1ccc(/C=N/c2nc3ccccc3[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I22 compound treatment 0.9974 -0.00257 -0.05 -0.0498 -1.0 1954104 Maybridge1_005654 [O-][N+](=O)C1Cc2ccccc2C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I23 mock treatment 1.0196 0.0196 0.38 0.38 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 I24 mock treatment 1.0153 0.0153 0.3 0.2968 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J01 compound treatment 1.0331 0.0331 0.64 0.6434 1.0 1190021 Maybridge1_005655 OC(=O)CC(CC(=O)Nc1ccc(Oc2ccc(Cl)cc2)cc1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J02 compound treatment 0.9739 -0.0261 -0.51 -0.5074 -1.0 1954105 Maybridge1_005656 COc1ccc(CC(=O)NNC(=S)NCC2CC2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J03 compound treatment 0.976 -0.024 -0.47 -0.4658 -1.0 1145439 Maybridge1_005657 O=C(Nc1ccc2OCCOc2c1)c3cnccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J04 compound treatment 1.0046 0.00457 0.09 0.0888 1.0 1954106 Maybridge1_005658 Cc1ccc(cc1)/C(=C/c2ccco2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J05 compound treatment 1.021 0.021 0.41 0.4077 1.0 1353715 Maybridge1_005659 CC1=CCC2C(C1)C(=O)N(C2=O)c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J06 compound treatment 1.0146 0.0146 0.28 0.2829 1.0 1954107 Maybridge1_005660 CC(Cc1ccc(cc1)C(C)(C)C)/C=C(\C#N)/c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J07 compound treatment 0.9996 -4.24E-4 -0.01 -0.0082 -1.0 1954108 Maybridge1_005661 Fc1cc(I)ccc1N2C(=O)CC(CC2=O)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J08 compound treatment 1.0331 0.0331 0.64 0.6434 1.0 1954109 Maybridge1_005662 COc1ccc(CCN2C(=O)c3cccc4cc(cc(C2=O)c34)[N+](=O)[O-])cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J09 compound treatment 0.9946 -0.00542 -0.11 -0.1053 -1.0 1075870 Maybridge1_005663 CNC(=O)Nc1ccc(C)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J10 compound treatment 1.0331 0.0331 0.64 0.6434 1.0 1954110 Maybridge1_005664 CCOc1ccccc1/C=C(\C#N)/c2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J11 compound treatment 1.0003 2.9E-4 0.01 0.0056 1.0 1954111 Maybridge1_005665 [O-][N+](=O)c1ccc(SCc2c(F)cccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J12 compound treatment 1.066 0.066 1.28 1.2813 1.0 1954112 Maybridge1_005666 Oc1ccc(/C=C(\C#N)/c2nc3ccccc3[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J13 compound treatment 1.0324 0.0324 0.63 0.6296 1.0 1200713 Maybridge1_005667 Nc1nc(cs1)c2csc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J14 compound treatment 0.9989 -0.00114 -0.02 -0.0221 -1.0 1954113 Maybridge1_005668 Cc1ccc(cc1)/C(=C/c2cccc(c2)[N+](=O)[O-])/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J15 compound treatment 0.9846 -0.0154 -0.3 -0.2994 -1.0 1355512 Maybridge1_005669 CN1CCC2(CC1)Nc3ccccc3S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J16 compound treatment 1.0039 0.00386 0.07 0.075 1.0 1954114 Maybridge1_005670 O=C1N(Cc2ccco2)C(=O)c3cccc4cccc1c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J17 compound treatment 1.0139 0.0139 0.27 0.2691 1.0 1527417 Maybridge1_005671 OC(=O)C1C(N(Cc2ccc(F)cc2)C(=O)c3ccccc13)c4ccncc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J18 compound treatment 0.9789 -0.0211 -0.41 -0.4103 -1.0 1954115 Maybridge1_005672 [O-][N+](=O)c1cc2C(=O)N(Cc3cccnc3)C(=O)c4cccc(c1)c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J19 compound treatment 0.9653 -0.0347 -0.67 -0.6738 -1.0 1394250 Maybridge1_005673 CCCSc1ncccc1C(=O)Nc2ccc(Oc3ccc(Cl)cc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J20 compound treatment 0.981 -0.019 -0.37 -0.3687 -1.0 1954116 Maybridge1_005674 CCSc1ccc2C(=O)N(Cc3ccccc3)C(=O)c4cccc1c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J21 compound treatment 0.986 -0.014 -0.27 -0.2717 -1.0 1456671 Maybridge1_005675 CCCCC1(C2CC(=O)N(C2=O)c3cc(F)ccc3F)C(=O)N(N(C1=O)c4ccccc4)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J22 compound treatment 0.9917 -0.00828 -0.16 -0.1608 -1.0 1954117 Maybridge1_005676 Cc1cccnc1NC(=S)Nc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J23 mock treatment 0.9746 -0.0254 -0.49 -0.4935 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 J24 mock treatment 1.0046 0.00457 0.09 0.0888 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K01 compound treatment 2.314 1.31 25.52 25.5181 1.0 1954118 Maybridge1_005677 OCC/N=C/c1c[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K02 compound treatment 1.0017 0.00172 0.03 0.0334 1.0 1246291 Maybridge1_005678 CCCCn1c(=O)c(c(O)c2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K03 compound treatment 1.021 0.021 0.41 0.4077 1.0 1473368 Maybridge1_005679 COc1cccc(OCc2ccccc2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K04 compound treatment 0.9817 -0.0183 -0.35 -0.3549 -1.0 1508064 Maybridge1_005680 Cc1ccc2[nH]c(=O)c(c(O)c2c1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K05 compound treatment 1.0031 0.00315 0.06 0.0611 1.0 1954119 Maybridge1_005681 Cc1ccc(Oc2cccc(F)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K06 compound treatment 1.0239 0.0239 0.46 0.4632 1.0 1954120 Maybridge1_005682 CCCCn1c(=O)c(C(=O)C)c(O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K07 compound treatment 1.0596 0.0596 1.16 1.1565 1.0 1954121 Maybridge1_005683 COc1ccc(cc1CS/C(=N/S(=O)(=O)c2ccccc2)/Nc3cccc(F)c3)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K08 compound treatment 1.0174 0.0174 0.34 0.3384 1.0 1220324 Maybridge1_005684 CC12CCC3C(CCC4=CC(=O)CCC34CO)C2CCC1OC(=O)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K09 compound treatment 0.9674 -0.0326 -0.63 -0.6322 -1.0 1954122 Maybridge1_005685 COc1ccc(OC)c(c1)S(=O)(=O)Nc2cccc(Br)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K10 compound treatment 1.0046 0.00457 0.09 0.0888 1.0 1954123 Maybridge1_005686 CC12CCC3C(CC4OCC53CCC(O)C[C@]45Br)C2CCC1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K11 compound treatment 1.011 0.011 0.21 0.2136 1.0 1954124 Maybridge1_005687 CC(C)(C)C(=O)NCNc1cc(ccc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K12 compound treatment 1.036 0.036 0.7 0.6989 1.0 1607696 Maybridge1_005688 CC(=O)OC1CCC2C3CCc4cc(OC(=O)C)ccc4C3=CCC12C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K13 compound treatment 0.9874 -0.0126 -0.24 -0.2439 -1.0 1954125 Maybridge1_005689 Fc1ccc(NC(=O)CSc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K14 compound treatment 1.0117 0.0117 0.23 0.2275 1.0 1954126 Maybridge1_005690 [O-][N+](=O)c1ccc(cc1)C(=O)c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K15 compound treatment 0.981 -0.019 -0.37 -0.3687 -1.0 1954127 Maybridge1_005691 OC(=O)c1cccc2cccc(I)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K16 compound treatment 1.0274 0.0274 0.53 0.5325 1.0 1025088 Maybridge1_005692 O=C1CSc2nc3ccccc3n12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K17 compound treatment 1.0317 0.0317 0.62 0.6157 1.0 1303991 Maybridge1_005693 CCCN(CCC)S(=O)(=O)c1cccc2c(N)cccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K18 compound treatment 1.0296 0.0296 0.57 0.5741 1.0 1597977 Maybridge1_005694 COc1ccc2CCC(=O)c3cccc1c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K19 compound treatment 1.0024 0.00243 0.05 0.0472 1.0 1954128 Maybridge1_005695 COCCCn1c(O)cc(C)c(C#N)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K20 compound treatment 0.9967 -0.00328 -0.06 -0.0637 -1.0 1930200 Maybridge1_005696 CC(=O)c1ccc(cc1)N2C(=O)c3ccccc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K21 compound treatment 0.9682 -0.0318 -0.62 -0.6183 -1.0 1954129 Maybridge1_005697 OC(=O)c1ccccc1/C=C/c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K22 compound treatment 1.0003 2.9E-4 0.01 0.0056 1.0 1954130 Maybridge1_005698 CN(C)c1ccc(/C=C(\C)/[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K23 mock treatment 1.0203 0.0203 0.39 0.3939 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 K24 mock treatment 1.0146 0.0146 0.28 0.2829 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L01 compound treatment 1.0388 0.0388 0.75 0.7544 1.0 1954131 Maybridge1_005699 CC(C)c1ccc(NNC(=S)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L02 compound treatment 0.9639 -0.0361 -0.7 -0.7015 -1.0 1740357 Maybridge1_005700 CCOC(=O)Cc1csc(NC(=O)COCC(=O)O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L03 compound treatment 1.011 0.011 0.21 0.2136 1.0 1954132 Maybridge1_005701 COc1ccc(cc1)C(=O)CSc2nc(SCC(=O)c3ccc(OC)cc3)c4ccccc4n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L04 compound treatment 1.0667 0.0667 1.3 1.2951 1.0 1954133 Maybridge1_005702 COc1ccc(cc1)/C(=C/c2ccco2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L05 compound treatment 1.006 0.006 0.12 0.1166 1.0 1954134 Maybridge1_005703 CCOC(=O)C1C(C(C(=O)OCC)C(O)(NC1(O)C(F)(F)F)C(F)(F)F)c2ccc(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L06 compound treatment 1.0346 0.0346 0.67 0.6712 1.0 1055764 Maybridge1_005704 [O-][N+](=O)c1ccc(cc1)c2cc3ccccc3oc2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L07 compound treatment 1.0596 0.0596 1.16 1.1565 1.0 1466179 Maybridge1_005705 Ic1ccc(NC(=O)c2cnccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L08 compound treatment 1.0353 0.0353 0.69 0.685 1.0 1954135 Maybridge1_005706 [O-][N+](=O)c1cc2C(=O)N(Cc3ccncc3)C(=O)c4cccc(c1)c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L09 compound treatment 0.9924 -0.00756 -0.15 -0.1469 -1.0 1565743 Maybridge1_005707 OCCn1ncc2ccccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L10 compound treatment 0.9803 -0.0197 -0.38 -0.3826 -1.0 1954136 Maybridge1_005708 CCOc1ccc(/C=C(\C#N)/c2cccc(Cl)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L11 compound treatment 1.0081 0.00814 0.16 0.1582 1.0 1257114 Maybridge1_005709 CSCC(O)Cn1ncc2ccccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L12 compound treatment 1.0024 0.00243 0.05 0.0472 1.0 1954137 Maybridge1_005710 N#C/C(=C\c1ccc2OCOc2c1)/c3nc4ccccc4[nH]3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L13 compound treatment 1.001 0.001 0.02 0.0195 1.0 1660703 Maybridge1_005711 O=C1N(CN2CCN(Cc3csc4ccccc34)CC2)C(=O)c5ccccc15 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L14 compound treatment 0.9218 -0.0782 -1.52 -1.5196 -1.0 1589700 Maybridge1_005712 CC(=O)N(C(=O)C)c1ccc2CCc3cccc1c32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L15 compound treatment 0.9882 -0.0118 -0.23 -0.2301 -1.0 1954138 Maybridge1_005713 CCOC(=O)CSC(=S)NCc1ccc(C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L16 compound treatment 0.9717 -0.0283 -0.55 -0.549 -1.0 1954139 Maybridge1_005714 O=C1N(CCc2ccccn2)C(=O)c3cccc4cccc1c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L17 compound treatment 1.0067 0.00672 0.13 0.1304 1.0 1954140 Maybridge1_005715 CC(=O)c1ccc(cc1)N2C(=O)CSCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L18 compound treatment 1.0267 0.0267 0.52 0.5187 1.0 1954141 Maybridge1_005716 [O-][N+](=O)c1cc2C(=O)N(Cc3ccco3)C(=O)c4cccc(c1)c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L19 compound treatment 0.9932 -0.00685 -0.13 -0.133 -1.0 1925350 Maybridge1_005717 COc1cc(/C=C/C(=O)NCc2ccc3OCOc3c2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L20 compound treatment 1.0281 0.0281 0.55 0.5464 1.0 1954142 Maybridge1_005718 Oc1ccc(Br)cc1/C=N/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L21 compound treatment 0.9824 -0.0176 -0.34 -0.341 -1.0 1235602 Maybridge1_005719 CC1CC(CC(C)(C)C1)N2CNc3c(C2)c(=O)n(C)c(=O)n3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L22 compound treatment 0.9939 -0.00614 -0.12 -0.1192 -1.0 1954143 Maybridge1_005720 Cc1cccnc1NC(=S)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L23 mock treatment 0.9489 -0.0511 -0.99 -0.9927 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 L24 mock treatment 0.9767 -0.0233 -0.45 -0.4519 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M01 compound treatment 1.0596 0.0596 1.16 1.1565 1.0 1351940 Maybridge1_005721 CC(C)c1ccc(cc1)C2CC(=O)Nc3ccccc3S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M02 compound treatment 1.0267 0.0267 0.52 0.5187 1.0 1619898 Maybridge1_005722 CCCCn1c(=O)c(CC)c(O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M03 compound treatment 1.0046 0.00457 0.09 0.0888 1.0 1615702 Maybridge1_005723 COc1cccc(OCc2ccc(Cl)cc2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M04 compound treatment 1.0053 0.00529 0.1 0.1027 1.0 1579375 Maybridge1_005724 Oc1cc(=O)n2CCCc3cccc1c32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M05 compound treatment 1.0017 0.00172 0.03 0.0334 1.0 1126929 Maybridge1_005725 Nc1nc(N)c2c(Oc3ccc(F)cc3)cccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M06 compound treatment 1.011 0.011 0.21 0.2136 1.0 1954144 Maybridge1_005726 CCOC(=O)C1=C(C)N(C(=O)C)C(=NC1c2ccccc2)SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M07 compound treatment 1.0338 0.0338 0.66 0.6573 1.0 1954145 Maybridge1_005727 OC(=O)CS/C(=N/S(=O)(=O)c1ccccc1)/Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M08 compound treatment 0.9867 -0.0133 -0.26 -0.2578 -1.0 1497952 Maybridge1_005728 CC(=O)OC1CCC2(C)C3C(CC4(C)C(CC=C4OC(=O)C)C3CC[C@@]2(C)C1)OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M09 compound treatment 1.0246 0.0246 0.48 0.4771 1.0 1954146 Maybridge1_005729 Clc1ccc(cc1Cl)n2c(=O)[nH][nH]c2=S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M10 compound treatment 0.9774 -0.0226 -0.44 -0.4381 -1.0 1954147 Maybridge1_005730 CC12CCC3C(CC[C@H]4CC5(CCC43C)OCCO5)C2CCC1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M11 compound treatment 1.0096 0.00957 0.19 0.1859 1.0 1954148 Maybridge1_005731 CC(C)(C)C(=O)NC(=S)Nc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M12 compound treatment 1.0046 0.00457 0.09 0.0888 1.0 1954149 Maybridge1_005732 CC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CCC4(C)C3(F)C(O)CC21C)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M13 compound treatment 1.031 0.031 0.6 0.6018 1.0 1954150 Maybridge1_005733 Clc1ccc(SCCC(=O)c2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M14 compound treatment 0.971 -0.029 -0.56 -0.5629 -1.0 1954151 Maybridge1_005734 CC12CCC3C(CCc4cc(Oc5ccc(cc5)[N+](=O)[O-])ccc34)C2CCC1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M15 compound treatment 1.0353 0.0353 0.69 0.685 1.0 1954152 Maybridge1_005735 OC(=O)c1ccccc1CS(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M16 compound treatment 0.976 -0.024 -0.47 -0.4658 -1.0 1954153 Maybridge1_005736 S=C1NN=C(CS1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M17 compound treatment 0.956 -0.044 -0.85 -0.854 -1.0 1954154 Maybridge1_005737 Cn1c(n[nH]c1=S)c2ccccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M18 compound treatment 1.0867 0.0867 1.68 1.6834 1.0 419 Maybridge1_005738 CC1=NN(C(=O)C1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M19 compound treatment 1.0274 0.0274 0.53 0.5325 1.0 1914168 Maybridge1_005739 CC1=NN(C(=O)C1N=Nc2ccc(cc2)[N+](=O)[O-])c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M20 compound treatment 0.9939 -0.00614 -0.12 -0.1192 -1.0 1954155 Maybridge1_005740 CSc1c(c(N)nn1S(=O)(=O)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M21 compound treatment 0.9846 -0.0154 -0.3 -0.2994 -1.0 1228318 Maybridge1_005741 Oc1c(Cc2ccccc2)c(=O)n(Cc3ccccc3)c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M22 compound treatment 0.9582 -0.0418 -0.81 -0.8124 -1.0 1954156 Maybridge1_005742 OC(=O)c1ccccc1NC(=O)Nc2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M23 mock treatment 1.0524 0.0524 1.02 1.0178 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 M24 mock treatment 0.9832 -0.0168 -0.33 -0.3271 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N01 compound treatment 1.0574 0.0574 1.11 1.1149 1.0 1198258 Maybridge1_005743 NCc1csc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N02 compound treatment 1.021 0.021 0.41 0.4077 1.0 1328597 Maybridge1_005744 Cn1c(NC2CCN(Cc3ccccc3)CC2)cc(=O)n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N03 compound treatment 1.0374 0.0374 0.73 0.7266 1.0 1954157 Maybridge1_005745 FC(F)(F)Oc1ccc(NC(=O)c2cnccn2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N04 compound treatment 1.0146 0.0146 0.28 0.2829 1.0 1668560 Maybridge1_005746 CN(C)c1ccc(C=C(c2ccc(N)cc2)c3ccc(N)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N05 compound treatment 0.9703 -0.0297 -0.58 -0.5767 -1.0 1954158 Maybridge1_005747 CCOC(=O)C1C(C(C(=O)OCC)C(O)(NC1(O)C(F)(F)F)C(F)(F)F)c2ccc(C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N06 compound treatment 1.0067 0.00672 0.13 0.1304 1.0 1954159 Maybridge1_005748 [O-][N+](=O)c1ccc(cc1)c2cc3cc(Br)ccc3oc2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N07 compound treatment 1.0003 2.9E-4 0.01 0.0056 1.0 1363436 Maybridge1_005749 COc1cc(NC(=O)c2cnccn2)cc(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N08 compound treatment 1.0317 0.0317 0.62 0.6157 1.0 1516801 Maybridge1_005750 COc1ccc(NC(C(=O)O)c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N09 compound treatment 1.0039 0.00386 0.07 0.075 1.0 1538120 Maybridge1_005751 CC(C)c1ccc(cc1)n2ncc3ccccc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N10 compound treatment 1.0024 0.00243 0.05 0.0472 1.0 1954160 Maybridge1_005752 COc1ccc(/C=C\2/N=C(OC2=O)c3ccc(cc3)[N+](=O)[O-])cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N11 compound treatment 0.996 -0.00399 -0.08 -0.0776 -1.0 1954161 Maybridge1_005753 OC(=O)CC(CC(=O)NCCc1c[nH]c2ccccc12)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N12 compound treatment 0.9924 -0.00756 -0.15 -0.1469 -1.0 1934652 Maybridge1_005754 COc1ccc(/C=C(\C#N)/c2nc3ccccc3[nH]2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N13 compound treatment 0.9846 -0.0154 -0.3 -0.2994 -1.0 1954162 Maybridge1_005755 COc1cc(/C=C/2\CCc3ccccc3C2=O)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N14 compound treatment 1.0267 0.0267 0.52 0.5187 1.0 1954163 Maybridge1_005756 O=C1N(CCCN2CCOCC2)C(=O)c3cccc4cccc1c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N15 compound treatment 0.9767 -0.0233 -0.45 -0.4519 -1.0 1156124 Maybridge1_005757 OCCN1CCN(Cn2nnc3ccccc23)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N16 compound treatment 1.026 0.026 0.5 0.5048 1.0 1954164 Maybridge1_005758 O=C1N(Cc2ccccn2)C(=O)c3cccc4cccc1c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N17 compound treatment 0.9867 -0.0133 -0.26 -0.2578 -1.0 1725522 Maybridge1_005759 COc1ccc(cc1)C2C(C(=O)O)c3ccccc3C(=O)N2CC4CC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N18 compound treatment 1.021 0.021 0.41 0.4077 1.0 1954165 Maybridge1_005760 [O-][N+](=O)c1cc2C(=O)N(Cc3ccccc3)C(=O)c4cccc(c1)c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N19 compound treatment 0.946 -0.054 -1.05 -1.0481 -1.0 1544026 Maybridge1_005761 OC(=O)C1C(N(Cc2ccc3OCOc3c2)C(=O)c4ccccc14)c5cccnc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N20 compound treatment 0.9903 -0.00971 -0.19 -0.1885 -1.0 1954166 Maybridge1_005762 Cc1ccc(NC(=S)Nc2ccc(Cl)c(Cl)c2)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N21 compound treatment 1.0096 0.00957 0.19 0.1859 1.0 1702594 Maybridge1_005763 COc1ccc(CCN2CNc3c(C2)c(=O)n(C)c(=O)n3C)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N22 compound treatment 0.9767 -0.0233 -0.45 -0.4519 -1.0 1136435 Maybridge1_005764 CCOC(=O)c1ccc(NC(=S)Nc2ncccc2C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N23 mock treatment 0.991 -0.00899 -0.17 -0.1746 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 N24 mock treatment 1.0239 0.0239 0.46 0.4632 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O01 compound treatment 1.0153 0.0153 0.3 0.2968 1.0 1954167 Maybridge1_005765 Cc1c(/C=N/NC(=S)N)sc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O02 compound treatment 1.0124 0.0124 0.24 0.2413 1.0 1570365 Maybridge1_005766 CCCCn1c(=O)c(Cc2ccccc2)c(O)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O03 compound treatment 1.001 0.001 0.02 0.0195 1.0 1685933 Maybridge1_005767 COc1cccc(OCc2ccccc2Cl)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O04 compound treatment 1.0081 0.00814 0.16 0.1582 1.0 1347568 Maybridge1_005768 COc1ccc2c(O)c(c3ccccc3)c(=O)[nH]c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O05 compound treatment 1.0046 0.00457 0.09 0.0888 1.0 1503605 Maybridge1_005769 Cc1ccc(COc2cccc(F)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O06 compound treatment 1.0017 0.00172 0.03 0.0334 1.0 1140779 Maybridge1_005770 CC1(C)c2ccccc2-n3c1cc(O)c(c4ccccc4)c3=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O07 compound treatment 1.001 0.001 0.02 0.0195 1.0 1954168 Maybridge1_005771 FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(=O)c2ccccc2C(=O)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O08 compound treatment 0.996 -0.00399 -0.08 -0.0776 -1.0 1227353 Maybridge1_005772 CC12CCC3C(CC[C@@]4(C)CC(=O)CCC34CO)C2CCC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O09 compound treatment 1.031 0.031 0.6 0.6018 1.0 1954169 Maybridge1_005773 COC(=O)c1ccc(COCOCc2ccc(o2)C(=O)OC)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O10 compound treatment 0.981 -0.019 -0.37 -0.3687 -1.0 1044579 Maybridge1_005774 CC12CCC3C(CCC4=CCCCC34)C2CCC1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O11 compound treatment 1.016 0.016 0.31 0.3107 1.0 1702653 Maybridge1_005775 Fc1ccc(cc1Cl)c2n[nH]c(=O)c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O12 compound treatment 0.9753 -0.0247 -0.48 -0.4797 -1.0 1011810 Maybridge1_005776 CC12CCC3C(CCC4=CC(=O)CCC34)C2CCC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O13 compound treatment 1.0374 0.0374 0.73 0.7266 1.0 1954170 Maybridge1_005777 Fc1ccc(N2C(=O)CCC2=O)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O14 compound treatment 1.0089 0.00886 0.17 0.172 1.0 1730077 Maybridge1_005778 CCOC(=O)Cc1cc(C)[nH]c1C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O15 compound treatment 0.9732 -0.0268 -0.52 -0.5213 -1.0 1116695 Maybridge1_005779 CCCCCCC(C)OC(=O)c1ccccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O16 compound treatment 1.0046 0.00457 0.09 0.0888 1.0 1954171 Maybridge1_005780 OC(=O)[C@@H]1CSC(N1)c2cccc(O)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O17 compound treatment 0.9846 -0.0154 -0.3 -0.2994 -1.0 1641535 Maybridge1_005781 CC(=O)Nc1ccc2C(=O)CCCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O18 compound treatment 0.9674 -0.0326 -0.63 -0.6322 -1.0 1083145 Maybridge1_005782 CC1C(OCCN1CN2C(=O)c3ccccc3C2=O)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O19 compound treatment 1.0131 0.0131 0.26 0.2552 1.0 1954172 Maybridge1_005783 CCC(C(=O)N)(c1ccccc1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O20 compound treatment 0.9696 -0.0304 -0.59 -0.5906 -1.0 1954173 Maybridge1_005784 COc1ccc(/C=C(\C#N)/c2cccs2)c(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O21 compound treatment 0.9989 -0.00114 -0.02 -0.0221 -1.0 1717986 Maybridge1_005785 Cc1ccc2c(O)c(c3ccccc3)c(=O)[nH]c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O22 compound treatment 0.9532 -0.0468 -0.91 -0.9095 -1.0 1954174 Maybridge1_005786 FC(F)(F)c1ccc(Nc2nc3ccccc3c(=O)o2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O23 mock treatment 0.9946 -0.00542 -0.11 -0.1053 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 O24 mock treatment 0.9917 -0.00828 -0.16 -0.1608 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P01 compound treatment 1.0374 0.0374 0.73 0.7266 1.0 1954175 Maybridge1_005787 Clc1ccc(/C=C\2/N=C(OC2=O)c3ccccc3I)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P02 compound treatment 1.0438 0.0438 0.85 0.8514 1.0 1383634 Maybridge1_005788 COc1ccc(cc1)C(=O)COc2cc(=O)oc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P03 compound treatment 1.0139 0.0139 0.27 0.2691 1.0 1683070 Maybridge1_005789 O=C1N(C(c2ccccc2)c3ccccc3)C(=O)c4nccnc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P04 compound treatment 1.0224 0.0224 0.44 0.4355 1.0 1954176 Maybridge1_005790 COc1ccc(cc1)/C(=C/c2ccc(NC(=O)C)cc2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P05 compound treatment 1.0681 0.0681 1.32 1.3229 1.0 1954177 Maybridge1_005791 COc1cc(NC(=O)CC(CC(=O)O)c2ccc(cc2)C(F)(F)F)cc(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P06 compound treatment 1.046 0.046 0.89 0.893 1.0 1583290 Maybridge1_005792 CC(=O)ON1C(=O)c2cccc3cccc(C1=O)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P07 compound treatment 1.0274 0.0274 0.53 0.5325 1.0 1131102 Maybridge1_005793 Cn1c2NCN(CCCn3ccnc3)Cc2c(=O)n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P08 compound treatment 1.0324 0.0324 0.63 0.6296 1.0 1419526 Maybridge1_005794 OC(=O)C(Nc1ccc2OCOc2c1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P09 compound treatment 1.0338 0.0338 0.66 0.6573 1.0 1954178 Maybridge1_005795 CN(C)C(=O)Nc1cccc(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P10 compound treatment 0.9789 -0.0211 -0.41 -0.4103 -1.0 1063962 Maybridge1_005796 Cc1ccc(cc1)C(=O)NCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P11 compound treatment 0.9981 -0.00185 -0.04 -0.036 -1.0 1954179 Maybridge1_005797 Fc1cccc(Cl)c1CSc2ccc(cn2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P12 compound treatment 1.0296 0.0296 0.57 0.5741 1.0 1954180 Maybridge1_005798 Oc1ccc(Br)cc1/C=C(\C#N)/c2nc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P13 compound treatment 0.9774 -0.0226 -0.44 -0.4381 -1.0 1954181 Maybridge1_005799 CCOC(=O)c1ccccc1CSC(=N)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P14 compound treatment 0.9974 -0.00257 -0.05 -0.0498 -1.0 1954182 Maybridge1_005800 Nc1ccc(cc1)C(=O)/C(=C\c2cccc(c2)[N+](=O)[O-])/C(=O)c3ccc(cc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P15 compound treatment 1.0024 0.00243 0.05 0.0472 1.0 1342828 Maybridge1_005801 Cn1c(=O)sn(c2cccc3ccccc23)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P16 compound treatment 0.9974 -0.00257 -0.05 -0.0498 -1.0 1400120 Maybridge1_005802 CCOC(=O)NN1C(=O)c2cccc3cccc(C1=O)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P17 compound treatment 0.9696 -0.0304 -0.59 -0.5906 -1.0 1954183 Maybridge1_005803 [O-][N+](=O)c1ccc(C=C2C(=O)c3ccccc3C2=O)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P18 compound treatment 1.0553 0.0553 1.07 1.0733 1.0 1954184 Maybridge1_005804 Brc1ccc2C(=O)N(CCc3ccccn3)C(=O)c4cccc1c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P19 compound treatment 0.9767 -0.0233 -0.45 -0.4519 -1.0 1474642 Maybridge1_005805 OC(=O)C1C(N(Cc2ccc(F)cc2)C(=O)c3ccccc13)c4cccnc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P20 compound treatment 1.0438 0.0438 0.85 0.8514 1.0 1083096 Maybridge1_005806 Clc1ccc(NC2=NCCS2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P21 compound treatment 0.9582 -0.0418 -0.81 -0.8124 -1.0 1954185 Maybridge1_005807 Cn1c2NCN(CCCCCCO)Cc2c(=O)n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P22 compound treatment 0.9439 -0.0561 -1.09 -1.0897 -1.0 1954186 Maybridge1_005808 Oc1csc(=N/N=C/c2ccccc2)n1c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P23 mock treatment 0.9882 -0.0118 -0.23 -0.2301 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.1233 P24 mock treatment 1.0089 0.00886 0.17 0.172 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A01 compound treatment 1.0535 0.0535 1.04 1.0381 1.0 2069431 Maybridge1_000177 OCCN1CCN(CC1)c2ncc(Cl)cc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A02 compound treatment 0.9873 -0.0127 -0.25 -0.2471 -1.0 1539016 Maybridge1_000178 CCOC(=O)C1CCN(CC1)c2ncnc3scc(c4ccccc4)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A03 compound treatment 1.1196 0.12 2.32 2.3234 1.0 2069432 Maybridge1_000179 c1csc(c1)c2cc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A04 compound treatment 1.0114 0.0114 0.22 0.2216 1.0 1705599 Maybridge1_000180 CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A05 compound treatment 0.9912 -0.00883 -0.17 -0.1715 -1.0 2069433 Maybridge1_000181 [O-][N+](=O)c1cccnc1N2CCCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A06 compound treatment 0.9351 -0.0649 -1.26 -1.2602 -1.0 1502090 Maybridge1_000182 CCc1cccc(C)c1NC(=O)N2CCN(CC2)C(=O)OC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A07 compound treatment 0.9818 -0.0182 -0.35 -0.353 -1.0 2069434 Maybridge1_000183 CC(C)(C)OC(=O)NCCNC(=O)Nc1cccc(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A08 compound treatment 0.9538 -0.0462 -0.9 -0.8973 -1.0 2069435 Maybridge1_000184 CC1CCCC(C)N1C(=S)Nc2ccc(C)cc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A09 compound treatment 0.9912 -0.00883 -0.17 -0.1715 -1.0 2069436 Maybridge1_000185 CC(=O)Nc1cc(ccc1n2cc(C)c(n2)C(F)(F)F)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A10 compound treatment 1.0099 0.00985 0.19 0.1914 1.0 1564219 Maybridge1_000186 Cc1ccc(cc1)c2csc3ncnc(N4CCc5ccccc5C4)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A11 compound treatment 0.9569 -0.0431 -0.84 -0.8368 -1.0 2069437 Maybridge1_000187 [O-][N+](=O)c1ccc(nc1)N2CCCN(CC2)C(=S)Nc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A12 compound treatment 1.0418 0.0418 0.81 0.8113 1.0 1073786 Maybridge1_000188 CCOC(=O)c1c(N)sc2CN(C)CCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A13 compound treatment 0.9725 -0.0275 -0.53 -0.5344 -1.0 2069438 Maybridge1_000189 CC(C)(C)c1ccc(cc1)C(=O)NCCNc2nccc(n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A14 compound treatment 0.9764 -0.0236 -0.46 -0.4588 -1.0 2069439 Maybridge1_000190 CC(C)(C)OC(=O)NCCCNC(=S)Nc1ccc2OCCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A15 compound treatment 0.9772 -0.0228 -0.44 -0.4437 -1.0 1122662 Maybridge1_000191 Clc1ccc(cc1)S(=O)(=O)N2CCCN(Cc3ccc(Cl)cc3Cl)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A16 compound treatment 0.9678 -0.0322 -0.63 -0.6251 -1.0 2069440 Maybridge1_000192 CCCCCc1ccc(NC(=O)NNc2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A17 compound treatment 0.9974 -0.0026 -0.05 -0.0506 -1.0 2069441 Maybridge1_000193 CC(=O)c1ccc(OCC(O)CN2CCCN(CC2)C(=O)c3cccs3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A18 compound treatment 1.02 0.02 0.39 0.3879 1.0 1083184 Maybridge1_000194 COc1ccccc1NC(=S)NCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A19 compound treatment 0.9725 -0.0275 -0.53 -0.5344 -1.0 1522108 Maybridge1_000195 COc1ccccc1C2CCN(CC2)C(=S)Nc3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A20 compound treatment 0.9717 -0.0283 -0.55 -0.5495 -1.0 1083188 Maybridge1_000196 CCOC(=O)c1cc(C)nc2ccc(Br)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A21 compound treatment 1.013 0.013 0.25 0.2519 1.0 1170678 Maybridge1_000197 COc1ccc(OCC(O)CNC2CCN(CC2)c3ncnc4scc(c5ccccc5)c34)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A22 compound treatment 0.9647 -0.0353 -0.69 -0.6856 -1.0 1914814 Maybridge1_000198 COc1ccc(/N=C/c2ccccc2O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A23 mock treatment 0.9717 -0.0283 -0.55 -0.5495 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 A24 mock treatment 1.0052 0.00518 0.1 0.1006 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B01 compound treatment 1.0099 0.00985 0.19 0.1914 1.0 1118509 Maybridge1_000199 Clc1c(sc2ccccc12)C(=O)N(CCC#N)Cc3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B02 compound treatment 1.0083 0.0083 0.16 0.1611 1.0 2069442 Maybridge1_000200 Clc1c(sc2ccccc12)C(=O)NNC(=S)Nc3cc(Cl)ccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B03 compound treatment 1.0013 0.00129 0.03 0.025 1.0 2069443 Maybridge1_000201 O=C(N/N=C/c1cccs1)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B04 compound treatment 0.9927 -0.00728 -0.14 -0.1413 -1.0 2069444 Maybridge1_000202 COc1ccc(cc1)C(=O)NNC(=S)Nc2ccc(Cl)cc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B05 compound treatment 0.9297 -0.0703 -1.37 -1.366 -1.0 2069445 Maybridge1_000203 COc1cc(cc(OC)c1OC)C2SCc3cc(C)c(C)cc3CS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B06 compound treatment 0.9764 -0.0236 -0.46 -0.4588 -1.0 2069446 Maybridge1_000204 CC(=O)CS(=O)(=O)c1ccc(C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B07 compound treatment 0.9585 -0.0415 -0.81 -0.8066 -1.0 2069447 Maybridge1_000205 Cc1cccc(Cl)c1/N=C/2\SC(=C)C3(CCCCC3)N2C(=O)c4sc5ccccc5c4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B08 compound treatment 0.9873 -0.0127 -0.25 -0.2471 -1.0 2069448 Maybridge1_000206 CC(C)CC(C)(SCC(=O)O)SCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B09 compound treatment 0.9522 -0.0478 -0.93 -0.9275 -1.0 1559306 Maybridge1_000207 COc1ccc(NC(=S)Nc2c(C)cccc2C)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B10 compound treatment 0.9655 -0.0345 -0.67 -0.6705 -1.0 2069449 Maybridge1_000208 Cc1cccc2CCCN(C(=S)Nc3cccc(Cl)c3)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B11 compound treatment 0.9125 -0.0875 -1.7 -1.6987 -1.0 1049127 Maybridge1_000209 CC(=O)Nc1ccc(C)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B12 compound treatment 0.9943 -0.00572 -0.11 -0.111 -1.0 2069450 Maybridge1_000210 Fc1ccc(NC(=O)c2ccccc2NC(=S)Nc3cccc(c3)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B13 compound treatment 0.9997 -2.68E-4 -0.01 -0.0052 -1.0 2069451 Maybridge1_000211 COc1ccc(NC(=O)/C=N/O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B14 compound treatment 1.0028 0.00285 0.06 0.0553 1.0 1083091 Maybridge1_000212 CC(=O)c1cc2cc(Br)ccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B15 compound treatment 1.0153 0.0153 0.3 0.2972 1.0 2069452 Maybridge1_000213 [O-][N+](=O)c1ccc(SCC(=O)Nc2ccc(F)cc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B16 compound treatment 1.0044 0.0044 0.09 0.0855 1.0 2069453 Maybridge1_000214 CN(C)c1ccc(/C=N/CCC\N=C\c2ccc(cc2)N(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B17 compound treatment 0.9826 -0.0174 -0.34 -0.3378 -1.0 1921422 Maybridge1_000215 COc1ccc(/C=N/Cc2ccccc2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B18 compound treatment 0.9701 -0.0299 -0.58 -0.5798 -1.0 1017542 Maybridge1_000216 Cc1cc(O)c2ccccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B19 compound treatment 0.9258 -0.0742 -1.44 -1.4416 -1.0 2069454 Maybridge1_000217 COc1cc(/N=C/c2ccc3OCOc3c2)c(OC)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B20 compound treatment 1.0091 0.00908 0.18 0.1762 1.0 2069455 Maybridge1_000218 Cc1ccc(NS(=O)(=O)C)cc1/N=C/c2ccccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B21 compound treatment 0.9336 -0.0664 -1.29 -1.2904 -1.0 1721646 Maybridge1_000219 Fc1ccc(cc1)N2C(SCC2=O)c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B22 compound treatment 1.0028 0.00285 0.06 0.0553 1.0 2069456 Maybridge1_000220 COCCCNC(=S)Nc1cccc(Cl)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B23 mock treatment 0.9779 -0.0221 -0.43 -0.4286 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 B24 mock treatment 0.9538 -0.0462 -0.9 -0.8973 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C01 compound treatment 1.0161 0.0161 0.31 0.3123 1.0 2069457 Maybridge1_000221 OCCN1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C02 compound treatment 0.9476 -0.0524 -1.02 -1.0183 -1.0 2069458 Maybridge1_000222 C1CC1Nc2ncnc3scc(c4ccccc4)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C03 compound treatment 1.0542 0.0542 1.05 1.0532 1.0 2069459 Maybridge1_000223 FC(F)(F)c1ccnc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C04 compound treatment 0.8962 -0.104 -2.02 -2.0162 -1.0 2069460 Maybridge1_000224 FC(F)(F)c1ccnc(n1)N2CCC(CC2)NC(=S)NC3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C05 compound treatment 0.9686 -0.0314 -0.61 -0.61 -1.0 2069461 Maybridge1_000225 CC(C)(C)OC(=O)NCCNc1ccc(cc1N)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C06 compound treatment 0.9554 -0.0446 -0.87 -0.8671 -1.0 2069462 Maybridge1_000226 CC(C)(C)OC(=O)N1CCN(CC1)C(=O)Nc2ccc(OC(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C07 compound treatment 1.0371 0.0371 0.72 0.7206 1.0 2069463 Maybridge1_000227 Cc1nc(ccc1C(=O)Nc2ccccc2F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C08 compound treatment 0.9624 -0.0376 -0.73 -0.731 -1.0 1241428 Maybridge1_000228 Clc1ccc(cc1Cl)C(=O)N2CCN(CC2)c3cccc4scc(c5ccccc5)c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C09 compound treatment 1.0426 0.0426 0.83 0.8264 1.0 2069464 Maybridge1_000229 FC(F)(F)c1cnc(N2CCCN(CC2)C(=O)Nc3ccc(Cl)cc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C10 compound treatment 1.0542 0.0542 1.05 1.0532 1.0 2069465 Maybridge1_000230 Cc1ccc(cc1)c2csc3ncnc(NCc4ccco4)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C11 compound treatment 0.9997 -2.68E-4 -0.01 -0.0052 -1.0 2069466 Maybridge1_000231 [O-][N+](=O)c1ccc(nc1)N2CCCN(CC2)C(=S)Nc3ccc(F)cc3Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C12 compound treatment 0.9779 -0.0221 -0.43 -0.4286 -1.0 2069467 Maybridge1_000232 Fc1ccccc1c2nnn[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C13 compound treatment 0.9881 -0.0119 -0.23 -0.232 -1.0 2069468 Maybridge1_000233 Cc1cc(c(C)cc1Cl)S(=O)(=O)NCCNc2nccc(n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C14 compound treatment 0.9312 -0.0688 -1.34 -1.3358 -1.0 2069469 Maybridge1_000234 COc1ccc(NC(=S)NNC(=O)c2ccccc2[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C15 compound treatment 0.9616 -0.0384 -0.75 -0.7461 -1.0 2069470 Maybridge1_000235 c1csc(c1)c2ccn(n2)c3nc(ns3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C16 compound treatment 0.897 -0.103 -2.0 -2.0011 -1.0 2069471 Maybridge1_000236 CCCCCc1ccc(NC(=O)NNc2ccc(F)c(Cl)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C17 compound treatment 0.9974 -0.0026 -0.05 -0.0506 -1.0 2069472 Maybridge1_000237 CCCCNC(=O)NCCNc1ccc(cn1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C18 compound treatment 0.9374 -0.0626 -1.21 -1.2148 -1.0 2069473 Maybridge1_000238 Cc1cccc(C)c1NC(=S)NCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C19 compound treatment 0.9958 -0.00416 -0.08 -0.0808 -1.0 1659799 Maybridge1_000239 CC(C)(C)OC(=O)N1CCCN(CC1)C(=S)Nc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C20 compound treatment 0.9429 -0.0571 -1.11 -1.109 -1.0 2069474 Maybridge1_000240 NS(=O)(=O)c1ccc(/N=C/c2ccc3OCOc3c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C21 compound treatment 0.9701 -0.0299 -0.58 -0.5798 -1.0 1545894 Maybridge1_000241 CCOC(=O)c1c(sc(C)c1c2ccccc2)N3C(=O)CC4(CCCC4)C3=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C22 compound treatment 0.9406 -0.0594 -1.15 -1.1544 -1.0 1922172 Maybridge1_000242 CCOc1ccc(/N=C/c2ccccc2O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C23 mock treatment 0.9709 -0.0291 -0.56 -0.5647 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 C24 mock treatment 0.9413 -0.0587 -1.14 -1.1392 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D01 compound treatment 0.974 -0.026 -0.5 -0.5042 -1.0 2069475 Maybridge1_000243 Clc1cccc(NC(=S)NNC(=O)c2cccnc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D02 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 2069476 Maybridge1_000244 COc1cc(/C=N/c2ccc(C)c(Cl)c2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D03 compound treatment 1.0106 0.0106 0.21 0.2065 1.0 1915764 Maybridge1_000245 O=C(N/N=C/c1cccc2ccccc12)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D04 compound treatment 1.0036 0.00363 0.07 0.0704 1.0 2069477 Maybridge1_000246 CCOC(=O)CSC(=O)c1c(C)onc1c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D05 compound treatment 0.9748 -0.0252 -0.49 -0.4891 -1.0 2069478 Maybridge1_000247 Cc1cc2CSC(SCc2cc1C)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D06 compound treatment 1.0075 0.00752 0.15 0.146 1.0 2069479 Maybridge1_000248 COc1cc(/C=N/CCCC\N=C\c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D07 compound treatment 1.0013 0.00129 0.03 0.025 1.0 2069480 Maybridge1_000249 Clc1c(sc2ccccc12)C(=O)N3/C(=N/c4ccccc4Cl)/SC(=C)C53CCCCC5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D08 compound treatment 0.9997 -2.68E-4 -0.01 -0.0052 -1.0 1353182 Maybridge1_000250 Cc1ccc2N(CCCc2c1)C(=S)Nc3c(C)cccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D09 compound treatment 0.9655 -0.0345 -0.67 -0.6705 -1.0 1404608 Maybridge1_000251 COc1ccc(NC(=S)Nc2ccccc2Cl)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D10 compound treatment 1.0387 0.0387 0.75 0.7508 1.0 1705422 Maybridge1_000252 Clc1cccc(NC(=S)N2CCCc3ccccc23)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D11 compound treatment 1.0394 0.0394 0.77 0.7659 1.0 2069481 Maybridge1_000253 CC(=O)Nc1ccc(C)c(/N=C/c2ccc(Cl)c(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D12 compound treatment 0.9624 -0.0376 -0.73 -0.731 -1.0 1653449 Maybridge1_000254 Fc1ccc(NC(=O)c2ccccc2NC(=S)Nc3ccccc3Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D13 compound treatment 1.0192 0.0192 0.37 0.3728 1.0 2069482 Maybridge1_000255 OC(=O)CSC(SCC(=O)O)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D14 compound treatment 0.9694 -0.0306 -0.59 -0.5949 -1.0 1541673 Maybridge1_000256 CS(=O)(=O)N(Cc1ccccc1)Cc2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D15 compound treatment 0.9647 -0.0353 -0.69 -0.6856 -1.0 2069483 Maybridge1_000257 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccc(CC#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D16 compound treatment 0.9958 -0.00416 -0.08 -0.0808 -1.0 1040327 Maybridge1_000258 CC(=O)Nc1cc2ccccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D17 compound treatment 0.9958 -0.00416 -0.08 -0.0808 -1.0 2069484 Maybridge1_000259 Cc1ccc(cc1Cl)n2c(C)nc3cc(Cl)ccc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D18 compound treatment 0.9803 -0.0197 -0.38 -0.3832 -1.0 1578175 Maybridge1_000260 Cc1cc(O)c2cc(F)ccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D19 compound treatment 0.9546 -0.0454 -0.88 -0.8822 -1.0 2069485 Maybridge1_000261 CC(=O)Nc1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D20 compound treatment 0.9452 -0.0548 -1.06 -1.0636 -1.0 2069486 Maybridge1_000262 Cc1ccc(NS(=O)(=O)C)cc1/N=C/c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D21 compound treatment 0.9772 -0.0228 -0.44 -0.4437 -1.0 2069487 Maybridge1_000263 COc1ccc(/N=C/c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D22 compound treatment 0.9974 -0.0026 -0.05 -0.0506 -1.0 2069488 Maybridge1_000264 COCCCn1c(=O)c2ccccc2[nH]c1=S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D23 mock treatment 0.974 -0.026 -0.5 -0.5042 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 D24 mock treatment 1.0301 0.0301 0.58 0.5845 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E01 compound treatment 0.9826 -0.0174 -0.34 -0.3378 -1.0 1245819 Maybridge1_000265 OCCN1CCN(Cc2ccc(F)cc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E02 compound treatment 1.0402 0.0402 0.78 0.7811 1.0 1738877 Maybridge1_000266 CN(C)CCNc1ncnc2scc(c3ccccc3)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E03 compound treatment 1.0278 0.0278 0.54 0.5391 1.0 2069489 Maybridge1_000267 CC(=O)Nc1cc(ccc1Sc2ccccc2N)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E04 compound treatment 0.9585 -0.0415 -0.81 -0.8066 -1.0 1611827 Maybridge1_000268 CC(C)(C)OC(=O)NC1CCN(Cc2c(F)cccc2Cl)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E05 compound treatment 0.9725 -0.0275 -0.53 -0.5344 -1.0 2069490 Maybridge1_000269 FC(F)(F)c1ccnc(n1)N2CCCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E06 compound treatment 0.9818 -0.0182 -0.35 -0.353 -1.0 2069491 Maybridge1_000270 FC(F)(F)c1ccc(NC(=O)N2CCCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E07 compound treatment 1.027 0.027 0.52 0.524 1.0 2069492 Maybridge1_000271 CC(N1CCCCC1)C(=O)Nc2c(C)cccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E08 compound treatment 1.0348 0.0348 0.68 0.6752 1.0 1434180 Maybridge1_000272 Cc1nc(cs1)c2ccc(s2)S(=O)(=O)N3CCN(CC3)c4ncnc5scc(c6ccccc6)c45 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E09 compound treatment 1.0067 0.00674 0.13 0.1309 1.0 2069493 Maybridge1_000273 OC(CNCCNc1nccc(n1)C(F)(F)F)Cn2ccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E10 compound treatment 1.1134 0.113 2.2 2.2024 1.0 2069494 Maybridge1_000274 Cc1onc(c1C(=O)N2CCN(CC2)c3ncnc4scc(c5ccccc5)c34)c6c(Cl)cccc6Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E11 compound treatment 1.0021 0.00207 0.04 0.0402 1.0 1286913 Maybridge1_000275 CC(=O)Nc1ccc(cc1Cl)S(=O)(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E12 compound treatment 0.9904 -0.00961 -0.19 -0.1866 -1.0 1722412 Maybridge1_000276 OC(COc1ccc(Cl)c(Cl)c1)CN2CCN(CC2)c3ncnc4scc(c5ccccc5)c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E13 compound treatment 1.0246 0.0246 0.48 0.4787 1.0 2069495 Maybridge1_000277 FC(F)(F)c1ccnc(NC2CCN(Cc3ccccc3)CC2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E14 compound treatment 0.9935 -0.0065 -0.13 -0.1262 -1.0 2069496 Maybridge1_000278 Nc1ccccc1Sc2ccc(cc2[N+](=O)[O-])c3cnc4ccccc4n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E15 compound treatment 0.9499 -0.0501 -0.97 -0.9729 -1.0 2069497 Maybridge1_000279 OC(COc1ccc(cc1)[N+](=O)[O-])CN2CCCN(CC2)c3nc4ccc(Cl)cc4s3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E16 compound treatment 0.9694 -0.0306 -0.59 -0.5949 -1.0 2069498 Maybridge1_000280 CC(Oc1ccc(Cl)cc1Cl)C(=O)NC2=NCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E17 compound treatment 1.0262 0.0262 0.51 0.5089 1.0 2069499 Maybridge1_000281 FC(F)(F)c1ccnc(NCC=C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E18 compound treatment 0.9351 -0.0649 -1.26 -1.2602 -1.0 2069500 Maybridge1_000282 CC(C)c1ccc(/C=C/2\CCC/C(=C\c3ccc(cc3)C(C)C)/C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E19 compound treatment 1.0083 0.0083 0.16 0.1611 1.0 2069501 Maybridge1_000283 FC(F)(F)c1cnc(NCCCNC(=S)Nc2cccnc2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E20 compound treatment 0.9499 -0.0501 -0.97 -0.9729 -1.0 2069502 Maybridge1_000284 Cc1cc(C)nc(NS(=O)(=O)c2ccc(/N=C/c3ccccc3O)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E21 compound treatment 0.9639 -0.0361 -0.7 -0.7007 -1.0 1322088 Maybridge1_000285 Cc1nc(cs1)c2ccc(s2)S(=O)(=O)N3CCCN(CC3)c4nc5ccc(Cl)cc5s4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E22 compound treatment 0.96 -0.04 -0.78 -0.7763 -1.0 2069503 Maybridge1_000286 Cc1ccc(/N=C/c2ccccc2O)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E23 mock treatment 1.0013 0.00129 0.03 0.025 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 E24 mock treatment 1.0254 0.0254 0.49 0.4938 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F01 compound treatment 0.9795 -0.0205 -0.4 -0.3983 -1.0 2069504 Maybridge1_000287 Cc1cccc(C)c1NC(=S)NNC(=O)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F02 compound treatment 1.0324 0.0324 0.63 0.6299 1.0 2069505 Maybridge1_000288 Fc1ccc(/N=C/c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F03 compound treatment 0.9842 -0.0158 -0.31 -0.3076 -1.0 2069506 Maybridge1_000289 Clc1ccccc1/C=N/NC(=O)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F04 compound treatment 0.9912 -0.00883 -0.17 -0.1715 -1.0 2069507 Maybridge1_000290 COC(=O)c1cccc(/N=C/c2cc(Cl)cc(Cl)c2O)c1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F05 compound treatment 0.9943 -0.00572 -0.11 -0.111 -1.0 2069508 Maybridge1_000291 Cc1cc2CSC(C)(SCc2cc1C)c3ccc(cc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F06 compound treatment 0.9631 -0.0369 -0.72 -0.7159 -1.0 1461154 Maybridge1_000292 CC(N(Cc1ccccc1)C(=S)Nc2ccc(Cl)c(Cl)c2)c3ccccc3O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F07 compound treatment 0.9958 -0.00416 -0.08 -0.0808 -1.0 2069509 Maybridge1_000293 Cc1cccc(Cl)c1/N=C/2\NC3(CCCCC3)C(=C)S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F08 compound treatment 1.0145 0.0145 0.28 0.2821 1.0 1680637 Maybridge1_000294 Cc1cccc(C)c1NC(=S)N2CCCc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F09 compound treatment 0.9756 -0.0244 -0.47 -0.4739 -1.0 1024118 Maybridge1_000295 CC(=O)Nc1cc(ccc1C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F10 compound treatment 0.9795 -0.0205 -0.4 -0.3983 -1.0 1253012 Maybridge1_000296 Cc1ccc(NC(=S)N2CCCc3cccc(C)c23)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F11 compound treatment 1.0488 0.0488 0.95 0.9474 1.0 1011159 Maybridge1_000297 CC(=O)Nc1ccc(C)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F12 compound treatment 0.9476 -0.0524 -1.02 -1.0183 -1.0 1486966 Maybridge1_000298 Cc1ccc(NC(=S)Nc2ccccc2C(=O)Nc3ccc(F)cc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F13 compound treatment 0.9281 -0.0719 -1.4 -1.3963 -1.0 2069510 Maybridge1_000299 COc1cc(cc(OC)c1OC)C(SCC(=O)O)SCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F14 compound treatment 1.0223 0.0223 0.43 0.4333 1.0 2069511 Maybridge1_000300 CC(C)N(Cc1ccc(cc1)N(C)C)C(=S)Nc2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F15 compound treatment 0.9592 -0.0408 -0.79 -0.7915 -1.0 2069512 Maybridge1_000301 Oc1ccc(Br)cc1/C=N/c2ccc(CC#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F16 compound treatment 0.9904 -0.00961 -0.19 -0.1866 -1.0 1177391 Maybridge1_000302 Oc1ccc(CCc2nnc(S)n2c3ccc(F)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F17 compound treatment 0.9476 -0.0524 -1.02 -1.0183 -1.0 2069513 Maybridge1_000303 Cc1nc2cc(Cl)ccc2c(=O)n1c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F18 compound treatment 0.9624 -0.0376 -0.73 -0.731 -1.0 1393574 Maybridge1_000304 Cc1cc(O)c2c(Cl)ccc(C)c2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F19 compound treatment 0.9694 -0.0306 -0.59 -0.5949 -1.0 1113094 Maybridge1_000305 COC(=O)c1ccccc1NC(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F20 compound treatment 0.9569 -0.0431 -0.84 -0.8368 -1.0 2069514 Maybridge1_000306 Cc1ccc(NS(=O)(=O)C)cc1/N=C/c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F21 compound treatment 0.9515 -0.0485 -0.94 -0.9427 -1.0 2069515 Maybridge1_000307 C(/N=C/c1ccc2OCOc2c1)c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F22 compound treatment 1.0028 0.00285 0.06 0.0553 1.0 2069516 Maybridge1_000308 COCCCNC(=S)Nc1ccc(C)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F23 mock treatment 0.9585 -0.0415 -0.81 -0.8066 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 F24 mock treatment 1.0028 0.00285 0.06 0.0553 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G01 compound treatment 0.9888 -0.0112 -0.22 -0.2169 -1.0 2069517 Maybridge1_000309 On1nnc2ccc(cc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G02 compound treatment 0.9795 -0.0205 -0.4 -0.3983 -1.0 2069518 Maybridge1_000310 CCOC(=O)c1cc(C(=S)N)c(C)nc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G03 compound treatment 0.9818 -0.0182 -0.35 -0.353 -1.0 1521295 Maybridge1_000311 CCOC(=O)C1CCN(CC1)c2nc3ccc(Cl)cc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G04 compound treatment 0.9655 -0.0345 -0.67 -0.6705 -1.0 2069519 Maybridge1_000312 CC(C)(C)OC(=O)NC1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G05 compound treatment 1.0114 0.0114 0.22 0.2216 1.0 2069520 Maybridge1_000313 Fc1cccc(Cl)c1CN2CCN(CC2)c3nccc(n3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G06 compound treatment 1.0348 0.0348 0.68 0.6752 1.0 2069521 Maybridge1_000314 COc1ccccc1NC(=O)NC2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G07 compound treatment 1.0535 0.0535 1.04 1.0381 1.0 1674114 Maybridge1_000315 CCc1ccccc1n2c(S)nc3ccccc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G08 compound treatment 0.9935 -0.0065 -0.13 -0.1262 -1.0 2069522 Maybridge1_000316 CCCCCc1ccc(cc1)S(=O)(=O)N2CCN(CC2)C(=O)OC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G09 compound treatment 1.0153 0.0153 0.3 0.2972 1.0 2069523 Maybridge1_000317 OC1CCCCC1NCCNc2nccc(n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G10 compound treatment 1.0355 0.0355 0.69 0.6903 1.0 2069524 Maybridge1_000318 FC(F)(F)c1ccnc(n1)N2CCCN(CC2)c3ncnc4scc(c5ccccc5)c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G11 compound treatment 1.0153 0.0153 0.3 0.2972 1.0 2069525 Maybridge1_000319 CC(C)(C)c1ccc(NC(=O)N2CCCN(CC2)c3ccc(cn3)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G12 compound treatment 0.9818 -0.0182 -0.35 -0.353 -1.0 2069526 Maybridge1_000320 CC(=O)Nc1ccc(cc1Cl)S(=O)(=O)NCCCN2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G13 compound treatment 0.9842 -0.0158 -0.31 -0.3076 -1.0 1664341 Maybridge1_000321 S=C(NCC1CC1)Nc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G14 compound treatment 0.9912 -0.00883 -0.17 -0.1715 -1.0 1019841 Maybridge1_000322 Cc1ccccc1C(=O)c2ccccc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G15 compound treatment 0.981 -0.019 -0.37 -0.3681 -1.0 2069527 Maybridge1_000323 FC(F)(F)c1ccnc(n1)n2ccc(n2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G16 compound treatment 0.9382 -0.0618 -1.2 -1.1997 -1.0 1780339 Maybridge1_000324 [O-][N+](=O)c1ccc(o1)C(=O)Nc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G17 compound treatment 0.9538 -0.0462 -0.9 -0.8973 -1.0 2069528 Maybridge1_000325 FC(F)(F)c1ccnc(NCCN2C(=O)CC3(CCCC3)C2=O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G18 compound treatment 0.9849 -0.0151 -0.29 -0.2925 -1.0 2069529 Maybridge1_000326 CC/1CC(C)(C)C\C1=N/Nc2ccc(cc2[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G19 compound treatment 0.9842 -0.0158 -0.31 -0.3076 -1.0 2069530 Maybridge1_000327 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccc(nc2C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G20 compound treatment 0.9577 -0.0423 -0.82 -0.8217 -1.0 2069531 Maybridge1_000328 C/C(=N\N=C(/C)\c1ccc(C)cc1)/c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G21 compound treatment 0.967 -0.033 -0.64 -0.6403 -1.0 2069532 Maybridge1_000329 CC(C)(C)OC(=O)NCCNc1ccc(cc1N2C(=O)CC3(CCCC3)C2=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G22 compound treatment 0.9398 -0.0602 -1.17 -1.1695 -1.0 2069533 Maybridge1_000330 CC(=O)Nc1ccc(Br)cc1C(=O)C(=O)Nc2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G23 mock treatment 0.9997 -2.68E-4 -0.01 -0.0052 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 G24 mock treatment 0.9826 -0.0174 -0.34 -0.3378 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H01 compound treatment 1.013 0.013 0.25 0.2519 1.0 1944160 Maybridge1_000331 O=C(NNC(=S)Nc1ccccc1)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H02 compound treatment 0.9951 -0.00494 -0.1 -0.0959 -1.0 2069534 Maybridge1_000332 Fc1ccc(cc1)N2C(SCC2=O)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H03 compound treatment 1.0114 0.0114 0.22 0.2216 1.0 2069535 Maybridge1_000333 CC(=O)N1N=C(OC1c2ccccc2Cl)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H04 compound treatment 1.0161 0.0161 0.31 0.3123 1.0 2069536 Maybridge1_000334 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)SCC(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H05 compound treatment 0.9927 -0.00728 -0.14 -0.1413 -1.0 2069537 Maybridge1_000335 Cc1cc2CSC(C)(SCc2cc1C)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H06 compound treatment 1.0005 5.11E-4 0.01 0.0099 1.0 2069538 Maybridge1_000336 NNS(=O)(=O)c1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H07 compound treatment 1.0285 0.0285 0.55 0.5543 1.0 1917064 Maybridge1_000337 S=c1nc2[nH]c3ccccc3c2n[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H08 compound treatment 1.02 0.02 0.39 0.3879 1.0 2069539 Maybridge1_000338 FC(F)(F)c1cccc(NC(=S)N2CCc3ccccc3C2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H09 compound treatment 1.0075 0.00752 0.15 0.146 1.0 1048074 Maybridge1_000339 CN(C)c1ccc(cc1)C2Nc3cccc4cccc(N2)c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H10 compound treatment 1.0099 0.00985 0.19 0.1914 1.0 1205163 Maybridge1_000340 Cc1ccc(NC(=S)N2CCCc3ccccc23)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H11 compound treatment 0.9826 -0.0174 -0.34 -0.3378 -1.0 2069540 Maybridge1_000341 COc1nc(Nc2cccc(c2)C(F)(F)F)nc(OC)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H12 compound treatment 0.9935 -0.0065 -0.13 -0.1262 -1.0 1127694 Maybridge1_000342 Fc1ccc(NC(=O)c2ccccc2NC(=S)Nc3ccc(Cl)c(Cl)c3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H13 compound treatment 1.0036 0.00363 0.07 0.0704 1.0 2069541 Maybridge1_000343 OC(=O)CSC(SCC(=O)O)c1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H14 compound treatment 0.9951 -0.00494 -0.1 -0.0959 -1.0 2069542 Maybridge1_000344 CC(C)N(Cc1ccc(cc1)N(C)C)C(=S)Nc2ccc(C)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H15 compound treatment 0.9733 -0.0267 -0.52 -0.5193 -1.0 1367412 Maybridge1_000345 CCOC(=O)c1ccc(cc1)N2C(=O)CC(SCC(=O)Nc3ccc(F)cc3)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H16 compound treatment 0.9507 -0.0493 -0.96 -0.9578 -1.0 1578868 Maybridge1_000346 Cc1c(Cl)cccc1n2c(S)nnc2CCc3ccc(O)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H17 compound treatment 0.9515 -0.0485 -0.94 -0.9427 -1.0 1141423 Maybridge1_000347 Cc1nc2cc(Cl)ccc2c(=O)n1c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H18 compound treatment 0.9857 -0.0143 -0.28 -0.2774 -1.0 1562593 Maybridge1_000348 Cc1cc(O)c2cc(Cl)ccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H19 compound treatment 0.9826 -0.0174 -0.34 -0.3378 -1.0 1160657 Maybridge1_000349 COC(=O)c1ccccc1NC(=O)c2cc(OC)c(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H20 compound treatment 1.0262 0.0262 0.51 0.5089 1.0 2069543 Maybridge1_000350 Cc1ccc(NS(=O)(=O)C)cc1/N=C/c2cc(Cl)cc(Cl)c2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H21 compound treatment 0.9966 -0.00338 -0.07 -0.0657 -1.0 1285265 Maybridge1_000351 CCOC(=O)C1CCN(CC1)c2nc(OC)nc(OC)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H22 compound treatment 1.1111 0.111 2.16 2.157 1.0 2069544 Maybridge1_000352 CN(C)c1ccc(/C=N/c2ccc(cc2)N3N=C(C)CC3=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H23 mock treatment 1.0223 0.0223 0.43 0.4333 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 H24 mock treatment 1.0137 0.0137 0.27 0.267 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I01 compound treatment 0.9966 -0.00338 -0.07 -0.0657 -1.0 1454622 Maybridge1_000353 OCCN1CCN(CC1)c2nc3ccc(Cl)cc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I02 compound treatment 1.0153 0.0153 0.3 0.2972 1.0 2069545 Maybridge1_000354 NC1CCN(CC1)c2nccc(n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I03 compound treatment 0.9951 -0.00494 -0.1 -0.0959 -1.0 1575257 Maybridge1_000355 Clc1ccc2nc(sc2c1)N3CCCNCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I04 compound treatment 1.0153 0.0153 0.3 0.2972 1.0 1654743 Maybridge1_000356 CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I05 compound treatment 1.0496 0.0496 0.96 0.9625 1.0 1266004 Maybridge1_000357 CCOC(=O)c1c(N)scc1C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I06 compound treatment 1.0192 0.0192 0.37 0.3728 1.0 2069546 Maybridge1_000358 FC(F)(F)c1ccc(NC(=O)NC2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I07 compound treatment 1.0901 0.0901 1.75 1.7488 1.0 2069547 Maybridge1_000359 Cc1nc(ccc1C#N)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I08 compound treatment 1.0192 0.0192 0.37 0.3728 1.0 2069548 Maybridge1_000360 Cc1nc(nc(N2CCCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c1Cl)c4cccnc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I09 compound treatment 0.9935 -0.0065 -0.13 -0.1262 -1.0 2069549 Maybridge1_000361 CC(C)(C)OC(=O)N/N=C\c1cccc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I10 compound treatment 0.9974 -0.0026 -0.05 -0.0506 -1.0 2069550 Maybridge1_000362 Cc1c(sc2ncnc(O)c12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I11 compound treatment 1.0215 0.0215 0.42 0.4182 1.0 1256094 Maybridge1_000363 OC(CNC1CCN(Cc2ccccc2)CC1)COc3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I12 compound treatment 0.8931 -0.107 -2.08 -2.0767 -1.0 2069551 Maybridge1_000364 FC(F)(F)c1ccnc(n1)N2CCN(CCCNC(=O)c3cccs3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I13 compound treatment 0.9904 -0.00961 -0.19 -0.1866 -1.0 1454379 Maybridge1_000365 S=C(NCc1ccco1)Nc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I14 compound treatment 0.9733 -0.0267 -0.52 -0.5193 -1.0 1651773 Maybridge1_000366 COC(=O)c1ccc(CSc2ccccc2NC(=S)Nc3cccc(SC)c3)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I15 compound treatment 0.9764 -0.0236 -0.46 -0.4588 -1.0 2069552 Maybridge1_000367 [O-][N+](=O)c1cc(ccc1n2ccc(n2)c3cccs3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I16 compound treatment 0.9655 -0.0345 -0.67 -0.6705 -1.0 2069553 Maybridge1_000368 CCOC(=O)c1ccc(NC(=O)c2ccc(o2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I17 compound treatment 0.9849 -0.0151 -0.29 -0.2925 -1.0 2069554 Maybridge1_000369 FC(F)(F)c1cccnc1NCCN2C(=O)CC3(CCCC3)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I18 compound treatment 0.9312 -0.0688 -1.34 -1.3358 -1.0 1352465 Maybridge1_000370 CC(C)c1ccc(NC2(CCCCC2)C(=O)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I19 compound treatment 0.999 -0.00105 -0.02 -0.0203 -1.0 2069555 Maybridge1_000371 COc1ccc(OCC(O)CNCCNc2ncccc2C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I20 compound treatment 0.9359 -0.0641 -1.25 -1.2451 -1.0 2069556 Maybridge1_000372 C/C(=N\N=C(/C)\c1ccc(C)cc1C)/c2ccc(C)cc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I21 compound treatment 1.0496 0.0496 0.96 0.9625 1.0 1262020 Maybridge1_000373 OC(CN1CCC(CC1)NC2CCCCC2O)Cn3ccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I22 compound treatment 1.0355 0.0355 0.69 0.6903 1.0 2069557 Maybridge1_000374 COc1ccc(cc1)/C(=N/N=C/c2cc(OC)c(OC)c(OC)c2)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I23 mock treatment 1.0052 0.00518 0.1 0.1006 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 I24 mock treatment 1.0013 0.00129 0.03 0.025 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J01 compound treatment 1.0737 0.0737 1.43 1.4312 1.0 2069558 Maybridge1_000375 COc1cc(cc(OC)c1OC)C(=O)NNC(=O)c2sc3ccccc3c2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J02 compound treatment 0.9974 -0.0026 -0.05 -0.0506 -1.0 2069559 Maybridge1_000376 COc1cc(NS(=O)(=O)c2cc(ccc2C)[N+](=O)[O-])c(OC)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J03 compound treatment 0.9919 -0.00805 -0.16 -0.1564 -1.0 2069560 Maybridge1_000377 COc1ccc(/C=N/NC(=O)c2ccncc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J04 compound treatment 1.0153 0.0153 0.3 0.2972 1.0 2069561 Maybridge1_000378 COc1ccc(cc1)c2nnc(S)n2c3cccc(OC)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J05 compound treatment 1.0644 0.0644 1.25 1.2498 1.0 2069562 Maybridge1_000379 COc1cc(ccc1O)C2(C)SCc3cc(C)c(C)cc3CS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J06 compound treatment 1.0122 0.0122 0.24 0.2367 1.0 2069563 Maybridge1_000380 CC(SCC(=O)O)(SCC(=O)O)c1cccc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J07 compound treatment 0.9982 -0.00182 -0.04 -0.0354 -1.0 1140994 Maybridge1_000381 Cc1onc(c1C(=O)N2CCc3ccccc3C2)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J08 compound treatment 1.0714 0.0714 1.39 1.3859 1.0 2069564 Maybridge1_000382 Cc1cccc2CCCN(C(=S)Nc3cccc(c3)C(F)(F)F)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J09 compound treatment 1.0511 0.0511 0.99 0.9928 1.0 1048961 Maybridge1_000383 COc1cc(cc(OC)c1OC)C2Nc3cccc4cccc(N2)c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J10 compound treatment 1.0083 0.0083 0.16 0.1611 1.0 2069565 Maybridge1_000384 Oc1ccc(CCC(=O)N/N=C/c2ccc(Cl)c(Cl)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J11 compound treatment 0.9966 -0.00338 -0.07 -0.0657 -1.0 2069566 Maybridge1_000385 Cc1ccc(Nc2nc3ccccc3s2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J12 compound treatment 1.0106 0.0106 0.21 0.2065 1.0 2069567 Maybridge1_000386 Oc1ccc(CCC(=O)NNC(=S)Nc2cccc(c2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J13 compound treatment 0.96 -0.04 -0.78 -0.7763 -1.0 1383075 Maybridge1_000387 CC1CC(=O)Nc2ccccc2N1C(=O)c3c(C)onc3c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J14 compound treatment 0.9764 -0.0236 -0.46 -0.4588 -1.0 2069568 Maybridge1_000388 CC(C)N(Cc1ccc(cc1)N(C)C)C(=S)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J15 compound treatment 0.9849 -0.0151 -0.29 -0.2925 -1.0 1030886 Maybridge1_000389 CC(=O)Nc1cc(Cl)ccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J16 compound treatment 0.96 -0.04 -0.78 -0.7763 -1.0 1516286 Maybridge1_000390 Cc1ccc(c(C)c1)n2c(S)nnc2CCc3ccc(O)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J17 compound treatment 1.0052 0.00518 0.1 0.1006 1.0 2069569 Maybridge1_000391 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccccc2C(=O)Nc3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J18 compound treatment 0.9795 -0.0205 -0.4 -0.3983 -1.0 2069570 Maybridge1_000392 Cc1ccc(NS(=O)(=O)C)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J19 compound treatment 0.9577 -0.0423 -0.82 -0.8217 -1.0 1040131 Maybridge1_000393 CC1CC(=O)Nc2cc(C)c(C)cc2N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J20 compound treatment 0.9912 -0.00883 -0.17 -0.1715 -1.0 2069571 Maybridge1_000394 Cc1ccc(NS(=O)(=O)C)cc1/N=C/c2cc(Br)ccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J21 compound treatment 1.0208 0.0208 0.4 0.4031 1.0 1635307 Maybridge1_000395 Clc1c(sc2ccccc12)C(=O)N3CCCc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J22 compound treatment 1.1196 0.12 2.32 2.3234 1.0 2069572 Maybridge1_000396 CC(C)CCCC(C)C1CCC2C3CC=C4C[C@H](CC[C@]4(C)C3CC[C@]12C)OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J23 mock treatment 1.0044 0.0044 0.09 0.0855 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 J24 mock treatment 1.0114 0.0114 0.22 0.2216 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K01 compound treatment 1.0472 0.0472 0.92 0.9172 1.0 2069573 Maybridge1_000397 OCCN1CCN(CC1)c2ncccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K02 compound treatment 0.9795 -0.0205 -0.4 -0.3983 -1.0 1587186 Maybridge1_000398 OC(CNCc1ccc2OCOc2c1)COc3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K03 compound treatment 1.0044 0.0044 0.09 0.0855 1.0 1185686 Maybridge1_000399 OCCN1CCN(Cc2ccccc2F)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K04 compound treatment 0.9974 -0.0026 -0.05 -0.0506 -1.0 1632887 Maybridge1_000400 CC(C)(C)OC(=O)N1CCN(CC1)C(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K05 compound treatment 1.0472 0.0472 0.92 0.9172 1.0 2069574 Maybridge1_000401 OC1CCN(CC1)c2nccc(n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K06 compound treatment 1.0013 0.00129 0.03 0.025 1.0 2069575 Maybridge1_000402 CCc1cccc(C)c1NC(=O)NC2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K07 compound treatment 0.9312 -0.0688 -1.34 -1.3358 -1.0 2069576 Maybridge1_000403 Cc1nc(ccc1C(=O)NN)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K08 compound treatment 1.0114 0.0114 0.22 0.2216 1.0 1289970 Maybridge1_000404 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCCN(CC2)c3ncnc4scc(c5ccccc5)c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K09 compound treatment 1.076 0.076 1.48 1.4766 1.0 2069577 Maybridge1_000405 CCOC(=O)c1cc(c2nc(cs2)C(=O)NN)c(C)nc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K10 compound treatment 0.9982 -0.00182 -0.04 -0.0354 -1.0 2069578 Maybridge1_000406 Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCNc2ncc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K11 compound treatment 1.0527 0.0527 1.02 1.023 1.0 2069579 Maybridge1_000407 FC(F)(F)c1ccnc(NCCNC(=O)c2cccs2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K12 compound treatment 0.9382 -0.0618 -1.2 -1.1997 -1.0 1651621 Maybridge1_000408 CCCc1cnc(nc1)N2CCCN(CC2)C(=O)OC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K13 compound treatment 0.9943 -0.00572 -0.11 -0.111 -1.0 2069580 Maybridge1_000409 FC(F)(F)c1ccnc(NCCNC(=S)Nc2cccnc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K14 compound treatment 0.9445 -0.0555 -1.08 -1.0788 -1.0 2069581 Maybridge1_000410 CC(=O)c1cc(Cl)cc(Cl)c1OC(=O)c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K15 compound treatment 0.9857 -0.0143 -0.28 -0.2774 -1.0 1570851 Maybridge1_000411 CCCc1cnc(nc1)N2CCCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K16 compound treatment 0.9413 -0.0587 -1.14 -1.1392 -1.0 2069582 Maybridge1_000412 FC(F)(F)c1cccc(NC(=S)NCc2ccco2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K17 compound treatment 1.0122 0.0122 0.24 0.2367 1.0 2069583 Maybridge1_000413 Cc1nc(ccc1NC(=O)NCCNc2nccc(n2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K18 compound treatment 0.9772 -0.0228 -0.44 -0.4437 -1.0 2069584 Maybridge1_000414 NC(=O)C1(CCCCC1)NC2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K19 compound treatment 0.9927 -0.00728 -0.14 -0.1413 -1.0 1388914 Maybridge1_000415 CCCc1cnc(nc1)N2CCCN(CC2)C(=S)Nc3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K20 compound treatment 1.0161 0.0161 0.31 0.3123 1.0 1913698 Maybridge1_000416 COc1ccc(cc1)/C(=N/N=C(\C)/c2ccc(OC)cc2)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K21 compound treatment 0.9919 -0.00805 -0.16 -0.1564 -1.0 1018970 Maybridge1_000417 OC(CNCc1ccccc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K22 compound treatment 1.0052 0.00518 0.1 0.1006 1.0 2069585 Maybridge1_000418 COc1cc(/C=N/Nc2ccccc2)ccc1OC(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K23 mock treatment 1.0426 0.0426 0.83 0.8264 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 K24 mock treatment 0.9935 -0.0065 -0.13 -0.1262 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L01 compound treatment 1.034 0.034 0.66 0.6601 1.0 1429726 Maybridge1_000419 CC(=O)N1N=C(OC1(C)C)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L02 compound treatment 1.0441 0.0441 0.86 0.8567 1.0 2069586 Maybridge1_000420 Cc1cc(C)c(NS(=O)(=O)c2cc(ccc2C)[N+](=O)[O-])c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L03 compound treatment 1.0527 0.0527 1.02 1.023 1.0 2069587 Maybridge1_000421 COc1cc(/C=N/CC\N=C\c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L04 compound treatment 1.0309 0.0309 0.6 0.5996 1.0 2069588 Maybridge1_000422 COc1ccc(cc1)c2nnc(S)n2c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L05 compound treatment 1.0426 0.0426 0.83 0.8264 1.0 2069589 Maybridge1_000423 CC1CCCCC21SCc3cc(C)c(C)cc3CS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L06 compound treatment 1.0581 0.0581 1.13 1.1288 1.0 2069590 Maybridge1_000424 CCCC(C)(SCC(=O)O)SCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L07 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 1367544 Maybridge1_000425 COc1ccc(NC(=O)C)c(NC(=O)c2c(C)onc2c3ccccc3Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L08 compound treatment 1.0636 0.0636 1.23 1.2347 1.0 2069591 Maybridge1_000426 FC(F)(F)c1cccc(NC(=S)N2CCCc3ccccc23)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L09 compound treatment 1.0067 0.00674 0.13 0.1309 1.0 1178859 Maybridge1_000427 C1Oc2ccc(cc2O1)C3Nc4cccc5cccc(N3)c45 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L10 compound treatment 1.0239 0.0239 0.46 0.4635 1.0 2069592 Maybridge1_000428 COc1cc(/C=N/NC(=O)CCc2ccc(O)cc2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L11 compound treatment 0.974 -0.026 -0.5 -0.5042 -1.0 1177022 Maybridge1_000429 COc1cccc(Nc2nc3ccccc3s2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L12 compound treatment 0.851 -0.149 -2.89 -2.8932 -1.0 2069593 Maybridge1_000430 Cc1ccccc1NC(=S)NNC(=O)CCc2ccc(O)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L13 compound treatment 0.9304 -0.0696 -1.35 -1.3509 -1.0 1242977 Maybridge1_000431 CC1CC(=O)Nc2ccccc2N1C(=O)c3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L14 compound treatment 1.0036 0.00363 0.07 0.0704 1.0 2069594 Maybridge1_000432 Clc1ccc(CNC(=O)c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L15 compound treatment 0.9367 -0.0633 -1.23 -1.23 -1.0 2069595 Maybridge1_000433 C(/N=C/c1ccc2OCOc2c1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L16 compound treatment 1.0239 0.0239 0.46 0.4635 1.0 1485674 Maybridge1_000434 Oc1ccc(CCc2nnc(S)n2c3ccc(Cl)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L17 compound treatment 0.9951 -0.00494 -0.1 -0.0959 -1.0 2069596 Maybridge1_000435 Cc1ccc(SCC(=O)c2cccc(c2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L18 compound treatment 0.9873 -0.0127 -0.25 -0.2471 -1.0 2069597 Maybridge1_000436 Cc1ccc(/N=C/c2cc(Cl)cc(Cl)c2O)cc1NS(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L19 compound treatment 0.9772 -0.0228 -0.44 -0.4437 -1.0 2069598 Maybridge1_000437 Cc1ccc2nc(C)oc(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L20 compound treatment 0.9912 -0.00883 -0.17 -0.1715 -1.0 2069599 Maybridge1_000438 CN(C)c1ccc(/C=N/c2cc(NS(=O)(=O)C)ccc2C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L21 compound treatment 1.02 0.02 0.39 0.3879 1.0 1294233 Maybridge1_000439 Cc1ccc2N(CCCc2c1)C(=O)c3sc4ccccc4c3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L22 compound treatment 1.1329 0.133 2.58 2.5804 1.0 2069600 Maybridge1_000440 COc1cc(/C=N/c2ccc(cc2)N3N=C(C)CC3=O)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L23 mock treatment 0.974 -0.026 -0.5 -0.5042 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 L24 mock treatment 1.0169 0.0169 0.33 0.3275 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M01 compound treatment 1.0978 0.0978 1.9 1.9 1.0 1610519 Maybridge1_000441 Cc1nc(nc(N2CCN(CCO)CC2)c1Cl)c3ccccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M02 compound treatment 1.0527 0.0527 1.02 1.023 1.0 2069601 Maybridge1_000442 COc1ccccc1NC(=O)NC2CCN(CC2)c3nccc(n3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M03 compound treatment 1.0021 0.00207 0.04 0.0402 1.0 1254354 Maybridge1_000443 C1CNCCN(C1)c2nc(ns2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M04 compound treatment 1.0464 0.0464 0.9 0.902 1.0 1391909 Maybridge1_000444 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCN(CC2)C(=O)OC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M05 compound treatment 1.0799 0.0799 1.55 1.5522 1.0 2069602 Maybridge1_000445 [O-][N+](=O)c1ccc(nc1)N2CCCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M06 compound treatment 1.0682 0.0682 1.33 1.3254 1.0 1581293 Maybridge1_000446 C1CN(CCN1)c2ncnc3scc(c4ccccc4)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M07 compound treatment 1.0099 0.00985 0.19 0.1914 1.0 1364451 Maybridge1_000447 Clc1ccc(CN2CCCN(CC2)C(=O)Nc3cccc(Cl)c3Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M08 compound treatment 1.0371 0.0371 0.72 0.7206 1.0 1658768 Maybridge1_000448 Cc1nc(nc(N2CCN(CC2)c3ncnc4scc(c5ccccc5)c34)c1Cl)c6ccccn6 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M09 compound treatment 0.9881 -0.0119 -0.23 -0.232 -1.0 2069603 Maybridge1_000449 OC(CNCCNc1ncccc1C(F)(F)F)COc2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M10 compound treatment 0.9709 -0.0291 -0.56 -0.5647 -1.0 2069604 Maybridge1_000450 CC(=O)c1ccc(OCc2c(F)cccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M11 compound treatment 1.0021 0.00207 0.04 0.0402 1.0 2069605 Maybridge1_000451 FC(F)(F)c1ccnc(NCCNC(=O)c2ccco2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M12 compound treatment 1.1866 0.187 3.62 3.6237 1.0 1301777 Maybridge1_000452 Nc1oc(cc1C#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M13 compound treatment 1.0091 0.00908 0.18 0.1762 1.0 1198042 Maybridge1_000453 S=C(NC1CCN(Cc2ccccc2)CC1)Nc3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M14 compound treatment 0.9655 -0.0345 -0.67 -0.6705 -1.0 2069606 Maybridge1_000454 CCCCCc1ccc(cc1)C(=O)O/N=C/c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M15 compound treatment 1.0036 0.00363 0.07 0.0704 1.0 1500883 Maybridge1_000455 CCCc1cnc(nc1)N2CCCN(CC2)C(=S)Nc3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M16 compound treatment 0.9709 -0.0291 -0.56 -0.5647 -1.0 1229893 Maybridge1_000456 COc1cccc(NC(=S)NCc2ccco2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M17 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 2069607 Maybridge1_000457 FC(F)(F)c1cnc(NCCCN2C(=O)CC3(CCCC3)C2=O)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M18 compound treatment 0.9515 -0.0485 -0.94 -0.9427 -1.0 1497535 Maybridge1_000458 OC1(CC(=O)c2ccc3ccccc3c2)C(=O)Nc4ccc(Br)cc41 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M19 compound treatment 1.0394 0.0394 0.77 0.7659 1.0 2069608 Maybridge1_000459 Cc1nc(ccc1NC(=O)N2CCCN(Cc3c(F)cccc3Cl)CC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M20 compound treatment 0.9686 -0.0314 -0.61 -0.61 -1.0 1920853 Maybridge1_000460 C/C(=N\N=C(/C)\c1ccc(F)cc1)/c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M21 compound treatment 1.0137 0.0137 0.27 0.267 1.0 1742985 Maybridge1_000461 COc1ccccc1C2CCN(CC2)c3ncnc4scc(c5ccccc5)c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M22 compound treatment 0.9943 -0.00572 -0.11 -0.111 -1.0 2069609 Maybridge1_000462 COC(=O)c1sc2ccccc2c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M23 mock treatment 1.006 0.00596 0.12 0.1158 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 M24 mock treatment 1.0114 0.0114 0.22 0.2216 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N01 compound treatment 1.0145 0.0145 0.28 0.2821 1.0 1061248 Maybridge1_000463 CC(=NNC(=O)c1cccnc1)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N02 compound treatment 1.0137 0.0137 0.27 0.267 1.0 2069610 Maybridge1_000464 Fc1ccc(NC(=O)CSC(=O)c2sc3ccccc3c2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N03 compound treatment 0.999 -0.00105 -0.02 -0.0203 -1.0 1918851 Maybridge1_000465 C(C/N=C/c1ccc2OCOc2c1)/N=C/c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N04 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 2069611 Maybridge1_000466 COc1ccc(cc1)c2nnc(S)n2c3ccc(Cl)cc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N05 compound treatment 1.0021 0.00207 0.04 0.0402 1.0 1155620 Maybridge1_000467 Cc1ccc2nc(oc(=O)c2c1)c3sc4ccccc4c3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N06 compound treatment 1.006 0.00596 0.12 0.1158 1.0 1731343 Maybridge1_000468 COc1ccc(CC2N(CCc3cc(OC)c(OC)cc23)C(=S)Nc4ccc(Cl)cc4C)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N07 compound treatment 1.006 0.00596 0.12 0.1158 1.0 1680835 Maybridge1_000469 COc1cccc(NC(=S)Nc2ccc(OC)c(OC)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N08 compound treatment 1.0153 0.0153 0.3 0.2972 1.0 1443259 Maybridge1_000470 Cc1cccc2CCCN(C(=S)Nc3ccccc3Cl)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N09 compound treatment 1.0028 0.00285 0.06 0.0553 1.0 1532986 Maybridge1_000471 CCOC(=O)C1CCN(CC1)C(=S)Nc2cccc(C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N10 compound treatment 0.9203 -0.0797 -1.55 -1.5475 -1.0 2069612 Maybridge1_000472 Oc1ccc(CCC(=O)N/N=C/C=C/c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N11 compound treatment 0.9554 -0.0446 -0.87 -0.8671 -1.0 1025368 Maybridge1_000473 CC1CC(=O)Nc2ccccc2N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N12 compound treatment 0.967 -0.033 -0.64 -0.6403 -1.0 2069613 Maybridge1_000474 Fc1ccc(cc1)N(Cc2ccc3OCOc3c2)C(=S)Nc4ccc(Cl)c(Cl)c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N13 compound treatment 0.9273 -0.0727 -1.41 -1.4114 -1.0 1356457 Maybridge1_000475 CC1CC(=O)Nc2ccccc2N1C(=O)c3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N14 compound treatment 0.9678 -0.0322 -0.63 -0.6251 -1.0 2069614 Maybridge1_000476 Oc1c(Cl)cc(Cl)cc1/C=N/Cc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N15 compound treatment 0.9842 -0.0158 -0.31 -0.3076 -1.0 2069615 Maybridge1_000477 Clc1cc(Cl)cc(/C=N/Cc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N16 compound treatment 0.9873 -0.0127 -0.25 -0.2471 -1.0 2069616 Maybridge1_000478 Oc1ccc(CCc2nnc(S)n2c3cccc(c3)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N17 compound treatment 0.9943 -0.00572 -0.11 -0.111 -1.0 1635176 Maybridge1_000479 COc1ccc(CN(Cc2ccccc2)C(=S)Nc3c(C)cccc3C)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N18 compound treatment 0.9966 -0.00338 -0.07 -0.0657 -1.0 2069617 Maybridge1_000480 Cc1ccc(NS(=O)(=O)C)cc1NC(=S)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N19 compound treatment 0.9951 -0.00494 -0.1 -0.0959 -1.0 1041825 Maybridge1_000481 COC(=O)c1cccc([N+](=O)[O-])c1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N20 compound treatment 0.9795 -0.0205 -0.4 -0.3983 -1.0 1733240 Maybridge1_000482 Cc1ccc(NS(=O)(=O)C)cc1NC(=S)Nc2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N21 compound treatment 0.974 -0.026 -0.5 -0.5042 -1.0 1669077 Maybridge1_000483 Cc1onc(c1C(=O)N2CCCc3cc(C)ccc23)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N22 compound treatment 1.1321 0.132 2.57 2.5653 1.0 2069618 Maybridge1_000484 CC1=NN(C(=O)C1)c2ccc(/N=C/c3ccc(Cl)c(Cl)c3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N23 mock treatment 0.9865 -0.0135 -0.26 -0.2622 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 N24 mock treatment 1.0589 0.0589 1.14 1.144 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O01 compound treatment 1.0371 0.0371 0.72 0.7206 1.0 1915043 Maybridge1_000485 CCOC(=O)c1c(N)scc1c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O02 compound treatment 1.0044 0.0044 0.09 0.0855 1.0 1150030 Maybridge1_000486 COc1ccccc1NC(=O)N2CCCN(CC2)C(=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O03 compound treatment 1.034 0.034 0.66 0.6601 1.0 2069619 Maybridge1_000487 c1csc(c1)c2csc(n2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O04 compound treatment 1.0278 0.0278 0.54 0.5391 1.0 1324207 Maybridge1_000488 COc1ccccc1NC(=O)N2CCN(CC2)C(=O)OC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O05 compound treatment 1.0137 0.0137 0.27 0.267 1.0 1231382 Maybridge1_000489 OC1CCN(CC1)C(=S)NCCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O06 compound treatment 1.0441 0.0441 0.86 0.8567 1.0 1249375 Maybridge1_000490 Fc1cccc(Cl)c1CN2CCN(CC2)c3ncnc4scc(c5ccccc5)c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O07 compound treatment 1.0472 0.0472 0.92 0.9172 1.0 2069620 Maybridge1_000491 OC(=O)CSCC(=O)NCCNc1nccc(n1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O08 compound treatment 0.9826 -0.0174 -0.34 -0.3378 -1.0 2069621 Maybridge1_000492 Brc1ccc(NC(=O)CN2CCN(CC2)c3ncnc4scc(c5ccccc5)c34)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O09 compound treatment 1.0176 0.0176 0.34 0.3426 1.0 2069622 Maybridge1_000493 OCCN1CCN(CC1)c2nccc(n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O10 compound treatment 0.9764 -0.0236 -0.46 -0.4588 -1.0 1549615 Maybridge1_000494 COc1ccc(CCNc2ncnc3scc(c4ccc(C)cc4)c23)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O11 compound treatment 0.9888 -0.0112 -0.22 -0.2169 -1.0 2069623 Maybridge1_000495 FC(F)(F)c1ccnc(NCCNC(=O)c2ccccc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O12 compound treatment 0.9561 -0.0439 -0.85 -0.8519 -1.0 2069624 Maybridge1_000496 FC(F)(F)c1cnc(NCCNC(=O)C2=Cc3cc(Cl)ccc3OC2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O13 compound treatment 0.9219 -0.0781 -1.52 -1.5172 -1.0 1702834 Maybridge1_000497 Cc1cc(c(C)cc1Cl)S(=O)(=O)N2CCCN(Cc3ccc(Cl)cc3Cl)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O14 compound treatment 0.9647 -0.0353 -0.69 -0.6856 -1.0 2069625 Maybridge1_000498 CCCCCCCc1ccc(NC(=O)Nc2ccc(F)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O15 compound treatment 0.932 -0.068 -1.32 -1.3207 -1.0 1280161 Maybridge1_000499 CCCc1cnc(nc1)N2CCCN(CC2)C(=S)Nc3ccc(C)cc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O16 compound treatment 0.9374 -0.0626 -1.21 -1.2148 -1.0 2069626 Maybridge1_000500 Cc1ccccc1NC(=S)NCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O17 compound treatment 1.006 0.00596 0.12 0.1158 1.0 2069627 Maybridge1_000501 OC(=O)c1ccccc1C(=O)NCCNc2ccc(cn2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O18 compound treatment 0.9616 -0.0384 -0.75 -0.7461 -1.0 1569206 Maybridge1_000502 CCc1cc2c(cc1C(=O)CC3(O)C(=O)Nc4ccc(Br)cc43)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O19 compound treatment 0.9616 -0.0384 -0.75 -0.7461 -1.0 2069628 Maybridge1_000503 CCOC(=O)c1c(N)sc(C)c1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O20 compound treatment 1.0153 0.0153 0.3 0.2972 1.0 2069629 Maybridge1_000504 Oc1ccccc1/C=N/c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O21 compound treatment 1.0355 0.0355 0.69 0.6903 1.0 1609990 Maybridge1_000505 Clc1ccc(CN2CCCN(CC2)c3ncnc4scc(c5ccccc5)c34)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O22 compound treatment 0.974 -0.026 -0.5 -0.5042 -1.0 2069630 Maybridge1_000506 NNC(=O)c1sc2ccccc2c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O23 mock treatment 0.9912 -0.00883 -0.17 -0.1715 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 O24 mock treatment 1.0285 0.0285 0.55 0.5543 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P01 compound treatment 1.0371 0.0371 0.72 0.7206 1.0 2069631 Maybridge1_000507 O=C(N/N=C/c1ccco1)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P02 compound treatment 1.0823 0.0823 1.6 1.5976 1.0 2069632 Maybridge1_000508 Clc1c(sc2ccccc12)C(=O)SCC(=O)Nc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P03 compound treatment 1.0488 0.0488 0.95 0.9474 1.0 1982147 Maybridge1_000509 Cc1cc2CSC(SCc2cc1C)c3cc(Cl)cc(Cl)c3O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P04 compound treatment 1.0807 0.0807 1.57 1.5673 1.0 2069633 Maybridge1_000510 COc1ccc(cc1)c2nnc(S)n2c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P05 compound treatment 1.0418 0.0418 0.81 0.8113 1.0 2069634 Maybridge1_000511 Cc1cc(C)c(/N=C/2\SC(=C)C3(CCCCC3)N2C(=O)c4c(Cl)sc5ccccc45)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P06 compound treatment 1.0784 0.0784 1.52 1.522 1.0 2069635 Maybridge1_000512 CCCCCCC(C)(SCC(=O)O)SCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P07 compound treatment 1.0449 0.0449 0.87 0.8718 1.0 1444113 Maybridge1_000513 COc1ccccc1NC(=S)Nc2ccc(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P08 compound treatment 1.0737 0.0737 1.43 1.4312 1.0 2069636 Maybridge1_000514 Cc1ccc2N(CCCc2c1)C(=S)Nc3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P09 compound treatment 0.9958 -0.00416 -0.08 -0.0808 -1.0 1715015 Maybridge1_000515 CCOC(=O)C1CCN(CC1)C(=S)Nc2cccc(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P10 compound treatment 1.0301 0.0301 0.58 0.5845 1.0 2069637 Maybridge1_000516 CN(C)c1ccc(/C=N/NC(=O)CCc2ccc(O)cc2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P11 compound treatment 0.9997 -2.68E-4 -0.01 -0.0052 -1.0 2069638 Maybridge1_000517 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccc3[nH]cnc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P12 compound treatment 0.9826 -0.0174 -0.34 -0.3378 -1.0 2069639 Maybridge1_000518 CS(=O)(=O)N1CCCc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P13 compound treatment 0.9538 -0.0462 -0.9 -0.8973 -1.0 2069640 Maybridge1_000519 CC1CC(=O)Nc2ccccc2N1C(=O)c3ccc(cc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P14 compound treatment 1.0682 0.0682 1.33 1.3254 1.0 1083099 Maybridge1_000520 CC(=O)c1cc2cc(Cl)cc(Cl)c2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P15 compound treatment 0.9538 -0.0462 -0.9 -0.8973 -1.0 2069641 Maybridge1_000521 Brc1cccc(/C=N/Cc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P16 compound treatment 0.96 -0.04 -0.78 -0.7763 -1.0 2069642 Maybridge1_000522 Cc1onc(c1NC(=O)NNC(=O)c2c(C)onc2c3ccccc3)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P17 compound treatment 0.9663 -0.0337 -0.66 -0.6554 -1.0 1164239 Maybridge1_000523 COc1cc(CN(Cc2ccccc2)C(=S)Nc3c(C)cccc3C)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P18 compound treatment 1.013 0.013 0.25 0.2519 1.0 1478744 Maybridge1_000524 Cc1ccc(NS(=O)(=O)C)cc1NC(=S)Nc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P19 compound treatment 0.9951 -0.00494 -0.1 -0.0959 -1.0 2069643 Maybridge1_000525 Fc1ccc(/N=C/c2ccc3OCOc3c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P20 compound treatment 1.0254 0.0254 0.49 0.4938 1.0 2069644 Maybridge1_000526 COCCCNC(=S)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P21 compound treatment 0.9577 -0.0423 -0.82 -0.8217 -1.0 2069645 Maybridge1_000527 Cc1ccc(cc1Cl)N2C(SCC2=O)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P22 compound treatment 0.9873 -0.0127 -0.25 -0.2471 -1.0 2069646 Maybridge1_000528 COCCCNC(=S)Nc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P23 mock treatment 0.9896 -0.0104 -0.2 -0.2018 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.542 P24 mock treatment 1.0472 0.0472 0.92 0.9172 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A01 compound treatment 1.1124 0.112 2.18 2.1838 1.0 1349488 Maybridge1_000529 CCOC(=O)C1=C(C)N(C(=O)C1CC(=O)Nc2ccc(F)cc2)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A02 compound treatment 1.0182 0.0182 0.35 0.3544 1.0 2069647 Maybridge1_000530 FC(F)(F)c1cccc(NC(=S)N2CCCCC2CCN3CCOCC3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A03 compound treatment 1.0377 0.0377 0.73 0.7314 1.0 1364330 Maybridge1_000531 OC(=O)c1cc2cc(Cl)cc(Cl)c2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A04 compound treatment 0.9967 -0.00333 -0.06 -0.0646 -1.0 2069648 Maybridge1_000532 [O-][N+](=O)c1ccc2NC(NC(=O)c2c1)c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A05 compound treatment 0.9816 -0.0184 -0.36 -0.3578 -1.0 2069649 Maybridge1_000533 Clc1ccc(/C=N/N=C(\C(=O)c2ccccc2)/c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A06 compound treatment 0.9996 -4.49E-4 -0.01 -0.0087 -1.0 1933703 Maybridge1_000534 COc1ccc(CCNC(=O)c2ccc(cc2)[N+](=O)[O-])cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A07 compound treatment 1.001 9.89E-4 0.02 0.0192 1.0 1547043 Maybridge1_000535 Clc1c(sc2ccccc12)C(=O)Nc3ccc4[nH]nnc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A08 compound treatment 1.0118 0.0118 0.23 0.2287 1.0 2069650 Maybridge1_000536 FC(F)(F)c1ccc(N2CCCCC2)c(NC=C(C#N)C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A09 compound treatment 0.9974 -0.00261 -0.05 -0.0506 -1.0 1471479 Maybridge1_000537 CCOC(=O)c1ccc(cc1)N2CC3CCCCN3C2c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A10 compound treatment 0.9873 -0.0127 -0.25 -0.2461 -1.0 1441228 Maybridge1_000538 COc1cc(CNc2cccc(F)c2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A11 compound treatment 0.9895 -0.0105 -0.2 -0.2042 -1.0 1248791 Maybridge1_000539 Fc1ccc(NC(=S)Nc2ccc(Cl)cc2C(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A12 compound treatment 0.9952 -0.00476 -0.09 -0.0925 -1.0 1664786 Maybridge1_000540 CCOC(=O)c1c[nH]c2c(F)cccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A13 compound treatment 0.9809 -0.0191 -0.37 -0.3718 -1.0 2069651 Maybridge1_000541 COc1cccc(C2SCc3cc(C)c(C)cc3CS2)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A14 compound treatment 0.9787 -0.0213 -0.41 -0.4137 -1.0 2069652 Maybridge1_000542 COc1c(/N=C/c2cc(Br)ccc2O)c(C)c(/N=C/c3cc(Br)ccc3O)cc1C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A15 compound treatment 1.0125 0.0125 0.24 0.2426 1.0 2069653 Maybridge1_000543 COc1ccccc1/N=C\2/NC(C)(C)C(=C)S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A16 compound treatment 0.9837 -0.0163 -0.32 -0.316 -1.0 1304585 Maybridge1_000544 Clc1ccc(Cl)c(NC(=S)N(CCc2ccccc2)CCc3ccccn3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A17 compound treatment 0.9844 -0.0156 -0.3 -0.302 -1.0 2069654 Maybridge1_000545 FC(F)(F)c1cc(NC(=O)c2cc3ccccc3oc2=O)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A18 compound treatment 1.1297 0.13 2.52 2.5189 1.0 2069655 Maybridge1_000546 [O-][N+](=O)c1ccc(C=C2C(=O)NC(=S)NC2=O)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A19 compound treatment 1.0262 0.0262 0.51 0.508 1.0 1673765 Maybridge1_000547 CC(=O)Nc1ccc(C)c(NC(=S)Nc2ccc(Cl)cc2C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A20 compound treatment 0.9895 -0.0105 -0.2 -0.2042 -1.0 1676755 Maybridge1_000548 Cc1ncc(CSCC(=O)Nc2ccccc2F)c(CO)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A21 compound treatment 1.0348 0.0348 0.68 0.6756 1.0 1714954 Maybridge1_000549 CC(C)c1ccc(cc1)N(CCc2ccccn2)C(=O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A22 compound treatment 1.0657 0.0657 1.28 1.276 1.0 2069656 Maybridge1_000550 Cc1ccc(cc1)S(=O)(=O)N/N=C/c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A23 mock treatment 1.0413 0.0413 0.8 0.8012 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 A24 mock treatment 1.0528 0.0528 1.02 1.0247 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B01 compound treatment 0.9945 -0.00548 -0.11 -0.1065 -1.0 1706179 Maybridge1_000551 Clc1ccc(cc1Cl)C2N(Cc3ccccc3)CCC4CCCCN24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B02 compound treatment 0.9305 -0.0695 -1.35 -1.3494 -1.0 2069657 Maybridge1_000552 [O-][N+](=O)c1cc(Cl)c(cc1N2CCCCC2)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B03 compound treatment 0.965 -0.035 -0.68 -0.679 -1.0 2069658 Maybridge1_000553 CCC(C(=O)NNC(=O)c1ccccc1N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B04 compound treatment 0.9859 -0.0141 -0.27 -0.2741 -1.0 1375753 Maybridge1_000554 Clc1cc(Cl)c(cc1Cl)S(=O)(=O)Nc2cccc3cccnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B05 compound treatment 0.978 -0.022 -0.43 -0.4277 -1.0 2069659 Maybridge1_000555 [O-][N+](=O)c1ccccc1C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B06 compound treatment 0.978 -0.022 -0.43 -0.4277 -1.0 2069660 Maybridge1_000556 CC1(C)CCC(C)(C)N=C(N1)SCC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B07 compound treatment 0.9729 -0.0271 -0.53 -0.5254 -1.0 2069661 Maybridge1_000557 COc1cc([N+](=O)[O-])c(OC)cc1SCC(=O)NNC(=S)Nc2cccc(Cl)c2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B08 compound treatment 0.9643 -0.0357 -0.69 -0.693 -1.0 2069662 Maybridge1_000558 Clc1ccc(cc1)S(=O)(=O)Nc2cccc(C#N)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B09 compound treatment 0.9471 -0.0529 -1.03 -1.0282 -1.0 2069663 Maybridge1_000559 COc1cc([N+](=O)[O-])c(OC)cc1SCc2nnc(S)n2c3cccc(Cl)c3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B10 compound treatment 0.9478 -0.0522 -1.01 -1.0142 -1.0 2069664 Maybridge1_000560 Cc1cccc(C)c1NC(=O)CSC(=O)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B11 compound treatment 0.9823 -0.0177 -0.34 -0.3439 -1.0 2069665 Maybridge1_000561 OCc1ccc(N2CCOCC2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B12 compound treatment 0.9801 -0.0199 -0.39 -0.3858 -1.0 2069666 Maybridge1_000562 [O-][N+](=O)c1cccc(c1)c2noc(n2)c3c(F)cccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B13 compound treatment 0.9658 -0.0342 -0.67 -0.6651 -1.0 2069667 Maybridge1_000563 Cc1ccc(cc1)S(=O)(=O)NNC(=O)CCc2nc(no2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B14 compound treatment 1.0175 0.0175 0.34 0.3404 1.0 2069668 Maybridge1_000564 Cc1cc(Oc2ccc(cc2)[N+](=O)[O-])c(Cl)c(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B15 compound treatment 0.9679 -0.0321 -0.62 -0.6232 -1.0 2069669 Maybridge1_000565 COC(=O)c1cc(ccc1n2cccc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B16 compound treatment 0.9406 -0.0594 -1.15 -1.1538 -1.0 1590064 Maybridge1_000566 CC(C)(C#C)N1CNC(=S)NC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B17 compound treatment 0.9276 -0.0724 -1.41 -1.4052 -1.0 2069670 Maybridge1_000567 Sc1nc2cc(Cl)c(Cl)cc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B18 compound treatment 0.978 -0.022 -0.43 -0.4277 -1.0 2069671 Maybridge1_000568 [O-][N+](=O)c1ccc(cc1)C(=O)Oc2ccc(Cl)cc2Sc3cc(Cl)ccc3OC(=O)c4ccc(cc4)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B19 compound treatment 0.9492 -0.0508 -0.99 -0.9863 -1.0 2069672 Maybridge1_000569 C/C(=N\NC1=NCCN1Cc2ccccc2)/c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B20 compound treatment 0.9471 -0.0529 -1.03 -1.0282 -1.0 2069673 Maybridge1_000570 NC(=O)c1ccc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B21 compound treatment 0.9492 -0.0508 -0.99 -0.9863 -1.0 2069674 Maybridge1_000571 Cc1ccc2cc(F)ccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B22 compound treatment 0.9758 -0.0242 -0.47 -0.4696 -1.0 2069675 Maybridge1_000572 [O-][N+](=O)c1ccc(OC(=O)c2cccnc2Oc3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B23 mock treatment 0.9542 -0.0458 -0.89 -0.8885 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 B24 mock treatment 1.0254 0.0254 0.49 0.494 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C01 compound treatment 1.0858 0.0858 1.67 1.6671 1.0 1663724 Maybridge1_000573 CCOC(=O)C1=C(CC(=O)Nc2ccc(OC)cc2)C(=O)N(C1C)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C02 compound treatment 0.9708 -0.0292 -0.57 -0.5673 -1.0 1566478 Maybridge1_000574 CSc1cccc(NC(=S)N2CCCCC2CCN3CCOCC3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C03 compound treatment 0.9787 -0.0213 -0.41 -0.4137 -1.0 1208608 Maybridge1_000575 Cc1cc(Cl)ccc1Nc2nnc(s2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C04 compound treatment 0.9996 -4.49E-4 -0.01 -0.0087 -1.0 2069676 Maybridge1_000576 Cc1ccccc1C(=O)N(c2nc3ccccc3s2)c4cc(cc(c4)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C05 compound treatment 0.9981 -0.00189 -0.04 -0.0367 -1.0 2069677 Maybridge1_000577 Cc1cc(OCc2c(C)c(C)c(C)c(C)c2C)c3c(Cl)ccc(C)c3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C06 compound treatment 0.9262 -0.0738 -1.43 -1.4331 -1.0 1323864 Maybridge1_000578 COc1ccc(CCNC(=O)c2c(Cl)cccc2Cl)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C07 compound treatment 0.9665 -0.0335 -0.65 -0.6511 -1.0 1488891 Maybridge1_000579 CC(C)N(Cc1ccc(cc1)N(C)C)C(=O)c2c(C)onc2c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C08 compound treatment 0.9334 -0.0666 -1.29 -1.2935 -1.0 1292706 Maybridge1_000580 COc1cc2CCNC(c3ccc(N)cc3)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C09 compound treatment 1.0175 0.0175 0.34 0.3404 1.0 2069678 Maybridge1_000581 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccc(cc2)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C10 compound treatment 0.9348 -0.0652 -1.27 -1.2656 -1.0 2069679 Maybridge1_000582 COc1ccc(CCNc2ccc(cc2N)C(F)(F)F)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C11 compound treatment 0.9974 -0.00261 -0.05 -0.0506 -1.0 2069680 Maybridge1_000583 Cc1ccc(cc1[N+](=O)[O-])C2=N/C(=C\c3cccs3)/C(=O)O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C12 compound treatment 0.9312 -0.0688 -1.34 -1.3354 -1.0 2069681 Maybridge1_000584 Fc1ccc(cc1)c2cn3Cc4ccccc4Cc3n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C13 compound treatment 1.0168 0.0168 0.33 0.3264 1.0 1396404 Maybridge1_000585 CC(=O)Nc1ccc(NC(=O)c2c(C)onc2c3c(Cl)cccc3Cl)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C14 compound treatment 0.9614 -0.0386 -0.75 -0.7489 -1.0 2069682 Maybridge1_000586 CCC(C(=O)Nc1ccc(cc1)C(F)(F)F)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C15 compound treatment 0.9463 -0.0537 -1.04 -1.0421 -1.0 2069683 Maybridge1_000587 Cc1ccc(cc1)S(=O)(=O)Nc2ccc(C)c(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C16 compound treatment 0.9801 -0.0199 -0.39 -0.3858 -1.0 2069684 Maybridge1_000588 FC(F)(F)c1cccc(NC(=S)N(CCc2ccccc2)CCc3ccccn3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C17 compound treatment 0.9672 -0.0328 -0.64 -0.6371 -1.0 2069685 Maybridge1_000589 CCOC(=O)C1CCN(CC1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C18 compound treatment 0.9708 -0.0292 -0.57 -0.5673 -1.0 2069686 Maybridge1_000590 Cc1c(NNc2cc3c(c([N+](=O)[O-])c2C)C(C)(C)CC3(C)C)cc4c(c1[N+](=O)[O-])C(C)(C)CC4(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C19 compound treatment 0.937 -0.063 -1.22 -1.2237 -1.0 1235622 Maybridge1_000591 CC(=O)Nc1ccc(C)c(NS(=O)(=O)c2cc(Cl)ccc2Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C20 compound treatment 0.9391 -0.0609 -1.18 -1.1818 -1.0 2069687 Maybridge1_000592 [O-][N+](=O)c1ccc(/C=N/c2cc(ccc2N3CCOCC3)C(F)(F)F)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C21 compound treatment 0.9873 -0.0127 -0.25 -0.2461 -1.0 2069688 Maybridge1_000593 Cc1ccc([N+](=O)[O-])c(c1)C(=O)N(CCc2ccccn2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C22 compound treatment 1.006 0.00602 0.12 0.117 1.0 1931746 Maybridge1_000594 Cc1ccc(cc1)S(=O)(=O)N/N=C/c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C23 mock treatment 0.9765 -0.0235 -0.46 -0.4556 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 C24 mock treatment 0.9996 -4.49E-4 -0.01 -0.0087 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D01 compound treatment 1.0269 0.0269 0.52 0.5219 1.0 1042344 Maybridge1_000595 [O-][N+](=O)c1ccccc1N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D02 compound treatment 1.0082 0.00818 0.16 0.1589 1.0 2069689 Maybridge1_000596 [O-][N+](=O)c1cc(Cl)c(cc1N2CCOCC2)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D03 compound treatment 0.965 -0.035 -0.68 -0.679 -1.0 1508813 Maybridge1_000597 CN1C(NC(=O)c2cc(Cl)ccc12)C3CCC=CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D04 compound treatment 0.9679 -0.0321 -0.62 -0.6232 -1.0 2069690 Maybridge1_000598 CC(C)(C)NNC(=S)Nc1cc(Cl)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D05 compound treatment 0.9729 -0.0271 -0.53 -0.5254 -1.0 2069691 Maybridge1_000599 N#Cc1cnn(c1n2cccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D06 compound treatment 0.9751 -0.0249 -0.48 -0.4835 -1.0 1154273 Maybridge1_000600 Cc1ccc(NC(=O)c2c(F)cccc2Cl)c(c1)C(=O)Nc3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D07 compound treatment 0.9629 -0.0371 -0.72 -0.7209 -1.0 2069692 Maybridge1_000601 COc1cc([N+](=O)[O-])c(OC)cc1SCC(=O)NNC(=S)Nc2cc(ccc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D08 compound treatment 0.919 -0.081 -1.57 -1.5728 -1.0 2069693 Maybridge1_000602 [O-][N+](=O)c1cc(ccc1N2CCCCC2)c3n[nH]c(=O)c4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D09 compound treatment 0.978 -0.022 -0.43 -0.4277 -1.0 2069694 Maybridge1_000603 COc1cc([N+](=O)[O-])c(OC)cc1SCc2nnc(S)n2c3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D10 compound treatment 1.001 9.89E-4 0.02 0.0192 1.0 2069695 Maybridge1_000604 COC(=O)C(C)SCC(=O)Nc1c(C)cccc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D11 compound treatment 0.9751 -0.0249 -0.48 -0.4835 -1.0 2069696 Maybridge1_000605 Sc1nc2ccccc2c(=O)n1NC(=O)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D12 compound treatment 0.9765 -0.0235 -0.46 -0.4556 -1.0 2069697 Maybridge1_000606 [O-][N+](=O)c1ccc(cc1)c2nc(no2)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D13 compound treatment 0.978 -0.022 -0.43 -0.4277 -1.0 2069698 Maybridge1_000607 Clc1ccc(cc1)c2noc(CCC(=O)NNS(=O)(=O)c3ccc(Cl)cc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D14 compound treatment 0.9981 -0.00189 -0.04 -0.0367 -1.0 2069699 Maybridge1_000608 CC1CCC(C)(C)CN(C1)c2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D15 compound treatment 0.9816 -0.0184 -0.36 -0.3578 -1.0 2069700 Maybridge1_000609 N#Cc1cccc(c1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D16 compound treatment 0.9809 -0.0191 -0.37 -0.3718 -1.0 2069701 Maybridge1_000610 [O-][N+](=O)c1ccc(c(C#N)c1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D17 compound treatment 0.9686 -0.0314 -0.61 -0.6092 -1.0 1031325 Maybridge1_000611 COc1ccccc1CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D18 compound treatment 0.9341 -0.0659 -1.28 -1.2795 -1.0 1622063 Maybridge1_000612 Clc1ccc(OC(=O)c2cccs2)c(Sc3cc(Cl)ccc3OC(=O)c4cccs4)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D19 compound treatment 0.9722 -0.0278 -0.54 -0.5394 -1.0 2069702 Maybridge1_000613 C/C(=N\NC1=NCCN1Cc2ccccc2)/c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D20 compound treatment 0.9765 -0.0235 -0.46 -0.4556 -1.0 1152323 Maybridge1_000614 Cc1cc(ccc1Cl)c2csc(N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D21 compound treatment 0.9614 -0.0386 -0.75 -0.7489 -1.0 1111385 Maybridge1_000615 CCOC(=O)CNC(=O)c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D22 compound treatment 0.9859 -0.0141 -0.27 -0.2741 -1.0 1353468 Maybridge1_000616 COc1ccc(OC(=O)c2cccnc2Oc3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D23 mock treatment 0.9801 -0.0199 -0.39 -0.3858 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 D24 mock treatment 1.0211 0.0211 0.41 0.4102 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E01 compound treatment 1.042 0.042 0.82 0.8152 1.0 1374907 Maybridge1_000617 CCOC(=O)C1=C(C)N(C(=O)C1CC(=O)Nc2ccc(cc2)C(=O)OCC)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E02 compound treatment 1.5331 0.533 10.35 10.3532 1.0 2069703 Maybridge1_000618 Oc1c(Cl)cc(Cl)cc1/C=C/2\SC(=S)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E03 compound treatment 0.9564 -0.0436 -0.85 -0.8466 -1.0 2069704 Maybridge1_000619 Fc1ccc(Nc2nnc(s2)c3ccccc3Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E04 compound treatment 0.978 -0.022 -0.43 -0.4277 -1.0 1921741 Maybridge1_000620 [O-][N+](=O)c1cc(ccc1N2CCCCC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E05 compound treatment 0.9844 -0.0156 -0.3 -0.302 -1.0 1147994 Maybridge1_000621 Cc1cc(OCc2c(C)c(C)c(C)c(C)c2C)c3cc(F)ccc3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E06 compound treatment 0.9787 -0.0213 -0.41 -0.4137 -1.0 2069705 Maybridge1_000622 [O-][N+](=O)c1cc(ccc1N2CCCC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E07 compound treatment 0.9701 -0.0299 -0.58 -0.5813 -1.0 1265948 Maybridge1_000623 Clc1cccc(NC(=S)Nc2ccc(Cl)cc2C(=O)c3ccccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E08 compound treatment 1.0211 0.0211 0.41 0.4102 1.0 1407219 Maybridge1_000624 COc1cc2CCN(C(c3cccc(C)c3)c2cc1OC)C(=O)c4sc5ccccc5c4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E09 compound treatment 0.9463 -0.0537 -1.04 -1.0421 -1.0 1372571 Maybridge1_000625 Cc1cccc(NC(=S)Nc2ccc(C)c(NS(=O)(=O)C)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E10 compound treatment 0.9391 -0.0609 -1.18 -1.1818 -1.0 2069706 Maybridge1_000626 [O-][N+](=O)c1cc(ccc1NCCc2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E11 compound treatment 2.3011 1.3 25.27 25.2677 1.0 2069707 Maybridge1_000627 CN(C)c1ccc(/C=C/2\N=C(OC2=O)c3ccc(C)c(c3)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E12 compound treatment 0.9844 -0.0156 -0.3 -0.302 -1.0 1239898 Maybridge1_000628 COc1ccc(cc1)C(=O)CC2(O)C(=O)N(CN3CCCCC3)c4ccc(Br)cc42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E13 compound treatment 0.9974 -0.00261 -0.05 -0.0506 -1.0 2069708 Maybridge1_000629 Cc1onc(c1C(=O)Nc2ccc(C)c(c2)[N+](=O)[O-])c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E14 compound treatment 0.983 -0.017 -0.33 -0.3299 -1.0 2069709 Maybridge1_000630 CCC(C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E15 compound treatment 0.9931 -0.00692 -0.13 -0.1344 -1.0 2069710 Maybridge1_000631 Cc1onc(c1C(=O)N(c2nc3ccccc3s2)c4cccc(Cl)c4)c5c(Cl)cccc5Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E16 compound treatment 0.9449 -0.0551 -1.07 -1.0701 -1.0 1278441 Maybridge1_000632 Cc1ccc(C)c(NC(=S)N(CCc2ccccc2)CCc3ccccn3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E17 compound treatment 1.0082 0.00818 0.16 0.1589 1.0 2069711 Maybridge1_000633 COc1cc(/C=C\2/SC(=S)NC2=O)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E18 compound treatment 0.9672 -0.0328 -0.64 -0.6371 -1.0 2069712 Maybridge1_000634 [O-][N+](=O)c1ccc(s1)C2NC(=O)c3ccccc3N2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E19 compound treatment 0.9643 -0.0357 -0.69 -0.693 -1.0 1046617 Maybridge1_000635 CC(=O)Nc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E20 compound treatment 0.9442 -0.0558 -1.08 -1.084 -1.0 1935254 Maybridge1_000636 Cc1ccc(/C=N/NS(=O)(=O)c2ccc(C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E21 compound treatment 0.9758 -0.0242 -0.47 -0.4696 -1.0 2069713 Maybridge1_000637 CN(CCC#N)c1ccc(/C=N/CCC\N=C/c2ccc(cc2)N(C)CCC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E22 compound treatment 0.9665 -0.0335 -0.65 -0.6511 -1.0 1699144 Maybridge1_000638 CN(C)c1ccc(CC(C#N)c2ccc(N)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E23 mock treatment 0.9672 -0.0328 -0.64 -0.6371 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 E24 mock treatment 0.9873 -0.0127 -0.25 -0.2461 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F01 compound treatment 1.0233 0.0233 0.45 0.4521 1.0 1013657 Maybridge1_000639 [O-][N+](=O)c1ccccc1N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F02 compound treatment 1.0075 0.00746 0.14 0.1449 1.0 1060533 Maybridge1_000640 COc1ccc(CCNC(=O)c2ccccc2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F03 compound treatment 0.9988 -0.00117 -0.02 -0.0227 -1.0 1243303 Maybridge1_000641 Nc1ccccc1C(=O)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F04 compound treatment 0.9909 -0.00908 -0.18 -0.1763 -1.0 2069714 Maybridge1_000642 NC(=O)C(C1CCCC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F05 compound treatment 1.0139 0.0139 0.27 0.2706 1.0 2069715 Maybridge1_000643 N#CCc1nn(c(c1C#N)n2cccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F06 compound treatment 0.9715 -0.0285 -0.55 -0.5534 -1.0 2069716 Maybridge1_000644 FC(F)(F)c1cc(Br)ccc1NC(=O)C(Cl)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F07 compound treatment 0.9643 -0.0357 -0.69 -0.693 -1.0 2069717 Maybridge1_000645 FC(F)(F)c1cc(cc(c1)C(F)(F)F)n2c(S)nnc2CCc3nc(no3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F08 compound treatment 0.9981 -0.00189 -0.04 -0.0367 -1.0 2069718 Maybridge1_000646 CN(C)c1ccc(cc1[N+](=O)[O-])c2n[nH]c(=O)c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F09 compound treatment 0.9744 -0.0256 -0.5 -0.4975 -1.0 1003095 Maybridge1_000647 Oc1nc(O)c2ccccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F10 compound treatment 0.9665 -0.0335 -0.65 -0.6511 -1.0 2069719 Maybridge1_000648 [O-][N+](=O)c1cccc(c1)c2ncon2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F11 compound treatment 1.0139 0.0139 0.27 0.2706 1.0 2069720 Maybridge1_000649 N#C/C(=C\c1ccc[nH]1)/c2nn(c(c2C#N)n3cccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F12 compound treatment 0.9844 -0.0156 -0.3 -0.302 -1.0 1572812 Maybridge1_000650 Cc1cc(Cl)cc2c(O)c(cnc12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F13 compound treatment 0.9751 -0.0249 -0.48 -0.4835 -1.0 2069721 Maybridge1_000651 FC(F)(F)c1cc(cc(c1)S(=O)(=O)NNC(=O)CCc2nc(no2)c3ccc(Cl)cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F14 compound treatment 0.9787 -0.0213 -0.41 -0.4137 -1.0 2069722 Maybridge1_000652 CC1(CC2CC(C)(C)C1)CN2c3ccc(cc3[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F15 compound treatment 0.942 -0.058 -1.13 -1.1259 -1.0 2069723 Maybridge1_000653 Cn1c(S)nnc1c2ccc(o2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F16 compound treatment 0.9672 -0.0328 -0.64 -0.6371 -1.0 2069724 Maybridge1_000654 N/C(=N\OC(=O)c1ccc(cc1)[N+](=O)[O-])/c2cccc(c2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F17 compound treatment 0.983 -0.017 -0.33 -0.3299 -1.0 2069725 Maybridge1_000655 Cc1nc2c(Br)cc(Br)cc2c(=O)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F18 compound treatment 1.0995 0.0995 1.93 1.9324 1.0 2069726 Maybridge1_000656 [O-][N+](=O)c1cc(ccc1Oc2ccc(C#N)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F19 compound treatment 1.006 0.00602 0.12 0.117 1.0 2069727 Maybridge1_000657 Cc1cc(C)c(NC(=O)CSc2cc(cc(c2)C(F)(F)F)C(F)(F)F)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F20 compound treatment 0.9866 -0.0134 -0.26 -0.2601 -1.0 2069728 Maybridge1_000658 COc1cc(/C=C(\C#N)/c2nn(c(c2C#N)n3cccc3)c4ccccc4)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F21 compound treatment 0.9967 -0.00333 -0.06 -0.0646 -1.0 2069729 Maybridge1_000659 CCOC(=O)CNC(=O)c1c(OC)cccc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F22 compound treatment 0.9327 -0.0673 -1.31 -1.3075 -1.0 1547053 Maybridge1_000660 CCOC(=O)c1ccc(OC(=O)c2cccnc2Oc3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F23 mock treatment 0.9406 -0.0594 -1.15 -1.1538 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 F24 mock treatment 1.0477 0.0477 0.93 0.9269 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G01 compound treatment 1.042 0.042 0.82 0.8152 1.0 2069730 Maybridge1_000661 Fc1ccc(NC(=S)NNC(=O)c2ccccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G02 compound treatment 0.9773 -0.0227 -0.44 -0.4416 -1.0 2069731 Maybridge1_000662 Fc1cccc(/N=C/c2ccc(Cl)c(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G03 compound treatment 1.1836 0.184 3.57 3.5663 1.0 2069732 Maybridge1_000663 CCOC(=O)CCc1cc(/N=C/c2cc(Br)ccc2O)c(O)c(/N=C/c3cc(Br)ccc3O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G04 compound treatment 0.914 -0.086 -1.67 -1.6705 -1.0 2069733 Maybridge1_000664 [O-][N+](=O)c1cc(ccc1N2CCOCC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G05 compound treatment 1.0154 0.0154 0.3 0.2985 1.0 2069734 Maybridge1_000665 Cc1cc(OC(=O)c2c(C)onc2c3c(Cl)cccc3Cl)n(n1)c4ccc(NC(=O)c5c(C)onc5c6c(Cl)cccc6Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G06 compound treatment 0.9708 -0.0292 -0.57 -0.5673 -1.0 2069735 Maybridge1_000666 COc1cc2CCN=C(c3ccc(cc3)[N+](=O)[O-])c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G07 compound treatment 0.9751 -0.0249 -0.48 -0.4835 -1.0 1681606 Maybridge1_000667 Cc1nc2cc(Cl)ccc2c(=O)n1c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G08 compound treatment 0.9737 -0.0263 -0.51 -0.5115 -1.0 1649904 Maybridge1_000668 Fc1ccc(NC(=O)c2ccncc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G09 compound treatment 0.9988 -0.00117 -0.02 -0.0227 -1.0 1446338 Maybridge1_000669 Cc1ccc(NC(=S)Nc2cccc(Cl)c2)cc1NS(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G10 compound treatment 0.9909 -0.00908 -0.18 -0.1763 -1.0 2069736 Maybridge1_000670 CC(Nc1ccc(cc1[N+](=O)[O-])C(F)(F)F)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G11 compound treatment 0.965 -0.035 -0.68 -0.679 -1.0 2069737 Maybridge1_000671 CC1(C)N/C(=N/c2ccccc2Cl)/SC1=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G12 compound treatment 0.9435 -0.0565 -1.1 -1.098 -1.0 1649200 Maybridge1_000672 Cc1ccc(cc1)C(=O)CC2(O)C(=O)N(CN3CCCCC3)c4ccc(Br)cc42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G13 compound treatment 1.0118 0.0118 0.23 0.2287 1.0 1671135 Maybridge1_000673 CC(=O)Nc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G14 compound treatment 0.9873 -0.0127 -0.25 -0.2461 -1.0 2069738 Maybridge1_000674 COc1cc(CN(C(=O)c2cccc(c2)[N+](=O)[O-])c3cccc(F)c3)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G15 compound treatment 0.9636 -0.0364 -0.71 -0.707 -1.0 2069739 Maybridge1_000675 Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G16 compound treatment 0.9859 -0.0141 -0.27 -0.2741 -1.0 2069740 Maybridge1_000676 Fc1cccc(Cl)c1/C=C/2\SC(=S)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G17 compound treatment 0.9773 -0.0227 -0.44 -0.4416 -1.0 1057803 Maybridge1_000677 Nc1nc2ccc(Cl)cc2c(c1C#N)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G18 compound treatment 0.965 -0.035 -0.68 -0.679 -1.0 2069741 Maybridge1_000678 Cc1ccc(cc1[N+](=O)[O-])N2C(=O)CC(SCC(=O)Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G19 compound treatment 1.0168 0.0168 0.33 0.3264 1.0 2069742 Maybridge1_000679 COc1cccc(/N=C/2\SC(=C)C(C)(C)N2C(=O)C(C3CCCC3)c4ccccc4)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G20 compound treatment 1.0578 0.0578 1.12 1.1224 1.0 2069743 Maybridge1_000680 [O-][N+](=O)c1ccc(s1)C2Nc3ccccc3O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G21 compound treatment 0.9636 -0.0364 -0.71 -0.707 -1.0 2069744 Maybridge1_000681 COc1cc(CN2CCCN(Cc3cc(OC)c(OC)c(OC)c3)C2c4cc(Br)ccc4O)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G22 compound treatment 0.9542 -0.0458 -0.89 -0.8885 -1.0 1014047 Maybridge1_000682 [O-][N+](=O)c1ccc(cc1)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G23 mock treatment 1.0262 0.0262 0.51 0.508 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 G24 mock treatment 1.0405 0.0405 0.79 0.7873 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H01 compound treatment 1.07 0.07 1.36 1.3598 1.0 2069745 Maybridge1_000683 Cc1onc(c1C(=O)SCC(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H02 compound treatment 0.9794 -0.0206 -0.4 -0.3997 -1.0 2069746 Maybridge1_000684 COc1cc2CCN(Cc2cc1OC)c3c(cc(cc3[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H03 compound treatment 1.006 0.00602 0.12 0.117 1.0 1364884 Maybridge1_000685 COc1ccc(CCNC(=O)c2ccccc2N)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H04 compound treatment 0.988 -0.012 -0.23 -0.2322 -1.0 2069747 Maybridge1_000686 [O-][N+](=O)c1ccc(cc1)c2cn3nc(sc3n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H05 compound treatment 0.9521 -0.0479 -0.93 -0.9304 -1.0 2069748 Maybridge1_000687 OC(C(=O)NNC(=S)Nc1cc(Cl)ccc1Cl)(c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H06 compound treatment 0.9852 -0.0148 -0.29 -0.288 -1.0 2069749 Maybridge1_000688 [O-][N+](=O)c1cc(ccc1Oc2ccc(Cl)cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H07 compound treatment 0.9988 -0.00117 -0.02 -0.0227 -1.0 2069750 Maybridge1_000689 Fc1ccccc1n2c(S)nnc2CCc3nc(no3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H08 compound treatment 1.0283 0.0283 0.55 0.5499 1.0 2069751 Maybridge1_000690 N/C(=N\O)/c1cccc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H09 compound treatment 1.0161 0.0161 0.31 0.3125 1.0 2069752 Maybridge1_000691 COc1cc(cc(OC)c1OC)C(=O)NNC(=O)CSc2cc(OC)c(cc2OC)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H10 compound treatment 1.0247 0.0247 0.48 0.48 1.0 2069753 Maybridge1_000692 N/C(=N\OC(=O)c1c(Cl)cccc1Cl)/c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H11 compound treatment 0.9586 -0.0414 -0.8 -0.8047 -1.0 2069754 Maybridge1_000693 [O-][N+](=O)c1cc(c(cc1N2CCCCC2)N3CCCCC3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H12 compound treatment 0.9729 -0.0271 -0.53 -0.5254 -1.0 2069755 Maybridge1_000694 CN(NC(=O)C)c1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H13 compound treatment 1.0003 2.7E-4 0.01 0.0052 1.0 2069756 Maybridge1_000695 Clc1ccc(cc1)c2noc(CCC(=O)NNS(=O)(=O)c3cc(Cl)c(Cl)cc3Cl)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H14 compound treatment 0.9586 -0.0414 -0.8 -0.8047 -1.0 2069757 Maybridge1_000696 [O-][N+](=O)c1cc(Cl)ccc1Sc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H15 compound treatment 0.919 -0.081 -1.57 -1.5728 -1.0 1295661 Maybridge1_000697 Cc1cccnc1N2C(=O)C3C4CC(C=C4)C3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H16 compound treatment 0.9643 -0.0357 -0.69 -0.693 -1.0 2069758 Maybridge1_000698 CC(C)(C)c1ccc(OS(=O)(=O)c2ccc(Oc3c(Cl)cccc3[N+](=O)[O-])cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H17 compound treatment 0.96 -0.04 -0.78 -0.7768 -1.0 2069759 Maybridge1_000699 Cc1nc2c(Br)cc(Br)cc2c(=O)n1c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H18 compound treatment 1.0247 0.0247 0.48 0.48 1.0 2069760 Maybridge1_000700 Nc1cc(ccc1Oc2ccc(C#N)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H19 compound treatment 0.9679 -0.0321 -0.62 -0.6232 -1.0 2069761 Maybridge1_000701 [O-][N+](=O)c1ccc(cc1)/C(=C/c2c(F)cccc2Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H20 compound treatment 0.996 -0.00404 -0.08 -0.0786 -1.0 2069762 Maybridge1_000702 Clc1ccc(/C=C(\C#N)/c2nn(c(c2C#N)n3cccc3)c4ccccc4)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H21 compound treatment 0.9571 -0.0429 -0.83 -0.8327 -1.0 2069763 Maybridge1_000703 O=C1CCC(=O)N(N1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H22 compound treatment 1.0139 0.0139 0.27 0.2706 1.0 2069764 Maybridge1_000704 O=C(NNC(=O)c1cccnc1Oc2ccccc2)c3cccnc3Oc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H23 mock treatment 0.9679 -0.0321 -0.62 -0.6232 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 H24 mock treatment 1.0391 0.0391 0.76 0.7593 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I01 compound treatment 1.0384 0.0384 0.75 0.7454 1.0 2069765 Maybridge1_000705 COc1cccc(NC(=S)NNC(=O)c2ccccc2Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I02 compound treatment 1.0197 0.0197 0.38 0.3823 1.0 1339133 Maybridge1_000706 Cc1ccc(cc1)S(=O)(=O)N2CN3CCN(C3)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I03 compound treatment 1.0384 0.0384 0.75 0.7454 1.0 2069766 Maybridge1_000707 CCOC(=O)CCc1cc(/N=C/c2cc(Cl)cc(Cl)c2O)c(O)c(/N=C/c3cc(Cl)cc(Cl)c3O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I04 compound treatment 0.9866 -0.0134 -0.26 -0.2601 -1.0 2069767 Maybridge1_000708 Oc1c(Cl)cc(Cl)cc1/C=N/c2cc(ccc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I05 compound treatment 0.9564 -0.0436 -0.85 -0.8466 -1.0 2069768 Maybridge1_000709 CC(C)N(Cc1ccc(cc1)N(C)C)S(=O)(=O)c2ccccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I06 compound treatment 0.9665 -0.0335 -0.65 -0.6511 -1.0 1491155 Maybridge1_000710 COc1ccc(CCNC(=O)c2c(C)onc2c3ccccc3Cl)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I07 compound treatment 1.042 0.042 0.82 0.8152 1.0 2069769 Maybridge1_000711 COc1cc(/C=N/N=C/c2cc(Br)ccc2O)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I08 compound treatment 1.006 0.00602 0.12 0.117 1.0 2069770 Maybridge1_000712 C/C=C(\C)/c1nc2c(Br)cc(Br)cc2c(=O)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I09 compound treatment 1.0355 0.0355 0.69 0.6895 1.0 1127116 Maybridge1_000713 Cc1ccc(NC(=S)Nc2ccccc2Cl)cc1NS(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I10 compound treatment 0.9809 -0.0191 -0.37 -0.3718 -1.0 2069771 Maybridge1_000714 Nc1cc(ccc1NCCc2ccccn2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I11 compound treatment 0.988 -0.012 -0.23 -0.2322 -1.0 2069772 Maybridge1_000715 Cc1cc(C)c(/N=C\2/NC(C)(C)C(=C)S2)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I12 compound treatment 0.9334 -0.0666 -1.29 -1.2935 -1.0 2069773 Maybridge1_000716 Oc1ccc(Br)cc1/C=N/c2cc(ccc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I13 compound treatment 0.9794 -0.0206 -0.4 -0.3997 -1.0 2069774 Maybridge1_000717 COc1ccc(NC(=S)NC(=O)c2ccccc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I14 compound treatment 0.9578 -0.0422 -0.82 -0.8187 -1.0 1116212 Maybridge1_000718 C(Cc1ccncc1)c2c[nH]c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I15 compound treatment 0.9348 -0.0652 -1.27 -1.2656 -1.0 2069775 Maybridge1_000719 CCOC(=O)c1ccc(NC(=O)CSc2ccc(cc2[N+](=O)[O-])C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I16 compound treatment 0.9765 -0.0235 -0.46 -0.4556 -1.0 2069776 Maybridge1_000720 Fc1cccc(Cl)c1C=C2C(=O)NC(=S)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I17 compound treatment 1.0154 0.0154 0.3 0.2985 1.0 1949968 Maybridge1_000721 Fc1cccc(F)c1C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I18 compound treatment 0.9794 -0.0206 -0.4 -0.3997 -1.0 2069777 Maybridge1_000722 CN1C(NC(=O)c2ccccc12)c3ccc(s3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I19 compound treatment 0.9643 -0.0357 -0.69 -0.693 -1.0 2069778 Maybridge1_000723 Cc1ccc(NC(=O)c2ccccc2[N+](=O)[O-])c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I20 compound treatment 1.0736 0.0736 1.43 1.4297 1.0 2069779 Maybridge1_000724 [O-][N+](=O)c1csc(c1)C2Nc3ccccc3N2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I21 compound treatment 0.9578 -0.0422 -0.82 -0.8187 -1.0 2069780 Maybridge1_000725 COc1cc(cc(OC)c1OC)C2OC(=NN2C(=O)C)c3cc(C)ccc3[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I22 compound treatment 0.9622 -0.0378 -0.73 -0.7349 -1.0 2069781 Maybridge1_000726 Fc1cccc(F)c1C(=O)Nc2nnc(s2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I23 mock treatment 0.9974 -0.00261 -0.05 -0.0506 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 I24 mock treatment 0.9888 -0.0112 -0.22 -0.2182 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J01 compound treatment 1.0298 0.0298 0.58 0.5778 1.0 2069782 Maybridge1_000727 FC(F)(F)c1cc(NC(=O)CSC(=O)c2c(Cl)cccc2Cl)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J02 compound treatment 0.9859 -0.0141 -0.27 -0.2741 -1.0 1367065 Maybridge1_000728 Cc1ccc2nc(NC(=O)C(C)(C)C)nc(O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J03 compound treatment 0.9399 -0.0601 -1.17 -1.1678 -1.0 2069783 Maybridge1_000729 Nc1nn(cc1C#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J04 compound treatment 0.9996 -4.49E-4 -0.01 -0.0087 -1.0 2069784 Maybridge1_000730 CC(C)(C)NNC(=O)c1ccccc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J05 compound treatment 0.9988 -0.00117 -0.02 -0.0227 -1.0 2069785 Maybridge1_000731 OC(C(=O)NNC(=S)Nc1ccc(F)cc1)(c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J06 compound treatment 0.978 -0.022 -0.43 -0.4277 -1.0 2069786 Maybridge1_000732 ClC(Cl)C(=O)Nc1cccc(C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J07 compound treatment 0.9708 -0.0292 -0.57 -0.5673 -1.0 2069787 Maybridge1_000733 COc1cc([N+](=O)[O-])c(OC)cc1SCC(=O)NNC(=O)c2cccc(C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J08 compound treatment 1.0226 0.0226 0.44 0.4381 1.0 1550932 Maybridge1_000734 Clc1ccc(SCC(=O)Nc2cccc(C#N)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J09 compound treatment 0.9535 -0.0465 -0.9 -0.9025 -1.0 2069788 Maybridge1_000735 COc1cc([N+](=O)[O-])c(OC)cc1SCC(=O)NNS(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J10 compound treatment 0.9888 -0.0112 -0.22 -0.2182 -1.0 2069789 Maybridge1_000736 N/C(=N\OC(=O)c1sc2ccccc2c1Cl)/c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J11 compound treatment 0.9924 -0.00764 -0.15 -0.1484 -1.0 2069790 Maybridge1_000737 CSC1=NC(C)(C)CCC(C)(C)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J12 compound treatment 0.9737 -0.0263 -0.51 -0.5115 -1.0 2069791 Maybridge1_000738 CN(NC(=O)C)c1ccc(cc1NC(=O)c2sc3ccccc3c2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J13 compound treatment 0.9852 -0.0148 -0.29 -0.288 -1.0 2069792 Maybridge1_000739 Cc1ccc(cc1)S(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J14 compound treatment 0.9535 -0.0465 -0.9 -0.9025 -1.0 1073582 Maybridge1_000740 [O-][N+](=O)c1cc(Cl)ccc1S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J15 compound treatment 0.9952 -0.00476 -0.09 -0.0925 -1.0 1272417 Maybridge1_000741 Cc1cccc(n1)N2C(=O)C3C4CC(C=C4)C3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J16 compound treatment 0.9693 -0.0307 -0.6 -0.5953 -1.0 1535750 Maybridge1_000742 Nc1cccc(Cl)c1Oc2ccc(cc2)S(=O)(=O)Nc3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J17 compound treatment 0.9895 -0.0105 -0.2 -0.2042 -1.0 2069793 Maybridge1_000743 C/C(=N\N=C1NCCN1)/c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J18 compound treatment 0.9715 -0.0285 -0.55 -0.5534 -1.0 1727927 Maybridge1_000744 OC(=O)c1cccnc1Oc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J19 compound treatment 0.9449 -0.0551 -1.07 -1.0701 -1.0 2069794 Maybridge1_000745 Cc1ccc(cc1)/C(=C/c2cccs2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J20 compound treatment 0.9614 -0.0386 -0.75 -0.7489 -1.0 2069795 Maybridge1_000746 [O-][N+](=O)c1cc(ccc1Sc2nnc(c3cccs3)n2c4cc(cc(c4)C(F)(F)F)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J21 compound treatment 0.9327 -0.0673 -1.31 -1.3075 -1.0 2069796 Maybridge1_000747 CCN(CC)C(=S)Oc1c(Br)cc(Br)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J22 compound treatment 0.965 -0.035 -0.68 -0.679 -1.0 2069797 Maybridge1_000748 CSC1=NCN(CN1)C(C)(C)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J23 mock treatment 0.9463 -0.0537 -1.04 -1.0421 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 J24 mock treatment 1.0369 0.0369 0.72 0.7174 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K01 compound treatment 1.0794 0.0794 1.54 1.5414 1.0 1285576 Maybridge1_000749 O=c1oc2ccccc2cc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K02 compound treatment 0.9686 -0.0314 -0.61 -0.6092 -1.0 2069798 Maybridge1_000750 FC(F)(F)c1cc(NC(=O)C(C2CCCC2)c3ccccc3)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K03 compound treatment 0.9952 -0.00476 -0.09 -0.0925 -1.0 1505255 Maybridge1_000751 CCN(Cc1cc(OC)c(OC)c(OC)c1)S(=O)(=O)c2cc(Cl)c(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K04 compound treatment 0.9895 -0.0105 -0.2 -0.2042 -1.0 2069799 Maybridge1_000752 Nc1cc(ccc1N2CCCCC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K05 compound treatment 1.0125 0.0125 0.24 0.2426 1.0 1366214 Maybridge1_000753 CC(C)N(Cc1ccc(cc1)N(C)C)S(=O)(=O)c2cc(Cl)c(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K06 compound treatment 0.9701 -0.0299 -0.58 -0.5813 -1.0 1452426 Maybridge1_000754 COc1ccc(CCNC(=O)c2c(C)onc2c3ccccc3)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K07 compound treatment 0.9384 -0.0616 -1.2 -1.1957 -1.0 2069800 Maybridge1_000755 CCOC(=O)c1ccc(/N=C/c2cc(Cl)cc(Cl)c2O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K08 compound treatment 1.0089 0.0089 0.17 0.1728 1.0 1462342 Maybridge1_000756 Cc1onc(c1C(=O)Nc2ccc3OCOCc3c2)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K09 compound treatment 1.0233 0.0233 0.45 0.4521 1.0 1525441 Maybridge1_000757 COc1ccc(NC(=S)Nc2ccc(C)c(NS(=O)(=O)C)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K10 compound treatment 0.9248 -0.0752 -1.46 -1.4611 -1.0 1633514 Maybridge1_000758 CCOC(=O)c1cnc2c(Cl)cc(Br)cc2c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K11 compound treatment 0.9809 -0.0191 -0.37 -0.3718 -1.0 2069801 Maybridge1_000759 Cc1cc2CSC(SCc2cc1C)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K12 compound treatment 0.9528 -0.0472 -0.92 -0.9164 -1.0 2069802 Maybridge1_000760 CCC(C(=O)NNC(=O)c1ccc(cc1)N(C)C)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K13 compound treatment 0.9442 -0.0558 -1.08 -1.084 -1.0 2069803 Maybridge1_000761 Clc1cccc(Nc2nc3ccccc3s2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K14 compound treatment 0.9765 -0.0235 -0.46 -0.4556 -1.0 1035571 Maybridge1_000762 OC(=O)CCc1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K15 compound treatment 0.9809 -0.0191 -0.37 -0.3718 -1.0 1004900 Maybridge1_000763 CC(=O)Nc1ccccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K16 compound treatment 0.9528 -0.0472 -0.92 -0.9164 -1.0 2069804 Maybridge1_000764 Cc1nc2ccc(Br)cc2c(=O)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K17 compound treatment 0.9693 -0.0307 -0.6 -0.5953 -1.0 2069805 Maybridge1_000765 Fc1cccc(F)c1C(=O)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K18 compound treatment 0.9571 -0.0429 -0.83 -0.8327 -1.0 2069806 Maybridge1_000766 [O-][N+](=O)c1cc(ccc1SCC(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K19 compound treatment 0.9809 -0.0191 -0.37 -0.3718 -1.0 2069807 Maybridge1_000767 FC(F)(F)c1cc(Nc2nc3ccccc3s2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K20 compound treatment 1.1556 0.156 3.02 3.0216 1.0 2069808 Maybridge1_000768 [O-][N+](=O)c1ccc(s1)C2Nc3cc(ccc3O2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K21 compound treatment 0.9866 -0.0134 -0.26 -0.2601 -1.0 2069809 Maybridge1_000769 Cc1ccc(cc1)S(=O)(=O)NNC(=S)NCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K22 compound treatment 1.0096 0.00962 0.19 0.1868 1.0 2069810 Maybridge1_000770 Cc1ccc(NS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)c(N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K23 mock treatment 0.9916 -0.00836 -0.16 -0.1623 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 K24 mock treatment 0.9837 -0.0163 -0.32 -0.316 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L01 compound treatment 1.0053 0.0053 0.1 0.103 1.0 1379387 Maybridge1_000771 Cc1nc2ccc(Br)cc2c(=O)n1c3ccccc3N4CCCCC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L02 compound treatment 1.0441 0.0441 0.86 0.8571 1.0 2069811 Maybridge1_000772 FC(F)(F)c1ccc(Cl)c(c1)C(=O)NNS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L03 compound treatment 1.006 0.00602 0.12 0.117 1.0 2069812 Maybridge1_000773 CCOC(=O)CCc1nc(no1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L04 compound treatment 0.9514 -0.0486 -0.94 -0.9444 -1.0 2069813 Maybridge1_000774 Fc1cccc(Cl)c1C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L05 compound treatment 0.9456 -0.0544 -1.06 -1.0561 -1.0 2069814 Maybridge1_000775 Clc1cccc(c1)n2ncc(C#N)c2n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L06 compound treatment 0.9981 -0.00189 -0.04 -0.0367 -1.0 2069815 Maybridge1_000776 Clc1cccc(Cl)c1C(=O)Nc2ccc(C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L07 compound treatment 1.0556 0.0556 1.08 1.0805 1.0 2069816 Maybridge1_000777 COc1cc([N+](=O)[O-])c(OC)cc1SCC(=O)NNC(=O)c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L08 compound treatment 1.0276 0.0276 0.54 0.5359 1.0 1037133 Maybridge1_000778 [O-][N+](=O)c1cc(ccc1Oc2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L09 compound treatment 1.0211 0.0211 0.41 0.4102 1.0 2069817 Maybridge1_000779 Oc1ccc(CCC(=O)NNC(=S)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L10 compound treatment 1.0312 0.0312 0.61 0.6057 1.0 2069818 Maybridge1_000780 N/C(=N\OC(=O)c1ccc(cc1)[N+](=O)[O-])/c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L11 compound treatment 1.0204 0.0204 0.4 0.3963 1.0 2069819 Maybridge1_000781 CCOC(=O)C1CCN(CC1)c2ccc(cc2[N+](=O)[O-])C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L12 compound treatment 0.9909 -0.00908 -0.18 -0.1763 -1.0 2069820 Maybridge1_000782 Cc1cc(OC(=O)c2cccs2)c(Cl)c(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L13 compound treatment 0.9866 -0.0134 -0.26 -0.2601 -1.0 2069821 Maybridge1_000783 Cc1ccc(cc1)S(=O)(=O)c2ccccc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L14 compound treatment 0.9535 -0.0465 -0.9 -0.9025 -1.0 2069822 Maybridge1_000784 OC(=O)c1ccccc1C(=O)c2ccc(Sc3ccc(Cl)cc3)c(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L15 compound treatment 0.9542 -0.0458 -0.89 -0.8885 -1.0 1632645 Maybridge1_000785 Cc1cc(C)nc(NS(=O)(=O)c2ccc(cc2)N3C(=O)C4C5CC(C=C5)C4C3=O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L16 compound treatment 1.0477 0.0477 0.93 0.9269 1.0 2090 Maybridge1_000786 CCOC(=O)C(C#N)C1C(=C(N)Oc2ccc(Br)cc12)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L17 compound treatment 0.9859 -0.0141 -0.27 -0.2741 -1.0 2069823 Maybridge1_000787 C/C(=N\N=C1NCCN1)/c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L18 compound treatment 0.955 -0.045 -0.87 -0.8745 -1.0 2069824 Maybridge1_000788 Cc1ccc(cc1)S(=O)(=O)Oc2ccc(Cl)cc2Sc3cc(Cl)ccc3OS(=O)(=O)c4ccc(C)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L19 compound treatment 0.9844 -0.0156 -0.3 -0.302 -1.0 2069825 Maybridge1_000789 COc1cc(CCC(=O)NNC(=S)Nc2ccc(F)cc2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L20 compound treatment 0.9708 -0.0292 -0.57 -0.5673 -1.0 1250861 Maybridge1_000790 Fc1ccc(NC(=O)c2cccnc2Oc3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L21 compound treatment 0.9852 -0.0148 -0.29 -0.288 -1.0 2069826 Maybridge1_000791 CCN(CC)C(=S)Oc1c(C)cc(C)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L22 compound treatment 0.9737 -0.0263 -0.51 -0.5115 -1.0 1032648 Maybridge1_000792 CC(=O)COc1ccc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L23 mock treatment 0.9542 -0.0458 -0.89 -0.8885 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 L24 mock treatment 1.0103 0.0103 0.2 0.2007 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M01 compound treatment 1.0197 0.0197 0.38 0.3823 1.0 1921024 Maybridge1_000793 FC(F)(F)c1cccc(NC(=O)c2ccc(Cl)cc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M02 compound treatment 0.996 -0.00404 -0.08 -0.0786 -1.0 2069827 Maybridge1_000794 [O-][N+](=O)c1ccc(cc1)C(=O)N(c2nc3ccccc3s2)c4cc(cc(c4)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M03 compound treatment 0.9701 -0.0299 -0.58 -0.5813 -1.0 2069828 Maybridge1_000795 CN(C)c1ccc(/C=N/N=C(\C(=O)c2ccccc2)/c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M04 compound treatment 1.0031 0.00315 0.06 0.0611 1.0 2069829 Maybridge1_000796 Oc1c(Cl)cc(Cl)cc1/C=N/c2cc(ccc2N3CCOCC3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M05 compound treatment 0.9823 -0.0177 -0.34 -0.3439 -1.0 1365502 Maybridge1_000797 Cc1onc(c1C(=O)Oc2cc(C)nc3ccc(F)cc23)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M06 compound treatment 0.9916 -0.00836 -0.16 -0.1623 -1.0 2069830 Maybridge1_000798 FC(F)(F)c1ccc(N2CCCCC2)c(NC(=O)c3sc4ccccc4c3Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M07 compound treatment 1.0067 0.00674 0.13 0.1309 1.0 1668985 Maybridge1_000799 CCOC(=O)c1ccc(cc1)N2CC3CCCCN3C2c4ccc(Cl)c(Cl)c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M08 compound treatment 0.9888 -0.0112 -0.22 -0.2182 -1.0 2069831 Maybridge1_000800 [O-][N+](=O)c1cc(ccc1NCc2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M09 compound treatment 1.0154 0.0154 0.3 0.2985 1.0 1516323 Maybridge1_000801 COc1ccccc1NC(=S)Nc2ccc(C)c(NS(=O)(=O)C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M10 compound treatment 0.9262 -0.0738 -1.43 -1.4331 -1.0 2069832 Maybridge1_000802 FC(F)(F)c1cc(NC=C2C(=O)NC(=O)NC2=O)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M11 compound treatment 1.0218 0.0218 0.42 0.4242 1.0 2069833 Maybridge1_000803 Cc1cc2CSC(SCc2cc1C)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M12 compound treatment 1.0003 2.7E-4 0.01 0.0052 1.0 2069834 Maybridge1_000804 Cc1c(Cl)cccc1NC(=S)Nc2cc3c(c([N+](=O)[O-])c2C)C(C)(C)CC3(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M13 compound treatment 1.0024 0.00243 0.05 0.0471 1.0 2069835 Maybridge1_000805 Cc1ccc(cc1)S(=O)(=O)Nc2ccc(C)cc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M14 compound treatment 0.9478 -0.0522 -1.01 -1.0142 -1.0 2069836 Maybridge1_000806 CCOC(=O)c1ccc(cc1)S(=O)(=O)NNC(=O)c2ccccc2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M15 compound treatment 1.0254 0.0254 0.49 0.494 1.0 2069837 Maybridge1_000807 Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c3cc(Cl)cc(Cl)c3O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M16 compound treatment 0.9952 -0.00476 -0.09 -0.0925 -1.0 1716824 Maybridge1_000808 COc1ccc(OC)c(CCC(=O)O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M17 compound treatment 0.9722 -0.0278 -0.54 -0.5394 -1.0 2069838 Maybridge1_000809 Cc1cc(/N=C/2\SC(=C)C(C)(C)N2C(=O)c3c(F)cccc3F)cc(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M18 compound treatment 0.9931 -0.00692 -0.13 -0.1344 -1.0 2069839 Maybridge1_000810 COc1cc(/C=C(\C#N)/c2ccc(cc2)[N+](=O)[O-])cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M19 compound treatment 1.0003 2.7E-4 0.01 0.0052 1.0 2069840 Maybridge1_000811 Cc1ccc(NC(=O)c2ccccc2/N=C/c3cc(Cl)cc(Cl)c3O)c(/N=C/c4cc(Cl)cc(Cl)c4O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M20 compound treatment 0.9773 -0.0227 -0.44 -0.4416 -1.0 2069841 Maybridge1_000812 Cc1ccc(cc1)S(=O)(=O)N/N=C/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M21 compound treatment 1.0067 0.00674 0.13 0.1309 1.0 2069842 Maybridge1_000813 COCCCNC(=S)NNS(=O)(=O)c1ccc(C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M22 compound treatment 0.9492 -0.0508 -0.99 -0.9863 -1.0 2069843 Maybridge1_000814 [O-][N+](=O)c1ccc(cc1)C2N(Cc3ccccc3)CCC4CCCCN24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M23 mock treatment 0.983 -0.017 -0.33 -0.3299 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 M24 mock treatment 0.9708 -0.0292 -0.57 -0.5673 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N01 compound treatment 1.0355 0.0355 0.69 0.6895 1.0 2069844 Maybridge1_000815 COc1ccc(cc1)N2C(=O)CC(SCC(=O)Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N02 compound treatment 0.9974 -0.00261 -0.05 -0.0506 -1.0 1531991 Maybridge1_000816 COc1cc2CCN=C(c3ccccc3)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N03 compound treatment 0.9586 -0.0414 -0.8 -0.8047 -1.0 1510864 Maybridge1_000817 CC(NC(=O)c1ccccc1N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N04 compound treatment 1.052 0.052 1.01 1.0107 1.0 1610286 Maybridge1_000818 Cc1ccc2nc(oc(=O)c2c1)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N05 compound treatment 0.988 -0.012 -0.23 -0.2322 -1.0 2069845 Maybridge1_000819 Cc1cccc(c1)C(=O)NNC(=O)CCc2nc(no2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N06 compound treatment 1.042 0.042 0.82 0.8152 1.0 1684490 Maybridge1_000820 Fc1cccc(F)c1C(=O)Nc2cccc(C#N)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N07 compound treatment 0.9931 -0.00692 -0.13 -0.1344 -1.0 2069846 Maybridge1_000821 [O-][N+](=O)c1cc(ccc1NNc2ccc(cc2[N+](=O)[O-])C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N08 compound treatment 0.9981 -0.00189 -0.04 -0.0367 -1.0 1471855 Maybridge1_000822 CN(C)c1ccc(cc1N)c2n[nH]c(=O)c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N09 compound treatment 0.9658 -0.0342 -0.67 -0.6651 -1.0 2069847 Maybridge1_000823 CNC(=S)NNC(=O)c1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N10 compound treatment 0.9442 -0.0558 -1.08 -1.084 -1.0 1933421 Maybridge1_000824 N/C(=N\OC(=O)c1cccs1)/c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N11 compound treatment 0.9571 -0.0429 -0.83 -0.8327 -1.0 1430952 Maybridge1_000825 Clc1ccc(cc1)c2noc(CCC(=O)Nc3cccc(Cl)c3Cl)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N12 compound treatment 0.9521 -0.0479 -0.93 -0.9304 -1.0 2069848 Maybridge1_000826 Cc1cc(OC(=O)C(C2CCCC2)c3ccccc3)c(Cl)c(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N13 compound treatment 0.9665 -0.0335 -0.65 -0.6511 -1.0 2069849 Maybridge1_000827 FC(F)(F)c1ccccc1S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N14 compound treatment 0.9693 -0.0307 -0.6 -0.5953 -1.0 2069850 Maybridge1_000828 Nc1ccccc1Sc2ccc(cc2[N+](=O)[O-])C(=O)c3ccccc3C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N15 compound treatment 0.9356 -0.0644 -1.25 -1.2516 -1.0 2069851 Maybridge1_000829 FC(F)(F)c1cc(cc(c1)S(=O)(=O)c2ccc(Br)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N16 compound treatment 0.9816 -0.0184 -0.36 -0.3578 -1.0 2069852 Maybridge1_000830 C/C(=N\O)/c1ccc(Cl)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N17 compound treatment 1.0024 0.00243 0.05 0.0471 1.0 2069853 Maybridge1_000831 C/C(=N\NC1=NCCN1Cc2ccccc2)/c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N18 compound treatment 0.9499 -0.0501 -0.97 -0.9723 -1.0 2069854 Maybridge1_000832 Cc1cc(ccc1Cl)C2=CSC3=NCCN23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N19 compound treatment 0.9708 -0.0292 -0.57 -0.5673 -1.0 1241971 Maybridge1_000833 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)NCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N20 compound treatment 0.9888 -0.0112 -0.22 -0.2182 -1.0 2069855 Maybridge1_000834 FC(F)(F)c1ccc(N2CCOCC2)c(NC(=O)c3cccnc3Oc4ccccc4)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N21 compound treatment 0.9758 -0.0242 -0.47 -0.4696 -1.0 1314785 Maybridge1_000835 O=C(Nc1ccccc1N2CCOCC2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N22 compound treatment 0.9873 -0.0127 -0.25 -0.2461 -1.0 2069856 Maybridge1_000836 COc1cc(/C=N/NS(=O)(=O)c2ccc(C)cc2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N23 mock treatment 1.0111 0.0111 0.21 0.2147 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 N24 mock treatment 1.001 9.89E-4 0.02 0.0192 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O01 compound treatment 1.024 0.024 0.47 0.4661 1.0 1345387 Maybridge1_000837 OC(=O)c1cc2cc(Br)ccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O02 compound treatment 0.9708 -0.0292 -0.57 -0.5673 -1.0 2069857 Maybridge1_000838 COc1cc(cc(OC)c1OC)C2NC(=O)c3cc(ccc3N2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O03 compound treatment 1.0024 0.00243 0.05 0.0471 1.0 2069858 Maybridge1_000839 O=C(/C(=N\N=C\c1cccs1)/c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O04 compound treatment 0.9844 -0.0156 -0.3 -0.302 -1.0 1315297 Maybridge1_000840 COc1ccc(CCNC(=O)c2ccccc2Cl)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O05 compound treatment 1.0182 0.0182 0.35 0.3544 1.0 2069859 Maybridge1_000841 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccc3OCOCc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O06 compound treatment 0.9945 -0.00548 -0.11 -0.1065 -1.0 2069860 Maybridge1_000842 FC(F)(F)c1ccc(N2CCCC2)c(NC=C(C#N)C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O07 compound treatment 1.0269 0.0269 0.52 0.5219 1.0 1573890 Maybridge1_000843 CCOC(=O)c1ccc(cc1)N2CC3CCCCN3C2c4cccc(OC)c4O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O08 compound treatment 0.9816 -0.0184 -0.36 -0.3578 -1.0 1949137 Maybridge1_000844 CCOC(=O)C(=CNc1ccccc1F)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O09 compound treatment 0.9859 -0.0141 -0.27 -0.2741 -1.0 1130032 Maybridge1_000845 Cc1c(Cl)cccc1NC(=S)Nc2ccc(Cl)cc2C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O10 compound treatment 0.9629 -0.0371 -0.72 -0.7209 -1.0 2069861 Maybridge1_000846 FC(F)(F)c1cc(NC=C(C#N)C#N)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O11 compound treatment 0.9844 -0.0156 -0.3 -0.302 -1.0 2069862 Maybridge1_000847 CN(C)c1ccc(cc1)C2SCc3cc(C)c(C)cc3CS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O12 compound treatment 0.9773 -0.0227 -0.44 -0.4416 -1.0 2069863 Maybridge1_000848 Clc1ccc(cc1)C2CN3C(=N2)C=Cc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O13 compound treatment 1.0075 0.00746 0.14 0.1449 1.0 2069864 Maybridge1_000849 CC1(C)N/C(=N\c2cccc(c2)C(F)(F)F)/SC1=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O14 compound treatment 0.9456 -0.0544 -1.06 -1.0561 -1.0 1186960 Maybridge1_000850 Cc1ccc(cc1)S(=O)(=O)NN2C(Nc3ccccc3C2=O)c4cc(Cl)cc(Cl)c4O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O15 compound treatment 0.9852 -0.0148 -0.29 -0.288 -1.0 1932406 Maybridge1_000851 FC(F)(F)c1ccccc1NC(=O)c2cc3ccccc3oc2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O16 compound treatment 1.029 0.029 0.56 0.5638 1.0 2069865 Maybridge1_000852 [O-][N+](=O)c1ccc(C=C2C(=O)NC(=O)NC2=O)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O17 compound treatment 0.9622 -0.0378 -0.73 -0.7349 -1.0 1041620 Maybridge1_000853 OC(=O)C(C1CCCC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O18 compound treatment 1.0664 0.0664 1.29 1.29 1.0 2069866 Maybridge1_000854 CN(C)c1ccc(/C=C(\C#N)/c2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O19 compound treatment 0.96 -0.04 -0.78 -0.7768 -1.0 2069867 Maybridge1_000855 FC(F)(F)c1cc(NCCC2CCCCN2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O20 compound treatment 0.9924 -0.00764 -0.15 -0.1484 -1.0 2069868 Maybridge1_000856 Cc1ccc(cc1)S(=O)(=O)N/N=C/c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O21 compound treatment 0.9873 -0.0127 -0.25 -0.2461 -1.0 2069869 Maybridge1_000857 FC(F)(F)c1cc(NC(=S)N2CCCCC2CCN3CCOCC3)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O22 compound treatment 0.9478 -0.0522 -1.01 -1.0142 -1.0 2069870 Maybridge1_000858 CC(=O)Nc1ccc(Br)cc1C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O23 mock treatment 1.0197 0.0197 0.38 0.3823 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 O24 mock treatment 1.0003 2.7E-4 0.01 0.0052 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P01 compound treatment 1.0211 0.0211 0.41 0.4102 1.0 2069871 Maybridge1_000859 CCOC(=O)C(=CNNS(=O)(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P02 compound treatment 1.0571 0.0571 1.11 1.1085 1.0 1214041 Maybridge1_000860 Cc1onc(c1C(=O)Nc2cccc3cccnc23)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P03 compound treatment 1.0111 0.0111 0.21 0.2147 1.0 809283 Maybridge1_000861 NC(=O)c1cnn(c1N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P04 compound treatment 0.9988 -0.00117 -0.02 -0.0227 -1.0 2069872 Maybridge1_000862 ClC(Cl)(Cl)C(=O)Nc1cccc2cccnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P05 compound treatment 1.0182 0.0182 0.35 0.3544 1.0 2069873 Maybridge1_000863 OC(c1nnc(S)n1c2ccc(F)cc2)(c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P06 compound treatment 1.0147 0.0147 0.28 0.2845 1.0 2069874 Maybridge1_000864 Cc1onc(c1C(=O)Nc2cccc(C#N)c2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P07 compound treatment 1.0089 0.0089 0.17 0.1728 1.0 2069875 Maybridge1_000865 CC(=O)c1c(O)nc2ccc(Cl)cc2c1c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P08 compound treatment 1.0168 0.0168 0.33 0.3264 1.0 2069876 Maybridge1_000866 Cc1cccc(C)c1NC(=O)CSc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P09 compound treatment 1.0254 0.0254 0.49 0.494 1.0 2069877 Maybridge1_000867 COc1cc([N+](=O)[O-])c(OC)cc1SCc2nnc(o2)c3ccccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P10 compound treatment 1.0053 0.0053 0.1 0.103 1.0 2069878 Maybridge1_000868 [O-][N+](=O)c1ccc(N2CCCCC2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P11 compound treatment 1.0053 0.0053 0.1 0.103 1.0 2069879 Maybridge1_000869 CCOC(=O)C1CCN(CC1)c2ccc(cc2N)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P12 compound treatment 0.9888 -0.0112 -0.22 -0.2182 -1.0 2069880 Maybridge1_000870 CN(NC(=O)c1ccncc1)c2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P13 compound treatment 0.9622 -0.0378 -0.73 -0.7349 -1.0 2069881 Maybridge1_000871 FC(F)(F)c1ccccc1S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P14 compound treatment 0.9866 -0.0134 -0.26 -0.2601 -1.0 2069882 Maybridge1_000872 Clc1ccc(SC(C(=O)c2ccc(Cl)cc2)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P15 compound treatment 0.9758 -0.0242 -0.47 -0.4696 -1.0 2069883 Maybridge1_000873 Fc1ccccc1NC(=O)CSc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P16 compound treatment 0.9708 -0.0292 -0.57 -0.5673 -1.0 2069884 Maybridge1_000874 COc1ccc(NC(=S)NCCSc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P17 compound treatment 0.9593 -0.0407 -0.79 -0.7908 -1.0 2069885 Maybridge1_000875 C/C(=N\NC1=NCCN1Cc2ccccc2)/c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P18 compound treatment 1.0053 0.0053 0.1 0.103 1.0 2069886 Maybridge1_000876 N/C(=N\O)/c1ccc(OCc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P19 compound treatment 0.978 -0.022 -0.43 -0.4277 -1.0 2069887 Maybridge1_000877 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)NNC(=O)CCc2cc(OC)c(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P20 compound treatment 1.0211 0.0211 0.41 0.4102 1.0 2069888 Maybridge1_000878 Cc1ccc(SC(=O)c2cccnc2Oc3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P21 compound treatment 0.965 -0.035 -0.68 -0.679 -1.0 1389928 Maybridge1_000879 S=C1NCN(CCN2CCCC2)CN1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P22 compound treatment 1.0499 0.0499 0.97 0.9688 1.0 2069889 Maybridge1_000880 C/C(=N\O)/COc1ccc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P23 mock treatment 1.0125 0.0125 0.24 0.2426 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.543 P24 mock treatment 1.0247 0.0247 0.48 0.48 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A01 compound treatment 1.0313 0.0313 0.61 0.6076 1.0 2069890 Maybridge1_000881 Clc1cc(Cl)cc(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A02 compound treatment 1.0061 0.00615 0.12 0.1194 1.0 2069891 Maybridge1_000882 Fc1cc2[nH]c(S)nc2cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A03 compound treatment 1.0385 0.0385 0.75 0.747 1.0 1488119 Maybridge1_000883 Clc1ccc(cc1)C(=O)CNc2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A04 compound treatment 1.0327 0.0327 0.64 0.6354 1.0 1497445 Maybridge1_000884 CCOC(=O)c1cnc2cc(Cl)c(F)cc2c1N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A05 compound treatment 1.0162 0.0162 0.31 0.3147 1.0 1022907 Maybridge1_000885 CC(=O)c1cc2ccccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A06 compound treatment 0.9868 -0.0132 -0.26 -0.2571 -1.0 2069892 Maybridge1_000886 [O-][N+](=O)c1ccc(Oc2ccccc2F)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A07 compound treatment 1.0047 0.00471 0.09 0.0915 1.0 1472485 Maybridge1_000887 Cc1onc(c1C(=O)Nc2ccc(Br)cn2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A08 compound treatment 1.0126 0.0126 0.24 0.2449 1.0 2069893 Maybridge1_000888 [O-][N+](=O)c1cc(Cl)ccc1Oc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A09 compound treatment 0.9846 -0.0154 -0.3 -0.299 -1.0 1619653 Maybridge1_000889 CC(=O)Nc1ccc(CC(C#N)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A10 compound treatment 0.943 -0.057 -1.11 -1.1079 -1.0 1480482 Maybridge1_000890 CC(=O)Nc1c(F)cc(F)cc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A11 compound treatment 0.976 -0.024 -0.47 -0.4663 -1.0 1657436 Maybridge1_000891 Clc1ccc(Cl)c(NC(=S)NCCc2ccncc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A12 compound treatment 1.0162 0.0162 0.31 0.3147 1.0 2069894 Maybridge1_000892 [O-][N+](=O)c1cccnc1Sc2cc(Cl)ccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A13 compound treatment 0.9982 -0.00175 -0.03 -0.034 -1.0 1208589 Maybridge1_000893 Cc1onc(c1C(=O)NCCc2ccncc2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A14 compound treatment 0.9631 -0.0369 -0.72 -0.7174 -1.0 2069895 Maybridge1_000894 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)Nc3ccc(F)cc3F)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A15 compound treatment 0.999 -0.00103 -0.02 -0.02 -1.0 2069896 Maybridge1_000895 Clc1ccc2OC(=O)N(C(OC(=O)Nc3ccccc3)c2c1)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A16 compound treatment 0.958 -0.042 -0.82 -0.815 -1.0 2069897 Maybridge1_000896 Cc1ccccc1C(=O)NCC(=O)c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A17 compound treatment 1.0033 0.00328 0.06 0.0636 1.0 2069898 Maybridge1_000897 Clc1ccc(SCc2ccc(cc2)c3nc4ccccc4s3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A18 compound treatment 0.9868 -0.0132 -0.26 -0.2571 -1.0 1045890 Maybridge1_000898 COc1ccccc1Oc2ccccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A19 compound treatment 1.0205 0.0205 0.4 0.3984 1.0 2069899 Maybridge1_000899 CSC1=NCCN1C(=O)c2c(C)onc2c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A20 compound treatment 1.032 0.032 0.62 0.6215 1.0 2069900 Maybridge1_000900 CC(C)(C)C(=O)Nc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A21 compound treatment 1.0169 0.0169 0.33 0.3286 1.0 1250979 Maybridge1_000901 O=C(Nc1nccs1)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A22 compound treatment 1.0097 0.00974 0.19 0.1892 1.0 1244212 Maybridge1_000902 Cn1sc(=O)c2cc(ccc12)S(=O)(=O)NC3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A23 mock treatment 1.0442 0.0442 0.86 0.8586 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 A24 mock treatment 0.9932 -0.00678 -0.13 -0.1316 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B01 compound treatment 0.9932 -0.00678 -0.13 -0.1316 -1.0 1364313 Maybridge1_000903 COc1cc2CCN(C(C)c2cc1OC)C(=O)c3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B02 compound treatment 0.9868 -0.0132 -0.26 -0.2571 -1.0 2069901 Maybridge1_000904 Cc1cc(NC(=O)c2cccs2)c(cc1C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B03 compound treatment 1.0284 0.0284 0.55 0.5518 1.0 2069902 Maybridge1_000905 CSC1=NCCN1CC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B04 compound treatment 1.0191 0.0191 0.37 0.3705 1.0 1571188 Maybridge1_000906 Clc1ccc(Oc2ccccc2NC(=O)c3cccs3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B05 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 2069903 Maybridge1_000907 COc1ccc(OC)c(c1)S(=O)(=O)N2CCC(CCCC3CCN(CC3)S(=O)(=O)c4cc(OC)ccc4OC)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B06 compound treatment 1.0148 0.0148 0.29 0.2868 1.0 1632115 Maybridge1_000908 Clc1ccc(Oc2ccccc2NC(=O)NC(=O)c3c(Cl)cccc3Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B07 compound treatment 1.0054 0.00543 0.11 0.1055 1.0 2069904 Maybridge1_000909 CN(NC(=O)NC(=O)c1c(Cl)cccc1Cl)c2cccc(F)c2C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B08 compound treatment 1.0047 0.00471 0.09 0.0915 1.0 2069905 Maybridge1_000910 C/C(=N\Nc1c(Cl)cc(Cl)cc1Cl)/c2cc(Br)ccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B09 compound treatment 1.0169 0.0169 0.33 0.3286 1.0 2069906 Maybridge1_000911 CSC1=NCCN1CC(=O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B10 compound treatment 1.0722 0.0722 1.4 1.4025 1.0 2069907 Maybridge1_000912 COc1ccc(/C=C/2\SC(=S)NC2=O)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B11 compound treatment 0.9724 -0.0276 -0.54 -0.5361 -1.0 1295895 Maybridge1_000913 NNC(=O)CNC(=O)c1c(F)cccc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B12 compound treatment 0.9796 -0.0204 -0.4 -0.3966 -1.0 2069908 Maybridge1_000914 CN(C)/C=N/c1nnc(s1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B13 compound treatment 0.9918 -0.00821 -0.16 -0.1595 -1.0 2069909 Maybridge1_000915 Brc1cc(cc(Br)c1n2cccc2)C3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B14 compound treatment 0.9947 -0.00534 -0.1 -0.1037 -1.0 1625161 Maybridge1_000916 Cc1ncc(COn2c(nc3ccccc3c2=O)c4ccccc4)c(CO)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B15 compound treatment 0.9724 -0.0276 -0.54 -0.5361 -1.0 2069910 Maybridge1_000917 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)NC(=N)c3cccnc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B16 compound treatment 0.9501 -0.0499 -0.97 -0.9684 -1.0 2069911 Maybridge1_000918 CC(C)(C)c1csc(Cc2ccc(Cl)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B17 compound treatment 0.9781 -0.0219 -0.42 -0.4245 -1.0 2069912 Maybridge1_000919 COc1ccc(cc1OC)S(=O)(=O)NNc2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B18 compound treatment 0.9516 -0.0484 -0.94 -0.9405 -1.0 1708614 Maybridge1_000920 Clc1cccc(Cl)c1C(=O)NC(=O)N2CCc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B19 compound treatment 0.9817 -0.0183 -0.35 -0.3548 -1.0 2069913 Maybridge1_000921 Cc1ccc(NC(=S)Nc2ccc(C)c(C)c2)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B20 compound treatment 1.0011 0.00112 0.02 0.0218 1.0 2069914 Maybridge1_000922 Clc1cccc(NC(=S)NN=C2CCCCCC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B21 compound treatment 0.9243 -0.0757 -1.47 -1.4705 -1.0 1545633 Maybridge1_000923 CC(=O)Nc1cc2cc(NC(=O)c3c(C)onc3c4c(Cl)cccc4Cl)ccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B22 compound treatment 0.9982 -0.00175 -0.03 -0.034 -1.0 2069915 Maybridge1_000924 C/C(=N\NC(=S)N)/c1cc2cc(Cl)ccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B23 mock treatment 0.9616 -0.0384 -0.75 -0.7453 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 B24 mock treatment 1.0047 0.00471 0.09 0.0915 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C01 compound treatment 1.0126 0.0126 0.24 0.2449 1.0 2069916 Maybridge1_000925 Cc1ccc(cc1)n2nnc(n2)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C02 compound treatment 1.0184 0.0184 0.36 0.3565 1.0 1116479 Maybridge1_000926 On1c(nc2ccccc2c1=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C03 compound treatment 0.9997 -3.14E-4 -0.01 -0.0061 -1.0 2069917 Maybridge1_000927 COc1ccc(cc1)c2c(C#N)c([nH]c(=O)c2C#N)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C04 compound treatment 1.0126 0.0126 0.24 0.2449 1.0 2069918 Maybridge1_000928 CC(C)(C)c1ccc(cc1)C(=O)N/N=C/c2cc(Cl)cc(Cl)c2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C05 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 1781213 Maybridge1_000929 CC(=O)Nc1cc2cc(ccc2oc1=O)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C06 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 2069919 Maybridge1_000930 N#Cc1ccccc1N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C07 compound treatment 1.0026 0.00256 0.05 0.0497 1.0 1019504 Maybridge1_000931 CCC(=O)c1ccc(cc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C08 compound treatment 1.0191 0.0191 0.37 0.3705 1.0 2069920 Maybridge1_000932 [O-][N+](=O)c1cc(ccc1Oc2c(Cl)cccc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C09 compound treatment 0.9817 -0.0183 -0.35 -0.3548 -1.0 2069921 Maybridge1_000933 [O-][N+](=O)c1ccc2oc(=O)c(NC(=O)c3c(F)cccc3F)cc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C10 compound treatment 0.9638 -0.0362 -0.7 -0.7034 -1.0 2069922 Maybridge1_000934 CC(C)(C)NC(=S)N/N=C/c1ccccc1SC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C11 compound treatment 1.0198 0.0198 0.38 0.3844 1.0 1708697 Maybridge1_000935 Cc1ccc(cc1)S(=O)(=O)NCCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C12 compound treatment 0.9738 -0.0262 -0.51 -0.5082 -1.0 2069923 Maybridge1_000936 Cc1ccc(Sc2ncccc2[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C13 compound treatment 0.999 -0.00103 -0.02 -0.02 -1.0 2069924 Maybridge1_000937 CCOC(=O)CNC(=O)c1c(C)onc1c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C14 compound treatment 0.9688 -0.0312 -0.61 -0.6058 -1.0 1019893 Maybridge1_000938 NCC(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C15 compound treatment 0.9968 -0.00319 -0.06 -0.0619 -1.0 2069925 Maybridge1_000939 Cc1nn(c(C)c1N=Nc2cc(Cl)cc(Cl)c2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C16 compound treatment 1.0119 0.0119 0.23 0.231 1.0 2069926 Maybridge1_000940 C/C(=N\NC(=S)NC(C)(C)C)/c1cc(F)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C17 compound treatment 1.0219 0.0219 0.43 0.4262 1.0 1556471 Maybridge1_000941 Clc1cccc(N2CCCCC2)c1C(C#N)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C18 compound treatment 0.9465 -0.0535 -1.04 -1.0382 -1.0 2069927 Maybridge1_000942 NC(=S)NNC(=O)c1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C19 compound treatment 1.0377 0.0377 0.73 0.7331 1.0 2069928 Maybridge1_000943 CSC1=NCCN1C(=O)c2c(C)onc2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C20 compound treatment 0.9523 -0.0477 -0.93 -0.9266 -1.0 2069929 Maybridge1_000944 CC(C)(C)C(=O)Nc1ccc(F)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C21 compound treatment 0.9796 -0.0204 -0.4 -0.3966 -1.0 2069930 Maybridge1_000945 Cc1onc(c1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-])c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C22 compound treatment 0.9746 -0.0254 -0.49 -0.4942 -1.0 2069931 Maybridge1_000946 Fc1cccc(Cl)c1CSC2=NCN(CN2)C3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C23 mock treatment 0.9652 -0.0348 -0.68 -0.6755 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 C24 mock treatment 0.9738 -0.0262 -0.51 -0.5082 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D01 compound treatment 1.0076 0.00759 0.15 0.1473 1.0 2069932 Maybridge1_000947 COc1cc2CCN(C(C)c2cc1OC)C(=O)Nc3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D02 compound treatment 1.032 0.032 0.62 0.6215 1.0 2069933 Maybridge1_000948 COC(OC)C(C)NC(=O)NC(=O)c1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D03 compound treatment 1.014 0.014 0.27 0.2728 1.0 2069934 Maybridge1_000949 COC(=O)/C=C/1\Nc2ccccc2C(=O)NC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D04 compound treatment 1.0069 0.00687 0.13 0.1334 1.0 1544141 Maybridge1_000950 Fc1cccc(F)c1C(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D05 compound treatment 0.9918 -0.00821 -0.16 -0.1595 -1.0 2069935 Maybridge1_000951 Clc1ccccc1C(=O)NC(=O)Nc2cccc(C#C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D06 compound treatment 1.0356 0.0356 0.69 0.6912 1.0 1494826 Maybridge1_000952 Fc1cccc(F)c1C(=O)NC(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D07 compound treatment 0.9875 -0.0125 -0.24 -0.2432 -1.0 2069936 Maybridge1_000953 CN(NC(=O)NC(=O)c1c(Cl)cccc1Cl)c2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D08 compound treatment 0.9896 -0.0104 -0.2 -0.2014 -1.0 2069937 Maybridge1_000954 CC(=O)c1cc(Cl)ccc1OC(=O)c2c(C)onc2c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D09 compound treatment 0.953 -0.047 -0.91 -0.9126 -1.0 1666692 Maybridge1_000955 Fc1ccc(NC(=O)c2c(F)cccc2NC(=O)c3cccs3)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D10 compound treatment 0.9961 -0.00391 -0.08 -0.0758 -1.0 2069938 Maybridge1_000956 [O-][N+](=O)c1ccc2oc3ncccc3c(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D11 compound treatment 1.027 0.027 0.52 0.5239 1.0 2069939 Maybridge1_000957 CCC(C)(OC(=O)NC(=O)c1c(F)cccc1Cl)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D12 compound treatment 0.9659 -0.0341 -0.66 -0.6616 -1.0 1099054 Maybridge1_000958 OC(=O)C1CSC(N1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D13 compound treatment 0.9717 -0.0283 -0.55 -0.55 -1.0 2069940 Maybridge1_000959 Clc1cc(Br)cc(Cl)c1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D14 compound treatment 1.0255 0.0255 0.5 0.496 1.0 1230634 Maybridge1_000960 Clc1ccccc1C(=O)On2c(nc3ccccc3c2=O)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D15 compound treatment 0.9746 -0.0254 -0.49 -0.4942 -1.0 2069941 Maybridge1_000961 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)NC(=N)c3ccccn3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D16 compound treatment 0.9868 -0.0132 -0.26 -0.2571 -1.0 1172112 Maybridge1_000962 Cc1onc(c1C(=O)On2c(nc3ccccc3c2=O)c4ccccc4)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D17 compound treatment 0.9889 -0.0111 -0.22 -0.2153 -1.0 2069942 Maybridge1_000963 COc1ccc(cc1OC)S(=O)(=O)N2CCN(CC2)c3ccc(cc3[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D18 compound treatment 1.0054 0.00543 0.11 0.1055 1.0 2069943 Maybridge1_000964 NNC(=S)Nc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D19 compound treatment 0.9846 -0.0154 -0.3 -0.299 -1.0 1615615 Maybridge1_000965 Clc1ccc(NC(=S)NCCn2ccnc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D20 compound treatment 0.9889 -0.0111 -0.22 -0.2153 -1.0 2069944 Maybridge1_000966 Cc1ccc(CSc2nc(C(=O)C(F)(F)F)c3ccccn23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D21 compound treatment 0.9473 -0.0527 -1.02 -1.0242 -1.0 2069945 Maybridge1_000967 CN(C)/C=N/C(=S)Nc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D22 compound treatment 0.9681 -0.0319 -0.62 -0.6198 -1.0 2069946 Maybridge1_000968 N/C(=N\O)/CC(=O)Nc1ccc(F)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D23 mock treatment 0.9846 -0.0154 -0.3 -0.299 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 D24 mock treatment 0.971 -0.029 -0.56 -0.564 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E01 compound treatment 1.0061 0.00615 0.12 0.1194 1.0 2069947 Maybridge1_000969 CC(C)(C)SCC(=O)Nc1cc(ccc1Oc2ccc(C#N)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E02 compound treatment 1.0715 0.0715 1.39 1.3886 1.0 2069948 Maybridge1_000970 Fc1ccc(/N=C/c2c(F)cccc2Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E03 compound treatment 1.0327 0.0327 0.64 0.6354 1.0 2069949 Maybridge1_000971 FC(F)(F)c1cc(NCC(=O)c2ccc(Cl)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E04 compound treatment 1.004 0.00399 0.08 0.0776 1.0 2069950 Maybridge1_000972 [O-][N+](=O)c1ccc(Oc2ccc(cc2)c3ccccc3)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E05 compound treatment 1.0076 0.00759 0.15 0.1473 1.0 1104647 Maybridge1_000973 Nc1c(C#N)cnn1CCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E06 compound treatment 1.0054 0.00543 0.11 0.1055 1.0 1104603 Maybridge1_000974 NC(=O)c1ccccc1N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E07 compound treatment 0.9667 -0.0333 -0.65 -0.6476 -1.0 1106751 Maybridge1_000975 Nc1cc2cc(ccc2oc1=O)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E08 compound treatment 0.999 -0.00103 -0.02 -0.02 -1.0 2069951 Maybridge1_000976 [O-][N+](=O)c1ccc(Oc2c(Cl)cccc2Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E09 compound treatment 0.9738 -0.0262 -0.51 -0.5082 -1.0 1516140 Maybridge1_000977 CNc1ccccc1C(=O)NCCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E10 compound treatment 1.0097 0.00974 0.19 0.1892 1.0 1122977 Maybridge1_000978 Cn1[nH]c(=O)c2cnc3c(F)cc(F)cc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E11 compound treatment 0.9889 -0.0111 -0.22 -0.2153 -1.0 1967118 Maybridge1_000979 FC(F)(F)c1cc(cc(c1)S(=O)(=O)NCCc2ccncc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E12 compound treatment 0.9544 -0.0456 -0.88 -0.8847 -1.0 2069952 Maybridge1_000980 [O-][N+](=O)c1cccnc1Sc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E13 compound treatment 1.0413 0.0413 0.8 0.8028 1.0 1352645 Maybridge1_000981 N#CC(N1CCOCC1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E14 compound treatment 0.9868 -0.0132 -0.26 -0.2571 -1.0 2069953 Maybridge1_000982 CC1CCN(CC1)S(=O)(=O)c2cc(Cl)c(Oc3ccc(cc3Cl)[N+](=O)[O-])c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E15 compound treatment 1.0026 0.00256 0.05 0.0497 1.0 1411187 Maybridge1_000983 CC(C)(C)NC(=O)NC(=O)c1c(F)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E16 compound treatment 0.9803 -0.0197 -0.38 -0.3827 -1.0 1134663 Maybridge1_000984 Cc1onc(c1C(=O)NCC(=O)c2ccc(Br)cc2)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E17 compound treatment 1.0047 0.00471 0.09 0.0915 1.0 2069954 Maybridge1_000985 COC(=O)c1nn(nc1C)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E18 compound treatment 1.0069 0.00687 0.13 0.1334 1.0 2069955 Maybridge1_000986 Fc1ccc(NC(=O)CS(=O)(=O)Cc2ccc(Cl)c(Cl)c2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E19 compound treatment 0.9731 -0.0269 -0.52 -0.5221 -1.0 2069956 Maybridge1_000987 CSC1=NCCN1C(=O)c2c(C)onc2c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E20 compound treatment 1.0148 0.0148 0.29 0.2868 1.0 2069957 Maybridge1_000988 C/C(=N\O)/c1cc2ccccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E21 compound treatment 0.9487 -0.0513 -1.0 -0.9963 -1.0 2069958 Maybridge1_000989 CC(=O)Nc1cc(Sc2ccc(Cl)cc2)c(F)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E22 compound treatment 0.9652 -0.0348 -0.68 -0.6755 -1.0 2069959 Maybridge1_000990 N#Cc1cccc(CSC2=NCN(CN2)C3CC3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E23 mock treatment 1.0227 0.0227 0.44 0.4402 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 E24 mock treatment 1.0069 0.00687 0.13 0.1334 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F01 compound treatment 1.0485 0.0485 0.94 0.9423 1.0 1593780 Maybridge1_000991 COc1cc2CCN(C(C)c2cc1OC)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F02 compound treatment 1.0428 0.0428 0.83 0.8307 1.0 2069960 Maybridge1_000992 Cc1cc(NC(=O)c2ccc(F)cc2)c(cc1C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F03 compound treatment 0.9961 -0.00391 -0.08 -0.0758 -1.0 2069961 Maybridge1_000993 COc1ccccc1Oc2ccc(cc2NC(=O)c3ccc(Cl)cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F04 compound treatment 1.0011 0.00112 0.02 0.0218 1.0 2069962 Maybridge1_000994 FC(F)(F)c1cccc(c1)C(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F05 compound treatment 0.9961 -0.00391 -0.08 -0.0758 -1.0 2069963 Maybridge1_000995 Fc1cccc(F)c1C(=O)NC(=O)Nc2cccc(C#C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F06 compound treatment 0.9724 -0.0276 -0.54 -0.5361 -1.0 1339372 Maybridge1_000996 Fc1cccc(Cl)c1C(=O)NC(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F07 compound treatment 1.0004 4.04E-4 0.01 0.0078 1.0 2069964 Maybridge1_000997 CN(NC(=O)NC(=O)c1c(Cl)cccc1Cl)c2ccc(Cl)cc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F08 compound treatment 1.0148 0.0148 0.29 0.2868 1.0 2069965 Maybridge1_000998 CC(=O)c1cc(F)cc(Cl)c1OC(=O)c2c(C)onc2c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F09 compound treatment 0.9695 -0.0305 -0.59 -0.5919 -1.0 2069966 Maybridge1_000999 Fc1ccc(NC(=O)c2c(F)cccc2NC(=O)c3cccc(c3)C(F)(F)F)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F10 compound treatment 0.9789 -0.0211 -0.41 -0.4106 -1.0 2069967 Maybridge1_001000 CCOc1ccc(Br)cc1/C=C/2\SC(=S)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F11 compound treatment 1.0047 0.00471 0.09 0.0915 1.0 2069968 Maybridge1_001001 CCCc1ccc(NC(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F12 compound treatment 1.0406 0.0406 0.79 0.7889 1.0 2069969 Maybridge1_001002 COc1cccc2sc(/N=C/N(C)C)nc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F13 compound treatment 1.0018 0.00184 0.04 0.0357 1.0 2069970 Maybridge1_001003 Brc1ccc(NC(=O)CSc2ccccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F14 compound treatment 0.9731 -0.0269 -0.52 -0.5221 -1.0 1281600 Maybridge1_001004 COC(=O)c1ccc(Cl)cc1NC(=O)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F15 compound treatment 0.9731 -0.0269 -0.52 -0.5221 -1.0 2069971 Maybridge1_001005 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)NC(=N)c3ccncc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F16 compound treatment 0.9746 -0.0254 -0.49 -0.4942 -1.0 2069972 Maybridge1_001006 Brc1ccc(COc2ccc(cc2)S(=O)(=O)c3ccc(OCc4ccc(Br)cc4)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F17 compound treatment 0.999 -0.00103 -0.02 -0.02 -1.0 2069973 Maybridge1_001007 CN(C)/C=N/C(=S)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F18 compound treatment 1.0004 4.04E-4 0.01 0.0078 1.0 2069974 Maybridge1_001008 NNC(=S)Nc1cc(ccc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F19 compound treatment 1.0054 0.00543 0.11 0.1055 1.0 2069975 Maybridge1_001009 Clc1ccc(Cl)c(NC(=S)NCCCn2ccnc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F20 compound treatment 0.976 -0.024 -0.47 -0.4663 -1.0 2069976 Maybridge1_001010 FC(F)(F)c1ccc(Cl)c(NC(=S)NN=C2CCCCCC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F21 compound treatment 0.9272 -0.0728 -1.41 -1.4147 -1.0 2069977 Maybridge1_001011 CSc1cccc(NC(=S)/N=C/N(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F22 compound treatment 1.0033 0.00328 0.06 0.0636 1.0 2069978 Maybridge1_001012 Clc1ccc(OCOc2ccc(Cl)cc2Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F23 mock treatment 1.0126 0.0126 0.24 0.2449 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 F24 mock treatment 1.0327 0.0327 0.64 0.6354 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G01 compound treatment 1.0162 0.0162 0.31 0.3147 1.0 2069979 Maybridge1_001013 O=c1s[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G02 compound treatment 1.0119 0.0119 0.23 0.231 1.0 1483646 Maybridge1_001014 Fc1cccc2nc(oc(=O)c12)C(C3CCCC3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G03 compound treatment 0.9882 -0.0118 -0.23 -0.2292 -1.0 1722347 Maybridge1_001015 COc1cc(cc(OC)c1OC)c2c(C#N)c(OC)[nH]c(=O)c2C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G04 compound treatment 1.0083 0.0083 0.16 0.1613 1.0 1136768 Maybridge1_001016 Nc1ccc(Oc2ccc(Cl)cc2Cl)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G05 compound treatment 1.0277 0.0277 0.54 0.5378 1.0 2069980 Maybridge1_001017 CC(C)NC(=O)N1CCN(CC1)c2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G06 compound treatment 1.0083 0.0083 0.16 0.1613 1.0 2069981 Maybridge1_001018 Cc1ccc(cc1)C(=O)CSC(=S)SC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G07 compound treatment 1.0004 4.04E-4 0.01 0.0078 1.0 2069982 Maybridge1_001019 FC(F)(F)c1cc(NC(=O)NC(=O)c2c(Cl)cccc2Cl)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G08 compound treatment 1.0018 0.00184 0.04 0.0357 1.0 2069983 Maybridge1_001020 [O-][N+](=O)c1ccc(Oc2c(Cl)cccc2Cl)c(Cl)c1Oc3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G09 compound treatment 1.0076 0.00759 0.15 0.1473 1.0 1698854 Maybridge1_001021 Fc1cccc(F)c1C(=O)NC(=O)NCCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G10 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 2069984 Maybridge1_001022 FC(F)(F)c1ccc(OCc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G11 compound treatment 1.0004 4.04E-4 0.01 0.0078 1.0 1033716 Maybridge1_001023 CC(=O)Nc1ccc(F)cc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G12 compound treatment 0.9875 -0.0125 -0.24 -0.2432 -1.0 2069985 Maybridge1_001024 [O-][N+](=O)c1cccnc1Sc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G13 compound treatment 0.9954 -0.00462 -0.09 -0.0898 -1.0 2069986 Maybridge1_001025 CCOC(=O)CCC(C#N)(N1CCOCC1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G14 compound treatment 0.9889 -0.0111 -0.22 -0.2153 -1.0 2069987 Maybridge1_001026 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)N3CCCCC3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G15 compound treatment 0.9796 -0.0204 -0.4 -0.3966 -1.0 1716717 Maybridge1_001027 Fc1cccc(Cl)c1C(=O)NC(=O)Nc2ccccc2N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G16 compound treatment 0.9839 -0.0161 -0.31 -0.3129 -1.0 2069988 Maybridge1_001028 COc1ccccc1Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G17 compound treatment 1.0061 0.00615 0.12 0.1194 1.0 2069989 Maybridge1_001029 Cc1nn(nc1C(=O)N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G18 compound treatment 1.0112 0.0112 0.22 0.217 1.0 2069990 Maybridge1_001030 N/C(=N\O)/c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G19 compound treatment 0.9681 -0.0319 -0.62 -0.6198 -1.0 2069991 Maybridge1_001031 CSC1=NCCCN1C(=O)c2c(C)onc2c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G20 compound treatment 0.9616 -0.0384 -0.75 -0.7453 -1.0 1190516 Maybridge1_001032 COc1ccc(c2c(C)n[nH]c2C)c(c1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G21 compound treatment 1.0406 0.0406 0.79 0.7889 1.0 1072508 Maybridge1_001033 Brc1ccc(cc1)C(=O)CSCC(=O)c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G22 compound treatment 0.9702 -0.0298 -0.58 -0.5779 -1.0 2069992 Maybridge1_001034 CCC1(CC)N/C(=N/c2cc(Cl)cc(Cl)c2)/SC1=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G23 mock treatment 1.0018 0.00184 0.04 0.0357 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 G24 mock treatment 0.986 -0.014 -0.27 -0.2711 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H01 compound treatment 0.9659 -0.0341 -0.66 -0.6616 -1.0 1541940 Maybridge1_001035 COc1ccc(OC)c(c1)S(=O)(=O)N2CCc3cc(OC)c(OC)cc3C2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H02 compound treatment 0.9997 -3.14E-4 -0.01 -0.0061 -1.0 2069993 Maybridge1_001036 Cc1onc(c1C(=O)Nc2cc(C)c(C)cc2[N+](=O)[O-])c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H03 compound treatment 0.9738 -0.0262 -0.51 -0.5082 -1.0 2069994 Maybridge1_001037 COc1ccccc1Oc2ccc(cc2NC(=O)NC(=O)c3ccccc3F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H04 compound treatment 1.0162 0.0162 0.31 0.3147 1.0 1249841 Maybridge1_001038 Cc1ccc(cc1)S(=O)(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H05 compound treatment 1.0112 0.0112 0.22 0.217 1.0 1681763 Maybridge1_001039 Clc1ccccc1C(=O)NC(=O)N2CCSCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H06 compound treatment 1.0119 0.0119 0.23 0.231 1.0 2069995 Maybridge1_001040 COc1cc(OC)cc(/N=C\2/NC(C)(C)C(=C)S2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H07 compound treatment 0.9932 -0.00678 -0.13 -0.1316 -1.0 1713948 Maybridge1_001041 Cc1cc(ccc1Cl)C(=O)CN2C(=O)c3ccccc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H08 compound treatment 1.0464 0.0464 0.9 0.9004 1.0 2069996 Maybridge1_001042 CC(=O)c1cc(Br)ccc1OC(=O)c2c(C)onc2c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H09 compound treatment 1.0349 0.0349 0.68 0.6773 1.0 2069997 Maybridge1_001043 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1Sc2nc(n[nH]2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H10 compound treatment 1.0119 0.0119 0.23 0.231 1.0 2069998 Maybridge1_001044 Cc1ccc(cc1)S(=O)(=O)Nc2ccc(F)cc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H11 compound treatment 0.9961 -0.00391 -0.08 -0.0758 -1.0 1107935 Maybridge1_001045 CC(=O)Nc1ccc(cc1)C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H12 compound treatment 1.0097 0.00974 0.19 0.1892 1.0 1300335 Maybridge1_001046 Cc1cc(Oc2cc(C)c(Cl)c(C)c2)c3ccccc3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H13 compound treatment 1.0413 0.0413 0.8 0.8028 1.0 2069999 Maybridge1_001047 Clc1ccc(SCC(=O)Nc2ccc(Br)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H14 compound treatment 0.9566 -0.0434 -0.84 -0.8429 -1.0 1404813 Maybridge1_001048 Fc1ccc(cc1)C(=O)On2c(nc3ccccc3c2=O)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H15 compound treatment 0.999 -0.00103 -0.02 -0.02 -1.0 2070000 Maybridge1_001049 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)NC(=N)c3ccncc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H16 compound treatment 0.9717 -0.0283 -0.55 -0.55 -1.0 1719758 Maybridge1_001050 Clc1cccc(Cl)c1CSc2ncc3ccccn23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H17 compound treatment 0.9465 -0.0535 -1.04 -1.0382 -1.0 2070001 Maybridge1_001051 [O-][N+](=O)c1cc(ccc1N2CCN(CC2)C(=O)NC(=O)c3ccccc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H18 compound treatment 0.999 -0.00103 -0.02 -0.02 -1.0 2070002 Maybridge1_001052 FC(F)(F)C(=O)c1nc(SCc2ccc(Cl)cc2)n3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H19 compound treatment 1.0155 0.0155 0.3 0.3007 1.0 2070003 Maybridge1_001053 FC(F)(F)c1cccc(NC(=S)Nc2ccccn2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H20 compound treatment 1.0069 0.00687 0.13 0.1334 1.0 2070004 Maybridge1_001054 Cc1ccc(NC(=S)NN=C2CCCCCC2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H21 compound treatment 0.9674 -0.0326 -0.63 -0.6337 -1.0 1593023 Maybridge1_001055 CC(=O)Nc1cc(=O)oc2ccc(NC(=O)c3ccc(F)cc3)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H22 compound treatment 0.9903 -0.00965 -0.19 -0.1874 -1.0 2070005 Maybridge1_001056 Cc1cc(OCOc2ccc(Cl)c(C)c2)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H23 mock treatment 1.0061 0.00615 0.12 0.1194 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 H24 mock treatment 1.0385 0.0385 0.75 0.747 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I01 compound treatment 1.0514 0.0514 1.0 0.9981 1.0 1094153 Maybridge1_001057 NNC(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I02 compound treatment 1.0263 0.0263 0.51 0.5099 1.0 2070006 Maybridge1_001058 Cc1onc(c1c2nc3cccc(F)c3c(=O)o2)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I03 compound treatment 1.0061 0.00615 0.12 0.1194 1.0 2070007 Maybridge1_001059 Cc1cc(=O)cc(C)n1NC(=O)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I04 compound treatment 1.0356 0.0356 0.69 0.6912 1.0 1492347 Maybridge1_001060 Nc1ccc(Oc2c(Cl)cccc2Cl)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I05 compound treatment 1.0026 0.00256 0.05 0.0497 1.0 2070008 Maybridge1_001061 Clc1ccc(cc1)C(C#N)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I06 compound treatment 0.9681 -0.0319 -0.62 -0.6198 -1.0 2070009 Maybridge1_001062 CC(C)(C)SC(=S)SCC(=O)c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I07 compound treatment 1.0184 0.0184 0.36 0.3565 1.0 2070010 Maybridge1_001063 Clc1cccc(Cl)c1C(=O)NC(=O)NCc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I08 compound treatment 0.9982 -0.00175 -0.03 -0.034 -1.0 2070011 Maybridge1_001064 CC(C=C)N1C(=O)c2ccccc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I09 compound treatment 1.0105 0.0105 0.2 0.2031 1.0 2070012 Maybridge1_001065 [O-][N+](=O)c1ccc(cc1)C(=O)NCCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I10 compound treatment 0.9609 -0.0391 -0.76 -0.7592 -1.0 1648615 Maybridge1_001066 CC1CN(Cc2cc(C)c(O)c(C)c2)CC(C)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I11 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 2070013 Maybridge1_001067 Clc1ccc(SCc2ccc(cc2)c3nc4ccccc4[nH]3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I12 compound treatment 0.9789 -0.0211 -0.41 -0.4106 -1.0 1024512 Maybridge1_001068 COc1cc2CCN=C(C)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I13 compound treatment 1.009 0.00902 0.18 0.1752 1.0 1715965 Maybridge1_001069 Cc1onc(c1C(=O)NCCS(=O)(=O)c2ccc(C)cc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I14 compound treatment 1.0026 0.00256 0.05 0.0497 1.0 2070014 Maybridge1_001070 NCC(=O)c1cccc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I15 compound treatment 1.0033 0.00328 0.06 0.0636 1.0 1230300 Maybridge1_001071 Nc1c(Cl)cc(cc1Cl)C(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I16 compound treatment 0.9681 -0.0319 -0.62 -0.6198 -1.0 2070015 Maybridge1_001072 Clc1ccc(COC(=O)c2cccs2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I17 compound treatment 0.9415 -0.0585 -1.14 -1.1358 -1.0 2070016 Maybridge1_001073 Cc1nn(nc1C(=O)NNC(=S)Nc2ccc(C)c(C)c2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I18 compound treatment 0.9695 -0.0305 -0.59 -0.5919 -1.0 2070017 Maybridge1_001074 Fc1ccc(NC(=O)CS(=O)(=O)Cc2c(F)cccc2Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I19 compound treatment 1.0119 0.0119 0.23 0.231 1.0 2070018 Maybridge1_001075 CSC1=NCCCN1C(=O)c2c(C)onc2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I20 compound treatment 0.9839 -0.0161 -0.31 -0.3129 -1.0 1565983 Maybridge1_001076 COc1ccc(c2c(C)nn(C)c2C)c(c1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I21 compound treatment 0.9746 -0.0254 -0.49 -0.4942 -1.0 1063570 Maybridge1_001077 [O-][N+](=O)c1ccc(Oc2ccc(Cl)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I22 compound treatment 1.0033 0.00328 0.06 0.0636 1.0 2070019 Maybridge1_001078 Nc1ccccc1C(=O)NCCCn2ccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I23 mock treatment 1.0105 0.0105 0.2 0.2031 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 I24 mock treatment 1.0011 0.00112 0.02 0.0218 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J01 compound treatment 1.0349 0.0349 0.68 0.6773 1.0 2070020 Maybridge1_001079 CC1CN(CC(C)O1)C2=NCCN2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J02 compound treatment 0.986 -0.014 -0.27 -0.2711 -1.0 2070021 Maybridge1_001080 Fc1ccc(OC(=O)NC(=O)c2c(Cl)cccc2Cl)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J03 compound treatment 1.0054 0.00543 0.11 0.1055 1.0 2070022 Maybridge1_001081 COc1ccccc1Oc2ccc(cc2NC(=O)NC(=O)c3c(F)cccc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J04 compound treatment 1.0083 0.0083 0.16 0.1613 1.0 1481239 Maybridge1_001082 COc1ccc(cc1OC)S(=O)(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J05 compound treatment 1.0126 0.0126 0.24 0.2449 1.0 2070023 Maybridge1_001083 Cc1cc(Oc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])c3c(Cl)ccc(C)c3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J06 compound treatment 1.0011 0.00112 0.02 0.0218 1.0 1920653 Maybridge1_001084 Clc1ccc(/C=C\2/N=C(OC2=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J07 compound treatment 1.0169 0.0169 0.33 0.3286 1.0 1043741 Maybridge1_001085 CSc1ccc(Br)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J08 compound treatment 0.9631 -0.0369 -0.72 -0.7174 -1.0 2070024 Maybridge1_001086 CC(=O)c1cc(Cl)cc(Cl)c1OC(=O)c2c(C)onc2c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J09 compound treatment 0.9939 -0.00606 -0.12 -0.1177 -1.0 2070025 Maybridge1_001087 Clc1c(sc2ccccc12)C(=O)N/N=C/c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J10 compound treatment 1.0126 0.0126 0.24 0.2449 1.0 1296994 Maybridge1_001088 Cc1cc(Oc2ccnc3cc(Cl)ccc23)cc(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J11 compound treatment 1.0033 0.00328 0.06 0.0636 1.0 2070026 Maybridge1_001089 Cc1cc(ccc1Cl)C(=O)CC(Sc2ccccc2N)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J12 compound treatment 1.0442 0.0442 0.86 0.8586 1.0 1724700 Maybridge1_001090 Cc1cc(Oc2ccc(Cl)c(C)c2)c3ccccc3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J13 compound treatment 1.0061 0.00615 0.12 0.1194 1.0 2070027 Maybridge1_001091 Cc1ccc(SCC(=O)Nc2ccc(Br)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J14 compound treatment 1.0241 0.0241 0.47 0.4681 1.0 2070028 Maybridge1_001092 COC(=O)c1sc2cc(Cl)ccc2c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J15 compound treatment 0.9731 -0.0269 -0.52 -0.5221 -1.0 2070029 Maybridge1_001093 CC(=N)NS(=O)(=O)c1cc(Cl)c(Oc2ccc(cc2)[N+](=O)[O-])c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J16 compound treatment 1.004 0.00399 0.08 0.0776 1.0 1006327 Maybridge1_001094 CCOC(=O)c1cc2ccccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J17 compound treatment 0.9724 -0.0276 -0.54 -0.5361 -1.0 2070030 Maybridge1_001095 Cc1ccc(SCC(=O)N2CCN(CC2)c3ccc(cc3[N+](=O)[O-])C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J18 compound treatment 1.0169 0.0169 0.33 0.3286 1.0 2070031 Maybridge1_001096 CC(=NNC(=S)Nc1ccc(C)cc1C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J19 compound treatment 0.971 -0.029 -0.56 -0.564 -1.0 2070032 Maybridge1_001097 C/C(=N\Nc1c(Cl)cc(Cl)cc1Cl)/C=N/OCc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J20 compound treatment 1.0399 0.0399 0.77 0.7749 1.0 2070033 Maybridge1_001098 Cc1cc(C)c(NC(=S)NN=C2CCCCCC2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J21 compound treatment 1.0011 0.00112 0.02 0.0218 1.0 1504079 Maybridge1_001099 COc1ccc(cc1OC)S(=O)(=O)Nc2ccc3oc(=O)c(NC(=O)C)cc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J22 compound treatment 0.9846 -0.0154 -0.3 -0.299 -1.0 2070034 Maybridge1_001100 CS/C(=N/N=C/c1c(Cl)cccc1Cl)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J23 mock treatment 0.9724 -0.0276 -0.54 -0.5361 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 J24 mock treatment 0.9803 -0.0197 -0.38 -0.3827 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K01 compound treatment 1.0442 0.0442 0.86 0.8586 1.0 2070035 Maybridge1_001101 Cc1cc(cc([N+](=O)[O-])c1Sc2ccc(Cl)cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K02 compound treatment 1.0033 0.00328 0.06 0.0636 1.0 2070036 Maybridge1_001102 Fc1cccc2nc(oc(=O)c12)c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K03 compound treatment 1.027 0.027 0.52 0.5239 1.0 2070037 Maybridge1_001103 CC(=O)c1cc2cc(ccc2o1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K04 compound treatment 1.0011 0.00112 0.02 0.0218 1.0 1359192 Maybridge1_001104 Cc1cc(Oc2ccc(N)cn2)cc(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K05 compound treatment 1.0133 0.0133 0.26 0.2589 1.0 1364082 Maybridge1_001105 COc1cc(cc(OC)c1OC)C(C#N)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K06 compound treatment 0.9573 -0.0427 -0.83 -0.829 -1.0 2070038 Maybridge1_001106 CC(C)(C)SC(=S)SCC(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K07 compound treatment 1.0119 0.0119 0.23 0.231 1.0 1127157 Maybridge1_001107 Nc1ccc(Cl)cc1C(=O)NCc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K08 compound treatment 0.971 -0.029 -0.56 -0.564 -1.0 2070039 Maybridge1_001108 CN(C)c1cc(N2CCCC2)c(F)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K09 compound treatment 1.0169 0.0169 0.33 0.3286 1.0 1208334 Maybridge1_001109 Clc1ccc(cc1Cl)C(=O)NCCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K10 compound treatment 1.0112 0.0112 0.22 0.217 1.0 1428930 Maybridge1_001110 CC1CC(C)CN(Cc2cc(C)c(O)c(C)c2)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K11 compound treatment 0.9588 -0.0412 -0.8 -0.8011 -1.0 2070040 Maybridge1_001111 COc1ccc(C(C(=O)C)C(=O)C)c(c1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K12 compound treatment 1.0097 0.00974 0.19 0.1892 1.0 2070041 Maybridge1_001112 Nc1cccc(NC=C(C#N)C#N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K13 compound treatment 0.9839 -0.0161 -0.31 -0.3129 -1.0 1667067 Maybridge1_001113 Cc1onc(c1C(=O)NCC(=O)NN)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K14 compound treatment 0.986 -0.014 -0.27 -0.2711 -1.0 1019894 Maybridge1_001114 NCC(=O)c1ccc(Br)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K15 compound treatment 1.0112 0.0112 0.22 0.217 1.0 2070042 Maybridge1_001115 Cc1nn(nc1C(=O)Nc2nnc(s2)C(F)(F)F)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K16 compound treatment 0.9868 -0.0132 -0.26 -0.2571 -1.0 2070043 Maybridge1_001116 Fc1ccc(NC(=O)CSCc2ccc(Cl)c(Cl)c2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K17 compound treatment 0.9738 -0.0262 -0.51 -0.5082 -1.0 2070044 Maybridge1_001117 Cc1nn(nc1C(=O)NNC(=S)Nc2ccc(Cl)cc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K18 compound treatment 0.9817 -0.0183 -0.35 -0.3548 -1.0 2070045 Maybridge1_001118 N/C(=N\OC(=O)c1cccs1)/c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K19 compound treatment 1.0205 0.0205 0.4 0.3984 1.0 1104645 Maybridge1_001119 Nc1ccccc1C(=O)NCCc2c[nH]c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K20 compound treatment 0.971 -0.029 -0.56 -0.564 -1.0 1573183 Maybridge1_001120 Cc1onc(c1C(=O)Oc2ccc(F)cc2Cl)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K21 compound treatment 0.976 -0.024 -0.47 -0.4663 -1.0 2070046 Maybridge1_001121 [O-][N+](=O)c1ccc(Oc2c(Cl)cccc2Cl)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K22 compound treatment 0.953 -0.047 -0.91 -0.9126 -1.0 1010836 Maybridge1_001122 CCOC(=O)c1cnc(S)nc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K23 mock treatment 1.0399 0.0399 0.77 0.7749 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 K24 mock treatment 1.0313 0.0313 0.61 0.6076 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L01 compound treatment 1.0629 0.0629 1.22 1.2212 1.0 1703714 Maybridge1_001123 Cc1cccc(c1)c2nc3cccc(F)c3c(=O)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L02 compound treatment 1.0112 0.0112 0.22 0.217 1.0 2070047 Maybridge1_001124 COc1ccc([N+](=O)[O-])c(OC)c1C(=O)Nc2ccc(F)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L03 compound treatment 0.9968 -0.00319 -0.06 -0.0619 -1.0 2070048 Maybridge1_001125 [O-][N+](=O)c1cccnc1Sc2ncc3ccccn23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L04 compound treatment 0.9939 -0.00606 -0.12 -0.1177 -1.0 1355972 Maybridge1_001126 Clc1ccc(cc1)S(=O)(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L05 compound treatment 0.9257 -0.0743 -1.44 -1.4426 -1.0 2070049 Maybridge1_001127 Cc1cc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)c3cc(F)ccc3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L06 compound treatment 0.9789 -0.0211 -0.41 -0.4106 -1.0 1558904 Maybridge1_001128 Nc1ccccc1C(=O)NCCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L07 compound treatment 0.9796 -0.0204 -0.4 -0.3966 -1.0 1540934 Maybridge1_001129 COc1ccc2N(CCCc2c1)C(=O)NC(=O)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L08 compound treatment 0.9746 -0.0254 -0.49 -0.4942 -1.0 2070050 Maybridge1_001130 CC(=O)c1cc(F)ccc1OC(=O)c2c(C)onc2c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L09 compound treatment 0.9817 -0.0183 -0.35 -0.3548 -1.0 2070051 Maybridge1_001131 CCOC(=O)CNC(=O)c1c(F)cccc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L10 compound treatment 1.009 0.00902 0.18 0.1752 1.0 2070052 Maybridge1_001132 COc1ccc(cc1CSc2nc3cc(ccc3[nH]2)C(F)(F)F)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L11 compound treatment 0.9925 -0.0075 -0.15 -0.1456 -1.0 2070053 Maybridge1_001133 Cc1cc(ccc1Cl)C2=Nc3ccccc3SC(C2)c4c(F)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L12 compound treatment 1.0076 0.00759 0.15 0.1473 1.0 1583726 Maybridge1_001134 Cc1cc(Oc2ccc(Cl)cc2)c3ccccc3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L13 compound treatment 1.0083 0.0083 0.16 0.1613 1.0 2070054 Maybridge1_001135 Brc1ccc(NC(=O)CSc2ncccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L14 compound treatment 1.0155 0.0155 0.3 0.3007 1.0 2070055 Maybridge1_001136 COc1ccc(Cc2nc(cs2)C(C)(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L15 compound treatment 0.9702 -0.0298 -0.58 -0.5779 -1.0 2070056 Maybridge1_001137 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)NC(=N)c3ccc(Cl)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L16 compound treatment 0.9918 -0.00821 -0.16 -0.1595 -1.0 2070057 Maybridge1_001138 Clc1cc(COc2ccc(cc2)S(=O)(=O)c3ccc(OCc4cc(Cl)cc5COCOc45)cc3)c6OCOCc6c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L17 compound treatment 0.9437 -0.0563 -1.09 -1.0939 -1.0 2070058 Maybridge1_001139 CC(=O)N1CCN(CC1)c2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L18 compound treatment 1.0184 0.0184 0.36 0.3565 1.0 2070059 Maybridge1_001140 Fc1ccc(NC(=O)CC#N)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L19 compound treatment 0.9753 -0.0247 -0.48 -0.4803 -1.0 2070060 Maybridge1_001141 Nc1nc2c(F)cc(F)cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L20 compound treatment 1.0219 0.0219 0.43 0.4262 1.0 2070061 Maybridge1_001142 C/C(=N\NC(=S)N)/c1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L21 compound treatment 1.0047 0.00471 0.09 0.0915 1.0 2070062 Maybridge1_001143 Cc1ccc2nc(N)sc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L22 compound treatment 1.0263 0.0263 0.51 0.5099 1.0 1919994 Maybridge1_001144 CN(C)c1ccc(/C=N/NC(=S)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L23 mock treatment 0.9616 -0.0384 -0.75 -0.7453 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 L24 mock treatment 1.0248 0.0248 0.48 0.482 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M01 compound treatment 1.0263 0.0263 0.51 0.5099 1.0 1469999 Maybridge1_001145 NC(=O)c1cccnc1Oc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M02 compound treatment 0.9824 -0.0176 -0.34 -0.3408 -1.0 1365534 Maybridge1_001146 CC(C)(C)C(=O)Nc1cccc(F)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M03 compound treatment 1.0356 0.0356 0.69 0.6912 1.0 1075845 Maybridge1_001147 OC(=O)c1ccccc1C(=O)Nc2cc(ccc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M04 compound treatment 0.986 -0.014 -0.27 -0.2711 -1.0 1223037 Maybridge1_001148 CC(C)(C)c1ccc(Oc2ccc(N)cn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M05 compound treatment 0.9846 -0.0154 -0.3 -0.299 -1.0 1020373 Maybridge1_001149 Nc1ccc(Br)cn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M06 compound treatment 1.0133 0.0133 0.26 0.2589 1.0 2070063 Maybridge1_001150 CC(C)(C)SC(=S)SCC(=O)c1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M07 compound treatment 1.0298 0.0298 0.58 0.5797 1.0 1571162 Maybridge1_001151 CNc1ccccc1C(=O)NCc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M08 compound treatment 0.9868 -0.0132 -0.26 -0.2571 -1.0 2070064 Maybridge1_001152 CC1CCCN(C1)c2cc(N(C)C)c(cc2F)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M09 compound treatment 1.0255 0.0255 0.5 0.496 1.0 1632631 Maybridge1_001153 O=C(NCCc1ccncc1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M10 compound treatment 0.981 -0.019 -0.37 -0.3687 -1.0 1432647 Maybridge1_001154 COc1cc2CCN(Cc3cc(C)c(O)c(C)c3)C(C)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M11 compound treatment 1.0385 0.0385 0.75 0.747 1.0 2070065 Maybridge1_001155 Clc1ccc(SCC(=O)NCc2cccs2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M12 compound treatment 0.9602 -0.0398 -0.77 -0.7732 -1.0 2070066 Maybridge1_001156 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)N3CCCCC3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M13 compound treatment 1.0227 0.0227 0.44 0.4402 1.0 2070067 Maybridge1_001157 COc1cc(cc(OC)c1OC)C2=NNC(=O)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M14 compound treatment 0.986 -0.014 -0.27 -0.2711 -1.0 2070068 Maybridge1_001158 Fc1ccc(OC(=O)c2cccs2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M15 compound treatment 0.9731 -0.0269 -0.52 -0.5221 -1.0 1504770 Maybridge1_001159 Cc1nn(nc1C(=O)Nc2ccc3[nH]ncc3c2)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M16 compound treatment 0.9753 -0.0247 -0.48 -0.4803 -1.0 2070069 Maybridge1_001160 Fc1ccc(NC(=O)CSCc2c(Cl)cccc2Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M17 compound treatment 0.9753 -0.0247 -0.48 -0.4803 -1.0 1236643 Maybridge1_001161 Fc1cccc(F)c1C(=O)NC(=O)N2CCSC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M18 compound treatment 0.9911 -0.00893 -0.17 -0.1735 -1.0 1108196 Maybridge1_001162 [O-][N+](=O)c1ccc(cc1)c2noc(n2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M19 compound treatment 0.9911 -0.00893 -0.17 -0.1735 -1.0 1093772 Maybridge1_001163 O=C(Nc1nncs1)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M20 compound treatment 0.9824 -0.0176 -0.34 -0.3408 -1.0 1737692 Maybridge1_001164 CC(=O)Nc1cccc(F)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M21 compound treatment 0.9451 -0.0549 -1.07 -1.0661 -1.0 2070070 Maybridge1_001165 Cc1cc(Oc2ccc(cn2)[N+](=O)[O-])cc(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M22 compound treatment 0.948 -0.052 -1.01 -1.0103 -1.0 2070071 Maybridge1_001166 CC(C)(C)c1cc([N+](=O)[O-])c(OC(=O)c2ccc(Cl)cc2Cl)c(c1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M23 mock treatment 1.0076 0.00759 0.15 0.1473 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 M24 mock treatment 0.9667 -0.0333 -0.65 -0.6476 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N01 compound treatment 1.0543 0.0543 1.05 1.0538 1.0 1602236 Maybridge1_001167 S=C(NCc1ccccn1)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N02 compound treatment 1.0298 0.0298 0.58 0.5797 1.0 1628081 Maybridge1_001168 Cc1onc(c1C(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N03 compound treatment 1.0291 0.0291 0.57 0.5657 1.0 2070072 Maybridge1_001169 [O-][N+](=O)c1ccc(Sc2ncc3ccccn23)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N04 compound treatment 0.9896 -0.0104 -0.2 -0.2014 -1.0 1468368 Maybridge1_001170 Clc1ccc(Oc2ccccc2NS(=O)(=O)c3ccc(Cl)c(Cl)c3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N05 compound treatment 1.0191 0.0191 0.37 0.3705 1.0 2070073 Maybridge1_001171 Cc1cc(Oc2ncccc2[N+](=O)[O-])c3cc(Cl)ccc3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N06 compound treatment 1.0097 0.00974 0.19 0.1892 1.0 1602444 Maybridge1_001172 Cc1c(Cl)cccc1Nc2nc(cs2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N07 compound treatment 1.0083 0.0083 0.16 0.1613 1.0 2070074 Maybridge1_001173 Clc1ccc(cc1)C2=NNC(=O)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N08 compound treatment 1.0155 0.0155 0.3 0.3007 1.0 2070075 Maybridge1_001174 C/C(=N\Nc1c(Cl)cc(Cl)cc1Cl)/c2cc(F)ccc2OC(=O)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N09 compound treatment 0.9566 -0.0434 -0.84 -0.8429 -1.0 2070076 Maybridge1_001175 C/C(=N\Nc1ccccc1)/C=N/O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N10 compound treatment 0.9824 -0.0176 -0.34 -0.3408 -1.0 1595657 Maybridge1_001176 Cc1ccc(cc1C)n2c(csc2=Nc3ccccn3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N11 compound treatment 0.9746 -0.0254 -0.49 -0.4942 -1.0 2070077 Maybridge1_001177 Cc1cc(ccc1Cl)C2=Nc3ccccc3SC(C2)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N12 compound treatment 1.0205 0.0205 0.4 0.3984 1.0 1257335 Maybridge1_001178 Fc1ccc(Oc2ccnc3cc(Cl)ccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N13 compound treatment 1.0069 0.00687 0.13 0.1334 1.0 2070078 Maybridge1_001179 Fc1cc(Br)c(c(Br)c1Cl)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N14 compound treatment 0.948 -0.052 -1.01 -1.0103 -1.0 2070079 Maybridge1_001180 Cc1ccc(Cc2nc(cs2)C(C)(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N15 compound treatment 0.9803 -0.0197 -0.38 -0.3827 -1.0 2070080 Maybridge1_001181 CS(=O)(=O)NNc1c(Cl)cc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N16 compound treatment 0.9803 -0.0197 -0.38 -0.3827 -1.0 1633692 Maybridge1_001182 Cc1onc(c1C(=O)Nc2nnc(s2)C3CC3)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N17 compound treatment 1.0119 0.0119 0.23 0.231 1.0 1014750 Maybridge1_001183 COc1ccc(NC(=O)CC(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N18 compound treatment 0.9925 -0.0075 -0.15 -0.1456 -1.0 2070081 Maybridge1_001184 Fc1ccc(OCOc2ccc(F)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N19 compound treatment 0.9609 -0.0391 -0.76 -0.7592 -1.0 2070082 Maybridge1_001185 Oc1ccnc(SCc2c(Cl)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N20 compound treatment 0.9358 -0.0642 -1.25 -1.2474 -1.0 2070083 Maybridge1_001186 CS/C(=N/N=C(\C)/c1ccc(Cl)c(Cl)c1)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N21 compound treatment 0.9667 -0.0333 -0.65 -0.6476 -1.0 2070084 Maybridge1_001187 Nc1nc2ccc(Cl)cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N22 compound treatment 1.0126 0.0126 0.24 0.2449 1.0 2070085 Maybridge1_001188 NC(=S)N/N=C/c1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N23 mock treatment 0.9573 -0.0427 -0.83 -0.829 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 N24 mock treatment 1.0306 0.0306 0.59 0.5936 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O01 compound treatment 1.014 0.014 0.27 0.2728 1.0 1177922 Maybridge1_001189 O=c1c2ccccc2oc3ncccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O02 compound treatment 0.9659 -0.0341 -0.66 -0.6616 -1.0 1120165 Maybridge1_001190 Fc1cccc(NC(=O)C(C2CCCC2)c3ccccc3)c1C(=O)NCc4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O03 compound treatment 0.9997 -3.14E-4 -0.01 -0.0061 -1.0 2070086 Maybridge1_001191 COC(=O)c1c(OC)ccc([N+](=O)[O-])c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O04 compound treatment 0.9932 -0.00678 -0.13 -0.1316 -1.0 2070087 Maybridge1_001192 Cc1cc(Oc2ccc(cn2)[N+](=O)[O-])ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O05 compound treatment 1.0162 0.0162 0.31 0.3147 1.0 1033922 Maybridge1_001193 Nc1ncc(Br)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O06 compound treatment 0.9724 -0.0276 -0.54 -0.5361 -1.0 1034245 Maybridge1_001194 [O-][N+](=O)c1ccc(Oc2c(Cl)cccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O07 compound treatment 1.0284 0.0284 0.55 0.5518 1.0 1249559 Maybridge1_001195 OC(=O)c1ccccc1NCC(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O08 compound treatment 0.9954 -0.00462 -0.09 -0.0898 -1.0 1221542 Maybridge1_001196 Clc1ccc(NC(=O)NC(=O)c2ccccc2N3CCCCC3)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O09 compound treatment 0.9961 -0.00391 -0.08 -0.0758 -1.0 1284064 Maybridge1_001197 CC(C)NC(=S)NCCc1ccncc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O10 compound treatment 0.9695 -0.0305 -0.59 -0.5919 -1.0 2070088 Maybridge1_001198 [O-][N+](=O)c1cccnc1Sc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O11 compound treatment 0.9832 -0.0168 -0.33 -0.3269 -1.0 2070089 Maybridge1_001199 SC1=NCN(CCc2ccncc2)CN1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O12 compound treatment 0.9731 -0.0269 -0.52 -0.5221 -1.0 2070090 Maybridge1_001200 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)N3CCOCC3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O13 compound treatment 1.004 0.00399 0.08 0.0776 1.0 2070091 Maybridge1_001201 CC(=O)C(=NNc1ccc(F)cc1F)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O14 compound treatment 0.9753 -0.0247 -0.48 -0.4803 -1.0 2070092 Maybridge1_001202 Fc1ccc(OC(=O)c2ccccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O15 compound treatment 1.0069 0.00687 0.13 0.1334 1.0 2070093 Maybridge1_001203 Cc1nn(nc1C(=O)NN)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O16 compound treatment 0.9896 -0.0104 -0.2 -0.2014 -1.0 2070094 Maybridge1_001204 Fc1ccc(NC(=O)CSCc2c(F)cccc2Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O17 compound treatment 1.0413 0.0413 0.8 0.8028 1.0 1542709 Maybridge1_001205 Cc1ccc(SCc2ccc(cc2)C(=O)Nc3ccc(C)cc3O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O18 compound treatment 0.9853 -0.0147 -0.29 -0.285 -1.0 2070095 Maybridge1_001206 CC1CN(CC(C)O1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O19 compound treatment 0.9846 -0.0154 -0.3 -0.299 -1.0 1582082 Maybridge1_001207 CCc1nnc(NC(=O)c2ccncc2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O20 compound treatment 1.0148 0.0148 0.29 0.2868 1.0 1207012 Maybridge1_001208 S=C1NCN(CN1)C2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O21 compound treatment 0.9724 -0.0276 -0.54 -0.5361 -1.0 2070096 Maybridge1_001209 Fc1cc2nn[nH]c2cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O22 compound treatment 0.9889 -0.0111 -0.22 -0.2153 -1.0 2070097 Maybridge1_001210 CCOC(=O)c1cnc(Sc2ccc(cc2[N+](=O)[O-])C(F)(F)F)nc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O23 mock treatment 1.0069 0.00687 0.13 0.1334 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 O24 mock treatment 0.9997 -3.14E-4 -0.01 -0.0061 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P01 compound treatment 0.9939 -0.00606 -0.12 -0.1177 -1.0 1307492 Maybridge1_001211 Clc1ccc(cc1)S(=O)(=O)NC2CCS(=O)(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P02 compound treatment 1.0234 0.0234 0.45 0.4541 1.0 1494020 Maybridge1_001212 Cc1onc(c1C(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P03 compound treatment 0.9918 -0.00821 -0.16 -0.1595 -1.0 2070098 Maybridge1_001213 Cc1cc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)c3c(Cl)ccc(C)c3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P04 compound treatment 1.0349 0.0349 0.68 0.6773 1.0 2070099 Maybridge1_001214 Clc1ccc(Oc2ccccc2NC(=O)C(Cl)(Cl)Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P05 compound treatment 0.9997 -3.14E-4 -0.01 -0.0061 -1.0 2070100 Maybridge1_001215 Cc1cc(Oc2ncccc2[N+](=O)[O-])c3ccccc3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P06 compound treatment 0.9896 -0.0104 -0.2 -0.2014 -1.0 1419346 Maybridge1_001216 Cc1ccc(Nc2nc(cs2)C(C)(C)C)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P07 compound treatment 1.0126 0.0126 0.24 0.2449 1.0 1133002 Maybridge1_001217 COc1cc(cc(OC)c1OC)C(=O)c2ccccc2C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P08 compound treatment 1.032 0.032 0.62 0.6215 1.0 2070101 Maybridge1_001218 CCOc1c(Br)cc(Br)cc1/C=C\2/SC(=S)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P09 compound treatment 0.9142 -0.0858 -1.67 -1.6658 -1.0 1920882 Maybridge1_001219 Clc1cccc(Cl)c1/C=N/NC(=O)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P10 compound treatment 0.9846 -0.0154 -0.3 -0.299 -1.0 2070102 Maybridge1_001220 OC1(CSc2nc3cc(ccc3n21)C(F)(F)F)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P11 compound treatment 0.9236 -0.0764 -1.48 -1.4845 -1.0 2070103 Maybridge1_001221 CCCc1cc(Br)c(c(Br)c1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P12 compound treatment 1.0191 0.0191 0.37 0.3705 1.0 1410530 Maybridge1_001222 Clc1ccc(Oc2ccnc3cc(Cl)ccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P13 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 2070104 Maybridge1_001223 [O-][N+](=O)c1ccc(Oc2c(Cl)cc(cc2Cl)S(=O)(=O)NC(=N)c3ccc(Cl)cc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P14 compound treatment 0.9896 -0.0104 -0.2 -0.2014 -1.0 2070105 Maybridge1_001224 CC(C)(C)c1csc(Cc2ccc(cc2)[N+](=O)[O-])n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P15 compound treatment 0.9947 -0.00534 -0.1 -0.1037 -1.0 2070106 Maybridge1_001225 Clc1cc(Cl)c(NNS(=O)(=O)c2ccc(Cl)c(Cl)c2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P16 compound treatment 1.4708 0.471 9.14 9.1429 1.0 2070107 Maybridge1_001226 COC(=O)/C=C/1\SC(=NC1=O)Cc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P17 compound treatment 1.0054 0.00543 0.11 0.1055 1.0 1036063 Maybridge1_001227 Clc1ccc(NC(=S)Nc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P18 compound treatment 1.0334 0.0334 0.65 0.6494 1.0 2070108 Maybridge1_001228 Fc1cccc(NC(=S)NN=C2CCCCCC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P19 compound treatment 1.0198 0.0198 0.38 0.3844 1.0 2070109 Maybridge1_001229 CC(=O)Nc1cc2cc(NC(=O)c3ccc(cc3)[N+](=O)[O-])ccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P20 compound treatment 0.981 -0.019 -0.37 -0.3687 -1.0 2070110 Maybridge1_001230 C/C(=N\Nc1nc(cs1)C(C)(C)C)/c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P21 compound treatment 0.9458 -0.0542 -1.05 -1.0521 -1.0 1723356 Maybridge1_001231 Clc1ccc2sc(NC(=O)NC(=O)c3c(Cl)cccc3Cl)nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P22 compound treatment 0.9875 -0.0125 -0.24 -0.2432 -1.0 2070111 Maybridge1_001232 CC(C)(C)c1csc(N/N=C/c2ccc(Cl)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P23 mock treatment 0.9903 -0.00965 -0.19 -0.1874 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.544 P24 mock treatment 1.0133 0.0133 0.26 0.2589 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A01 compound treatment 1.0461 0.0484 0.94 0.9408 1.0 2070112 Maybridge1_001233 CS/C(=N\N=C(/C)\c1ccc(Br)cc1)/N=C/N(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A02 compound treatment 0.986 -0.0116 -0.23 -0.2253 -1.0 2070113 Maybridge1_001234 CC(C)c1ccc(cc1)S(=O)(=O)NC(=N)CSc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A03 compound treatment 1.0508 0.0532 1.03 1.0336 1.0 2070114 Maybridge1_001235 Cc1onc(c1C(=O)Oc2ccc(cc2)c3ccc(OC(=O)c4c(C)onc4c5c(Cl)cccc5Cl)cc3)c6c(Cl)cccc6Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A04 compound treatment 1.0085 0.0109 0.21 0.212 1.0 2070115 Maybridge1_001236 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1OC(=O)c2c(F)cccc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A05 compound treatment 0.9997 0.00205 0.04 0.0398 1.0 2070116 Maybridge1_001237 Fc1ccc(NC(=O)CC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A06 compound treatment 0.9997 0.00205 0.04 0.0398 1.0 2070117 Maybridge1_001238 OCCCc1nc2cc(ccc2[nH]1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A07 compound treatment 0.9812 -0.0164 -0.32 -0.318 -1.0 1705513 Maybridge1_001239 COC(=O)c1sc2ccccc2c1OC(=O)c3cccnc3Oc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A08 compound treatment 0.9458 -0.0519 -1.01 -1.0071 -1.0 2070118 Maybridge1_001240 CCOC(=O)c1cc(CC)sc1NC(=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A09 compound treatment 0.986 -0.0116 -0.23 -0.2253 -1.0 2070119 Maybridge1_001241 CSC1=NC=C(C#N)C2=NC(NN21)c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A10 compound treatment 0.9655 -0.0321 -0.62 -0.6228 -1.0 1020861 Maybridge1_001242 [O-][N+](=O)c1ccc(cc1)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A11 compound treatment 1.0133 0.0157 0.3 0.3048 1.0 1214080 Maybridge1_001243 Clc1ccc(cc1Cl)S(=O)(=O)Nc2ccc3oc4ncccc4c(=O)c3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A12 compound treatment 1.115 0.117 2.28 2.2792 1.0 2070120 Maybridge1_001244 Cc1cc(OC(=O)c2c(C)onc2c3ccccc3)n(n1)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A13 compound treatment 1.0017 0.00409 0.08 0.0795 1.0 2070121 Maybridge1_001245 [O-][N+](=O)c1cc(ccc1OC(=O)c2c(F)cccc2F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A14 compound treatment 0.9655 -0.0321 -0.62 -0.6228 -1.0 2070122 Maybridge1_001246 Nc1cc(ccc1N2CCCC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A15 compound treatment 0.9908 -0.00682 -0.13 -0.1325 -1.0 2070123 Maybridge1_001247 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1Oc2ccc(Cl)c(Cl)c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A16 compound treatment 1.1109 0.113 2.2 2.1997 1.0 2070124 Maybridge1_001248 Cc1cc(OC(=O)c2cccc(F)c2)n(n1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A17 compound treatment 0.9826 -0.015 -0.29 -0.2915 -1.0 2070125 Maybridge1_001249 Fc1ccc(cc1)c2cnc3c(Cl)cc(cc3n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A18 compound treatment 0.9908 -0.00682 -0.13 -0.1325 -1.0 2070126 Maybridge1_001250 COc1ccc([N+](=O)[O-])c(OC)c1C(=O)NCC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A19 compound treatment 1.0038 0.00614 0.12 0.1193 1.0 2070127 Maybridge1_001251 CC(C)(COC(=O)c1ccc(o1)[N+](=O)[O-])Nc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A20 compound treatment 0.9846 -0.013 -0.25 -0.2518 -1.0 2070128 Maybridge1_001252 Oc1cc(ccc1[N+](=O)[O-])N2CCSCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A21 compound treatment 1.0051 0.00751 0.15 0.1458 1.0 2070129 Maybridge1_001253 O=C/1NC(=S)S\C1=C/c2ccc(C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A22 compound treatment 1.0092 0.0116 0.23 0.2253 1.0 2070130 Maybridge1_001254 CCC(CC)(NC(=O)NC(=O)c1ccc(F)c(Cl)c1)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A23 mock treatment 0.9894 -0.00819 -0.16 -0.159 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 A24 mock treatment 1.0065 0.00887 0.17 0.1723 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B01 compound treatment 1.0433 0.0457 0.89 0.8878 1.0 1223843 Maybridge1_001255 COC(=O)c1sccc1OC(=O)c2c(F)cccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B02 compound treatment 1.029 0.0314 0.61 0.6096 1.0 1150918 Maybridge1_001256 CCCc1cc(=O)oc2n(nc(C)c12)c3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B03 compound treatment 0.9874 -0.0102 -0.2 -0.1988 -1.0 2070131 Maybridge1_001257 [O-][N+](=O)c1cc(ccc1NCCCn2ccnc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B04 compound treatment 0.9608 -0.0368 -0.72 -0.7156 -1.0 2070132 Maybridge1_001258 Oc1cc(ccc1[N+](=O)[O-])S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B05 compound treatment 0.9812 -0.0164 -0.32 -0.318 -1.0 2070133 Maybridge1_001259 CN(C)/C=N/c1nnc(Sc2nc3cc(Cl)ccc3s2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B06 compound treatment 0.9662 -0.0314 -0.61 -0.6096 -1.0 2070134 Maybridge1_001260 Cc1ccc(cc1)S(=O)(=O)Oc2ccc(OCc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B07 compound treatment 0.9396 -0.058 -1.13 -1.1264 -1.0 1257406 Maybridge1_001261 Clc1ccc2sc3nc4ccccc4c(=O)n3c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B08 compound treatment 1.0038 0.00614 0.12 0.1193 1.0 2070135 Maybridge1_001262 O=C1NCCCCC1N2CNC(=S)NC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B09 compound treatment 1.089 0.0914 1.78 1.7757 1.0 2070136 Maybridge1_001263 CN1N=C(C)/C(=C\c2c(C)nn(C)c2O)/C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B10 compound treatment 0.9771 -0.0205 -0.4 -0.3975 -1.0 2070137 Maybridge1_001264 Clc1ccc(cc1Cl)C(=O)NNC(=O)c2cnn(n2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B11 compound treatment 0.9451 -0.0525 -1.02 -1.0204 -1.0 2070138 Maybridge1_001265 Cc1nn(C)c2oc(=O)c(Cl)c(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B12 compound treatment 0.9478 -0.0498 -0.97 -0.9674 -1.0 2070139 Maybridge1_001266 Cc1ccc(cc1)S(=O)(=O)Oc2cc(ccc2[N+](=O)[O-])S(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B13 compound treatment 0.9546 -0.043 -0.83 -0.8348 -1.0 2070140 Maybridge1_001267 Clc1ccc(cc1)c2nnnn2c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B14 compound treatment 0.9737 -0.0239 -0.46 -0.4638 -1.0 1063878 Maybridge1_001268 Cc1ccc(C)c(c1)C(O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B15 compound treatment 0.9928 -0.00478 -0.09 -0.0928 -1.0 2070141 Maybridge1_001269 Cc1cc(SCC#N)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B16 compound treatment 0.9669 -0.0307 -0.6 -0.5963 -1.0 2070142 Maybridge1_001270 CC(C)(C)c1cc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)ccc1Oc3ccc(cc3[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B17 compound treatment 0.9765 -0.0212 -0.41 -0.4108 -1.0 1085663 Maybridge1_001271 Cc1cc(ccc1S(=O)(=O)N)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B18 compound treatment 0.9826 -0.015 -0.29 -0.2915 -1.0 2070143 Maybridge1_001272 Cc1cc(c(C)cc1Cl)S(=O)(=O)c2ccc(cc2[N+](=O)[O-])C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B19 compound treatment 0.9785 -0.0191 -0.37 -0.371 -1.0 2070144 Maybridge1_001273 CCCCCSc1ncccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B20 compound treatment 0.9553 -0.0423 -0.82 -0.8216 -1.0 1382605 Maybridge1_001274 COC(=O)c1ccccc1NS(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B21 compound treatment 0.9874 -0.0102 -0.2 -0.1988 -1.0 1166413 Maybridge1_001275 CCCSc1ncccc1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B22 compound treatment 0.9717 -0.0259 -0.5 -0.5036 -1.0 1543350 Maybridge1_001276 COc1cccc(c1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B23 mock treatment 0.9928 -0.00478 -0.09 -0.0928 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 B24 mock treatment 0.9758 -0.0218 -0.42 -0.424 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C01 compound treatment 1.0003 0.00273 0.05 0.053 1.0 2070145 Maybridge1_001277 CSC1=NC=C(C#N)C2=NC(C)(NN21)c3ccc(Br)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C02 compound treatment 1.0003 0.00273 0.05 0.053 1.0 2070146 Maybridge1_001278 Brc1csc(/C=C/2\N=C(OC2=O)c3ccccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C03 compound treatment 1.0317 0.0341 0.66 0.6626 1.0 2070147 Maybridge1_001279 CS/C(=N/N=C/c1ccc2OCOc2c1)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C04 compound treatment 0.9819 -0.0157 -0.3 -0.3048 -1.0 2070148 Maybridge1_001280 COC(OC)/C(=N/NC(=S)N)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C05 compound treatment 0.9915 -0.00614 -0.12 -0.1193 -1.0 2070149 Maybridge1_001281 CCCc1nc2cc(Cl)c(Cl)cc2nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C06 compound treatment 0.8987 -0.0989 -1.92 -1.9214 -1.0 2070150 Maybridge1_001282 OCCCc1nc2cc(Cl)ccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C07 compound treatment 0.9662 -0.0314 -0.61 -0.6096 -1.0 2070151 Maybridge1_001283 N/C(=N\O)/CC(=O)Nc1cc(Cl)cc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C08 compound treatment 0.9478 -0.0498 -0.97 -0.9674 -1.0 2070152 Maybridge1_001284 CCOC(=O)c1cc(CC)sc1NC(=O)C(Cl)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C09 compound treatment 0.9812 -0.0164 -0.32 -0.318 -1.0 2070153 Maybridge1_001285 Cc1cc(Oc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C10 compound treatment 0.9539 -0.0437 -0.85 -0.8481 -1.0 2070154 Maybridge1_001286 [O-][N+](=O)c1cnc(s1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C11 compound treatment 1.0085 0.0109 0.21 0.212 1.0 1249008 Maybridge1_001287 COc1ccc(cc1OC)S(=O)(=O)Nc2ccc3oc4ncccc4c(=O)c3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C12 compound treatment 0.9587 -0.0389 -0.76 -0.7553 -1.0 2070155 Maybridge1_001288 CCc1nnc(N/C=N/O)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C13 compound treatment 0.9355 -0.0621 -1.21 -1.2059 -1.0 2070156 Maybridge1_001289 CN(C)/C=N/S(=O)(=O)c1cc(Cl)c(Oc2ccc(cc2)[N+](=O)[O-])c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C14 compound treatment 0.9444 -0.0532 -1.03 -1.0336 -1.0 2070157 Maybridge1_001290 Cc1cc(NC(=O)NC(=O)c2c(Cl)cccc2Cl)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C15 compound treatment 0.9949 -0.00273 -0.05 -0.053 -1.0 2070158 Maybridge1_001291 [O-][N+](=O)c1cc(cc(Br)c1OC(=O)c2ccccc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C16 compound treatment 0.9655 -0.0321 -0.62 -0.6228 -1.0 2070159 Maybridge1_001292 Cc1cc(OS(=O)(=O)c2ccc(F)c(Cl)c2)n(n1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C17 compound treatment 0.9642 -0.0334 -0.65 -0.6493 -1.0 2070160 Maybridge1_001293 FC(F)(F)c1cc(Br)c2ncc(nc2c1)c3ccc(Br)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C18 compound treatment 0.9744 -0.0232 -0.45 -0.4505 -1.0 2070161 Maybridge1_001294 Fc1cccc(Cl)c1C(=O)NC(=O)NCC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C19 compound treatment 0.9307 -0.0669 -1.3 -1.2986 -1.0 2070162 Maybridge1_001295 COCCCNC(=S)NNC(=O)c1cc(OC)c(OC)c(OC)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C20 compound treatment 0.9635 -0.0341 -0.66 -0.6626 -1.0 2070163 Maybridge1_001296 Oc1cc(ccc1[N+](=O)[O-])N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C21 compound treatment 0.9942 -0.00341 -0.07 -0.0663 -1.0 2070164 Maybridge1_001297 Brc1csc(/C=C\2/SC(=S)NC2=O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C22 compound treatment 0.9539 -0.0437 -0.85 -0.8481 -1.0 2070165 Maybridge1_001298 [O-][N+](=O)c1ccc(nc1)N2CCN(CC2)C(=O)c3c(F)cccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C23 mock treatment 1.0072 0.00955 0.19 0.1855 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 C24 mock treatment 1.0235 0.0259 0.5 0.5036 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D01 compound treatment 1.0133 0.0157 0.3 0.3048 1.0 1295753 Maybridge1_001299 Cc1cc(c(C)cc1Cl)S(=O)(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D02 compound treatment 1.2173 0.22 4.27 4.2669 1.0 2070166 Maybridge1_001300 CCCC1=NN(C(=O)C1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D03 compound treatment 0.9533 -0.0444 -0.86 -0.8613 -1.0 2070167 Maybridge1_001301 [O-][N+](=O)c1cc(ccc1NCC2CC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D04 compound treatment 0.9703 -0.0273 -0.53 -0.5301 -1.0 2070168 Maybridge1_001302 CSc1ncccc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D05 compound treatment 0.9846 -0.013 -0.25 -0.2518 -1.0 2070169 Maybridge1_001303 CN(C)/C=N/c1nnc(Sc2nc3c(Cl)cc(Cl)cc3s2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D06 compound treatment 0.9771 -0.0205 -0.4 -0.3975 -1.0 2070170 Maybridge1_001304 Clc1cc(Cl)cc(c1)S(=O)(=O)Oc2ccc(OCc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D07 compound treatment 0.9976 4.19E-10 0.0 0.0 1.0 2070171 Maybridge1_001305 Clc1cc(Cl)cc(OS(=O)(=O)c2cccc(c2)S(=O)(=O)Oc3cc(Cl)cc(Cl)c3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D08 compound treatment 0.9976 4.19E-10 0.0 0.0 1.0 2070172 Maybridge1_001306 CCCc1cc(O)nc(SCC(=O)Nc2ccc(F)c(Cl)c2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D09 compound treatment 0.9628 -0.0348 -0.68 -0.6758 -1.0 1009028 Maybridge1_001307 Clc1ccc(NC(=O)c2ccccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D10 compound treatment 0.9567 -0.0409 -0.8 -0.7951 -1.0 2070173 Maybridge1_001308 Cc1cc(OC(=O)c2nn(nc2C)c3ccccc3)n(n1)c4cccc(Cl)c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D11 compound treatment 0.9628 -0.0348 -0.68 -0.6758 -1.0 1258378 Maybridge1_001309 CCOC(=O)Cc1csc(NS(=O)(=O)c2ccc(Cl)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D12 compound treatment 0.9771 -0.0205 -0.4 -0.3975 -1.0 2070174 Maybridge1_001310 FC(F)(F)c1cccc(Sc2ncccc2C(=O)Nc3ccc(Cl)cc3Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D13 compound treatment 0.9867 -0.0109 -0.21 -0.212 -1.0 2070175 Maybridge1_001311 Cc1cc(SCc2c(Cl)cccc2Cl)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D14 compound treatment 0.9478 -0.0498 -0.97 -0.9674 -1.0 2070176 Maybridge1_001312 CN(C(=O)CSc1ccc(Cl)cc1)c2ccc(F)cc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D15 compound treatment 0.9669 -0.0307 -0.6 -0.5963 -1.0 2070177 Maybridge1_001313 CC(=O)NCCSc1cc(C)c(Cl)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D16 compound treatment 0.9492 -0.0484 -0.94 -0.9408 -1.0 2070178 Maybridge1_001314 Cc1ccc([N+](=O)[O-])c(NC(=O)NC(=O)c2c(Cl)cccc2Cl)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D17 compound treatment 0.926 -0.0716 -1.39 -1.3914 -1.0 2070179 Maybridge1_001315 COc1cc(cc(Br)c1O)C2SCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D18 compound treatment 0.9137 -0.0839 -1.63 -1.6299 -1.0 2070180 Maybridge1_001316 OC(=O)c1ccc(c(c1)[N+](=O)[O-])S(=O)(=O)c2cc(Cl)ccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D19 compound treatment 0.9451 -0.0525 -1.02 -1.0204 -1.0 1469626 Maybridge1_001317 OC(=O)c1cccnc1SCC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D20 compound treatment 0.9792 -0.0184 -0.36 -0.3578 -1.0 2070181 Maybridge1_001318 CSC(=NS(=O)(=O)c1ccc(cc1)n2nc(cc2c3cccs3)C(F)(F)F)SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D21 compound treatment 1.0058 0.00819 0.16 0.159 1.0 1678057 Maybridge1_001319 CCSc1ncccc1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D22 compound treatment 1.0078 0.0102 0.2 0.1988 1.0 2070182 Maybridge1_001320 Nc1ccccc1C(=O)NNC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D23 mock treatment 0.9826 -0.015 -0.29 -0.2915 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 D24 mock treatment 1.0522 0.0546 1.06 1.0601 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E01 compound treatment 1.0467 0.0491 0.95 0.9541 1.0 2070183 Maybridge1_001321 C/C(=N\Nc1nc(cs1)C(C)(C)C)/c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E02 compound treatment 1.0038 0.00614 0.12 0.1193 1.0 2070184 Maybridge1_001322 Nc1ccccc1C(=O)NCCCN2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E03 compound treatment 0.9908 -0.00682 -0.13 -0.1325 -1.0 2070185 Maybridge1_001323 CS/C(=N/N=C/c1cccs1)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E04 compound treatment 0.9744 -0.0232 -0.45 -0.4505 -1.0 1582393 Maybridge1_001324 COC(=O)c1cc(OC)c(OC)c(OC)c1NS(=O)(=O)c2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E05 compound treatment 0.9922 -0.00546 -0.11 -0.106 -1.0 2070186 Maybridge1_001325 CCCc1nc2cc(C)c(C)cc2nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E06 compound treatment 0.9676 -0.03 -0.58 -0.5831 -1.0 1004703 Maybridge1_001326 OC(=O)c1ccccc1I 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E07 compound treatment 1.0263 0.0287 0.56 0.5566 1.0 2070187 Maybridge1_001327 Cc1ccc(NC(=O)C/C(=N/O)/N)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E08 compound treatment 0.9649 -0.0328 -0.64 -0.6361 -1.0 2070188 Maybridge1_001328 CCOC(=O)c1cc(CC)sc1NC(=O)C(Cl)(Cl)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E09 compound treatment 0.999 0.00136 0.03 0.0265 1.0 1222255 Maybridge1_001329 Fc1ccc(NC(=O)Cc2ncon2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E10 compound treatment 0.9655 -0.0321 -0.62 -0.6228 -1.0 1363938 Maybridge1_001330 CCOC(=O)c1c(O)c2ccccc2n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E11 compound treatment 1.0229 0.0252 0.49 0.4903 1.0 2070189 Maybridge1_001331 NS(=O)(=O)c1ccc(Oc2c(Cl)cccc2[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E12 compound treatment 0.9744 -0.0232 -0.45 -0.4505 -1.0 2070190 Maybridge1_001332 CN(C)/C=N/c1nnc(s1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E13 compound treatment 0.9737 -0.0239 -0.46 -0.4638 -1.0 2070191 Maybridge1_001333 FC(F)(F)c1ccc2nc(cnc2c1)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E14 compound treatment 0.9635 -0.0341 -0.66 -0.6626 -1.0 2070192 Maybridge1_001334 Cc1cc(NC(=O)NC(=O)c2c(F)cccc2Cl)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E15 compound treatment 0.9956 -0.00205 -0.04 -0.0398 -1.0 2070193 Maybridge1_001335 CC(=O)OCc1csc(n1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E16 compound treatment 0.9867 -0.0109 -0.21 -0.212 -1.0 2070194 Maybridge1_001336 CN(C)/C=N/c1nnc(Sc2ccc(cc2[N+](=O)[O-])C(F)(F)F)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E17 compound treatment 0.9962 -0.00136 -0.03 -0.0265 -1.0 2070195 Maybridge1_001337 CC(O)CNc1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E18 compound treatment 0.9594 -0.0382 -0.74 -0.7421 -1.0 1525564 Maybridge1_001338 Clc1cc(Cl)cc(c1)S(=O)(=O)NCC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E19 compound treatment 0.9997 0.00205 0.04 0.0398 1.0 1055254 Maybridge1_001339 OCCNc1ccc(cn1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E20 compound treatment 0.9635 -0.0341 -0.66 -0.6626 -1.0 2070196 Maybridge1_001340 CC1CN(CC(C)O1)c2ccc([N+](=O)[O-])c(O)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E21 compound treatment 0.9724 -0.0252 -0.49 -0.4903 -1.0 2070197 Maybridge1_001341 C/C(=N\Nc1c(Cl)cc(Cl)cc1Cl)/C(=N\O)/C(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E22 compound treatment 0.9778 -0.0198 -0.38 -0.3843 -1.0 2070198 Maybridge1_001342 [O-][N+](=O)c1ccc(nc1)N2CCN(CC2)C(=O)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E23 mock treatment 0.9799 -0.0177 -0.34 -0.3445 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 E24 mock treatment 1.0167 0.0191 0.37 0.371 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F01 compound treatment 1.0038 0.00614 0.12 0.1193 1.0 2070199 Maybridge1_001343 N/C(=N\O)/CS(=O)(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F02 compound treatment 0.999 0.00136 0.03 0.0265 1.0 1573123 Maybridge1_001344 Clc1ccc(cc1)C(=O)N2CCN(CC2)C(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F03 compound treatment 0.9806 -0.0171 -0.33 -0.3313 -1.0 1428169 Maybridge1_001345 Cc1cc(O)c2cc(F)cc(F)c2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F04 compound treatment 0.9956 -0.00205 -0.04 -0.0398 -1.0 1002355 Maybridge1_001346 CC(=O)Nc1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F05 compound treatment 0.9881 -0.00955 -0.19 -0.1855 -1.0 1357459 Maybridge1_001347 Cc1cc(Sc2nnc(N)s2)c3ccccc3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F06 compound treatment 0.9403 -0.0573 -1.11 -1.1131 -1.0 2070200 Maybridge1_001348 [O-][N+](=O)c1cccnc1Oc2ccc(OCc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F07 compound treatment 1.0126 0.015 0.29 0.2915 1.0 1567712 Maybridge1_001349 Cc1cc(C)c2nc(C)cc(O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F08 compound treatment 1.0092 0.0116 0.23 0.2253 1.0 1275354 Maybridge1_001350 O=C(Nc1ccccc1C(=O)NC2CCCCNC2=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F09 compound treatment 0.9717 -0.0259 -0.5 -0.5036 -1.0 2070201 Maybridge1_001351 Clc1ccc(/C=C/2\C(=O)ON=C2c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F10 compound treatment 0.9751 -0.0225 -0.44 -0.4373 -1.0 1686372 Maybridge1_001352 O=C(CC#N)NC1CCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F11 compound treatment 0.941 -0.0566 -1.1 -1.0999 -1.0 1741154 Maybridge1_001353 CCOC(=O)Cc1csc(NS(=O)(=O)c2ccc(F)cc2F)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F12 compound treatment 0.9853 -0.0123 -0.24 -0.2385 -1.0 2070202 Maybridge1_001354 [O-][N+](=O)c1ccc(cc1OC(=O)c2ccc(Cl)c(Cl)c2)S(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F13 compound treatment 0.9703 -0.0273 -0.53 -0.5301 -1.0 2070203 Maybridge1_001355 Cc1cc(SCc2cccc(F)c2)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F14 compound treatment 0.9703 -0.0273 -0.53 -0.5301 -1.0 2070204 Maybridge1_001356 Clc1ccc(cc1)C(=O)Nc2ncccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F15 compound treatment 0.9969 -6.82E-4 -0.01 -0.0133 -1.0 2070205 Maybridge1_001357 Clc1cn[nH]c(=O)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F16 compound treatment 0.9369 -0.0607 -1.18 -1.1794 -1.0 2070206 Maybridge1_001358 OC(=O)c1ccc(Sc2ccc(Cl)cc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F17 compound treatment 0.9498 -0.0478 -0.93 -0.9276 -1.0 2070207 Maybridge1_001359 CCOC(=O)CC(=O)CSc1cc(C)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F18 compound treatment 0.9478 -0.0498 -0.97 -0.9674 -1.0 1863471 Maybridge1_001360 OC(=O)c1ccc(Sc2ccccn2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F19 compound treatment 0.969 -0.0287 -0.56 -0.5566 -1.0 2070208 Maybridge1_001361 CN(C)/C=C\1/C(=O)NN=C1CSc2cc(C)c(Cl)cc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F20 compound treatment 0.9471 -0.0505 -0.98 -0.9806 -1.0 2070209 Maybridge1_001362 FC(F)(F)c1cc(c2cccs2)n(n1)c3ccc(cc3)S(=O)(=O)NC(=S)Nc4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F21 compound treatment 0.9785 -0.0191 -0.37 -0.371 -1.0 1783937 Maybridge1_001363 [O-][N+](=O)c1ccc(cc1)C(=O)N2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F22 compound treatment 1.0324 0.0348 0.68 0.6758 1.0 2070210 Maybridge1_001364 COc1ccc(Br)c(c1)C(=O)NNC(=O)c2ccccc2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F23 mock treatment 0.9922 -0.00546 -0.11 -0.106 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 F24 mock treatment 0.9881 -0.00955 -0.19 -0.1855 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G01 compound treatment 1.0304 0.0328 0.64 0.6361 1.0 2070211 Maybridge1_001365 CS/C(=N/N=C/c1ccc(Cl)cc1)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G02 compound treatment 0.984 -0.0136 -0.27 -0.265 -1.0 2070212 Maybridge1_001366 NS(=O)(=O)c1cc(Cl)cc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G03 compound treatment 0.984 -0.0136 -0.27 -0.265 -1.0 2070213 Maybridge1_001367 [O-][N+](=O)c1ccc(Oc2ccc(cc2)c3ccc(Oc4ccc(cn4)[N+](=O)[O-])cc3)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G04 compound treatment 0.9806 -0.0171 -0.33 -0.3313 -1.0 1737783 Maybridge1_001368 COC(=O)c1cc(OC)c(OC)c(OC)c1NC(=O)c2cc3ccccc3oc2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G05 compound treatment 0.9601 -0.0375 -0.73 -0.7288 -1.0 2070214 Maybridge1_001369 [O-][N+](=O)c1cc(ccc1Oc2ccc(F)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G06 compound treatment 0.9205 -0.0771 -1.5 -1.4974 -1.0 2070215 Maybridge1_001370 CN(C)/C=N/c1cc(C)on1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G07 compound treatment 0.9116 -0.086 -1.67 -1.6697 -1.0 2070216 Maybridge1_001371 CSc1ccc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G08 compound treatment 0.9348 -0.0628 -1.22 -1.2191 -1.0 1380289 Maybridge1_001372 Cc1nn(nc1C(=O)Nc2nnc(s2)C3CC3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G09 compound treatment 0.9485 -0.0491 -0.95 -0.9541 -1.0 2070217 Maybridge1_001373 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1Oc2ccc(Cl)cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G10 compound treatment 0.9758 -0.0218 -0.42 -0.424 -1.0 2070218 Maybridge1_001374 CSC(=S)Nc1ccc(F)cc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G11 compound treatment 1.0386 0.0409 0.8 0.7951 1.0 2070219 Maybridge1_001375 FC(F)(F)c1ccc2nc3C(=O)c4ccccc4-c3nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G12 compound treatment 0.9539 -0.0437 -0.85 -0.8481 -1.0 2070220 Maybridge1_001376 CN(C)/C=N/c1nnc(C)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G13 compound treatment 0.9396 -0.058 -1.13 -1.1264 -1.0 1052629 Maybridge1_001377 COc1cc(C(=O)O)c([N+](=O)[O-])c(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G14 compound treatment 0.9744 -0.0232 -0.45 -0.4505 -1.0 2070221 Maybridge1_001378 Cc1onc(NC(=O)NC(=O)c2c(F)cccc2Cl)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G15 compound treatment 0.9444 -0.0532 -1.03 -1.0336 -1.0 2070222 Maybridge1_001379 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1Oc2ccc(cc2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G16 compound treatment 0.9799 -0.0177 -0.34 -0.3445 -1.0 2070223 Maybridge1_001380 CN(C)/C=N/c1nnc(Sc2ccc(cn2)[N+](=O)[O-])s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G17 compound treatment 0.9396 -0.058 -1.13 -1.1264 -1.0 1500459 Maybridge1_001381 COc1cc2c(=O)n(CC=C)c(=S)[nH]c2c(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G18 compound treatment 0.9512 -0.0464 -0.9 -0.9011 -1.0 1441622 Maybridge1_001382 Cc1cc(c(C)cc1Cl)S(=O)(=O)NCC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G19 compound treatment 0.9812 -0.0164 -0.32 -0.318 -1.0 2070224 Maybridge1_001383 [O-][N+](=O)c1ccc(o1)C(=O)OCCNc2ccc(cn2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G20 compound treatment 0.9526 -0.045 -0.87 -0.8746 -1.0 2070225 Maybridge1_001384 Oc1cc(ccc1[N+](=O)[O-])N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G21 compound treatment 0.9744 -0.0232 -0.45 -0.4505 -1.0 2070226 Maybridge1_001385 CC(C)c1ccc(cc1)S(=O)(=O)Oc2cccc3ccc(C)nc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G22 compound treatment 0.9997 0.00205 0.04 0.0398 1.0 2070227 Maybridge1_001386 [O-][N+](=O)c1ccc(nc1)N2CCN(CC2)S(=O)(=O)c3ccc(F)cc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G23 mock treatment 0.9894 -0.00819 -0.16 -0.159 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 G24 mock treatment 1.0017 0.00409 0.08 0.0795 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H01 compound treatment 1.0113 0.0136 0.27 0.265 1.0 2070228 Maybridge1_001387 Cc1cc(C)n(n1)c2ccc(Sc3ccc(Cl)cc3)nn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H02 compound treatment 1.0304 0.0328 0.64 0.6361 1.0 2070229 Maybridge1_001388 CC/1=NN(C(=O)\C1=C/c2cc(Br)cs2)c3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H03 compound treatment 0.9369 -0.0607 -1.18 -1.1794 -1.0 2070230 Maybridge1_001389 Cc1nn(c2ccccc2)c3oc(=O)cc(C)c13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H04 compound treatment 0.9751 -0.0225 -0.44 -0.4373 -1.0 2070231 Maybridge1_001390 [O-][N+](=O)c1ccc(Oc2ccc(cc2)C3SCCS3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H05 compound treatment 0.9949 -0.00273 -0.05 -0.053 -1.0 2070232 Maybridge1_001391 Cc1n[nH]c2oc(=O)cc(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H06 compound treatment 0.9553 -0.0423 -0.82 -0.8216 -1.0 2070233 Maybridge1_001392 [O-][N+](=O)c1ccc(Oc2ccc(OCc3ccccc3)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H07 compound treatment 0.9533 -0.0444 -0.86 -0.8613 -1.0 1033256 Maybridge1_001393 CC1=NN(C(=O)CC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H08 compound treatment 0.9301 -0.0676 -1.31 -1.3119 -1.0 1408705 Maybridge1_001394 O=C(Nc1ccccc1C(=O)NC2CCCCNC2=O)c3cc4ccccc4s3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H09 compound treatment 0.9894 -0.00819 -0.16 -0.159 -1.0 2070234 Maybridge1_001395 CC/1=NN(C(=O)\C1=C/c2ccc(Cl)cc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H10 compound treatment 0.9826 -0.015 -0.29 -0.2915 -1.0 2070235 Maybridge1_001396 Cc1nn(nc1c2nnc(o2)c3ccc(Cl)cc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H11 compound treatment 0.958 -0.0396 -0.77 -0.7686 -1.0 2070236 Maybridge1_001397 CCOC(=O)Cc1csc(N/C=N/O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H12 compound treatment 0.9983 6.82E-4 0.01 0.0133 1.0 2070237 Maybridge1_001398 [O-][N+](=O)c1cc2ccccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H13 compound treatment 0.9894 -0.00819 -0.16 -0.159 -1.0 2070238 Maybridge1_001399 Cc1cc(c(Cl)cc1Cl)S(=O)(=O)Cc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H14 compound treatment 0.9683 -0.0293 -0.57 -0.5698 -1.0 1441513 Maybridge1_001400 COC(=O)c1ccc(Cl)cc1NS(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H15 compound treatment 0.9533 -0.0444 -0.86 -0.8613 -1.0 2070239 Maybridge1_001401 Cc1cc(SCC#N)c(C)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H16 compound treatment 0.9608 -0.0368 -0.72 -0.7156 -1.0 2070240 Maybridge1_001402 Clc1ccc(cc1)C(=O)Nc2cnccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H17 compound treatment 0.9642 -0.0334 -0.65 -0.6493 -1.0 2070241 Maybridge1_001403 Cc1cc(SCC2=NNC(=O)C2)c(C)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H18 compound treatment 0.9785 -0.0191 -0.37 -0.371 -1.0 2070242 Maybridge1_001404 Cc1nn(c2cccc(Cl)c2)c3oc(=O)cc(c13)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H19 compound treatment 0.9792 -0.0184 -0.36 -0.3578 -1.0 1030549 Maybridge1_001405 O=C1N(CC#N)S(=O)(=O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H20 compound treatment 0.9369 -0.0607 -1.18 -1.1794 -1.0 2070243 Maybridge1_001406 NS(=O)(=O)c1cc(Cl)sc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H21 compound treatment 0.9567 -0.0409 -0.8 -0.7951 -1.0 2070244 Maybridge1_001407 CCCC(=O)c1cc2cc(ccc2oc1=O)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H22 compound treatment 0.9799 -0.0177 -0.34 -0.3445 -1.0 2070245 Maybridge1_001408 COc1cccc(c1)C(=O)NNC(=O)c2ccccc2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H23 mock treatment 0.928 -0.0696 -1.35 -1.3516 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 H24 mock treatment 1.0235 0.0259 0.5 0.5036 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I01 compound treatment 1.0338 0.0362 0.7 0.7023 1.0 2070246 Maybridge1_001409 CS/C(=N/N=C/c1c(F)cccc1Cl)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I02 compound treatment 0.9901 -0.00751 -0.15 -0.1458 -1.0 2070247 Maybridge1_001410 CC(=O)C(C)(C)OC(=O)N1CCOCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I03 compound treatment 0.9744 -0.0232 -0.45 -0.4505 -1.0 1019766 Maybridge1_001411 CC(=O)Nc1ccc(C)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I04 compound treatment 0.9874 -0.0102 -0.2 -0.1988 -1.0 1658637 Maybridge1_001412 CC1CN(CC(C)O1)C(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I05 compound treatment 0.9649 -0.0328 -0.64 -0.6361 -1.0 2070248 Maybridge1_001413 Cc1cccc(Cl)c1Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I06 compound treatment 0.9806 -0.0171 -0.33 -0.3313 -1.0 1442310 Maybridge1_001414 Clc1ccc(cc1Cl)C(=O)CSC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I07 compound treatment 0.984 -0.0136 -0.27 -0.265 -1.0 2070249 Maybridge1_001415 COC(=O)c1sc2ccccc2c1OS(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I08 compound treatment 0.9567 -0.0409 -0.8 -0.7951 -1.0 2070250 Maybridge1_001416 Cc1nnc(NC(=O)c2nn(nc2C)c3ccccc3)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I09 compound treatment 1.0194 0.0218 0.42 0.424 1.0 2070251 Maybridge1_001417 Cc1cccc(C)c1Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I10 compound treatment 0.9853 -0.0123 -0.24 -0.2385 -1.0 1165063 Maybridge1_001418 Nc1nc(=O)c2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I11 compound treatment 0.9881 -0.00955 -0.19 -0.1855 -1.0 2070252 Maybridge1_001419 N/C(=N\OC(=O)c1cccs1)/CC(=O)Nc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I12 compound treatment 0.9417 -0.056 -1.09 -1.0866 -1.0 2070253 Maybridge1_001420 Cc1nnc(N/C=N/O)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I13 compound treatment 0.9717 -0.0259 -0.5 -0.5036 -1.0 2070254 Maybridge1_001421 NC(=O)NCc1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I14 compound treatment 0.9922 -0.00546 -0.11 -0.106 -1.0 2070255 Maybridge1_001422 Cc1onc(NC(=O)NC(=O)c2c(Cl)cccc2Cl)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I15 compound treatment 0.9771 -0.0205 -0.4 -0.3975 -1.0 2070256 Maybridge1_001423 CC(C)(C)c1ccc(Oc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I16 compound treatment 0.9812 -0.0164 -0.32 -0.318 -1.0 2070257 Maybridge1_001424 CN(C)/C=N/c1nnc(Sc2ncccc2[N+](=O)[O-])s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I17 compound treatment 0.9608 -0.0368 -0.72 -0.7156 -1.0 2070258 Maybridge1_001425 OCCNc1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I18 compound treatment 0.9355 -0.0621 -1.21 -1.2059 -1.0 1236124 Maybridge1_001426 S=C1NCN(CC2CC2)CN1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I19 compound treatment 0.9703 -0.0273 -0.53 -0.5301 -1.0 1158168 Maybridge1_001427 COC(=O)c1cc(OC)c(OC)c(OC)c1NC(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I20 compound treatment 0.9628 -0.0348 -0.68 -0.6758 -1.0 1229472 Maybridge1_001428 Cc1cc(c(Cl)cc1Cl)S(=O)(=O)Nc2ccccc2C(=O)NCC3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I21 compound treatment 0.9956 -0.00205 -0.04 -0.0398 -1.0 1694034 Maybridge1_001429 CN1C(NC(=O)c2ccccc12)c3cc(Br)cs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I22 compound treatment 0.9587 -0.0389 -0.76 -0.7553 -1.0 2070259 Maybridge1_001430 [O-][N+](=O)c1ccc(nc1)N2CCN(CC2)S(=O)(=O)c3ccc(F)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I23 mock treatment 0.9935 -0.00409 -0.08 -0.0795 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 I24 mock treatment 0.9717 -0.0259 -0.5 -0.5036 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J01 compound treatment 1.0556 0.058 1.13 1.1264 1.0 2070260 Maybridge1_001431 Nc1ccc(Cl)cc1C(=O)N2CCN(CC2)c3ccc(cn3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J02 compound treatment 0.969 -0.0287 -0.56 -0.5566 -1.0 2070261 Maybridge1_001432 Oc1cc(Sc2ccccc2)ccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J03 compound treatment 0.9614 -0.0362 -0.7 -0.7023 -1.0 2070262 Maybridge1_001433 Cc1nn(C)c2oc(=O)cc(c12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J04 compound treatment 0.973 -0.0246 -0.48 -0.477 -1.0 1021654 Maybridge1_001434 CC(=O)Nc1ccc(cc1C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J05 compound treatment 0.9519 -0.0457 -0.89 -0.8878 -1.0 2070263 Maybridge1_001435 CC1CCN(CC1)c2ccc([N+](=O)[O-])c(Oc3nc4c(Cl)cc(Cl)cc4s3)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J06 compound treatment 0.958 -0.0396 -0.77 -0.7686 -1.0 2070264 Maybridge1_001436 [O-][N+](=O)c1ccc(Oc2ccc(OCc3ccccc3)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J07 compound treatment 0.971 -0.0266 -0.52 -0.5168 -1.0 2070265 Maybridge1_001437 Clc1ccc(I)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J08 compound treatment 1.0133 0.0157 0.3 0.3048 1.0 1424245 Maybridge1_001438 Clc1ccc(cc1)C(=O)Nc2ccccc2C(=O)NC3CCCCNC3=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J09 compound treatment 0.9819 -0.0157 -0.3 -0.3048 -1.0 2070266 Maybridge1_001439 Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J10 compound treatment 0.9485 -0.0491 -0.95 -0.9541 -1.0 2070267 Maybridge1_001440 Cc1nn(nc1c2nnc(o2)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J11 compound treatment 1.001 0.00341 0.07 0.0663 1.0 2070268 Maybridge1_001441 Cc1ccc2cc(ccc2n1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J12 compound treatment 0.958 -0.0396 -0.77 -0.7686 -1.0 2070269 Maybridge1_001442 Clc1ccc(NC(=O)CC#N)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J13 compound treatment 0.941 -0.0566 -1.1 -1.0999 -1.0 1013980 Maybridge1_001443 OS(=O)(=O)c1cccc2cccc(Cl)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J14 compound treatment 0.971 -0.0266 -0.52 -0.5168 -1.0 2070270 Maybridge1_001444 O=C(CC#N)Nc1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J15 compound treatment 0.9744 -0.0232 -0.45 -0.4505 -1.0 2070271 Maybridge1_001445 CSc1ncccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J16 compound treatment 0.9785 -0.0191 -0.37 -0.371 -1.0 1160934 Maybridge1_001446 Clc1ccc(NC(=O)c2cnccn2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J17 compound treatment 0.9833 -0.0143 -0.28 -0.2783 -1.0 2070272 Maybridge1_001447 O=C1CC(=NN1)CSc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J18 compound treatment 0.9669 -0.0307 -0.6 -0.5963 -1.0 2070273 Maybridge1_001448 Cc1nn(c2ccccc2)c3oc(=O)cc(c13)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J19 compound treatment 0.9533 -0.0444 -0.86 -0.8613 -1.0 1234815 Maybridge1_001449 CCSc1ncccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J20 compound treatment 0.9696 -0.028 -0.54 -0.5433 -1.0 1422595 Maybridge1_001450 Fc1cccc(Cl)c1CN2c3ccccc3C(=O)CS2(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J21 compound treatment 0.9355 -0.0621 -1.21 -1.2059 -1.0 1531298 Maybridge1_001451 CCCC(=O)c1cc2cc(Br)cc(Br)c2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J22 compound treatment 1.0065 0.00887 0.17 0.1723 1.0 1487398 Maybridge1_001452 Fc1ccc(cc1F)C(=O)c2cc3ccccc3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J23 mock treatment 0.9601 -0.0375 -0.73 -0.7288 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 J24 mock treatment 0.9942 -0.00341 -0.07 -0.0663 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K01 compound treatment 1.0345 0.0368 0.72 0.7156 1.0 2070274 Maybridge1_001453 CS/C(=N/N=C/c1ccc(cc1)N(C)C)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K02 compound treatment 0.9533 -0.0444 -0.86 -0.8613 -1.0 2070275 Maybridge1_001454 Clc1ccc2[nH]c(nc(=O)c2c1)c3cc(Br)cs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K03 compound treatment 0.9894 -0.00819 -0.16 -0.159 -1.0 1143063 Maybridge1_001455 COc1ccc(Oc2cc(C)nc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K04 compound treatment 0.9642 -0.0334 -0.65 -0.6493 -1.0 2070276 Maybridge1_001456 O=C(CC#N)N1CCSCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K05 compound treatment 0.9642 -0.0334 -0.65 -0.6493 -1.0 1037135 Maybridge1_001457 Cc1cc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K06 compound treatment 0.9819 -0.0157 -0.3 -0.3048 -1.0 2070277 Maybridge1_001458 Cc1onc(NC(=O)c2ccc(o2)[N+](=O)[O-])c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K07 compound treatment 0.9614 -0.0362 -0.7 -0.7023 -1.0 2070278 Maybridge1_001459 COC(=O)c1sc2ccccc2c1OS(=O)(=O)c3ccc(OC)c(OC)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K08 compound treatment 0.9417 -0.056 -1.09 -1.0866 -1.0 1403130 Maybridge1_001460 CCc1nnc(NC(=O)c2nn(nc2C)c3ccccc3)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K09 compound treatment 0.9853 -0.0123 -0.24 -0.2385 -1.0 2070279 Maybridge1_001461 CSc1ccc(Oc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K10 compound treatment 0.9567 -0.0409 -0.8 -0.7951 -1.0 2070280 Maybridge1_001462 CC(=O)c1cc2cc(Br)ccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K11 compound treatment 0.9846 -0.013 -0.25 -0.2518 -1.0 2070281 Maybridge1_001463 COc1ccc(OC)c2nc3-c4ccccc4C(=O)c3nc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K12 compound treatment 0.958 -0.0396 -0.77 -0.7686 -1.0 1537115 Maybridge1_001464 Fc1ccc(NC(=O)Cc2nn[nH]n2)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K13 compound treatment 0.9901 -0.00751 -0.15 -0.1458 -1.0 2070282 Maybridge1_001465 CC(=O)C1=CN=C(SC1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K14 compound treatment 0.958 -0.0396 -0.77 -0.7686 -1.0 2070283 Maybridge1_001466 COC(=O)CS(=O)(=O)c1cc(C)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K15 compound treatment 1.001 0.00341 0.07 0.0663 1.0 1046920 Maybridge1_001467 COC(=O)c1cc(OC)c(OC)c(OC)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K16 compound treatment 0.969 -0.0287 -0.56 -0.5566 -1.0 2070284 Maybridge1_001468 CCc1ccc(cc1)c2ccc(OC(=O)c3c(Br)cc(cc3[N+](=O)[O-])C(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K17 compound treatment 1.0235 0.0259 0.5 0.5036 1.0 2070285 Maybridge1_001469 CC(C)(CO)Nc1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K18 compound treatment 0.9232 -0.0744 -1.44 -1.4444 -1.0 1162688 Maybridge1_001470 Fc1ccc(cc1Cl)S(=O)(=O)NCC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K19 compound treatment 0.9601 -0.0375 -0.73 -0.7288 -1.0 2070286 Maybridge1_001471 OC(=O)CSc1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K20 compound treatment 0.9703 -0.0273 -0.53 -0.5301 -1.0 2070287 Maybridge1_001472 COc1ccc([N+](=O)[O-])c(OC)c1C(=O)Nc2ccccc2C(=O)NCC3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K21 compound treatment 0.9485 -0.0491 -0.95 -0.9541 -1.0 1227697 Maybridge1_001473 Brc1csc(c1)C2NC(=O)c3ccccc3N2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K22 compound treatment 0.9765 -0.0212 -0.41 -0.4108 -1.0 2070288 Maybridge1_001474 [O-][N+](=O)c1ccc(nc1)N2CCN(CC2)S(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K23 mock treatment 0.9901 -0.00751 -0.15 -0.1458 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 K24 mock treatment 0.9962 -0.00136 -0.03 -0.0265 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L01 compound treatment 1.0426 0.045 0.87 0.8746 1.0 2070289 Maybridge1_001475 Nc1ccccc1C(=O)N2CCN(CC2)c3ccc(cn3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L02 compound treatment 1.0358 0.0382 0.74 0.7421 1.0 2070290 Maybridge1_001476 Cc1cc(Sc2ccc([N+](=O)[O-])c(O)c2)c(C)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L03 compound treatment 1.0024 0.00478 0.09 0.0928 1.0 1174018 Maybridge1_001477 Cc1nc2ccc(Cl)cc2c(O)c1I 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L04 compound treatment 0.9635 -0.0341 -0.66 -0.6626 -1.0 2070291 Maybridge1_001478 N#Cc1cccnc1Sc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L05 compound treatment 0.9683 -0.0293 -0.57 -0.5698 -1.0 2070292 Maybridge1_001479 Cc1cc(C)n(n1)c2ccc(Sc3ccccn3)nn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L06 compound treatment 0.9771 -0.0205 -0.4 -0.3975 -1.0 2070293 Maybridge1_001480 COc1cc(cc(Br)c1OS(=O)(=O)c2ccc(C)cc2)C3SCCS3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L07 compound treatment 1.0051 0.00751 0.15 0.1458 1.0 2070294 Maybridge1_001481 CN(C)/C=C/1\C(=NN(C1=O)c2ccccc2)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L08 compound treatment 1.0331 0.0355 0.69 0.6891 1.0 2070295 Maybridge1_001482 COc1cc(Sc2ccc(Cl)cc2)ccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L09 compound treatment 0.9976 4.19E-10 0.0 0.0 1.0 2070296 Maybridge1_001483 Fc1cccc(NC(=O)c2cccc(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L10 compound treatment 1.001 0.00341 0.07 0.0663 1.0 1412717 Maybridge1_001484 Fc1ccccc1NC(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L11 compound treatment 0.9533 -0.0444 -0.86 -0.8613 -1.0 2070297 Maybridge1_001485 Cc1cc(Sc2ncccc2[N+](=O)[O-])c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L12 compound treatment 0.9874 -0.0102 -0.2 -0.1988 -1.0 2070298 Maybridge1_001486 [O-][N+](=O)c1ccc(Oc2cc(ccc2[N+](=O)[O-])S(=O)(=O)c3ccccc3)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L13 compound treatment 0.986 -0.0116 -0.23 -0.2253 -1.0 2070299 Maybridge1_001487 Cc1cc(c(Cl)cc1Cl)S(=O)(=O)c2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L14 compound treatment 0.9935 -0.00409 -0.08 -0.0795 -1.0 1076266 Maybridge1_001488 Clc1ccc(NC(=O)c2cccnc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L15 compound treatment 0.9382 -0.0594 -1.15 -1.1529 -1.0 2070300 Maybridge1_001489 Cc1cc(c(C)cc1Cl)S(=O)(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L16 compound treatment 0.9956 -0.00205 -0.04 -0.0398 -1.0 2070301 Maybridge1_001490 Cc1ccc(Sc2ccc(cc2[N+](=O)[O-])C(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L17 compound treatment 0.984 -0.0136 -0.27 -0.265 -1.0 2070302 Maybridge1_001491 Clc1ccc(SCC2=NNC(=O)C2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L18 compound treatment 0.9683 -0.0293 -0.57 -0.5698 -1.0 1046560 Maybridge1_001492 COc1ccc(NC(=S)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L19 compound treatment 0.9744 -0.0232 -0.45 -0.4505 -1.0 2070303 Maybridge1_001493 CC(=O)CN1C(=O)c2ccccc2S1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L20 compound treatment 1.0222 0.0246 0.48 0.477 1.0 1450792 Maybridge1_001494 COC(=O)c1ccc(Cl)cc1N(Cc2ccccc2)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L21 compound treatment 0.9778 -0.0198 -0.38 -0.3843 -1.0 1377255 Maybridge1_001495 CCCC(=O)c1cc2cc(Br)ccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L22 compound treatment 0.9621 -0.0355 -0.69 -0.6891 -1.0 1230653 Maybridge1_001496 Clc1ccc2C(=O)CS(=O)(=O)N(Cc3ccccc3)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L23 mock treatment 0.9696 -0.028 -0.54 -0.5433 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 L24 mock treatment 1.0495 0.0519 1.01 1.0071 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M01 compound treatment 1.0044 0.00682 0.13 0.1325 1.0 2070304 Maybridge1_001497 CSC1=NC=C(C#N)C2=NC(NN21)c3ccc(cc3)N(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M02 compound treatment 0.9533 -0.0444 -0.86 -0.8613 -1.0 2070305 Maybridge1_001498 CC(=O)C(C)(C)OC(=O)NCCc1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M03 compound treatment 0.9806 -0.0171 -0.33 -0.3313 -1.0 2070306 Maybridge1_001499 [O-][N+](=O)c1cccc(Cl)c1Oc2ccc(cc2)c3ccc(Oc4c(Cl)cccc4[N+](=O)[O-])cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M04 compound treatment 0.9935 -0.00409 -0.08 -0.0795 -1.0 2070307 Maybridge1_001500 COC(=O)c1cc(OC)c(OC)c(OC)c1NS(=O)(=O)c2cc(OC)ccc2OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M05 compound treatment 0.971 -0.0266 -0.52 -0.5168 -1.0 2070308 Maybridge1_001501 COc1ccc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M06 compound treatment 0.9806 -0.0171 -0.33 -0.3313 -1.0 2070309 Maybridge1_001502 COc1ccccc1NC(=O)/C=N/O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M07 compound treatment 1.0106 0.013 0.25 0.2518 1.0 2070310 Maybridge1_001503 [O-][N+](=O)c1cc(ccc1Oc2ccc(F)cc2F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M08 compound treatment 0.9355 -0.0621 -1.21 -1.2059 -1.0 2070311 Maybridge1_001504 CSC1=NCCN1C(=O)c2nn(nc2C)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M09 compound treatment 0.9874 -0.0102 -0.2 -0.1988 -1.0 2070312 Maybridge1_001505 [O-][N+](=O)c1cc(ccc1Oc2ccc(cc2)c3ccccc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M10 compound treatment 0.9819 -0.0157 -0.3 -0.3048 -1.0 2070313 Maybridge1_001506 CN(C)/C=C(\C#N)/C(=O)Nc1ccc(C)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M11 compound treatment 0.969 -0.0287 -0.56 -0.5566 -1.0 1452789 Maybridge1_001507 Cc1ccc2nc3C(=O)c4ccccc4-c3nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M12 compound treatment 0.9492 -0.0484 -0.94 -0.9408 -1.0 1172166 Maybridge1_001508 Clc1cc(Cl)cc(NC(=O)Cc2nn[nH]n2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M13 compound treatment 1.0181 0.0205 0.4 0.3975 1.0 2070314 Maybridge1_001509 Nc1ccccc1C(=O)NNc2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M14 compound treatment 0.9553 -0.0423 -0.82 -0.8216 -1.0 2070315 Maybridge1_001510 COC(=O)CS(=O)(=O)c1cc(C)c(Cl)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M15 compound treatment 0.9594 -0.0382 -0.74 -0.7421 -1.0 2070316 Maybridge1_001511 Cc1onc(c1C(=O)Nc2ccccc2C(=O)NNc3c(Cl)cc(Cl)cc3Cl)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M16 compound treatment 0.9444 -0.0532 -1.03 -1.0336 -1.0 1284149 Maybridge1_001512 O=C(NCC1CC1)c2cccnc2Oc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M17 compound treatment 0.969 -0.0287 -0.56 -0.5566 -1.0 1482069 Maybridge1_001513 COc1cc(C(=O)O)c(NC(=O)C)c(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M18 compound treatment 0.9901 -0.00751 -0.15 -0.1458 -1.0 1148165 Maybridge1_001514 Cc1cc(c(Cl)cc1Cl)S(=O)(=O)NCC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M19 compound treatment 0.9655 -0.0321 -0.62 -0.6228 -1.0 2070317 Maybridge1_001515 COc1ccc(cc1)/C(=C/c2cc(Br)cs2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M20 compound treatment 0.9669 -0.0307 -0.6 -0.5963 -1.0 2070318 Maybridge1_001516 CN(C)/C=N/S(=O)(=O)c1cc(C)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M21 compound treatment 0.958 -0.0396 -0.77 -0.7686 -1.0 2070319 Maybridge1_001517 CCCCCC(=O)c1cc(C)c(C)cc1NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M22 compound treatment 0.9362 -0.0614 -1.19 -1.1926 -1.0 2070320 Maybridge1_001518 Cc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ccc(cn3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M23 mock treatment 1.074 0.0764 1.48 1.4842 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 M24 mock treatment 1.0194 0.0218 0.42 0.424 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N01 compound treatment 1.0229 0.0252 0.49 0.4903 1.0 2070321 Maybridge1_001519 Fc1cccc(Cl)c1CN(NC(=O)NC(=O)c2c(F)cccc2Cl)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N02 compound treatment 0.9717 -0.0259 -0.5 -0.5036 -1.0 2070322 Maybridge1_001520 Oc1cc(ccc1[N+](=O)[O-])S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N03 compound treatment 0.9997 0.00205 0.04 0.0398 1.0 2070323 Maybridge1_001521 Nc1nnc(Sc2ccc(cc2[N+](=O)[O-])C(F)(F)F)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N04 compound treatment 0.9922 -0.00546 -0.11 -0.106 -1.0 2070324 Maybridge1_001522 Clc1ccc(cc1Cl)C(=O)CN2CCSC2=N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N05 compound treatment 0.9587 -0.0389 -0.76 -0.7553 -1.0 2070325 Maybridge1_001523 N/C(=N\O)/CS(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N06 compound treatment 0.9901 -0.00751 -0.15 -0.1458 -1.0 2070326 Maybridge1_001524 CCc1nn2cc(nc2s1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N07 compound treatment 0.9567 -0.0409 -0.8 -0.7951 -1.0 2070327 Maybridge1_001525 CC/1=NN(C(=O)\C1=C\c2c(C)nn(c2O)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N08 compound treatment 0.9778 -0.0198 -0.38 -0.3843 -1.0 2070328 Maybridge1_001526 [O-][N+](=O)c1ccc(Sc2ccccc2)cc1OCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N09 compound treatment 0.9608 -0.0368 -0.72 -0.7156 -1.0 1037692 Maybridge1_001527 O=C1CC(=NN1c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N10 compound treatment 0.9881 -0.00955 -0.19 -0.1855 -1.0 2070329 Maybridge1_001528 CCCc1nn(C)c(O)c1C(=O)c2cc3ccccc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N11 compound treatment 0.9655 -0.0321 -0.62 -0.6228 -1.0 2070330 Maybridge1_001529 Cc1cc(Sc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N12 compound treatment 1.0092 0.0116 0.23 0.2253 1.0 2070331 Maybridge1_001530 CCOC(=O)C(NC(=O)c1nn(nc1C)c2ccccc2)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N13 compound treatment 0.9403 -0.0573 -1.11 -1.1131 -1.0 2070332 Maybridge1_001531 Clc1ccc(NC(=O)CC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N14 compound treatment 0.9901 -0.00751 -0.15 -0.1458 -1.0 1633510 Maybridge1_001532 Clc1ccc(NC(=O)c2cccnc2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N15 compound treatment 0.9853 -0.0123 -0.24 -0.2385 -1.0 2070333 Maybridge1_001533 N/C(=N\OS(=O)(=O)c1ccc(Cl)cc1)/c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N16 compound treatment 0.9594 -0.0382 -0.74 -0.7421 -1.0 2070334 Maybridge1_001534 Cc1cc(Sc2ccc(cc2[N+](=O)[O-])C(=O)O)c(C)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N17 compound treatment 0.9819 -0.0157 -0.3 -0.3048 -1.0 2070335 Maybridge1_001535 CN(C)/C=C\1/C(=O)NN=C1CSc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N18 compound treatment 1.0208 0.0232 0.45 0.4505 1.0 2070336 Maybridge1_001536 Clc1ccc(cc1)c2nnnn2c3cnccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N19 compound treatment 1.0031 0.00546 0.11 0.106 1.0 2070337 Maybridge1_001537 CN(C)/C=C\1/C(=O)NN=C1CSc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N20 compound treatment 0.9765 -0.0212 -0.41 -0.4108 -1.0 2070338 Maybridge1_001538 COc1ccc(Br)c(c1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N21 compound treatment 0.9949 -0.00273 -0.05 -0.053 -1.0 2070339 Maybridge1_001539 CCCC(=O)c1cc2ccccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N22 compound treatment 0.984 -0.0136 -0.27 -0.265 -1.0 2070340 Maybridge1_001540 [O-][N+](=O)c1ccccc1C(=O)NNC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N23 mock treatment 0.9792 -0.0184 -0.36 -0.3578 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 N24 mock treatment 0.9976 4.19E-10 0.0 0.0 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O01 compound treatment 0.9983 6.82E-4 0.01 0.0133 1.0 2070341 Maybridge1_001541 CS/C(=N/N=C/c1c(F)cccc1Cl)/N=C/N(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O02 compound treatment 0.9662 -0.0314 -0.61 -0.6096 -1.0 2070342 Maybridge1_001542 COc1ccc(CCNC(=O)OC(C)(C)C(=O)C)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O03 compound treatment 0.9956 -0.00205 -0.04 -0.0398 -1.0 2070343 Maybridge1_001543 Cc1ccc(N(CC=C)C2=NC(C)(C)C(=C)S2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O04 compound treatment 1.0051 0.00751 0.15 0.1458 1.0 2070344 Maybridge1_001544 CC(C)(C)SCCNc1nc(Oc2ccc(Cl)cc2)nc(Oc3ccc(Cl)cc3)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O05 compound treatment 0.9894 -0.00819 -0.16 -0.159 -1.0 2070345 Maybridge1_001545 COC(=O)c1sc2ccccc2c1OS(=O)(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O06 compound treatment 1.0044 0.00682 0.13 0.1325 1.0 2070346 Maybridge1_001546 OCCCCCNc1ccc(cn1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O07 compound treatment 0.9724 -0.0252 -0.49 -0.4903 -1.0 2070347 Maybridge1_001547 CSc1ncc(C#N)c2nc(nn12)c3ccc(cc3)N(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O08 compound treatment 0.9737 -0.0239 -0.46 -0.4638 -1.0 2070348 Maybridge1_001548 CSC1=NCCCN1C(=O)c2nn(nc2C)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O09 compound treatment 0.9928 -0.00478 -0.09 -0.0928 -1.0 1555636 Maybridge1_001549 Clc1ccc(cc1)S(=O)(=O)Nc2ccc3oc4ncccc4c(=O)c3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O10 compound treatment 0.9492 -0.0484 -0.94 -0.9408 -1.0 2070349 Maybridge1_001550 Cc1cc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)n(n1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O11 compound treatment 0.984 -0.0136 -0.27 -0.265 -1.0 2070350 Maybridge1_001551 CCOC(=O)/C(=C/Nc1ccc2oc3ncccc3c(=O)c2c1)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O12 compound treatment 0.9533 -0.0444 -0.86 -0.8613 -1.0 2070351 Maybridge1_001552 COC(=O)CSc1cc(C)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O13 compound treatment 0.9485 -0.0491 -0.95 -0.9541 -1.0 2070352 Maybridge1_001553 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1Oc2ccc(F)cc2F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O14 compound treatment 0.9594 -0.0382 -0.74 -0.7421 -1.0 2070353 Maybridge1_001554 [O-][N+](=O)c1cc(ccc1SCC(=O)Nc2ccc(F)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O15 compound treatment 0.9928 -0.00478 -0.09 -0.0928 -1.0 1047215 Maybridge1_001555 COc1cc(C(=O)O)c(N)c(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O16 compound treatment 0.9614 -0.0362 -0.7 -0.7023 -1.0 1739779 Maybridge1_001556 Fc1ccccc1C(=O)NC(=O)NCC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O17 compound treatment 0.9655 -0.0321 -0.62 -0.6228 -1.0 2070354 Maybridge1_001557 [O-][N+](=O)c1ccc(o1)c2nc3ccccc3c(=O)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O18 compound treatment 0.9833 -0.0143 -0.28 -0.2783 -1.0 1274234 Maybridge1_001558 Cc1cc(c(Cl)cc1Cl)S(=O)(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O19 compound treatment 0.9669 -0.0307 -0.6 -0.5963 -1.0 2070355 Maybridge1_001559 Fc1ccc(NC(=O)/C(=C/c2cc(Br)cs2)/C#N)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O20 compound treatment 0.913 -0.0846 -1.64 -1.6432 -1.0 1128554 Maybridge1_001560 Cc1nn(nc1C(=O)NC(=O)N2CCCC2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O21 compound treatment 1.0426 0.045 0.87 0.8746 1.0 2070356 Maybridge1_001561 Fc1ccc(cc1Cl)S(=O)(=O)NC(=N)CSc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O22 compound treatment 0.9614 -0.0362 -0.7 -0.7023 -1.0 2070357 Maybridge1_001562 COC(=O)c1sccc1OC(=O)c2cccnc2Oc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O23 mock treatment 1.0058 0.00819 0.16 0.159 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 O24 mock treatment 1.044 0.0464 0.9 0.9011 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P01 compound treatment 1.0058 0.00819 0.16 0.159 1.0 2070358 Maybridge1_001563 Fc1cccc(Cl)c1CN(NC(=O)C(Cl)(Cl)Cl)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P02 compound treatment 1.0276 0.03 0.58 0.5831 1.0 1489801 Maybridge1_001564 CSc1ncccc1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P03 compound treatment 0.9819 -0.0157 -0.3 -0.3048 -1.0 2070359 Maybridge1_001565 Nc1nnc(Sc2nc3c(Cl)cc(Cl)cc3s2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P04 compound treatment 1.0208 0.0232 0.45 0.4505 1.0 2070360 Maybridge1_001566 Cc1cc(c(C)cc1Cl)S(=O)(=O)Oc2ccc(OCc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P05 compound treatment 0.9771 -0.0205 -0.4 -0.3975 -1.0 1602461 Maybridge1_001567 Cc1ccc2nc3sc4ccc(Cl)cc4n3c(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P06 compound treatment 0.9765 -0.0212 -0.41 -0.4108 -1.0 2070361 Maybridge1_001568 CC(C)(C)c1cn2nc(sc2n1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P07 compound treatment 0.9546 -0.043 -0.83 -0.8348 -1.0 2070362 Maybridge1_001569 CN(C)/C=C/1\C(=NN(C)C1=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P08 compound treatment 0.9846 -0.013 -0.25 -0.2518 -1.0 2070363 Maybridge1_001570 Cc1nn(nc1C(=O)NNC(=O)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P09 compound treatment 1.1198 0.122 2.37 2.372 1.0 2070364 Maybridge1_001571 Cc1n[nH]c2oc(=O)c([N+](=O)[O-])c(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P10 compound treatment 0.9956 -0.00205 -0.04 -0.0398 -1.0 2070365 Maybridge1_001572 Clc1cccc(NC(=O)CC#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P11 compound treatment 0.984 -0.0136 -0.27 -0.265 -1.0 2070366 Maybridge1_001573 Cc1cc(Sc2ccc(cc2[N+](=O)[O-])C(F)(F)F)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P12 compound treatment 0.986 -0.0116 -0.23 -0.2253 -1.0 2070367 Maybridge1_001574 CCOC(=O)C(NC(=O)c1cc2ccccc2s1)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P13 compound treatment 0.9826 -0.015 -0.29 -0.2915 -1.0 1008534 Maybridge1_001575 O=C(CC#N)Nc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P14 compound treatment 1.1436 0.146 2.84 2.8358 1.0 1518071 Maybridge1_001576 CCCC1=NN(C(=O)C1)c2ccc(cc2)S(=O)(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P15 compound treatment 0.9655 -0.0321 -0.62 -0.6228 -1.0 2070368 Maybridge1_001577 Cc1ccc(cc1)S(=O)(=O)O/N=C(\N)/c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P16 compound treatment 1.0147 0.0171 0.33 0.3313 1.0 2070369 Maybridge1_001578 Cc1ccc(cc1)S(=O)(=O)c2ccc(cc2[N+](=O)[O-])C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P17 compound treatment 0.9567 -0.0409 -0.8 -0.7951 -1.0 1484466 Maybridge1_001579 CCCSc1ncccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P18 compound treatment 1.0017 0.00409 0.08 0.0795 1.0 2070370 Maybridge1_001580 Cc1cc(=O)oc2n(nc(c12)C(F)(F)F)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P19 compound treatment 0.9403 -0.0573 -1.11 -1.1131 -1.0 2070371 Maybridge1_001581 CN(C)/C=C\1/C(=O)NN=C1CSc2cc(C)c(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P20 compound treatment 1.0092 0.0116 0.23 0.2253 1.0 2070372 Maybridge1_001582 CC(C)(C)c1ccc(cc1)C(=O)NNC(=O)c2ccccc2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P21 compound treatment 0.9901 -0.00751 -0.15 -0.1458 -1.0 1740892 Maybridge1_001583 CCCc1cc(=O)oc2n(nc(C)c12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P22 compound treatment 1.0065 0.00887 0.17 0.1723 1.0 2070373 Maybridge1_001584 CC(C)(C)c1ccc(cc1)C(=O)NNC(=O)c2ccccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P23 mock treatment 0.9874 -0.0102 -0.2 -0.1988 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.545 P24 mock treatment 1.0181 0.0205 0.4 0.3975 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A01 compound treatment 1.0403 0.0403 0.78 0.7836 1.0 2070374 Maybridge1_001585 CC(C)(C)c1ccc(cc1)c2nnc(o2)c3ccccc3[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A02 compound treatment 0.9872 -0.0128 -0.25 -0.2476 -1.0 2070375 Maybridge1_001586 Cc1ccc(OS(=O)(=O)c2ccc(Cl)cc2)c(n1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A03 compound treatment 1.0124 0.0124 0.24 0.2408 1.0 2070376 Maybridge1_001587 Nc1ccccc1c2nnc(o2)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A04 compound treatment 0.9977 -0.00227 -0.04 -0.0441 -1.0 2070377 Maybridge1_001588 CC(=O)Nc1ccc(cc1Br)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A05 compound treatment 1.011 0.011 0.21 0.2137 1.0 2070378 Maybridge1_001589 FC(F)(F)C1=NNC(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A06 compound treatment 0.99 -0.00996 -0.19 -0.1934 -1.0 2070379 Maybridge1_001590 CC(C)(C)c1ccc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A07 compound treatment 1.1088 0.109 2.11 2.1133 1.0 1036891 Maybridge1_001591 CC(C)(C)C1=NN(C(=O)C1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A08 compound treatment 0.9376 -0.0624 -1.21 -1.211 -1.0 2070380 Maybridge1_001592 COc1ccc(Br)cc1S(=O)(=O)Oc2c(Cl)cc(cc2Br)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A09 compound treatment 0.9677 -0.0323 -0.63 -0.6275 -1.0 2070381 Maybridge1_001593 Clc1ccc(cc1)S(=O)(=O)Oc2ccc(CC#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A10 compound treatment 1.0019 0.00192 0.04 0.0373 1.0 2070382 Maybridge1_001594 NC(=O)c1sc2ccccc2c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A11 compound treatment 0.9537 -0.0463 -0.9 -0.8989 -1.0 2070383 Maybridge1_001595 C/C(=N\OC(=O)c1ccc(Cl)cc1)/c2ccn(c2)S(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A12 compound treatment 0.96 -0.04 -0.78 -0.7768 -1.0 1169386 Maybridge1_001596 COc1ccc(Br)c(OC)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A13 compound treatment 0.9628 -0.0372 -0.72 -0.7225 -1.0 2070384 Maybridge1_001597 [O-][N+](=O)c1ccc(Sc2cc(Cl)ccc2Cl)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A14 compound treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 2070385 Maybridge1_001598 COc1c(Cl)cc([N+](=O)[O-])c(OC)c1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A15 compound treatment 1.011 0.011 0.21 0.2137 1.0 2070386 Maybridge1_001599 C/C(=N\OC(=O)c1cc2ccccc2s1)/c3cc[nH]c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A16 compound treatment 0.9782 -0.0218 -0.42 -0.424 -1.0 2070387 Maybridge1_001600 [O-][N+](=O)c1ccc2ncccc2c1n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A17 compound treatment 0.9733 -0.0267 -0.52 -0.519 -1.0 1262589 Maybridge1_001601 Cc1cc(Oc2ccc(N)cn2)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A18 compound treatment 0.9558 -0.0442 -0.86 -0.8582 -1.0 2070388 Maybridge1_001602 Clc1ccc(cc1)C(=O)CSC(=S)NNc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A19 compound treatment 1.004 0.00402 0.08 0.078 1.0 2070389 Maybridge1_001603 C/C(=N\N=C(/N)\SCc1ccc(Cl)cc1Cl)/c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A20 compound treatment 1.0103 0.0103 0.2 0.2001 1.0 2070390 Maybridge1_001604 CCOC(=O)N1CCCN=C1SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A21 compound treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 2070391 Maybridge1_001605 Cc1ccc(OCc2ccc(Cl)c(Cl)c2)c(n1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A22 compound treatment 0.9817 -0.0183 -0.36 -0.3562 -1.0 2070392 Maybridge1_001606 CN(C)/C=N/c1n[nH]c(Sc2ccc(cc2[N+](=O)[O-])C(F)(F)F)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A23 mock treatment 1.0194 0.0194 0.38 0.3765 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 A24 mock treatment 1.0033 0.00332 0.06 0.0645 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B01 compound treatment 1.0222 0.0222 0.43 0.4308 1.0 2070393 Maybridge1_001607 CN(C)Cc1ccc(CSCCNC(=O)Nc2ccc(Cl)cc2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B02 compound treatment 1.0103 0.0103 0.2 0.2001 1.0 2070394 Maybridge1_001608 O=C(NNc1ccccc1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B03 compound treatment 0.9607 -0.0393 -0.76 -0.7632 -1.0 1389651 Maybridge1_001609 O=S(=O)(NCc1cccnc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B04 compound treatment 0.9768 -0.0232 -0.45 -0.4512 -1.0 1135267 Maybridge1_001610 COc1ccc(OC)c(CNC(=O)Cc2cccs2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B05 compound treatment 1.0501 0.0501 0.97 0.9735 1.0 2070395 Maybridge1_001611 COc1ccc(/C=C/2\C(=NN(C2=O)c3ccccc3)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B06 compound treatment 0.9656 -0.0344 -0.67 -0.6682 -1.0 1245092 Maybridge1_001612 COC(=O)CNC(=O)c1cccnc1Oc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B07 compound treatment 0.9956 -0.00437 -0.08 -0.0848 -1.0 1583698 Maybridge1_001613 COc1ccccc1N2CC(C)(C)C(=O)NC2=S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B08 compound treatment 0.9991 -8.73E-4 -0.02 -0.017 -1.0 2070396 Maybridge1_001614 CCOC(=O)CNC(=O)c1cccnc1Oc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B09 compound treatment 1.004 0.00402 0.08 0.078 1.0 2070397 Maybridge1_001615 CCOC(=O)N1CCCN=C1NNc2cc(Cl)ccc2OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B10 compound treatment 0.9307 -0.0693 -1.35 -1.3467 -1.0 2070398 Maybridge1_001616 CCOC(=O)CNC(=O)c1cc(ccc1Oc2ccc(OC)cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B11 compound treatment 0.9789 -0.0211 -0.41 -0.4104 -1.0 2070399 Maybridge1_001617 Cc1cc(cc(C)c1OC(=O)Nc2ccc(OC(F)(F)F)cc2)c3nn(C)c(=O)c4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B12 compound treatment 1.2087 0.209 4.05 4.0536 1.0 2070400 Maybridge1_001618 CCOC(=O)c1nn(c2ccc(Cl)cc2)c(=N)c(C#N)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B13 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 2070401 Maybridge1_001619 COc1ccc(Oc2ccc(NC(=O)Nc3ccc(SC(F)(F)F)cc3)cn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B14 compound treatment 0.9656 -0.0344 -0.67 -0.6682 -1.0 2070402 Maybridge1_001620 Clc1cccc(c1)C(=O)OCCSc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B15 compound treatment 0.9544 -0.0456 -0.89 -0.8853 -1.0 2070403 Maybridge1_001621 Cc1ccc(SCC(=O)Nc2ccc(F)c(F)c2F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B16 compound treatment 0.9544 -0.0456 -0.89 -0.8853 -1.0 2070404 Maybridge1_001622 Cc1n[nH]c(=O)c2noc(/C=C/c3ccsc3)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B17 compound treatment 0.9677 -0.0323 -0.63 -0.6275 -1.0 2070405 Maybridge1_001623 COC(=O)c1ccc(Cl)cc1NS(=O)(=O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B18 compound treatment 0.9921 -0.00786 -0.15 -0.1526 -1.0 2070406 Maybridge1_001624 COc1cc(OC)c([N+](=O)[O-])c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B19 compound treatment 0.9705 -0.0295 -0.57 -0.5733 -1.0 2070407 Maybridge1_001625 COC(=O)c1ccc(Cl)cc1N(CCCC#N)S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B20 compound treatment 1.0047 0.00472 0.09 0.0916 1.0 1008366 Maybridge1_001626 [O-][N+](=O)c1ccc(NN=C2CCCCC2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B21 compound treatment 0.9558 -0.0442 -0.86 -0.8582 -1.0 2070408 Maybridge1_001627 Cc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2NS(=O)(=O)c3ccc(C)cc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B22 compound treatment 0.9879 -0.0121 -0.23 -0.2341 -1.0 2070409 Maybridge1_001628 Cn1nc(O)cc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B23 mock treatment 0.9565 -0.0435 -0.84 -0.8446 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 B24 mock treatment 1.0543 0.0543 1.05 1.0549 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C01 compound treatment 1.0285 0.0285 0.55 0.5529 1.0 2070410 Maybridge1_001629 [O-][N+](=O)c1ccccc1c2nnc(o2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C02 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 1438164 Maybridge1_001630 COc1ccc(COc2ccc(CC#N)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C03 compound treatment 0.9914 -0.00856 -0.17 -0.1662 -1.0 1286595 Maybridge1_001631 OC(=O)CCC(=O)Nc1ccccc1c2nnc(o2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C04 compound treatment 0.9789 -0.0211 -0.41 -0.4104 -1.0 2070411 Maybridge1_001632 Clc1cncc(OS(=O)(=O)c2cc(Cl)cc(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C05 compound treatment 1.0201 0.0201 0.39 0.3901 1.0 2070412 Maybridge1_001633 Fc1ccc(cc1F)c2cn(c3ccccc3)c(=Nc4ccccc4)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C06 compound treatment 0.9558 -0.0442 -0.86 -0.8582 -1.0 2070413 Maybridge1_001634 CC(C)(C)c1ccc(Oc2ccc(cn2)[N+](=O)[O-])c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C07 compound treatment 1.0208 0.0208 0.4 0.4037 1.0 1503866 Maybridge1_001635 Cc1onc(c1C(=O)Oc2ccc(CC#N)cc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C08 compound treatment 1.0131 0.0131 0.25 0.2544 1.0 2070414 Maybridge1_001636 CC(C)(C)c1cc(Cl)c(OS(=O)(=O)c2cc(Cl)cc(Cl)c2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C09 compound treatment 0.9803 -0.0197 -0.38 -0.3833 -1.0 2070415 Maybridge1_001637 Cc1ccc(cc1)S(=O)(=O)Oc2ccc(CC#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C10 compound treatment 0.9502 -0.0498 -0.97 -0.9668 -1.0 2070416 Maybridge1_001638 [O-][N+](=O)c1cccnc1NCc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C11 compound treatment 0.9768 -0.0232 -0.45 -0.4512 -1.0 2070417 Maybridge1_001639 C/C(=N\OC(=O)c1ccc(cc1)C(F)(F)F)/c2ccn(c2)S(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C12 compound treatment 1.0026 0.00262 0.05 0.0509 1.0 1478654 Maybridge1_001640 COc1ccc(Br)c(OC)c1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C13 compound treatment 1.0047 0.00472 0.09 0.0916 1.0 2070418 Maybridge1_001641 CC(=O)c1cccn1S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C14 compound treatment 0.9845 -0.0155 -0.3 -0.3019 -1.0 2070419 Maybridge1_001642 Nc1nnc(SCC#N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C15 compound treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 1565189 Maybridge1_001643 CC(C)Oc1ccccc1Oc2ccc(N)cn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C16 compound treatment 0.946 -0.054 -1.05 -1.0482 -1.0 2070420 Maybridge1_001644 CCOC(=O)CC(=O)CSc1nnc(NC(=O)c2c(F)cccc2F)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C17 compound treatment 0.9879 -0.0121 -0.23 -0.2341 -1.0 1225421 Maybridge1_001645 CC(C)c1cc(Oc2ccc(N)cn2)cc(c1)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C18 compound treatment 0.9509 -0.0491 -0.95 -0.9532 -1.0 2070421 Maybridge1_001646 [O-][N+](=O)c1cccc(c1)c2csc(=S)n2N(C(=O)c3ccc(cc3)C(F)(F)F)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C19 compound treatment 0.9879 -0.0121 -0.23 -0.2341 -1.0 2070422 Maybridge1_001647 CCO/N=C(\C)/c1ccc(C)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C20 compound treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 2070423 Maybridge1_001648 Cn1cc(C(=O)Nc2ccc(F)c(F)c2F)c(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C21 compound treatment 0.9824 -0.0176 -0.34 -0.3426 -1.0 1781058 Maybridge1_001649 Cc1cccc(NC(=O)c2ccc(Cl)cc2[N+](=O)[O-])n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C22 compound treatment 0.9782 -0.0218 -0.42 -0.424 -1.0 2070424 Maybridge1_001650 [O-][N+](=O)c1cccnc1Oc2ccc(F)cc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C23 mock treatment 0.9621 -0.0379 -0.74 -0.7361 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 C24 mock treatment 0.9824 -0.0176 -0.34 -0.3426 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D01 compound treatment 1.0082 0.00821 0.16 0.1594 1.0 2070425 Maybridge1_001651 Nc1cccnc1Oc2ccccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D02 compound treatment 1.0131 0.0131 0.25 0.2544 1.0 1679983 Maybridge1_001652 Cc1ccc(cc1)S(=O)(=O)Nc2ccc(C)cc2NS(=O)(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D03 compound treatment 0.9998 -1.75E-4 0.0 -0.0034 -1.0 1304103 Maybridge1_001653 Clc1ccc(CNS(=O)(=O)c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D04 compound treatment 1.0054 0.00541 0.11 0.1052 1.0 2070426 Maybridge1_001654 CN(C)/C=N/c1cc(C)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D05 compound treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 2070427 Maybridge1_001655 [O-][N+](=O)c1ccc(Sc2ccccc2)c(C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D06 compound treatment 0.9551 -0.0449 -0.87 -0.8718 -1.0 1575755 Maybridge1_001656 COc1ccc(SCC(=O)O)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D07 compound treatment 1.0187 0.0187 0.36 0.363 1.0 1662175 Maybridge1_001657 COc1ccc(cc1)n2c(=S)[nH]c(=O)c3cccnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D08 compound treatment 0.9789 -0.0211 -0.41 -0.4104 -1.0 1709190 Maybridge1_001658 Cc1ccc(cc1)S(=O)(=O)N(CC=C)c2ccccc2C(=O)NCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D09 compound treatment 0.9963 -0.00367 -0.07 -0.0712 -1.0 2070428 Maybridge1_001659 COc1ccccc1N2CC(C)(C)C(=O)N=C2Sc3ccc(cc3[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D10 compound treatment 0.9956 -0.00437 -0.08 -0.0848 -1.0 2070429 Maybridge1_001660 COc1ccc(Oc2ccc(cc2C(=O)NCC(=O)O)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D11 compound treatment 1.0187 0.0187 0.36 0.363 1.0 2070430 Maybridge1_001661 Nc1nnc(Sc2cc3C(=O)NC(=O)c3cc2[N+](=O)[O-])s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D12 compound treatment 0.9621 -0.0379 -0.74 -0.7361 -1.0 2070431 Maybridge1_001662 CC(C)(C)OC(=O)C(C)(C)Sc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D13 compound treatment 1.0145 0.0145 0.28 0.2815 1.0 2070432 Maybridge1_001663 Cc1ccc(N/C=C(\C#N)/c2nc3ccccc3[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D14 compound treatment 0.9907 -0.00926 -0.18 -0.1798 -1.0 1038633 Maybridge1_001664 Cc1ccc(cc1)S(=O)(=O)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D15 compound treatment 1.0005 5.24E-4 0.01 0.0102 1.0 2070433 Maybridge1_001665 Fc1ccc(NC(=O)CSc2ccccc2)c(F)c1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D16 compound treatment 1.0019 0.00192 0.04 0.0373 1.0 1513571 Maybridge1_001666 Cc1nn(C)c(=O)c(N)c1c2cc([nH]n2)c3ccsc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D17 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 2070434 Maybridge1_001667 S=c1nc2sccn2c3ncccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D18 compound treatment 0.9831 -0.0169 -0.33 -0.329 -1.0 1025893 Maybridge1_001668 [O-][N+](=O)c1cccc(c1)C(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D19 compound treatment 0.9705 -0.0295 -0.57 -0.5733 -1.0 2070435 Maybridge1_001669 [O-][N+](=O)c1ccc(cc1)N2N=C(CCC2=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D20 compound treatment 0.9991 -8.73E-4 -0.02 -0.017 -1.0 1500830 Maybridge1_001670 CC(C)(Oc1ccc(cc1)C(=O)N)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D21 compound treatment 0.9761 -0.0239 -0.46 -0.4647 -1.0 2070436 Maybridge1_001671 OC1=C(CCN(c2ccccc12)S(=O)(=O)c3ccc(Cl)cc3)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D22 compound treatment 0.9726 -0.0274 -0.53 -0.5326 -1.0 2070437 Maybridge1_001672 Nc1ccc(Oc2cc(ccc2Cl)C(F)(F)F)cc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D23 mock treatment 0.9726 -0.0274 -0.53 -0.5326 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 D24 mock treatment 1.0124 0.0124 0.24 0.2408 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E01 compound treatment 1.0124 0.0124 0.24 0.2408 1.0 2070438 Maybridge1_001673 CC(C)(C)c1ccc(cc1)c2nnc(o2)c3ccccc3NC(=O)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E02 compound treatment 0.9726 -0.0274 -0.53 -0.5326 -1.0 2070439 Maybridge1_001674 [O-][N+](=O)c1ccc(Oc2ccc(CC#N)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E03 compound treatment 0.9991 -8.73E-4 -0.02 -0.017 -1.0 2070440 Maybridge1_001675 COc1ccc(Br)c(c1)c2nnc(o2)c3ccccc3NC(=O)NC(=O)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E04 compound treatment 0.9886 -0.0114 -0.22 -0.2205 -1.0 1006390 Maybridge1_001676 S=C(Nc1ccccc1)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E05 compound treatment 0.9845 -0.0155 -0.3 -0.3019 -1.0 2070441 Maybridge1_001677 Fc1ccc(cc1F)c2csc(n2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E06 compound treatment 0.9579 -0.0421 -0.82 -0.8175 -1.0 2070442 Maybridge1_001678 COc1ccc([N+](=O)[O-])c(OC)c1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E07 compound treatment 0.9558 -0.0442 -0.86 -0.8582 -1.0 2070443 Maybridge1_001679 Cc1onc(c1C(=O)Nc2ccc(F)c(Cl)c2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E08 compound treatment 0.9698 -0.0302 -0.59 -0.5868 -1.0 1110266 Maybridge1_001680 CNc1ccccc1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E09 compound treatment 0.9558 -0.0442 -0.86 -0.8582 -1.0 2070444 Maybridge1_001681 Clc1cc(Cl)cc(c1)S(=O)(=O)Oc2ccc(CC#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E10 compound treatment 0.9656 -0.0344 -0.67 -0.6682 -1.0 2070445 Maybridge1_001682 [O-][N+](=O)c1cccnc1NCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E11 compound treatment 0.9607 -0.0393 -0.76 -0.7632 -1.0 2070446 Maybridge1_001683 C/C(=N\O)/c1ccn(c1)S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E12 compound treatment 0.939 -0.061 -1.18 -1.1839 -1.0 1178220 Maybridge1_001684 COc1ccc(Cl)c(OC)c1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E13 compound treatment 0.9411 -0.0589 -1.14 -1.1431 -1.0 2070447 Maybridge1_001685 Nc1ccc(Sc2cc(Cl)ccc2Cl)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E14 compound treatment 0.9935 -0.00646 -0.13 -0.1255 -1.0 1323451 Maybridge1_001686 COc1c(Cl)cc(Br)c(OC)c1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E15 compound treatment 1.0054 0.00541 0.11 0.1052 1.0 2070448 Maybridge1_001687 C/C(=N\O)/c1ccc(C)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E16 compound treatment 0.8056 -0.194 -3.78 -3.7754 -1.0 2070449 Maybridge1_001688 COC(=O)c1c(OC)ccc(N/C=N/O)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E17 compound treatment 1.0026 0.00262 0.05 0.0509 1.0 2070450 Maybridge1_001689 COc1ccc(Oc2ccc(N)cn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E18 compound treatment 0.9726 -0.0274 -0.53 -0.5326 -1.0 2070451 Maybridge1_001690 CCOC(CN(c1ccc(F)cc1)S(=O)(=O)c2cc(Cl)cc(Cl)c2)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E19 compound treatment 0.9984 -0.00157 -0.03 -0.0305 -1.0 2070452 Maybridge1_001691 OCCNc1ccc(NCCO)nn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E20 compound treatment 0.9286 -0.0714 -1.39 -1.3874 -1.0 1098980 Maybridge1_001692 COC(=O)c1ccncc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E21 compound treatment 0.9977 -0.00227 -0.04 -0.0441 -1.0 1078393 Maybridge1_001693 Nc1ncc(Br)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E22 compound treatment 0.9446 -0.0554 -1.08 -1.0753 -1.0 2070453 Maybridge1_001694 [O-][N+](=O)c1cccnc1Oc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E23 mock treatment 1.0138 0.0138 0.27 0.268 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 E24 mock treatment 1.0005 5.24E-4 0.01 0.0102 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F01 compound treatment 1.0369 0.0369 0.72 0.7157 1.0 2070454 Maybridge1_001695 OC(=O)CSc1ccc(cn1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F02 compound treatment 1.0222 0.0222 0.43 0.4308 1.0 2070455 Maybridge1_001696 CC(C)(C)c1ccc(cc1)C(=O)NNC(=O)c2cc(cc(c2)C(C)(C)C)C(=O)NNC(=O)c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F03 compound treatment 1.0026 0.00262 0.05 0.0509 1.0 2070456 Maybridge1_001697 CS(=O)(=O)NCc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F04 compound treatment 0.9663 -0.0337 -0.65 -0.6547 -1.0 1918990 Maybridge1_001698 c1csc(c1)c2cnc3ccccc3n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F05 compound treatment 0.9956 -0.00437 -0.08 -0.0848 -1.0 2070457 Maybridge1_001699 [O-][N+](=O)c1ccc(Sc2ccc(Cl)cc2)c(C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F06 compound treatment 0.9859 -0.0141 -0.27 -0.2748 -1.0 1570677 Maybridge1_001700 OC(=O)c1cccnc1Oc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F07 compound treatment 1.0026 0.00262 0.05 0.0509 1.0 1524701 Maybridge1_001701 Brc1ccc(cc1)n2c(=S)[nH]c(=O)c3cccnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F08 compound treatment 0.9474 -0.0526 -1.02 -1.021 -1.0 1346644 Maybridge1_001702 Cc1ccc(Sc2ncccc2C(=O)NCC(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F09 compound treatment 0.9879 -0.0121 -0.23 -0.2341 -1.0 2070458 Maybridge1_001703 COc1ccccc1N2CC(C)(C)C(=O)N(C(=O)c3c(F)cccc3Cl)C2=S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F10 compound treatment 0.9537 -0.0463 -0.9 -0.8989 -1.0 2070459 Maybridge1_001704 Cc1c(Cl)cccc1SCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F11 compound treatment 0.9914 -0.00856 -0.17 -0.1662 -1.0 1538792 Maybridge1_001705 Nc1cc2C(=O)NC(=O)c2cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F12 compound treatment 1.0068 0.00681 0.13 0.1323 1.0 2070460 Maybridge1_001706 CC(C)(C)OC(=O)C(C)(C)Sc1ccc(cn1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F13 compound treatment 1.0152 0.0152 0.3 0.2951 1.0 2070461 Maybridge1_001707 COc1ccc(Oc2ccc(cc2C(=O)O)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F14 compound treatment 1.0131 0.0131 0.25 0.2544 1.0 1013662 Maybridge1_001708 Cc1ccc(cc1)S(=O)(=O)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F15 compound treatment 1.0222 0.0222 0.43 0.4308 1.0 2070462 Maybridge1_001709 Fc1ccc(NC(=O)CSc2ssc(=S)c2c3ccccc3)c(F)c1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F16 compound treatment 0.9914 -0.00856 -0.17 -0.1662 -1.0 2070463 Maybridge1_001710 CC(C)(C(=O)Oc1ccc(Cl)cc1)S(=O)(=O)c2ccc(cn2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F17 compound treatment 0.9642 -0.0358 -0.7 -0.6954 -1.0 2070464 Maybridge1_001711 O/N=C/C(=O)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F18 compound treatment 0.9789 -0.0211 -0.41 -0.4104 -1.0 2070465 Maybridge1_001712 COC(=O)c1ccc(cc1)c2ccc(cc2)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F19 compound treatment 0.93 -0.07 -1.36 -1.3602 -1.0 2070466 Maybridge1_001713 Cn1c(SCC(=O)c2ccc(Cl)cc2)nnc1SCC(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F20 compound treatment 0.9817 -0.0183 -0.36 -0.3562 -1.0 2070467 Maybridge1_001714 COc1ccc(N)c(Sc2ccc(Cl)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F21 compound treatment 0.96 -0.04 -0.78 -0.7768 -1.0 1048764 Maybridge1_001715 CCOC(=O)c1cnn(c1C)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F22 compound treatment 0.9845 -0.0155 -0.3 -0.3019 -1.0 1408448 Maybridge1_001716 Cc1nc(cs1)c2cc(C#N)c(=O)[nH]c2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F23 mock treatment 1.0187 0.0187 0.36 0.363 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 F24 mock treatment 1.0061 0.00611 0.12 0.1187 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G01 compound treatment 1.0564 0.0564 1.1 1.0957 1.0 2070468 Maybridge1_001717 CC(C)(C)c1ccc(cc1)c2nnc(o2)c3ccccc3NC(=O)NC(=O)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G02 compound treatment 0.9593 -0.0407 -0.79 -0.7904 -1.0 1111505 Maybridge1_001718 CC(=O)Nc1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G03 compound treatment 0.9852 -0.0148 -0.29 -0.2883 -1.0 2070469 Maybridge1_001719 COc1ccc(Br)c(c1)c2nnc(o2)c3ccccc3NS(=O)(=O)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G04 compound treatment 0.9754 -0.0246 -0.48 -0.4783 -1.0 2070470 Maybridge1_001720 [O-][N+](=O)c1cccnc1Oc2cncc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G05 compound treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 1029371 Maybridge1_001721 OC(=O)CCC(N1C(=O)c2ccccc2C1=O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G06 compound treatment 0.9481 -0.0519 -1.01 -1.0075 -1.0 2070471 Maybridge1_001722 CC(C)(C)c1ccc(Oc2ncccc2[N+](=O)[O-])c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G07 compound treatment 1.0201 0.0201 0.39 0.3901 1.0 2070472 Maybridge1_001723 Cc1onc(c1C(=O)Nc2cccc(Cl)c2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G08 compound treatment 0.9726 -0.0274 -0.53 -0.5326 -1.0 2070473 Maybridge1_001724 CCOC(=O)CC(=O)CSc1nnc(N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G09 compound treatment 0.967 -0.033 -0.64 -0.6411 -1.0 1396369 Maybridge1_001725 CN(c1c2CCCCc2nn1C)S(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G10 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 2070474 Maybridge1_001726 [O-][N+](=O)c1cccnc1NCc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G11 compound treatment 1.0362 0.0362 0.7 0.7022 1.0 1274708 Maybridge1_001727 COc1cccc(OC)c1C(=O)NC(=O)Oc2c(F)cccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G12 compound treatment 0.9852 -0.0148 -0.29 -0.2883 -1.0 2070475 Maybridge1_001728 Cc1ccc(cc1)n2ncc(C#N)c2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G13 compound treatment 0.9921 -0.00786 -0.15 -0.1526 -1.0 1070439 Maybridge1_001729 [O-][N+](=O)c1ccc(Oc2cccc(c2)C(F)(F)F)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G14 compound treatment 0.9698 -0.0302 -0.59 -0.5868 -1.0 2070476 Maybridge1_001730 Nc1c(C#N)cnn1c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G15 compound treatment 0.9921 -0.00786 -0.15 -0.1526 -1.0 1575604 Maybridge1_001731 Cc1cc(Cl)ccc1Oc2ccc(N)cn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G16 compound treatment 0.9733 -0.0267 -0.52 -0.519 -1.0 2070477 Maybridge1_001732 Oc1c(cnn(c2ccccc2)c1=O)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G17 compound treatment 0.9824 -0.0176 -0.34 -0.3426 -1.0 1065659 Maybridge1_001733 Nc1ccc(Oc2ccc(F)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G18 compound treatment 0.9621 -0.0379 -0.74 -0.7361 -1.0 2070478 Maybridge1_001734 CCOC(CN(c1ccc(F)cc1)S(=O)(=O)c2ccc(F)cc2F)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G19 compound treatment 0.974 -0.026 -0.51 -0.5054 -1.0 2070479 Maybridge1_001735 Cc1ccc(Oc2ccc(cn2)[N+](=O)[O-])c(n1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G20 compound treatment 0.9928 -0.00716 -0.14 -0.1391 -1.0 1049801 Maybridge1_001736 NC(=O)c1ncccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G21 compound treatment 0.9831 -0.0169 -0.33 -0.329 -1.0 1725682 Maybridge1_001737 CC(=O)Nc1ncccc1OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G22 compound treatment 0.9418 -0.0582 -1.13 -1.1296 -1.0 2070480 Maybridge1_001738 Nc1cccnc1Oc2ccc(F)cc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G23 mock treatment 0.9614 -0.0386 -0.75 -0.7497 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 G24 mock treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H01 compound treatment 1.0054 0.00541 0.11 0.1052 1.0 2070481 Maybridge1_001739 COC(=O)CS(=O)(=O)c1ccc(cn1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H02 compound treatment 0.99 -0.00996 -0.19 -0.1934 -1.0 2070482 Maybridge1_001740 CC(C)(C)c1cc(cc(c1)C(=O)NNC(=O)c2ccc(Cl)cc2Cl)C(=O)NNC(=O)c3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H03 compound treatment 1.0124 0.0124 0.24 0.2408 1.0 1025749 Maybridge1_001741 CS(=O)(=O)NCc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H04 compound treatment 1.0194 0.0194 0.38 0.3765 1.0 2070483 Maybridge1_001742 COC(=O)CNC(=O)c1cc(ccc1Oc2ccc(OC)cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H05 compound treatment 0.9831 -0.0169 -0.33 -0.329 -1.0 2070484 Maybridge1_001743 [O-][N+](=O)c1ccc(SCc2ccccc2)c(C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H06 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 2070485 Maybridge1_001744 OC(=O)c1cccnc1Sc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H07 compound treatment 0.9998 -1.75E-4 0.0 -0.0034 -1.0 1297323 Maybridge1_001745 CSc1nc(=O)c2cccnc2n1c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H08 compound treatment 0.9866 -0.0134 -0.26 -0.2612 -1.0 1641310 Maybridge1_001746 NC(=O)c1cccnc1Oc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H09 compound treatment 1.0334 0.0334 0.65 0.6479 1.0 1733777 Maybridge1_001747 COC(=O)c1ccccc1C(=O)c2cc(C)c(O)c(C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H10 compound treatment 0.9439 -0.0561 -1.09 -1.0889 -1.0 2070486 Maybridge1_001748 OC(=O)CSc1cccc2cccc(Cl)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H11 compound treatment 1.0271 0.0271 0.53 0.5258 1.0 2070487 Maybridge1_001749 CCCCNC(=O)Nc1nnc(s1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H12 compound treatment 0.953 -0.047 -0.91 -0.9125 -1.0 2070488 Maybridge1_001750 CC(C)(C)OC(=O)C(C)(C)S(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H13 compound treatment 0.9726 -0.0274 -0.53 -0.5326 -1.0 2070489 Maybridge1_001751 Cc1nc2ccccn2c(=O)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H14 compound treatment 0.9796 -0.0204 -0.4 -0.3969 -1.0 1038637 Maybridge1_001752 Cc1ccc(cc1)S(=O)(=O)N2CCCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H15 compound treatment 0.9474 -0.0526 -1.02 -1.021 -1.0 2070490 Maybridge1_001753 [O-][N+](=O)c1cc(ccc1Oc2ccc(SC(F)(F)F)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H16 compound treatment 0.9656 -0.0344 -0.67 -0.6682 -1.0 1597019 Maybridge1_001754 Cc1onc2c(=O)n(nc(c3ccccc3)c12)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H17 compound treatment 0.9523 -0.0477 -0.93 -0.926 -1.0 2070491 Maybridge1_001755 Cn1ccnc1SCC(=O)c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H18 compound treatment 0.9698 -0.0302 -0.59 -0.5868 -1.0 1060482 Maybridge1_001756 N#Cc1ccc(cc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H19 compound treatment 0.9586 -0.0414 -0.8 -0.8039 -1.0 2070492 Maybridge1_001757 COC(=O)c1ccc(Cl)cc1N(CCCC#N)S(=O)(=O)c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H20 compound treatment 0.9362 -0.0638 -1.24 -1.2381 -1.0 2070493 Maybridge1_001758 COc1cc(OC)c([N+](=O)[O-])c(OC)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H21 compound treatment 1.0019 0.00192 0.04 0.0373 1.0 2070494 Maybridge1_001759 CCOC(=O)c1cnn(c1C)c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H22 compound treatment 1.018 0.018 0.35 0.3494 1.0 1644615 Maybridge1_001760 COc1nc(C)c(cc1C#N)c2csc(C)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H23 mock treatment 0.9817 -0.0183 -0.36 -0.3562 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 H24 mock treatment 1.0215 0.0215 0.42 0.4172 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I01 compound treatment 1.0473 0.0473 0.92 0.9193 1.0 2070495 Maybridge1_001761 COc1ccc(cc1OC)S(=O)(=O)Nc2ccccc2c3nnc(o3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I02 compound treatment 1.0068 0.00681 0.13 0.1323 1.0 2070496 Maybridge1_001762 CC(C)(C)c1cc(OC(=O)c2ccc(Cl)cc2)c(cc1OC(=O)c3ccc(Cl)cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I03 compound treatment 0.997 -0.00297 -0.06 -0.0577 -1.0 1257183 Maybridge1_001763 COc1ccc(Br)c(c1)c2nnc(o2)c3ccccc3NS(=O)(=O)c4ccc(C)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I04 compound treatment 0.9579 -0.0421 -0.82 -0.8175 -1.0 2070497 Maybridge1_001764 [O-][N+](=O)c1ccc(Oc2cncc(Cl)c2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I05 compound treatment 0.9914 -0.00856 -0.17 -0.1662 -1.0 1460964 Maybridge1_001765 Cc1ccc(COc2ccc(CC#N)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I06 compound treatment 0.9279 -0.0721 -1.4 -1.4009 -1.0 2070498 Maybridge1_001766 CN(C)/C=N/c1c(C#N)cnn1c2ccc(F)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I07 compound treatment 1.004 0.00402 0.08 0.078 1.0 2070499 Maybridge1_001767 Clc1ccc(cc1)C(=O)NC(=O)Oc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I08 compound treatment 0.9789 -0.0211 -0.41 -0.4104 -1.0 2070500 Maybridge1_001768 CCCn1c(SC)nnc1SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I09 compound treatment 0.99 -0.00996 -0.19 -0.1934 -1.0 1949637 Maybridge1_001769 Clc1ccc(cc1)S(=O)(=O)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I10 compound treatment 0.9977 -0.00227 -0.04 -0.0441 -1.0 2070501 Maybridge1_001770 Nc1cc(Cl)c(cc1Cl)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I11 compound treatment 1.0236 0.0236 0.46 0.4579 1.0 2070502 Maybridge1_001771 [O-][N+](=O)c1cc(ccc1Oc2ccc(Cl)cc2C3CCCCC3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I12 compound treatment 0.9928 -0.00716 -0.14 -0.1391 -1.0 1210951 Maybridge1_001772 COc1c(Cl)cc(Cl)c(OC)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I13 compound treatment 0.9803 -0.0197 -0.38 -0.3833 -1.0 2070503 Maybridge1_001773 [O-][N+](=O)c1ccc(Oc2ccc(F)cc2F)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I14 compound treatment 0.946 -0.054 -1.05 -1.0482 -1.0 2070504 Maybridge1_001774 N#CCSc1nnc(s1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I15 compound treatment 0.9642 -0.0358 -0.7 -0.6954 -1.0 2070505 Maybridge1_001775 [O-][N+](=O)c1ccc(Oc2cccnc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I16 compound treatment 0.9237 -0.0763 -1.48 -1.4824 -1.0 2070506 Maybridge1_001776 COC(=O)C1=NN(C(=O)C1)c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I17 compound treatment 0.9866 -0.0134 -0.26 -0.2612 -1.0 1562566 Maybridge1_001777 Cc1cccc(Oc2ccc(N)cn2)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I18 compound treatment 1.0075 0.00751 0.15 0.1459 1.0 2070507 Maybridge1_001778 CCOC(CN(C(=O)c1ccc(F)cc1)c2ccc(F)cc2)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I19 compound treatment 0.9719 -0.0281 -0.55 -0.5461 -1.0 2070508 Maybridge1_001779 Cc1ccc(Oc2ncccc2[N+](=O)[O-])c(n1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I20 compound treatment 0.9383 -0.0617 -1.2 -1.1974 -1.0 1002904 Maybridge1_001780 OC(=O)c1nccnc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I21 compound treatment 0.9775 -0.0225 -0.44 -0.4376 -1.0 2070509 Maybridge1_001781 Cc1ccc(cc1)S(=O)(=O)Oc2ccc(C)nc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I22 compound treatment 0.9977 -0.00227 -0.04 -0.0441 -1.0 2070510 Maybridge1_001782 Nc1ccc(Oc2ccccc2F)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I23 mock treatment 1.0145 0.0145 0.28 0.2815 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 I24 mock treatment 1.0215 0.0215 0.42 0.4172 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J01 compound treatment 1.0075 0.00751 0.15 0.1459 1.0 2070511 Maybridge1_001783 FC(F)(F)c1ccc(nc1)S(=O)(=O)CC(=O)NNC(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J02 compound treatment 0.9893 -0.0107 -0.21 -0.2069 -1.0 2070512 Maybridge1_001784 CC(C)(C)c1cc(cc(c1)C(=O)NNC(=O)c2ccc(cc2)C(F)(F)F)C(=O)NNC(=O)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J03 compound treatment 0.9775 -0.0225 -0.44 -0.4376 -1.0 2070513 Maybridge1_001785 COc1ccc(/C=C/2\C(=NN(C2=O)c3ccc(Cl)c(Cl)c3)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J04 compound treatment 0.9824 -0.0176 -0.34 -0.3426 -1.0 1139373 Maybridge1_001786 OC(=O)c1cccnc1Sc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J05 compound treatment 1.0809 0.0809 1.57 1.5706 1.0 2070514 Maybridge1_001787 CC/1=NN(C(=O)\C1=C\c2ccc(OCc3ccccc3)cc2)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J06 compound treatment 0.9803 -0.0197 -0.38 -0.3833 -1.0 1243528 Maybridge1_001788 COC(=O)CNC(=O)c1cccnc1Sc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J07 compound treatment 1.0285 0.0285 0.55 0.5529 1.0 1168374 Maybridge1_001789 Brc1ccc(cc1)n2c(SCC#C)nc(=O)c3cccnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J08 compound treatment 0.9928 -0.00716 -0.14 -0.1391 -1.0 1458502 Maybridge1_001790 Cc1ccc(Oc2ncccc2C(=O)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J09 compound treatment 0.9831 -0.0169 -0.33 -0.329 -1.0 2070515 Maybridge1_001791 Cc1cc(cc(C)c1OC(=O)c2ccc(cc2)C(F)(F)F)c3nn(C)c(=O)c4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J10 compound treatment 1.0061 0.00611 0.12 0.1187 1.0 2070516 Maybridge1_001792 [O-][N+](=O)c1cc(Br)c(Oc2cncc(Cl)c2)cc1Oc3cncc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J11 compound treatment 0.9488 -0.0512 -0.99 -0.9939 -1.0 2070517 Maybridge1_001793 COC(=O)COc1ccc(SC(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J12 compound treatment 0.9991 -8.73E-4 -0.02 -0.017 -1.0 2070518 Maybridge1_001794 CC(C)(C)OC(=O)C(C)(C)S(=O)(=O)c1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J13 compound treatment 0.9977 -0.00227 -0.04 -0.0441 -1.0 2070519 Maybridge1_001795 CCOC(=O)c1cnc2nc(SC)nn2c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J14 compound treatment 0.9726 -0.0274 -0.53 -0.5326 -1.0 1386298 Maybridge1_001796 O=C(OCCS(=O)(=O)c1ccccn1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J15 compound treatment 0.9572 -0.0428 -0.83 -0.8311 -1.0 2070520 Maybridge1_001797 Fc1ccc(NC(=O)CS(=O)(=O)c2ccc(Cl)cc2)c(F)c1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J16 compound treatment 0.9998 -1.75E-4 0.0 -0.0034 -1.0 2070521 Maybridge1_001798 Cc1nn(C)c(=O)c2noc(/C=C/c3ccc(cc3)C(F)(F)F)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J17 compound treatment 1.0089 0.00891 0.17 0.173 1.0 2070522 Maybridge1_001799 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccc(OC(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J18 compound treatment 0.9663 -0.0337 -0.65 -0.6547 -1.0 2070523 Maybridge1_001800 CN(C)/C=N\c1cc(C)nc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J19 compound treatment 0.9719 -0.0281 -0.55 -0.5461 -1.0 1098259 Maybridge1_001801 Nc1ncccc1OCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J20 compound treatment 0.981 -0.019 -0.37 -0.3697 -1.0 1711015 Maybridge1_001802 Fc1ccc(NC(=O)c2c(F)cccc2NC(=O)c3cccs3)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J21 compound treatment 1.0012 0.00122 0.02 0.0237 1.0 2070524 Maybridge1_001803 Nc1nc(Oc2ccc(Cl)cc2)ncc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J22 compound treatment 0.9928 -0.00716 -0.14 -0.1391 -1.0 1159034 Maybridge1_001804 Cc1nc(cs1)c2cc(C#N)c(Sc3ccccc3)nc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J23 mock treatment 1.0229 0.0229 0.44 0.4444 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 J24 mock treatment 1.0166 0.0166 0.32 0.3223 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K01 compound treatment 1.0445 0.0445 0.86 0.865 1.0 2070525 Maybridge1_001805 [O-][N+](=O)c1ccccc1C(=O)NNC(=O)c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K02 compound treatment 0.9789 -0.0211 -0.41 -0.4104 -1.0 2070526 Maybridge1_001806 CC(C)(C)c1cc(OC(=O)c2ccc(cc2)C(F)(F)F)c(cc1OC(=O)c3ccc(cc3)C(F)(F)F)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K03 compound treatment 1.0369 0.0369 0.72 0.7157 1.0 2070527 Maybridge1_001807 CS/C(=N\S(=O)(=O)c1ccc(cc1)n2nc(cc2c3cccs3)C(F)(F)F)/N4CCCCC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K04 compound treatment 0.9852 -0.0148 -0.29 -0.2883 -1.0 2070528 Maybridge1_001808 COc1ccc(Oc2c(O)occ2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K05 compound treatment 0.9614 -0.0386 -0.75 -0.7497 -1.0 1589783 Maybridge1_001809 Clc1ccc(COc2ccc(CC#N)cc2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K06 compound treatment 1.0082 0.00821 0.16 0.1594 1.0 2070529 Maybridge1_001810 CC1=NN(C(=O)C1CCO)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K07 compound treatment 0.9935 -0.00646 -0.13 -0.1255 -1.0 1044477 Maybridge1_001811 OC(=O)c1cc2cc(ccc2oc1=O)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K08 compound treatment 0.9642 -0.0358 -0.7 -0.6954 -1.0 2070530 Maybridge1_001812 COC(=O)c1cc2ccccc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K09 compound treatment 0.9796 -0.0204 -0.4 -0.3969 -1.0 2070531 Maybridge1_001813 COc1cc(CC=C)ccc1Oc2ccc(cn2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K10 compound treatment 0.9397 -0.0603 -1.17 -1.1703 -1.0 2070532 Maybridge1_001814 CN(C)/C=N/c1cc(Cl)c(cc1Cl)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K11 compound treatment 0.981 -0.019 -0.37 -0.3697 -1.0 2070533 Maybridge1_001815 Cc1cccc(NC(=O)C(F)(F)F)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K12 compound treatment 0.9796 -0.0204 -0.4 -0.3969 -1.0 2070534 Maybridge1_001816 COc1c(Cl)cc([N+](=O)[O-])c(OC)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K13 compound treatment 0.9439 -0.0561 -1.09 -1.0889 -1.0 2070535 Maybridge1_001817 [O-][N+](=O)c1ccc(Oc2ccc(Br)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K14 compound treatment 0.9544 -0.0456 -0.89 -0.8853 -1.0 2070536 Maybridge1_001818 FC(F)(F)c1cccc(c1)C(=O)CN2C(=O)c3ccccc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K15 compound treatment 0.9544 -0.0456 -0.89 -0.8853 -1.0 2070537 Maybridge1_001819 Nc1ccc(Oc2ccc(F)cc2F)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K16 compound treatment 0.9579 -0.0421 -0.82 -0.8175 -1.0 1003999 Maybridge1_001820 [O-][N+](=O)c1cccc2cnccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K17 compound treatment 1.011 0.011 0.21 0.2137 1.0 1711963 Maybridge1_001821 Nc1ccc(Oc2ccc(Cl)cc2C3CCCCC3)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K18 compound treatment 0.9579 -0.0421 -0.82 -0.8175 -1.0 2070538 Maybridge1_001822 CCOC(CN(C(=O)c1ccc(C)cc1)c2ccc(F)cc2)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K19 compound treatment 1.011 0.011 0.21 0.2137 1.0 2070539 Maybridge1_001823 Cc1ccc(OCc2c(Cl)cccc2Cl)c(n1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K20 compound treatment 0.9509 -0.0491 -0.95 -0.9532 -1.0 1513140 Maybridge1_001824 COC(=O)c1ccncc1C(=O)Nc2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K21 compound treatment 0.9886 -0.0114 -0.22 -0.2205 -1.0 2070540 Maybridge1_001825 Cc1nn(nc1C(=O)Oc2ccc(C)nc2[N+](=O)[O-])c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K22 compound treatment 0.9803 -0.0197 -0.38 -0.3833 -1.0 2070541 Maybridge1_001826 Clc1ccc(cc1)S(=O)(=O)Oc2ccc(/C=C/3\NC(=O)NC3=O)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K23 mock treatment 1.0026 0.00262 0.05 0.0509 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 K24 mock treatment 1.0145 0.0145 0.28 0.2815 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L01 compound treatment 1.0299 0.0299 0.58 0.5801 1.0 1323730 Maybridge1_001827 Clc1ccc(Cl)c(c1)S(=O)(=O)N2CCC(CC2)C(c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L02 compound treatment 0.9914 -0.00856 -0.17 -0.1662 -1.0 2070542 Maybridge1_001828 CCOC(=O)c1cnn(c1C)c2ccc(F)cc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L03 compound treatment 1.1018 0.102 1.98 1.9776 1.0 2070543 Maybridge1_001829 CC/1=NN(C(=O)\C1=C\c2ccc(O)cc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L04 compound treatment 0.9949 -0.00507 -0.1 -0.0984 -1.0 1356933 Maybridge1_001830 Cc1ccc(Sc2ncccc2C(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L05 compound treatment 1.0187 0.0187 0.36 0.363 1.0 2070544 Maybridge1_001831 CC/1=NN(C(=O)\C1=C\c2ccc(OCc3ccccc3)cc2)c4cccc(Cl)c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L06 compound treatment 0.9453 -0.0547 -1.06 -1.0617 -1.0 1009523 Maybridge1_001832 Cc1cc(O)n2cnnc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L07 compound treatment 0.9907 -0.00926 -0.18 -0.1798 -1.0 1684089 Maybridge1_001833 COc1ccccc1NC(=S)NCC(C)(C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L08 compound treatment 0.9726 -0.0274 -0.53 -0.5326 -1.0 1563767 Maybridge1_001834 NC(=O)c1cccnc1Sc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L09 compound treatment 0.9607 -0.0393 -0.76 -0.7632 -1.0 2070545 Maybridge1_001835 CC(C)(C)c1nnc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L10 compound treatment 0.9551 -0.0449 -0.87 -0.8718 -1.0 2070546 Maybridge1_001836 COC(=O)c1c(SC)nc([nH]c1=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L11 compound treatment 0.9586 -0.0414 -0.8 -0.8039 -1.0 2070547 Maybridge1_001837 Cc1ccc(Sc2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L12 compound treatment 1.0033 0.00332 0.06 0.0645 1.0 2070548 Maybridge1_001838 Cc1ccc(SCc2cc(=O)[nH]c(=O)[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L13 compound treatment 0.9866 -0.0134 -0.26 -0.2612 -1.0 2070549 Maybridge1_001839 CSc1nc2ncc(C(=O)O)c(N)n2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L14 compound treatment 0.9202 -0.0798 -1.55 -1.5502 -1.0 1630711 Maybridge1_001840 Nc1[nH]nc2[nH]c(nc(=O)c12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L15 compound treatment 0.9817 -0.0183 -0.36 -0.3562 -1.0 2070550 Maybridge1_001841 COC(=O)c1ccc(Cl)cc1NS(=O)(=O)c2ccc(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L16 compound treatment 0.9593 -0.0407 -0.79 -0.7904 -1.0 2070551 Maybridge1_001842 Cc1nn(C)c(=O)c2noc(/C=C/c3ccc(Cl)c(Cl)c3)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L17 compound treatment 0.9439 -0.0561 -1.09 -1.0889 -1.0 1168720 Maybridge1_001843 Cc1cc(Oc2ccc(NS(=O)(=O)c3cccc4cccnc34)cn2)cc(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L18 compound treatment 0.9558 -0.0442 -0.86 -0.8582 -1.0 2070552 Maybridge1_001844 Cc1cc(N/C=N/O)c2ccccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L19 compound treatment 0.9677 -0.0323 -0.63 -0.6275 -1.0 1497053 Maybridge1_001845 CC(C)(C)c1ccc(COc2cccnc2N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L20 compound treatment 1.011 0.011 0.21 0.2137 1.0 2070553 Maybridge1_001846 Cc1cc(O)n(n1)c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L21 compound treatment 0.9453 -0.0547 -1.06 -1.0617 -1.0 2070554 Maybridge1_001847 Cn1c(S)nnc1SCc2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L22 compound treatment 0.9859 -0.0141 -0.27 -0.2748 -1.0 1428836 Maybridge1_001848 Cc1nc(cs1)c2ccc3NC(=O)CCc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L23 mock treatment 0.9984 -0.00157 -0.03 -0.0305 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 L24 mock treatment 1.032 0.032 0.62 0.6208 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M01 compound treatment 1.0397 0.0397 0.77 0.77 1.0 2070555 Maybridge1_001849 Clc1ccc(cc1)C(=O)CC(=S)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M02 compound treatment 0.974 -0.026 -0.51 -0.5054 -1.0 2070556 Maybridge1_001850 CC(C)(C)c1cc(OC(=O)c2ccc(Cl)cc2Cl)c(cc1OC(=O)c3ccc(Cl)cc3Cl)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M03 compound treatment 0.9803 -0.0197 -0.38 -0.3833 -1.0 2070557 Maybridge1_001851 Cc1ccc(=O)n(Cc2ccc(Cl)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M04 compound treatment 1.0047 0.00472 0.09 0.0916 1.0 2070558 Maybridge1_001852 Nc1c(C#N)cnn1c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M05 compound treatment 0.9852 -0.0148 -0.29 -0.2883 -1.0 1397157 Maybridge1_001853 Fc1cccc(Cl)c1COc2ccc(CC#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M06 compound treatment 0.997 -0.00297 -0.06 -0.0577 -1.0 1212300 Maybridge1_001854 COc1ccc(Oc2c(Cl)cnn(c3ccc(Cl)cc3)c2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M07 compound treatment 0.9761 -0.0239 -0.46 -0.4647 -1.0 1271392 Maybridge1_001855 O=C(Nc1ccccc1)Oc2ccc(CC#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M08 compound treatment 0.9663 -0.0337 -0.65 -0.6547 -1.0 2070559 Maybridge1_001856 [O-][N+](=O)c1cc(Cl)c(cc1Oc2ccc(Cl)cc2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M09 compound treatment 0.9866 -0.0134 -0.26 -0.2612 -1.0 2070560 Maybridge1_001857 CC(C)Oc1ccccc1Oc2ccc(cn2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M10 compound treatment 0.9544 -0.0456 -0.89 -0.8853 -1.0 1239145 Maybridge1_001858 Nc1cc(Cl)c(cc1Oc2ccc(Cl)cc2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M11 compound treatment 0.9893 -0.0107 -0.21 -0.2069 -1.0 2070561 Maybridge1_001859 [O-][N+](=O)c1ccc(Sc2ccc(Cl)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M12 compound treatment 0.953 -0.047 -0.91 -0.9125 -1.0 1175941 Maybridge1_001860 COc1c(Cl)cc(Cl)c(OC)c1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M13 compound treatment 0.9845 -0.0155 -0.3 -0.3019 -1.0 2070562 Maybridge1_001861 Cc1cccc(Oc2ccc(cn2)[N+](=O)[O-])c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M14 compound treatment 0.9852 -0.0148 -0.29 -0.2883 -1.0 2070563 Maybridge1_001862 CSc1ncccc1C(=O)c2c(C)nn(c2O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M15 compound treatment 1.004 0.00402 0.08 0.078 1.0 2070564 Maybridge1_001863 Nc1ccc(Oc2cccnc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M16 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 1616749 Maybridge1_001864 CCOC(=O)c1c[nH]c2c(F)ccc(F)c2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M17 compound treatment 0.9824 -0.0176 -0.34 -0.3426 -1.0 2070565 Maybridge1_001865 CCOC(=O)/C(=C/Nc1ccc(Oc2cccnc2)nc1)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M18 compound treatment 0.9796 -0.0204 -0.4 -0.3969 -1.0 2070566 Maybridge1_001866 CCOC(CN(C(=O)c1ccc(cc1)[N+](=O)[O-])c2ccc(F)cc2)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M19 compound treatment 0.9621 -0.0379 -0.74 -0.7361 -1.0 2070567 Maybridge1_001867 Cc1ccc(OCc2c(F)cccc2Cl)c(n1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M20 compound treatment 0.9817 -0.0183 -0.36 -0.3562 -1.0 2070568 Maybridge1_001868 CN(C)/C=N/c1ncc(cc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M21 compound treatment 0.9817 -0.0183 -0.36 -0.3562 -1.0 2070569 Maybridge1_001869 Cc1ccc(OS(=O)(=O)c2ccc(F)cc2)c(n1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M22 compound treatment 0.9223 -0.0777 -1.51 -1.5095 -1.0 2070570 Maybridge1_001870 Clc1ccc(cc1)C(=O)Oc2ccc(/C=C/3\NC(=O)NC3=O)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M23 mock treatment 0.9726 -0.0274 -0.53 -0.5326 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 M24 mock treatment 1.0054 0.00541 0.11 0.1052 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N01 compound treatment 1.0362 0.0362 0.7 0.7022 1.0 1425744 Maybridge1_001871 Cc1ccc(cc1)S(=O)(=O)N2CCC(CC2)C(c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N02 compound treatment 1.0082 0.00821 0.16 0.1594 1.0 2070571 Maybridge1_001872 Fc1ccc(cc1F)C(=O)CSC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N03 compound treatment 1.1046 0.105 2.03 2.0319 1.0 2070572 Maybridge1_001873 CC/1=NN(C(=O)\C1=C\c2ccc(O)cc2)c3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N04 compound treatment 1.0096 0.00961 0.19 0.1866 1.0 1917780 Maybridge1_001874 CCOC(=O)CNC(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N05 compound treatment 1.0012 0.00122 0.02 0.0237 1.0 1067559 Maybridge1_001875 CCOc1ccc(N=c2ssc(SC)c2c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N06 compound treatment 0.9712 -0.0288 -0.56 -0.5597 -1.0 2070573 Maybridge1_001876 CCOC(=O)CNC(=O)c1ccccc1NCC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N07 compound treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 2070574 Maybridge1_001877 Fc1ccc(NC(=O)CSc2ccc(Cl)cc2)c(F)c1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N08 compound treatment 0.9817 -0.0183 -0.36 -0.3562 -1.0 1313213 Maybridge1_001878 Cc1ccc(Sc2ncccc2C(=O)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N09 compound treatment 0.9879 -0.0121 -0.23 -0.2341 -1.0 1213969 Maybridge1_001879 COC(=O)COc1c(C)cc(cc1C)c2nn(C)c(=O)c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N10 compound treatment 1.0047 0.00472 0.09 0.0916 1.0 2070575 Maybridge1_001880 CSc1nc([nH]c(=O)c1C#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N11 compound treatment 1.0082 0.00821 0.16 0.1594 1.0 2070576 Maybridge1_001881 FC(F)(F)Sc1ccc(NC(=O)Nc2ccc(Sc3ccc(Cl)cc3)nc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N12 compound treatment 0.9733 -0.0267 -0.52 -0.519 -1.0 2070577 Maybridge1_001882 Clc1ccc(SCc2cc(=O)[nH]c(=O)[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N13 compound treatment 1.0362 0.0362 0.7 0.7022 1.0 2070578 Maybridge1_001883 CSc1nc2nccc(N)n2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N14 compound treatment 1.0306 0.0306 0.59 0.5936 1.0 2070579 Maybridge1_001884 OCCSc1ccc(Cl)cn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N15 compound treatment 0.9824 -0.0176 -0.34 -0.3426 -1.0 2070580 Maybridge1_001885 Cc1ccc(cc1)S(=O)(=O)Nc2ccc(F)cc2NS(=O)(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N16 compound treatment 1.0886 0.0886 1.72 1.7198 1.0 1510809 Maybridge1_001886 CCOC(=O)C1=C(N)CC(=C(N)C1)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N17 compound treatment 0.9796 -0.0204 -0.4 -0.3969 -1.0 2070581 Maybridge1_001887 COc1cccc(c1)C(=O)N/N=C(\C)/c2ccccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N18 compound treatment 1.0054 0.00541 0.11 0.1052 1.0 2070582 Maybridge1_001888 CC(=O)c1cc(C#N)c(=O)[nH]c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N19 compound treatment 0.9404 -0.0596 -1.16 -1.1567 -1.0 1163521 Maybridge1_001889 Cc1cccc(COc2cccnc2N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N20 compound treatment 1.1759 0.176 3.42 3.4159 1.0 2070583 Maybridge1_001890 Cc1cc(O)n(n1)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N21 compound treatment 0.9719 -0.0281 -0.55 -0.5461 -1.0 2070584 Maybridge1_001891 Cn1c(S)nnc1SCc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N22 compound treatment 0.9984 -0.00157 -0.03 -0.0305 -1.0 2070585 Maybridge1_001892 COc1cccc(CC(=O)N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N23 mock treatment 0.9614 -0.0386 -0.75 -0.7497 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 N24 mock treatment 0.9893 -0.0107 -0.21 -0.2069 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O01 compound treatment 1.0417 0.0417 0.81 0.8107 1.0 2070586 Maybridge1_001893 COc1ccc(Br)c(c1)c2nnc(o2)c3ccccc3[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O02 compound treatment 0.9789 -0.0211 -0.41 -0.4104 -1.0 2070587 Maybridge1_001894 CC(C)(C)c1cc(OS(=O)(=O)c2ccc(Cl)cc2)c(cc1OS(=O)(=O)c3ccc(Cl)cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O03 compound treatment 1.0187 0.0187 0.36 0.363 1.0 2070588 Maybridge1_001895 Cc1ccc(=O)n(Cc2ccc(Cl)c(Cl)c2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O04 compound treatment 1.0397 0.0397 0.77 0.77 1.0 2070589 Maybridge1_001896 Nc1nn(cc1C#N)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O05 compound treatment 0.9879 -0.0121 -0.23 -0.2341 -1.0 1152248 Maybridge1_001897 Clc1ccc(COc2ccc(CC#N)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O06 compound treatment 0.9824 -0.0176 -0.34 -0.3426 -1.0 2070590 Maybridge1_001898 CC(C)(C)c1cc(Cl)c(OS(=O)(=O)c2ccc(Cl)cc2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O07 compound treatment 0.9579 -0.0421 -0.82 -0.8175 -1.0 2070591 Maybridge1_001899 FC(F)(F)c1ccc(/C=C(\C#N)/c2ccc(OCc3ccc(Cl)cc3)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O08 compound treatment 0.9921 -0.00786 -0.15 -0.1526 -1.0 2070592 Maybridge1_001900 [O-][N+](=O)c1cc(Cl)c(cc1Sc2ccc(Cl)cc2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O09 compound treatment 1.011 0.011 0.21 0.2137 1.0 2070593 Maybridge1_001901 C/C(=N/O)/c1ccn(c1)S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O10 compound treatment 0.9642 -0.0358 -0.7 -0.6954 -1.0 2070594 Maybridge1_001902 COc1ccc(Cl)c(OC)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O11 compound treatment 1.0124 0.0124 0.24 0.2408 1.0 2070595 Maybridge1_001903 Cc1ccc(Sc2ccc(cn2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O12 compound treatment 0.9754 -0.0246 -0.48 -0.4783 -1.0 2070596 Maybridge1_001904 COc1c(Br)cc([N+](=O)[O-])c(OC)c1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O13 compound treatment 0.9977 -0.00227 -0.04 -0.0441 -1.0 2070597 Maybridge1_001905 [O-][N+](=O)c1ccc(Oc2cccc(Cl)c2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O14 compound treatment 0.9963 -0.00367 -0.07 -0.0712 -1.0 2070598 Maybridge1_001906 CN(C)/C=C(/Sc1nnc(s1)n2cccc2)\C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O15 compound treatment 0.9789 -0.0211 -0.41 -0.4104 -1.0 2070599 Maybridge1_001907 Nc1ccc(Oc2ccc(Br)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O16 compound treatment 0.9761 -0.0239 -0.46 -0.4647 -1.0 2070600 Maybridge1_001908 Clc1ccc(cc1Cl)c2csc(=S)n2Nc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O17 compound treatment 0.9998 -1.75E-4 0.0 -0.0034 -1.0 2070601 Maybridge1_001909 COC(=O)c1ccc(Cl)cc1NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O18 compound treatment 0.9886 -0.0114 -0.22 -0.2205 -1.0 2070602 Maybridge1_001910 Fc1ccc(NC(=O)CC#N)c(F)c1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O19 compound treatment 0.9754 -0.0246 -0.48 -0.4783 -1.0 2070603 Maybridge1_001911 Cc1ccc(COc2ccc(C)nc2[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O20 compound treatment 0.9928 -0.00716 -0.14 -0.1391 -1.0 2070604 Maybridge1_001912 FC(F)(F)c1cnc(NCc2cccnc2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O21 compound treatment 1.0096 0.00961 0.19 0.1866 1.0 2070605 Maybridge1_001913 Cc1ccc(OS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)c(n1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O22 compound treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 2070606 Maybridge1_001914 [O-][N+](=O)c1cccnc1Oc2ccccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O23 mock treatment 1.0033 0.00332 0.06 0.0645 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 O24 mock treatment 0.9852 -0.0148 -0.29 -0.2883 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P01 compound treatment 1.0054 0.00541 0.11 0.1052 1.0 1019665 Maybridge1_001915 O=S(=O)(NCc1ccccc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P02 compound treatment 1.0438 0.0438 0.85 0.8514 1.0 1595756 Maybridge1_001916 CC(C)(C)c1ccc(Oc2ccc(NC(=O)Cc3cccs3)cn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P03 compound treatment 0.9991 -8.73E-4 -0.02 -0.017 -1.0 2070607 Maybridge1_001917 COc1ccc(/C=C/2\C(=NN(C2=O)c3cccc(Cl)c3)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P04 compound treatment 1.0417 0.0417 0.81 0.8107 1.0 2070608 Maybridge1_001918 CCOC(=O)CNC(=O)c1cccnc1SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P05 compound treatment 0.9949 -0.00507 -0.1 -0.0984 -1.0 1552765 Maybridge1_001919 COc1ccccc1NC(=S)N2CC(C)(C)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P06 compound treatment 0.9789 -0.0211 -0.41 -0.4104 -1.0 2070609 Maybridge1_001920 CCOC(=O)CNC(=O)c1ccccc1N(CC=C)C(=O)c2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P07 compound treatment 0.9879 -0.0121 -0.23 -0.2341 -1.0 2070610 Maybridge1_001921 CCOC(=O)N1CCCN=C1NNc2cc(F)ccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P08 compound treatment 0.9691 -0.0309 -0.6 -0.6004 -1.0 2070611 Maybridge1_001922 FC(F)(F)C1=NN2C(=NC(=O)CC2=N)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P09 compound treatment 0.9768 -0.0232 -0.45 -0.4512 -1.0 1305583 Maybridge1_001923 Cc1cc(cc(C)c1OC(=O)Nc2ccccc2)c3nn(C)c(=O)c4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P10 compound treatment 1.1892 0.189 3.67 3.6737 1.0 2070612 Maybridge1_001924 CCOC(=O)c1nn(c2ccc(cc2)C(C)(C)C)c(=N)c(C#N)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P11 compound treatment 0.9928 -0.00716 -0.14 -0.1391 -1.0 2070613 Maybridge1_001925 Cc1ccc(Sc2ccc(NC(=O)Nc3ccc(SC(F)(F)F)cc3)cn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P12 compound treatment 0.9733 -0.0267 -0.52 -0.519 -1.0 2070614 Maybridge1_001926 CN(C)/C=N/c1ncccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P13 compound treatment 0.9872 -0.0128 -0.25 -0.2476 -1.0 2070615 Maybridge1_001927 Nc1nnc(SCC(=O)Nc2ccc(F)c(F)c2F)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P14 compound treatment 0.9754 -0.0246 -0.48 -0.4783 -1.0 2070616 Maybridge1_001928 Clc1ccc(nc1)S(=O)(=O)CCOC(=O)c2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P15 compound treatment 0.9733 -0.0267 -0.52 -0.519 -1.0 2070617 Maybridge1_001929 COC(=O)c1ccc(Cl)cc1NS(=O)(=O)c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P16 compound treatment 1.0075 0.00751 0.15 0.1459 1.0 2070618 Maybridge1_001930 Nc1nc(cs1)c2ccc(Br)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P17 compound treatment 1.0341 0.0341 0.66 0.6615 1.0 2070619 Maybridge1_001931 OC(=O)CC/C(=N\Nc1ccc(cc1)[N+](=O)[O-])/c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P18 compound treatment 0.9649 -0.0351 -0.68 -0.6818 -1.0 2070620 Maybridge1_001932 NC(=N)NCCS(=O)(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P19 compound treatment 0.9607 -0.0393 -0.76 -0.7632 -1.0 2070621 Maybridge1_001933 CN(C)/C=N/c1ncccc1OCc2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P20 compound treatment 0.9838 -0.0162 -0.32 -0.3155 -1.0 1950715 Maybridge1_001934 Cc1cc(O)n(n1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P21 compound treatment 0.939 -0.061 -1.18 -1.1839 -1.0 2070622 Maybridge1_001935 Cn1c(S)nnc1SCc2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P22 compound treatment 0.9956 -0.00437 -0.08 -0.0848 -1.0 2070623 Maybridge1_001936 COc1ccc(C(=O)O)c(Cl)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P23 mock treatment 1.0047 0.00472 0.09 0.0916 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.546 P24 mock treatment 1.0194 0.0194 0.38 0.3765 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A01 compound treatment 1.0466 0.0466 0.9 0.9048 1.0 1585994 Maybridge1_001937 COc1cccc(CC(=O)NN)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A02 compound treatment 1.053 0.053 1.03 1.0291 1.0 2070624 Maybridge1_001938 CCCCCc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A03 compound treatment 1.0409 0.0409 0.79 0.7944 1.0 1506162 Maybridge1_001939 CCOC(=O)C1=C(O)C(=O)N(C1)C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A04 compound treatment 0.9947 -0.00531 -0.1 -0.1031 -1.0 2070625 Maybridge1_001940 CCCCCCN(CCCCCC)c1ccc(cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A05 compound treatment 1.0317 0.0317 0.61 0.6149 1.0 1271035 Maybridge1_001941 NC(=O)C1=C(O)C(=O)N(C1)C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A06 compound treatment 1.0082 0.0082 0.16 0.1592 1.0 2070626 Maybridge1_001942 C/C(=N/O)/c1cc(cc2c1CCC2(C)C)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A07 compound treatment 0.9876 -0.0124 -0.24 -0.2412 -1.0 1014249 Maybridge1_001943 CCOC(=O)c1[nH]c(C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A08 compound treatment 1.0103 0.0103 0.2 0.2006 1.0 2070627 Maybridge1_001944 COc1cc(CC/C(=N/O)/C)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A09 compound treatment 1.0025 0.00251 0.05 0.0488 1.0 2070628 Maybridge1_001945 COC(=O)c1cc2ccccc2cn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A10 compound treatment 0.9634 -0.0366 -0.71 -0.7107 -1.0 1168073 Maybridge1_001946 CCCc1c2CCCCc2cc3c(=O)cc(oc13)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A11 compound treatment 1.0182 0.0182 0.35 0.3525 1.0 2070629 Maybridge1_001947 CC(=O)c1ccc(OCc2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A12 compound treatment 1.0068 0.00678 0.13 0.1316 1.0 1280207 Maybridge1_001948 CCOC(=O)c1cc(=O)c2ccc(OCC=C)cc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A13 compound treatment 1.0217 0.0217 0.42 0.4216 1.0 2070630 Maybridge1_001949 O=C1CCCc2[nH]c(=O)c(C#N)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A14 compound treatment 1.0132 0.0132 0.26 0.2559 1.0 2070631 Maybridge1_001950 CCCCCCc1cc2c(C)cc(=O)oc2cc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A15 compound treatment 0.9961 -0.00389 -0.08 -0.0755 -1.0 1026728 Maybridge1_001951 c1coc(c1)c2nc3ccccc3nc2c4ccco4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A16 compound treatment 0.9826 -0.0174 -0.34 -0.3379 -1.0 2070632 Maybridge1_001952 CCCc1cc([N+](=O)[O-])c(O)c2c(=O)cc(oc12)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A17 compound treatment 1.0096 0.00962 0.19 0.1868 1.0 1449566 Maybridge1_001953 COC(=O)CSc1cc(C)nc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A18 compound treatment 1.0054 0.00535 0.1 0.104 1.0 1555484 Maybridge1_001954 Brc1ccc(OCc2ccccc2)c(OCc3ccccc3)c1CCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A19 compound treatment 1.0146 0.0146 0.28 0.2835 1.0 2070633 Maybridge1_001955 CCn1cc(nc1C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A20 compound treatment 0.9819 -0.0181 -0.35 -0.3517 -1.0 2070634 Maybridge1_001956 CC(=O)Nc1ccc(CC=C)c(O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A21 compound treatment 1.0281 0.0281 0.55 0.5458 1.0 2070635 Maybridge1_001957 Cn1c2CCCC(=O)c2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A22 compound treatment 0.984 -0.016 -0.31 -0.3102 -1.0 1190426 Maybridge1_001958 CCCc1ccc(SC(=O)N(C)C)cc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A23 mock treatment 1.0075 0.00749 0.15 0.1454 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 A24 mock treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B01 compound treatment 1.0046 0.00464 0.09 0.0902 1.0 2070636 Maybridge1_001959 CCCCCCc1ccc(cc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B02 compound treatment 1.0046 0.00464 0.09 0.0902 1.0 1913687 Maybridge1_001960 COC(=O)CCC(=O)Nc1ccc(C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B03 compound treatment 0.9741 -0.0259 -0.5 -0.5035 -1.0 2070637 Maybridge1_001961 [O-][N+](=O)c1ccc(Sc2ccccc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B04 compound treatment 0.9719 -0.0281 -0.54 -0.545 -1.0 1478461 Maybridge1_001962 O=C1Cc2ccccc2C(N1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B05 compound treatment 1.0103 0.0103 0.2 0.2006 1.0 2070638 Maybridge1_001963 CC(C)(C)c1ccc(O)c(c1)/C(=N/O)/c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B06 compound treatment 1.0132 0.0132 0.26 0.2559 1.0 2070639 Maybridge1_001964 NC(=O)c1ccccc1OCCOc2ccccc2C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B07 compound treatment 0.9982 -0.00176 -0.03 -0.0341 -1.0 2070640 Maybridge1_001965 Cc1ccc(C)n1c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B08 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 1214488 Maybridge1_001966 O=C1CCC(=O)N1CCc2cnc[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B09 compound treatment 0.9805 -0.0195 -0.38 -0.3793 -1.0 2070641 Maybridge1_001967 CCOC(=O)CC(=O)c1cccc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B10 compound treatment 0.9606 -0.0394 -0.77 -0.7659 -1.0 2070642 Maybridge1_001968 OC(=O)CSc1nnc(S)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B11 compound treatment 0.9641 -0.0359 -0.7 -0.6969 -1.0 1056525 Maybridge1_001969 COC(=O)c1cccc([N+](=O)[O-])c1c2c(cccc2[N+](=O)[O-])C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B12 compound treatment 0.9492 -0.0508 -0.99 -0.9868 -1.0 2070643 Maybridge1_001970 N#CC(C1CCC=CC1)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B13 compound treatment 0.9613 -0.0387 -0.75 -0.7521 -1.0 1287839 Maybridge1_001971 CN1C2CCC1CC(=NO)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B14 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 2070644 Maybridge1_001972 CC(=O)c1cc2OCCOc2cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B15 compound treatment 0.9862 -0.0138 -0.27 -0.2688 -1.0 2070645 Maybridge1_001973 COc1ccc(NC(=O)C)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B16 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 1275916 Maybridge1_001974 OC(=O)CCC(=O)c1ccc2OCCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B17 compound treatment 0.979 -0.021 -0.41 -0.4069 -1.0 1040375 Maybridge1_001975 Ic1ccc-2c(c1)C(=O)c3ccccc32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B18 compound treatment 1.0174 0.0174 0.34 0.3387 1.0 2070646 Maybridge1_001976 CC1Cc2cc(ccc2O1)/C(=N/O)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B19 compound treatment 0.9478 -0.0522 -1.01 -1.0144 -1.0 1708515 Maybridge1_001977 CC(=CC1C(C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B20 compound treatment 0.9634 -0.0366 -0.71 -0.7107 -1.0 2070647 Maybridge1_001978 C/C(=N\O)/C1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B21 compound treatment 0.9869 -0.0131 -0.26 -0.255 -1.0 2070648 Maybridge1_001979 CCN(C(=O)C(Cc1ccccc1)C(=O)N(CC)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B22 compound treatment 0.9805 -0.0195 -0.38 -0.3793 -1.0 1342250 Maybridge1_001980 Cc1ccc(cc1)S(=O)(=O)N2CC(=O)NC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B23 mock treatment 0.999 -0.00104 -0.02 -0.0203 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 B24 mock treatment 1.0288 0.0288 0.56 0.5596 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C01 compound treatment 1.0096 0.00962 0.19 0.1868 1.0 2070649 Maybridge1_001981 COC(=O)c1ccc(OC)c(OC)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C02 compound treatment 0.979 -0.021 -0.41 -0.4069 -1.0 1697962 Maybridge1_001982 CCCCc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C03 compound treatment 0.9698 -0.0302 -0.59 -0.5864 -1.0 1018390 Maybridge1_001983 CCOC(=O)c1[nH]c(Cc2[nH]c(C(=O)OCC)c(C)c2CC)c(CC)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C04 compound treatment 0.9499 -0.0501 -0.97 -0.973 -1.0 1079253 Maybridge1_001984 CCCCCCCCc1ccc(cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C05 compound treatment 0.9769 -0.0231 -0.45 -0.4483 -1.0 1087705 Maybridge1_001985 CCOC(=O)C1=C(O)C(=O)N(Cc2ccccc2)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C06 compound treatment 0.9705 -0.0295 -0.57 -0.5726 -1.0 2070650 Maybridge1_001986 C/C(=N\OC(=O)c1cccs1)/c2cc(cc3c2CCC3(C)C)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C07 compound treatment 1.0011 0.00109 0.02 0.0211 1.0 2070651 Maybridge1_001987 CCN(CC)C(=O)c1[nH]c(C)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C08 compound treatment 0.9769 -0.0231 -0.45 -0.4483 -1.0 1330494 Maybridge1_001988 CCn1c(cc(=O)c2cc(OC)ccc12)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C09 compound treatment 0.9634 -0.0366 -0.71 -0.7107 -1.0 1210480 Maybridge1_001989 Cc1ccc(Oc2ncccc2N)c3CCCc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C10 compound treatment 0.9997 -3.33E-4 -0.01 -0.0065 -1.0 1601940 Maybridge1_001990 CCCc1c(OCC=C)ccc2c(=O)cc(oc12)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C11 compound treatment 0.9876 -0.0124 -0.24 -0.2412 -1.0 2070652 Maybridge1_001991 Cc1nc(cs1)c2cc(C#N)c(SCCNS(=O)(=O)c3cccc(c3)C(F)(F)F)nc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C12 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 1621208 Maybridge1_001992 COC(=O)c1cc(=O)c2cccc(OC)c2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C13 compound treatment 1.0011 0.00109 0.02 0.0211 1.0 2070653 Maybridge1_001993 CC1(C)OC(=O)C(=Cc2ccc(OCc3ccc(F)cc3)cc2)C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C14 compound treatment 1.0025 0.00251 0.05 0.0488 1.0 2070654 Maybridge1_001994 COc1ccc(C(=O)C)c(OCc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C15 compound treatment 1.0267 0.0267 0.52 0.5182 1.0 1071664 Maybridge1_001995 CC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C16 compound treatment 0.9513 -0.0487 -0.95 -0.9454 -1.0 2070655 Maybridge1_001996 Cc1ccc(cc1)S(=O)(=O)N2CCC(=N2)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C17 compound treatment 1.0089 0.00891 0.17 0.173 1.0 2070656 Maybridge1_001997 Clc1c(Cl)c(Cl)c(C#N)c(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C18 compound treatment 0.9762 -0.0238 -0.46 -0.4621 -1.0 2070657 Maybridge1_001998 CC(=O)C1COc2ccc(C)cc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C19 compound treatment 1.0039 0.00393 0.08 0.0764 1.0 683 Maybridge1_001999 Cc1ncc([N+](=O)[O-])n1CCO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C20 compound treatment 0.9591 -0.0409 -0.79 -0.7935 -1.0 2070658 Maybridge1_002000 CC(=O)Nc1cc(OCC=C)c(cc1C(=O)C)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C21 compound treatment 0.9847 -0.0153 -0.3 -0.2964 -1.0 2070659 Maybridge1_002001 Sc1nc(c2cccs2)c(C#N)c(=O)[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C22 compound treatment 0.9236 -0.0764 -1.48 -1.4839 -1.0 2070660 Maybridge1_002002 CCOC(=O)c1cc(=O)c2cc(I)ccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C23 mock treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 C24 mock treatment 1.0338 0.0338 0.66 0.6563 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D01 compound treatment 1.0231 0.0231 0.45 0.4492 1.0 1012007 Maybridge1_002003 COc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D02 compound treatment 1.0075 0.00749 0.15 0.1454 1.0 1022157 Maybridge1_002004 NS(=O)(=O)c1ccc(NC(=O)CCC(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D03 compound treatment 1.0203 0.0203 0.39 0.3939 1.0 1036639 Maybridge1_002005 O=c1c(c1c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D04 compound treatment 0.9982 -0.00176 -0.03 -0.0341 -1.0 1303231 Maybridge1_002006 CN(C)CC(O)Cn1c2ccc(Br)cc2c3cc(Br)ccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D05 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 1663982 Maybridge1_002007 CCOC(=O)Cc1c([nH]c(C)c1C(=O)OCc2ccccc2)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D06 compound treatment 1.0018 0.0018 0.03 0.035 1.0 1010260 Maybridge1_002008 COc1ccccc1OCCOc2ccccc2OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D07 compound treatment 1.0082 0.0082 0.16 0.1592 1.0 1062747 Maybridge1_002009 c1ccc(cc1)c2nc(c(o2)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D08 compound treatment 0.9826 -0.0174 -0.34 -0.3379 -1.0 1183034 Maybridge1_002010 OC1CCC(=O)N1CCc2cnc[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D09 compound treatment 0.9307 -0.0693 -1.35 -1.3458 -1.0 1038951 Maybridge1_002011 CCOC(=O)CC(=O)c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D10 compound treatment 0.9947 -0.00531 -0.1 -0.1031 -1.0 1126784 Maybridge1_002012 OC(=O)CC(Sc1nnc(S)s1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D11 compound treatment 0.9904 -0.00958 -0.19 -0.186 -1.0 1696384 Maybridge1_002013 CCN(CC)CCN(C)CC1c2ccccc2Oc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D12 compound treatment 1.0139 0.0139 0.27 0.2697 1.0 2070661 Maybridge1_002014 O=C1/C(=C\C2CCC=CC2)/Cc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D13 compound treatment 0.9876 -0.0124 -0.24 -0.2412 -1.0 2070662 Maybridge1_002015 CC(C)C(C#N)C(C#N)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D14 compound treatment 1.0032 0.00322 0.06 0.0626 1.0 1561456 Maybridge1_002016 Nc1ccc2OCCCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D15 compound treatment 0.9776 -0.0224 -0.43 -0.4345 -1.0 1084645 Maybridge1_002017 [O-][N+](=O)c1ccc(OCc2ccccc2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D16 compound treatment 0.979 -0.021 -0.41 -0.4069 -1.0 1720787 Maybridge1_002018 Brc1cc2OCCOc2cc1C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D17 compound treatment 1.0082 0.0082 0.16 0.1592 1.0 1060198 Maybridge1_002019 COC(=O)c1cccc2C(=O)c3ccccc3-c21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D18 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 2070663 Maybridge1_002020 CCCCCc1ccc(cc1)C(C)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D19 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 1542963 Maybridge1_002021 COc1ccc2c(c1)nnc3nnc(SCC(=O)N4CCOCC4)n32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D20 compound treatment 0.9748 -0.0252 -0.49 -0.4897 -1.0 1647393 Maybridge1_002022 CCC1(CC2CC3C1)CC(C2)(C3)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D21 compound treatment 0.9627 -0.0373 -0.72 -0.7245 -1.0 1026941 Maybridge1_002023 Clc1ccc2[nH]c3ccc(Cl)cc3c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D22 compound treatment 1.0388 0.0388 0.75 0.7529 1.0 1780030 Maybridge1_002024 [O-][N+](=O)c1ccc(cc1)S(=O)(=O)N2CC(=O)NC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D23 mock treatment 0.9492 -0.0508 -0.99 -0.9868 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 D24 mock treatment 0.9961 -0.00389 -0.08 -0.0755 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E01 compound treatment 1.0196 0.0196 0.38 0.3801 1.0 1371050 Maybridge1_002025 COc1ccc(C(=O)N)c(Cl)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E02 compound treatment 1.0089 0.00891 0.17 0.173 1.0 1675178 Maybridge1_002026 CCCc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E03 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 1018385 Maybridge1_002027 CCOC(=O)c1[nH]c(C)c(CC)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E04 compound treatment 0.967 -0.033 -0.64 -0.6416 -1.0 1079173 Maybridge1_002028 CCCCCCc1ccc(cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E05 compound treatment 1.0288 0.0288 0.56 0.5596 1.0 1330795 Maybridge1_002029 CCCCN1CC(=C(O)C1=O)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E06 compound treatment 0.9904 -0.00958 -0.19 -0.186 -1.0 2070664 Maybridge1_002030 C/C(=N\OC(=O)C(F)(F)F)/c1cc(cc2c1CCC2(C)C)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E07 compound treatment 0.9883 -0.0117 -0.23 -0.2274 -1.0 1032259 Maybridge1_002031 CC(=O)NC(CO)C(=O)c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E08 compound treatment 0.9463 -0.0537 -1.04 -1.042 -1.0 1074369 Maybridge1_002032 Cc1c(OCc2ccccc2)cccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E09 compound treatment 1.0174 0.0174 0.34 0.3387 1.0 2070665 Maybridge1_002033 Cc1ccc(Oc2ncccc2C(F)(F)F)c3CCCc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E10 compound treatment 0.9918 -0.00815 -0.16 -0.1584 -1.0 2070666 Maybridge1_002034 COc1ccc(C(=O)C)c(NC(=O)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E11 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 2070667 Maybridge1_002035 Cc1nc(c(o1)c2ccccc2)c3ccc(cc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E12 compound treatment 0.9833 -0.0167 -0.32 -0.324 -1.0 1026166 Maybridge1_002036 [O-][N+](=O)c1cc(OCc2ccccc2)c(OCc3ccccc3)c(OCc4ccccc4)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E13 compound treatment 0.9947 -0.00531 -0.1 -0.1031 -1.0 2070668 Maybridge1_002037 Cc1cc(Oc2ncccc2[N+](=O)[O-])cc(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E14 compound treatment 0.9606 -0.0394 -0.77 -0.7659 -1.0 1174165 Maybridge1_002038 CCCc1c(SC(=O)N(C)C)ccc2c(C)cc(=O)oc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E15 compound treatment 1.0018 0.0018 0.03 0.035 1.0 2070669 Maybridge1_002039 CSc1cc(C)nc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E16 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 2070670 Maybridge1_002040 CCCc1c(O)c(ccc1SC(=O)N(C)C)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E17 compound treatment 0.9463 -0.0537 -1.04 -1.042 -1.0 2070671 Maybridge1_002041 Oc1ccc(cc1)n2nnnc2SCC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E18 compound treatment 0.9385 -0.0615 -1.19 -1.1939 -1.0 1434029 Maybridge1_002042 CCCc1c(O)ccc2c(=O)cc(oc12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E19 compound treatment 1.0011 0.00109 0.02 0.0211 1.0 1404645 Maybridge1_002043 CC(C)(C)c1ccc(Oc2cnn(c3ccccc3)c(=O)c2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E20 compound treatment 0.9762 -0.0238 -0.46 -0.4621 -1.0 2070672 Maybridge1_002044 CCOC(=O)c1ccc2oc3ccc(O)cc3c(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E21 compound treatment 0.9826 -0.0174 -0.34 -0.3379 -1.0 1027240 Maybridge1_002045 CCCCCCCCCCc1ccc(cc1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E22 compound treatment 0.9599 -0.0401 -0.78 -0.7797 -1.0 1016459 Maybridge1_002046 CCC(=O)NNc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E23 mock treatment 0.9997 -3.33E-4 -0.01 -0.0065 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 E24 mock treatment 0.9769 -0.0231 -0.45 -0.4483 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F01 compound treatment 1.0359 0.0359 0.7 0.6977 1.0 1627859 Maybridge1_002047 CCOc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F02 compound treatment 1.0366 0.0366 0.71 0.7115 1.0 1177385 Maybridge1_002048 COC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F03 compound treatment 0.9719 -0.0281 -0.54 -0.545 -1.0 1053852 Maybridge1_002049 N#CC(=c1ccc(=C(C#N)C#N)cc1)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F04 compound treatment 1.0338 0.0338 0.66 0.6563 1.0 1235461 Maybridge1_002050 OC(CN1CCCCCC1)Cn2c3ccc(Br)cc3c4cc(Br)ccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F05 compound treatment 0.9748 -0.0252 -0.49 -0.4897 -1.0 1532455 Maybridge1_002051 COC(=O)CCc1c([nH]c(C)c1C(=O)OC(C)(C)C)C(=O)OCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F06 compound treatment 0.9762 -0.0238 -0.46 -0.4621 -1.0 2070673 Maybridge1_002052 CC(=O)Nc1cccc(OCCOc2cccc(NC(=O)C)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F07 compound treatment 0.9755 -0.0245 -0.48 -0.4759 -1.0 1007924 Maybridge1_002053 c1c(noc1c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F08 compound treatment 0.9876 -0.0124 -0.24 -0.2412 -1.0 1452323 Maybridge1_002054 Cn1c(=O)c2c(O)cc(=O)oc2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F09 compound treatment 0.9698 -0.0302 -0.59 -0.5864 -1.0 2070674 Maybridge1_002055 CCCCCc1ccc-2c(Cc3cc(ccc32)C(=O)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F10 compound treatment 0.9776 -0.0224 -0.43 -0.4345 -1.0 1114824 Maybridge1_002056 OC(=O)c1ccc(Br)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F11 compound treatment 0.9456 -0.0544 -1.06 -1.0558 -1.0 1029662 Maybridge1_002057 CC1(O)c2ccccc2-c3ccccc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F12 compound treatment 1.0203 0.0203 0.39 0.3939 1.0 2070675 Maybridge1_002058 CC(N1CCOCC1)C(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F13 compound treatment 0.994 -0.00602 -0.12 -0.1169 -1.0 1039044 Maybridge1_002059 C(CC=C(c1ccccc1)c2ccccc2)C=C(c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F14 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 2070676 Maybridge1_002060 CC1(C)CC(C)(c2cccc3ccccc23)c4cccc5cccc1c45 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F15 compound treatment 0.9819 -0.0181 -0.35 -0.3517 -1.0 1260687 Maybridge1_002061 Cc1cccc(c1)C(=O)c2ccccc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F16 compound treatment 0.9662 -0.0338 -0.66 -0.6554 -1.0 1004784 Maybridge1_002062 Oc1c(Cl)c(Cl)c(Cl)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F17 compound treatment 0.979 -0.021 -0.41 -0.4069 -1.0 2070677 Maybridge1_002063 Oc1cc(cc2C(=O)c3cc(ccc3-c21)[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F18 compound treatment 0.9954 -0.0046 -0.09 -0.0893 -1.0 2070678 Maybridge1_002064 OCC(O)C(O)c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F19 compound treatment 0.9734 -0.0266 -0.52 -0.5174 -1.0 1685691 Maybridge1_002065 COc1ccc2c(c1)nnc3nnc(SCC(=O)NN)n32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F20 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 1084281 Maybridge1_002066 CC(N)C1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F21 compound treatment 0.9655 -0.0345 -0.67 -0.6692 -1.0 1062012 Maybridge1_002067 Brc1ccc2[nH]c3c(Br)cc(Br)cc3c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F22 compound treatment 0.9755 -0.0245 -0.48 -0.4759 -1.0 2070679 Maybridge1_002068 CCCCCCCCCCCC(=O)N1CC(=O)NC(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F23 mock treatment 0.9741 -0.0259 -0.5 -0.5035 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 F24 mock treatment 1.0004 3.78E-4 0.01 0.0073 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G01 compound treatment 1.0836 0.0836 1.62 1.6228 1.0 2070680 Maybridge1_002069 COc1ccc(/C=C/C#N)c(Cl)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G02 compound treatment 1.0317 0.0317 0.61 0.6149 1.0 1089966 Maybridge1_002070 CCc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G03 compound treatment 0.9634 -0.0366 -0.71 -0.7107 -1.0 2070681 Maybridge1_002071 CC(=O)C1=C(C)NC(=O)C1CC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G04 compound treatment 0.9862 -0.0138 -0.27 -0.2688 -1.0 2070682 Maybridge1_002072 Cc1ccc(Br)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G05 compound treatment 0.9698 -0.0302 -0.59 -0.5864 -1.0 1398285 Maybridge1_002073 COC(=O)Cc1c(OC(=O)C)[nH]c(C)c1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G06 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 2070683 Maybridge1_002074 CC1(C)C2CCC1(C)/C(=N/O)/C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G07 compound treatment 0.9933 -0.00673 -0.13 -0.1307 -1.0 1472613 Maybridge1_002075 Cc1ccc(OC(C)(C)C(=O)O)c2CCCc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G08 compound treatment 0.9726 -0.0274 -0.53 -0.5312 -1.0 1092704 Maybridge1_002076 COc1cc(Br)c(CCC#N)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G09 compound treatment 1.0139 0.0139 0.27 0.2697 1.0 1252404 Maybridge1_002077 COc1ccccc1C2OC(=O)CC2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G10 compound treatment 1.0004 3.78E-4 0.01 0.0073 1.0 2732 Maybridge1_002078 Cc1cc(=O)oc2cc(O)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G11 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 2070684 Maybridge1_002079 O=C(C1COC(=O)C1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G12 compound treatment 0.9712 -0.0288 -0.56 -0.5588 -1.0 2070685 Maybridge1_002080 COc1ccc2C(=O)C(CCc2c1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G13 compound treatment 1.3118 0.312 6.06 6.055 1.0 1639767 Maybridge1_002081 O=C1Cc2ccccc2C(=O)c3ccsc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G14 compound treatment 0.9535 -0.0465 -0.9 -0.904 -1.0 1686304 Maybridge1_002082 CCOC(=O)c1cc(=O)c2ccc(O)cc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G15 compound treatment 0.9712 -0.0288 -0.56 -0.5588 -1.0 1339494 Maybridge1_002083 CC(=O)Nc1cccc(C)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G16 compound treatment 0.9833 -0.0167 -0.32 -0.324 -1.0 1515846 Maybridge1_002084 CCCc1c(O)ccc2C(=O)CC(C)(CCC(=O)OC)Oc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G17 compound treatment 0.9712 -0.0288 -0.56 -0.5588 -1.0 1660066 Maybridge1_002085 CCOC(=O)c1cc2cc(Br)cc(Br)c2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G18 compound treatment 0.9286 -0.0714 -1.39 -1.3872 -1.0 2070686 Maybridge1_002086 CCCc1c(O)c(ccc1OCc2ccccc2)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G19 compound treatment 1.0046 0.00464 0.09 0.0902 1.0 1397141 Maybridge1_002087 O=C(ON1C(=O)C2C3OC(C=C3)C2C1=O)c4cccnc4Oc5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G20 compound treatment 0.9982 -0.00176 -0.03 -0.0341 -1.0 2070687 Maybridge1_002088 CS/C(=N/c1ccccc1)/Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G21 compound treatment 1.0331 0.0331 0.64 0.6425 1.0 1080745 Maybridge1_002089 CC(=O)c1ccc(cc1)c2ccc(cc2)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G22 compound treatment 0.9513 -0.0487 -0.95 -0.9454 -1.0 2070688 Maybridge1_002090 CCCc1ccc(OC)cc1NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G23 mock treatment 1.0132 0.0132 0.26 0.2559 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 G24 mock treatment 0.9847 -0.0153 -0.3 -0.2964 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H01 compound treatment 1.0267 0.0267 0.52 0.5182 1.0 1274795 Maybridge1_002091 CCCOc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H02 compound treatment 1.016 0.016 0.31 0.3111 1.0 1254947 Maybridge1_002092 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2c(C)n(C)n(c3ccccc3)c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H03 compound treatment 1.0153 0.0153 0.3 0.2973 1.0 1026066 Maybridge1_002093 CCOC(=O)C1c2ccccc2Oc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H04 compound treatment 1.3857 0.386 7.49 7.491 1.0 1033421 Maybridge1_002094 Nc1cccc2-c3ccccc3C(=O)c21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H05 compound treatment 1.0381 0.0381 0.74 0.7391 1.0 2070689 Maybridge1_002095 O=C1N(CCCCCN2C(=O)c3ccccc3S2(=O)=O)S(=O)(=O)c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H06 compound treatment 1.0146 0.0146 0.28 0.2835 1.0 2070690 Maybridge1_002096 COc1cccc(OCCOc2cccc(OC)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H07 compound treatment 1.0032 0.00322 0.06 0.0626 1.0 1022179 Maybridge1_002097 CN(C)Cc1cc(O)c(CN(C)C)cc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H08 compound treatment 0.9883 -0.0117 -0.23 -0.2274 -1.0 2070691 Maybridge1_002098 O[C@H]1C2C3C4C2C5CC4C([C@@H]3O)C15 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H09 compound treatment 1.0046 0.00464 0.09 0.0902 1.0 1011924 Maybridge1_002099 CC(=O)c1ccc-2c(Cc3ccccc32)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H10 compound treatment 0.9705 -0.0295 -0.57 -0.5726 -1.0 1047733 Maybridge1_002100 N#CCCC(CCC#N)(C#N)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H11 compound treatment 0.9812 -0.0188 -0.37 -0.3655 -1.0 1520838 Maybridge1_002101 CCC(C#N)(c1ccccc1)c2ccc(N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H12 compound treatment 0.9762 -0.0238 -0.46 -0.4621 -1.0 1472477 Maybridge1_002102 OC(=O)C1(CC2CC3CC(O)(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H13 compound treatment 0.9471 -0.0529 -1.03 -1.0282 -1.0 3177555 Maybridge1_002103 Cc1ccc(cc1)S(=O)(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)OCC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H14 compound treatment 0.9599 -0.0401 -0.78 -0.7797 -1.0 2070693 Maybridge1_002104 [O-][N+](=O)c1ccc2[nH]c3ccc(cc3c2c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H15 compound treatment 0.9399 -0.0601 -1.17 -1.1663 -1.0 1073082 Maybridge1_002105 c1csc(c1)c2nc3ccccc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H16 compound treatment 0.9748 -0.0252 -0.49 -0.4897 -1.0 2070694 Maybridge1_002106 NC(=O)C1CC1(Cl)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H17 compound treatment 0.9634 -0.0366 -0.71 -0.7107 -1.0 1041298 Maybridge1_002107 OC(=O)c1cccc2Cc3ccccc3-c21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H18 compound treatment 0.9726 -0.0274 -0.53 -0.5312 -1.0 2070695 Maybridge1_002108 CCCCCc1ccc(/C=N/O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H19 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 2070696 Maybridge1_002109 OC(=O)C(F)(F)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H20 compound treatment 0.957 -0.043 -0.83 -0.8349 -1.0 1132443 Maybridge1_002110 CCOC(=O)c1c(C)n(c2ccccc2)c3ccc(O)cc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H21 compound treatment 0.9634 -0.0366 -0.71 -0.7107 -1.0 1421410 Maybridge1_002111 OCC(O)Cn1c2ccccc2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H22 compound treatment 0.9506 -0.0494 -0.96 -0.9592 -1.0 1405657 Maybridge1_002112 O=C1CN(CC(=O)N1)S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H23 mock treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 H24 mock treatment 1.0345 0.0345 0.67 0.6701 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I01 compound treatment 1.021 0.021 0.41 0.4078 1.0 2070697 Maybridge1_002113 CCOC(=O)c1ccc(OC)c(OC)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I02 compound treatment 0.9591 -0.0409 -0.79 -0.7935 -1.0 1083770 Maybridge1_002114 N#Cc1nccc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I03 compound treatment 0.9627 -0.0373 -0.72 -0.7245 -1.0 1679978 Maybridge1_002115 CCOC(=O)C1=C(N)C(=O)N(C1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I04 compound treatment 1.0345 0.0345 0.67 0.6701 1.0 1071677 Maybridge1_002116 CN(C)c1cccc2cccc(N(C)C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I05 compound treatment 0.9982 -0.00176 -0.03 -0.0341 -1.0 1007323 Maybridge1_002117 CCOC(=O)c1[nH]c(C)c(C(=O)C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I06 compound treatment 1.0061 0.00607 0.12 0.1178 1.0 2070698 Maybridge1_002118 Cc1oc(nc1CC(=O)O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I07 compound treatment 0.9769 -0.0231 -0.45 -0.4483 -1.0 1275946 Maybridge1_002119 OC(C(=O)c1cccs1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I08 compound treatment 0.9634 -0.0366 -0.71 -0.7107 -1.0 1204024 Maybridge1_002120 N#CCCc1cccc(OCc2ccccc2)c1OCc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I09 compound treatment 1.0253 0.0253 0.49 0.4906 1.0 2070699 Maybridge1_002121 Clc1ccc(C(=O)NCCSC(=O)c2ccc(Cl)cc2Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I10 compound treatment 0.9854 -0.0146 -0.28 -0.2826 -1.0 2070700 Maybridge1_002122 Nc1nnc(s1)c2ccc(o2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I11 compound treatment 1.0558 0.0558 1.08 1.0843 1.0 2070701 Maybridge1_002123 [O-][N+](=O)c1cccnc1Oc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I12 compound treatment 1.0046 0.00464 0.09 0.0902 1.0 1928073 Maybridge1_002124 COC(=O)c1cccc(OC)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I13 compound treatment 0.9783 -0.0217 -0.42 -0.4207 -1.0 2070702 Maybridge1_002125 CCCCCc1ccc(cc1)c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I14 compound treatment 0.9435 -0.0565 -1.1 -1.0973 -1.0 1727984 Maybridge1_002126 COC(=O)c1ccc(cc1)C2=NC(C)(C)CO2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I15 compound treatment 0.9847 -0.0153 -0.3 -0.2964 -1.0 2070703 Maybridge1_002127 [O-][N+](=O)c1ccc(Sc2ccccn2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I16 compound treatment 0.9599 -0.0401 -0.78 -0.7797 -1.0 1698123 Maybridge1_002128 COc1ccc2nc(N)sc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I17 compound treatment 1.0324 0.0324 0.63 0.6287 1.0 2070704 Maybridge1_002129 Nc1cccnc1Sc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I18 compound treatment 0.9584 -0.0416 -0.81 -0.8073 -1.0 1022546 Maybridge1_002130 CCOC(=O)c1cc2cc(OCc3ccccc3)ccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I19 compound treatment 0.9826 -0.0174 -0.34 -0.3379 -1.0 2070705 Maybridge1_002131 COC(=O)c1cccnc1Oc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I20 compound treatment 0.9535 -0.0465 -0.9 -0.904 -1.0 2070706 Maybridge1_002132 CS/C(=N/C(C)C)/NC(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I21 compound treatment 0.9869 -0.0131 -0.26 -0.255 -1.0 1111975 Maybridge1_002133 Cc1cc(C)n(C)c(=O)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I22 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 1018233 Maybridge1_002134 CCN(CC)S(=O)(=O)c1ccc(C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I23 mock treatment 0.9769 -0.0231 -0.45 -0.4483 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 I24 mock treatment 1.0196 0.0196 0.38 0.3801 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J01 compound treatment 1.0587 0.0587 1.14 1.1396 1.0 2070707 Maybridge1_002135 CCCCOc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J02 compound treatment 1.011 0.011 0.21 0.2144 1.0 1169013 Maybridge1_002136 Cc1c(NS(=O)(=O)c2ccc(NC(=O)CCC(=O)O)cc2)c(=O)n(c3ccccc3)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J03 compound treatment 0.9776 -0.0224 -0.43 -0.4345 -1.0 1075281 Maybridge1_002137 Cc1ccc2ncccc2c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J04 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 2070708 Maybridge1_002138 OC(=O)c1cccc2cccc(Br)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J05 compound treatment 0.9776 -0.0224 -0.43 -0.4345 -1.0 2070709 Maybridge1_002139 CC(C)(C)c1cc2CCc3cc(cc(c1)c23)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J06 compound treatment 0.9869 -0.0131 -0.26 -0.255 -1.0 1056658 Maybridge1_002140 Clc1ccc(OCCOc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J07 compound treatment 0.9947 -0.00531 -0.1 -0.1031 -1.0 2070710 Maybridge1_002141 [O-][N+](=O)c1sccc1CS(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J08 compound treatment 1.0189 0.0189 0.37 0.3663 1.0 2070711 Maybridge1_002142 COC(F)(C(=O)N)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J09 compound treatment 0.9812 -0.0188 -0.37 -0.3655 -1.0 1289810 Maybridge1_002143 Brc1ccc(CC(=O)c2ccc-3c(Cc4ccccc43)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J10 compound treatment 0.9904 -0.00958 -0.19 -0.186 -1.0 1007301 Maybridge1_002144 NC(=O)C(CCC#N)(CCC#N)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J11 compound treatment 0.9655 -0.0345 -0.67 -0.6692 -1.0 2070712 Maybridge1_002145 CC(=O)/C(=N/NC(=O)CC#N)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J12 compound treatment 0.9726 -0.0274 -0.53 -0.5312 -1.0 2070713 Maybridge1_002146 CO[C@H]1CC2(N3CC=C2C=C1)c4cc(OC)c(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc4CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J13 compound treatment 0.9741 -0.0259 -0.5 -0.5035 -1.0 2070714 Maybridge1_002147 Cc1csc(c1c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J14 compound treatment 0.9677 -0.0323 -0.63 -0.6278 -1.0 2070715 Maybridge1_002148 Cn1c2ccccc2c3cc(ccc13)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J15 compound treatment 1.0046 0.00464 0.09 0.0902 1.0 2070716 Maybridge1_002149 Cn1c(nc2ccccc12)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J16 compound treatment 0.984 -0.016 -0.31 -0.3102 -1.0 1368311 Maybridge1_002150 Clc1ccc(cc1)C(=O)c2cc3OCCOc3cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J17 compound treatment 0.967 -0.033 -0.64 -0.6416 -1.0 1055459 Maybridge1_002151 OC(=O)C1Cc2c(CN1)[nH]c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J18 compound treatment 1.0011 0.00109 0.02 0.0211 1.0 2070717 Maybridge1_002152 [O-][N+](=O)c1ccc(cc1)C(=O)c2cc3OCCOc3cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J19 compound treatment 0.9918 -0.00815 -0.16 -0.1584 -1.0 1059900 Maybridge1_002153 OC(=O)c1cc(Br)c(cc1Br)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J20 compound treatment 0.9492 -0.0508 -0.99 -0.9868 -1.0 2070718 Maybridge1_002154 Cc1c(NC(=O)/C=N/O)c(=O)n(c2ccccc2)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J21 compound treatment 1.0096 0.00962 0.19 0.1868 1.0 1159242 Maybridge1_002155 Cc1ccc(cc1)S(=O)(=O)Nc2ccc3ncccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J22 compound treatment 0.9613 -0.0387 -0.75 -0.7521 -1.0 1117231 Maybridge1_002156 BrC1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J23 mock treatment 0.9741 -0.0259 -0.5 -0.5035 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 J24 mock treatment 1.048 0.048 0.93 0.9324 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K01 compound treatment 1.0153 0.0153 0.3 0.2973 1.0 1050460 Maybridge1_002157 OC1(CCNCC1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K02 compound treatment 1.0046 0.00464 0.09 0.0902 1.0 1051267 Maybridge1_002158 Oc1nc2cccnc2nc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K03 compound treatment 0.9904 -0.00958 -0.19 -0.186 -1.0 1003036 Maybridge1_002159 CCOC(=O)c1[nH]c(C)c(C(=O)OCC)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K04 compound treatment 0.9833 -0.0167 -0.32 -0.324 -1.0 1037780 Maybridge1_002160 CCc1ccc(cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K05 compound treatment 1.0096 0.00962 0.19 0.1868 1.0 1010424 Maybridge1_002161 C(CNc1ccccc1)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K06 compound treatment 0.9627 -0.0373 -0.72 -0.7245 -1.0 2070719 Maybridge1_002162 COc1ccc2nccc(C(=O)C3CC4CCN3C(C4)C=C)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K07 compound treatment 0.9776 -0.0224 -0.43 -0.4345 -1.0 2070720 Maybridge1_002163 COc1ccc(C)c2CCCc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K08 compound treatment 0.9734 -0.0266 -0.52 -0.5174 -1.0 2070721 Maybridge1_002164 COc1c(O)c(C(=O)C)c(OC)c2ccoc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K09 compound treatment 1.0118 0.0118 0.23 0.2283 1.0 2070722 Maybridge1_002165 Fc1ccc(cc1)C(=O)NCCSC(=O)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K10 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 1231125 Maybridge1_002166 CCOC(=O)c1cc(=O)c2c(O)c(CC=C)ccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K11 compound treatment 0.9655 -0.0345 -0.67 -0.6692 -1.0 2070723 Maybridge1_002167 COc1ccc(Oc2ncccc2[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K12 compound treatment 0.9421 -0.0579 -1.12 -1.1249 -1.0 1174068 Maybridge1_002168 COc1c(OC)c(sc1C(=O)O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K13 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 2070724 Maybridge1_002169 COc1cc(ccc1N2CCCC2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K14 compound treatment 0.9577 -0.0423 -0.82 -0.8211 -1.0 2070725 Maybridge1_002170 CCOCCOc1ccc2oc(cc(=O)c2c1)C(=O)CC(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K15 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 1283944 Maybridge1_002171 Cc1cccc(Oc2ncccc2N)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K16 compound treatment 1.0118 0.0118 0.23 0.2283 1.0 1216999 Maybridge1_002172 CC1(C)CC(=O)C=C(C1)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K17 compound treatment 0.9556 -0.0444 -0.86 -0.8625 -1.0 2070726 Maybridge1_002173 CN(C)/C=N/c1cc(on1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K18 compound treatment 0.9719 -0.0281 -0.54 -0.545 -1.0 1502251 Maybridge1_002174 CCn1c(cc(=O)c2cc(OCC=C)ccc12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K19 compound treatment 0.984 -0.016 -0.31 -0.3102 -1.0 2070727 Maybridge1_002175 CC(C)n1cc(nc1C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K20 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 1514172 Maybridge1_002176 CCC(=O)c1ccc(SC(=O)N(C)C)cc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K21 compound treatment 0.9876 -0.0124 -0.24 -0.2412 -1.0 1721896 Maybridge1_002177 Oc1ccc(cc1)C(C#N)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K22 compound treatment 0.9634 -0.0366 -0.71 -0.7107 -1.0 1075100 Maybridge1_002178 Cc1cc2OCCOc2cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K23 mock treatment 1.0523 0.0523 1.02 1.0153 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 K24 mock treatment 1.021 0.021 0.41 0.4078 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L01 compound treatment 1.0338 0.0338 0.66 0.6563 1.0 2070728 Maybridge1_002179 CCCCCCOc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L02 compound treatment 1.0153 0.0153 0.3 0.2973 1.0 2070729 Maybridge1_002180 CC(=O)c1ccc2OCCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L03 compound treatment 0.984 -0.016 -0.31 -0.3102 -1.0 2070730 Maybridge1_002181 CCCCCCCCCCc1ccc(cc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L04 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 1027383 Maybridge1_002182 Cn1c(=O)cc(O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L05 compound treatment 1.0075 0.00749 0.15 0.1454 1.0 2070731 Maybridge1_002183 FC(F)(F)c1cnc(/N=C/N2CCOCC2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L06 compound treatment 1.0679 0.0679 1.32 1.3191 1.0 2070732 Maybridge1_002184 COc1ccc(OCCOc2ccc(OC)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L07 compound treatment 1.0302 0.0302 0.59 0.5873 1.0 1135835 Maybridge1_002185 Sc1nc2cc3OCCOc3cc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L08 compound treatment 1.0061 0.00607 0.12 0.1178 1.0 1660986 Maybridge1_002186 NC1=C(C(=O)NC1=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L09 compound treatment 0.9684 -0.0316 -0.61 -0.614 -1.0 1056325 Maybridge1_002187 O=C(c1ccccc1)c2ccc-3c(Cc4ccccc43)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L10 compound treatment 0.999 -0.00104 -0.02 -0.0203 -1.0 1004888 Maybridge1_002188 N#CCCn1c2ccccc2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L11 compound treatment 0.9641 -0.0359 -0.7 -0.6969 -1.0 1101325 Maybridge1_002189 OC1CN(C1)C(c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L12 compound treatment 1.0146 0.0146 0.28 0.2835 1.0 2070733 Maybridge1_002190 COC(=O)Cc1nc(sc1C)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L13 compound treatment 0.9535 -0.0465 -0.9 -0.904 -1.0 2070734 Maybridge1_002191 Cc1c(Br)sc(Br)c1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L14 compound treatment 1.0061 0.00607 0.12 0.1178 1.0 1019205 Maybridge1_002192 OC(=O)c1cccc2-c3ccccc3C(=O)c21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L15 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 2070735 Maybridge1_002193 c1nnc2nnc3ccccc3n12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L16 compound treatment 0.999 -0.00104 -0.02 -0.0203 -1.0 1329133 Maybridge1_002194 Brc1ccc(cc1)C(=O)c2cc3OCCOc3cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L17 compound treatment 0.9812 -0.0188 -0.37 -0.3655 -1.0 2070736 Maybridge1_002195 COc1cc(CC/C(=N\O)/C)ccc1OCc2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L18 compound treatment 0.9606 -0.0394 -0.77 -0.7659 -1.0 1051539 Maybridge1_002196 CC(C)(C(=O)O)C(C)(C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L19 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 1185814 Maybridge1_002197 Cn1c(=O)c(c(O)c2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L20 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 2070737 Maybridge1_002198 O=C1COc2ccccc2C(=O)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L21 compound treatment 0.9527 -0.0473 -0.92 -0.9178 -1.0 1340494 Maybridge1_002199 COc1ccc(OCC(O)CN)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L22 compound treatment 0.9883 -0.0117 -0.23 -0.2274 -1.0 1100237 Maybridge1_002200 OC(=O)CC1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L23 mock treatment 1.0004 3.78E-4 0.01 0.0073 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 L24 mock treatment 1.0153 0.0153 0.3 0.2973 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M01 compound treatment 1.0701 0.0701 1.36 1.3605 1.0 1623886 Maybridge1_002201 CC1(C)C(Oc2ccc(O)cc21)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M02 compound treatment 0.9947 -0.00531 -0.1 -0.1031 -1.0 2070738 Maybridge1_002202 CC(=O)c1ccc(OCc2ccc(F)cc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M03 compound treatment 1.0238 0.0238 0.46 0.463 1.0 2070739 Maybridge1_002203 CC(=O)CNC(=O)Cc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M04 compound treatment 1.0039 0.00393 0.08 0.0764 1.0 1013471 Maybridge1_002204 CC(C)(C)C1=CC(=O)C=C(C1=O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M05 compound treatment 1.0004 3.78E-4 0.01 0.0073 1.0 1061166 Maybridge1_002205 Cc1ccc(cc1)S(=O)(=O)NCC(=O)OCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M06 compound treatment 0.9918 -0.00815 -0.16 -0.1584 -1.0 2070740 Maybridge1_002206 O/N=C/1\C(=O)Nc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M07 compound treatment 1.0196 0.0196 0.38 0.3801 1.0 2070741 Maybridge1_002207 COc1c2CCCc2c(C)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M08 compound treatment 1.0125 0.0125 0.24 0.2421 1.0 1068351 Maybridge1_002208 CC(=O)c1c(C)cc2cc(C)cc(O)c2c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M09 compound treatment 0.999 -0.00104 -0.02 -0.0203 -1.0 2070742 Maybridge1_002209 CC(C)(C)c1ccc(cc1)C(=O)NCCSC(=O)c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M10 compound treatment 0.9513 -0.0487 -0.95 -0.9454 -1.0 1413315 Maybridge1_002210 CCOC(=O)c1c(O)c(O)c(C(=O)OCC)n1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M11 compound treatment 0.9563 -0.0437 -0.85 -0.8487 -1.0 2070743 Maybridge1_002211 CC(C)(C)c1ccc(Oc2ncccc2[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M12 compound treatment 0.962 -0.038 -0.74 -0.7383 -1.0 2070744 Maybridge1_002212 COc1ccc(OC)c2c(=O)cc([nH]c12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M13 compound treatment 0.9954 -0.0046 -0.09 -0.0893 -1.0 2070745 Maybridge1_002213 CCCCCOc1ccc(cc1)c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M14 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 1087097 Maybridge1_002214 OC(=O)C1CC(=O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M15 compound treatment 0.9961 -0.00389 -0.08 -0.0755 -1.0 1572932 Maybridge1_002215 Cc1cc(c2ccccc2n1)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M16 compound treatment 0.9542 -0.0458 -0.89 -0.8902 -1.0 1623580 Maybridge1_002216 CCCc1c(O)ccc2c(=O)cc(sc12)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M17 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 1068971 Maybridge1_002217 [O-][N+](=O)c1ccc(cc1)C(=O)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M18 compound treatment 0.957 -0.043 -0.83 -0.8349 -1.0 2070746 Maybridge1_002218 Clc1ccc(cc1)C(=S)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M19 compound treatment 1.011 0.011 0.21 0.2144 1.0 2070747 Maybridge1_002219 CC(=O)CCn1cc(nc1C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M20 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 3063067 Maybridge1_002220 CS/C(=N/C(C)C)/NC(C)C.Cc1ccc(cc1)S(=O)(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M21 compound treatment 0.9577 -0.0423 -0.82 -0.8211 -1.0 2070748 Maybridge1_002221 CCOC(=O)C(C(NC(=N)S)c1ccsc1)C(=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M22 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 1013118 Maybridge1_002222 Clc1cccc2C(=O)c3c(Cl)cccc3C(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M23 mock treatment 1.0103 0.0103 0.2 0.2006 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 M24 mock treatment 0.9371 -0.0629 -1.22 -1.2215 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N01 compound treatment 1.0537 0.0537 1.04 1.0429 1.0 2070749 Maybridge1_002223 CCCCCCCCOc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N02 compound treatment 0.9641 -0.0359 -0.7 -0.6969 -1.0 1558428 Maybridge1_002224 OCCn1c(=O)c2cc3c(=O)n(CCO)c(=O)c3cc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N03 compound treatment 0.9783 -0.0217 -0.42 -0.4207 -1.0 1577930 Maybridge1_002225 CCNc1ccc(cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N04 compound treatment 1.0224 0.0224 0.44 0.4354 1.0 1031309 Maybridge1_002226 [O-][N+](=O)c1ccc2oc(=O)ccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N05 compound treatment 0.9997 -3.33E-4 -0.01 -0.0065 -1.0 2070750 Maybridge1_002227 CN1CCN(CC1)/C=N/c2ncc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N06 compound treatment 1.0132 0.0132 0.26 0.2559 1.0 2070751 Maybridge1_002228 Clc1ccc(Cl)c(OCCOc2cc(Cl)ccc2Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N07 compound treatment 0.9997 -3.33E-4 -0.01 -0.0065 -1.0 1223178 Maybridge1_002229 O=C(c1ccccc1)c2ccc3OCCCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N08 compound treatment 1.0445 0.0445 0.86 0.8634 1.0 1045283 Maybridge1_002230 CCCCC(=O)c1ccc(Br)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N09 compound treatment 0.9904 -0.00958 -0.19 -0.186 -1.0 2070752 Maybridge1_002231 Cc1ccc(cc1)S(=O)(=O)N/N=C/C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N10 compound treatment 1.0238 0.0238 0.46 0.463 1.0 1022399 Maybridge1_002232 N#CCCC1(CCC#N)c2ccccc2-c3ccccc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N11 compound treatment 0.9648 -0.0352 -0.68 -0.683 -1.0 2070753 Maybridge1_002233 COC(=O)c1cccc2cccc(c3cccc4cccc(C(=O)OC)c34)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N12 compound treatment 0.9556 -0.0444 -0.86 -0.8625 -1.0 2070754 Maybridge1_002234 O=C1CCc2cccc3cccc1c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N13 compound treatment 0.9677 -0.0323 -0.63 -0.6278 -1.0 2070755 Maybridge1_002235 c1cc(c(s1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N14 compound treatment 0.9968 -0.00318 -0.06 -0.0617 -1.0 2070756 Maybridge1_002236 Brc1cc2OCCOc2cc1C(=O)Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N15 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 1011927 Maybridge1_002237 Ic1ccc-2c(Cc3ccccc32)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N16 compound treatment 0.9485 -0.0515 -1.0 -1.0006 -1.0 1657689 Maybridge1_002238 COc1ccccc1C(=O)c2cc3OCCOc3cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N17 compound treatment 0.9435 -0.0565 -1.1 -1.0973 -1.0 2070757 Maybridge1_002239 CCOC(=O)COc1ccccc1C(O)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N18 compound treatment 0.9833 -0.0167 -0.32 -0.324 -1.0 1488255 Maybridge1_002240 CC1(CC2CC3(C)C1)CC(C2)(C3)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N19 compound treatment 0.9926 -0.00744 -0.14 -0.1445 -1.0 1611622 Maybridge1_002241 O=C1N(C(=O)c2cccc3cccc1c23)c4nc5ccccc5[nH]4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N20 compound treatment 0.9819 -0.0181 -0.35 -0.3517 -1.0 1323508 Maybridge1_002242 CCC1Oc2ccccc2C(=O)NC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N21 compound treatment 0.9847 -0.0153 -0.3 -0.2964 -1.0 1675924 Maybridge1_002243 Cc1c(NC(=O)CCC(=O)O)c(=O)n(c2ccccc2)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N22 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 2070758 Maybridge1_002244 CC1CN=C(Nc2ccccc2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N23 mock treatment 0.9954 -0.0046 -0.09 -0.0893 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 N24 mock treatment 1.0189 0.0189 0.37 0.3663 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O01 compound treatment 1.0253 0.0253 0.49 0.4906 1.0 2070759 Maybridge1_002245 COC(=O)CC1C(=O)NC(=C1C(=O)OC)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O02 compound treatment 0.9719 -0.0281 -0.54 -0.545 -1.0 2070760 Maybridge1_002246 CC(=O)c1ccc(OCc2ccc(Cl)c(Cl)c2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O03 compound treatment 1.026 0.026 0.5 0.5044 1.0 1505833 Maybridge1_002247 COC(=O)C1=C(C)NC(=O)C1CC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O04 compound treatment 1.0196 0.0196 0.38 0.3801 1.0 2070761 Maybridge1_002248 COc1ccc(CO)c(Cl)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O05 compound treatment 0.994 -0.00602 -0.12 -0.1169 -1.0 2070762 Maybridge1_002249 CC1=C(C(=O)NC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O06 compound treatment 0.9755 -0.0245 -0.48 -0.4759 -1.0 2070763 Maybridge1_002250 ON=C(c1cccs1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O07 compound treatment 1.0132 0.0132 0.26 0.2559 1.0 2070764 Maybridge1_002251 Cc1ccc(Oc2ncccc2[N+](=O)[O-])c3CCCc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O08 compound treatment 0.9613 -0.0387 -0.75 -0.7521 -1.0 2070765 Maybridge1_002252 CCCc1c(cc(cc1[N+](=O)[O-])C(=O)O)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O09 compound treatment 1.0089 0.00891 0.17 0.173 1.0 2070766 Maybridge1_002253 CC(=O)c1ccc(OCc2ccc(Cl)c(Cl)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O10 compound treatment 0.9975 -0.00247 -0.05 -0.0479 -1.0 1601320 Maybridge1_002254 CCCc1cc(=O)c2ccc(O)cc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O11 compound treatment 1.0125 0.0125 0.24 0.2421 1.0 2070767 Maybridge1_002255 Oc1ncc(cc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O12 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 2070768 Maybridge1_002256 CC/C(=N\NS(=O)(=O)c1ccc(C)cc1)/c2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O13 compound treatment 0.9599 -0.0401 -0.78 -0.7797 -1.0 2070769 Maybridge1_002257 N#CCCOc1ccc2ccccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O14 compound treatment 0.9563 -0.0437 -0.85 -0.8487 -1.0 1495792 Maybridge1_002258 Clc1ccc(cc1)N2CCC(=O)N2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O15 compound treatment 0.9591 -0.0409 -0.79 -0.7935 -1.0 1400259 Maybridge1_002259 COc1cc(OC)nc(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O16 compound treatment 0.9613 -0.0387 -0.75 -0.7521 -1.0 2070770 Maybridge1_002260 CC(=O)c1c(OCC=C)cc(OCc2ccccc2)c(C(=O)C)c1OCc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O17 compound treatment 0.9876 -0.0124 -0.24 -0.2412 -1.0 2070771 Maybridge1_002261 CN(C)/C=N/c1noc(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O18 compound treatment 0.9883 -0.0117 -0.23 -0.2274 -1.0 1420016 Maybridge1_002262 S=C(N1CCOCC1)c2ccc(C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O19 compound treatment 1.0146 0.0146 0.28 0.2835 1.0 1175684 Maybridge1_002263 OC(=O)CCC1CCCCCCCCCCC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O20 compound treatment 0.9634 -0.0366 -0.71 -0.7107 -1.0 2070772 Maybridge1_002264 CCN(C(=N)SC)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O21 compound treatment 0.9535 -0.0465 -0.9 -0.904 -1.0 2070773 Maybridge1_002265 CCCCCCCCc1ccc(cc1)C(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O22 compound treatment 0.9762 -0.0238 -0.46 -0.4621 -1.0 1036785 Maybridge1_002266 OC(=O)c1ccc(Cl)cc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O23 mock treatment 1.0174 0.0174 0.34 0.3387 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 O24 mock treatment 0.9698 -0.0302 -0.59 -0.5864 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P01 compound treatment 1.0118 0.0118 0.23 0.2283 1.0 2070774 Maybridge1_002267 CSc1ncc(Cl)c(n1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P02 compound treatment 0.9982 -0.00176 -0.03 -0.0341 -1.0 2070775 Maybridge1_002268 CC(=O)C1C(CC(=CC1=O)/C=C/c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P03 compound treatment 1.2315 0.231 4.49 4.4948 1.0 2070776 Maybridge1_002269 CN(C)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P04 compound treatment 1.0509 0.0509 0.99 0.9877 1.0 1237161 Maybridge1_002270 OC(COc1ccccc1)CN2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P05 compound treatment 1.0004 3.78E-4 0.01 0.0073 1.0 2070777 Maybridge1_002271 FC(F)(F)c1cnc(/N=C/N2CCCCC2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P06 compound treatment 1.0459 0.0459 0.89 0.891 1.0 1026005 Maybridge1_002272 C(COc1cccc2ccccc12)Oc3cccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P07 compound treatment 1.0046 0.00464 0.09 0.0902 1.0 1023158 Maybridge1_002273 Cc1cc(O)n2ncnc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P08 compound treatment 0.9847 -0.0153 -0.3 -0.2964 -1.0 1022119 Maybridge1_002274 OC(=O)c1cc(Br)c(Br)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P09 compound treatment 0.9641 -0.0359 -0.7 -0.6969 -1.0 1250550 Maybridge1_002275 OC(=O)C1Cc2ccccc2-c3ccccc3C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P10 compound treatment 0.967 -0.033 -0.64 -0.6416 -1.0 1028547 Maybridge1_002276 Cc1ccc(C)n1CCn2c(C)ccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P11 compound treatment 0.9798 -0.0202 -0.39 -0.3931 -1.0 1009725 Maybridge1_002277 OC(=O)c1cccc2cccc(c3cccc4cccc(C(=O)O)c34)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P12 compound treatment 1.0331 0.0331 0.64 0.6425 1.0 1305565 Maybridge1_002278 OC(COc1ccc(cc1)C2(CC3CC4CC(C3)C2)C4)CN5CCCCC5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P13 compound treatment 0.9869 -0.0131 -0.26 -0.255 -1.0 1030892 Maybridge1_002279 Cc1cc(=O)oc2cc(N)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P14 compound treatment 0.9933 -0.00673 -0.13 -0.1307 -1.0 1414498 Maybridge1_002280 Brc1cc2OCCCOc2cc1C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P15 compound treatment 0.994 -0.00602 -0.12 -0.1169 -1.0 1067594 Maybridge1_002281 CC(=O)c1ccc-2c(Cc3cc(ccc32)C(=O)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P16 compound treatment 1.026 0.026 0.5 0.5044 1.0 1371529 Maybridge1_002282 Cc1ccc(cc1)C(=O)c2cc3OCCOc3cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P17 compound treatment 0.9456 -0.0544 -1.06 -1.0558 -1.0 2070778 Maybridge1_002283 CC(=O)Nc1cccc([N+](=O)[O-])c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P18 compound treatment 0.979 -0.021 -0.41 -0.4069 -1.0 1172246 Maybridge1_002284 OC(=O)CCC1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P19 compound treatment 1.6922 0.692 13.44 13.4421 1.0 1366365 Maybridge1_002285 CN(C)c1ccc2C(=O)N(C(=O)c3cccc1c32)c4nc5ccccc5[nH]4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P20 compound treatment 0.9762 -0.0238 -0.46 -0.4621 -1.0 1503386 Maybridge1_002286 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CC(=O)NC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P21 compound treatment 0.999 -0.00104 -0.02 -0.0203 -1.0 1467705 Maybridge1_002287 Cc1ccc(NC(=O)CCC(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P22 compound treatment 1.0224 0.0224 0.44 0.4354 1.0 2070779 Maybridge1_002288 CC1CN=C(Nc2ccc(C)cc2)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P23 mock treatment 0.9556 -0.0444 -0.86 -0.8625 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.547 P24 mock treatment 1.0217 0.0217 0.42 0.4216 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A01 compound treatment 1.0754 0.0728 1.41 1.4137 1.0 2070780 Maybridge1_002993 CC(C)(C)SCCNC(=O)c1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A02 compound treatment 1.0272 0.0247 0.48 0.4792 1.0 2070781 Maybridge1_002994 CS/C(=N/C#N)/NCCSCc1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A03 compound treatment 1.074 0.0714 1.39 1.3866 1.0 1677090 Maybridge1_002995 Clc1ccc(Oc2ccccc2S(=O)(=O)Nc3cc(Cl)cc(Cl)c3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A04 compound treatment 1.0224 0.0198 0.38 0.3844 1.0 2070782 Maybridge1_002996 Cc1nc(C)c(s1)c2ccn(n2)C(=O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A05 compound treatment 1.0335 0.031 0.6 0.6011 1.0 2070783 Maybridge1_002997 [O-][N+](=O)c1ccc(Sc2nnc(S)s2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A06 compound treatment 1.0105 0.00794 0.15 0.1542 1.0 2070784 Maybridge1_002998 CC(=O)c1nnn(c1C)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A07 compound treatment 1.0126 0.01 0.19 0.1948 1.0 2070785 Maybridge1_002999 Cc1onc(c1C(=O)c2ccccc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A08 compound treatment 0.984 -0.0186 -0.36 -0.3604 -1.0 2070786 Maybridge1_003000 CS/C(=N\C#N)/N1CCN(CC1)c2ccc(cn2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A09 compound treatment 1.0251 0.0226 0.44 0.4386 1.0 1267859 Maybridge1_003001 Cc1onc(c1C(O)c2ccc(F)cc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A10 compound treatment 0.998 -0.00461 -0.09 -0.0896 -1.0 1463907 Maybridge1_003002 O=C(NC1CCCCNC1=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A11 compound treatment 1.0035 9.67E-4 0.02 0.0188 1.0 2070787 Maybridge1_003003 CC1(C)OC(=O)C(=Cc2cc(Br)cs2)C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A12 compound treatment 0.9945 -0.0081 -0.16 -0.1573 -1.0 2070788 Maybridge1_003004 CS/C(=N\C#N)/N1CCC(CC1)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A13 compound treatment 0.9945 -0.0081 -0.16 -0.1573 -1.0 2070789 Maybridge1_003005 CC1(C)C(=C(Br)C(=O)C1(Br)Br)Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A14 compound treatment 1.0042 0.00166 0.03 0.0323 1.0 1086555 Maybridge1_003006 COc1ccc(OC)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A15 compound treatment 0.9917 -0.0109 -0.21 -0.2114 -1.0 2070790 Maybridge1_003007 Cc1nn(cc1c2ccccc2)C(=O)Nc3c(C)onc3c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A16 compound treatment 0.9812 -0.0213 -0.41 -0.4146 -1.0 2070791 Maybridge1_003008 CS/C(=N/C#N)/NCC#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A17 compound treatment 1.0335 0.031 0.6 0.6011 1.0 1691204 Maybridge1_003009 CNn1cnc2ccccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A18 compound treatment 0.9945 -0.0081 -0.16 -0.1573 -1.0 2070792 Maybridge1_003010 FC(F)(F)c1ccc(/C=C\2/C(=O)Nc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A19 compound treatment 0.9889 -0.0137 -0.27 -0.2656 -1.0 1195410 Maybridge1_003011 Clc1cccc(Cl)c1COc2cccc(c2)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A20 compound treatment 0.9791 -0.0234 -0.46 -0.4552 -1.0 1225869 Maybridge1_003012 CC(C)(CO)NC(=O)c1cccc(C(=O)NC(C)(C)CO)c1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A21 compound treatment 1.0035 9.67E-4 0.02 0.0188 1.0 2070793 Maybridge1_003013 O/N=C/N/C(=N\OCc1c(F)cccc1Cl)/c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A22 compound treatment 0.9847 -0.0179 -0.35 -0.3469 -1.0 1355108 Maybridge1_003014 CCNS(=O)(=O)c1cc(Cl)sc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A23 mock treatment 1.0168 0.0142 0.28 0.2761 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 A24 mock treatment 1.0544 0.0519 1.01 1.0074 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B01 compound treatment 0.991 -0.0116 -0.22 -0.225 -1.0 2070794 Maybridge1_003015 Cc1ccc(cc1)C2CC(=O)CC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B02 compound treatment 1.0482 0.0456 0.89 0.8855 1.0 2070795 Maybridge1_003016 CC(C)c1ccc(/C=N/NC(=O)CC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B03 compound treatment 1.0105 0.00794 0.15 0.1542 1.0 2070796 Maybridge1_003017 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)S(=O)(=O)NCc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B04 compound treatment 0.9666 -0.036 -0.7 -0.699 -1.0 2070797 Maybridge1_003018 COc1cc([N+](=O)[O-])c2NC(CC(c3ccccc3)c2c1)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B05 compound treatment 1.0203 0.0177 0.34 0.3438 1.0 1469336 Maybridge1_003019 Cn1nccc1c2ccc(Oc3cccc(Cl)c3C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B06 compound treatment 0.984 -0.0186 -0.36 -0.3604 -1.0 1005561 Maybridge1_003020 Cc1cccc(NC(=O)c2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B07 compound treatment 0.9861 -0.0165 -0.32 -0.3198 -1.0 2070798 Maybridge1_003021 CC1=C(C#N)S(=O)(=O)C(C#N)C(C1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B08 compound treatment 0.9798 -0.0227 -0.44 -0.4417 -1.0 1083105 Maybridge1_003022 O=C(CC#N)NCc1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B09 compound treatment 0.9952 -0.0074 -0.14 -0.1437 -1.0 2070799 Maybridge1_003023 CC(=O)c1ccc(o1)c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B10 compound treatment 1.0021 -4.27E-4 -0.01 -0.0083 -1.0 1083112 Maybridge1_003024 Cc1ccc(cc1C)C(=O)c2ccccc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B11 compound treatment 0.977 -0.0255 -0.5 -0.4959 -1.0 1717233 Maybridge1_003025 COc1cccc(OC)c1C(=O)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B12 compound treatment 1.0084 0.00585 0.11 0.1136 1.0 2070800 Maybridge1_003026 Cc1ccc(cc1)c2nc3cc(C)c(C)cc3nc2c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B13 compound treatment 0.9819 -0.0207 -0.4 -0.401 -1.0 1210739 Maybridge1_003027 CC1(C)OC(=O)C(=C2CCCN2)C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B14 compound treatment 1.0147 0.0121 0.24 0.2355 1.0 1571466 Maybridge1_003028 Clc1ccc(NC(=O)c2ccccc2NC(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B15 compound treatment 1.0203 0.0177 0.34 0.3438 1.0 2070801 Maybridge1_003029 [O-][N+](=O)c1cc(/C=N/N2CCOCC2)cs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B16 compound treatment 0.9394 -0.0632 -1.23 -1.2272 -1.0 2070802 Maybridge1_003030 CC(C)(NC(=O)Nc1ccccc1)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B17 compound treatment 0.9847 -0.0179 -0.35 -0.3469 -1.0 1384934 Maybridge1_003031 Cc1cc(SCCS(=O)(=O)CCSc2cc(C)c(Cl)cc2C)c(C)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B18 compound treatment 0.9701 -0.0325 -0.63 -0.6313 -1.0 1244752 Maybridge1_003032 CC(C)c1ccc(NC(=O)c2ccccc2NC(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B19 compound treatment 0.9931 -0.00949 -0.18 -0.1844 -1.0 2070803 Maybridge1_003033 CC(C)NC(=O)N1CCc2sccc2C1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B20 compound treatment 0.9512 -0.0513 -1.0 -0.9969 -1.0 1206974 Maybridge1_003034 COc1ccc(cc1)n2c(csc2=N)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B21 compound treatment 0.9575 -0.0451 -0.88 -0.8751 -1.0 1696004 Maybridge1_003035 OC(=O)C1CN(Cc2ccco2)C(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B22 compound treatment 0.947 -0.0555 -1.08 -1.0782 -1.0 1406609 Maybridge1_003036 CC1CC(CC(C)(C)C1)NC(=O)c2ccccc2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B23 mock treatment 0.9533 -0.0492 -0.96 -0.9563 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 B24 mock treatment 0.9798 -0.0227 -0.44 -0.4417 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C01 compound treatment 1.0279 0.0254 0.49 0.4928 1.0 1943772 Maybridge1_003037 Clc1ccc(CSc2nsc(SCc3ccc(Cl)cc3)n2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C02 compound treatment 1.0251 0.0226 0.44 0.4386 1.0 2070804 Maybridge1_003038 Cc1cc(OS(=O)(=O)CS(=O)(=O)Oc2ccc(Cl)c(C)c2)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C03 compound treatment 1.0419 0.0393 0.76 0.7637 1.0 1679950 Maybridge1_003039 Clc1ccc(Oc2ccccc2S(=O)(=O)N3CCCCC3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C04 compound treatment 0.9575 -0.0451 -0.88 -0.8751 -1.0 2070805 Maybridge1_003040 CN(C)/C=C(\C#N)/S(=O)(=O)\C(=C\N(C)C)\C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C05 compound treatment 0.9561 -0.0465 -0.9 -0.9021 -1.0 2070806 Maybridge1_003041 Cc1onc(c1C(=O)OCC(F)(F)F)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C06 compound treatment 0.9986 -0.00391 -0.08 -0.076 -1.0 2070807 Maybridge1_003042 CC(=O)OCC(=O)c1cc(Cl)sc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C07 compound treatment 1.014 0.0114 0.22 0.2219 1.0 2070808 Maybridge1_003043 Cc1onc(c1C(=O)c2ccccc2)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C08 compound treatment 0.9917 -0.0109 -0.21 -0.2114 -1.0 2070809 Maybridge1_003044 CC(=O)C(=NNc1c(C)nn(C)c1C)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C09 compound treatment 0.9882 -0.0144 -0.28 -0.2792 -1.0 2070810 Maybridge1_003045 CC(=O)c1ccccc1OC(=O)c2ccc(o2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C10 compound treatment 0.961 -0.0416 -0.81 -0.8073 -1.0 2070811 Maybridge1_003046 CC1=C(OS(=O)(=O)c2cc(C)c(Cl)cc2Cl)C(=O)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C11 compound treatment 1.0175 0.0149 0.29 0.2896 1.0 2070812 Maybridge1_003047 Cc1nn(C(=O)c2c(Cl)cccc2Cl)c(C)c1Cc3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C12 compound treatment 0.9742 -0.0283 -0.55 -0.55 -1.0 1659368 Maybridge1_003048 Nc1nnc(SCc2c(Cl)cccc2Cl)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C13 compound treatment 0.9687 -0.0339 -0.66 -0.6584 -1.0 2070813 Maybridge1_003049 Cc1cc(NN=Nc2cc(C)on2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C14 compound treatment 0.9742 -0.0283 -0.55 -0.55 -1.0 2070814 Maybridge1_003050 CC(=O)c1nnn(c1C)c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C15 compound treatment 0.9959 -0.0067 -0.13 -0.1302 -1.0 2070815 Maybridge1_003051 Clc1ccc(cc1)c2noc(n2)c3c[nH]nc3c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C16 compound treatment 0.9721 -0.0304 -0.59 -0.5907 -1.0 2070816 Maybridge1_003052 Fc1c(COC(=O)Nc2ccccc2)cccc1COC(=O)Nc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C17 compound treatment 0.968 -0.0346 -0.67 -0.6719 -1.0 1381264 Maybridge1_003053 CN(C(=O)Nc1ccccc1)n2cnc3ccccc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C18 compound treatment 1.0126 0.01 0.19 0.1948 1.0 2070817 Maybridge1_003054 CS(=O)(=O)CS(=O)(=O)Oc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C19 compound treatment 0.9917 -0.0109 -0.21 -0.2114 -1.0 2070818 Maybridge1_003055 Clc1cc(c(Cl)s1)S(=O)(=O)NC(=N)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C20 compound treatment 0.9415 -0.0611 -1.19 -1.1865 -1.0 2070819 Maybridge1_003056 Cn1cccc1C(=O)N/N=C/c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C21 compound treatment 0.9833 -0.0193 -0.37 -0.374 -1.0 2070820 Maybridge1_003057 CN(C)/C=C/c1nn(C)c(C)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C22 compound treatment 0.9687 -0.0339 -0.66 -0.6584 -1.0 2070821 Maybridge1_003058 CN(C)CCCN(S(=O)(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)S(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C23 mock treatment 0.9673 -0.0353 -0.69 -0.6855 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 C24 mock treatment 1.0482 0.0456 0.89 0.8855 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D01 compound treatment 1.0656 0.063 1.22 1.2241 1.0 2070822 Maybridge1_003059 Clc1ccc(cc1Cl)C2CC(=O)CC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D02 compound treatment 0.9959 -0.0067 -0.13 -0.1302 -1.0 2070823 Maybridge1_003060 O=C(CC#N)NN=C1CCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D03 compound treatment 0.9666 -0.036 -0.7 -0.699 -1.0 2070824 Maybridge1_003061 FC(F)(F)COc1cccc(Cl)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D04 compound treatment 0.9868 -0.0158 -0.31 -0.3062 -1.0 1183271 Maybridge1_003062 Clc1ccc(Cl)c(c1)S(=O)(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D05 compound treatment 1.0286 0.0261 0.51 0.5063 1.0 1686627 Maybridge1_003063 Nc1nccc(n1)c2ccc(Oc3cccc(Cl)c3C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D06 compound treatment 0.9917 -0.0109 -0.21 -0.2114 -1.0 1214473 Maybridge1_003064 Cc1ccc(NC(=S)C(C#N)C(=O)Nc2ccccc2C)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D07 compound treatment 0.9617 -0.0409 -0.79 -0.7938 -1.0 1394780 Maybridge1_003065 COc1ccc(cc1)C2CC(=C(C#N)S(=O)(=O)C2C#N)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D08 compound treatment 1.0049 0.00236 0.05 0.0459 1.0 1580315 Maybridge1_003066 Cc1ccc(NC(=S)C(C#N)C(=O)N2CCCC2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D09 compound treatment 0.9966 -0.00601 -0.12 -0.1166 -1.0 2070825 Maybridge1_003067 Nc1nn(cc1C#N)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D10 compound treatment 0.9966 -0.00601 -0.12 -0.1166 -1.0 1472381 Maybridge1_003068 Cc1ccc(cc1C)c2nn(c3ccccc3)c(=O)c4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D11 compound treatment 0.9959 -0.0067 -0.13 -0.1302 -1.0 1571233 Maybridge1_003069 COC(OC)C(C)(O)c1c(OC)cccc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D12 compound treatment 0.9157 -0.0869 -1.69 -1.6876 -1.0 2070826 Maybridge1_003070 CCc1nn2cc(nc2s1)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D13 compound treatment 0.9896 -0.013 -0.25 -0.2521 -1.0 2070827 Maybridge1_003071 Cc1nn(C)c(O)c1N=Nc2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D14 compound treatment 1.0063 0.00376 0.07 0.073 1.0 1486629 Maybridge1_003072 COc1ccc(NC(=O)c2ccccc2NC(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D15 compound treatment 0.9526 -0.0499 -0.97 -0.9699 -1.0 2070828 Maybridge1_003073 [O-][N+](=O)c1cc(/C=N/Nc2ccccn2)cs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D16 compound treatment 0.9791 -0.0234 -0.46 -0.4552 -1.0 1162448 Maybridge1_003074 O=C1Nc2ccccc2N=C(c3ccccc3)c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D17 compound treatment 0.9882 -0.0144 -0.28 -0.2792 -1.0 1573828 Maybridge1_003075 O=S1(=O)CCN(Cc2cccs2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D18 compound treatment 1.0091 0.00655 0.13 0.1271 1.0 1247208 Maybridge1_003076 CC(=O)Nc1ccc(NC(=O)c2ccccc2NC(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D19 compound treatment 0.9324 -0.0702 -1.36 -1.3626 -1.0 2070829 Maybridge1_003077 FC(F)(F)c1cccc(/N=C/c2ccc(Cl)cc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D20 compound treatment 1.0 -0.00252 -0.05 -0.0489 -1.0 1698556 Maybridge1_003078 Clc1cccc(c1Cl)n2c(csc2=N)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D21 compound treatment 0.9589 -0.0437 -0.85 -0.848 -1.0 2070830 Maybridge1_003079 FC(F)(F)c1cc(NC2=C(C(=O)c3ccccc23)c4ccccc4)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D22 compound treatment 1.0286 0.0261 0.51 0.5063 1.0 2070831 Maybridge1_003080 Cc1ccc(CS/C(=N/N)/N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D23 mock treatment 0.9205 -0.082 -1.59 -1.5928 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 D24 mock treatment 0.9959 -0.0067 -0.13 -0.1302 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E01 compound treatment 1.0433 0.0407 0.79 0.7907 1.0 2070832 Maybridge1_003081 CC(C)(C)c1csc(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E02 compound treatment 0.9854 -0.0172 -0.33 -0.3333 -1.0 2070833 Maybridge1_003082 Clc1ccc(cc1)C2CC(=O)CC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E03 compound treatment 1.0035 9.67E-4 0.02 0.0188 1.0 2070834 Maybridge1_003083 CC(C)(C)c1csc(=S)n1CCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E04 compound treatment 0.9805 -0.022 -0.43 -0.4281 -1.0 1080296 Maybridge1_003084 CC1SCC(=NO)CS1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E05 compound treatment 1.0133 0.0107 0.21 0.2084 1.0 2070835 Maybridge1_003085 Cc1cc(C)n(n1)C2=NCCN2C(=O)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E06 compound treatment 0.9324 -0.0702 -1.36 -1.3626 -1.0 2070836 Maybridge1_003086 CSC(=N)n1nc(SC)nc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E07 compound treatment 1.0433 0.0407 0.79 0.7907 1.0 1349717 Maybridge1_003087 Cc1onc(c1C(O)c2ccccc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E08 compound treatment 0.968 -0.0346 -0.67 -0.6719 -1.0 1322001 Maybridge1_003088 Cc1nn(C)c(C)c1NC(=O)c2ccccc2NS(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E09 compound treatment 1.03 0.0275 0.53 0.5334 1.0 1387444 Maybridge1_003089 Fc1ccc(cc1)C(=O)CCCC(=O)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E10 compound treatment 0.9617 -0.0409 -0.79 -0.7938 -1.0 2070837 Maybridge1_003090 CCOC(=O)c1cnn(c1c2ccccc2)c3c(Cl)cc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E11 compound treatment 0.9931 -0.00949 -0.18 -0.1844 -1.0 2070838 Maybridge1_003091 Cc1nn(c(C)c1Cc2c(Cl)cccc2Cl)S(=O)(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E12 compound treatment 1.0621 0.0595 1.16 1.1564 1.0 2070839 Maybridge1_003092 CN(C)c1c(/C=C/2\C(=O)Nc3ccccc23)cc(\C=C/4\C(=O)Nc5ccccc45)c(N(C)C)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E13 compound treatment 1.0217 0.0191 0.37 0.3709 1.0 1073411 Maybridge1_003093 NC1=C(C(=O)c2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E14 compound treatment 0.977 -0.0255 -0.5 -0.4959 -1.0 2070840 Maybridge1_003094 CC(=O)c1nnn(c1C)c2cc(Cl)ccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E15 compound treatment 0.9282 -0.0743 -1.44 -1.4439 -1.0 1552363 Maybridge1_003095 O=S(=O)(CS(=O)(=O)N1CCOCC1)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E16 compound treatment 0.9617 -0.0409 -0.79 -0.7938 -1.0 1720964 Maybridge1_003096 O=S(=O)(NCC#C)c1ccc(C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E17 compound treatment 0.9791 -0.0234 -0.46 -0.4552 -1.0 2070841 Maybridge1_003097 Clc1cc(c(Cl)s1)S(=O)(=O)NCCCNS(=O)(=O)c2cc(Cl)sc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E18 compound treatment 0.9938 -0.0088 -0.17 -0.1708 -1.0 2070842 Maybridge1_003098 Fc1ccc(c2ccc(CNC(=O)c3ccc(Cl)cc3)o2)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E19 compound treatment 0.984 -0.0186 -0.36 -0.3604 -1.0 2070843 Maybridge1_003099 Cc1nn(C)c(C)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E20 compound treatment 0.924 -0.0785 -1.53 -1.5251 -1.0 2070844 Maybridge1_003100 CN(C)c1cc(oc(=O)c1Cl)c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E21 compound treatment 0.9735 -0.029 -0.56 -0.5636 -1.0 2070845 Maybridge1_003101 Cc1c([N+](=O)[O-])c(C/C=N/O)nn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E22 compound treatment 0.9875 -0.0151 -0.29 -0.2927 -1.0 2070846 Maybridge1_003102 COc1ccc(OCC(F)(F)F)c(c1)C(=O)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E23 mock treatment 1.007 0.00445 0.09 0.0865 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 E24 mock treatment 0.977 -0.0255 -0.5 -0.4959 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F01 compound treatment 0.9805 -0.022 -0.43 -0.4281 -1.0 2070847 Maybridge1_003103 O=C1CC(CC(=O)C1)c2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F02 compound treatment 0.9938 -0.0088 -0.17 -0.1708 -1.0 2070848 Maybridge1_003104 CC(C)C/1CCC(C)C\C1=N/NC(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F03 compound treatment 0.977 -0.0255 -0.5 -0.4959 -1.0 2070849 Maybridge1_003105 CC1(C)OC(=O)C(CC#C)(CC#C)C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F04 compound treatment 0.9854 -0.0172 -0.33 -0.3333 -1.0 1413077 Maybridge1_003106 Clc1cc(Cl)c(cc1Cl)S(=O)(=O)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F05 compound treatment 0.9477 -0.0548 -1.06 -1.0647 -1.0 2070850 Maybridge1_003107 CC(NC=C(C#N)C#N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F06 compound treatment 1.0007 -0.00182 -0.04 -0.0354 -1.0 1183062 Maybridge1_003108 Cc1ccc(NC(=S)C(C#N)C(=O)N2CCOCC2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F07 compound treatment 0.9903 -0.0123 -0.24 -0.2385 -1.0 1504515 Maybridge1_003109 Clc1ccc(Oc2cccc(Cl)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F08 compound treatment 1.014 0.0114 0.22 0.2219 1.0 1083106 Maybridge1_003110 CC1CC(CC(C)(C)C1)NC(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F09 compound treatment 0.9931 -0.00949 -0.18 -0.1844 -1.0 1521482 Maybridge1_003111 Nc1nn(cc1c2nnn[nH]2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F10 compound treatment 0.9791 -0.0234 -0.46 -0.4552 -1.0 1058518 Maybridge1_003112 OC(=O)c1ccccc1C(=O)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F11 compound treatment 0.9945 -0.0081 -0.16 -0.1573 -1.0 2070851 Maybridge1_003113 CC(=O)OC(C(OC(=O)C)C(=O)Nc1ccc(Cl)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F12 compound treatment 1.0754 0.0728 1.41 1.4137 1.0 2070852 Maybridge1_003114 Cn1c2CCCCc2c3CCCCc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F13 compound treatment 0.9261 -0.0764 -1.48 -1.4845 -1.0 2070853 Maybridge1_003115 Cc1nn(C)c(O)c1N=Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F14 compound treatment 0.9456 -0.0569 -1.11 -1.1053 -1.0 2070854 Maybridge1_003116 [O-][N+](=O)c1ccc(cc1)C(=O)CSC2=NCCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F15 compound treatment 0.9812 -0.0213 -0.41 -0.4146 -1.0 2070855 Maybridge1_003117 [O-][N+](=O)c1cc(C#N)cs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F16 compound treatment 1.0049 0.00236 0.05 0.0459 1.0 1264193 Maybridge1_003118 CC1CN=C(c2ccccc2)c3ccccc3C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F17 compound treatment 0.9498 -0.0527 -1.02 -1.024 -1.0 2070856 Maybridge1_003119 O=C1NCCCCC1N2CCS(=O)(=O)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F18 compound treatment 0.9798 -0.0227 -0.44 -0.4417 -1.0 1181207 Maybridge1_003120 O=c1n(c(nc2ccccc12)c3ccccc3)C4(CCCCC4)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F19 compound treatment 0.9938 -0.0088 -0.17 -0.1708 -1.0 2070857 Maybridge1_003121 FC(F)(F)c1ccc(cc1)C(=O)NC(=O)Nc2ccc(cc2)c3cnco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F20 compound treatment 0.924 -0.0785 -1.53 -1.5251 -1.0 2070858 Maybridge1_003122 Clc1ccc(cc1)c2csc(=N)n2c3cc(Cl)c(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F21 compound treatment 0.984 -0.0186 -0.36 -0.3604 -1.0 1562587 Maybridge1_003123 CC(=O)N1C=CC(C=C1)c2c[nH]c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F22 compound treatment 0.9882 -0.0144 -0.28 -0.2792 -1.0 2070859 Maybridge1_003124 COc1ccc(CS/C(=N/N)/N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F23 mock treatment 0.9603 -0.0423 -0.82 -0.8209 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 F24 mock treatment 1.0224 0.0198 0.38 0.3844 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G01 compound treatment 1.0335 0.031 0.6 0.6011 1.0 2070860 Maybridge1_003125 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1NCCc2ccc(Cl)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G02 compound treatment 0.9603 -0.0423 -0.82 -0.8209 -1.0 1222526 Maybridge1_003126 CN(C1CC2CC1C=C2)C(=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G03 compound treatment 1.0189 0.0163 0.32 0.3167 1.0 2070861 Maybridge1_003127 Clc1ccc(Oc2ccccc2N/N=C(\C#N)/C(=O)N3CCCC3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G04 compound treatment 0.9728 -0.0297 -0.58 -0.5771 -1.0 2070862 Maybridge1_003128 CC(=O)N1CCC(CC1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G05 compound treatment 1.0105 0.00794 0.15 0.1542 1.0 2070863 Maybridge1_003129 [O-][N+](=O)c1ccc(Sc2nc[nH]n2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G06 compound treatment 0.968 -0.0346 -0.67 -0.6719 -1.0 1701114 Maybridge1_003130 COC(CNc1cccc(F)c1C#N)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G07 compound treatment 0.9805 -0.022 -0.43 -0.4281 -1.0 2070864 Maybridge1_003131 COC(=O)c1sccc1NC(=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G08 compound treatment 0.9735 -0.029 -0.56 -0.5636 -1.0 2070865 Maybridge1_003132 CCOC(=O)c1cnn(c1C)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G09 compound treatment 1.0098 0.00724 0.14 0.1407 1.0 2070866 Maybridge1_003133 O=C(Oc1ccccc1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G10 compound treatment 0.9715 -0.0311 -0.6 -0.6042 -1.0 1177640 Maybridge1_003134 CCOC(=O)c1cnc(Nc2nc(cs2)C(C)(C)C)nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G11 compound treatment 0.9966 -0.00601 -0.12 -0.1166 -1.0 2070867 Maybridge1_003135 Fc1c(CSC2=NCCN2)cccc1CSC3=NCCN3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G12 compound treatment 0.9833 -0.0193 -0.37 -0.374 -1.0 2070868 Maybridge1_003136 CC(=O)CC(=O)c1c(C)nn(c1O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G13 compound treatment 0.9875 -0.0151 -0.29 -0.2927 -1.0 2070869 Maybridge1_003137 CN(C)/C=C(\C#N)/C(=O)Nc1cc(C)on1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G14 compound treatment 0.991 -0.0116 -0.22 -0.225 -1.0 1652979 Maybridge1_003138 NC(=O)c1cccc(C(=O)N)c1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G15 compound treatment 0.9784 -0.0241 -0.47 -0.4688 -1.0 2070870 Maybridge1_003139 Clc1cccc(Cl)c1CC(Cc2c(Cl)cccc2Cl)(C#N)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G16 compound treatment 0.9666 -0.036 -0.7 -0.699 -1.0 2070871 Maybridge1_003140 Cc1c(C)c(C)c(C(=O)C2CCN(CC2)S(=O)(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G17 compound treatment 0.984 -0.0186 -0.36 -0.3604 -1.0 2070872 Maybridge1_003141 CC(O)c1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G18 compound treatment 0.977 -0.0255 -0.5 -0.4959 -1.0 2070873 Maybridge1_003142 Cc1cccc(C(=O)O)c1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G19 compound treatment 0.9408 -0.0618 -1.2 -1.2001 -1.0 1353717 Maybridge1_003143 OCCCc1cc(n[nH]1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G20 compound treatment 0.9749 -0.0276 -0.54 -0.5365 -1.0 1487603 Maybridge1_003144 Clc1ccc(NS(=O)(=O)CC(=O)CS(=O)(=O)Nc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G21 compound treatment 1.0091 0.00655 0.13 0.1271 1.0 2070874 Maybridge1_003145 Cc1cn(nc1c2ccccc2)C(=O)Nc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G22 compound treatment 0.9701 -0.0325 -0.63 -0.6313 -1.0 2070875 Maybridge1_003146 CCOC(=O)C(/C=N/c1ccc(Cl)cc1Cl)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G23 mock treatment 0.9484 -0.0541 -1.05 -1.0511 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 G24 mock treatment 1.014 0.0114 0.22 0.2219 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H01 compound treatment 1.0007 -0.00182 -0.04 -0.0354 -1.0 2070876 Maybridge1_003147 CC12CCC(=O)NC2=CC(=O)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H02 compound treatment 1.0133 0.0107 0.21 0.2084 1.0 1018434 Maybridge1_003148 O=C(CC#N)N1CCOCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H03 compound treatment 0.9603 -0.0423 -0.82 -0.8209 -1.0 2070877 Maybridge1_003149 COc1cccc(CNC(=S)SCC(=O)C(C)(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H04 compound treatment 0.9645 -0.0381 -0.74 -0.7396 -1.0 2070878 Maybridge1_003150 CC1CCCN(C1)S(=O)(=O)c2cc(Cl)ccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H05 compound treatment 0.9415 -0.0611 -1.19 -1.1865 -1.0 1494113 Maybridge1_003151 Nc1oncc1c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H06 compound treatment 0.9868 -0.0158 -0.31 -0.3062 -1.0 1370912 Maybridge1_003152 Clc1ccccc1NC(=S)C(C#N)C(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H07 compound treatment 1.044 0.0414 0.8 0.8043 1.0 1262194 Maybridge1_003153 CNn1cnc2ccsc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H08 compound treatment 0.9735 -0.029 -0.56 -0.5636 -1.0 1083104 Maybridge1_003154 O=C(CC#N)NCCc1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H09 compound treatment 0.9359 -0.0667 -1.29 -1.2949 -1.0 1311727 Maybridge1_003155 Clc1cccc(N2CCC(CC2)C#N)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H10 compound treatment 0.9875 -0.0151 -0.29 -0.2927 -1.0 1742190 Maybridge1_003156 Fc1ccc(cc1)c2nn(c3ccccc3)c(=O)c4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H11 compound treatment 0.9533 -0.0492 -0.96 -0.9563 -1.0 1029322 Maybridge1_003157 CC(=O)c1ccc(Oc2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H12 compound treatment 1.0098 0.00724 0.14 0.1407 1.0 1055233 Maybridge1_003158 O=c1onc(c2ccccc2)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H13 compound treatment 0.9896 -0.013 -0.25 -0.2521 -1.0 1074389 Maybridge1_003159 CC(=O)c1ccc(Sc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H14 compound treatment 1.0063 0.00376 0.07 0.073 1.0 1929006 Maybridge1_003160 Brc1ccc(NC(=O)c2ccccc2NC(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H15 compound treatment 0.9749 -0.0276 -0.54 -0.5365 -1.0 1534999 Maybridge1_003161 C=CCN1CCS(=O)(=O)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H16 compound treatment 0.9596 -0.043 -0.83 -0.8344 -1.0 2070879 Maybridge1_003162 O=C(NCCCCCCNC(=O)NC1(CCCCC1)C#C)NC2(CCCCC2)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H17 compound treatment 0.9749 -0.0276 -0.54 -0.5365 -1.0 2070880 Maybridge1_003163 CC(C)c1ccc(NC(=S)N/N=C(\C)/c2ccco2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H18 compound treatment 0.9861 -0.0165 -0.32 -0.3198 -1.0 1202690 Maybridge1_003164 Cc1c(C)c(C)c(C(=O)CCC(=O)O)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H19 compound treatment 0.9324 -0.0702 -1.36 -1.3626 -1.0 2070881 Maybridge1_003165 CC(C)(C)c1ccc(cc1)c2nnc(o2)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H20 compound treatment 0.9847 -0.0179 -0.35 -0.3469 -1.0 1171356 Maybridge1_003166 CC(C)c1ccc(NC(=O)c2ccccc2N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H21 compound treatment 0.9812 -0.0213 -0.41 -0.4146 -1.0 1330601 Maybridge1_003167 CCOC(=O)c1c(N)c(sc1Nc2ccccc2OC)C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H22 compound treatment 0.9917 -0.0109 -0.21 -0.2114 -1.0 2070882 Maybridge1_003168 COc1cc(I)c(OC)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H23 mock treatment 0.9903 -0.0123 -0.24 -0.2385 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 H24 mock treatment 1.0245 0.0219 0.43 0.4251 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I01 compound treatment 1.0342 0.0317 0.61 0.6147 1.0 2070883 Maybridge1_003169 CC(C)(C)c1csc(n1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I02 compound treatment 0.9917 -0.0109 -0.21 -0.2114 -1.0 2070884 Maybridge1_003170 CCCCNC(=O)N(C)C1CC2CC1C=C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I03 compound treatment 1.0161 0.0135 0.26 0.2626 1.0 2070885 Maybridge1_003171 Clc1ccc(Oc2ccccc2NN=C(C#N)C#N)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I04 compound treatment 1.0489 0.0463 0.9 0.8991 1.0 2070886 Maybridge1_003172 Cc1c(O)c(C#N)sc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I05 compound treatment 0.9889 -0.0137 -0.27 -0.2656 -1.0 2070887 Maybridge1_003173 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1Sc2nc[nH]n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I06 compound treatment 0.9645 -0.0381 -0.74 -0.7396 -1.0 1437874 Maybridge1_003174 Clc1ccc(cc1)C(=O)C2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I07 compound treatment 1.0035 9.67E-4 0.02 0.0188 1.0 2070888 Maybridge1_003175 Cc1onc(c1C(=O)c2ccc(F)cc2)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I08 compound treatment 0.9749 -0.0276 -0.54 -0.5365 -1.0 1265175 Maybridge1_003176 CCOC(=O)c1cnc(N)nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I09 compound treatment 0.977 -0.0255 -0.5 -0.4959 -1.0 1708110 Maybridge1_003177 Cc1onc(c1C(=O)Oc2ccccc2)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I10 compound treatment 0.968 -0.0346 -0.67 -0.6719 -1.0 2070889 Maybridge1_003178 CCCc1c(cnn1c2c(Cl)cc(Cl)cc2Cl)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I11 compound treatment 1.0217 0.0191 0.37 0.3709 1.0 2070890 Maybridge1_003179 Clc1cccc(NCCCN2CCCCC2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I12 compound treatment 0.9652 -0.0374 -0.73 -0.7261 -1.0 1604920 Maybridge1_003180 NC(=O)C1CCN(CC1)C(=S)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I13 compound treatment 1.0419 0.0393 0.76 0.7637 1.0 1611997 Maybridge1_003181 Cc1cc(NC(=O)c2ccccc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I14 compound treatment 0.9861 -0.0165 -0.32 -0.3198 -1.0 2070891 Maybridge1_003182 Cc1noc(C)c1S(=O)(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I15 compound treatment 1.0189 0.0163 0.32 0.3167 1.0 1451795 Maybridge1_003183 Cc1cccn(Cc2c(F)cccc2Cl)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I16 compound treatment 1.0056 0.00306 0.06 0.0594 1.0 2070892 Maybridge1_003184 O=C(Nc1ccccc1)OC2CCSC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I17 compound treatment 0.9889 -0.0137 -0.27 -0.2656 -1.0 1173925 Maybridge1_003185 Clc1sc(Cl)c(c1Br)S(=O)(=O)N2CCSCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I18 compound treatment 0.9666 -0.036 -0.7 -0.699 -1.0 1703198 Maybridge1_003186 NC(=O)c1cccc2cccc(C(=O)O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I19 compound treatment 1.0007 -0.00182 -0.04 -0.0354 -1.0 2070893 Maybridge1_003187 N/C(=N\O)/CSc1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I20 compound treatment 0.9721 -0.0304 -0.59 -0.5907 -1.0 2070894 Maybridge1_003188 CN(C)/C=C/C(=N)SCc1cc(F)cc2COCOc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I21 compound treatment 0.9596 -0.043 -0.83 -0.8344 -1.0 2070895 Maybridge1_003189 Cc1c[nH]nc1c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I22 compound treatment 0.9582 -0.0444 -0.86 -0.8615 -1.0 2070896 Maybridge1_003190 Clc1ccc(C2CC(=O)CC(=O)C2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I23 mock treatment 0.9861 -0.0165 -0.32 -0.3198 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 I24 mock treatment 1.0112 0.00864 0.17 0.1678 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J01 compound treatment 1.0293 0.0268 0.52 0.5199 1.0 2070897 Maybridge1_003191 NC(=N)Nc1nc(cs1)c2cc(Cl)sc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J02 compound treatment 1.0523 0.0498 0.97 0.9668 1.0 1642787 Maybridge1_003192 COC(=O)c1sc(NCC=C)c(C(=O)OC)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J03 compound treatment 0.9687 -0.0339 -0.66 -0.6584 -1.0 2070898 Maybridge1_003193 COc1cc2COC(=O)/C(=C\N(C)C)/c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J04 compound treatment 0.9798 -0.0227 -0.44 -0.4417 -1.0 2070899 Maybridge1_003194 CC1CCCN(C1)S(=O)(=O)c2cc(Cl)c(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J05 compound treatment 1.0091 0.00655 0.13 0.1271 1.0 2070900 Maybridge1_003195 C(SCc1nnn[nH]1)c2nnn[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J06 compound treatment 1.0021 -4.27E-4 -0.01 -0.0083 -1.0 1282320 Maybridge1_003196 COc1ccccc1NC(=S)C(C#N)C(=O)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J07 compound treatment 1.0042 0.00166 0.03 0.0323 1.0 2070901 Maybridge1_003197 Oc1nccn(c2cccc(c2)C(F)(F)F)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J08 compound treatment 1.0098 0.00724 0.14 0.1407 1.0 2070902 Maybridge1_003198 Cc1ccc(CC(=O)c2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J09 compound treatment 0.984 -0.0186 -0.36 -0.3604 -1.0 2070903 Maybridge1_003199 CC(=O)c1ccc(o1)c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J10 compound treatment 0.9959 -0.0067 -0.13 -0.1302 -1.0 1006292 Maybridge1_003200 Oc1nnc(c2ccccc2)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J11 compound treatment 0.9896 -0.013 -0.25 -0.2521 -1.0 2070904 Maybridge1_003201 CC(=O)c1ccc(Oc2ccc(Cl)cc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J12 compound treatment 0.961 -0.0416 -0.81 -0.8073 -1.0 1401466 Maybridge1_003202 O=C(Nc1ccccc1C(=O)Nc2ccncc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J13 compound treatment 0.9303 -0.0723 -1.4 -1.4032 -1.0 2070905 Maybridge1_003203 Cc1nn(c(O)c1N=Nc2ccc(C)cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J14 compound treatment 0.9805 -0.022 -0.43 -0.4281 -1.0 1730722 Maybridge1_003204 CCOC(=O)c1ccc(NC(=O)c2ccccc2NC(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J15 compound treatment 0.954 -0.0485 -0.94 -0.9428 -1.0 1091121 Maybridge1_003205 O=S1(=O)CCN(Cc2ccccc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J16 compound treatment 0.9575 -0.0451 -0.88 -0.8751 -1.0 1049219 Maybridge1_003206 Nc1sc2CCCc2c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J17 compound treatment 0.9226 -0.0799 -1.55 -1.5522 -1.0 2070906 Maybridge1_003207 N#Cc1ccc(cc1)c2cnco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J18 compound treatment 0.9212 -0.0813 -1.58 -1.5793 -1.0 1087389 Maybridge1_003208 Cn1ncc2ccccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J19 compound treatment 0.9819 -0.0207 -0.4 -0.401 -1.0 1393767 Maybridge1_003209 CCOC(=O)c1cnc2ccc(Cl)cc2c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J20 compound treatment 0.9966 -0.00601 -0.12 -0.1166 -1.0 2070907 Maybridge1_003210 Clc1ccc(CSc2nsc(Nc3ccc(Cl)cc3)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J21 compound treatment 0.9638 -0.0388 -0.75 -0.7532 -1.0 1395752 Maybridge1_003211 CCOC(=O)c1c(N)c(sc1Nc2ccccc2OC)C(=O)c3ccc(Br)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J22 compound treatment 0.9603 -0.0423 -0.82 -0.8209 -1.0 2070908 Maybridge1_003212 O=C/1/C(=C/c2ccc3OCOc3c2)/CCC\C1=C/c4ccc5OCOc5c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J23 mock treatment 0.9721 -0.0304 -0.59 -0.5907 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 J24 mock treatment 1.0238 0.0212 0.41 0.4115 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K01 compound treatment 1.0147 0.0121 0.24 0.2355 1.0 2070909 Maybridge1_003213 NCCSCc1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K02 compound treatment 0.9742 -0.0283 -0.55 -0.55 -1.0 2070910 Maybridge1_003214 CC(=O)c1nnn(c1C)c2ccc(F)cc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K03 compound treatment 0.9735 -0.029 -0.56 -0.5636 -1.0 1650150 Maybridge1_003215 OC(=O)c1nnn(c1c2ccccc2)c3ccccc3Oc4ccc(Cl)cc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K04 compound treatment 0.9847 -0.0179 -0.35 -0.3469 -1.0 2070911 Maybridge1_003216 COC(CN/C(=N\C#N)/SC)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K05 compound treatment 1.0063 0.00376 0.07 0.073 1.0 1005731 Maybridge1_003217 CCCCCCCCCCCC(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K06 compound treatment 0.9624 -0.0402 -0.78 -0.7803 -1.0 2070912 Maybridge1_003218 Cc1nn(C)c(C)c1NC(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K07 compound treatment 0.9875 -0.0151 -0.29 -0.2927 -1.0 2070913 Maybridge1_003219 Cc1nn(C)c(O)c1C(=O)c2c(C)onc2c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K08 compound treatment 0.9903 -0.0123 -0.24 -0.2385 -1.0 2070914 Maybridge1_003220 Cc1cc(C)n(n1)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K09 compound treatment 1.0182 0.0156 0.3 0.3032 1.0 1459994 Maybridge1_003221 Clc1ccc(Oc2ccccc2C#N)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K10 compound treatment 0.9687 -0.0339 -0.66 -0.6584 -1.0 2070915 Maybridge1_003222 CCOC(=O)c1cnn(c1COC)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K11 compound treatment 0.9512 -0.0513 -1.0 -0.9969 -1.0 2070916 Maybridge1_003223 CSc1cc(cc(SC)c1SC)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K12 compound treatment 0.9819 -0.0207 -0.4 -0.401 -1.0 2070917 Maybridge1_003224 CCCCNC(=O)NS(=O)(=O)c1cc(Cl)sc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K13 compound treatment 0.9422 -0.0604 -1.17 -1.173 -1.0 1108929 Maybridge1_003225 CC(=O)Cc1ncn(n1)c2cc(C)on2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K14 compound treatment 0.9296 -0.073 -1.42 -1.4168 -1.0 2070918 Maybridge1_003226 Fc1c(CC#N)cccc1CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K15 compound treatment 0.9791 -0.0234 -0.46 -0.4552 -1.0 1936403 Maybridge1_003227 CN(C)/C=N/S(=O)(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K16 compound treatment 0.9268 -0.0757 -1.47 -1.471 -1.0 2070919 Maybridge1_003228 FC(F)(F)c1ccc(CNS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K17 compound treatment 0.9791 -0.0234 -0.46 -0.4552 -1.0 2070920 Maybridge1_003229 Clc1sc(Cl)c(c1Br)S(=O)(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K18 compound treatment 0.9882 -0.0144 -0.28 -0.2792 -1.0 2070921 Maybridge1_003230 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1NCCC2CC2(Cl)Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K19 compound treatment 1.8878 0.885 17.19 17.1914 1.0 2070922 Maybridge1_003231 CN(C)/C=C(\C#N)/c1nc(cs1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K20 compound treatment 1.0077 0.00515 0.1 0.1 1.0 2070923 Maybridge1_003232 NC(=O)N/1CCCCC\C1=N/O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K21 compound treatment 0.9735 -0.029 -0.56 -0.5636 -1.0 1068856 Maybridge1_003233 CC(=O)c1cnn(c1C)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K22 compound treatment 0.9721 -0.0304 -0.59 -0.5907 -1.0 1510203 Maybridge1_003234 CN(C)c1ccc(cc1)C2CC(=O)CC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K23 mock treatment 0.9854 -0.0172 -0.33 -0.3333 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 K24 mock treatment 0.9938 -0.0088 -0.17 -0.1708 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L01 compound treatment 1.0516 0.0491 0.95 0.9533 1.0 2070924 Maybridge1_003235 CCOC(=O)CC1NCCNC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L02 compound treatment 1.0 -0.00252 -0.05 -0.0489 -1.0 2070925 Maybridge1_003236 COc1cccc(/C=N/NC(=O)CC#N)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L03 compound treatment 1.0258 0.0233 0.45 0.4522 1.0 2070926 Maybridge1_003237 FC(F)(F)c1ccc(cc1)C2CC(=CC(=O)C2)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L04 compound treatment 1.0049 0.00236 0.05 0.0459 1.0 2070927 Maybridge1_003238 CC1CCN(CC1)S(=O)(=O)c2cc(Cl)c(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L05 compound treatment 1.0035 9.67E-4 0.02 0.0188 1.0 1517662 Maybridge1_003239 Clc1ccc(cc1)C2CC(=O)C=C(C2)NCc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L06 compound treatment 1.0014 -0.00112 -0.02 -0.0218 -1.0 1557130 Maybridge1_003240 COc1ccccc1NC(=S)C(C#N)C(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L07 compound treatment 1.0154 0.0128 0.25 0.249 1.0 2070928 Maybridge1_003241 CC1=C(C#N)S(=O)(=O)C(C#N)C(C1)c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L08 compound treatment 0.9603 -0.0423 -0.82 -0.8209 -1.0 2070929 Maybridge1_003242 Clc1ccc(/N=C\2/C(=O)Nc3ccc(Br)cc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L09 compound treatment 0.9708 -0.0318 -0.62 -0.6177 -1.0 2070930 Maybridge1_003243 CC(=O)c1ccc(o1)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L10 compound treatment 0.9345 -0.0681 -1.32 -1.322 -1.0 1205536 Maybridge1_003244 Fc1ccc(cc1)c2n[nH]c(=O)c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L11 compound treatment 1.0154 0.0128 0.25 0.249 1.0 2070931 Maybridge1_003245 COc1ccc(Oc2ccc(cc2)C(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L12 compound treatment 0.9708 -0.0318 -0.62 -0.6177 -1.0 1517312 Maybridge1_003246 O=C(Nc1nccs1)c2ccccc2NC(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L13 compound treatment 0.9568 -0.0458 -0.89 -0.8886 -1.0 1386165 Maybridge1_003247 CSc1cc(n[nH]1)c2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L14 compound treatment 1.0098 0.00724 0.14 0.1407 1.0 2070932 Maybridge1_003248 COc1cc(/C=N/NC(=S)N\N=C\c2ccc(O)c(OC)c2)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L15 compound treatment 1.0251 0.0226 0.44 0.4386 1.0 2070933 Maybridge1_003249 OC(=O)c1csc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L16 compound treatment 1.0391 0.0365 0.71 0.7095 1.0 1453213 Maybridge1_003250 Nc1sc2CCCCCc2c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L17 compound treatment 0.9854 -0.0172 -0.33 -0.3333 -1.0 2070934 Maybridge1_003251 [O-][N+](=O)c1ccccc1c2cnco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L18 compound treatment 1.0203 0.0177 0.34 0.3438 1.0 1026020 Maybridge1_003252 O=c1n(ncc2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L19 compound treatment 0.9575 -0.0451 -0.88 -0.8751 -1.0 2070935 Maybridge1_003253 COC(=O)c1cccc(NS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L20 compound treatment 1.0035 9.67E-4 0.02 0.0188 1.0 1569306 Maybridge1_003254 Cc1ccc(NC(=O)c2ccccc2N)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L21 compound treatment 0.9986 -0.00391 -0.08 -0.076 -1.0 2070936 Maybridge1_003255 COc1ccc(/C=N/NC(=O)CC#N)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L22 compound treatment 0.9715 -0.0311 -0.6 -0.6042 -1.0 2070937 Maybridge1_003256 Clc1ccc(/C=C/2\CCC/C(=C\c3ccc(Cl)cc3)/C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L23 mock treatment 0.9715 -0.0311 -0.6 -0.6042 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 L24 mock treatment 1.0035 9.67E-4 0.02 0.0188 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M01 compound treatment 1.0307 0.0282 0.55 0.547 1.0 2070938 Maybridge1_003257 NC(CSCc1c(F)cccc1Cl)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M02 compound treatment 0.9986 -0.00391 -0.08 -0.076 -1.0 2070939 Maybridge1_003258 Cc1nn(C)c(C)c1NS(=O)(=O)c2cc(Cl)sc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M03 compound treatment 0.998 -0.00461 -0.09 -0.0896 -1.0 1504154 Maybridge1_003259 Fc1cc(CSc2nc3ccccc3[nH]2)c4OCOCc4c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M04 compound treatment 0.9959 -0.0067 -0.13 -0.1302 -1.0 2070940 Maybridge1_003260 CC(=O)c1nnn(c1C)c2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M05 compound treatment 1.0189 0.0163 0.32 0.3167 1.0 2070941 Maybridge1_003261 COC(=O)c1sccc1NS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M06 compound treatment 0.984 -0.0186 -0.36 -0.3604 -1.0 2070942 Maybridge1_003262 CS/C(=N\C#N)/N1CCN(CC1)c2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M07 compound treatment 1.0035 9.67E-4 0.02 0.0188 1.0 2070943 Maybridge1_003263 Cc1onc(c1C(=O)c2ccc(F)cc2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M08 compound treatment 1.0398 0.0372 0.72 0.723 1.0 2070944 Maybridge1_003264 CC(=O)c1cnc(N)nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M09 compound treatment 1.0049 0.00236 0.05 0.0459 1.0 2070945 Maybridge1_003265 CN(C)c1cccc(N(C)C)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M10 compound treatment 0.9568 -0.0458 -0.89 -0.8886 -1.0 2070946 Maybridge1_003266 NC(=O)C1CCN(CC1)c2ncccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M11 compound treatment 0.9847 -0.0179 -0.35 -0.3469 -1.0 2070947 Maybridge1_003267 CS(=O)(=O)c1cc(cc(c1S(=O)(=O)C)S(=O)(=O)C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M12 compound treatment 0.968 -0.0346 -0.67 -0.6719 -1.0 1469154 Maybridge1_003268 Clc1ccc(NC(=O)NC(=O)C2CCN(CC2)c3cccc(Cl)c3C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M13 compound treatment 0.9484 -0.0541 -1.05 -1.0511 -1.0 2070948 Maybridge1_003269 Nc1oc(c(C#N)c1c2ccc(Cl)cc2Cl)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M14 compound treatment 0.9861 -0.0165 -0.32 -0.3198 -1.0 2070949 Maybridge1_003270 CNC(=O)c1cnn(c1COC)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M15 compound treatment 0.9938 -0.0088 -0.17 -0.1708 -1.0 1054566 Maybridge1_003271 NC(=O)c1ccc(cc1C(=O)N)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M16 compound treatment 0.9429 -0.0597 -1.16 -1.1595 -1.0 2070950 Maybridge1_003272 Fc1ccc(CNS(=O)(=O)c2cccc(c2)C(F)(F)F)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M17 compound treatment 0.961 -0.0416 -0.81 -0.8073 -1.0 2070951 Maybridge1_003273 CC(OS(=O)(=O)c1ccc(Cl)cc1)c2nc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M18 compound treatment 0.9694 -0.0332 -0.64 -0.6448 -1.0 2070952 Maybridge1_003274 Cc1nc(NC(=N)N)sc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M19 compound treatment 0.9959 -0.0067 -0.13 -0.1302 -1.0 2070953 Maybridge1_003275 N/C(=N\OCc1c(F)cccc1Cl)/c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M20 compound treatment 0.9959 -0.0067 -0.13 -0.1302 -1.0 2070954 Maybridge1_003276 CC(=O)C1=C(C)Nc2ccccc2S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M21 compound treatment 1.0042 0.00166 0.03 0.0323 1.0 2070955 Maybridge1_003277 CC(=O)c1cnn(c1C)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M22 compound treatment 0.9749 -0.0276 -0.54 -0.5365 -1.0 1326338 Maybridge1_003278 O=C1CC(CC(=O)C1)c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M23 mock treatment 1.0238 0.0212 0.41 0.4115 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 M24 mock treatment 1.0168 0.0142 0.28 0.2761 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N01 compound treatment 1.0405 0.0379 0.74 0.7366 1.0 2070956 Maybridge1_003279 N#CC1CN(Cc2ccccc2)CN(Cc3ccccc3)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N02 compound treatment 1.0 -0.00252 -0.05 -0.0489 -1.0 1083103 Maybridge1_003280 Cc1ccc(NC(=O)CC#N)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N03 compound treatment 1.0063 0.00376 0.07 0.073 1.0 1644674 Maybridge1_003281 COc1cc(CO)c(cc1OC)c2c[nH][nH]c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N04 compound treatment 0.9903 -0.0123 -0.24 -0.2385 -1.0 1437622 Maybridge1_003282 COc1ccc(CCNS(=O)(=O)c2cc(Cl)c(Cl)cc2Cl)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N05 compound treatment 0.9715 -0.0311 -0.6 -0.6042 -1.0 1322518 Maybridge1_003283 Clc1cccc(Oc2ccccc2)c1CNC(=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N06 compound treatment 0.9742 -0.0283 -0.55 -0.55 -1.0 1211475 Maybridge1_003284 COc1cccc(NC(=S)C(C#N)C(=O)N2CCCC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N07 compound treatment 0.9966 -0.00601 -0.12 -0.1166 -1.0 1530793 Maybridge1_003285 CCOC(=O)c1cc(C#N)c2ccccn2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N08 compound treatment 0.9986 -0.00391 -0.08 -0.076 -1.0 1533510 Maybridge1_003286 Clc1ccc(cc1)c2nn(c3ccccc3)c(=O)c4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N09 compound treatment 0.9966 -0.00601 -0.12 -0.1166 -1.0 2070957 Maybridge1_003287 OCC(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N10 compound treatment 0.9645 -0.0381 -0.74 -0.7396 -1.0 1021562 Maybridge1_003288 COc1ccc(cc1)C(=O)c2ccccc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N11 compound treatment 0.9735 -0.029 -0.56 -0.5636 -1.0 1660239 Maybridge1_003289 COc1ccc(Oc2ccc(cc2)c3ccn[nH]3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N12 compound treatment 0.9882 -0.0144 -0.28 -0.2792 -1.0 2070958 Maybridge1_003290 FC(F)(F)c1cccc(NC(=O)c2ccccc2NC(=O)c3ccccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N13 compound treatment 0.9673 -0.0353 -0.69 -0.6855 -1.0 2070959 Maybridge1_003291 Cc1nccnc1c2ccn[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N14 compound treatment 1.0049 0.00236 0.05 0.0459 1.0 1917407 Maybridge1_003292 COc1cc(/C=N/NC(=S)N)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N15 compound treatment 0.9359 -0.0667 -1.29 -1.2949 -1.0 1091122 Maybridge1_003293 O=S1(=O)CCN(Cc2ccco2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N16 compound treatment 1.0 -0.00252 -0.05 -0.0489 -1.0 1636044 Maybridge1_003294 Cc1ccc(Nc2ncnc3ccccc23)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N17 compound treatment 0.9338 -0.0688 -1.34 -1.3355 -1.0 2070960 Maybridge1_003295 Clc1ccc(/N=C/c2ccc(C#N)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N18 compound treatment 0.9694 -0.0332 -0.64 -0.6448 -1.0 1191412 Maybridge1_003296 O=c1n(Cc2ccccc2)ncc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N19 compound treatment 0.9812 -0.0213 -0.41 -0.4146 -1.0 2070961 Maybridge1_003297 CCOC(=O)c1c[nH]c2ccc(cc2c1=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N20 compound treatment 0.9882 -0.0144 -0.28 -0.2792 -1.0 1226007 Maybridge1_003298 Nc1ccccc1C(=O)NC2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N21 compound treatment 0.9484 -0.0541 -1.05 -1.0511 -1.0 2070962 Maybridge1_003299 COc1cc(/C=N/NC(=O)CC#N)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N22 compound treatment 0.945 -0.0576 -1.12 -1.1188 -1.0 2070963 Maybridge1_003300 Clc1ccccc1/C=C/2\CCC/C(=C\c3ccccc3Cl)/C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N23 mock treatment 1.0251 0.0226 0.44 0.4386 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 N24 mock treatment 1.0426 0.04 0.78 0.7772 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O01 compound treatment 1.03 0.0275 0.53 0.5334 1.0 1263209 Maybridge1_003301 CC(C)(C)c1nc(N)sc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O02 compound treatment 0.9638 -0.0388 -0.75 -0.7532 -1.0 2070964 Maybridge1_003302 Cc1nn(C)c(C)c1NS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O03 compound treatment 0.9701 -0.0325 -0.63 -0.6313 -1.0 2070965 Maybridge1_003303 Brc1cc(Br)cc(CSc2ccccn2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O04 compound treatment 0.9694 -0.0332 -0.64 -0.6448 -1.0 1171047 Maybridge1_003304 Fc1ccc(cc1)C(=O)C2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O05 compound treatment 1.0314 0.0289 0.56 0.5605 1.0 1441367 Maybridge1_003305 CC(C)(C)C(=O)c1sc2sc(C(=O)C(C)(C)C)c(N)c2c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O06 compound treatment 0.9952 -0.0074 -0.14 -0.1437 -1.0 2070966 Maybridge1_003306 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1N2CCNCC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O07 compound treatment 0.9952 -0.0074 -0.14 -0.1437 -1.0 1985191 Maybridge1_003307 COC(=O)c1sccc1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O08 compound treatment 0.9728 -0.0297 -0.58 -0.5771 -1.0 2070967 Maybridge1_003308 CS/C(=N\C#N)/NC1CCCCNC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O09 compound treatment 0.9833 -0.0193 -0.37 -0.374 -1.0 2070968 Maybridge1_003309 NC(=O)c1ccc(cc1)C(=N)NS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O10 compound treatment 0.9924 -0.0102 -0.2 -0.1979 -1.0 2070969 Maybridge1_003310 CN(C)/C=N/C(=O)C1CCN(CC1)c2cccc(F)c2C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O11 compound treatment 0.9826 -0.02 -0.39 -0.3875 -1.0 2070970 Maybridge1_003311 CN(C)/C=C/1\C(=O)ON=C1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O12 compound treatment 0.9777 -0.0248 -0.48 -0.4823 -1.0 2070971 Maybridge1_003312 CSC1=NS(=O)(=O)c2c(C)nn(C)c2S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O13 compound treatment 0.9512 -0.0513 -1.0 -0.9969 -1.0 2070972 Maybridge1_003313 Cc1n[nH]cc1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O14 compound treatment 0.9394 -0.0632 -1.23 -1.2272 -1.0 2070973 Maybridge1_003314 Cc1c(nnn1c2ccc(Cl)cc2Cl)c3ccnc(N)n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O15 compound treatment 0.9554 -0.0472 -0.92 -0.9157 -1.0 1419671 Maybridge1_003315 Clc1cc(c(Cl)s1)S(=O)(=O)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O16 compound treatment 0.9631 -0.0395 -0.77 -0.7667 -1.0 2070974 Maybridge1_003316 Fc1ccc(C(=O)NCc2cc(cc(c2)C(F)(F)F)C(F)(F)F)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O17 compound treatment 1.0098 0.00724 0.14 0.1407 1.0 2070975 Maybridge1_003317 [O-][N+](=O)c1cccnc1NCc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O18 compound treatment 0.9986 -0.00391 -0.08 -0.076 -1.0 2070976 Maybridge1_003318 OC(=O)c1cc(Br)cc(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O19 compound treatment 1.0042 0.00166 0.03 0.0323 1.0 2070977 Maybridge1_003319 CN(C)/C=N/C(=N\OCc1c(F)cccc1Cl)/c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O20 compound treatment 0.9694 -0.0332 -0.64 -0.6448 -1.0 2070978 Maybridge1_003320 Fc1cccc(Cl)c1/C=C/c2cnc3ccccc3n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O21 compound treatment 0.9708 -0.0318 -0.62 -0.6177 -1.0 2070979 Maybridge1_003321 CS/C(=N/C#N)/NCCSC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O22 compound treatment 0.9952 -0.0074 -0.14 -0.1437 -1.0 2070980 Maybridge1_003322 FC(F)(F)c1cc(cc(c1)S(=O)(=O)NCc2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O23 mock treatment 1.03 0.0275 0.53 0.5334 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 O24 mock treatment 1.0265 0.024 0.47 0.4657 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P01 compound treatment 1.0245 0.0219 0.43 0.4251 1.0 2070981 Maybridge1_003323 CSC(=NS(=O)(=O)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F)SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P02 compound treatment 1.051 0.0484 0.94 0.9397 1.0 1083128 Maybridge1_003324 Cc1ccccc1NC(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P03 compound treatment 1.0712 0.0686 1.33 1.3325 1.0 2070982 Maybridge1_003325 CN(C)/C=N/C(=O)c1sc(C#N)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P04 compound treatment 1.0321 0.0296 0.57 0.5741 1.0 1735768 Maybridge1_003326 COc1ccccc1Nc2snc3sc(C(=O)c4ccc(C)cc4)c(N)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P05 compound treatment 0.9966 -0.00601 -0.12 -0.1166 -1.0 2070983 Maybridge1_003327 CC(=O)C1C(=O)CC(CC1=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P06 compound treatment 1.0405 0.0379 0.74 0.7366 1.0 1585004 Maybridge1_003328 COc1cccc(NC(=S)C(C#N)C(=O)N2CCC(C)CC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P07 compound treatment 0.9784 -0.0241 -0.47 -0.4688 -1.0 2070984 Maybridge1_003329 Fc1ccccc1S(=O)(=O)CCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P08 compound treatment 1.0314 0.0289 0.56 0.5605 1.0 1007678 Maybridge1_003330 Cc1ccc(cc1)C(=O)c2ccccc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P09 compound treatment 1.0328 0.0303 0.59 0.5876 1.0 2070985 Maybridge1_003331 CC(=O)c1ccc(o1)c2ccc(F)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P10 compound treatment 1.0049 0.00236 0.05 0.0459 1.0 1101361 Maybridge1_003332 N1C(Nc2ccccc12)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P11 compound treatment 1.0056 0.00306 0.06 0.0594 1.0 1282449 Maybridge1_003333 Nc1c(cnn1c2cc(Cl)cc(Cl)c2)c3nn[nH]n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P12 compound treatment 0.9938 -0.0088 -0.17 -0.1708 -1.0 1612743 Maybridge1_003334 Cc1ccc(NC(=O)c2ccccc2NC(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P13 compound treatment 1.0279 0.0254 0.49 0.4928 1.0 2070986 Maybridge1_003335 Cc1nc(COc2ccc(C#N)cc2)cs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P14 compound treatment 1.0175 0.0149 0.29 0.2896 1.0 1029735 Maybridge1_003336 OC(=O)CC1SC(=N)NC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P15 compound treatment 1.0475 0.0449 0.87 0.872 1.0 2070987 Maybridge1_003337 Clc1ccc(SCCS(=O)(=O)CCSc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P16 compound treatment 0.961 -0.0416 -0.81 -0.8073 -1.0 2070988 Maybridge1_003338 O=C1OCCC/N=C(/c2ccccc2)\c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P17 compound treatment 0.9498 -0.0527 -1.02 -1.024 -1.0 2070989 Maybridge1_003339 Clc1ccc(/C=N/c2cc(Cl)cc(Cl)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P18 compound treatment 0.9708 -0.0318 -0.62 -0.6177 -1.0 2070990 Maybridge1_003340 Cc1ccc(cc1)C(=O)CSC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P19 compound treatment 0.9819 -0.0207 -0.4 -0.401 -1.0 1133957 Maybridge1_003341 OC(=O)C1CN(Cc2cccs2)C(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P20 compound treatment 0.9903 -0.0123 -0.24 -0.2385 -1.0 1913964 Maybridge1_003342 Cc1ccc(cc1C)n2nnc3ccccc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P21 compound treatment 1.0112 0.00864 0.17 0.1678 1.0 2070991 Maybridge1_003343 COc1ccc(/C=N/NC(=O)CC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P22 compound treatment 1.1249 0.122 2.38 2.3753 1.0 2070992 Maybridge1_003344 O=C/1/C(=C/c2ccco2)/CCC\C1=C/c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P23 mock treatment 0.9673 -0.0353 -0.69 -0.6855 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.550 P24 mock treatment 1.0405 0.0379 0.74 0.7366 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A01 compound treatment 1.0791 0.0791 1.54 1.5367 1.0 2070993 Maybridge1_003345 O=C/1/C(=C/c2cccs2)/CCC\C1=C/c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A02 compound treatment 1.0195 0.0195 0.38 0.3785 1.0 2070994 Maybridge1_003346 CSC1=NCCN1C(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A03 compound treatment 1.0356 0.0356 0.69 0.6919 1.0 2070995 Maybridge1_003347 Clc1ccccc1/C=C/2\CC/C(=C\c3ccccc3Cl)/C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A04 compound treatment 1.0258 0.0258 0.5 0.5012 1.0 2070996 Maybridge1_003348 Clc1ccc(cc1)c2csc(Nc3ccccc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A05 compound treatment 1.0223 0.0223 0.43 0.433 1.0 2070997 Maybridge1_003349 CN1C/C(=C\C=C\c2ccccc2)/C(=O)\C(=C\C=C\c3ccccc3)\C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A06 compound treatment 0.9921 -0.00787 -0.15 -0.1529 -1.0 2070998 Maybridge1_003350 Cc1cc(C)c(CS/C(=N/N)/N)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A07 compound treatment 0.997 -0.00296 -0.06 -0.0575 -1.0 2070999 Maybridge1_003351 Cc1ccc(CSC2=NCCN2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A08 compound treatment 0.9809 -0.0191 -0.37 -0.3709 -1.0 2071000 Maybridge1_003352 Cc1c(C)c(C)c(CSC2=NCCCN2C3CCCCC3)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A09 compound treatment 1.0328 0.0328 0.64 0.6374 1.0 2071001 Maybridge1_003353 C(SC1=NCCCN1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A10 compound treatment 1.0223 0.0223 0.43 0.433 1.0 1664303 Maybridge1_003354 CC(=O)Nc1ccc(cc1)C(=C(C#N)C#N)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A11 compound treatment 0.9956 -0.00436 -0.08 -0.0847 -1.0 2071002 Maybridge1_003355 Cc1c(C)c(C)c(CSC2=NCCN2Cc3ccccc3)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A12 compound treatment 0.9634 -0.0366 -0.71 -0.7115 -1.0 2071003 Maybridge1_003356 Clc1ccc(cc1)C2=NC(N=C(S2)c3ccc(Cl)cc3)c4ccc(Cl)c(Cl)c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A13 compound treatment 1.0034 0.00335 0.07 0.0651 1.0 2071004 Maybridge1_003357 CNC(=S)N/N=C(\C)/c1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A14 compound treatment 0.9577 -0.0423 -0.82 -0.8205 -1.0 2071005 Maybridge1_003358 Cc1ccc(CSC2=NCN(CN2)C(C)(C)CC(C)(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A15 compound treatment 1.03 0.03 0.58 0.5829 1.0 2071006 Maybridge1_003359 Clc1ccc2OC(Nc2c1)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A16 compound treatment 0.976 -0.024 -0.47 -0.4663 -1.0 2071007 Maybridge1_003360 CCOC(=O)c1sc2ccccc2c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A17 compound treatment 0.9977 -0.00226 -0.04 -0.0439 -1.0 1345383 Maybridge1_003361 N1C(c2ccccc2)n3c(nc4ccccc34)-c5ccccc15 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A18 compound treatment 0.9914 -0.00857 -0.17 -0.1665 -1.0 2071008 Maybridge1_003362 FC(F)(F)c1nn2cc(nc2s1)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A19 compound treatment 0.9823 -0.0177 -0.34 -0.3436 -1.0 1222161 Maybridge1_003363 N1C(Oc2ccccc12)c3cccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A20 compound treatment 0.9592 -0.0408 -0.79 -0.7933 -1.0 2071009 Maybridge1_003364 Clc1cc(Cl)c(Cl)c(I)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A21 compound treatment 0.9914 -0.00857 -0.17 -0.1665 -1.0 2071010 Maybridge1_003365 CCN1CNC(=NC1)SCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A22 compound treatment 0.976 -0.024 -0.47 -0.4663 -1.0 1879466 Maybridge1_003366 [O-][N+](=O)c1ccc(cc1)C(=O)NCc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A23 mock treatment 1.0048 0.00476 0.09 0.0924 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 A24 mock treatment 1.0216 0.0216 0.42 0.4194 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B01 compound treatment 1.0216 0.0216 0.42 0.4194 1.0 2071011 Maybridge1_003367 Clc1ccccc1CSC2=Nc3ccccc3C(=O)NN2c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B02 compound treatment 0.9949 -0.00507 -0.1 -0.0984 -1.0 1510166 Maybridge1_003368 Clc1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)c3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B03 compound treatment 0.9928 -0.00717 -0.14 -0.1392 -1.0 2071012 Maybridge1_003369 [O-][N+](=O)c1ccc(SC2=NCCN2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B04 compound treatment 0.9844 -0.0156 -0.3 -0.3028 -1.0 1291880 Maybridge1_003370 CCOC(=O)c1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B05 compound treatment 0.9451 -0.0549 -1.07 -1.0658 -1.0 1085749 Maybridge1_003371 CCOC(=O)CSc1ccc(cc1Cl)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B06 compound treatment 1.0083 0.00827 0.16 0.1605 1.0 1454539 Maybridge1_003372 Cc1onc(c1C(=O)Nc2ccc(F)c(F)c2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B07 compound treatment 0.9577 -0.0423 -0.82 -0.8205 -1.0 2071013 Maybridge1_003373 CC(C)c1ccc(/N=C/c2cc(Br)ccc2O)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B08 compound treatment 1.0293 0.0293 0.57 0.5693 1.0 2071014 Maybridge1_003374 NS(=O)(=O)c1ccc(Sc2ccccn2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B09 compound treatment 0.9704 -0.0296 -0.58 -0.5753 -1.0 1658093 Maybridge1_003375 COc1ccc(CCNC2(CCCCC2)C#N)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B10 compound treatment 0.9767 -0.0233 -0.45 -0.4526 -1.0 2071015 Maybridge1_003376 ClC(Cl)(Cl)C(=O)N1CCc2ccccc2C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B11 compound treatment 0.9963 -0.00366 -0.07 -0.0711 -1.0 1004134 Maybridge1_003377 CCOC(=O)NCc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B12 compound treatment 0.9732 -0.0268 -0.52 -0.5208 -1.0 2071016 Maybridge1_003378 Cc1ccc(nc1)N2C(=O)C3C4CC(C=C4)C3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B13 compound treatment 1.0005 5.48E-4 0.01 0.0106 1.0 1410553 Maybridge1_003379 CC(C)N(CCC#N)C(=O)c1c(C)onc1c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B14 compound treatment 1.0111 0.0111 0.22 0.215 1.0 1690979 Maybridge1_003380 Cc1cccc(NC(=S)NCc2ccncc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B15 compound treatment 0.9493 -0.0507 -0.98 -0.984 -1.0 2071017 Maybridge1_003381 O=C/1C2CCN(CC2)\C1=C/c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B16 compound treatment 0.9844 -0.0156 -0.3 -0.3028 -1.0 1200805 Maybridge1_003382 COc1ccccc1NC(=S)NCc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B17 compound treatment 0.9613 -0.0387 -0.75 -0.7524 -1.0 2071018 Maybridge1_003383 C=C1S/C(=N/c2ccc(cc2)S(=O)(=O)N3CCCCC3)/NC41CCCCC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B18 compound treatment 0.9795 -0.0205 -0.4 -0.3981 -1.0 2071019 Maybridge1_003384 Cc1ccccc1NC(=S)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B19 compound treatment 1.7275 0.727 14.13 14.1271 1.0 2071020 Maybridge1_003385 C[C@@]1(CCC2C(CCC3C[C@H](O)CC[C@@]32C)C1/C=C\4/Nc5ccccc5C4=O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B20 compound treatment 0.9872 -0.0128 -0.25 -0.2482 -1.0 2071021 Maybridge1_003386 COc1cccc(NC(=S)N2CC(C)OC(C)C2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B21 compound treatment 0.9809 -0.0191 -0.37 -0.3709 -1.0 1162137 Maybridge1_003387 Clc1ccc(cc1Cl)C(NCc2ccccc2)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B22 compound treatment 0.9577 -0.0423 -0.82 -0.8205 -1.0 2071022 Maybridge1_003388 Cc1ccc(NC(=S)NCc2ccncc2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B23 mock treatment 0.9732 -0.0268 -0.52 -0.5208 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 B24 mock treatment 0.9907 -0.00927 -0.18 -0.1801 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C01 compound treatment 1.0455 0.0455 0.88 0.8827 1.0 2071023 Maybridge1_003389 O=C/1/C(=C/c2ccccc2)/CC\C1=C/c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C02 compound treatment 1.0111 0.0111 0.22 0.215 1.0 2071024 Maybridge1_003390 Clc1ccc(cc1)c2csc(n2)c3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C03 compound treatment 1.39 0.39 7.57 7.573 1.0 2071025 Maybridge1_003391 CN(C)c1ccc(/C=C/2\CCC/C(=C\c3ccc(cc3)N(C)C)/C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C04 compound treatment 0.95 -0.05 -0.97 -0.9704 -1.0 2071026 Maybridge1_003392 NC(=S)Cc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C05 compound treatment 0.99 -0.00998 -0.19 -0.1937 -1.0 1433637 Maybridge1_003393 CNc1ccc(Cl)cc1C(=O)NCCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C06 compound treatment 0.9669 -0.0331 -0.64 -0.6434 -1.0 1101362 Maybridge1_003394 CC(O)CN1CNC(=S)NC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C07 compound treatment 0.9914 -0.00857 -0.17 -0.1665 -1.0 1018871 Maybridge1_003395 C(SC1=NCCN1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C08 compound treatment 0.9627 -0.0373 -0.73 -0.7252 -1.0 2071027 Maybridge1_003396 Clc1cccc(Cl)c1CSC2=NCCCN2C3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C09 compound treatment 0.976 -0.024 -0.47 -0.4663 -1.0 2071028 Maybridge1_003397 CC1CNC(=N1)SCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C10 compound treatment 0.9556 -0.0444 -0.86 -0.8614 -1.0 2071029 Maybridge1_003398 COc1ccc(cc1OC)C2N=C(SC(=N2)c3ccc(Cl)cc3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C11 compound treatment 1.0335 0.0335 0.65 0.6511 1.0 2071030 Maybridge1_003399 Cc1c(C)c(C)c(CSc2nc3ccccc3[nH]2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C12 compound treatment 0.9395 -0.0605 -1.17 -1.1748 -1.0 1734920 Maybridge1_003400 Brc1ccc(cc1)c2csc(=N)n2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C13 compound treatment 0.9732 -0.0268 -0.52 -0.5208 -1.0 2071031 Maybridge1_003401 CNC(=S)N/N=C(\C)/c1cccc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C14 compound treatment 0.9942 -0.00577 -0.11 -0.112 -1.0 2071032 Maybridge1_003402 FC(F)(F)c1cc(cc(c1)C(F)(F)F)n2c(nc3ccccc3c2=O)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C15 compound treatment 0.9704 -0.0296 -0.58 -0.5753 -1.0 2071033 Maybridge1_003403 COc1ccc(cc1)C2Nc3cc(Cl)ccc3O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C16 compound treatment 0.9865 -0.0135 -0.26 -0.2619 -1.0 2071034 Maybridge1_003404 Clc1ccc(cc1)C(=N)NCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C17 compound treatment 0.9949 -0.00507 -0.1 -0.0984 -1.0 2071035 Maybridge1_003405 CN(C)c1ccc(C2Nc3ccccc3O2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C18 compound treatment 0.9949 -0.00507 -0.1 -0.0984 -1.0 2071036 Maybridge1_003406 CCOC(=O)c1c(NC(=O)COc2ccccc2)sc3CCCCc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C19 compound treatment 0.9662 -0.0338 -0.66 -0.657 -1.0 1150673 Maybridge1_003407 COc1cc(cc(OC)c1OC)C2Nc3ccccc3O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C20 compound treatment 0.929 -0.071 -1.38 -1.3792 -1.0 1057038 Maybridge1_003408 CNc1ccccc1C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C21 compound treatment 1.0139 0.0139 0.27 0.2695 1.0 2071037 Maybridge1_003409 CCN1CNC(=NC1)SCc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C22 compound treatment 0.9465 -0.0535 -1.04 -1.0385 -1.0 2071038 Maybridge1_003410 [O-][N+](=O)c1ccc(N2CCOCC2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C23 mock treatment 0.9711 -0.0289 -0.56 -0.5616 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 C24 mock treatment 0.9662 -0.0338 -0.66 -0.657 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D01 compound treatment 1.0104 0.0104 0.2 0.2014 1.0 1049869 Maybridge1_003411 OC(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D02 compound treatment 0.9949 -0.00507 -0.1 -0.0984 -1.0 2071039 Maybridge1_003412 OC1=NC(Nc2ccccc12)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D03 compound treatment 0.9816 -0.0184 -0.36 -0.3573 -1.0 2071040 Maybridge1_003413 [O-][N+](=O)c1ccc(Sc2ccccc2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D04 compound treatment 0.9907 -0.00927 -0.18 -0.1801 -1.0 1922174 Maybridge1_003414 Oc1ccccc1/C=N/c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D05 compound treatment 0.9977 -0.00226 -0.04 -0.0439 -1.0 2071041 Maybridge1_003415 Cc1ccc(C(=O)NNC(=O)c2ccncc2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D06 compound treatment 0.9921 -0.00787 -0.15 -0.1529 -1.0 1180385 Maybridge1_003416 Cc1c(C)c(C)c(CSCC(=O)NN)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D07 compound treatment 0.9683 -0.0317 -0.62 -0.6161 -1.0 1484448 Maybridge1_003417 Clc1ccc2oc(cc2c1)c3csc(NCC=C)n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D08 compound treatment 0.983 -0.017 -0.33 -0.33 -1.0 2071042 Maybridge1_003418 [O-][N+](=O)c1cc(ccc1Sc2ccccn2)C(=O)N3CCC=CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D09 compound treatment 0.9451 -0.0549 -1.07 -1.0658 -1.0 1675509 Maybridge1_003419 CC(C)c1ccc(NC2(CCCCC2)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D10 compound treatment 0.9486 -0.0514 -1.0 -0.9977 -1.0 2071043 Maybridge1_003420 ClC(Cl)(Cl)C(=O)N1CCN2C(=O)c3ccccc3C12c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D11 compound treatment 0.9718 -0.0282 -0.55 -0.548 -1.0 2071044 Maybridge1_003421 Nc1ccc(Cl)cc1/C(=N/O)/c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D12 compound treatment 0.9648 -0.0352 -0.68 -0.6843 -1.0 2071045 Maybridge1_003422 O=C1C2C3CC(C=C3)C2C(=O)N1c4cccc(n4)N5C(=O)C6C7CC(C=C7)C6C5=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D13 compound treatment 1.0146 0.0146 0.28 0.2832 1.0 1204368 Maybridge1_003423 COC(=O)c1ccccc1NC(=O)c2c(C)onc2c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D14 compound treatment 0.9634 -0.0366 -0.71 -0.7115 -1.0 2071046 Maybridge1_003424 Cc1ccc(NC(=S)NCc2ccncc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D15 compound treatment 0.9521 -0.0479 -0.93 -0.9295 -1.0 2071047 Maybridge1_003425 COc1ccc(/C=C\2/N3CCC(CC3)C2=O)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D16 compound treatment 0.9753 -0.0247 -0.48 -0.4799 -1.0 2071048 Maybridge1_003426 Clc1ccccc1NC(=S)NCc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D17 compound treatment 1.0012 0.00125 0.02 0.0243 1.0 2071049 Maybridge1_003427 COc1cccc(/N=C\2/NC(C)(C)C(=C)S2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D18 compound treatment 0.9851 -0.0149 -0.29 -0.2891 -1.0 2071050 Maybridge1_003428 COc1ccc(NC(=S)N2CCOCC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D19 compound treatment 1.7141 0.714 13.87 13.8682 1.0 2071051 Maybridge1_003429 C[C@@]1(CCC2C(CCC3CC=CC[C@@]32C)C1/C=C\4/Nc5ccccc5C4=O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D20 compound treatment 0.9991 -8.55E-4 -0.02 -0.0166 -1.0 2071052 Maybridge1_003430 COc1ccccc1NC(=S)N2CC(C)OC(C)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D21 compound treatment 1.0153 0.0153 0.3 0.2968 1.0 1698522 Maybridge1_003431 COc1ccc(CCNC(C#N)c2ccc(Cl)c(Cl)c2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D22 compound treatment 0.9704 -0.0296 -0.58 -0.5753 -1.0 2071053 Maybridge1_003432 Cc1cccc(C)c1NC(=S)NCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D23 mock treatment 0.9683 -0.0317 -0.62 -0.6161 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 D24 mock treatment 1.037 0.037 0.72 0.7192 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E01 compound treatment 1.0812 0.0812 1.58 1.5776 1.0 2071054 Maybridge1_003433 COc1cc(C#N)c(OC)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E02 compound treatment 0.9921 -0.00787 -0.15 -0.1529 -1.0 2071055 Maybridge1_003434 S=C1NCN(Cc2ccccc2)CN1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E03 compound treatment 0.9823 -0.0177 -0.34 -0.3436 -1.0 2071056 Maybridge1_003435 CN1C/C(=C\c2ccc(Cl)cc2)/C(=O)\C(=C\c3ccc(Cl)cc3)\C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E04 compound treatment 1.0076 0.00756 0.15 0.1469 1.0 2071057 Maybridge1_003436 COc1ccc(CC(=S)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E05 compound treatment 1.0132 0.0132 0.26 0.2559 1.0 1643078 Maybridge1_003437 CNc1ccccc1C(=O)NCCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E06 compound treatment 0.9732 -0.0268 -0.52 -0.5208 -1.0 1305363 Maybridge1_003438 Nc1nc(cs1)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E07 compound treatment 1.0167 0.0167 0.32 0.324 1.0 2071058 Maybridge1_003439 Clc1ccc(CSC2=NCCN2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E08 compound treatment 0.9739 -0.0261 -0.51 -0.5071 -1.0 2071059 Maybridge1_003440 N#Cc1ccc(CSC2=NCCCN2C3CCCCC3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E09 compound treatment 0.9592 -0.0408 -0.79 -0.7933 -1.0 2071060 Maybridge1_003441 Cc1ccc(CSc2nc3ccccc3[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E10 compound treatment 0.9928 -0.00717 -0.14 -0.1392 -1.0 2071061 Maybridge1_003442 COc1cc(cc(OC)c1OC)C2N=C(SC(=N2)c3ccc(Cl)cc3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E11 compound treatment 1.0146 0.0146 0.28 0.2832 1.0 2071062 Maybridge1_003443 CN(C)c1ccc(cc1)C2NN=C(N2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E12 compound treatment 0.9837 -0.0163 -0.32 -0.3164 -1.0 1055541 Maybridge1_003444 FC(F)(F)c1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E13 compound treatment 0.9318 -0.0682 -1.32 -1.3247 -1.0 1922670 Maybridge1_003445 Nc1ccccc1C(=O)N/N=C/c2cccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E14 compound treatment 0.9542 -0.0458 -0.89 -0.8887 -1.0 1085424 Maybridge1_003446 OC(=O)c1ccccc1NC(=O)COc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E15 compound treatment 0.9795 -0.0205 -0.4 -0.3981 -1.0 2071063 Maybridge1_003447 COc1ccc(OC)c(c1)/C(=N/O)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E16 compound treatment 0.9613 -0.0387 -0.75 -0.7524 -1.0 2071064 Maybridge1_003448 Nc1nnc(s1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E17 compound treatment 0.9725 -0.0275 -0.53 -0.5344 -1.0 1267546 Maybridge1_003449 CN(C)c1ccc(C2Nc3cc(Cl)ccc3O2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E18 compound treatment 0.9528 -0.0472 -0.92 -0.9159 -1.0 2071065 Maybridge1_003450 NC(=S)c1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E19 compound treatment 1.0244 0.0244 0.47 0.4739 1.0 1585575 Maybridge1_003451 CN(CCC#N)c1ccc(cc1)C2Nc3ccccc3O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E20 compound treatment 0.9367 -0.0633 -1.23 -1.2293 -1.0 1334251 Maybridge1_003452 Clc1ccccc1C(=O)NCc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E21 compound treatment 0.9746 -0.0254 -0.49 -0.4935 -1.0 2071066 Maybridge1_003453 COCCCN1CNC(=S)NC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E22 compound treatment 0.943 -0.057 -1.11 -1.1067 -1.0 1726130 Maybridge1_003454 Nc1ccc(N2CCOCC2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E23 mock treatment 0.9746 -0.0254 -0.49 -0.4935 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 E24 mock treatment 0.9816 -0.0184 -0.36 -0.3573 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F01 compound treatment 1.0174 0.0174 0.34 0.3377 1.0 2071067 Maybridge1_003455 Cc1nnc(NC(=S)N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F02 compound treatment 1.0153 0.0153 0.3 0.2968 1.0 1079948 Maybridge1_003456 Clc1ccccc1C2NC(=O)c3ccccc3N2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F03 compound treatment 0.9963 -0.00366 -0.07 -0.0711 -1.0 2071068 Maybridge1_003457 OC(=O)c1cc(ccc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F04 compound treatment 1.0202 0.0202 0.39 0.3922 1.0 1910594 Maybridge1_003458 Oc1c(Br)cc(Br)cc1/C=N/c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F05 compound treatment 1.0321 0.0321 0.62 0.6238 1.0 2071069 Maybridge1_003459 FC(F)(F)c1cccc(c1)C(=O)NNC(=O)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F06 compound treatment 1.0216 0.0216 0.42 0.4194 1.0 2071070 Maybridge1_003460 NNC(=O)CSc1ccccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F07 compound treatment 1.0069 0.00686 0.13 0.1333 1.0 2071071 Maybridge1_003461 FC(F)(F)c1cc(cc(c1)S(=O)(=O)c2ccc(Cl)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F08 compound treatment 1.0251 0.0251 0.49 0.4876 1.0 2071072 Maybridge1_003462 [O-][N+](=O)c1ccc(NC(=O)c2ccc(Sc3ccc(Cl)cc3)c(c2)[N+](=O)[O-])nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F09 compound treatment 1.0132 0.0132 0.26 0.2559 1.0 1049326 Maybridge1_003463 Fc1ccc(cc1)C(=O)CCN2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F10 compound treatment 0.9641 -0.0359 -0.7 -0.6979 -1.0 2071073 Maybridge1_003464 C/C(=N\O)/c1ccc(Cl)c(NC(=O)c2c(C)onc2c3ccccc3Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F11 compound treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 2071074 Maybridge1_003465 [O-][N+](=O)c1ccc(N/N=C/2\CCCCC2CCC#N)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F12 compound treatment 0.9528 -0.0472 -0.92 -0.9159 -1.0 1613737 Maybridge1_003466 COc1ccc(NC(=S)N(CCC#N)C2CCCCC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F13 compound treatment 0.9458 -0.0542 -1.05 -1.0522 -1.0 1056544 Maybridge1_003467 CCOC(=O)c1c(N)sc2CCCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F14 compound treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 1138910 Maybridge1_003468 COc1ccc(NC(=S)NCc2ccncc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F15 compound treatment 0.9683 -0.0317 -0.62 -0.6161 -1.0 2071075 Maybridge1_003469 O=C/1C2CCN(CC2)\C1=C\c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F16 compound treatment 1.023 0.023 0.45 0.4467 1.0 2071076 Maybridge1_003470 FC(F)(F)c1cccc(NC(=S)NCc2cccnc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F17 compound treatment 0.9837 -0.0163 -0.32 -0.3164 -1.0 2071077 Maybridge1_003471 Cc1ccc(/N=C\2/NC(C)(C)C(=C)S2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F18 compound treatment 0.9648 -0.0352 -0.68 -0.6843 -1.0 2071078 Maybridge1_003472 CCOC(=O)c1ccc(NC(=S)N2CCOCC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F19 compound treatment 0.9823 -0.0177 -0.34 -0.3436 -1.0 2071079 Maybridge1_003473 Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4cccc(c4)[N+](=O)[O-])cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F20 compound treatment 0.9711 -0.0289 -0.56 -0.5616 -1.0 2071080 Maybridge1_003474 Cc1onc(c1C(=O)Nc2cccc(c2)C(F)(F)F)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F21 compound treatment 0.9423 -0.0577 -1.12 -1.1203 -1.0 1271674 Maybridge1_003475 Brc1ccc(cc1)S(=O)(=O)N(CCC#N)CC2CCCO2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F22 compound treatment 0.9942 -0.00577 -0.11 -0.112 -1.0 2071081 Maybridge1_003476 COc1cccc(NC(=S)N(CCC#N)C2CCCCC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F23 mock treatment 1.0321 0.0321 0.62 0.6238 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 F24 mock treatment 0.9458 -0.0542 -1.05 -1.0522 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G01 compound treatment 1.0532 0.0532 1.03 1.0326 1.0 2071082 Maybridge1_003477 COc1ccc(/C=C/2\CC/C(=C\c3ccc(OC)cc3)/C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G02 compound treatment 1.0602 0.0602 1.17 1.1688 1.0 2071083 Maybridge1_003478 Cc1nc(cs1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G03 compound treatment 1.0525 0.0525 1.02 1.019 1.0 2071084 Maybridge1_003479 CN1C/C(=C\c2ccccc2)/C(=O)\C(=C\c3ccccc3)\C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G04 compound treatment 0.983 -0.017 -0.33 -0.33 -1.0 2071085 Maybridge1_003480 Clc1ccc(Cc2nc(cs2)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G05 compound treatment 0.9865 -0.0135 -0.26 -0.2619 -1.0 1494940 Maybridge1_003481 CNc1ccccc1C(=O)NCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G06 compound treatment 1.0349 0.0349 0.68 0.6783 1.0 2071086 Maybridge1_003482 S=C1NCCCN1C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G07 compound treatment 1.0069 0.00686 0.13 0.1333 1.0 2071087 Maybridge1_003483 Clc1ccccc1CSC2=NCCN2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G08 compound treatment 0.9879 -0.0121 -0.23 -0.2346 -1.0 1632209 Maybridge1_003484 CCC(CO)N1CNC(=S)NC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G09 compound treatment 1.0034 0.00335 0.07 0.0651 1.0 2071088 Maybridge1_003485 Clc1ccccc1CSc2nc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G10 compound treatment 0.9788 -0.0212 -0.41 -0.4118 -1.0 2071089 Maybridge1_003486 Cc1cc(C)c(CSc2ccccn2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G11 compound treatment 0.9549 -0.0451 -0.88 -0.875 -1.0 2071090 Maybridge1_003487 Clc1ccc(cc1)C2=NNC(N2)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G12 compound treatment 0.9599 -0.0401 -0.78 -0.7797 -1.0 2071091 Maybridge1_003488 CSC1=NCN(Cc2ccccc2)CN1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G13 compound treatment 1.0012 0.00125 0.02 0.0243 1.0 2071092 Maybridge1_003489 CNC(=S)NN=C1CCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G14 compound treatment 0.9963 -0.00366 -0.07 -0.0711 -1.0 2071093 Maybridge1_003490 CCCCCCCCCCCCN1CNC(=S)NC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G15 compound treatment 1.0027 0.00265 0.05 0.0515 1.0 1017701 Maybridge1_003491 CSc1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G16 compound treatment 0.9444 -0.0556 -1.08 -1.0794 -1.0 1329134 Maybridge1_003492 Cc1nn(Cc2ccccc2Cl)c(=N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G17 compound treatment 0.9872 -0.0128 -0.25 -0.2482 -1.0 1250043 Maybridge1_003493 Clc1ccc(cc1)C2Nc3ccccc3-c4nc5ccccc5n24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G18 compound treatment 0.9886 -0.0114 -0.22 -0.221 -1.0 1231206 Maybridge1_003494 COC(=O)c1ccccc1NC(=S)N(N)CCO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G19 compound treatment 1.0012 0.00125 0.02 0.0243 1.0 2071094 Maybridge1_003495 N1C(Oc2ccccc12)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G20 compound treatment 0.9704 -0.0296 -0.58 -0.5753 -1.0 1245464 Maybridge1_003496 Clc1cccc(c1)C(=O)NCc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G21 compound treatment 0.9914 -0.00857 -0.17 -0.1665 -1.0 2071095 Maybridge1_003497 CSC1=NCCN1S(=O)(=O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G22 compound treatment 0.95 -0.05 -0.97 -0.9704 -1.0 1370776 Maybridge1_003498 Clc1ccccc1C(=O)Nc2ccc(N3CCOCC3)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G23 mock treatment 1.03 0.03 0.58 0.5829 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 G24 mock treatment 1.0153 0.0153 0.3 0.2968 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H01 compound treatment 0.9991 -8.55E-4 -0.02 -0.0166 -1.0 2071096 Maybridge1_003499 Nc1ccccc1C(=O)N/N=C/c2cc(Br)ccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H02 compound treatment 0.9851 -0.0149 -0.29 -0.2891 -1.0 2071097 Maybridge1_003500 Clc1cc(Cl)c(cc1Cl)S(=O)(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H03 compound treatment 0.9325 -0.0675 -1.31 -1.3111 -1.0 2071098 Maybridge1_003501 CC(=O)Nc1ccc(F)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H04 compound treatment 1.0328 0.0328 0.64 0.6374 1.0 2071099 Maybridge1_003502 COc1cc(/C=N/c2ccc(F)cc2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H05 compound treatment 1.0055 0.00546 0.11 0.106 1.0 2071100 Maybridge1_003503 COC(=O)c1cc(ccc1Sc2ccccc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H06 compound treatment 1.0076 0.00756 0.15 0.1469 1.0 2071101 Maybridge1_003504 [O-][N+](=O)c1ccccc1SCC(=O)NNC(=S)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H07 compound treatment 1.0027 0.00265 0.05 0.0515 1.0 2071102 Maybridge1_003505 FC(F)(F)c1cc(cc(c1)S(=O)(=O)c2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H08 compound treatment 0.9984 -0.00156 -0.03 -0.0302 -1.0 1464611 Maybridge1_003506 Oc1ccccc1c2nc3ccccc3c(=O)[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H09 compound treatment 0.9648 -0.0352 -0.68 -0.6843 -1.0 1412023 Maybridge1_003507 O=C(CCN1CCOCC1)c2ccc3OCCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H10 compound treatment 0.9921 -0.00787 -0.15 -0.1529 -1.0 2071103 Maybridge1_003508 CC1(C)N/C(=N/c2cc(Cl)c(Cl)cc2Cl)/SC1=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H11 compound treatment 0.9963 -0.00366 -0.07 -0.0711 -1.0 2071104 Maybridge1_003509 CC1(C)C2CCC1(C)/C(=N/Nc3ccc(cc3[N+](=O)[O-])[N+](=O)[O-])/C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H12 compound treatment 0.983 -0.017 -0.33 -0.33 -1.0 2071105 Maybridge1_003510 Clc1ccccc1NC(=S)N(CCC#N)C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H13 compound treatment 1.0216 0.0216 0.42 0.4194 1.0 1284432 Maybridge1_003511 COc1ccc(CC(=C(C#N)C#N)C)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H14 compound treatment 0.9648 -0.0352 -0.68 -0.6843 -1.0 1510455 Maybridge1_003512 COc1ccccc1NC(=S)NCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H15 compound treatment 0.9816 -0.0184 -0.36 -0.3573 -1.0 2071106 Maybridge1_003513 Clc1ccc(cc1Cl)C2NN=C3C2N4CCC3CC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H16 compound treatment 0.9592 -0.0408 -0.79 -0.7933 -1.0 1737399 Maybridge1_003514 CCOC(=O)c1ccc(NC(=S)NCc2cccnc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H17 compound treatment 0.9549 -0.0451 -0.88 -0.875 -1.0 2071107 Maybridge1_003515 Cc1cccc(C)c1/N=C\2/NC(C)(C)C(=C)S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H18 compound treatment 0.9774 -0.0226 -0.44 -0.439 -1.0 2071108 Maybridge1_003516 S=C(Nc1cccc2ccccc12)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H19 compound treatment 0.9648 -0.0352 -0.68 -0.6843 -1.0 1646121 Maybridge1_003517 Cc1ccc2nc(sc2c1)c3ccc(NC(=O)C(C)(C)C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H20 compound treatment 0.9472 -0.0528 -1.02 -1.0249 -1.0 1236412 Maybridge1_003518 Cc1onc(c1C(=O)Nc2ccc3OCOc3c2)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H21 compound treatment 0.9935 -0.00647 -0.13 -0.1256 -1.0 2071109 Maybridge1_003519 COc1cc(cc(OC)c1OC)C(=O)N/N=C/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H22 compound treatment 0.9683 -0.0317 -0.62 -0.6161 -1.0 2071110 Maybridge1_003520 Clc1ccc(NC(=S)N(CCC#N)C2CCCCC2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H23 mock treatment 0.9725 -0.0275 -0.53 -0.5344 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 H24 mock treatment 1.0174 0.0174 0.34 0.3377 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I01 compound treatment 1.0644 0.0644 1.25 1.2506 1.0 2071111 Maybridge1_003521 COc1ccc(/C=C/2\CC/C(=C\c3ccc(OC)c(OC)c3)/C2=O)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I02 compound treatment 1.0202 0.0202 0.39 0.3922 1.0 2071112 Maybridge1_003522 Clc1ccc(cc1)c2csc(n2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I03 compound treatment 1.0083 0.00827 0.16 0.1605 1.0 1013283 Maybridge1_003523 CCOC(=O)CSc1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I04 compound treatment 1.03 0.03 0.58 0.5829 1.0 2071113 Maybridge1_003524 Cc1ccc(CC(=S)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I05 compound treatment 0.9802 -0.0198 -0.38 -0.3845 -1.0 1461883 Maybridge1_003525 CNc1ccc(Cl)cc1C(=O)NCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I06 compound treatment 1.0181 0.0181 0.35 0.3513 1.0 2071114 Maybridge1_003526 CC(=O)Nc1ccc(cc1)/C(=N/O)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I07 compound treatment 1.0342 0.0342 0.66 0.6647 1.0 1030955 Maybridge1_003527 COC(=O)c1ccccc1NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I08 compound treatment 1.0034 0.00335 0.07 0.0651 1.0 2071115 Maybridge1_003528 Cc1cc(C)c(CSC2=NCCN2)c(C)c1CSC3=NCCN3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I09 compound treatment 1.009 0.00897 0.17 0.1742 1.0 2071116 Maybridge1_003529 Nc1ccccc1C(=O)NNC(=O)c2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I10 compound treatment 0.9507 -0.0493 -0.96 -0.9568 -1.0 2071117 Maybridge1_003530 Cc1cc(C)c(CSc2nccn2C)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I11 compound treatment 1.0314 0.0314 0.61 0.6102 1.0 2071118 Maybridge1_003531 Clc1ccc(cc1)C2=NNC(N2)c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I12 compound treatment 0.9991 -8.55E-4 -0.02 -0.0166 -1.0 1397307 Maybridge1_003532 CC(C)c1nc2ccccc2n1C3CC(=O)N(C3=O)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I13 compound treatment 1.002 0.00195 0.04 0.0379 1.0 2071119 Maybridge1_003533 CNC(=S)NN=C1CCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I14 compound treatment 0.9472 -0.0528 -1.02 -1.0249 -1.0 2071120 Maybridge1_003534 CN(N)C(=S)Nc1cc(Cl)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I15 compound treatment 0.9928 -0.00717 -0.14 -0.1392 -1.0 1565188 Maybridge1_003535 CN(C)c1ccc(cc1)C2Nc3ccccc3O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I16 compound treatment 0.9465 -0.0535 -1.04 -1.0385 -1.0 1604536 Maybridge1_003536 CNc1ccccc1C(=O)NC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I17 compound treatment 0.997 -0.00296 -0.06 -0.0575 -1.0 1340303 Maybridge1_003537 COc1ccc(CNc2ccccc2c3nc4ccccc4[nH]3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I18 compound treatment 0.9507 -0.0493 -0.96 -0.9568 -1.0 2071121 Maybridge1_003538 Clc1ccc(NC(=O)CC2NCCN(Cc3ccccc3)C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I19 compound treatment 0.9956 -0.00436 -0.08 -0.0847 -1.0 2071122 Maybridge1_003539 CN1CNC(=NC1)SCc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I20 compound treatment 0.9991 -8.55E-4 -0.02 -0.0166 -1.0 1470325 Maybridge1_003540 Clc1ccc(cc1)C(=C)NCc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I21 compound treatment 1.009 0.00897 0.17 0.1742 1.0 2071123 Maybridge1_003541 CSC1=NCCN1S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I22 compound treatment 0.9613 -0.0387 -0.75 -0.7524 -1.0 2071124 Maybridge1_003542 OC(=O)CCc1nc(no1)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I23 mock treatment 1.0062 0.00616 0.12 0.1197 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 I24 mock treatment 1.0223 0.0223 0.43 0.433 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J01 compound treatment 1.0525 0.0525 1.02 1.019 1.0 2071125 Maybridge1_003543 NC(=O)N/N=C/1\CCOc2ccc3ccccc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J02 compound treatment 0.9851 -0.0149 -0.29 -0.2891 -1.0 2071126 Maybridge1_003544 Clc1cc(Cl)c(cc1Cl)S(=O)(=O)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J03 compound treatment 0.9367 -0.0633 -1.23 -1.2293 -1.0 1049119 Maybridge1_003545 CC(C)c1ccc(NC(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J04 compound treatment 1.0174 0.0174 0.34 0.3377 1.0 2071127 Maybridge1_003546 Nc1ccccc1Sc2ccccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J05 compound treatment 0.99 -0.00998 -0.19 -0.1937 -1.0 2071128 Maybridge1_003547 COC(=O)c1cc(ccc1Sc2ccc(Cl)cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J06 compound treatment 1.0146 0.0146 0.28 0.2832 1.0 2071129 Maybridge1_003548 [O-][N+](=O)c1ccccc1SCc2nnc(S)n2c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J07 compound treatment 0.99 -0.00998 -0.19 -0.1937 -1.0 1303668 Maybridge1_003549 CCOC(=O)c1sc2ccc(NC(=O)c3ccccc3Cl)cc2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J08 compound treatment 1.0146 0.0146 0.28 0.2832 1.0 2071130 Maybridge1_003550 CCOC(=O)c1ccc(/N=C\2/NC(CC)(CC)C(=C)S2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J09 compound treatment 1.016 0.016 0.31 0.3104 1.0 1057159 Maybridge1_003551 Cc1ccc(C(=O)CCN2CCOCC2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J10 compound treatment 1.0181 0.0181 0.35 0.3513 1.0 1378916 Maybridge1_003552 COc1cc(Cl)cc(OC)c1NC(=S)N2CCN3C(=O)c4ccccc4C23c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J11 compound treatment 0.9697 -0.0303 -0.59 -0.5889 -1.0 1652494 Maybridge1_003553 Cc1onc(c1C(=O)Nc2ccc(cc2)S(=O)(=O)Nc3nccs3)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J12 compound treatment 0.9388 -0.0612 -1.19 -1.1884 -1.0 1192076 Maybridge1_003554 CC(C)c1ccc(NC(=S)Nc2c(C)cccc2C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J13 compound treatment 1.0048 0.00476 0.09 0.0924 1.0 2071131 Maybridge1_003555 COc1ccc(cc1)C(CCC#N)(CCC#N)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J14 compound treatment 0.9991 -8.55E-4 -0.02 -0.0166 -1.0 1213155 Maybridge1_003556 COc1cccc(NC(=S)NCc2ccncc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J15 compound treatment 0.9991 -8.55E-4 -0.02 -0.0166 -1.0 2071132 Maybridge1_003557 C1Oc2ccc(cc2O1)C3NN=C4C3N5CCC4CC5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J16 compound treatment 1.0097 0.00967 0.19 0.1878 1.0 2071133 Maybridge1_003558 Clc1ccc(NC(=S)NCc2cccnc2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J17 compound treatment 0.9465 -0.0535 -1.04 -1.0385 -1.0 1081790 Maybridge1_003559 FC(F)(F)c1cccc(NC(=O)COc2cc(Cl)c(Cl)cc2Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J18 compound treatment 0.969 -0.031 -0.6 -0.6025 -1.0 1736870 Maybridge1_003560 Cc1onc(c1C(=O)N2CCOCC2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J19 compound treatment 0.9669 -0.0331 -0.64 -0.6434 -1.0 1568250 Maybridge1_003561 Clc1ccc(Cl)c(c1)S(=O)(=O)NC2(CCCCC2)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J20 compound treatment 0.9886 -0.0114 -0.22 -0.221 -1.0 1226028 Maybridge1_003562 Cc1onc(c1C(=O)Nc2ccc(C)c(F)c2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J21 compound treatment 0.9879 -0.0121 -0.23 -0.2346 -1.0 2071134 Maybridge1_003563 ClC(Cl)C(=O)Nc1ccc(Cl)cc1C(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J22 compound treatment 0.9206 -0.0794 -1.54 -1.5427 -1.0 2071135 Maybridge1_003564 Cc1ccc(Cl)cc1NC(=S)N(CCC#N)/N=C/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J23 mock treatment 0.9984 -0.00156 -0.03 -0.0302 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 J24 mock treatment 1.0146 0.0146 0.28 0.2832 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K01 compound treatment 1.1268 0.127 2.46 2.4633 1.0 1913140 Maybridge1_003565 O=C/1/C(=C/c2ccc3OCOc3c2)/CC\C1=C/c4ccc5OCOc5c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K02 compound treatment 0.9599 -0.0401 -0.78 -0.7797 -1.0 2071136 Maybridge1_003566 Nc1nc(cs1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K03 compound treatment 0.9837 -0.0163 -0.32 -0.3164 -1.0 1344801 Maybridge1_003567 CNc1ccccc1C(=O)NC2CC(C)CC(C)(C)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K04 compound treatment 1.0167 0.0167 0.32 0.324 1.0 2071137 Maybridge1_003568 Clc1ccc(Cc2nc(cs2)c3ccc(Cl)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K05 compound treatment 1.0497 0.0497 0.96 0.9645 1.0 2071138 Maybridge1_003569 CN1C/C(=C\c2ccco2)/C(=O)\C(=C\c3ccco3)\C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K06 compound treatment 1.0111 0.0111 0.22 0.215 1.0 1712799 Maybridge1_003570 OCCCN1CNC(=S)NC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K07 compound treatment 1.0412 0.0412 0.8 0.8009 1.0 2071139 Maybridge1_003571 Clc1ccc(CSC2=NCCCN2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K08 compound treatment 1.0335 0.0335 0.65 0.6511 1.0 2071140 Maybridge1_003572 Cc1cc(C)c(CSC(=N)N)c(C)c1CSC(=N)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K09 compound treatment 1.0398 0.0398 0.77 0.7737 1.0 1035818 Maybridge1_003573 Clc1ccc(CSc2nc3ccccc3[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K10 compound treatment 0.9444 -0.0556 -1.08 -1.0794 -1.0 2071141 Maybridge1_003574 CC(C)(C)N1CNC(=S)NC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K11 compound treatment 1.0055 0.00546 0.11 0.106 1.0 2071142 Maybridge1_003575 CNC(=S)N/N=C(\C)/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K12 compound treatment 0.9984 -0.00156 -0.03 -0.0302 -1.0 1074367 Maybridge1_003576 CCOC(=O)c1c(NC(=O)C)sc2CCCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K13 compound treatment 0.9648 -0.0352 -0.68 -0.6843 -1.0 2071143 Maybridge1_003577 CNC(=S)NN=C1CCCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K14 compound treatment 0.9592 -0.0408 -0.79 -0.7933 -1.0 2071144 Maybridge1_003578 COC(=O)c1ccccc1NC(=S)N(C)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K15 compound treatment 1.0005 5.48E-4 0.01 0.0106 1.0 1181884 Maybridge1_003579 CN(C)c1ccc(cc1)C2Nc3cc(Cl)ccc3O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K16 compound treatment 0.9493 -0.0507 -0.98 -0.984 -1.0 1597144 Maybridge1_003580 CNc1ccc(Cl)cc1C(=O)NC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K17 compound treatment 0.9416 -0.0584 -1.13 -1.1339 -1.0 1090814 Maybridge1_003581 Nc1ccc(Cl)cc1c2nc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K18 compound treatment 0.9542 -0.0458 -0.89 -0.8887 -1.0 2071145 Maybridge1_003582 NNC(=O)CC1NCCN(Cc2ccccc2)C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K19 compound treatment 0.9746 -0.0254 -0.49 -0.4935 -1.0 2071146 Maybridge1_003583 CN1CNC(=NC1)SCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K20 compound treatment 0.976 -0.024 -0.47 -0.4663 -1.0 1226276 Maybridge1_003584 c1nc(c2ccccc2)n3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K21 compound treatment 0.9599 -0.0401 -0.78 -0.7797 -1.0 2071147 Maybridge1_003585 COCCCN1CNC(=NC1)SCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K22 compound treatment 0.9655 -0.0345 -0.67 -0.6706 -1.0 1650617 Maybridge1_003586 Cc1ccc(cc1)S(=O)(=O)Nc2ccc(N3CCOCC3)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K23 mock treatment 0.9879 -0.0121 -0.23 -0.2346 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 K24 mock treatment 1.0041 0.00406 0.08 0.0788 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L01 compound treatment 0.9893 -0.0107 -0.21 -0.2074 -1.0 2071148 Maybridge1_003587 COc1ccc(CCNC(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L02 compound treatment 1.0279 0.0279 0.54 0.5421 1.0 2071149 Maybridge1_003588 Fc1ccc(NS(=O)(=O)c2cc(Cl)c(Cl)cc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L03 compound treatment 0.9991 -8.55E-4 -0.02 -0.0166 -1.0 2071150 Maybridge1_003589 [O-][N+](=O)c1cc(F)ccc1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L04 compound treatment 1.0062 0.00616 0.12 0.1197 1.0 2071151 Maybridge1_003590 Nc1ccccc1Sc2ccc(Cl)cc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L05 compound treatment 1.016 0.016 0.31 0.3104 1.0 2071152 Maybridge1_003591 CC(=O)c1cc2cc(Cl)ccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L06 compound treatment 1.0265 0.0265 0.51 0.5148 1.0 2071153 Maybridge1_003592 [O-][N+](=O)c1ccccc1SCC(=O)NNC(=S)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L07 compound treatment 0.9942 -0.00577 -0.11 -0.112 -1.0 2071154 Maybridge1_003593 FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L08 compound treatment 0.9956 -0.00436 -0.08 -0.0847 -1.0 1150396 Maybridge1_003594 O=C1N2CCNC2(c3ccccc13)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L09 compound treatment 0.9465 -0.0535 -1.04 -1.0385 -1.0 1562697 Maybridge1_003595 CCc1cc2c(cc1C(=O)CCN3CCCC3)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L10 compound treatment 1.0202 0.0202 0.39 0.3922 1.0 1382047 Maybridge1_003596 CSc1cccc(NC(=S)N2CCN3C(=O)c4ccccc4C23c5ccccc5)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L11 compound treatment 0.9865 -0.0135 -0.26 -0.2619 -1.0 1599520 Maybridge1_003597 CC(NC1(C#N)C2CC3CC(C2)CC1C3)c4ccc(C)cc4C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L12 compound treatment 0.9886 -0.0114 -0.22 -0.221 -1.0 2071155 Maybridge1_003598 CC(C)c1ccc(NC(=S)Nc2ccccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L13 compound treatment 0.9395 -0.0605 -1.17 -1.1748 -1.0 1678992 Maybridge1_003599 Cc1onc(c1C(=O)N2CCCN3C2c4ccccc4C3=O)c5ccccc5Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L14 compound treatment 0.9739 -0.0261 -0.51 -0.5071 -1.0 1253884 Maybridge1_003600 CCOC(=O)c1ccc(NC(=S)NCc2ccncc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L15 compound treatment 0.9823 -0.0177 -0.34 -0.3436 -1.0 1387935 Maybridge1_003601 O=C1N2CCCN(C2c3ccccc13)S(=O)(=O)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L16 compound treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 2071156 Maybridge1_003602 FC(F)(F)c1cccc(NC(=S)N2CCOCC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L17 compound treatment 0.9739 -0.0261 -0.51 -0.5071 -1.0 2071157 Maybridge1_003603 [O-][N+](=O)c1cccc(/C=C/c2ccccn2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L18 compound treatment 1.0356 0.0356 0.69 0.6919 1.0 1370915 Maybridge1_003604 Cc1onc(c1C(=O)N2CCCCC2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L19 compound treatment 0.9472 -0.0528 -1.02 -1.0249 -1.0 1629964 Maybridge1_003605 Cc1ccc(cc1)S(=O)(=O)Nc2cccc(CCc3ccccn3)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L20 compound treatment 0.9662 -0.0338 -0.66 -0.657 -1.0 2071158 Maybridge1_003606 CSc1cccc(NC(=O)c2c(C)onc2c3ccccc3Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L21 compound treatment 0.9648 -0.0352 -0.68 -0.6843 -1.0 1731713 Maybridge1_003607 Clc1ccc(cc1)C(=O)Nc2ccc(Cl)cc2C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L22 compound treatment 0.9514 -0.0486 -0.94 -0.9432 -1.0 2071159 Maybridge1_003608 Cc1ccc(NC(=S)NCc2cccnc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L23 mock treatment 0.9893 -0.0107 -0.21 -0.2074 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 L24 mock treatment 1.0258 0.0258 0.5 0.5012 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M01 compound treatment 1.0419 0.0419 0.81 0.8146 1.0 2071160 Maybridge1_003609 Clc1ccc(/C=C/2\CC/C(=C\c3ccc(Cl)cc3)/C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M02 compound treatment 0.9437 -0.0563 -1.09 -1.0931 -1.0 1024036 Maybridge1_003610 Clc1ccc(cc1)C2=CSC3=NCCN23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M03 compound treatment 1.0005 5.48E-4 0.01 0.0106 1.0 2071161 Maybridge1_003611 CC(C)c1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M04 compound treatment 0.9977 -0.00226 -0.04 -0.0439 -1.0 2071162 Maybridge1_003612 Clc1ccc(cc1)c2csc(Cc3ccccc3Cl)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M05 compound treatment 1.0188 0.0188 0.36 0.3649 1.0 1013280 Maybridge1_003613 OC(=O)CSc1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M06 compound treatment 0.9479 -0.0521 -1.01 -1.0113 -1.0 2071163 Maybridge1_003614 Clc1ccccc1CSC2=NCCCN2C3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M07 compound treatment 0.9963 -0.00366 -0.07 -0.0711 -1.0 2071164 Maybridge1_003615 Clc1ccccc1CSC2=NCCCN2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M08 compound treatment 0.9507 -0.0493 -0.96 -0.9568 -1.0 1218071 Maybridge1_003616 NNC(=O)c1nc2ccccc2c(=O)[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M09 compound treatment 1.0286 0.0286 0.56 0.5557 1.0 1328191 Maybridge1_003617 Clc1ccc(cc1)c2csc(=N)n2c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M10 compound treatment 0.9613 -0.0387 -0.75 -0.7524 -1.0 2071165 Maybridge1_003618 Clc1ccc(cc1)C2=NC(N=C(S2)c3ccc(Cl)cc3)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M11 compound treatment 1.0202 0.0202 0.39 0.3922 1.0 2071166 Maybridge1_003619 CNC(=S)N/N=C(\C)/c1ccc(C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M12 compound treatment 0.9865 -0.0135 -0.26 -0.2619 -1.0 1493034 Maybridge1_003620 COC(=O)c1ccccc1NC(=S)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M13 compound treatment 0.9584 -0.0416 -0.81 -0.8069 -1.0 2071167 Maybridge1_003621 CC1CN(CC(C)O1)C(=N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M14 compound treatment 0.983 -0.017 -0.33 -0.33 -1.0 1677509 Maybridge1_003622 Cc1c(Cl)cccc1NC(=S)N(N)CCO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M15 compound treatment 0.9641 -0.0359 -0.7 -0.6979 -1.0 1272679 Maybridge1_003623 OC(=O)CCCc1nc(no1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M16 compound treatment 0.9837 -0.0163 -0.32 -0.3164 -1.0 2071168 Maybridge1_003624 FC(F)(F)c1nn2cc(nc2s1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M17 compound treatment 1.0027 0.00265 0.05 0.0515 1.0 2071169 Maybridge1_003625 Clc1ccccc1C2Nc3ccccc3O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M18 compound treatment 0.9634 -0.0366 -0.71 -0.7115 -1.0 1730982 Maybridge1_003626 Nc1ccc(Cl)cc1C(=O)NCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M19 compound treatment 0.9493 -0.0507 -0.98 -0.984 -1.0 2071170 Maybridge1_003627 CCN1CNC(=NC1)SCc2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M20 compound treatment 0.9879 -0.0121 -0.23 -0.2346 -1.0 2071171 Maybridge1_003628 [O-][N+](=O)c1ccccc1c2ncc3ccccn23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M21 compound treatment 0.9872 -0.0128 -0.25 -0.2482 -1.0 2071172 Maybridge1_003629 CCN1CNC(=NC1)SCc2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M22 compound treatment 0.9599 -0.0401 -0.78 -0.7797 -1.0 2071173 Maybridge1_003630 CNc1ccc(Cl)cc1C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M23 mock treatment 1.0111 0.0111 0.22 0.215 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 M24 mock treatment 1.0363 0.0363 0.71 0.7056 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N01 compound treatment 1.0279 0.0279 0.54 0.5421 1.0 2071174 Maybridge1_003631 Cc1cccc2CCCN(C(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N02 compound treatment 1.0048 0.00476 0.09 0.0924 1.0 2071175 Maybridge1_003632 COc1cc(NS(=O)(=O)c2cc(Cl)c(Cl)cc2Cl)c(OC)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N03 compound treatment 1.0146 0.0146 0.28 0.2832 1.0 2071176 Maybridge1_003633 Nc1ccccc1C(=O)NCCCNC(=O)c2ccccc2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N04 compound treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 2071177 Maybridge1_003634 COc1cc(cc(OC)c1OC)C(=O)Nc2ccccc2Sc3ccc(Cl)cc3[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N05 compound treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 1180989 Maybridge1_003635 Clc1ccc2oc(cc2c1)C(=O)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N06 compound treatment 1.0195 0.0195 0.38 0.3785 1.0 2071178 Maybridge1_003636 NS(=O)(=O)c1ccc(Sc2ccc(Cl)cc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N07 compound treatment 0.9956 -0.00436 -0.08 -0.0847 -1.0 2071179 Maybridge1_003637 N#CCCN/N=C/c1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N08 compound treatment 0.9802 -0.0198 -0.38 -0.3845 -1.0 2071180 Maybridge1_003638 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCN3C(=O)c4ccccc4C23c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N09 compound treatment 0.9998 -1.53E-4 0.0 -0.003 -1.0 1699549 Maybridge1_003639 O=C(CCN1CCCC1)c2ccc3ccccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N10 compound treatment 1.0062 0.00616 0.12 0.1197 1.0 1490310 Maybridge1_003640 CCOC(=O)c1ccc(NC(=S)N2CCN3C(=O)c4ccccc4C23c5ccccc5)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N11 compound treatment 0.9907 -0.00927 -0.18 -0.1801 -1.0 1596245 Maybridge1_003641 Cc1onc(c1C(=O)N(CCC#N)Cc2ccccc2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N12 compound treatment 0.9998 -1.53E-4 0.0 -0.003 -1.0 2071181 Maybridge1_003642 Clc1ccccc1NC(=S)NCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N13 compound treatment 0.9886 -0.0114 -0.22 -0.221 -1.0 1193847 Maybridge1_003643 Cc1onc(c1C(=O)NC(C)(C)CCO)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N14 compound treatment 0.9767 -0.0233 -0.45 -0.4526 -1.0 1545358 Maybridge1_003644 Cc1cccc(NC(=S)NCc2cccnc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N15 compound treatment 0.9493 -0.0507 -0.98 -0.984 -1.0 2071182 Maybridge1_003645 FC(F)(F)c1cccc(/N=C/2\NC3(CCCCC3)C(=C)S2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N16 compound treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 2071183 Maybridge1_003646 COc1cccc(NC(=S)N2CCOCC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N17 compound treatment 1.0146 0.0146 0.28 0.2832 1.0 2071184 Maybridge1_003647 CC(C)c1ccc(/C=N/c2ccc(cc2)C(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N18 compound treatment 0.9886 -0.0114 -0.22 -0.221 -1.0 2071185 Maybridge1_003648 CC1CN(CC(C)O1)C(=S)Nc2ccccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N19 compound treatment 0.9528 -0.0472 -0.92 -0.9159 -1.0 1215090 Maybridge1_003649 Clc1ccc(Cl)c(c1)S(=O)(=O)Nc2cccc(CCc3ccccn3)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N20 compound treatment 0.9648 -0.0352 -0.68 -0.6843 -1.0 2071186 Maybridge1_003650 CCCCNC(=S)N(CCC#N)C1CCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N21 compound treatment 1.0125 0.0125 0.24 0.2423 1.0 1734074 Maybridge1_003651 Cc1onc(c1C(=O)Nc2ccc(Cl)cc2C(=O)c3ccccc3)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N22 compound treatment 1.0027 0.00265 0.05 0.0515 1.0 2071187 Maybridge1_003652 Cc1c(Cl)cccc1NC(=S)NCc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N23 mock treatment 0.9914 -0.00857 -0.17 -0.1665 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 N24 mock treatment 0.9928 -0.00717 -0.14 -0.1392 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O01 compound treatment 1.0174 0.0174 0.34 0.3377 1.0 2071188 Maybridge1_003653 O=C/1/C(=C/c2cccc3ccccc23)/CC\C1=C/c4cccc5ccccc45 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O02 compound treatment 0.9809 -0.0191 -0.37 -0.3709 -1.0 2071189 Maybridge1_003654 Clc1ccc(cc1)C2=CSC3=NCCCN23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O03 compound treatment 1.009 0.00897 0.17 0.1742 1.0 1508216 Maybridge1_003655 CNc1ccccc1C(=O)NCCc2ccc(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O04 compound treatment 0.9816 -0.0184 -0.36 -0.3573 -1.0 2071190 Maybridge1_003656 COc1ccc(Cc2nc(cs2)c3ccc(Cl)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O05 compound treatment 1.0286 0.0286 0.56 0.5557 1.0 2071191 Maybridge1_003657 CN1C/C(=C\c2ccccc2Cl)/C(=O)\C(=C\c3ccccc3Cl)\C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O06 compound treatment 0.9774 -0.0226 -0.44 -0.439 -1.0 2071192 Maybridge1_003658 Clc1ccc(CSC2=NCCCN2C3CCCCC3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O07 compound treatment 1.0174 0.0174 0.34 0.3377 1.0 2071193 Maybridge1_003659 Cc1ccc(CSC2=NCCCN2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O08 compound treatment 0.9697 -0.0303 -0.59 -0.5889 -1.0 1482022 Maybridge1_003660 CCOC(=O)c1nc2sc3CCCCc3c2c(=O)[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O09 compound treatment 1.0209 0.0209 0.41 0.4058 1.0 1226826 Maybridge1_003661 Nc1ccccc1c2nc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O10 compound treatment 1.0139 0.0139 0.27 0.2695 1.0 2071194 Maybridge1_003662 Clc1ccc(cc1)C2N=C(SC(=N2)c3ccc(Cl)cc3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O11 compound treatment 1.0167 0.0167 0.32 0.324 1.0 2071195 Maybridge1_003663 CNC(=S)N/N=C(\C)/c1ccc(OC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O12 compound treatment 0.9928 -0.00717 -0.14 -0.1392 -1.0 2071196 Maybridge1_003664 CSC1=NCN(CN1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O13 compound treatment 0.9718 -0.0282 -0.55 -0.548 -1.0 2071197 Maybridge1_003665 C1Oc2ccc(cc2O1)C3Nc4ccccc4O3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O14 compound treatment 0.976 -0.024 -0.47 -0.4663 -1.0 2071198 Maybridge1_003666 CN(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O15 compound treatment 0.9823 -0.0177 -0.34 -0.3436 -1.0 2071199 Maybridge1_003667 COc1ccc(Br)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O16 compound treatment 0.983 -0.017 -0.33 -0.33 -1.0 2071200 Maybridge1_003668 Fc1ccc(cc1)c2cn3nc(sc3n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O17 compound treatment 0.9528 -0.0472 -0.92 -0.9159 -1.0 2071201 Maybridge1_003669 Clc1ccc2OC(Nc2c1)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O18 compound treatment 0.9521 -0.0479 -0.93 -0.9295 -1.0 1605476 Maybridge1_003670 Nc1ccccc1C(=O)NCc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O19 compound treatment 0.9928 -0.00717 -0.14 -0.1392 -1.0 2071202 Maybridge1_003671 CCN1CNC(=NC1)SCc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O20 compound treatment 1.0097 0.00967 0.19 0.1878 1.0 2071203 Maybridge1_003672 FC(F)(F)c1nnc(NC(=O)c2ccccc2NC(=O)c3ccccc3)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O21 compound treatment 0.9669 -0.0331 -0.64 -0.6434 -1.0 2071204 Maybridge1_003673 CCN1CNC(=NC1)SCc2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O22 compound treatment 0.9802 -0.0198 -0.38 -0.3845 -1.0 2071205 Maybridge1_003674 O=C1NN(C(=S)Nc2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O23 mock treatment 0.9781 -0.0219 -0.43 -0.4254 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 O24 mock treatment 1.0055 0.00546 0.11 0.106 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P01 compound treatment 0.983 -0.017 -0.33 -0.33 -1.0 1006990 Maybridge1_003675 CC(=O)Nc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P02 compound treatment 1.0426 0.0426 0.83 0.8282 1.0 1253391 Maybridge1_003676 CCOC(=O)c1ccc(NC(=O)c2c(C)onc2c3c(Cl)cccc3Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P03 compound treatment 0.9963 -0.00366 -0.07 -0.0711 -1.0 2071206 Maybridge1_003677 [O-][N+](=O)c1ccc(c(Cl)c1)S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P04 compound treatment 0.9914 -0.00857 -0.17 -0.1665 -1.0 1561288 Maybridge1_003678 Clc1ccccc1C(=O)N(CCC#N)C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P05 compound treatment 0.9648 -0.0352 -0.68 -0.6843 -1.0 2071207 Maybridge1_003679 Oc1ccccc1/C=N/c2ccc(F)cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P06 compound treatment 0.9991 -8.55E-4 -0.02 -0.0166 -1.0 2071208 Maybridge1_003680 NS(=O)(=O)c1ccc(Sc2ccccc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P07 compound treatment 0.9991 -8.55E-4 -0.02 -0.0166 -1.0 1034875 Maybridge1_003681 N#CC1(CCCCC1)NC2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P08 compound treatment 1.0055 0.00546 0.11 0.106 1.0 1017270 Maybridge1_003682 ClC(Cl)(Cl)C(=O)N1CCOCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P09 compound treatment 0.9802 -0.0198 -0.38 -0.3845 -1.0 1915614 Maybridge1_003683 C/C(=N\Nc1ccccc1)/c2ccc(cc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P10 compound treatment 0.9865 -0.0135 -0.26 -0.2619 -1.0 2071209 Maybridge1_003684 Fc1ccc(cc1F)N2C(=O)C3C4CC(C=C4)C3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P11 compound treatment 1.009 0.00897 0.17 0.1742 1.0 2071210 Maybridge1_003685 Cc1onc(c1C(=O)N(CCC#N)C2CCCCC2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P12 compound treatment 0.9914 -0.00857 -0.17 -0.1665 -1.0 2071211 Maybridge1_003686 FC(F)(F)c1cccc(NC(=S)NCc2ccncc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P13 compound treatment 0.9907 -0.00927 -0.18 -0.1801 -1.0 2071212 Maybridge1_003687 COc1cc(/C=C\2/N3CCC(CC3)C2=O)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P14 compound treatment 1.0216 0.0216 0.42 0.4194 1.0 1349974 Maybridge1_003688 COc1cccc(NC(=S)NCc2cccnc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P15 compound treatment 0.9662 -0.0338 -0.66 -0.657 -1.0 2071213 Maybridge1_003689 Clc1ccccc1/N=C/2\NC3(CCCCC3)C(=C)S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P16 compound treatment 1.0125 0.0125 0.24 0.2423 1.0 2071214 Maybridge1_003690 COc1ccccc1NC(=S)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P17 compound treatment 0.9465 -0.0535 -1.04 -1.0385 -1.0 2071215 Maybridge1_003691 OC(=O)c1ccc(/N=C/c2ccc3OCOc3c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P18 compound treatment 1.0027 0.00265 0.05 0.0515 1.0 2071216 Maybridge1_003692 CC1CN(CC(C)O1)C(=S)Nc2cccc(C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P19 compound treatment 0.9774 -0.0226 -0.44 -0.439 -1.0 1272372 Maybridge1_003693 COc1cc(cc(OC)c1OC)C(NCc2ccccc2)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P20 compound treatment 1.0027 0.00265 0.05 0.0515 1.0 2071217 Maybridge1_003694 Cc1ccc(Cl)cc1NC(=S)NCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P21 compound treatment 0.9556 -0.0444 -0.86 -0.8614 -1.0 1862715 Maybridge1_003695 [O-][N+](=O)c1ccc(cc1)C(=O)Nc2ccc(Cl)cc2C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P22 compound treatment 1.0188 0.0188 0.36 0.3649 1.0 2071218 Maybridge1_003696 Cc1cccc(C)c1NC(=S)NCc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P23 mock treatment 1.0153 0.0153 0.3 0.2968 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.551 P24 mock treatment 1.0188 0.0188 0.36 0.3649 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A01 compound treatment 1.0712 0.0737 1.43 1.4304 1.0 2071219 Maybridge1_003697 Cc1ccc(NC(=S)NCc2cccnc2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A02 compound treatment 1.0243 0.0267 0.52 0.5187 1.0 2071220 Maybridge1_003698 CCOC(=O)c1cnc(N)nc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A03 compound treatment 1.0627 0.0651 1.26 1.2646 1.0 2071221 Maybridge1_003699 CSC(=C(C#N)c1ccc(Cl)cc1Cl)SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A04 compound treatment 1.0535 0.0559 1.09 1.085 1.0 1658773 Maybridge1_003700 Cn1ccc(NS(=O)(=O)c2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A05 compound treatment 1.0648 0.0673 1.31 1.3061 1.0 2071222 Maybridge1_003701 Clc1ccc(NC(=O)Sc2ccccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A06 compound treatment 0.9738 -0.0238 -0.46 -0.4621 -1.0 2071223 Maybridge1_003702 CSc1cc(n[nH]1)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A07 compound treatment 1.0385 0.0409 0.79 0.795 1.0 568 Maybridge1_003703 COc1ccc(C=C(C#N)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A08 compound treatment 1.0172 0.0196 0.38 0.3805 1.0 2071224 Maybridge1_003704 Cc1csc(C(=O)N)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A09 compound treatment 1.0805 0.0829 1.61 1.61 1.0 2071225 Maybridge1_003705 NC1=C(C#N)C(C(C#N)C#N)c2cc(Br)cc(Br)c2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A10 compound treatment 0.9838 -0.0138 -0.27 -0.2687 -1.0 2071226 Maybridge1_003706 COC(=O)c1sc(Br)c(Br)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A11 compound treatment 1.0463 0.0488 0.95 0.9469 1.0 2071227 Maybridge1_003707 COC(=O)C(C#N)C1C(=C(N)Oc2c(OC)cc(Br)cc12)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A12 compound treatment 0.9937 -0.00388 -0.08 -0.0753 -1.0 1192357 Maybridge1_003708 Cc1csc2ncnc(NCCc3ccc(Cl)cc3)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A13 compound treatment 0.9916 -0.00601 -0.12 -0.1167 -1.0 2071228 Maybridge1_003709 Clc1ccc(cc1)C(=O)NC2=CC3C(COC3=O)OC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A14 compound treatment 0.9994 0.00181 0.04 0.0352 1.0 2071229 Maybridge1_003710 Nc1cc(sc1C#N)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A15 compound treatment 0.9973 -3.21E-4 -0.01 -0.0062 -1.0 1702696 Maybridge1_003711 COC(=O)c1sccc1NC(=O)CC(=O)Nc2ccsc2C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A16 compound treatment 0.9994 0.00181 0.04 0.0352 1.0 1361943 Maybridge1_003712 COC(=O)Cn1nnc(n1)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A17 compound treatment 0.9781 -0.0195 -0.38 -0.3792 -1.0 1219663 Maybridge1_003713 CCOC(=O)c1c(C)csc1NC(=O)c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A18 compound treatment 1.0314 0.0338 0.66 0.6568 1.0 1116540 Maybridge1_003714 COC(=O)c1ccsc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A19 compound treatment 0.9944 -0.00317 -0.06 -0.0615 -1.0 2071230 Maybridge1_003715 CCOC(=O)c1cnn(C)c1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A20 compound treatment 1.0108 0.0132 0.26 0.2562 1.0 2071231 Maybridge1_003716 Clc1ccc(c2nn[nH]n2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A21 compound treatment 1.0229 0.0253 0.49 0.4911 1.0 1669188 Maybridge1_003717 CC(C)(C)c1cc(N)c(s1)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A22 compound treatment 0.9631 -0.0345 -0.67 -0.6693 -1.0 2071232 Maybridge1_003718 Cn1nccc1N2C(=O)CCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A23 mock treatment 1.0193 0.0217 0.42 0.422 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 A24 mock treatment 0.9987 0.0011 0.02 0.0214 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B01 compound treatment 1.0094 0.0118 0.23 0.2286 1.0 2071233 Maybridge1_003719 COC(=O)c1cc(OC)c(OC)cc1NS(=O)(=O)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B02 compound treatment 1.0343 0.0367 0.71 0.7121 1.0 2071234 Maybridge1_003720 Cn1ncc(C(=O)O/N=C/c2c(F)cccc2Cl)c1n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B03 compound treatment 1.0271 0.0296 0.57 0.5739 1.0 2071235 Maybridge1_003721 FC(F)(F)c1ccc2Oc3ccsc3C(=O)Nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B04 compound treatment 1.0193 0.0217 0.42 0.422 1.0 1384033 Maybridge1_003722 CC(C)(C)c1ccc(CSc2nc(N)cc(O)n2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B05 compound treatment 1.015 0.0175 0.34 0.3391 1.0 2071236 Maybridge1_003723 COC(=O)CSc1ncnc2sc3CCCCc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B06 compound treatment 1.0158 0.0182 0.35 0.3529 1.0 2071237 Maybridge1_003724 COCCOc1ccccc1NC(=S)NNC(=O)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B07 compound treatment 0.9788 -0.0188 -0.37 -0.3654 -1.0 1091059 Maybridge1_003725 CCOC(=O)c1ccc(NC(=S)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B08 compound treatment 0.9589 -0.0387 -0.75 -0.7522 -1.0 2071238 Maybridge1_003726 COC(=O)c1csc2c(cc(nc12)N3CCN(CC3)C(=O)Nc4ccccc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B09 compound treatment 1.0015 0.00395 0.08 0.0766 1.0 2071239 Maybridge1_003727 COc1cc(C(=O)NNS(=O)(=O)c2cc(C)c(Cl)c(C)c2)c(cc1OC)n3c(C)ccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B10 compound treatment 0.9496 -0.048 -0.93 -0.9318 -1.0 2071240 Maybridge1_003728 FC(F)(F)Oc1ccc(cc1)c2nnc(S)n2c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B11 compound treatment 0.9695 -0.0281 -0.54 -0.545 -1.0 2071241 Maybridge1_003729 C(c1nn[nH]n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B12 compound treatment 1.0293 0.0317 0.62 0.6154 1.0 1919317 Maybridge1_003730 FC(F)(F)C1=Nc2ccccc2NC(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B13 compound treatment 1.015 0.0175 0.34 0.3391 1.0 1394339 Maybridge1_003731 Cc1cc(Br)ccc1S(=O)(=O)Nc2ccnn2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B14 compound treatment 0.9731 -0.0245 -0.48 -0.4759 -1.0 2071242 Maybridge1_003732 Cc1onc(c1C(=O)NC(=S)N2CCOCC2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B15 compound treatment 0.9809 -0.0167 -0.32 -0.324 -1.0 1654305 Maybridge1_003733 Cc1cc(c(Cl)cc1Cl)S(=O)(=O)Nc2ccnn2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B16 compound treatment 0.9966 -0.00103 -0.02 -0.0201 -1.0 1322744 Maybridge1_003734 Cc1cccc(NC(=S)NC2CC3CC2C=C3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B17 compound treatment 1.0307 0.0331 0.64 0.643 1.0 2071243 Maybridge1_003735 Cc1cc(NS(=O)(=O)c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B18 compound treatment 1.0243 0.0267 0.52 0.5187 1.0 1614026 Maybridge1_003736 COc1ccc(cc1OC)c2c(C)nc3ccc(Cl)cc3c2c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B19 compound treatment 0.9859 -0.0117 -0.23 -0.2273 -1.0 1276489 Maybridge1_003737 Cc1cc(NS(=O)(=O)c2ccc(NC(=O)CCC(=O)O)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B20 compound treatment 0.9631 -0.0345 -0.67 -0.6693 -1.0 2071244 Maybridge1_003738 FC(F)(F)c1ccc(nc1)N2CCN(CC(=O)Nc3ccc4OCOc4c3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B21 compound treatment 0.988 -0.00957 -0.19 -0.1858 -1.0 1271205 Maybridge1_003739 COc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B22 compound treatment 0.9667 -0.0309 -0.6 -0.6002 -1.0 1738916 Maybridge1_003740 COC(=O)c1sccc1NC(=O)CC(C)(C)CC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B23 mock treatment 0.993 -0.00459 -0.09 -0.0891 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 B24 mock treatment 1.0158 0.0182 0.35 0.3529 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C01 compound treatment 1.0136 0.016 0.31 0.3115 1.0 2071245 Maybridge1_003741 Cc1ccccc1NC(=S)NCc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C02 compound treatment 1.0022 0.00466 0.09 0.0905 1.0 2071246 Maybridge1_003742 COC(=O)c1scc(C)c1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C03 compound treatment 1.0599 0.0623 1.21 1.2094 1.0 2071247 Maybridge1_003743 Cc1onc(c1C(=O)Oc2cc(nn2C)C(F)(F)F)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C04 compound treatment 1.0243 0.0267 0.52 0.5187 1.0 2071248 Maybridge1_003744 C(c1nn[nH]n1)c2nc3ccccc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C05 compound treatment 1.0143 0.0168 0.33 0.3253 1.0 2071249 Maybridge1_003745 CCOC(=O)c1cnn(c1N)c2c([N+](=O)[O-])c(C)nn2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C06 compound treatment 0.9923 -0.0053 -0.1 -0.1029 -1.0 2071250 Maybridge1_003746 Cn1ncc2c(=O)[nH]cnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C07 compound treatment 1.0008 0.00324 0.06 0.0628 1.0 1505403 Maybridge1_003747 O=C1CCc2ccccc2N1Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C08 compound treatment 0.9873 -0.0103 -0.2 -0.1996 -1.0 1586389 Maybridge1_003748 CCCc1nc(N)ncc1C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C09 compound treatment 1.0115 0.0139 0.27 0.27 1.0 1045287 Maybridge1_003749 COC(=O)C1CCC(CC1)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C10 compound treatment 0.9951 -0.00246 -0.05 -0.0477 -1.0 2071251 Maybridge1_003750 NNC(=O)c1cnn(c1C(F)(F)F)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C11 compound treatment 1.1481 0.15 2.92 2.9223 1.0 2071252 Maybridge1_003751 COC(=O)C(C#N)C1C(=C(N)Oc2c(Br)cc(Br)cc12)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C12 compound treatment 0.9674 -0.0302 -0.59 -0.5864 -1.0 2071253 Maybridge1_003752 COC(=O)c1sccc1Oc2ccc(cc2NS(=O)(=O)c3ccc(F)cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C13 compound treatment 0.998 3.9E-4 0.01 0.0076 1.0 2071254 Maybridge1_003753 Cc1ccc(OCC2SCCN2C(=O)c3ccc(F)cc3)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C14 compound treatment 0.9795 -0.0181 -0.35 -0.3516 -1.0 2071255 Maybridge1_003754 CCOc1ccsc1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C15 compound treatment 0.9944 -0.00317 -0.06 -0.0615 -1.0 2071256 Maybridge1_003755 CCOC(=O)c1c(C)csc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C16 compound treatment 0.9475 -0.0501 -0.97 -0.9732 -1.0 2071257 Maybridge1_003756 Cc1csc2c(S)ncnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C17 compound treatment 1.0193 0.0217 0.42 0.422 1.0 2071258 Maybridge1_003757 Nc1c(C#N)cnc2c(Br)cnn12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C18 compound treatment 0.9446 -0.053 -1.03 -1.0285 -1.0 1400072 Maybridge1_003758 CC(=O)Nc1ccc(cc1)S(=O)(=O)N(c2ccc(F)cc2F)S(=O)(=O)c3ccc(NC(=O)C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C19 compound treatment 0.9731 -0.0245 -0.48 -0.4759 -1.0 1647208 Maybridge1_003759 CCOC(=O)c1c(C)csc1NC(=O)Nc2c(C)onc2c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C20 compound treatment 0.9482 -0.0494 -0.96 -0.9594 -1.0 2071259 Maybridge1_003760 Clc1ccc(cc1Cl)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C21 compound treatment 0.993 -0.00459 -0.09 -0.0891 -1.0 2071260 Maybridge1_003761 CC(=O)c1sc(cc1N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C22 compound treatment 0.9859 -0.0117 -0.23 -0.2273 -1.0 2071261 Maybridge1_003762 CCOC(=O)c1ccsc1NC(=O)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C23 mock treatment 0.956 -0.0416 -0.81 -0.8074 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 C24 mock treatment 0.9603 -0.0373 -0.72 -0.7246 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D01 compound treatment 0.9987 0.0011 0.02 0.0214 1.0 1343139 Maybridge1_003763 COC(=O)c1cc(OC)c(OC)cc1NS(=O)(=O)c2ccc(F)c(F)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D02 compound treatment 0.9845 -0.0131 -0.25 -0.2549 -1.0 1490566 Maybridge1_003764 Cc1onc(c1C(=O)Nc2ccccc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D03 compound treatment 1.0072 0.00964 0.19 0.1872 1.0 1387616 Maybridge1_003765 COC(=O)c1cc(OC)c(OC)cc1NC(=O)c2cccc(C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D04 compound treatment 0.9973 -3.21E-4 -0.01 -0.0062 -1.0 2071262 Maybridge1_003766 Oc1cc(O)nc(SCc2c(Cl)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D05 compound treatment 1.0108 0.0132 0.26 0.2562 1.0 1544193 Maybridge1_003767 COc1cc2ncnc(Sc3ccc(C)cc3)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D06 compound treatment 0.9845 -0.0131 -0.25 -0.2549 -1.0 2071263 Maybridge1_003768 COC(=O)c1ccccc1NC(=S)NNC(=O)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D07 compound treatment 0.983 -0.0145 -0.28 -0.2825 -1.0 2071264 Maybridge1_003769 Cn1nccc1NC(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D08 compound treatment 1.0044 0.00679 0.13 0.1319 1.0 2071265 Maybridge1_003770 COC(=O)c1csc2c(cc(nc12)N3CCN(CC3)C(=O)Nc4cc(Cl)cc(Cl)c4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D09 compound treatment 0.9624 -0.0352 -0.68 -0.6831 -1.0 2071266 Maybridge1_003771 Cc1ccc(C)n1c2sc3CCCCc3c2C(=O)NNC(=O)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D10 compound treatment 1.0115 0.0139 0.27 0.27 1.0 2071267 Maybridge1_003772 FC(F)(F)c1ccc(OCC#N)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D11 compound treatment 1.0179 0.0203 0.39 0.3944 1.0 1194918 Maybridge1_003773 Cc1cc(NS(=O)(=O)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D12 compound treatment 0.9553 -0.0423 -0.82 -0.8212 -1.0 2071268 Maybridge1_003774 CCOC(=O)c1c(N)scc1c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D13 compound treatment 0.9966 -0.00103 -0.02 -0.0201 -1.0 1589664 Maybridge1_003775 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)S(=O)(=O)Nc3cc(C)on3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D14 compound treatment 1.0051 0.0075 0.15 0.1457 1.0 1122688 Maybridge1_003776 CC1CCCC(C)N1C(=S)NC(=O)c2c(C)onc2c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D15 compound treatment 0.9923 -0.0053 -0.1 -0.1029 -1.0 2071269 Maybridge1_003777 Clc1ccc(CSc2ncnc3sc4CCCCc4c23)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D16 compound treatment 0.9667 -0.0309 -0.6 -0.6002 -1.0 2071270 Maybridge1_003778 S=C(NC1CC2CC1C=C2)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D17 compound treatment 0.9873 -0.0103 -0.2 -0.1996 -1.0 1545146 Maybridge1_003779 Cc1cc(NS(=O)(=O)c2ccc(NC(=O)Nc3ccc4ccccc4c3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D18 compound treatment 0.9674 -0.0302 -0.59 -0.5864 -1.0 1144861 Maybridge1_003780 CCN(CC)c1ccc(NC(=S)Nc2ccc(OC)cc2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D19 compound treatment 0.9425 -0.0551 -1.07 -1.0699 -1.0 1466175 Maybridge1_003781 COc1cc(NC(=O)c2ccccc2)c(cc1OC)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D20 compound treatment 0.9596 -0.038 -0.74 -0.7384 -1.0 1146514 Maybridge1_003782 Cc1cc(N2CCN(CC2)S(=O)(=O)c3ccc(Cl)cc3)c4ccccc4n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D21 compound treatment 0.9396 -0.0579 -1.13 -1.1251 -1.0 2071271 Maybridge1_003783 COc1cc2ncnc(Nc3ccc(OC(F)(F)F)cc3)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D22 compound treatment 0.9958 -0.00174 -0.03 -0.0339 -1.0 2071272 Maybridge1_003784 C1Oc2ccc(/N=C/3\SCC4CCCCN43)cc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D23 mock treatment 0.9944 -0.00317 -0.06 -0.0615 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 D24 mock treatment 1.0051 0.0075 0.15 0.1457 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E01 compound treatment 1.0542 0.0566 1.1 1.0989 1.0 1546515 Maybridge1_003785 Cc1ccc(NC(=S)N(CCC#N)CCc2ccccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E02 compound treatment 1.2861 0.288 5.6 5.6021 1.0 1704263 Maybridge1_003786 CCOC(=O)CC(=O)Nc1c(C)csc1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E03 compound treatment 0.9923 -0.0053 -0.1 -0.1029 -1.0 1427173 Maybridge1_003787 COc1ccc(Cc2n[nH]c(=O)o2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E04 compound treatment 0.9653 -0.0323 -0.63 -0.6279 -1.0 2071273 Maybridge1_003788 OC(=O)c1cnn(c1C(F)(F)F)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E05 compound treatment 0.993 -0.00459 -0.09 -0.0891 -1.0 2071274 Maybridge1_003789 Cc1nn(C)c(c1[N+](=O)[O-])n2ncc(C#N)c2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E06 compound treatment 0.966 -0.0316 -0.61 -0.614 -1.0 2071275 Maybridge1_003790 COC(=O)CSc1ncnc2c(C)csc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E07 compound treatment 0.9944 -0.00317 -0.06 -0.0615 -1.0 2071276 Maybridge1_003791 CCOC(=O)C1=C(C)N=C2SCCC(=O)N2C1c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E08 compound treatment 1.0186 0.021 0.41 0.4082 1.0 1257517 Maybridge1_003792 Clc1ccc(NC(=O)C2CCc3ccccc3O2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E09 compound treatment 1.0051 0.0075 0.15 0.1457 1.0 1196450 Maybridge1_003793 COc1ccc2-c3nc(N)sc3CCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E10 compound treatment 0.966 -0.0316 -0.61 -0.614 -1.0 2071277 Maybridge1_003794 COC(=O)c1sccc1Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E11 compound treatment 1.0784 0.0808 1.57 1.5685 1.0 2071278 Maybridge1_003795 COc1ccc(/C=C(\C#N)/c2nc3ccccc3[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E12 compound treatment 0.9951 -0.00246 -0.05 -0.0477 -1.0 2071279 Maybridge1_003796 COC(=O)c1scc(C)c1N2C(=O)C=CC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E13 compound treatment 0.9695 -0.0281 -0.54 -0.545 -1.0 2071280 Maybridge1_003797 OC(=O)c1ccccc1SCC(=O)c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E14 compound treatment 0.988 -0.00957 -0.19 -0.1858 -1.0 2071281 Maybridge1_003798 CCOc1ccsc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E15 compound treatment 0.9852 -0.0124 -0.24 -0.2411 -1.0 2071282 Maybridge1_003799 CC(=O)CSc1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E16 compound treatment 0.9695 -0.0281 -0.54 -0.545 -1.0 2071283 Maybridge1_003800 CCOC(=O)c1cc2c(nn(C)c2s1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E17 compound treatment 1.0072 0.00964 0.19 0.1872 1.0 1108872 Maybridge1_003801 N#CCc1nc2ccccc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E18 compound treatment 0.9596 -0.038 -0.74 -0.7384 -1.0 2071284 Maybridge1_003802 CC(=O)Nc1ccc(cc1)S(=O)(=O)N(c2ccccc2C(F)(F)F)S(=O)(=O)c3ccc(NC(=O)C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E19 compound treatment 0.9702 -0.0274 -0.53 -0.5312 -1.0 2071285 Maybridge1_003803 CCOC(=O)c1c(C)csc1NC(=O)Nc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E20 compound treatment 0.9994 0.00181 0.04 0.0352 1.0 2071286 Maybridge1_003804 Clc1cccc(Cl)c1c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E21 compound treatment 1.0727 0.0751 1.46 1.458 1.0 1360504 Maybridge1_003805 CC(C)(C)c1cc(NC(=O)CC#N)c(s1)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E22 compound treatment 0.9638 -0.0338 -0.66 -0.6555 -1.0 1513979 Maybridge1_003806 COC(=O)c1cc(OC)c(OC)cc1NS(=O)(=O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E23 mock treatment 1.015 0.0175 0.34 0.3391 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 E24 mock treatment 0.988 -0.00957 -0.19 -0.1858 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F01 compound treatment 1.0463 0.0488 0.95 0.9469 1.0 1584709 Maybridge1_003807 COC(=O)c1cc(OC)c(OC)cc1NS(=O)(=O)c2ccc(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F02 compound treatment 1.0186 0.021 0.41 0.4082 1.0 2071287 Maybridge1_003808 CCOC(=O)C(=CNNC(=O)c1cnn(c1C(F)(F)F)c2ccc(cc2)[N+](=O)[O-])C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F03 compound treatment 1.0222 0.0246 0.48 0.4772 1.0 1486847 Maybridge1_003809 O=c1[nH]cnc2sc3CCCCc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F04 compound treatment 0.9781 -0.0195 -0.38 -0.3792 -1.0 1945423 Maybridge1_003810 Nc1cc(O)nc(SCc2ccc(Cl)cc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F05 compound treatment 1.0086 0.0111 0.21 0.2148 1.0 2071288 Maybridge1_003811 COc1ncnc2sc3CCCCc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F06 compound treatment 1.0236 0.026 0.5 0.5049 1.0 2071289 Maybridge1_003812 Cc1csc(N)c1c2nc3ccccc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F07 compound treatment 1.0243 0.0267 0.52 0.5187 1.0 2071290 Maybridge1_003813 Cn1nccc1NC(=O)Nc2cccc(Br)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F08 compound treatment 0.9781 -0.0195 -0.38 -0.3792 -1.0 2071291 Maybridge1_003814 COC(=O)c1csc2c(cc(nc12)N3CCN(CC3)C(=O)Nc4ccc(F)cc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F09 compound treatment 0.9667 -0.0309 -0.6 -0.6002 -1.0 1728277 Maybridge1_003815 Cc1cc(NS(=O)(=O)c2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F10 compound treatment 1.0136 0.016 0.31 0.3115 1.0 2071292 Maybridge1_003816 Nc1ccccc1Sc2nccc(n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F11 compound treatment 0.9866 -0.011 -0.21 -0.2134 -1.0 1590495 Maybridge1_003817 Cc1cc(c(C)cc1Cl)S(=O)(=O)Nc2ccnn2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F12 compound treatment 0.9958 -0.00174 -0.03 -0.0339 -1.0 2071293 Maybridge1_003818 O=c1[nH]cnc2scc(c3ccccc3)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F13 compound treatment 0.9681 -0.0295 -0.57 -0.5726 -1.0 1333321 Maybridge1_003819 Cc1cc(NS(=O)(=O)c2ccc(NS(=O)(=O)c3cccc(Cl)c3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F14 compound treatment 1.0008 0.00324 0.06 0.0628 1.0 1199492 Maybridge1_003820 CC1CCN(CC1)C(=S)NC2CC3CCC2C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F15 compound treatment 0.9368 -0.0608 -1.18 -1.1804 -1.0 1180444 Maybridge1_003821 COc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)S(=O)(=O)Nc3cc(C)on3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F16 compound treatment 0.9909 -0.00672 -0.13 -0.1306 -1.0 1218416 Maybridge1_003822 CCOc1ccc(NC(=S)NC2CC3CC2C=C3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F17 compound treatment 0.9902 -0.00743 -0.14 -0.1444 -1.0 1356531 Maybridge1_003823 COc1cc(NC(=O)c2ccc(Cl)cc2)c(cc1OC)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F18 compound treatment 0.9894 -0.00815 -0.16 -0.1582 -1.0 1299812 Maybridge1_003824 NC(=O)c1c(N)sc2CCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F19 compound treatment 0.934 -0.0636 -1.24 -1.2357 -1.0 1679441 Maybridge1_003825 COc1cc(NC(=O)c2cccs2)c(cc1OC)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F20 compound treatment 0.9717 -0.0259 -0.5 -0.5035 -1.0 1704487 Maybridge1_003826 Cc1cc(N2CCN(CC2)S(=O)(=O)c3ccc(F)cc3)c4ccccc4n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F21 compound treatment 0.9773 -0.0202 -0.39 -0.393 -1.0 2071294 Maybridge1_003827 CC(=O)c1sc(cc1NC(=O)c2ccc(Cl)cc2)c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F22 compound treatment 1.0037 0.00608 0.12 0.1181 1.0 2071295 Maybridge1_003828 Cc1scc(NS(=O)(=O)c2ccc(C)cc2)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F23 mock treatment 0.9802 -0.0174 -0.34 -0.3378 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 F24 mock treatment 1.0058 0.00821 0.16 0.1595 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G01 compound treatment 1.0527 0.0552 1.07 1.0712 1.0 2071296 Maybridge1_003829 FC(F)(F)c1cccc(NC(=S)N(CCC#N)CCc2ccccn2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G02 compound treatment 1.0072 0.00964 0.19 0.1872 1.0 2071297 Maybridge1_003830 COC(=O)c1sccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G03 compound treatment 0.9873 -0.0103 -0.2 -0.1996 -1.0 2071298 Maybridge1_003831 CSc1cc(n[nH]1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G04 compound treatment 1.0222 0.0246 0.48 0.4772 1.0 2071299 Maybridge1_003832 CCCc1c(cnn1c2ccccc2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G05 compound treatment 1.0307 0.0331 0.64 0.643 1.0 1059689 Maybridge1_003833 CCOC(=O)c1cnn(C)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G06 compound treatment 1.0001 0.00252 0.05 0.049 1.0 2071300 Maybridge1_003834 Cc1csc2c(SCC(=O)NN)ncnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G07 compound treatment 0.9738 -0.0238 -0.46 -0.4621 -1.0 1006328 Maybridge1_003835 OC(=O)C1CCC(CC1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G08 compound treatment 1.0072 0.00964 0.19 0.1872 1.0 2071301 Maybridge1_003836 N/C(=N/OC(=O)C1CCc2ccccc2O1)/c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G09 compound treatment 0.9759 -0.0217 -0.42 -0.4206 -1.0 1162404 Maybridge1_003837 Nc1nc-2c(CCc3ccccc23)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G10 compound treatment 1.0307 0.0331 0.64 0.643 1.0 2071302 Maybridge1_003838 NNC(=O)c1cnn(c1C(F)(F)F)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G11 compound treatment 0.9894 -0.00815 -0.16 -0.1582 -1.0 2071303 Maybridge1_003839 Clc1ccc(cc1)C(=O)ON=C2C3CC4CC(C3)CC2C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G12 compound treatment 1.0186 0.021 0.41 0.4082 1.0 2071304 Maybridge1_003840 COC(=O)c1scc(N)c1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G13 compound treatment 1.0143 0.0168 0.33 0.3253 1.0 2071305 Maybridge1_003841 CCOC(=O)c1csc(N/N=C/2\CCCc3cc(OC)ccc23)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G14 compound treatment 0.9894 -0.00815 -0.16 -0.1582 -1.0 1415299 Maybridge1_003842 CCOc1ccsc1C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G15 compound treatment 0.9852 -0.0124 -0.24 -0.2411 -1.0 1245805 Maybridge1_003843 COC(=O)c1ccccc1NC(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G16 compound treatment 0.9738 -0.0238 -0.46 -0.4621 -1.0 1626184 Maybridge1_003844 COC(=O)C1=C(N)CCS1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G17 compound treatment 0.9624 -0.0352 -0.68 -0.6831 -1.0 2071306 Maybridge1_003845 O=c1nc[nH]c2ccsc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G18 compound treatment 0.9418 -0.0558 -1.08 -1.0837 -1.0 2071307 Maybridge1_003846 CC(=O)Nc1ccc(cc1)S(=O)(=O)N(c2ccc(cc2)C(F)(F)F)S(=O)(=O)c3ccc(NC(=O)C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G19 compound treatment 1.0527 0.0552 1.07 1.0712 1.0 1512183 Maybridge1_003847 CCOC(=O)CC(=O)Nc1scc(C)c1C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G20 compound treatment 0.9823 -0.0153 -0.3 -0.2963 -1.0 2071308 Maybridge1_003848 CC(C)(C)c1ccc(cc1)c2nnnn2Cc3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G21 compound treatment 1.0058 0.00821 0.16 0.1595 1.0 1630143 Maybridge1_003849 CCOC(=O)c1cnn(C)c1NC(=O)c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G22 compound treatment 0.9653 -0.0323 -0.63 -0.6279 -1.0 2071309 Maybridge1_003850 COC(=O)c1cc(OC)c(OC)cc1NS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G23 mock treatment 1.0022 0.00466 0.09 0.0905 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 G24 mock treatment 1.0044 0.00679 0.13 0.1319 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H01 compound treatment 1.0094 0.0118 0.23 0.2286 1.0 1247158 Maybridge1_003851 COC(=O)c1cc(OC)c(OC)cc1NC(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H02 compound treatment 1.0215 0.0239 0.46 0.4634 1.0 2071310 Maybridge1_003852 Cc1ccc(cc1)c2nnc(o2)c3cnn(c3C(F)(F)F)c4ccc(cc4)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H03 compound treatment 0.9859 -0.0117 -0.23 -0.2273 -1.0 1273506 Maybridge1_003853 COC(=O)c1cc(OC)c(OC)cc1NC(=O)CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H04 compound treatment 0.9894 -0.00815 -0.16 -0.1582 -1.0 1004482 Maybridge1_003854 CC(=O)CC(=O)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H05 compound treatment 0.9645 -0.033 -0.64 -0.6417 -1.0 2071311 Maybridge1_003855 COc1cc2ncnc(Sc3ccc(Cl)cc3)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H06 compound treatment 1.0022 0.00466 0.09 0.0905 1.0 2071312 Maybridge1_003856 COC(=O)c1csc2c(cc(nc12)N3CCN(CC3)S(=O)(=O)c4ccc(C)cc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H07 compound treatment 0.9987 0.0011 0.02 0.0214 1.0 2071313 Maybridge1_003857 Cn1nccc1NC(=S)Nc2ccc(Br)cc2OC(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H08 compound treatment 1.0094 0.0118 0.23 0.2286 1.0 2071314 Maybridge1_003858 COC(=O)c1csc2c(cc(nc12)N3CCN(CC3)C(=S)Nc4cc(cc(c4)C(F)(F)F)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H09 compound treatment 0.9966 -0.00103 -0.02 -0.0201 -1.0 1333925 Maybridge1_003859 COc1cccc(OC)c1C(=O)Nc2ccnn2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H10 compound treatment 1.0051 0.0075 0.15 0.1457 1.0 2071315 Maybridge1_003860 N/C(=N/O)/Cn1ccc(n1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H11 compound treatment 0.9887 -0.00886 -0.17 -0.172 -1.0 2071316 Maybridge1_003861 Cn1nccc1NC(=O)CCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H12 compound treatment 0.9823 -0.0153 -0.3 -0.2963 -1.0 2071317 Maybridge1_003862 CC1(C)COCCN1C(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H13 compound treatment 0.9709 -0.0266 -0.52 -0.5173 -1.0 1484331 Maybridge1_003863 Cc1cc(NS(=O)(=O)c2ccc(NS(=O)(=O)c3ccc(C#N)cc3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H14 compound treatment 0.9838 -0.0138 -0.27 -0.2687 -1.0 1510294 Maybridge1_003864 CCC(CO)NC(=S)NC1CC2CCC1C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H15 compound treatment 0.9382 -0.0594 -1.15 -1.1528 -1.0 1985554 Maybridge1_003865 CCSc1ncnc2sc3CCCCc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H16 compound treatment 0.9752 -0.0224 -0.43 -0.4345 -1.0 1390457 Maybridge1_003866 CCOc1ccccc1NC(=S)NC2CC3CCC2C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H17 compound treatment 0.9951 -0.00246 -0.05 -0.0477 -1.0 2071318 Maybridge1_003867 COc1cc(NC(=O)c2ccc(OC(F)(F)F)cc2)c(cc1OC)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H18 compound treatment 0.9667 -0.0309 -0.6 -0.6002 -1.0 1566872 Maybridge1_003868 COc1cccc(NC(=S)Nc2ccccc2n3cccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H19 compound treatment 0.9773 -0.0202 -0.39 -0.393 -1.0 2071319 Maybridge1_003869 COC(=O)c1cc(OC)c(OC)cc1NC(=O)CN2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H20 compound treatment 0.9709 -0.0266 -0.52 -0.5173 -1.0 1337960 Maybridge1_003870 CN1CCN(CC1)c2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H21 compound treatment 0.9617 -0.0359 -0.7 -0.6969 -1.0 1393179 Maybridge1_003871 CC(=O)Nc1cc(sc1C(=O)N)c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H22 compound treatment 1.0108 0.0132 0.26 0.2562 1.0 1363593 Maybridge1_003872 Cc1cc(Cl)ccc1Nc2nnns2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H23 mock treatment 0.9546 -0.043 -0.84 -0.8351 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 H24 mock treatment 0.9838 -0.0138 -0.27 -0.2687 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I01 compound treatment 1.0855 0.0879 1.71 1.7067 1.0 2071320 Maybridge1_003873 CN(C)CCCNc1c([N+](=O)[O-])c(C)nn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I02 compound treatment 1.0122 0.0146 0.28 0.2838 1.0 2071321 Maybridge1_003874 COC(=O)c1scc(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I03 compound treatment 1.0328 0.0352 0.68 0.6844 1.0 2071322 Maybridge1_003875 CCOc1cc(nc(S)n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I04 compound treatment 1.0179 0.0203 0.39 0.3944 1.0 2071323 Maybridge1_003876 CCCc1c(cnn1c2ccc(Cl)cc2)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I05 compound treatment 1.062 0.0644 1.25 1.2508 1.0 2071324 Maybridge1_003877 O=C1/C(=C/c2cccs2)/Cc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I06 compound treatment 1.0421 0.0445 0.86 0.864 1.0 2071325 Maybridge1_003878 Cc1csc2ncnc(Sc3ccccc3N)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I07 compound treatment 0.9845 -0.0131 -0.25 -0.2549 -1.0 2071326 Maybridge1_003879 CCOC(=O)CCSC1=NC(C(=C(C)N1)C(=O)OCC)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I08 compound treatment 0.993 -0.00459 -0.09 -0.0891 -1.0 2071327 Maybridge1_003880 COC(=O)c1cscc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I09 compound treatment 1.0022 0.00466 0.09 0.0905 1.0 1035457 Maybridge1_003881 CC(C)CC1NC(=O)NC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I10 compound treatment 0.9894 -0.00815 -0.16 -0.1582 -1.0 2071328 Maybridge1_003882 COC(=O)c1sccc1Oc2ccc(Cl)cc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I11 compound treatment 1.0101 0.0125 0.24 0.2424 1.0 2071329 Maybridge1_003883 Fc1ccc(cc1)C(=O)ON=C2C3CC4CC(C3)CC2C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I12 compound treatment 0.9318 -0.0658 -1.28 -1.2771 -1.0 1732993 Maybridge1_003884 COC(=O)c1c(C)scc1NC(=O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I13 compound treatment 1.0314 0.0338 0.66 0.6568 1.0 2071330 Maybridge1_003885 COC(=O)CN(C(=O)c1ccccc1[N+](=O)[O-])C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I14 compound treatment 1.0129 0.0153 0.3 0.2977 1.0 2071331 Maybridge1_003886 COC(=O)c1sccc1n2c(C)ccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I15 compound treatment 1.0001 0.00252 0.05 0.049 1.0 2071332 Maybridge1_003887 CC(=O)CSC(=O)c1c(C)onc1c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I16 compound treatment 0.9859 -0.0117 -0.23 -0.2273 -1.0 2071333 Maybridge1_003888 COC(=O)C(Cc1ccc(F)cc1)(Cc2ccc(F)cc2)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I17 compound treatment 1.0044 0.00679 0.13 0.1319 1.0 2071334 Maybridge1_003889 O/C=C(\C#N)/c1nc2ccccc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I18 compound treatment 0.9567 -0.0409 -0.79 -0.7936 -1.0 1618849 Maybridge1_003890 OCCNc1ncnc2sccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I19 compound treatment 1.0122 0.0146 0.28 0.2838 1.0 2071335 Maybridge1_003891 COC(=O)c1sc(cc1N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I20 compound treatment 0.9461 -0.0515 -1.0 -1.0008 -1.0 2071336 Maybridge1_003892 CC(=O)c1sc(cc1N)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I21 compound treatment 0.983 -0.0145 -0.28 -0.2825 -1.0 2071337 Maybridge1_003893 COC(=O)c1sc(cc1N)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I22 compound treatment 0.9802 -0.0174 -0.34 -0.3378 -1.0 2071338 Maybridge1_003894 COC(=O)c1cc(OC)c(OC)cc1NS(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I23 mock treatment 1.0115 0.0139 0.27 0.27 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 I24 mock treatment 0.9667 -0.0309 -0.6 -0.6002 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J01 compound treatment 1.015 0.0175 0.34 0.3391 1.0 2071339 Maybridge1_003895 COC(=O)c1cc(OC)c(OC)cc1NC(=O)Nc2ccc(OC(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J02 compound treatment 0.9553 -0.0423 -0.82 -0.8212 -1.0 1724940 Maybridge1_003896 CC(C)(C)c1cc2ncnc(N3CCN(CC3)c4ncnc5cc(sc45)C(C)(C)C)c2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J03 compound treatment 0.9994 0.00181 0.04 0.0352 1.0 2071340 Maybridge1_003897 CCOC(=O)c1c(sc2CCCCc12)n3c(C)ccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J04 compound treatment 0.983 -0.0145 -0.28 -0.2825 -1.0 2071341 Maybridge1_003898 NC(=N)NC(=N)NCc1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J05 compound treatment 1.0108 0.0132 0.26 0.2562 1.0 2071342 Maybridge1_003899 CCNC(=S)Nc1c(C)cc(C)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J06 compound treatment 0.9966 -0.00103 -0.02 -0.0201 -1.0 2071343 Maybridge1_003900 COC(=O)c1csc2c(cc(nc12)N3CCN(CC3)S(=O)(=O)c4ccc(Cl)cc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J07 compound treatment 1.0086 0.0111 0.21 0.2148 1.0 2071344 Maybridge1_003901 Cn1nccc1NC(=O)Nc2ccc(OC(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J08 compound treatment 0.9916 -0.00601 -0.12 -0.1167 -1.0 2071345 Maybridge1_003902 Clc1ccc(Sc2ncnc3ccsc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J09 compound treatment 0.9717 -0.0259 -0.5 -0.5035 -1.0 1286388 Maybridge1_003903 Cc1cc(NS(=O)(=O)c2ccc(NS(=O)(=O)c3ccc(C)cc3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J10 compound treatment 0.9766 -0.0209 -0.41 -0.4068 -1.0 2071346 Maybridge1_003904 FC(F)(F)c1ccn(n1)c2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J11 compound treatment 0.9389 -0.0586 -1.14 -1.139 -1.0 1327348 Maybridge1_003905 Cn1nccc1NS(=O)(=O)c2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J12 compound treatment 1.0648 0.0673 1.31 1.3061 1.0 2071347 Maybridge1_003906 CN(C)/N=C(/C(=O)C(F)(F)F)\c1ccc(C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J13 compound treatment 0.9581 -0.0394 -0.77 -0.766 -1.0 1205526 Maybridge1_003907 Cn1nccc1NS(=O)(=O)c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J14 compound treatment 0.983 -0.0145 -0.28 -0.2825 -1.0 2071348 Maybridge1_003908 [O-][N+](=O)c1cccc(c1)C(=O)NC(=S)Nc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J15 compound treatment 0.9645 -0.033 -0.64 -0.6417 -1.0 2071349 Maybridge1_003909 CC(=O)c1sc(cc1N)c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J16 compound treatment 0.9781 -0.0195 -0.38 -0.3792 -1.0 2071350 Maybridge1_003910 OCCNNC(=S)NC1CC2CC1C=C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J17 compound treatment 0.983 -0.0145 -0.28 -0.2825 -1.0 1513059 Maybridge1_003911 Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3ccc(Cl)cc3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J18 compound treatment 0.9759 -0.0217 -0.42 -0.4206 -1.0 2071351 Maybridge1_003912 CNc1nc(cs1)c2ccc(Cl)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J19 compound treatment 0.9489 -0.0487 -0.95 -0.9456 -1.0 1212957 Maybridge1_003913 COC(=O)c1cc(OC)c(OC)cc1NC(=O)CSc2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J20 compound treatment 0.9731 -0.0245 -0.48 -0.4759 -1.0 1715187 Maybridge1_003914 COC(=O)c1sccc1S(=O)(=O)Nc2ccc(cc2)N3CCN(C)CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J21 compound treatment 0.9873 -0.0103 -0.2 -0.1996 -1.0 2071352 Maybridge1_003915 Cn1ncc2c(N/N=C/c3ccc(Cl)cc3)ncnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J22 compound treatment 0.9482 -0.0494 -0.96 -0.9594 -1.0 1397071 Maybridge1_003916 OC(=O)COCC(=O)N1CCN(CC1)C(c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J23 mock treatment 0.9631 -0.0345 -0.67 -0.6693 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 J24 mock treatment 1.0748 0.0772 1.5 1.4995 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K01 compound treatment 1.0954 0.0978 1.9 1.9001 1.0 2071353 Maybridge1_003917 CSC(=NC(=O)c1c(Cl)cccc1Cl)SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K02 compound treatment 1.0086 0.0111 0.21 0.2148 1.0 2071354 Maybridge1_003918 Cc1csc(C(=O)O)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K03 compound treatment 1.0599 0.0623 1.21 1.2094 1.0 2071355 Maybridge1_003919 COc1ccc(NCCC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K04 compound treatment 0.9781 -0.0195 -0.38 -0.3792 -1.0 2071356 Maybridge1_003920 CCOC(=O)c1cnn(c1C(F)(F)F)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K05 compound treatment 0.9923 -0.0053 -0.1 -0.1029 -1.0 2071357 Maybridge1_003921 COc1nc-2c(Cc3ccccc32)c(c4cccs4)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K06 compound treatment 1.0022 0.00466 0.09 0.0905 1.0 2071358 Maybridge1_003922 Nc1cc(nc(N)n1)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K07 compound treatment 1.0094 0.0118 0.23 0.2286 1.0 1317778 Maybridge1_003923 CCOC(=O)C1=C(C)NC(=S)N(C1c2cccs2)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K08 compound treatment 1.0215 0.0239 0.46 0.4634 1.0 2071327 Maybridge1_003924 COC(=O)c1cscc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K09 compound treatment 1.0954 0.0978 1.9 1.9001 1.0 2071359 Maybridge1_003925 N#C/C(=C\c1cccs1)/c2nc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K10 compound treatment 0.9717 -0.0259 -0.5 -0.5035 -1.0 2071360 Maybridge1_003926 CCOC(=O)c1cnn(c1C(F)(F)F)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K11 compound treatment 0.9937 -0.00388 -0.08 -0.0753 -1.0 2071361 Maybridge1_003927 FC(F)(F)c1cccc(c1)C(=O)ON=C2C3CC4CC(C3)CC2C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K12 compound treatment 1.0015 0.00395 0.08 0.0766 1.0 2071362 Maybridge1_003928 CCOC(=O)c1cnn(c1C(F)(F)F)c2ccc(N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K13 compound treatment 0.9802 -0.0174 -0.34 -0.3378 -1.0 2071363 Maybridge1_003929 CCOC(=O)CN(C(=O)c1ccccc1[N+](=O)[O-])C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K14 compound treatment 0.9951 -0.00246 -0.05 -0.0477 -1.0 2071364 Maybridge1_003930 COC(=O)c1scc(Br)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K15 compound treatment 1.0357 0.0381 0.74 0.7397 1.0 1075012 Maybridge1_003931 Cc1csc(N)c1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K16 compound treatment 0.9581 -0.0394 -0.77 -0.766 -1.0 1734344 Maybridge1_003932 OC(=O)c1ccccc1C(=O)Nc2sc3CCCCc3c2C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K17 compound treatment 1.2114 0.214 4.15 4.1517 1.0 2071365 Maybridge1_003933 NC1=C(C(C(=C2Sc3ccccc3N21)C#N)c4ccc(C#N)cc4)c5nc6ccccc6s5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K18 compound treatment 0.9852 -0.0124 -0.24 -0.2411 -1.0 1160325 Maybridge1_003934 Cc1ccc(C)n1c2sccc2C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K19 compound treatment 1.0215 0.0239 0.46 0.4634 1.0 1634867 Maybridge1_003935 COC(=O)c1sc(cc1N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K20 compound treatment 1.0101 0.0125 0.24 0.2424 1.0 2071366 Maybridge1_003936 COC(=O)c1sc(cc1N)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K21 compound treatment 1.0115 0.0139 0.27 0.27 1.0 1701180 Maybridge1_003937 COc1ccc(cc1)c2cc(N)c(s2)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K22 compound treatment 0.9909 -0.00672 -0.13 -0.1306 -1.0 2071367 Maybridge1_003938 COC(=O)c1sccc1Oc2ccc(cc2NC(=O)NS(=O)(=O)c3ccc(C)cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K23 mock treatment 1.0136 0.016 0.31 0.3115 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 K24 mock treatment 1.0122 0.0146 0.28 0.2838 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L01 compound treatment 1.0101 0.0125 0.24 0.2424 1.0 1674796 Maybridge1_003939 COC(=O)c1cc(OC)c(OC)cc1NC(=O)Nc2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L02 compound treatment 1.0392 0.0416 0.81 0.8088 1.0 2071368 Maybridge1_003940 COc1ccc(/C=N/NC(=O)c2cnn(c2C(F)(F)F)c3ccc(cc3)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L03 compound treatment 1.0407 0.0431 0.84 0.8364 1.0 1370879 Maybridge1_003941 COC(=O)c1cc(OC)c(OC)cc1n2c(C)ccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L04 compound treatment 0.9766 -0.0209 -0.41 -0.4068 -1.0 2071369 Maybridge1_003942 Cc1ccc(/C=N/c2ccc(C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L05 compound treatment 1.0101 0.0125 0.24 0.2424 1.0 2071370 Maybridge1_003943 Cc1cc(C)c(NC(=S)NCc2ccco2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L06 compound treatment 0.9788 -0.0188 -0.37 -0.3654 -1.0 2071371 Maybridge1_003944 COC(=O)c1csc2c(cc(nc12)N3CCN(CC3)C(=O)c4cccs4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L07 compound treatment 0.9852 -0.0124 -0.24 -0.2411 -1.0 2071372 Maybridge1_003945 Cn1nccc1NC(=O)Nc2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L08 compound treatment 1.003 0.00537 0.1 0.1043 1.0 2071373 Maybridge1_003946 Fc1cc(Br)c(F)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L09 compound treatment 0.998 3.9E-4 0.01 0.0076 1.0 1398582 Maybridge1_003947 Cn1nccc1NS(=O)(=O)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L10 compound treatment 0.9909 -0.00672 -0.13 -0.1306 -1.0 1537015 Maybridge1_003948 C1CN(CCN1)c2nc(ns2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L11 compound treatment 0.9766 -0.0209 -0.41 -0.4068 -1.0 1723996 Maybridge1_003949 CC(C)Nc1ncnc2sc3CCCCc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L12 compound treatment 1.0022 0.00466 0.09 0.0905 1.0 2071374 Maybridge1_003950 Cc1ccc(cc1)C(=O)C(O)(O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L13 compound treatment 0.9973 -3.21E-4 -0.01 -0.0062 -1.0 1530996 Maybridge1_003951 COc1ccc(cc1)S(=O)(=O)Nc2ccnn2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L14 compound treatment 1.0222 0.0246 0.48 0.4772 1.0 2071375 Maybridge1_003952 [O-][N+](=O)c1cccc(c1)C(=O)NC(=S)Nc2cccc(Cl)c2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L15 compound treatment 1.0086 0.0111 0.21 0.2148 1.0 1661227 Maybridge1_003953 CC(C)(C)c1ccc(cc1)c2cc(N)c(s2)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L16 compound treatment 1.0008 0.00324 0.06 0.0628 1.0 1680767 Maybridge1_003954 CC(C)c1ccc(NC(=S)NC2CC3CC2C4C=CCC34)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L17 compound treatment 0.9717 -0.0259 -0.5 -0.5035 -1.0 1594290 Maybridge1_003955 Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L18 compound treatment 0.9887 -0.00886 -0.17 -0.172 -1.0 2071376 Maybridge1_003956 CC(C)c1ccc(NC(=O)CN2CCN(CC2)c3ccc(cn3)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L19 compound treatment 0.988 -0.00957 -0.19 -0.1858 -1.0 1728790 Maybridge1_003957 COC(=O)c1cc(OC)c(OC)cc1NC(=O)CSc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L20 compound treatment 0.983 -0.0145 -0.28 -0.2825 -1.0 2071377 Maybridge1_003958 Cc1onc(c1C(=O)NCc2nc(no2)c3ccc(cc3)C(F)(F)F)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L21 compound treatment 0.993 -0.00459 -0.09 -0.0891 -1.0 2071378 Maybridge1_003959 Cc1ccc(cc1)C(=O)NNc2ncnc3cc(sc23)c4ccc(cc4)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L22 compound treatment 0.9916 -0.00601 -0.12 -0.1167 -1.0 1122099 Maybridge1_003960 OCCN1CCN(CN2C(=O)C3(OCCO3)c4ccccc24)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L23 mock treatment 0.983 -0.0145 -0.28 -0.2825 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 L24 mock treatment 1.0563 0.0587 1.14 1.1403 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M01 compound treatment 1.0584 0.0609 1.18 1.1817 1.0 2071379 Maybridge1_003961 CS/C(=N/C(=O)c1c(Cl)cccc1Cl)/NCCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M02 compound treatment 1.015 0.0175 0.34 0.3391 1.0 2071380 Maybridge1_003962 Cc1csc(C(=O)NN)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M03 compound treatment 1.0186 0.021 0.41 0.4082 1.0 1636017 Maybridge1_003963 COC(=O)CCNc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M04 compound treatment 0.9731 -0.0245 -0.48 -0.4759 -1.0 2071381 Maybridge1_003964 CCCc1c(cnn1c2ccc(Cl)cc2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M05 compound treatment 1.0407 0.0431 0.84 0.8364 1.0 2071382 Maybridge1_003965 CC(C)(C)c1cc(/C=C/2\Cc3ccccc3C2=O)cc(c1O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M06 compound treatment 0.9702 -0.0274 -0.53 -0.5312 -1.0 2071383 Maybridge1_003966 CCOC(=O)c1c[nH]c(=O)nc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M07 compound treatment 1.0399 0.0424 0.82 0.8226 1.0 2071384 Maybridge1_003967 NC1=C(C#N)C(C(C#N)C#N)c2cc(Cl)ccc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M08 compound treatment 0.9923 -0.0053 -0.1 -0.1029 -1.0 2071385 Maybridge1_003968 CC(=O)c1sc(cc1N)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M09 compound treatment 1.0207 0.0232 0.45 0.4496 1.0 2071386 Maybridge1_003969 COC(=O)C(C#N)C1C(=C(N)Oc2ccccc12)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M10 compound treatment 0.9866 -0.011 -0.21 -0.2134 -1.0 2071387 Maybridge1_003970 OC(=O)c1cnn(c1C(F)(F)F)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M11 compound treatment 0.961 -0.0366 -0.71 -0.7107 -1.0 2071388 Maybridge1_003971 Cc1onc(c1C(=O)ON=C2C3CC4CC(C3)CC2C4)c5ccccc5Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M12 compound treatment 0.9958 -0.00174 -0.03 -0.0339 -1.0 2071389 Maybridge1_003972 CCCc1c(cnn1c2ccc(cc2)[N+](=O)[O-])C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M13 compound treatment 0.9852 -0.0124 -0.24 -0.2411 -1.0 1130128 Maybridge1_003973 Clc1ccc(c(Cl)c1)c2cc3C(=O)c4ccccc4-c3nn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M14 compound treatment 0.951 -0.0466 -0.9 -0.9041 -1.0 2071390 Maybridge1_003974 CC(C)(C)c1cc(N)c(C#N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M15 compound treatment 1.0101 0.0125 0.24 0.2424 1.0 1355900 Maybridge1_003975 COC(=O)c1sccc1NC(=O)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M16 compound treatment 0.9973 -3.21E-4 -0.01 -0.0062 -1.0 3177423 Maybridge1_003976 Cc1ccc(cc1)S(=O)(=O)O.N[C@@H](CC(=O)OCc1ccccc1)C(=O)OCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M17 compound treatment 1.0101 0.0125 0.24 0.2424 1.0 2071392 Maybridge1_003977 COC(=O)c1sc(cc1N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M18 compound treatment 0.9745 -0.0231 -0.45 -0.4483 -1.0 2071393 Maybridge1_003978 C/C(=N\O)/C(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M19 compound treatment 1.0421 0.0445 0.86 0.864 1.0 2071394 Maybridge1_003979 CCOC(=O)c1c[nH]nc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M20 compound treatment 0.956 -0.0416 -0.81 -0.8074 -1.0 1358367 Maybridge1_003980 NS(=O)(=O)c1cccc(C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M21 compound treatment 0.9909 -0.00672 -0.13 -0.1306 -1.0 2071395 Maybridge1_003981 CNNC(=O)Cc1ccc(OC)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M22 compound treatment 0.9475 -0.0501 -0.97 -0.9732 -1.0 2071396 Maybridge1_003982 COC(=O)c1cc(OC)c(OC)cc1NS(=O)(=O)c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M23 mock treatment 0.983 -0.0145 -0.28 -0.2825 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 M24 mock treatment 1.0399 0.0424 0.82 0.8226 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N01 compound treatment 1.0079 0.0103 0.2 0.201 1.0 2071397 Maybridge1_003983 Cn1nccc1NC(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N02 compound treatment 1.0271 0.0296 0.57 0.5739 1.0 2071398 Maybridge1_003984 [O-][N+](=O)c1ccc(cc1)n2ncc(C(=O)N/N=C/c3ccc(C#N)cc3)c2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N03 compound treatment 1.025 0.0274 0.53 0.5325 1.0 1532326 Maybridge1_003985 Cc1ccc(C)n1c2sc3CCCCc3c2C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N04 compound treatment 1.0136 0.016 0.31 0.3115 1.0 2071399 Maybridge1_003986 CNC(=S)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N05 compound treatment 1.0037 0.00608 0.12 0.1181 1.0 2071400 Maybridge1_003987 NC(=S)NCc1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N06 compound treatment 0.9994 0.00181 0.04 0.0352 1.0 2071401 Maybridge1_003988 COC(=O)c1csc2c(cc(nc12)N3CCN(CC3)C(=O)c4ccco4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N07 compound treatment 0.9653 -0.0323 -0.63 -0.6279 -1.0 1669792 Maybridge1_003989 COC(=O)c1cc(OC)c(OC)cc1NC(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N08 compound treatment 0.9752 -0.0224 -0.43 -0.4345 -1.0 1239102 Maybridge1_003990 OC(=O)C(Cc1ccccc1)NC(=O)c2ccc(cc2)C(=O)NC(Cc3ccccc3)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N09 compound treatment 0.9795 -0.0181 -0.35 -0.3516 -1.0 1681140 Maybridge1_003991 Cc1c(Cl)cccc1S(=O)(=O)Nc2ccnn2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N10 compound treatment 0.9752 -0.0224 -0.43 -0.4345 -1.0 1531989 Maybridge1_003992 OC(=O)CSCC(=O)N1CCN(CC1)c2nc(ns2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N11 compound treatment 1.003 0.00537 0.1 0.1043 1.0 1552824 Maybridge1_003993 COC(=O)c1ccccc1NC(=O)c2c(F)cccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N12 compound treatment 0.9987 0.0011 0.02 0.0214 1.0 1634253 Maybridge1_003994 CCOC(=O)c1ccc(NC(=S)NCCc2ccc(OC)c(OC)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N13 compound treatment 0.9624 -0.0352 -0.68 -0.6831 -1.0 1325092 Maybridge1_003995 COC(=O)c1cc(OC)c(OC)cc1NC(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N14 compound treatment 0.9916 -0.00601 -0.12 -0.1167 -1.0 1305504 Maybridge1_003996 COc1ccc(CCNC(=S)NC2CC3CC2C=C3)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N15 compound treatment 0.9731 -0.0245 -0.48 -0.4759 -1.0 1295871 Maybridge1_003997 Cc1cc(NS(=O)(=O)c2ccc(NC(=O)Nc3cc(C)cc(C)c3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N16 compound treatment 1.0129 0.0153 0.3 0.2977 1.0 2071402 Maybridge1_003998 Clc1ccc(cc1)c2nc(cs2)c3ccc(Br)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N17 compound treatment 0.9823 -0.0153 -0.3 -0.2963 -1.0 1660249 Maybridge1_003999 Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N18 compound treatment 0.9453 -0.0522 -1.01 -1.0146 -1.0 2071403 Maybridge1_004000 FC(F)(F)Oc1ccc(NC(=O)CN2CCN(CC2)c3ccc(cn3)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N19 compound treatment 0.998 3.9E-4 0.01 0.0076 1.0 331 Maybridge1_004001 COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N20 compound treatment 0.9802 -0.0174 -0.34 -0.3378 -1.0 1381468 Maybridge1_004002 CC(C)(CC(=O)O)CC(=O)Nc1ccc2OCCCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N21 compound treatment 0.9937 -0.00388 -0.08 -0.0753 -1.0 1577705 Maybridge1_004003 CC(C)(C)c1cc2ncnc(N3CCOCC3)c2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N22 compound treatment 0.9795 -0.0181 -0.35 -0.3516 -1.0 2071404 Maybridge1_004004 COc1ccc(cc1)c2ccnc(SCC(=O)Nc3ccccc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N23 mock treatment 0.9795 -0.0181 -0.35 -0.3516 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 N24 mock treatment 1.0357 0.0381 0.74 0.7397 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O01 compound treatment 1.0328 0.0352 0.68 0.6844 1.0 2071405 Maybridge1_004005 CSC(=C(C#N)c1ccccc1)SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O02 compound treatment 0.9866 -0.011 -0.21 -0.2134 -1.0 2071406 Maybridge1_004006 OC(=O)c1sccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O03 compound treatment 0.9994 0.00181 0.04 0.0352 1.0 2071407 Maybridge1_004007 C/C(=N\O)/C=C/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O04 compound treatment 0.9781 -0.0195 -0.38 -0.3792 -1.0 2071408 Maybridge1_004008 OC(=O)c1cnn(c1C(F)(F)F)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O05 compound treatment 1.0143 0.0168 0.33 0.3253 1.0 2071409 Maybridge1_004009 [O-][N+](=O)c1ccc(OC(=O)OC2(CC3CC4CC(C3)C2)C4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O06 compound treatment 0.9702 -0.0274 -0.53 -0.5312 -1.0 2071410 Maybridge1_004010 CC(C)(C)c1cc(N)nc(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O07 compound treatment 1.0421 0.0445 0.86 0.864 1.0 2071411 Maybridge1_004011 NC1=C(C#N)C(C(C#N)C#N)c2cc(Br)ccc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O08 compound treatment 0.9894 -0.00815 -0.16 -0.1582 -1.0 2071412 Maybridge1_004012 COC(=O)c1scc(Br)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O09 compound treatment 1.0328 0.0352 0.68 0.6844 1.0 2071413 Maybridge1_004013 CCOC(=O)C(C#N)C1C(=C(N)Oc2ccccc12)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O10 compound treatment 0.9624 -0.0352 -0.68 -0.6831 -1.0 1117875 Maybridge1_004014 COC(=O)c1sc(cc1N)c2ccc(CC(C)C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O11 compound treatment 1.0143 0.0168 0.33 0.3253 1.0 2071414 Maybridge1_004015 CC/1=C2CCCC2CC\C1=N/NC(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O12 compound treatment 0.9894 -0.00815 -0.16 -0.1582 -1.0 2071415 Maybridge1_004016 CC(=O)c1sccc1NC(=O)c2ccccc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O13 compound treatment 0.9937 -0.00388 -0.08 -0.0753 -1.0 2071416 Maybridge1_004017 COC(=O)c1sccc1NC(=S)Nc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O14 compound treatment 0.9987 0.0011 0.02 0.0214 1.0 2071417 Maybridge1_004018 Clc1ccc(Cc2nn[nH]n2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O15 compound treatment 0.9937 -0.00388 -0.08 -0.0753 -1.0 1415121 Maybridge1_004019 COC(=O)c1sccc1NC(=O)c2c(F)cccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O16 compound treatment 0.9944 -0.00317 -0.06 -0.0615 -1.0 2071418 Maybridge1_004020 COC(=O)c1sccc1NC(=S)Nc2ccsc2C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O17 compound treatment 0.9845 -0.0131 -0.25 -0.2549 -1.0 2071419 Maybridge1_004021 NNC(=O)c1sccc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O18 compound treatment 0.9624 -0.0352 -0.68 -0.6831 -1.0 2071420 Maybridge1_004022 [O-][N+](=O)c1ccc(cc1)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O19 compound treatment 1.0435 0.0459 0.89 0.8917 1.0 2071421 Maybridge1_004023 FC(F)(F)c1cc(NC(=O)N/C=C/c2ccco2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O20 compound treatment 1.0136 0.016 0.31 0.3115 1.0 2071422 Maybridge1_004024 Cc1c(sc2cc(sc12)C(C)(C)C)C(=O)O/N=C/c3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O21 compound treatment 0.9795 -0.0181 -0.35 -0.3516 -1.0 2071423 Maybridge1_004025 Nc1cc(nc(N)n1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O22 compound treatment 0.9795 -0.0181 -0.35 -0.3516 -1.0 1637926 Maybridge1_004026 COC(=O)c1cc(OC)c(OC)cc1NS(=O)(=O)c2ccc(OC)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O23 mock treatment 1.02 0.0224 0.44 0.4358 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 O24 mock treatment 0.993 -0.00459 -0.09 -0.0891 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P01 compound treatment 1.003 0.00537 0.1 0.1043 1.0 2071424 Maybridge1_004027 CCOC(=O)CN(C)S(=O)(=O)c1ccsc1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P02 compound treatment 1.0663 0.0687 1.33 1.3337 1.0 2071425 Maybridge1_004028 Cc1nc(Cc2ccc(cc2)[N+](=O)[O-])no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P03 compound treatment 1.0215 0.0239 0.46 0.4634 1.0 1678568 Maybridge1_004029 COC(=O)CSc1ncnc2cc(OC)c(OC)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P04 compound treatment 1.0001 0.00252 0.05 0.049 1.0 2071426 Maybridge1_004030 Nc1cc(O)nc(SCc2c(Cl)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P05 compound treatment 0.9944 -0.00317 -0.06 -0.0615 -1.0 2071427 Maybridge1_004031 Nc1ncnc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P06 compound treatment 1.0065 0.00893 0.17 0.1733 1.0 2071428 Maybridge1_004032 COC(=O)c1csc2c(cc(nc12)N3CCN(CC3)C(=O)c4cc(Cl)cc(Cl)c4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P07 compound treatment 0.9695 -0.0281 -0.54 -0.545 -1.0 1607107 Maybridge1_004033 CCCc1c(cnn1c2ccccc2)C(=O)Nc3ccnn3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P08 compound treatment 1.0527 0.0552 1.07 1.0712 1.0 2071429 Maybridge1_004034 Fc1cc(NC(=O)NC(=O)c2c(Cl)cccc2Cl)c(F)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P09 compound treatment 1.0022 0.00466 0.09 0.0905 1.0 2071430 Maybridge1_004035 Cn1nccc1NC(=O)C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P10 compound treatment 1.0371 0.0395 0.77 0.7673 1.0 2071431 Maybridge1_004036 COC(=O)c1ccccc1CSc2nccc(n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P11 compound treatment 1.0044 0.00679 0.13 0.1319 1.0 1214297 Maybridge1_004037 COC(=O)c1ccccc1NC(=O)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P12 compound treatment 0.9866 -0.011 -0.21 -0.2134 -1.0 1335445 Maybridge1_004038 COc1ccc(CCNC(=S)Nc2ccc(C)cc2C)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P13 compound treatment 1.0022 0.00466 0.09 0.0905 1.0 1232563 Maybridge1_004039 COC(=O)c1cc(OC)c(OC)cc1NC(=O)c2ccccc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P14 compound treatment 1.0172 0.0196 0.38 0.3805 1.0 1130038 Maybridge1_004040 S=C(NC1CC2CC1C=C2)NC3CCCCCCCCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P15 compound treatment 0.988 -0.00957 -0.19 -0.1858 -1.0 2071432 Maybridge1_004041 Cn1ncc(Br)c1NC(=O)Nc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P16 compound treatment 1.0044 0.00679 0.13 0.1319 1.0 2071433 Maybridge1_004042 [O-][N+](=O)c1ccc(cc1)c2csc(n2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P17 compound treatment 0.9788 -0.0188 -0.37 -0.3654 -1.0 1213717 Maybridge1_004043 Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3cccs3)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P18 compound treatment 1.0108 0.0132 0.26 0.2562 1.0 2071434 Maybridge1_004044 [O-][N+](=O)c1ccc(nc1)N2CCN(CC(=O)Nc3ccc4OCOc4c3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P19 compound treatment 0.9709 -0.0266 -0.52 -0.5173 -1.0 1179493 Maybridge1_004045 COc1cc2ncnc(Nc3ccc(F)c(F)c3)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P20 compound treatment 0.9923 -0.0053 -0.1 -0.1029 -1.0 2071435 Maybridge1_004046 COC(=O)c1sccc1NC(=O)CSCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P21 compound treatment 0.9581 -0.0394 -0.77 -0.766 -1.0 2071436 Maybridge1_004047 Cn1ncc(C(=O)O/N=C/c2ccc(Cl)cc2Cl)c1n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P22 compound treatment 0.9809 -0.0167 -0.32 -0.324 -1.0 1264484 Maybridge1_004048 CCOC(=O)C1C(CC(=CC1=O)c2cccs2)c3ccc(OC)c(OC)c3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P23 mock treatment 0.9944 -0.00317 -0.06 -0.0615 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.552 P24 mock treatment 0.9966 -0.00103 -0.02 -0.0201 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A01 mock treatment 1.0631 0.0333 0.65 0.646 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A02 mock treatment 1.0423 0.0125 0.24 0.2431 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A03 compound treatment 1.0488 0.019 0.37 0.3682 1.0 2071437 Maybridge1_004049 ClC(Cl)(Cl)C(=O)Nc1c(Br)c(nn1c2ccccc2)C3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A04 compound treatment 1.0094 -0.0204 -0.4 -0.396 -1.0 1036161 Maybridge1_004050 Clc1ccc(C=C2c3ccccc3-c4ccccc24)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A05 compound treatment 1.028 -0.00179 -0.03 -0.0347 -1.0 2071438 Maybridge1_004051 Cc1ccc(cc1)S(=O)(=O)CCSc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A06 compound treatment 1.0059 -0.024 -0.47 -0.4654 -1.0 2071439 Maybridge1_004052 CCCc1cc(O)nc(SCc2ccccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A07 compound treatment 0.993 -0.0368 -0.72 -0.7155 -1.0 1618329 Maybridge1_004053 Cc1cc2[nH]c(cc(=O)n2n1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A08 compound treatment 1.0152 -0.0147 -0.28 -0.2848 -1.0 2071440 Maybridge1_004054 Cn1nc(nc1O)c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A09 compound treatment 1.0209 -0.00894 -0.17 -0.1737 -1.0 2071441 Maybridge1_004055 Cc1cc(NC(=O)Nc2ccccc2)n(n1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A10 compound treatment 0.983 -0.0469 -0.91 -0.91 -1.0 2071442 Maybridge1_004056 COC(=O)c1ccc(Oc2cc(Cl)cc(Cl)c2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A11 compound treatment 0.9851 -0.0447 -0.87 -0.8683 -1.0 2071443 Maybridge1_004057 CNC(=O)Nc1cc(C)nn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A12 compound treatment 0.9744 -0.0554 -1.08 -1.0767 -1.0 2071444 Maybridge1_004058 CS/C(=N\C#N)/Nc1cccc(SC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A13 compound treatment 0.9923 -0.0376 -0.73 -0.7294 -1.0 2071445 Maybridge1_004059 OCc1ccccc1C(=O)N/N=C/c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A14 compound treatment 0.9837 -0.0461 -0.9 -0.8961 -1.0 1006104 Maybridge1_004060 Cc1cc(=O)oc2cc(O)cc(O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A15 compound treatment 1.0373 0.00751 0.15 0.1459 1.0 2071446 Maybridge1_004061 Fc1ccc(NC(=S)N(CCC#N)Cc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A16 compound treatment 1.0016 -0.0283 -0.55 -0.5488 -1.0 1043641 Maybridge1_004062 CCCCCCCOc1ccc(cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A17 compound treatment 0.9937 -0.0361 -0.7 -0.7016 -1.0 1282423 Maybridge1_004063 CSc1cccc(NC2OC(=O)c3ccccc23)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A18 compound treatment 1.0087 -0.0211 -0.41 -0.4098 -1.0 1931114 Maybridge1_004064 [O-][N+](=O)c1ccc(cc1)c2ccc(I)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A19 compound treatment 1.0051 -0.0247 -0.48 -0.4793 -1.0 1159824 Maybridge1_004065 CCOC(=O)c1ccc(N2CCOCC2)c(NS(=O)(=O)c3ccc(F)cc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A20 compound treatment 1.0903 0.0605 1.17 1.174 1.0 1557241 Maybridge1_004066 CCn1c(O)cc(C)c(C#N)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A21 compound treatment 1.0295 -3.58E-4 -0.01 -0.0069 -1.0 1374202 Maybridge1_004067 CCOC(=O)c1ccc(N2CCOCC2)c(N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A22 compound treatment 1.0023 -0.0275 -0.53 -0.5349 -1.0 1100255 Maybridge1_004068 Clc1ccc(C2NC(=O)Cc3ccccc23)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A23 compound treatment 1.0159 -0.014 -0.27 -0.2709 -1.0 1526172 Maybridge1_004069 O=C1OC(Nc2ccccc2SCc3ccc(C#N)cc3)c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 A24 compound treatment 0.9887 -0.0411 -0.8 -0.7989 -1.0 2071447 Maybridge1_004070 Sc1nnc(SCCSc2nnc(S)s2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B01 mock treatment 1.0266 -0.00322 -0.06 -0.0625 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B02 mock treatment 1.0159 -0.014 -0.27 -0.2709 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B03 compound treatment 1.0159 -0.014 -0.27 -0.2709 -1.0 1069883 Maybridge1_004071 CS(=O)(=O)OC1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B04 compound treatment 1.0338 0.00393 0.08 0.0764 1.0 1103910 Maybridge1_004072 COc1ccc(O)c(c1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B05 compound treatment 1.0016 -0.0283 -0.55 -0.5488 -1.0 2071448 Maybridge1_004073 COc1cccc2c(OC(=O)C)coc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B06 compound treatment 0.9572 -0.0726 -1.41 -1.4101 -1.0 2071449 Maybridge1_004074 CCO[C@@H]1O[C@H](COC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B07 compound treatment 1.0402 0.0104 0.2 0.2014 1.0 2071450 Maybridge1_004075 [O-][N+](=O)c1ccc(cc1)C(=O)O/N=C/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B08 compound treatment 1.0159 -0.014 -0.27 -0.2709 -1.0 1611061 Maybridge1_004076 CC(C)C(=O)Nc1ncnc2[nH]cnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B09 compound treatment 0.9958 -0.034 -0.66 -0.6599 -1.0 1145454 Maybridge1_004077 Cc1ccc(cc1)S(=O)(=O)N2CCC(CC2)NC(=O)Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B10 compound treatment 0.9937 -0.0361 -0.7 -0.7016 -1.0 2071451 Maybridge1_004078 C(=C/c1ccncc1)\c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B11 compound treatment 0.9815 -0.0483 -0.94 -0.9378 -1.0 2071452 Maybridge1_004079 O=C1CC23CC(=O)CC3(C1)CCCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B12 compound treatment 0.9715 -0.0583 -1.13 -1.1323 -1.0 1651448 Maybridge1_004080 COc1ccc(cc1)c2cc(C(=O)O)c3ccc(C)cc3n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B13 compound treatment 0.9873 -0.0426 -0.83 -0.8266 -1.0 2071453 Maybridge1_004081 Nc1c(Oc2ccccc2)cc(O)c3C(=O)c4ccccc4C(=O)c13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B14 compound treatment 1.0144 -0.0154 -0.3 -0.2987 -1.0 1287428 Maybridge1_004082 COc1cc2CCN(C(C)c2cc1OC)C(=O)c3ccc(s3)c4ccccn4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B15 compound treatment 0.998 -0.0318 -0.62 -0.6182 -1.0 2071454 Maybridge1_004083 CN1CC(=O)N=C1NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B16 compound treatment 1.0094 -0.0204 -0.4 -0.396 -1.0 1639300 Maybridge1_004084 O=C(NCc1ccc2OCOc2c1)NC3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B17 compound treatment 0.9594 -0.0705 -1.37 -1.3685 -1.0 1269668 Maybridge1_004085 COc1ccccc1N2CCN(CC2)C(=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B18 compound treatment 1.003 -0.0268 -0.52 -0.521 -1.0 2071455 Maybridge1_004086 Cc1cc(C)c(c(C)c1)n2nnnc2SCC(=O)Nc3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B19 compound treatment 0.9744 -0.0554 -1.08 -1.0767 -1.0 2071456 Maybridge1_004087 Cn1c2CCC/C(=N\OC(=O)C3CCCCC3)/c2c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B20 compound treatment 0.9822 -0.0476 -0.92 -0.9239 -1.0 2071457 Maybridge1_004088 Cc1cc(nn1C(C)(C)C)C(=O)NNC(=O)C2CCN(CC2)c3nccc(n3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B21 compound treatment 0.9601 -0.0698 -1.35 -1.3546 -1.0 1010925 Maybridge1_004089 Sc1nc2ccccc2nc1S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B22 compound treatment 1.0044 -0.0254 -0.49 -0.4932 -1.0 1460321 Maybridge1_004090 COC(=O)c1ccc(n1C)S(=O)(=O)N2CCCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B23 compound treatment 0.9751 -0.0547 -1.06 -1.0628 -1.0 1196658 Maybridge1_004091 ON=C1CCN(Cc2ccccc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 B24 compound treatment 1.0016 -0.0283 -0.55 -0.5488 -1.0 1230437 Maybridge1_004092 OC(CSc1ccccc1)CN2CCN(CC2)C(c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C01 mock treatment 1.0688 0.039 0.76 0.7572 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C02 mock treatment 0.9873 -0.0426 -0.83 -0.8266 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C03 compound treatment 1.0466 0.0168 0.33 0.3265 1.0 1637319 Maybridge1_004093 CC(C)(C)C(=O)Nc1cc(nn1c2ccccc2)C3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C04 compound treatment 1.0109 -0.019 -0.37 -0.3682 -1.0 2071458 Maybridge1_004094 O/N=C(/c1ccccc1)\c2ccccc2\N=C\c3cc(Cl)cc(Cl)c3O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C05 compound treatment 1.0266 -0.00322 -0.06 -0.0625 -1.0 2071459 Maybridge1_004095 Cc1ccc(cc1)S(=O)(=O)CCSc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C06 compound treatment 0.9915 -0.0383 -0.74 -0.7433 -1.0 2071460 Maybridge1_004096 Nc1ncnc(SCc2c(F)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C07 compound treatment 1.0051 -0.0247 -0.48 -0.4793 -1.0 2071461 Maybridge1_004097 Nc1cc(n[nH]1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C08 compound treatment 1.0259 -0.00393 -0.08 -0.0764 -1.0 2071462 Maybridge1_004098 CNC(=O)NNC(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C09 compound treatment 1.0137 -0.0161 -0.31 -0.3126 -1.0 2071463 Maybridge1_004099 Cc1cc(NC(=O)C(C)(C)C)n(C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C10 compound treatment 0.9365 -0.0934 -1.81 -1.813 -1.0 1569859 Maybridge1_004100 CC(C)c1ccc(Nc2cc(O)nn2C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C11 compound treatment 1.0059 -0.024 -0.47 -0.4654 -1.0 2071464 Maybridge1_004101 Cc1cc(NC(=O)c2ccccc2)n(C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C12 compound treatment 0.9751 -0.0547 -1.06 -1.0628 -1.0 2071465 Maybridge1_004102 CN(C)/C=N/S(=O)(=O)c1ccc(C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C13 compound treatment 1.0023 -0.0275 -0.53 -0.5349 -1.0 2071466 Maybridge1_004103 COc1ccc(cc1)C(=O)NNC(=O)C2C(C3CC2C=C3)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C14 compound treatment 0.9679 -0.0619 -1.2 -1.2017 -1.0 1005598 Maybridge1_004104 CC[n+]1c(C)ccc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C15 compound treatment 0.9787 -0.0512 -0.99 -0.9934 -1.0 2071467 Maybridge1_004105 C/C(=N/NC(=O)N)/c1ccc(Sc2ccc(Cl)cc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C16 compound treatment 0.9515 -0.0783 -1.52 -1.5213 -1.0 1011181 Maybridge1_004106 c1ccc2c(c1)ccc3ncccc32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C17 compound treatment 0.9958 -0.034 -0.66 -0.6599 -1.0 1703659 Maybridge1_004107 COc1cc2CCN=C(c3ccccc3NC(=O)c4ccc(F)cc4)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C18 compound treatment 0.9672 -0.0626 -1.22 -1.2156 -1.0 1009943 Maybridge1_004108 O=C(Nc1cccc2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C19 compound treatment 1.0209 -0.00894 -0.17 -0.1737 -1.0 1418039 Maybridge1_004109 CCOC(=O)c1ccc(N2CCOCC2)c(NC(=O)c3c(C)onc3c4c(Cl)cccc4Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C20 compound treatment 0.9944 -0.0354 -0.69 -0.6877 -1.0 1153807 Maybridge1_004110 OC(CN1CCCC1)Cn2c3ccc(Cl)cc3c4cc(Cl)ccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C21 compound treatment 0.9772 -0.0526 -1.02 -1.0211 -1.0 2071468 Maybridge1_004111 CCOC(=O)c1ccc(N2CCOCC2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C22 compound treatment 0.9336 -0.0962 -1.87 -1.8686 -1.0 1373411 Maybridge1_004112 Clc1ccccc1C2NC(=O)Cc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C23 compound treatment 1.0059 -0.024 -0.47 -0.4654 -1.0 1111528 Maybridge1_004113 Nc1ccccc1Sc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 C24 compound treatment 0.9851 -0.0447 -0.87 -0.8683 -1.0 2071469 Maybridge1_004114 C(CSc1nnc[nH]1)Sc2nnc[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D01 mock treatment 1.0288 -0.00107 -0.02 -0.0208 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D02 mock treatment 0.9737 -0.0562 -1.09 -1.0906 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D03 compound treatment 1.0073 -0.0225 -0.44 -0.4376 -1.0 1090692 Maybridge1_004115 CC1(CC2(C)CC3(C)C1)CC(Br)(C2)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D04 compound treatment 1.0094 -0.0204 -0.4 -0.396 -1.0 2071470 Maybridge1_004116 Ic1cc(C#N)cc(I)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D05 compound treatment 1.003 -0.0268 -0.52 -0.521 -1.0 2071471 Maybridge1_004117 Cc1ccc(cc1)S(=O)(=O)OCC(C)(C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D06 compound treatment 1.0195 -0.0104 -0.2 -0.2014 -1.0 2071472 Maybridge1_004118 CC(=O)OC[C@H](OC(=O)C)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D07 compound treatment 0.9715 -0.0583 -1.13 -1.1323 -1.0 2071473 Maybridge1_004119 Brc1ccccc1C(=O)O/N=C/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D08 compound treatment 0.9987 -0.0311 -0.6 -0.6043 -1.0 2071474 Maybridge1_004120 CC(=O)O[C@@H]1CO[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D09 compound treatment 0.9851 -0.0447 -0.87 -0.8683 -1.0 2071475 Maybridge1_004121 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCC(CC2)NC(=O)Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D10 compound treatment 0.9844 -0.0454 -0.88 -0.8822 -1.0 1269639 Maybridge1_004122 CCC(=O)Nc1cccc2c(NC(=O)CC)cccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D11 compound treatment 1.0059 -0.024 -0.47 -0.4654 -1.0 1920748 Maybridge1_004123 CC(C)(C)c1cc(nc(N)n1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D12 compound treatment 1.003 -0.0268 -0.52 -0.521 -1.0 2071476 Maybridge1_004124 COc1ccc(Br)cc1/C=N/N=C\2/C(=O)Nc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D13 compound treatment 0.9615 -0.0683 -1.33 -1.3268 -1.0 2071477 Maybridge1_004125 CC(=O)C1C(=O)c2cccc([N+](=O)[O-])c2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D14 compound treatment 0.988 -0.0419 -0.81 -0.8127 -1.0 2071478 Maybridge1_004126 FC(F)(F)C1N(CCc2c1[nH]c3ccccc23)C(=O)CSc4nccc(n4)c5cccs5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D15 compound treatment 0.9286 -0.101 -1.97 -1.9659 -1.0 2071479 Maybridge1_004127 CCOC(=O)/C(=N/Nc1ccc(C)cc1C)/C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D16 compound treatment 0.9694 -0.0605 -1.17 -1.174 -1.0 1309532 Maybridge1_004128 Cc1ccc(NC(=O)Nc2ccc3COC(=O)c3c2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D17 compound treatment 0.9601 -0.0698 -1.35 -1.3546 -1.0 2071480 Maybridge1_004129 O=c1[nH]ccn1Cc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D18 compound treatment 0.9765 -0.0533 -1.04 -1.035 -1.0 2071481 Maybridge1_004130 OC(=O)CSCC(=O)Nc1ccc(Br)c(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D19 compound treatment 0.9844 -0.0454 -0.88 -0.8822 -1.0 2071482 Maybridge1_004131 Cn1c2CCC/C(=N\OC(=O)c3ccc(Cl)cc3Cl)/c2c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D20 compound treatment 0.993 -0.0368 -0.72 -0.7155 -1.0 2071483 Maybridge1_004132 COC(=O)c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)ccc1N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D21 compound treatment 0.9758 -0.054 -1.05 -1.0489 -1.0 1205234 Maybridge1_004133 CS(=O)(=O)c1ccc(C(=O)O)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D22 compound treatment 1.0051 -0.0247 -0.48 -0.4793 -1.0 1525016 Maybridge1_004134 OC(CSc1ccc(F)cc1)CN2CCN(CC2)C(c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D23 compound treatment 0.9458 -0.0841 -1.63 -1.6324 -1.0 2071484 Maybridge1_004135 CCOC(=O)/C(=N/Nc1ccccc1)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 D24 compound treatment 1.003 -0.0268 -0.52 -0.521 -1.0 2071485 Maybridge1_004136 CC(=O)c1ccc(OCC(O)CN2CCN(CC2)c3ccc(cn3)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E01 mock treatment 1.0559 0.0261 0.51 0.5071 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E02 mock treatment 1.0001 -0.0297 -0.58 -0.5766 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E03 compound treatment 1.0252 -0.00465 -0.09 -0.0903 -1.0 1157986 Maybridge1_004137 CCN(CCS(=O)(=O)c1ccc(C)cc1)S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E04 compound treatment 1.0016 -0.0283 -0.55 -0.5488 -1.0 2071486 Maybridge1_004138 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E05 compound treatment 0.978 -0.0519 -1.01 -1.0072 -1.0 1925341 Maybridge1_004139 Nc1cc(nn1c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E06 compound treatment 0.9851 -0.0447 -0.87 -0.8683 -1.0 2071487 Maybridge1_004140 Nc1ncnc(SCc2ccc(Cl)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E07 compound treatment 1.0152 -0.0147 -0.28 -0.2848 -1.0 2071488 Maybridge1_004141 Cc1cc2[nH]c(C)cc(=O)n2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E08 compound treatment 1.033 0.00322 0.06 0.0625 1.0 2071489 Maybridge1_004142 CNC(=O)NNC(=O)c1cccnc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E09 compound treatment 1.0101 -0.0197 -0.38 -0.3821 -1.0 1549660 Maybridge1_004143 CC1CCCCN1Cc2c(C)n(C)n(c3ccccc3)c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E10 compound treatment 1.0223 -0.00751 -0.15 -0.1459 -1.0 1568475 Maybridge1_004144 Cn1nc(O)cc1Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E11 compound treatment 0.9923 -0.0376 -0.73 -0.7294 -1.0 2071490 Maybridge1_004145 CCc1ccc(NC(=S)Nc2cc(C)cc(C)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E12 compound treatment 0.9551 -0.0748 -1.45 -1.4518 -1.0 1731945 Maybridge1_004146 COc1cc(CCC(C)N)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E13 compound treatment 1.0008 -0.029 -0.56 -0.5627 -1.0 2071491 Maybridge1_004147 OC(=O)C1C(C2CC1C=C2)C(=O)NNC(=O)CCc3ccc(O)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E14 compound treatment 0.9772 -0.0526 -1.02 -1.0211 -1.0 43143 Maybridge1_004148 O[C@@H](C(=O)O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E15 compound treatment 1.0395 0.00966 0.19 0.1876 1.0 2071492 Maybridge1_004149 COc1cc2CCC(=O)c2c(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E16 compound treatment 0.9837 -0.0461 -0.9 -0.8961 -1.0 1022845 Maybridge1_004150 CC(=O)Nc1ncc(s1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E17 compound treatment 1.0137 -0.0161 -0.31 -0.3126 -1.0 2071493 Maybridge1_004151 CC(=O)c1ccc(Sc2ccccc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E18 compound treatment 0.9729 -0.0569 -1.1 -1.1045 -1.0 1503681 Maybridge1_004152 OC(CN1CCCC1)Cn2c3ccccc3c4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E19 compound treatment 0.9558 -0.074 -1.44 -1.4379 -1.0 1399804 Maybridge1_004153 CCOC(=O)c1ccc(N2CCOCC2)c(NC(=O)c3c(C)onc3c4ccccc4)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E20 compound treatment 0.9658 -0.064 -1.24 -1.2434 -1.0 2071494 Maybridge1_004154 OC1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E21 compound treatment 0.9908 -0.039 -0.76 -0.7572 -1.0 2071495 Maybridge1_004155 [O-][N+](=O)c1ccc(NC2OC(=O)c3ccccc23)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E22 compound treatment 1.0123 -0.0175 -0.34 -0.3404 -1.0 1498806 Maybridge1_004156 Brc1ccc(cc1)C2NC(=O)Cc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E23 compound treatment 0.9751 -0.0547 -1.06 -1.0628 -1.0 2071496 Maybridge1_004157 Nc1ccccc1SCc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 E24 compound treatment 1.0116 -0.0182 -0.35 -0.3543 -1.0 1082377 Maybridge1_004158 CC1(O)C2CC3CC(C2)CC1C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F01 mock treatment 1.0209 -0.00894 -0.17 -0.1737 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F02 mock treatment 1.0159 -0.014 -0.27 -0.2709 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F03 compound treatment 1.0259 -0.00393 -0.08 -0.0764 -1.0 1462680 Maybridge1_004159 CC(=O)Oc1cc(CO)cc(OC(=O)C)c1OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F04 compound treatment 1.0381 0.00823 0.16 0.1598 1.0 1021543 Maybridge1_004160 Oc1cc(nc2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F05 compound treatment 1.008 -0.0218 -0.42 -0.4237 -1.0 2071497 Maybridge1_004161 O=C1c2cccc(Oc3ccccc3)c2C(=O)c4c(Oc5ccccc5)cccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F06 compound treatment 0.9651 -0.0647 -1.26 -1.2573 -1.0 2071498 Maybridge1_004162 CC(=O)OC[C@@H](OC(=O)C)C(O[C@@H]1O[C@H](COC(=O)C)[C@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C)[C@H](OC(=O)C)[C@@H](OC(=O)C)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F07 compound treatment 1.0373 0.00751 0.15 0.1459 1.0 2071499 Maybridge1_004163 Clc1ccc(cc1)C(=O)O/N=C/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F08 compound treatment 1.0338 0.00393 0.08 0.0764 1.0 2071500 Maybridge1_004164 CC(=O)O[C@H]1CO[C@@H](C#N)[C@H](OC(=O)C)[C@H]1OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F09 compound treatment 0.9822 -0.0476 -0.92 -0.9239 -1.0 1240231 Maybridge1_004165 Clc1ccc(cc1)S(=O)(=O)N2CCC(CC2)NC(=O)Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F10 compound treatment 1.0066 -0.0233 -0.45 -0.4515 -1.0 2071501 Maybridge1_004166 Cc1ccc(cc1)/C(=C/2\C=C(\Br)/C(=N/O)/C=C2/Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F11 compound treatment 0.945 -0.0848 -1.65 -1.6463 -1.0 1722183 Maybridge1_004167 C(N1CCOCC1)n2cnc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F12 compound treatment 1.008 -0.0218 -0.42 -0.4237 -1.0 2071502 Maybridge1_004168 Oc1c(Br)cc(Br)cc1/C=N/N=C\2/C(=O)Nc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F13 compound treatment 0.9851 -0.0447 -0.87 -0.8683 -1.0 1075384 Maybridge1_004169 O=C1C(C#N)C(=O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F14 compound treatment 1.0309 0.00107 0.02 0.0208 1.0 2071503 Maybridge1_004170 Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4cccc(Cl)c4)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F15 compound treatment 1.0016 -0.0283 -0.55 -0.5488 -1.0 2071504 Maybridge1_004171 CCOC(=O)/C(=N/Nc1ccc(OC)cc1)/C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F16 compound treatment 0.978 -0.0519 -1.01 -1.0072 -1.0 1030966 Maybridge1_004172 O=C(NCc1ccco1)Nc2cccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F17 compound treatment 1.0123 -0.0175 -0.34 -0.3404 -1.0 2071505 Maybridge1_004173 CC1[C@@H]([C@H]1C(=O)NN)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F18 compound treatment 0.9937 -0.0361 -0.7 -0.7016 -1.0 1204063 Maybridge1_004174 Cc1onc(c1C(=O)Nc2ccc3OCCOc3c2)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F19 compound treatment 1.013 -0.0168 -0.33 -0.3265 -1.0 2071506 Maybridge1_004175 Cn1c2CCC/C(=N\OC(=O)c3cccc(c3)C(F)(F)F)/c2c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F20 compound treatment 0.9601 -0.0698 -1.35 -1.3546 -1.0 2071507 Maybridge1_004176 Cc1c(sc2ccc(Cl)cc12)C(=O)CN3CCN(CC3)c4ccc(cn4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F21 compound treatment 0.9551 -0.0748 -1.45 -1.4518 -1.0 1019643 Maybridge1_004177 Clc1ccc2ocnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F22 compound treatment 0.9765 -0.0533 -1.04 -1.035 -1.0 2071508 Maybridge1_004178 Cc1cc(Cl)cc(Br)c1OCC(O)CN2CCN(CC2)c3ccc(cn3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F23 compound treatment 0.9493 -0.0805 -1.56 -1.563 -1.0 1046573 Maybridge1_004179 CCOC(=O)C(=CNc1ccccc1Cl)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 F24 compound treatment 1.013 -0.0168 -0.33 -0.3265 -1.0 2071509 Maybridge1_004180 CC(=O)c1ccc(OCC(O)CN2CCC(CC2)C(=O)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G01 mock treatment 1.0803 0.0504 0.98 0.9795 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G02 mock treatment 0.9915 -0.0383 -0.74 -0.7433 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G03 compound treatment 1.0273 -0.0025 -0.05 -0.0486 -1.0 2071510 Maybridge1_004181 N/C(=C(\NCc1cccc(Cl)c1)/C#N)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G04 compound treatment 1.0073 -0.0225 -0.44 -0.4376 -1.0 2071511 Maybridge1_004182 COc1cc(cc(OC)c1OC)C(=O)NNC(=O)c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G05 compound treatment 1.0302 3.58E-4 0.01 0.0069 1.0 1083345 Maybridge1_004183 Cc1ccc(cc1)S(=O)(=O)C=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G06 compound treatment 0.9944 -0.0354 -0.69 -0.6877 -1.0 2071512 Maybridge1_004184 Nc1ncnc(SCc2c(Cl)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G07 compound treatment 1.018 -0.0118 -0.23 -0.2292 -1.0 1456405 Maybridge1_004185 CCN(CCS(=O)(=O)c1ccccc1)S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G08 compound treatment 0.9844 -0.0454 -0.88 -0.8822 -1.0 2071513 Maybridge1_004186 Cn1nc(O)cc1C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G09 compound treatment 1.0352 0.00537 0.1 0.1042 1.0 1143794 Maybridge1_004187 CC1CCCN(Cc2c(C)n(C)n(c3ccccc3)c2=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G10 compound treatment 0.9958 -0.034 -0.66 -0.6599 -1.0 2071514 Maybridge1_004188 CSc1nc(N)n(n1)c2c(Cl)cc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G11 compound treatment 1.0216 -0.00823 -0.16 -0.1598 -1.0 1296321 Maybridge1_004189 Cc1ccc(NC(=S)Nc2cc(C)cc(C)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G12 compound treatment 1.0137 -0.0161 -0.31 -0.3126 -1.0 2071515 Maybridge1_004190 Cc1nn(c(O)c1C(=O)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G13 compound treatment 1.0438 0.014 0.27 0.2709 1.0 1087761 Maybridge1_004191 NNC(=O)c1ccccc1CO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G14 compound treatment 0.9665 -0.0633 -1.23 -1.2295 -1.0 1005858 Maybridge1_004192 CC1=NN(C(=O)C1[N+](=O)[O-])c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G15 compound treatment 1.0109 -0.019 -0.37 -0.3682 -1.0 2071516 Maybridge1_004193 Clc1ccc(cc1)C2=NN(C(C2)c3cccs3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G16 compound treatment 0.9636 -0.0662 -1.29 -1.2851 -1.0 1103751 Maybridge1_004194 OCC(NC(=O)c1ccccc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G17 compound treatment 1.0216 -0.00823 -0.16 -0.1598 -1.0 1436971 Maybridge1_004195 Cc1ccc(cc1)S(=O)(=O)Nc2sc3CCCCc3c2C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G18 compound treatment 0.9458 -0.0841 -1.63 -1.6324 -1.0 1642807 Maybridge1_004196 COc1cc2CC(=O)NC(c3ccc(Cl)cc3)c2cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G19 compound treatment 1.3385 0.309 5.99 5.9949 1.0 2071517 Maybridge1_004197 CCOC(=O)c1ccc(N2CCOCC2)c(/N=C/c3c(O)ccc4ccccc34)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G20 compound treatment 0.9622 -0.0676 -1.31 -1.3129 -1.0 1049679 Maybridge1_004198 CNc1ccc(cc1)S(=O)(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G21 compound treatment 1.0223 -0.00751 -0.15 -0.1459 -1.0 2071518 Maybridge1_004199 CCOC(=O)c1ccc(SCC(=O)Nc2c(C)cc(C)cc2C)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G22 compound treatment 0.9501 -0.0798 -1.55 -1.5491 -1.0 1448022 Maybridge1_004200 Clc1ccc(cc1)C2NC(=O)Cc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G23 compound treatment 1.008 -0.0218 -0.42 -0.4237 -1.0 2071519 Maybridge1_004201 [O-][N+](=O)c1cc(Cl)ccc1Sc2ccccc2NC3OC(=O)c4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 G24 compound treatment 0.9622 -0.0676 -1.31 -1.3129 -1.0 2071520 Maybridge1_004202 CC(C)c1cccc(C(C)C)c1N=C=Nc2c(cccc2C(C)C)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H01 mock treatment 1.0502 0.0204 0.4 0.396 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H02 mock treatment 1.0423 0.0125 0.24 0.2431 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H03 compound treatment 0.9858 -0.044 -0.85 -0.8544 -1.0 1446039 Maybridge1_004203 CCN(CC)c1cccc(NC(=O)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H04 compound treatment 0.9579 -0.0719 -1.4 -1.3963 -1.0 2071521 Maybridge1_004204 O=C(CCN1C(=O)c2ccccc2C1=O)CCC(=O)CCN3C(=O)c4ccccc4C3=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H05 compound treatment 0.9694 -0.0605 -1.17 -1.174 -1.0 2071522 Maybridge1_004205 Cc1cc(C)c(N=C=Nc2c(C)cc(C)cc2C)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H06 compound treatment 1.003 -0.0268 -0.52 -0.521 -1.0 2071523 Maybridge1_004206 NC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H07 compound treatment 0.9844 -0.0454 -0.88 -0.8822 -1.0 2071524 Maybridge1_004207 O=C(O/N=C/c1ccc2OCOc2c1)c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H08 compound treatment 1.0202 -0.00966 -0.19 -0.1876 -1.0 2071525 Maybridge1_004208 OC(C(O)C(=O)OCc1ccccc1)C(=O)OCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H09 compound treatment 0.9858 -0.044 -0.85 -0.8544 -1.0 1356101 Maybridge1_004209 Clc1cccc(c1Cl)S(=O)(=O)N2CCC(CC2)NC(=O)Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H10 compound treatment 1.0051 -0.0247 -0.48 -0.4793 -1.0 2071526 Maybridge1_004210 O/N=C/C(=O)Nc1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H11 compound treatment 0.998 -0.0318 -0.62 -0.6182 -1.0 1312285 Maybridge1_004211 C(N1CCCCC1)n2cnc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H12 compound treatment 1.0352 0.00537 0.1 0.1042 1.0 1112784 Maybridge1_004212 ON=C1C=CC(=C(C#N)c2ccccc2)C=C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H13 compound treatment 0.9672 -0.0626 -1.22 -1.2156 -1.0 1055766 Maybridge1_004213 c1cc(oc1c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H14 compound treatment 0.9586 -0.0712 -1.38 -1.3824 -1.0 1533369 Maybridge1_004214 Clc1cccc(Oc2cccc(c2)S(=O)(=O)NCc3ccc4OCOc4c3)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H15 compound treatment 0.9794 -0.0504 -0.98 -0.9795 -1.0 2071527 Maybridge1_004215 CCOC(=O)/C(=N/Nc1ccc(Br)cc1)/C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H16 compound treatment 0.9944 -0.0354 -0.69 -0.6877 -1.0 1284097 Maybridge1_004216 O=C(NCc1ccco1)NC2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H17 compound treatment 0.9601 -0.0698 -1.35 -1.3546 -1.0 2071528 Maybridge1_004217 CC(C)(C)OC(=O)N1CCC(=O)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H18 compound treatment 0.9822 -0.0476 -0.92 -0.9239 -1.0 2071529 Maybridge1_004218 FC(F)(F)c1oc(cc1C(=O)Nc2ccc3OCCOc3c2)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H19 compound treatment 0.9865 -0.0433 -0.84 -0.8405 -1.0 2071530 Maybridge1_004219 Cn1c2CCC/C(=N\OC(=O)c3ccc(cc3)C(C)(C)C)/c2c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H20 compound treatment 1.0001 -0.0297 -0.58 -0.5766 -1.0 1178132 Maybridge1_004220 Fc1ccc(F)c(NC(=O)N2CCN(CC2)c3ccnc4cc(Cl)ccc34)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H21 compound treatment 1.0001 -0.0297 -0.58 -0.5766 -1.0 2071531 Maybridge1_004221 Cc1ccc(cc1)S(=O)(=O)Oc2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H22 compound treatment 1.0288 -0.00107 -0.02 -0.0208 -1.0 2071532 Maybridge1_004222 Oc1ccc(cc1)n2nnnc2SCc3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H23 compound treatment 0.9594 -0.0705 -1.37 -1.3685 -1.0 1580966 Maybridge1_004223 COc1ccccc1N2CCN(Cc3ccc(F)cc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 H24 compound treatment 1.0488 0.019 0.37 0.3682 1.0 2071533 Maybridge1_004224 CC(=O)c1ccc(OCC(O)CN2CCN(CC2)C(c3ccccc3)c4ccccc4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I01 mock treatment 1.0302 3.58E-4 0.01 0.0069 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I02 mock treatment 1.0538 0.024 0.47 0.4654 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I03 compound treatment 1.0087 -0.0211 -0.41 -0.4098 -1.0 2071534 Maybridge1_004225 NC(=O)c1nnc2cc(nn2c1c3ccccc3Cl)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I04 compound treatment 1.0266 -0.00322 -0.06 -0.0625 -1.0 2071535 Maybridge1_004226 Cc1onc(c1C(=O)NNC(=O)c2c(C)onc2c3ccccc3Cl)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I05 compound treatment 1.0474 0.0175 0.34 0.3404 1.0 2071536 Maybridge1_004227 Cc1cc(NC(=O)C(Cl)(Cl)Cl)n(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I06 compound treatment 0.9873 -0.0426 -0.83 -0.8266 -1.0 1731523 Maybridge1_004228 CC(C)(C)c1ccc(OC(C)(C)C(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I07 compound treatment 0.998 -0.0318 -0.62 -0.6182 -1.0 2071537 Maybridge1_004229 Clc1ccc(cc1)S(=O)(=O)CCSc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I08 compound treatment 0.9944 -0.0354 -0.69 -0.6877 -1.0 1664186 Maybridge1_004230 Clc1ccc(cc1)c2n[nH]c(=S)[nH]c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I09 compound treatment 1.0552 0.0254 0.49 0.4932 1.0 1328726 Maybridge1_004231 Cc1nn(C)c(NC(=O)c2ccccc2Cl)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I10 compound treatment 0.9973 -0.0326 -0.63 -0.6321 -1.0 2071538 Maybridge1_004232 CSc1nc(N)n(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I11 compound treatment 0.9715 -0.0583 -1.13 -1.1323 -1.0 2071539 Maybridge1_004233 Cc1cc(C)cc(NC(=S)Nc2cccc(Cl)c2C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I12 compound treatment 0.9636 -0.0662 -1.29 -1.2851 -1.0 1056014 Maybridge1_004234 OCc1ccccc1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I13 compound treatment 0.9822 -0.0476 -0.92 -0.9239 -1.0 2071540 Maybridge1_004235 Clc1ccc(NC(=O)C(=O)NCc2ccncc2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I14 compound treatment 1.0094 -0.0204 -0.4 -0.396 -1.0 2071541 Maybridge1_004236 CC1(C)COC2(CCC(=O)CC2)OC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I15 compound treatment 1.0008 -0.029 -0.56 -0.5627 -1.0 1261522 Maybridge1_004237 Cc1cccnc1NC2OC(=O)c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I16 compound treatment 0.9565 -0.0733 -1.42 -1.424 -1.0 1531996 Maybridge1_004238 COC(=O)C(Cc1cccc(C)n1)(c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I17 compound treatment 1.0216 -0.00823 -0.16 -0.1598 -1.0 2071542 Maybridge1_004239 CC(=O)c1ccc(Sc2ccccn2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I18 compound treatment 0.9708 -0.059 -1.15 -1.1462 -1.0 1118153 Maybridge1_004240 Cc1c(sc(N)c1C(=O)N)C(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I19 compound treatment 1.0109 -0.019 -0.37 -0.3682 -1.0 2071543 Maybridge1_004241 CCOC(=O)c1ccc(N2CCOCC2)c(/N=C/c3cc(Br)ccc3O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I20 compound treatment 0.9586 -0.0712 -1.38 -1.3824 -1.0 1231395 Maybridge1_004242 O=C(Cc1ccccc1)Nc2ccc3ccccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I21 compound treatment 0.9644 -0.0655 -1.27 -1.2712 -1.0 2071544 Maybridge1_004243 COc1cc([N+](=O)[O-])c(OC)cc1SCC(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I22 compound treatment 1.013 -0.0168 -0.33 -0.3265 -1.0 1627134 Maybridge1_004244 Nc1nc(cs1)c2ccc-3c(Cc4ccccc43)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I23 compound treatment 1.0123 -0.0175 -0.34 -0.3404 -1.0 1549155 Maybridge1_004245 Cc1c(C)c(C)c(CSc2ccccc2NC3OC(=O)c4ccccc34)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 I24 compound treatment 1.0516 0.0218 0.42 0.4237 1.0 2071545 Maybridge1_004246 COC(=O)C(COS(=O)(=O)c1ccc(C)cc1)NC(=O)OC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J01 mock treatment 1.0524 0.0225 0.44 0.4376 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J02 mock treatment 0.9744 -0.0554 -1.08 -1.0767 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J03 compound treatment 1.0259 -0.00393 -0.08 -0.0764 -1.0 2071546 Maybridge1_004247 C(C1=N[C@@H]([C@@H](O1)c2ccccc2)c3ccccc3)C4=N[C@@H]([C@@H](O4)c5ccccc5)c6ccccc6 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J04 compound treatment 0.9987 -0.0311 -0.6 -0.6043 -1.0 2071547 Maybridge1_004248 OC[C@H]1O[C@H](O)[C@H](NNc2ccccc2)[C@@H](O)[C@@H]1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J05 compound treatment 0.9651 -0.0647 -1.26 -1.2573 -1.0 1069755 Maybridge1_004249 COc1cc(OC)c(OC)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J06 compound treatment 1.0202 -0.00966 -0.19 -0.1876 -1.0 2071548 Maybridge1_004250 CC(=O)OC[C@H]1O[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@@H]1O[C@@H]2O[C@H](COC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]2OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J07 compound treatment 0.9858 -0.044 -0.85 -0.8544 -1.0 2071549 Maybridge1_004251 Clc1ccc(C(=O)O/N=C/c2ccc3OCOc3c2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J08 compound treatment 0.9737 -0.0562 -1.09 -1.0906 -1.0 2071550 Maybridge1_004252 CCSC(SCC)[C@H](O)[C@@H](O)[C@@H](O)CO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J09 compound treatment 1.0195 -0.0104 -0.2 -0.2014 -1.0 1215373 Maybridge1_004253 Cc1ccc(cc1)C(=O)NC2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J10 compound treatment 0.9651 -0.0647 -1.26 -1.2573 -1.0 2071551 Maybridge1_004254 Cc1ccc(CSc2ssc(=S)c2c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J11 compound treatment 1.0202 -0.00966 -0.19 -0.1876 -1.0 2071552 Maybridge1_004255 COC(=O)C1(C)CCC(C(=O)O)C1(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J12 compound treatment 1.0116 -0.0182 -0.35 -0.3543 -1.0 2071553 Maybridge1_004256 Oc1ccc(Br)cc1/C=N/N2C(=O)c3ccccc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J13 compound treatment 0.9608 -0.069 -1.34 -1.3407 -1.0 1396701 Maybridge1_004257 COc1ccc(CCNC(=O)c2ccc(Cl)cc2Cl)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J14 compound treatment 1.0166 -0.0132 -0.26 -0.257 -1.0 1397018 Maybridge1_004258 Fc1ccc(cc1Cl)S(=O)(=O)NCc2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J15 compound treatment 0.9586 -0.0712 -1.38 -1.3824 -1.0 2071554 Maybridge1_004259 CCOC(=O)/C(=N/Nc1cccc(c1)[N+](=O)[O-])/C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J16 compound treatment 0.9751 -0.0547 -1.06 -1.0628 -1.0 2071555 Maybridge1_004260 CCOC(=O)C(C#N)C1C(=C(N)Oc2c(OC)cc(Br)cc12)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J17 compound treatment 0.9901 -0.0397 -0.77 -0.7711 -1.0 2071556 Maybridge1_004261 Cn1c2CCC/C(=N\OC(=O)c3cccc4ccccc34)/c2c5ccccc15 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J18 compound treatment 0.9865 -0.0433 -0.84 -0.8405 -1.0 1598126 Maybridge1_004262 COC(=O)c1ccc(n1C)S(=O)(=O)NCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J19 compound treatment 0.9715 -0.0583 -1.13 -1.1323 -1.0 1546260 Maybridge1_004263 CC1(C)C(NC(=O)c2c(Cl)cccc2Cl)[C@]3(C)CCC1C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J20 compound treatment 0.9679 -0.0619 -1.2 -1.2017 -1.0 1367531 Maybridge1_004264 Clc1ccc2nc(sc2c1)N3CCN(CC3)S(=O)(=O)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J21 compound treatment 0.935 -0.0948 -1.84 -1.8408 -1.0 1298924 Maybridge1_004265 CC1(C)C2CCC1(C)C(C2)N3CCN(Cc4ccccc4)CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J22 compound treatment 0.9744 -0.0554 -1.08 -1.0767 -1.0 2071557 Maybridge1_004266 Oc1ccc(cc1)n2nnnc2SCc3cc(F)cc(F)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J23 compound treatment 0.9858 -0.044 -0.85 -0.8544 -1.0 2071558 Maybridge1_004267 Fc1ccc(cc1)C(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 J24 compound treatment 1.0266 -0.00322 -0.06 -0.0625 -1.0 2071559 Maybridge1_004268 Oc1ccc(cc1)n2nnnc2SCC(=O)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K01 mock treatment 1.081 0.0512 0.99 0.9934 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K02 mock treatment 1.0144 -0.0154 -0.3 -0.2987 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K03 compound treatment 1.0373 0.00751 0.15 0.1459 1.0 2071560 Maybridge1_004269 CCOC(=O)/C(=N/Nc1cc(n[nH]1)c2ccccc2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K04 compound treatment 1.0316 0.00179 0.03 0.0347 1.0 2071561 Maybridge1_004270 Cc1nc(COc2ccc(cc2)/C(=N/O)/N)cs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K05 compound treatment 1.0381 0.00823 0.16 0.1598 1.0 1493954 Maybridge1_004271 Cc1cc(=O)n2nc(cc2[nH]1)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K06 compound treatment 1.0016 -0.0283 -0.55 -0.5488 -1.0 1671220 Maybridge1_004272 CC(C)(Oc1ccc2ccccc2c1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K07 compound treatment 0.9851 -0.0447 -0.87 -0.8683 -1.0 1588381 Maybridge1_004273 Clc1ccc(cc1)S(=O)(=O)CCN2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K08 compound treatment 0.9687 -0.0612 -1.19 -1.1879 -1.0 2071562 Maybridge1_004274 CSc1nc(O)nc(n1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K09 compound treatment 1.0824 0.0526 1.02 1.0211 1.0 2071563 Maybridge1_004275 CCOc1cc(/C=N/C(=C(\N)/C#N)/C#N)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K10 compound treatment 1.0881 0.0583 1.13 1.1323 1.0 1542810 Maybridge1_004276 CCc1nc(O)cc2cc(OC)c(OC)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K11 compound treatment 1.033 0.00322 0.06 0.0625 1.0 2071564 Maybridge1_004277 OCc1ccccc1C(=O)N/N=C/c2ccc(O)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K12 compound treatment 1.0008 -0.029 -0.56 -0.5627 -1.0 2071565 Maybridge1_004278 Brc1ccc(cc1)C(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K13 compound treatment 1.0066 -0.0233 -0.45 -0.4515 -1.0 2071566 Maybridge1_004279 [O-][N+](=O)c1ccc(cc1)C(=O)c2ccc3CCCc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K14 compound treatment 0.9944 -0.0354 -0.69 -0.6877 -1.0 2071567 Maybridge1_004280 OC1(Cc2ccccc2C3=NCCN31)c4ccc(F)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K15 compound treatment 1.0109 -0.019 -0.37 -0.3682 -1.0 2071568 Maybridge1_004281 COc1cc(cc(OC)c1OC)C(=O)Nc2ccccc2SCCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K16 compound treatment 0.983 -0.0469 -0.91 -0.91 -1.0 2071569 Maybridge1_004282 C1CN(CCN1)c2ncccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K17 compound treatment 0.9694 -0.0605 -1.17 -1.174 -1.0 2071570 Maybridge1_004283 CC(=O)c1ccc(Sc2ccc(Cl)cc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K18 compound treatment 0.9944 -0.0354 -0.69 -0.6877 -1.0 2071571 Maybridge1_004284 Oc1ccccc1/C=N/CC\N=C\c2ccccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K19 compound treatment 0.9801 -0.0497 -0.97 -0.9656 -1.0 2071572 Maybridge1_004285 CCOC(=O)c1ccc(N2CCOCC2)c(/N=C/c3cc(Cl)ccc3O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K20 compound treatment 0.998 -0.0318 -0.62 -0.6182 -1.0 2071573 Maybridge1_004286 Cc1ccc(cc1C)C(=O)c2c(C)ccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K21 compound treatment 1.033 0.00322 0.06 0.0625 1.0 2071574 Maybridge1_004287 CCOC(=O)CSc1cc(OC)c(cc1OC)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K22 compound treatment 0.9729 -0.0569 -1.1 -1.1045 -1.0 2071575 Maybridge1_004288 CCCCSc1nnc(S)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K23 compound treatment 0.9887 -0.0411 -0.8 -0.7989 -1.0 2071576 Maybridge1_004289 CC(=O)c1ccc(Sc2ccccc2N)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 K24 compound treatment 1.0459 0.0161 0.31 0.3126 1.0 2071577 Maybridge1_004290 CCC(C)C(NC(=O)OCC1c2ccccc2-c3ccccc13)C(=O)NC(C(C)C)C(=O)NC(CCCCNC(=O)OC(C)(C)C)C(=O)NC(CCC(=O)OC(C)(C)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L01 mock treatment 1.0245 -0.00537 -0.1 -0.1042 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L02 mock treatment 1.0538 0.024 0.47 0.4654 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L03 compound treatment 0.9873 -0.0426 -0.83 -0.8266 -1.0 2071578 Maybridge1_004291 Cc1ccc(cc1)S(=O)(=O)OCC(NC(=O)OC(C)(C)C)C(=O)OCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L04 compound treatment 1.0173 -0.0125 -0.24 -0.2431 -1.0 1026962 Maybridge1_004292 COc1cc(cc(OC)c1OC)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L05 compound treatment 0.9744 -0.0554 -1.08 -1.0767 -1.0 2071579 Maybridge1_004293 O=C(O/N=C/c1ccc2OCOc2c1)C3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L06 compound treatment 1.0137 -0.0161 -0.31 -0.3126 -1.0 2071580 Maybridge1_004294 CC(=O)OC[C@H]1O[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@@H]1O[C@@H]2O[C@H](COC(=O)C)[C@H](OC(=O)C)[C@H](OC(=O)C)[C@H]2OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L07 compound treatment 1.028 -0.00179 -0.03 -0.0347 -1.0 2071581 Maybridge1_004295 O=C(O/N=C/c1ccc2OCOc2c1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L08 compound treatment 0.9694 -0.0605 -1.17 -1.174 -1.0 2071582 Maybridge1_004296 CCSC(SCC)[C@H](O)[C@@H](O)[C@H](O)CO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L09 compound treatment 0.9908 -0.039 -0.76 -0.7572 -1.0 1408083 Maybridge1_004297 Clc1ccc(C(=O)N2CCC(CC2)NC(=O)C3CCCCC3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L10 compound treatment 1.013 -0.0168 -0.33 -0.3265 -1.0 2071583 Maybridge1_004298 Cc1ccc(cc1)/C(=C/2\C=C(\Cl)/C(=N/O)/C=C2/Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L11 compound treatment 1.0245 -0.00537 -0.1 -0.1042 -1.0 2071584 Maybridge1_004299 COC(=O)C1CCC(C)(C(=O)O)C1(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L12 compound treatment 1.0237 -0.00608 -0.12 -0.1181 -1.0 1570985 Maybridge1_004300 CC(=O)Nc1ccc(NC(=O)c2ccccc2C(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L13 compound treatment 0.9515 -0.0783 -1.52 -1.5213 -1.0 1533685 Maybridge1_004301 CCOC(=O)C1=C(C)NC(=O)NC1c2ccc(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L14 compound treatment 1.0109 -0.019 -0.37 -0.3682 -1.0 2071585 Maybridge1_004302 Cn1c(Sc2nc3ccc(Cl)cc3s2)nnc1c4ccc(Cl)cc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L15 compound treatment 0.9808 -0.049 -0.95 -0.9517 -1.0 1713236 Maybridge1_004303 CC(=O)NCc1ccc(cc1)S(=O)(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L16 compound treatment 0.9594 -0.0705 -1.37 -1.3685 -1.0 1467188 Maybridge1_004304 CCOC(=O)c1cc(NC(=O)Nc2ccc(C)c(Cl)c2)ccc1N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L17 compound treatment 0.9572 -0.0726 -1.41 -1.4101 -1.0 2071586 Maybridge1_004305 FC(F)(F)c1cccc(c1)C(=O)O/N=C/2\CCCc3[nH]c4ccccc4c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L18 compound treatment 1.0237 -0.00608 -0.12 -0.1181 -1.0 1376744 Maybridge1_004306 Cc1cc(C)c(C#N)c(OCC(=O)Nc2ccc(Oc3ccccc3)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L19 compound treatment 0.9701 -0.0597 -1.16 -1.1601 -1.0 1402584 Maybridge1_004307 CC1(C)C(NC(=O)c2ccc(Cl)cc2Cl)[C@]3(C)CCC1C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L20 compound treatment 0.9636 -0.0662 -1.29 -1.2851 -1.0 1196364 Maybridge1_004308 OC(=O)C1CCC1C(=O)N2CCN(CC2)c3nc4ccc(Cl)cc4s3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L21 compound treatment 0.9708 -0.059 -1.15 -1.1462 -1.0 2071587 Maybridge1_004309 COc1ccc(CC2CCC(=O)CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L22 compound treatment 0.9851 -0.0447 -0.87 -0.8683 -1.0 2071588 Maybridge1_004310 COC(=O)Cc1nc(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)sc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L23 compound treatment 0.9601 -0.0698 -1.35 -1.3546 -1.0 1044240 Maybridge1_004311 Brc1ccc2[nH]c3ccccc3c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 L24 compound treatment 1.0037 -0.0261 -0.51 -0.5071 -1.0 1291967 Maybridge1_004312 OC(COc1ccc(F)cc1)CN2CCN(CC2)C(c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M01 mock treatment 1.0366 0.0068 0.13 0.132 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M02 mock treatment 1.0101 -0.0197 -0.38 -0.3821 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M03 compound treatment 0.998 -0.0318 -0.62 -0.6182 -1.0 1140868 Maybridge1_004313 Nc1cc(nn1c2ccccc2)C3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M04 compound treatment 0.988 -0.0419 -0.81 -0.8127 -1.0 1497141 Maybridge1_004314 Cc1c(Cl)c(O)nc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M05 compound treatment 1.0237 -0.00608 -0.12 -0.1181 -1.0 2071589 Maybridge1_004315 FC(F)(F)c1cc(=O)n([nH]1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M06 compound treatment 1.0094 -0.0204 -0.4 -0.396 -1.0 2071590 Maybridge1_004316 CC1(C)N=C(N)N=C(N)N1c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M07 compound treatment 1.0166 -0.0132 -0.26 -0.257 -1.0 1701903 Maybridge1_004317 Clc1ccc(cc1)S(=O)(=O)CCN2CCSCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M08 compound treatment 0.9515 -0.0783 -1.52 -1.5213 -1.0 1496378 Maybridge1_004318 Clc1ccc(cc1)c2nc(=O)[nH]c(=S)[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M09 compound treatment 0.9658 -0.064 -1.24 -1.2434 -1.0 1369556 Maybridge1_004319 Cc1nn(C)c(NC(=O)c2ccc(Cl)cc2Cl)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M10 compound treatment 0.9708 -0.059 -1.15 -1.1462 -1.0 1006055 Maybridge1_004320 CCCCCCCCCCCCCO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M11 compound treatment 0.9858 -0.044 -0.85 -0.8544 -1.0 2071591 Maybridge1_004321 OCc1ccccc1C(=O)N/N=C/c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M12 compound treatment 0.9679 -0.0619 -1.2 -1.2017 -1.0 1049047 Maybridge1_004322 [O-][N+](=O)c1ccc-2c(c1)C(=O)c3cc(ccc32)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M13 compound treatment 0.9658 -0.064 -1.24 -1.2434 -1.0 2071592 Maybridge1_004323 Cc1onc(c1C(=O)N2CCC(CCCC3CCN(CC3)C(=O)c4c(C)onc4c5c(Cl)cccc5Cl)CC2)c6c(Cl)cccc6Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M14 compound treatment 0.9679 -0.0619 -1.2 -1.2017 -1.0 2071593 Maybridge1_004324 CCC[C@H]1[C@@H](Cc2cncn2C)COC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M15 compound treatment 1.023 -0.0068 -0.13 -0.132 -1.0 2071594 Maybridge1_004325 Clc1c(sc2ccccc12)C(=O)Nc3ccccc3SCCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M16 compound treatment 1.0116 -0.0182 -0.35 -0.3543 -1.0 2071595 Maybridge1_004326 N[C@@H](C(=O)O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M17 compound treatment 1.0094 -0.0204 -0.4 -0.396 -1.0 1313557 Maybridge1_004327 CCOC(=O)c1ccc(N2CCCCC2)c(NS(=O)(=O)c3cc(Cl)c(Cl)cc3Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M18 compound treatment 1.0123 -0.0175 -0.34 -0.3404 -1.0 1011577 Maybridge1_004328 Cc1ccc2cc(C)c(C)cc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M19 compound treatment 1.0051 -0.0247 -0.48 -0.4793 -1.0 2071596 Maybridge1_004329 CCOC(=O)c1ccc(N2CCOCC2)c(/N=C/c3cc(Br)cc(Br)c3O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M20 compound treatment 1.0094 -0.0204 -0.4 -0.396 -1.0 1686247 Maybridge1_004330 CC(=O)Oc1cc(OC(=O)C)cc(c1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M21 compound treatment 1.0144 -0.0154 -0.3 -0.2987 -1.0 2071597 Maybridge1_004331 [O-][N+](=O)c1cc(Cl)c(Sc2ccccc2)cc1Sc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M22 compound treatment 0.9536 -0.0762 -1.48 -1.4796 -1.0 2071598 Maybridge1_004332 Sc1nc(c([nH]1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M23 compound treatment 0.9515 -0.0783 -1.52 -1.5213 -1.0 2071599 Maybridge1_004333 Nc1ccccc1SCc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 M24 compound treatment 1.033 0.00322 0.06 0.0625 1.0 2071600 Maybridge1_004334 CCCCCCSc1nnc(S)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N01 mock treatment 0.9901 -0.0397 -0.77 -0.7711 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N02 mock treatment 1.0195 -0.0104 -0.2 -0.2014 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N03 compound treatment 1.0173 -0.0125 -0.24 -0.2431 -1.0 2071601 Maybridge1_004335 COC(=O)C(NC(=O)OCc1ccccc1)C(C)OS(=O)(=O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N04 compound treatment 1.008 -0.0218 -0.42 -0.4237 -1.0 931 Maybridge1_004336 NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N05 compound treatment 0.9837 -0.0461 -0.9 -0.8961 -1.0 2071602 Maybridge1_004337 COc1ccccc1CC(=O)O/N=C/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N06 compound treatment 1.013 -0.0168 -0.33 -0.3265 -1.0 2071603 Maybridge1_004338 CC(=O)OC[C@H]1O[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@@H]1O[C@H]2O[C@H](COC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]2OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N07 compound treatment 1.0137 -0.0161 -0.31 -0.3126 -1.0 1654475 Maybridge1_004339 Cc1ccc(cc1)C(=O)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N08 compound treatment 1.0008 -0.029 -0.56 -0.5627 -1.0 2071604 Maybridge1_004340 COCC1(C)OC(=O)C(=C1C)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N09 compound treatment 1.0051 -0.0247 -0.48 -0.4793 -1.0 1437551 Maybridge1_004341 O=C(NC1CCN(CC1)C(=O)c2ccco2)C3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N10 compound treatment 1.018 -0.0118 -0.23 -0.2292 -1.0 2071605 Maybridge1_004342 Cc1ccc(cc1)/C(=C/2\C=C/C(=N\O)/C(=C2/Cl)/Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N11 compound treatment 1.013 -0.0168 -0.33 -0.3265 -1.0 2071606 Maybridge1_004343 CC(C)(C)c1cc(n[nH]1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N12 compound treatment 1.0109 -0.019 -0.37 -0.3682 -1.0 1478375 Maybridge1_004344 COc1cc2CCN(C(C)c2cc1OC)C(=O)c3c(C)onc3c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N13 compound treatment 0.9887 -0.0411 -0.8 -0.7989 -1.0 1075430 Maybridge1_004345 OCC(NC(=O)C(Cl)Cl)C(O)c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N14 compound treatment 1.0059 -0.024 -0.47 -0.4654 -1.0 2071607 Maybridge1_004346 Cn1c(Sc2nc3ccc(Cl)cc3s2)nnc1c4ccc5ncccc5c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N15 compound treatment 0.9443 -0.0855 -1.66 -1.6602 -1.0 1510250 Maybridge1_004347 COc1ccccc1N2CCN(CC2)C(=O)Nc3ccc(Br)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N16 compound treatment 1.0259 -0.00393 -0.08 -0.0764 -1.0 2071608 Maybridge1_004348 COCc1cc(O)nc(SC2CC(=O)N(C2=O)c3ccc(cc3)N4CCOCC4)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N17 compound treatment 0.9536 -0.0762 -1.48 -1.4796 -1.0 2071609 Maybridge1_004349 Cn1c2CCC/C(=N\OC(=O)c3ccc(Cl)cc3)/c2c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N18 compound treatment 0.9873 -0.0426 -0.83 -0.8266 -1.0 1382314 Maybridge1_004350 Cc1nnsc1C(=O)NCc2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N19 compound treatment 1.028 -0.00179 -0.03 -0.0347 -1.0 1354484 Maybridge1_004351 CC1(C)C(NS(=O)(=O)c2ccc(Cl)cc2)[C@]3(C)CCC1C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N20 compound treatment 1.0445 0.0147 0.28 0.2848 1.0 1437585 Maybridge1_004352 CC(C)(CC(=O)O)CC(=O)N1CCN(CC1)c2nc3ccc(Cl)cc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N21 compound treatment 0.9222 -0.108 -2.09 -2.0909 -1.0 2071610 Maybridge1_004353 Brc1cnc(nc1)N2CCN(CC2)C(c3ccccc3)(c4ccccc4)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N22 compound treatment 0.9744 -0.0554 -1.08 -1.0767 -1.0 2071611 Maybridge1_004354 COC(=O)Cc1nc(NS(=O)(=O)c2cccc(c2)C(F)(F)F)sc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N23 compound treatment 0.9787 -0.0512 -0.99 -0.9934 -1.0 1983514 Maybridge1_004355 O/N=C/C(=O)Nc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 N24 compound treatment 1.0295 -3.58E-4 -0.01 -0.0069 -1.0 2071612 Maybridge1_004356 Cc1nc(cs1)c2ccc(s2)S(=O)(=O)NCc3nc(no3)c4ccc(cc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O01 mock treatment 1.0159 -0.014 -0.27 -0.2709 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O02 mock treatment 1.0302 3.58E-4 0.01 0.0069 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O03 compound treatment 0.9994 -0.0304 -0.59 -0.5905 -1.0 1044275 Maybridge1_004357 CS(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O04 compound treatment 1.0137 -0.0161 -0.31 -0.3126 -1.0 2071613 Maybridge1_004358 CCCc1cc(O)nc(SCc2ccc(Cl)cc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O05 compound treatment 1.0087 -0.0211 -0.41 -0.4098 -1.0 1596267 Maybridge1_004359 CCN(CCS(=O)(=O)c1ccc(Cl)cc1)C(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O06 compound treatment 0.9722 -0.0576 -1.12 -1.1184 -1.0 1044282 Maybridge1_004360 Clc1ccc(NC(=N)NC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O07 compound treatment 1.0187 -0.0111 -0.22 -0.2153 -1.0 2071614 Maybridge1_004361 Nc1cc(n[nH]1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O08 compound treatment 0.9644 -0.0655 -1.27 -1.2712 -1.0 2071615 Maybridge1_004362 CSc1nc(O)nc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O09 compound treatment 1.0431 0.0132 0.26 0.257 1.0 2071616 Maybridge1_004363 Cc1cc(NC(=O)Nc2cccc(c2)C(F)(F)F)n(C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O10 compound treatment 0.9758 -0.054 -1.05 -1.0489 -1.0 2071617 Maybridge1_004364 COC(=O)c1c(N)cccc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O11 compound treatment 1.0373 0.00751 0.15 0.1459 1.0 2071618 Maybridge1_004365 OCc1ccccc1C(=O)N/N=C/C=C/c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O12 compound treatment 0.9865 -0.0433 -0.84 -0.8405 -1.0 2071619 Maybridge1_004366 Oc1ccccc1/C=N/CC2CCC(C\N=C\c3ccccc3O)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O13 compound treatment 1.0073 -0.0225 -0.44 -0.4376 -1.0 2071620 Maybridge1_004367 CC(C)N(CCC#N)C(=S)Nc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O14 compound treatment 0.9558 -0.074 -1.44 -1.4379 -1.0 1340247 Maybridge1_004368 Cc1nc2ccccc2c(C(=O)O)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O15 compound treatment 0.9808 -0.049 -0.95 -0.9517 -1.0 2071621 Maybridge1_004369 COc1cccc(/C=N/c2ccccc2SCCC#N)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O16 compound treatment 0.9744 -0.0554 -1.08 -1.0767 -1.0 1015426 Maybridge1_004370 Cc1ccc(NC(=O)c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O17 compound treatment 1.0209 -0.00894 -0.17 -0.1737 -1.0 1558027 Maybridge1_004371 CCOC(=O)c1ccc(N2CCOCC2)c(NC(=O)c3ccc(Cl)c(Cl)c3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O18 compound treatment 0.9572 -0.0726 -1.41 -1.4101 -1.0 2071622 Maybridge1_004372 Cc1ccc(C#Cc2ccc(C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O19 compound treatment 0.993 -0.0368 -0.72 -0.7155 -1.0 2071623 Maybridge1_004373 CCOC(=O)c1ccc(N2CCOCC2)c(/N=C/c3cc(Cl)cc(Cl)c3O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O20 compound treatment 0.9729 -0.0569 -1.1 -1.1045 -1.0 2071624 Maybridge1_004374 CC(OCc1ccccc1)C(NC(=O)OC(C)(C)C)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O21 compound treatment 1.008 -0.0218 -0.42 -0.4237 -1.0 2071625 Maybridge1_004375 Nc1ccccc1Sc2cc(Sc3ccccc3N)c(cc2Cl)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O22 compound treatment 0.9958 -0.034 -0.66 -0.6599 -1.0 2071626 Maybridge1_004376 CCCSc1nnc(S)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O23 compound treatment 1.0252 -0.00465 -0.09 -0.0903 -1.0 1022261 Maybridge1_004377 Nc1ccccc1Sc2ccc(cc2[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 O24 compound treatment 1.0588 0.029 0.56 0.5627 1.0 1577497 Maybridge1_004378 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P01 mock treatment 1.0216 -0.00823 -0.16 -0.1598 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P02 mock treatment 1.0824 0.0526 1.02 1.0211 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P03 compound treatment 0.9844 -0.0454 -0.88 -0.8822 -1.0 2071627 Maybridge1_004379 COc1cccc2C(=O)COc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P04 compound treatment 1.0431 0.0132 0.26 0.257 1.0 1045862 Maybridge1_004380 c1c(nc2ccccn12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P05 compound treatment 0.9951 -0.0347 -0.67 -0.6738 -1.0 2071628 Maybridge1_004381 O=C(O/N=C/c1ccc2OCOc2c1)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P06 compound treatment 0.9815 -0.0483 -0.94 -0.9378 -1.0 2071629 Maybridge1_004382 CC1(C)O[C@H]2CO[C@@H]3OC(C)(C)O[C@@H]3[C@H]2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P07 compound treatment 1.0066 -0.0233 -0.45 -0.4515 -1.0 1133999 Maybridge1_004383 Clc1cccc(Cl)c1C(=O)N2CCC(CC2)NC(=O)Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P08 compound treatment 1.0416 0.0118 0.23 0.2292 1.0 2071630 Maybridge1_004384 C1=CC=CC(C=C1)C2C=CC=CC=C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P09 compound treatment 1.0674 0.0376 0.73 0.7294 1.0 1014809 Maybridge1_004385 O=C1NC(=O)C2(CCCCC2)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P10 compound treatment 1.0237 -0.00608 -0.12 -0.1181 -1.0 1454866 Maybridge1_004386 COc1cc(cc(OC)c1OC)c2cc(C(=O)O)c3ccc(C)cc3n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P11 compound treatment 1.1675 0.138 2.67 2.6744 1.0 2071631 Maybridge1_004387 Nc1ccc2nonc2c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P12 compound treatment 0.9801 -0.0497 -0.97 -0.9656 -1.0 2071632 Maybridge1_004388 OC(=O)c1cccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P13 compound treatment 0.9951 -0.0347 -0.67 -0.6738 -1.0 2431 Maybridge1_004389 CCN(CC)CCNC(=O)c1ccc(N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P14 compound treatment 0.998 -0.0318 -0.62 -0.6182 -1.0 2071633 Maybridge1_004390 Cn1cnc([N+](=O)[O-])c1Sc2nnc(c3ccc(cc3)C(C)(C)C)n2c4ccc5OCOc5c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P15 compound treatment 0.978 -0.0519 -1.01 -1.0072 -1.0 1511723 Maybridge1_004391 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3cc(Cl)c(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P16 compound treatment 1.0137 -0.0161 -0.31 -0.3126 -1.0 2071634 Maybridge1_004392 OC(=O)c1ccccc1SCCS(=O)(=O)c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P17 compound treatment 0.9551 -0.0748 -1.45 -1.4518 -1.0 2071635 Maybridge1_004393 CC(C)(C)c1ccc(cc1)C(=O)O/N=C/2\CCCc3[nH]c4ccccc4c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P18 compound treatment 1.0016 -0.0283 -0.55 -0.5488 -1.0 2071636 Maybridge1_004394 Oc1ccc(cc1)n2nnnc2SCC(=O)Nc3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P19 compound treatment 0.993 -0.0368 -0.72 -0.7155 -1.0 1632411 Maybridge1_004395 Cc1ccc(cc1)S(=O)(=O)NC2C(C)(C)C3CC[C@]2(C)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P20 compound treatment 1.0016 -0.0283 -0.55 -0.5488 -1.0 2071637 Maybridge1_004396 Cc1ccc(OCC(O)CN2CCN(CC2)c3nc(ns3)c4ccccc4)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P21 compound treatment 1.0037 -0.0261 -0.51 -0.5071 -1.0 1113187 Maybridge1_004397 Clc1ccc2noc(c3ccccc3)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P22 compound treatment 1.0245 -0.00537 -0.1 -0.1042 -1.0 2071638 Maybridge1_004398 OC(CSc1ccccc1)CN2CCN(CC2)c3ccc(cn3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P23 compound treatment 0.9772 -0.0526 -1.02 -1.0211 -1.0 1555086 Maybridge1_004399 CC(C)(C)OC(=O)N1CCC(CC1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.553 P24 compound treatment 1.023 -0.0068 -0.13 -0.132 -1.0 2071639 Maybridge1_004400 COc1ccc(cc1)c2ccnc(SCC(=O)c3ccc(Cl)s3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A01 compound treatment 1.1731 0.173 3.36 3.3621 1.0 1341040 Maybridge1_004401 CC(C)(C)n1nc(cc1N)C2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A02 compound treatment 1.0311 0.0311 0.6 0.6049 1.0 2071640 Maybridge1_004402 COC(=O)c1scc(c1C)S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A03 compound treatment 1.057 0.057 1.11 1.1062 1.0 2071641 Maybridge1_004403 Fc1cccc(Cl)c1CN/C(=C(\N=C\c2ccccc2)/C#N)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A04 compound treatment 1.0182 0.0182 0.35 0.3542 1.0 2071642 Maybridge1_004404 CC(=O)c1nnc2cc(C)nn2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A05 compound treatment 1.0993 0.0993 1.93 1.9278 1.0 2071643 Maybridge1_004405 CN1c2ccccc2C(=O)CS1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A06 compound treatment 1.0441 0.0441 0.86 0.8555 1.0 2071644 Maybridge1_004406 Cc1c(csc1S(=O)(=O)N/N=C/c2c(Cl)cccc2Cl)S(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A07 compound treatment 0.9996 -4.03E-4 -0.01 -0.0078 -1.0 2071645 Maybridge1_004407 CCO/C=C(\C#N)/S(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A08 compound treatment 0.9745 -0.0255 -0.5 -0.4952 -1.0 2071646 Maybridge1_004408 CCOC(=O)c1cnc2cc(C)nn2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A09 compound treatment 1.0261 0.0261 0.51 0.5074 1.0 1582142 Maybridge1_004409 CC(C)(C)c1ccc(cc1)c2cc(NS(=O)(=O)c3ccccc3)[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A10 compound treatment 1.0096 0.00964 0.19 0.1871 1.0 2071647 Maybridge1_004410 CSCCC(CC(=O)O)NC(=O)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A11 compound treatment 1.0039 0.0039 0.08 0.0757 1.0 1125786 Maybridge1_004411 Cc1cc(=O)n2ncc(C#N)c2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A12 compound treatment 1.0017 0.00175 0.03 0.0339 1.0 2071648 Maybridge1_004412 COC(=O)c1sc(SC)c(c1C)S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A13 compound treatment 1.0075 0.00748 0.15 0.1453 1.0 1490917 Maybridge1_004413 O=S(=O)(CCN1CCN(CCS(=O)(=O)c2ccccc2)CC1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A14 compound treatment 1.0075 0.00748 0.15 0.1453 1.0 1944746 Maybridge1_004414 CC(=O)c1cnc2cc(nn2c1C)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A15 compound treatment 1.0147 0.0147 0.28 0.2846 1.0 1738962 Maybridge1_004415 COCc1cc(O)nc2n(C)nc(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A16 compound treatment 1.062 0.062 1.2 1.2037 1.0 2071649 Maybridge1_004416 CCO/C=C(\C#N)/S(=O)(=O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A17 compound treatment 1.001 0.00103 0.02 0.02 1.0 2071650 Maybridge1_004417 COC(=O)c1ccccc1S(=O)(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A18 compound treatment 0.9767 -0.0233 -0.45 -0.4534 -1.0 1242984 Maybridge1_004418 COc1ncccc1C(=O)Nc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A19 compound treatment 1.0075 0.00748 0.15 0.1453 1.0 2071651 Maybridge1_004419 Clc1ccc(cc1)S(=O)(=O)/C(=C/Nc2cccnc2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A20 compound treatment 0.9709 -0.0291 -0.56 -0.5649 -1.0 2071652 Maybridge1_004420 Cn1cc(Br)c(n1)c2cccc(N)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A21 compound treatment 0.9924 -0.00757 -0.15 -0.1471 -1.0 2071653 Maybridge1_004421 O=S(CC#N)c1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A22 compound treatment 1.0326 0.0326 0.63 0.6327 1.0 1235734 Maybridge1_004422 Cc1ncc(c(N)n1)S(=O)(=O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A23 mock treatment 1.039 0.039 0.76 0.7581 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 A24 mock treatment 1.0562 0.0562 1.09 1.0923 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B01 compound treatment 1.029 0.029 0.56 0.5631 1.0 2071654 Maybridge1_004423 FC(F)(F)c1ccc(N/N=C(\C#N)/C(=O)C2CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B02 compound treatment 1.0412 0.0412 0.8 0.7998 1.0 1515343 Maybridge1_004424 NC(=O)c1ccc(s1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B03 compound treatment 1.0061 0.00605 0.12 0.1175 1.0 2071655 Maybridge1_004425 Cc1cc(n2nc(cc2n1)c3ccc(cc3)C(C)(C)C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B04 compound treatment 1.0147 0.0147 0.28 0.2846 1.0 2071656 Maybridge1_004426 CCSc1sc(C(=O)OC)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B05 compound treatment 0.9896 -0.0104 -0.2 -0.2028 -1.0 2071657 Maybridge1_004427 N/C(=N\OC(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)/CSc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B06 compound treatment 0.9623 -0.0377 -0.73 -0.732 -1.0 1465696 Maybridge1_004428 CCOC(=O)c1sc(SC)c2C(=O)CCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B07 compound treatment 0.9982 -0.00184 -0.04 -0.0357 -1.0 2071658 Maybridge1_004429 COC(=O)c1sc(SC)c(C#N)c1c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B08 compound treatment 1.0075 0.00748 0.15 0.1453 1.0 2071659 Maybridge1_004430 CC(=O)c1sc(SCc2ccc(Cl)cc2)c3C(=O)CC(C)(C)Cc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B09 compound treatment 0.9501 -0.0499 -0.97 -0.9687 -1.0 2071660 Maybridge1_004431 CC(C)S(=O)(=O)c1cnc(nc1N)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B10 compound treatment 0.968 -0.032 -0.62 -0.6206 -1.0 2071661 Maybridge1_004432 CCOC(=O)c1sc(SCc2ccc(Cl)cc2)c3C(=O)/C(=C/N(C)C)/CCc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B11 compound treatment 1.0218 0.0218 0.42 0.4239 1.0 1242567 Maybridge1_004433 CC(C)(C)S(=O)(=O)c1cnc(nc1N)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B12 compound treatment 1.0369 0.0369 0.72 0.7163 1.0 2071662 Maybridge1_004434 CNC(=O)c1sc(SC)c2C=CCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B13 compound treatment 0.948 -0.052 -1.01 -1.0105 -1.0 1481192 Maybridge1_004435 CC(C)(C)S(=O)(=O)c1cnc(N)nc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B14 compound treatment 1.0247 0.0247 0.48 0.4796 1.0 2071663 Maybridge1_004436 Cc1csc2sc(COC(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)c(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B15 compound treatment 1.0254 0.0254 0.49 0.4935 1.0 2071664 Maybridge1_004437 CSc1sc(C(=O)O)c(c1C#N)c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B16 compound treatment 1.0161 0.0161 0.31 0.3125 1.0 2071665 Maybridge1_004438 Cn1cncc1S(=O)(=O)/C(=N/Nc2ccc(OC(F)(F)F)cc2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B17 compound treatment 0.9946 -0.00542 -0.11 -0.1053 -1.0 2071666 Maybridge1_004439 Cn1ncc(C(=O)N=S(=O)(C)c2ccccc2)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B18 compound treatment 0.9967 -0.00327 -0.06 -0.0635 -1.0 1666267 Maybridge1_004440 CCOC(=O)c1sc(c2C(=O)CC(C)(C)Cc12)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B19 compound treatment 0.9652 -0.0348 -0.68 -0.6763 -1.0 1154613 Maybridge1_004441 CCCS(=O)(=O)c1cscc1NC(=O)c2c(C)onc2c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B20 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 2071667 Maybridge1_004442 COC(=O)c1sccc1N/C=C(\C#N)/C(=O)C2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B21 compound treatment 0.9587 -0.0413 -0.8 -0.8016 -1.0 2071668 Maybridge1_004443 O=S(=O)(CC#N)Cc1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B22 compound treatment 1.019 0.019 0.37 0.3682 1.0 2071669 Maybridge1_004444 CC(=O)OCc1ccc(/C=C(/C#N)\S(=O)(=O)c2ccccn2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B23 mock treatment 0.9695 -0.0305 -0.59 -0.5927 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 B24 mock treatment 0.9853 -0.0147 -0.29 -0.2863 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C01 compound treatment 1.029 0.029 0.56 0.5631 1.0 1573411 Maybridge1_004445 Clc1ccc(cc1)S(=O)(=O)CCNC2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C02 compound treatment 0.996 -0.00399 -0.08 -0.0775 -1.0 2071670 Maybridge1_004446 CSc1sc(C(=O)O)c(c1C#N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C03 compound treatment 0.9817 -0.0183 -0.36 -0.356 -1.0 2071671 Maybridge1_004447 Brc1ccc(N/N=C(\C#N)/C(=O)C2CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C04 compound treatment 1.0433 0.0433 0.84 0.8416 1.0 1522059 Maybridge1_004448 Cc1nc(ncc1S(=O)(=O)c2ccc(Cl)cc2)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C05 compound treatment 1.0362 0.0362 0.7 0.7024 1.0 2071672 Maybridge1_004449 Fc1cccc(Cl)c1CN/C(=C(\NCc2ccccc2Cl)/C#N)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C06 compound treatment 0.948 -0.052 -1.01 -1.0105 -1.0 2071673 Maybridge1_004450 Fc1ccc(SCC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C07 compound treatment 0.9853 -0.0147 -0.29 -0.2863 -1.0 2071674 Maybridge1_004451 Clc1ccc(cc1)S(=O)(=O)/C(=C/N2CCOCC2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C08 compound treatment 1.0046 0.00462 0.09 0.0896 1.0 2071675 Maybridge1_004452 COC(=O)CSCCS(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C09 compound treatment 0.9831 -0.0169 -0.33 -0.3281 -1.0 2071676 Maybridge1_004453 CN1c2ccccc2C(=O)/C(=N\Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F)/S1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C10 compound treatment 0.963 -0.037 -0.72 -0.718 -1.0 1609422 Maybridge1_004454 COc1cscc1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C11 compound treatment 0.9795 -0.0205 -0.4 -0.3977 -1.0 2071677 Maybridge1_004455 Nc1ccc(cc1)C2SCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C12 compound treatment 0.9931 -0.00686 -0.13 -0.1332 -1.0 2071678 Maybridge1_004456 COC(=O)c1scc(c1N)S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C13 compound treatment 0.981 -0.019 -0.37 -0.3699 -1.0 1673936 Maybridge1_004457 COCc1cc(=O)n2nc(cc2[nH]1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C14 compound treatment 1.0061 0.00605 0.12 0.1175 1.0 2071679 Maybridge1_004458 CC(=O)c1cnc2cc(C)nn2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C15 compound treatment 1.0225 0.0225 0.44 0.4378 1.0 1413264 Maybridge1_004459 CSc1nc(N)n2nc(cc2n1)C3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C16 compound treatment 0.9939 -0.00614 -0.12 -0.1192 -1.0 2071680 Maybridge1_004460 COC(=O)[C@H](CCSC)NC(=O)c1cccnc1SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C17 compound treatment 0.9931 -0.00686 -0.13 -0.1332 -1.0 2071681 Maybridge1_004461 CCOC(=O)/C(=N/Nc1cc(Cl)cc(Cl)c1)/C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C18 compound treatment 1.0003 3.14E-4 0.01 0.0061 1.0 2071682 Maybridge1_004462 CCCS(=O)(=O)/C(=C/Nc1ncccn1)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C19 compound treatment 1.0104 0.0104 0.2 0.201 1.0 2071683 Maybridge1_004463 N#CCSc1nc2ccccc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C20 compound treatment 1.0046 0.00462 0.09 0.0896 1.0 2071684 Maybridge1_004464 CCCS(=O)(=O)c1csc(C(=O)OC)c1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C21 compound treatment 0.9896 -0.0104 -0.2 -0.2028 -1.0 2071685 Maybridge1_004465 Cn1nc(cc1N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C22 compound treatment 0.9559 -0.0441 -0.86 -0.8573 -1.0 2071686 Maybridge1_004466 CS(=O)(=O)c1scc(c1C#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C23 mock treatment 0.9967 -0.00327 -0.06 -0.0635 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 C24 mock treatment 0.9781 -0.0219 -0.43 -0.4256 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D01 compound treatment 1.0089 0.00892 0.17 0.1732 1.0 2071687 Maybridge1_004467 Clc1ccc(N/C=C(\C#N)/S(=O)(=O)c2ccccn2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D02 compound treatment 1.0147 0.0147 0.28 0.2846 1.0 2071688 Maybridge1_004468 CC(C)S(=O)(=O)/C(=C/Nc1ccc(Cl)cc1)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D03 compound treatment 1.0154 0.0154 0.3 0.2985 1.0 1336734 Maybridge1_004469 CCOC(=O)c1cnc2n(C)nc(C)c2c1Oc3ccc(OC)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D04 compound treatment 1.0204 0.0204 0.4 0.396 1.0 2071689 Maybridge1_004470 CCCSc1sc(C(=O)OC)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D05 compound treatment 1.0276 0.0276 0.54 0.5353 1.0 1347108 Maybridge1_004471 COC(=O)C1=C(CSC1)Nc2ccccc2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D06 compound treatment 0.9824 -0.0176 -0.34 -0.342 -1.0 2071690 Maybridge1_004472 CCOC(=O)CSc1sc(C(=O)OCC)c2CCCC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D07 compound treatment 0.9781 -0.0219 -0.43 -0.4256 -1.0 2071691 Maybridge1_004473 CC1(C)OC(=O)C(=CNc2ccccn2)C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D08 compound treatment 0.9917 -0.00829 -0.16 -0.161 -1.0 2071692 Maybridge1_004474 CCO/C=C(\C#N)/S(=O)(=O)Cc1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D09 compound treatment 1.0017 0.00175 0.03 0.0339 1.0 2071693 Maybridge1_004475 COC(=O)c1sc(SC)c(c1N)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D10 compound treatment 0.9723 -0.0277 -0.54 -0.537 -1.0 2071694 Maybridge1_004476 CSc1sc(C#N)c2CCCC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D11 compound treatment 0.986 -0.014 -0.27 -0.2724 -1.0 1239901 Maybridge1_004477 CC(C)(C)S(=O)(=O)c1cnc(nc1N)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D12 compound treatment 0.9946 -0.00542 -0.11 -0.1053 -1.0 2071695 Maybridge1_004478 CCOC(=O)c1sc2sc(C#N)c(C)c2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D13 compound treatment 0.9989 -0.00112 -0.02 -0.0218 -1.0 2071696 Maybridge1_004479 Fc1ccc(NC(=O)CSc2cccs2)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D14 compound treatment 1.0061 0.00605 0.12 0.1175 1.0 2071697 Maybridge1_004480 CCOC(=O)c1sc(SC)c(C(=O)C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D15 compound treatment 0.9422 -0.0578 -1.12 -1.1219 -1.0 2071698 Maybridge1_004481 Cc1cscc1S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D16 compound treatment 0.9888 -0.0112 -0.22 -0.2167 -1.0 2071699 Maybridge1_004482 CCOC(=O)c1sc(SC)c2C(=O)CC(Cc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D17 compound treatment 0.9551 -0.0449 -0.87 -0.8712 -1.0 2071700 Maybridge1_004483 COC(=O)C(CCSC)NC(=O)c1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D18 compound treatment 0.9874 -0.0126 -0.24 -0.2446 -1.0 1555939 Maybridge1_004484 NNC(=O)CC1Sc2ccccc2NC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D19 compound treatment 0.9723 -0.0277 -0.54 -0.537 -1.0 1460263 Maybridge1_004485 CC(C)Sc1c(cnc2n(C)nc(C)c12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D20 compound treatment 1.0311 0.0311 0.6 0.6049 1.0 2071701 Maybridge1_004486 COC(=O)c1sccc1N/N=C(\C#N)/S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D21 compound treatment 0.9465 -0.0535 -1.04 -1.0383 -1.0 2071702 Maybridge1_004487 NNC(=O)CSCCS(=O)(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D22 compound treatment 0.9688 -0.0312 -0.61 -0.6066 -1.0 1417176 Maybridge1_004488 CCCSc1sc(C(=O)OCC)c2CCCC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D23 mock treatment 0.9702 -0.0298 -0.58 -0.5788 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 D24 mock treatment 1.0498 0.0498 0.97 0.9669 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E01 compound treatment 1.0469 0.0469 0.91 0.9112 1.0 2071703 Maybridge1_004489 Clc1cccc(/C=C(\C#N)/C(=O)C2CC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E02 compound treatment 1.0369 0.0369 0.72 0.7163 1.0 1003712 Maybridge1_004490 N#CCSc1ccc2ccccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E03 compound treatment 0.9924 -0.00757 -0.15 -0.1471 -1.0 2071704 Maybridge1_004491 Clc1ccc(N/N=C(\C#N)/C(=O)C2CC2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E04 compound treatment 0.9939 -0.00614 -0.12 -0.1192 -1.0 2071705 Maybridge1_004492 CN1c2ccccc2C(=O)/C(=C\Nc3ccc(F)cc3)/S1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E05 compound treatment 1.001 0.00103 0.02 0.02 1.0 2071706 Maybridge1_004493 O=C(NC(=S)Nc1cc(n[nH]1)c2cccs2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E06 compound treatment 0.9931 -0.00686 -0.13 -0.1332 -1.0 2071707 Maybridge1_004494 Fc1ccc(cc1)S(=O)(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E07 compound treatment 1.034 0.034 0.66 0.6606 1.0 2071708 Maybridge1_004495 CN(C)/C=C(\C#N)/S(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E08 compound treatment 1.0075 0.00748 0.15 0.1453 1.0 2071709 Maybridge1_004496 OC(=O)CSCCS(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E09 compound treatment 1.0139 0.0139 0.27 0.2707 1.0 2071710 Maybridge1_004497 NC(=S)Nc1ccccc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E10 compound treatment 0.9537 -0.0463 -0.9 -0.8991 -1.0 1632861 Maybridge1_004498 Clc1ccc(OCc2cccc(C#N)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E11 compound treatment 1.0211 0.0211 0.41 0.4099 1.0 2071711 Maybridge1_004499 Clc1ccc(cc1)S(=O)(=O)/C(=N/Nc2ccccc2Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E12 compound treatment 1.0075 0.00748 0.15 0.1453 1.0 1931850 Maybridge1_004500 OC(=O)CSCCS(=O)(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E13 compound treatment 1.0233 0.0233 0.45 0.4517 1.0 1613806 Maybridge1_004501 COCc1cc(=O)n2nc(C)cc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E14 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 2071712 Maybridge1_004502 Cc1cccc(c1)C(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E15 compound treatment 0.9874 -0.0126 -0.24 -0.2446 -1.0 2071713 Maybridge1_004503 CSc1c(C#N)c(nn1C)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E16 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 2071714 Maybridge1_004504 CC(C)(C)S(=O)(=O)/C(=C/N1CCOCC1)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E17 compound treatment 1.019 0.019 0.37 0.3682 1.0 2071715 Maybridge1_004505 CSc1nc(nc(c1C#N)c2ccccc2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E18 compound treatment 0.9473 -0.0527 -1.02 -1.0244 -1.0 2071716 Maybridge1_004506 FC(F)(F)c1cc(CN/C=C(\C#N)/S(=O)(=O)c2ccc(Cl)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E19 compound treatment 1.0147 0.0147 0.28 0.2846 1.0 2071717 Maybridge1_004507 Cc1n[nH]c(N)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E20 compound treatment 0.981 -0.019 -0.37 -0.3699 -1.0 2071718 Maybridge1_004508 COC(=O)c1scc(C#N)c1n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E21 compound treatment 1.0182 0.0182 0.35 0.3542 1.0 2071719 Maybridge1_004509 Clc1ccc(cc1)C(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E22 compound treatment 0.986 -0.014 -0.27 -0.2724 -1.0 2071720 Maybridge1_004510 CS(=O)(=O)c1csc(C(=O)O)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E23 mock treatment 0.9774 -0.0226 -0.44 -0.4395 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 E24 mock treatment 1.001 0.00103 0.02 0.02 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F01 compound treatment 1.0268 0.0268 0.52 0.5213 1.0 2071721 Maybridge1_004511 Clc1ccc(Sc2ccccc2/C=C(\C#N)/S(=O)(=O)c3ccc(Cl)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F02 compound treatment 1.039 0.039 0.76 0.7581 1.0 2071722 Maybridge1_004512 CC(=O)c1cc(ccc1Sc2ccc(Cl)cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F03 compound treatment 1.0046 0.00462 0.09 0.0896 1.0 1672437 Maybridge1_004513 CCOC(=O)c1cnc2n(C)nc(C)c2c1Oc3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F04 compound treatment 0.9767 -0.0233 -0.45 -0.4534 -1.0 1590459 Maybridge1_004514 NC(=S)c1ccc(cc1)C2OCCO2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F05 compound treatment 1.0283 0.0283 0.55 0.5492 1.0 2071723 Maybridge1_004515 CCSc1sc(C(=O)OC)c(c1C#N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F06 compound treatment 1.0161 0.0161 0.31 0.3125 1.0 1200963 Maybridge1_004516 CCOC(=O)c1sc(SC(C)C)c2c1-c3ccccc3N(C)S2(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F07 compound treatment 1.0211 0.0211 0.41 0.4099 1.0 2071724 Maybridge1_004517 Cc1cc(C)nc(NC=C2C(=O)OC(C)(C)OC2=O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F08 compound treatment 0.9967 -0.00327 -0.06 -0.0635 -1.0 2071725 Maybridge1_004518 COC(=O)c1scc(c1N)S(=O)(=O)Cc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F09 compound treatment 0.9745 -0.0255 -0.5 -0.4952 -1.0 2071726 Maybridge1_004519 COC(=O)c1sc(SC)c(C#N)c1c2ccc(OC)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F10 compound treatment 1.0096 0.00964 0.19 0.1871 1.0 2071727 Maybridge1_004520 CSc1sc(C#N)c2CCCC(O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F11 compound treatment 0.9881 -0.0119 -0.23 -0.2306 -1.0 2071728 Maybridge1_004521 COC(=O)c1sc(SC)c(c1SC)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F12 compound treatment 0.9953 -0.00471 -0.09 -0.0914 -1.0 1293398 Maybridge1_004522 CCOC(=O)c1sc(c2C(O)CCCc12)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F13 compound treatment 0.93 -0.07 -1.36 -1.3586 -1.0 1592097 Maybridge1_004523 CC(C)(C)S(=O)(=O)c1cnc(nc1N)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F14 compound treatment 1.0182 0.0182 0.35 0.3542 1.0 1445978 Maybridge1_004524 CCOC(=O)c1sc2sc(C(=O)c3ccc(Cl)cc3)c(C)c2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F15 compound treatment 0.9931 -0.00686 -0.13 -0.1332 -1.0 1390085 Maybridge1_004525 OC(=O)c1sc(SC2CCCCC2)c(C#N)c1c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F16 compound treatment 0.9494 -0.0506 -0.98 -0.9826 -1.0 2071729 Maybridge1_004526 CSc1sc(C#N)c(C)c1C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F17 compound treatment 1.0025 0.00246 0.05 0.0479 1.0 2071730 Maybridge1_004527 CC(C)S(=O)(=O)c1csc(C(=O)N)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F18 compound treatment 0.9745 -0.0255 -0.5 -0.4952 -1.0 2071731 Maybridge1_004528 CSc1sc(Br)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F19 compound treatment 1.0225 0.0225 0.44 0.4378 1.0 2071732 Maybridge1_004529 FC(F)(F)c1cc(n2ncc(C#N)c2n1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F20 compound treatment 1.0046 0.00462 0.09 0.0896 1.0 2071733 Maybridge1_004530 COC(=O)c1sccc1N/N=C(\C#N)/S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F21 compound treatment 0.9989 -0.00112 -0.02 -0.0218 -1.0 1083260 Maybridge1_004531 Cc1ccc(cc1)S(=O)(=O)N=S(=O)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F22 compound treatment 1.0261 0.0261 0.51 0.5074 1.0 1056221 Maybridge1_004532 CC(=C(C#N)C#N)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F23 mock treatment 1.0304 0.0304 0.59 0.591 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 F24 mock treatment 1.0297 0.0297 0.58 0.577 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G01 compound treatment 3.0389 2.04 39.6 39.5961 1.0 2071734 Maybridge1_004533 CN(C)c1ccc(/C=C(\C#N)/C(=O)C2CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G02 compound treatment 1.0218 0.0218 0.42 0.4239 1.0 2071735 Maybridge1_004534 O=S(=O)(CC#N)c1ccc2ccccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G03 compound treatment 1.0512 0.0512 0.99 0.9948 1.0 2071736 Maybridge1_004535 CC(C)(C)c1ccc(cc1)c2cc3nc(cc(n3n2)C(F)(F)F)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G04 compound treatment 1.0125 0.0125 0.24 0.2428 1.0 2071737 Maybridge1_004536 Cc1c(csc1C(=O)O)S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G05 compound treatment 0.991 -0.00901 -0.17 -0.1749 -1.0 2071738 Maybridge1_004537 Brc1ccc(N=Nc2c(NC(=S)NC(=O)c3ccccc3)[nH]nc2C4CC4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G06 compound treatment 1.0598 0.0598 1.16 1.1619 1.0 2071739 Maybridge1_004538 Clc1ccc(cc1Cl)S(=O)(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G07 compound treatment 1.0484 0.0484 0.94 0.9391 1.0 2071740 Maybridge1_004539 FC(F)(F)c1cc(N/C=C(\C#N)/S(=O)(=O)c2ccc(Cl)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G08 compound treatment 0.9967 -0.00327 -0.06 -0.0635 -1.0 2071741 Maybridge1_004540 CC1(C)CC(=O)C(=CNc2ccc(F)cc2F)C(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G09 compound treatment 1.0333 0.0333 0.65 0.6467 1.0 2071742 Maybridge1_004541 Clc1ccc(SCc2cccc(C#N)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G10 compound treatment 1.0139 0.0139 0.27 0.2707 1.0 2071743 Maybridge1_004542 CCSc1sc(C(=O)OC)c(c1C#N)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G11 compound treatment 0.963 -0.037 -0.72 -0.718 -1.0 2071744 Maybridge1_004543 Fc1ccc(N/N=C(\C#N)/S(=O)(=O)c2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G12 compound treatment 0.953 -0.047 -0.91 -0.913 -1.0 2071745 Maybridge1_004544 Cc1ccc(cc1)S(=O)(=O)/C(=N/O)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G13 compound treatment 0.9831 -0.0169 -0.33 -0.3281 -1.0 2071746 Maybridge1_004545 Cc1cc(C)n2ncc(/C(=N/OC(=O)c3ccccc3Cl)/N)c2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G14 compound treatment 1.0096 0.00964 0.19 0.1871 1.0 2071747 Maybridge1_004546 Clc1ccc(cc1)S(=O)(=O)CCSCCOC(=O)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G15 compound treatment 0.9781 -0.0219 -0.43 -0.4256 -1.0 2071748 Maybridge1_004547 Clc1ccc(cc1)S(=O)(=O)C(=C2SCCS2)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G16 compound treatment 0.9817 -0.0183 -0.36 -0.356 -1.0 2071749 Maybridge1_004548 CSc1ncccc1C(=O)NC(CC(C)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G17 compound treatment 1.0154 0.0154 0.3 0.2985 1.0 2071750 Maybridge1_004549 CCOC(=O)Cn1nc(C)c(Br)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G18 compound treatment 1.0082 0.0082 0.16 0.1593 1.0 2071751 Maybridge1_004550 COC(=O)c1scc(c1N)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G19 compound treatment 0.9802 -0.0198 -0.38 -0.3838 -1.0 2071752 Maybridge1_004551 CC1CN(CC(C)O1)/C=C(\C#N)/S(=O)(=O)Cc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G20 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 2071753 Maybridge1_004552 Nc1ccccc1SCCS(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G21 compound treatment 1.0046 0.00462 0.09 0.0896 1.0 2071754 Maybridge1_004553 CSc1nc(nc(c1C#N)c2ccccc2)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G22 compound treatment 1.0154 0.0154 0.3 0.2985 1.0 2071755 Maybridge1_004554 COC(=O)c1scc(c1I)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G23 mock treatment 1.0089 0.00892 0.17 0.1732 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 G24 mock treatment 0.9602 -0.0398 -0.77 -0.7737 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H01 compound treatment 1.0455 0.0455 0.88 0.8834 1.0 2071756 Maybridge1_004555 Clc1ccc(cc1)S(=O)(=O)/C(=C/Nc2ccc(Cl)cn2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H02 compound treatment 1.0333 0.0333 0.65 0.6467 1.0 2071757 Maybridge1_004556 CC(=O)c1cc([N+](=O)[O-])c(Sc2ccc(Cl)cc2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H03 compound treatment 0.9723 -0.0277 -0.54 -0.537 -1.0 1147627 Maybridge1_004557 CCOC(=O)c1cnc2n(C)nc(C)c2c1Oc3cc(Cl)cc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H04 compound treatment 1.0125 0.0125 0.24 0.2428 1.0 1550952 Maybridge1_004558 CCOC(=O)c1sc(SC(C)C)c2C(=O)CC(C)(C)Cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H05 compound treatment 1.0096 0.00964 0.19 0.1871 1.0 2071758 Maybridge1_004559 COC(=O)c1cc(Cl)cc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H06 compound treatment 1.0068 0.00677 0.13 0.1314 1.0 2071759 Maybridge1_004560 CSc1sc(C(=O)C)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H07 compound treatment 0.9924 -0.00757 -0.15 -0.1471 -1.0 2071760 Maybridge1_004561 CSc1sc(C(=O)O)c(c1C#N)c2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H08 compound treatment 1.019 0.019 0.37 0.3682 1.0 2071761 Maybridge1_004562 CCOC(=O)c1sc(SCc2ccc(Cl)cc2)c(c1N)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H09 compound treatment 0.9888 -0.0112 -0.22 -0.2167 -1.0 2071762 Maybridge1_004563 CSc1sc(C(=O)O)c(N)c1S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H10 compound treatment 1.0104 0.0104 0.2 0.201 1.0 1553259 Maybridge1_004564 CSc1sc(C(=O)NN)c2CCCC(O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H11 compound treatment 0.981 -0.019 -0.37 -0.3699 -1.0 2071763 Maybridge1_004565 COC(=O)c1sc(SC)c(c1I)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H12 compound treatment 1.0104 0.0104 0.2 0.201 1.0 2071764 Maybridge1_004566 CC(=O)c1sc2sc(C#N)c(C)c2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H13 compound treatment 1.0161 0.0161 0.31 0.3125 1.0 1735674 Maybridge1_004567 CC(C)(C)S(=O)(=O)c1cnc(nc1N)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H14 compound treatment 0.9946 -0.00542 -0.11 -0.1053 -1.0 2071765 Maybridge1_004568 CCOC(=O)c1sc2sc(C(=O)C)c(C)c2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H15 compound treatment 0.9903 -0.00973 -0.19 -0.1889 -1.0 2071766 Maybridge1_004569 CS(=O)(=NC(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H16 compound treatment 1.039 0.039 0.76 0.7581 1.0 2071767 Maybridge1_004570 CSc1sc(C(=O)O)c(C)c1C=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H17 compound treatment 0.9931 -0.00686 -0.13 -0.1332 -1.0 2071768 Maybridge1_004571 CNC(=S)NNC(=O)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H18 compound treatment 0.9795 -0.0205 -0.4 -0.3977 -1.0 2071769 Maybridge1_004572 COc1ccc(cc1)C2CC(=O)c3c(SCc4ccccc4)sc(C#N)c3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H19 compound treatment 0.958 -0.042 -0.82 -0.8155 -1.0 2071770 Maybridge1_004573 Cc1ccc(cc1)S(=O)(=O)/N=S\2/CCCSC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H20 compound treatment 1.0154 0.0154 0.3 0.2985 1.0 2071771 Maybridge1_004574 COC(=O)c1sccc1N/N=C(\C#N)/S(=O)(=O)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H21 compound treatment 0.9917 -0.00829 -0.16 -0.161 -1.0 2071772 Maybridge1_004575 O=C(CSCCS(=O)(=O)c1ccccc1)N/N=C/c2ccsc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H22 compound treatment 1.0032 0.00318 0.06 0.0618 1.0 2071773 Maybridge1_004576 O=S(=O)(CC#N)Cc1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H23 mock treatment 0.9523 -0.0477 -0.93 -0.9269 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 H24 mock treatment 1.034 0.034 0.66 0.6606 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I01 compound treatment 1.0512 0.0512 0.99 0.9948 1.0 1154606 Maybridge1_004577 Cc1nc2ccc(Br)cc2c(C(=O)O)c1I 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I02 compound treatment 0.9767 -0.0233 -0.45 -0.4534 -1.0 2071774 Maybridge1_004578 N/C(=N\OC(=O)c1ccc(Cl)cc1)/CS(=O)(=O)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I03 compound treatment 1.0254 0.0254 0.49 0.4935 1.0 2071775 Maybridge1_004579 Nc1[nH]nc(c1Br)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I04 compound treatment 1.0039 0.0039 0.08 0.0757 1.0 2071776 Maybridge1_004580 CN1c2ccccc2C(=O)/C(=C\Nc3ccccn3)/S1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I05 compound treatment 0.9917 -0.00829 -0.16 -0.161 -1.0 2071777 Maybridge1_004581 Clc1ccc(N=Nc2c(NC(=S)NC(=O)c3ccccc3)[nH]nc2C4CC4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I06 compound treatment 1.1093 0.109 2.12 2.1228 1.0 1023040 Maybridge1_004582 COc1ccc(cc1)C(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I07 compound treatment 0.9802 -0.0198 -0.38 -0.3838 -1.0 1033270 Maybridge1_004583 O=S(=O)(CC#N)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I08 compound treatment 1.0068 0.00677 0.13 0.1314 1.0 2071778 Maybridge1_004584 Fc1ccc(NC(=O)CSCCS(=O)(=O)c2ccc(Cl)cc2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I09 compound treatment 1.001 0.00103 0.02 0.02 1.0 2071779 Maybridge1_004585 CCOC(=O)c1[nH]c(C)c(C(=O)C)c1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I10 compound treatment 0.9931 -0.00686 -0.13 -0.1332 -1.0 2071780 Maybridge1_004586 N/C(=N\O)/c1cccc(COc2ccc(Cl)cc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I11 compound treatment 0.991 -0.00901 -0.17 -0.1749 -1.0 1706372 Maybridge1_004587 Fc1ccccc1C(=O)Nc2ccc(cc2)C3SCCS3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I12 compound treatment 0.9752 -0.0248 -0.48 -0.4813 -1.0 2071781 Maybridge1_004588 Nc1c(csc1C(=O)O)S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I13 compound treatment 0.9924 -0.00757 -0.15 -0.1471 -1.0 2071782 Maybridge1_004589 CC(C)(C)N/C=C(\C#N)/S(=O)(=O)c1ccc(Br)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I14 compound treatment 0.9702 -0.0298 -0.58 -0.5788 -1.0 2071783 Maybridge1_004590 CCSc1ncccc1C(=O)N[C@@H](CCSC)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I15 compound treatment 0.9702 -0.0298 -0.58 -0.5788 -1.0 2071784 Maybridge1_004591 COC(=O)c1sc(SC)c(C#N)c1c2cccc(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I16 compound treatment 0.9573 -0.0427 -0.83 -0.8294 -1.0 2071785 Maybridge1_004592 CSCCC(NC(=O)c1cccnc1SC)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I17 compound treatment 1.0118 0.0118 0.23 0.2289 1.0 2071786 Maybridge1_004593 Cc1nn(CC(=O)NN)c(C)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I18 compound treatment 0.9781 -0.0219 -0.43 -0.4256 -1.0 2071787 Maybridge1_004594 COC(=O)c1scc(c1N)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I19 compound treatment 1.0498 0.0498 0.97 0.9669 1.0 2071788 Maybridge1_004595 Clc1ccc(CS(=O)(=O)/C(=C/NCc2cccs2)/C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I20 compound treatment 0.9967 -0.00327 -0.06 -0.0635 -1.0 2071789 Maybridge1_004596 COC(=O)c1sc(SC)c(C(=O)C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I21 compound treatment 0.9573 -0.0427 -0.83 -0.8294 -1.0 2071790 Maybridge1_004597 Cc1nn(CC#N)c(C)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I22 compound treatment 0.9817 -0.0183 -0.36 -0.356 -1.0 2071791 Maybridge1_004598 CSc1nn2c(C)cc(C)nc2c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I23 mock treatment 1.0125 0.0125 0.24 0.2428 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 I24 mock treatment 0.9516 -0.0484 -0.94 -0.9408 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J01 compound treatment 1.0233 0.0233 0.45 0.4517 1.0 2071792 Maybridge1_004599 CC(C)S(=O)(=O)C/C(=N/OC(=O)c1cc(Cl)cc(Cl)c1)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J02 compound treatment 1.0276 0.0276 0.54 0.5353 1.0 1594963 Maybridge1_004600 NC(=S)CS(=O)(=O)Cc1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J03 compound treatment 1.0168 0.0168 0.33 0.3264 1.0 2071793 Maybridge1_004601 COC(=O)c1scc(c1Cl)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J04 compound treatment 1.0139 0.0139 0.27 0.2707 1.0 1638468 Maybridge1_004602 CCOC(=O)c1sc(SCc2ccccc2)c3C(=O)CC(C)(C)Cc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J05 compound treatment 1.0147 0.0147 0.28 0.2846 1.0 2071794 Maybridge1_004603 Clc1ccc(cc1)C(=O)O/N=C(\C#N)/S(=O)(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J06 compound treatment 0.9896 -0.0104 -0.2 -0.2028 -1.0 1255582 Maybridge1_004604 COC(=O)c1sccc1NS(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J07 compound treatment 0.9767 -0.0233 -0.45 -0.4534 -1.0 1569903 Maybridge1_004605 CC(C)S(=O)(=O)c1cnc(nc1N)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J08 compound treatment 1.0311 0.0311 0.6 0.6049 1.0 1326008 Maybridge1_004606 CCOC(=O)c1sc(SC)c2C(O)CCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J09 compound treatment 1.0025 0.00246 0.05 0.0479 1.0 2071795 Maybridge1_004607 COC(=O)c1scc(c1N/N=C(\C#N)/C(=O)c2ccc(Cl)cc2)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J10 compound treatment 1.0254 0.0254 0.49 0.4935 1.0 2071796 Maybridge1_004608 CC(=O)c1cc([N+](=O)[O-])c(SCCO)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J11 compound treatment 1.0125 0.0125 0.24 0.2428 1.0 2071797 Maybridge1_004609 COC(=O)c1sc(SC)c(c1N/N=C(\C#N)/S(=O)(=O)C(C)C)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J12 compound treatment 0.9752 -0.0248 -0.48 -0.4813 -1.0 2071798 Maybridge1_004610 COC(=O)c1sc(SC)c2/C(=N\O)/CC(C)(C)Cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J13 compound treatment 1.0032 0.00318 0.06 0.0618 1.0 2071799 Maybridge1_004611 COC(=O)C(CCSC)NS(=O)(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J14 compound treatment 0.9551 -0.0449 -0.87 -0.8712 -1.0 2071800 Maybridge1_004612 CCOC(=O)CSc1sc(C(=O)OCC)c(C)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J15 compound treatment 0.9688 -0.0312 -0.61 -0.6066 -1.0 2071801 Maybridge1_004613 CN(C)/C=C(\C#N)/S(=O)(=O)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J16 compound treatment 0.9974 -0.00255 -0.05 -0.0496 -1.0 2071802 Maybridge1_004614 COC(=O)c1cc(c(s1)S(=O)C)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J17 compound treatment 0.9774 -0.0226 -0.44 -0.4395 -1.0 2071803 Maybridge1_004615 Cn1c(S)nnc1c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J18 compound treatment 0.9967 -0.00327 -0.06 -0.0635 -1.0 2071804 Maybridge1_004616 COC(=O)c1sc2scc(C)c2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J19 compound treatment 0.9845 -0.0155 -0.3 -0.3003 -1.0 1717909 Maybridge1_004617 NC(=S)CS(=O)(=O)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J20 compound treatment 0.9688 -0.0312 -0.61 -0.6066 -1.0 1134337 Maybridge1_004618 CCOC(=O)c1sc(SCc2ccccc2)c3C(=O)CCCc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J21 compound treatment 1.0276 0.0276 0.54 0.5353 1.0 2071805 Maybridge1_004619 Cc1cc(C)nc(N/C=C(\C#N)/S(=O)(=O)Cc2ccco2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J22 compound treatment 0.9774 -0.0226 -0.44 -0.4395 -1.0 2071806 Maybridge1_004620 Cc1c(/C=N/O)c(=O)n(c2ccccc2)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J23 mock treatment 0.9709 -0.0291 -0.56 -0.5649 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 J24 mock treatment 1.0182 0.0182 0.35 0.3542 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K01 compound treatment 1.0484 0.0484 0.94 0.9391 1.0 1662640 Maybridge1_004621 O=C(Nc1cc(n[nH]1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K02 compound treatment 1.0161 0.0161 0.31 0.3125 1.0 2071807 Maybridge1_004622 CCO/C=C(\C#N)/S(=O)(=O)c1ccc2ccccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K03 compound treatment 0.9609 -0.0391 -0.76 -0.7598 -1.0 2071808 Maybridge1_004623 Clc1ccc(SCC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K04 compound treatment 0.9874 -0.0126 -0.24 -0.2446 -1.0 2071809 Maybridge1_004624 O/N=C(\C#N)/S(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K05 compound treatment 0.9838 -0.0162 -0.31 -0.3142 -1.0 2071810 Maybridge1_004625 COC(=O)c1cscc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K06 compound treatment 0.9716 -0.0284 -0.55 -0.5509 -1.0 2071811 Maybridge1_004626 O/N=C(/C#N)\S(=O)(=O)c1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K07 compound treatment 1.0061 0.00605 0.12 0.1175 1.0 2071812 Maybridge1_004627 CCO/C=C(\C#N)/S(=O)(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K08 compound treatment 1.0211 0.0211 0.41 0.4099 1.0 2071813 Maybridge1_004628 Nc1cc(n[nH]1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K09 compound treatment 0.9946 -0.00542 -0.11 -0.1053 -1.0 1194284 Maybridge1_004629 Nc1c(cnc2cc(nn12)c3ccccc3)S(=O)(=O)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K10 compound treatment 0.9903 -0.00973 -0.19 -0.1889 -1.0 1948797 Maybridge1_004630 CCOC(=O)c1cnc2cc(nn2c1C)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K11 compound treatment 1.029 0.029 0.56 0.5631 1.0 2071814 Maybridge1_004631 N/C=C(\C#N)/S(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K12 compound treatment 0.9896 -0.0104 -0.2 -0.2028 -1.0 2071815 Maybridge1_004632 Nc1cscc1S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K13 compound treatment 0.9924 -0.00757 -0.15 -0.1471 -1.0 1989025 Maybridge1_004633 CCOC(=O)c1cn[nH]c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K14 compound treatment 0.9566 -0.0434 -0.84 -0.8434 -1.0 2071816 Maybridge1_004634 CCSc1ncccc1C(=O)NC(CCSC)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K15 compound treatment 1.0476 0.0476 0.93 0.9252 1.0 2071817 Maybridge1_004635 CCO/C=C(\C#N)/S(=O)(=O)c1ccc(C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K16 compound treatment 0.9831 -0.0169 -0.33 -0.3281 -1.0 2071818 Maybridge1_004636 CC(C)(C)S(=O)(=O)/C(=C/N1CCCCC1)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K17 compound treatment 0.9767 -0.0233 -0.45 -0.4534 -1.0 2071819 Maybridge1_004637 Clc1ccc(CS(=O)(=O)CC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K18 compound treatment 0.9802 -0.0198 -0.38 -0.3838 -1.0 1360241 Maybridge1_004638 COC(=O)C1=C(CSC1)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K19 compound treatment 0.9939 -0.00614 -0.12 -0.1192 -1.0 2071820 Maybridge1_004639 CN(C)/C=C/1\C(=O)c2ccccc2N(C)S1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K20 compound treatment 0.9494 -0.0506 -0.98 -0.9826 -1.0 2071821 Maybridge1_004640 CSc1scc(c1C#N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K21 compound treatment 0.9781 -0.0219 -0.43 -0.4256 -1.0 2071822 Maybridge1_004641 COC(=O)c1sc(SC)c(c1N)S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K22 compound treatment 1.0225 0.0225 0.44 0.4378 1.0 1168939 Maybridge1_004642 CC(C)S(=O)(=O)c1csc(C(=O)O)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K23 mock treatment 0.9989 -0.00112 -0.02 -0.0218 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 K24 mock treatment 0.9982 -0.00184 -0.04 -0.0357 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L01 compound treatment 0.9924 -0.00757 -0.15 -0.1471 -1.0 2071823 Maybridge1_004643 Clc1ccc(CSc2cccs2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L02 compound treatment 1.0032 0.00318 0.06 0.0618 1.0 2071824 Maybridge1_004644 [O-][N+](=O)c1ccc(Sc2ccc(Cl)cc2)c(c1)c3cc[nH]n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L03 compound treatment 1.001 0.00103 0.02 0.02 1.0 2071825 Maybridge1_004645 O=S(=O)(CCSc1cccs1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L04 compound treatment 1.0068 0.00677 0.13 0.1314 1.0 1170462 Maybridge1_004646 CCOC(=O)c1sc(SC)c2c1-c3ccccc3N(C)S2(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L05 compound treatment 1.0046 0.00462 0.09 0.0896 1.0 2071826 Maybridge1_004647 CS(=O)c1noc(c1C#N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L06 compound treatment 0.9996 -4.03E-4 -0.01 -0.0078 -1.0 2071827 Maybridge1_004648 CSc1sc(C#N)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L07 compound treatment 0.9673 -0.0327 -0.63 -0.6345 -1.0 2071828 Maybridge1_004649 COC(=O)c1scc(c1N/N=C(\C#N)/C(=O)c2ccccc2)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L08 compound treatment 1.0462 0.0462 0.9 0.8973 1.0 1669213 Maybridge1_004650 CCOC(=O)c1sc(SCc2ccc(Cl)cc2)c3C(=O)CCCc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L09 compound treatment 0.9695 -0.0305 -0.59 -0.5927 -1.0 2071829 Maybridge1_004651 COC(=O)c1sc(SC)c2C(=O)CC(C)(C)Cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L10 compound treatment 1.0641 0.0641 1.25 1.2455 1.0 2071830 Maybridge1_004652 O=C1NCCSC1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L11 compound treatment 0.9781 -0.0219 -0.43 -0.4256 -1.0 1611340 Maybridge1_004653 CC(C)S(=O)(=O)c1cnc(nc1N)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L12 compound treatment 0.9702 -0.0298 -0.58 -0.5788 -1.0 2071831 Maybridge1_004654 CSc1sc(C(=O)NNC(=O)C)c2CCC=Cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L13 compound treatment 1.0347 0.0347 0.67 0.6745 1.0 2071832 Maybridge1_004655 CS(=O)(=O)c1sc(Cl)c(c1C#N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L14 compound treatment 1.0096 0.00964 0.19 0.1871 1.0 2071833 Maybridge1_004656 Cc1csc2sc(C(=O)N3CCOCC3)c(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L15 compound treatment 0.9731 -0.0269 -0.52 -0.5231 -1.0 2071834 Maybridge1_004657 CCOC(=O)c1sc(SC(C)CC)c(C#N)c1c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L16 compound treatment 0.9838 -0.0162 -0.31 -0.3142 -1.0 2071835 Maybridge1_004658 CCOC(=O)c1sc(SC)c2C(=O)CC(Cc12)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L17 compound treatment 0.9781 -0.0219 -0.43 -0.4256 -1.0 1322824 Maybridge1_004659 COC(=O)c1sc(N2CCOCC2)c(C#N)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L18 compound treatment 0.9989 -0.00112 -0.02 -0.0218 -1.0 2071836 Maybridge1_004660 CSc1sc(C#N)c(C)c1c2ccn(n2)S(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L19 compound treatment 0.9745 -0.0255 -0.5 -0.4952 -1.0 2071837 Maybridge1_004661 [O-][N+](=O)c1cc(ccc1Sc2ccc(Cl)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L20 compound treatment 0.9924 -0.00757 -0.15 -0.1471 -1.0 2071838 Maybridge1_004662 COC(=O)c1sccc1N/C=C(\C#N)/S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L21 compound treatment 1.001 0.00103 0.02 0.02 1.0 2071839 Maybridge1_004663 Cn1ncc(C(=O)N)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L22 compound treatment 0.9953 -0.00471 -0.09 -0.0914 -1.0 2071840 Maybridge1_004664 Cc1c(/C=N/OC(=O)c2ccc(Cl)cc2)c(=O)n(c3ccccc3)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L23 mock treatment 1.0096 0.00964 0.19 0.1871 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 L24 mock treatment 1.0233 0.0233 0.45 0.4517 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M01 compound treatment 1.0749 0.0749 1.45 1.4543 1.0 1122245 Maybridge1_004665 Clc1ccc(cc1)C(=O)Nc2cc(n[nH]2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M02 compound treatment 0.9967 -0.00327 -0.06 -0.0635 -1.0 2071841 Maybridge1_004666 CSc1[nH]nc(c1C#N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M03 compound treatment 1.0175 0.0175 0.34 0.3403 1.0 2071842 Maybridge1_004667 Fc1cccc(Cl)c1CN/C(=C(\NCc2cccs2)/C#N)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M04 compound treatment 0.9881 -0.0119 -0.23 -0.2306 -1.0 2071843 Maybridge1_004668 O/N=C(\C#N)/S(=O)(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M05 compound treatment 1.0125 0.0125 0.24 0.2428 1.0 2071844 Maybridge1_004669 CCOC(=O)c1nnc2cc(C)nn2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M06 compound treatment 0.9903 -0.00973 -0.19 -0.1889 -1.0 1023037 Maybridge1_004670 Clc1cccc(c1)C(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M07 compound treatment 1.0326 0.0326 0.63 0.6327 1.0 2071845 Maybridge1_004671 Cc1cc2nc3CSCc3c(O)n2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M08 compound treatment 0.963 -0.037 -0.72 -0.718 -1.0 2071846 Maybridge1_004672 Cc1cc2ncc(C(=O)O)c(C)n2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M09 compound treatment 1.024 0.024 0.47 0.4656 1.0 1917986 Maybridge1_004673 CCOC(=O)c1[nH]c(C)c(/C(=N/O)/C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M10 compound treatment 0.9688 -0.0312 -0.61 -0.6066 -1.0 2071847 Maybridge1_004674 CCOC(=O)c1cnc2cc(nn2c1C)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M11 compound treatment 1.0104 0.0104 0.2 0.201 1.0 2071848 Maybridge1_004675 Cc1ccc(cc1)S(=O)(=O)CCN(CCS(=O)(=O)c2ccc(C)cc2)c3ncccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M12 compound treatment 1.0104 0.0104 0.2 0.201 1.0 2071849 Maybridge1_004676 CSc1nc(C)nc(C2CC2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M13 compound treatment 1.001 0.00103 0.02 0.02 1.0 1147922 Maybridge1_004677 CN(C)C(=O)Oc1cc(C)c2c(C)nn(C)c2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M14 compound treatment 0.9838 -0.0162 -0.31 -0.3142 -1.0 2071850 Maybridge1_004678 CC(C)(C)S(=O)(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M15 compound treatment 0.9896 -0.0104 -0.2 -0.2028 -1.0 2071851 Maybridge1_004679 COC(=O)c1ccccc1SCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M16 compound treatment 0.9874 -0.0126 -0.24 -0.2446 -1.0 2071852 Maybridge1_004680 CCO/C=C(\C#N)/S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M17 compound treatment 1.024 0.024 0.47 0.4656 1.0 2071853 Maybridge1_004681 Cc1nn(c(C)c1[N+](=O)[O-])S(=O)(=O)c2ccc(Cl)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M18 compound treatment 0.9573 -0.0427 -0.83 -0.8294 -1.0 2071854 Maybridge1_004682 COC(=O)c1scc(c1n2cccc2)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M19 compound treatment 0.986 -0.014 -0.27 -0.2724 -1.0 2071855 Maybridge1_004683 Cc1cc2nnc(C(=O)O)c(C)n2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M20 compound treatment 0.9795 -0.0205 -0.4 -0.3977 -1.0 1303068 Maybridge1_004684 Cc1c(cnc2cc(nn12)C(C)(C)C)S(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M21 compound treatment 1.024 0.024 0.47 0.4656 1.0 2071856 Maybridge1_004685 CC(=O)CS(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M22 compound treatment 0.9738 -0.0262 -0.51 -0.5091 -1.0 1428823 Maybridge1_004686 CCOC(=O)c1c[nH]c2cc(C)nn2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M23 mock treatment 0.9652 -0.0348 -0.68 -0.6763 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 M24 mock treatment 1.0297 0.0297 0.58 0.577 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N01 compound treatment 1.0441 0.0441 0.86 0.8555 1.0 2071857 Maybridge1_004687 Clc1cccc(Cl)c1/C=C(\C#N)/S(=O)(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N02 compound treatment 1.039 0.039 0.76 0.7581 1.0 2071858 Maybridge1_004688 CSc1ccc(cc1c2cc[nH]n2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N03 compound treatment 0.9924 -0.00757 -0.15 -0.1471 -1.0 2071859 Maybridge1_004689 OC(=O)c1cccc(CSc2cccs2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N04 compound treatment 1.0247 0.0247 0.48 0.4796 1.0 2071860 Maybridge1_004690 CCCCSc1sc(C(=O)OCC)c2CCCC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N05 compound treatment 0.991 -0.00901 -0.17 -0.1749 -1.0 2071861 Maybridge1_004691 O=C(O/N=C(\C#N)/S(=O)(=O)c1cccs1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N06 compound treatment 1.001 0.00103 0.02 0.02 1.0 2071862 Maybridge1_004692 CC1(C)CC(=O)c2c(SCc3ccc(Cl)cc3)sc(C#N)c2C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N07 compound treatment 0.9688 -0.0312 -0.61 -0.6066 -1.0 1258455 Maybridge1_004693 CC(C)S(=O)(=O)c1cnc(nc1N)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N08 compound treatment 1.0405 0.0405 0.79 0.7859 1.0 2071863 Maybridge1_004694 O=S(=O)(Cc1ccco1)C(=C2SCCS2)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N09 compound treatment 0.9652 -0.0348 -0.68 -0.6763 -1.0 2071864 Maybridge1_004695 COc1ccc(cc1)c2c(C#N)c(SC)sc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N10 compound treatment 0.9917 -0.00829 -0.16 -0.161 -1.0 2071865 Maybridge1_004696 CSc1sc(C(=O)C)c(N)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N11 compound treatment 1.0376 0.0376 0.73 0.7302 1.0 1517019 Maybridge1_004697 CC(C)(C)S(=O)(=O)c1cnc(nc1N)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N12 compound treatment 1.0061 0.00605 0.12 0.1175 1.0 2071866 Maybridge1_004698 Nc1c(C#N)sc2sc(C#N)c(c3ccc(Cl)cc3)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N13 compound treatment 0.9838 -0.0162 -0.31 -0.3142 -1.0 2071867 Maybridge1_004699 CSc1sc(C(=O)O)c(Cl)c1S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N14 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 1183735 Maybridge1_004700 CSc1sc(C(=O)OCc2ccccc2)c3CC(C)(C)CC(=O)c13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N15 compound treatment 0.9623 -0.0377 -0.73 -0.732 -1.0 2071868 Maybridge1_004701 CCC(C)Sc1sc(C(=O)O)c(c1C#N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N16 compound treatment 1.0197 0.0197 0.38 0.3821 1.0 2071869 Maybridge1_004702 N/C(=C(/N=C/c1ccccc1Sc2ccc(Cl)cc2)\C#N)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N17 compound treatment 0.9731 -0.0269 -0.52 -0.5231 -1.0 2071870 Maybridge1_004703 CNC(=S)NNC(=O)Cn1nc(C)c(Br)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N18 compound treatment 1.0225 0.0225 0.44 0.4378 1.0 2071871 Maybridge1_004704 COC(=O)c1sccc1N/N=C(\C#N)/C(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N19 compound treatment 0.9831 -0.0169 -0.33 -0.3281 -1.0 2071872 Maybridge1_004705 CSc1n[nH]c(N)c1S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N20 compound treatment 0.9465 -0.0535 -1.04 -1.0383 -1.0 2071873 Maybridge1_004706 CC(=O)OCc1ccc(/C=C(\C#N)/S(=O)(=O)c2cccs2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N21 compound treatment 1.0003 3.14E-4 0.01 0.0061 1.0 2071874 Maybridge1_004707 Cc1nc(no1)c2cccc(CSc3nnc(n3C)C(F)(F)F)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N22 compound treatment 0.986 -0.014 -0.27 -0.2724 -1.0 2071875 Maybridge1_004708 CS(=O)c1sc(C#N)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N23 mock treatment 0.981 -0.019 -0.37 -0.3699 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 N24 mock treatment 1.001 0.00103 0.02 0.02 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O01 compound treatment 1.0828 0.0828 1.61 1.6075 1.0 1610946 Maybridge1_004709 Clc1ccc(cc1)C(=O)Nc2[nH]nc(c2Br)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O02 compound treatment 0.9673 -0.0327 -0.63 -0.6345 -1.0 2071876 Maybridge1_004710 O=S(=O)(CC#N)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O03 compound treatment 1.0448 0.0448 0.87 0.8695 1.0 2071877 Maybridge1_004711 Cc1cc(O)n2nc(c(Br)c2n1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O04 compound treatment 1.0268 0.0268 0.52 0.5213 1.0 2071878 Maybridge1_004712 Cc1c(csc1C(=O)NN)S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O05 compound treatment 1.072 0.072 1.4 1.3986 1.0 2071879 Maybridge1_004713 COc1cscc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O06 compound treatment 0.9931 -0.00686 -0.13 -0.1332 -1.0 2071880 Maybridge1_004714 Cc1ccc(cc1)C(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O07 compound treatment 1.0247 0.0247 0.48 0.4796 1.0 2071881 Maybridge1_004715 CN1c2ccccc2C(=O)/C(=N\Nc3ccccc3F)/S1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O08 compound treatment 0.9723 -0.0277 -0.54 -0.537 -1.0 2071882 Maybridge1_004716 N/C(=N\O)/c1cccc(CS(=O)(=O)c2ccccn2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O09 compound treatment 1.019 0.019 0.37 0.3682 1.0 2071883 Maybridge1_004717 Fc1ccc(N/C(=C\C#N)/c2ccccc2Cl)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O10 compound treatment 0.963 -0.037 -0.72 -0.718 -1.0 1586034 Maybridge1_004718 CCOC(=O)c1cnc2cc(nn2c1C)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O11 compound treatment 1.0096 0.00964 0.19 0.1871 1.0 1435418 Maybridge1_004719 Cc1ccc(cc1)S(=O)(=O)CCN2CCN(CCS(=O)(=O)c3ccc(C)cc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O12 compound treatment 0.9838 -0.0162 -0.31 -0.3142 -1.0 2071884 Maybridge1_004720 OCCSCCS(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O13 compound treatment 1.0075 0.00748 0.15 0.1453 1.0 2071885 Maybridge1_004721 CSc1nc(N)n2nc(C)cc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O14 compound treatment 0.9709 -0.0291 -0.56 -0.5649 -1.0 1329939 Maybridge1_004722 COc1ncccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O15 compound treatment 0.9831 -0.0169 -0.33 -0.3281 -1.0 2071886 Maybridge1_004723 CCOC(=O)/C(=N\Nc1ccc(F)cc1F)/C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O16 compound treatment 0.9666 -0.0334 -0.65 -0.6484 -1.0 1061097 Maybridge1_004724 Cc1cc(C)c2ccc(N)nc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O17 compound treatment 0.9867 -0.0133 -0.26 -0.2585 -1.0 2071887 Maybridge1_004725 COc1sc(/C=N/O)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O18 compound treatment 0.9874 -0.0126 -0.24 -0.2446 -1.0 2071888 Maybridge1_004726 COC(=O)c1scc(c1Cl)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O19 compound treatment 0.9594 -0.0406 -0.79 -0.7877 -1.0 2071889 Maybridge1_004727 O=S(=O)(CC#N)c1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O20 compound treatment 0.9695 -0.0305 -0.59 -0.5927 -1.0 1521014 Maybridge1_004728 Clc1ccc(cc1)c2cc3ncc(cn3n2)S(=O)(=O)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O21 compound treatment 0.9881 -0.0119 -0.23 -0.2306 -1.0 2071890 Maybridge1_004729 COC(=O)c1sc(SC)c(C#N)c1c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O22 compound treatment 1.0132 0.0132 0.26 0.2568 1.0 1278022 Maybridge1_004730 CCOC(=O)c1cnc2n(C)nc(C)c2c1Sc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O23 mock treatment 0.9939 -0.00614 -0.12 -0.1192 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 O24 mock treatment 0.9709 -0.0291 -0.56 -0.5649 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P01 compound treatment 1.0333 0.0333 0.65 0.6467 1.0 2071891 Maybridge1_004731 N/C(=N\O)/CS(=O)(=O)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P02 compound treatment 1.0082 0.0082 0.16 0.1593 1.0 2071892 Maybridge1_004732 Brc1ccc(s1)c2cc[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P03 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 2071893 Maybridge1_004733 Cc1cc(nc2c([N+](=O)[O-])c(nn12)C(C)(C)C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P04 compound treatment 1.0046 0.00462 0.09 0.0896 1.0 1542166 Maybridge1_004734 CCOC(=O)c1sc(SC(C)C)c2C(=O)CCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P05 compound treatment 0.9967 -0.00327 -0.06 -0.0635 -1.0 2071894 Maybridge1_004735 CC1(C)OC(=O)C(=CNc2ccc(F)c(Cl)c2)C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P06 compound treatment 1.0605 0.0605 1.18 1.1758 1.0 2071895 Maybridge1_004736 CSc1sc(C(=O)/C=C/N(C)C)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P07 compound treatment 0.9853 -0.0147 -0.29 -0.2863 -1.0 2071896 Maybridge1_004737 CSC(=C(C#N)S(=O)(=O)C(C)C)SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P08 compound treatment 1.0276 0.0276 0.54 0.5353 1.0 2071897 Maybridge1_004738 CCOC(=O)c1sc(SC)c(C#N)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P09 compound treatment 0.9888 -0.0112 -0.22 -0.2167 -1.0 1253540 Maybridge1_004739 CCCS(=O)(=O)c1cnc(C)nc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P10 compound treatment 1.0412 0.0412 0.8 0.7998 1.0 2071898 Maybridge1_004740 Cc1c(sc2sc(C(=O)O)c(C)c12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P11 compound treatment 0.9931 -0.00686 -0.13 -0.1332 -1.0 1012008 Maybridge1_004741 CN(C)CCC(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P12 compound treatment 1.0068 0.00677 0.13 0.1314 1.0 2071899 Maybridge1_004742 Cc1csc2sc(CO)c(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P13 compound treatment 1.0175 0.0175 0.34 0.3403 1.0 2071900 Maybridge1_004743 CSc1sc(C(=O)O)c(C)c1C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P14 compound treatment 0.9903 -0.00973 -0.19 -0.1889 -1.0 1410702 Maybridge1_004744 CSc1sc(C(=O)OCC=C)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P15 compound treatment 0.9974 -0.00255 -0.05 -0.0496 -1.0 2071901 Maybridge1_004745 CSc1sc(Br)c(Cl)c1S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P16 compound treatment 0.9774 -0.0226 -0.44 -0.4395 -1.0 1123577 Maybridge1_004746 CCOC(=O)CC1Sc2ccccc2NC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P17 compound treatment 0.9824 -0.0176 -0.34 -0.342 -1.0 1646261 Maybridge1_004747 COC(=O)c1sc(N2CCCCC2)c(C#N)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P18 compound treatment 0.996 -0.00399 -0.08 -0.0775 -1.0 2071902 Maybridge1_004748 COC(=O)c1sccc1N/N=C(\C#N)/C(=O)c2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P19 compound treatment 0.9874 -0.0126 -0.24 -0.2446 -1.0 1280343 Maybridge1_004749 Cc1ccc(cc1)S(=O)(=O)N=S2(=O)CCCS(=O)(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P20 compound treatment 0.9967 -0.00327 -0.06 -0.0635 -1.0 2071903 Maybridge1_004750 CC(=O)OCc1ccc(/C=C(\C#N)/S(=O)(=O)c2ccc(Cl)cc2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P21 compound treatment 0.9896 -0.0104 -0.2 -0.2028 -1.0 2071904 Maybridge1_004751 CC(C)(C)OC(=O)NC(CC(=O)N)C(=O)Oc1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P22 compound treatment 1.0182 0.0182 0.35 0.3542 1.0 2071905 Maybridge1_004752 CC1(C)CC(=O)c2c(sc(C#N)c2C1)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P23 mock treatment 0.9817 -0.0183 -0.36 -0.356 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.554 P24 mock treatment 1.0548 0.0548 1.06 1.0644 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A01 compound treatment 1.0604 0.0604 1.17 1.1736 1.0 1151876 Maybridge1_004753 CCOC(=O)c1sc(SCC)c2C(=O)CC(C)(C)Cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A02 compound treatment 1.0171 0.0171 0.33 0.3325 1.0 3177140 Maybridge1_004754 Cc1cc(C)c(c(C)c1)S(=O)(=O)O.Clc1ccc(cc1)S(=N)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A03 compound treatment 1.0648 0.0648 1.26 1.2577 1.0 2071907 Maybridge1_004755 CCSc1sc(C#N)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A04 compound treatment 1.0929 0.0929 1.8 1.8045 1.0 3177141 Maybridge1_004756 CS(=N)c1ccsc1.Cc1cc(C)c(c(C)c1)S(=O)(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A05 compound treatment 1.0446 0.0446 0.87 0.8652 1.0 1678777 Maybridge1_004757 NS(=O)(=O)c1ccc(Sc2ccc(Cl)cc2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A06 compound treatment 1.0092 0.00918 0.18 0.1783 1.0 1150718 Maybridge1_004758 NNC(=O)C1SCCN1S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A07 compound treatment 1.0583 0.0583 1.13 1.1316 1.0 2071909 Maybridge1_004759 COc1ccc(cc1)c2ccnc(S)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A08 compound treatment 1.033 0.033 0.64 0.6409 1.0 2071910 Maybridge1_004760 OC(=O)c1ccc(CSc2ccc(cn2)C(F)(F)F)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A09 compound treatment 1.0236 0.0236 0.46 0.4587 1.0 2071911 Maybridge1_004761 O=C(NCc1cccs1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A10 compound treatment 1.0005 5.19E-4 0.01 0.0101 1.0 2071912 Maybridge1_004762 CSc1ccc(OC(=O)Nc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A11 compound treatment 1.0005 5.19E-4 0.01 0.0101 1.0 2071913 Maybridge1_004763 CSc1nnc(c2cccs2)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A12 compound treatment 1.0121 0.0121 0.23 0.2344 1.0 1448822 Maybridge1_004764 NNC(=O)CNS(=O)(=O)c1cccc2nsnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A13 compound treatment 1.0012 0.00124 0.02 0.0241 1.0 2071914 Maybridge1_004765 CNc1ccc(CSc2ccc(cn2)C(F)(F)F)cc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A14 compound treatment 1.0041 0.00413 0.08 0.0802 1.0 1026900 Maybridge1_004766 N=C(Nc1ccccc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A15 compound treatment 1.0308 0.0308 0.6 0.5989 1.0 2071915 Maybridge1_004767 CCOC(=O)c1ncn(Cc2ccc(Cl)cc2)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A16 compound treatment 0.989 -0.011 -0.21 -0.2142 -1.0 2071916 Maybridge1_004768 Clc1ccc2nonc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A17 compound treatment 1.0128 0.0128 0.25 0.2484 1.0 2071917 Maybridge1_004769 Cc1nc(ncc1S(=O)(=O)c2ccc(Cl)cc2)c3cnccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A18 compound treatment 1.0525 0.0525 1.02 1.0194 1.0 1087586 Maybridge1_004770 Cc1ccc(Sc2ccc([N+](=O)[O-])c3nonc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A19 compound treatment 1.0308 0.0308 0.6 0.5989 1.0 2071918 Maybridge1_004771 FC(F)(F)c1ccc(nc1)S(=O)(=O)/C(=C/Nc2ccc3OCCOc3c2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A20 compound treatment 0.9745 -0.0255 -0.49 -0.4946 -1.0 1774528 Maybridge1_004772 OC(=O)Cc1n[nH]c(=O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A21 compound treatment 1.0193 0.0193 0.37 0.3746 1.0 2071919 Maybridge1_004773 COC(=O)c1cccc(CSc2nnc(n2C)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A22 compound treatment 1.0049 0.00485 0.09 0.0942 1.0 1507929 Maybridge1_004774 COC(=O)c1sccc1NS(=O)(=O)c2cccc3nsnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A23 mock treatment 1.0359 0.0359 0.7 0.697 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 A24 mock treatment 1.0467 0.0467 0.91 0.9073 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B01 compound treatment 1.064 0.064 1.24 1.2437 1.0 1573898 Maybridge1_004775 CC1=Cn2n(C1)c(=O)c3ccccc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B02 compound treatment 1.0099 0.0099 0.19 0.1923 1.0 2071920 Maybridge1_004776 CC1=CS(=O)(=O)c2ccc(Cl)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B03 compound treatment 1.0099 0.0099 0.19 0.1923 1.0 2071921 Maybridge1_004777 NNC(=O)CSc1cc(nc2ccccc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B04 compound treatment 1.0077 0.00774 0.15 0.1503 1.0 2071922 Maybridge1_004778 [O-][N+](=O)c1ccc(cc1)N2CCC(CC2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B05 compound treatment 1.0049 0.00485 0.09 0.0942 1.0 1644315 Maybridge1_004779 Clc1ccccc1n2cc(C#N)c(=O)[nH]c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B06 compound treatment 1.046 0.046 0.89 0.8933 1.0 2071923 Maybridge1_004780 CCOC(=O)NC(=O)/C(=C/Nc1sc(C)c(C)c1C(=O)OCC)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B07 compound treatment 0.994 -0.00598 -0.12 -0.1161 -1.0 1717562 Maybridge1_004781 CC(C)n1cc(C(=S)N)c(=O)n(Cc2ccccc2)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B08 compound treatment 0.976 -0.024 -0.47 -0.4666 -1.0 2071924 Maybridge1_004782 CC(=O)Nc1cc(n[nH]1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B09 compound treatment 1.028 0.028 0.54 0.5428 1.0 2071925 Maybridge1_004783 O=C1N(CCCCN2CCN(CC2)C(c3ccccc3)c4ccccc4)C(=O)c5ccccc15 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B10 compound treatment 1.0063 0.00629 0.12 0.1222 1.0 2071926 Maybridge1_004784 CN1CCN(CC1)/C=C(\C#N)/S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B11 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2071927 Maybridge1_004785 FC(F)(F)c1ccc(nc1)n2ccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B12 compound treatment 0.9854 -0.0146 -0.28 -0.2843 -1.0 1042218 Maybridge1_004786 OC(=O)c1cc2cccc([N+](=O)[O-])c2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B13 compound treatment 0.9356 -0.0644 -1.25 -1.2516 -1.0 2071928 Maybridge1_004787 O/N=C/c1ccc(C#Cc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B14 compound treatment 1.0409 0.0409 0.8 0.7951 1.0 2071929 Maybridge1_004788 O/N=C/1\CCCc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B15 compound treatment 0.9868 -0.0132 -0.26 -0.2563 -1.0 1076140 Maybridge1_004789 CSc1ncc(C#N)c(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B16 compound treatment 0.9803 -0.0197 -0.38 -0.3824 -1.0 2071930 Maybridge1_004790 CN(C)c1ncnc(N(C)C)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B17 compound treatment 0.9991 -9.25E-4 -0.02 -0.018 -1.0 2071931 Maybridge1_004791 COC(=O)C(C#N)c1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B18 compound treatment 0.9947 -0.00526 -0.1 -0.1021 -1.0 2071932 Maybridge1_004792 CCCCC#Cc1ccc(o1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B19 compound treatment 1.0157 0.0157 0.3 0.3045 1.0 1585976 Maybridge1_004793 NC(=O)CCOC1CCN(Cc2ccccc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B20 compound treatment 0.9854 -0.0146 -0.28 -0.2843 -1.0 2071933 Maybridge1_004794 CCOC(=O)CCN(Cc1ccco1)S(=O)(=O)c2ccc(s2)c3ccnc(SC)n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B21 compound treatment 0.9666 -0.0334 -0.65 -0.6488 -1.0 2071934 Maybridge1_004795 CSc1nn(cc1C(=S)N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B22 compound treatment 1.0243 0.0243 0.47 0.4727 1.0 1302174 Maybridge1_004796 Cc1ccccc1n2c(N)cc(=O)[nH]c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B23 mock treatment 0.968 -0.032 -0.62 -0.6208 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 B24 mock treatment 1.0352 0.0352 0.68 0.683 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C01 compound treatment 0.9998 -2.03E-4 0.0 -0.0039 -1.0 2071935 Maybridge1_004797 CC1(C)CC(=O)c2c(sc(Br)c2C1)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C02 compound treatment 1.0113 0.0113 0.22 0.2204 1.0 2071936 Maybridge1_004798 FC(F)(F)c1cnc(Sc2cccs2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C03 compound treatment 1.0265 0.0265 0.51 0.5148 1.0 1490688 Maybridge1_004799 CSc1sc(C(=S)N)c2CCCC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C04 compound treatment 0.9774 -0.0226 -0.44 -0.4385 -1.0 3177144 Maybridge1_004800 CS(=N)c1ncc(Cl)cc1C(F)(F)F.Cc1cc(C)c(c(C)c1)S(=O)(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C05 compound treatment 1.0705 0.0705 1.37 1.3699 1.0 2071938 Maybridge1_004801 NNS(=O)(=O)c1ccc(s1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C06 compound treatment 0.9991 -9.25E-4 -0.02 -0.018 -1.0 2071939 Maybridge1_004802 CC(=O)c1ccc2OCCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C07 compound treatment 1.0121 0.0121 0.23 0.2344 1.0 2071940 Maybridge1_004803 NC(=S)CSc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C08 compound treatment 1.0106 0.0106 0.21 0.2063 1.0 2071941 Maybridge1_004804 C1Cc2cc(ccc2O1)c3cc[nH]n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C09 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 2071942 Maybridge1_004805 O=S(=O)(NCc1cccs1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C10 compound treatment 0.9854 -0.0146 -0.28 -0.2843 -1.0 2071943 Maybridge1_004806 COC(=O)c1cccc(Cn2nc(C)c(Br)c2C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C11 compound treatment 1.0215 0.0215 0.42 0.4166 1.0 1920568 Maybridge1_004807 Clc1ccc(NC(=O)c2cccs2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C12 compound treatment 0.9789 -0.0211 -0.41 -0.4105 -1.0 1087839 Maybridge1_004808 COc1ccc2nonc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C13 compound treatment 0.9984 -0.00165 -0.03 -0.032 -1.0 1068635 Maybridge1_004809 O=S(=O)(c1cccs1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C14 compound treatment 1.028 0.028 0.54 0.5428 1.0 2071944 Maybridge1_004810 Sc1nnc(CSCCOc2ccc(Cl)cc2Cl)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C15 compound treatment 1.0272 0.0272 0.53 0.5288 1.0 2071945 Maybridge1_004811 [O-][N+](=O)c1cc(cs1)S(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C16 compound treatment 0.9875 -0.0125 -0.24 -0.2423 -1.0 2071946 Maybridge1_004812 C/C(=N\O)/c1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C17 compound treatment 1.0424 0.0424 0.82 0.8232 1.0 2071947 Maybridge1_004813 CS(=O)(=O)c1sc(Cl)c2CCCC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C18 compound treatment 3.5531 2.55 49.58 49.5803 1.0 2071948 Maybridge1_004814 [O-][N+](=O)c1ccc(N2CCCCC2)c3nonc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C19 compound treatment 1.0207 0.0207 0.4 0.4026 1.0 2071949 Maybridge1_004815 CC1(C)CCc2cc(/C=C(\C#N)/S(=O)(=O)C)ccc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C20 compound treatment 1.0157 0.0157 0.3 0.3045 1.0 1517114 Maybridge1_004816 CCOC(=O)Cc1n[nH]c(=O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C21 compound treatment 0.9789 -0.0211 -0.41 -0.4105 -1.0 2071950 Maybridge1_004817 CSc1sc(c2cc[nH]n2)c(c1C#N)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C22 compound treatment 0.9724 -0.0276 -0.54 -0.5367 -1.0 1032639 Maybridge1_004818 COc1cc(Cl)c(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C23 mock treatment 0.9839 -0.0161 -0.31 -0.3124 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 C24 mock treatment 0.9868 -0.0132 -0.26 -0.2563 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D01 compound treatment 1.0568 0.0568 1.1 1.1035 1.0 2071951 Maybridge1_004819 Oc1cc(nc2cc(Cl)cc(Cl)c12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D02 compound treatment 1.033 0.033 0.64 0.6409 1.0 2071952 Maybridge1_004820 COc1ccc(cc1)C(=O)/C(=C/NC2CCN(Cc3ccccc3)CC2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D03 compound treatment 1.0272 0.0272 0.53 0.5288 1.0 1578495 Maybridge1_004821 NC(=O)C1CCN(CCS(=O)(=O)c2ccc(Cl)cc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D04 compound treatment 1.0113 0.0113 0.22 0.2204 1.0 2071953 Maybridge1_004822 COC(=O)c1cc(ccc1N2CCC(CC2)n3cccc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D05 compound treatment 1.0012 0.00124 0.02 0.0241 1.0 2071954 Maybridge1_004823 [O-][N+](=O)c1c(Sc2ccc(cn2)C(F)(F)F)ncnc1Sc3ccc(cn3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D06 compound treatment 1.0236 0.0236 0.46 0.4587 1.0 1005737 Maybridge1_004824 [O-][N+](=O)c1cccc(C=C(C#N)C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D07 compound treatment 0.9933 -0.0067 -0.13 -0.1301 -1.0 2071955 Maybridge1_004825 NCCSc1cc(nc2ccccc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D08 compound treatment 1.0352 0.0352 0.68 0.683 1.0 1144898 Maybridge1_004826 Cc1nn(C)c2ncc3c(=O)[nH]n(C)c3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D09 compound treatment 0.9716 -0.0284 -0.55 -0.5507 -1.0 2071956 Maybridge1_004827 CNc1ncnc(Oc2cccc(c2)C(F)(F)F)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D10 compound treatment 1.0287 0.0287 0.56 0.5568 1.0 2071957 Maybridge1_004828 Cn1c(S)nnc1CSCC(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D11 compound treatment 0.9832 -0.0168 -0.33 -0.3264 -1.0 2071958 Maybridge1_004829 O=C(Nc1cccc(C#C)c1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D12 compound treatment 1.0171 0.0171 0.33 0.3325 1.0 1634031 Maybridge1_004830 CCCn1c(=O)c(C#N)cn(c2ccc(Cl)cc2)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D13 compound treatment 0.9926 -0.00742 -0.14 -0.1441 -1.0 2071959 Maybridge1_004831 CC(C)(O)C#Cc1ccc(/C=N/O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D14 compound treatment 0.9882 -0.0118 -0.23 -0.2282 -1.0 1465353 Maybridge1_004832 COc1ccc(cc1OC2CCCC2)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D15 compound treatment 0.9738 -0.0262 -0.51 -0.5086 -1.0 1914741 Maybridge1_004833 OC(=O)CSc1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D16 compound treatment 1.033 0.033 0.64 0.6409 1.0 2071960 Maybridge1_004834 CCCCC#Cc1cncc(c1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D17 compound treatment 1.0157 0.0157 0.3 0.3045 1.0 1341007 Maybridge1_004835 Clc1ccc(cc1Cl)C(=O)CSC2=NCCc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D18 compound treatment 0.9457 -0.0543 -1.06 -1.0553 -1.0 2071961 Maybridge1_004836 Oc1cc(nc2c(cccc12)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D19 compound treatment 1.0099 0.0099 0.19 0.1923 1.0 2071962 Maybridge1_004837 CN(C)CC#Cc1cccc(/C=N/O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D20 compound treatment 1.0373 0.0373 0.73 0.725 1.0 2071963 Maybridge1_004838 CCOC(=O)c1ccc2nonc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D21 compound treatment 0.9745 -0.0255 -0.49 -0.4946 -1.0 2071964 Maybridge1_004839 NC(=O)C1CCN(CC1)c2ncc(Cl)cc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D22 compound treatment 1.0215 0.0215 0.42 0.4166 1.0 2071965 Maybridge1_004840 Cn1c(SCC(=O)Nc2ccc(cc2)C(F)(F)F)nnc1c3ccc4nonc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D23 mock treatment 0.9745 -0.0255 -0.49 -0.4946 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 D24 mock treatment 1.0272 0.0272 0.53 0.5288 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E01 compound treatment 1.0431 0.0431 0.84 0.8372 1.0 1679279 Maybridge1_004841 CCOC(=O)c1sc(SCC=C)c2C(=O)CCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E02 compound treatment 1.0496 0.0496 0.96 0.9634 1.0 2071966 Maybridge1_004842 CCOC(=O)c1ccc(Oc2sccc2[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E03 compound treatment 1.0323 0.0323 0.63 0.6269 1.0 2071967 Maybridge1_004843 Clc1ccc(cc1)S(=O)(=O)CCN(Cc2cccs2)/C=C(\C#N)/S(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E04 compound treatment 0.9955 -0.00453 -0.09 -0.0881 -1.0 2071968 Maybridge1_004844 FC(F)(F)c1cccc(NC(=O)Nc2cnn3c(cc(nc23)C(F)(F)F)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E05 compound treatment 1.0157 0.0157 0.3 0.3045 1.0 2071969 Maybridge1_004845 Clc1ccc(/C=N/NS(=O)(=O)c2ccc(s2)c3ccccn3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E06 compound treatment 1.0106 0.0106 0.21 0.2063 1.0 1313983 Maybridge1_004846 CC(=O)N1CCSC1C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E07 compound treatment 1.0301 0.0301 0.58 0.5848 1.0 1397201 Maybridge1_004847 CCOC(=O)c1c(C)nsc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E08 compound treatment 0.9716 -0.0284 -0.55 -0.5507 -1.0 2071970 Maybridge1_004848 FC(F)(F)c1ccc(SCc2ccc(o2)C(=O)Oc3ccccc3)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E09 compound treatment 1.0193 0.0193 0.37 0.3746 1.0 2071971 Maybridge1_004849 Cn1c(S)nnc1CSc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E10 compound treatment 1.0092 0.00918 0.18 0.1783 1.0 1445026 Maybridge1_004850 Cc1nn(Cc2cccc(c2)C(=O)O)c(C)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E11 compound treatment 1.002 0.00196 0.04 0.0381 1.0 2071972 Maybridge1_004851 O=S(=O)(c1ccsc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E12 compound treatment 0.9998 -2.03E-4 0.0 -0.0039 -1.0 2071973 Maybridge1_004852 Clc1ccc(SCC#N)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E13 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 2071974 Maybridge1_004853 COC(=O)C1=C(CSC1)OS(=O)(=O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E14 compound treatment 1.0049 0.00485 0.09 0.0942 1.0 1552646 Maybridge1_004854 CS(=O)c1ccc(Oc2cccc(F)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E15 compound treatment 0.9947 -0.00526 -0.1 -0.1021 -1.0 1323369 Maybridge1_004855 Cc1c(ncn1Cc2ccc(Cl)cc2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E16 compound treatment 0.9702 -0.0298 -0.58 -0.5787 -1.0 2071975 Maybridge1_004856 CC(=O)NCCc1ccc(OC(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E17 compound treatment 1.0164 0.0164 0.32 0.3185 1.0 2071976 Maybridge1_004857 CS(=O)c1sc(Cl)c2CCCC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E18 compound treatment 2.3771 1.38 26.74 26.7438 1.0 2071977 Maybridge1_004858 [O-][N+](=O)c1ccc(N2CCCC2)c3nonc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E19 compound treatment 1.0352 0.0352 0.68 0.683 1.0 2071978 Maybridge1_004859 O=C1CSC(C1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E20 compound treatment 1.0027 0.00268 0.05 0.0521 1.0 2071979 Maybridge1_004860 CSc1nn2c(cc(nc2c1C(=O)N)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E21 compound treatment 0.9724 -0.0276 -0.54 -0.5367 -1.0 2071980 Maybridge1_004861 [O-][N+](=O)c1ccsc1Sc2ccc(cn2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E22 compound treatment 0.9955 -0.00453 -0.09 -0.0881 -1.0 2071981 Maybridge1_004862 N/C(=N\O)/COc1ccc2nonc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E23 mock treatment 0.9861 -0.0139 -0.27 -0.2703 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 E24 mock treatment 0.9897 -0.0103 -0.2 -0.2002 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F01 compound treatment 1.0474 0.0474 0.92 0.9213 1.0 2071982 Maybridge1_004863 Oc1cc(nc2cc(Cl)ccc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F02 compound treatment 1.0207 0.0207 0.4 0.4026 1.0 1426067 Maybridge1_004864 O=C(N1CCC(CC1)n2cccc2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F03 compound treatment 1.0171 0.0171 0.33 0.3325 1.0 1407522 Maybridge1_004865 NC(=O)C1CCN(CCC#N)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F04 compound treatment 1.0113 0.0113 0.22 0.2204 1.0 2071983 Maybridge1_004866 [O-][N+](=O)c1cc(ccc1N2CCC(CC2)n3cccc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F05 compound treatment 0.9991 -9.25E-4 -0.02 -0.018 -1.0 2071984 Maybridge1_004867 CSc1nn(c(N)c1C#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F06 compound treatment 0.9947 -0.00526 -0.1 -0.1021 -1.0 1579683 Maybridge1_004868 CCCn1c(=O)c(C#N)nn(c2ccccc2)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F07 compound treatment 0.9926 -0.00742 -0.14 -0.1441 -1.0 1545160 Maybridge1_004869 CCOC(=O)NC(=O)c1cn(C(C)C)c(=O)n(Cc2ccccc2)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F08 compound treatment 1.0207 0.0207 0.4 0.4026 1.0 2071985 Maybridge1_004870 NS(=O)(=O)c1cc([N+](=O)[O-])c(s1)N2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F09 compound treatment 1.0612 0.0612 1.19 1.1876 1.0 1229841 Maybridge1_004871 Cc1[nH]c2ccccc2c1SCc3nnc(S)n3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F10 compound treatment 0.9702 -0.0298 -0.58 -0.5787 -1.0 1160768 Maybridge1_004872 OC(=O)c1c(nnc2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F11 compound treatment 0.9846 -0.0154 -0.3 -0.2983 -1.0 2071986 Maybridge1_004873 CC(=O)c1ccc(C#Cc2ccccc2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F12 compound treatment 0.9803 -0.0197 -0.38 -0.3824 -1.0 2071987 Maybridge1_004874 Cc1ccc2snc(C(=O)N)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F13 compound treatment 0.9947 -0.00526 -0.1 -0.1021 -1.0 2071988 Maybridge1_004875 NC(CC(=O)O)c1ccccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F14 compound treatment 0.9803 -0.0197 -0.38 -0.3824 -1.0 2071989 Maybridge1_004876 OC(=O)c1cc2cc(OC(F)(F)F)ccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F15 compound treatment 1.0034 0.00341 0.07 0.0662 1.0 1013621 Maybridge1_004877 CSc1ncc(C(=O)N)c(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F16 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 2071990 Maybridge1_004878 CSc1nccc(n1)c2ccc(s2)S(=O)(=O)N(CCC#N)Cc3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F17 compound treatment 0.9839 -0.0161 -0.31 -0.3124 -1.0 1635590 Maybridge1_004879 O=C(Nc1ccccc1)N2CCN(CC2)C(c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F18 compound treatment 0.9745 -0.0255 -0.49 -0.4946 -1.0 2071991 Maybridge1_004880 Cc1cccc2c(O)cc(nc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F19 compound treatment 1.0222 0.0222 0.43 0.4306 1.0 2071992 Maybridge1_004881 NNC(=O)CN1C(=O)CSc2ccc(cc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F20 compound treatment 0.9543 -0.0457 -0.89 -0.8871 -1.0 2071993 Maybridge1_004882 CCOC1O[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O1)n3cnc4c(N)ncnc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F21 compound treatment 0.9514 -0.0486 -0.94 -0.9432 -1.0 2071994 Maybridge1_004883 N#Cc1cncc(C#Cc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F22 compound treatment 0.976 -0.024 -0.47 -0.4666 -1.0 2071995 Maybridge1_004884 COC(=O)c1c(C)oc(=O)c(Br)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F23 mock treatment 0.9522 -0.0478 -0.93 -0.9292 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 F24 mock treatment 1.0113 0.0113 0.22 0.2204 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G01 compound treatment 1.0734 0.0734 1.43 1.426 1.0 2071996 Maybridge1_004885 NS(=O)(=O)c1ccc(Br)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G02 compound treatment 1.02 0.02 0.39 0.3886 1.0 2071997 Maybridge1_004886 [O-][N+](=O)c1ccsc1NCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G03 compound treatment 1.0128 0.0128 0.25 0.2484 1.0 2071998 Maybridge1_004887 CSc1sc(c2CC(C)(C)CC(=O)c12)c3ccnc(S)n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G04 compound treatment 0.9976 -0.00237 -0.05 -0.046 -1.0 2071999 Maybridge1_004888 Sc1nccc(n1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G05 compound treatment 1.0113 0.0113 0.22 0.2204 1.0 2072000 Maybridge1_004889 Cn1nc(cc1N)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G06 compound treatment 0.9724 -0.0276 -0.54 -0.5367 -1.0 2072001 Maybridge1_004890 FC(F)(F)c1cnc(N2CCSCC2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G07 compound treatment 1.0157 0.0157 0.3 0.3045 1.0 2072002 Maybridge1_004891 CN1c2sc(C)c(C)c2C(=O)CS1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G08 compound treatment 1.0222 0.0222 0.43 0.4306 1.0 1408174 Maybridge1_004892 COC(=O)C1SCCN1C(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G09 compound treatment 1.0272 0.0272 0.53 0.5288 1.0 2072003 Maybridge1_004893 CCOC(=O)c1sc(SC)c2/C(=N\OC)/CCCc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G10 compound treatment 0.9933 -0.0067 -0.13 -0.1301 -1.0 2072004 Maybridge1_004894 C/C(=N\OCC(=O)O)/c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G11 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 2072005 Maybridge1_004895 Cc1nn(Cc2nnc(S)o2)c(C)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G12 compound treatment 1.0056 0.00557 0.11 0.1082 1.0 2072006 Maybridge1_004896 Clc1ccc(c(Cl)c1)S(=O)(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G13 compound treatment 1.0669 0.0669 1.3 1.2998 1.0 2072007 Maybridge1_004897 FC(F)(F)Oc1ccc(cc1)C(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G14 compound treatment 0.9998 -2.03E-4 0.0 -0.0039 -1.0 2072008 Maybridge1_004898 CC1(C)Oc2ccc(C#N)cc2C=C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G15 compound treatment 1.0121 0.0121 0.23 0.2344 1.0 2072009 Maybridge1_004899 CSc1sc(Cl)c2CC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G16 compound treatment 0.9651 -0.0349 -0.68 -0.6768 -1.0 2072010 Maybridge1_004900 C/C(=N\OCc1cccc(c1)C(=O)O)/c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G17 compound treatment 1.0106 0.0106 0.21 0.2063 1.0 2072011 Maybridge1_004901 CSc1scc2CCc3cnc(S)nc3-c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G18 compound treatment 1.1095 0.11 2.13 2.1269 1.0 1931686 Maybridge1_004902 Cc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G19 compound treatment 1.0417 0.0417 0.81 0.8091 1.0 2072012 Maybridge1_004903 CN1c2ccccc2C(=O)/C(=C/N=S(=O)(C)C)/S1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G20 compound treatment 0.9709 -0.0291 -0.56 -0.5647 -1.0 1025517 Maybridge1_004904 NNC(=O)C1COc2ccccc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G21 compound treatment 1.0323 0.0323 0.63 0.6269 1.0 1593337 Maybridge1_004905 Cc1cc(C)n(n1)c2ncc(C#N)c(N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G22 compound treatment 0.9731 -0.0269 -0.52 -0.5226 -1.0 2072013 Maybridge1_004906 Cc1ccc2nc(cc(O)c2c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G23 mock treatment 0.9406 -0.0594 -1.15 -1.1535 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 G24 mock treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H01 compound treatment 1.0178 0.0178 0.35 0.3465 1.0 2072014 Maybridge1_004907 CC(C)Oc1cc(nc2ccc(CSCCO)cc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H02 compound treatment 1.0655 0.0655 1.27 1.2718 1.0 1164963 Maybridge1_004908 Fc1ccc(cc1)S(=O)(=O)Cc2noc(n2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H03 compound treatment 0.989 -0.011 -0.21 -0.2142 -1.0 2072015 Maybridge1_004909 NC(=O)C1CCN(CC1)c2ccc(cn2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H04 compound treatment 1.0474 0.0474 0.92 0.9213 1.0 2072016 Maybridge1_004910 [O-][N+](=O)c1ccc(N2CCC(CC2)n3cccc3)c(C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H05 compound treatment 1.0352 0.0352 0.68 0.683 1.0 2072017 Maybridge1_004911 CSc1nn(cc1C#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H06 compound treatment 0.9688 -0.0312 -0.61 -0.6067 -1.0 2072018 Maybridge1_004912 CCCn1c(=O)c(nn(c2cccc(c2)C(F)(F)F)c1=O)/C(=N/O)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H07 compound treatment 0.9738 -0.0262 -0.51 -0.5086 -1.0 2072019 Maybridge1_004913 COc1ccc(cc1)S(=O)(=O)NCCSc2cc(nc3ccccc23)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H08 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 2072020 Maybridge1_004914 CC(=O)c1ccc(C#Cc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H09 compound treatment 1.0402 0.0402 0.78 0.7811 1.0 2072021 Maybridge1_004915 Clc1ccc(SCC2N3CCC(CC3)C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H10 compound treatment 1.0193 0.0193 0.37 0.3746 1.0 2072022 Maybridge1_004916 CC(C)(C)c1cc2nc(cc(N3CCN(CC3)c4cc(nc5cc(nn45)C(C)(C)C)C(F)(F)F)n2n1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H11 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 1619884 Maybridge1_004917 Cn1ccnc1SCc2nccn2Cc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H12 compound treatment 0.9781 -0.0219 -0.42 -0.4245 -1.0 2072023 Maybridge1_004918 OC(=O)CSc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H13 compound treatment 0.9688 -0.0312 -0.61 -0.6067 -1.0 2072024 Maybridge1_004919 CC(C)(O)C#Cc1ccc(/C=N/Nc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H14 compound treatment 1.0092 0.00918 0.18 0.1783 1.0 1019296 Maybridge1_004920 NC(=O)CCSCCC(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H15 compound treatment 0.9659 -0.0341 -0.66 -0.6628 -1.0 2072025 Maybridge1_004921 Cc1c(Br)sc2ccc(Cl)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H16 compound treatment 0.9976 -0.00237 -0.05 -0.046 -1.0 2072026 Maybridge1_004922 CCCCCCC#Cc1cncc(c1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H17 compound treatment 0.9608 -0.0392 -0.76 -0.761 -1.0 1555072 Maybridge1_004923 Clc1cc(Cl)cc(NC(=O)N2CCN(CC2)C(c3ccccc3)c4ccccc4)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H18 compound treatment 0.9976 -0.00237 -0.05 -0.046 -1.0 2072027 Maybridge1_004924 Oc1cc(nc2ccc(cc12)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H19 compound treatment 0.963 -0.037 -0.72 -0.7189 -1.0 1254018 Maybridge1_004925 OC(=O)c1cncc(C#Cc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H20 compound treatment 0.989 -0.011 -0.21 -0.2142 -1.0 2072028 Maybridge1_004926 NNC(=O)c1ccc2nonc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H21 compound treatment 0.9796 -0.0204 -0.4 -0.3965 -1.0 1012399 Maybridge1_004927 [O-][N+](=O)c1ccc(Oc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H22 compound treatment 0.9897 -0.0103 -0.2 -0.2002 -1.0 2072029 Maybridge1_004928 FC(F)(F)c1cc(no1)c2ccc(s2)S(=O)(=O)N3CCC(CC3)C(c4ccccc4)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H23 mock treatment 0.9659 -0.0341 -0.66 -0.6628 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 H24 mock treatment 1.0294 0.0294 0.57 0.5708 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I01 compound treatment 1.0106 0.0106 0.21 0.2063 1.0 2072030 Maybridge1_004929 Cc1cc(O)c2nncn2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I02 compound treatment 1.0453 0.0453 0.88 0.8792 1.0 2072031 Maybridge1_004930 Clc1ccc(cc1)S(=O)(=O)CCC2CCCCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I03 compound treatment 1.0121 0.0121 0.23 0.2344 1.0 2072032 Maybridge1_004931 CSc1scc2CC(C)(C)C/C(=N/O)/c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I04 compound treatment 1.0063 0.00629 0.12 0.1222 1.0 2072033 Maybridge1_004932 NS(=O)(=O)c1ccc(Sc2cccs2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I05 compound treatment 0.9846 -0.0154 -0.3 -0.2983 -1.0 2072034 Maybridge1_004933 CC1(C)CC(=O)C=C(Sc2ccc(C#N)cc2[N+](=O)[O-])S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I06 compound treatment 0.9825 -0.0175 -0.34 -0.3404 -1.0 2072035 Maybridge1_004934 CC(=O)CSc1sc(C(=O)C)c(c1C#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I07 compound treatment 1.0446 0.0446 0.87 0.8652 1.0 2072036 Maybridge1_004935 CSc1nccc(n1)c2ccc(Br)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I08 compound treatment 0.9594 -0.0406 -0.79 -0.789 -1.0 2072037 Maybridge1_004936 CCOC(=O)c1cnc(SCC(=O)c2ccc(Cl)cc2Cl)[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I09 compound treatment 1.0316 0.0316 0.61 0.6129 1.0 1569480 Maybridge1_004937 COC(=O)C1=C(CSC1)Nc2ccc(O)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I10 compound treatment 1.1406 0.141 2.73 2.7297 1.0 1043570 Maybridge1_004938 Nc1cccc2nsnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I11 compound treatment 0.9897 -0.0103 -0.2 -0.2002 -1.0 2072038 Maybridge1_004939 CN1c2ccccc2C(=C(C(=O)Nc3ccc(OC(F)(F)F)cc3)S1(=O)=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I12 compound treatment 1.0178 0.0178 0.35 0.3465 1.0 2072039 Maybridge1_004940 CSc1ccc(OS(=O)(=O)c2cc(cs2)S(=O)(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I13 compound treatment 1.0539 0.0539 1.05 1.0475 1.0 2072040 Maybridge1_004941 COC(=O)c1cscc1Sc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I14 compound treatment 0.976 -0.024 -0.47 -0.4666 -1.0 1068477 Maybridge1_004942 Clc1ccc2nsnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I15 compound treatment 0.9947 -0.00526 -0.1 -0.1021 -1.0 2072041 Maybridge1_004943 CSc1sc(c(C)c1c2cc[nH]n2)c3nc(C)cs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I16 compound treatment 0.9716 -0.0284 -0.55 -0.5507 -1.0 2072042 Maybridge1_004944 C/C(=N\OCc1cccc(c1)C(=O)O)/c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I17 compound treatment 1.0207 0.0207 0.4 0.4026 1.0 2072043 Maybridge1_004945 CSc1nc(N)nc(n1)c2cnccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I18 compound treatment 1.1167 0.117 2.27 2.2671 1.0 2072044 Maybridge1_004946 OCCSc1ccc([N+](=O)[O-])c2nonc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I19 compound treatment 0.9789 -0.0211 -0.41 -0.4105 -1.0 2072045 Maybridge1_004947 C1CSC(S1)C2CSC(C2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I20 compound treatment 0.9962 -0.00381 -0.07 -0.074 -1.0 1153413 Maybridge1_004948 CCOC(=O)Cc1nn(CC(=S)N)c(=O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I21 compound treatment 0.9933 -0.0067 -0.13 -0.1301 -1.0 2072046 Maybridge1_004949 CSc1nnc(n1C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I22 compound treatment 1.0085 0.00846 0.16 0.1643 1.0 2072047 Maybridge1_004950 Clc1ccc(OC(=O)c2csc(COc3ccc4nonc4c3)n2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I23 mock treatment 1.0272 0.0272 0.53 0.5288 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 I24 mock treatment 0.9514 -0.0486 -0.94 -0.9432 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J01 compound treatment 1.0215 0.0215 0.42 0.4166 1.0 1736035 Maybridge1_004951 Cc1nn(Cc2ccc(o2)C(=O)O)c(C)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J02 compound treatment 1.015 0.015 0.29 0.2905 1.0 2072048 Maybridge1_004952 Fc1ccc(cc1)S(=O)(=O)Cc2noc(n2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J03 compound treatment 0.989 -0.011 -0.21 -0.2142 -1.0 1428447 Maybridge1_004953 CCOC(=O)NC(=O)c1cn(Cc2cccs2)c(=O)[nH]c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J04 compound treatment 1.0525 0.0525 1.02 1.0194 1.0 2072049 Maybridge1_004954 O=C1NC(=O)N2CSCC21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J05 compound treatment 1.0294 0.0294 0.57 0.5708 1.0 2072050 Maybridge1_004955 CC(C)n1cc(C#N)c(=O)[nH]c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J06 compound treatment 1.0438 0.0438 0.85 0.8512 1.0 1270484 Maybridge1_004956 CCOC(=O)c1c(Oc2ccccc2)c3cc(Cl)ccc3nc1SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J07 compound treatment 0.9608 -0.0392 -0.76 -0.761 -1.0 2072051 Maybridge1_004957 CC(=O)c1ccc(C#CC(C)(C)O)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J08 compound treatment 1.0077 0.00774 0.15 0.1503 1.0 2072052 Maybridge1_004958 C/C(=N\Nc1c(Cl)cc(Cl)cc1Cl)/c2ccc(C#CCC3CCCCC3)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J09 compound treatment 0.9933 -0.0067 -0.13 -0.1301 -1.0 2072053 Maybridge1_004959 CCOC(=O)Cn1cc(C#N)c(=O)[nH]c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J10 compound treatment 0.9818 -0.0182 -0.35 -0.3544 -1.0 2072054 Maybridge1_004960 CCCN(C(=O)CC#N)C(=O)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J11 compound treatment 0.9962 -0.00381 -0.07 -0.074 -1.0 1072028 Maybridge1_004961 OCc1nccn1Cc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J12 compound treatment 1.02 0.02 0.39 0.3886 1.0 1166253 Maybridge1_004962 COC(=O)c1cccc(NC(=O)NCc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J13 compound treatment 0.9688 -0.0312 -0.61 -0.6067 -1.0 1052980 Maybridge1_004963 OC(=O)CSc1ncccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J14 compound treatment 0.9818 -0.0182 -0.35 -0.3544 -1.0 2072055 Maybridge1_004964 CCOC(=O)c1cnc2ccc(OC(F)(F)F)cc2c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J15 compound treatment 0.9579 -0.0421 -0.82 -0.817 -1.0 2072056 Maybridge1_004965 O/N=C/c1ccc(Br)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J16 compound treatment 0.9796 -0.0204 -0.4 -0.3965 -1.0 2072057 Maybridge1_004966 Oc1cc(nc2c(Cl)cccc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J17 compound treatment 1.0229 0.0229 0.44 0.4447 1.0 2072058 Maybridge1_004967 COc1cc(nc2ccc(C)c([N+](=O)[O-])c12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J18 compound treatment 0.9991 -9.25E-4 -0.02 -0.018 -1.0 2072059 Maybridge1_004968 Oc1cc(nc2cc(ccc12)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J19 compound treatment 0.9955 -0.00453 -0.09 -0.0881 -1.0 2072060 Maybridge1_004969 CCOC(=O)C(Cc1cc([N+](=O)[O-])c(Oc2ccc(OC)cc2)c(c1)[N+](=O)[O-])NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J20 compound treatment 1.0186 0.0186 0.36 0.3605 1.0 2072061 Maybridge1_004970 N#CCCOCC1CCN(Cc2ccccc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J21 compound treatment 0.9767 -0.0233 -0.45 -0.4525 -1.0 2072062 Maybridge1_004971 O/N=C/c1sccc1Oc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J22 compound treatment 0.9724 -0.0276 -0.54 -0.5367 -1.0 1524000 Maybridge1_004972 N#Cc1nccnc1N2CCN(CC2)C(c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J23 mock treatment 0.9731 -0.0269 -0.52 -0.5226 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 J24 mock treatment 1.0128 0.0128 0.25 0.2484 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K01 compound treatment 1.0958 0.0958 1.86 1.8605 1.0 2072063 Maybridge1_004973 CSc1sc(Br)c2CCCC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K02 compound treatment 0.9904 -0.00959 -0.19 -0.1862 -1.0 1446780 Maybridge1_004974 CC1(C)CCc2cc(ccc2O1)c3cc[nH]n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K03 compound treatment 1.0251 0.0251 0.49 0.4867 1.0 2072064 Maybridge1_004975 CCOC(=O)c1sc(SC)c(c1N)S(=O)(=O)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K04 compound treatment 1.0207 0.0207 0.4 0.4026 1.0 2072065 Maybridge1_004976 CSc1sc(c(c1C#N)c2ccccc2)c3ccnc(SCCS(=O)(=O)C)n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K05 compound treatment 1.0171 0.0171 0.33 0.3325 1.0 1506894 Maybridge1_004977 Clc1ccc(cc1)S(=O)(=O)CCN2C(=O)CSC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K06 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 2072066 Maybridge1_004978 OC(=O)c1cccnc1SCCS(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K07 compound treatment 1.0597 0.0597 1.16 1.1596 1.0 2072067 Maybridge1_004979 Cc1ccc(cc1)S(=O)(=O)Cc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K08 compound treatment 1.0337 0.0337 0.65 0.6549 1.0 2072068 Maybridge1_004980 CCOC(=O)c1cnc2n(C)nc(C)c2c1Sc3ccc(cn3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K09 compound treatment 0.9904 -0.00959 -0.19 -0.1862 -1.0 2072069 Maybridge1_004981 Cn1c(S)nnc1CSc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K10 compound treatment 1.0352 0.0352 0.68 0.683 1.0 2072070 Maybridge1_004982 Clc1ccc(Sc2nccnc2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K11 compound treatment 1.0301 0.0301 0.58 0.5848 1.0 1412588 Maybridge1_004983 NNC(=O)COc1ccccc1CSc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K12 compound treatment 1.0027 0.00268 0.05 0.0521 1.0 2072071 Maybridge1_004984 C/C(=N\O)/c1ccc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K13 compound treatment 1.0359 0.0359 0.7 0.697 1.0 2072072 Maybridge1_004985 FC(F)(F)Oc1ccc(cc1)C(=O)/C(=C/Nc2ccccn2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K14 compound treatment 0.9558 -0.0442 -0.86 -0.8591 -1.0 1339863 Maybridge1_004986 NC(=S)C1COc2ccccc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K15 compound treatment 0.9688 -0.0312 -0.61 -0.6067 -1.0 2072073 Maybridge1_004987 COc1ccc(OC(=O)c2cscc2Sc3ccc(Cl)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K16 compound treatment 1.0749 0.0749 1.45 1.454 1.0 1083340 Maybridge1_004988 CSc1nc2ccc(cc2s1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K17 compound treatment 1.0171 0.0171 0.33 0.3325 1.0 1213967 Maybridge1_004989 CCOC(=O)c1cnc2n(C)nc(C)c2c1Oc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K18 compound treatment 1.0272 0.0272 0.53 0.5288 1.0 2072074 Maybridge1_004990 [O-][N+](=O)c1ccc(Sc2ccc(F)cc2)c3nonc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K19 compound treatment 1.0135 0.0135 0.26 0.2624 1.0 2072075 Maybridge1_004991 CCOC(=O)c1sc(SCCS(=O)(=O)c2ccccc2)c3C(=O)CC(C)(C)Cc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K20 compound treatment 1.0258 0.0258 0.5 0.5007 1.0 2072076 Maybridge1_004992 CNC(=S)NNC(=O)C(CCSC)NC(=O)c1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K21 compound treatment 1.0503 0.0503 0.98 0.9774 1.0 1407614 Maybridge1_004993 COC(=O)c1cccc(CN2C(=O)CSC2=O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K22 compound treatment 0.9637 -0.0363 -0.7 -0.7049 -1.0 2072077 Maybridge1_004994 COc1cc(nc2ccc(Br)cc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K23 mock treatment 1.002 0.00196 0.04 0.0381 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 K24 mock treatment 1.0157 0.0157 0.3 0.3045 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L01 compound treatment 1.0229 0.0229 0.44 0.4447 1.0 2072078 Maybridge1_004995 ONC(=O)c1ncc(cc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L02 compound treatment 0.9926 -0.00742 -0.14 -0.1441 -1.0 2072079 Maybridge1_004996 COC(=O)c1ccc(Br)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L03 compound treatment 1.0301 0.0301 0.58 0.5848 1.0 1442715 Maybridge1_004997 CCOC(=O)NC(=O)c1cn(Cc2ccccn2)c(=O)[nH]c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L04 compound treatment 0.9933 -0.0067 -0.13 -0.1301 -1.0 2072080 Maybridge1_004998 FC(F)(F)c1cccc(c1)n2nc(C#N)c(=O)[nH]c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L05 compound treatment 1.0359 0.0359 0.7 0.697 1.0 1505343 Maybridge1_004999 CC(C)n1cc(C#N)c(=O)n(Cc2ccccc2)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L06 compound treatment 1.0034 0.00341 0.07 0.0662 1.0 2072081 Maybridge1_005000 O=C(Nc1ccccc1)ON=C2CC3CCCC(C2)N3Cc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L07 compound treatment 1.0409 0.0409 0.8 0.7951 1.0 1599249 Maybridge1_005001 CCOC(=O)Cn1c(=O)c(C#N)cn(C(C)C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L08 compound treatment 1.028 0.028 0.54 0.5428 1.0 1037742 Maybridge1_005002 NC(=O)CC(NC(=O)OCc1ccccc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L09 compound treatment 0.9984 -0.00165 -0.03 -0.032 -1.0 2072082 Maybridge1_005003 CC(C)(C)c1cc2nc(cc(N/N=C/c3ccc(cc3)C(F)(F)F)n2n1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L10 compound treatment 0.9911 -0.00887 -0.17 -0.1722 -1.0 1727567 Maybridge1_005004 COc1ccc(cc1OC2CCCC2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L11 compound treatment 0.955 -0.045 -0.87 -0.8731 -1.0 2072083 Maybridge1_005005 N#Cc1ccc(C#Cc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L12 compound treatment 0.9572 -0.0428 -0.83 -0.831 -1.0 1611812 Maybridge1_005006 OC(=O)c1cnc2cc(Cl)cc(Cl)c2c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L13 compound treatment 1.028 0.028 0.54 0.5428 1.0 2072084 Maybridge1_005007 Nc1nc(S)ncc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L14 compound treatment 0.9854 -0.0146 -0.28 -0.2843 -1.0 2072085 Maybridge1_005008 OC(=O)c1cnc2ccc(OC(F)(F)F)cc2c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L15 compound treatment 0.9926 -0.00742 -0.14 -0.1441 -1.0 1110028 Maybridge1_005009 NC(CC(=O)O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L16 compound treatment 0.9356 -0.0644 -1.25 -1.2516 -1.0 2072086 Maybridge1_005010 CCOc1cc(ccc1OC)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L17 compound treatment 1.0063 0.00629 0.12 0.1222 1.0 2072087 Maybridge1_005011 CC(=O)N1CCc2cc(Br)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L18 compound treatment 1.0005 5.19E-4 0.01 0.0101 1.0 2072088 Maybridge1_005012 CCCCC#Cc1ccc(o1)C(=O)NNC(=O)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L19 compound treatment 1.0265 0.0265 0.51 0.5148 1.0 2072089 Maybridge1_005013 OCCSC1CS(=O)(=O)c2cc(ccc12)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L20 compound treatment 0.9926 -0.00742 -0.14 -0.1441 -1.0 2072090 Maybridge1_005014 CC(=O)c1cc2c3ccccc3ccc2c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L21 compound treatment 1.0128 0.0128 0.25 0.2484 1.0 2072091 Maybridge1_005015 FC(F)(F)Oc1ccc(NC(=O)Nc2cc(n[nH]2)c3ccco3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L22 compound treatment 0.9818 -0.0182 -0.35 -0.3544 -1.0 1173437 Maybridge1_005016 NNC(=O)C1CCN(Cc2cccnc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L23 mock treatment 0.9818 -0.0182 -0.35 -0.3544 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 L24 mock treatment 1.0597 0.0597 1.16 1.1596 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M01 compound treatment 1.0691 0.0691 1.34 1.3419 1.0 2072092 Maybridge1_005017 Cc1nn(Cc2nn[nH]n2)c(C)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M02 compound treatment 1.0337 0.0337 0.65 0.6549 1.0 2072093 Maybridge1_005018 CC(C)S(=O)(=O)C/C(=N/OCc1c(Cl)cccc1Cl)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M03 compound treatment 0.9688 -0.0312 -0.61 -0.6067 -1.0 2072094 Maybridge1_005019 CC1(C)CC(=CC(=S)S1)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M04 compound treatment 0.9623 -0.0377 -0.73 -0.7329 -1.0 3177265 Maybridge1_005020 CS(=N)c1ncccc1C(F)(F)F.Cc1cc(C)c(c(C)c1)S(=O)(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M05 compound treatment 1.0171 0.0171 0.33 0.3325 1.0 1393462 Maybridge1_005021 Cc1ccc(cc1)S(=O)(=O)CCN2C(=O)CSC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M06 compound treatment 0.9832 -0.0168 -0.33 -0.3264 -1.0 2072096 Maybridge1_005022 COC(=O)c1ccc(CSc2ccc(cn2)C(F)(F)F)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M07 compound treatment 1.0417 0.0417 0.81 0.8091 1.0 1275401 Maybridge1_005023 ONC(=O)CC1Sc2ccccc2NC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M08 compound treatment 1.0388 0.0388 0.75 0.7531 1.0 2072097 Maybridge1_005024 [O-][N+](=O)c1cc(ccc1C#N)N2CCSCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M09 compound treatment 0.9962 -0.00381 -0.07 -0.074 -1.0 2072098 Maybridge1_005025 Fc1c(Cl)cccc1n2sccc2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M10 compound treatment 0.9731 -0.0269 -0.52 -0.5226 -1.0 2072099 Maybridge1_005026 Clc1cc(Cl)cc(OS(=O)(=O)c2cccc3nsnc23)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M11 compound treatment 0.9919 -0.00814 -0.16 -0.1581 -1.0 1279337 Maybridge1_005027 CCOC(=O)COc1ccccc1CS(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M12 compound treatment 1.0005 5.19E-4 0.01 0.0101 1.0 1310444 Maybridge1_005028 Clc1cc(c(Cl)s1)S(=O)(=O)Nc2cccc3nsnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M13 compound treatment 0.9933 -0.0067 -0.13 -0.1301 -1.0 2072100 Maybridge1_005029 FC(F)(F)c1ccc(nc1)S(=O)(=O)CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M14 compound treatment 0.9933 -0.0067 -0.13 -0.1301 -1.0 2072101 Maybridge1_005030 OC(=O)CSCCOc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M15 compound treatment 1.0049 0.00485 0.09 0.0942 1.0 1360550 Maybridge1_005031 COC(=O)c1ccc2C(=O)CS(=O)(=O)N(C)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M16 compound treatment 0.9781 -0.0219 -0.42 -0.4245 -1.0 2072102 Maybridge1_005032 NC(=S)c1ccc2nonc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M17 compound treatment 0.9933 -0.0067 -0.13 -0.1301 -1.0 1983576 Maybridge1_005033 CN(c1ccccc1)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M18 compound treatment 0.9818 -0.0182 -0.35 -0.3544 -1.0 2072103 Maybridge1_005034 Clc1ccc(cc1)S(=O)(=O)NCc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M19 compound treatment 1.0207 0.0207 0.4 0.4026 1.0 2072104 Maybridge1_005035 CSc1sc(C(=O)N)c2CCc3conc3-c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M20 compound treatment 0.9399 -0.0601 -1.17 -1.1675 -1.0 2072105 Maybridge1_005036 FC(F)(F)c1cccc(c1)S(=O)(=O)NCC2COc3ccccc3O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M21 compound treatment 1.033 0.033 0.64 0.6409 1.0 2072106 Maybridge1_005037 COC(=O)CSCCC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M22 compound treatment 0.9882 -0.0118 -0.23 -0.2282 -1.0 2072107 Maybridge1_005038 COC(=O)c1scc2c(O)cc(nc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M23 mock treatment 1.0063 0.00629 0.12 0.1222 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 M24 mock treatment 1.033 0.033 0.64 0.6409 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N01 compound treatment 1.0027 0.00268 0.05 0.0521 1.0 1088056 Maybridge1_005039 Oc1cc(nc2ccccc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N02 compound treatment 1.0178 0.0178 0.35 0.3465 1.0 2072108 Maybridge1_005040 COC(=O)c1ccc(C#Cc2ccccc2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N03 compound treatment 1.0251 0.0251 0.49 0.4867 1.0 2072109 Maybridge1_005041 O=c1[nH]c(=O)n(cc1C#N)C2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N04 compound treatment 0.9984 -0.00165 -0.03 -0.032 -1.0 2072110 Maybridge1_005042 CCOC(=O)c1c(O)c2cccc(c2nc1SC)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N05 compound treatment 0.9991 -9.25E-4 -0.02 -0.018 -1.0 2072111 Maybridge1_005043 CSc1nn(cc1/C(=N/O)/N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N06 compound treatment 1.033 0.033 0.64 0.6409 1.0 2072112 Maybridge1_005044 NC(Cc1csc2ccc(Cl)cc12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N07 compound treatment 1.0157 0.0157 0.3 0.3045 1.0 2072113 Maybridge1_005045 COC(=O)c1sccc1Oc2nccnc2C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N08 compound treatment 1.0272 0.0272 0.53 0.5288 1.0 2072114 Maybridge1_005046 CC(=O)c1ccc(C#CCO)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N09 compound treatment 1.0113 0.0113 0.22 0.2204 1.0 2072115 Maybridge1_005047 OCc1nccn1Cc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N10 compound treatment 1.1204 0.12 2.34 2.3372 1.0 1913810 Maybridge1_005048 [O-][N+](=O)c1ccc(/C=N/Nc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N11 compound treatment 0.9854 -0.0146 -0.28 -0.2843 -1.0 1043306 Maybridge1_005049 Cc1c(Cl)cc(cc1Cl)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N12 compound treatment 0.9839 -0.0161 -0.31 -0.3124 -1.0 1455622 Maybridge1_005050 Oc1ccnc2cc(Cl)cc(Cl)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N13 compound treatment 0.9955 -0.00453 -0.09 -0.0881 -1.0 1334136 Maybridge1_005051 Cn1c(=O)c(C#N)cn(c2ccccc2)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N14 compound treatment 0.9507 -0.0493 -0.96 -0.9572 -1.0 2072116 Maybridge1_005052 N/C(=N\O)/CCN(Cc1ccco1)S(=O)(=O)c2cccc3nsnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N15 compound treatment 0.9716 -0.0284 -0.55 -0.5507 -1.0 2072117 Maybridge1_005053 COC(=O)C(C#N)c1ccccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N16 compound treatment 1.0301 0.0301 0.58 0.5848 1.0 2072118 Maybridge1_005054 Oc1cc(nc2c(F)cccc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N17 compound treatment 0.9731 -0.0269 -0.52 -0.5226 -1.0 1382524 Maybridge1_005055 CCOC(=O)c1cncc(C#Cc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N18 compound treatment 0.9976 -0.00237 -0.05 -0.046 -1.0 2072119 Maybridge1_005056 CCCCC#Cc1ccc(o1)C(=O)NNC(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N19 compound treatment 0.9731 -0.0269 -0.52 -0.5226 -1.0 1473501 Maybridge1_005057 CC(=O)NC(Cc1ccc(OC(=O)C)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N20 compound treatment 0.9774 -0.0226 -0.44 -0.4385 -1.0 2072120 Maybridge1_005058 CN(C)S(=O)(=O)Nc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N21 compound treatment 0.9984 -0.00165 -0.03 -0.032 -1.0 2072121 Maybridge1_005059 N/C(=N\O)/CS(=O)(=O)c1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N22 compound treatment 0.9637 -0.0363 -0.7 -0.7049 -1.0 2072122 Maybridge1_005060 COc1ccc(CNC(=O)Nc2ccccc2C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N23 mock treatment 1.002 0.00196 0.04 0.0381 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 N24 mock treatment 0.9991 -9.25E-4 -0.02 -0.018 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O01 compound treatment 1.033 0.033 0.64 0.6409 1.0 1299316 Maybridge1_005061 NS(=O)(=O)c1ccc(Sc2ccccc2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O02 compound treatment 0.9753 -0.0247 -0.48 -0.4806 -1.0 2072123 Maybridge1_005062 [O-][N+](=O)c1ccsc1Oc2ccc(C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O03 compound treatment 1.0077 0.00774 0.15 0.1503 1.0 2072124 Maybridge1_005063 CSC1=CC(=O)CC(C)(C)S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O04 compound treatment 0.9767 -0.0233 -0.45 -0.4525 -1.0 1317959 Maybridge1_005064 O=C1NC2(CCCCC2)NC3=C1CCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O05 compound treatment 1.0171 0.0171 0.33 0.3325 1.0 2072125 Maybridge1_005065 CN(C)/C=C/C(=O)c1sc2sc(Br)c(C)c2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O06 compound treatment 1.0171 0.0171 0.33 0.3325 1.0 2072126 Maybridge1_005066 CCOC(=O)c1c[nH]c(S)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O07 compound treatment 1.0121 0.0121 0.23 0.2344 1.0 2072127 Maybridge1_005067 CC(C)(C)c1cc(ccc1/C=N/O)c2nccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O08 compound treatment 1.0229 0.0229 0.44 0.4447 1.0 2072128 Maybridge1_005068 N#Cc1nccnc1Sc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O09 compound treatment 0.9976 -0.00237 -0.05 -0.046 -1.0 2072129 Maybridge1_005069 CSc1nccc(n1)c2ccsc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O10 compound treatment 0.9868 -0.0132 -0.26 -0.2563 -1.0 2072130 Maybridge1_005070 CCOC(=O)CNS(=O)(=O)c1cccc2nsnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O11 compound treatment 1.007 0.00702 0.14 0.1362 1.0 2072131 Maybridge1_005071 CN1c2sc(C)c(C)c2C(=C(C(=O)Nc3ccc(OC(F)(F)F)cc3)S1(=O)=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O12 compound treatment 0.9803 -0.0197 -0.38 -0.3824 -1.0 1180269 Maybridge1_005072 CSc1ccc(Oc2cccc(F)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O13 compound treatment 0.9998 -2.03E-4 0.0 -0.0039 -1.0 1344419 Maybridge1_005073 CCCS(=O)(=O)c1cc2ccccc2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O14 compound treatment 0.994 -0.00598 -0.12 -0.1161 -1.0 2072132 Maybridge1_005074 COc1ccc(cc1OC)/C(=N/O)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O15 compound treatment 1.0063 0.00629 0.12 0.1222 1.0 2072133 Maybridge1_005075 CSc1nc(nc(C2CC2)c1C#N)c3cnccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O16 compound treatment 0.9904 -0.00959 -0.19 -0.1862 -1.0 1476668 Maybridge1_005076 CCOC(=O)CC1Sc2ccccc2NC1=S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O17 compound treatment 1.0243 0.0243 0.47 0.4727 1.0 2072134 Maybridge1_005077 CS(=O)(=O)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O18 compound treatment 1.0308 0.0308 0.6 0.5989 1.0 2072135 Maybridge1_005078 [O-][N+](=O)c1ccc(SCCOC(=O)Nc2ccccc2)c3nonc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O19 compound treatment 0.9644 -0.0356 -0.69 -0.6909 -1.0 2072136 Maybridge1_005079 CC(=O)c1sc(SCCS(=O)(=O)c2ccccc2)c3C(=O)CC(C)(C)Cc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O20 compound treatment 0.9774 -0.0226 -0.44 -0.4385 -1.0 1004503 Maybridge1_005080 CCOC(=O)N(c1ccccc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O21 compound treatment 0.9854 -0.0146 -0.28 -0.2843 -1.0 1983526 Maybridge1_005081 CC(=O)N1CCc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O22 compound treatment 0.9933 -0.0067 -0.13 -0.1301 -1.0 2072137 Maybridge1_005082 COc1cc(nc2cc(nn12)C(C)(C)C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O23 mock treatment 0.9774 -0.0226 -0.44 -0.4385 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 O24 mock treatment 1.0063 0.00629 0.12 0.1222 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P01 compound treatment 1.072 0.072 1.4 1.3979 1.0 2072138 Maybridge1_005083 COC(=O)CSc1cc(nc2ccccc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P02 compound treatment 1.0511 0.0511 0.99 0.9914 1.0 1423734 Maybridge1_005084 NNC(=O)Cc1nc(no1)c2cnccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P03 compound treatment 1.0496 0.0496 0.96 0.9634 1.0 1704264 Maybridge1_005085 Fc1ccc(c(F)c1)n2cc(C#N)c(=O)[nH]c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P04 compound treatment 1.0489 0.0489 0.95 0.9493 1.0 1652651 Maybridge1_005086 N#CC1CN(C1)C(c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P05 compound treatment 1.0554 0.0554 1.08 1.0755 1.0 1427912 Maybridge1_005087 COc1ccc(cc1OC)C2=NC(C)(C)CO2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P06 compound treatment 1.0965 0.0965 1.87 1.8746 1.0 2072139 Maybridge1_005088 COC(=O)c1ccc(cc1Cl)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P07 compound treatment 1.0265 0.0265 0.51 0.5148 1.0 1433980 Maybridge1_005089 CC(C)n1cc(c2nc(C)cs2)c(=O)n(CC(=O)NN)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P08 compound treatment 1.0467 0.0467 0.91 0.9073 1.0 2072140 Maybridge1_005090 Cc1ccc2nc(cc(N3CCNCC3)c2c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P09 compound treatment 1.0424 0.0424 0.82 0.8232 1.0 2072141 Maybridge1_005091 Cc1[nH]c2ccccc2c1SCc3nnc(SCC(=O)Nc4cccc(c4)C(F)(F)F)n3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P10 compound treatment 1.0453 0.0453 0.88 0.8792 1.0 2072142 Maybridge1_005092 C/C(=N\O)/c1cccc(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P11 compound treatment 1.0229 0.0229 0.44 0.4447 1.0 2072143 Maybridge1_005093 CCOC(=O)c1ccc(OCC#C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P12 compound treatment 0.963 -0.037 -0.72 -0.7189 -1.0 2072144 Maybridge1_005094 CCOC(=O)c1cc2cc(OC(F)(F)F)ccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P13 compound treatment 1.0287 0.0287 0.56 0.5568 1.0 2072145 Maybridge1_005095 O=S1(=O)CC(Sc2cccs2)c3ccccc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P14 compound treatment 1.0388 0.0388 0.75 0.7531 1.0 1077343 Maybridge1_005096 OC1(CN2CCC1CC2)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P15 compound treatment 1.0027 0.00268 0.05 0.0521 1.0 2072146 Maybridge1_005097 CN(CCO)c1cc(nc2ccccc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P16 compound treatment 1.0049 0.00485 0.09 0.0942 1.0 2072147 Maybridge1_005098 Oc1cc(nc2ccc(OC(F)(F)F)cc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P17 compound treatment 1.0344 0.0344 0.67 0.669 1.0 1415776 Maybridge1_005099 CCOC(=O)c1cncc(C#CCO)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P18 compound treatment 1.0128 0.0128 0.25 0.2484 1.0 2072148 Maybridge1_005100 CCCCC#Cc1ccc(o1)C(=O)NNC(=O)Nc2ccc(OC(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P19 compound treatment 0.9659 -0.0341 -0.66 -0.6628 -1.0 1007764 Maybridge1_005101 [O-][N+](=O)c1ccc2COC(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P20 compound treatment 0.9882 -0.0118 -0.23 -0.2282 -1.0 2072149 Maybridge1_005102 Fc1ccccc1CN(C(=O)CC#N)C(=O)NC2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P21 compound treatment 1.0229 0.0229 0.44 0.4447 1.0 1716936 Maybridge1_005103 O=C(C1COc2ccccc2O1)N3CCNCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P22 compound treatment 1.0215 0.0215 0.42 0.4166 1.0 1136589 Maybridge1_005104 CCCOc1cc(ccc1OC)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P23 mock treatment 0.9818 -0.0182 -0.35 -0.3544 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.555 P24 mock treatment 1.0453 0.0453 0.88 0.8792 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A01 compound treatment 1.0795 0.0795 1.54 1.5439 1.0 1229519 Maybridge1_005105 COc1ccc(cc1OC(C)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A02 compound treatment 1.0141 0.0141 0.27 0.2746 1.0 2072150 Maybridge1_005106 O=C(NCc1ccccc1)c2ccc3nonc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A03 compound treatment 1.0134 0.0134 0.26 0.2607 1.0 2072151 Maybridge1_005107 CC(=O)Nc1ccc(Br)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A04 compound treatment 1.0307 0.0307 0.6 0.5954 1.0 1323461 Maybridge1_005108 COc1ccc(Cl)cc1NC(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A05 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 2072152 Maybridge1_005109 CCCCNC(=O)NCCSCc1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A06 compound treatment 0.9991 -9.43E-4 -0.02 -0.0183 -1.0 1296767 Maybridge1_005110 Clc1ccc(NC(=O)NC2Cc3ccccc3C2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A07 compound treatment 1.04 0.04 0.78 0.7767 1.0 2072153 Maybridge1_005111 Clc1cc(Cl)cc(NC(=O)NCCSCc2ccco2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A08 compound treatment 0.9775 -0.0225 -0.44 -0.4367 -1.0 2072154 Maybridge1_005112 Cn1c(SCc2ccc(OC(F)(F)F)cc2)nnc1c3ccc4ncccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A09 compound treatment 0.9933 -0.00669 -0.13 -0.1299 -1.0 2072155 Maybridge1_005113 Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A10 compound treatment 1.0098 0.00983 0.19 0.1909 1.0 1151309 Maybridge1_005114 O=C(NC1Cc2ccccc2C1)C3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A11 compound treatment 1.0328 0.0328 0.64 0.6372 1.0 2072156 Maybridge1_005115 O=C(NCCSCc1ccco1)C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A12 compound treatment 0.9912 -0.00884 -0.17 -0.1717 -1.0 1589902 Maybridge1_005116 Brc1ccc(s1)S(=O)(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A13 compound treatment 1.035 0.035 0.68 0.6791 1.0 1661456 Maybridge1_005117 Clc1ccc(NC(=O)c2ccc3snnc3c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A14 compound treatment 1.0141 0.0141 0.27 0.2746 1.0 2072157 Maybridge1_005118 CC(C)(C)c1cc2nc(cc(n2n1)C(F)(F)F)c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A15 compound treatment 1.0285 0.0285 0.55 0.5536 1.0 2072158 Maybridge1_005119 COc1ccc(cc1OC)c2cc([nH]n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A16 compound treatment 0.9746 -0.0254 -0.49 -0.4925 -1.0 1539036 Maybridge1_005120 O=C(CSc1nc2ccccc2o1)NC3Cc4ccccc4C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A17 compound treatment 1.0199 0.0199 0.39 0.3862 1.0 2072159 Maybridge1_005121 Cc1cc2nc(cc(n2n1)C(F)(F)F)c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A18 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 1365169 Maybridge1_005122 CC(C)(C)OC(=O)NCc1nnc(S)n1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A19 compound treatment 1.0321 0.0321 0.62 0.6233 1.0 2072160 Maybridge1_005123 Fc1cccc(Cl)c1CSCC(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A20 compound treatment 0.9969 -0.0031 -0.06 -0.0602 -1.0 2072161 Maybridge1_005124 Fc1cccc2c(cc(nc12)C(F)(F)F)N3CCN(CCOC(=O)C(F)(F)F)CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A21 compound treatment 1.0156 0.0156 0.3 0.3025 1.0 2072162 Maybridge1_005125 FC(F)(F)c1cc(nc2cc(nn12)C3CC3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A22 compound treatment 0.9739 -0.0261 -0.51 -0.5065 -1.0 2072163 Maybridge1_005126 CCOC(=O)c1ccc2nc(cc(N3CCCCC3)c2c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A23 mock treatment 1.0644 0.0644 1.25 1.251 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 A24 mock treatment 0.9897 -0.0103 -0.2 -0.1996 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B01 compound treatment 0.9904 -0.00956 -0.19 -0.1857 -1.0 2072164 Maybridge1_005127 CSc1nc2ccc(NC(=O)c3ccccc3C(F)(F)F)cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B02 compound treatment 1.0098 0.00983 0.19 0.1909 1.0 2072165 Maybridge1_005128 CCOC(=O)NNC(=S)Nc1ccccc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B03 compound treatment 1.0113 0.0113 0.22 0.2188 1.0 2072166 Maybridge1_005129 Cc1ccc(cc1Cl)c2ccc(C)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B04 compound treatment 0.9682 -0.0318 -0.62 -0.6181 -1.0 2072167 Maybridge1_005130 FC(F)(F)c1cccc(NNC(=S)Nc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B05 compound treatment 0.9768 -0.0232 -0.45 -0.4507 -1.0 1020737 Maybridge1_005131 COc1cc(Br)c(OC)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B06 compound treatment 1.017 0.017 0.33 0.3304 1.0 2072168 Maybridge1_005132 CCOC(=O)N/N=C/c1cc(OC)c(OC)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B07 compound treatment 0.9797 -0.0203 -0.39 -0.3949 -1.0 2072169 Maybridge1_005133 CCSc1nc2ccccc2nc1SCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B08 compound treatment 0.966 -0.034 -0.66 -0.6599 -1.0 2072170 Maybridge1_005134 COc1ccccc1NC(=S)NNC(=O)NNC(=S)Nc2ccccc2OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B09 compound treatment 1.0077 0.00768 0.15 0.1491 1.0 2072171 Maybridge1_005135 [O-][N+](=O)c1cccc(c1)c2csc(n2)c3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B10 compound treatment 0.9488 -0.0512 -0.99 -0.9947 -1.0 2072172 Maybridge1_005136 Clc1ccc(/C=N/NC(=S)NC2CC3CC2C=C3)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B11 compound treatment 0.984 -0.016 -0.31 -0.3112 -1.0 2072173 Maybridge1_005137 Cc1ccc(cc1)c2csc(n2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B12 compound treatment 0.9976 -0.00238 -0.05 -0.0462 -1.0 2072174 Maybridge1_005138 CNC(=S)N/N=C/c1cccc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B13 compound treatment 0.9854 -0.0146 -0.28 -0.2833 -1.0 2072175 Maybridge1_005139 CCc1cc2c(cc1c3csc(Nc4ccccc4Cl)n3)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B14 compound treatment 0.9969 -0.0031 -0.06 -0.0602 -1.0 2072176 Maybridge1_005140 CNC(=S)N/N=C/c1ccc(OC)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B15 compound treatment 0.9509 -0.0491 -0.95 -0.9528 -1.0 2072177 Maybridge1_005141 CC(C)c1ccc(/C=N/NC(=O)N\N=C\c2ccc(cc2)C(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B16 compound treatment 1.0249 0.0249 0.48 0.4838 1.0 2072178 Maybridge1_005142 COc1cc(cc(OC)c1OC)c2n[nH]c(=S)n2c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B17 compound treatment 0.9912 -0.00884 -0.17 -0.1717 -1.0 1912581 Maybridge1_005143 COc1ccc(/C=N/NC(=S)N)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B18 compound treatment 1.0091 0.00911 0.18 0.177 1.0 1046961 Maybridge1_005144 O=C(NNC(=S)NC1CCCCC1)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B19 compound treatment 0.9696 -0.0304 -0.59 -0.5902 -1.0 1922073 Maybridge1_005145 CCOC(=O)N/N=C/c1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B20 compound treatment 1.0026 0.00265 0.05 0.0514 1.0 2072179 Maybridge1_005146 Cc1c(C)c(C)c(CSC2=NCN(Cc3cccnc3)CN2)c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B21 compound treatment 0.9631 -0.0369 -0.72 -0.7157 -1.0 2072180 Maybridge1_005147 CCOC(=O)N/N=C/c1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B22 compound treatment 1.0034 0.00337 0.07 0.0654 1.0 2072181 Maybridge1_005148 [O-][N+](=O)c1ccc2C=CS(=O)(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B23 mock treatment 0.9617 -0.0383 -0.74 -0.7436 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 B24 mock treatment 0.9969 -0.0031 -0.06 -0.0602 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C01 compound treatment 1.0443 0.0443 0.86 0.8604 1.0 2072182 Maybridge1_005149 CCCCOc1cc(ccc1OC)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C02 compound treatment 0.9998 -2.24E-4 0.0 -0.0044 -1.0 2072183 Maybridge1_005150 OC1(CC(=NN1)c2ccc3ccccc3c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C03 compound treatment 1.0177 0.0177 0.34 0.3443 1.0 2072184 Maybridge1_005151 COC(=O)c1ccc2snnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C04 compound treatment 1.0335 0.0335 0.65 0.6512 1.0 1125721 Maybridge1_005152 O=C(NC1Cc2ccccc2C1)Nc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C05 compound treatment 1.0149 0.0149 0.29 0.2885 1.0 2072185 Maybridge1_005153 CC(C)(C)c1ccc(NC(=O)NCCSCc2ccco2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C06 compound treatment 0.9761 -0.0239 -0.46 -0.4646 -1.0 1693944 Maybridge1_005154 Clc1cc(Cl)cc(NC(=O)NC2Cc3ccccc3C2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C07 compound treatment 1.0529 0.0529 1.03 1.0278 1.0 2072186 Maybridge1_005155 COc1cc(NC(=O)NCCSCc2ccco2)cc(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C08 compound treatment 1.0163 0.0163 0.32 0.3164 1.0 2072187 Maybridge1_005156 Cn1c(SCc2c(Cl)cccc2Cl)nnc1c3ccc4ncccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C09 compound treatment 1.0105 0.0105 0.2 0.2049 1.0 2072188 Maybridge1_005157 Clc1ccc(cc1)C(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C10 compound treatment 0.9667 -0.0333 -0.65 -0.646 -1.0 2072189 Maybridge1_005158 CC(C)n1c(nc2cc(ccc12)C(=O)O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C11 compound treatment 0.9804 -0.0196 -0.38 -0.381 -1.0 2072190 Maybridge1_005159 COc1ccc(cc1)c2cc(nc(N)n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C12 compound treatment 0.9962 -0.00382 -0.07 -0.0741 -1.0 1327971 Maybridge1_005160 CC(C)n1nnc2cc(ccc12)C(=O)Nc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C13 compound treatment 1.0034 0.00337 0.07 0.0654 1.0 2072191 Maybridge1_005161 CC(=O)Nc1ccc(cc1)S(=O)(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C14 compound treatment 0.9746 -0.0254 -0.49 -0.4925 -1.0 1942145 Maybridge1_005162 COc1ccc(cc1)c2cc(n3nc(cc3n2)c4ccccc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C15 compound treatment 1.0041 0.00408 0.08 0.0793 1.0 2072192 Maybridge1_005163 Cc1onc(c1C(=O)NCCSCc2ccco2)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C16 compound treatment 0.9883 -0.0117 -0.23 -0.2275 -1.0 1549521 Maybridge1_005164 Cc1ccc2[nH]c(SCC(=O)NC3Cc4ccccc4C3)nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C17 compound treatment 0.9904 -0.00956 -0.19 -0.1857 -1.0 2072193 Maybridge1_005165 FC(F)(F)c1cc(nc2cc(nn12)c3ccccc3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C18 compound treatment 0.971 -0.029 -0.56 -0.5623 -1.0 2072194 Maybridge1_005166 CC(C)(C)OC(=O)NCc1nnc(S)n1CC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C19 compound treatment 1.0357 0.0357 0.69 0.693 1.0 2072195 Maybridge1_005167 FC(F)(F)c1c(cnn1c2ccccc2)C(=O)NCCSCc3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C20 compound treatment 0.9732 -0.0268 -0.52 -0.5204 -1.0 1065781 Maybridge1_005168 O=C(NC1CCCC1)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C21 compound treatment 1.0472 0.0472 0.92 0.9162 1.0 2072196 Maybridge1_005169 CC(C)(C)c1cc2c(CCC2(C)C)c(c1)c3cc(n4nc(cc4n3)c5ccccc5)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C22 compound treatment 1.0055 0.00552 0.11 0.1072 1.0 2072197 Maybridge1_005170 CCOC(=O)c1ccc2nc(cc(N3CCN(Cc4ccccc4)CC3)c2c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C23 mock treatment 0.9481 -0.0519 -1.01 -1.0086 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 C24 mock treatment 0.9718 -0.0282 -0.55 -0.5483 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D01 compound treatment 1.017 0.017 0.33 0.3304 1.0 2072198 Maybridge1_005171 CSc1nc2ccc(NS(=O)(=O)c3ccc(cc3)[N+](=O)[O-])cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D02 compound treatment 1.0235 0.0235 0.46 0.4559 1.0 2072199 Maybridge1_005172 CCOC(=O)N/N=C/c1ccccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D03 compound treatment 1.0328 0.0328 0.64 0.6372 1.0 2072200 Maybridge1_005173 Cc1cc2CN(Cc2cc1C)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D04 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 2072201 Maybridge1_005174 Clc1ccccc1NC(=S)NNc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D05 compound treatment 0.9768 -0.0232 -0.45 -0.4507 -1.0 1245333 Maybridge1_005175 COc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D06 compound treatment 0.9962 -0.00382 -0.07 -0.0741 -1.0 2072202 Maybridge1_005176 COc1cc(/C=N/NC(=O)N\N=C\c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D07 compound treatment 0.9883 -0.0117 -0.23 -0.2275 -1.0 2072203 Maybridge1_005177 S(c1ccccc1)c2nc3ccccc3nc2Sc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D08 compound treatment 1.022 0.022 0.43 0.428 1.0 2072204 Maybridge1_005178 Clc1cccc(Cl)c1/C=N/NC(=S)NC2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D09 compound treatment 1.0048 0.0048 0.09 0.0933 1.0 2072205 Maybridge1_005179 [O-][N+](=O)c1ccc(cc1)c2csc(n2)c3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D10 compound treatment 1.0213 0.0213 0.41 0.4141 1.0 2072206 Maybridge1_005180 C/C(=N\NC(=O)N/N=C(\C)/c1ccc(cc1)[N+](=O)[O-])/c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D11 compound treatment 0.9646 -0.0354 -0.69 -0.6878 -1.0 2072207 Maybridge1_005181 Brc1ccc(cc1)c2csc(n2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D12 compound treatment 1.0041 0.00408 0.08 0.0793 1.0 2072208 Maybridge1_005182 CNC(=S)N/N=C/c1ccc(OC)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D13 compound treatment 0.9696 -0.0304 -0.59 -0.5902 -1.0 2072209 Maybridge1_005183 CCOc1ccc(/C=N/NC(=S)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D14 compound treatment 0.9962 -0.00382 -0.07 -0.0741 -1.0 2072210 Maybridge1_005184 CNC(=S)N/N=C/c1cc(OC)c(OC)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D15 compound treatment 0.966 -0.034 -0.66 -0.6599 -1.0 2072211 Maybridge1_005185 Clc1cccc(Cl)c1/C=N/NC(=O)N\N=C\c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D16 compound treatment 1.0026 0.00265 0.05 0.0514 1.0 2072212 Maybridge1_005186 COc1ccc(NC(=S)NNC(=O)c2ccncc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D17 compound treatment 0.971 -0.029 -0.56 -0.5623 -1.0 2072213 Maybridge1_005187 NC(=S)N/N=C/c1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D18 compound treatment 0.9825 -0.0175 -0.34 -0.3391 -1.0 2072214 Maybridge1_005188 COc1cc(cc(OC)c1OC)C(=O)N/N=C\2/C(=O)Nc3ccc(Br)cc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D19 compound treatment 0.9545 -0.0455 -0.88 -0.8831 -1.0 2072215 Maybridge1_005189 Oc1ccc2ccccc2c1/C=N/NC(=O)N\N=C\c3c(O)ccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D20 compound treatment 0.9473 -0.0527 -1.02 -1.0226 -1.0 2072216 Maybridge1_005190 Brc1ccc(CSC2=NCN(Cc3cccnc3)CN2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D21 compound treatment 0.9675 -0.0325 -0.63 -0.632 -1.0 2072217 Maybridge1_005191 CCOC(=O)N/N=C/c1cccc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D22 compound treatment 1.0429 0.0429 0.83 0.8325 1.0 2072218 Maybridge1_005192 Nc1ccc2C=CS(=O)(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D23 mock treatment 0.9811 -0.0189 -0.37 -0.367 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 D24 mock treatment 1.035 0.035 0.68 0.6791 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E01 compound treatment 1.0371 0.0371 0.72 0.7209 1.0 2072219 Maybridge1_005193 CCCCOc1cc(ccc1OC)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E02 compound treatment 0.9868 -0.0132 -0.26 -0.2554 -1.0 2072220 Maybridge1_005194 COC(=O)c1ccc(NC(C)C)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E03 compound treatment 1.0012 0.00121 0.02 0.0235 1.0 1042155 Maybridge1_005195 Clc1cccc(NC(=O)Nc2cccc(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E04 compound treatment 0.9897 -0.0103 -0.2 -0.1996 -1.0 2072221 Maybridge1_005196 Cn1c(SCC(=O)N2CCOCC2)nnc1c3ccc4ncccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E05 compound treatment 1.0429 0.0429 0.83 0.8325 1.0 2072222 Maybridge1_005197 CCCCc1ccc(NC(=O)NCCSCc2ccco2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E06 compound treatment 0.9797 -0.0203 -0.39 -0.3949 -1.0 1306801 Maybridge1_005198 COc1cc(NC(=O)NC2Cc3ccccc3C2)cc(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E07 compound treatment 0.9818 -0.0182 -0.35 -0.3531 -1.0 2072223 Maybridge1_005199 COc1ccc(cc1)c2cc(n3nc(cc3n2)C(C)(C)C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E08 compound treatment 0.971 -0.029 -0.56 -0.5623 -1.0 1576756 Maybridge1_005200 Clc1ccc(cc1)C(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E09 compound treatment 1.0012 0.00121 0.02 0.0235 1.0 2072224 Maybridge1_005201 CCOc1ccccc1NC(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E10 compound treatment 0.9854 -0.0146 -0.28 -0.2833 -1.0 1497192 Maybridge1_005202 CCOc1ccccc1NC(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E11 compound treatment 1.0026 0.00265 0.05 0.0514 1.0 2072225 Maybridge1_005203 CC(C)(C)c1cc2nc(cc(n2n1)C(F)(F)F)c3ccc4CCCc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E12 compound treatment 1.012 0.012 0.23 0.2328 1.0 2072226 Maybridge1_005204 FC(F)(F)c1ccc(Cl)c(c1)S(=O)(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E13 compound treatment 0.9567 -0.0433 -0.84 -0.8412 -1.0 1738674 Maybridge1_005205 COC(=O)c1ccc(Cn2nnc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E14 compound treatment 0.9639 -0.0361 -0.7 -0.7018 -1.0 1433447 Maybridge1_005206 COc1cccc(SCC(=O)NC2Cc3ccccc3C2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E15 compound treatment 0.9983 -0.00166 -0.03 -0.0323 -1.0 2072227 Maybridge1_005207 O=S(=O)(NCCSCc1ccco1)c2cccc3nonc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E16 compound treatment 0.9804 -0.0196 -0.38 -0.381 -1.0 1496993 Maybridge1_005208 O=C(CSc1nnc(SCC(=O)NC2Cc3ccccc3C2)s1)NC4Cc5ccccc5C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E17 compound treatment 0.9861 -0.0139 -0.27 -0.2694 -1.0 2072228 Maybridge1_005209 Cc1cc2nc(cc(n2n1)C(F)(F)F)c3ccc4ccccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E18 compound treatment 0.9675 -0.0325 -0.63 -0.632 -1.0 2072229 Maybridge1_005210 CCCCn1c(S)nnc1CNC(=O)OC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E19 compound treatment 0.9739 -0.0261 -0.51 -0.5065 -1.0 2072230 Maybridge1_005211 O=S(=O)(NCCSCc1ccco1)c2cc(cs2)S(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E20 compound treatment 0.961 -0.039 -0.76 -0.7575 -1.0 2072231 Maybridge1_005212 CCOC(=O)C1CCN(CC1)c2cc(nc3c(F)cccc23)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E21 compound treatment 0.9797 -0.0203 -0.39 -0.3949 -1.0 2072232 Maybridge1_005213 [O-][N+](=O)c1cccc(c1)c2cc(n3nc(cc3n2)c4ccco4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E22 compound treatment 0.9509 -0.0491 -0.95 -0.9528 -1.0 2072233 Maybridge1_005214 OC1(CC(=NN1)c2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E23 mock treatment 1.0264 0.0264 0.51 0.5117 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 E24 mock treatment 1.017 0.017 0.33 0.3304 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F01 compound treatment 1.0414 0.0414 0.8 0.8046 1.0 1592040 Maybridge1_005215 CSc1nc2ccc(NS(=O)(=O)c3ccc(NC(=O)C)cc3)cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F02 compound treatment 1.0659 0.0659 1.28 1.2789 1.0 2072234 Maybridge1_005216 CCOC(=O)N/N=C/c1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F03 compound treatment 0.9739 -0.0261 -0.51 -0.5065 -1.0 1040140 Maybridge1_005217 Cc1ccc(CC(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F04 compound treatment 1.0084 0.00839 0.16 0.163 1.0 2072235 Maybridge1_005218 [O-][N+](=O)c1cccc(c1)C(=O)CSC2=NCCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F05 compound treatment 0.9854 -0.0146 -0.28 -0.2833 -1.0 1080225 Maybridge1_005219 COc1ccc(CCNC(=O)c2ccc(Cl)c(Cl)c2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F06 compound treatment 0.9531 -0.0469 -0.91 -0.911 -1.0 2072236 Maybridge1_005220 CCOC(=O)N/N=C/c1ccc(OC)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F07 compound treatment 0.9912 -0.00884 -0.17 -0.1717 -1.0 1116092 Maybridge1_005221 Oc1c([N+](=O)[O-])c(=O)oc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F08 compound treatment 1.0127 0.0127 0.25 0.2467 1.0 2072237 Maybridge1_005222 Oc1ccc(Cl)cc1/C=N/NC(=O)N\N=C\c2cc(Cl)ccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F09 compound treatment 1.0048 0.0048 0.09 0.0933 1.0 2072238 Maybridge1_005223 c1nc(sc1c2ccc(cc2)c3ccccc3)c4ccncc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F10 compound treatment 0.9833 -0.0167 -0.33 -0.3252 -1.0 2072239 Maybridge1_005224 C/C(=N\NC(=O)N/N=C(\C)/c1ccc2ccccc2c1)/c3ccc4ccccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F11 compound treatment 0.9825 -0.0175 -0.34 -0.3391 -1.0 2072240 Maybridge1_005225 [O-][N+](=O)c1ccc(cc1)c2csc(n2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F12 compound treatment 1.0005 4.94E-4 0.01 0.0096 1.0 2072241 Maybridge1_005226 CNC(=S)N/N=C/c1cc(Br)cc(Br)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F13 compound treatment 1.0084 0.00839 0.16 0.163 1.0 2072242 Maybridge1_005227 COc1cccc(/C=N/NC(=S)NCCc2ccccc2)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F14 compound treatment 0.9947 -0.00525 -0.1 -0.102 -1.0 1333393 Maybridge1_005228 COc1ccc(cc1)n2c(n[nH]c2=S)c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F15 compound treatment 1.0199 0.0199 0.39 0.3862 1.0 2072243 Maybridge1_005229 CC(=O)Nc1ccc(/C=N/NC(=O)N\N=C\c2ccc(NC(=O)C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F16 compound treatment 0.9294 -0.0706 -1.37 -1.3713 -1.0 2072244 Maybridge1_005230 Cc1cccc(C)c1NC(=S)NNC(=O)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F17 compound treatment 0.9667 -0.0333 -0.65 -0.646 -1.0 2072245 Maybridge1_005231 O=C(N/N=C/c1ccncc1)N/N=C/c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F18 compound treatment 1.0055 0.00552 0.11 0.1072 1.0 2072246 Maybridge1_005232 Cn1c(S)nnc1c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F19 compound treatment 0.9445 -0.0555 -1.08 -1.0784 -1.0 2072247 Maybridge1_005233 CCOC(=O)NNC(=S)Nc1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F20 compound treatment 0.9912 -0.00884 -0.17 -0.1717 -1.0 2072248 Maybridge1_005234 CCOC(=O)N/N=C(\C)/c1ccc(OC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F21 compound treatment 0.984 -0.016 -0.31 -0.3112 -1.0 2072249 Maybridge1_005235 CCOC(=O)N/N=C/c1ccccc1OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F22 compound treatment 0.9919 -0.00812 -0.16 -0.1578 -1.0 1087914 Maybridge1_005236 CC(=O)c1ccc(cc1Cl)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F23 mock treatment 0.9789 -0.0211 -0.41 -0.4088 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 F24 mock treatment 1.0149 0.0149 0.29 0.2885 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G01 compound treatment 1.0235 0.0235 0.46 0.4559 1.0 1043563 Maybridge1_005237 Nc1ccccc1NC2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G02 compound treatment 1.0271 0.0271 0.53 0.5257 1.0 2072250 Maybridge1_005238 Cc1cc(NC(=O)c2ccc3nonc3c2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G03 compound treatment 0.9868 -0.0132 -0.26 -0.2554 -1.0 1536217 Maybridge1_005239 COC(=O)c1sccc1NC(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G04 compound treatment 1.0149 0.0149 0.29 0.2885 1.0 2072251 Maybridge1_005240 CC(C)NC(=O)CSc1nnc(c2ccc3ncccc3c2)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G05 compound treatment 1.0091 0.00911 0.18 0.177 1.0 2072252 Maybridge1_005241 COc1ccc(Cl)cc1NC(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G06 compound treatment 0.9718 -0.0282 -0.55 -0.5483 -1.0 1639001 Maybridge1_005242 COc1cccc(NC(=O)NC2Cc3ccccc3C2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G07 compound treatment 1.0256 0.0256 0.5 0.4978 1.0 2072253 Maybridge1_005243 Fc1ccc(NC(=O)NCCSCc2ccco2)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G08 compound treatment 1.0371 0.0371 0.72 0.7209 1.0 1301968 Maybridge1_005244 CC(C)n1nnc2cc(ccc12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G09 compound treatment 1.0019 0.00193 0.04 0.0375 1.0 2072254 Maybridge1_005245 Brc1cncc(c1)C(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G10 compound treatment 0.9912 -0.00884 -0.17 -0.1717 -1.0 1511751 Maybridge1_005246 O=C(NC1Cc2ccccc2C1)Nc3cccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G11 compound treatment 0.9438 -0.0562 -1.09 -1.0923 -1.0 2072255 Maybridge1_005247 FC(F)(F)c1cc(nc2cc(nn12)c3ccco3)c4ccco4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G12 compound treatment 0.9998 -2.24E-4 0.0 -0.0044 -1.0 1330371 Maybridge1_005248 COc1ccc(Cl)cc1S(=O)(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G13 compound treatment 0.9545 -0.0455 -0.88 -0.8831 -1.0 2072256 Maybridge1_005249 CS(=O)(=NC(=O)c1ccc2nnsc2c1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G14 compound treatment 0.9876 -0.0124 -0.24 -0.2415 -1.0 1139185 Maybridge1_005250 COc1ccc(cc1)c2ccnc(SCC(=O)NC3Cc4ccccc4C3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G15 compound treatment 0.9947 -0.00525 -0.1 -0.102 -1.0 2072257 Maybridge1_005251 O=C(NCc1ccc(s1)S(=O)(=O)NCCSCc2ccco2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G16 compound treatment 0.9955 -0.00453 -0.09 -0.088 -1.0 1248175 Maybridge1_005252 Fc1ccc(SCC(=O)NC2Cc3ccccc3C2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G17 compound treatment 0.9804 -0.0196 -0.38 -0.381 -1.0 2072258 Maybridge1_005253 Brc1cncc(c1)C(=O)NNC(=O)c2ccc3ncccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G18 compound treatment 1.0005 4.94E-4 0.01 0.0096 1.0 2072259 Maybridge1_005254 FC(F)(F)c1cc(nc2cc(nn12)C3CC3)c4ccc5ccccc5c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G19 compound treatment 1.0041 0.00408 0.08 0.0793 1.0 2072260 Maybridge1_005255 Clc1ccc(cc1)S(=O)(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G20 compound treatment 1.0134 0.0134 0.26 0.2607 1.0 2072261 Maybridge1_005256 Cn1c(SCC(=O)O)nnc1c2ccc3ncccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G21 compound treatment 1.0041 0.00408 0.08 0.0793 1.0 2072262 Maybridge1_005257 [O-][N+](=O)c1cccc(c1)c2cc(n3nc(cc3n2)C4CC4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G22 compound treatment 1.0077 0.00768 0.15 0.1491 1.0 1703981 Maybridge1_005258 OC(=O)c1ccc(Cn2cnc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G23 mock treatment 0.9983 -0.00166 -0.03 -0.0323 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 G24 mock treatment 1.0019 0.00193 0.04 0.0375 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H01 compound treatment 1.035 0.035 0.68 0.6791 1.0 1553141 Maybridge1_005259 CSc1nc2ccc(NC(=O)c3c(C)onc3c4ccccc4)cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H02 compound treatment 0.9617 -0.0383 -0.74 -0.7436 -1.0 2072263 Maybridge1_005260 CCOC(=O)N/N=C/c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H03 compound treatment 1.0321 0.0321 0.62 0.6233 1.0 2072264 Maybridge1_005261 COc1cc2Cc3c(OC)c(OC)c(OC)cc3Cc2c(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H04 compound treatment 1.0299 0.0299 0.58 0.5815 1.0 1912813 Maybridge1_005262 Oc1ccccc1/C=N/c2nccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H05 compound treatment 1.0062 0.00624 0.12 0.1212 1.0 2072265 Maybridge1_005263 COC(=O)c1ccc(s1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H06 compound treatment 1.0055 0.00552 0.11 0.1072 1.0 2072266 Maybridge1_005264 Clc1ccccc1/C=N/NC(=S)NC2CC3CCC2C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H07 compound treatment 0.966 -0.034 -0.66 -0.6599 -1.0 2072267 Maybridge1_005265 Nc1c([N+](=O)[O-])c(=O)oc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H08 compound treatment 0.9962 -0.00382 -0.07 -0.0741 -1.0 2072268 Maybridge1_005266 CCOC(=O)N/N=C/c1cc(Cl)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H09 compound treatment 0.9574 -0.0426 -0.83 -0.8273 -1.0 1671736 Maybridge1_005267 CCOC(=O)c1ccc(NC(=S)NN)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H10 compound treatment 1.0141 0.0141 0.27 0.2746 1.0 2072269 Maybridge1_005268 O=C(N/N=C/c1cccnc1)N/N=C/c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H11 compound treatment 0.9574 -0.0426 -0.83 -0.8273 -1.0 2072270 Maybridge1_005269 Cc1ccc(cc1)c2csc(Nc3ccccc3Cl)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H12 compound treatment 1.1183 0.118 2.3 2.2971 1.0 2072271 Maybridge1_005270 CNC(=S)N/N=C/c1c(O)ccc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H13 compound treatment 0.9617 -0.0383 -0.74 -0.7436 -1.0 2072272 Maybridge1_005271 COc1ccc(OC)c(/C=N/NC(=S)NCCc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H14 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 2072273 Maybridge1_005272 COc1ccc(cc1)n2c(SCc3ccc(Br)cc3)nnc2c4ccco4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H15 compound treatment 0.9438 -0.0562 -1.09 -1.0923 -1.0 2072274 Maybridge1_005273 [O-][N+](=O)c1cccc(/C=N/NC(=O)N\N=C\c2cccc(c2)[N+](=O)[O-])c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H16 compound treatment 0.984 -0.016 -0.31 -0.3112 -1.0 2072275 Maybridge1_005274 FC(F)(F)c1cccc(NC(=S)NNC(=O)c2ccncc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H17 compound treatment 1.0005 4.94E-4 0.01 0.0096 1.0 2072276 Maybridge1_005275 O=C(N/N=C/c1cccs1)N/N=C/c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H18 compound treatment 0.9804 -0.0196 -0.38 -0.381 -1.0 2072277 Maybridge1_005276 CCCCCCCNC(=S)NNC(=O)c1ccncc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H19 compound treatment 0.9947 -0.00525 -0.1 -0.102 -1.0 2072278 Maybridge1_005277 CCOC(=O)N/N=C/c1ccc(OC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H20 compound treatment 0.9782 -0.0218 -0.42 -0.4228 -1.0 2072279 Maybridge1_005278 CCOC(=O)NN=C1CCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H21 compound treatment 0.9581 -0.0419 -0.81 -0.8133 -1.0 2072280 Maybridge1_005279 CCOC(=O)N/N=C/c1cc(Br)cc(Br)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H22 compound treatment 0.9588 -0.0412 -0.8 -0.7994 -1.0 2072281 Maybridge1_005280 COC(=O)Cc1csc2ccc(Cl)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H23 mock treatment 0.933 -0.067 -1.3 -1.3015 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 H24 mock treatment 1.0091 0.00911 0.18 0.177 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I01 compound treatment 1.0228 0.0228 0.44 0.442 1.0 2072282 Maybridge1_005281 Cc1ccc(cc1)S(=O)(=O)OCC2COc3ccccc3O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I02 compound treatment 0.9682 -0.0318 -0.62 -0.6181 -1.0 1273865 Maybridge1_005282 O=C(NC1Cc2ccccc2C1)Nc3ccc(OCc4ccccc4)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I03 compound treatment 1.0228 0.0228 0.44 0.442 1.0 2072283 Maybridge1_005283 COC(=O)c1ccc(CNC(=O)Nc2cccc(SC)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I04 compound treatment 1.0026 0.00265 0.05 0.0514 1.0 1930349 Maybridge1_005284 Cc1cc(C)n2nc(cc2n1)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I05 compound treatment 0.9976 -0.00238 -0.05 -0.0462 -1.0 2072284 Maybridge1_005285 Cc1ccc2nc(sc2c1)c3ccc(NS(=O)(=O)c4cccc5nonc45)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I06 compound treatment 0.9818 -0.0182 -0.35 -0.3531 -1.0 1585869 Maybridge1_005286 Cc1ccc(cc1)S(=O)(=O)NC(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I07 compound treatment 0.9983 -0.00166 -0.03 -0.0323 -1.0 2072285 Maybridge1_005287 COc1cccc(NC(=O)NCCSCc2ccco2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I08 compound treatment 0.9933 -0.00669 -0.13 -0.1299 -1.0 1175274 Maybridge1_005288 Brc1cncc(c1)C(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I09 compound treatment 0.9962 -0.00382 -0.07 -0.0741 -1.0 1343669 Maybridge1_005289 NNC(=O)c1cc2cc(OCc3ccccc3)ccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I10 compound treatment 0.9847 -0.0153 -0.3 -0.2973 -1.0 1273246 Maybridge1_005290 O=C(NC1Cc2ccccc2C1)C3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I11 compound treatment 0.9775 -0.0225 -0.44 -0.4367 -1.0 2072286 Maybridge1_005291 Nc1nc(cc(n1)C(F)(F)F)c2ccc3CCCc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I12 compound treatment 0.9883 -0.0117 -0.23 -0.2275 -1.0 1126364 Maybridge1_005292 Clc1ccc(s1)S(=O)(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I13 compound treatment 0.9861 -0.0139 -0.27 -0.2694 -1.0 2072287 Maybridge1_005293 FC(F)(F)c1cc(n[nH]1)c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I14 compound treatment 0.989 -0.011 -0.21 -0.2136 -1.0 1287710 Maybridge1_005294 O=C(CSCc1ccccc1)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I15 compound treatment 1.0012 0.00121 0.02 0.0235 1.0 2072288 Maybridge1_005295 COc1ccc(Cl)cc1S(=O)(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I16 compound treatment 0.9416 -0.0584 -1.13 -1.1341 -1.0 1566045 Maybridge1_005296 Clc1ccc(SCC(=O)NC2Cc3ccccc3C2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I17 compound treatment 0.9718 -0.0282 -0.55 -0.5483 -1.0 2072289 Maybridge1_005297 FC(F)(F)c1cc(nc2cc(nn12)c3ccccc3)c4ccc5OCOc5c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I18 compound treatment 0.9696 -0.0304 -0.59 -0.5902 -1.0 2072290 Maybridge1_005298 FC(F)(F)c1cc(N2CCN(Cc3ccccc3)CC2)c4ccccc4n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I19 compound treatment 0.9538 -0.0462 -0.9 -0.897 -1.0 2072291 Maybridge1_005299 COc1ccc(cc1)c2cc(n3nc(C)cc3n2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I20 compound treatment 0.9696 -0.0304 -0.59 -0.5902 -1.0 2072292 Maybridge1_005300 Oc1ccc(cc1)n2nnnc2SCc3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I21 compound treatment 0.9466 -0.0534 -1.04 -1.0365 -1.0 2072293 Maybridge1_005301 CC(C)(C)c1cc2nc(cc(n2n1)C(F)(F)F)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I22 compound treatment 0.9725 -0.0275 -0.53 -0.5344 -1.0 1165427 Maybridge1_005302 NNC(=O)CSc1ccnc2cc(Cl)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I23 mock treatment 0.966 -0.034 -0.66 -0.6599 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 I24 mock treatment 0.989 -0.011 -0.21 -0.2136 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J01 compound treatment 1.0601 0.0601 1.17 1.1673 1.0 2072294 Maybridge1_005303 Brc1ccc(s1)S(=O)(=O)Nc2ccc3CS(=O)(=O)Cc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J02 compound treatment 1.0292 0.0292 0.57 0.5675 1.0 2072295 Maybridge1_005304 CCOC(=O)N/N=C/c1ccc(OC)c(O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J03 compound treatment 1.0141 0.0141 0.27 0.2746 1.0 2072296 Maybridge1_005305 CCOc1ccc(/C=N/NS(=O)(=O)c2ccc(C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J04 compound treatment 1.0228 0.0228 0.44 0.442 1.0 1019747 Maybridge1_005306 [O-][N+](=O)c1ccc(cc1)C(=O)Nc2nccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J05 compound treatment 0.9861 -0.0139 -0.27 -0.2694 -1.0 1467929 Maybridge1_005307 CC(C)(C)c1ccc(s1)C(=O)NC(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J06 compound treatment 1.0048 0.0048 0.09 0.0933 1.0 2072297 Maybridge1_005308 COc1ccc(/C=N/NC(=S)NC2CC3CCC2C3)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J07 compound treatment 1.0192 0.0192 0.37 0.3722 1.0 1530152 Maybridge1_005309 c1sc(nc1c2ccccc2)c3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J08 compound treatment 0.9926 -0.00741 -0.14 -0.1438 -1.0 2072298 Maybridge1_005310 COc1ccc(cc1)c2nc(cs2)c3ccc(Br)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J09 compound treatment 1.0249 0.0249 0.48 0.4838 1.0 1561476 Maybridge1_005311 COc1ccccc1Nc2nnns2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J10 compound treatment 0.9919 -0.00812 -0.16 -0.1578 -1.0 2072299 Maybridge1_005312 C/C(=N\NC(=O)N/N=C(\C)/c1ccc(C)cc1)/c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J11 compound treatment 1.0249 0.0249 0.48 0.4838 1.0 2072300 Maybridge1_005313 Fc1ccc(cc1)c2csc(Nc3ccccc3Cl)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J12 compound treatment 0.9991 -9.43E-4 -0.02 -0.0183 -1.0 2072301 Maybridge1_005314 CNC(=S)N/N=C/c1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J13 compound treatment 0.984 -0.016 -0.31 -0.3112 -1.0 2072302 Maybridge1_005315 COc1cc(/C=N/NC(=S)NCCc2ccccc2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J14 compound treatment 0.984 -0.016 -0.31 -0.3112 -1.0 2072303 Maybridge1_005316 COc1cc(cc(OC)c1OC)C(=O)NNC(=S)Nc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J15 compound treatment 0.9538 -0.0462 -0.9 -0.897 -1.0 2072304 Maybridge1_005317 Oc1c(Cl)cc(Cl)cc1/C=N/NC(=O)N\N=C\c2cc(Cl)cc(Cl)c2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J16 compound treatment 1.0012 0.00121 0.02 0.0235 1.0 1083192 Maybridge1_005318 Clc1cccc(NC(=S)NNC(=O)c2ccncc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J17 compound treatment 0.9969 -0.0031 -0.06 -0.0602 -1.0 2072305 Maybridge1_005319 O=C(N/N=C/c1cccc2ccccc12)N/N=C/c3cccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J18 compound treatment 0.9897 -0.0103 -0.2 -0.1996 -1.0 2072306 Maybridge1_005320 CCOC(=O)N/N=C(\C)/c1cccc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J19 compound treatment 0.971 -0.029 -0.56 -0.5623 -1.0 2072307 Maybridge1_005321 CCOC(=O)NNC(=S)Nc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J20 compound treatment 1.0465 0.0465 0.9 0.9023 1.0 2072308 Maybridge1_005322 Brc1ccc2NC(=O)/C(=N\NC(=O)c3ccco3)/c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J21 compound treatment 1.0041 0.00408 0.08 0.0793 1.0 2072309 Maybridge1_005323 CCOC(=O)N/N=C/c1cc(Br)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J22 compound treatment 0.9833 -0.0167 -0.33 -0.3252 -1.0 1371563 Maybridge1_005324 Cc1c(CC(=S)N2CCOCC2)sc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J23 mock treatment 0.9567 -0.0433 -0.84 -0.8412 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 J24 mock treatment 1.0077 0.00768 0.15 0.1491 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K01 compound treatment 1.0429 0.0429 0.83 0.8325 1.0 2072310 Maybridge1_005325 CC(C)Sc1c(Cl)cccc1NC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K02 compound treatment 0.9488 -0.0512 -0.99 -0.9947 -1.0 2072311 Maybridge1_005326 CCCCNC(=O)NC1Cc2ccccc2C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K03 compound treatment 0.9868 -0.0132 -0.26 -0.2554 -1.0 2072312 Maybridge1_005327 O=C(NCCSCc1ccco1)Nc2ccc(OCc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K04 compound treatment 0.9818 -0.0182 -0.35 -0.3531 -1.0 1232037 Maybridge1_005328 Cc1c(Cl)cccc1NC(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K05 compound treatment 0.961 -0.039 -0.76 -0.7575 -1.0 2072313 Maybridge1_005329 Cc1c(Cl)cccc1NC(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K06 compound treatment 1.0034 0.00337 0.07 0.0654 1.0 2072314 Maybridge1_005330 FC(F)(F)Oc1ccc(NC(=O)NC2Cc3ccccc3C2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K07 compound treatment 1.0077 0.00768 0.15 0.1491 1.0 2072315 Maybridge1_005331 O=C(NCCSCc1ccco1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K08 compound treatment 1.007 0.00696 0.14 0.1351 1.0 1478124 Maybridge1_005332 Cc1occ(c1C(=O)NC2Cc3ccccc3C2)c4cc(F)ccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K09 compound treatment 1.0134 0.0134 0.26 0.2607 1.0 1022545 Maybridge1_005333 OC(=O)c1cc2cc(OCc3ccccc3)ccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K10 compound treatment 0.9976 -0.00238 -0.05 -0.0462 -1.0 1514678 Maybridge1_005334 CC(=O)Nc1ccc(cc1)S(=O)(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K11 compound treatment 0.9739 -0.0261 -0.51 -0.5065 -1.0 2072316 Maybridge1_005335 CC(C)(C)c1cc2c(CCC2(C)C)c(c1)c3cc(nc(N)n3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K12 compound treatment 0.9581 -0.0419 -0.81 -0.8133 -1.0 1395391 Maybridge1_005336 Clc1cccc(c1)S(=O)(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K13 compound treatment 1.0407 0.0407 0.79 0.7907 1.0 2072317 Maybridge1_005337 CC(C)(C)c1cc2c(CCC2(C)C)c(c1)c3cc([nH]n3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K14 compound treatment 0.9718 -0.0282 -0.55 -0.5483 -1.0 1326753 Maybridge1_005338 CCn1nnnc1SCC(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K15 compound treatment 0.9868 -0.0132 -0.26 -0.2554 -1.0 2072318 Maybridge1_005339 FC(F)(F)c1ccc(Cl)c(c1)S(=O)(=O)NCCSCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K16 compound treatment 0.9667 -0.0333 -0.65 -0.646 -1.0 1589432 Maybridge1_005340 O=C(CSc1cccs1)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K17 compound treatment 0.9596 -0.0404 -0.79 -0.7854 -1.0 2072319 Maybridge1_005341 O=C(NCCSCc1ccco1)C2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K18 compound treatment 0.9976 -0.00238 -0.05 -0.0462 -1.0 2072320 Maybridge1_005342 Sc1nnc(c2ccc3ncccc3c2)n1CC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K19 compound treatment 1.0321 0.0321 0.62 0.6233 1.0 2072321 Maybridge1_005343 CC(C)(C)OC(=O)NCC(=O)NNC(=S)NCc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K20 compound treatment 1.0192 0.0192 0.37 0.3722 1.0 2072322 Maybridge1_005344 CSc1nccc(n1)c2ccc(s2)S(=O)(=O)Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K21 compound treatment 0.9315 -0.0685 -1.33 -1.3294 -1.0 2072323 Maybridge1_005345 Cc1ccc2[nH]c(SCC(=O)NCCSCc3ccco3)nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K22 compound treatment 0.9725 -0.0275 -0.53 -0.5344 -1.0 2072324 Maybridge1_005346 COc1ccc(cc1)c2ccnc(SCc3cccc(c3)[N+](=O)[O-])n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K23 mock treatment 0.9804 -0.0196 -0.38 -0.381 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 K24 mock treatment 1.0264 0.0264 0.51 0.5117 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L01 compound treatment 1.0206 0.0206 0.4 0.4001 1.0 2072325 Maybridge1_005347 COC(=O)/C=C(/c1ccccc1)\n2cnc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L02 compound treatment 1.0192 0.0192 0.37 0.3722 1.0 1920895 Maybridge1_005348 CCOC(=O)N/N=C/c1c[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L03 compound treatment 0.9811 -0.0189 -0.37 -0.367 -1.0 1004905 Maybridge1_005349 COc1cccc(NC(=O)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L04 compound treatment 1.0041 0.00408 0.08 0.0793 1.0 1061299 Maybridge1_005350 Clc1ccc(cc1)C(=O)Nc2nccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L05 compound treatment 0.9761 -0.0239 -0.46 -0.4646 -1.0 2072326 Maybridge1_005351 FC(F)(F)c1cc(NC(=O)NC(=O)c2ccc(s2)c3ccc(Cl)cc3)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L06 compound treatment 1.012 0.012 0.23 0.2328 1.0 2072327 Maybridge1_005352 COc1cc(/C=N/NC(=S)NC2CC3CCC2C3)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L07 compound treatment 1.0012 0.00121 0.02 0.0235 1.0 2072328 Maybridge1_005353 Brc1ccc(cc1)c2csc(n2)c3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L08 compound treatment 1.0012 0.00121 0.02 0.0235 1.0 2072329 Maybridge1_005354 COc1ccc(cc1)c2nc(cs2)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L09 compound treatment 1.0055 0.00552 0.11 0.1072 1.0 2072330 Maybridge1_005355 c1sc(nc1c2ccc(cc2)c3ccccc3)c4cccnc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L10 compound treatment 0.9991 -9.43E-4 -0.02 -0.0183 -1.0 2072331 Maybridge1_005356 CNC(=S)N/N=C/c1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L11 compound treatment 1.0192 0.0192 0.37 0.3722 1.0 2072332 Maybridge1_005357 Clc1ccccc1Nc2nc(cs2)c3ccc(cc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L12 compound treatment 1.0357 0.0357 0.69 0.693 1.0 2072333 Maybridge1_005358 CNC(=S)N/N=C/c1ccc(OC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L13 compound treatment 0.9811 -0.0189 -0.37 -0.367 -1.0 2072334 Maybridge1_005359 CCOc1ccccc1/C=N/NC(=O)N\N=C\c2ccccc2OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L14 compound treatment 0.9947 -0.00525 -0.1 -0.102 -1.0 1125175 Maybridge1_005360 COc1cc(cc(OC)c1OC)c2n[nH]c(=S)n2c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L15 compound treatment 0.9624 -0.0376 -0.73 -0.7297 -1.0 2072335 Maybridge1_005361 Oc1ccc(Br)cc1/C=N/NC(=O)N\N=C\c2cc(Br)ccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L16 compound treatment 1.007 0.00696 0.14 0.1351 1.0 1472644 Maybridge1_005362 O=S(=O)(N1CCCCC1)c2ccc(cc2)n3c(n[nH]c3=S)c4ccncc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L17 compound treatment 0.9818 -0.0182 -0.35 -0.3531 -1.0 2072336 Maybridge1_005363 COc1cc(/C=N/NC(=O)N\N=C\c2ccc(O)c(OC)c2)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L18 compound treatment 0.9868 -0.0132 -0.26 -0.2554 -1.0 1014806 Maybridge1_005364 CC12NC(=O)NC2(C)NC(=O)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L19 compound treatment 0.938 -0.062 -1.2 -1.2039 -1.0 2072337 Maybridge1_005365 CCOC(=O)N/N=C/c1ccc(OC)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L20 compound treatment 1.0292 0.0292 0.57 0.5675 1.0 1090220 Maybridge1_005366 Cc1csc2ccc(Cl)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L21 compound treatment 1.0271 0.0271 0.53 0.5257 1.0 2072338 Maybridge1_005367 CCOC(=O)N/N=C/c1ccc(O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L22 compound treatment 1.0457 0.0457 0.89 0.8883 1.0 1250303 Maybridge1_005368 Cc1c(CC(=O)O)sc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L23 mock treatment 0.9904 -0.00956 -0.19 -0.1857 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 L24 mock treatment 1.0321 0.0321 0.62 0.6233 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M01 compound treatment 1.045 0.045 0.87 0.8744 1.0 1525913 Maybridge1_005369 CC(C)Sc1c(Cl)cccc1NC(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M02 compound treatment 1.012 0.012 0.23 0.2328 1.0 1302742 Maybridge1_005370 CC(C)(C)c1ccc(NC(=O)NC2Cc3ccccc3C2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M03 compound treatment 1.0386 0.0386 0.75 0.7488 1.0 2072339 Maybridge1_005371 O=C(NCCSCc1ccco1)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M04 compound treatment 0.9861 -0.0139 -0.27 -0.2694 -1.0 1537203 Maybridge1_005372 Clc1cccc(NC(=O)NC2Cc3ccccc3C2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M05 compound treatment 1.0005 4.94E-4 0.01 0.0096 1.0 2072340 Maybridge1_005373 Clc1cccc(NC(=O)NCCSCc2ccco2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M06 compound treatment 1.012 0.012 0.23 0.2328 1.0 2072341 Maybridge1_005374 Cn1c(SCc2ccc(Cl)cc2)nnc1c3ccc4ncccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M07 compound treatment 1.0292 0.0292 0.57 0.5675 1.0 2072342 Maybridge1_005375 FC(F)(F)Oc1ccc(NC(=O)NCCSCc2ccco2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M08 compound treatment 1.0034 0.00337 0.07 0.0654 1.0 1379425 Maybridge1_005376 Cc1onc(c1C(=O)NC2Cc3ccccc3C2)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M09 compound treatment 0.9947 -0.00525 -0.1 -0.102 -1.0 2072343 Maybridge1_005377 Cn1c(S)nnc1c2ccc3ncccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M10 compound treatment 1.0256 0.0256 0.5 0.4978 1.0 1211239 Maybridge1_005378 O=S(=O)(NC1Cc2ccccc2C1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M11 compound treatment 1.0335 0.0335 0.65 0.6512 1.0 2072344 Maybridge1_005379 FC(F)(F)C(=O)CC(=O)c1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M12 compound treatment 0.9991 -9.43E-4 -0.02 -0.0183 -1.0 1477772 Maybridge1_005380 Fc1cccc(Cl)c1CSCC(=O)NC2Cc3ccccc3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M13 compound treatment 1.0098 0.00983 0.19 0.1909 1.0 2072345 Maybridge1_005381 Nc1nc(cc(n1)C(F)(F)F)c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M14 compound treatment 0.9883 -0.0117 -0.23 -0.2275 -1.0 2072346 Maybridge1_005382 CCCc1cc(O)nc(SCC(=O)NC2Cc3ccccc3C2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M15 compound treatment 0.9337 -0.0663 -1.29 -1.2876 -1.0 2072347 Maybridge1_005383 Cn1c(SCc2ccccc2)nnc1c3ccc4ncccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M16 compound treatment 0.9603 -0.0397 -0.77 -0.7715 -1.0 1244204 Maybridge1_005384 O=C(Cn1nnc2ccccc12)NC3Cc4ccccc4C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M17 compound treatment 0.9617 -0.0383 -0.74 -0.7436 -1.0 2072348 Maybridge1_005385 Oc1ccc(cc1)n2nnnc2SCC(=O)NCCSCc3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M18 compound treatment 0.9768 -0.0232 -0.45 -0.4507 -1.0 2072349 Maybridge1_005386 OCCN1CCN(CC1)c2cc(nc3c(F)cccc23)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M19 compound treatment 0.9703 -0.0297 -0.58 -0.5762 -1.0 2072350 Maybridge1_005387 CC(C)(C)OC(=O)NCC(=O)NNC(=S)Nc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M20 compound treatment 0.9983 -0.00166 -0.03 -0.0323 -1.0 2072351 Maybridge1_005388 CCOC(=O)c1ccc2nc(cc(N3CCOCC3)c2c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M21 compound treatment 1.0465 0.0465 0.9 0.9023 1.0 2072352 Maybridge1_005389 O=C(CSc1nnc(SCC(=O)NCCSCc2ccco2)s1)NCCSCc3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M22 compound treatment 0.9574 -0.0426 -0.83 -0.8273 -1.0 1205842 Maybridge1_005390 COc1ccc(cc1)c2ccnc(SCC(=O)Nc3ccc(cc3)C(C)C)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M23 mock treatment 0.9754 -0.0246 -0.48 -0.4786 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 M24 mock treatment 1.0307 0.0307 0.6 0.5954 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N01 compound treatment 1.0091 0.00911 0.18 0.177 1.0 1080875 Maybridge1_005391 OC(=O)Cc1noc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N02 compound treatment 1.0034 0.00337 0.07 0.0654 1.0 2072353 Maybridge1_005392 CCOC(=O)N/N=C/c1cccc(O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N03 compound treatment 0.9789 -0.0211 -0.41 -0.4088 -1.0 1008357 Maybridge1_005393 CC(=O)Nc1cccc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N04 compound treatment 0.9818 -0.0182 -0.35 -0.3531 -1.0 2072354 Maybridge1_005394 Cc1ccccc1C(=O)Nc2nccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N05 compound treatment 0.9811 -0.0189 -0.37 -0.367 -1.0 2072355 Maybridge1_005395 FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2nnc(o2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N06 compound treatment 1.0105 0.0105 0.2 0.2049 1.0 2072356 Maybridge1_005396 CCOC(=O)NNC(=S)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N07 compound treatment 1.017 0.017 0.33 0.3304 1.0 1632182 Maybridge1_005397 Cc1ccc(cc1)c2csc(n2)c3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N08 compound treatment 1.0026 0.00265 0.05 0.0514 1.0 2072357 Maybridge1_005398 COc1ccc(cc1)c2nc(cs2)c3ccc(cc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N09 compound treatment 0.9789 -0.0211 -0.41 -0.4088 -1.0 2072358 Maybridge1_005399 Fc1ccc(cc1)c2csc(n2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N10 compound treatment 1.007 0.00696 0.14 0.1351 1.0 2072359 Maybridge1_005400 CNC(=S)N/N=C/c1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N11 compound treatment 0.9531 -0.0469 -0.91 -0.911 -1.0 2072360 Maybridge1_005401 [O-][N+](=O)c1cccc(c1)c2csc(Nc3ccccc3Cl)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N12 compound treatment 1.0249 0.0249 0.48 0.4838 1.0 2072361 Maybridge1_005402 CCOc1ccccc1/C=N/NC(=S)NC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N13 compound treatment 0.9581 -0.0419 -0.81 -0.8133 -1.0 2072362 Maybridge1_005403 Clc1ccc(/C=N/NC(=O)N\N=C\c2ccc(Cl)c(Cl)c2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N14 compound treatment 1.0019 0.00193 0.04 0.0375 1.0 2072363 Maybridge1_005404 COc1ccc(NC(=S)NNC(=O)c2cc(OC)c(OC)c(OC)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N15 compound treatment 0.9847 -0.0153 -0.3 -0.2973 -1.0 2072364 Maybridge1_005405 CCOc1ccccc1/C=N/NC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N16 compound treatment 0.9797 -0.0203 -0.39 -0.3949 -1.0 1083185 Maybridge1_005406 CNC(=S)NNC(=O)c1ccncc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N17 compound treatment 0.9947 -0.00525 -0.1 -0.102 -1.0 2072365 Maybridge1_005407 Oc1cccc(/C=N/NC(=O)N\N=C\c2cccc(O)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N18 compound treatment 0.9933 -0.00669 -0.13 -0.1299 -1.0 1550576 Maybridge1_005408 CC1CC(CC(C)(C)C1)N2CNC(=S)NC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N19 compound treatment 0.9653 -0.0347 -0.67 -0.6739 -1.0 2072366 Maybridge1_005409 CCOC(=O)N/N=C/c1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N20 compound treatment 0.9904 -0.00956 -0.19 -0.1857 -1.0 2072367 Maybridge1_005410 CC(=O)c1sc2ccccc2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N21 compound treatment 0.9811 -0.0189 -0.37 -0.367 -1.0 1934343 Maybridge1_005411 CCOC(=O)N/N=C/c1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N22 compound treatment 0.9797 -0.0203 -0.39 -0.3949 -1.0 2072368 Maybridge1_005412 CC(=O)c1sc2ccc(Cl)cc2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N23 mock treatment 0.9596 -0.0404 -0.79 -0.7854 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 N24 mock treatment 1.0278 0.0278 0.54 0.5396 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O01 compound treatment 1.0041 0.00408 0.08 0.0793 1.0 1627038 Maybridge1_005413 C(N1CCC(CC1)n2nnc3cccnc23)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O02 compound treatment 0.9481 -0.0519 -1.01 -1.0086 -1.0 1443998 Maybridge1_005414 CCCCc1ccc(NC(=O)NC2Cc3ccccc3C2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O03 compound treatment 1.022 0.022 0.43 0.428 1.0 2072369 Maybridge1_005415 COC(=O)c1ccc2ncccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O04 compound treatment 0.9883 -0.0117 -0.23 -0.2275 -1.0 1532931 Maybridge1_005416 Fc1ccc(NC(=O)NC2Cc3ccccc3C2)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O05 compound treatment 1.0062 0.00624 0.12 0.1212 1.0 2072370 Maybridge1_005417 Clc1ccc(NC(=O)NCCSCc2ccco2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O06 compound treatment 1.0242 0.0242 0.47 0.4699 1.0 1469809 Maybridge1_005418 O=C(NC1Cc2ccccc2C1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O07 compound treatment 0.9782 -0.0218 -0.42 -0.4228 -1.0 2072371 Maybridge1_005419 O=C(NCCSCc1ccco1)Nc2cccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O08 compound treatment 0.9991 -9.43E-4 -0.02 -0.0183 -1.0 1635085 Maybridge1_005420 O=C(NC1Cc2ccccc2C1)C3CCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O09 compound treatment 0.994 -0.00597 -0.12 -0.1159 -1.0 2072372 Maybridge1_005421 FC(F)(F)c1cc(nc2cc(nn12)c3ccccc3)c4ccco4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O10 compound treatment 1.0307 0.0307 0.6 0.5954 1.0 1248490 Maybridge1_005422 O=S(=O)(NC1Cc2ccccc2C1)c3cccc4nonc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O11 compound treatment 0.984 -0.016 -0.31 -0.3112 -1.0 1076165 Maybridge1_005423 Nc1nc(cc(n1)C(F)(F)F)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O12 compound treatment 0.9761 -0.0239 -0.46 -0.4646 -1.0 1250785 Maybridge1_005424 CC(C)(C)OC(=O)NCc1nnc(S)n1Cc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O13 compound treatment 1.0141 0.0141 0.27 0.2746 1.0 2072373 Maybridge1_005425 COc1ccc2cc(ccc2c1)c3cc(nc(N)n3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O14 compound treatment 0.9782 -0.0218 -0.42 -0.4228 -1.0 1228553 Maybridge1_005426 O=C(CSc1nnnn1c2ccccc2)NC3Cc4ccccc4C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O15 compound treatment 0.9991 -9.43E-4 -0.02 -0.0183 -1.0 2072374 Maybridge1_005427 Cn1c(SCC(=O)Nc2ccccc2)nnc1c3ccc4ncccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O16 compound treatment 0.9567 -0.0433 -0.84 -0.8412 -1.0 1220510 Maybridge1_005428 CC(C)(C)OC(=O)NCc1nnc(S)n1C2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O17 compound treatment 0.9797 -0.0203 -0.39 -0.3949 -1.0 2072375 Maybridge1_005429 COc1ccc(cc1)c2ccnc(SCC(=O)NCCSCc3ccco3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O18 compound treatment 1.0307 0.0307 0.6 0.5954 1.0 2072376 Maybridge1_005430 Fc1cccc2c(OC3CCN(Cc4ccccc4)CC3)cc(nc12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O19 compound treatment 0.9955 -0.00453 -0.09 -0.088 -1.0 2072377 Maybridge1_005431 FC(F)(F)c1cc(nc2cc(nn12)C3CC3)c4nccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O20 compound treatment 0.9833 -0.0167 -0.33 -0.3252 -1.0 2072378 Maybridge1_005432 CCOC(=O)C1CCN(CC1)c2cc(nc3ccc(cc23)C(=O)OCC)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O21 compound treatment 0.9236 -0.0764 -1.48 -1.4828 -1.0 1467023 Maybridge1_005433 O=C(NCCc1ccccc1)c2ccc3nonc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O22 compound treatment 0.9897 -0.0103 -0.2 -0.1996 -1.0 1422747 Maybridge1_005434 COc1ccc(cc1)c2ccnc(SCc3ccccc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O23 mock treatment 0.9897 -0.0103 -0.2 -0.1996 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 O24 mock treatment 1.0601 0.0601 1.17 1.1673 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P01 compound treatment 1.0019 0.00193 0.04 0.0375 1.0 2072379 Maybridge1_005435 Cc1ccc(c(c1)[N+](=O)[O-])c2ccc(C)cc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P02 compound treatment 1.0429 0.0429 0.83 0.8325 1.0 2072380 Maybridge1_005436 COc1cccc(NC(=S)NNc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P03 compound treatment 1.0005 4.94E-4 0.01 0.0096 1.0 1002354 Maybridge1_005437 CC(=O)Nc1cccc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P04 compound treatment 1.0551 0.0551 1.07 1.0696 1.0 1783745 Maybridge1_005438 [O-][N+](=O)c1cccc(c1)C(=O)Nc2nccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P05 compound treatment 1.0113 0.0113 0.22 0.2188 1.0 2072381 Maybridge1_005439 CCc1nc2ccccc2[nH]c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P06 compound treatment 1.012 0.012 0.23 0.2328 1.0 2072382 Maybridge1_005440 Brc1ccc2NC(=O)/C(=N\NC(=O)N/N=C\3/C(=O)Nc4ccc(Br)cc34)/c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P07 compound treatment 1.0321 0.0321 0.62 0.6233 1.0 1288646 Maybridge1_005441 Cc1ccc(c2csc(n2)c3ccncc3)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P08 compound treatment 0.994 -0.00597 -0.12 -0.1159 -1.0 2072383 Maybridge1_005442 CCc1cc2c(cc1c3csc(n3)c4ccc(OC)cc4)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P09 compound treatment 1.0141 0.0141 0.27 0.2746 1.0 2072384 Maybridge1_005443 [O-][N+](=O)c1cccc(c1)c2csc(n2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P10 compound treatment 1.0192 0.0192 0.37 0.3722 1.0 2072385 Maybridge1_005444 CNC(=S)N/N=C/c1cc(Br)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P11 compound treatment 0.9675 -0.0325 -0.63 -0.632 -1.0 2072386 Maybridge1_005445 Clc1ccccc1Nc2nc(cs2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P12 compound treatment 0.9797 -0.0203 -0.39 -0.3949 -1.0 2072387 Maybridge1_005446 CCOc1ccc(/C=N/NC(=S)NC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P13 compound treatment 0.9689 -0.0311 -0.6 -0.6041 -1.0 2072388 Maybridge1_005447 Clc1ccccc1/C=N/NC(=O)N\N=C\c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P14 compound treatment 0.9998 -2.24E-4 0.0 -0.0044 -1.0 2072389 Maybridge1_005448 COc1cc(cc(OC)c1OC)C(=O)NNC(=S)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P15 compound treatment 1.0249 0.0249 0.48 0.4838 1.0 2072390 Maybridge1_005449 CCOc1ccccc1/C=N/Nc2nc(cs2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P16 compound treatment 1.0278 0.0278 0.54 0.5396 1.0 1083198 Maybridge1_005450 C=CCNC(=S)NNC(=O)c1ccncc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P17 compound treatment 0.971 -0.029 -0.56 -0.5623 -1.0 2072391 Maybridge1_005451 CCOc1ccc(/C=N/NC(=O)N\N=C\c2ccc(OCC)c(OC)c2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P18 compound treatment 1.0321 0.0321 0.62 0.6233 1.0 1713698 Maybridge1_005452 S=C1NCN(Cc2cccnc2)CN1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P19 compound treatment 0.9962 -0.00382 -0.07 -0.0741 -1.0 2072392 Maybridge1_005453 CCOC(=O)NNC(=S)Nc1c(C)cccc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P20 compound treatment 0.9876 -0.0124 -0.24 -0.2415 -1.0 1047435 Maybridge1_005454 O=S1(=O)C=Cc2ccccc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P21 compound treatment 1.0141 0.0141 0.27 0.2746 1.0 2072393 Maybridge1_005455 CCOC(=O)N/N=C/c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P22 compound treatment 1.0407 0.0407 0.79 0.7907 1.0 2072394 Maybridge1_005456 CC(=O)c1sc2ccc(C)cc2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P23 mock treatment 1.0156 0.0156 0.3 0.3025 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.556 P24 mock treatment 1.0644 0.0644 1.25 1.251 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A01 compound treatment 1.0812 0.0839 1.63 1.6298 1.0 2072395 Maybridge1_005809 [O-][N+](=O)c1cccc(c1)c2cc(cc(n2)c3ccccc3)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A02 compound treatment 1.0941 0.0969 1.88 1.8811 1.0 1085165 Maybridge1_005810 NNC(=S)NCCc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A03 compound treatment 1.0424 0.0451 0.88 0.8759 1.0 2072396 Maybridge1_005811 Cc1cccc(C)c1Nc2nnc(S)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A04 compound treatment 1.0682 0.071 1.38 1.3785 1.0 2072397 Maybridge1_005812 S=C(NCc1ccco1)N/N=C/c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A05 compound treatment 1.0294 0.0322 0.62 0.6246 1.0 1250520 Maybridge1_005813 O=C(NC(=S)NCc1cccnc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A06 compound treatment 1.0416 0.0444 0.86 0.8619 1.0 2072398 Maybridge1_005814 CC1=NC2SC=C(N2C(=O)C1)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A07 compound treatment 1.0028 0.00557 0.11 0.1081 1.0 2072399 Maybridge1_005815 CCc1cccc(CC)c1N2C(=O)C(=C(C)C2=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A08 compound treatment 1.0086 0.0113 0.22 0.2198 1.0 2072400 Maybridge1_005816 Cc1cccc(C)c1n2nnnc2SCC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A09 compound treatment 1.0064 0.00916 0.18 0.1779 1.0 1398190 Maybridge1_005817 CCOC(=O)c1ccc(NC(=O)CCC(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A10 compound treatment 0.9892 -0.00809 -0.16 -0.1572 -1.0 2072401 Maybridge1_005818 Cc1ccc(NC(=S)N2CCCCC2)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A11 compound treatment 1.0086 0.0113 0.22 0.2198 1.0 2072402 Maybridge1_005819 COc1ccc2nsnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A12 compound treatment 1.0222 0.025 0.49 0.485 1.0 2072403 Maybridge1_005820 Oc1ccccc1C(=O)Nc2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A13 compound treatment 1.0165 0.0192 0.37 0.3733 1.0 1114517 Maybridge1_005821 COc1ccccc1C(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A14 compound treatment 1.0359 0.0386 0.75 0.7503 1.0 1484645 Maybridge1_005822 COc1cc(cc(OC)c1OC)C(=O)OCC(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A15 compound treatment 1.0438 0.0465 0.9 0.9038 1.0 2072404 Maybridge1_005823 O=c1c2NCCCNc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A16 compound treatment 1.0488 0.0516 1.0 1.0016 1.0 1666948 Maybridge1_005824 OC(=O)CCC(=O)Nc1cccnc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A17 compound treatment 1.0524 0.0552 1.07 1.0714 1.0 1938917 Maybridge1_005825 CC(=O)Nc1ccc(I)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A18 compound treatment 1.0129 0.0156 0.3 0.3035 1.0 2072405 Maybridge1_005826 COc1ccc(cc1)/C(=C/c2ccccc2OC)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A19 compound treatment 1.0079 0.0106 0.21 0.2058 1.0 2072406 Maybridge1_005827 FC(F)(F)c1cccc(NC(=S)Nc2ccc(NC(=S)Nc3cccc(c3)C(F)(F)F)cc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A20 compound treatment 0.9741 -0.0232 -0.45 -0.4503 -1.0 2072407 Maybridge1_005828 Clc1ccc(Cl)c(NC(=N)SCc2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A21 compound treatment 0.9885 -0.00881 -0.17 -0.1711 -1.0 2072408 Maybridge1_005829 COCCCNC(=S)Nc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A22 compound treatment 1.0316 0.0343 0.67 0.6665 1.0 1421262 Maybridge1_005830 COc1ccc(CCNC(=S)Nc2ccc(Cl)cc2Cl)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A23 mock treatment 1.0352 0.0379 0.74 0.7363 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 A24 mock treatment 1.0194 0.0221 0.43 0.4292 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B01 compound treatment 1.0431 0.0458 0.89 0.8899 1.0 2072409 Maybridge1_005831 CC(C)(CO)/N=C/c1cc(Cl)cc(Cl)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B02 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 1598073 Maybridge1_005832 Cc1onc(c1C(=O)NN2CCCCC2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B03 compound treatment 1.0021 0.00485 0.09 0.0941 1.0 2072410 Maybridge1_005833 CC(=O)Nc1ccc(OCCCCCCOc2ccc(Cl)cc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B04 compound treatment 1.0402 0.0429 0.83 0.834 1.0 2072411 Maybridge1_005834 Cc1ccc(Sc2nc(C)c([N+](=O)[O-])c(C)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B05 compound treatment 1.0395 0.0422 0.82 0.8201 1.0 2072412 Maybridge1_005835 CCOC(=O)CSC(=S)Nc1ccc(C)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B06 compound treatment 1.0294 0.0322 0.62 0.6246 1.0 1704501 Maybridge1_005836 Cc1onc(c1C(=S)N)c2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B07 compound treatment 1.0309 0.0336 0.65 0.6525 1.0 2072413 Maybridge1_005837 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B08 compound treatment 1.01 0.0128 0.25 0.2477 1.0 2072414 Maybridge1_005838 CN(C)NC(=O)Nc1c(C)onc1c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B09 compound treatment 0.9662 -0.0311 -0.6 -0.6039 -1.0 2072415 Maybridge1_005839 Clc1ccccc1NC(=S)SCCSC(=S)Nc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B10 compound treatment 1.0143 0.0171 0.33 0.3314 1.0 1642340 Maybridge1_005840 CCc1onc(c1C(=O)O)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B11 compound treatment 0.9777 -0.0196 -0.38 -0.3805 -1.0 2072416 Maybridge1_005841 COc1cc(/C=N/OC(=O)c2ccc(Cl)cc2Cl)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B12 compound treatment 1.023 0.0257 0.5 0.499 1.0 2072417 Maybridge1_005842 OC(=O)c1coc2ccccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B13 compound treatment 0.9841 -0.0131 -0.25 -0.2549 -1.0 1450030 Maybridge1_005843 OC(=O)c1cnc2sc3ccccc3n2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B14 compound treatment 1.0043 0.007 0.14 0.136 1.0 2072418 Maybridge1_005844 Cc1onc(c1NC(=O)O/N=C/c2ccc(F)cc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B15 compound treatment 1.0258 0.0286 0.55 0.5548 1.0 2072419 Maybridge1_005845 CC(C)(C)CC(C)(C)NC(=O)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B16 compound treatment 1.0913 0.094 1.83 1.8252 1.0 2072420 Maybridge1_005846 Clc1cncc(Cl)c1N/N=C/c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B17 compound treatment 0.9791 -0.0182 -0.35 -0.3526 -1.0 2072421 Maybridge1_005847 ClC(Cl)(Cl)C(=O)NCCOC(=O)C(Cl)(Cl)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B18 compound treatment 0.9662 -0.0311 -0.6 -0.6039 -1.0 2072422 Maybridge1_005848 FC(F)(F)c1ccc(NC(=O)O/N=C/c2ccccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B19 compound treatment 0.9489 -0.0484 -0.94 -0.939 -1.0 2072423 Maybridge1_005849 FC(F)(F)c1cc(nc(S)c1C#N)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B20 compound treatment 1.0273 0.03 0.58 0.5827 1.0 1421916 Maybridge1_005850 Cc1nccc(O)c1OCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B21 compound treatment 0.9597 -0.0376 -0.73 -0.7295 -1.0 1003776 Maybridge1_005851 CCOC(=O)C1=C(C)NC(=O)NC1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B22 compound treatment 1.023 0.0257 0.5 0.499 1.0 2072424 Maybridge1_005852 N/C(=N\OC(=O)C(Cl)Cl)/c1ccc(OCc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B23 mock treatment 0.9626 -0.0347 -0.67 -0.6737 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 B24 mock treatment 0.9885 -0.00881 -0.17 -0.1711 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C01 compound treatment 1.0395 0.0422 0.82 0.8201 1.0 2072425 Maybridge1_005853 O=C/1OC(=N\C1=C\c2cccs2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C02 compound treatment 1.005 0.00772 0.15 0.15 1.0 2072426 Maybridge1_005854 Clc1ccc(/C=N/NC(=S)NCCc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C03 compound treatment 1.0136 0.0163 0.32 0.3175 1.0 1083084 Maybridge1_005855 O=C(NC(=S)N1CCOCC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C04 compound treatment 1.0345 0.0372 0.72 0.7223 1.0 2072427 Maybridge1_005856 Clc1ccc(/C=N/NC(=S)NCC2CCCO2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C05 compound treatment 1.0496 0.0523 1.02 1.0155 1.0 2072428 Maybridge1_005857 CC1=C(C)C(=O)N(C1=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C06 compound treatment 0.992 -0.00522 -0.1 -0.1013 -1.0 2072429 Maybridge1_005858 Cc1ccc(cc1)S(=O)(=O)NNC(=S)NCCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C07 compound treatment 1.0136 0.0163 0.32 0.3175 1.0 2072430 Maybridge1_005859 O=C/1Nc2ccccc2S\C1=C\c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C08 compound treatment 0.982 -0.0153 -0.3 -0.2968 -1.0 1004237 Maybridge1_005860 Clc1ccc(cc1)c2cc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C09 compound treatment 1.0352 0.0379 0.74 0.7363 1.0 1190809 Maybridge1_005861 CCOC(=O)c1ccc(cc1)N2C(=O)CCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C10 compound treatment 1.0 0.00269 0.05 0.0522 1.0 2072431 Maybridge1_005862 CCCOc1ccccc1/C=N/NC(=S)Nc2cccc(F)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C11 compound treatment 1.2645 0.267 5.19 5.1897 1.0 1077735 Maybridge1_005863 [O-][N+](=O)c1ccc2nsnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C12 compound treatment 0.982 -0.0153 -0.3 -0.2968 -1.0 1587025 Maybridge1_005864 Nc1ccc(NC(=O)c2ccccc2O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C13 compound treatment 0.9791 -0.0182 -0.35 -0.3526 -1.0 2072432 Maybridge1_005865 Cc1c(C)c2nsnc2cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C14 compound treatment 0.9798 -0.0174 -0.34 -0.3387 -1.0 2072433 Maybridge1_005866 Cc1cc(ccc1[N+](=O)[O-])C(=O)OCC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C15 compound treatment 0.9899 -0.00737 -0.14 -0.1432 -1.0 1006765 Maybridge1_005867 NC(=O)c1ccccc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C16 compound treatment 0.9611 -0.0361 -0.7 -0.7016 -1.0 2072434 Maybridge1_005868 CC1(CO)CS/C(=N/c2ccc(F)cc2)/N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C17 compound treatment 1.0165 0.0192 0.37 0.3733 1.0 2072435 Maybridge1_005869 FC(F)(F)c1ccc2nccnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C18 compound treatment 0.964 -0.0333 -0.65 -0.6458 -1.0 1481839 Maybridge1_005870 Nc1cc(NC(=O)c2ccccc2O)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C19 compound treatment 0.9942 -0.00306 -0.06 -0.0594 -1.0 2072436 Maybridge1_005871 OC(=O)CCNC(=S)Nc1cc(Cl)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C20 compound treatment 1.0 0.00269 0.05 0.0522 1.0 2072437 Maybridge1_005872 Cc1cccc(C)c1NC(=N)NC(=N)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C21 compound treatment 1.0524 0.0552 1.07 1.0714 1.0 1271117 Maybridge1_005873 CCOC(=O)c1cc2cc(Cl)cc(Cl)c2oc1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C22 compound treatment 0.9791 -0.0182 -0.35 -0.3526 -1.0 1735016 Maybridge1_005874 Clc1ccc(cc1)C(=O)COC(=O)c2ccccc2Nc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C23 mock treatment 0.9705 -0.0268 -0.52 -0.5201 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 C24 mock treatment 1.0266 0.0293 0.57 0.5688 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D01 compound treatment 1.0352 0.0379 0.74 0.7363 1.0 2072438 Maybridge1_005875 CC[n+]1c(C)csc1Nc2ccc(C)cc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D02 compound treatment 1.0323 0.035 0.68 0.6805 1.0 1023658 Maybridge1_005876 OC(=O)CSc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D03 compound treatment 1.0503 0.053 1.03 1.0295 1.0 2072439 Maybridge1_005877 CCOC(=O)C(C)Oc1ccc(NC(=O)C(Cl)Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D04 compound treatment 1.0287 0.0314 0.61 0.6107 1.0 1491174 Maybridge1_005878 CN(C(=O)N(C)C(=O)c1c(C)onc1c2c(F)cccc2Cl)C(=O)c3c(C)onc3c4c(F)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D05 compound treatment 1.0 0.00269 0.05 0.0522 1.0 2072440 Maybridge1_005879 CCOC(=O)CSC(=S)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D06 compound treatment 1.0352 0.0379 0.74 0.7363 1.0 1326646 Maybridge1_005880 Cc1onc(c1C(=S)N)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D07 compound treatment 1.0115 0.0142 0.28 0.2756 1.0 1029766 Maybridge1_005881 Cc1c(Cc2ccccc2)c(=O)oc3cc(O)ccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D08 compound treatment 0.9885 -0.00881 -0.17 -0.1711 -1.0 2072441 Maybridge1_005882 Clc1cccc(Cl)c1/C=C/2\C(=O)ON=C2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D09 compound treatment 1.0359 0.0386 0.75 0.7503 1.0 1275847 Maybridge1_005883 Clc1ccc(NC(=S)CCC(=S)Nc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D10 compound treatment 0.9949 -0.00234 -0.05 -0.0455 -1.0 1317532 Maybridge1_005884 CC(C)(C)c1cc(nn1c2ccccc2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D11 compound treatment 0.9992 0.00197 0.04 0.0383 1.0 1536772 Maybridge1_005885 COc1cccc(Cl)c1c2nc(N)nc(N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D12 compound treatment 0.9992 0.00197 0.04 0.0383 1.0 2072442 Maybridge1_005886 Clc1ccc(Sc2c(Cl)cncc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D13 compound treatment 0.9892 -0.00809 -0.16 -0.1572 -1.0 2072443 Maybridge1_005887 NNC(=O)COc1ccc(OC(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D14 compound treatment 1.0107 0.0135 0.26 0.2616 1.0 2072444 Maybridge1_005888 CN(C)c1ccc(/C=N/OC(=O)Nc2c(C)onc2c3c(Cl)cccc3Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D15 compound treatment 0.9978 5.33E-4 0.01 0.0104 1.0 2072445 Maybridge1_005889 Cc1cc(C)c(C#N)c(OC(=O)c2ccccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D16 compound treatment 1.0079 0.0106 0.21 0.2058 1.0 2072446 Maybridge1_005890 Clc1cncc(Cl)c1N/N=C/C2CC3CC2C=C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D17 compound treatment 0.9949 -0.00234 -0.05 -0.0455 -1.0 1274198 Maybridge1_005891 Cc1cc(C)c2c(N)c(sc2n1)C(=O)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D18 compound treatment 0.9935 -0.00378 -0.07 -0.0734 -1.0 2072447 Maybridge1_005892 FC(F)(F)c1ccc(NC(=O)O/N=C/c2c(Cl)cccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D19 compound treatment 1.0215 0.0243 0.47 0.4711 1.0 1942919 Maybridge1_005893 Cc1cc(C)c(C#N)c(SCC#C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D20 compound treatment 1.0143 0.0171 0.33 0.3314 1.0 1656205 Maybridge1_005894 CCOC(=O)Cn1cc(Cl)c(=O)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D21 compound treatment 0.9539 -0.0433 -0.84 -0.8412 -1.0 1270254 Maybridge1_005895 CCOC(=O)C1=C(C)NC(=O)NC1c2cc(OC)c(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D22 compound treatment 0.9949 -0.00234 -0.05 -0.0455 -1.0 1520983 Maybridge1_005896 Clc1ccc(COc2ccc(cc2)c3noc(n3)C4CC4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D23 mock treatment 0.9863 -0.011 -0.21 -0.213 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 D24 mock treatment 1.0064 0.00916 0.18 0.1779 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E01 compound treatment 1.0438 0.0465 0.9 0.9038 1.0 2072448 Maybridge1_005897 C1Oc2ccc(/N=C/c3cccs3)cc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E02 compound treatment 0.9964 -9.04E-4 -0.02 -0.0176 -1.0 2072449 Maybridge1_005898 S=C(NCCc1ccccc1)N/N=C/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E03 compound treatment 1.0194 0.0221 0.43 0.4292 1.0 1085188 Maybridge1_005899 CCOC(=O)NC(=S)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E04 compound treatment 1.0546 0.0573 1.11 1.1132 1.0 2072450 Maybridge1_005900 S=C(NCC1CCCO1)N/N=C/c2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E05 compound treatment 1.0294 0.0322 0.62 0.6246 1.0 2072451 Maybridge1_005901 Cc1ccccc1SC(CC(=O)c2ccc3ccccc3c2)c4ccc(Cl)c(Cl)c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E06 compound treatment 1.0086 0.0113 0.22 0.2198 1.0 2072452 Maybridge1_005902 Cc1ccc(cc1)S(=O)(=O)NNC(=S)Nc2cccc(F)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E07 compound treatment 1.0409 0.0437 0.85 0.848 1.0 2072453 Maybridge1_005903 Clc1ccc(/C=C\2/Sc3ccccc3NC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E08 compound treatment 0.9971 -1.86E-4 0.0 -0.0036 -1.0 1052672 Maybridge1_005904 c1c([nH]c2ccccc12)c3ccc4ccccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E09 compound treatment 1.0273 0.03 0.58 0.5827 1.0 1022340 Maybridge1_005905 CC(=O)Nc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E10 compound treatment 1.0294 0.0322 0.62 0.6246 1.0 2072454 Maybridge1_005906 CCCOc1ccccc1/C=N/NC(=S)Nc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E11 compound treatment 1.0086 0.0113 0.22 0.2198 1.0 2072455 Maybridge1_005907 Fc1cc2nsnc2cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E12 compound treatment 0.9784 -0.0189 -0.37 -0.3666 -1.0 1296646 Maybridge1_005908 Fc1ccccc1Nc2ccccc2C(=O)OCC(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E13 compound treatment 1.0287 0.0314 0.61 0.6107 1.0 1722583 Maybridge1_005909 NNC(=O)c1ccc2nsnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E14 compound treatment 1.0409 0.0437 0.85 0.848 1.0 2072456 Maybridge1_005910 Cc1onc(c1C(=O)OCC(=O)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E15 compound treatment 0.9748 -0.0225 -0.44 -0.4364 -1.0 1592470 Maybridge1_005911 CC(C)(Oc1ccc(Cl)cc1)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E16 compound treatment 0.9518 -0.0455 -0.88 -0.8831 -1.0 2072457 Maybridge1_005912 COc1ccc(/N=C\2/NC(C)(CO)CS2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E17 compound treatment 1.0208 0.0235 0.46 0.4571 1.0 2072458 Maybridge1_005913 Cc1cc2nsnc2cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E18 compound treatment 0.9604 -0.0368 -0.72 -0.7156 -1.0 2072459 Maybridge1_005914 COc1c(Br)cc(cc1Br)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E19 compound treatment 0.992 -0.00522 -0.1 -0.1013 -1.0 2072460 Maybridge1_005915 CSC(=N)Nc1cc(Cl)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E20 compound treatment 0.9877 -0.00953 -0.19 -0.1851 -1.0 2072461 Maybridge1_005916 Cc1ccc(NC(=N)NC(=N)N)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E21 compound treatment 1.0567 0.0595 1.16 1.1551 1.0 2072462 Maybridge1_005917 COc1ccc(NC(=S)N/N=C/c2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E22 compound treatment 0.964 -0.0333 -0.65 -0.6458 -1.0 1568412 Maybridge1_005918 COc1ccc(CCNC(=S)Nc2ccc(Cl)cc2C)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E23 mock treatment 1.0143 0.0171 0.33 0.3314 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 E24 mock treatment 0.982 -0.0153 -0.3 -0.2968 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F01 compound treatment 1.0488 0.0516 1.0 1.0016 1.0 1047734 Maybridge1_005919 [O-][N+](=O)c1ccc(OCCCOc2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F02 compound treatment 1.0014 0.00413 0.08 0.0802 1.0 2072463 Maybridge1_005920 Cc1onc(c1C(=O)NNc2ccccc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F03 compound treatment 1.005 0.00772 0.15 0.15 1.0 2072464 Maybridge1_005921 CCOC(=O)C(C)Oc1ccc(NC(=O)C(Cl)(Cl)Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F04 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 2072465 Maybridge1_005922 NC(=S)N/N=C/c1ccc(s1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F05 compound treatment 1.0079 0.0106 0.21 0.2058 1.0 2072466 Maybridge1_005923 CCOC(=O)c1ccc(OCc2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F06 compound treatment 1.0431 0.0458 0.89 0.8899 1.0 1017491 Maybridge1_005924 OC(=O)c1cc(O)nc2ccc(Br)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F07 compound treatment 1.0021 0.00485 0.09 0.0941 1.0 2072467 Maybridge1_005925 Cc1nc(SCC(=O)c2ccc(Cl)cc2)nc(O)c1CC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F08 compound treatment 0.9827 -0.0146 -0.28 -0.2828 -1.0 2072468 Maybridge1_005926 Fc1cccc(Cl)c1N/N=C\2/C(=O)ON=C2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F09 compound treatment 0.9885 -0.00881 -0.17 -0.1711 -1.0 2072469 Maybridge1_005927 FC(F)(F)c1cc(NC(=S)SCCSC(=S)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F10 compound treatment 1.0395 0.0422 0.82 0.8201 1.0 2072470 Maybridge1_005928 Cc1onc(c1C(=O)Oc2c(Cl)cncc2Cl)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F11 compound treatment 1.0143 0.0171 0.33 0.3314 1.0 2072471 Maybridge1_005929 Cc1ccc(OC(=O)/C=C/c2cccs2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F12 compound treatment 1.0287 0.0314 0.61 0.6107 1.0 2072472 Maybridge1_005930 CN(C)C(=O)Oc1noc2ccc(Cl)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F13 compound treatment 0.9712 -0.0261 -0.51 -0.5062 -1.0 2072473 Maybridge1_005931 S=C1NC(C=C(N1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F14 compound treatment 0.9964 -9.04E-4 -0.02 -0.0176 -1.0 2072474 Maybridge1_005932 Cc1onc(c1NC(=O)O/N=C/c2ccccc2[N+](=O)[O-])c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F15 compound treatment 1.0172 0.0199 0.39 0.3873 1.0 1663929 Maybridge1_005933 Cc1cc(C)c(C#N)c(OC(=O)c2c(F)cccc2F)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F16 compound treatment 1.0093 0.012 0.23 0.2337 1.0 2072475 Maybridge1_005934 CC(=N/N=C/1\SCC(=N1)c2ccc(Cl)cc2)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F17 compound treatment 0.9928 -0.0045 -0.09 -0.0874 -1.0 1393277 Maybridge1_005935 CSc1cccc(NC(=O)c2sc3nc(C)cc(C)c3c2N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F18 compound treatment 1.0237 0.0264 0.51 0.5129 1.0 1574754 Maybridge1_005936 Cc1nccc(O)c1OCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F19 compound treatment 1.7303 0.733 14.24 14.2361 1.0 2072476 Maybridge1_005937 Nc1c(sc2nc(cc(c12)C(F)(F)F)c3cccs3)C(=O)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F20 compound treatment 0.9367 -0.0606 -1.18 -1.1763 -1.0 1261435 Maybridge1_005938 NNC(=O)Cn1cc(Cl)c(=O)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F21 compound treatment 0.9496 -0.0476 -0.92 -0.925 -1.0 1237977 Maybridge1_005939 CCOC(=O)C1=C(C)NC(=O)NC1c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F22 compound treatment 1.0071 0.00988 0.19 0.1918 1.0 1652480 Maybridge1_005940 CC(=O)Nc1cccc(c1)c2cc(no2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F23 mock treatment 0.9885 -0.00881 -0.17 -0.1711 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 F24 mock treatment 1.0848 0.0875 1.7 1.6996 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G01 compound treatment 1.0596 0.0624 1.21 1.211 1.0 2072477 Maybridge1_005941 CCOc1ccc(/N=C/c2cccs2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G02 compound treatment 1.0 0.00269 0.05 0.0522 1.0 2072478 Maybridge1_005942 CC(=O)CCCNc1nc(cs1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G03 compound treatment 1.0596 0.0624 1.21 1.211 1.0 1537010 Maybridge1_005943 CCOC(=O)n1c(=O)c2cc(C)ccc2[nH]c1=S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G04 compound treatment 1.0007 0.00341 0.07 0.0662 1.0 2072479 Maybridge1_005944 Oc1c(Cl)cc(Cl)cc1/C=N/NC(=S)NCC2CCCO2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G05 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 2072480 Maybridge1_005945 COc1ccc(cc1)C(=O)CC(Sc2ccccc2)c3ccc(cc3)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G06 compound treatment 1.0007 0.00341 0.07 0.0662 1.0 2072481 Maybridge1_005946 Clc1ccc(/C=N/c2cccnc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G07 compound treatment 1.028 0.0307 0.6 0.5967 1.0 1395171 Maybridge1_005947 CC1C(OCCN1C(=O)CCC(=O)N2CCOC(C2C)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G08 compound treatment 0.9971 -1.86E-4 0.0 -0.0036 -1.0 2072482 Maybridge1_005948 [O-][N+](=O)/C=C/c1c([nH]c2ccccc12)c3ccc4ccccc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G09 compound treatment 1.0309 0.0336 0.65 0.6525 1.0 2072483 Maybridge1_005949 [O-][N+](=O)c1ccc(Oc2ccc(Cl)cc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G10 compound treatment 1.0014 0.00413 0.08 0.0802 1.0 2072484 Maybridge1_005950 CCCOc1ccccc1/C=N/NC(=S)Nc2ccc(C)c(C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G11 compound treatment 1.056 0.0588 1.14 1.1412 1.0 1019401 Maybridge1_005951 CCOC(=O)C(N)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G12 compound treatment 1.023 0.0257 0.5 0.499 1.0 1696641 Maybridge1_005952 Fc1cccc(Nc2ccccc2C(=O)OCC(=O)c3ccccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G13 compound treatment 1.0079 0.0106 0.21 0.2058 1.0 2072485 Maybridge1_005953 Cc1ccc2nsnc2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G14 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 2072486 Maybridge1_005954 Cc1onc(c1C(=O)OCC(=O)c2ccc(Cl)cc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G15 compound treatment 1.0115 0.0142 0.28 0.2756 1.0 2072487 Maybridge1_005955 FC(F)(F)c1cc(Cl)c2nsnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G16 compound treatment 0.9841 -0.0131 -0.25 -0.2549 -1.0 1032061 Maybridge1_005956 CSc1nc(O)cc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G17 compound treatment 0.9877 -0.00953 -0.19 -0.1851 -1.0 2072488 Maybridge1_005957 CCOC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G18 compound treatment 1.0582 0.0609 1.18 1.183 1.0 1077975 Maybridge1_005958 COc1cc(CCC(=O)O)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G19 compound treatment 0.9676 -0.0297 -0.58 -0.576 -1.0 2072489 Maybridge1_005959 OC(=O)CCNC(=S)Nc1cccc(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G20 compound treatment 0.977 -0.0203 -0.39 -0.3945 -1.0 1065810 Maybridge1_005960 CNC(=S)NC1CCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G21 compound treatment 1.0258 0.0286 0.55 0.5548 1.0 2072490 Maybridge1_005961 Sc1nccn1c2cc(Cl)ccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G22 compound treatment 0.9784 -0.0189 -0.37 -0.3666 -1.0 1310850 Maybridge1_005962 COc1ccc(CCNC(=S)Nc2ccc(Br)c(C)c2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G23 mock treatment 0.9978 5.33E-4 0.01 0.0104 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 G24 mock treatment 1.01 0.0128 0.25 0.2477 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H01 compound treatment 1.0258 0.0286 0.55 0.5548 1.0 2072491 Maybridge1_005963 [O-][N+](=O)c1ccc(OCCCCOc2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H02 compound treatment 1.0071 0.00988 0.19 0.1918 1.0 2072492 Maybridge1_005964 Clc1ccc(SC(=S)Nc2cc(Cl)ccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H03 compound treatment 0.977 -0.0203 -0.39 -0.3945 -1.0 1085517 Maybridge1_005965 Nc1nc(N)nc(n1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H04 compound treatment 0.9827 -0.0146 -0.28 -0.2828 -1.0 2072493 Maybridge1_005966 Cc1onc(c1C#N)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H05 compound treatment 0.9813 -0.016 -0.31 -0.3107 -1.0 1698586 Maybridge1_005967 CC(Oc1ccc(Cl)cc1Cl)C(=O)Nc2c(C)cccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H06 compound treatment 1.0409 0.0437 0.85 0.848 1.0 1023952 Maybridge1_005968 O=C1CC(=NO1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H07 compound treatment 0.9964 -9.04E-4 -0.02 -0.0176 -1.0 1205192 Maybridge1_005969 Clc1ccc(Oc2ccc(NS(=O)(=O)c3ccccc3)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H08 compound treatment 1.01 0.0128 0.25 0.2477 1.0 2072494 Maybridge1_005970 FC(F)(F)c1cc(N/N=C\2/C(=O)ON=C2c3ccccc3)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H09 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 2072495 Maybridge1_005971 [O-][N+](=O)c1ccc(cc1)c2cc3cc(Cl)ccc3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H10 compound treatment 1.005 0.00772 0.15 0.15 1.0 2072496 Maybridge1_005972 CCOC(=O)c1c(Cl)c(nc(O)c1C#N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H11 compound treatment 0.9877 -0.00953 -0.19 -0.1851 -1.0 1540102 Maybridge1_005973 NCCSC(=S)NC1CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H12 compound treatment 1.0086 0.0113 0.22 0.2198 1.0 2072497 Maybridge1_005974 CN(C)C(=O)Oc1noc2cc(Cl)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H13 compound treatment 0.9841 -0.0131 -0.25 -0.2549 -1.0 2072498 Maybridge1_005975 OC(=O)C1=Cc2cc(Cl)ccc2OC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H14 compound treatment 0.9899 -0.00737 -0.14 -0.1432 -1.0 2072499 Maybridge1_005976 Cc1onc(c1NC(=O)O/N=C/c2ccccn2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H15 compound treatment 0.9755 -0.0218 -0.42 -0.4224 -1.0 1330733 Maybridge1_005977 Cc1cc(C)c(C#N)c(OC(=O)c2cccs2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H16 compound treatment 1.0107 0.0135 0.26 0.2616 1.0 2072500 Maybridge1_005978 CCOC(=O)c1nnn(c1O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H17 compound treatment 1.0079 0.0106 0.21 0.2058 1.0 1719106 Maybridge1_005979 Cc1cc(C)c2c(c(sc2n1)C(=O)c3ccc(Cl)cc3)n4cccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H18 compound treatment 1.0 0.00269 0.05 0.0522 1.0 2072501 Maybridge1_005980 [O-][N+](=O)c1ccc(C#N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H19 compound treatment 1.478 0.481 9.34 9.336 1.0 2072502 Maybridge1_005981 CC(=O)c1sc2nc(cc(c2c1N)C(F)(F)F)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H20 compound treatment 0.9949 -0.00234 -0.05 -0.0455 -1.0 1604442 Maybridge1_005982 N#Cc1ccc(OCc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H21 compound treatment 0.9647 -0.0325 -0.63 -0.6318 -1.0 2072503 Maybridge1_005983 Nc1ccccc1SC(C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H22 compound treatment 0.9892 -0.00809 -0.16 -0.1572 -1.0 2072504 Maybridge1_005984 N/C(=N\O)/c1ccc(OCc2ccc(Cl)cc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H23 mock treatment 1.0043 0.007 0.14 0.136 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 H24 mock treatment 0.9647 -0.0325 -0.63 -0.6318 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I01 compound treatment 1.0287 0.0314 0.61 0.6107 1.0 2072505 Maybridge1_005985 Cc1ccc(/N=C/c2cccs2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I02 compound treatment 1.0222 0.025 0.49 0.485 1.0 1187362 Maybridge1_005986 Nc1cc(O)n(Cc2ccco2)c(=S)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I03 compound treatment 1.0208 0.0235 0.46 0.4571 1.0 2072506 Maybridge1_005987 CCOC(=O)NC(=S)NCCO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I04 compound treatment 0.9762 -0.021 -0.41 -0.4085 -1.0 2072507 Maybridge1_005988 COc1ccc(/C=N/NC(=S)NCC2CCCO2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I05 compound treatment 1.0043 0.007 0.14 0.136 1.0 1524757 Maybridge1_005989 Clc1ccc2c(=O)[nH]c(=O)[nH]c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I06 compound treatment 1.0431 0.0458 0.89 0.8899 1.0 2072508 Maybridge1_005990 CSc1cccc(NC(=O)/C=C/C(=O)O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I07 compound treatment 1.0438 0.0465 0.9 0.9038 1.0 1089852 Maybridge1_005991 ON1C(=O)C2C3OC(C=C3)C2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I08 compound treatment 1.0057 0.00844 0.16 0.1639 1.0 2072509 Maybridge1_005992 C/C(=N\Nc1ccc(cc1[N+](=O)[O-])[N+](=O)[O-])/c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I09 compound treatment 1.0064 0.00916 0.18 0.1779 1.0 1446187 Maybridge1_005993 COC(=O)c1ccc(NC(=O)C)c(NC(=O)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I10 compound treatment 0.9791 -0.0182 -0.35 -0.3526 -1.0 2072510 Maybridge1_005994 CCCOc1ccccc1/C=N/NC(=S)Nc2cc(Cl)ccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I11 compound treatment 0.9683 -0.0289 -0.56 -0.562 -1.0 2072511 Maybridge1_005995 COC(=O)c1ccc2[nH]nnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I12 compound treatment 0.959 -0.0383 -0.74 -0.7435 -1.0 1147787 Maybridge1_005996 O=C(COC(=O)c1ccccc1NCc2ccco2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I13 compound treatment 0.9928 -0.0045 -0.09 -0.0874 -1.0 1005880 Maybridge1_005997 [O-][N+](=O)C1C(=O)NC(=O)NC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I14 compound treatment 1.0129 0.0156 0.3 0.3035 1.0 1242165 Maybridge1_005998 O=C(COC(=O)c1ccccc1C(=O)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I15 compound treatment 1.0021 0.00485 0.09 0.0941 1.0 1040518 Maybridge1_005999 Cc1cc2nc(C)c(C)nc2cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I16 compound treatment 0.959 -0.0383 -0.74 -0.7435 -1.0 1590570 Maybridge1_006000 COc1cccc(C2NC(=O)c3ccccc3N2)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I17 compound treatment 1.0129 0.0156 0.3 0.3035 1.0 1351125 Maybridge1_006001 CC(=O)Nc1ccc(cc1NC(=O)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I18 compound treatment 0.9805 -0.0167 -0.32 -0.3247 -1.0 2072512 Maybridge1_006002 Cc1cc(C)c(NC(=N)NC(=N)NN)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I19 compound treatment 1.0021 0.00485 0.09 0.0941 1.0 1428290 Maybridge1_006003 OC(=O)CCNC(=S)Nc1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I20 compound treatment 0.977 -0.0203 -0.39 -0.3945 -1.0 2072513 Maybridge1_006004 C/N=C(/NC1CCCCC1)\SCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I21 compound treatment 1.0237 0.0264 0.51 0.5129 1.0 2072514 Maybridge1_006005 COCCC[n+]1c(C)csc1Nc2c(C)cc(C)cc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I22 compound treatment 0.9741 -0.0232 -0.45 -0.4503 -1.0 2072515 Maybridge1_006006 CC[n+]1c(C)csc1Nc2c(C)cccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I23 mock treatment 1.0086 0.0113 0.22 0.2198 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 I24 mock treatment 0.9439 -0.0534 -1.04 -1.0367 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J01 compound treatment 0.9942 -0.00306 -0.06 -0.0594 -1.0 2072516 Maybridge1_006007 CCOC(=O)c1ccc(cc1)c2ccc(/C=N/NC(=S)Nc3ccc(OC)cc3)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J02 compound treatment 0.9942 -0.00306 -0.06 -0.0594 -1.0 2072517 Maybridge1_006008 FC(F)(F)c1ccc(Cl)c(NC(=S)Sc2ccc(Cl)cc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J03 compound treatment 1.033 0.0358 0.69 0.6944 1.0 2072518 Maybridge1_006009 OC(=O)c1cc(ccc1NCc2ccco2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J04 compound treatment 1.0151 0.0178 0.35 0.3454 1.0 2072519 Maybridge1_006010 Cc1onc(c1C(=O)N)c2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J05 compound treatment 0.9719 -0.0253 -0.49 -0.4922 -1.0 1724484 Maybridge1_006011 CC(Oc1ccc(Cl)cc1Cl)C(=O)Nc2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J06 compound treatment 0.9863 -0.011 -0.21 -0.213 -1.0 2072520 Maybridge1_006012 O/N=C\1/C(=O)ON=C1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J07 compound treatment 0.9913 -0.00594 -0.12 -0.1153 -1.0 2072521 Maybridge1_006013 COc1ccc(OS(=O)(=O)c2ccc(NC(=O)C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J08 compound treatment 1.0172 0.0199 0.39 0.3873 1.0 2072522 Maybridge1_006014 CN(C)/C=N/c1nonc1c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J09 compound treatment 1.0 0.00269 0.05 0.0522 1.0 2072523 Maybridge1_006015 FC(F)(F)c1cc(NC(=O)CN2CCOCC2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J10 compound treatment 0.9798 -0.0174 -0.34 -0.3387 -1.0 2072524 Maybridge1_006016 Nc1c(Cl)cncc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J11 compound treatment 1.0165 0.0192 0.37 0.3733 1.0 2072525 Maybridge1_006017 Cc1cccc(C)c1N=C2SCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J12 compound treatment 1.0366 0.0394 0.76 0.7642 1.0 2072526 Maybridge1_006018 CN(C)C(=O)Oc1noc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J13 compound treatment 0.9813 -0.016 -0.31 -0.3107 -1.0 1462709 Maybridge1_006019 Cc1cc(=O)[nH]c(n1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J14 compound treatment 1.0208 0.0235 0.46 0.4571 1.0 2072527 Maybridge1_006020 Cc1onc(c1NC(=O)O/N=C/c2cccnc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J15 compound treatment 0.9913 -0.00594 -0.12 -0.1153 -1.0 2072528 Maybridge1_006021 Clc1cc(Cl)c(NC(=O)C(Cl)(Cl)Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J16 compound treatment 1.0273 0.03 0.58 0.5827 1.0 1029309 Maybridge1_006022 CC(=O)Nc1ccc(cc1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J17 compound treatment 0.9863 -0.011 -0.21 -0.213 -1.0 2072529 Maybridge1_006023 COc1nc(C)cc(C)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J18 compound treatment 1.0582 0.0609 1.18 1.183 1.0 2072530 Maybridge1_006024 CC(C)(C)c1ccc(NC(=O)c2ccco2)c(NC(=O)C(Cl)Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J19 compound treatment 0.9813 -0.016 -0.31 -0.3107 -1.0 2072531 Maybridge1_006025 FC(F)(F)c1cc(NC(=O)C(Sc2ccc(Cl)cc2)c3ccccc3)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J20 compound treatment 0.9935 -0.00378 -0.07 -0.0734 -1.0 1095814 Maybridge1_006026 Oc1nc(nc(n1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J21 compound treatment 0.9942 -0.00306 -0.06 -0.0594 -1.0 1782371 Maybridge1_006027 CCOC(=O)C1=C(C)NC(=O)NC1c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J22 compound treatment 0.9956 -0.00162 -0.03 -0.0315 -1.0 1679639 Maybridge1_006028 Clc1ccc(cc1)C(=O)CSC(=S)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J23 mock treatment 0.9885 -0.00881 -0.17 -0.1711 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 J24 mock treatment 0.9899 -0.00737 -0.14 -0.1432 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K01 compound treatment 1.069 0.0717 1.39 1.3924 1.0 2072532 Maybridge1_006029 Oc1ccc(/N=C/c2cccs2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K02 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 2072533 Maybridge1_006030 CC(C)(C)NC(=S)N/N=C/c1cccnc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K03 compound treatment 1.0273 0.03 0.58 0.5827 1.0 2072534 Maybridge1_006031 C=CCN(CC=C)C(=S)NC(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K04 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 2072535 Maybridge1_006032 COc1cc(/C=N/NC(=S)NCC2CCCO2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K05 compound treatment 1.0129 0.0156 0.3 0.3035 1.0 2072536 Maybridge1_006033 COc1ccc(OC)c(NC2=NCCS2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K06 compound treatment 1.0122 0.0149 0.29 0.2896 1.0 2072537 Maybridge1_006034 Clc1cccc(NC(=S)N/N=C/c2ccccc2Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K07 compound treatment 1.0553 0.058 1.13 1.1272 1.0 1697868 Maybridge1_006035 O=C(ON1C(=O)C2C3OC(C=C3)C2C1=O)Oc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K08 compound treatment 0.9956 -0.00162 -0.03 -0.0315 -1.0 2072538 Maybridge1_006036 Cc1ccc(C2N=NNC2=S)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K09 compound treatment 1.0402 0.0429 0.83 0.834 1.0 2072539 Maybridge1_006037 Fc1ccc2nsnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K10 compound treatment 1.0165 0.0192 0.37 0.3733 1.0 1603 Maybridge1_006038 OC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2nccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K11 compound treatment 0.992 -0.00522 -0.1 -0.1013 -1.0 2072540 Maybridge1_006039 FC(F)(F)c1ccc2nsnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K12 compound treatment 0.9992 0.00197 0.04 0.0383 1.0 1228269 Maybridge1_006040 Oc1ccccc1C(=O)Nc2ccc(NC(=S)NCCc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K13 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 2072541 Maybridge1_006041 CC(C)(C)C(=O)Nc1cccc(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K14 compound treatment 0.9561 -0.0412 -0.8 -0.7993 -1.0 1437700 Maybridge1_006042 Nc1cccc(NC(=O)c2ccccc2O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K15 compound treatment 1.0122 0.0149 0.29 0.2896 1.0 2072542 Maybridge1_006043 COC(=O)c1ccc2nc(C)c(C)nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K16 compound treatment 1.0194 0.0221 0.43 0.4292 1.0 1579367 Maybridge1_006044 Oc1cccc(C(=O)OCC(=O)c2ccc(Cl)cc2)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K17 compound treatment 1.0186 0.0214 0.42 0.4152 1.0 2072543 Maybridge1_006045 CCC(=O)Oc1ccc(NC(=S)NCCCO)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K18 compound treatment 1.0222 0.025 0.49 0.485 1.0 2072544 Maybridge1_006046 NNC(=N)NC(=N)Nc1cccc(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K19 compound treatment 0.9734 -0.0239 -0.46 -0.4643 -1.0 2072545 Maybridge1_006047 Clc1ccc(NC(=S)NCc2ccco2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K20 compound treatment 1.005 0.00772 0.15 0.15 1.0 2072546 Maybridge1_006048 Cc1csc(NC2CCCCC2)[n+]1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K21 compound treatment 1.0086 0.0113 0.22 0.2198 1.0 2072547 Maybridge1_006049 FC(F)(F)c1cc(/N=C/2\NCCN/C(=N/c3cc(cc(c3)C(F)(F)F)C(F)(F)F)/SS2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K22 compound treatment 1.0251 0.0279 0.54 0.5409 1.0 2072548 Maybridge1_006050 Cc1csc(Nc2ccc(C)cc2C)[n+]1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K23 mock treatment 0.992 -0.00522 -0.1 -0.1013 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 K24 mock treatment 0.9899 -0.00737 -0.14 -0.1432 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L01 compound treatment 1.0151 0.0178 0.35 0.3454 1.0 1088868 Maybridge1_006051 Nc1nc(N)nc(n1)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L02 compound treatment 1.0388 0.0415 0.81 0.8061 1.0 2072549 Maybridge1_006052 Cc1onc(c1CO)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L03 compound treatment 1.0165 0.0192 0.37 0.3733 1.0 2072550 Maybridge1_006053 OC(=O)c1cc(ccc1NCCc2ccccc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L04 compound treatment 1.0524 0.0552 1.07 1.0714 1.0 1015353 Maybridge1_006054 CCOC(=O)c1cc(C)nc(O)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L05 compound treatment 1.0064 0.00916 0.18 0.1779 1.0 1192699 Maybridge1_006055 CC(Oc1ccc(I)cc1)C(=O)Nc2ccc(Br)cc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L06 compound treatment 1.0115 0.0142 0.28 0.2756 1.0 2072551 Maybridge1_006056 CNC(=O)O/N=C(\N)/c1c(C)onc1c2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L07 compound treatment 1.0014 0.00413 0.08 0.0802 1.0 2072552 Maybridge1_006057 Clc1ccc(cc1)c2[nH]c3ccccc3c2/C=N/NC(=S)NCCc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L08 compound treatment 1.0007 0.00341 0.07 0.0662 1.0 1199365 Maybridge1_006058 CCOC(=O)c1cc(nc(O)c1C#N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L09 compound treatment 1.005 0.00772 0.15 0.15 1.0 2072553 Maybridge1_006059 FC(F)(F)c1cc(NC(=O)CN2CCCCC2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L10 compound treatment 1.0409 0.0437 0.85 0.848 1.0 2072554 Maybridge1_006060 Cc1onc(c1C(=O)NNc2c(Cl)cncc2Cl)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L11 compound treatment 1.0496 0.0523 1.02 1.0155 1.0 2072555 Maybridge1_006061 OC(c1cccc(c1)[N+](=O)[O-])C(Cl)(Cl)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L12 compound treatment 0.9813 -0.016 -0.31 -0.3107 -1.0 2072556 Maybridge1_006062 Cc1onc(c1NC(=O)O/N=C/c2ccc(Cl)c(Cl)c2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L13 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 2072557 Maybridge1_006063 Cc1nc(nc(S)c1Cl)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L14 compound treatment 1.0129 0.0156 0.3 0.3035 1.0 1616538 Maybridge1_006064 CNC(=O)Oc1noc2ccc(Cl)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L15 compound treatment 0.992 -0.00522 -0.1 -0.1013 -1.0 1104196 Maybridge1_006065 CCOC(=O)c1sc2nc(C)cc(C)c2c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L16 compound treatment 1.0337 0.0365 0.71 0.7084 1.0 1294656 Maybridge1_006066 COC(=O)COc1c(C)nccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L17 compound treatment 0.9676 -0.0297 -0.58 -0.576 -1.0 2072558 Maybridge1_006067 Cc1cc(C)c(C#N)c(SC(=O)c2c(F)cccc2F)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L18 compound treatment 1.0352 0.0379 0.74 0.7363 1.0 2072559 Maybridge1_006068 CCOC(=O)c1ccc(OCc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L19 compound treatment 0.9798 -0.0174 -0.34 -0.3387 -1.0 2072560 Maybridge1_006069 FC(F)(F)c1cc(NC(=O)C(Sc2ccccn2)c3ccccc3)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L20 compound treatment 1.0057 0.00844 0.16 0.1639 1.0 1203411 Maybridge1_006070 Clc1ccc(COc2ccc(C#N)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L21 compound treatment 1.0079 0.0106 0.21 0.2058 1.0 1192282 Maybridge1_006071 CCOC(=O)C1=C(C)NC(=O)NC1c2cccc(OC)c2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L22 compound treatment 1.0251 0.0279 0.54 0.5409 1.0 2072561 Maybridge1_006072 CS/C(=N\C#N)/NCc1cccnc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L23 mock treatment 1.0007 0.00341 0.07 0.0662 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 L24 mock treatment 0.982 -0.0153 -0.3 -0.2968 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M01 compound treatment 1.0769 0.0796 1.55 1.546 1.0 2072562 Maybridge1_006073 Sc1nnc(Nc2ccccc2Cl)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M02 compound treatment 1.0337 0.0365 0.71 0.7084 1.0 1539962 Maybridge1_006074 CC(NC(=S)Nc1ccc(Oc2ccc(Cl)cc2)cc1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M03 compound treatment 1.0424 0.0451 0.88 0.8759 1.0 2072563 Maybridge1_006075 O=C(NC(=S)NCc1ccncc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M04 compound treatment 0.9863 -0.011 -0.21 -0.213 -1.0 2072564 Maybridge1_006076 COc1ccc(cc1)/C(=C/c2cc(OC)c(OC)c(OC)c2)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M05 compound treatment 1.0129 0.0156 0.3 0.3035 1.0 1083150 Maybridge1_006077 COc1cccc(NC(=S)NC(=O)c2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M06 compound treatment 1.0035 0.00628 0.12 0.122 1.0 1121329 Maybridge1_006078 OC(=O)CCC(=O)Nc1cccc(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M07 compound treatment 1.0093 0.012 0.23 0.2337 1.0 1107198 Maybridge1_006079 CCOC(=O)c1cncc(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M08 compound treatment 0.9841 -0.0131 -0.25 -0.2549 -1.0 2072565 Maybridge1_006080 COc1cccc(/N=C/c2cc(OC)c(OC)c(OC)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M09 compound treatment 1.0093 0.012 0.23 0.2337 1.0 2072566 Maybridge1_006081 COC(=O)c1ccc2nccnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M10 compound treatment 0.9899 -0.00737 -0.14 -0.1432 -1.0 2072567 Maybridge1_006082 Cc1cccc(C)c1n2nnnc2SCc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M11 compound treatment 1.0309 0.0336 0.65 0.6525 1.0 2072568 Maybridge1_006083 Cc1cc2nsnc2cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M12 compound treatment 0.964 -0.0333 -0.65 -0.6458 -1.0 1334594 Maybridge1_006084 Oc1ccccc1C(=O)Nc2ccc(NC(=S)Nc3cccc(Cl)c3Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M13 compound treatment 1.0079 0.0106 0.21 0.2058 1.0 1653923 Maybridge1_006085 CC1(C)C2CCC1(C)C(N)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M14 compound treatment 0.982 -0.0153 -0.3 -0.2968 -1.0 2072569 Maybridge1_006086 CCCc1c(C)nc2scc(c3ccccc3)n2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M15 compound treatment 0.9885 -0.00881 -0.17 -0.1711 -1.0 1015121 Maybridge1_006087 CCOC(=O)CNC(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M16 compound treatment 1.0 0.00269 0.05 0.0522 1.0 2072570 Maybridge1_006088 Cc1cc(C)c(NC(=S)NCCCN2CCOCC2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M17 compound treatment 1.0158 0.0185 0.36 0.3594 1.0 2072571 Maybridge1_006089 Nc1ccccc1NC(=S)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M18 compound treatment 0.9734 -0.0239 -0.46 -0.4643 -1.0 1450707 Maybridge1_006090 OCCNC(=S)NC1CCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M19 compound treatment 1.0165 0.0192 0.37 0.3733 1.0 2072572 Maybridge1_006091 COc1ccccc1/N=C/2\SCC(=O)N2Cc3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M20 compound treatment 0.9798 -0.0174 -0.34 -0.3387 -1.0 2072573 Maybridge1_006092 Oc1cc(nc(SCC(=O)c2ccc(cc2)[N+](=O)[O-])n1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M21 compound treatment 1.0071 0.00988 0.19 0.1918 1.0 1514590 Maybridge1_006093 Fc1ccc(NC(=S)Nc2ccc3cn[nH]c3c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M22 compound treatment 0.9611 -0.0361 -0.7 -0.7016 -1.0 2072574 Maybridge1_006094 Cc1csc(Nc2cccc3ccccc23)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M23 mock treatment 1.0258 0.0286 0.55 0.5548 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 M24 mock treatment 1.0107 0.0135 0.26 0.2616 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N01 compound treatment 1.033 0.0358 0.69 0.6944 1.0 2072575 Maybridge1_006095 CS/C(=N\C)/Nc1cc(C)c(C)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N02 compound treatment 0.9913 -0.00594 -0.12 -0.1153 -1.0 2072576 Maybridge1_006096 COc1ccc(OC)c(Sc2nc(C)c([N+](=O)[O-])c(C)c2C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N03 compound treatment 1.0165 0.0192 0.37 0.3733 1.0 2067914 Maybridge1_006097 C=CCSc1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N04 compound treatment 1.0208 0.0235 0.46 0.4571 1.0 1012507 Maybridge1_006098 CCOC(=O)c1c(C#N)c(O)nc(C)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N05 compound treatment 1.023 0.0257 0.5 0.499 1.0 2072577 Maybridge1_006099 NS(=O)(=O)c1ccc(cc1)c2ccc(/C=N/O)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N06 compound treatment 1.005 0.00772 0.15 0.15 1.0 2072578 Maybridge1_006100 Cc1nc(O)c(C#N)c(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N07 compound treatment 0.964 -0.0333 -0.65 -0.6458 -1.0 2072579 Maybridge1_006101 Nc1ncnc(Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N08 compound treatment 1.005 0.00772 0.15 0.15 1.0 2072580 Maybridge1_006102 Cc1nc(nc(O)c1Cl)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N09 compound treatment 0.9877 -0.00953 -0.19 -0.1851 -1.0 2072581 Maybridge1_006103 COc1cc(/C=N/OC(=O)c2ccc(Cl)cc2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N10 compound treatment 0.9798 -0.0174 -0.34 -0.3387 -1.0 2072582 Maybridge1_006104 Brc1coc2ccccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N11 compound treatment 1.0035 0.00628 0.12 0.122 1.0 2072583 Maybridge1_006105 OC(=O)COc1ccc(OC(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N12 compound treatment 1.0316 0.0343 0.67 0.6665 1.0 2072584 Maybridge1_006106 Cc1onc(c1NC(=O)O/N=C/c2ccc(Cl)cc2Cl)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N13 compound treatment 0.9863 -0.011 -0.21 -0.213 -1.0 1007516 Maybridge1_006107 Cc1cc(cc(C)c1[N+](=O)[O-])C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N14 compound treatment 1.0309 0.0336 0.65 0.6525 1.0 2072585 Maybridge1_006108 Clc1ccc(NC(=O)NNc2c(Cl)cncc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N15 compound treatment 1.0136 0.0163 0.32 0.3175 1.0 2072586 Maybridge1_006109 CSc1nc(C)cc(C)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N16 compound treatment 0.9734 -0.0239 -0.46 -0.4643 -1.0 2072587 Maybridge1_006110 CCOC(=O)NC(=S)Nc1ccc(cc1NC(=S)NC(=O)OCC)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N17 compound treatment 0.964 -0.0333 -0.65 -0.6458 -1.0 2072588 Maybridge1_006111 FC(F)(F)c1cc(N=NN2CCOCC2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N18 compound treatment 1.0043 0.007 0.14 0.136 1.0 1552789 Maybridge1_006112 Cc1nccc(O)c1OCc2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N19 compound treatment 1.0057 0.00844 0.16 0.1639 1.0 2072589 Maybridge1_006113 CCc1cccc(CC)c1NC(=O)C(Sc2ccccn2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N20 compound treatment 0.9518 -0.0455 -0.88 -0.8831 -1.0 2072590 Maybridge1_006114 N/C(=N\O)/c1ccc(OCc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N21 compound treatment 0.9928 -0.0045 -0.09 -0.0874 -1.0 2072591 Maybridge1_006115 Sc1nnc([nH]1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N22 compound treatment 1.0474 0.0501 0.97 0.9736 1.0 2072592 Maybridge1_006116 CS/C(=N\C#N)/NCc1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N23 mock treatment 0.9669 -0.0304 -0.59 -0.5899 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 N24 mock treatment 1.0582 0.0609 1.18 1.183 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O01 compound treatment 1.0136 0.0163 0.32 0.3175 1.0 2072593 Maybridge1_006117 Cc1ccc(Nc2nnc(S)s2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O02 compound treatment 1.01 0.0128 0.25 0.2477 1.0 2072594 Maybridge1_006118 COCCCNC(=S)Nc1ccc(Oc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O03 compound treatment 1.0244 0.0271 0.53 0.5269 1.0 2072595 Maybridge1_006119 NC(=S)NCc1ccncc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O04 compound treatment 0.987 -0.0102 -0.2 -0.199 -1.0 1091572 Maybridge1_006120 Cc1cc(=O)n2c(csc2n1)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O05 compound treatment 0.9892 -0.00809 -0.16 -0.1572 -1.0 1065250 Maybridge1_006121 COc1cccc(NC(=S)N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O06 compound treatment 0.9978 5.33E-4 0.01 0.0104 1.0 2072596 Maybridge1_006122 CSc1nnnn1c2c(C)cccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O07 compound treatment 1.0107 0.0135 0.26 0.2616 1.0 2072597 Maybridge1_006123 NNC(=O)c1cncc(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O08 compound treatment 0.987 -0.0102 -0.2 -0.199 -1.0 2072598 Maybridge1_006124 Cc1cc(NC(=S)N2CCCCC2)ccc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O09 compound treatment 0.9762 -0.021 -0.41 -0.4085 -1.0 1312083 Maybridge1_006125 COC(=O)c1ccc(NS(=O)(=O)c2ccc(C)cc2)c(NS(=O)(=O)c3ccc(C)cc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O10 compound treatment 1.0165 0.0192 0.37 0.3733 1.0 1774250 Maybridge1_006126 [O-][N+](=O)c1ccc(cc1)c2cn3ccccc3n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O11 compound treatment 1.0151 0.0178 0.35 0.3454 1.0 2072599 Maybridge1_006127 CCOC(=O)[C@@H](N)Cc1c[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O12 compound treatment 0.9669 -0.0304 -0.59 -0.5899 -1.0 1252858 Maybridge1_006128 OC(=O)c1ccccc1NC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O13 compound treatment 0.9913 -0.00594 -0.12 -0.1153 -1.0 2072600 Maybridge1_006129 COC(=O)C[C@H](N)C(=O)N[C@H](Cc1ccccc1)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O14 compound treatment 0.982 -0.0153 -0.3 -0.2968 -1.0 1206269 Maybridge1_006130 CCCCn1c(O)cc(N)nc1=S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O15 compound treatment 1.0151 0.0178 0.35 0.3454 1.0 2072601 Maybridge1_006131 Cc1nc2ccc(cc2nc1C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O16 compound treatment 1.0093 0.012 0.23 0.2337 1.0 1664455 Maybridge1_006132 COc1ccccc1C(=O)OCC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O17 compound treatment 0.964 -0.0333 -0.65 -0.6458 -1.0 1522957 Maybridge1_006133 Cc1cc(C)c(Nc2nnns2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O18 compound treatment 0.9482 -0.0491 -0.95 -0.9529 -1.0 2072602 Maybridge1_006134 COc1ccccc1NC(=N)SCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O19 compound treatment 0.9985 0.00125 0.02 0.0243 1.0 2072603 Maybridge1_006135 Cc1csc(Nc2ccc(Cl)cc2)[n+]1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O20 compound treatment 0.9611 -0.0361 -0.7 -0.7016 -1.0 1133744 Maybridge1_006136 COc1ccc(CCNC(=S)Nc2c(C)cccc2C)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O21 compound treatment 0.9935 -0.00378 -0.07 -0.0734 -1.0 2072604 Maybridge1_006137 Fc1ccccc1/N=C/2\SCC(=O)N2c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O22 compound treatment 0.959 -0.0383 -0.74 -0.7435 -1.0 2072605 Maybridge1_006138 CC(C)(C)c1ccc(OC(=O)c2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O23 mock treatment 1.0014 0.00413 0.08 0.0802 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 O24 mock treatment 0.987 -0.0102 -0.2 -0.199 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P01 compound treatment 1.0007 0.00341 0.07 0.0662 1.0 2072606 Maybridge1_006139 COc1ccccc1N/C(=N/C)/SC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P02 compound treatment 0.9928 -0.0045 -0.09 -0.0874 -1.0 2072607 Maybridge1_006140 Cc1nc(Sc2ccc(Br)cc2)c(C#N)c(C)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P03 compound treatment 1.0079 0.0106 0.21 0.2058 1.0 2072608 Maybridge1_006141 CCOC(=O)CSC(=S)Nc1c(C)cc(C)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P04 compound treatment 0.9712 -0.0261 -0.51 -0.5062 -1.0 2072609 Maybridge1_006142 Cc1onc(c1C#N)c2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P05 compound treatment 1.0071 0.00988 0.19 0.1918 1.0 2072610 Maybridge1_006143 FC(F)(F)c1nnc(Nc2ccc(Cl)cc2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P06 compound treatment 1.0352 0.0379 0.74 0.7363 1.0 2072611 Maybridge1_006144 CCOC(=O)c1cc(C)nc(SC)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P07 compound treatment 0.9913 -0.00594 -0.12 -0.1153 -1.0 1729679 Maybridge1_006145 Nc1ncnc(Nc2ccccc2F)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P08 compound treatment 1.0323 0.035 0.68 0.6805 1.0 2072612 Maybridge1_006146 Cc1cc(O)nc(n1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P09 compound treatment 1.0043 0.007 0.14 0.136 1.0 2072613 Maybridge1_006147 COc1cc(/C=N/OC(=O)c2ccc(Cl)c(Cl)c2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P10 compound treatment 0.9748 -0.0225 -0.44 -0.4364 -1.0 1170374 Maybridge1_006148 O=c1c(C#N)coc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P11 compound treatment 0.9777 -0.0196 -0.38 -0.3805 -1.0 2072614 Maybridge1_006149 CC(Oc1ccc(OC(F)(F)F)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P12 compound treatment 1.0316 0.0343 0.67 0.6665 1.0 2072615 Maybridge1_006150 Cc1onc(c1NC(=O)O/N=C/c2cccc(c2)[N+](=O)[O-])c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P13 compound treatment 1.0194 0.0221 0.43 0.4292 1.0 2072616 Maybridge1_006151 COCCCNC(=O)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P14 compound treatment 1.1229 0.126 2.44 2.4395 1.0 2072617 Maybridge1_006152 C/C(=N\OC(=O)Nc1c(C)onc1c2c(Cl)cccc2Cl)/c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P15 compound treatment 0.969 -0.0282 -0.55 -0.5481 -1.0 2072618 Maybridge1_006153 Cc1cc(C)c(C#N)c(S)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P16 compound treatment 0.9791 -0.0182 -0.35 -0.3526 -1.0 2072619 Maybridge1_006154 CC(=NOC(=O)Nc1ccc(cc1)C(F)(F)F)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P17 compound treatment 1.0071 0.00988 0.19 0.1918 1.0 2072620 Maybridge1_006155 Oc1nc(cc(c1C#N)C(F)(F)F)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P18 compound treatment 0.9877 -0.00953 -0.19 -0.1851 -1.0 2072621 Maybridge1_006156 Cc1onc(c1NC(=O)O/N=C(\N)/Cc2ccc(cc2)C(C)(C)C)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P19 compound treatment 0.9626 -0.0347 -0.67 -0.6737 -1.0 1493707 Maybridge1_006157 COc1ccc(CCNC(=O)C(Sc2ccccc2N)c3ccccc3)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P20 compound treatment 1.0021 0.00485 0.09 0.0941 1.0 2072622 Maybridge1_006158 N/C(=N\OC(=O)C(Cl)Cl)/c1ccc(OCc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P21 compound treatment 0.9849 -0.0124 -0.24 -0.2409 -1.0 2072623 Maybridge1_006159 Sc1nnc([nH]1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P22 compound treatment 1.0165 0.0192 0.37 0.3733 1.0 2072624 Maybridge1_006160 Clc1ccc(/N=C/2\SCC(=O)N2C(=O)c3ccccc3Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P23 mock treatment 0.9647 -0.0325 -0.63 -0.6318 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.558 P24 mock treatment 1.0481 0.0509 0.99 0.9876 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A01 compound treatment 1.089 0.089 1.73 1.728 1.0 2072625 Maybridge1_006161 Fc1cccc(F)c1C(=O)NC(=S)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A02 compound treatment 1.0387 0.0387 0.75 0.7515 1.0 2072626 Maybridge1_006162 COC(=O)c1ccc(OCC(F)(F)F)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A03 compound treatment 1.0653 0.0653 1.27 1.2677 1.0 1461450 Maybridge1_006163 COC(=O)c1cc(=O)nc(N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A04 compound treatment 1.0409 0.0409 0.79 0.7934 1.0 2072627 Maybridge1_006164 CC1(C)ONC(=O)N(CCc2cccs2)C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A05 compound treatment 1.0459 0.0459 0.89 0.891 1.0 2072628 Maybridge1_006165 N/C(=N\OC(=O)Nc1ccccc1)/c2ccc(cc2)C3SCCS3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A06 compound treatment 0.9877 -0.0123 -0.24 -0.2389 -1.0 2072629 Maybridge1_006166 FC(F)(F)c1cccc(c1)C(=O)NNC(=O)C2c3ccccc3Oc4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A07 compound treatment 1.0236 0.0236 0.46 0.4586 1.0 1378127 Maybridge1_006167 COc1nc(N)nc(n1)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A08 compound treatment 0.9992 -8.08E-4 -0.02 -0.0157 -1.0 1110159 Maybridge1_006168 CC(=O)Nc1ccc(NC(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A09 compound treatment 1.0157 0.0157 0.31 0.3052 1.0 2072630 Maybridge1_006169 CSc1nc(N)nc(n1)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A10 compound treatment 1.0286 0.0286 0.56 0.5562 1.0 2072631 Maybridge1_006170 CCOC(=O)c1cnn(c1N)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A11 compound treatment 1.0085 0.00853 0.17 0.1657 1.0 1652130 Maybridge1_006171 Cn1c(nc(N)nc1=O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A12 compound treatment 1.0207 0.0207 0.4 0.4028 1.0 2072632 Maybridge1_006172 CN(C)/C=N\c1ccc2nnc(c3ccccc3)n2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A13 compound treatment 1.0136 0.0136 0.26 0.2633 1.0 2072633 Maybridge1_006173 O=C1CNC(=S)N1CCCn2ccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A14 compound treatment 1.0251 0.0251 0.49 0.4865 1.0 1083204 Maybridge1_006174 Cc1ccc2ncnc(O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A15 compound treatment 1.0236 0.0236 0.46 0.4586 1.0 2072634 Maybridge1_006175 Clc1ccc(CN2C(=O)CNC2=S)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A16 compound treatment 1.015 0.015 0.29 0.2912 1.0 2072635 Maybridge1_006176 [O-][N+](=O)c1cccnc1NC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A17 compound treatment 1.0401 0.0401 0.78 0.7794 1.0 1052429 Maybridge1_006177 COc1nc(N)nc(OC)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A18 compound treatment 1.0064 0.00638 0.12 0.1238 1.0 2072636 Maybridge1_006178 FC(F)(F)c1cc(cc(c1)S(=O)(=O)NNC(=O)CSc2nc3cccnc3s2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A19 compound treatment 0.987 -0.013 -0.25 -0.2528 -1.0 2072637 Maybridge1_006179 NC(=O)c1cnccc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A20 compound treatment 1.0437 0.0437 0.85 0.8492 1.0 1546171 Maybridge1_006180 Clc1ccc2c(Sc3nnc(NC(=O)c4cccnc4Oc5ccccc5)s3)ccnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A21 compound treatment 1.0092 0.00925 0.18 0.1796 1.0 2072638 Maybridge1_006181 COc1cc(c(cn1)C(=O)N)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A22 compound treatment 0.9791 -0.0209 -0.41 -0.4063 -1.0 1012003 Maybridge1_006182 COC(=O)c1cc(ccc1NC(=O)C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A23 mock treatment 1.0107 0.0107 0.21 0.2075 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 A24 mock treatment 0.9877 -0.0123 -0.24 -0.2389 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B01 compound treatment 1.0559 0.0559 1.09 1.0863 1.0 1304551 Maybridge1_006183 CCCCc1ccc(NC(=O)CSc2nc(c(o2)c3ccccc3)c4ccccc4)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B02 compound treatment 1.0128 0.0128 0.25 0.2494 1.0 2072639 Maybridge1_006184 CCOC(=O)CNC(=O)CC(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B03 compound treatment 1.0207 0.0207 0.4 0.4028 1.0 2072640 Maybridge1_006185 CC(NCc1ccc(OCc2ccc(F)cc2)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B04 compound treatment 1.0315 0.0315 0.61 0.612 1.0 2072641 Maybridge1_006186 COc1ccc(cc1)/C(=N/O)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B05 compound treatment 1.0308 0.0308 0.6 0.5981 1.0 1600962 Maybridge1_006187 COc1ccc(cc1)N(Cc2ccccc2)Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B06 compound treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 2072642 Maybridge1_006188 COc1cc(N2CCCC2)c(cc1[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B07 compound treatment 1.0222 0.0222 0.43 0.4307 1.0 1280583 Maybridge1_006189 Oc1c(c2ccccc2)c(=O)n3CCc4cccc1c43 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B08 compound treatment 1.0028 0.00278 0.05 0.0541 1.0 2072643 Maybridge1_006190 CCOC(=O)c1cc2cc(F)ccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B09 compound treatment 0.9755 -0.0245 -0.48 -0.476 -1.0 2072644 Maybridge1_006191 COc1ccc(c(OC)c1)S(=O)(=O)Nc2cc(C)c(C)cc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B10 compound treatment 1.0207 0.0207 0.4 0.4028 1.0 1648563 Maybridge1_006192 O=C(NC1CCN(Cc2ccccc2)CC1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B11 compound treatment 0.9848 -0.0152 -0.29 -0.2947 -1.0 2072645 Maybridge1_006193 CCCCCOc1ccc(cc1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B12 compound treatment 1.0071 0.00709 0.14 0.1378 1.0 2072646 Maybridge1_006194 CCCCCCCCCCCCCCCCCCN1CNC(=S)NC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B13 compound treatment 1.0035 0.0035 0.07 0.068 1.0 1044813 Maybridge1_006195 Brc1ccc2[nH]ccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B14 compound treatment 1.0179 0.0179 0.35 0.347 1.0 2072647 Maybridge1_006196 Nc1nc(cs1)c2ccc(Cl)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B15 compound treatment 0.9848 -0.0152 -0.29 -0.2947 -1.0 1089306 Maybridge1_006197 COC(=O)CNCC(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B16 compound treatment 0.9884 -0.0116 -0.22 -0.2249 -1.0 1008328 Maybridge1_006198 CC(=O)Nc1ccc(OC(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B17 compound treatment 0.9863 -0.0137 -0.27 -0.2668 -1.0 1371751 Maybridge1_006199 Cc1cc(Nc2ccccc2C(=O)O)n(n1)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B18 compound treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 1238043 Maybridge1_006200 Fc1cccc(Cl)c1C(=O)Nc2cccc(c2)C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B19 compound treatment 1.0114 0.0114 0.22 0.2215 1.0 1685353 Maybridge1_006201 COC(=O)c1[nH]c2ccccc2c1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B20 compound treatment 0.9956 -0.0044 -0.09 -0.0854 -1.0 2072648 Maybridge1_006202 Cc1cc(Sc2nnc(n2C)C(F)(F)F)c(cc1[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B21 compound treatment 0.9855 -0.0145 -0.28 -0.2807 -1.0 2072649 Maybridge1_006203 COc1ccc(Oc2ccc(cc2N)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B22 compound treatment 0.9697 -0.0303 -0.59 -0.5876 -1.0 2072650 Maybridge1_006204 CCCCCCNC(=O)NCCCCCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B23 mock treatment 1.0164 0.0164 0.32 0.3191 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 B24 mock treatment 1.0085 0.00853 0.17 0.1657 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C01 compound treatment 1.0595 0.0595 1.16 1.1561 1.0 2072651 Maybridge1_006205 COC(=O)c1onc(c1C(=O)OC)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C02 compound treatment 1.0301 0.0301 0.58 0.5841 1.0 2072652 Maybridge1_006206 COC(=O)c1cc(OCC(F)(F)F)nc(OCC(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C03 compound treatment 1.0452 0.0452 0.88 0.8771 1.0 1728994 Maybridge1_006207 CCOC(=O)c1sc(N)nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C04 compound treatment 1.0193 0.0193 0.37 0.3749 1.0 2072653 Maybridge1_006208 O=C1CS/C(=N/N=C/c2ccn[nH]2)/N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C05 compound treatment 0.9726 -0.0274 -0.53 -0.5318 -1.0 2072654 Maybridge1_006209 N/C(=N\OC(=O)Nc1ccc(Cl)cc1)/c2ccc(cc2)C3SCCS3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C06 compound treatment 0.9834 -0.0166 -0.32 -0.3226 -1.0 2072655 Maybridge1_006210 [O-][N+](=O)c1cccc(c1)C(=O)NNC(=O)C2c3ccccc3Oc4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C07 compound treatment 0.9949 -0.00512 -0.1 -0.0994 -1.0 2072656 Maybridge1_006211 CSc1nc(C)nc(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C08 compound treatment 1.1084 0.108 2.1 2.1047 1.0 2072657 Maybridge1_006212 Nc1c(C#N)cnn1c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C09 compound treatment 0.9791 -0.0209 -0.41 -0.4063 -1.0 1409063 Maybridge1_006213 CSc1nc(N)nc(n1)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C10 compound treatment 0.9187 -0.0813 -1.58 -1.5781 -1.0 1005947 Maybridge1_006214 OC(=O)CCC(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C11 compound treatment 1.0157 0.0157 0.31 0.3052 1.0 2072658 Maybridge1_006215 Cc1onc(c1C(=O)O/N=C(\N)/c2ccc(o2)[N+](=O)[O-])c3cccc(Cl)c3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C12 compound treatment 0.9784 -0.0216 -0.42 -0.4202 -1.0 2072659 Maybridge1_006216 Sc1nc2cc(Cl)ccc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C13 compound treatment 1.0294 0.0294 0.57 0.5702 1.0 2072660 Maybridge1_006217 CC(C)(C)C(=O)OCc1nc(cs1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C14 compound treatment 1.0085 0.00853 0.17 0.1657 1.0 2072661 Maybridge1_006218 COC(=O)C(C)(C)Oc1ccc(C)c2CCCc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C15 compound treatment 1.02 0.02 0.39 0.3889 1.0 1222937 Maybridge1_006219 COc1ccc(CN2C(=O)CNC2=S)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C16 compound treatment 0.9863 -0.0137 -0.27 -0.2668 -1.0 2072662 Maybridge1_006220 CS(=O)(=O)OCCN1CCN(CC1)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C17 compound treatment 1.0114 0.0114 0.22 0.2215 1.0 2072663 Maybridge1_006221 CSC1=N/C(=C\N(C)C)/C(=O)N1CCOc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C18 compound treatment 0.997 -0.00296 -0.06 -0.0575 -1.0 2072664 Maybridge1_006222 COC(=O)C(C(=O)OC)c1ccc(Cl)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C19 compound treatment 0.9791 -0.0209 -0.41 -0.4063 -1.0 2072665 Maybridge1_006223 OC1c2ccnn2[C@@H](O)c3ccnn13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C20 compound treatment 0.9647 -0.0353 -0.69 -0.6853 -1.0 1038600 Maybridge1_006224 [O-][N+](=O)c1ccc2NCCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C21 compound treatment 1.0128 0.0128 0.25 0.2494 1.0 2072666 Maybridge1_006225 CC(C)(C)C(=O)OC/C(=N/OC(=O)c1cccs1)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C22 compound treatment 0.9618 -0.0382 -0.74 -0.7411 -1.0 1918351 Maybridge1_006226 Oc1ccc2ccccc2c1C(/N=C/c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C23 mock treatment 0.9547 -0.0453 -0.88 -0.8806 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 C24 mock treatment 0.9949 -0.00512 -0.1 -0.0994 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D01 compound treatment 0.9942 -0.00584 -0.11 -0.1133 -1.0 2072667 Maybridge1_006227 COC(=O)c1ccccc1CSc2ccccc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D02 compound treatment 1.0236 0.0236 0.46 0.4586 1.0 2072668 Maybridge1_006228 NC(=O)CSc1ccc(cn1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D03 compound treatment 1.0552 0.0552 1.07 1.0724 1.0 1381669 Maybridge1_006229 CCOC(=O)COc1ccc(C)c2CCCc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D04 compound treatment 1.0078 0.00781 0.15 0.1517 1.0 2072669 Maybridge1_006230 c1sc(nc1c2ccccc2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D05 compound treatment 0.9899 -0.0101 -0.2 -0.197 -1.0 2072670 Maybridge1_006231 Fc1ccc(OCc2ccccc2)c(c1)C(=O)CCc3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D06 compound treatment 1.0035 0.0035 0.07 0.068 1.0 2072671 Maybridge1_006232 CCOC(=O)C(Cc1ccc(F)cc1)(NC(=O)C)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D07 compound treatment 1.0057 0.00566 0.11 0.1099 1.0 2072672 Maybridge1_006233 C(Cc1ccccc1)/N=C/c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D08 compound treatment 0.992 -0.00799 -0.16 -0.1552 -1.0 2072673 Maybridge1_006234 CCCCCC(=O)Nc1nc-2c(CCc3cc(OC)ccc23)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D09 compound treatment 0.9985 -0.00153 -0.03 -0.0296 -1.0 1250582 Maybridge1_006235 Cc1ccc(COc2c(c3ccccc3)c(=O)n4CCCc5cc(C)cc2c54)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D10 compound treatment 0.9934 -0.00655 -0.13 -0.1273 -1.0 2072674 Maybridge1_006236 COc1ccc2-c3nc(N/C=N/O)sc3CCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D11 compound treatment 0.9597 -0.0403 -0.78 -0.7829 -1.0 1077542 Maybridge1_006237 C1Cc2ccccc2-c3[nH]c4ccccc4c13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D12 compound treatment 1.0444 0.0444 0.86 0.8631 1.0 1021563 Maybridge1_006238 CCc1c(C)[nH]c2ccc(cc12)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D13 compound treatment 1.0207 0.0207 0.4 0.4028 1.0 1561441 Maybridge1_006239 CC(=O)Nc1ccc(cc1)c2cc(C(=O)O)c3ccccc3n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D14 compound treatment 0.9769 -0.0231 -0.45 -0.4481 -1.0 2072675 Maybridge1_006240 FC(F)(F)c1cccc(c1)N2CCCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D15 compound treatment 0.9848 -0.0152 -0.29 -0.2947 -1.0 1509391 Maybridge1_006241 OC(=O)CC(CC(=O)O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D16 compound treatment 0.9877 -0.0123 -0.24 -0.2389 -1.0 1177095 Maybridge1_006242 Cc1cc(O)cc2OC(C)(C)CC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D17 compound treatment 0.9489 -0.0511 -0.99 -0.9922 -1.0 1384385 Maybridge1_006243 Clc1cc(Cl)c2cccnc2c1OC(=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D18 compound treatment 0.9942 -0.00584 -0.11 -0.1133 -1.0 2072676 Maybridge1_006244 [O-][N+](=O)c1cc(ccc1Sc2nc(C3CCCCC3)c(C#N)c(=O)[nH]2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D19 compound treatment 1.0136 0.0136 0.26 0.2633 1.0 2072677 Maybridge1_006245 CCOC(=O)Cc1ccccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D20 compound treatment 1.0028 0.00278 0.05 0.0541 1.0 2072678 Maybridge1_006246 Cn1c(Sc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])nnc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D21 compound treatment 0.9784 -0.0216 -0.42 -0.4202 -1.0 2072679 Maybridge1_006247 N/N=C/1\C(=O)Nc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D22 compound treatment 0.9956 -0.0044 -0.09 -0.0854 -1.0 2072680 Maybridge1_006248 COc1ccccc1C2CCN(CC2)C(=O)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D23 mock treatment 0.9942 -0.00584 -0.11 -0.1133 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 D24 mock treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E01 compound treatment 1.0567 0.0567 1.1 1.1003 1.0 2072681 Maybridge1_006249 Clc1cccc(Cl)c1c2nsc(=O)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E02 compound treatment 0.9647 -0.0353 -0.69 -0.6853 -1.0 2072682 Maybridge1_006250 NC(=O)c1ccc(OCC(F)(F)F)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E03 compound treatment 1.0078 0.00781 0.15 0.1517 1.0 1004151 Maybridge1_006251 NC(=O)c1ccc(o1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E04 compound treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 1031001 Maybridge1_006252 Oc1ccccc1C(=O)CC(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E05 compound treatment 1.0042 0.00422 0.08 0.082 1.0 2072683 Maybridge1_006253 NC(=S)c1ccc(cc1)C2SCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E06 compound treatment 1.0028 0.00278 0.05 0.0541 1.0 1735704 Maybridge1_006254 O=c1[nH]c2c(C#N)cnn2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E07 compound treatment 1.0243 0.0243 0.47 0.4726 1.0 2072684 Maybridge1_006255 CSc1nc(N)nc(n1)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E08 compound treatment 1.0049 0.00494 0.1 0.0959 1.0 1419577 Maybridge1_006256 Oc1c(c2ccccc2)c(=O)n3c4CCCCc4c5cccc1c53 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E09 compound treatment 1.0459 0.0459 0.89 0.891 1.0 1301788 Maybridge1_006257 CSc1nc(N)nc(n1)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E10 compound treatment 1.0021 0.00207 0.04 0.0401 1.0 2072685 Maybridge1_006258 CCOC(=O)c1ccc2nc(/N=C/N(C)C)sc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E11 compound treatment 0.9324 -0.0676 -1.31 -1.313 -1.0 2072686 Maybridge1_006259 Cc1nc(N)nc(N/N=C/c2ccccc2O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E12 compound treatment 1.0057 0.00566 0.11 0.1099 1.0 2072687 Maybridge1_006260 Oc1ncnc2ccc(Br)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E13 compound treatment 0.9489 -0.0511 -0.99 -0.9922 -1.0 2072688 Maybridge1_006261 FC(F)(F)C(=O)NNC(=O)c1ccc[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E14 compound treatment 1.0272 0.0272 0.53 0.5283 1.0 2072689 Maybridge1_006262 Cc1ccc2ncnc(Oc3ncccc3[N+](=O)[O-])c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E15 compound treatment 1.02 0.02 0.39 0.3889 1.0 2072690 Maybridge1_006263 Clc1cccc(CN2C(=O)CNC2=S)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E16 compound treatment 0.9985 -0.00153 -0.03 -0.0296 -1.0 2072691 Maybridge1_006264 CCOC(=O)c1cnn(c1N)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E17 compound treatment 0.9776 -0.0224 -0.43 -0.4342 -1.0 1330771 Maybridge1_006265 CC(C)NC(=O)N(Cc1cccnc1)Cc2cccc(Cl)c2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E18 compound treatment 0.9769 -0.0231 -0.45 -0.4481 -1.0 2072692 Maybridge1_006266 COc1ccc2[nH]c(S)nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E19 compound treatment 1.015 0.015 0.29 0.2912 1.0 2072693 Maybridge1_006267 OC(=O)c1cnccc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E20 compound treatment 0.9611 -0.0389 -0.76 -0.755 -1.0 1049568 Maybridge1_006268 CC(=O)N1CCc2cc(ccc12)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E21 compound treatment 1.015 0.015 0.29 0.2912 1.0 2072694 Maybridge1_006269 CCOC(=O)c1csc(n1)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E22 compound treatment 0.9748 -0.0252 -0.49 -0.49 -1.0 2072695 Maybridge1_006270 Oc1ccc2ccccc2c1C(/N=C/c3ccc(cc3)C(F)(F)F)c4ccc(cc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E23 mock treatment 1.048 0.048 0.93 0.9329 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 E24 mock treatment 0.9733 -0.0267 -0.52 -0.5179 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F01 compound treatment 1.0279 0.0279 0.54 0.5423 1.0 2072696 Maybridge1_006271 Cc1ccc(cc1)C(=O)c2ccccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F02 compound treatment 1.0042 0.00422 0.08 0.082 1.0 1667943 Maybridge1_006272 OC(=O)CCNc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F03 compound treatment 1.0215 0.0215 0.42 0.4168 1.0 1351203 Maybridge1_006273 CCOC(=O)COc1cccc2c(C)cc(=O)oc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F04 compound treatment 0.9776 -0.0224 -0.43 -0.4342 -1.0 1028837 Maybridge1_006274 OC1(Cc2ccccn2)C(=O)Nc3ccccc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F05 compound treatment 1.0021 0.00207 0.04 0.0401 1.0 2072697 Maybridge1_006275 CC(=O)c1ccc(OCc2ccccc2)cc1OCc3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F06 compound treatment 0.9424 -0.0576 -1.12 -1.1177 -1.0 2072698 Maybridge1_006276 CCOC(=O)CC1=Nn2c(nnc2SC1)c3cc(Cl)cc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F07 compound treatment 0.9985 -0.00153 -0.03 -0.0296 -1.0 2072699 Maybridge1_006277 Cc1cc(ccc1[N+](=O)[O-])C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F08 compound treatment 1.0236 0.0236 0.46 0.4586 1.0 1044908 Maybridge1_006278 CCOC(=O)c1cnn(c1N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F09 compound treatment 1.0236 0.0236 0.46 0.4586 1.0 2072700 Maybridge1_006279 CCCCCc1ccc(cc1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F10 compound treatment 1.0286 0.0286 0.56 0.5562 1.0 2072701 Maybridge1_006280 O/N=C/Nc1nc-2c(CCc3ccccc23)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F11 compound treatment 1.0021 0.00207 0.04 0.0401 1.0 1060684 Maybridge1_006281 C1CCCc2c(CC1)[nH]c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F12 compound treatment 1.0394 0.0394 0.77 0.7655 1.0 2072702 Maybridge1_006282 COc1ccc2-c3nc(/N=C/c4ccc(cc4)C(F)(F)F)sc3CCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F13 compound treatment 0.9733 -0.0267 -0.52 -0.5179 -1.0 1049405 Maybridge1_006283 CS(=O)(=O)c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F14 compound treatment 1.0128 0.0128 0.25 0.2494 1.0 2072703 Maybridge1_006284 C1Oc2ccc(/C=N/c3nc-4c(CCc5ccccc45)s3)cc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F15 compound treatment 0.9547 -0.0453 -0.88 -0.8806 -1.0 2072704 Maybridge1_006285 Clc1ccc(cc1)C2CC(=O)NC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F16 compound treatment 0.9956 -0.0044 -0.09 -0.0854 -1.0 2072705 Maybridge1_006286 COc1ccc(C)nc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F17 compound treatment 0.982 -0.018 -0.35 -0.3505 -1.0 2072706 Maybridge1_006287 OC(=O)c1cc(ccc1Sc2ccc(cc2C(=O)O)[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F18 compound treatment 1.0143 0.0143 0.28 0.2773 1.0 1620619 Maybridge1_006288 Cc1c(OCc2ccccc2F)ccc3C(=O)CC(C)(C)Oc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F19 compound treatment 1.0473 0.0473 0.92 0.9189 1.0 1102313 Maybridge1_006289 Clc1cc2nc[nH]c2cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F20 compound treatment 0.9733 -0.0267 -0.52 -0.5179 -1.0 2072707 Maybridge1_006290 CC(=O)COc1ccc2C(=O)CC(C)(C)Oc2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F21 compound treatment 0.9884 -0.0116 -0.22 -0.2249 -1.0 1017701 Maybridge1_006291 CSc1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F22 compound treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 1781380 Maybridge1_006292 COc1ccccc1N2CCN(CC2)C(=O)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F23 mock treatment 0.9812 -0.0188 -0.36 -0.3644 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 F24 mock treatment 0.9841 -0.0159 -0.31 -0.3086 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G01 compound treatment 1.0847 0.0847 1.64 1.6443 1.0 2072708 Maybridge1_006293 NC(=N)C1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G02 compound treatment 1.0085 0.00853 0.17 0.1657 1.0 2072709 Maybridge1_006294 OC(=O)c1cc(OCC(F)(F)F)nc(OCC(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G03 compound treatment 1.0294 0.0294 0.57 0.5702 1.0 1166265 Maybridge1_006295 CC(C)c1ccc(Nc2snc(O)c2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G04 compound treatment 1.0193 0.0193 0.37 0.3749 1.0 2072710 Maybridge1_006296 CC(=O)c1ccccc1OC(=O)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G05 compound treatment 1.0308 0.0308 0.6 0.5981 1.0 2072711 Maybridge1_006297 Clc1ccc(N2C(=N)SCC2=O)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G06 compound treatment 1.0006 6.29E-4 0.01 0.0122 1.0 2072712 Maybridge1_006298 Cc1[nH]c(=O)[nH]c(=O)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G07 compound treatment 1.0437 0.0437 0.85 0.8492 1.0 1556343 Maybridge1_006299 CSc1nc(N)nc(n1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G08 compound treatment 0.9978 -0.00224 -0.04 -0.0436 -1.0 2072713 Maybridge1_006300 NC(=O)c1cnn(c1N)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G09 compound treatment 1.0107 0.0107 0.21 0.2075 1.0 2072714 Maybridge1_006301 CCCCNC(=O)NS(=O)(=O)c1ccccc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G10 compound treatment 1.0351 0.0351 0.68 0.6818 1.0 2072715 Maybridge1_006302 CCOC(=O)/C(=C/Nc1nc2ccc(cc2s1)C(=O)OCC)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G11 compound treatment 1.0114 0.0114 0.22 0.2215 1.0 2072716 Maybridge1_006303 CC(C)(C)C(=O)OCC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G12 compound treatment 0.9101 -0.0899 -1.75 -1.7455 -1.0 1030016 Maybridge1_006304 Oc1ncnc2cc(Cl)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G13 compound treatment 1.0157 0.0157 0.31 0.3052 1.0 1714880 Maybridge1_006305 O=C1CNC(=S)N1Cc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G14 compound treatment 0.9568 -0.0432 -0.84 -0.8387 -1.0 2072717 Maybridge1_006306 CC(C)(C)c1ccc(cc1)c2ncc(s2)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G15 compound treatment 0.9963 -0.00368 -0.07 -0.0715 -1.0 1083878 Maybridge1_006307 Clc1ccc(OCC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G16 compound treatment 1.0301 0.0301 0.58 0.5841 1.0 2072718 Maybridge1_006308 CCOC(=O)c1cnn(c1n2cccc2)c3ccc(cc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G17 compound treatment 1.0128 0.0128 0.25 0.2494 1.0 2072719 Maybridge1_006309 CSC1=NCC(=O)N1CCc2c[nH]c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G18 compound treatment 0.9985 -0.00153 -0.03 -0.0296 -1.0 1666680 Maybridge1_006310 CCOC(=O)c1cc(=O)c2ccc(OC(=O)c3sc4ccccc4c3Cl)cc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G19 compound treatment 0.9798 -0.0202 -0.39 -0.3923 -1.0 2072720 Maybridge1_006311 NC(=O)C1=CNCCC1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G20 compound treatment 0.9683 -0.0317 -0.62 -0.6155 -1.0 2072721 Maybridge1_006312 [O-][N+](=O)c1ccc2N(CCc2c1)C(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G21 compound treatment 1.061 0.061 1.18 1.184 1.0 2072722 Maybridge1_006313 FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2nc(CSc3ncccn3)no2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G22 compound treatment 0.9841 -0.0159 -0.31 -0.3086 -1.0 1603340 Maybridge1_006314 Oc1cc(=O)n2CCc3cccc1c32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G23 mock treatment 1.0143 0.0143 0.28 0.2773 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 G24 mock treatment 1.0143 0.0143 0.28 0.2773 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H01 compound treatment 1.1227 0.123 2.38 2.3837 1.0 2072723 Maybridge1_006315 CSc1c(C#N)c(N)[nH]c(=S)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H02 compound treatment 0.9755 -0.0245 -0.48 -0.476 -1.0 2072724 Maybridge1_006316 Nc1ccc(cc1)c2nnc(Nc3ccccc3C(F)(F)F)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H03 compound treatment 1.0164 0.0164 0.32 0.3191 1.0 2072725 Maybridge1_006317 CC(=O)c1cc(F)ccc1OCc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H04 compound treatment 0.992 -0.00799 -0.16 -0.1552 -1.0 1285144 Maybridge1_006318 OC1(Cc2ccncc2)C(=O)Nc3ccccc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H05 compound treatment 0.9618 -0.0382 -0.74 -0.7411 -1.0 1112292 Maybridge1_006319 COc1ccc(Cl)cc1NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H06 compound treatment 1.0057 0.00566 0.11 0.1099 1.0 2072726 Maybridge1_006320 [O-][N+](=O)c1ccc(cc1)C(=O)Nc2nc-3c(CCc4ccccc34)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H07 compound treatment 1.0301 0.0301 0.58 0.5841 1.0 2072727 Maybridge1_006321 OC(=O)C1CC(CC(C1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H08 compound treatment 0.9848 -0.0152 -0.29 -0.2947 -1.0 2072728 Maybridge1_006322 CN(C)/C=N/c1nc-2c(CCc3ccccc23)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H09 compound treatment 0.9956 -0.0044 -0.09 -0.0854 -1.0 1425686 Maybridge1_006323 CCCCn1c(=O)c(C)c(C)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H10 compound treatment 1.0114 0.0114 0.22 0.2215 1.0 2072729 Maybridge1_006324 CC(C)/C=C/C1=CC2=C(C1)Cc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H11 compound treatment 0.9547 -0.0453 -0.88 -0.8806 -1.0 1556202 Maybridge1_006325 C1CCCCCc2c(CCCC1)[nH]c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H12 compound treatment 1.0114 0.0114 0.22 0.2215 1.0 2072730 Maybridge1_006326 S=C1NCN(CCCCc2ccccc2)CN1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H13 compound treatment 0.9661 -0.0339 -0.66 -0.6574 -1.0 2072731 Maybridge1_006327 [O-][N+](=O)/C=C/c1cc2OCOc2cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H14 compound treatment 0.9719 -0.0281 -0.55 -0.5458 -1.0 1266526 Maybridge1_006328 Cc1ccc(cc1)S(=O)(=O)c2ccc(Cl)c(N)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H15 compound treatment 1.0013 0.00135 0.03 0.0262 1.0 1053450 Maybridge1_006329 Cc1ccc2[nH]c3CCCCc3c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H16 compound treatment 0.992 -0.00799 -0.16 -0.1552 -1.0 2072732 Maybridge1_006330 [O-][N+](=O)c1ccc(cc1)C(=O)Nc2cccc(c2)C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H17 compound treatment 0.9604 -0.0396 -0.77 -0.769 -1.0 1411302 Maybridge1_006331 COC(=O)COc1c(Br)cc(Br)cc1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H18 compound treatment 0.9755 -0.0245 -0.48 -0.476 -1.0 2072733 Maybridge1_006332 Cc1c(OCc2cc(cc(c2)C(F)(F)F)C(F)(F)F)ccc3C(=O)CC(C)(C)Oc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H19 compound treatment 0.9647 -0.0353 -0.69 -0.6853 -1.0 2072734 Maybridge1_006333 Clc1ccc2C(=O)N(Cc3ccccc3)C(=O)c4cccc1c42 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H20 compound treatment 0.997 -0.00296 -0.06 -0.0575 -1.0 2072735 Maybridge1_006334 Cn1c(Sc2ccc(cn2)[N+](=O)[O-])nnc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H21 compound treatment 0.9805 -0.0195 -0.38 -0.3784 -1.0 2072736 Maybridge1_006335 CC(C)(C)c1ccc(cc1)C(=O)NNC(=O)c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H22 compound treatment 0.431 -0.569 -11.05 -11.05 -1.0 1015808 Maybridge1_006336 Cc1cc2nc3c(=O)[nH]c(=O)nc3n(CC(O)C(O)C(O)CO)c2cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H23 mock treatment 0.9884 -0.0116 -0.22 -0.2249 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 H24 mock treatment 1.0057 0.00566 0.11 0.1099 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I01 compound treatment 1.0631 0.0631 1.23 1.2258 1.0 1681466 Maybridge1_006337 Cc1cc(O)nc(n1)C2(CC3CC4CC(C3)C2)C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I02 compound treatment 1.0193 0.0193 0.37 0.3749 1.0 2072737 Maybridge1_006338 FC(F)(F)c1ccc[nH]c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I03 compound treatment 1.0423 0.0423 0.82 0.8213 1.0 2072738 Maybridge1_006339 Oc1nsc(Nc2ccccc2C(F)(F)F)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I04 compound treatment 0.9719 -0.0281 -0.55 -0.5458 -1.0 1040552 Maybridge1_006340 OC(=O)C1c2ccccc2Oc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I05 compound treatment 1.0265 0.0265 0.51 0.5144 1.0 2072739 Maybridge1_006341 Fc1ccc(cc1Cl)N2C(=N)SCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I06 compound treatment 0.9913 -0.00871 -0.17 -0.1691 -1.0 1033843 Maybridge1_006342 O=C1CCC(=NN1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I07 compound treatment 0.9942 -0.00584 -0.11 -0.1133 -1.0 2072740 Maybridge1_006343 CSc1nc(N)nc(n1)C2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I08 compound treatment 0.964 -0.036 -0.7 -0.6992 -1.0 1335096 Maybridge1_006344 CCC(=O)Nc1ccc(OC)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I09 compound treatment 1.015 0.015 0.29 0.2912 1.0 1713393 Maybridge1_006345 CSc1nc(N)nc(n1)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I10 compound treatment 0.9705 -0.0295 -0.57 -0.5737 -1.0 2072741 Maybridge1_006346 CCOC(=O)c1ccc2nc(sc2c1)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I11 compound treatment 0.9841 -0.0159 -0.31 -0.3086 -1.0 2072742 Maybridge1_006347 CC(C)(C)C(=O)OC/C(=N/OC(=O)c1ccccc1)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I12 compound treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 1189503 Maybridge1_006348 NC(=O)c1cccnc1Oc2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I13 compound treatment 0.9575 -0.0425 -0.82 -0.8248 -1.0 1373573 Maybridge1_006349 O=C1CNC(=S)N1Cc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I14 compound treatment 0.941 -0.059 -1.15 -1.1456 -1.0 1032780 Maybridge1_006350 COC(=O)COc1ccc(cc1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I15 compound treatment 0.9776 -0.0224 -0.43 -0.4342 -1.0 2072743 Maybridge1_006351 Cc1cc(NCc2cccc(Cl)c2Cl)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I16 compound treatment 0.9525 -0.0475 -0.92 -0.9224 -1.0 2072744 Maybridge1_006352 CN(C)/C=C/c1ccc(cc1[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I17 compound treatment 1.0035 0.0035 0.07 0.068 1.0 1331627 Maybridge1_006353 COC(=O)c1cc(Cl)cc2SS(=O)Nc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I18 compound treatment 1.0459 0.0459 0.89 0.891 1.0 1524120 Maybridge1_006354 CCOC(=O)c1cc(=O)c2ccc(OC(=O)c3cccnc3Oc4ccccc4)cc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I19 compound treatment 0.9661 -0.0339 -0.66 -0.6574 -1.0 2072745 Maybridge1_006355 FC(F)(F)c1ccncc1C(=O)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I20 compound treatment 0.9784 -0.0216 -0.42 -0.4202 -1.0 2072746 Maybridge1_006356 CC(=O)c1ccc(OCc2ccc(Cl)c(Cl)c2)c(C)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I21 compound treatment 1.0128 0.0128 0.25 0.2494 1.0 2072747 Maybridge1_006357 COC(=O)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I22 compound treatment 1.0042 0.00422 0.08 0.082 1.0 2072748 Maybridge1_006358 O=C/1/C(=C/c2ccccc2)/CCC\C1=C/c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I23 mock treatment 1.0193 0.0193 0.37 0.3749 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 I24 mock treatment 0.9956 -0.0044 -0.09 -0.0854 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J01 compound treatment 1.0358 0.0358 0.7 0.6957 1.0 2072749 Maybridge1_006359 COc1ccc([N+](=O)[O-])c(SC(C)C(=O)O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J02 compound treatment 0.982 -0.018 -0.35 -0.3505 -1.0 2072750 Maybridge1_006360 Cc1ccc(OCC(=O)NNC(=O)NC(=O)c2ccccc2Cl)c3CCCc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J03 compound treatment 0.9963 -0.00368 -0.07 -0.0715 -1.0 1463171 Maybridge1_006361 Cc1ccc(OCC(=O)NN)c2CCCc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J04 compound treatment 1.0078 0.00781 0.15 0.1517 1.0 1712700 Maybridge1_006362 OC1(Cc2ccccn2)C(=O)Nc3ccc(Br)cc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J05 compound treatment 0.9942 -0.00584 -0.11 -0.1133 -1.0 1158376 Maybridge1_006363 O=C(C(C(=O)N1CCc2ccccc12)c3ccccc3)N4CCc5ccccc45 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J06 compound treatment 1.0193 0.0193 0.37 0.3749 1.0 2072751 Maybridge1_006364 [O-][N+](=O)c1ccc(cc1)C(=O)Nc2nc-3c(Cc4ccccc34)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J07 compound treatment 0.9913 -0.00871 -0.17 -0.1691 -1.0 1201826 Maybridge1_006365 CCOC(=O)C1=C(C)NC(=S)NC1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J08 compound treatment 0.9834 -0.0166 -0.32 -0.3226 -1.0 2072752 Maybridge1_006366 COc1ccc2-c3nc(/N=C/N(C)C)sc3CCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J09 compound treatment 1.0351 0.0351 0.68 0.6818 1.0 2072753 Maybridge1_006367 COC(=O)CSc1ncccc1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J10 compound treatment 0.9913 -0.00871 -0.17 -0.1691 -1.0 1149514 Maybridge1_006368 O=C1CCCc2c1c3ccccc3n2Cc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J11 compound treatment 0.9676 -0.0324 -0.63 -0.6295 -1.0 2072754 Maybridge1_006369 Brc1ccc2cc[nH]c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J12 compound treatment 1.0114 0.0114 0.22 0.2215 1.0 1458567 Maybridge1_006370 OCc1cn(Cc2ccccc2)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J13 compound treatment 0.9755 -0.0245 -0.48 -0.476 -1.0 2072755 Maybridge1_006371 Cc1cc(c[nH]c1=O)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J14 compound treatment 1.1227 0.123 2.38 2.3837 1.0 1013983 Maybridge1_006372 CC1=NN(C(=O)C1)c2cccc(c2)S(=O)(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J15 compound treatment 1.0107 0.0107 0.21 0.2075 1.0 2072756 Maybridge1_006373 COC(=O)Cc1cc(OC)c(OC)cc1C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J16 compound treatment 1.0186 0.0186 0.36 0.361 1.0 1300508 Maybridge1_006374 Cc1c(O)ccc2C(=O)CC(C)(C)Oc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J17 compound treatment 0.9798 -0.0202 -0.39 -0.3923 -1.0 2072757 Maybridge1_006375 OC(=O)c1ccccc1Sc2c(cc(cc2[N+](=O)[O-])[N+](=O)[O-])C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J18 compound treatment 1.0538 0.0538 1.04 1.0445 1.0 2072758 Maybridge1_006376 Cn1c(Sc2ncccc2[N+](=O)[O-])nnc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J19 compound treatment 0.9611 -0.0389 -0.76 -0.755 -1.0 1313637 Maybridge1_006377 S=C(NCc1ccco1)Nc2ccc3[nH]ccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J20 compound treatment 1.0157 0.0157 0.31 0.3052 1.0 1593978 Maybridge1_006378 COc1ccccc1C2CCN(CC2)C(=S)Nc3ccc(Br)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J21 compound treatment 0.9618 -0.0382 -0.74 -0.7411 -1.0 2072759 Maybridge1_006379 CC(C)(C)c1ccc(cc1)c2nnc(o2)c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J22 compound treatment 0.9913 -0.00871 -0.17 -0.1691 -1.0 2072760 Maybridge1_006380 COc1cc(CC/C(=N/O)/C)ccc1OCc2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J23 mock treatment 0.9669 -0.0331 -0.64 -0.6434 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 J24 mock treatment 1.0459 0.0459 0.89 0.891 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K01 compound treatment 1.0502 0.0502 0.97 0.9747 1.0 1921895 Maybridge1_006381 NC(=S)NNC(=O)C1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K02 compound treatment 1.0143 0.0143 0.28 0.2773 1.0 2072761 Maybridge1_006382 CC(C)(C)c1cc([nH]n1)C(=O)NNS(=O)(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K03 compound treatment 1.0502 0.0502 0.97 0.9747 1.0 1272169 Maybridge1_006383 Cc1onc(c1NC(=O)SCc2c(Cl)cccc2Cl)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K04 compound treatment 0.997 -0.00296 -0.06 -0.0575 -1.0 2072762 Maybridge1_006384 CSc1nc(c2cccs2)c(C#N)c(=O)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K05 compound treatment 1.0322 0.0322 0.63 0.626 1.0 2072763 Maybridge1_006385 CC(C)(C)c1ccc(cc1)N2C(=N)SCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K06 compound treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 2072764 Maybridge1_006386 CCC(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K07 compound treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 2072765 Maybridge1_006387 CSc1nc(N)nc(n1)c2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K08 compound treatment 1.0401 0.0401 0.78 0.7794 1.0 2072766 Maybridge1_006388 OC(=O)c1cnn2c1[nH]c(=O)c3ccccc32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K09 compound treatment 1.0179 0.0179 0.35 0.347 1.0 1238111 Maybridge1_006389 CC(C)(C)c1nc(N)nc(O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K10 compound treatment 1.0444 0.0444 0.86 0.8631 1.0 1653742 Maybridge1_006390 CCOC(=O)c1ccc2nc(NC(=O)c3ccc(F)c(Cl)c3)sc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K11 compound treatment 0.9956 -0.0044 -0.09 -0.0854 -1.0 1025079 Maybridge1_006391 COC(=O)c1ccc(nc1)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K12 compound treatment 1.0006 6.29E-4 0.01 0.0122 1.0 1391060 Maybridge1_006392 CCOC(=O)C1(O)C(=O)Nc2cc(OC)cc(OC)c21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K13 compound treatment 1.0164 0.0164 0.32 0.3191 1.0 2072767 Maybridge1_006393 Clc1ccc(CCN2C(=O)CNC2=S)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K14 compound treatment 0.9812 -0.0188 -0.36 -0.3644 -1.0 2072768 Maybridge1_006394 CCOC(=O)COc1cccc(c1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K15 compound treatment 0.9626 -0.0374 -0.73 -0.7271 -1.0 2072769 Maybridge1_006395 NC(=S)c1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K16 compound treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 2072770 Maybridge1_006396 OC(=O)c1cc(ccc1F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K17 compound treatment 0.9906 -0.00943 -0.18 -0.1831 -1.0 1469361 Maybridge1_006397 O=C1CNC(=S)N1Cc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K18 compound treatment 0.9978 -0.00224 -0.04 -0.0436 -1.0 2072771 Maybridge1_006398 CCCCCCCC(=O)Nc1nnc(Sc2ccnc3cc(Cl)ccc23)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K19 compound treatment 1.0164 0.0164 0.32 0.3191 1.0 2072772 Maybridge1_006399 FC(F)(F)c1ccncc1C(=O)Nc2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K20 compound treatment 0.9942 -0.00584 -0.11 -0.1133 -1.0 1614406 Maybridge1_006400 Cc1c(O)c(ccc1OCc2ccc(Cl)c(Cl)c2)c3cc[nH]n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K21 compound treatment 1.0057 0.00566 0.11 0.1099 1.0 2072773 Maybridge1_006401 COC(=O)c1cc(I)c(OC(=O)C)c(I)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K22 compound treatment 0.9784 -0.0216 -0.42 -0.4202 -1.0 2072774 Maybridge1_006402 C1CCN(C1)C/23OC4=C(CCCC4)C(C3CCC\C2=C/c5ccccc5)c6ccccc6 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K23 mock treatment 0.9748 -0.0252 -0.49 -0.49 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 K24 mock treatment 1.0128 0.0128 0.25 0.2494 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L01 compound treatment 1.0502 0.0502 0.97 0.9747 1.0 2072775 Maybridge1_006403 COc1cccc(CNC(C)C(=O)O)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L02 compound treatment 1.0128 0.0128 0.25 0.2494 1.0 1528089 Maybridge1_006404 CCOC(=O)c1c(C)n(c2ccccc2)c3ccc(OC)cc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L03 compound treatment 0.9568 -0.0432 -0.84 -0.8387 -1.0 2072776 Maybridge1_006405 OC(=O)C(Cc1ccccc1)NCc2ccccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L04 compound treatment 0.9547 -0.0453 -0.88 -0.8806 -1.0 1684989 Maybridge1_006406 O=C(NCCc1ccccc1)c2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L05 compound treatment 1.0344 0.0344 0.67 0.6678 1.0 1054407 Maybridge1_006407 O=C(Nc1ccccc1)C(C(=O)Nc2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L06 compound treatment 1.0049 0.00494 0.1 0.0959 1.0 2072777 Maybridge1_006408 [O-][N+](=O)c1cccc2[nH]ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L07 compound treatment 1.0071 0.00709 0.14 0.1378 1.0 2072778 Maybridge1_006409 CCCCCCCCCCCC1SC[C@H](N1C(=O)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L08 compound treatment 1.0466 0.0466 0.9 0.905 1.0 2072779 Maybridge1_006410 C[C@@H](O[C@@H]1[C@@H](NC(=O)C)[C@@H](OCc2ccccc2)O[C@@H]3COC(O[C@@H]13)c4ccccc4)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L09 compound treatment 0.9683 -0.0317 -0.62 -0.6155 -1.0 2072780 Maybridge1_006411 OC(=O)c1[nH]c2ccc(cc2c1c3ccccc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L10 compound treatment 1.0488 0.0488 0.95 0.9468 1.0 1290636 Maybridge1_006412 CC1(C)CC(=O)c2ccc(OCC(=O)Nc3ccccc3)cc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L11 compound treatment 1.0646 0.0646 1.25 1.2537 1.0 2072781 Maybridge1_006413 Cc1cc(OC(=O)c2c(C)onc2c3c(Cl)cccc3Cl)n(n1)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L12 compound treatment 1.0186 0.0186 0.36 0.361 1.0 1688823 Maybridge1_006414 OC(=O)Cc1csc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L13 compound treatment 0.9942 -0.00584 -0.11 -0.1133 -1.0 1037728 Maybridge1_006415 Brc1ccc2CCc3cccc1c32 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L14 compound treatment 1.0157 0.0157 0.31 0.3052 1.0 1017937 Maybridge1_006416 CCOC(=O)Cc1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L15 compound treatment 0.9633 -0.0367 -0.71 -0.7132 -1.0 2072782 Maybridge1_006417 C/C(=N\Nc1ccccc1)/c2cc3cc(Br)ccc3oc2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L16 compound treatment 0.9748 -0.0252 -0.49 -0.49 -1.0 1595740 Maybridge1_006418 CCCCc1ccc(NC(=S)N2CCC(CC2)C(=O)OCC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L17 compound treatment 0.9726 -0.0274 -0.53 -0.5318 -1.0 1944028 Maybridge1_006419 Sc1nnc(c2ccccc2)n1Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L18 compound treatment 0.987 -0.013 -0.25 -0.2528 -1.0 2072783 Maybridge1_006420 Cc1nc(cn1CC/C(=N/O)/N)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L19 compound treatment 0.9604 -0.0396 -0.77 -0.769 -1.0 2072784 Maybridge1_006421 CCC(=O)c1cc(OC)c(OC)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L20 compound treatment 0.987 -0.013 -0.25 -0.2528 -1.0 1447787 Maybridge1_006422 CCOc1ccc(NC(=S)N2CCC(CC2)c3ccccc3OC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L21 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 1007880 Maybridge1_006423 COc1ccc(NC(=O)C)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L22 compound treatment 0.9848 -0.0152 -0.29 -0.2947 -1.0 2072785 Maybridge1_006424 COS(=O)(=O)c1ccc2C(=O)CC(C)(C)Oc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L23 mock treatment 1.0006 6.29E-4 0.01 0.0122 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 L24 mock treatment 1.0373 0.0373 0.72 0.7236 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M01 compound treatment 1.0804 0.0804 1.56 1.5606 1.0 2072786 Maybridge1_006425 CCOC(=O)CN/C(=N\O)/c1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M02 compound treatment 1.0538 0.0538 1.04 1.0445 1.0 2072787 Maybridge1_006426 FC(F)(F)c1ccc(=O)[nH]c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M03 compound treatment 1.0128 0.0128 0.25 0.2494 1.0 2072788 Maybridge1_006427 N/C(=N\O)/c1ccc(cc1)C2SCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M04 compound treatment 0.982 -0.018 -0.35 -0.3505 -1.0 2072789 Maybridge1_006428 Oc1nnc(o1)C2c3ccccc3Oc4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M05 compound treatment 0.9827 -0.0173 -0.34 -0.3365 -1.0 2072790 Maybridge1_006429 CSc1nc(N)nc(n1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M06 compound treatment 1.0057 0.00566 0.11 0.1099 1.0 2072791 Maybridge1_006430 CCC(=O)Nc1cc(F)ccc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M07 compound treatment 1.038 0.038 0.74 0.7376 1.0 2072792 Maybridge1_006431 CCSc1nc(N)nc(n1)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M08 compound treatment 1.0258 0.0258 0.5 0.5004 1.0 2072793 Maybridge1_006432 COc1ccc2nnc(c3ccc(cc3)C(F)(F)F)n2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M09 compound treatment 0.9827 -0.0173 -0.34 -0.3365 -1.0 1579175 Maybridge1_006433 CSc1nc(N)nc(n1)C2(CC3CC4CC(C3)C2)C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M10 compound treatment 0.969 -0.031 -0.6 -0.6016 -1.0 1940042 Maybridge1_006434 CCOC(=O)C1=C(C)Nc2ccccc2S1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M11 compound treatment 1.0207 0.0207 0.4 0.4028 1.0 1295563 Maybridge1_006435 CC(C)(C)C(=O)OCc1noc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M12 compound treatment 0.9791 -0.0209 -0.41 -0.4063 -1.0 2072794 Maybridge1_006436 COc1ccc(OC)c([N+](=O)[O-])c1/C=C/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M13 compound treatment 1.0315 0.0315 0.61 0.612 1.0 1533787 Maybridge1_006437 O=C1CNC(=S)N1CCc2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M14 compound treatment 0.9712 -0.0288 -0.56 -0.5597 -1.0 2072795 Maybridge1_006438 FC(F)(F)c1ccc2[nH]nnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M15 compound treatment 1.0243 0.0243 0.47 0.4726 1.0 1266151 Maybridge1_006439 O=C1CNC(=S)N1CCOc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M16 compound treatment 0.9719 -0.0281 -0.55 -0.5458 -1.0 1729344 Maybridge1_006440 COc1ccc(OC)c2[nH]ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M17 compound treatment 0.9712 -0.0288 -0.56 -0.5597 -1.0 2072796 Maybridge1_006441 CSC1=N/C(=C\c2ccc(Cl)cc2)/C(=O)N1Cc3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M18 compound treatment 0.9518 -0.0482 -0.94 -0.9364 -1.0 2072797 Maybridge1_006442 COc1ccc(cc1)/C(=N/NC2=NCCCN2)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M19 compound treatment 0.9626 -0.0374 -0.73 -0.7271 -1.0 2072798 Maybridge1_006443 CSc1nc(nc(N)c1C#N)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M20 compound treatment 1.0394 0.0394 0.77 0.7655 1.0 1006201 Maybridge1_006444 CC(=O)OC(OC(=O)C)c1ccc(o1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M21 compound treatment 0.9618 -0.0382 -0.74 -0.7411 -1.0 2072799 Maybridge1_006445 FC(F)(F)c1ccccc1NC(=O)c2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M22 compound treatment 1.0114 0.0114 0.22 0.2215 1.0 1540353 Maybridge1_006446 CCCCn1c(=O)c2c(O)cc(=O)oc2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M23 mock treatment 0.9992 -8.08E-4 -0.02 -0.0157 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 M24 mock treatment 1.0251 0.0251 0.49 0.4865 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N01 compound treatment 1.0172 0.0172 0.33 0.3331 1.0 2072800 Maybridge1_006447 COc1cc(Cl)cc(CNC(C)C(=O)O)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N02 compound treatment 1.0042 0.00422 0.08 0.082 1.0 1618130 Maybridge1_006448 CCc1c(C(=O)OC)c2cc(O)ccc2n1Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N03 compound treatment 1.0294 0.0294 0.57 0.5702 1.0 2072801 Maybridge1_006449 CC(=CC(NCc1ccccc1O)C(=O)O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N04 compound treatment 1.0559 0.0559 1.09 1.0863 1.0 2072802 Maybridge1_006450 Cc1cc(ccc1n2cccc2)c3nnc(o3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N05 compound treatment 1.0179 0.0179 0.35 0.347 1.0 1291953 Maybridge1_006451 Cc1cc2CCCn3c(=O)cc(O)c(c1)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N06 compound treatment 1.015 0.015 0.29 0.2912 1.0 1162160 Maybridge1_006452 Cc1cc(O)c2c3[nH]ncc3ccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N07 compound treatment 0.9697 -0.0303 -0.59 -0.5876 -1.0 1006493 Maybridge1_006453 CCCCC(C(=O)O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N08 compound treatment 1.0021 0.00207 0.04 0.0401 1.0 2072803 Maybridge1_006454 CC(=O)N[C@@H]1[C@@H](O)[C@@H]2OC(OC[C@H]2O[C@@H]1OCc3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N09 compound treatment 0.9841 -0.0159 -0.31 -0.3086 -1.0 2072804 Maybridge1_006455 CC1=N/C(=C\c2ccccc2)/C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N10 compound treatment 0.9827 -0.0173 -0.34 -0.3365 -1.0 1355251 Maybridge1_006456 OC(=O)C(CC(=O)c1cccs1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N11 compound treatment 0.9762 -0.0238 -0.46 -0.4621 -1.0 1027704 Maybridge1_006457 OC(=O)c1ccccc1Oc2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N12 compound treatment 0.9712 -0.0288 -0.56 -0.5597 -1.0 2072805 Maybridge1_006458 FC(F)(F)c1ccc2[nH]c(S)nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N13 compound treatment 0.946 -0.054 -1.05 -1.048 -1.0 2072806 Maybridge1_006459 Cc1cc(ccc1[N+](=O)[O-])C(=O)NNC(=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N14 compound treatment 1.0358 0.0358 0.7 0.6957 1.0 1003119 Maybridge1_006460 O=C(CC(=O)Nc1ccccc1)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N15 compound treatment 0.982 -0.018 -0.35 -0.3505 -1.0 1913136 Maybridge1_006461 OC(=O)c1ccccc1N/C=C/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N16 compound treatment 0.9949 -0.00512 -0.1 -0.0994 -1.0 2072807 Maybridge1_006462 CCOC(=O)C1CCN(CC1)C(=S)Nc2ccccc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N17 compound treatment 0.9791 -0.0209 -0.41 -0.4063 -1.0 1208730 Maybridge1_006463 CCc1cc2c(cc1C(=O)CSc3ncccc3C(=O)O)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N18 compound treatment 1.0035 0.0035 0.07 0.068 1.0 2072808 Maybridge1_006464 Cc1c(OCc2cccc(OC(F)(F)F)c2)ccc3C(=O)CC(C)(C)Oc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N19 compound treatment 0.9848 -0.0152 -0.29 -0.2947 -1.0 1013422 Maybridge1_006465 CC(=O)OC(C(=O)O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N20 compound treatment 0.9992 -8.08E-4 -0.02 -0.0157 -1.0 2072809 Maybridge1_006466 COc1ccccc1C2CCN(CC2)c3ncccc3[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N21 compound treatment 0.9805 -0.0195 -0.38 -0.3784 -1.0 2072810 Maybridge1_006467 ClC1=C(Cl)C(=O)OC1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N22 compound treatment 0.9877 -0.0123 -0.24 -0.2389 -1.0 1057919 Maybridge1_006468 OC(=O)c1ccccc1C(=O)Nc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N23 mock treatment 0.9647 -0.0353 -0.69 -0.6853 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 N24 mock treatment 1.02 0.02 0.39 0.3889 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O01 compound treatment 1.0452 0.0452 0.88 0.8771 1.0 1440413 Maybridge1_006469 COC(=O)c1c(NC(=O)NN2CCCCC2)onc1c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O02 compound treatment 1.0021 0.00207 0.04 0.0401 1.0 2072811 Maybridge1_006470 Brc1c[nH]nc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O03 compound treatment 1.0394 0.0394 0.77 0.7655 1.0 2072812 Maybridge1_006471 CN(C)C(=O)O/N=C(\N)/c1ccc(cc1)C2SCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O04 compound treatment 1.0222 0.0222 0.43 0.4307 1.0 1434269 Maybridge1_006472 NNC(=O)C1c2ccccc2Oc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O05 compound treatment 1.0272 0.0272 0.53 0.5283 1.0 1739883 Maybridge1_006473 COc1nc(N)nc(n1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O06 compound treatment 1.0085 0.00853 0.17 0.1657 1.0 2072813 Maybridge1_006474 CCC(=O)Nc1ccc(F)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O07 compound treatment 0.9978 -0.00224 -0.04 -0.0436 -1.0 2072814 Maybridge1_006475 CSc1nc(N)nc(n1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O08 compound treatment 1.0488 0.0488 0.95 0.9468 1.0 1571659 Maybridge1_006476 Oc1ncnc2n(ncc12)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O09 compound treatment 0.9762 -0.0238 -0.46 -0.4621 -1.0 1382127 Maybridge1_006477 Nc1nc(O)nc(n1)C2(CC3CC4CC(C3)C2)C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O10 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 1374339 Maybridge1_006478 Cc1cc2CCCn3c(=O)c(c(O)c(c1)c23)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O11 compound treatment 1.0279 0.0279 0.54 0.5423 1.0 2072815 Maybridge1_006479 O=C1CNC(=S)N1Cc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O12 compound treatment 0.9827 -0.0173 -0.34 -0.3365 -1.0 1003148 Maybridge1_006480 CC(=O)Nc1ccc(I)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O13 compound treatment 1.0272 0.0272 0.53 0.5283 1.0 1400940 Maybridge1_006481 O=C1CNC(=S)N1CCc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O14 compound treatment 0.9762 -0.0238 -0.46 -0.4621 -1.0 2072816 Maybridge1_006482 O=c1[nH]c(=S)[nH]c(C2CCCCC2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O15 compound treatment 1.0057 0.00566 0.11 0.1099 1.0 2072817 Maybridge1_006483 COc1nc(N)nc(SC)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O16 compound treatment 0.9798 -0.0202 -0.39 -0.3923 -1.0 2072818 Maybridge1_006484 O=C(CC#N)NNC(=S)NC1CCCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O17 compound treatment 0.992 -0.00799 -0.16 -0.1552 -1.0 2072819 Maybridge1_006485 Fc1ccc(SC(=O)Nc2ccc(Cl)cc2)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O18 compound treatment 0.9539 -0.0461 -0.89 -0.8945 -1.0 1339858 Maybridge1_006486 Oc1nc(Nc2ccccc2)nc(Nc3ccccc3)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O19 compound treatment 0.9934 -0.00655 -0.13 -0.1273 -1.0 2072820 Maybridge1_006487 N/C(=N\O)/c1cnccc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O20 compound treatment 0.9776 -0.0224 -0.43 -0.4342 -1.0 2072821 Maybridge1_006488 CS(=O)(=O)c1ccc(cc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O21 compound treatment 0.9999 -8.98E-5 0.0 -0.0017 -1.0 2072822 Maybridge1_006489 FC(F)(F)c1cnc(c(Cl)c1)n2nc(oc2=O)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O22 compound treatment 0.9805 -0.0195 -0.38 -0.3784 -1.0 1687593 Maybridge1_006490 CCCCc1ccc(NC(=O)CSc2nnc(N)s2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O23 mock treatment 0.9855 -0.0145 -0.28 -0.2807 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 O24 mock treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P01 compound treatment 1.0107 0.0107 0.21 0.2075 1.0 2072823 Maybridge1_006491 CC(NCc1cc2ccccc2cc1O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P02 compound treatment 1.0523 0.0523 1.02 1.0166 1.0 2072824 Maybridge1_006492 Cc1ccc2cc(F)ccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P03 compound treatment 1.0552 0.0552 1.07 1.0724 1.0 1443250 Maybridge1_006493 Oc1cc(=O)[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P04 compound treatment 1.0459 0.0459 0.89 0.891 1.0 2072825 Maybridge1_006494 OC(=O)CNC(=O)CCCCC(=O)NCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P05 compound treatment 1.0057 0.00566 0.11 0.1099 1.0 2072826 Maybridge1_006495 OC(=O)[C@@H]1CSC(N1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P06 compound treatment 1.0502 0.0502 0.97 0.9747 1.0 2072827 Maybridge1_006496 CCCCCCCCCC(=O)Nc1nc-2c(Cc3ccccc23)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P07 compound treatment 1.0207 0.0207 0.4 0.4028 1.0 1071563 Maybridge1_006497 Clc1ccc(OC(=O)CC(=O)Oc2ccc(Cl)cc2Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P08 compound treatment 1.0136 0.0136 0.26 0.2633 1.0 2072828 Maybridge1_006498 COc1cccc(c1)C2CCCCN(C)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P09 compound treatment 1.02 0.02 0.39 0.3889 1.0 2072829 Maybridge1_006499 Ic1ccc2[nH]ccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P10 compound treatment 1.0085 0.00853 0.17 0.1657 1.0 2072830 Maybridge1_006500 COc1ccc2nccc(C(=O)C3CC4CCN3CC4C=C)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P11 compound treatment 0.9791 -0.0209 -0.41 -0.4063 -1.0 2072831 Maybridge1_006501 CC(=O)c1c(O)c2ccccc2n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P12 compound treatment 1.0243 0.0243 0.47 0.4726 1.0 2072832 Maybridge1_006502 CCC(=O)N/N=C(\C)/c1ccc(Oc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P13 compound treatment 1.0337 0.0337 0.65 0.6539 1.0 2072833 Maybridge1_006503 [O-][N+](=O)c1cc(ccc1N2CCN(CC2)c3ccc(cc3[N+](=O)[O-])C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P14 compound treatment 1.0251 0.0251 0.49 0.4865 1.0 1387909 Maybridge1_006504 Cc1ccc(C)c(COc2ccc(C)nc2N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P15 compound treatment 1.0028 0.00278 0.05 0.0541 1.0 1089969 Maybridge1_006505 Oc1c(cnc2ccccc12)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P16 compound treatment 0.9712 -0.0288 -0.56 -0.5597 -1.0 2072834 Maybridge1_006506 CCOC(=O)C1CCN(CC1)C(=S)Nc2ccccc2OC(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P17 compound treatment 1.0071 0.00709 0.14 0.1378 1.0 2072835 Maybridge1_006507 OC(=O)c1cccnc1SCC(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P18 compound treatment 1.0653 0.0653 1.27 1.2677 1.0 2072836 Maybridge1_006508 Cn1c(Sc2ccc(cc2[N+](=O)[O-])C(F)(F)F)nnc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P19 compound treatment 0.9712 -0.0288 -0.56 -0.5597 -1.0 2072837 Maybridge1_006509 CC(=O)OCCCCN1C(=O)c2ccccc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P20 compound treatment 0.9985 -0.00153 -0.03 -0.0296 -1.0 2072838 Maybridge1_006510 COc1ccccc1C2CCN(CC2)c3ccc(cc3[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P21 compound treatment 0.9676 -0.0324 -0.63 -0.6295 -1.0 2072839 Maybridge1_006511 CCOC(=O)CNc1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P22 compound treatment 1.0279 0.0279 0.54 0.5423 1.0 2072840 Maybridge1_006512 CC1CC2CN(C)C1C/C(=N/O)/C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P23 mock treatment 0.9776 -0.0224 -0.43 -0.4342 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.559 P24 mock treatment 1.0092 0.00925 0.18 0.1796 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A01 compound treatment 1.0601 0.0601 1.17 1.1671 1.0 2072841 Maybridge1_006513 CN1CC2CCC1C/C(=N/O)/C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A02 compound treatment 0.9956 -0.00441 -0.09 -0.0857 -1.0 2072842 Maybridge1_006514 COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A03 compound treatment 1.0422 0.0422 0.82 0.8191 1.0 1577271 Maybridge1_006515 Fc1cccc(OCC(=O)Nc2ccccc2C(=O)c3ccccc3Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A04 compound treatment 1.0357 0.0357 0.69 0.6938 1.0 2072843 Maybridge1_006516 Cc1cccc(c1)n2c(S)nnc2CSCc3cccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A05 compound treatment 1.0386 0.0386 0.75 0.7495 1.0 1557801 Maybridge1_006517 COc1ccc(CC2CCC(=NO)CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A06 compound treatment 0.9985 -0.00155 -0.03 -0.03 -1.0 2072844 Maybridge1_006518 CN(C(=O)CSc1nnc(COc2ccc(C)c3CCCc32)n1c4ccccc4)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A07 compound treatment 1.0243 0.0243 0.47 0.4711 1.0 1285371 Maybridge1_006519 COc1ccc(cc1)C(=O)N2CCC(CC2)c3ccccc3OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A08 compound treatment 0.9791 -0.0209 -0.41 -0.4058 -1.0 1737597 Maybridge1_006520 OC(=O)CCC1CCCC(CCC(=O)O)C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A09 compound treatment 1.0013 0.00132 0.03 0.0257 1.0 1393835 Maybridge1_006521 CC(=O)N(O)CC(=O)Nc1ccccc1C(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A10 compound treatment 0.987 -0.013 -0.25 -0.2527 -1.0 1166338 Maybridge1_006522 Cc1onc(c1C(=O)NCC(=O)O)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A11 compound treatment 1.0286 0.0286 0.55 0.5546 1.0 1059002 Maybridge1_006523 OC(=O)CSCc1cccc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A12 compound treatment 0.9985 -0.00155 -0.03 -0.03 -1.0 2072845 Maybridge1_006524 Cc1ccc(OCc2nnc(SCC(=O)c3ccc(F)c(F)c3)n2c4ccccc4)c5CCCc51 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A13 compound treatment 0.9899 -0.0101 -0.2 -0.197 -1.0 1464667 Maybridge1_006525 COc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3ccccc3OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A14 compound treatment 1.0192 0.0192 0.37 0.3737 1.0 1370472 Maybridge1_006526 COc1ccc(cc1)C(=O)c2cc3cc(Br)cc(Br)c3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A15 compound treatment 1.0379 0.0379 0.74 0.7356 1.0 1250811 Maybridge1_006527 COc1ccccc1C2CCN(CC2)S(=O)(=O)c3cc(Cl)cc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A16 compound treatment 0.9985 -0.00155 -0.03 -0.03 -1.0 1338954 Maybridge1_006528 COc1ccc(cc1)C(=O)c2cc3cc(Cl)cc(Cl)c3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A17 compound treatment 1.0286 0.0286 0.55 0.5546 1.0 2072846 Maybridge1_006529 COc1ccccc1C2CCN(CC2)S(=O)(=O)c3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A18 compound treatment 0.9863 -0.0137 -0.27 -0.2666 -1.0 2072847 Maybridge1_006530 Cc1cc(Br)c(OCc2nnc(S)n2CC=C)c3CCCc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A19 compound treatment 1.0049 0.00491 0.1 0.0953 1.0 2072848 Maybridge1_006531 OC(=O)CCCNCc1cccc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A20 compound treatment 1.0178 0.0178 0.35 0.3458 1.0 2072849 Maybridge1_006532 Cc1onc(c1C(=O)Nc2cc(ccc2Oc3ccc(C)c4CCCc43)C(F)(F)F)c5c(F)cccc5Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A21 compound treatment 0.9662 -0.0338 -0.66 -0.6564 -1.0 2072850 Maybridge1_006533 Clc1ccccc1NC(=S)NNC(=O)CSCc2cccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A22 compound treatment 0.9633 -0.0367 -0.71 -0.7121 -1.0 2072851 Maybridge1_006534 Cc1ccc(Oc2ccc(cc2NS(=O)(=O)c3cc(ccc3C)[N+](=O)[O-])C(F)(F)F)c4CCCc41 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A23 mock treatment 1.0149 0.0149 0.29 0.2901 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 A24 mock treatment 1.0192 0.0192 0.37 0.3737 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B01 compound treatment 0.9963 -0.0037 -0.07 -0.0718 -1.0 1671490 Maybridge1_006535 Cc1cccc(C)c1NC(=O)c2cccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B02 compound treatment 1.0221 0.0221 0.43 0.4293 1.0 2072852 Maybridge1_006536 CCOC(=O)/C(=C/Nc1ccccc1Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B03 compound treatment 1.0214 0.0214 0.42 0.4154 1.0 2072853 Maybridge1_006537 CC(=O)c1ccc(Nc2cc(C)nc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B04 compound treatment 0.997 -0.00298 -0.06 -0.0579 -1.0 2072854 Maybridge1_006538 Cc1c(sc2ccccc12)C(=O)COc3nc(cc(c3C#N)C(F)(F)F)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B05 compound treatment 0.992 -0.008 -0.16 -0.1553 -1.0 2072855 Maybridge1_006539 [O-][N+](=O)c1cc(ccc1NCCNC(=O)c2cccs2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B06 compound treatment 0.9705 -0.0295 -0.57 -0.5729 -1.0 1292709 Maybridge1_006540 Cc1ccc2cc(NC(=O)c3ccccc3C)ccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B07 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 2072856 Maybridge1_006541 CC(=O)C(=NNc1cccc(c1)C(F)(F)F)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B08 compound treatment 1.0228 0.0228 0.44 0.4432 1.0 2072857 Maybridge1_006542 NC/1=NNC(=O)\C1=C/c2cc(ccc2N3CCOCC3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B09 compound treatment 1.0221 0.0221 0.43 0.4293 1.0 1521748 Maybridge1_006543 CC(C)(C)c1ccc(Oc2ncccc2NC(=O)c3ccccc3Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B10 compound treatment 0.9698 -0.0302 -0.59 -0.5868 -1.0 1438392 Maybridge1_006544 CC1(C)CC(=O)c2ccc(OCC(=O)O)cc2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B11 compound treatment 0.9884 -0.0116 -0.22 -0.2249 -1.0 2072858 Maybridge1_006545 COc1ccc(Oc2ncccc2NC(=O)Nc3cccc(c3)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B12 compound treatment 0.992 -0.008 -0.16 -0.1553 -1.0 1565207 Maybridge1_006546 Nc1nc2ccc(F)cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B13 compound treatment 1.0028 0.00276 0.05 0.0535 1.0 2072859 Maybridge1_006547 COc1ccc(Oc2ncccc2NC(=O)c3cccc4ccccc34)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B14 compound treatment 1.0035 0.00347 0.07 0.0674 1.0 2072860 Maybridge1_006548 O=C(CCCCC(=O)NCC(=O)ON1C(=O)CCC1=O)NCC(=O)ON2C(=O)CCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B15 compound treatment 0.9748 -0.0252 -0.49 -0.4894 -1.0 2072861 Maybridge1_006549 CC(C)(C)c1ccc(Oc2ncccc2NS(=O)(=O)c3ccccc3C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B16 compound treatment 0.9626 -0.0374 -0.73 -0.726 -1.0 1050253 Maybridge1_006550 CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B17 compound treatment 0.9734 -0.0266 -0.52 -0.5172 -1.0 1543501 Maybridge1_006551 CCOc1ccc(CC(C(=O)O)C(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B18 compound treatment 0.9705 -0.0295 -0.57 -0.5729 -1.0 2072862 Maybridge1_006552 Clc1c2C(=O)CC(=O)c2c(Cl)c(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B19 compound treatment 0.9404 -0.0596 -1.16 -1.1575 -1.0 2072863 Maybridge1_006553 CC(=O)c1sc(nc1C)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B20 compound treatment 0.9691 -0.0309 -0.6 -0.6007 -1.0 2072864 Maybridge1_006554 COc1ccc(C=C2CCC(=O)CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B21 compound treatment 0.987 -0.013 -0.25 -0.2527 -1.0 1015396 Maybridge1_006555 O=C(CC(=O)c1cccnc1)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B22 compound treatment 0.9856 -0.0144 -0.28 -0.2806 -1.0 2072865 Maybridge1_006556 Cc1cc2/C(=N\O)/CCCc2nn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B23 mock treatment 0.9569 -0.0431 -0.84 -0.8373 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 B24 mock treatment 1.0099 0.00992 0.19 0.1927 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C01 compound treatment 1.0164 0.0164 0.32 0.318 1.0 1704397 Maybridge1_006557 COc1ccc(CCNC(=O)C2CCCO2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C02 compound treatment 1.0178 0.0178 0.35 0.3458 1.0 1520985 Maybridge1_006558 COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C03 compound treatment 1.0472 0.0472 0.92 0.9165 1.0 2072866 Maybridge1_006559 Cn1cnnc1SCc2cccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C04 compound treatment 0.9554 -0.0446 -0.87 -0.8652 -1.0 2072867 Maybridge1_006560 CCOC(=O)/C(=N/Nc1ccc(C)cc1)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C05 compound treatment 1.0207 0.0207 0.4 0.4015 1.0 2072868 Maybridge1_006561 Cn1c2CCC/C(=N\O)/c2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C06 compound treatment 0.987 -0.013 -0.25 -0.2527 -1.0 1083147 Maybridge1_006562 Cc1cccc(c1)C(=O)NCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C07 compound treatment 0.9992 -8.29E-4 -0.02 -0.0161 -1.0 2072869 Maybridge1_006563 CC1(C)C(N)C2(C)CCC1C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C08 compound treatment 1.0329 0.0329 0.64 0.6381 1.0 2072870 Maybridge1_006564 COc1ccc(OC)c(Sc2cc(c(Cl)cc2[N+](=O)[O-])n3cccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C09 compound treatment 0.9949 -0.00513 -0.1 -0.0996 -1.0 1028362 Maybridge1_006565 NC(=O)NC(=O)c1cccnc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C10 compound treatment 0.9899 -0.0101 -0.2 -0.197 -1.0 2072871 Maybridge1_006566 FC(F)(F)c1ccc(cc1)C(=O)CSc2nnc(CSCc3cccc4ccccc34)n2c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C11 compound treatment 0.9884 -0.0116 -0.22 -0.2249 -1.0 2072872 Maybridge1_006567 [O-][N+](=O)c1cccc(c1)C(=O)Nc2nnc(SCC(=O)Nc3ccc4OCOc4c3)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C12 compound treatment 0.9705 -0.0295 -0.57 -0.5729 -1.0 2072873 Maybridge1_006568 [O-][N+](=O)c1ccc2oc(cc2c1)C(=O)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C13 compound treatment 0.9977 -0.00226 -0.04 -0.0439 -1.0 2072874 Maybridge1_006569 Cc1nc(cn1Cc2ccc(F)cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C14 compound treatment 0.9533 -0.0467 -0.91 -0.9069 -1.0 2072875 Maybridge1_006570 Clc1ccc(NC(=O)CN2CCCCC2)c(c1)C(=O)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C15 compound treatment 1.02 0.02 0.39 0.3876 1.0 2072876 Maybridge1_006571 COc1ccccc1C2CCN(CC2)S(=O)(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C16 compound treatment 0.9246 -0.0754 -1.46 -1.4637 -1.0 2072877 Maybridge1_006572 FC(F)(F)Oc1ccc(cc1)C(=O)c2cc3cc(Cl)cc(Cl)c3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C17 compound treatment 1.0264 0.0264 0.51 0.5128 1.0 1447824 Maybridge1_006573 COc1ccccc1C2CCN(CC2)S(=O)(=O)c3ccc(F)cc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C18 compound treatment 1.0013 0.00132 0.03 0.0257 1.0 1633199 Maybridge1_006574 Clc1cc(Cl)c2oc(cc2c1)C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C19 compound treatment 1.0178 0.0178 0.35 0.3458 1.0 1019887 Maybridge1_006575 OC1(C(=O)Nc2ccccc21)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C20 compound treatment 0.9727 -0.0273 -0.53 -0.5311 -1.0 2072878 Maybridge1_006576 OS(=O)(=O)c1ccc(Nc2ncnc3cc(Cl)ccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C21 compound treatment 1.0386 0.0386 0.75 0.7495 1.0 2072879 Maybridge1_006577 Cc1cccc(NC(=S)NNC(=O)CSCc2cccc3ccccc23)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C22 compound treatment 0.9583 -0.0417 -0.81 -0.8095 -1.0 1193041 Maybridge1_006578 Cc1ccc(C)n1c2ccc(cc2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C23 mock treatment 0.9877 -0.0123 -0.24 -0.2388 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 C24 mock treatment 1.0185 0.0185 0.36 0.3597 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D01 compound treatment 1.0694 0.0694 1.35 1.348 1.0 1425989 Maybridge1_006579 C1COC2(O1)C3NCC4(CCCCC4)CN3c5ccccc52 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D02 compound treatment 0.9877 -0.0123 -0.24 -0.2388 -1.0 2072880 Maybridge1_006580 CN(C(=O)CSc1nccc(n1)c2sc(nc2C)c3ccc(Cl)cc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D03 compound treatment 1.0501 0.0501 0.97 0.9722 1.0 2072881 Maybridge1_006581 [O-][N+](=O)c1cc(ccc1NCCNC(=O)c2ccccc2F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D04 compound treatment 1.0357 0.0357 0.69 0.6938 1.0 2072882 Maybridge1_006582 COC(=O)/C(=C/c1cc(Br)c(OC(=O)C)c(OC)c1)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D05 compound treatment 0.9712 -0.0288 -0.56 -0.559 -1.0 2072883 Maybridge1_006583 [O-][N+](=O)c1cc(ccc1NCCNC(=S)Nc2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D06 compound treatment 0.9813 -0.0187 -0.36 -0.3641 -1.0 1340853 Maybridge1_006584 Cc1ccc2cc(NC(=O)c3ccc(cc3)C(C)(C)C)ccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D07 compound treatment 1.0336 0.0336 0.65 0.652 1.0 2072884 Maybridge1_006585 Cc1ccc(C)n1c2ccc(cc2)C(=O)NNS(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D08 compound treatment 0.949 -0.051 -0.99 -0.9905 -1.0 2072885 Maybridge1_006586 COC(=O)/C(=C/c1ccc(OC)c(OC)c1Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D09 compound treatment 0.9791 -0.0209 -0.41 -0.4058 -1.0 1483254 Maybridge1_006587 CCCc1ccc(cc1)C(=O)Nc2cccnc2Oc3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D10 compound treatment 0.9684 -0.0316 -0.61 -0.6146 -1.0 1594559 Maybridge1_006588 CCOC(=O)COc1ccc2C(=O)CC(C)(C)Oc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D11 compound treatment 0.9963 -0.0037 -0.07 -0.0718 -1.0 2072886 Maybridge1_006589 COc1ccc(Oc2ncccc2NC(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D12 compound treatment 1.0006 6.05E-4 0.01 0.0117 1.0 2072887 Maybridge1_006590 C1C2C3C4C5C3C6OC5(C(C14)C26)c7ccccc7 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D13 compound treatment 0.982 -0.018 -0.35 -0.3502 -1.0 2072888 Maybridge1_006591 CCCCCCCCCC(=O)n1c2ccc(F)cc2c3nc4ccccc4nc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D14 compound treatment 0.9167 -0.0833 -1.62 -1.6168 -1.0 2072889 Maybridge1_006592 [O-][N+](=O)c1cccc2C(=O)CC(=O)c21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D15 compound treatment 1.0314 0.0314 0.61 0.6103 1.0 2072890 Maybridge1_006593 [O-][N+](=O)c1cc(Cl)c(cc1Sc2ccc(F)cc2Cl)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D16 compound treatment 0.9927 -0.00728 -0.14 -0.1414 -1.0 2072891 Maybridge1_006594 CC(=O)N[C@@H](Cc1ccc(OC(=O)C)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D17 compound treatment 0.9404 -0.0596 -1.16 -1.1575 -1.0 1129476 Maybridge1_006595 Clc1ccc(Sc2ncccc2NC(=O)C(C3CCCC3)c4ccccc4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D18 compound treatment 0.9999 -1.12E-4 0.0 -0.0022 -1.0 1547187 Maybridge1_006596 COc1ccccc1C2CCN(CC2)S(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D19 compound treatment 0.939 -0.061 -1.19 -1.1853 -1.0 2072892 Maybridge1_006597 FC(F)(F)c1cc([nH]c(=O)c1C#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D20 compound treatment 1.0192 0.0192 0.37 0.3737 1.0 1554163 Maybridge1_006598 OC(C(=O)Nc1ccc(Cl)cc1)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D21 compound treatment 1.0135 0.0135 0.26 0.2623 1.0 2072893 Maybridge1_006599 COc1ccc(cc1)C(=O)CN2CCN(CC2)c3cc(C)nc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D22 compound treatment 0.992 -0.008 -0.16 -0.1553 -1.0 2072894 Maybridge1_006600 CC(C)(NO)/C(=N\O)/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D23 mock treatment 0.9827 -0.0173 -0.34 -0.3362 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 D24 mock treatment 0.9676 -0.0324 -0.63 -0.6286 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E01 compound treatment 1.0501 0.0501 0.97 0.9722 1.0 1627375 Maybridge1_006601 CN1C(=O)CN=C(c2ccccc2)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E02 compound treatment 1.0343 0.0343 0.67 0.666 1.0 2072895 Maybridge1_006602 Sc1nnc(CSCc2cccc3ccccc23)n1c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E03 compound treatment 1.0157 0.0157 0.3 0.3041 1.0 2072896 Maybridge1_006603 COc1ccccc1C2CCN(CC2)c3ccc(CO)cc3[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E04 compound treatment 0.9784 -0.0216 -0.42 -0.4198 -1.0 2072897 Maybridge1_006604 Nc1nnc(Sc2cc(c(Cl)cc2[N+](=O)[O-])n3cccc3)[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E05 compound treatment 1.0056 0.00562 0.11 0.1092 1.0 1141662 Maybridge1_006605 COc1ccccc1C2CCN(CC2)C(=O)c3c(C)onc3c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E06 compound treatment 1.0071 0.00706 0.14 0.137 1.0 2072898 Maybridge1_006606 Cc1ccc(OCc2nnc(SCC(=O)Nc3ccc(cc3)C4CCCCC4)n2c5ccccc5)c6CCCc61 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E07 compound treatment 0.992 -0.008 -0.16 -0.1553 -1.0 1914101 Maybridge1_006607 OC(=O)c1ccccc1C(=O)Nc2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E08 compound treatment 0.954 -0.046 -0.89 -0.893 -1.0 2072899 Maybridge1_006608 CCOC(=O)CCSc1cc(c(Cl)cc1[N+](=O)[O-])n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E09 compound treatment 0.9942 -0.00585 -0.11 -0.1135 -1.0 1225998 Maybridge1_006609 Clc1ccc(OC2CN(C2)C(c3ccccc3)c4ccccc4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E10 compound treatment 0.9612 -0.0388 -0.75 -0.7538 -1.0 2072900 Maybridge1_006610 [O-][N+](=O)c1ccc2oc(cc2c1)C(=O)c3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E11 compound treatment 1.0049 0.00491 0.1 0.0953 1.0 1666166 Maybridge1_006611 O=C1N(CCC#N)C2CCCCC2C31OCCO3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E12 compound treatment 0.9526 -0.0474 -0.92 -0.9209 -1.0 2072901 Maybridge1_006612 [O-][N+](=O)c1cc(Cl)c(cc1N2CCOCC2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E13 compound treatment 1.0178 0.0178 0.35 0.3458 1.0 1653130 Maybridge1_006613 COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c3cc(C)no3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E14 compound treatment 0.9691 -0.0309 -0.6 -0.6007 -1.0 2072902 Maybridge1_006614 Clc1ccc(NC(=O)CN2CCOCC2)c(c1)C(=O)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E15 compound treatment 1.0357 0.0357 0.69 0.6938 1.0 1328099 Maybridge1_006615 CCCCc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3ccccc3OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E16 compound treatment 1.0192 0.0192 0.37 0.3737 1.0 2072903 Maybridge1_006616 COc1cc(I)c(OC)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E17 compound treatment 0.9999 -1.12E-4 0.0 -0.0022 -1.0 2072904 Maybridge1_006617 CCCCOc1ccc(cc1)S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E18 compound treatment 0.9906 -0.00943 -0.18 -0.1831 -1.0 1550589 Maybridge1_006618 Cc1ccc(C)c2c(O)ccnc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E19 compound treatment 0.9841 -0.0159 -0.31 -0.3084 -1.0 2072905 Maybridge1_006619 CC(=O)Nc1cccc(OCCCN2C(=O)c3ccccc3C2=O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E20 compound treatment 0.9841 -0.0159 -0.31 -0.3084 -1.0 1437311 Maybridge1_006620 C1CN(C1)C=C(c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E21 compound treatment 0.959 -0.041 -0.8 -0.7956 -1.0 2072906 Maybridge1_006621 FC(F)(F)Oc1ccc(NC(=S)NNC(=O)CSCc2cccc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E22 compound treatment 0.987 -0.013 -0.25 -0.2527 -1.0 2072907 Maybridge1_006622 Clc1ccc2c(=O)[nH]cnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E23 mock treatment 0.9906 -0.00943 -0.18 -0.1831 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 E24 mock treatment 1.0035 0.00347 0.07 0.0674 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F01 compound treatment 1.0092 0.00921 0.18 0.1788 1.0 1196658 Maybridge1_006623 ON=C1CCN(Cc2ccccc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F02 compound treatment 1.0379 0.0379 0.74 0.7356 1.0 2072908 Maybridge1_006624 CCOC(=O)COc1nc(cc(c1C#N)C(F)(F)F)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F03 compound treatment 1.0135 0.0135 0.26 0.2623 1.0 1065469 Maybridge1_006625 Oc1nc(nc2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F04 compound treatment 1.0486 0.0486 0.94 0.9444 1.0 2072909 Maybridge1_006626 CCOC(=O)/C(=C/Nc1cc(C)ccn1)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F05 compound treatment 0.977 -0.023 -0.45 -0.4476 -1.0 2072910 Maybridge1_006627 Cc1onc(c1C(=O)NCCNc2ccc(cc2[N+](=O)[O-])C(F)(F)F)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F06 compound treatment 0.9511 -0.0489 -0.95 -0.9487 -1.0 1642696 Maybridge1_006628 COc1ccc(cc1)C(=O)c2oc3ccc4ccccc4c3c2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F07 compound treatment 0.9827 -0.0173 -0.34 -0.3362 -1.0 2072911 Maybridge1_006629 CCCc1ccc(cc1)S(=O)(=O)NNC(=O)c2ccc(cc2)n3c(C)ccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F08 compound treatment 0.9848 -0.0152 -0.29 -0.2945 -1.0 2072912 Maybridge1_006630 CC(=O)CC1(O)C(=O)Nc2ccc(F)cc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F09 compound treatment 0.9447 -0.0553 -1.07 -1.074 -1.0 2072913 Maybridge1_006631 CC(C)(C)c1ccc(Oc2ncccc2NC(=O)c3ccccc3C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F10 compound treatment 0.9798 -0.0202 -0.39 -0.3919 -1.0 1110972 Maybridge1_006632 C1=CC(=C(c2ccccc2)c3ccccc3)C=C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F11 compound treatment 1.0185 0.0185 0.36 0.3597 1.0 2072914 Maybridge1_006633 CCC(=O)Nc1cc(C)cc(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F12 compound treatment 1.0035 0.00347 0.07 0.0674 1.0 1246126 Maybridge1_006634 NC(=O)CC1(CC2CC3CC(C2)C1)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F13 compound treatment 0.9755 -0.0245 -0.48 -0.4754 -1.0 2072915 Maybridge1_006635 CCCCCC(=O)n1c2ccc(F)cc2c3nc4ccccc4nc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F14 compound treatment 1.0006 6.05E-4 0.01 0.0117 1.0 1441808 Maybridge1_006636 Oc1c(c2ccccc2)c(=O)n3CCCc4cccc1c43 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F15 compound treatment 0.9476 -0.0524 -1.02 -1.0183 -1.0 1565903 Maybridge1_006637 CC(C)(C)OC(=O)C(C)(C)Sc1nc(c(o1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F16 compound treatment 0.9511 -0.0489 -0.95 -0.9487 -1.0 2072916 Maybridge1_006638 CC(C)(C)OC(=O)N[C@@H](CCCNC(=N)N)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F17 compound treatment 1.0192 0.0192 0.37 0.3737 1.0 1378454 Maybridge1_006639 Cc1ccc(Sc2ncccc2n3cccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F18 compound treatment 1.0063 0.00634 0.12 0.1231 1.0 1185730 Maybridge1_006640 O=C1N(CC2(CCC=CC2)C#N)c3ccccc3C41OCCO4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F19 compound treatment 0.964 -0.036 -0.7 -0.6982 -1.0 2072917 Maybridge1_006641 CCOC(=O)CSc1nc2cc(Cl)ccc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F20 compound treatment 0.9633 -0.0367 -0.71 -0.7121 -1.0 2072918 Maybridge1_006642 CNS(=O)(=O)Cc1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F21 compound treatment 0.9734 -0.0266 -0.52 -0.5172 -1.0 2072919 Maybridge1_006643 Cc1[nH]c(=O)c(C#N)c(C)c1CC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F22 compound treatment 0.9397 -0.0603 -1.17 -1.1714 -1.0 2072920 Maybridge1_006644 CC(C)(NO)C(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F23 mock treatment 0.9813 -0.0187 -0.36 -0.3641 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 F24 mock treatment 1.0128 0.0128 0.25 0.2484 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G01 compound treatment 1.0909 0.0909 1.77 1.7656 1.0 1576730 Maybridge1_006645 Nc1nnc(SCC(=O)Nc2ccc3OCOc3c2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G02 compound treatment 0.9934 -0.00656 -0.13 -0.1275 -1.0 1130064 Maybridge1_006646 COc1ccccc1N2CCN(CC(C)N(C(=O)C3CCCCC3)c4ccccn4)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G03 compound treatment 1.0293 0.0293 0.57 0.5685 1.0 2072921 Maybridge1_006647 Clc1cccc(SCc2cccc3ccccc23)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G04 compound treatment 0.9712 -0.0288 -0.56 -0.559 -1.0 2072922 Maybridge1_006648 Cc1ccc(OCc2nnc(S)n2c3ccccc3)c4CCCc41 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G05 compound treatment 0.9999 -1.12E-4 0.0 -0.0022 -1.0 2072923 Maybridge1_006649 COc1ccccc1C2CCN(CC2)C(=O)c3ccccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G06 compound treatment 0.9519 -0.0481 -0.93 -0.9348 -1.0 2072924 Maybridge1_006650 Cc1ccc(OCc2nnc(SCC(=O)Nc3cccc4OCOc43)n2c5ccccc5)c6CCCc61 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G07 compound treatment 1.0035 0.00347 0.07 0.0674 1.0 1072142 Maybridge1_006651 C1COC2(CCC3(CC2)OCCO3)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G08 compound treatment 1.0314 0.0314 0.61 0.6103 1.0 2072925 Maybridge1_006652 Cc1ccc(OCc2nnc(SCC(=O)c3ccc(cc3)[N+](=O)[O-])n2c4ccccc4)c5CCCc51 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G09 compound treatment 1.0013 0.00132 0.03 0.0257 1.0 1059089 Maybridge1_006653 O=C1NNC(C1c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G10 compound treatment 0.9856 -0.0144 -0.28 -0.2806 -1.0 2072926 Maybridge1_006654 [O-][N+](=O)c1cc(Cl)c(cc1N2CCCCC2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G11 compound treatment 1.0443 0.0443 0.86 0.8608 1.0 2072927 Maybridge1_006655 [O-][N+](=O)c1cccc(c1)C(=O)Oc2ccc(Oc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G12 compound treatment 0.9748 -0.0252 -0.49 -0.4894 -1.0 2072928 Maybridge1_006656 [O-][N+](=O)c1cc(Cl)c(cc1N2CCCC2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G13 compound treatment 1.0092 0.00921 0.18 0.1788 1.0 1573326 Maybridge1_006657 COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c3cc(Cl)cc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G14 compound treatment 1.002 0.00204 0.04 0.0396 1.0 1433613 Maybridge1_006658 Brc1ccc(cc1)C(=O)c2cc3cc(Br)cc(Br)c3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G15 compound treatment 1.0372 0.0372 0.72 0.7216 1.0 2072929 Maybridge1_006659 [O-][N+](=O)c1ccc(o1)C2NC(=O)c3c4CCCCc4sc3N2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G16 compound treatment 0.964 -0.036 -0.7 -0.6982 -1.0 2072930 Maybridge1_006660 [O-][N+](=O)c1cccc(c1)c2csc(=Nc3ccccc3)n2c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G17 compound treatment 0.9798 -0.0202 -0.39 -0.3919 -1.0 2072931 Maybridge1_006661 COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c3ccccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G18 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 1731945 Maybridge1_006662 COc1cc(CCC(C)N)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G19 compound treatment 0.9748 -0.0252 -0.49 -0.4894 -1.0 2072932 Maybridge1_006663 CC(C)(C)c1ccc(cc1)C(=O)O/N=C/c2ccc3OCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G20 compound treatment 1.0063 0.00634 0.12 0.1231 1.0 1589048 Maybridge1_006664 CCC(=O)Cc1c(C)[nH]c2ccc(OC)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G21 compound treatment 1.0035 0.00347 0.07 0.0674 1.0 2072933 Maybridge1_006665 COc1ccc(NC(=S)NNC(=O)CSCc2cccc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G22 compound treatment 0.9411 -0.0589 -1.14 -1.1436 -1.0 1004920 Maybridge1_006666 OC(=O)Cc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G23 mock treatment 0.9519 -0.0481 -0.93 -0.9348 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 G24 mock treatment 1.0314 0.0314 0.61 0.6103 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H01 compound treatment 1.0823 0.0823 1.6 1.5986 1.0 1522882 Maybridge1_006667 Cc1ccc(C)n1c2ccc(cc2)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H02 compound treatment 0.9977 -0.00226 -0.04 -0.0439 -1.0 2072934 Maybridge1_006668 COc1ccc(cc1)C(=O)COc2nc(cc(c2C#N)C(F)(F)F)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H03 compound treatment 0.9684 -0.0316 -0.61 -0.6146 -1.0 2072935 Maybridge1_006669 Cc1ccc(cc1)S(=O)(=O)NCCNc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H04 compound treatment 0.9827 -0.0173 -0.34 -0.3362 -1.0 2072936 Maybridge1_006670 CCOC(=O)/C(=C/Nc1ccc2OCOc2c1)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H05 compound treatment 0.977 -0.023 -0.45 -0.4476 -1.0 2072937 Maybridge1_006671 Cc1onc(c1C(=O)NCCNc2ccc(cc2[N+](=O)[O-])C(F)(F)F)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H06 compound treatment 1.0063 0.00634 0.12 0.1231 1.0 2072938 Maybridge1_006672 CC1(C)N=c2ccc(cc2=N1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H07 compound treatment 1.0121 0.0121 0.23 0.2345 1.0 2072939 Maybridge1_006673 Cc1ccc(C)n1c2ccc(cc2)C(=O)NNS(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H08 compound treatment 1.0135 0.0135 0.26 0.2623 1.0 1147764 Maybridge1_006674 COC(=O)c1cccnc1Sc2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H09 compound treatment 0.9942 -0.00585 -0.11 -0.1135 -1.0 1479714 Maybridge1_006675 COc1ccc(cc1OC)C(=O)Nc2cccnc2Oc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H10 compound treatment 0.9992 -8.29E-4 -0.02 -0.0161 -1.0 2072940 Maybridge1_006676 O=C(N/N=C/1\C(=O)Nc2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H11 compound treatment 0.9848 -0.0152 -0.29 -0.2945 -1.0 1528049 Maybridge1_006677 CCC(=O)Nc1cc(OC)cc(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H12 compound treatment 0.9992 -8.29E-4 -0.02 -0.0161 -1.0 2072941 Maybridge1_006678 OC(=O)C1(CC2CC3C1)CC(C2)(C3)c4ccc(cc4)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H13 compound treatment 0.9884 -0.0116 -0.22 -0.2249 -1.0 1468197 Maybridge1_006679 Clc1ccc(Oc2ncccc2NS(=O)(=O)c3ccc(Cl)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H14 compound treatment 0.9856 -0.0144 -0.28 -0.2806 -1.0 1264289 Maybridge1_006680 COc1ccc2c(O)c(Cc3ccccc3)c(=O)[nH]c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H15 compound treatment 0.9712 -0.0288 -0.56 -0.559 -1.0 2072942 Maybridge1_006681 Cc1nc(cn1CC=C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H16 compound treatment 0.9884 -0.0116 -0.22 -0.2249 -1.0 2072943 Maybridge1_006682 N[C@@H](Cc1ccc(cc1)[N+](=O)[O-])C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H17 compound treatment 0.9526 -0.0474 -0.92 -0.9209 -1.0 2072944 Maybridge1_006683 Cc1nc(cn1CC(=O)c2ccccc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H18 compound treatment 1.0085 0.00849 0.16 0.1649 1.0 2072945 Maybridge1_006684 COC(=O)C(C)(N)Cc1c[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H19 compound treatment 0.9906 -0.00943 -0.18 -0.1831 -1.0 2072946 Maybridge1_006685 CN(C(=O)CN1CCN(CC1)c2cc(C)nc3ccccc23)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H20 compound treatment 0.997 -0.00298 -0.06 -0.0579 -1.0 1224541 Maybridge1_006686 O=C1CN=C(c2ccccc2)c3ccccc3N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H21 compound treatment 0.9497 -0.0503 -0.98 -0.9765 -1.0 2072947 Maybridge1_006687 Cc1cc(N2CCN(CC(=O)c3ccccc3)CC2)c4ccccc4n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H22 compound treatment 1.0608 0.0608 1.18 1.181 1.0 1340087 Maybridge1_006688 Cc1cc2c(N)cccc2nn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H23 mock treatment 0.9569 -0.0431 -0.84 -0.8373 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 H24 mock treatment 0.9798 -0.0202 -0.39 -0.3919 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I01 compound treatment 0.9748 -0.0252 -0.49 -0.4894 -1.0 2072948 Maybridge1_006689 Cc1ccc(cc1)S(=O)(=O)Oc2ccc(C)cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I02 compound treatment 1.0085 0.00849 0.16 0.1649 1.0 2072949 Maybridge1_006690 Cc1cnc2CCCC(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I03 compound treatment 1.0135 0.0135 0.26 0.2623 1.0 1290694 Maybridge1_006691 COc1ccccc1C2CCN(CC2)C(=O)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I04 compound treatment 0.9877 -0.0123 -0.24 -0.2388 -1.0 2072950 Maybridge1_006692 COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CN3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I05 compound treatment 1.0142 0.0142 0.28 0.2762 1.0 1611583 Maybridge1_006693 COc1ccccc1C2CCN(CC2)C(=O)c3ccccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I06 compound treatment 1.0078 0.00777 0.15 0.1509 1.0 2072951 Maybridge1_006694 CCc1cc2c(cc1C(=O)CSc3nnc(COc4ccc(C)c5CCCc54)n3c6ccccc6)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I07 compound treatment 0.9684 -0.0316 -0.61 -0.6146 -1.0 2072952 Maybridge1_006695 Fc1ccc(CCc2ccc(F)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I08 compound treatment 1.0035 0.00347 0.07 0.0674 1.0 2072953 Maybridge1_006696 Cc1ccc(OCc2nnc(SCC(=O)c3ccc(F)cc3)n2c4ccccc4)c5CCCc51 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I09 compound treatment 1.0063 0.00634 0.12 0.1231 1.0 1226641 Maybridge1_006697 O=C1CCCc2nc3CCCC(=O)c3cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I10 compound treatment 0.9834 -0.0166 -0.32 -0.3223 -1.0 1616269 Maybridge1_006698 Cc1ccc(C)c2c(O)c(cnc12)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I11 compound treatment 0.9906 -0.00943 -0.18 -0.1831 -1.0 1571873 Maybridge1_006699 COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I12 compound treatment 0.9741 -0.0259 -0.5 -0.5033 -1.0 2072954 Maybridge1_006700 COc1ccc(cc1)C(=O)c2cc3cc(ccc3o2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I13 compound treatment 1.0278 0.0278 0.54 0.5407 1.0 2072955 Maybridge1_006701 Fc1ccc(cc1)C(=O)NNC(=O)CSCc2cccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I14 compound treatment 0.9992 -8.29E-4 -0.02 -0.0161 -1.0 1342049 Maybridge1_006702 Clc1cc(Cl)c2oc(cc2c1)C(=O)c3ccc(Br)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I15 compound treatment 1.0142 0.0142 0.28 0.2762 1.0 2072956 Maybridge1_006703 Cc1nnc(Sc2ccc([N+](=O)[O-])c(Sc3nnc(C)s3)n2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I16 compound treatment 0.9777 -0.0223 -0.43 -0.4337 -1.0 2072957 Maybridge1_006704 [O-][N+](=O)c1cc(Cl)c(cc1SCc2ccc(Cl)cc2Cl)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I17 compound treatment 1.0171 0.0171 0.33 0.3319 1.0 1731945 Maybridge1_006705 COc1cc(CCC(C)N)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I18 compound treatment 0.9382 -0.0618 -1.2 -1.1993 -1.0 2072958 Maybridge1_006706 OC(c1cc2cc(ccc2o1)[N+](=O)[O-])c3ccc(cc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I19 compound treatment 1.0128 0.0128 0.25 0.2484 1.0 1682780 Maybridge1_006707 CCOC(=O)c1c[nH]c2ccccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I20 compound treatment 0.9375 -0.0625 -1.21 -1.2132 -1.0 2072959 Maybridge1_006708 OS(=O)(=O)c1ccc(Nc2ncnc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I21 compound treatment 0.9626 -0.0374 -0.73 -0.726 -1.0 2072960 Maybridge1_006709 CCCCc1ccc(NC(=S)NNC(=O)CSCc2cccc3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I22 compound treatment 0.9942 -0.00585 -0.11 -0.1135 -1.0 1020457 Maybridge1_006710 OC(=O)c1ccccc1C(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I23 mock treatment 1.0228 0.0228 0.44 0.4432 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 I24 mock treatment 0.9841 -0.0159 -0.31 -0.3084 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J01 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 1719291 Maybridge1_006711 COc1cc(Br)cc2cc(C(=O)O)c(=O)oc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J02 compound treatment 1.0149 0.0149 0.29 0.2901 1.0 2072961 Maybridge1_006712 FC(F)(F)c1cc(nc(OCC(=O)c2ccc(Cl)cc2)c1C#N)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J03 compound treatment 1.0028 0.00276 0.05 0.0535 1.0 2072962 Maybridge1_006713 CC(=O)OCc1cc(/C=N/N(C(=O)C)c2ccccc2)nn1c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J04 compound treatment 1.0486 0.0486 0.94 0.9444 1.0 1464724 Maybridge1_006714 COc1ccc(cc1)C(=O)COc2ccc(C)cc2NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J05 compound treatment 1.0307 0.0307 0.6 0.5964 1.0 2072963 Maybridge1_006715 CC(=O)C(=NNc1ccc(C)cc1[N+](=O)[O-])C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J06 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 1626134 Maybridge1_006716 Cc1ccc2cc(NC(=O)c3ccco3)ccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J07 compound treatment 1.0558 0.0558 1.08 1.0835 1.0 2072964 Maybridge1_006717 [O-][N+](=O)c1cc(ccc1NCCNC(=O)c2cccnc2Oc3ccccc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J08 compound treatment 1.0343 0.0343 0.67 0.666 1.0 2072965 Maybridge1_006718 [O-][N+](=O)c1ccc(o1)c2nnc(S)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J09 compound treatment 0.9748 -0.0252 -0.49 -0.4894 -1.0 1362612 Maybridge1_006719 Clc1ccc(Oc2ncccc2NC(=O)c3cccc4ccccc34)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J10 compound treatment 1.0228 0.0228 0.44 0.4432 1.0 2072966 Maybridge1_006720 OC(=O)C1CC1(Cl)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J11 compound treatment 0.9727 -0.0273 -0.53 -0.5311 -1.0 2072967 Maybridge1_006721 Cc1ccc(C)n1c2ccc(cc2)C(=O)NNC(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J12 compound treatment 1.0321 0.0321 0.62 0.6242 1.0 2072968 Maybridge1_006722 OC1(CCN(Cc2ccccc2)CC1)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J13 compound treatment 0.9483 -0.0517 -1.0 -1.0044 -1.0 2072969 Maybridge1_006723 CCCCCc1ccc(cc1)S(=O)(=O)Nc2cccnc2Oc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J14 compound treatment 1.0063 0.00634 0.12 0.1231 1.0 1060930 Maybridge1_006724 CCCC(NC(=O)CN)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J15 compound treatment 0.9992 -8.29E-4 -0.02 -0.0161 -1.0 1319787 Maybridge1_006725 Cc1ccc(C)n1c2cccnc2Sc3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J16 compound treatment 0.9368 -0.0632 -1.23 -1.2271 -1.0 1320822 Maybridge1_006726 Clc1ccc(cc1)C2C(=O)c3ccccc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J17 compound treatment 0.9934 -0.00656 -0.13 -0.1275 -1.0 2072970 Maybridge1_006727 COc1ccc(cc1)C(=O)Cn2cc(nc2C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J18 compound treatment 0.9655 -0.0345 -0.67 -0.6703 -1.0 1369467 Maybridge1_006728 COC(=O)CCC1CC2(CCC1=O)OCCO2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J19 compound treatment 0.9411 -0.0589 -1.14 -1.1436 -1.0 2072971 Maybridge1_006729 CCOC(=O)COc1nc(C)cc(c1C#N)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J20 compound treatment 0.9934 -0.00656 -0.13 -0.1275 -1.0 1331647 Maybridge1_006730 CC1(C)C2CCC1(C)C(C2)NC(=O)c3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J21 compound treatment 0.9476 -0.0524 -1.02 -1.0183 -1.0 2072972 Maybridge1_006731 Nc1nnc(SCCCCOC2CCCCO2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J22 compound treatment 0.997 -0.00298 -0.06 -0.0579 -1.0 2072973 Maybridge1_006732 Cc1cc2-c3nonc3CCc2nn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J23 mock treatment 0.9942 -0.00585 -0.11 -0.1135 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 J24 mock treatment 1.0207 0.0207 0.4 0.4015 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K01 compound treatment 1.0594 0.0594 1.15 1.1531 1.0 2072974 Maybridge1_006733 COc1ccc(OS(=O)(=O)c2ccc(C)cc2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K02 compound treatment 1.0078 0.00777 0.15 0.1509 1.0 1205178 Maybridge1_006734 N#Cc1ccc2[nH]cc(CCN(Cc3ccccc3)Cc4ccccc4)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K03 compound treatment 1.002 0.00204 0.04 0.0396 1.0 1727215 Maybridge1_006735 COc1ccccc1C2CCN(CC2)C(=O)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K04 compound treatment 1.03 0.03 0.58 0.5824 1.0 2072975 Maybridge1_006736 [O-][N+](=O)/C=C/c1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K05 compound treatment 1.0106 0.0106 0.21 0.2066 1.0 2072976 Maybridge1_006737 COC(=O)C1Cc2c([nH]c3ccccc23)C4(CCN(C)CC4)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K06 compound treatment 1.0314 0.0314 0.61 0.6103 1.0 2072977 Maybridge1_006738 Cc1ccc(OCc2nnc(SCC(=O)NCc3ccccc3)n2c4ccccc4)c5CCCc51 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K07 compound treatment 1.0207 0.0207 0.4 0.4015 1.0 2072949 Maybridge1_006739 Cc1cnc2CCCC(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K08 compound treatment 0.982 -0.018 -0.35 -0.3502 -1.0 2072978 Maybridge1_006740 Cc1ccc(OCc2nnc(SCC(=O)c3ccccc3)n2c4ccccc4)c5CCCc51 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K09 compound treatment 1.0207 0.0207 0.4 0.4015 1.0 1702857 Maybridge1_006741 Cc1cccc(NC(=O)c2cccc3ccccc23)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K10 compound treatment 1.0149 0.0149 0.29 0.2901 1.0 2072979 Maybridge1_006742 [O-][N+](=O)c1ccc2oc(cc2c1)C(=O)c3ccc(cc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K11 compound treatment 1.0035 0.00347 0.07 0.0674 1.0 1540037 Maybridge1_006743 COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c3ccccc3Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K12 compound treatment 0.9999 -1.12E-4 0.0 -0.0022 -1.0 2072980 Maybridge1_006744 COc1cc(NC(=O)C)cc(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K13 compound treatment 1.0092 0.00921 0.18 0.1788 1.0 2072981 Maybridge1_006745 COC(=O)C(Cc1c[nH]c2ccccc12)/N=C/c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K14 compound treatment 0.9762 -0.0238 -0.46 -0.4615 -1.0 1427936 Maybridge1_006746 Fc1ccc(cc1)C(=O)c2cc3cc(Cl)cc(Cl)c3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K15 compound treatment 0.9798 -0.0202 -0.39 -0.3919 -1.0 1705365 Maybridge1_006747 CN1CCCC21NCCc3c2[nH]c4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K16 compound treatment 0.9963 -0.0037 -0.07 -0.0718 -1.0 1024400 Maybridge1_006748 COC(=O)C(N)Cc1c[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K17 compound treatment 0.9985 -0.00155 -0.03 -0.03 -1.0 2072982 Maybridge1_006749 O/N=C/1\CCCc2[nH]c3ccccc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K18 compound treatment 0.9734 -0.0266 -0.52 -0.5172 -1.0 2072983 Maybridge1_006750 OC(c1cc2cc(ccc2o1)[N+](=O)[O-])c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K19 compound treatment 0.997 -0.00298 -0.06 -0.0579 -1.0 1554526 Maybridge1_006751 Brc1cnc(nc1)N2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K20 compound treatment 0.9784 -0.0216 -0.42 -0.4198 -1.0 2072984 Maybridge1_006752 Cc1ccc(N/N=C\2/CCCNC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K21 compound treatment 1.0006 6.05E-4 0.01 0.0117 1.0 2072985 Maybridge1_006753 O=C(CSCc1cccc2ccccc12)NNC(=S)NC3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K22 compound treatment 1.0056 0.00562 0.11 0.1092 1.0 1324807 Maybridge1_006754 O=C(C1CCCCC1)N2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K23 mock treatment 0.9992 -8.29E-4 -0.02 -0.0161 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 K24 mock treatment 1.0228 0.0228 0.44 0.4432 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L01 compound treatment 1.0257 0.0257 0.5 0.4989 1.0 1004718 Maybridge1_006755 OC(=O)Cc1c[nH]c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L02 compound treatment 0.9949 -0.00513 -0.1 -0.0996 -1.0 2072986 Maybridge1_006756 COc1ccc(cc1)C(=O)COc2nc(cc(c2C#N)C(F)(F)F)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L03 compound treatment 0.9805 -0.0195 -0.38 -0.378 -1.0 1921262 Maybridge1_006757 O=C(NNC(=O)c1ccccc1)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L04 compound treatment 1.0436 0.0436 0.85 0.8469 1.0 2072987 Maybridge1_006758 COc1ccc(C=C2C(=O)OC(C)(C)OC2=O)c(Cl)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L05 compound treatment 0.9712 -0.0288 -0.56 -0.559 -1.0 2072988 Maybridge1_006759 [O-][N+](=O)c1cc(ccc1NCCNS(=O)(=O)c2ccc3ccccc3c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L06 compound treatment 0.997 -0.00298 -0.06 -0.0579 -1.0 1687379 Maybridge1_006760 Cc1ccc2cc(NC(=O)c3cccs3)ccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L07 compound treatment 0.987 -0.013 -0.25 -0.2527 -1.0 2072989 Maybridge1_006761 CCCc1ccc(cc1)C(=O)NNC(=O)c2ccc(cc2)n3c(C)ccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L08 compound treatment 1.0142 0.0142 0.28 0.2762 1.0 2072990 Maybridge1_006762 Sc1nnc2nc(c3ccccc3)c(nn12)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L09 compound treatment 1.0078 0.00777 0.15 0.1509 1.0 1360230 Maybridge1_006763 CC(C)(C)c1ccc(Oc2ncccc2NC(=O)c3ccco3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L10 compound treatment 1.0364 0.0364 0.71 0.7077 1.0 2072991 Maybridge1_006764 CC(=O)c1ccc(cc1)C2CC2(Cl)Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L11 compound treatment 0.9906 -0.00943 -0.18 -0.1831 -1.0 1505726 Maybridge1_006765 CC(C)(C)OC(=O)C(C)(C)Sc1nnc(N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L12 compound treatment 0.9762 -0.0238 -0.46 -0.4615 -1.0 1005800 Maybridge1_006766 Cc1ccc2cccc(Cl)c2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L13 compound treatment 0.9612 -0.0388 -0.75 -0.7538 -1.0 2072992 Maybridge1_006767 NC(=O)c1ccccc1NC(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L14 compound treatment 0.9992 -8.29E-4 -0.02 -0.0161 -1.0 1050132 Maybridge1_006768 NCC(=O)NC(Cc1ccccc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L15 compound treatment 0.9999 -1.12E-4 0.0 -0.0022 -1.0 1424974 Maybridge1_006769 CCOC(=O)c1ccc2nc(cc(O)c2c1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L16 compound treatment 0.9798 -0.0202 -0.39 -0.3919 -1.0 2072993 Maybridge1_006770 OC1=C(C(=O)c2ccccc12)c3ccc(Br)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L17 compound treatment 0.9827 -0.0173 -0.34 -0.3362 -1.0 1433410 Maybridge1_006771 Cc1cc(N2CCNCC2)c3ccccc3n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L18 compound treatment 0.964 -0.036 -0.7 -0.6982 -1.0 2072994 Maybridge1_006772 CC(Nc1ccccc1)C2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L19 compound treatment 0.9684 -0.0316 -0.61 -0.6146 -1.0 2072995 Maybridge1_006773 COc1cccc(c1)c2nnc(o2)c3ccccc3NC(=O)c4ccc(F)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L20 compound treatment 0.9569 -0.0431 -0.84 -0.8373 -1.0 1406897 Maybridge1_006774 CC(C)(C)c1ccc(cc1)C(=O)NC2CC3CCC2(C)C3(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L21 compound treatment 0.9784 -0.0216 -0.42 -0.4198 -1.0 2072996 Maybridge1_006775 CC(O)c1sc(nc1C)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L22 compound treatment 1.0235 0.0235 0.46 0.4572 1.0 1614912 Maybridge1_006776 C1Cc2nnc(cc2-c3nonc13)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L23 mock treatment 0.9727 -0.0273 -0.53 -0.5311 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 L24 mock treatment 1.0121 0.0121 0.23 0.2345 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M01 compound treatment 1.0608 0.0608 1.18 1.181 1.0 2072997 Maybridge1_006777 COS(=O)(=O)c1ccc2C(=O)CC(C)(C)Oc2c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M02 compound treatment 0.9942 -0.00585 -0.11 -0.1135 -1.0 2072998 Maybridge1_006778 FC(F)(F)Oc1ccc(cc1)n2c(S)nnc2CSCc3cccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M03 compound treatment 1.04 0.04 0.78 0.7773 1.0 1048869 Maybridge1_006779 Cc1cc(OCc2ccccc2)ccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M04 compound treatment 1.149 0.149 2.89 2.8931 1.0 2072999 Maybridge1_006780 CC1=NN(C(=O)C1)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M05 compound treatment 1.0192 0.0192 0.37 0.3737 1.0 2073000 Maybridge1_006781 CCOC(CN(Cc1ccc(OC)c(OS(=O)(=O)c2ccc(C)cc2)c1)S(=O)(=O)c3ccc(C)cc3)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M06 compound treatment 0.9877 -0.0123 -0.24 -0.2388 -1.0 2073001 Maybridge1_006782 Cc1ccc(OCc2nnc(SCC(=O)Nc3cccc(c3)C(F)(F)F)n2c4ccccc4)c5CCCc51 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M07 compound treatment 1.0121 0.0121 0.23 0.2345 1.0 1287839 Maybridge1_006783 CN1C2CCC1CC(=NO)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M08 compound treatment 0.992 -0.008 -0.16 -0.1553 -1.0 2073002 Maybridge1_006784 CSc1nnc(COc2ccc(C)c3CCCc32)n1c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M09 compound treatment 1.0336 0.0336 0.65 0.652 1.0 1652203 Maybridge1_006785 Fc1ccc(CN2CCC(CC2)NC(=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M10 compound treatment 0.9655 -0.0345 -0.67 -0.6703 -1.0 2073003 Maybridge1_006786 [O-][N+](=O)c1ccc2oc(cc2c1)C(=O)c3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M11 compound treatment 1.0407 0.0407 0.79 0.7912 1.0 1134551 Maybridge1_006787 COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c3ccc(OC)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M12 compound treatment 0.977 -0.023 -0.45 -0.4476 -1.0 2073004 Maybridge1_006788 [O-][N+](=O)c1cccc(c1)C(=O)c2cc3cc(Br)cc(Br)c3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M13 compound treatment 0.954 -0.046 -0.89 -0.893 -1.0 2073005 Maybridge1_006789 CC/1(C)C2CC[C@](C)(C2)\C1=N\O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M14 compound treatment 1.0049 0.00491 0.1 0.0953 1.0 1223857 Maybridge1_006790 Clc1ccc(cc1)C(=O)c2cc3cc(Cl)cc(Cl)c3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M15 compound treatment 0.977 -0.023 -0.45 -0.4476 -1.0 1337456 Maybridge1_006791 CC(C)(C)NC(=O)N1CCN(CC1)c2ncnc3scc(c4ccccc4)c23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M16 compound treatment 0.9777 -0.0223 -0.43 -0.4337 -1.0 2073006 Maybridge1_006792 [O-][N+](=O)c1cc(Cl)c(cc1SCc2ccc(Cl)c(Cl)c2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M17 compound treatment 1.0013 0.00132 0.03 0.0257 1.0 1427039 Maybridge1_006793 COc1ccccc1N2CCN(CC2)C(=O)c3ccc(N)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M18 compound treatment 1.0013 0.00132 0.03 0.0257 1.0 2073007 Maybridge1_006794 CCOC(=O)c1ccc(cc1)n2c(C)ccc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M19 compound treatment 0.9899 -0.0101 -0.2 -0.197 -1.0 2073008 Maybridge1_006795 COc1ccccc1C2CCN(CC2)S(=O)(=O)c3ccc(Oc4c(Cl)cccc4[N+](=O)[O-])cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M20 compound treatment 0.964 -0.036 -0.7 -0.6982 -1.0 1248044 Maybridge1_006796 CC(Nc1ccccn1)C(=O)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M21 compound treatment 1.035 0.035 0.68 0.6799 1.0 1364670 Maybridge1_006797 COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M22 compound treatment 0.9597 -0.0403 -0.78 -0.7817 -1.0 1495828 Maybridge1_006798 O=C1N(CCC#N)c2ccccc2C31OCCO3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M23 mock treatment 1.0228 0.0228 0.44 0.4432 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 M24 mock treatment 1.0056 0.00562 0.11 0.1092 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N01 compound treatment 0.9863 -0.0137 -0.27 -0.2666 -1.0 2073009 Maybridge1_006799 CC(=O)c1ccc(Nc2ccnc3cc(Cl)ccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N02 compound treatment 1.0114 0.0114 0.22 0.2205 1.0 2073010 Maybridge1_006800 Cc1c(sc2ccc(Cl)cc12)C(=O)COc3nc(cc(c3C#N)C(F)(F)F)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N03 compound treatment 0.9863 -0.0137 -0.27 -0.2666 -1.0 2073011 Maybridge1_006801 Cc1ccc(C)n1c2ccc(cc2)c3nnc(S)n3c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N04 compound treatment 0.9856 -0.0144 -0.28 -0.2806 -1.0 1218710 Maybridge1_006802 Cc1c(oc2ccc3ccccc3c12)C(=O)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N05 compound treatment 0.9906 -0.00943 -0.18 -0.1831 -1.0 2073012 Maybridge1_006803 CC(=O)Nc1ccc(cc1)S(=O)(=O)NCCNc2ccc(cc2[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N06 compound treatment 1.0264 0.0264 0.51 0.5128 1.0 1505499 Maybridge1_006804 OC(=O)c1cc2c(Cl)cc(Cl)cc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N07 compound treatment 1.0149 0.0149 0.29 0.2901 1.0 1384754 Maybridge1_006805 CCCc1ccc(cc1)C(=O)Nc2cccnc2Oc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N08 compound treatment 0.9999 -1.12E-4 0.0 -0.0022 -1.0 2073013 Maybridge1_006806 CCSC(SCC)[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)CO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N09 compound treatment 1.0171 0.0171 0.33 0.3319 1.0 1138325 Maybridge1_006807 CCCc1ccc(cc1)C(=O)Nc2cccnc2Oc3ccc(OC)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N10 compound treatment 0.992 -0.008 -0.16 -0.1553 -1.0 1187040 Maybridge1_006808 C(c1nc2ccccc2s1)c3nc4ccccc4s3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N11 compound treatment 1.0092 0.00921 0.18 0.1788 1.0 1051542 Maybridge1_006809 CC1(CC2CC1C=C2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N12 compound treatment 0.964 -0.036 -0.7 -0.6982 -1.0 864479 Maybridge1_006810 COc1cc(CC(N)C(=O)O)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N13 compound treatment 1.03 0.03 0.58 0.5824 1.0 1194173 Maybridge1_006811 CC(C)(C)c1ccc(Oc2ncccc2NC(=O)c3cccc4ccccc34)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N14 compound treatment 0.9727 -0.0273 -0.53 -0.5311 -1.0 2073014 Maybridge1_006812 NCC(=O)NCC(=O)NCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N15 compound treatment 0.9956 -0.00441 -0.09 -0.0857 -1.0 2073015 Maybridge1_006813 [O-][N+](=O)c1cc(Cl)c(cc1Sc2nc(c(o2)c3ccccc3)c4ccccc4)n5cccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N16 compound treatment 1.0558 0.0558 1.08 1.0835 1.0 2073016 Maybridge1_006814 OC1=C(C(=O)c2ccccc12)c3ccc(cc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N17 compound treatment 0.9139 -0.0861 -1.67 -1.6725 -1.0 1375532 Maybridge1_006815 Nn1c(cc(c(C#N)c1=O)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N18 compound treatment 1.002 0.00204 0.04 0.0396 1.0 1477161 Maybridge1_006816 COc1ccccc1N2CCN(CC2)C(=O)C(C)Nc3ccccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N19 compound treatment 0.982 -0.018 -0.35 -0.3502 -1.0 2073017 Maybridge1_006817 Fc1ccc(cc1)C(=O)Nc2ccccc2c3nnc(o3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N20 compound treatment 1.0049 0.00491 0.1 0.0953 1.0 1368775 Maybridge1_006818 CC1(C)C2CCC1(C)C(C2)NC(=O)C3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N21 compound treatment 0.9755 -0.0245 -0.48 -0.4754 -1.0 1177559 Maybridge1_006819 CCN(CC)c1ccc2cc(C(=O)O)c(=O)oc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N22 compound treatment 0.9963 -0.0037 -0.07 -0.0718 -1.0 2073018 Maybridge1_006820 Cc1cc(cnn1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N23 mock treatment 0.9813 -0.0187 -0.36 -0.3641 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 N24 mock treatment 1.0207 0.0207 0.4 0.4015 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O01 compound treatment 1.0235 0.0235 0.46 0.4572 1.0 1664938 Maybridge1_006821 Cc1c(OCC(=O)Nc2ccc(Cl)cc2C(=O)c3ccccc3Cl)ccc4C(=O)CC(C)(C)Oc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O02 compound treatment 0.9583 -0.0417 -0.81 -0.8095 -1.0 1466695 Maybridge1_006822 O=C(Cc1ccccc1)N2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O03 compound treatment 1.0594 0.0594 1.15 1.1531 1.0 1641395 Maybridge1_006823 COc1cc(ccc1O)C(=O)c2cc(Cl)ccc2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O04 compound treatment 0.9956 -0.00441 -0.09 -0.0857 -1.0 2073019 Maybridge1_006824 CCc1ccc(NC(=O)/C=C/c2ccc(N3CCC(CC3)c4ccccc4OC)c(c2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O05 compound treatment 0.9597 -0.0403 -0.78 -0.7817 -1.0 2073020 Maybridge1_006825 [O-][N+](=O)c1cc(Cl)ccc1NCNc2ccc(Cl)cc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O06 compound treatment 0.9784 -0.0216 -0.42 -0.4198 -1.0 2073021 Maybridge1_006826 CCOC(=O)CSc1cc(c(Cl)cc1[N+](=O)[O-])n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O07 compound treatment 1.0028 0.00276 0.05 0.0535 1.0 2073022 Maybridge1_006827 OC(=O)C1=CN(C2CCCCC2)c3ccccc3C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O08 compound treatment 1.0142 0.0142 0.28 0.2762 1.0 2073023 Maybridge1_006828 Cc1ccc(Oc2ccc(cc2[N+](=O)[O-])C(F)(F)F)c3CCCc31 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O09 compound treatment 0.9841 -0.0159 -0.31 -0.3084 -1.0 2073024 Maybridge1_006829 COC(=O)C1Cc2c([nH]c3ccccc23)C4(CCN(Cc5ccccc5)CC4)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O10 compound treatment 0.9877 -0.0123 -0.24 -0.2388 -1.0 2073025 Maybridge1_006830 Cc1ccc(OCc2nnc(SCc3c(F)cccc3Cl)n2c4ccccc4)c5CCCc51 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O11 compound treatment 0.9813 -0.0187 -0.36 -0.3641 -1.0 1454277 Maybridge1_006831 COc1ccccc1C2CCN(CC2)S(=O)(=O)c3cccc(Br)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O12 compound treatment 1.0056 0.00562 0.11 0.1092 1.0 1385820 Maybridge1_006832 Fc1ccc(cc1)C(=O)c2cc3cc(Br)cc(Br)c3o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O13 compound treatment 1.0085 0.00849 0.16 0.1649 1.0 2073026 Maybridge1_006833 O/N=C/c1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O14 compound treatment 0.987 -0.013 -0.25 -0.2527 -1.0 1675089 Maybridge1_006834 Cc1cc(Br)c(OCC(=O)NN)c2CCCc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O15 compound treatment 1.0085 0.00849 0.16 0.1649 1.0 1565927 Maybridge1_006835 CC(C)(C)c1ccc(cc1)N2C(=O)c3cc(Cl)c(Cl)cc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O16 compound treatment 1.0264 0.0264 0.51 0.5128 1.0 2073027 Maybridge1_006836 CN(C)/C(=C\1/N=C(OC1=O)c2ccccc2)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O17 compound treatment 1.0042 0.00419 0.08 0.0813 1.0 1255675 Maybridge1_006837 O=C(NC1CCN(Cc2c[nH]c3ccccc23)CC1)C4CCCCC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O18 compound treatment 0.9992 -8.29E-4 -0.02 -0.0161 -1.0 2073028 Maybridge1_006838 Cc1ccc(cc1)S(=O)(=O)Nc2cc(ccc2Oc3ccc(C)c4CCCc43)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O19 compound treatment 1.0128 0.0128 0.25 0.2484 1.0 2073029 Maybridge1_006839 O=C(CSCc1cccc2ccccc12)NNC(=S)Nc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O20 compound treatment 0.9562 -0.0438 -0.85 -0.8513 -1.0 1028002 Maybridge1_006840 OCCCN1C(=O)c2ccccc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O21 compound treatment 0.9576 -0.0424 -0.82 -0.8234 -1.0 1259711 Maybridge1_006841 COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c3cncc(Br)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O22 compound treatment 0.9483 -0.0517 -1.0 -1.0044 -1.0 1036029 Maybridge1_006842 OC(=O)CCC(=O)Nc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O23 mock treatment 0.987 -0.013 -0.25 -0.2527 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 O24 mock treatment 1.0393 0.0393 0.76 0.7634 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P01 compound treatment 1.002 0.00204 0.04 0.0396 1.0 2073030 Maybridge1_006843 Cc1cc(C)c(C(=O)NCCNc2ccc(cc2[N+](=O)[O-])C(F)(F)F)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P02 compound treatment 1.0171 0.0171 0.33 0.3319 1.0 2073031 Maybridge1_006844 O=C(CC(=O)c1ccccn1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P03 compound treatment 0.9913 -0.00871 -0.17 -0.1692 -1.0 1673412 Maybridge1_006845 Brc1ccc2OC(=O)C(Cc2c1)C(=O)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P04 compound treatment 0.992 -0.008 -0.16 -0.1553 -1.0 1143576 Maybridge1_006846 Cc1ccc2cc(NC(=O)c3ccccc3)ccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P05 compound treatment 0.9669 -0.0331 -0.64 -0.6425 -1.0 2073032 Maybridge1_006847 COc1ccc(cc1)S(=O)(=O)NNC(=O)c2ccc(cc2)n3c(C)ccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P06 compound treatment 1.0286 0.0286 0.55 0.5546 1.0 1150448 Maybridge1_006848 CCc1ccc(cc1)C(=O)Nc2ccc3nc(C)ccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P07 compound treatment 1.0336 0.0336 0.65 0.652 1.0 2073033 Maybridge1_006849 COc1ccc(cc1OC)C(=O)NNC(=O)c2ccc(cc2)n3c(C)ccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P08 compound treatment 1.04 0.04 0.78 0.7773 1.0 2073034 Maybridge1_006850 CC(=O)OC[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P09 compound treatment 1.0013 0.00132 0.03 0.0257 1.0 1405837 Maybridge1_006851 COc1ccc(Oc2ncccc2NS(=O)(=O)c3ccc(OC)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P10 compound treatment 0.9942 -0.00585 -0.11 -0.1135 -1.0 2073035 Maybridge1_006852 CC(=NNC(=N)NC(=S)Nc1ccccc1)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P11 compound treatment 0.9698 -0.0302 -0.59 -0.5868 -1.0 1637974 Maybridge1_006853 Cc1ccc(C)n1c2ccc(cc2)C(=O)ON3C(=O)CCC3=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P12 compound treatment 1.0099 0.00992 0.19 0.1927 1.0 2073036 Maybridge1_006854 CCCCCCCc1c(O)c2ccccc2[nH]c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P13 compound treatment 0.9848 -0.0152 -0.29 -0.2945 -1.0 2073037 Maybridge1_006855 Cc1cc(Oc2ccccc2)ccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P14 compound treatment 1.0257 0.0257 0.5 0.4989 1.0 1050525 Maybridge1_006856 CCCC(NC(=O)C(C)N)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P15 compound treatment 0.9942 -0.00585 -0.11 -0.1135 -1.0 1044269 Maybridge1_006857 Cc1nc(O)c([N+](=O)[O-])c(O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P16 compound treatment 0.9827 -0.0173 -0.34 -0.3362 -1.0 1926183 Maybridge1_006858 O=C1C(C(=O)c2ccccc12)c3cccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P17 compound treatment 0.9648 -0.0352 -0.68 -0.6842 -1.0 2073038 Maybridge1_006859 Cc1cc(c(C#N)c(=O)[nH]1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P18 compound treatment 0.9813 -0.0187 -0.36 -0.3641 -1.0 1464027 Maybridge1_006860 OC(=O)c1cn(C2CCCCC2)c3ccccc3c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P19 compound treatment 1.0221 0.0221 0.43 0.4293 1.0 2073039 Maybridge1_006861 O=C(CC#N)NNC(=S)NCC1CCCO1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P20 compound treatment 1.0028 0.00276 0.05 0.0535 1.0 2073040 Maybridge1_006862 CC/1(C)C2CC[C@](C)(C2)\C1=N\OC(=O)c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P21 compound treatment 0.9777 -0.0223 -0.43 -0.4337 -1.0 1165383 Maybridge1_006863 Cc1cc(N2CCN(CC2)c3nc4cc(Cl)ccc4s3)c5ccccc5n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P22 compound treatment 1.0028 0.00276 0.05 0.0535 1.0 2073041 Maybridge1_006864 NNC(=O)[C@H]1C[C@H]1C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P23 mock treatment 1.0407 0.0407 0.79 0.7912 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.560 P24 mock treatment 1.0085 0.00849 0.16 0.1649 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A01 compound treatment 1.0569 0.0569 1.11 1.1057 1.0 2073042 Maybridge1_006865 Cc1cc(C)nc(SC(=O)OC(C)(C)C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A02 compound treatment 1.0195 0.0195 0.38 0.3796 1.0 2073043 Maybridge1_006866 Cc1nc(SCc2c(F)cccc2Cl)nc(O)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A03 compound treatment 1.0814 0.0814 1.58 1.5804 1.0 1208677 Maybridge1_006867 OC(=O)CNC(=O)c1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A04 compound treatment 0.9728 -0.0272 -0.53 -0.528 -1.0 2073044 Maybridge1_006868 Clc1cc(Cl)cc(NC(=S)NCc2cccs2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A05 compound treatment 1.0188 0.0188 0.37 0.3657 1.0 2073045 Maybridge1_006869 CC(=O)c1c(C)n(O)c2ccc3nonc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A06 compound treatment 0.9728 -0.0272 -0.53 -0.528 -1.0 2073046 Maybridge1_006870 COCc1cc(O)nc(S)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A07 compound treatment 1.0311 0.0311 0.6 0.603 1.0 1520977 Maybridge1_006871 CC(C)(C)c1ccc(cc1)C(=O)N2CCC(CC2)NC(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A08 compound treatment 0.9872 -0.0128 -0.25 -0.2487 -1.0 2073047 Maybridge1_006872 Cc1cc(Br)ccc1Nc2ncnc(N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A09 compound treatment 1.0001 1.35E-4 0.0 0.0026 1.0 1307029 Maybridge1_006873 COc1ccccc1CC(=O)NC2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A10 compound treatment 0.9843 -0.0157 -0.3 -0.3046 -1.0 2073048 Maybridge1_006874 Clc1cccc(NC(=S)NNC(=O)C2CC2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A11 compound treatment 1.0318 0.0318 0.62 0.617 1.0 2073049 Maybridge1_006875 COc1ccc(CCNS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A12 compound treatment 1.0001 1.35E-4 0.0 0.0026 1.0 2073050 Maybridge1_006876 COCc1cc(O)nc(NC(=N)Nc2ccc(Cl)c(Cl)c2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A13 compound treatment 1.0469 0.0469 0.91 0.9102 1.0 1130829 Maybridge1_006877 Clc1cccc(c1Cl)S(=O)(=O)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A14 compound treatment 1.039 0.039 0.76 0.7566 1.0 1698799 Maybridge1_006878 OC(=O)CCNC(=S)Nc1ccc(F)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A15 compound treatment 1.0066 0.00661 0.13 0.1283 1.0 1523035 Maybridge1_006879 CC1(C)C2CCC1(C)C(C2)(Nc3ccccc3)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A16 compound treatment 0.9541 -0.0459 -0.89 -0.891 -1.0 1525521 Maybridge1_006880 Cc1nc(N)nc(O)c1Cc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A17 compound treatment 0.9743 -0.0257 -0.5 -0.5 -1.0 2073051 Maybridge1_006881 C/C(=C\c1ccccc1[N+](=O)[O-])/c2cc3ccccc3c4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A18 compound treatment 1.0044 0.00445 0.09 0.0864 1.0 2073052 Maybridge1_006882 CSc1nc(C)c(CC(=C)C)c(O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A19 compound treatment 0.9678 -0.0322 -0.63 -0.6257 -1.0 2073053 Maybridge1_006883 N#CCc1nc(cs1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A20 compound treatment 0.9793 -0.0207 -0.4 -0.4023 -1.0 2073054 Maybridge1_006884 CSC(=N)NC(=S)Nc1cccc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A21 compound treatment 1.0109 0.0109 0.21 0.2121 1.0 1067983 Maybridge1_006885 Oc1ccc2c(cc(=O)oc2c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A22 compound treatment 0.985 -0.015 -0.29 -0.2906 -1.0 2073055 Maybridge1_006886 CC(C)(C)/N=C(\NN)/NCC1CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A23 mock treatment 1.0289 0.0289 0.56 0.5611 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 A24 mock treatment 1.008 0.00804 0.16 0.1562 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B01 compound treatment 1.0648 0.0648 1.26 1.2593 1.0 2073056 Maybridge1_006887 CC(C)(C)C(=O)Cn1nnc(n1)c2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B02 compound treatment 1.0361 0.0361 0.7 0.7008 1.0 1076487 Maybridge1_006888 COc1ccc(CCN2CSC(=S)N(CCc3ccc(OC)c(OC)c3)C2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B03 compound treatment 0.9973 -0.00274 -0.05 -0.0532 -1.0 2073057 Maybridge1_006889 NNC(=O)Cn1nnc(n1)c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B04 compound treatment 0.9973 -0.00274 -0.05 -0.0532 -1.0 1080223 Maybridge1_006890 CCOC(=O)c1ccc(NC(=S)NC(=O)c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B05 compound treatment 0.9973 -0.00274 -0.05 -0.0532 -1.0 1668302 Maybridge1_006891 CCCc1cc(=O)oc2cc(OCC(=O)NN)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B06 compound treatment 1.0275 0.0275 0.53 0.5332 1.0 2073058 Maybridge1_006892 Cc1cc(C)c(NC(=O)CC2SC(=N)NC2=O)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B07 compound treatment 1.0109 0.0109 0.21 0.2121 1.0 1364298 Maybridge1_006893 COCc1cc(=O)oc2cc(O)c(Cl)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B08 compound treatment 1.0728 0.0728 1.41 1.4129 1.0 2073059 Maybridge1_006894 CCO/C=C/1\SC(=S)N(CCc2ccccc2)C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B09 compound treatment 1.0354 0.0354 0.69 0.6868 1.0 2073060 Maybridge1_006895 NNC(=S)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B10 compound treatment 0.9814 -0.0186 -0.36 -0.3604 -1.0 2073061 Maybridge1_006896 [O-][N+](=O)/C=C/c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B11 compound treatment 0.9764 -0.0236 -0.46 -0.4582 -1.0 2073062 Maybridge1_006897 Sc1nc2ccccc2[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B12 compound treatment 0.962 -0.038 -0.74 -0.7374 -1.0 1275541 Maybridge1_006898 CC(N1CSC(=S)N(C1)C(C)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B13 compound treatment 0.9771 -0.0229 -0.44 -0.4442 -1.0 2073063 Maybridge1_006899 Cc1cccc(Cl)c1NC(=S)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B14 compound treatment 0.9778 -0.0222 -0.43 -0.4302 -1.0 2073064 Maybridge1_006900 Clc1ccc(/N=C\2/NCCS2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B15 compound treatment 1.0195 0.0195 0.38 0.3796 1.0 2073065 Maybridge1_006901 N/C(=N\O)/Cc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B16 compound treatment 1.021 0.021 0.41 0.4075 1.0 1683503 Maybridge1_006902 CCc1ccccc1Nc2nnc(S)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B17 compound treatment 1.0088 0.00876 0.17 0.1702 1.0 2073066 Maybridge1_006903 Cc1ccc(/C=C/[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B18 compound treatment 0.9908 -0.00921 -0.18 -0.1789 -1.0 1671035 Maybridge1_006904 Cc1cccc(NCN2C(=O)c3ccccc3C2=O)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B19 compound treatment 4.8698 3.87 75.15 75.1514 1.0 2073067 Maybridge1_006905 CCN(CC)c1ccc(/C=C/2\N=C(OC2=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B20 compound treatment 0.9721 -0.0279 -0.54 -0.5419 -1.0 2073068 Maybridge1_006906 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccc(Cl)cn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B21 compound treatment 0.9735 -0.0265 -0.51 -0.514 -1.0 1074249 Maybridge1_006907 CC1CCN(CC1)c2ccc(cc2[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B22 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 2073069 Maybridge1_006908 [O-][N+](=O)/C=C/c1ccccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B23 mock treatment 1.0138 0.0138 0.27 0.2679 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 B24 mock treatment 1.0095 0.00948 0.18 0.1841 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C01 compound treatment 1.0763 0.0763 1.48 1.4827 1.0 1464302 Maybridge1_006909 CC(NCc1ccccc1)C2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C02 compound treatment 1.0404 0.0404 0.78 0.7845 1.0 2073070 Maybridge1_006910 C1CCN(CC1)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C03 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 2073071 Maybridge1_006911 CC(C)(C)c1cc([N+](=O)[O-])c2cc(cc([N+](=O)[O-])c2c1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C04 compound treatment 0.9879 -0.0121 -0.23 -0.2348 -1.0 1313220 Maybridge1_006912 Cc1cc(Nc2ccc(F)c(Cl)c2)nc(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C05 compound treatment 1.008 0.00804 0.16 0.1562 1.0 1497623 Maybridge1_006913 CCOC(=O)c1c(C)n(OC)c2ccc3nonc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C06 compound treatment 0.9994 -5.84E-4 -0.01 -0.0113 -1.0 2073072 Maybridge1_006914 COCc1cc(O)nc(SC)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C07 compound treatment 1.0404 0.0404 0.78 0.7845 1.0 1260724 Maybridge1_006915 Clc1ccc(cc1)C(=O)N2CCC(CC2)NC(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C08 compound treatment 0.9987 -0.0013 -0.03 -0.0253 -1.0 1030238 Maybridge1_006916 NC(=N)NC(=N)Nc1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C09 compound treatment 0.9879 -0.0121 -0.23 -0.2348 -1.0 1394196 Maybridge1_006917 O=C(NC1CCN(Cc2ccccc2)CC1)c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C10 compound treatment 1.0016 0.00157 0.03 0.0305 1.0 1117027 Maybridge1_006918 NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C11 compound treatment 0.9814 -0.0186 -0.36 -0.3604 -1.0 1778921 Maybridge1_006919 [O-][N+](=O)c1ccc(cc1)C(=O)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C12 compound treatment 0.9872 -0.0128 -0.25 -0.2487 -1.0 2073073 Maybridge1_006920 NC(=N)NC(=N)Nc1ccccc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C13 compound treatment 1.0296 0.0296 0.58 0.5751 1.0 1216085 Maybridge1_006921 O=C(Cc1ccccc1)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C14 compound treatment 0.9879 -0.0121 -0.23 -0.2348 -1.0 1324187 Maybridge1_006922 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(F)cc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C15 compound treatment 1.0354 0.0354 0.69 0.6868 1.0 2073074 Maybridge1_006923 COC(=O)C1C(=O)CC(=O)CC1(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C16 compound treatment 0.9606 -0.0394 -0.77 -0.7653 -1.0 2073075 Maybridge1_006924 NC(=N)NC(=N)Nc1ccc2OCCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C17 compound treatment 0.952 -0.048 -0.93 -0.9329 -1.0 2073076 Maybridge1_006925 CC(=O)[C@@H]1[C@H]([C@H](C(=O)C)[C@](C)(O)CC1=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C18 compound treatment 1.0152 0.0152 0.3 0.2958 1.0 1617897 Maybridge1_006926 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2cc(C)on2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C19 compound treatment 0.9951 -0.0049 -0.1 -0.0951 -1.0 1006315 Maybridge1_006927 OC(=O)C(c1ccccc1)(c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C20 compound treatment 0.9599 -0.0401 -0.78 -0.7793 -1.0 2073077 Maybridge1_006928 FC(F)(F)c1ccccc1c2nnn[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C21 compound treatment 0.9764 -0.0236 -0.46 -0.4582 -1.0 2073078 Maybridge1_006929 NC(=N)NC(=N)Nc1ccc(F)cc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C22 compound treatment 0.9793 -0.0207 -0.4 -0.4023 -1.0 2073079 Maybridge1_006930 S=C(NCC1CC1)NCC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C23 mock treatment 0.9707 -0.0293 -0.57 -0.5699 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 C24 mock treatment 1.0088 0.00876 0.17 0.1702 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D01 compound treatment 1.0346 0.0346 0.67 0.6728 1.0 1361400 Maybridge1_006931 Nc1ncnc(Nc2cccc(C#N)c2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D02 compound treatment 1.0548 0.0548 1.06 1.0638 1.0 1076055 Maybridge1_006932 CCOc1ccc(C=C(C#N)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D03 compound treatment 1.0275 0.0275 0.53 0.5332 1.0 2073080 Maybridge1_006933 CCCc1cc(O)nc(SCc2c(Cl)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D04 compound treatment 1.0116 0.0116 0.23 0.226 1.0 2073081 Maybridge1_006934 COc1ccc(CCN2C(=O)/C(=C/c3c(F)c(F)c(F)c(F)c3F)/SC2=S)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D05 compound treatment 0.9563 -0.0437 -0.85 -0.8491 -1.0 2073082 Maybridge1_006935 CCCc1cc(O)nc(NC(=N)Nc2cc(Cl)cc(Cl)c2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D06 compound treatment 0.9973 -0.00274 -0.05 -0.0532 -1.0 1351539 Maybridge1_006936 O=C1Nc2ccccc2C1(C3C(=O)NC(=O)NC3=O)C4C(=O)NC(=O)NC4=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D07 compound treatment 0.9656 -0.0344 -0.67 -0.6676 -1.0 2073083 Maybridge1_006937 Clc1cccc(c2nnn[nH]2)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D08 compound treatment 0.9987 -0.0013 -0.03 -0.0253 -1.0 2073084 Maybridge1_006938 Clc1cccc(Cl)c1NC(=S)NC(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D09 compound treatment 0.975 -0.025 -0.49 -0.4861 -1.0 1603314 Maybridge1_006939 Fc1ccc(NC(=S)NC2CCCCCCCCCCC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D10 compound treatment 1.0023 0.00229 0.04 0.0445 1.0 1023877 Maybridge1_006940 CC(C)C(NS(=O)(=O)c1ccc(C)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D11 compound treatment 0.9735 -0.0265 -0.51 -0.514 -1.0 2073085 Maybridge1_006941 Fc1ccccc1Nc2nnc(S)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D12 compound treatment 0.9951 -0.0049 -0.1 -0.0951 -1.0 2073086 Maybridge1_006942 NNC(=S)NCCCN1CCOCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D13 compound treatment 0.998 -0.00202 -0.04 -0.0393 -1.0 1065962 Maybridge1_006943 NNC(=S)Nc1cccc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D14 compound treatment 0.9901 -0.00993 -0.19 -0.1929 -1.0 2073087 Maybridge1_006944 Clc1cccc(NC2=NCCS2)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D15 compound treatment 0.9807 -0.0193 -0.37 -0.3744 -1.0 1014454 Maybridge1_006945 O=c1oc(nc2ccccc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D16 compound treatment 1.0073 0.00732 0.14 0.1422 1.0 2073088 Maybridge1_006946 CCOc1ccc(/C=C(\C)/[N+](=O)[O-])cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D17 compound treatment 0.9656 -0.0344 -0.67 -0.6676 -1.0 1037879 Maybridge1_006947 NC(=N)SCc1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D18 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 2073089 Maybridge1_006948 CSc1cccc(NC(=S)NCc2cccnc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D19 compound treatment 0.9908 -0.00921 -0.18 -0.1789 -1.0 2073090 Maybridge1_006949 CCN(CC)c1ccc(/C=N/N=C/c2ccc(cc2)N(CC)CC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D20 compound treatment 0.9671 -0.0329 -0.64 -0.6397 -1.0 2073091 Maybridge1_006950 Oc1ccccc1/C=N/c2ccc(Cl)cn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D21 compound treatment 0.98 -0.02 -0.39 -0.3883 -1.0 1039360 Maybridge1_006951 CN(C)C(=S)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D22 compound treatment 0.9951 -0.0049 -0.1 -0.0951 -1.0 2073092 Maybridge1_006952 CC(=O)Nc1ccc(cc1)C2=N/C(=C\c3cccs3)/C(=O)O2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D23 mock treatment 0.9584 -0.0416 -0.81 -0.8072 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 D24 mock treatment 0.998 -0.00202 -0.04 -0.0393 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E01 compound treatment 1.0346 0.0346 0.67 0.6728 1.0 1005170 Maybridge1_006953 OC(=O)C(c1ccc(Cl)cc1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E02 compound treatment 1.0224 0.0224 0.44 0.4355 1.0 1402665 Maybridge1_006954 Clc1ccc(cc1)C(=O)Cn2nnc(n2)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E03 compound treatment 0.9944 -0.00562 -0.11 -0.1091 -1.0 1077391 Maybridge1_006955 COc1cc(CC#N)c(OC)cc1CC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E04 compound treatment 0.9592 -0.0408 -0.79 -0.7933 -1.0 1322296 Maybridge1_006956 Cc1cc(Nc2ccc(F)cc2F)nc(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E05 compound treatment 0.9721 -0.0279 -0.54 -0.5419 -1.0 2073093 Maybridge1_006957 CCCCCCCCCCCCC/1CCCC\C1=N\O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E06 compound treatment 1.0275 0.0275 0.53 0.5332 1.0 1256576 Maybridge1_006958 Cc1cc(C)c(N=c2oc(cs2)C(C)(C)C)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E07 compound treatment 1.0188 0.0188 0.37 0.3657 1.0 1456979 Maybridge1_006959 Brc1ccccc1C(=O)N2CCC(CC2)NC(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E08 compound treatment 1.003 0.00301 0.06 0.0585 1.0 2073094 Maybridge1_006960 NC(=N)NC(=N)Nc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E09 compound treatment 1.0311 0.0311 0.6 0.603 1.0 1736885 Maybridge1_006961 Clc1ccc(cc1)S(=O)(=O)NC2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E10 compound treatment 0.9886 -0.0114 -0.22 -0.2208 -1.0 2073095 Maybridge1_006962 NC(=N)NC(=N)Nc1ccc(I)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E11 compound treatment 1.0217 0.0217 0.42 0.4215 1.0 1670579 Maybridge1_006963 Clc1ccc(cc1)S(=O)(=O)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E12 compound treatment 0.998 -0.00202 -0.04 -0.0393 -1.0 2073096 Maybridge1_006964 COCc1cc(O)nc(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E13 compound treatment 0.9793 -0.0207 -0.4 -0.4023 -1.0 2073097 Maybridge1_006965 CC(C)(C)NS(=O)(=O)NC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E14 compound treatment 0.9937 -0.00634 -0.12 -0.123 -1.0 2073098 Maybridge1_006966 OC(=O)CCNC(=S)Nc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E15 compound treatment 0.9498 -0.0502 -0.97 -0.9748 -1.0 2073099 Maybridge1_006967 S(c1c(nc2sccn12)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E16 compound treatment 0.9649 -0.0351 -0.68 -0.6816 -1.0 2073100 Maybridge1_006968 FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E17 compound treatment 0.9879 -0.0121 -0.23 -0.2348 -1.0 2073101 Maybridge1_006969 O=C1c2ccccc2-c3ccc4ccccc4c13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E18 compound treatment 0.9915 -0.00849 -0.16 -0.1649 -1.0 2073102 Maybridge1_006970 Cc1cc(NC(=N)NC(=N)N)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E19 compound treatment 0.975 -0.025 -0.49 -0.4861 -1.0 2073103 Maybridge1_006971 CC(=O)OC[C@H](OC(=O)C)[C@H](OC(=O)C)[C@@H](CNC(=O)c1ccc(C)c(C)c1)OC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E20 compound treatment 0.9901 -0.00993 -0.19 -0.1929 -1.0 2073104 Maybridge1_006972 CCOC(=N)c1ccc(C)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E21 compound treatment 0.9872 -0.0128 -0.25 -0.2487 -1.0 2073105 Maybridge1_006973 NC(=N)NC(=N)Nc1ccc(F)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E22 compound treatment 0.9441 -0.0559 -1.09 -1.0865 -1.0 2073106 Maybridge1_006974 Fc1ccc(NC(=S)NCCNC(=S)Nc2ccc(F)cc2F)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E23 mock treatment 1.0253 0.0253 0.49 0.4913 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 E24 mock treatment 1.0095 0.00948 0.18 0.1841 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F01 compound treatment 1.0116 0.0116 0.23 0.226 1.0 1107832 Maybridge1_006975 CC1(C)CC2(C)OC(=O)c3ccccc3N2C(=S)N1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F02 compound treatment 1.0965 0.0965 1.87 1.8737 1.0 1921381 Maybridge1_006976 CCOc1ccc(/C=C/[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F03 compound treatment 1.0102 0.0102 0.2 0.1981 1.0 1536659 Maybridge1_006977 CCCc1cc(=O)oc2cc(O)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F04 compound treatment 1.0016 0.00157 0.03 0.0305 1.0 2073107 Maybridge1_006978 Nc1ccccc1SC(CC(=O)c2ccccc2)c3ccc(cc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F05 compound treatment 1.039 0.039 0.76 0.7566 1.0 1061990 Maybridge1_006979 Nc1nc(N)nc(n1)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F06 compound treatment 0.9512 -0.0488 -0.95 -0.9469 -1.0 1497584 Maybridge1_006980 CC(C)c1ccc(cc1)N2CSC(=S)N(C2)c3ccc(cc3)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F07 compound treatment 0.9858 -0.0142 -0.28 -0.2766 -1.0 2073108 Maybridge1_006981 Nc1ccc(cc1)S(=O)(=O)Nc2ccccc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F08 compound treatment 0.9915 -0.00849 -0.16 -0.1649 -1.0 2073109 Maybridge1_006982 Cc1cc(C)c(NC(=S)N)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F09 compound treatment 1.008 0.00804 0.16 0.1562 1.0 2073110 Maybridge1_006983 COc1cc(/C=N/C2CCCCCCCCCCC2)ccc1OCc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F10 compound treatment 1.0066 0.00661 0.13 0.1283 1.0 1211869 Maybridge1_006984 Cc1cc(NC(=O)CCC(=O)O)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F11 compound treatment 0.9807 -0.0193 -0.37 -0.3744 -1.0 2073111 Maybridge1_006985 COc1ccccc1Nc2nnc(S)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F12 compound treatment 1.0476 0.0476 0.92 0.9242 1.0 2073112 Maybridge1_006986 C/C(=C\c1ccccc1Cl)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F13 compound treatment 0.985 -0.015 -0.29 -0.2906 -1.0 1119197 Maybridge1_006987 Cc1ccc(Cl)cc1NC(=S)NCCO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F14 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 2073113 Maybridge1_006988 COc1ccc(CC/N=C/c2cc(Br)ccc2O)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F15 compound treatment 0.9893 -0.0107 -0.21 -0.2068 -1.0 2073114 Maybridge1_006989 O=C/1OC(=N\C1=C/c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F16 compound treatment 0.9807 -0.0193 -0.37 -0.3744 -1.0 2073115 Maybridge1_006990 C/C(=C\c1cccc(c1)[N+](=O)[O-])/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F17 compound treatment 1.0023 0.00229 0.04 0.0445 1.0 1018868 Maybridge1_006991 NC(=N)SCc1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F18 compound treatment 1.0246 0.0246 0.48 0.4774 1.0 2073116 Maybridge1_006992 Cc1cc(C)cc(/N=C/c2cc(Br)ccc2O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F19 compound treatment 0.9901 -0.00993 -0.19 -0.1929 -1.0 2073117 Maybridge1_006993 NC(=N)SCc1cccc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F20 compound treatment 0.9958 -0.00418 -0.08 -0.0812 -1.0 2073118 Maybridge1_006994 Oc1ccccc1/C=N/c2ccccc2SCCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F21 compound treatment 0.9685 -0.0315 -0.61 -0.6118 -1.0 1071877 Maybridge1_006995 COc1ccc(NC(=S)Nc2ccccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F22 compound treatment 1.008 0.00804 0.16 0.1562 1.0 1111249 Maybridge1_006996 O=C1N(Nc2ccccc2)C(=O)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F23 mock treatment 1.0102 0.0102 0.2 0.1981 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 F24 mock treatment 1.0224 0.0224 0.44 0.4355 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G01 compound treatment 1.0821 0.0821 1.59 1.5944 1.0 1219183 Maybridge1_006997 O=c1c(C#N)c2[nH]c3ccccc3n2c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G02 compound treatment 0.9822 -0.0178 -0.35 -0.3465 -1.0 1370310 Maybridge1_006998 CCOC(=O)Cn1nnc(n1)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G03 compound treatment 0.9958 -0.00418 -0.08 -0.0812 -1.0 1983575 Maybridge1_006999 Nc1oc(c(c1C#N)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G04 compound treatment 1.0001 1.35E-4 0.0 0.0026 1.0 1449956 Maybridge1_007000 Cc1cc(O)nc(NC(=O)C2CC2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G05 compound treatment 1.0296 0.0296 0.58 0.5751 1.0 2073119 Maybridge1_007001 CCCCCCCCCCCCCCCCC/1CCCC\C1=N\O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G06 compound treatment 1.003 0.00301 0.06 0.0585 1.0 2073120 Maybridge1_007002 NC(=N)NC(=N)Nc1c(F)cccc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G07 compound treatment 1.0152 0.0152 0.3 0.2958 1.0 1337485 Maybridge1_007003 COc1ccccc1C2CCN(CC2)C(=O)c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G08 compound treatment 0.9893 -0.0107 -0.21 -0.2068 -1.0 1013598 Maybridge1_007004 NC(=N)NC(=N)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G09 compound treatment 0.9814 -0.0186 -0.36 -0.3604 -1.0 1439324 Maybridge1_007005 CCOC(=O)c1ccc(NC(=O)CCCN2CCN(Cc3ccccc3)CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G10 compound treatment 0.9987 -0.0013 -0.03 -0.0253 -1.0 2073121 Maybridge1_007006 Cc1ccc(NC(=N)NC(=N)N)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G11 compound treatment 1.0411 0.0411 0.8 0.7985 1.0 1390951 Maybridge1_007007 Cc1ccc(cc1)S(=O)(=O)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G12 compound treatment 0.9685 -0.0315 -0.61 -0.6118 -1.0 2073122 Maybridge1_007008 NC(=N)NC(=N)Nc1cccc(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G13 compound treatment 0.9721 -0.0279 -0.54 -0.5419 -1.0 2073123 Maybridge1_007009 CC1(O)CCCCCCCCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G14 compound treatment 1.0246 0.0246 0.48 0.4774 1.0 1600021 Maybridge1_007010 CC(C)(C)c1ccc(NC(=S)NCCC(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G15 compound treatment 0.975 -0.025 -0.49 -0.4861 -1.0 2073124 Maybridge1_007011 NC(=O)c1c(cccc1C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G16 compound treatment 0.9858 -0.0142 -0.28 -0.2766 -1.0 1700634 Maybridge1_007012 Clc1cc(Cl)cc(Nc2ncnc(n2)n3cccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G17 compound treatment 0.9764 -0.0236 -0.46 -0.4582 -1.0 2073125 Maybridge1_007013 Cc1ccc(Oc2ccc(C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G18 compound treatment 0.9642 -0.0358 -0.7 -0.6955 -1.0 2073126 Maybridge1_007014 COc1ccccc1N/2C(=O)CS\C2=N/N=C/c3ccccc3O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G19 compound treatment 0.9692 -0.0308 -0.6 -0.5978 -1.0 2073127 Maybridge1_007015 CCOc1c(C)nc(C)c(OCC)c1c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G20 compound treatment 0.9584 -0.0416 -0.81 -0.8072 -1.0 2073128 Maybridge1_007016 Cc1ccc(cc1Cl)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G21 compound treatment 0.9908 -0.00921 -0.18 -0.1789 -1.0 1103787 Maybridge1_007017 Nc1ccc2c(cc(=O)oc2c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G22 compound treatment 0.9922 -0.00777 -0.15 -0.151 -1.0 2073129 Maybridge1_007018 Clc1cccc(NC(=S)NCCNC(=S)Nc2cccc(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G23 mock treatment 0.9793 -0.0207 -0.4 -0.4023 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 G24 mock treatment 1.0009 8.54E-4 0.02 0.0166 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H01 compound treatment 1.0181 0.0181 0.35 0.3517 1.0 1037188 Maybridge1_007019 CCc1cc(O)nc(S)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H02 compound treatment 1.0009 8.54E-4 0.02 0.0166 1.0 1080220 Maybridge1_007020 CCc1cccc(CC)c1N2C(=O)C=CC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H03 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 2073130 Maybridge1_007021 CCCC1=NNC(=O)C1Cc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H04 compound treatment 1.0088 0.00876 0.17 0.1702 1.0 2073131 Maybridge1_007022 Clc1ccc(N2C(=O)C=CC2=O)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H05 compound treatment 1.0109 0.0109 0.21 0.2121 1.0 1486875 Maybridge1_007023 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H06 compound treatment 0.9814 -0.0186 -0.36 -0.3604 -1.0 2073132 Maybridge1_007024 CC(C)c1ccc(NC(=O)/C=C/C(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H07 compound treatment 0.9958 -0.00418 -0.08 -0.0812 -1.0 2073133 Maybridge1_007025 Nc1ccc(cc1)S(=O)(=O)Nc2cc(F)ccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H08 compound treatment 0.9915 -0.00849 -0.16 -0.1649 -1.0 1250169 Maybridge1_007026 COc1ccc(CCn2c(=O)c3cc4c(=O)n(CCc5ccc(OC)c(OC)c5)c(=O)c4cc3c2=O)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H09 compound treatment 0.9901 -0.00993 -0.19 -0.1929 -1.0 1033953 Maybridge1_007027 O=C(CN1C(=O)c2ccccc2C1=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H10 compound treatment 0.9915 -0.00849 -0.16 -0.1649 -1.0 2073134 Maybridge1_007028 Clc1cc(NC(=S)NC(=O)c2ccccc2)ccc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H11 compound treatment 0.9771 -0.0229 -0.44 -0.4442 -1.0 1006142 Maybridge1_007029 NC(=O)c1ccccc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H12 compound treatment 1.0483 0.0483 0.94 0.9381 1.0 2073135 Maybridge1_007030 C/C(=C/c1cccc2ccccc12)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H13 compound treatment 0.9822 -0.0178 -0.35 -0.3465 -1.0 1594746 Maybridge1_007031 OCCNC(=S)NCc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H14 compound treatment 0.9613 -0.0387 -0.75 -0.7514 -1.0 2073136 Maybridge1_007032 Sc1nc2cc(Cl)ccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H15 compound treatment 0.9951 -0.0049 -0.1 -0.0951 -1.0 1113880 Maybridge1_007033 CCOc1ccc(NCN2C(=O)c3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H16 compound treatment 1.008 0.00804 0.16 0.1562 1.0 2073137 Maybridge1_007034 C/C(=C\c1ccccc1[N+](=O)[O-])/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H17 compound treatment 0.962 -0.038 -0.74 -0.7374 -1.0 1166307 Maybridge1_007035 Cc1ccc(NC(=S)NCCO)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H18 compound treatment 1.0174 0.0174 0.34 0.3377 1.0 1606002 Maybridge1_007036 O=C1N(CNc2ccc(cc2)N3CCOCC3)C(=O)c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H19 compound treatment 1.0073 0.00732 0.14 0.1422 1.0 1653424 Maybridge1_007037 O=C1N(CNc2ccc(Oc3ccccc3)cc2)C(=O)c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H20 compound treatment 1.0001 1.35E-4 0.0 0.0026 1.0 2073138 Maybridge1_007038 Cc1cc(Br)ccc1NC(=S)Nc2ccc3ccccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H21 compound treatment 1.0224 0.0224 0.44 0.4355 1.0 2073139 Maybridge1_007039 COc1ccc(Br)cc1/C=C/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H22 compound treatment 1.0037 0.00373 0.07 0.0724 1.0 2073140 Maybridge1_007040 Cn1nc(O)c2ccccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H23 mock treatment 0.9872 -0.0128 -0.25 -0.2487 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 H24 mock treatment 1.0052 0.00517 0.1 0.1004 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I01 compound treatment 1.0404 0.0404 0.78 0.7845 1.0 1774525 Maybridge1_007041 OC(CNCc1ccccc1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I02 compound treatment 0.998 -0.00202 -0.04 -0.0393 -1.0 1332598 Maybridge1_007042 O=C(Cn1nnc(n1)N2CCCCC2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I03 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 2073141 Maybridge1_007043 OC(=O)c1ccc(o1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I04 compound treatment 1.0037 0.00373 0.07 0.0724 1.0 2073142 Maybridge1_007044 Cc1nc(SCC(=O)C(C)(C)C)nc(O)c1CC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I05 compound treatment 1.0073 0.00732 0.14 0.1422 1.0 1277061 Maybridge1_007045 COC(=O)c1ccccc1Sc2c(nc3ccccn23)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I06 compound treatment 1.0426 0.0426 0.83 0.8264 1.0 2073143 Maybridge1_007046 CSc1ccccc1NC(=N)NC(=N)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I07 compound treatment 0.9872 -0.0128 -0.25 -0.2487 -1.0 1211026 Maybridge1_007047 O=C(NC1CCN(Cc2ccccc2)CC1)C3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I08 compound treatment 0.98 -0.02 -0.39 -0.3883 -1.0 2073144 Maybridge1_007048 NC(=N)NC(=N)Nc1nc(cs1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I09 compound treatment 1.0332 0.0332 0.64 0.6449 1.0 1402258 Maybridge1_007049 COc1ccc(CCNC(=O)c2ccccc2Br)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I10 compound treatment 0.9908 -0.00921 -0.18 -0.1789 -1.0 1202989 Maybridge1_007050 Nc1ncnc(Nc2ccc(Cl)c(Cl)c2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I11 compound treatment 1.0152 0.0152 0.3 0.2958 1.0 2073145 Maybridge1_007051 FC(F)(F)c1cc(cc(c1)S(=O)(=O)N2CCN(Cc3ccccc3)CC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I12 compound treatment 1.0102 0.0102 0.2 0.1981 1.0 2073146 Maybridge1_007052 NC(=N)NC(=N)Nc1ccc(Cl)cc1C(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I13 compound treatment 1.0231 0.0231 0.45 0.4494 1.0 2073147 Maybridge1_007053 CC(C)(C)n1nn[nH]c1=S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I14 compound treatment 0.9893 -0.0107 -0.21 -0.2068 -1.0 2073148 Maybridge1_007054 OC(=O)CCNC(=S)Nc1ccccc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I15 compound treatment 0.9778 -0.0222 -0.43 -0.4302 -1.0 2073149 Maybridge1_007055 CCCCCSc1nnc[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I16 compound treatment 0.9786 -0.0214 -0.42 -0.4163 -1.0 2073150 Maybridge1_007056 Clc1ccccc1Nc2ncnc(n2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I17 compound treatment 0.9678 -0.0322 -0.63 -0.6257 -1.0 1071543 Maybridge1_007057 c1cc2cc3ccccc3cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I18 compound treatment 0.9592 -0.0408 -0.79 -0.7933 -1.0 2073151 Maybridge1_007058 CCCCc1c(O)nc(S)nc1COC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I19 compound treatment 0.9814 -0.0186 -0.36 -0.3604 -1.0 2073152 Maybridge1_007059 CCOC(=O)c1c(/N=C/c2cc(Br)c(Br)cc2O)sc3CCCCc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I20 compound treatment 0.9728 -0.0272 -0.53 -0.528 -1.0 1181266 Maybridge1_007060 COCc1cc(=O)oc2cc(N)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I21 compound treatment 1.0289 0.0289 0.56 0.5611 1.0 2073153 Maybridge1_007061 NC(=N)NC(=N)Nc1cc(Cl)cc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I22 compound treatment 1.0167 0.0167 0.32 0.3238 1.0 2073154 Maybridge1_007062 NC(=N)NC(=N)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I23 mock treatment 1.0037 0.00373 0.07 0.0724 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 I24 mock treatment 0.9743 -0.0257 -0.5 -0.5 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J01 compound treatment 1.0584 0.0584 1.13 1.1336 1.0 2073155 Maybridge1_007063 CCc1cc(O)nc(SCc2c(F)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J02 compound treatment 1.008 0.00804 0.16 0.1562 1.0 1434301 Maybridge1_007064 CCc1cccc(CC)c1N2C(=O)CC(Sc3ccccc3N)C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J03 compound treatment 1.0009 8.54E-4 0.02 0.0166 1.0 1237906 Maybridge1_007065 CCCC1=NN(C(=O)c2ccc(Cl)cc2)C(=O)C1Cc3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J04 compound treatment 1.0152 0.0152 0.3 0.2958 1.0 1056222 Maybridge1_007066 Cc1ccc(C=C(C#N)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J05 compound treatment 1.0203 0.0203 0.39 0.3936 1.0 2073156 Maybridge1_007067 COCc1cc(O)nc(SCC2CC2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J06 compound treatment 1.008 0.00804 0.16 0.1562 1.0 1084580 Maybridge1_007068 Nc1ccccc1SC(CC(=O)c2ccccc2)c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J07 compound treatment 0.9865 -0.0135 -0.26 -0.2627 -1.0 2073157 Maybridge1_007069 FC(F)(F)c1cccc(c1)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J08 compound treatment 1.0181 0.0181 0.35 0.3517 1.0 1928 Maybridge1_007070 [O-][N+](=O)c1ccc(C=C(C#N)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J09 compound treatment 1.0052 0.00517 0.1 0.1004 1.0 2073158 Maybridge1_007071 Cc1cccc(/N=C/c2cc(I)cc(I)c2O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J10 compound treatment 1.0217 0.0217 0.42 0.4215 1.0 2073159 Maybridge1_007072 COc1cc(NC(=S)NC(=O)c2ccccc2)c(OC)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J11 compound treatment 0.9965 -0.00346 -0.07 -0.0672 -1.0 1006360 Maybridge1_007073 Oc1nnc(O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J12 compound treatment 1.0375 0.0375 0.73 0.7287 1.0 1921383 Maybridge1_007074 C/C(=C\c1ccc(Cl)cc1)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J13 compound treatment 0.9534 -0.0466 -0.9 -0.905 -1.0 1042465 Maybridge1_007075 OCCNC(=S)NCC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J14 compound treatment 1.008 0.00804 0.16 0.1562 1.0 2073160 Maybridge1_007076 C/C(=N\Cc1ccncc1)/c2ccccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J15 compound treatment 1.0044 0.00445 0.09 0.0864 1.0 2073161 Maybridge1_007077 O=C/1OC(=N\C1=C/c2ccc(cc2)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J16 compound treatment 1.0037 0.00373 0.07 0.0724 1.0 2073162 Maybridge1_007078 COc1cc(/C=N/CCC\N=C\c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J17 compound treatment 0.98 -0.02 -0.39 -0.3883 -1.0 1018228 Maybridge1_007079 Nc1c(C#N)c(CC#N)nn1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J18 compound treatment 0.9944 -0.00562 -0.11 -0.1091 -1.0 2073163 Maybridge1_007080 Oc1ccc(Br)cc1/C=N/c2ccc(cc2)S(=O)(=O)Nc3nccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J19 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 1259024 Maybridge1_007081 Clc1ccc(NC(=S)Nc2ccccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J20 compound treatment 1.0195 0.0195 0.38 0.3796 1.0 2073164 Maybridge1_007082 COC(=O)c1ccccc1N=NNc2cc(OC)cc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J21 compound treatment 0.9469 -0.0531 -1.03 -1.0306 -1.0 2073165 Maybridge1_007083 COc1ccc(Br)cc1/C=N/N=C/c2cc(Br)ccc2OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J22 compound treatment 1.0009 8.54E-4 0.02 0.0166 1.0 1524469 Maybridge1_007084 O=C1N(Nc2ccccc2)C(=O)c3cccc4cccc1c34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J23 mock treatment 0.9534 -0.0466 -0.9 -0.905 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 J24 mock treatment 1.0195 0.0195 0.38 0.3796 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K01 compound treatment 1.0462 0.0462 0.9 0.8962 1.0 1050488 Maybridge1_007085 OC(=O)CCCNc1ccc(cc1[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K02 compound treatment 0.9879 -0.0121 -0.23 -0.2348 -1.0 1267668 Maybridge1_007086 Fc1cccc(Cl)c1Cn2nnc(n2)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K03 compound treatment 1.0037 0.00373 0.07 0.0724 1.0 2073166 Maybridge1_007087 CC/1(CCCC\C1=N\O)NO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K04 compound treatment 0.9951 -0.0049 -0.1 -0.0951 -1.0 2073167 Maybridge1_007088 Cc1cc(O)nc(SCC(=O)C(C)(C)C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K05 compound treatment 1.0203 0.0203 0.39 0.3936 1.0 2073168 Maybridge1_007089 OC(=O)C1(CC2CC3C1)CC(C2)(C3)C(F)(F)C(F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K06 compound treatment 1.0023 0.00229 0.04 0.0445 1.0 2073169 Maybridge1_007090 Cc1cccc(NC(=N)NC(=N)N)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K07 compound treatment 1.0016 0.00157 0.03 0.0305 1.0 1627929 Maybridge1_007091 Clc1ccc(cc1)C(=O)NC2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K08 compound treatment 0.985 -0.015 -0.29 -0.2906 -1.0 2073170 Maybridge1_007092 NC(=N)NC(=N)Nc1cc(Cl)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K09 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 1202748 Maybridge1_007093 COc1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K10 compound treatment 0.9786 -0.0214 -0.42 -0.4163 -1.0 2073171 Maybridge1_007094 Cc1cc(NC(=N)NC(=N)N)ccc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K11 compound treatment 0.9929 -0.00706 -0.14 -0.137 -1.0 1729064 Maybridge1_007095 Clc1cc(Cl)c(cc1Cl)S(=O)(=O)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K12 compound treatment 0.9901 -0.00993 -0.19 -0.1929 -1.0 2073172 Maybridge1_007096 Oc1cc(nc(n1)C2CC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K13 compound treatment 1.1533 0.153 2.98 2.9767 1.0 2073173 Maybridge1_007097 CC1=CC(=O)C(=CC1=O)Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K14 compound treatment 0.9814 -0.0186 -0.36 -0.3604 -1.0 1137690 Maybridge1_007098 OC(=O)CCNC(=S)Nc1cccc(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K15 compound treatment 0.9965 -0.00346 -0.07 -0.0672 -1.0 2073174 Maybridge1_007099 C1c2ccccc2-c3ncccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K16 compound treatment 0.9793 -0.0207 -0.4 -0.4023 -1.0 1013598 Maybridge1_007100 NC(=N)NC(=N)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K17 compound treatment 1.0124 0.0124 0.24 0.24 1.0 724 Maybridge1_007101 CCn1cc(C(=O)O)c(=O)c2ccc(C)nc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K18 compound treatment 0.998 -0.00202 -0.04 -0.0393 -1.0 2073175 Maybridge1_007102 CCSc1nc(N)c(Br)c(O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K19 compound treatment 1.0131 0.0131 0.25 0.254 1.0 1037873 Maybridge1_007103 Cc1c(cc2c(c1[N+](=O)[O-])C(C)(C)CC2(C)C)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K20 compound treatment 1.0052 0.00517 0.1 0.1004 1.0 1208794 Maybridge1_007104 CC1=CC2N=C(C)C=C(O)N2O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K21 compound treatment 1.0332 0.0332 0.64 0.6449 1.0 2073176 Maybridge1_007105 Cc1nc(S)nc(O)c1Cc2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K22 compound treatment 0.9476 -0.0524 -1.02 -1.0167 -1.0 1027920 Maybridge1_007106 CC1=CC(C)(C)NC(=S)N1c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K23 mock treatment 0.998 -0.00202 -0.04 -0.0393 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 K24 mock treatment 1.0102 0.0102 0.2 0.1981 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L01 compound treatment 1.0102 0.0102 0.2 0.1981 1.0 1659710 Maybridge1_007107 COc1ccccc1NC(=S)NCCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L02 compound treatment 1.0346 0.0346 0.67 0.6728 1.0 1080211 Maybridge1_007108 CCc1cccc(CC)c1NC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L03 compound treatment 1.0656 0.0656 1.27 1.2732 1.0 2073177 Maybridge1_007109 CCCC1=NNC(=O)C1CC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L04 compound treatment 1.0224 0.0224 0.44 0.4355 1.0 1002383 Maybridge1_007110 N#CC(=Cc1ccc2OCOc2c1)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L05 compound treatment 0.9944 -0.00562 -0.11 -0.1091 -1.0 2073178 Maybridge1_007111 CCCc1nc(nc(O)c1CC2CC2)c3ccccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L06 compound treatment 0.9893 -0.0107 -0.21 -0.2068 -1.0 1604878 Maybridge1_007112 COc1cccc(Nc2nnc(S)s2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L07 compound treatment 0.9937 -0.00634 -0.12 -0.123 -1.0 2073179 Maybridge1_007113 FC(F)(F)c1cccc(c1)c2nnc(o2)c3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L08 compound treatment 1.0361 0.0361 0.7 0.7008 1.0 2073180 Maybridge1_007114 COc1cccc(/C=N/N=C/c2cccc(OC)c2O)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L09 compound treatment 0.952 -0.048 -0.93 -0.9329 -1.0 2073181 Maybridge1_007115 Oc1c(Br)cc(Br)cc1/C=N/c2ccc(Oc3ccc(Cl)cc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L10 compound treatment 1.0009 8.54E-4 0.02 0.0166 1.0 2073182 Maybridge1_007116 C/C(=N\Cc1ccc2OCOc2c1)/c3ccccc3O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L11 compound treatment 0.9865 -0.0135 -0.26 -0.2627 -1.0 1084579 Maybridge1_007117 Clc1ccc(Oc2ccc(NCN3C(=O)c4ccccc4C3=O)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L12 compound treatment 1.0016 0.00157 0.03 0.0305 1.0 1012383 Maybridge1_007118 NC(=O)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L13 compound treatment 1.0037 0.00373 0.07 0.0724 1.0 1183837 Maybridge1_007119 CCOC(=O)c1ccc(NCN2C(=O)c3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L14 compound treatment 1.0109 0.0109 0.21 0.2121 1.0 2073183 Maybridge1_007120 CCOc1ccc(Br)cc1/C=C(\C)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L15 compound treatment 1.0555 0.0555 1.08 1.0778 1.0 2073184 Maybridge1_007121 [O-][N+](=O)/C=C/c1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L16 compound treatment 0.9484 -0.0516 -1.0 -1.0027 -1.0 2073185 Maybridge1_007122 C/C(=N\NC(=S)N)/c1ccc(Br)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L17 compound treatment 0.9635 -0.0365 -0.71 -0.7095 -1.0 2073186 Maybridge1_007123 O=C/1OC(=N\C1=C/c2ccco2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L18 compound treatment 1.0073 0.00732 0.14 0.1422 1.0 1569211 Maybridge1_007124 COc1ccc(cc1)C(=O)CC2OC(=O)c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L19 compound treatment 0.9563 -0.0437 -0.85 -0.8491 -1.0 1045646 Maybridge1_007125 Cc1ccc(CSC(=N)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L20 compound treatment 0.998 -0.00202 -0.04 -0.0393 -1.0 2073187 Maybridge1_007126 CN(C)c1ccc(cc1)n2nnnc2S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L21 compound treatment 0.9879 -0.0121 -0.23 -0.2348 -1.0 1384061 Maybridge1_007127 Sc1nnc(NC2CCCCC2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L22 compound treatment 0.9397 -0.0603 -1.17 -1.1703 -1.0 1040878 Maybridge1_007128 CN(C)N1C(=O)c2ccccc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L23 mock treatment 0.9858 -0.0142 -0.28 -0.2766 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 L24 mock treatment 1.0253 0.0253 0.49 0.4913 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M01 compound treatment 1.0548 0.0548 1.06 1.0638 1.0 1153336 Maybridge1_007129 S(c1c(nc2ccccn12)c3ccccc3)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M02 compound treatment 1.0426 0.0426 0.83 0.8264 1.0 1304742 Maybridge1_007130 Cc1nc(SCc2c(F)cccc2Cl)nc(O)c1Cc3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M03 compound treatment 1.0382 0.0382 0.74 0.7427 1.0 2073188 Maybridge1_007131 Cc1cnnc2ccc3nonc3c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M04 compound treatment 0.9886 -0.0114 -0.22 -0.2208 -1.0 2073189 Maybridge1_007132 CCOC(=N)c1ccc(F)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M05 compound treatment 1.0224 0.0224 0.44 0.4355 1.0 1652029 Maybridge1_007133 Clc1ccc(CN2CCC(CC2)NC(=O)c3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M06 compound treatment 0.9901 -0.00993 -0.19 -0.1929 -1.0 2073190 Maybridge1_007134 Nc1ncnc(Nc2cccc(c2)C(F)(F)F)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M07 compound treatment 0.9865 -0.0135 -0.26 -0.2627 -1.0 1684864 Maybridge1_007135 Brc1ccccc1C(=O)NC2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M08 compound treatment 0.9929 -0.00706 -0.14 -0.137 -1.0 2073191 Maybridge1_007136 CCOC(=N)c1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M09 compound treatment 0.9922 -0.00777 -0.15 -0.151 -1.0 1607644 Maybridge1_007137 COc1ccc(CCNS(=O)(=O)c2ccc(Cl)c(Cl)c2Cl)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M10 compound treatment 0.9685 -0.0315 -0.61 -0.6118 -1.0 2073192 Maybridge1_007138 NC(=N)NC(=N)Nc1ccc(Oc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M11 compound treatment 1.0246 0.0246 0.48 0.4774 1.0 1513968 Maybridge1_007139 Cc1cc(c(Cl)cc1Cl)S(=O)(=O)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M12 compound treatment 0.9721 -0.0279 -0.54 -0.5419 -1.0 1471831 Maybridge1_007140 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M13 compound treatment 0.9807 -0.0193 -0.37 -0.3744 -1.0 686 Maybridge1_007141 C(Nc1ncnc2[nH]cnc12)c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M14 compound treatment 1.0001 1.35E-4 0.0 0.0026 1.0 1022398 Maybridge1_007142 Nc1ccc(cc1)S(=O)(=O)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M15 compound treatment 1.0052 0.00517 0.1 0.1004 1.0 1074320 Maybridge1_007143 O=C1c2ccccc2-c3ncccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M16 compound treatment 0.9441 -0.0559 -1.09 -1.0865 -1.0 2073193 Maybridge1_007144 CC(C)CCc1c(C)nc(SCC(=O)C(C)(C)C)nc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M17 compound treatment 0.9778 -0.0222 -0.43 -0.4302 -1.0 1644993 Maybridge1_007145 Cc1nn(c(N)c1c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M18 compound treatment 0.9707 -0.0293 -0.57 -0.5699 -1.0 2073194 Maybridge1_007146 NC(=N)NC(=N)Nc1ccc2OCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M19 compound treatment 0.9793 -0.0207 -0.4 -0.4023 -1.0 2073195 Maybridge1_007147 Cc1cc(O)n(n1)c2cc(Cl)c(cc2Cl)S(=O)(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M20 compound treatment 0.9577 -0.0423 -0.82 -0.8212 -1.0 2073196 Maybridge1_007148 Cc1cc(O)nc(n1)c2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M21 compound treatment 1.0073 0.00732 0.14 0.1422 1.0 2073197 Maybridge1_007149 COc1ccc(CCN/2C(=O)CS\C2=N/c3cc(Cl)cc(Cl)c3)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M22 compound treatment 1.0088 0.00876 0.17 0.1702 1.0 2073198 Maybridge1_007150 COCc1cc(=O)oc2[nH]nc(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M23 mock treatment 0.9951 -0.0049 -0.1 -0.0951 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 M24 mock treatment 1.0073 0.00732 0.14 0.1422 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N01 compound treatment 1.0728 0.0728 1.41 1.4129 1.0 2073199 Maybridge1_007151 [O-][N+](=O)c1cccc(c1)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N02 compound treatment 0.9858 -0.0142 -0.28 -0.2766 -1.0 2073200 Maybridge1_007152 Sc1nnnn1Cc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N03 compound treatment 0.9678 -0.0322 -0.63 -0.6257 -1.0 1205916 Maybridge1_007153 CCCc1cc(=O)oc2cc(OCC(=O)OCC)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N04 compound treatment 1.0497 0.0497 0.97 0.9661 1.0 2073201 Maybridge1_007154 Cc1cc(C)c(NC(=S)NN)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N05 compound treatment 1.0397 0.0397 0.77 0.7706 1.0 1694603 Maybridge1_007155 CC(C(=O)NN)n1nnc(n1)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N06 compound treatment 1.0346 0.0346 0.67 0.6728 1.0 1058453 Maybridge1_007156 N#CC(=Cc1c[nH]c2ccccc12)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N07 compound treatment 1.0217 0.0217 0.42 0.4215 1.0 1643270 Maybridge1_007157 NNC(=O)CCn1nnc(n1)c2cccc(Cl)c2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N08 compound treatment 1.0181 0.0181 0.35 0.3517 1.0 2073202 Maybridge1_007158 CCO/C=C/1\SC(=S)NC1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N09 compound treatment 1.0188 0.0188 0.37 0.3657 1.0 2073203 Maybridge1_007159 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccccc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N10 compound treatment 1.0001 1.35E-4 0.0 0.0026 1.0 2073204 Maybridge1_007160 CCOC(=O)c1ccc(NC(=S)NCCCN2CCOCC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N11 compound treatment 1.0052 0.00517 0.1 0.1004 1.0 1487751 Maybridge1_007161 Cc1ccccc1NC(=S)NCCO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N12 compound treatment 1.0044 0.00445 0.09 0.0864 1.0 2073205 Maybridge1_007162 O=C/1OC(=N\C1=C/c2ccc(\C=C\3/N=C(OC3=O)c4ccccc4)cc2)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N13 compound treatment 0.9642 -0.0358 -0.7 -0.6955 -1.0 1264587 Maybridge1_007163 Cc1cccc(C)c1NC(=S)NCCO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N14 compound treatment 0.9987 -0.0013 -0.03 -0.0253 -1.0 2073206 Maybridge1_007164 COc1ccccc1C=C(C#N)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N15 compound treatment 0.962 -0.038 -0.74 -0.7374 -1.0 2073207 Maybridge1_007165 Clc1ccc(/C=C/2\N=C(OC2=O)c3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N16 compound treatment 1.0066 0.00661 0.13 0.1283 1.0 1056276 Maybridge1_007166 NC1=C(C#N)C2=CCCC2C3(CCCC3)C1(C#N)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N17 compound treatment 0.9599 -0.0401 -0.78 -0.7793 -1.0 2073208 Maybridge1_007167 Cc1cc(CSC(=N)N)c(CSC(=N)N)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N18 compound treatment 0.9743 -0.0257 -0.5 -0.5 -1.0 2073209 Maybridge1_007168 CCCCC(C(=O)N/N=C/c1ccc(OCC)c(OC)c1)C(=O)N/N=C/c2ccc(OCC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N19 compound treatment 1.0346 0.0346 0.67 0.6728 1.0 1719191 Maybridge1_007169 Cc1ccc(NC(=S)Nc2ccccn2)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N20 compound treatment 1.0052 0.00517 0.1 0.1004 1.0 1506578 Maybridge1_007170 NNC(=S)Nc1ccc2OCCOc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N21 compound treatment 0.9822 -0.0178 -0.35 -0.3465 -1.0 1239520 Maybridge1_007171 COc1ccc(CCNC(=S)NCCc2ccc(OC)c(OC)c2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N22 compound treatment 0.9714 -0.0286 -0.56 -0.5559 -1.0 2073210 Maybridge1_007172 COc1ccc(CC/N=C(\C)/c2ccc3ccccc3c2)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N23 mock treatment 0.9512 -0.0488 -0.95 -0.9469 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 N24 mock treatment 1.0188 0.0188 0.37 0.3657 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O01 compound treatment 1.0303 0.0303 0.59 0.5891 1.0 1278108 Maybridge1_007173 OC(=O)c1nonc1c2nonc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O02 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 2073211 Maybridge1_007174 S=C(NCc1cccs1)NC2CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O03 compound treatment 0.9937 -0.00634 -0.12 -0.123 -1.0 1922564 Maybridge1_007175 c1ccc(cc1)c2cc3c4nonc4ccc3nn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O04 compound treatment 1.0009 8.54E-4 0.02 0.0166 1.0 1679982 Maybridge1_007176 Cc1nc(nc(O)c1CC2CC2)c3ccccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O05 compound treatment 1.0332 0.0332 0.64 0.6449 1.0 1426502 Maybridge1_007177 Clc1ccc(CN2CCC(CC2)NC(=O)c3ccccc3)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O06 compound treatment 0.9829 -0.0171 -0.33 -0.3325 -1.0 2073212 Maybridge1_007178 NC(=N)NC(=N)Nc1cccc(C#C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O07 compound treatment 1.0325 0.0325 0.63 0.631 1.0 1152846 Maybridge1_007179 Clc1cccc(Cl)c1C(=O)NC2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O08 compound treatment 1.0009 8.54E-4 0.02 0.0166 1.0 1393987 Maybridge1_007180 Nc1ncnc(Nc2nc(cs2)c3ccccc3)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O09 compound treatment 1.0066 0.00661 0.13 0.1283 1.0 1728517 Maybridge1_007181 COc1ccc(CCNS(=O)(=O)c2cc(C)c(Cl)cc2Cl)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O10 compound treatment 0.9901 -0.00993 -0.19 -0.1929 -1.0 2073213 Maybridge1_007182 COc1cc(NC(=N)NC(=N)N)cc(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O11 compound treatment 1.0253 0.0253 0.49 0.4913 1.0 1498392 Maybridge1_007183 Brc1ccccc1C(=O)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O12 compound treatment 0.9872 -0.0128 -0.25 -0.2487 -1.0 1006238 Maybridge1_007184 Nc1ccc(cc1)S(=O)(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O13 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 1092526 Maybridge1_007185 c1cn2cc(nc2s1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O14 compound treatment 0.975 -0.025 -0.49 -0.4861 -1.0 2073214 Maybridge1_007186 CC(=O)N(C1=NCCC(=O)S1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O15 compound treatment 1.0152 0.0152 0.3 0.2958 1.0 2073215 Maybridge1_007187 Cc1ccc(cc1)C(=O)c2c(C)ccc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O16 compound treatment 0.998 -0.00202 -0.04 -0.0393 -1.0 2073216 Maybridge1_007188 CC(=C)Cc1c(C)nc(S)nc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O17 compound treatment 1.003 0.00301 0.06 0.0585 1.0 1716974 Maybridge1_007189 OC1CC(NC2(CCCC2)C1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O18 compound treatment 0.9642 -0.0358 -0.7 -0.6955 -1.0 1256 Maybridge1_007190 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O19 compound treatment 1.0217 0.0217 0.42 0.4215 1.0 1176932 Maybridge1_007191 CC1CC(=O)c2c(F)c(F)cc3c(=O)c(cn1c23)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O20 compound treatment 1.0059 0.00589 0.11 0.1143 1.0 2073217 Maybridge1_007192 Sc1nc2ccccc2c(=O)n1CC3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O21 compound treatment 1.008 0.00804 0.16 0.1562 1.0 1023643 Maybridge1_007193 Nc1nc(O)cc(n1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O22 compound treatment 0.9462 -0.0538 -1.04 -1.0446 -1.0 2073218 Maybridge1_007194 NC(=N)NC(=N)Nc1cccc(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O23 mock treatment 0.9929 -0.00706 -0.14 -0.137 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 O24 mock treatment 0.9929 -0.00706 -0.14 -0.137 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P01 compound treatment 0.9685 -0.0315 -0.61 -0.6118 -1.0 1183103 Maybridge1_007195 CC(C)c1ccc(NC(=S)NCCC(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P02 compound treatment 1.0368 0.0368 0.71 0.7147 1.0 1080218 Maybridge1_007196 O=C(NC(=S)Nc1ccccn1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P03 compound treatment 1.0346 0.0346 0.67 0.6728 1.0 2073219 Maybridge1_007197 CC1=NNC(=O)C1Cc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P04 compound treatment 0.9843 -0.0157 -0.3 -0.3046 -1.0 2073220 Maybridge1_007198 NC(=S)Nc1cc(Cl)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P05 compound treatment 1.0066 0.00661 0.13 0.1283 1.0 2073221 Maybridge1_007199 CCCCCCCc1c(O)[nH]nc1COC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P06 compound treatment 1.0742 0.0742 1.44 1.4408 1.0 1083209 Maybridge1_007200 S=C1SCN(CCc2ccccc2)CN1CCc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P07 compound treatment 0.9973 -0.00274 -0.05 -0.0532 -1.0 1430187 Maybridge1_007201 COc1ccccc1NC(=S)NCCc2ccc(OC)c(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P08 compound treatment 1.0375 0.0375 0.73 0.7287 1.0 2073222 Maybridge1_007202 S=C(NCCc1ccccc1)N2CCC(CCCC3CCN(CC3)C(=S)NCCc4ccccc4)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P09 compound treatment 0.9872 -0.0128 -0.25 -0.2487 -1.0 2073223 Maybridge1_007203 Cc1ccc(Cl)cc1NC(=S)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P10 compound treatment 0.9929 -0.00706 -0.14 -0.137 -1.0 2073224 Maybridge1_007204 Oc1ccc(Br)cc1/C=N/c2ccc(F)c(F)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P11 compound treatment 1.021 0.021 0.41 0.4075 1.0 2073225 Maybridge1_007205 Cc1cc(Cl)ccc1NC(=S)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P12 compound treatment 0.9807 -0.0193 -0.37 -0.3744 -1.0 2073226 Maybridge1_007206 Clc1cccc(/C=C/2\N=C(OC2=O)c3ccccc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P13 compound treatment 1.0203 0.0203 0.39 0.3936 1.0 2073227 Maybridge1_007207 N/C(=N\O)/Cc1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P14 compound treatment 1.0634 0.0634 1.23 1.2314 1.0 2073228 Maybridge1_007208 COc1ccccc1/C=C/2\N=C(OC2=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P15 compound treatment 0.9836 -0.0164 -0.32 -0.3185 -1.0 2073229 Maybridge1_007209 Cc1ccc(/C=C/2\N=C(OC2=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P16 compound treatment 1.1001 0.1 1.94 1.9435 1.0 2073230 Maybridge1_007210 FC(F)(F)c1cc(cc(c1)C(F)(F)F)N2C(=O)C=CC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P17 compound treatment 1.0526 0.0526 1.02 1.0219 1.0 2073231 Maybridge1_007211 [O-][N+](=O)/C=C/c1cccc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P18 compound treatment 1.0037 0.00373 0.07 0.0724 1.0 1063067 Maybridge1_007212 COc1ccc(CNc2ccccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P19 compound treatment 0.9699 -0.0301 -0.58 -0.5838 -1.0 1003767 Maybridge1_007213 O=C1N(Cc2ccccc2)C(=O)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P20 compound treatment 1.0088 0.00876 0.17 0.1702 1.0 1107460 Maybridge1_007214 C=CCCN1C(=O)c2ccccc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P21 compound treatment 1.0037 0.00373 0.07 0.0724 1.0 1076485 Maybridge1_007215 S=C1SCN(CN1C2CCCCC2)C3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P22 compound treatment 1.0109 0.0109 0.21 0.2121 1.0 1627643 Maybridge1_007216 Clc1ccc(Oc2ccc(NC(=S)NCc3ccco3)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P23 mock treatment 0.9965 -0.00346 -0.07 -0.0672 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.561 P24 mock treatment 1.039 0.039 0.76 0.7566 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A01 compound treatment 1.042 0.042 0.81 0.8149 1.0 2073232 Maybridge1_007217 Clc1ccc(NC(=O)CC2S/C(=N/CC=C)/NC2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A02 compound treatment 1.0514 0.0514 1.0 0.9974 1.0 2073233 Maybridge1_007218 NC(=N)SCc1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A03 compound treatment 1.06 0.06 1.17 1.1659 1.0 1218556 Maybridge1_007219 Clc1ccc(cc1)C2SCC(=O)N2c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A04 compound treatment 1.0347 0.0347 0.67 0.6745 1.0 2073234 Maybridge1_007220 OC(=O)CCS(=O)(=O)/C=C/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A05 compound treatment 1.0412 0.0412 0.8 0.8008 1.0 2073235 Maybridge1_007221 Cc1ccc(NC(=S)NNC(C)(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A06 compound treatment 0.9769 -0.0231 -0.45 -0.4489 -1.0 1626568 Maybridge1_007222 CCc1cccc(C)c1NC(=O)CC(C)(C)CC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A07 compound treatment 0.9957 -0.00432 -0.08 -0.0838 -1.0 1218008 Maybridge1_007223 Cc1ccc2[nH]c(=S)n(c3ccc(cc3)S(=O)(=O)N4CCCCC4)c(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A08 compound treatment 0.9552 -0.0448 -0.87 -0.8702 -1.0 1558896 Maybridge1_007224 OC(=O)CCc1ccccc1OC(=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A09 compound treatment 1.06 0.06 1.17 1.1659 1.0 2073236 Maybridge1_007225 [O-][N+](=O)/C=C/c1c(F)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A10 compound treatment 0.9979 -0.00215 -0.04 -0.0417 -1.0 1019656 Maybridge1_007226 COc1ccc(Cl)cc1NC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A11 compound treatment 1.0239 0.0239 0.46 0.4638 1.0 2073237 Maybridge1_007227 CCCc1ccc(NC(=S)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A12 compound treatment 0.9798 -0.0202 -0.39 -0.3927 -1.0 1411224 Maybridge1_007228 Cn1cc(c2ccccc2C(=O)N)c(=O)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A13 compound treatment 1.0962 0.0962 1.87 1.868 1.0 2073238 Maybridge1_007229 [O-][N+](=O)/C=C/c1ccc(C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A14 compound treatment 1.0355 0.0355 0.69 0.6885 1.0 2073239 Maybridge1_007230 CCCCCCCCCCCCSC1CC(=O)N(C1=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A15 compound treatment 1.0203 0.0203 0.39 0.3936 1.0 2073240 Maybridge1_007231 COc1cc(cc(OC)c1OC)C2CC(=O)N(C(=O)C2)c3cc(C)on3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A16 compound treatment 1.0195 0.0195 0.38 0.3796 1.0 1594868 Maybridge1_007232 Cc1ccc(NC(=O)C2CCCCC2C(=O)O)cc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A17 compound treatment 1.0347 0.0347 0.67 0.6745 1.0 2073241 Maybridge1_007233 CC(CC(=O)O)CC(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A18 compound treatment 0.9899 -0.0101 -0.2 -0.1962 -1.0 2073242 Maybridge1_007234 CCOc1ccc(/C=C/2\CCc3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A19 compound treatment 1.0239 0.0239 0.46 0.4638 1.0 2073243 Maybridge1_007235 CC1CCC2C(C1)C(=O)N(C2=O)c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A20 compound treatment 0.9819 -0.0181 -0.35 -0.3506 -1.0 1509219 Maybridge1_007236 Brc1ccc2NC(=O)C3(OCCO3)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A21 compound treatment 1.0181 0.0181 0.35 0.3515 1.0 1004667 Maybridge1_007237 CCCCNC(=S)NCCCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A22 compound treatment 0.9776 -0.0224 -0.43 -0.4349 -1.0 1193653 Maybridge1_007238 O=C1CC(Nc2ccccc2)C(=O)N1c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A23 mock treatment 1.06 0.06 1.17 1.1659 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 A24 mock treatment 1.0217 0.0217 0.42 0.4217 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B01 compound treatment 1.0224 0.0224 0.44 0.4357 1.0 1229042 Maybridge1_007239 CC(C)Cc1ccc(cc1)C(=O)CC2OC(=O)c3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B02 compound treatment 1.0159 0.0159 0.31 0.3094 1.0 1698232 Maybridge1_007240 OC(=O)C1CN(Cc2ccccc2Cl)C(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B03 compound treatment 1.0174 0.0174 0.34 0.3375 1.0 1699918 Maybridge1_007241 COc1ccc(CN2C(SCC2=O)c3ccccn3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B04 compound treatment 1.0318 0.0318 0.62 0.6183 1.0 1329181 Maybridge1_007242 Clc1ccc(cc1)C2NCCc3sccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B05 compound treatment 1.0362 0.0362 0.7 0.7025 1.0 2073244 Maybridge1_007243 [O-][N+](=O)/C=C/c1ccc(OCC=C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B06 compound treatment 1.0326 0.0326 0.63 0.6323 1.0 1479953 Maybridge1_007244 OC(=O)C1C(C2CC1C=C2)C(=O)Nc3ccc(cc3)c4csnn4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B07 compound treatment 1.0029 0.00291 0.06 0.0566 1.0 2073245 Maybridge1_007245 Fc1ccc(/C=C/2\CC/C(=C\c3ccc(F)cc3)/C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B08 compound treatment 0.9957 -0.00432 -0.08 -0.0838 -1.0 2073246 Maybridge1_007246 Cc1cc(C(=O)C(F)(F)F)c(C)n1c2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B09 compound treatment 0.9942 -0.00576 -0.11 -0.1119 -1.0 2073247 Maybridge1_007247 O/N=C/C(=O)Nc1ccc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B10 compound treatment 1.0073 0.00725 0.14 0.1409 1.0 1202826 Maybridge1_007248 CC(C)N(C(C)C)C(=O)NC(=O)c1ccc(cc1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B11 compound treatment 0.9942 -0.00576 -0.11 -0.1119 -1.0 1011631 Maybridge1_007249 O=C(N1C(C=Cc2ccccc12)C#N)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B12 compound treatment 1.0007 7.46E-4 0.01 0.0145 1.0 2073248 Maybridge1_007250 FC(F)(F)c1cc(cc(c1)S(=O)(=O)Nc2cccc(c2)c3nnco3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B13 compound treatment 1.008 0.00798 0.15 0.1549 1.0 1259298 Maybridge1_007251 CCOC(=O)c1c(N)nc(SC)n1c2ccc(cc2)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B14 compound treatment 1.0282 0.0282 0.55 0.5481 1.0 2073249 Maybridge1_007252 Fc1ccc2OCCC(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B15 compound treatment 0.9805 -0.0195 -0.38 -0.3787 -1.0 1492443 Maybridge1_007253 CSc1nsc(SC)c1C(=O)NC(=O)Nc2ccc(cc2)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B16 compound treatment 0.9812 -0.0188 -0.36 -0.3647 -1.0 2073250 Maybridge1_007254 Cc1cc(oc(=O)c1)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B17 compound treatment 1.141 0.141 2.74 2.7387 1.0 2073251 Maybridge1_007255 CNC(=S)NNC(=N)c1ccccn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B18 compound treatment 0.9906 -0.00938 -0.18 -0.1821 -1.0 2073252 Maybridge1_007256 COC(=O)c1cc2CS(=O)(=O)c3ccc(Cl)cc3-c2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B19 compound treatment 1.0109 0.0109 0.21 0.2111 1.0 1046067 Maybridge1_007257 CCOC(=O)c1csnn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B20 compound treatment 0.9639 -0.0361 -0.7 -0.7017 -1.0 1429277 Maybridge1_007258 COC(=O)C1=C(C)NC(=C(C1c2ccc(o2)c3ccsc3C(=O)OC)C(=O)OC)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B21 compound treatment 0.9624 -0.0376 -0.73 -0.7298 -1.0 1596341 Maybridge1_007259 CC(C)(CC(=O)O)Sc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B22 compound treatment 0.9848 -0.0152 -0.29 -0.2944 -1.0 2073253 Maybridge1_007260 CC(=O)c1ccc(s1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B23 mock treatment 1.0181 0.0181 0.35 0.3515 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 B24 mock treatment 1.013 0.013 0.25 0.2532 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C01 compound treatment 1.0564 0.0564 1.1 1.0957 1.0 2073254 Maybridge1_007261 CCOC(=O)c1ccc(NC(=S)N2CCN(CC2)C(=S)Nc3ccc(cc3)C(=O)OCC)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C02 compound treatment 1.0058 0.00581 0.11 0.1128 1.0 2073255 Maybridge1_007262 Clc1ccc(C2SCC(=O)N2c3ccccn3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C03 compound treatment 1.0412 0.0412 0.8 0.8008 1.0 2073256 Maybridge1_007263 C/C(=C\c1ccccc1)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C04 compound treatment 1.0058 0.00581 0.11 0.1128 1.0 2073257 Maybridge1_007264 CC(SCSC(C)C(=O)O)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C05 compound treatment 1.0044 0.00436 0.08 0.0847 1.0 2073258 Maybridge1_007265 Cc1ccc(NC(=S)NNC(C)(C)C)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C06 compound treatment 1.0029 0.00291 0.06 0.0566 1.0 2073259 Maybridge1_007266 COc1cccc(/C=C/[N+](=O)[O-])c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C07 compound treatment 1.021 0.021 0.41 0.4077 1.0 2073260 Maybridge1_007267 CCCCCCCCCCCCSc1nnc(N)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C08 compound treatment 0.9885 -0.0115 -0.22 -0.2242 -1.0 1142484 Maybridge1_007268 Fc1cccc(Cl)c1C2NC(=O)c3ccccc3N2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C09 compound treatment 0.9993 -7.0E-4 -0.01 -0.0136 -1.0 1706531 Maybridge1_007269 O=C1CSC(N1c2ccc(cc2)C3CCCCC3)c4cccnc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C10 compound treatment 1.0 2.26E-5 0.0 4.0E-4 1.0 2073261 Maybridge1_007270 COc1cc(OC)cc(c1)N2C(=O)C=CC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C11 compound treatment 0.987 -0.013 -0.25 -0.2523 -1.0 1664547 Maybridge1_007271 CCCc1ccc(NC(=S)NC(=O)c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C12 compound treatment 0.9776 -0.0224 -0.43 -0.4349 -1.0 2073262 Maybridge1_007272 COc1cc(OC)cc(/C=C/2\CCc3ccccc3C2=O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C13 compound treatment 1.0376 0.0376 0.73 0.7306 1.0 2073263 Maybridge1_007273 C/C(=C\c1ccc(C#N)cc1)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C14 compound treatment 0.987 -0.013 -0.25 -0.2523 -1.0 2073264 Maybridge1_007274 [O-][N+](=O)/C=C/c1cccc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C15 compound treatment 0.9877 -0.0123 -0.24 -0.2383 -1.0 1139439 Maybridge1_007275 Cc1cc(no1)N2C(SCC2=O)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C16 compound treatment 0.9733 -0.0267 -0.52 -0.5191 -1.0 1204560 Maybridge1_007276 CSc1ccc(cc1)C(=O)C(CC(=O)c2ccc(Cl)cc2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C17 compound treatment 1.0109 0.0109 0.21 0.2111 1.0 2073265 Maybridge1_007277 CC1CC(=O)N(C(=O)C1)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C18 compound treatment 0.9545 -0.0455 -0.88 -0.8842 -1.0 2073266 Maybridge1_007278 Cc1cc(Cl)ccc1NC(=O)/C=N/O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C19 compound treatment 0.9588 -0.0412 -0.8 -0.8 -1.0 2073267 Maybridge1_007279 CCOC(=O)c1ccc(cc1)N2C(=O)C3CCC(C)CC3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C20 compound treatment 0.9834 -0.0166 -0.32 -0.3225 -1.0 2073268 Maybridge1_007280 COc1ccc(cc1)C2Oc3ccc(Cl)cc3C=C2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C21 compound treatment 0.9574 -0.0426 -0.83 -0.828 -1.0 1934763 Maybridge1_007281 CCOC(=O)C1=C(C)NC(=S)NC1c2cccc(Br)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C22 compound treatment 0.9624 -0.0376 -0.73 -0.7298 -1.0 1145248 Maybridge1_007282 Fc1ccc(NC2CC(=O)N(C2=O)c3ccc(F)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C23 mock treatment 1.013 0.013 0.25 0.2532 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 C24 mock treatment 1.0 2.26E-5 0.0 4.0E-4 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D01 compound treatment 1.034 0.034 0.66 0.6604 1.0 2073269 Maybridge1_007283 C/C(=N\Cc1ccc(F)cc1)/c2ccccc2O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D02 compound treatment 1.042 0.042 0.81 0.8149 1.0 1601159 Maybridge1_007284 OC(=O)C1CN(Cc2ccc(Cl)cc2)C(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D03 compound treatment 1.0412 0.0412 0.8 0.8008 1.0 1337825 Maybridge1_007285 S=C1SCN(Cc2ccncc2)CN1Cc3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D04 compound treatment 1.0022 0.00219 0.04 0.0426 1.0 2073270 Maybridge1_007286 Cc1ccc(C)n1c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D05 compound treatment 1.021 0.021 0.41 0.4077 1.0 2073271 Maybridge1_007287 OC(=O)c1ccccc1NC(=O)/C=N/Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D06 compound treatment 1.0101 0.0101 0.2 0.197 1.0 2073272 Maybridge1_007288 COc1ccc(/C=N/c2ccc(cc2)c3csnn3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D07 compound treatment 1.0044 0.00436 0.08 0.0847 1.0 2073273 Maybridge1_007289 O=C(NC(=S)Nc1cccnc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D08 compound treatment 1.0015 0.00147 0.03 0.0285 1.0 2073274 Maybridge1_007290 Cc1cc(C(=O)C(F)(F)F)c(C)n1c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D09 compound treatment 1.042 0.042 0.81 0.8149 1.0 2073275 Maybridge1_007291 O=C1/C(=C/c2cccnc2)/CCc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D10 compound treatment 0.9913 -0.00865 -0.17 -0.1681 -1.0 2073276 Maybridge1_007292 FC(F)(F)c1ccc(cc1)C(=O)NCCc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D11 compound treatment 0.9704 -0.0296 -0.58 -0.5753 -1.0 2073277 Maybridge1_007293 CC(C)c1ccc(/C=C/2\CCc3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D12 compound treatment 0.9776 -0.0224 -0.43 -0.4349 -1.0 2073278 Maybridge1_007294 CC(CSc1ccc(Cl)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D13 compound treatment 0.9588 -0.0412 -0.8 -0.8 -1.0 2073279 Maybridge1_007295 COC(=O)c1nnn(c1C(=O)OC)c2ccc(F)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D14 compound treatment 0.9841 -0.0159 -0.31 -0.3085 -1.0 2073280 Maybridge1_007296 OC(=O)CC(Sc1ccc(Cl)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D15 compound treatment 0.9906 -0.00938 -0.18 -0.1821 -1.0 1157422 Maybridge1_007297 CSc1nsc(SC)c1C(=O)NC(=O)Nc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D16 compound treatment 0.9668 -0.0332 -0.65 -0.6455 -1.0 2073281 Maybridge1_007298 N#CCc1ccc(cc1)c2nnco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D17 compound treatment 0.9653 -0.0347 -0.67 -0.6736 -1.0 2073282 Maybridge1_007299 COC(=O)c1sc(cc1CS(=O)(=O)c2ccc(Cl)cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D18 compound treatment 0.9624 -0.0376 -0.73 -0.7298 -1.0 2073283 Maybridge1_007300 Cc1ccc(cc1)c2ncns2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D19 compound treatment 0.9624 -0.0376 -0.73 -0.7298 -1.0 1282916 Maybridge1_007301 O=C(NC(=O)c1csnn1)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D20 compound treatment 0.9769 -0.0231 -0.45 -0.4489 -1.0 1487892 Maybridge1_007302 Cc1nc(C)c(C(=O)O)c(c2ccsc2)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D21 compound treatment 0.9964 -0.00359 -0.07 -0.0698 -1.0 2073284 Maybridge1_007303 CC(C)(C)c1ccc(OC(=O)c2csnn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D22 compound treatment 1.0051 0.00508 0.1 0.0987 1.0 2073285 Maybridge1_007304 Brc1ccc(s1)c2ccon2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D23 mock treatment 0.9523 -0.0477 -0.93 -0.9263 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 D24 mock treatment 0.9725 -0.0275 -0.53 -0.5332 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E01 compound treatment 1.0991 0.0991 1.92 1.9242 1.0 1541047 Maybridge1_007305 CCOC(=O)c1ccc(NC(=S)N(Cc2ccccc2)C(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E02 compound treatment 1.0188 0.0188 0.37 0.3655 1.0 2073286 Maybridge1_007306 C/C(=C\c1ccc(F)cc1)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E03 compound treatment 1.0181 0.0181 0.35 0.3515 1.0 2073287 Maybridge1_007307 CCCCCCCCCCCC/N=C(\C)/c1ccccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E04 compound treatment 0.9906 -0.00938 -0.18 -0.1821 -1.0 2073288 Maybridge1_007308 FC(F)(F)c1ccc(cc1)N2C(SCC2=O)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E05 compound treatment 0.9942 -0.00576 -0.11 -0.1119 -1.0 2073289 Maybridge1_007309 CC(C)(C)NNC(=S)Nc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E06 compound treatment 1.0145 0.0145 0.28 0.2813 1.0 2073290 Maybridge1_007310 Cn1c(N)c(C(C[N+](=O)[O-])c2ccc(Cl)cc2Cl)c(=O)n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E07 compound treatment 1.0051 0.00508 0.1 0.0987 1.0 1598300 Maybridge1_007311 Fc1ccccc1c2nc3ccccc3c(=O)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E08 compound treatment 0.9762 -0.0238 -0.46 -0.463 -1.0 2073291 Maybridge1_007312 CC(=O)c1ccccc1NC(=O)CSCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E09 compound treatment 0.9863 -0.0137 -0.27 -0.2664 -1.0 1607615 Maybridge1_007313 CCC(C)c1ccc(NCN2C(=O)c3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E10 compound treatment 0.995 -0.00504 -0.1 -0.0979 -1.0 2073292 Maybridge1_007314 FC(F)(F)c1ccc(cc1)c2nnc(S)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E11 compound treatment 1.0477 0.0477 0.93 0.9272 1.0 2073293 Maybridge1_007315 C/C(=C\c1c2ccccc2cc3ccccc13)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E12 compound treatment 0.9812 -0.0188 -0.36 -0.3647 -1.0 2073294 Maybridge1_007316 Cc1ccc(/C=C/2\CCc3ccccc3C2=O)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E13 compound treatment 1.0557 0.0557 1.08 1.0817 1.0 2073295 Maybridge1_007317 CSc1ccc(C=C(C#N)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E14 compound treatment 0.9791 -0.0209 -0.41 -0.4068 -1.0 2073296 Maybridge1_007318 O/N=C/C(=O)Nc1cc(Cl)ccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E15 compound treatment 0.9957 -0.00432 -0.08 -0.0838 -1.0 2073297 Maybridge1_007319 CSc1ccc(/C=C/2\N=C(OC2=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E16 compound treatment 0.9971 -0.00287 -0.06 -0.0557 -1.0 2073298 Maybridge1_007320 NC(=S)Nc1ccc(F)c(F)c1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E17 compound treatment 0.9892 -0.0108 -0.21 -0.2102 -1.0 2073299 Maybridge1_007321 [O-][N+](=O)C1CCC(=O)NC1C2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E18 compound treatment 1.0167 0.0167 0.32 0.3234 1.0 1034190 Maybridge1_007322 CC(=O)N1C(=O)c2ccccc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E19 compound treatment 1.0253 0.0253 0.49 0.4919 1.0 2073300 Maybridge1_007323 Cc1onc(c1C(=O)NC(=S)Nc2ccc(cc2)C(C)(C)C)c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E20 compound treatment 0.9089 -0.0911 -1.77 -1.7689 -1.0 2073301 Maybridge1_007324 Oc1cc2OCOc2cc1C(N3CCCCC3)c4ccc(cc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E21 compound treatment 1.0181 0.0181 0.35 0.3515 1.0 1007115 Maybridge1_007325 Cc1sc2ccccc2[n+]1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E22 compound treatment 1.0087 0.0087 0.17 0.1689 1.0 1071585 Maybridge1_007326 O=C1C=C(Nc2ccccc2)C(=O)N1c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E23 mock treatment 0.974 -0.026 -0.51 -0.5051 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 E24 mock treatment 0.9776 -0.0224 -0.43 -0.4349 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F01 compound treatment 1.0167 0.0167 0.32 0.3234 1.0 1199558 Maybridge1_007327 Cc1ccc(cc1)n2sc(=O)n(Cc3ccc(F)cc3)c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F02 compound treatment 1.0275 0.0275 0.53 0.534 1.0 2073302 Maybridge1_007328 OC(=O)C1CN(Cc2ccc(cc2)C(F)(F)F)C(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F03 compound treatment 0.9921 -0.00793 -0.15 -0.154 -1.0 1372305 Maybridge1_007329 Clc1ccc2n(CN3CCN(Cn4nnc5cc(Cl)ccc45)C3)nnc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F04 compound treatment 1.0058 0.00581 0.11 0.1128 1.0 2073303 Maybridge1_007330 FC(F)(F)c1ccccc1C(=O)NNc2ccc(cc2)c3csnn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F05 compound treatment 1.0318 0.0318 0.62 0.6183 1.0 1208089 Maybridge1_007331 COc1ccc(cc1)N2CSCc3nc4ccccc4n3C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F06 compound treatment 0.9754 -0.0246 -0.48 -0.477 -1.0 2073304 Maybridge1_007332 NC(=S)N/N=C/c1ccc(F)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F07 compound treatment 1.0087 0.0087 0.17 0.1689 1.0 1213772 Maybridge1_007333 O=C1NCCN=C(c2ccccc2)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F08 compound treatment 0.9733 -0.0267 -0.52 -0.5191 -1.0 2073305 Maybridge1_007334 N/C(=N\O)/c1ccc(cc1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F09 compound treatment 0.9776 -0.0224 -0.43 -0.4349 -1.0 2073306 Maybridge1_007335 Fc1ccc(/C=C/2\Cc3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F10 compound treatment 1.0094 0.00942 0.18 0.183 1.0 1212754 Maybridge1_007336 OC(=O)C1C(C2CC1C=C2)C(=O)Nc3ccc(cc3)c4cnco4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F11 compound treatment 0.9885 -0.0115 -0.22 -0.2242 -1.0 2073307 Maybridge1_007337 Clc1ccc(/C=C/2\CCc3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F12 compound treatment 0.9422 -0.0578 -1.12 -1.1229 -1.0 2073308 Maybridge1_007338 NS(=O)(=O)c1ccc(cc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F13 compound treatment 1.0253 0.0253 0.49 0.4919 1.0 2073309 Maybridge1_007339 Clc1cc(Cl)cc(N/C=N/C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F14 compound treatment 0.9791 -0.0209 -0.41 -0.4068 -1.0 1374387 Maybridge1_007340 COc1ccc(cc1)C2=NCCc3sccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F15 compound treatment 0.9957 -0.00432 -0.08 -0.0838 -1.0 2073310 Maybridge1_007341 CSc1nsc(SC)c1C(=O)NC(=O)Nc2cc(C)on2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F16 compound treatment 0.9812 -0.0188 -0.36 -0.3647 -1.0 2073311 Maybridge1_007342 Clc1ccc(OCc2ccsc2C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F17 compound treatment 0.9812 -0.0188 -0.36 -0.3647 -1.0 2073312 Maybridge1_007343 CC1CC(=O)c2cc(Cl)ccc2S1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F18 compound treatment 0.9754 -0.0246 -0.48 -0.477 -1.0 2073313 Maybridge1_007344 OC(=O)c1sccc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F19 compound treatment 0.9747 -0.0253 -0.49 -0.491 -1.0 1173364 Maybridge1_007345 O=C(NC(=O)c1csnn1)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F20 compound treatment 0.9725 -0.0275 -0.53 -0.5332 -1.0 2073314 Maybridge1_007346 COC(=O)c1cc2sccc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F21 compound treatment 0.9754 -0.0246 -0.48 -0.477 -1.0 2073315 Maybridge1_007347 [O-][N+](=O)c1ccc(cc1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F22 compound treatment 0.9451 -0.0549 -1.07 -1.0668 -1.0 2073316 Maybridge1_007348 Cc1cn(CCC#N)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F23 mock treatment 0.9906 -0.00938 -0.18 -0.1821 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 F24 mock treatment 1.0297 0.0297 0.58 0.5762 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G01 compound treatment 1.0665 0.0665 1.29 1.2923 1.0 1206001 Maybridge1_007349 CC1(C)CC(=O)C2=C(C1)NC3=C(C2c4cccs4)C(=O)CC(C)(C)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G02 compound treatment 1.0145 0.0145 0.28 0.2813 1.0 1304403 Maybridge1_007350 Cc1onc(c1C(=O)NCc2csc3ccccc23)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G03 compound treatment 1.0391 0.0391 0.76 0.7587 1.0 2073317 Maybridge1_007351 CCCCCCCCCCCCN1CSC(=S)N(CCCCCCCCCCCC)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G04 compound treatment 0.9993 -7.0E-4 -0.01 -0.0136 -1.0 2073318 Maybridge1_007352 C/C(=C\c1ccc(Cl)cc1Cl)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G05 compound treatment 0.9928 -0.00721 -0.14 -0.14 -1.0 2073319 Maybridge1_007353 CCOC(=O)c1ccc(NC(=S)NNC(C)(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G06 compound treatment 1.0716 0.0716 1.39 1.3906 1.0 2073320 Maybridge1_007354 COc1ccc(cc1)C(C[N+](=O)[O-])c2c(N)n(C)c(=O)n(C)c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G07 compound treatment 0.9979 -0.00215 -0.04 -0.0417 -1.0 2073321 Maybridge1_007355 Nc1ccccc1C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G08 compound treatment 1.0232 0.0232 0.45 0.4498 1.0 2073322 Maybridge1_007356 FC(F)(F)c1ccc(cc1)N2C(SCC2=O)c3ccccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G09 compound treatment 1.0138 0.0138 0.27 0.2672 1.0 2073323 Maybridge1_007357 O=C1N(CNc2cccc(C#C)c2)C(=O)c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G10 compound treatment 1.0007 7.46E-4 0.01 0.0145 1.0 2073324 Maybridge1_007358 COc1cc(OC)cc(/C=C(\C)/[N+](=O)[O-])c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G11 compound treatment 0.9979 -0.00215 -0.04 -0.0417 -1.0 1075529 Maybridge1_007359 OC(=O)CSCSCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G12 compound treatment 0.94 -0.06 -1.17 -1.1651 -1.0 2073325 Maybridge1_007360 COc1ccc(/C=C/2\CCc3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G13 compound treatment 1.0058 0.00581 0.11 0.1128 1.0 2073326 Maybridge1_007361 CSc1ccc(/C=C/[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G14 compound treatment 1.0101 0.0101 0.2 0.197 1.0 2073327 Maybridge1_007362 CCOC(=O)C1C(C(C(=O)OCC)C(O)(NC1(O)C(F)(F)F)C(F)(F)F)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G15 compound treatment 1.0188 0.0188 0.37 0.3655 1.0 2073328 Maybridge1_007363 Cc1ccc2oc(=S)[nH]c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G16 compound treatment 0.9841 -0.0159 -0.31 -0.3085 -1.0 2073329 Maybridge1_007364 FC(F)(F)Oc1ccc(NC2=NCCCS2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G17 compound treatment 1.0145 0.0145 0.28 0.2813 1.0 2073330 Maybridge1_007365 Clc1cc(Cl)cc(c1)N2C(=O)CCCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G18 compound treatment 0.9856 -0.0144 -0.28 -0.2804 -1.0 1921512 Maybridge1_007366 OCC12COC3N2C(OC1)c4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G19 compound treatment 0.9747 -0.0253 -0.49 -0.491 -1.0 2073331 Maybridge1_007367 CCC1(C)CC(=O)N(C(=O)C1)c2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G20 compound treatment 0.927 -0.073 -1.42 -1.4178 -1.0 2073332 Maybridge1_007368 Cc1ccccc1C(=O)N2N=C(Nc3ccccc3)SC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G21 compound treatment 0.9885 -0.0115 -0.22 -0.2242 -1.0 1016108 Maybridge1_007369 OC(=O)Cc1csc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G22 compound treatment 0.9856 -0.0144 -0.28 -0.2804 -1.0 2073333 Maybridge1_007370 COc1cccc(/C=C/[N+](=O)[O-])c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G23 mock treatment 1.0022 0.00219 0.04 0.0426 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 G24 mock treatment 0.9711 -0.0289 -0.56 -0.5612 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H01 compound treatment 1.0333 0.0333 0.65 0.6464 1.0 1642823 Maybridge1_007371 COc1ccccc1CCNC(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H02 compound treatment 1.0347 0.0347 0.67 0.6745 1.0 2073334 Maybridge1_007372 CSc1nnc(o1)c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H03 compound treatment 1.0087 0.0087 0.17 0.1689 1.0 1003758 Maybridge1_007373 NC(=O)NNc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H04 compound treatment 1.0109 0.0109 0.21 0.2111 1.0 2073335 Maybridge1_007374 Clc1cccc(c1)c2cnco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H05 compound treatment 0.9805 -0.0195 -0.38 -0.3787 -1.0 2073336 Maybridge1_007375 OC(=O)c1ccccc1C(=O)Nc2ccc(OC(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H06 compound treatment 1.0167 0.0167 0.32 0.3234 1.0 2073337 Maybridge1_007376 C(=N/c1ccc(cc1)c2csnn2)\c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H07 compound treatment 1.0145 0.0145 0.28 0.2813 1.0 1584836 Maybridge1_007377 O=c1n(CN2CCCCC2)nc(c3ccccc3)c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H08 compound treatment 1.0 2.26E-5 0.0 4.0E-4 1.0 2073338 Maybridge1_007378 N/C(=N\OC(=O)c1ccccc1)/c2ccc(cc2)c3csnn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H09 compound treatment 0.9762 -0.0238 -0.46 -0.463 -1.0 1403274 Maybridge1_007379 CN1CNc2c(C1)c(=O)n(C)c(=O)n2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H10 compound treatment 1.013 0.013 0.25 0.2532 1.0 2073339 Maybridge1_007380 COC(=O)CSc1nc2ccc(Cl)cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H11 compound treatment 0.9812 -0.0188 -0.36 -0.3647 -1.0 1098997 Maybridge1_007381 CCC1(O)C(=O)OCc2c1cc3-c4nc5ccccc5cc4Cn3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H12 compound treatment 0.9921 -0.00793 -0.15 -0.154 -1.0 1452355 Maybridge1_007382 CC(CS(=O)(=O)c1ccc(Cl)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H13 compound treatment 1.0087 0.0087 0.17 0.1689 1.0 2073340 Maybridge1_007383 CSc1nc(N)c(C#N)n1Cc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H14 compound treatment 1.0181 0.0181 0.35 0.3515 1.0 1422458 Maybridge1_007384 COc1ccc(cc1)C2NCCc3sccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H15 compound treatment 0.9877 -0.0123 -0.24 -0.2383 -1.0 1702639 Maybridge1_007385 Clc1cc(Cl)c2nc(sc2c1)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H16 compound treatment 0.9798 -0.0202 -0.39 -0.3927 -1.0 2073341 Maybridge1_007386 Cc1ccc(C)n1c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H17 compound treatment 1.0174 0.0174 0.34 0.3375 1.0 2073342 Maybridge1_007387 CCOC(=O)N/N=C/1\CC(C)S(=O)(=O)c2ccc(Cl)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H18 compound treatment 1.0065 0.00653 0.13 0.1268 1.0 2073343 Maybridge1_007388 Cc1noc(C)c1C(=O)NC(=N)C2(CC3CC4CC(C3)C2)C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H19 compound treatment 0.9899 -0.0101 -0.2 -0.1962 -1.0 2073344 Maybridge1_007389 O=C(NC(=O)c1csnn1)Nc2ncccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H20 compound treatment 0.9603 -0.0397 -0.77 -0.7719 -1.0 2073345 Maybridge1_007390 FC(F)(F)c1ccc(/C=C\2/CSc3sccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H21 compound treatment 0.961 -0.039 -0.76 -0.7578 -1.0 2073346 Maybridge1_007391 Cc1noc(C)c1c2nc(CSc3ccc(Cl)cc3)no2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H22 compound treatment 1.0116 0.0116 0.23 0.2251 1.0 1358842 Maybridge1_007392 Cc1cn(CCC(=O)O)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H23 mock treatment 0.9668 -0.0332 -0.65 -0.6455 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 H24 mock treatment 1.0441 0.0441 0.86 0.857 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I01 compound treatment 1.0065 0.00653 0.13 0.1268 1.0 2073347 Maybridge1_007393 CC1(C)CC(=O)C2=C(C1)NC3=C(C2c4ccc(s4)[N+](=O)[O-])C(=O)CC(C)(C)C3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I02 compound treatment 1.0593 0.0593 1.15 1.1519 1.0 2073348 Maybridge1_007394 FC(F)(F)c1ccc(cc1)C(=O)OCCc2csc3ccccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I03 compound treatment 1.0051 0.00508 0.1 0.0987 1.0 1609960 Maybridge1_007395 Clc1ccc(cc1Cl)N2C(SCC2=O)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I04 compound treatment 1.0058 0.00581 0.11 0.1128 1.0 2073349 Maybridge1_007396 NC(=N)SCc1cc2ccccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I05 compound treatment 1.0007 7.46E-4 0.01 0.0145 1.0 2073350 Maybridge1_007397 CC(C)(C)NNC(=S)Nc1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I06 compound treatment 0.9856 -0.0144 -0.28 -0.2804 -1.0 2073351 Maybridge1_007398 Cn1c(N)c(C(C[N+](=O)[O-])c2ccccc2Cl)c(=O)n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I07 compound treatment 1.0297 0.0297 0.58 0.5762 1.0 2073352 Maybridge1_007399 N#CCCSc1nc2ccccc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I08 compound treatment 0.9841 -0.0159 -0.31 -0.3085 -1.0 1689513 Maybridge1_007400 Clc1ccc(cc1)N2C(=O)c3ccncc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I09 compound treatment 1.0463 0.0463 0.9 0.8991 1.0 1648925 Maybridge1_007401 Nc1ccccc1SC2CC(=O)N(C2=O)c3ccccc3Oc4ccc(Cl)cc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I10 compound treatment 0.9986 -0.00142 -0.03 -0.0276 -1.0 2073353 Maybridge1_007402 COc1cc(OC)cc(c1)C2NC(CS2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I11 compound treatment 0.9783 -0.0217 -0.42 -0.4208 -1.0 2073354 Maybridge1_007403 OC(=O)CCSCSCCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I12 compound treatment 1.0167 0.0167 0.32 0.3234 1.0 1184785 Maybridge1_007404 CC1(C)CC2=C(C3CCCCC3O2)C(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I13 compound treatment 1.0217 0.0217 0.42 0.4217 1.0 2073355 Maybridge1_007405 [O-][N+](=O)c1cc(ccc1N2CCSCC2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I14 compound treatment 0.9805 -0.0195 -0.38 -0.3787 -1.0 2073356 Maybridge1_007406 CCOC(=O)C1C(C(C(=O)OCC)C(O)(NC1(O)C(F)(F)F)C(F)(F)F)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I15 compound treatment 1.0246 0.0246 0.48 0.4779 1.0 1421594 Maybridge1_007407 S=C1SCN(CC2CC2)CN1CC3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I16 compound treatment 0.9733 -0.0267 -0.52 -0.5191 -1.0 2073357 Maybridge1_007408 CCOC(=O)C1C(C(C(=O)OCC)C(O)(NC1(O)C(F)(F)F)C(F)(F)F)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I17 compound treatment 1.0282 0.0282 0.55 0.5481 1.0 2073358 Maybridge1_007409 [O-][N+](=O)/C=C/c1cc(Br)cs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I18 compound treatment 0.9277 -0.0723 -1.4 -1.4038 -1.0 2073359 Maybridge1_007410 Clc1ccc(cc1Cl)N2CCCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I19 compound treatment 0.9856 -0.0144 -0.28 -0.2804 -1.0 1413447 Maybridge1_007411 OC(=O)COCC(=O)Nc1ccc(I)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I20 compound treatment 0.9617 -0.0383 -0.74 -0.7438 -1.0 2073360 Maybridge1_007412 CC(C)(C)c1ccc(cc1)C(=O)N2N=C(Nc3ccccc3)SC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I21 compound treatment 1.0022 0.00219 0.04 0.0426 1.0 2073361 Maybridge1_007413 C/C(=C\c1ccc2OCOc2c1)/[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I22 compound treatment 0.9407 -0.0593 -1.15 -1.151 -1.0 2073362 Maybridge1_007414 CCOC(=O)CNc1ccc(OC(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I23 mock treatment 1.0094 0.00942 0.18 0.183 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 I24 mock treatment 0.9603 -0.0397 -0.77 -0.7719 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J01 compound treatment 1.0326 0.0326 0.63 0.6323 1.0 2073363 Maybridge1_007415 NC(=O)NCc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J02 compound treatment 0.9711 -0.0289 -0.56 -0.5612 -1.0 1162604 Maybridge1_007416 CNc1scnc1S(=O)(=O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J03 compound treatment 1.0188 0.0188 0.37 0.3655 1.0 2073364 Maybridge1_007417 CC(C)c1ccc(/C=C/[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J04 compound treatment 0.9675 -0.0325 -0.63 -0.6315 -1.0 2073365 Maybridge1_007418 Cn1ncc2C(=O)CS(=O)(=O)Cc21 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J05 compound treatment 1.0203 0.0203 0.39 0.3936 1.0 2073366 Maybridge1_007419 NC(=S)/C(=C/c1ccc(Cl)cc1Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J06 compound treatment 1.0159 0.0159 0.31 0.3094 1.0 1079133 Maybridge1_007420 Cc1nc(C#N)c(C#N)nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J07 compound treatment 1.0391 0.0391 0.76 0.7587 1.0 2073367 Maybridge1_007421 CCCCCCCCCCCCSC(=S)c1c(C)nn(c1O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J08 compound treatment 0.9819 -0.0181 -0.35 -0.3506 -1.0 2073368 Maybridge1_007422 N/C(=N\OC(=O)c1ccc(Cl)cc1)/c2ccc(cc2)c3csnn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J09 compound treatment 1.0181 0.0181 0.35 0.3515 1.0 1611910 Maybridge1_007423 Cn1c2NCN(Cc2c(=O)n(C)c1=O)C3CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J10 compound treatment 0.9993 -7.0E-4 -0.01 -0.0136 -1.0 2073369 Maybridge1_007424 NC(=O)CSc1nc2ccc(Cl)cc2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J11 compound treatment 0.9863 -0.0137 -0.27 -0.2664 -1.0 2073370 Maybridge1_007425 COC(=O)c1nnn(c1O)c2ccc(cc2)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J12 compound treatment 1.0521 0.0521 1.01 1.0115 1.0 2073371 Maybridge1_007426 CCOC(=O)c1cnc2SCCn2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J13 compound treatment 0.9921 -0.00793 -0.15 -0.154 -1.0 1205660 Maybridge1_007427 CC(C)Oc1cccc(NC(=O)c2ccccc2C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J14 compound treatment 1.0058 0.00581 0.11 0.1128 1.0 2073372 Maybridge1_007428 CCOC(=O)c1ncoc1c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J15 compound treatment 1.0109 0.0109 0.21 0.2111 1.0 1161071 Maybridge1_007429 Clc1cc(Cl)c2nc(sc2c1)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J16 compound treatment 0.9733 -0.0267 -0.52 -0.5191 -1.0 2073373 Maybridge1_007430 Cc1ccc(C)n1c2ccc(/C=N/Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J17 compound treatment 1.0015 0.00147 0.03 0.0285 1.0 1039635 Maybridge1_007431 Clc1ccc2SCCC(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J18 compound treatment 0.9762 -0.0238 -0.46 -0.463 -1.0 2073374 Maybridge1_007432 COC(=O)c1sccc1c2ccc(o2)C(=O)/C=C/N(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J19 compound treatment 0.9704 -0.0296 -0.58 -0.5753 -1.0 2073375 Maybridge1_007433 O=C(NC(=O)c1csnn1)Nc2nc3ccccc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J20 compound treatment 1.0282 0.0282 0.55 0.5481 1.0 2073376 Maybridge1_007434 FC(F)(F)Oc1ccc(cc1)C2=NCCc3sccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J21 compound treatment 0.9798 -0.0202 -0.39 -0.3927 -1.0 1196266 Maybridge1_007435 Cc1noc(C)c1c2nc(CSc3ccccn3)no2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J22 compound treatment 0.9906 -0.00938 -0.18 -0.1821 -1.0 2073377 Maybridge1_007436 Cc1c2C(=O)CCn2c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J23 mock treatment 0.9971 -0.00287 -0.06 -0.0557 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 J24 mock treatment 1.0224 0.0224 0.44 0.4357 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K01 compound treatment 1.2386 0.239 4.63 4.6344 1.0 2073378 Maybridge1_007437 CC1=N/C(=C\c2ccc3OCOc3c2)/C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K02 compound treatment 0.9906 -0.00938 -0.18 -0.1821 -1.0 2073379 Maybridge1_007438 OC(=O)CS/C=C/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K03 compound treatment 1.0253 0.0253 0.49 0.4919 1.0 2073380 Maybridge1_007439 Cc1ccc(CSc2ccccc2[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K04 compound treatment 0.9754 -0.0246 -0.48 -0.477 -1.0 1661485 Maybridge1_007440 Cc1cccc(c1O)C2(O)C(=O)c3ccccc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K05 compound treatment 1.0123 0.0123 0.24 0.2392 1.0 2073381 Maybridge1_007441 O=C(Nc1ccccc1)OCCSc2nc3ccccc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K06 compound treatment 1.0492 0.0492 0.96 0.9553 1.0 2073382 Maybridge1_007442 COc1cccc(/C=C(\C)/[N+](=O)[O-])c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K07 compound treatment 1.0261 0.0261 0.51 0.506 1.0 2073383 Maybridge1_007443 Cc1cc(Br)c(NC(=S)N)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K08 compound treatment 1.0094 0.00942 0.18 0.183 1.0 2073384 Maybridge1_007444 CC1=CC(=O)N(C1=O)c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K09 compound treatment 0.9986 -0.00142 -0.03 -0.0276 -1.0 1186215 Maybridge1_007445 OC(=O)CCC(=O)Nc1ccccc1Oc2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K10 compound treatment 0.9906 -0.00938 -0.18 -0.1821 -1.0 2073385 Maybridge1_007446 NC(=S)N/N=C/c1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K11 compound treatment 1.0456 0.0456 0.89 0.8851 1.0 1112791 Maybridge1_007447 COc1ccc(cc1)C(=C2C=CC(=NO)C=C2)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K12 compound treatment 0.9834 -0.0166 -0.32 -0.3225 -1.0 1047662 Maybridge1_007448 C1CN=C(C(=N1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K13 compound treatment 1.0051 0.00508 0.1 0.0987 1.0 2073386 Maybridge1_007449 C/C(=N\NC(=O)N)/c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K14 compound treatment 0.9711 -0.0289 -0.56 -0.5612 -1.0 2073387 Maybridge1_007450 CCOC(=O)C1C(C(C(=O)OCC)C(O)(NC1(O)C(F)(F)F)C(F)(F)F)c2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K15 compound treatment 1.0116 0.0116 0.23 0.2251 1.0 2073388 Maybridge1_007451 Fc1ccc(cc1Cl)N2C(=O)CSCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K16 compound treatment 0.9805 -0.0195 -0.38 -0.3787 -1.0 1171426 Maybridge1_007452 CCOC(=O)Nc1cc(ccc1C(=O)OC)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K17 compound treatment 1.0145 0.0145 0.28 0.2813 1.0 2073389 Maybridge1_007453 CC(C)(CC(=O)O)CC(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K18 compound treatment 0.9407 -0.0593 -1.15 -1.151 -1.0 2073390 Maybridge1_007454 CN(C)/N=C/c1ccc(o1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K19 compound treatment 1.008 0.00798 0.15 0.1549 1.0 2073391 Maybridge1_007455 Ic1ccc(cc1)N2C(=O)COCC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K20 compound treatment 0.9646 -0.0354 -0.69 -0.6876 -1.0 1391986 Maybridge1_007456 Cc1ccc(cc1)n2c(SCC(=O)C(C)(C)C)nc3ccc(C)cc3c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K21 compound treatment 0.9848 -0.0152 -0.29 -0.2944 -1.0 2073392 Maybridge1_007457 NC(=N)SCc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K22 compound treatment 0.9588 -0.0412 -0.8 -0.8 -1.0 1920845 Maybridge1_007458 CCOC(=O)CNc1ccc(I)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K23 mock treatment 1.0022 0.00219 0.04 0.0426 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 K24 mock treatment 0.9841 -0.0159 -0.31 -0.3085 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L01 compound treatment 1.0369 0.0369 0.72 0.7166 1.0 2073393 Maybridge1_007459 Cc1ccc(OC(=O)c2ccc(cc2)C(F)(F)F)c(NC(=O)c3ccc(cc3)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L02 compound treatment 0.9798 -0.0202 -0.39 -0.3927 -1.0 2073394 Maybridge1_007460 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L03 compound treatment 1.0355 0.0355 0.69 0.6885 1.0 2073395 Maybridge1_007461 CC(C)c1ccc(/C=C/2\N=C(OC2=O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L04 compound treatment 1.0383 0.0383 0.74 0.7447 1.0 2073396 Maybridge1_007462 Cc1ccc(C)n1c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L05 compound treatment 0.9631 -0.0369 -0.72 -0.7157 -1.0 1293252 Maybridge1_007463 COc1ccccc1CNC(=S)NCCO 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L06 compound treatment 1.0188 0.0188 0.37 0.3655 1.0 1271776 Maybridge1_007464 Clc1ccc(cc1)C2N(CCc3sccc23)C(=O)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L07 compound treatment 1.008 0.00798 0.15 0.1549 1.0 2073397 Maybridge1_007465 CC1=NN(C(=O)C1=C2SCCS2)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L08 compound treatment 0.9942 -0.00576 -0.11 -0.1119 -1.0 2073398 Maybridge1_007466 NC(=S)c1ccc(cc1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L09 compound treatment 1.021 0.021 0.41 0.4077 1.0 1495976 Maybridge1_007467 Cn1c2NCN(CCO)Cc2c(=O)n(C)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L10 compound treatment 0.9523 -0.0477 -0.93 -0.9263 -1.0 2073399 Maybridge1_007468 CCOC(=O)c1cc(C)nn1c2nc3ccc(Cl)cc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L11 compound treatment 1.0015 0.00147 0.03 0.0285 1.0 1483326 Maybridge1_007469 COc1ccc(cc1)c2nnn(c2N)c3cc(Cl)cc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L12 compound treatment 0.9928 -0.00721 -0.14 -0.14 -1.0 1268448 Maybridge1_007470 O=C(Nc1ccccc1)c2ncoc2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L13 compound treatment 1.013 0.013 0.25 0.2532 1.0 2073400 Maybridge1_007471 CC(C)Oc1cccc(NC(=O)c2ccccc2C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L14 compound treatment 1.0376 0.0376 0.73 0.7306 1.0 2073401 Maybridge1_007472 Fc1ccc2OC/C(=C\c3ccc(Cl)cc3)/C(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L15 compound treatment 0.9725 -0.0275 -0.53 -0.5332 -1.0 2073402 Maybridge1_007473 FC(F)(F)c1ccc(cc1)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L16 compound treatment 0.9668 -0.0332 -0.65 -0.6455 -1.0 2073403 Maybridge1_007474 Cc1oc(nc1c2ccccc2)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L17 compound treatment 0.9436 -0.0564 -1.09 -1.0949 -1.0 2073404 Maybridge1_007475 CC1c2snnc2-c3cc(Cl)ccc3S1(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L18 compound treatment 1.0044 0.00436 0.08 0.0847 1.0 2073405 Maybridge1_007476 Cc1n[nH]cc1c2nsc(Nc3ccccc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L19 compound treatment 0.9407 -0.0593 -1.15 -1.151 -1.0 2073406 Maybridge1_007477 c1snnc1c2nc(no2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L20 compound treatment 1.0073 0.00725 0.14 0.1409 1.0 1345036 Maybridge1_007478 COC(=O)C1=C(C)NC(=C(C1c2ccc(OC)cc2)C(=O)OC)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L21 compound treatment 0.966 -0.034 -0.66 -0.6595 -1.0 2073407 Maybridge1_007479 Cc1ccc(cc1)c2cnco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L22 compound treatment 1.0116 0.0116 0.23 0.2251 1.0 2073408 Maybridge1_007480 N#Cc1ccc(s1)c2ccon2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L23 mock treatment 1.0007 7.46E-4 0.01 0.0145 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 L24 mock treatment 1.0116 0.0116 0.23 0.2251 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M01 compound treatment 1.0796 0.0796 1.55 1.5451 1.0 2073409 Maybridge1_007481 CC(=O)N1C(=O)c2ccc(cc2C1=O)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M02 compound treatment 0.9885 -0.0115 -0.22 -0.2242 -1.0 2073410 Maybridge1_007482 OC(=O)CS(=O)(=O)/C=C/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M03 compound treatment 0.9689 -0.0311 -0.6 -0.6034 -1.0 2073411 Maybridge1_007483 CC(C)(C)NNC(=S)Nc1cccc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M04 compound treatment 0.9819 -0.0181 -0.35 -0.3506 -1.0 2073412 Maybridge1_007484 [O-][N+](=O)/C=C/c1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M05 compound treatment 0.9971 -0.00287 -0.06 -0.0557 -1.0 2073413 Maybridge1_007485 Clc1ccc(NC(=O)OCCSc2nc3ccccc3s2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M06 compound treatment 0.9819 -0.0181 -0.35 -0.3506 -1.0 2073414 Maybridge1_007486 NC(=S)Nc1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M07 compound treatment 1.0463 0.0463 0.9 0.8991 1.0 2073415 Maybridge1_007487 COc1ccc(cc1)C2Oc3ccccc3C=C2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M08 compound treatment 1.0181 0.0181 0.35 0.3515 1.0 2073416 Maybridge1_007488 Clc1ccc(c(Cl)c1)c2nc3ccc(I)cc3c(=O)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M09 compound treatment 1.0145 0.0145 0.28 0.2813 1.0 1268324 Maybridge1_007489 Clc1ccc(Oc2ccccc2N3C(=O)CCC3=O)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M10 compound treatment 0.9631 -0.0369 -0.72 -0.7157 -1.0 1089151 Maybridge1_007490 c1ccc(cc1)c2nnc(nc2c3ccccc3)c4ccccn4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M11 compound treatment 0.9971 -0.00287 -0.06 -0.0557 -1.0 1067264 Maybridge1_007491 COc1ccc(CC(=O)NN)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M12 compound treatment 0.974 -0.026 -0.51 -0.5051 -1.0 1034877 Maybridge1_007492 c1ccc(cc1)c2nccnc2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M13 compound treatment 1.0268 0.0268 0.52 0.52 1.0 2073417 Maybridge1_007493 Fc1cccc(Cl)c1/C=C/2\NC(=S)NC2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M14 compound treatment 0.9675 -0.0325 -0.63 -0.6315 -1.0 2073418 Maybridge1_007494 OCC12COC(N2C(OC1)c3ccc(cc3)[N+](=O)[O-])c4ccc(cc4)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M15 compound treatment 1.0145 0.0145 0.28 0.2813 1.0 2073419 Maybridge1_007495 OC(=O)COCC(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M16 compound treatment 0.9299 -0.0701 -1.36 -1.3617 -1.0 1413903 Maybridge1_007496 Cc1csc2c(=O)n(CCO)c(=O)[nH]c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M17 compound treatment 1.021 0.021 0.41 0.4077 1.0 1267085 Maybridge1_007497 COc1ccc(OC)c(NC(=O)CSCC(=O)O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M18 compound treatment 0.9639 -0.0361 -0.7 -0.7017 -1.0 1066415 Maybridge1_007498 O=C1Nc2ccccc2C31OCCO3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M19 compound treatment 0.9856 -0.0144 -0.28 -0.2804 -1.0 2073420 Maybridge1_007499 [O-][N+](=O)/C=C/c1ccsc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M20 compound treatment 0.9501 -0.0499 -0.97 -0.9685 -1.0 1255373 Maybridge1_007500 O=C1NC2(CCN(Cc3ccccc3)CC2)Oc4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M21 compound treatment 0.995 -0.00504 -0.1 -0.0979 -1.0 1912573 Maybridge1_007501 NC(=N)SCc1ccccc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M22 compound treatment 0.9942 -0.00576 -0.11 -0.1119 -1.0 1525218 Maybridge1_007502 CCOC(=O)CNc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M23 mock treatment 0.9639 -0.0361 -0.7 -0.7017 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 M24 mock treatment 0.9848 -0.0152 -0.29 -0.2944 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N01 compound treatment 1.0261 0.0261 0.51 0.506 1.0 2073421 Maybridge1_007503 Clc1ccc(OC(=O)c2cc(Cl)cc(Cl)c2)c(NC(=O)c3cc(Cl)cc(Cl)c3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N02 compound treatment 1.0094 0.00942 0.18 0.183 1.0 1603122 Maybridge1_007504 OC(=O)C1CN(C(=O)C1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N03 compound treatment 0.987 -0.013 -0.25 -0.2523 -1.0 2073422 Maybridge1_007505 Oc1nc(c2cccs2)n(n1)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N04 compound treatment 1.0087 0.0087 0.17 0.1689 1.0 2073423 Maybridge1_007506 Cc1cc(C(=O)C(F)(F)F)c(C)n1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N05 compound treatment 1.0347 0.0347 0.67 0.6745 1.0 2073424 Maybridge1_007507 Cc1ccc(Cn2nn[nH]c2=S)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N06 compound treatment 1.0275 0.0275 0.53 0.534 1.0 1190115 Maybridge1_007508 Cc1cc(C(=O)O)c(C)n1c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N07 compound treatment 1.0261 0.0261 0.51 0.506 1.0 2073425 Maybridge1_007509 Clc1ccc(/C=C\2/Cc3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N08 compound treatment 0.9964 -0.00359 -0.07 -0.0698 -1.0 2073426 Maybridge1_007510 COc1ccc(cc1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N09 compound treatment 0.9827 -0.0173 -0.34 -0.3366 -1.0 2073427 Maybridge1_007511 O=C1/C(=C/c2cccs2)/CCc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N10 compound treatment 1.0477 0.0477 0.93 0.9272 1.0 2073428 Maybridge1_007512 CC1Sc2ccc(Cl)cc2-c3nc(N)ncc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N11 compound treatment 1.0065 0.00653 0.13 0.1268 1.0 1348357 Maybridge1_007513 COc1ccc(cc1)c2nnn(c2N)c3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N12 compound treatment 1.0015 0.00147 0.03 0.0285 1.0 1575425 Maybridge1_007514 OC(=O)c1cnc2SCCn2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N13 compound treatment 0.9805 -0.0195 -0.38 -0.3787 -1.0 1083393 Maybridge1_007515 CSc1nsc(SC)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N14 compound treatment 1.0355 0.0355 0.69 0.6885 1.0 2073429 Maybridge1_007516 CC(C)(C)c1ccc(s1)C(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N15 compound treatment 0.9913 -0.00865 -0.17 -0.1681 -1.0 2073430 Maybridge1_007517 NNC(=O)Cn1nnc(n1)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N16 compound treatment 0.9725 -0.0275 -0.53 -0.5332 -1.0 2073431 Maybridge1_007518 CCOC(=O)c1c(N)c(sc1Nc2ccccc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N17 compound treatment 0.9718 -0.0282 -0.55 -0.5472 -1.0 2073432 Maybridge1_007519 Clc1ccc2c(c1)C(=O)CCS2(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N18 compound treatment 0.9509 -0.0491 -0.95 -0.9544 -1.0 2073433 Maybridge1_007520 N/C(=N/OC(=O)c1ccsc1)/COc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N19 compound treatment 0.9545 -0.0455 -0.88 -0.8842 -1.0 2073434 Maybridge1_007521 Cc1ccc(cc1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N20 compound treatment 1.0116 0.0116 0.23 0.2251 1.0 1631791 Maybridge1_007522 COC(=O)c1c(C)nc(C)c(C(=O)OC)c1c2ccc(OC)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N21 compound treatment 0.9906 -0.00938 -0.18 -0.1821 -1.0 1614300 Maybridge1_007523 Fc1cccc(Cl)c1C(=O)Nc2ccc(cc2)c3csnn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N22 compound treatment 0.9646 -0.0354 -0.69 -0.6876 -1.0 2073435 Maybridge1_007524 COC(=O)c1nn(c(O)c1N=Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N23 mock treatment 0.9805 -0.0195 -0.38 -0.3787 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 N24 mock treatment 1.0224 0.0224 0.44 0.4357 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O01 compound treatment 1.0926 0.0926 1.8 1.7978 1.0 1596156 Maybridge1_007525 Clc1ccc(cc1)N2C(SCC2=O)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O02 compound treatment 0.9711 -0.0289 -0.56 -0.5612 -1.0 2073436 Maybridge1_007526 OC(=O)CCS/C=C/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O03 compound treatment 1.0564 0.0564 1.1 1.0957 1.0 2073437 Maybridge1_007527 COc1cccc(NC(=S)NNC(C)(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O04 compound treatment 1.0094 0.00942 0.18 0.183 1.0 2073438 Maybridge1_007528 CCOc1cc(=O)oc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O05 compound treatment 1.0159 0.0159 0.31 0.3094 1.0 1250787 Maybridge1_007529 O=C1CSC(N1Cc2cccs2)c3cccnc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O06 compound treatment 1.0015 0.00147 0.03 0.0285 1.0 2073439 Maybridge1_007530 NC(=O)NCc1cccc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O07 compound treatment 0.9906 -0.00938 -0.18 -0.1821 -1.0 2073440 Maybridge1_007531 [O-][N+](=O)C1=Cc2ccccc2OC1c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O08 compound treatment 1.0015 0.00147 0.03 0.0285 1.0 2073441 Maybridge1_007532 OC(=O)c1cc(I)ccc1NC(=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O09 compound treatment 1.0224 0.0224 0.44 0.4357 1.0 2073442 Maybridge1_007533 CSc1ccccc1NCN2C(=O)c3ccccc3C2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O10 compound treatment 0.9574 -0.0426 -0.83 -0.828 -1.0 2073443 Maybridge1_007534 c1ccc(nc1)c2nnc(c3ccccn3)c(n2)c4ccccn4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O11 compound treatment 0.9819 -0.0181 -0.35 -0.3506 -1.0 1400974 Maybridge1_007535 COc1ccc(Cc2nnc(S)n2c3ccc(Cl)cc3)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O12 compound treatment 0.9791 -0.0209 -0.41 -0.4068 -1.0 1019170 Maybridge1_007536 CC(=O)c1cc2ccccc2o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O13 compound treatment 1.0101 0.0101 0.2 0.197 1.0 1516762 Maybridge1_007537 COc1cc(cc(OC)c1OC)C(CC(=O)O)CC(=O)Nc2cc(C)on2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O14 compound treatment 0.9819 -0.0181 -0.35 -0.3506 -1.0 2073444 Maybridge1_007538 Cc1cccc(NC2=NC(CO)(CO)CS2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O15 compound treatment 0.9957 -0.00432 -0.08 -0.0838 -1.0 1732801 Maybridge1_007539 CCOC(=O)CCn1c(=S)n(CCC(=O)OCC)c2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O16 compound treatment 0.9566 -0.0434 -0.84 -0.8421 -1.0 2073445 Maybridge1_007540 FC(F)(F)c1ccc(/C=C/2\Cc3ccccc3C2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O17 compound treatment 0.9957 -0.00432 -0.08 -0.0838 -1.0 2073446 Maybridge1_007541 CC1CCC2C(C1)C(=O)N(C2=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O18 compound treatment 1.7716 0.772 14.98 14.9834 1.0 2073447 Maybridge1_007542 COc1cccc(/C=C(\C#N)/C(=O)c2ccc(cc2)C(C)(C)C)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O19 compound treatment 0.9689 -0.0311 -0.6 -0.6034 -1.0 2073448 Maybridge1_007543 CCOC(=O)C1=C(C)NC(=S)NC1c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O20 compound treatment 1.0116 0.0116 0.23 0.2251 1.0 2073449 Maybridge1_007544 COc1ccc(OC)c(C=C2C(=O)OC(C)(C)OC2=O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O21 compound treatment 1.0253 0.0253 0.49 0.4919 1.0 2073450 Maybridge1_007545 NC(=N)SCc1c(F)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O22 compound treatment 0.9819 -0.0181 -0.35 -0.3506 -1.0 1081745 Maybridge1_007546 CCOC(=O)CNc1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O23 mock treatment 0.9986 -0.00142 -0.03 -0.0276 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 O24 mock treatment 1.0405 0.0405 0.79 0.7868 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P01 compound treatment 0.9986 -0.00142 -0.03 -0.0276 -1.0 2073451 Maybridge1_007547 Cc1ccc(NC(=O)c2ccc(cc2)C(F)(F)F)c(OC(=O)c3ccc(cc3)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P02 compound treatment 1.0239 0.0239 0.46 0.4638 1.0 2073452 Maybridge1_007548 NC(=N)SCc1ccc(cc1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P03 compound treatment 1.034 0.034 0.66 0.6604 1.0 2073453 Maybridge1_007549 COc1ccc(/N=C/2\SCC(=NN2C)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P04 compound treatment 1.0528 0.0528 1.03 1.0255 1.0 2073454 Maybridge1_007550 N#Cc1ccc(cc1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P05 compound treatment 1.0073 0.00725 0.14 0.1409 1.0 1928310 Maybridge1_007551 COc1cccc(/C=C\2/N=C(OC2=O)c3ccc(NC(=O)C)cc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P06 compound treatment 1.0449 0.0449 0.87 0.8711 1.0 2073455 Maybridge1_007552 Cc1cccc(Cl)c1/C=N/NC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P07 compound treatment 0.9725 -0.0275 -0.53 -0.5332 -1.0 2073456 Maybridge1_007553 O=C1/C(=C/c2ccccn2)/CCc3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P08 compound treatment 0.9928 -0.00721 -0.14 -0.14 -1.0 1363727 Maybridge1_007554 NC(=O)c1ccc(cc1)c2csnn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P09 compound treatment 1.0029 0.00291 0.06 0.0566 1.0 2073457 Maybridge1_007555 COc1ccc2C(=O)/C(=C/c3ccc(C)cc3)/CCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P10 compound treatment 1.0029 0.00291 0.06 0.0566 1.0 1449237 Maybridge1_007556 Clc1ccc(NC(=O)c2ccc(cc2)c3csnn3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P11 compound treatment 1.0116 0.0116 0.23 0.2251 1.0 2073458 Maybridge1_007557 CS/C(=N/C#N)/Nc1ccc(cc1)C(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P12 compound treatment 0.9552 -0.0448 -0.87 -0.8702 -1.0 2073459 Maybridge1_007558 OC(=O)CCOc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P13 compound treatment 1.0 2.26E-5 0.0 4.0E-4 1.0 1108926 Maybridge1_007559 CSc1nsc(SC)c1C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P14 compound treatment 0.9928 -0.00721 -0.14 -0.14 -1.0 2073460 Maybridge1_007560 Cc1cc(oc(=O)c1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P15 compound treatment 1.0036 0.00364 0.07 0.0706 1.0 2073461 Maybridge1_007561 N=C(NNC(=O)Nc1ccccc1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P16 compound treatment 1.0123 0.0123 0.24 0.2392 1.0 2073462 Maybridge1_007562 Cc1nc(C)c(o1)c2ccnc(n2)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P17 compound treatment 0.9805 -0.0195 -0.38 -0.3787 -1.0 1574791 Maybridge1_007563 CCOC(=O)C1CSC(=C(C)N1)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P18 compound treatment 0.9436 -0.0564 -1.09 -1.0949 -1.0 1137432 Maybridge1_007564 COC(=O)c1c(C)nc(C)c(C(=O)OC)c1c2ccsc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P19 compound treatment 0.9841 -0.0159 -0.31 -0.3085 -1.0 2073463 Maybridge1_007565 CC(C)(C)S(=O)(=O)/C(=C/c1ccc(F)cc1F)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P20 compound treatment 1.0051 0.00508 0.1 0.0987 1.0 2073464 Maybridge1_007566 FC(F)(F)Oc1ccc(cc1)C2NCCc3sccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P21 compound treatment 1.0159 0.0159 0.31 0.3094 1.0 1381208 Maybridge1_007567 CS(=O)(=O)c1nsc(c1C(=O)N)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P22 compound treatment 1.0203 0.0203 0.39 0.3936 1.0 2073465 Maybridge1_007568 CCOC(=O)c1cnc2ccc(cn2c1=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P23 mock treatment 0.9971 -0.00287 -0.06 -0.0557 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.562 P24 mock treatment 1.0174 0.0174 0.34 0.3375 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A01 compound treatment 1.0922 0.0922 1.79 1.7904 1.0 2073466 Maybridge1_007569 Clc1ccc(OS(=O)(=O)c2ccc(s2)c3ccc(s3)S(=O)(=O)Oc4ccc(Cl)c(Cl)c4)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A02 compound treatment 1.0237 0.0237 0.46 0.4603 1.0 2073467 Maybridge1_007570 COC(=O)c1ccc(CO/N=C(\N)/c2cc(Cl)c(N)c(Cl)c2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A03 compound treatment 1.0499 0.0499 0.97 0.9697 1.0 2073468 Maybridge1_007571 CN(C)S(=O)(=O)Oc1ccc(C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A04 compound treatment 0.9953 -0.00471 -0.09 -0.0915 -1.0 2073469 Maybridge1_007572 Cc1nn(c(O)c1N=Nc2cccc(c2)C(F)(F)F)c3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A05 compound treatment 1.0368 0.0368 0.71 0.715 1.0 2073470 Maybridge1_007573 CC(=O)Nc1ccccc1OCC(O)CNCc2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A06 compound treatment 1.0011 0.00112 0.02 0.0217 1.0 1226336 Maybridge1_007574 NNC(=O)Cc1csc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A07 compound treatment 1.0266 0.0266 0.52 0.5169 1.0 1488274 Maybridge1_007575 NC(=S)Nc1ccncc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A08 compound treatment 1.0222 0.0222 0.43 0.432 1.0 2073471 Maybridge1_007576 CCOC(=O)c1c(C)nn(c1C)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A09 compound treatment 1.0077 0.00767 0.15 0.149 1.0 2073472 Maybridge1_007577 NC(=O)c1sc(C#N)c(c1c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A10 compound treatment 1.0069 0.00694 0.13 0.1349 1.0 2073473 Maybridge1_007578 OCCSc1ccc(C#N)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A11 compound treatment 1.0222 0.0222 0.43 0.432 1.0 2073474 Maybridge1_007579 Fc1ccc(cc1)c2csc(Nc3cccnc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A12 compound treatment 0.9887 -0.0113 -0.22 -0.2189 -1.0 1655148 Maybridge1_007580 Fc1cccc(F)c1C(=O)N2CCC(CC2)C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A13 compound treatment 0.9938 -0.00617 -0.12 -0.1198 -1.0 2073475 Maybridge1_007581 OC(=O)c1c[nH]c2c(c(sc2c1=O)C(F)(F)F)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A14 compound treatment 0.9931 -0.0069 -0.13 -0.134 -1.0 2073476 Maybridge1_007582 CC1(C)C2CCC1(CS(=O)(=O)NCc3ccc(cc3)C(F)(F)F)C(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A15 compound treatment 1.0463 0.0463 0.9 0.8989 1.0 2073477 Maybridge1_007583 Brc1cc(sc1Br)S(=O)(=O)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A16 compound treatment 0.9785 -0.0215 -0.42 -0.417 -1.0 2073478 Maybridge1_007584 Cc1ccc(cc1)S(=O)(=O)NC(=O)NNC(=O)c2ccsc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A17 compound treatment 1.0186 0.0186 0.36 0.3613 1.0 2073479 Maybridge1_007585 Nc1nc(ncc1C#N)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A18 compound treatment 0.9887 -0.0113 -0.22 -0.2189 -1.0 1513083 Maybridge1_007586 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A19 compound treatment 0.9938 -0.00617 -0.12 -0.1198 -1.0 2073480 Maybridge1_007587 Cc1ccc(C=C2C(=O)OC(C)(C)OC2=O)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A20 compound treatment 0.9989 -0.00107 -0.02 -0.0208 -1.0 2073481 Maybridge1_007588 CCOC(=O)c1c(C)nn(c1C)c2ncccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A21 compound treatment 1.0426 0.0426 0.83 0.8282 1.0 2073482 Maybridge1_007589 O=C1CSC(=N1)Cc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A22 compound treatment 0.9997 -3.42E-4 -0.01 -0.0066 -1.0 2073483 Maybridge1_007590 COc1ccc2cc(ccc2c1)/C(=N/Oc3ncccc3[N+](=O)[O-])/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A23 mock treatment 0.9698 -0.0302 -0.59 -0.5868 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 A24 mock treatment 1.0237 0.0237 0.46 0.4603 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B01 compound treatment 1.0419 0.0419 0.81 0.814 1.0 2073484 Maybridge1_007591 COc1cc(CC(=O)NN)c(cc1OC)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B02 compound treatment 1.0179 0.0179 0.35 0.3471 1.0 2073485 Maybridge1_007592 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2c(Cl)cc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B03 compound treatment 1.0237 0.0237 0.46 0.4603 1.0 2073486 Maybridge1_007593 COC(=O)c1cccn1c2ccccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B04 compound treatment 1.0397 0.0397 0.77 0.7716 1.0 2073487 Maybridge1_007594 Cc1ccc(N/N=C/2\C(=O)Nc3ccc(F)cc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B05 compound treatment 1.0186 0.0186 0.36 0.3613 1.0 2073488 Maybridge1_007595 CCOC(=O)c1c(C)nn(c1C)c2ncccc2N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B06 compound treatment 1.0288 0.0288 0.56 0.5594 1.0 2073489 Maybridge1_007596 CC/C(=N\OC(=O)c1cccc(c1)C(F)(F)F)/c2ccc(cc2)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B07 compound treatment 1.0055 0.00549 0.11 0.1066 1.0 2073490 Maybridge1_007597 CC(=O)c1ccc(OCc2cc(F)cc(F)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B08 compound treatment 1.0135 0.0135 0.26 0.2622 1.0 2073491 Maybridge1_007598 Fc1ccccc1c2ccc(cc2)C(=O)Nc3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B09 compound treatment 0.9916 -0.00836 -0.16 -0.1623 -1.0 1021442 Maybridge1_007599 OC(C1CCCCC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B10 compound treatment 1.0055 0.00549 0.11 0.1066 1.0 1194389 Maybridge1_007600 NC(=S)Nc1ccccc1N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B11 compound treatment 0.9654 -0.0346 -0.67 -0.6717 -1.0 2073492 Maybridge1_007601 NC(=S)C1(CC1)c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B12 compound treatment 1.0077 0.00767 0.15 0.149 1.0 1411788 Maybridge1_007602 Cc1sc(Nc2ccccc2N3CCOCC3)nc1c4ccc(cc4)c5ccccc5F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B13 compound treatment 0.9836 -0.0164 -0.32 -0.3179 -1.0 2073493 Maybridge1_007603 CCOC(=O)Nc1cc(Cl)cc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B14 compound treatment 1.0091 0.00913 0.18 0.1773 1.0 2073494 Maybridge1_007604 COc1ccc(/C=N/c2ccc(OC)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B15 compound treatment 0.9924 -0.00763 -0.15 -0.1481 -1.0 2073495 Maybridge1_007605 Clc1sc(cc1Br)S(=O)(=O)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B16 compound treatment 1.0062 0.00622 0.12 0.1207 1.0 1351444 Maybridge1_007606 Cc1ccc(c2csc(N)n2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B17 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2073496 Maybridge1_007607 FC(F)(F)Oc1ccccc1NN=C(C#N)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B18 compound treatment 0.9807 -0.0193 -0.37 -0.3745 -1.0 2073497 Maybridge1_007608 CC(C)(NC(=O)c1ccc(cc1)c2ccccc2F)C#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B19 compound treatment 1.0004 3.87E-4 0.01 0.0075 1.0 2073498 Maybridge1_007609 Cc1csc(n1)c2c(Cl)cc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B20 compound treatment 0.9953 -0.00471 -0.09 -0.0915 -1.0 2073499 Maybridge1_007610 COc1cccc(c1)N2C=CC(C)(C)NC2=S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B21 compound treatment 0.9581 -0.0419 -0.81 -0.8132 -1.0 1620872 Maybridge1_007611 OC(=O)c1cccn1c2ccccc2C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B22 compound treatment 1.0077 0.00767 0.15 0.149 1.0 1602815 Maybridge1_007612 COC(=O)c1cc(NC(=O)c2c(C)noc2C)ccc1N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B23 mock treatment 0.9749 -0.0251 -0.49 -0.4877 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 B24 mock treatment 1.0339 0.0339 0.66 0.6584 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C01 compound treatment 1.0434 0.0434 0.84 0.8423 1.0 2073500 Maybridge1_007613 CN(/N=C/c1ccccc1)c2ncc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C02 compound treatment 1.0033 0.0033 0.06 0.0641 1.0 1201110 Maybridge1_007614 COc1cc(Cl)c(NC(=O)C)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C03 compound treatment 1.0397 0.0397 0.77 0.7716 1.0 2073501 Maybridge1_007615 Cc1cc(cc(C)c1C#N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C04 compound treatment 1.106 0.106 2.06 2.0592 1.0 2073502 Maybridge1_007616 NC(=N)Sc1cnc2ccccc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C05 compound treatment 0.9814 -0.0186 -0.36 -0.3604 -1.0 2073503 Maybridge1_007617 COc1ccc(OS(=O)(=O)c2sc(Br)cc2Br)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C06 compound treatment 1.015 0.015 0.29 0.2905 1.0 2073504 Maybridge1_007618 [O-][N+](=O)c1cc(cc2c1nc3ccccn32)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C07 compound treatment 1.031 0.031 0.6 0.6018 1.0 2073505 Maybridge1_007619 Fc1ccc(cc1)c2cc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C08 compound treatment 1.012 0.012 0.23 0.2339 1.0 2073506 Maybridge1_007620 CCOC(=O)c1c(C)nn(c1C)c2ccc(N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C09 compound treatment 1.0084 0.0084 0.16 0.1632 1.0 1003495 Maybridge1_007621 c1ccc(cc1)c2nnsc2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C10 compound treatment 0.9756 -0.0244 -0.47 -0.4736 -1.0 2073507 Maybridge1_007622 Fc1ccc(cc1Cl)C(=O)c2ccc(F)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C11 compound treatment 1.0004 3.87E-4 0.01 0.0075 1.0 2073508 Maybridge1_007623 Brc1cccc(c1)c2csc(Nc3cccnc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C12 compound treatment 0.9844 -0.0156 -0.3 -0.3038 -1.0 1218712 Maybridge1_007624 Cc1onc(c1C(=O)N2CCC(CC2)C(=O)c3ccccc3)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C13 compound treatment 1.023 0.023 0.45 0.4462 1.0 2073509 Maybridge1_007625 CC(=O)c1ccc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C14 compound treatment 0.9924 -0.00763 -0.15 -0.1481 -1.0 2073510 Maybridge1_007626 N#CN=C(Oc1ccccc1)Oc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C15 compound treatment 0.9873 -0.0127 -0.25 -0.2472 -1.0 2073511 Maybridge1_007627 CN(C)S(=O)(=O)c1cc(Br)c(Br)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C16 compound treatment 0.9822 -0.0178 -0.35 -0.3462 -1.0 1282569 Maybridge1_007628 Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C17 compound treatment 0.9661 -0.0339 -0.66 -0.6575 -1.0 2073512 Maybridge1_007629 CC(C)(C)c1nc(c2ccc(cc2)C(F)(F)F)c3c(cccc3n1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C18 compound treatment 0.9844 -0.0156 -0.3 -0.3038 -1.0 2073513 Maybridge1_007630 CCOC(=O)c1cc(C)n(c1c2ccccc2)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C19 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2073514 Maybridge1_007631 FC(F)(F)c1cc(Cl)c(N/N=C/c2cccs2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C20 compound treatment 0.9618 -0.0382 -0.74 -0.7424 -1.0 2073515 Maybridge1_007632 OC(=O)/C=C/C(=O)Nc1ccc(cc1)n2nc(cc2C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C21 compound treatment 1.0171 0.0171 0.33 0.333 1.0 2073516 Maybridge1_007633 CCNCC(=O)Nc1c(C)cccc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C22 compound treatment 0.9734 -0.0266 -0.52 -0.516 -1.0 2073517 Maybridge1_007634 COCCCNC(=S)N/N=C/c1ccc[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C23 mock treatment 0.9763 -0.0237 -0.46 -0.4594 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 C24 mock treatment 0.9975 -0.00253 -0.05 -0.0491 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D01 compound treatment 1.0674 0.0674 1.31 1.3093 1.0 2073518 Maybridge1_007635 FC(F)(F)c1cc(cc(c1)S(=O)(=O)n2cccc2C(=O)c3ccccc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D02 compound treatment 1.0295 0.0295 0.57 0.5735 1.0 2073519 Maybridge1_007636 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2c(Cl)cc(Cl)cc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D03 compound treatment 1.015 0.015 0.29 0.2905 1.0 2073520 Maybridge1_007637 Fc1cc(F)cc(COC(=O)c2c(F)cccc2F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D04 compound treatment 1.0324 0.0324 0.63 0.6301 1.0 2073521 Maybridge1_007638 Fc1ccc2NC(=O)/C(=N\N3CCOCC3)/c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D05 compound treatment 0.9982 -0.0018 -0.03 -0.0349 -1.0 2073522 Maybridge1_007639 COC(=O)c1cccn1c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D06 compound treatment 1.0135 0.0135 0.26 0.2622 1.0 2073523 Maybridge1_007640 CC/C(=N\OC(=O)c1cccs1)/c2ccc(cc2)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D07 compound treatment 1.0084 0.0084 0.16 0.1632 1.0 2073524 Maybridge1_007641 CC(=O)c1coc2ccccc2c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D08 compound treatment 1.0273 0.0273 0.53 0.5311 1.0 1437052 Maybridge1_007642 Fc1ccccc1c2ccc(cc2)C(=O)Nc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D09 compound treatment 1.1716 0.172 3.33 3.3327 1.0 2073525 Maybridge1_007643 OC(c1cccs1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D10 compound treatment 1.0069 0.00694 0.13 0.1349 1.0 2073526 Maybridge1_007644 NC(=S)Nc1cc(Cl)cc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D11 compound treatment 0.9661 -0.0339 -0.66 -0.6575 -1.0 2073527 Maybridge1_007645 COC(=O)c1cc(ccc1N2CCOCC2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D12 compound treatment 1.0113 0.0113 0.22 0.2198 1.0 2073528 Maybridge1_007646 CN(C)/C=C/1\CSc2ccc(F)cc2C1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D13 compound treatment 1.004 0.00403 0.08 0.0783 1.0 1033621 Maybridge1_007647 CCOC(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D14 compound treatment 0.9836 -0.0164 -0.32 -0.3179 -1.0 2073529 Maybridge1_007648 N#Cc1cnc2CCCCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D15 compound treatment 1.0106 0.0106 0.21 0.2056 1.0 2073530 Maybridge1_007649 CCOC(=O)C1CCN(CC1)S(=O)(=O)c2sc(Cl)cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D16 compound treatment 1.0004 3.87E-4 0.01 0.0075 1.0 2073531 Maybridge1_007650 Cc1nc(cs1)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D17 compound treatment 0.9683 -0.0317 -0.62 -0.6151 -1.0 2073532 Maybridge1_007651 COC(=O)CCCCCCCC(=O)Nc1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D18 compound treatment 0.9873 -0.0127 -0.25 -0.2472 -1.0 2073533 Maybridge1_007652 Cc1ccc(cc1)c2csc(NC(=N)N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D19 compound treatment 1.0091 0.00913 0.18 0.1773 1.0 2073534 Maybridge1_007653 Cc1ccc(cc1)C(=O)C2CCN(CC2)S(=O)(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D20 compound treatment 0.9895 -0.0105 -0.2 -0.2047 -1.0 2073535 Maybridge1_007654 Fc1ccc2c(c1)C(=O)CCS2(=O)=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D21 compound treatment 1.0004 3.87E-4 0.01 0.0075 1.0 2073536 Maybridge1_007655 FC(F)(F)C1N(CCc2c1[nH]c3ccccc23)C(=O)CC4(CC5CC6CC(C5)C4)C6 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D22 compound treatment 0.9844 -0.0156 -0.3 -0.3038 -1.0 2073537 Maybridge1_007656 FC(F)(F)c1cc(Oc2ccc(NS(=O)(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D23 mock treatment 1.0048 0.00476 0.09 0.0924 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 D24 mock treatment 0.996 -0.00398 -0.08 -0.0774 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E01 compound treatment 1.0485 0.0485 0.94 0.9414 1.0 2073538 Maybridge1_007657 CN(NC(=O)c1ccccc1Cl)c2ncc(Cl)cc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E02 compound treatment 1.015 0.015 0.29 0.2905 1.0 1341856 Maybridge1_007658 COc1ccc(Nc2c(Cl)cc(OC)cc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E03 compound treatment 1.0623 0.0623 1.21 1.2102 1.0 2073539 Maybridge1_007659 OC(=O)CSCC(=O)N1CCc2c([nH]c3ccccc23)C1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E04 compound treatment 0.9924 -0.00763 -0.15 -0.1481 -1.0 2073540 Maybridge1_007660 FC(F)(F)c1cnc(N2CCNCC2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E05 compound treatment 1.0324 0.0324 0.63 0.6301 1.0 2073541 Maybridge1_007661 C(/N=C/c1cccs1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E06 compound treatment 0.9363 -0.0637 -1.24 -1.2376 -1.0 2073542 Maybridge1_007662 CNc1nc(CC(=O)C)ns1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E07 compound treatment 1.012 0.012 0.23 0.2339 1.0 2073543 Maybridge1_007663 Fc1ccc(cc1Cl)c2cc3ccccc3[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E08 compound treatment 1.0259 0.0259 0.5 0.5028 1.0 2073544 Maybridge1_007664 Nc1ccc(cc1)n2nc(cc2C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E09 compound treatment 1.0208 0.0208 0.4 0.4037 1.0 1168457 Maybridge1_007665 COc1ccc(cc1)c2c(C#N)sc(C(=O)N)c2c3ccc(OC)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E10 compound treatment 0.9924 -0.00763 -0.15 -0.1481 -1.0 1033735 Maybridge1_007666 Fc1ccccc1NC(=S)Nc2ccccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E11 compound treatment 1.015 0.015 0.29 0.2905 1.0 2073545 Maybridge1_007667 Cc1noc(c1C(=O)O/N=C(\N)/c2cccc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E12 compound treatment 1.0018 0.00184 0.04 0.0358 1.0 2073546 Maybridge1_007668 FC(F)(F)Oc1ccc(cc1)C2CC(=O)Nc3ccccc3S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E13 compound treatment 1.0099 0.00986 0.19 0.1915 1.0 2073547 Maybridge1_007669 Fc1ccc(cc1)/C(=N/OC(=O)c2sc3sccc3c2Cl)/C4CC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E14 compound treatment 0.9756 -0.0244 -0.47 -0.4736 -1.0 2073548 Maybridge1_007670 CCOC(=O)c1cc(C)n(N(C)c2cc(ccn2)C(F)(F)F)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E15 compound treatment 1.0084 0.0084 0.16 0.1632 1.0 2073549 Maybridge1_007671 CCOC(=O)c1sc(nc1C)c2cnccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E16 compound treatment 0.9698 -0.0302 -0.59 -0.5868 -1.0 2073550 Maybridge1_007672 Cc1ccc(cc1)S(=O)(=O)NC(=O)NNc2c(Cl)cc(Cl)cc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E17 compound treatment 1.1192 0.119 2.31 2.3139 1.0 2073551 Maybridge1_007673 N/C(=N\O)/c1cnc(nc1N)c2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E18 compound treatment 1.0055 0.00549 0.11 0.1066 1.0 2073552 Maybridge1_007674 CCOC(=O)c1cc(C)n(c1c2ccccc2)c3cccc(Cl)c3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E19 compound treatment 0.9938 -0.00617 -0.12 -0.1198 -1.0 2073553 Maybridge1_007675 CS(=O)(=O)c1ccc(s1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E20 compound treatment 0.9997 -3.42E-4 -0.01 -0.0066 -1.0 2073554 Maybridge1_007676 COc1ccc2cc(ccc2c1)/C(=N/OC(=O)c3cccs3)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E21 compound treatment 0.9756 -0.0244 -0.47 -0.4736 -1.0 2073555 Maybridge1_007677 NS(=O)(=O)c1ccc(s1)c2ccon2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E22 compound treatment 0.9603 -0.0397 -0.77 -0.7707 -1.0 1006361 Maybridge1_007678 NNC(=O)c1ccccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E23 mock treatment 1.0303 0.0303 0.59 0.5877 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 E24 mock treatment 1.015 0.015 0.29 0.2905 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F01 compound treatment 1.1425 0.142 2.77 2.7667 1.0 2073556 Maybridge1_007679 COc1ccc(cc1)c2ccc(C=C(C#N)C#N)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F02 compound treatment 1.0448 0.0448 0.87 0.8706 1.0 2073557 Maybridge1_007680 Fc1ccc2SCCC(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F03 compound treatment 1.0339 0.0339 0.66 0.6584 1.0 2073558 Maybridge1_007681 [O-][N+](=O)c1cc(cc(c1)[N+](=O)[O-])C(=O)OCc2cc(F)cc(F)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F04 compound treatment 1.0463 0.0463 0.9 0.8989 1.0 2073559 Maybridge1_007682 CN(/N=C/1\C(=O)Nc2ccc(F)cc12)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F05 compound treatment 0.9552 -0.0448 -0.87 -0.8698 -1.0 2073560 Maybridge1_007683 Oc1ccc(/C=N/Nc2ncccc2[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F06 compound treatment 1.0164 0.0164 0.32 0.3188 1.0 2073561 Maybridge1_007684 CC/C(=N\OC(=O)CC1(CC2CC3CC(C2)C1)C3)/c4ccc(cc4)c5ccccc5F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F07 compound treatment 0.9946 -0.00544 -0.11 -0.1057 -1.0 2073562 Maybridge1_007685 COc1cc(/C=C/2\COC/C(=C\c3ccc(O)c(OC)c3)/C2=O)ccc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F08 compound treatment 1.1898 0.19 3.69 3.6864 1.0 2073563 Maybridge1_007686 CC/C(=N\Nc1ccc(cc1)[N+](=O)[O-])/c2ccc(cc2)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F09 compound treatment 0.9865 -0.0135 -0.26 -0.2613 -1.0 2073564 Maybridge1_007687 CC(C)c1ccc(C)c2c(/C=N\Nc3ccc(cc3)[N+](=O)[O-])cc(C)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F10 compound treatment 1.004 0.00403 0.08 0.0783 1.0 2073565 Maybridge1_007688 Cc1sc(Nc2ccc(cc2)C(F)(F)F)nc1c3ccc(cc3)c4ccccc4F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F11 compound treatment 1.0011 0.00112 0.02 0.0217 1.0 1738910 Maybridge1_007689 COC(=O)c1cc(NC(=O)c2ccco2)ccc1N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F12 compound treatment 1.0077 0.00767 0.15 0.149 1.0 2073566 Maybridge1_007690 NC(=S)N/N=C/1\CCSc2ccc(F)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F13 compound treatment 0.9763 -0.0237 -0.46 -0.4594 -1.0 2073567 Maybridge1_007691 CCOC(=O)Nc1ccsc1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F14 compound treatment 1.0295 0.0295 0.57 0.5735 1.0 2073568 Maybridge1_007692 CC(=O)C/C(=N/c1ccc(cc1)C(F)(F)F)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F15 compound treatment 1.012 0.012 0.23 0.2339 1.0 415 Maybridge1_007693 FC(F)(F)Oc1ccc(NN=C(C#N)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F16 compound treatment 0.98 -0.02 -0.39 -0.3887 -1.0 2073569 Maybridge1_007694 Fc1ccc2SCC/C(=N\OS(=O)(=O)c3ccc(Cl)cc3)/c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F17 compound treatment 0.9749 -0.0251 -0.49 -0.4877 -1.0 2073570 Maybridge1_007695 Clc1cc(Cl)cc(NN=C(C#N)C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F18 compound treatment 0.9436 -0.0564 -1.1 -1.0962 -1.0 2073571 Maybridge1_007696 Cc1ccc(c2csc(NC(=N)N)n2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F19 compound treatment 0.9749 -0.0251 -0.49 -0.4877 -1.0 1507272 Maybridge1_007697 Cc1ccc(cc1)C(=O)C2CCN(CC2)S(=O)(=O)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F20 compound treatment 1.0222 0.0222 0.43 0.432 1.0 2073572 Maybridge1_007698 Cc1ccc(c2csc(n2)c3ccccc3)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F21 compound treatment 0.9742 -0.0258 -0.5 -0.5019 -1.0 1275457 Maybridge1_007699 COc1ccc(NC(=O)CC2(CC3CC4CC(C3)C2)C4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F22 compound treatment 0.996 -0.00398 -0.08 -0.0774 -1.0 2073573 Maybridge1_007700 FC(F)(F)c1cc(Oc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F23 mock treatment 1.0091 0.00913 0.18 0.1773 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 F24 mock treatment 1.0426 0.0426 0.83 0.8282 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G01 compound treatment 1.047 0.047 0.91 0.9131 1.0 2073574 Maybridge1_007701 CCOC(=O)c1c(C)oc2c(F)c(F)c(F)c(F)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G02 compound treatment 1.0281 0.0281 0.55 0.5452 1.0 2073575 Maybridge1_007702 FC(F)(F)c1ccnc(c1)N2CCN(CC2)S(=O)(=O)c3cc(Cl)c(Cl)s3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G03 compound treatment 1.1396 0.14 2.71 2.7101 1.0 2073576 Maybridge1_007703 Cc1nn(C)c(O)c1N=Nc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G04 compound treatment 0.9785 -0.0215 -0.42 -0.417 -1.0 2073577 Maybridge1_007704 c1csc(c1)c2ccc(s2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G05 compound treatment 1.0594 0.0594 1.15 1.1536 1.0 2073578 Maybridge1_007705 FC(F)(F)c1cccc(N/N=C(\C#N)/C(=O)c2ccsc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G06 compound treatment 0.9873 -0.0127 -0.25 -0.2472 -1.0 2073579 Maybridge1_007706 COC(=O)c1cc(Br)cc(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G07 compound treatment 1.0324 0.0324 0.63 0.6301 1.0 2073580 Maybridge1_007707 CSc1sccc1/C=C(/C#N)\S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G08 compound treatment 0.9836 -0.0164 -0.32 -0.3179 -1.0 1579600 Maybridge1_007708 O=C1CC(Sc2ccccc2N1)c3ccsc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G09 compound treatment 1.047 0.047 0.91 0.9131 1.0 2073581 Maybridge1_007709 O/N=C/c1c([nH]c2ccccc12)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G10 compound treatment 1.0091 0.00913 0.18 0.1773 1.0 2073582 Maybridge1_007710 Fc1ccccc1NC(=S)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G11 compound treatment 1.0106 0.0106 0.21 0.2056 1.0 2073583 Maybridge1_007711 Cc1noc(c1c2nc(no2)c3ccc(Cl)cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G12 compound treatment 0.9785 -0.0215 -0.42 -0.417 -1.0 2073584 Maybridge1_007712 [O-][N+](=O)c1cc(ccc1N2CCC(CC2)C(=O)c3ccccc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G13 compound treatment 1.0601 0.0601 1.17 1.1678 1.0 1092357 Maybridge1_007713 NC(=S)c1cncnc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G14 compound treatment 1.0091 0.00913 0.18 0.1773 1.0 2073585 Maybridge1_007714 CCSc1ccc(C#N)cn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G15 compound treatment 1.0106 0.0106 0.21 0.2056 1.0 2073586 Maybridge1_007715 N/C(=N\O)/c1cncnc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G16 compound treatment 0.9421 -0.0579 -1.12 -1.1245 -1.0 2073587 Maybridge1_007716 CCSc1ccc(cn1)c2noc(n2)c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G17 compound treatment 0.9931 -0.0069 -0.13 -0.134 -1.0 1983516 Maybridge1_007717 CSc1ccc(s1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G18 compound treatment 0.9902 -0.00981 -0.19 -0.1906 -1.0 2073588 Maybridge1_007718 COc1ccc(OC)c(NS(=O)(=O)c2cc(ccc2OCC(F)(F)F)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G19 compound treatment 1.015 0.015 0.29 0.2905 1.0 2073589 Maybridge1_007719 OC(=O)CCC(=O)N1CCc2c([nH]c3ccccc23)C1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G20 compound treatment 0.9931 -0.0069 -0.13 -0.134 -1.0 2073590 Maybridge1_007720 COc1ccc2cc(ccc2c1)/C(=N/OC(=O)Nc3ccc(OC(F)(F)F)cc3)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G21 compound treatment 0.9785 -0.0215 -0.42 -0.417 -1.0 2073591 Maybridge1_007721 COc1ccc(cc1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G22 compound treatment 1.1483 0.148 2.88 2.8799 1.0 2073592 Maybridge1_007722 Oc1cc2cc(O)[nH]c(=O)c2c(=O)[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G23 mock treatment 1.015 0.015 0.29 0.2905 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 G24 mock treatment 0.9967 -0.00326 -0.06 -0.0632 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H01 compound treatment 1.0601 0.0601 1.17 1.1678 1.0 2073593 Maybridge1_007723 COC(=O)c1cccn1c2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H02 compound treatment 1.012 0.012 0.23 0.2339 1.0 2073594 Maybridge1_007724 FC(F)(F)c1ccc(Cl)c(c1)c2ccc(C=C(C#N)C#N)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H03 compound treatment 1.0354 0.0354 0.69 0.6867 1.0 2073595 Maybridge1_007725 NC(=O)N/N=C/c1cc(F)cc(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H04 compound treatment 1.1563 0.156 3.04 3.0355 1.0 2073596 Maybridge1_007726 Fc1ccc2NC(=O)/C(=N\CC3CC3)/c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H05 compound treatment 0.9953 -0.00471 -0.09 -0.0915 -1.0 2073597 Maybridge1_007727 COc1cccc(/C=N/Nc2ncccc2[N+](=O)[O-])c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H06 compound treatment 1.0077 0.00767 0.15 0.149 1.0 2073598 Maybridge1_007728 CC/C(=N\OC(=O)Nc1ccc(OC(F)(F)F)cc1)/c2ccc(cc2)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H07 compound treatment 1.012 0.012 0.23 0.2339 1.0 2073599 Maybridge1_007729 CCOC(=O)c1c(C)nn(c1C)c2ncccc2NC(=S)NC(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H08 compound treatment 1.0412 0.0412 0.8 0.7999 1.0 2073600 Maybridge1_007730 Cc1sc(Nc2ccccc2)nc1c3ccc(cc3)c4ccccc4F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H09 compound treatment 1.0077 0.00767 0.15 0.149 1.0 2073601 Maybridge1_007731 N/C(=N\O)/c1cnn2c(ccnc12)c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H10 compound treatment 1.0266 0.0266 0.52 0.5169 1.0 1287144 Maybridge1_007732 Cc1sc(nc1c2ccc(cc2)c3ccccc3F)N4CCOCC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H11 compound treatment 0.9581 -0.0419 -0.81 -0.8132 -1.0 2073602 Maybridge1_007733 NC(=S)c1cnn2c(ccnc12)c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H12 compound treatment 1.012 0.012 0.23 0.2339 1.0 2073603 Maybridge1_007734 O/N=C\c1c2ccccc2c(Sc3ccc(Cl)cc3)c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H13 compound treatment 0.9895 -0.0105 -0.2 -0.2047 -1.0 2073604 Maybridge1_007735 CN(C)c1ccc(C=C(C#N)C#N)c(F)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H14 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 1025801 Maybridge1_007736 CC(=O)Nc1ccc(cc1[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H15 compound treatment 0.9887 -0.0113 -0.22 -0.2189 -1.0 2073605 Maybridge1_007737 COC(=O)CCCCCCCC(=O)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H16 compound treatment 1.0259 0.0259 0.5 0.5028 1.0 2073606 Maybridge1_007738 Fc1cc(F)c2OCCC(=O)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H17 compound treatment 0.972 -0.028 -0.54 -0.5443 -1.0 2073607 Maybridge1_007739 COC(=O)CCCCCCCC(=O)Nc1ccc(OC)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H18 compound treatment 0.9625 -0.0375 -0.73 -0.7283 -1.0 2073608 Maybridge1_007740 OC(=O)C(Cc1ccccc1)NCCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H19 compound treatment 0.9742 -0.0258 -0.5 -0.5019 -1.0 1337126 Maybridge1_007741 Cc1noc(C)c1S(=O)(=O)N2CCC(CC2)C(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H20 compound treatment 0.9836 -0.0164 -0.32 -0.3179 -1.0 2073609 Maybridge1_007742 FC(F)(F)Oc1ccc(cc1)C(=O)Nc2ccc(cc2)n3nc(cc3C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H21 compound treatment 0.9807 -0.0193 -0.37 -0.3745 -1.0 1449635 Maybridge1_007743 Clc1cccc(CNC(=O)CC2(CC3CC4CC(C3)C2)C4)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H22 compound treatment 0.988 -0.012 -0.23 -0.233 -1.0 2073610 Maybridge1_007744 FC(F)(F)Oc1ccc(NC(=O)Nc2ccc(Oc3cc(cc(c3)C(F)(F)F)C(F)(F)F)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H23 mock treatment 0.9946 -0.00544 -0.11 -0.1057 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 H24 mock treatment 1.0084 0.0084 0.16 0.1632 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I01 compound treatment 1.0171 0.0171 0.33 0.333 1.0 1379773 Maybridge1_007745 OC(=O)c1coc2CCCC(=O)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I02 compound treatment 1.0397 0.0397 0.77 0.7716 1.0 2073611 Maybridge1_007746 Cc1cc(cc(c1)/C(=N/O)/N)/C(=N/O)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I03 compound treatment 1.0179 0.0179 0.35 0.3471 1.0 2073612 Maybridge1_007747 Cc1nn(C)c(O)c1N=Nc2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I04 compound treatment 1.0055 0.00549 0.11 0.1066 1.0 2073613 Maybridge1_007748 CC(=O)c1sc(nc1C)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I05 compound treatment 0.9967 -0.00326 -0.06 -0.0632 -1.0 2073614 Maybridge1_007749 Brc1ccsc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I06 compound treatment 0.9967 -0.00326 -0.06 -0.0632 -1.0 2073615 Maybridge1_007750 NC(=O)c1cc(Br)cc(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I07 compound treatment 0.9902 -0.00981 -0.19 -0.1906 -1.0 2073616 Maybridge1_007751 CC(CCc1ccccc1)C/C=N/Nc2ccc(cc2[N+](=O)[O-])[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I08 compound treatment 0.9698 -0.0302 -0.59 -0.5868 -1.0 1060484 Maybridge1_007752 Cc1ccc(cc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I09 compound treatment 1.0514 0.0514 1.0 0.998 1.0 2073617 Maybridge1_007753 NC(=S)N/N=C/c1cc2COc3ccc(Cl)cc3-c2s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I10 compound treatment 0.9691 -0.0309 -0.6 -0.6009 -1.0 1320459 Maybridge1_007754 OC(=O)C1CCCN1C(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I11 compound treatment 1.0317 0.0317 0.62 0.616 1.0 2073618 Maybridge1_007755 COC(=O)c1csc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I12 compound treatment 0.9727 -0.0273 -0.53 -0.5302 -1.0 2073619 Maybridge1_007756 COC(=O)C(=NNc1ccc(cc1)n2nc(C)cc2C)C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I13 compound treatment 1.0106 0.0106 0.21 0.2056 1.0 2073620 Maybridge1_007757 Clc1cccc(c1)C2CC(=O)CC(=O)C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I14 compound treatment 0.9982 -0.0018 -0.03 -0.0349 -1.0 2073621 Maybridge1_007758 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I15 compound treatment 0.9742 -0.0258 -0.5 -0.5019 -1.0 2073622 Maybridge1_007759 NC(=S)c1sccc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I16 compound treatment 1.0018 0.00184 0.04 0.0358 1.0 2073623 Maybridge1_007760 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccc(cn2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I17 compound treatment 1.0215 0.0215 0.42 0.4179 1.0 2073624 Maybridge1_007761 O=S(=O)(CC#N)c1ccsc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I18 compound treatment 0.9771 -0.0229 -0.45 -0.4453 -1.0 2073625 Maybridge1_007762 CC(C)(C)c1ccc(cc1)C(=O)c2ccc3CCCc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I19 compound treatment 1.004 0.00403 0.08 0.0783 1.0 2073626 Maybridge1_007763 FC(F)(F)C1N(CCc2c1[nH]c3ccccc23)C(=O)CSc4ccc(cn4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I20 compound treatment 0.9749 -0.0251 -0.49 -0.4877 -1.0 2073627 Maybridge1_007764 COc1ccc2cc(ccc2c1)/C(=N/OC(=O)Nc3ccccc3)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I21 compound treatment 0.9742 -0.0258 -0.5 -0.5019 -1.0 2073628 Maybridge1_007765 CCOc1cc(cnc1C#N)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I22 compound treatment 0.9873 -0.0127 -0.25 -0.2472 -1.0 2073629 Maybridge1_007766 Fc1cccc(Cl)c1C/N=C/c2c(F)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I23 mock treatment 0.9997 -3.42E-4 -0.01 -0.0066 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 I24 mock treatment 0.9567 -0.0433 -0.84 -0.8415 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J01 compound treatment 1.0346 0.0346 0.67 0.6725 1.0 2073630 Maybridge1_007767 FC(F)(F)c1ccc(NC2OC(=O)c3ccccc23)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J02 compound treatment 1.0754 0.0754 1.46 1.4649 1.0 2073631 Maybridge1_007768 FC(F)(F)Oc1ccccc1c2ccc(C=C3C(=O)c4ccccc4C3=O)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J03 compound treatment 0.9982 -0.0018 -0.03 -0.0349 -1.0 2073632 Maybridge1_007769 NC(=S)N/N=C/c1cc(F)cc(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J04 compound treatment 1.0499 0.0499 0.97 0.9697 1.0 2073633 Maybridge1_007770 Fc1ccc2NC(=O)/C(=N\c3ccc(Cl)cc3)/c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J05 compound treatment 1.0077 0.00767 0.15 0.149 1.0 2073634 Maybridge1_007771 Cc1cc(C)n(n1)c2ncccc2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J06 compound treatment 0.9647 -0.0353 -0.69 -0.6858 -1.0 2073635 Maybridge1_007772 CC/C(=N\OC(=O)NS(=O)(=O)c1ccc(C)cc1)/c2ccc(cc2)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J07 compound treatment 1.0419 0.0419 0.81 0.814 1.0 1678399 Maybridge1_007773 Cc1ccc(cc1)C(=O)C2CCN(CC2)C(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J08 compound treatment 0.9982 -0.0018 -0.03 -0.0349 -1.0 2073636 Maybridge1_007774 Cc1ccc(C)n1c2ccc(OC(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J09 compound treatment 1.0354 0.0354 0.69 0.6867 1.0 2073637 Maybridge1_007775 CC(C)c1ccc(C)c2c(N=Nc3ccc(Cl)cc3)cc(C)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J10 compound treatment 1.0244 0.0244 0.47 0.4745 1.0 2073638 Maybridge1_007776 Cc1sc(nc1c2ccc(cc2)c3ccccc3F)c4ccsc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J11 compound treatment 0.972 -0.028 -0.54 -0.5443 -1.0 2073639 Maybridge1_007777 FC(F)(F)c1cccc(c1)c2ccnc3cc(nn23)c4nc(cs4)c5ccc(Cl)cc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J12 compound treatment 1.0222 0.0222 0.43 0.432 1.0 1365785 Maybridge1_007778 COC(=O)Cc1nc(Nc2ccccc2)sc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J13 compound treatment 0.996 -0.00398 -0.08 -0.0774 -1.0 2073640 Maybridge1_007779 Clc1sc(cc1Br)S(=O)(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J14 compound treatment 0.961 -0.039 -0.76 -0.7566 -1.0 1597624 Maybridge1_007780 CCOc1ccc(CCCC(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J15 compound treatment 0.9946 -0.00544 -0.11 -0.1057 -1.0 1715742 Maybridge1_007781 COc1ccc(CNCc2ccc(OC)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J16 compound treatment 0.9975 -0.00253 -0.05 -0.0491 -1.0 2073641 Maybridge1_007782 Cc1nnsc1C(=O)O/N=C/2\CCSc3ccc(F)cc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J17 compound treatment 0.9581 -0.0419 -0.81 -0.8132 -1.0 2073642 Maybridge1_007783 COc1ccc(CN(Cc2ccc(OC)cc2)C(=O)Nc3ccc(Cl)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J18 compound treatment 1.0157 0.0157 0.3 0.3047 1.0 2073643 Maybridge1_007784 Cc1ccc(cc1)c2csc(n2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J19 compound treatment 0.9785 -0.0215 -0.42 -0.417 -1.0 1570246 Maybridge1_007785 Clc1ccc(NC(=O)CC2(CC3CC4CC(C3)C2)C4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J20 compound treatment 0.9975 -0.00253 -0.05 -0.0491 -1.0 2073644 Maybridge1_007786 FC(F)(F)c1cc(n(n1)c2ccc(NC(=O)Nc3cc(Cl)cc(Cl)c3)cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J21 compound treatment 0.9916 -0.00836 -0.16 -0.1623 -1.0 2073645 Maybridge1_007787 CCOC(=O)Cc1nn[nH]n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J22 compound treatment 0.9734 -0.0266 -0.52 -0.516 -1.0 2073646 Maybridge1_007788 FC(F)(F)c1cc(Oc2ccc(NC(=S)NC(=O)c3ccccc3)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J23 mock treatment 0.9763 -0.0237 -0.46 -0.4594 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 J24 mock treatment 1.0405 0.0405 0.79 0.7857 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K01 compound treatment 1.0864 0.0864 1.68 1.6772 1.0 2073647 Maybridge1_007789 CN(/N=C/1\CCCc2occ(C(=O)O)c12)c3ncc(Cl)cc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K02 compound treatment 1.0048 0.00476 0.09 0.0924 1.0 2073648 Maybridge1_007790 [O-][N+](=O)c1cccnc1ON=C(c2cccs2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K03 compound treatment 1.0106 0.0106 0.21 0.2056 1.0 2073649 Maybridge1_007791 Cc1nn(C)c(O)c1N=Nc2ccccc2OC(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K04 compound treatment 0.9814 -0.0186 -0.36 -0.3604 -1.0 2073650 Maybridge1_007792 COc1cc(CCC(=O)NNC(=O)c2ccc(Cl)cc2)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K05 compound treatment 1.004 0.00403 0.08 0.0783 1.0 2073651 Maybridge1_007793 CCOC(=O)c1ccc(COC(=O)C)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K06 compound treatment 1.0011 0.00112 0.02 0.0217 1.0 2073652 Maybridge1_007794 Brc1cc(Br)cc(C#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K07 compound treatment 1.023 0.023 0.45 0.4462 1.0 2073653 Maybridge1_007795 COc1ccc(cc1)C2=C(C(=O)C)C(=NC(=S)C2C#N)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K08 compound treatment 1.012 0.012 0.23 0.2339 1.0 2073654 Maybridge1_007796 Fc1ccc(NC(=O)C2CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K09 compound treatment 1.0368 0.0368 0.71 0.715 1.0 2073655 Maybridge1_007797 CC(=O)Nc1ccc(cc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K10 compound treatment 1.0135 0.0135 0.26 0.2622 1.0 1014540 Maybridge1_007798 O=C(C1CCNCC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K11 compound treatment 1.1527 0.153 2.96 2.9648 1.0 2073656 Maybridge1_007799 Nc1csc2cc(cc(Cl)c12)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K12 compound treatment 0.9763 -0.0237 -0.46 -0.4594 -1.0 2073657 Maybridge1_007800 COc1cc(Cl)c(NC(=O)c2cccc(c2)C(F)(F)F)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K13 compound treatment 0.9982 -0.0018 -0.03 -0.0349 -1.0 2073658 Maybridge1_007801 COc1ccc(cc1)c2cc[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K14 compound treatment 0.9924 -0.00763 -0.15 -0.1481 -1.0 2073659 Maybridge1_007802 Cc1ccc(cc1)S(=O)(=O)NC(=O)O/N=C(\N)/c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K15 compound treatment 1.0018 0.00184 0.04 0.0358 1.0 2073660 Maybridge1_007803 CC(C)(C)C(=O)Nc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K16 compound treatment 0.9989 -0.00107 -0.02 -0.0208 -1.0 1275090 Maybridge1_007804 COC(=O)c1sccc1NC(=O)NS(=O)(=O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K17 compound treatment 1.004 0.00403 0.08 0.0783 1.0 2073661 Maybridge1_007805 CC(=O)C(N=Nc1ccc2OCOCc2c1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K18 compound treatment 0.9654 -0.0346 -0.67 -0.6717 -1.0 2073662 Maybridge1_007806 O=C(C1CCC1)c2ccc3CCCc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K19 compound treatment 0.9975 -0.00253 -0.05 -0.0491 -1.0 2073663 Maybridge1_007807 COc1ccc(OC)c(SCC(=O)N2CCc3c([nH]c4ccccc34)C2C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K20 compound treatment 0.9669 -0.0331 -0.64 -0.6434 -1.0 2073664 Maybridge1_007808 COc1ccc2cc(ccc2c1)/C(=N/OC(=O)Nc3cc(Cl)cc(Cl)c3)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K21 compound treatment 1.015 0.015 0.29 0.2905 1.0 2073665 Maybridge1_007809 FC(F)(F)c1cnc(C#N)c(Oc2ccc(Cl)cc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K22 compound treatment 0.9749 -0.0251 -0.49 -0.4877 -1.0 2073666 Maybridge1_007810 [O-][N+](=O)c1cc(ccc1Oc2ccc(cc2)c3nnco3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K23 mock treatment 0.9975 -0.00253 -0.05 -0.0491 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 K24 mock treatment 1.0033 0.0033 0.06 0.0641 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L01 compound treatment 1.0521 0.0521 1.01 1.0121 1.0 2073667 Maybridge1_007811 Cc1ccc(NC(=O)Cc2cc(F)cc(F)c2)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L02 compound treatment 1.0099 0.00986 0.19 0.1915 1.0 2073668 Maybridge1_007812 CC(=O)c1ccc(o1)c2cc(ccc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L03 compound treatment 0.988 -0.012 -0.23 -0.233 -1.0 2073669 Maybridge1_007813 FC(F)(F)C1OC(=O)C(=N1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L04 compound treatment 1.0011 0.00112 0.02 0.0217 1.0 2073670 Maybridge1_007814 NC(=S)N/N=C/1\C(=O)Nc2ccc(F)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L05 compound treatment 0.9873 -0.0127 -0.25 -0.2472 -1.0 2073671 Maybridge1_007815 Fc1cc(F)cc(Cc2nc(no2)c3cccs3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L06 compound treatment 1.0215 0.0215 0.42 0.4179 1.0 1274013 Maybridge1_007816 OC1C(=O)Nc2ccc(F)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L07 compound treatment 1.023 0.023 0.45 0.4462 1.0 1653929 Maybridge1_007817 Cc1ccc(cc1)C(=O)C2CCN(CC2)C(=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L08 compound treatment 0.988 -0.012 -0.23 -0.233 -1.0 2073672 Maybridge1_007818 CC/C(=N\OC(=O)Nc1ccccc1)/c2ccc(cc2)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L09 compound treatment 1.0237 0.0237 0.46 0.4603 1.0 2073673 Maybridge1_007819 CC(C)c1ccc(C)c2c(N=Nc3ccc(cc3)C(F)(F)F)cc(C)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L10 compound treatment 1.0354 0.0354 0.69 0.6867 1.0 2073674 Maybridge1_007820 COC(=O)c1cc(C)c(s1)c2ccc(cc2)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L11 compound treatment 0.9778 -0.0222 -0.43 -0.4311 -1.0 2073675 Maybridge1_007821 CC(C)(C)c1csc(n1)c2cc3nccc(c4cccc(c4)C(F)(F)F)n3n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L12 compound treatment 0.9647 -0.0353 -0.69 -0.6858 -1.0 2073676 Maybridge1_007822 CCOC(=O)c1cc(C)n(c1C)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L13 compound treatment 0.9829 -0.0171 -0.33 -0.3321 -1.0 2073677 Maybridge1_007823 CC1CN(CC(C)O1)S(=O)(=O)c2sc(Cl)cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L14 compound treatment 0.9895 -0.0105 -0.2 -0.2047 -1.0 1122416 Maybridge1_007824 N#CC(=Cc1ccccc1N2CCN(Cc3ccccc3)CC2)C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L15 compound treatment 0.9771 -0.0229 -0.45 -0.4453 -1.0 2073678 Maybridge1_007825 COc1ccc(C/N=C/c2cc(OC)c(OC)c(OC)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L16 compound treatment 0.9669 -0.0331 -0.64 -0.6434 -1.0 1454417 Maybridge1_007826 Fc1ccccc1c2ccc(cc2)C(=O)N3CCCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L17 compound treatment 0.9887 -0.0113 -0.22 -0.2189 -1.0 1213439 Maybridge1_007827 COc1ccc(CN(Cc2ccc(OC)cc2)C(=O)c3cccs3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L18 compound treatment 1.0011 0.00112 0.02 0.0217 1.0 2073679 Maybridge1_007828 Cc1ccc(c2csc(n2)c3ccc(Cl)cc3)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L19 compound treatment 0.98 -0.02 -0.39 -0.3887 -1.0 2073680 Maybridge1_007829 FC(F)(F)c1ccc(NC(=O)CC2(CC3CC4CC(C3)C2)C4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L20 compound treatment 0.9836 -0.0164 -0.32 -0.3179 -1.0 2073681 Maybridge1_007830 CCCNC(=O)Nc1ccc(cc1)n2nc(cc2C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L21 compound treatment 0.9887 -0.0113 -0.22 -0.2189 -1.0 1530096 Maybridge1_007831 COc1ccc(CNC(=O)CC2(CC3CC4CC(C3)C2)C4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L22 compound treatment 1.023 0.023 0.45 0.4462 1.0 1616864 Maybridge1_007832 CC1(C)C2(C)CCC1(OC2=O)C(=O)N3CCSCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L23 mock treatment 0.9632 -0.0368 -0.71 -0.7141 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 L24 mock treatment 1.0288 0.0288 0.56 0.5594 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M01 compound treatment 1.1133 0.113 2.2 2.2007 1.0 2073682 Maybridge1_007833 CSc1ccc(N=Nc2c(C)nn(C)c2O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M02 compound treatment 1.0004 3.87E-4 0.01 0.0075 1.0 1581490 Maybridge1_007834 COc1ccc(cc1)C(=O)C2CCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M03 compound treatment 1.0113 0.0113 0.22 0.2198 1.0 1025611 Maybridge1_007835 O=C(c1cccs1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M04 compound treatment 0.964 -0.036 -0.7 -0.7 -1.0 1419896 Maybridge1_007836 Cc1nc(sc1C(=O)NN)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M05 compound treatment 1.0324 0.0324 0.63 0.6301 1.0 1172986 Maybridge1_007837 N#Cc1c(nsc1c2ccccc2)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M06 compound treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 2073683 Maybridge1_007838 CCOC(=O)c1c(C)n[nH]c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M07 compound treatment 1.0055 0.00549 0.11 0.1066 1.0 2073684 Maybridge1_007839 CC(=O)c1cc(c(s1)C(F)(F)F)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M08 compound treatment 0.9698 -0.0302 -0.59 -0.5868 -1.0 2073685 Maybridge1_007840 NNC(=S)NC1CC2CC1C=C2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M09 compound treatment 1.0332 0.0332 0.64 0.6442 1.0 1577926 Maybridge1_007841 Clc1cccc(c1)c2csc(Nc3cccnc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M10 compound treatment 0.9989 -0.00107 -0.02 -0.0208 -1.0 2073686 Maybridge1_007842 Cc1cc(cc(C)n1)c2ccsc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M11 compound treatment 0.9596 -0.0404 -0.78 -0.7849 -1.0 1062972 Maybridge1_007843 COC(=O)c1nccnc1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M12 compound treatment 0.9676 -0.0324 -0.63 -0.6292 -1.0 2073687 Maybridge1_007844 COc1cc(Cl)c(NS(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M13 compound treatment 1.0244 0.0244 0.47 0.4745 1.0 2073688 Maybridge1_007845 Nc1nc(ncc1C#N)c2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M14 compound treatment 1.012 0.012 0.23 0.2339 1.0 2073689 Maybridge1_007846 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccc(OC(F)(F)F)cc2Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M15 compound treatment 0.988 -0.012 -0.23 -0.233 -1.0 2073690 Maybridge1_007847 Cc1cc(/C=N/NC(=O)N)c(C)n1c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M16 compound treatment 0.9661 -0.0339 -0.66 -0.6575 -1.0 1353764 Maybridge1_007848 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M17 compound treatment 1.0004 3.87E-4 0.01 0.0075 1.0 2073691 Maybridge1_007849 FC(F)(F)Oc1ccc(NC(=O)OC(Cc2ccccc2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M18 compound treatment 1.0215 0.0215 0.42 0.4179 1.0 2073692 Maybridge1_007850 COc1ccc2cc(ccc2c1)c3ccn[nH]3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M19 compound treatment 0.9909 -0.00908 -0.18 -0.1764 -1.0 2073693 Maybridge1_007851 NS(=O)(=O)c1ccc(F)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M20 compound treatment 0.9829 -0.0171 -0.33 -0.3321 -1.0 2073694 Maybridge1_007852 O=C/1/C(=C/c2ccco2)/COC\C1=C/c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M21 compound treatment 1.0055 0.00549 0.11 0.1066 1.0 2073695 Maybridge1_007853 CN(C)c1cc(cnc1C(=S)C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M22 compound treatment 1.0295 0.0295 0.57 0.5735 1.0 1004095 Maybridge1_007854 O=C(N1CCOCC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M23 mock treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 M24 mock treatment 1.0084 0.0084 0.16 0.1632 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N01 compound treatment 1.0426 0.0426 0.83 0.8282 1.0 2073696 Maybridge1_007855 FC(F)(F)c1ccc(NC2OC(=O)c3ccccc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N02 compound treatment 0.9793 -0.0207 -0.4 -0.4028 -1.0 2073697 Maybridge1_007856 CC(=O)c1ccc(o1)c2ccccc2OC(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N03 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2073698 Maybridge1_007857 COC(=O)c1sc(c(c1/N=C/N)c2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N04 compound treatment 1.031 0.031 0.6 0.6018 1.0 2073699 Maybridge1_007858 CCOC(=O)N/N=C/1\C(=O)Nc2ccc(F)cc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N05 compound treatment 0.9742 -0.0258 -0.5 -0.5019 -1.0 2073700 Maybridge1_007859 Fc1cc(F)cc(COc2cc(Cl)cc(Cl)c2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N06 compound treatment 1.0026 0.00257 0.05 0.05 1.0 2073701 Maybridge1_007860 CC/C(=N\OC(=O)Nc1cc(Cl)cc(Cl)c1)/c2ccc(cc2)c3ccccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N07 compound treatment 0.9865 -0.0135 -0.26 -0.2613 -1.0 2073702 Maybridge1_007861 CC(C)c1ccc(C)c2c(/C=N\NC(=S)N)cc(C)c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N08 compound treatment 0.9975 -0.00253 -0.05 -0.0491 -1.0 1490455 Maybridge1_007862 Fc1ccccc1c2ccc(cc2)C(=O)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N09 compound treatment 0.9916 -0.00836 -0.16 -0.1623 -1.0 1320292 Maybridge1_007863 CCc1ccc(C)nc1NC(=O)c2snnc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N10 compound treatment 1.0113 0.0113 0.22 0.2198 1.0 2073703 Maybridge1_007864 COC(=O)c1cc(ccc1N2CCCC2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N11 compound treatment 0.9618 -0.0382 -0.74 -0.7424 -1.0 1079409 Maybridge1_007865 N#Cc1nc(c2ccccc2)c(nc1C#N)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N12 compound treatment 0.9742 -0.0258 -0.5 -0.5019 -1.0 1695330 Maybridge1_007866 COc1ccc(NC(=O)c2ccc(cc2)c3ccccc3F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N13 compound treatment 1.0186 0.0186 0.36 0.3613 1.0 2073704 Maybridge1_007867 Clc1sc(cc1Br)S(=O)(=O)N2CCSCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N14 compound treatment 0.9734 -0.0266 -0.52 -0.516 -1.0 2073705 Maybridge1_007868 Fc1ccc2SCC/C(=N\OC(=O)c3ccc(Cl)cc3)/c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N15 compound treatment 0.9902 -0.00981 -0.19 -0.1906 -1.0 1454399 Maybridge1_007869 COc1ccc(CNCc2cc(OC)c(OC)c(OC)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N16 compound treatment 0.9873 -0.0127 -0.25 -0.2472 -1.0 2073706 Maybridge1_007870 Nc1ccc(Oc2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N17 compound treatment 0.9581 -0.0419 -0.81 -0.8132 -1.0 2073707 Maybridge1_007871 Fc1ccc(NN=C(C#N)C#N)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N18 compound treatment 0.9691 -0.0309 -0.6 -0.6009 -1.0 2073708 Maybridge1_007872 Cc1ccc(cc1)c2csc(n2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N19 compound treatment 0.9785 -0.0215 -0.42 -0.417 -1.0 2073709 Maybridge1_007873 COC(=O)c1cccn1c2ccccc2C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N20 compound treatment 0.9661 -0.0339 -0.66 -0.6575 -1.0 2073710 Maybridge1_007874 [O-][N+](=O)c1cc(ccc1Oc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N21 compound treatment 0.98 -0.02 -0.39 -0.3887 -1.0 1566906 Maybridge1_007875 O=C(CC1(CC2CC3CC(C2)C1)C3)Nc4nccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N22 compound treatment 0.9931 -0.0069 -0.13 -0.134 -1.0 1567147 Maybridge1_007876 OC1(CCOCC1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N23 mock treatment 0.9793 -0.0207 -0.4 -0.4028 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 N24 mock treatment 1.0128 0.0128 0.25 0.2481 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O01 compound treatment 1.0856 0.0856 1.66 1.663 1.0 2073711 Maybridge1_007877 Cc1nn(C)c(O)c1N=Nc2ccc(cc2)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O02 compound treatment 1.0026 0.00257 0.05 0.05 1.0 2073712 Maybridge1_007878 Cc1nn(c(O)c1N=Nc2ccc(cc2)C(C)(C)C)c3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O03 compound treatment 1.0062 0.00622 0.12 0.1207 1.0 2073713 Maybridge1_007879 COC(=O)c1sc(c(c1N)c2ccccc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O04 compound treatment 1.0128 0.0128 0.25 0.2481 1.0 2073714 Maybridge1_007880 FC(F)(F)c1ccc(NC(=O)Nc2ccccc2)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O05 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 1138575 Maybridge1_007881 N#Cc1c(nsc1c2ccccc2)N3CCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O06 compound treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 2073715 Maybridge1_007882 CCOC(=O)c1c(C)nn(c1C)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O07 compound treatment 1.0317 0.0317 0.62 0.616 1.0 2073716 Maybridge1_007883 N/C(=N\O)/c1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O08 compound treatment 0.9953 -0.00471 -0.09 -0.0915 -1.0 2073717 Maybridge1_007884 Cc1nn(c(C)c1C(=O)NNC(=O)c2ccc(Cl)cc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O09 compound treatment 1.0128 0.0128 0.25 0.2481 1.0 2073718 Maybridge1_007885 Brc1ccc(cc1)c2csc(Nc3cccnc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O10 compound treatment 1.0084 0.0084 0.16 0.1632 1.0 1705189 Maybridge1_007886 Cc1noc(C)c1C(=O)N2CCC(CC2)C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O11 compound treatment 0.9712 -0.0288 -0.56 -0.5585 -1.0 2073719 Maybridge1_007887 CC(=O)c1csc(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O12 compound treatment 0.9647 -0.0353 -0.69 -0.6858 -1.0 2073720 Maybridge1_007888 COc1cc(Cl)c(NS(=O)(=O)c2cc(Br)c(Br)s2)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O13 compound treatment 1.0339 0.0339 0.66 0.6584 1.0 2073721 Maybridge1_007889 FC(F)(F)c1ccc(C=C(C#N)C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O14 compound treatment 0.9334 -0.0666 -1.29 -1.2942 -1.0 1241193 Maybridge1_007890 Cc1cc(NC(=O)NS(=O)(=O)c2ccc(C)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O15 compound treatment 1.023 0.023 0.45 0.4462 1.0 2073722 Maybridge1_007891 FC(F)(F)c1ccc(CNS(=O)(=O)c2cc(Br)c(Br)s2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O16 compound treatment 0.9727 -0.0273 -0.53 -0.5302 -1.0 1559301 Maybridge1_007892 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCN(CC2)C(=O)NS(=O)(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O17 compound treatment 0.98 -0.02 -0.39 -0.3887 -1.0 2073723 Maybridge1_007893 O=C(CC(C(=O)c1cccs1)c2ccsc2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O18 compound treatment 1.0164 0.0164 0.32 0.3188 1.0 2073724 Maybridge1_007894 NC(=S)c1c(Cl)cc(cc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O19 compound treatment 0.9938 -0.00617 -0.12 -0.1198 -1.0 2073725 Maybridge1_007895 NC(=O)c1sccc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O20 compound treatment 1.0179 0.0179 0.35 0.3471 1.0 2073726 Maybridge1_007896 CCCCNC(=O)O/N=C(\C)/c1ccc2cc(OC)ccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O21 compound treatment 0.9778 -0.0222 -0.43 -0.4311 -1.0 2073727 Maybridge1_007897 COC(=O)c1ccc(/C=C/c2cccc(Cl)c2)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O22 compound treatment 0.972 -0.028 -0.54 -0.5443 -1.0 2073728 Maybridge1_007898 Clc1ccc(cc1)C(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O23 mock treatment 0.9523 -0.0477 -0.93 -0.9264 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 O24 mock treatment 1.0295 0.0295 0.57 0.5735 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P01 compound treatment 1.0405 0.0405 0.79 0.7857 1.0 2073729 Maybridge1_007899 Cc1onc(c1/C=C\2/C(=O)Nc3ccccc23)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P02 compound treatment 1.0601 0.0601 1.17 1.1678 1.0 2073730 Maybridge1_007900 Fc1ccc2NC(=O)/C(=N\Nc3ccccc3)/c2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P03 compound treatment 1.0179 0.0179 0.35 0.3471 1.0 2073731 Maybridge1_007901 Fc1ccc(cc1)n2cccc2C(=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P04 compound treatment 1.0623 0.0623 1.21 1.2102 1.0 2073732 Maybridge1_007902 NC(=O)c1ccc(cc1)c2ccccc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P05 compound treatment 1.0681 0.0681 1.32 1.3234 1.0 2073733 Maybridge1_007903 Cc1cc(OCc2cc(F)cc(F)c2)ccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P06 compound treatment 1.6394 0.639 12.42 12.4167 1.0 2073734 Maybridge1_007904 [O-][N+](=O)c1ccc(N/N=C/c2ccc(o2)c3cc(ccc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P07 compound treatment 0.9967 -0.00326 -0.06 -0.0632 -1.0 2073735 Maybridge1_007905 FC(F)(F)c1cccc(c1)c2ccnc3c(C#N)cnn23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P08 compound treatment 1.015 0.015 0.29 0.2905 1.0 2073736 Maybridge1_007906 NC(=S)Nc1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P09 compound treatment 0.9778 -0.0222 -0.43 -0.4311 -1.0 1682759 Maybridge1_007907 CCOC(=O)N1CCN(CN2CCCCC2=O)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P10 compound treatment 1.0259 0.0259 0.5 0.5028 1.0 2073737 Maybridge1_007908 Cc1sc(Nc2cc(Cl)cc(Cl)c2)nc1c3ccc(cc3)c4ccccc4F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P11 compound treatment 0.9916 -0.00836 -0.16 -0.1623 -1.0 1033603 Maybridge1_007909 CCOC(=O)Nc1ccc(F)cc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P12 compound treatment 1.0106 0.0106 0.21 0.2056 1.0 2073738 Maybridge1_007910 Fc1ccccc1c2ccc(cc2)C(=O)Nc3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P13 compound treatment 1.0033 0.0033 0.06 0.0641 1.0 2073739 Maybridge1_007911 Clc1sc(cc1Br)S(=O)(=O)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P14 compound treatment 1.0324 0.0324 0.63 0.6301 1.0 2073740 Maybridge1_007912 Fc1ccc2SCc3cn(nc3-c2c1)C(=O)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P15 compound treatment 1.0062 0.00622 0.12 0.1207 1.0 2073741 Maybridge1_007913 FC(F)(F)c1cc(NN=C(C#N)C#N)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P16 compound treatment 1.012 0.012 0.23 0.2339 1.0 2073742 Maybridge1_007914 N/C(=N\O)/COc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P17 compound treatment 0.9975 -0.00253 -0.05 -0.0491 -1.0 2073743 Maybridge1_007915 COC(=O)CCCCCCCC(=O)Nc1ccc(OC)c(OC)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P18 compound treatment 0.9916 -0.00836 -0.16 -0.1623 -1.0 1632182 Maybridge1_007916 Cc1ccc(cc1)c2csc(n2)c3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P19 compound treatment 1.0157 0.0157 0.3 0.3047 1.0 2073744 Maybridge1_007917 FC(F)(F)c1ccnc(c1)N2CCN(CC2)C(=O)Nc3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P20 compound treatment 1.0186 0.0186 0.36 0.3613 1.0 2073745 Maybridge1_007918 COc1cc(cc(c1C(=O)O)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P21 compound treatment 0.9858 -0.0142 -0.28 -0.2755 -1.0 1012024 Maybridge1_007919 N#CC(C(C#N)c1ccccc1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P22 compound treatment 0.9938 -0.00617 -0.12 -0.1198 -1.0 2073746 Maybridge1_007920 COc1cc(cc(c1C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P23 mock treatment 0.9763 -0.0237 -0.46 -0.4594 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.563 P24 mock treatment 1.0011 0.00112 0.02 0.0217 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A01 compound treatment 1.0544 0.0544 1.06 1.0556 1.0 2073747 Maybridge1_007921 FC(F)(F)c1cc(Oc2ccc(C#N)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A02 compound treatment 1.0653 0.0653 1.27 1.269 1.0 1556858 Maybridge1_007922 Cc1noc(C)c1C(=O)NCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A03 compound treatment 1.0683 0.0683 1.33 1.326 1.0 2073748 Maybridge1_007923 O=S(=O)(/C(=C/c1ccc(Oc2ccccc2)nc1)/C#N)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A04 compound treatment 0.9884 -0.0116 -0.22 -0.225 -1.0 1662020 Maybridge1_007924 CC(C)(C)c1ccc(s1)C(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A05 compound treatment 1.0514 0.0514 1.0 0.9987 1.0 2073749 Maybridge1_007925 CSc1ccc([N+](=O)[O-])c(SC)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A06 compound treatment 1.028 0.028 0.54 0.5434 1.0 2073750 Maybridge1_007926 COc1cc(NC(=S)Nc2ccc(Cl)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A07 compound treatment 1.0514 0.0514 1.0 0.9987 1.0 2073751 Maybridge1_007927 Nc1ccccc1Sc2nc(ccc2[N+](=O)[O-])c3ccccc3N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A08 compound treatment 0.995 -0.00499 -0.1 -0.0969 -1.0 2073752 Maybridge1_007928 COc1cc(NC(=O)Nc2cc(Cl)cc(Cl)c2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A09 compound treatment 0.9994 -5.95E-4 -0.01 -0.0116 -1.0 2073753 Maybridge1_007929 Cc1ccc(cc1)C2CC=CCC2[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A10 compound treatment 1.0316 0.0316 0.61 0.6145 1.0 2073754 Maybridge1_007930 CC(C)(C)C(=O)N1CCN(CC1)c2ncccc2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A11 compound treatment 1.0419 0.0419 0.81 0.8137 1.0 2073755 Maybridge1_007931 FC(F)(F)c1cccc(NC(=S)NNC(=O)c2ccc[nH]2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A12 compound treatment 1.0617 0.0617 1.2 1.1979 1.0 2073756 Maybridge1_007932 Cc1noc(C)c1C(=O)O/N=C(\N)/c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A13 compound treatment 1.0463 0.0463 0.9 0.8991 1.0 2073757 Maybridge1_007933 COC(=O)c1cccn1S(=O)(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A14 compound treatment 0.9833 -0.0167 -0.32 -0.3246 -1.0 2073758 Maybridge1_007934 Cc1noc(C)c1c2nc(no2)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A15 compound treatment 1.017 0.017 0.33 0.3299 1.0 1027194 Maybridge1_007935 COc1ccc(Oc2ccc(cc2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A16 compound treatment 0.9664 -0.0336 -0.65 -0.6519 -1.0 2073759 Maybridge1_007936 Cc1onc(c1C(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A17 compound treatment 1.0309 0.0309 0.6 0.6003 1.0 2073760 Maybridge1_007937 CN1CCN(CC1)c2ccccc2/C=N\NC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A18 compound treatment 1.0133 0.0133 0.26 0.2588 1.0 2073761 Maybridge1_007938 FC(F)(F)c1cnc(N2CCN(CC2)S(=O)(=O)c3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A19 compound treatment 1.0104 0.0104 0.2 0.2019 1.0 2073762 Maybridge1_007939 FC(F)(F)c1cc(NC(=O)NC(=O)c2cc(Br)cc(Br)c2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A20 compound treatment 0.9913 -0.00866 -0.17 -0.1681 -1.0 2073763 Maybridge1_007940 Cc1ccc(C)n1c2ccc(cc2)n3nc(cc3C(C)(C)C)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A21 compound treatment 1.0089 0.00893 0.17 0.1734 1.0 1304594 Maybridge1_007941 Cc1noc(C)c1C(=O)Nc2ccccc2Oc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A22 compound treatment 0.9957 -0.00426 -0.08 -0.0827 -1.0 1380697 Maybridge1_007942 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A23 mock treatment 1.0287 0.0287 0.56 0.5576 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 A24 mock treatment 1.0163 0.0163 0.32 0.3157 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B01 compound treatment 1.061 0.061 1.18 1.1837 1.0 2073764 Maybridge1_007943 Cc1cc(C)cc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B02 compound treatment 1.0683 0.0683 1.33 1.326 1.0 1172726 Maybridge1_007944 Cc1ccc(cc1)C(=O)Oc2cccc3cccnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B03 compound treatment 1.0045 0.00453 0.09 0.088 1.0 2073765 Maybridge1_007945 Cc1cccc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B04 compound treatment 1.0111 0.0111 0.22 0.2161 1.0 1119199 Maybridge1_007946 COC(=O)c1cc(OC)ccc1Oc2cccc(OC)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B05 compound treatment 1.0258 0.0258 0.5 0.5007 1.0 1683143 Maybridge1_007947 COc1ccccc1N2CCN(CC2)C(=O)c3c(C)onc3c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B06 compound treatment 0.9994 -5.95E-4 -0.01 -0.0116 -1.0 2073766 Maybridge1_007948 OC(=O)C1CN(C(=O)C1)c2cccc(c2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B07 compound treatment 1.0434 0.0434 0.84 0.8422 1.0 1509551 Maybridge1_007949 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B08 compound treatment 0.9738 -0.0262 -0.51 -0.5096 -1.0 2073767 Maybridge1_007950 COc1ccc(cc1)c2n[nH]cc2/C=N/Nc3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B09 compound treatment 1.0185 0.0185 0.36 0.3584 1.0 2073768 Maybridge1_007951 CCc1cc2c(cc1c3csc(n3)c4ccccc4)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B10 compound treatment 0.9848 -0.0152 -0.3 -0.2961 -1.0 2073769 Maybridge1_007952 COc1ccc(cc1)c2n[nH]cc2/C=N/NC(=S)NC3CC4CCC3C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B11 compound treatment 0.9606 -0.0394 -0.77 -0.7657 -1.0 1410819 Maybridge1_007953 COc1ccccc1N2CCN(CC2)C(=O)Nc3cccc(Cl)c3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B12 compound treatment 0.9789 -0.0211 -0.41 -0.41 -1.0 2073770 Maybridge1_007954 COc1ccc(cc1)C2N(CCc3sccc23)C(=S)Nc4ccc(OC(F)(F)F)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B13 compound treatment 1.0265 0.0265 0.51 0.5149 1.0 1504486 Maybridge1_007955 COc1ccccc1N2CCN(CC2)C(=S)Nc3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B14 compound treatment 0.9789 -0.0211 -0.41 -0.41 -1.0 2073771 Maybridge1_007956 CC(C)(C)c1ccc(NC(=O)Cc2cc(F)cc(F)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B15 compound treatment 0.9701 -0.0299 -0.58 -0.5807 -1.0 2073772 Maybridge1_007957 CCC(C)CNC(=S)N1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B16 compound treatment 1.0192 0.0192 0.37 0.3726 1.0 2073773 Maybridge1_007958 Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCSCc2c(C)cc(C)cc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B17 compound treatment 0.9921 -0.00792 -0.15 -0.1539 -1.0 2073774 Maybridge1_007959 COC(=O)/C(=C/c1cccn1c2ccc(cc2)C(F)(F)F)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B18 compound treatment 0.9913 -0.00866 -0.17 -0.1681 -1.0 1652319 Maybridge1_007960 COc1ccccc1N2CCN(CC(=S)N)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B19 compound treatment 0.9723 -0.0277 -0.54 -0.538 -1.0 2073775 Maybridge1_007961 OC(=O)COCC(=O)N1CCc2c([nH]c3ccccc23)C1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B20 compound treatment 1.0031 0.00307 0.06 0.0596 1.0 2073776 Maybridge1_007962 FC(F)(F)c1cnc(N2CCN(CC2)C(=O)CCSc3cccs3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B21 compound treatment 0.9789 -0.0211 -0.41 -0.41 -1.0 2073777 Maybridge1_007963 FC(F)(F)C1N(CCc2c1[nH]c3ccccc23)C(=O)Nc4cc(Cl)cc(Cl)c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B22 compound treatment 0.9804 -0.0196 -0.38 -0.3815 -1.0 2073778 Maybridge1_007964 COc1cc(Br)cc(/C=N/CCSCc2ccccc2Cl)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B23 mock treatment 0.9884 -0.0116 -0.22 -0.225 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 B24 mock treatment 1.0097 0.00966 0.19 0.1876 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C01 compound treatment 1.0485 0.0485 0.94 0.9418 1.0 1385577 Maybridge1_007965 COC(=O)c1cc(NC(=O)Nc2cc(Cl)cc(Cl)c2)ccc1N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C02 compound treatment 1.0045 0.00453 0.09 0.088 1.0 2073779 Maybridge1_007966 Cc1nnsc1C(=O)Nc2cccc(N)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C03 compound treatment 1.08 0.08 1.55 1.5536 1.0 2073780 Maybridge1_007967 CC1(C)OC(=O)C(=Cc2ccc(Oc3ccccc3)nc2)C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C04 compound treatment 0.9796 -0.0204 -0.4 -0.3957 -1.0 2073781 Maybridge1_007968 CC(C)(C)c1ccc(s1)C(=O)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C05 compound treatment 0.9635 -0.0365 -0.71 -0.7088 -1.0 2073782 Maybridge1_007969 [O-][N+](=O)c1ccc(nc1N2CCCCC2)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C06 compound treatment 0.9738 -0.0262 -0.51 -0.5096 -1.0 2073783 Maybridge1_007970 COc1cccc(NC(=O)Nc2cc(OC)cc(c2)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C07 compound treatment 1.0566 0.0566 1.1 1.0983 1.0 2073784 Maybridge1_007971 Cn1c(Sc2ccc([N+](=O)[O-])c(Sc3nnc(n3C)C(F)(F)F)n2)nnc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C08 compound treatment 1.0111 0.0111 0.22 0.2161 1.0 2073785 Maybridge1_007972 COC(=O)c1ccc(CSc2ccccn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C09 compound treatment 1.017 0.017 0.33 0.3299 1.0 1501900 Maybridge1_007973 Clc1ccc2nc(sc2c1)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C10 compound treatment 0.9891 -0.0109 -0.21 -0.2108 -1.0 2073786 Maybridge1_007974 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C11 compound treatment 1.0353 0.0353 0.69 0.6857 1.0 2073787 Maybridge1_007975 Cc1ccc(NC(=S)NNC(=O)c2ccc[nH]2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C12 compound treatment 0.973 -0.027 -0.52 -0.5238 -1.0 2073788 Maybridge1_007976 Cc1noc(C)c1C(=O)O/N=C(\N)/c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C13 compound treatment 1.0133 0.0133 0.26 0.2588 1.0 2073789 Maybridge1_007977 CN(C)c1ccc(/C=N/Nc2cnc3ccccc3n2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C14 compound treatment 1.0353 0.0353 0.69 0.6857 1.0 2073790 Maybridge1_007978 Cc1ccc(cc1)C(=O)N2CCN(CC2)c3ncccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C15 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 2073791 Maybridge1_007979 CCOC(=O)c1ccc(cc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C16 compound treatment 0.9283 -0.0717 -1.39 -1.3918 -1.0 2073792 Maybridge1_007980 Cc1onc(c1C(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C17 compound treatment 0.9804 -0.0196 -0.38 -0.3815 -1.0 1672229 Maybridge1_007981 COc1cccc(c1)c2nc(C#N)c(N)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C18 compound treatment 0.9913 -0.00866 -0.17 -0.1681 -1.0 2073793 Maybridge1_007982 FC(F)(F)c1cnc(N2CCN(CC2)S(=O)(=O)c3ccc(Cl)c(Cl)c3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C19 compound treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 1127055 Maybridge1_007983 CN(Cc1ccccc1)S(=O)(=O)c2c(C)noc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C20 compound treatment 0.9752 -0.0248 -0.48 -0.4811 -1.0 2073794 Maybridge1_007984 FC(F)(F)c1cnc(N2CCN(CC2)C(=S)NCc3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C21 compound treatment 0.9994 -5.95E-4 -0.01 -0.0116 -1.0 1397120 Maybridge1_007985 Cc1noc(C)c1S(=O)(=O)Nc2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C22 compound treatment 0.9327 -0.0673 -1.31 -1.3064 -1.0 1706710 Maybridge1_007986 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3ccc(s3)c4cnoc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C23 mock treatment 0.9994 -5.95E-4 -0.01 -0.0116 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 C24 mock treatment 0.9789 -0.0211 -0.41 -0.41 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D01 compound treatment 1.0214 0.0214 0.42 0.4153 1.0 2073795 Maybridge1_007987 COc1ccc(OC)c(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D02 compound treatment 1.017 0.017 0.33 0.3299 1.0 2073796 Maybridge1_007988 FC(F)(F)c1cnc(N2CCN(CC2)C(=O)CSc3ccccn3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D03 compound treatment 1.0309 0.0309 0.6 0.6003 1.0 2073797 Maybridge1_007989 FC(F)(F)c1cnc(N2CCN(CC2)C(=S)Nc3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D04 compound treatment 1.0053 0.00527 0.1 0.1023 1.0 2073798 Maybridge1_007990 [O-][N+](=O)c1ccc(nc1)N2CCN(CC2)c3ncccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D05 compound treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 1535919 Maybridge1_007991 CCN(CC)c1ccc(NC(=O)c2c(C)onc2c3c(Cl)cccc3Cl)c(n1)N(CC)CC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D06 compound treatment 0.9979 -0.00206 -0.04 -0.04 -1.0 2073799 Maybridge1_007992 COc1ccc(/N=C/c2ccc(N(C)C)c(C#N)c2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D07 compound treatment 0.9965 -0.00353 -0.07 -0.0685 -1.0 2073800 Maybridge1_007993 Cc1noc(C)c1c2nc(no2)c3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D08 compound treatment 1.0133 0.0133 0.26 0.2588 1.0 2073801 Maybridge1_007994 COc1ccc(cc1)C(=O)NCCSCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D09 compound treatment 1.0001 1.37E-4 0.0 0.0027 1.0 1578068 Maybridge1_007995 COc1ccccc1N2CCN(CC2)C(=O)Nc3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D10 compound treatment 0.973 -0.027 -0.52 -0.5238 -1.0 2073802 Maybridge1_007996 FC(F)(F)c1cccc(c1)C(=O)Nc2ccccc2SCc3noc(n3)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D11 compound treatment 0.9818 -0.0182 -0.35 -0.3531 -1.0 1434748 Maybridge1_007997 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D12 compound treatment 0.9598 -0.0402 -0.78 -0.7799 -1.0 2073803 Maybridge1_007998 Cc1ccc(c(NC(=O)c2cccc(c2)C(F)(F)F)c1)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D13 compound treatment 0.9884 -0.0116 -0.22 -0.225 -1.0 1219861 Maybridge1_007999 COc1ccccc1N2CCN(CC2)C(=S)Nc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D14 compound treatment 0.9547 -0.0453 -0.88 -0.8795 -1.0 2073804 Maybridge1_008000 Fc1cccc(Cl)c1C(=O)Nc2ccc(Oc3cc(cc(c3)C(F)(F)F)C(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D15 compound treatment 0.9386 -0.0614 -1.19 -1.1926 -1.0 2073805 Maybridge1_008001 CN(C)c1ccc(/C=N/NC(=S)N)cc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D16 compound treatment 1.0133 0.0133 0.26 0.2588 1.0 2073806 Maybridge1_008002 Cc1cc(C)c(CSCCNC(=O)Nc2ccc(F)cc2F)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D17 compound treatment 1.0104 0.0104 0.2 0.2019 1.0 2073807 Maybridge1_008003 NC(=S)N/N=C/c1cccn1c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D18 compound treatment 0.9987 -0.00133 -0.03 -0.0258 -1.0 2073808 Maybridge1_008004 Cc1onc(c1C(=O)Nc2ccccc2SCc3noc(n3)c4cccs4)c5c(Cl)cccc5Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D19 compound treatment 0.9569 -0.0431 -0.84 -0.8368 -1.0 2073809 Maybridge1_008005 FC(F)(F)C1N(CCc2c1[nH]c3ccccc23)C(=O)NC(=O)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D20 compound treatment 0.9628 -0.0372 -0.72 -0.723 -1.0 2073810 Maybridge1_008006 FC(F)(F)c1ccc(NC(=O)NCCSCc2ccccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D21 compound treatment 0.9379 -0.0621 -1.21 -1.2068 -1.0 2073811 Maybridge1_008007 [O-][N+](=O)c1cccc(OCC(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D22 compound treatment 0.9488 -0.0512 -0.99 -0.9934 -1.0 1142424 Maybridge1_008008 CCOC(=O)c1[nH]c2cc(Cl)cc(Cl)c2c1CCC(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D23 mock treatment 0.965 -0.035 -0.68 -0.6803 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 D24 mock treatment 1.0229 0.0229 0.44 0.4438 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E01 compound treatment 1.08 0.08 1.55 1.5536 1.0 1709671 Maybridge1_008009 COC(=O)c1cc(ccc1N2CCOCC2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E02 compound treatment 0.9884 -0.0116 -0.22 -0.225 -1.0 1559282 Maybridge1_008010 Cc1noc(C)c1C(=O)Oc2ccc(F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E03 compound treatment 1.0485 0.0485 0.94 0.9418 1.0 2073812 Maybridge1_008011 CCOC(=O)N/N=C(\C)/C(=N/NC(=O)OCC)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E04 compound treatment 1.0009 8.7E-4 0.02 0.0169 1.0 2073813 Maybridge1_008012 CC(C)(C)c1ccc(s1)C(=O)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E05 compound treatment 1.0023 0.00234 0.05 0.0454 1.0 2073814 Maybridge1_008013 [O-][N+](=O)c1ccc(Sc2ccc(Cl)cc2)nc1Sc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E06 compound treatment 1.0082 0.0082 0.16 0.1592 1.0 2073815 Maybridge1_008014 [O-][N+](=O)c1ccc(nc1)N2CCC(CC2)C(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E07 compound treatment 1.0133 0.0133 0.26 0.2588 1.0 2073816 Maybridge1_008015 N#Cc1ccc(nc1)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E08 compound treatment 0.9694 -0.0306 -0.59 -0.5949 -1.0 2073817 Maybridge1_008016 OC(=O)c1ccccc1C(=O)N2CCN(CC2)c3ncccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E09 compound treatment 1.0426 0.0426 0.83 0.8279 1.0 2073818 Maybridge1_008017 COc1ccc(N)c(OC)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E10 compound treatment 0.9877 -0.0123 -0.24 -0.2392 -1.0 2073819 Maybridge1_008018 CC(C)(C)c1ccc(cc1)C(=O)N2CCN(CC2)c3ncccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E11 compound treatment 1.017 0.017 0.33 0.3299 1.0 2073820 Maybridge1_008019 [O-][N+](=O)c1cc(C#N)ccc1N/N=C/c2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E12 compound treatment 1.0053 0.00527 0.1 0.1023 1.0 2073821 Maybridge1_008020 Cc1onc(c1C(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)c4c(F)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E13 compound treatment 1.0214 0.0214 0.42 0.4153 1.0 2073822 Maybridge1_008021 COc1ccc(Oc2ccc([N+](=O)[O-])c(Oc3ccc(OC)cc3)n2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E14 compound treatment 0.951 -0.049 -0.95 -0.9507 -1.0 2073823 Maybridge1_008022 [O-][N+](=O)c1ccc(nc1)N2CCN(CC2)c3ccc(cn3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E15 compound treatment 0.984 -0.016 -0.31 -0.3104 -1.0 1168565 Maybridge1_008023 OC(=O)C(c1ccccc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E16 compound treatment 1.0016 0.0016 0.03 0.0311 1.0 1273402 Maybridge1_008024 CC(C)(C)c1cc(n(n1)c2ccc(N)cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E17 compound treatment 1.0126 0.0126 0.24 0.2446 1.0 2073824 Maybridge1_008025 Clc1ccc(c2ccon2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E18 compound treatment 1.0287 0.0287 0.56 0.5576 1.0 2073825 Maybridge1_008026 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E19 compound treatment 0.9642 -0.0358 -0.69 -0.6946 -1.0 1524187 Maybridge1_008027 COc1ccc(NS(=O)(=O)c2c(C)noc2C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E20 compound treatment 0.9554 -0.0446 -0.87 -0.8653 -1.0 2073826 Maybridge1_008028 CNC(=S)N1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E21 compound treatment 1.0141 0.0141 0.27 0.273 1.0 1344467 Maybridge1_008029 Cc1noc(C)c1S(=O)(=O)N2CCSCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E22 compound treatment 0.9547 -0.0453 -0.88 -0.8795 -1.0 1617817 Maybridge1_008030 COc1ccccc1N2CCN(CC2)C(=O)c3c(F)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E23 mock treatment 0.9987 -0.00133 -0.03 -0.0258 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 E24 mock treatment 0.9994 -5.95E-4 -0.01 -0.0116 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F01 compound treatment 1.0617 0.0617 1.2 1.1979 1.0 2073827 Maybridge1_008031 Fc1ccc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F02 compound treatment 1.1423 0.142 2.76 2.7631 1.0 1561192 Maybridge1_008032 Fc1cccc(F)c1C(=O)Oc2cccc3cccnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F03 compound treatment 1.0023 0.00234 0.05 0.0454 1.0 2073828 Maybridge1_008033 FC(F)(F)Oc1ccc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F04 compound treatment 0.9884 -0.0116 -0.22 -0.225 -1.0 2073829 Maybridge1_008034 FC(F)(F)c1ccc(nc1)N2CCN(CC2)S(=O)(=O)c3ccc(C#N)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F05 compound treatment 0.9672 -0.0328 -0.64 -0.6376 -1.0 1402639 Maybridge1_008035 CCN(CC)c1ccc(NC(=O)c2c(F)cccc2F)c(n1)N(CC)CC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F06 compound treatment 0.9598 -0.0402 -0.78 -0.7799 -1.0 2073830 Maybridge1_008036 CC(=O)CCC(=O)c1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F07 compound treatment 1.0038 0.0038 0.07 0.0738 1.0 2073831 Maybridge1_008037 FC(F)(F)c1cnc(N2CCN(CC2)C(=S)NC3CC4CC3C=C4)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F08 compound treatment 1.0009 8.7E-4 0.02 0.0169 1.0 2073832 Maybridge1_008038 FC(F)(F)c1cccc(c1)C(=O)NCCSCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F09 compound treatment 0.9657 -0.0343 -0.67 -0.6661 -1.0 1560524 Maybridge1_008039 COc1ccccc1N2CCN(CC2)C(=O)Nc3cc(F)ccc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F10 compound treatment 1.0016 0.0016 0.03 0.0311 1.0 2073833 Maybridge1_008040 Cc1ccc(cc1)C(=O)Nc2ccccc2SCc3noc(n3)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F11 compound treatment 0.9532 -0.0468 -0.91 -0.908 -1.0 1517384 Maybridge1_008041 COc1ccccc1N2CCN(CC2)C(=O)Nc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F12 compound treatment 1.0119 0.0119 0.23 0.2303 1.0 2073834 Maybridge1_008042 COC(=O)c1cc(/C=N/NS(=O)(=O)c2ccc(C)cc2)cn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F13 compound treatment 0.9943 -0.00572 -0.11 -0.1112 -1.0 2073835 Maybridge1_008043 COc1ccccc1N2CCN(CC2)C(=S)Nc3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F14 compound treatment 1.0016 0.0016 0.03 0.0311 1.0 2073836 Maybridge1_008044 FC(F)(F)c1cc(Oc2ccc(NC(=O)c3cccs3)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F15 compound treatment 1.0089 0.00893 0.17 0.1734 1.0 1441649 Maybridge1_008045 CCc1cc2c(cc1c3csc(N)n3)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F16 compound treatment 1.0075 0.00746 0.14 0.145 1.0 2073837 Maybridge1_008046 Cc1cc(C)c(CSCCNC(=O)Nc2ccc(OC(F)(F)F)cc2)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F17 compound treatment 0.9642 -0.0358 -0.69 -0.6946 -1.0 2073838 Maybridge1_008047 Cc1ccc(NC(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F18 compound treatment 0.9686 -0.0314 -0.61 -0.6092 -1.0 2073839 Maybridge1_008048 Cc1ccc(c(NC(=S)Nc2ccc(Br)cc2OC(F)(F)F)c1)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F19 compound treatment 1.0207 0.0207 0.4 0.4011 1.0 2073840 Maybridge1_008049 COc1cccc(Cl)c1NC(=O)N2CCc3c([nH]c4ccccc34)C2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F20 compound treatment 0.984 -0.016 -0.31 -0.3104 -1.0 2073841 Maybridge1_008050 Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCSCc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F21 compound treatment 1.017 0.017 0.33 0.3299 1.0 2073842 Maybridge1_008051 FC(F)(F)c1cnc(N2CCN(CC2)C(=O)COc3ccc4OCOc4c3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F22 compound treatment 1.0141 0.0141 0.27 0.273 1.0 2073843 Maybridge1_008052 Clc1sc(Cl)c(c1Br)S(=O)(=O)NCCSCc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F23 mock treatment 0.9921 -0.00792 -0.15 -0.1539 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 F24 mock treatment 1.0163 0.0163 0.32 0.3157 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G01 compound treatment 0.9935 -0.00646 -0.13 -0.1254 -1.0 2073844 Maybridge1_008053 COc1ccc(cc1)C(=O)NNC(=O)c2c(OC)cc(cc2C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G02 compound treatment 1.0001 1.37E-4 0.0 0.0027 1.0 2073845 Maybridge1_008054 Cc1noc(C)c1C(=O)Oc2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G03 compound treatment 0.9928 -0.00719 -0.14 -0.1396 -1.0 2073846 Maybridge1_008055 CCOC(=O)N/N=C(\C)/c1ccccc1c2ccccc2\C(=N\NC(=O)OCC)\C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G04 compound treatment 0.9965 -0.00353 -0.07 -0.0685 -1.0 2073847 Maybridge1_008056 COc1cc(NC(=S)NC(=O)c2ccccc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G05 compound treatment 1.0236 0.0236 0.46 0.458 1.0 2073848 Maybridge1_008057 Oc1ccc2ccccc2c1N=Nc3ccccc3OC(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G06 compound treatment 1.0229 0.0229 0.44 0.4438 1.0 2073849 Maybridge1_008058 [O-][N+](=O)c1ccc(nc1)N2CCC(CC2)C(=O)c3ccc(F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G07 compound treatment 0.9855 -0.0145 -0.28 -0.2819 -1.0 1329908 Maybridge1_008059 COc1ccc(NC(=O)C(C)c2ccc(CC(C)C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G08 compound treatment 0.9613 -0.0387 -0.75 -0.7515 -1.0 2073850 Maybridge1_008060 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)c3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G09 compound treatment 1.0053 0.00527 0.1 0.1023 1.0 1164325 Maybridge1_008061 COC(=O)c1cccn1S(=O)(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G10 compound treatment 0.9987 -0.00133 -0.03 -0.0258 -1.0 2073851 Maybridge1_008062 Oc1c(Br)cc(Br)cc1/C=N/c2ccc(Sc3ccccc3)nc2Sc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G11 compound treatment 1.0302 0.0302 0.59 0.5861 1.0 2073852 Maybridge1_008063 CN(C)c1ccc(/C=C/2\C(=O)Nc3ccccc23)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G12 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 1457693 Maybridge1_008064 Cc1noc(C)c1C(=O)NCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G13 compound treatment 1.0155 0.0155 0.3 0.3015 1.0 1044663 Maybridge1_008065 Nc1oc(nc1C#N)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G14 compound treatment 0.9855 -0.0145 -0.28 -0.2819 -1.0 2073853 Maybridge1_008066 Cc1onc(c1C(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G15 compound treatment 1.0119 0.0119 0.23 0.2303 1.0 1550324 Maybridge1_008067 OC(=O)c1ccc(cc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G16 compound treatment 1.0272 0.0272 0.53 0.5291 1.0 2073854 Maybridge1_008068 FC(F)(F)c1ccc(nc1)N2CCN(CC2)c3ccc(NC(=O)c4ccc(Cl)cc4)cn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G17 compound treatment 0.954 -0.046 -0.89 -0.8938 -1.0 2073855 Maybridge1_008069 CCOC(=O)c1cnn(c1C)c2ccc(N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G18 compound treatment 0.9848 -0.0152 -0.3 -0.2961 -1.0 2073856 Maybridge1_008070 CC(C)(C)c1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G19 compound treatment 1.0009 8.7E-4 0.02 0.0169 1.0 1690043 Maybridge1_008071 Cc1noc(C)c1C(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G20 compound treatment 0.9891 -0.0109 -0.21 -0.2108 -1.0 2073857 Maybridge1_008072 Cc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G21 compound treatment 1.0126 0.0126 0.24 0.2446 1.0 2073858 Maybridge1_008073 CC(C)(C)c1cc(n(n1)c2ccc(cc2)[N+](=O)[O-])C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G22 compound treatment 0.9686 -0.0314 -0.61 -0.6092 -1.0 2073859 Maybridge1_008074 FC(F)(F)c1cnc(N2CCN(CC2)S(=O)(=O)c3ccc(Cl)cc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G23 mock treatment 0.9613 -0.0387 -0.75 -0.7515 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 G24 mock treatment 0.9891 -0.0109 -0.21 -0.2108 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H01 compound treatment 1.0316 0.0316 0.61 0.6145 1.0 2073860 Maybridge1_008075 CCc1cc2c(cc1c3csc(n3)c4ccc(Cl)cc4)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H02 compound treatment 0.9921 -0.00792 -0.15 -0.1539 -1.0 1965709 Maybridge1_008076 FC(F)(F)c1ccc(nc1)N2CCN(CC2)S(=O)(=O)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H03 compound treatment 1.0214 0.0214 0.42 0.4153 1.0 2073861 Maybridge1_008077 FC(F)(F)c1cccc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H04 compound treatment 0.9994 -5.95E-4 -0.01 -0.0116 -1.0 2073862 Maybridge1_008078 CC(C)Cc1ccc(cc1)C(C)c2nc(no2)c3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H05 compound treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 2073863 Maybridge1_008079 FC(F)(F)c1cnc(N2CCN(CC2)C(=S)NCC=C)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H06 compound treatment 1.0163 0.0163 0.32 0.3157 1.0 2073864 Maybridge1_008080 CC(=O)CCC(=O)c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H07 compound treatment 1.0053 0.00527 0.1 0.1023 1.0 1387737 Maybridge1_008081 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3cc(C)c(Cl)cc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H08 compound treatment 1.0207 0.0207 0.4 0.4011 1.0 2073865 Maybridge1_008082 Fc1cccc(F)c1C(=O)NCCSCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H09 compound treatment 1.0133 0.0133 0.26 0.2588 1.0 2073866 Maybridge1_008083 FC(F)(F)c1cnc(N2CCN(CC2)S(=O)(=O)c3ccc(C#N)cc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H10 compound treatment 1.006 0.006 0.12 0.1165 1.0 2073867 Maybridge1_008084 Cc1ccc(cc1)S(=O)(=O)NC(=O)Oc2ccc(Oc3ccc(cn3)C(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H11 compound treatment 0.9994 -5.95E-4 -0.01 -0.0116 -1.0 2073868 Maybridge1_008085 Fc1ccc(NC(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H12 compound treatment 0.9987 -0.00133 -0.03 -0.0258 -1.0 2073869 Maybridge1_008086 [O-][N+](=O)c1ccc(Oc2cc(cc(c2)C(F)(F)F)C(F)(F)F)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H13 compound treatment 0.9613 -0.0387 -0.75 -0.7515 -1.0 1347507 Maybridge1_008087 COc1ccccc1N2CCN(CC2)C(=S)Nc3c(C)cc(C)cc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H14 compound treatment 0.9943 -0.00572 -0.11 -0.1112 -1.0 2073870 Maybridge1_008088 COC(=O)c1cc(/C=N/NC(=O)c2cccc(c2)[N+](=O)[O-])cn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H15 compound treatment 0.9613 -0.0387 -0.75 -0.7515 -1.0 2073871 Maybridge1_008089 CCc1cc2c(cc1c3csc(NC(=N)N)n3)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H16 compound treatment 0.9877 -0.0123 -0.24 -0.2392 -1.0 2073872 Maybridge1_008090 Cc1cc(C)c(CSCCNC(=O)Nc2cccc3ccccc23)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H17 compound treatment 0.9921 -0.00792 -0.15 -0.1539 -1.0 2073873 Maybridge1_008091 FC(F)(F)Oc1ccc(NC(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H18 compound treatment 1.0272 0.0272 0.53 0.5291 1.0 1132312 Maybridge1_008092 Cc1ccc(c(NC(=S)NC(=O)c2ccccc2)c1)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H19 compound treatment 0.9503 -0.0497 -0.96 -0.9649 -1.0 2073874 Maybridge1_008093 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)Nc3cc(Cl)cc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H20 compound treatment 0.9877 -0.0123 -0.24 -0.2392 -1.0 2073875 Maybridge1_008094 COc1ccccc1NC(=O)NCCSCc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H21 compound treatment 0.9547 -0.0453 -0.88 -0.8795 -1.0 2073876 Maybridge1_008095 FC(F)(F)c1cnc(N2CCN(CC2)C(=O)CSCc3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H22 compound treatment 0.9686 -0.0314 -0.61 -0.6092 -1.0 2073877 Maybridge1_008096 CC(C)(C)c1cc(n(n1)c2ccc(NC(=O)c3ccc(cc3)C(C)(C)C)cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H23 mock treatment 1.006 0.006 0.12 0.1165 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 H24 mock treatment 1.006 0.006 0.12 0.1165 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I01 compound treatment 1.058 0.058 1.13 1.1268 1.0 2073878 Maybridge1_008097 COc1ccc(NC(=O)OC(C)(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I02 compound treatment 1.0082 0.0082 0.16 0.1592 1.0 2073879 Maybridge1_008098 Cc1noc(C)c1C(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I03 compound treatment 1.0097 0.00966 0.19 0.1876 1.0 2073880 Maybridge1_008099 CC(=O)c1ccc(OCCCOc2ccc(cc2)C(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I04 compound treatment 0.9862 -0.0138 -0.27 -0.2677 -1.0 1396305 Maybridge1_008100 COc1cc(CNS(=O)(=O)c2c(C)noc2C)cc(OC)c1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I05 compound treatment 1.0507 0.0507 0.98 0.9845 1.0 2073881 Maybridge1_008101 [O-][N+](=O)c1ccc(Sc2ccccc2)nc1Sc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I06 compound treatment 0.9979 -0.00206 -0.04 -0.04 -1.0 2073882 Maybridge1_008102 Cc1ccc(cc1)C(=O)C2CCN(CC2)c3ccc(cn3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I07 compound treatment 0.984 -0.016 -0.31 -0.3104 -1.0 2073883 Maybridge1_008103 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I08 compound treatment 1.0016 0.0016 0.03 0.0311 1.0 2073884 Maybridge1_008104 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)C3CCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I09 compound treatment 1.0448 0.0448 0.87 0.8706 1.0 2073885 Maybridge1_008105 Fc1ccc(NC(=S)NNC(=O)c2ccc[nH]2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I10 compound treatment 0.9855 -0.0145 -0.28 -0.2819 -1.0 2073886 Maybridge1_008106 Oc1c(Cl)cc(Cl)cc1/C=N/c2ccc(Sc3ccccc3)nc2Sc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I11 compound treatment 1.0053 0.00527 0.1 0.1023 1.0 2073887 Maybridge1_008107 CN(C)c1ccc(/C=C(\C#N)/S(=O)(=O)C)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I12 compound treatment 0.9598 -0.0402 -0.78 -0.7799 -1.0 2073888 Maybridge1_008108 Cc1noc(C)c1C(=O)NNC(=O)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I13 compound treatment 1.0287 0.0287 0.56 0.5576 1.0 2073889 Maybridge1_008109 Cc1ccc(I)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I14 compound treatment 1.0001 1.37E-4 0.0 0.0027 1.0 2073890 Maybridge1_008110 Cc1onc(c1C(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I15 compound treatment 0.9869 -0.0131 -0.25 -0.2535 -1.0 1067691 Maybridge1_008111 Nc1ncnc2oc(nc12)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I16 compound treatment 0.9723 -0.0277 -0.54 -0.538 -1.0 2073891 Maybridge1_008112 CS(=O)(=O)N1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I17 compound treatment 0.9664 -0.0336 -0.65 -0.6519 -1.0 2073892 Maybridge1_008113 Brc1cc(Br)cc(c1)C(=O)NC(=O)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I18 compound treatment 0.9496 -0.0504 -0.98 -0.9791 -1.0 2073893 Maybridge1_008114 [O-][N+](=O)c1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I19 compound treatment 1.0031 0.00307 0.06 0.0596 1.0 2073894 Maybridge1_008115 Cc1noc(C)c1C(=O)Nc2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I20 compound treatment 0.9782 -0.0218 -0.42 -0.4242 -1.0 2073895 Maybridge1_008116 CC(C)c1ccc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I21 compound treatment 1.0412 0.0412 0.8 0.7995 1.0 1584969 Maybridge1_008117 Cc1cc(NC(=O)c2c(C)noc2C)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I22 compound treatment 0.9928 -0.00719 -0.14 -0.1396 -1.0 2073896 Maybridge1_008118 FC(F)(F)c1cnc(N2CCN(CC2)S(=O)(=O)c3ccc4ccccc4c3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I23 mock treatment 1.028 0.028 0.54 0.5434 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 I24 mock treatment 0.9935 -0.00646 -0.13 -0.1254 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J01 compound treatment 1.0185 0.0185 0.36 0.3584 1.0 2073897 Maybridge1_008119 FC(F)(F)c1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J02 compound treatment 1.0624 0.0624 1.21 1.2121 1.0 1470614 Maybridge1_008120 COc1cccc(c1)C(=O)Oc2cccc3cccnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J03 compound treatment 0.995 -0.00499 -0.1 -0.0969 -1.0 2073898 Maybridge1_008121 FC(F)(F)c1ccc(cc1)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J04 compound treatment 0.9899 -0.0101 -0.2 -0.1965 -1.0 2073899 Maybridge1_008122 FC(F)(F)c1ccc(nc1)N2CCN(CC2)C(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J05 compound treatment 1.0001 1.37E-4 0.0 0.0027 1.0 2073900 Maybridge1_008123 CC(C)(C)C(=O)Nc1ccc(nc1)N2CCN(CC2)c3ccc(cn3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J06 compound treatment 1.0316 0.0316 0.61 0.6145 1.0 2073901 Maybridge1_008124 FC(F)(F)Oc1ccc(cc1)n2cccc2/C=C(\C#N)/S(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J07 compound treatment 1.0412 0.0412 0.8 0.7995 1.0 1147308 Maybridge1_008125 O=C(N1CCCCC1)C2(CC3CC4CC(C3)C2)C4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J08 compound treatment 1.0258 0.0258 0.5 0.5007 1.0 2073902 Maybridge1_008126 CC(C)(C)c1ccc(cc1)C(=O)NCCSCc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J09 compound treatment 0.9833 -0.0167 -0.32 -0.3246 -1.0 2073903 Maybridge1_008127 CC(C)c1ccccc1NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J10 compound treatment 1.0463 0.0463 0.9 0.8991 1.0 2073904 Maybridge1_008128 Fc1cccc(F)c1C(=O)Nc2ccccc2SCc3noc(n3)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J11 compound treatment 0.9833 -0.0167 -0.32 -0.3246 -1.0 2073905 Maybridge1_008129 COc1cccc(NC(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J12 compound treatment 0.9848 -0.0152 -0.3 -0.2961 -1.0 1164375 Maybridge1_008130 COc1ccc(cc1)C2N(CCc3sccc23)C(=O)c4ccc(F)cc4F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J13 compound treatment 1.0126 0.0126 0.24 0.2446 1.0 2073906 Maybridge1_008131 FC(F)(F)c1cccnc1N2CCN(CC2)c3ccc(C#N)cn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J14 compound treatment 0.9606 -0.0394 -0.77 -0.7657 -1.0 2073907 Maybridge1_008132 COC(=O)c1cc(/C=N/NC(=O)c2cccnc2)cn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J15 compound treatment 0.9818 -0.0182 -0.35 -0.3531 -1.0 2073908 Maybridge1_008133 CCc1cc2c(cc1c3csc(n3)c4ccc(F)cc4)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J16 compound treatment 0.9708 -0.0292 -0.57 -0.5665 -1.0 2073909 Maybridge1_008134 Cc1cc(C)c(CSCCNC(=O)Nc2ccc(cc2)C(F)(F)F)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J17 compound treatment 0.9796 -0.0204 -0.4 -0.3957 -1.0 2073910 Maybridge1_008135 CC(C)(C)c1ccc(OCC(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J18 compound treatment 1.006 0.006 0.12 0.1165 1.0 2073911 Maybridge1_008136 Cc1ccc(c(NC(=O)Nc2ccccc2C(F)(F)F)c1)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J19 compound treatment 0.9532 -0.0468 -0.91 -0.908 -1.0 2073912 Maybridge1_008137 [O-][N+](=O)c1cccc(NC(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J20 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 2073913 Maybridge1_008138 CC(C)Cc1ccc(cc1)C(C)/C(=N/O)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J21 compound treatment 0.9657 -0.0343 -0.67 -0.6661 -1.0 2073914 Maybridge1_008139 FC(F)(F)c1cnc(N2CCN(CC2)C(=O)CSc3ccc(Cl)cc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J22 compound treatment 1.0478 0.0478 0.93 0.9276 1.0 2073915 Maybridge1_008140 CC(C)(C)c1cc(n(n1)c2ccc(/N=C\c3cc(Br)cc(Br)c3O)cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J23 mock treatment 1.0089 0.00893 0.17 0.1734 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 J24 mock treatment 1.0309 0.0309 0.6 0.6003 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K01 compound treatment 1.0514 0.0514 1.0 0.9987 1.0 2073916 Maybridge1_008141 CC(C)(C)OC(=O)Nc1ccc(cc1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K02 compound treatment 0.9752 -0.0248 -0.48 -0.4811 -1.0 2073917 Maybridge1_008142 COC(=O)c1ccc(CSc2ccc(cn2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K03 compound treatment 1.0023 0.00234 0.05 0.0454 1.0 2073918 Maybridge1_008143 OC(=O)C1CC=CCC1c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K04 compound treatment 0.9635 -0.0365 -0.71 -0.7088 -1.0 2073919 Maybridge1_008144 COc1cc(NC(=O)NS(=O)(=O)c2ccc(C)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K05 compound treatment 0.9957 -0.00426 -0.08 -0.0827 -1.0 2073920 Maybridge1_008145 CCN(CC)c1ccc([N+](=O)[O-])c(n1)N(CC)CC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K06 compound treatment 0.976 -0.024 -0.47 -0.4669 -1.0 2073921 Maybridge1_008146 Cc1c(C)c(C)c(C(=O)C2CCN(CC2)c3ccc(cn3)[N+](=O)[O-])c(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K07 compound treatment 1.0119 0.0119 0.23 0.2303 1.0 2073922 Maybridge1_008147 COc1ccc([N+](=O)[O-])c(OC)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K08 compound treatment 0.9767 -0.0233 -0.45 -0.4527 -1.0 2073923 Maybridge1_008148 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K09 compound treatment 0.9979 -0.00206 -0.04 -0.04 -1.0 2073924 Maybridge1_008149 Clc1cc(Cl)cc(NC(=O)NNC(=O)c2ccc[nH]2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K10 compound treatment 0.9877 -0.0123 -0.24 -0.2392 -1.0 2073925 Maybridge1_008150 COc1cc(Br)cc(/C=N/c2ccc(Sc3ccccc3)nc2Sc4ccccc4)c1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K11 compound treatment 1.0221 0.0221 0.43 0.4295 1.0 2073926 Maybridge1_008151 Nc1ccccc1Sc2nc(Sc3ccccc3N)c(cc2C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K12 compound treatment 0.9796 -0.0204 -0.4 -0.3957 -1.0 2073927 Maybridge1_008152 COc1ccc(cc1)C(=O)NNC(=O)c2c(C)noc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K13 compound treatment 0.9796 -0.0204 -0.4 -0.3957 -1.0 2073928 Maybridge1_008153 [O-][N+](=O)c1ccc(Oc2cc(cc(c2)C(F)(F)F)C(F)(F)F)nc1Oc3cc(cc(c3)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K14 compound treatment 0.9694 -0.0306 -0.59 -0.5949 -1.0 2073929 Maybridge1_008154 Cc1noc(C)c1C(=O)NNC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K15 compound treatment 1.0324 0.0324 0.63 0.6287 1.0 2073930 Maybridge1_008155 CN1CCN(CC1)c2ccccc2/C=C(/C#N)\S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K16 compound treatment 1.0031 0.00307 0.06 0.0596 1.0 2073931 Maybridge1_008156 Cc1noc(C)c1c2nc(no2)c3cc(cc(c3)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K17 compound treatment 0.9342 -0.0658 -1.28 -1.2779 -1.0 2073932 Maybridge1_008157 Cc1c(cnn1c2ccc(N)cc2)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K18 compound treatment 0.9782 -0.0218 -0.42 -0.4242 -1.0 2073933 Maybridge1_008158 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)Nc3cccc4ccccc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K19 compound treatment 1.0265 0.0265 0.51 0.5149 1.0 1261356 Maybridge1_008159 COc1ccc(NC(=O)c2c(C)noc2C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K20 compound treatment 0.9518 -0.0482 -0.94 -0.9364 -1.0 2073934 Maybridge1_008160 Cc1ccc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K21 compound treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 1733003 Maybridge1_008161 Cc1noc(C)c1C(=O)Nc2ccc(C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K22 compound treatment 1.0382 0.0382 0.74 0.7426 1.0 2073935 Maybridge1_008162 Cc1cc(C)c(c(C)c1)S(=O)(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K23 mock treatment 0.9811 -0.0189 -0.37 -0.3673 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 K24 mock treatment 1.0631 0.0631 1.23 1.2264 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L01 compound treatment 1.0265 0.0265 0.51 0.5149 1.0 2073936 Maybridge1_008163 CCOc1ccc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L02 compound treatment 1.0566 0.0566 1.1 1.0983 1.0 1657471 Maybridge1_008164 Clc1ccc(cc1)C(=O)Oc2cccc3cccnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L03 compound treatment 0.9899 -0.0101 -0.2 -0.1965 -1.0 1711782 Maybridge1_008165 COc1ccccc1N2CCN(CC2)C(=O)c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L04 compound treatment 1.0155 0.0155 0.3 0.3015 1.0 1423636 Maybridge1_008166 Cc1c(noc1c2c(Cl)cccc2Cl)C(=O)Oc3cccc4cccnc34 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L05 compound treatment 1.0023 0.00234 0.05 0.0454 1.0 2073937 Maybridge1_008167 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)Nc3cccc(Br)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L06 compound treatment 1.0148 0.0148 0.29 0.2872 1.0 2073938 Maybridge1_008168 COC(=O)c1cc(/C=C(\C#N)/S(=O)(=O)c2ccccc2)cn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L07 compound treatment 1.0148 0.0148 0.29 0.2872 1.0 2073939 Maybridge1_008169 Cc1cccc(c1)C(=O)Nc2ccc(nc2)N3CCN(CC3)c4ccc(cn4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L08 compound treatment 1.0177 0.0177 0.34 0.3442 1.0 2073940 Maybridge1_008170 Clc1ccc(CSCCNC(=O)c2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L09 compound treatment 0.973 -0.027 -0.52 -0.5238 -1.0 1456244 Maybridge1_008171 COc1ccccc1N2CCN(CC2)C(=O)Nc3cccc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L10 compound treatment 1.0243 0.0243 0.47 0.4722 1.0 2073941 Maybridge1_008172 CCOC(=O)c1c(C)nn(c1C)c2ccc(NC(=O)Nc3ccc(cc3)C(C)(C)C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L11 compound treatment 1.0001 1.37E-4 0.0 0.0027 1.0 2073942 Maybridge1_008173 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)Nc3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L12 compound treatment 1.017 0.017 0.33 0.3299 1.0 2073943 Maybridge1_008174 Cc1nnsc1C(=O)Nc2ccccc2SCc3noc(n3)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L13 compound treatment 0.965 -0.035 -0.68 -0.6803 -1.0 2073944 Maybridge1_008175 CCOc1ccccc1NC(=O)N2CCN(CC2)c3ncccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L14 compound treatment 1.0097 0.00966 0.19 0.1876 1.0 2073945 Maybridge1_008176 COC(=O)c1cc(/C=N/NC(=S)NC(C)(C)C)cn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L15 compound treatment 0.9401 -0.0599 -1.16 -1.1641 -1.0 2073946 Maybridge1_008177 CCc1cc2c(cc1c3csc(n3)c4ccc(cc4)C(C)(C)C)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L16 compound treatment 0.9833 -0.0167 -0.32 -0.3246 -1.0 2073947 Maybridge1_008178 Cc1cc(C)c(CSCCNC(=O)Nc2cccc(Cl)c2C)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L17 compound treatment 0.9928 -0.00719 -0.14 -0.1396 -1.0 2073948 Maybridge1_008179 FC(F)(F)c1cnc(N2CCN(CC2)C(=O)COc3ccc(Cl)cc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L18 compound treatment 0.9796 -0.0204 -0.4 -0.3957 -1.0 2073949 Maybridge1_008180 Fc1cccc(Cl)c1CSCCC(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L19 compound treatment 0.9818 -0.0182 -0.35 -0.3531 -1.0 2073950 Maybridge1_008181 CC(C)C(=O)Nc1ccc(nc1)N2CCN(CC2)c3ccc(cn3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L20 compound treatment 0.9855 -0.0145 -0.28 -0.2819 -1.0 2073951 Maybridge1_008182 Cc1ccc(cc1)C(=O)NCCSCc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L21 compound treatment 1.0331 0.0331 0.64 0.643 1.0 2073952 Maybridge1_008183 CC(C)Cc1ccc(cc1)C(C)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L22 compound treatment 1.0104 0.0104 0.2 0.2019 1.0 2073953 Maybridge1_008184 Cc1cc(C)c(CSCCNC2=CC(=O)CC(C2)c3ccc(Cl)cc3)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L23 mock treatment 0.9972 -0.00279 -0.05 -0.0542 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 L24 mock treatment 1.0038 0.0038 0.07 0.0738 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M01 compound treatment 1.0207 0.0207 0.4 0.4011 1.0 2073954 Maybridge1_008185 CCOC(=O)N/N=C/c1csnn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M02 compound treatment 0.9481 -0.0519 -1.01 -1.0076 -1.0 2073955 Maybridge1_008186 Cc1noc(C)c1C(=O)Oc2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M03 compound treatment 1.0404 0.0404 0.79 0.7853 1.0 2073956 Maybridge1_008187 CN(N=C(C)C)c1ncccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M04 compound treatment 1.0082 0.0082 0.16 0.1592 1.0 2073957 Maybridge1_008188 COC(=O)c1ccc(CSc2ccccc2N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M05 compound treatment 1.0155 0.0155 0.3 0.3015 1.0 2073958 Maybridge1_008189 OCCN1CCN(CC1)c2ccc([N+](=O)[O-])c(n2)N3CCN(CCO)CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M06 compound treatment 0.9877 -0.0123 -0.24 -0.2392 -1.0 2073959 Maybridge1_008190 [O-][N+](=O)c1ccc(nc1)N2CCC(CC2)C(=O)c3ccc(F)cc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M07 compound treatment 1.0038 0.0038 0.07 0.0738 1.0 1596301 Maybridge1_008191 Clc1ccc2nc(sc2c1)N3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M08 compound treatment 0.9987 -0.00133 -0.03 -0.0258 -1.0 2073960 Maybridge1_008192 COC(=O)c1ccc(CSc2ccc(Cl)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M09 compound treatment 1.039 0.039 0.76 0.7568 1.0 1409042 Maybridge1_008193 OC(=O)c1c2CCCCCc2nc3ccc(F)cc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M10 compound treatment 0.9826 -0.0174 -0.34 -0.3388 -1.0 2073961 Maybridge1_008194 FC(F)(F)Oc1ccc(NC(=O)Nc2ccc(Sc3ccccc3)nc2Sc4ccccc4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M11 compound treatment 1.0075 0.00746 0.14 0.145 1.0 2073962 Maybridge1_008195 CCN(CC)c1cc(Cl)cc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M12 compound treatment 1.0038 0.0038 0.07 0.0738 1.0 2073963 Maybridge1_008196 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M13 compound treatment 1.0412 0.0412 0.8 0.7995 1.0 2073964 Maybridge1_008197 COc1ccc(Oc2cc(ccn2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M14 compound treatment 1.0199 0.0199 0.39 0.3869 1.0 2073965 Maybridge1_008198 COc1ccc(cc1)C(=O)N2CCN(CC2)c3ncccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M15 compound treatment 1.0229 0.0229 0.44 0.4438 1.0 2073966 Maybridge1_008199 NC(=S)c1cc(Br)cc(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M16 compound treatment 0.9899 -0.0101 -0.2 -0.1965 -1.0 2073967 Maybridge1_008200 OC(=O)c1ccccc1C(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M17 compound treatment 0.9782 -0.0218 -0.42 -0.4242 -1.0 2073968 Maybridge1_008201 [O-][N+](=O)c1ccc(N/N=C/c2cc(Cl)cc(Cl)c2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M18 compound treatment 0.976 -0.024 -0.47 -0.4669 -1.0 2073969 Maybridge1_008202 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)NC3CCCCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M19 compound treatment 0.9635 -0.0365 -0.71 -0.7088 -1.0 1415355 Maybridge1_008203 Cc1noc(C)c1C(=O)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M20 compound treatment 0.9833 -0.0167 -0.32 -0.3246 -1.0 2073970 Maybridge1_008204 FC(F)(F)c1cnc(N2CCN(CC2)C(=S)NC(=O)c3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M21 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 2073971 Maybridge1_008205 Cc1noc(C)c1C(=O)Nc2ccccc2OC(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M22 compound treatment 0.984 -0.016 -0.31 -0.3104 -1.0 1568151 Maybridge1_008206 COc1ccccc1N2CCN(CC2)C(=O)c3c(F)cccc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M23 mock treatment 0.9738 -0.0262 -0.51 -0.5096 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 M24 mock treatment 0.9877 -0.0123 -0.24 -0.2392 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N01 compound treatment 1.0338 0.0338 0.66 0.6572 1.0 2073972 Maybridge1_008207 COC(=O)c1ccccc1NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N02 compound treatment 1.0207 0.0207 0.4 0.4011 1.0 1648286 Maybridge1_008208 O=C(Oc1cccc2cccnc12)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N03 compound treatment 1.0243 0.0243 0.47 0.4722 1.0 1371722 Maybridge1_008209 COc1ccccc1N2CCN(CC2)C(=O)c3snnc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N04 compound treatment 1.0141 0.0141 0.27 0.273 1.0 1261145 Maybridge1_008210 CC(C)Cc1ccc(cc1)C(C)c2nnc(o2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N05 compound treatment 0.9928 -0.00719 -0.14 -0.1396 -1.0 1642423 Maybridge1_008211 COc1cccc(c1)C(=O)N2CCN(CC2)c3ccccc3OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N06 compound treatment 1.0097 0.00966 0.19 0.1876 1.0 2073973 Maybridge1_008212 COc1ccc(cc1)c2n[nH]cc2/C=N/NC(=O)c3cccc(c3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N07 compound treatment 1.0001 1.37E-4 0.0 0.0027 1.0 2073974 Maybridge1_008213 COc1ccc(cc1)C(=O)Nc2ccc(nc2)N3CCN(CC3)c4ccc(cn4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N08 compound treatment 1.006 0.006 0.12 0.1165 1.0 2073975 Maybridge1_008214 CC(=O)c1sc(nc1C)c2cnccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N09 compound treatment 1.0133 0.0133 0.26 0.2588 1.0 1331296 Maybridge1_008215 COc1ccc(Cl)cc1NC(=O)N2CCN(CC2)c3ccccc3OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N10 compound treatment 1.0236 0.0236 0.46 0.458 1.0 2073976 Maybridge1_008216 CCOC(=O)c1c(C)nn(c1C)c2ccc(NC(=O)Nc3ccc(cc3)C(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N11 compound treatment 0.9752 -0.0248 -0.48 -0.4811 -1.0 2073977 Maybridge1_008217 FC(F)(F)c1cccc(NC(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N12 compound treatment 1.0199 0.0199 0.39 0.3869 1.0 1232430 Maybridge1_008218 COc1ccc(NC(=O)NC(=O)C(C)c2ccc(CC(C)C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N13 compound treatment 0.9488 -0.0512 -0.99 -0.9934 -1.0 1271373 Maybridge1_008219 COc1ccccc1N2CCN(CC2)C(=O)Nc3cc(Cl)cc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N14 compound treatment 1.0229 0.0229 0.44 0.4438 1.0 2073978 Maybridge1_008220 COC(=O)c1cc(/C=N/NC(=S)NC2CC3CC2C=C3)cn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N15 compound treatment 0.9664 -0.0336 -0.65 -0.6519 -1.0 1535191 Maybridge1_008221 COc1ccccc1N2CCN(CC2)C(=O)Nc3c(C)onc3c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N16 compound treatment 0.9877 -0.0123 -0.24 -0.2392 -1.0 2073979 Maybridge1_008222 CC(C)c1cc(Br)c(NC(=O)NCCSCc2c(C)cc(C)cc2C)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N17 compound treatment 0.9613 -0.0387 -0.75 -0.7515 -1.0 2073980 Maybridge1_008223 CC(=O)Nc1ccc(OCC(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N18 compound treatment 0.9862 -0.0138 -0.27 -0.2677 -1.0 2073981 Maybridge1_008224 CCc1cc2c(cc1c3csc(n3)c4cnccn4)C(C)(C)CCC2(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N19 compound treatment 0.9826 -0.0174 -0.34 -0.3388 -1.0 2073982 Maybridge1_008225 COc1ccccc1NC(=O)N2CCc3c([nH]c4ccccc34)C2C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N20 compound treatment 1.0089 0.00893 0.17 0.1734 1.0 1929721 Maybridge1_008226 COc1ccc(cc1)C(=O)NCCSCc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N21 compound treatment 0.9782 -0.0218 -0.42 -0.4242 -1.0 1503355 Maybridge1_008227 CC(C)Cc1ccc(cc1)C(C)C(=O)Nc2ccc3OCCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N22 compound treatment 0.9767 -0.0233 -0.45 -0.4527 -1.0 1725517 Maybridge1_008228 Clc1ccc(cc1)C2CC(=O)C=C(C2)NCc3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N23 mock treatment 0.9503 -0.0497 -0.96 -0.9649 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 N24 mock treatment 1.0163 0.0163 0.32 0.3157 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O01 compound treatment 1.0756 0.0756 1.47 1.4683 1.0 2073983 Maybridge1_008229 CC(C)(C)OC(=O)Nc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O02 compound treatment 1.0287 0.0287 0.56 0.5576 1.0 1458129 Maybridge1_008230 CC(C)(C)c1ccc(s1)C(=O)Nc2ccc(Oc3ccc(Cl)cc3Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O03 compound treatment 1.0141 0.0141 0.27 0.273 1.0 2073984 Maybridge1_008231 [O-][N+](=O)c1ccc(nc1N2CCOCC2)N3CCOCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O04 compound treatment 1.0316 0.0316 0.61 0.6145 1.0 2073985 Maybridge1_008232 COC(=O)c1ccc(CC(=S)C(c2ccccc2)(c3ccccc3)c4ccccc4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O05 compound treatment 1.0419 0.0419 0.81 0.8137 1.0 2073986 Maybridge1_008233 OCCSc1ccc([N+](=O)[O-])c(SCCO)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O06 compound treatment 0.9965 -0.00353 -0.07 -0.0685 -1.0 2073987 Maybridge1_008234 COc1cc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O07 compound treatment 1.0067 0.00673 0.13 0.1307 1.0 1282369 Maybridge1_008235 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O08 compound treatment 0.9994 -5.95E-4 -0.01 -0.0116 -1.0 2073988 Maybridge1_008236 COc1ccc(NC(=O)c2ccc(s2)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O09 compound treatment 0.9957 -0.00426 -0.08 -0.0827 -1.0 2073989 Maybridge1_008237 COc1ccc(cc1)C(=O)N/N=C/c2cccn2c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O10 compound treatment 0.9774 -0.0226 -0.44 -0.4384 -1.0 1660914 Maybridge1_008238 Cc1noc(C)c1C(=O)NCc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O11 compound treatment 0.9804 -0.0196 -0.38 -0.3815 -1.0 2073990 Maybridge1_008239 Cc1noc(C)c1C(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O12 compound treatment 0.9811 -0.0189 -0.37 -0.3673 -1.0 2073991 Maybridge1_008240 Cc1noc(C)c1C(=O)O/N=C(\N)/c2cc(cc(c2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O13 compound treatment 0.9796 -0.0204 -0.4 -0.3957 -1.0 2073992 Maybridge1_008241 CN(C)c1cc(Cl)cc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O14 compound treatment 0.9716 -0.0284 -0.55 -0.5523 -1.0 2073993 Maybridge1_008242 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)c3cc(Cl)cc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O15 compound treatment 0.9848 -0.0152 -0.3 -0.2961 -1.0 2073994 Maybridge1_008243 CN1CCN(CC1)c2ccccc2/C=N\Nc3cc(Cl)ccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O16 compound treatment 0.9635 -0.0365 -0.71 -0.7088 -1.0 2073995 Maybridge1_008244 OC(=O)c1ccccc1C(=O)N2CCN(CC2)c3ccc(cn3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O17 compound treatment 0.9591 -0.0409 -0.79 -0.7942 -1.0 2073996 Maybridge1_008245 Cn1cnc2cccc(F)c2c1=N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O18 compound treatment 0.9496 -0.0504 -0.98 -0.9791 -1.0 2073997 Maybridge1_008246 Fc1ccc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O19 compound treatment 1.0045 0.00453 0.09 0.088 1.0 1447262 Maybridge1_008247 Cc1noc(C)c1C(=O)Nc2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O20 compound treatment 0.9496 -0.0504 -0.98 -0.9791 -1.0 2073998 Maybridge1_008248 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O21 compound treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 2073999 Maybridge1_008249 Cc1noc(C)c1C(=O)Oc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O22 compound treatment 1.0155 0.0155 0.3 0.3015 1.0 2074000 Maybridge1_008250 FC(F)(F)c1cnc(N2CCN(CC2)C(=S)Nc3cccc(Cl)c3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O23 mock treatment 0.9833 -0.0167 -0.32 -0.3246 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 O24 mock treatment 0.9745 -0.0255 -0.5 -0.4953 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P01 compound treatment 1.0243 0.0243 0.47 0.4722 1.0 2074001 Maybridge1_008251 CN(C)c1ccc(NC(=S)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P02 compound treatment 1.0346 0.0346 0.67 0.6714 1.0 1382298 Maybridge1_008252 Cc1noc(C)c1C(=O)Oc2cccc3cccnc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P03 compound treatment 1.0221 0.0221 0.43 0.4295 1.0 1392030 Maybridge1_008253 COc1ccccc1N2CCN(CC2)S(=O)(=O)c3c(C)c(C)c(C)c(C)c3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P04 compound treatment 1.0177 0.0177 0.34 0.3442 1.0 2074002 Maybridge1_008254 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)c3cccc(CSc4ccc(Cl)cc4)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P05 compound treatment 1.0353 0.0353 0.69 0.6857 1.0 1204874 Maybridge1_008255 Clc1sc(cc1Br)S(=O)(=O)N2CCN(CC2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P06 compound treatment 1.0207 0.0207 0.4 0.4011 1.0 2074003 Maybridge1_008256 COc1ccc(cc1)c2n[nH]cc2/C=N/NC(=O)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P07 compound treatment 0.9811 -0.0189 -0.37 -0.3673 -1.0 2074004 Maybridge1_008257 COc1ccc(Cl)cc1NC(=O)N2CCN(CC2)c3ncccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P08 compound treatment 1.0126 0.0126 0.24 0.2446 1.0 2074005 Maybridge1_008258 COc1ccccc1N2CCN(CCCCNS(=O)(=O)c3ccc(C)cc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P09 compound treatment 1.0133 0.0133 0.26 0.2588 1.0 2074006 Maybridge1_008259 COc1ccccc1N2CCN(CC2)C(=O)Nc3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P10 compound treatment 1.0566 0.0566 1.1 1.0983 1.0 2074007 Maybridge1_008260 [O-][N+](=O)c1ccc(Oc2cccc3cccnc23)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P11 compound treatment 0.9657 -0.0343 -0.67 -0.6661 -1.0 2074008 Maybridge1_008261 Cc1ccc(SCC(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P12 compound treatment 1.0075 0.00746 0.14 0.145 1.0 2074009 Maybridge1_008262 COC(=O)c1cc(/C=C/2\CSc3ccc(Cl)cc3C2=O)cn1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P13 compound treatment 1.0397 0.0397 0.77 0.771 1.0 2074010 Maybridge1_008263 COc1ccccc1N2CCN(CC2)C(=O)Nc3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P14 compound treatment 1.0089 0.00893 0.17 0.1734 1.0 1463730 Maybridge1_008264 O=C(Nc1ccc(Oc2cccc3cccnc23)cc1)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P15 compound treatment 0.973 -0.027 -0.52 -0.5238 -1.0 1653299 Maybridge1_008265 COc1ccccc1N2CCN(CC2)C(=S)Nc3cc(OC)c(Cl)cc3OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P16 compound treatment 0.9943 -0.00572 -0.11 -0.1112 -1.0 1491039 Maybridge1_008266 CC(C)Cc1ccc(cc1)C(C)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P17 compound treatment 0.9606 -0.0394 -0.77 -0.7657 -1.0 2074011 Maybridge1_008267 CN(C)c1ccc(/C=C/2\C(=O)ON=C2c3ccccc3)cc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P18 compound treatment 0.9921 -0.00792 -0.15 -0.1539 -1.0 1336300 Maybridge1_008268 OCc1ccccc1N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P19 compound treatment 0.9899 -0.0101 -0.2 -0.1965 -1.0 2074012 Maybridge1_008269 C(Sc1ccccn1)c2nnn[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P20 compound treatment 0.9935 -0.00646 -0.13 -0.1254 -1.0 2074013 Maybridge1_008270 Oc1c(Cl)cc(Cl)cc1/C=N/CCSCc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P21 compound treatment 0.9789 -0.0211 -0.41 -0.41 -1.0 1487225 Maybridge1_008271 CC(C)Cc1ccc(cc1)C(C)C(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P22 compound treatment 1.028 0.028 0.54 0.5434 1.0 2074014 Maybridge1_008272 COc1cc(OC)c(C=C2C(=O)OC(C)(C)OC2=O)cc1OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P23 mock treatment 0.9708 -0.0292 -0.57 -0.5665 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.564 P24 mock treatment 1.0588 0.0588 1.14 1.141 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A01 compound treatment 1.08 0.08 1.55 1.5536 1.0 2074015 Maybridge1_008273 Clc1ccccc1CSCCNC2=CC(=O)CC(C2)c3ccc4OCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A02 compound treatment 1.0112 0.0112 0.22 0.2171 1.0 2074016 Maybridge1_008274 COc1ccc(Oc2ccc(cc2c3nc(no3)c4ccc(cc4)C(F)(F)F)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A03 compound treatment 1.0316 0.0316 0.61 0.6137 1.0 1638111 Maybridge1_008275 OC(=O)C1CN(Cc2ccc3OCOc3c2)C(=O)C1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A04 compound treatment 1.0036 0.00362 0.07 0.0702 1.0 2074017 Maybridge1_008276 Cc1c(sc2ccccc12)c3csc(n3)c4ccc(cc4)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A05 compound treatment 1.0399 0.0399 0.78 0.7752 1.0 2074018 Maybridge1_008277 COC(=O)c1c(C)n(C)c(C)c1C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A06 compound treatment 0.9892 -0.0108 -0.21 -0.2088 -1.0 1300315 Maybridge1_008278 Cc1c(sc2ccccc12)c3csc(CC#N)n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A07 compound treatment 1.0271 0.0271 0.53 0.5255 1.0 1334149 Maybridge1_008279 Cc1oc(cc1C(=O)CC#N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A08 compound treatment 0.9991 -9.22E-4 -0.02 -0.0179 -1.0 2074019 Maybridge1_008280 CCn1nc(C)c(Br)c1c2nc(no2)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A09 compound treatment 0.9771 -0.0229 -0.44 -0.4438 -1.0 2074020 Maybridge1_008281 COc1ccc(cc1)c2cc(C(=O)O)c(o2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A10 compound treatment 0.9855 -0.0145 -0.28 -0.2823 -1.0 2074021 Maybridge1_008282 COc1ccc(Oc2ccc(cc2c3nc(no3)c4cnccn4)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A11 compound treatment 1.0233 0.0233 0.45 0.4521 1.0 1640175 Maybridge1_008283 Cc1c(cc(c2ccccc2)n1c3ccccc3)C(=O)Nc4ccccc4C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A12 compound treatment 1.0066 0.00664 0.13 0.129 1.0 2074022 Maybridge1_008284 Cc1ccc(cc1C)n2nc(cc2NC(=O)Nc3ccc(OC(F)(F)F)cc3)c4ccc(OC(F)(F)F)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A13 compound treatment 1.0271 0.0271 0.53 0.5255 1.0 1726197 Maybridge1_008285 CC(C)(C)c1ccc(cc1)c2nc(cs2)c3ccc4OCCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A14 compound treatment 1.0044 0.00437 0.08 0.0849 1.0 2074023 Maybridge1_008286 Cc1oc(cc1C(=O)N2CCN(CC2)c3ccc(cn3)C(F)(F)F)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A15 compound treatment 1.0082 0.00815 0.16 0.1583 1.0 1625077 Maybridge1_008287 Cc1nc(cs1)c2ccc3OCCCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A16 compound treatment 1.0127 0.0127 0.25 0.2465 1.0 1700251 Maybridge1_008288 COc1ccc(C)cc1NC(=O)c2cc(oc2C)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A17 compound treatment 0.9749 -0.0251 -0.49 -0.4879 -1.0 2074024 Maybridge1_008289 Fc1ccc(cc1F)c2csc(n2)c3ccc(Oc4ccc(cn4)C(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A18 compound treatment 0.9756 -0.0244 -0.47 -0.4732 -1.0 1421877 Maybridge1_008290 CN(C)S(=O)(=O)c1cc(C(=O)O)c(C)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A19 compound treatment 0.9908 -0.00924 -0.18 -0.1795 -1.0 2074025 Maybridge1_008291 Cc1c(cc(c2ccccc2)n1CCSCc3c(Cl)cccc3Cl)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A20 compound treatment 0.9824 -0.0176 -0.34 -0.341 -1.0 2074026 Maybridge1_008292 CCOC(=O)c1cc(C)nc(Sc2ccccc2)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A21 compound treatment 0.993 -0.00697 -0.14 -0.1354 -1.0 1122468 Maybridge1_008293 COc1ccc(OCc2nc(cs2)c3ccc(F)c(F)c3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A22 compound treatment 0.9688 -0.0312 -0.61 -0.6054 -1.0 2074027 Maybridge1_008294 COc1c(Br)cc(cc1Br)/C(=N/OC(=O)c2c(C)onc2c3c(Cl)cccc3Cl)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A23 mock treatment 1.0255 0.0255 0.5 0.4962 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 A24 mock treatment 1.0407 0.0407 0.79 0.7899 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B01 compound treatment 1.0535 0.0535 1.04 1.0396 1.0 1375743 Maybridge1_008295 Cc1cc(nn1c2c(Cl)cc(Cl)cc2Cl)C(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B02 compound treatment 1.0339 0.0339 0.66 0.6577 1.0 2074028 Maybridge1_008296 CC(C)Sc1c(Cl)cccc1NC(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B03 compound treatment 1.0218 0.0218 0.42 0.4227 1.0 2074029 Maybridge1_008297 CC(C)(C)c1ccc(cc1)c2nnc(S)n2c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B04 compound treatment 0.9983 -0.00168 -0.03 -0.0326 -1.0 2074030 Maybridge1_008298 Oc1nnc(Sc2ncc(s2)[N+](=O)[O-])n1CC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B05 compound treatment 1.0286 0.0286 0.55 0.5549 1.0 2074031 Maybridge1_008299 CC(C)(C)c1ccc(cc1)n2c(SCc3ccc(Cl)cc3)nnc2c4ccccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B06 compound treatment 0.9499 -0.0501 -0.97 -0.9726 -1.0 2074032 Maybridge1_008300 NNC(=O)c1csc(n1)c2cccc(Cl)c2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B07 compound treatment 0.9666 -0.0334 -0.65 -0.6495 -1.0 2074033 Maybridge1_008301 Clc1ccc(NC(=O)Oc2ccc(cc2)C3SCCS3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B08 compound treatment 0.9968 -0.00319 -0.06 -0.062 -1.0 2074034 Maybridge1_008302 CCOC(=O)c1sc(nc1C)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B09 compound treatment 0.9393 -0.0607 -1.18 -1.1782 -1.0 2074035 Maybridge1_008303 [O-][N+](=O)c1ccc(o1)C(=O)NC(=S)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B10 compound treatment 1.1284 0.128 2.49 2.4936 1.0 1356228 Maybridge1_008304 CCCS(=O)(=O)c1c(C)c(C)n(CCc2ccc(Cl)cc2)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B11 compound treatment 0.9529 -0.0471 -0.91 -0.9138 -1.0 2074036 Maybridge1_008305 N/C(=N\O)/c1cccc(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B12 compound treatment 1.0263 0.0263 0.51 0.5108 1.0 2074037 Maybridge1_008306 Cc1nc(cs1)c2nnc(S)n2c3cccc(F)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B13 compound treatment 0.9635 -0.0365 -0.71 -0.7082 -1.0 2074038 Maybridge1_008307 Cc1cc(no1)C(=O)NNC(=O)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B14 compound treatment 0.9635 -0.0365 -0.71 -0.7082 -1.0 1681297 Maybridge1_008308 NNC(=O)c1ccc(Oc2ccc(cc2)C3SCCS3)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B15 compound treatment 0.9643 -0.0357 -0.69 -0.6935 -1.0 2074039 Maybridge1_008309 NNC(=O)COc1ccc(cc1)C2SCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B16 compound treatment 0.9817 -0.0183 -0.36 -0.3557 -1.0 2074040 Maybridge1_008310 CCOC(=O)c1sc(nc1O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B17 compound treatment 0.9605 -0.0395 -0.77 -0.767 -1.0 2074041 Maybridge1_008311 COC(CNC(=O)COc1ccc(Cl)cc1Cl)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B18 compound treatment 0.9673 -0.0327 -0.63 -0.6348 -1.0 2074042 Maybridge1_008312 NC(=S)c1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B19 compound treatment 0.993 -0.00697 -0.14 -0.1354 -1.0 2074043 Maybridge1_008313 FC(F)(F)c1ccc(cc1)C(=O)NC(=O)OCC#C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B20 compound treatment 0.987 -0.013 -0.25 -0.2529 -1.0 1462880 Maybridge1_008314 OC(=O)CCn1c(=O)oc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B21 compound treatment 0.9923 -0.00773 -0.15 -0.1501 -1.0 2074044 Maybridge1_008315 COc1ccc(Oc2ccc(cc2[N+](=O)[O-])/C(=N/O)/N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B22 compound treatment 0.9537 -0.0463 -0.9 -0.8991 -1.0 1195100 Maybridge1_008316 NNC(=O)c1csc(n1)c2ccc(cc2)C3SCCS3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B23 mock treatment 0.9703 -0.0297 -0.58 -0.576 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 B24 mock treatment 1.0157 0.0157 0.31 0.3052 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C01 compound treatment 1.0203 0.0203 0.39 0.3933 1.0 2074045 Maybridge1_008317 CC(C)(C)c1ccc(CSCCNC2=CC(=O)CC(C2)c3ccc4OCOc4c3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C02 compound treatment 1.0339 0.0339 0.66 0.6577 1.0 2074046 Maybridge1_008318 COC(=O)CSCCc1nc(cs1)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C03 compound treatment 1.0044 0.00437 0.08 0.0849 1.0 2074047 Maybridge1_008319 CN(NC(=O)c1ccncc1Cl)c2cnc3ccccc3n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C04 compound treatment 0.9885 -0.0115 -0.22 -0.2235 -1.0 2074048 Maybridge1_008320 FC(F)(F)c1ccc(cc1)c2csc(n2)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C05 compound treatment 1.0225 0.0225 0.44 0.4374 1.0 2074049 Maybridge1_008321 CCOC(=O)c1cc(C)n(c1C)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C06 compound treatment 0.965 -0.035 -0.68 -0.6788 -1.0 2074050 Maybridge1_008322 Cc1c(cc(n1CCSCc2c(F)cccc2Cl)C(C)(C)C)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C07 compound treatment 0.9862 -0.0138 -0.27 -0.2676 -1.0 2074051 Maybridge1_008323 Cc1cc(C(=O)N)c(o1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C08 compound treatment 0.9598 -0.0402 -0.78 -0.7816 -1.0 2074052 Maybridge1_008324 Cc1ccc(cc1)c2noc(n2)c3ccc(F)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C09 compound treatment 1.0172 0.0172 0.33 0.3346 1.0 2074053 Maybridge1_008325 OC(=O)c1cc(oc1C(F)(F)F)c2cccc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C10 compound treatment 0.9892 -0.0108 -0.21 -0.2088 -1.0 2074054 Maybridge1_008326 Fc1ccc(c2nc(no2)c3ccccc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C11 compound treatment 1.0119 0.0119 0.23 0.2318 1.0 1598391 Maybridge1_008327 COc1cccc(NC(=O)c2cc(c3ccccc3)n(c2C)c4ccccc4)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C12 compound treatment 0.9197 -0.0803 -1.56 -1.5601 -1.0 2074055 Maybridge1_008328 Cc1ccc(cc1C)n2nc(cc2NC(=O)Nc3ccccc3C#N)c4ccc(OC(F)(F)F)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C13 compound treatment 0.9764 -0.0236 -0.46 -0.4585 -1.0 2074056 Maybridge1_008329 Cc1ccc(c2csc(n2)c3ccc(cc3)C(C)(C)C)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C14 compound treatment 0.9681 -0.0319 -0.62 -0.6201 -1.0 2074057 Maybridge1_008330 Cc1oc(cc1C(=O)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C15 compound treatment 1.0142 0.0142 0.28 0.2758 1.0 2074058 Maybridge1_008331 CC(C)(C)c1cc(cc(c1O)C(C)(C)C)c2csc(n2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C16 compound treatment 0.9605 -0.0395 -0.77 -0.767 -1.0 1420936 Maybridge1_008332 COc1ccc2[nH]c(cc2c1)C(=O)Nc3ccc(I)cc3F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C17 compound treatment 1.0089 0.00891 0.17 0.173 1.0 2074059 Maybridge1_008333 FC(F)(F)c1ccc(Oc2ccc(cc2)c3nc(cs3)c4ccc5OCCCOc5c4)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C18 compound treatment 0.965 -0.035 -0.68 -0.6788 -1.0 2074060 Maybridge1_008334 FC(F)(F)c1cc(n[nH]1)c2ccc3ccccc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C19 compound treatment 1.0203 0.0203 0.39 0.3933 1.0 2074061 Maybridge1_008335 FC(F)(F)c1ccc(cc1)c2csc(n2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C20 compound treatment 0.9537 -0.0463 -0.9 -0.8991 -1.0 2074062 Maybridge1_008336 CCOC(=O)c1c(Cl)c(nc(Sc2ccccc2)c1C#N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C21 compound treatment 1.0414 0.0414 0.8 0.8046 1.0 1343867 Maybridge1_008337 COc1ccc(OCc2nc(cs2)c3cc(c(O)c(c3)C(C)(C)C)C(C)(C)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C22 compound treatment 0.9749 -0.0251 -0.49 -0.4879 -1.0 2074063 Maybridge1_008338 Cn1c(SC(=O)Cc2cccc(c2)[N+](=O)[O-])nnc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C23 mock treatment 1.021 0.021 0.41 0.408 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 C24 mock treatment 0.993 -0.00697 -0.14 -0.1354 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D01 compound treatment 0.9877 -0.0123 -0.24 -0.2382 -1.0 1036975 Maybridge1_008339 Clc1ccc(OCC#N)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D02 compound treatment 0.9605 -0.0395 -0.77 -0.767 -1.0 2074064 Maybridge1_008340 [O-][N+](=O)c1cc(C#N)ccc1Oc2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D03 compound treatment 0.9726 -0.0274 -0.53 -0.532 -1.0 1564721 Maybridge1_008341 Clc1ccc(COc2ccc(C#N)cc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D04 compound treatment 0.9658 -0.0342 -0.66 -0.6641 -1.0 2074065 Maybridge1_008342 [O-][N+](=O)c1cnc(Sc2nnc([nH]2)c3ccc(Cl)cc3)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D05 compound treatment 0.9802 -0.0198 -0.39 -0.3851 -1.0 2074066 Maybridge1_008343 N/C(=N\O)/Cc1cccc2ccccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D06 compound treatment 0.9787 -0.0213 -0.41 -0.4145 -1.0 1317844 Maybridge1_008344 Cc1c(C)n(Cc2cccc(C)c2C)c(N)c1S(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D07 compound treatment 0.9522 -0.0478 -0.93 -0.9285 -1.0 2074067 Maybridge1_008345 [O-][N+](=O)c1ccc(OCc2c(Cl)cccc2Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D08 compound treatment 1.0104 0.0104 0.2 0.2024 1.0 2074068 Maybridge1_008346 Cc1noc(c1C(=O)NN)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D09 compound treatment 0.9741 -0.0259 -0.5 -0.5026 -1.0 2074069 Maybridge1_008347 [O-][N+](=O)c1ccc(o1)C(=O)NC(=S)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D10 compound treatment 0.9908 -0.00924 -0.18 -0.1795 -1.0 1074754 Maybridge1_008348 CCOC(=O)c1csc(C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D11 compound treatment 0.9635 -0.0365 -0.71 -0.7082 -1.0 2074070 Maybridge1_008349 N/C(=N\OC(=O)C(Cl)Cl)/c1cccc(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D12 compound treatment 0.9787 -0.0213 -0.41 -0.4145 -1.0 1373540 Maybridge1_008350 NNC(=O)Cc1ccsc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D13 compound treatment 0.9461 -0.0539 -1.05 -1.046 -1.0 2074071 Maybridge1_008351 O=c1cc(CSc2ccccn2)[nH]c(=O)[nH]1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D14 compound treatment 1.0286 0.0286 0.55 0.5549 1.0 2074072 Maybridge1_008352 N#CCOc1ccc(cc1)C2=NCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D15 compound treatment 0.9666 -0.0334 -0.65 -0.6495 -1.0 2074073 Maybridge1_008353 Clc1cc(Cl)cc(OCC#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D16 compound treatment 1.0059 0.00588 0.11 0.1143 1.0 2074074 Maybridge1_008354 CC(=O)c1sc(COc2cccc(Cl)c2)nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D17 compound treatment 1.0021 0.0021 0.04 0.0408 1.0 1002173 Maybridge1_008355 CCCCCCCCCCCC(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D18 compound treatment 1.018 0.018 0.35 0.3493 1.0 2074075 Maybridge1_008356 CCOC(=O)c1sc(nc1O)c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D19 compound treatment 0.9658 -0.0342 -0.66 -0.6641 -1.0 2074076 Maybridge1_008357 FC(F)(F)c1ccc(cc1)C(=O)NC(=O)NN2CCCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D20 compound treatment 0.9749 -0.0251 -0.49 -0.4879 -1.0 2074077 Maybridge1_008358 Fc1ccc(c2nc(C#N)cs2)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D21 compound treatment 0.9643 -0.0357 -0.69 -0.6935 -1.0 2074078 Maybridge1_008359 Clc1ccc(SCc2nn[nH]n2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D22 compound treatment 0.9991 -9.22E-4 -0.02 -0.0179 -1.0 2074079 Maybridge1_008360 CCn1nc(cc1C(=O)O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D23 mock treatment 1.0074 0.0074 0.14 0.1437 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 D24 mock treatment 1.0308 0.0308 0.6 0.599 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E01 compound treatment 1.0369 0.0369 0.72 0.7165 1.0 2074080 Maybridge1_008361 FC(F)(F)c1cccc(CSCCNC2=CC(=O)CC(C2)c3ccc(Cl)cc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E02 compound treatment 0.9787 -0.0213 -0.41 -0.4145 -1.0 2074081 Maybridge1_008362 COC(=O)CSCCc1nc(cs1)c2ccc(C#N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E03 compound treatment 1.0029 0.00286 0.06 0.0555 1.0 2074082 Maybridge1_008363 Cc1onc(c1C(=O)NCCSCc2ccc(Cl)cc2Cl)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E04 compound treatment 0.9363 -0.0637 -1.24 -1.237 -1.0 2074083 Maybridge1_008364 Fc1cccc(c1)c2csc(n2)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E05 compound treatment 0.9408 -0.0592 -1.15 -1.1488 -1.0 1239370 Maybridge1_008365 CCOC(=O)c1cc(C)n(Cc2ccncc2)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E06 compound treatment 0.9983 -0.00168 -0.03 -0.0326 -1.0 2074084 Maybridge1_008366 CC(C)(C)C(=O)OCc1nc(cs1)c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E07 compound treatment 0.987 -0.013 -0.25 -0.2529 -1.0 2074085 Maybridge1_008367 CCOC(=O)c1cc(oc1C)c2ccc(N)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E08 compound treatment 0.956 -0.044 -0.86 -0.8551 -1.0 1198978 Maybridge1_008368 COc1ccc(cc1OC)c2nc(CS(=O)(=O)c3ccsc3)no2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E09 compound treatment 0.962 -0.038 -0.74 -0.7376 -1.0 1514731 Maybridge1_008369 OC(=O)c1csc(n1)c2ccc3OCCc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E10 compound treatment 1.0051 0.00513 0.1 0.0996 1.0 1308823 Maybridge1_008370 CCOC(=O)C1=C(C)NC(=O)NC1c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E11 compound treatment 1.0354 0.0354 0.69 0.6871 1.0 1458517 Maybridge1_008371 Cc1c(cc(c2ccccc2)n1CCCN3CCOCC3)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E12 compound treatment 0.9802 -0.0198 -0.39 -0.3851 -1.0 2074086 Maybridge1_008372 Cc1oc(cc1C(=O)Nc2cc(nn2c3ccc(F)cc3)c4ccc(Cl)cc4)c5ccc(Cl)cc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E13 compound treatment 1.0082 0.00815 0.16 0.1583 1.0 2074087 Maybridge1_008373 Cc1ccc(cc1)c2csc(n2)c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E14 compound treatment 0.9401 -0.0599 -1.16 -1.1635 -1.0 1345565 Maybridge1_008374 Cc1oc(cc1C(=O)Nc2ccccc2Cl)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E15 compound treatment 0.9847 -0.0153 -0.3 -0.297 -1.0 1401711 Maybridge1_008375 Clc1ccc(cc1)c2nc(cs2)c3ccc4OCCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E16 compound treatment 0.993 -0.00697 -0.14 -0.1354 -1.0 2074088 Maybridge1_008376 FC(F)(F)c1ccc(cc1)n2ncc(N3CCOCC3)c(Cl)c2=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E17 compound treatment 1.0044 0.00437 0.08 0.0849 1.0 2074089 Maybridge1_008377 Cc1ccc(c2csc(n2)c3ccc(Oc4ccc(cn4)C(F)(F)F)cc3)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E18 compound treatment 0.9688 -0.0312 -0.61 -0.6054 -1.0 1249944 Maybridge1_008378 COC(=O)c1ccc(o1)S(=O)(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E19 compound treatment 0.99 -0.01 -0.19 -0.1941 -1.0 2074090 Maybridge1_008379 Fc1cccc(c1)c2csc(n2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E20 compound treatment 0.9545 -0.0455 -0.88 -0.8845 -1.0 2074091 Maybridge1_008380 CCOC(=O)c1c(Cl)c(nc(Sc2ccc(C)cc2)c1C#N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E21 compound treatment 0.984 -0.016 -0.31 -0.3116 -1.0 1586173 Maybridge1_008381 COc1ccc(OCc2nc(cs2)c3ccc4OCCCOc4c3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E22 compound treatment 0.9378 -0.0622 -1.21 -1.2076 -1.0 2074092 Maybridge1_008382 CCN(CC)C(=O)O/N=C(\N)/c1cc(Br)c(OC)c(Br)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E23 mock treatment 1.0074 0.0074 0.14 0.1437 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 E24 mock treatment 0.9658 -0.0342 -0.66 -0.6641 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F01 compound treatment 0.987 -0.013 -0.25 -0.2529 -1.0 2074093 Maybridge1_008383 N/C(=N\O)/COc1ccc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F02 compound treatment 1.0074 0.0074 0.14 0.1437 1.0 2074094 Maybridge1_008384 N/C(=N\O)/COc1ccc(cc1)C2SCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F03 compound treatment 0.959 -0.041 -0.8 -0.7963 -1.0 2074095 Maybridge1_008385 O=C(CN1C(=O)CCC1=O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F04 compound treatment 0.99 -0.01 -0.19 -0.1941 -1.0 2074096 Maybridge1_008386 NC(=S)CS(=O)(=O)Cc1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F05 compound treatment 0.984 -0.016 -0.31 -0.3116 -1.0 2074097 Maybridge1_008387 Cc1cc(C)n2nc(S)nc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F06 compound treatment 1.0301 0.0301 0.58 0.5843 1.0 1191850 Maybridge1_008388 CC(C)S(=O)(=O)c1c(C)c(C)n(Cc2cccnc2)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F07 compound treatment 0.9998 -1.65E-4 0.0 -0.0032 -1.0 2074098 Maybridge1_008389 Cc1cc(C)n2nc(Sc3ccc(cc3[N+](=O)[O-])C(F)(F)F)nc2n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F08 compound treatment 0.9908 -0.00924 -0.18 -0.1795 -1.0 1502654 Maybridge1_008390 CCOC(=O)c1csc(COc2ccc(OC)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F09 compound treatment 0.9741 -0.0259 -0.5 -0.5026 -1.0 2074099 Maybridge1_008391 O/N=C/c1cccc(Cl)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F10 compound treatment 0.9847 -0.0153 -0.3 -0.297 -1.0 2074100 Maybridge1_008392 Cc1nc(sc1C(=O)NN)c2cccc(c2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F11 compound treatment 0.9998 -1.65E-4 0.0 -0.0032 -1.0 2074101 Maybridge1_008393 NC(=S)Cc1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F12 compound treatment 0.9522 -0.0478 -0.93 -0.9285 -1.0 2074102 Maybridge1_008394 Cn1c(S)nnc1Cc2ccsc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F13 compound treatment 1.0293 0.0293 0.57 0.5696 1.0 1329032 Maybridge1_008395 CC(C)(C)c1cc([nH]n1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F14 compound treatment 0.9628 -0.0372 -0.72 -0.7229 -1.0 2074103 Maybridge1_008396 N/C(=N\O)/COc1ccc(cc1)C2=NCCS2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F15 compound treatment 0.962 -0.038 -0.74 -0.7376 -1.0 2074104 Maybridge1_008397 N/C(=N\O)/c1ccc(Oc2ccccc2Cl)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F16 compound treatment 0.9953 -0.0047 -0.09 -0.0913 -1.0 2074105 Maybridge1_008398 NC(=S)c1ccc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F17 compound treatment 0.962 -0.038 -0.74 -0.7376 -1.0 2074106 Maybridge1_008399 COCCCNC(=S)NNC(=O)c1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F18 compound treatment 0.9968 -0.00319 -0.06 -0.062 -1.0 2074107 Maybridge1_008400 NC(=S)CS(=O)(=O)c1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F19 compound treatment 0.9711 -0.0289 -0.56 -0.5613 -1.0 2074108 Maybridge1_008401 CCOC(=O)c1nn(C)c(C)c1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F20 compound treatment 0.9832 -0.0168 -0.33 -0.3263 -1.0 2074109 Maybridge1_008402 N/C(=N\O)/c1csc(n1)c2ccc(F)cc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F21 compound treatment 0.9764 -0.0236 -0.46 -0.4585 -1.0 1198509 Maybridge1_008403 CCOC(=O)c1nc(CS(=O)(=O)c2ccc(Cl)cc2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F22 compound treatment 1.0089 0.00891 0.17 0.173 1.0 2074110 Maybridge1_008404 Fc1ccc(NC(=O)NC(=O)c2ccno2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F23 mock treatment 0.9575 -0.0425 -0.83 -0.8257 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 F24 mock treatment 1.0127 0.0127 0.25 0.2465 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G01 compound treatment 1.0505 0.0505 0.98 0.9808 1.0 2074111 Maybridge1_008405 FC(F)(F)c1cccc(CSCCNC2=CC(=O)CC(C2)c3ccc4OCOc4c3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G02 compound treatment 0.9802 -0.0198 -0.39 -0.3851 -1.0 2074112 Maybridge1_008406 Fc1ccc(cc1F)c2csc(n2)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G03 compound treatment 0.9847 -0.0153 -0.3 -0.297 -1.0 2074113 Maybridge1_008407 Cc1nnsc1C(=O)NCCSCc2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G04 compound treatment 0.9666 -0.0334 -0.65 -0.6495 -1.0 2074114 Maybridge1_008408 CCOC(=O)Cc1nn(Cc2nc(cs2)c3ccc(cc3)C(F)(F)F)c(=O)c4ccccc14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G05 compound treatment 0.9938 -0.00622 -0.12 -0.1207 -1.0 2074115 Maybridge1_008409 CCOC(=O)c1cc(c2ccccc2)n(c1C)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G06 compound treatment 0.9991 -9.22E-4 -0.02 -0.0179 -1.0 2074116 Maybridge1_008410 COc1ccc(Oc2ccc(cc2c3nc(no3)c4ccccn4)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G07 compound treatment 1.0354 0.0354 0.69 0.6871 1.0 2074117 Maybridge1_008411 Cc1cc(C(=O)CC#N)c(o1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G08 compound treatment 0.9658 -0.0342 -0.66 -0.6641 -1.0 1599665 Maybridge1_008412 Cc1noc(C)c1c2nc(no2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G09 compound treatment 0.9908 -0.00924 -0.18 -0.1795 -1.0 2074118 Maybridge1_008413 OC(=O)c1cc(oc1C(F)(F)F)c2ccc(Br)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G10 compound treatment 0.9998 -1.65E-4 0.0 -0.0032 -1.0 2074119 Maybridge1_008414 Cc1ccc(cc1C)n2nc(cc2N)c3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G11 compound treatment 0.9726 -0.0274 -0.53 -0.532 -1.0 2074120 Maybridge1_008415 Cc1c(cc(c2ccccc2)n1CCSCCO)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G12 compound treatment 0.9552 -0.0448 -0.87 -0.8698 -1.0 2074121 Maybridge1_008416 Cc1oc(cc1C(=O)Nc2cc(nn2c3cc(cc(c3)C(F)(F)F)C(F)(F)F)c4ccco4)c5ccc(Cl)cc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G13 compound treatment 0.9605 -0.0395 -0.77 -0.767 -1.0 2074122 Maybridge1_008417 CC(C)(C)c1ccc(cc1)c2nc(cs2)c3ccc(cc3)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G14 compound treatment 0.9908 -0.00924 -0.18 -0.1795 -1.0 1586499 Maybridge1_008418 Cc1oc(cc1C(=O)Nc2ccc(cc2)C(C)(C)C)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G15 compound treatment 1.0203 0.0203 0.39 0.3933 1.0 1918664 Maybridge1_008419 Cc1nc(cs1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G16 compound treatment 0.965 -0.035 -0.68 -0.6788 -1.0 2074123 Maybridge1_008420 COc1ccccc1N2CCN(Cc3nc(C)c(s3)C(=O)C)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G17 compound treatment 0.9824 -0.0176 -0.34 -0.341 -1.0 2074124 Maybridge1_008421 Cc1ccc(cc1)c2csc(n2)c3ccc(Oc4ccc(cn4)C(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G18 compound treatment 0.9703 -0.0297 -0.58 -0.576 -1.0 1600126 Maybridge1_008422 COC(=O)c1ccc(o1)S(=O)(=O)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G19 compound treatment 1.0172 0.0172 0.33 0.3346 1.0 2074125 Maybridge1_008423 FC(F)(F)c1ccc(Oc2ccc(cc2)c3nc(cs3)c4ccc(C#N)cc4)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G20 compound treatment 0.9923 -0.00773 -0.15 -0.1501 -1.0 2074126 Maybridge1_008424 CCOC(=O)c1c(Cl)c(nc(N2CCOCC2)c1C#N)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G21 compound treatment 1.0097 0.00967 0.19 0.1877 1.0 1230345 Maybridge1_008425 COc1ccc(OCc2nc(cs2)c3ccc(C)cc3C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G22 compound treatment 0.9877 -0.0123 -0.24 -0.2382 -1.0 2074127 Maybridge1_008426 Cn1c(S)nnc1c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G23 mock treatment 0.987 -0.013 -0.25 -0.2529 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 G24 mock treatment 1.0263 0.0263 0.51 0.5108 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H01 compound treatment 1.0566 0.0566 1.1 1.0983 1.0 2074128 Maybridge1_008427 COCCCn1c(n[nH]c1=S)c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H02 compound treatment 1.1163 0.116 2.26 2.2586 1.0 1510220 Maybridge1_008428 Cc1c(C)n(Cc2cccs2)c(N)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H03 compound treatment 0.9824 -0.0176 -0.34 -0.341 -1.0 2074129 Maybridge1_008429 OC(=O)CCC(=O)NCC(=O)c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H04 compound treatment 0.9719 -0.0281 -0.55 -0.5466 -1.0 2074130 Maybridge1_008430 CCOC(=O)c1csc(COc2ccccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H05 compound treatment 0.9507 -0.0493 -0.96 -0.9579 -1.0 2074131 Maybridge1_008431 Nc1n[nH]c(SCc2ccc(Cl)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H06 compound treatment 1.0082 0.00815 0.16 0.1583 1.0 1459095 Maybridge1_008432 NC(=S)CS(=O)(=O)Cc1ccc(F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H07 compound treatment 1.0422 0.0422 0.82 0.8193 1.0 2074132 Maybridge1_008433 Brc1ccc(OC(=O)c2cccs2)c(c1)C3SCCS3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H08 compound treatment 1.1193 0.119 2.32 2.3174 1.0 1694073 Maybridge1_008434 CCCS(=O)(=O)c1c(C)c(C)n(Cc2ccccc2)c1N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H09 compound treatment 1.0013 0.00135 0.03 0.0262 1.0 2074133 Maybridge1_008435 [O-][N+](=O)c1cc(C#N)ccc1Oc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H10 compound treatment 0.987 -0.013 -0.25 -0.2529 -1.0 1571326 Maybridge1_008436 Cc1nc(cs1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H11 compound treatment 0.9787 -0.0213 -0.41 -0.4145 -1.0 2074134 Maybridge1_008437 CC(C)(C)c1ccc(cc1)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H12 compound treatment 1.0044 0.00437 0.08 0.0849 1.0 2074135 Maybridge1_008438 Cn1c(S)nnc1c2csc(n2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H13 compound treatment 0.9908 -0.00924 -0.18 -0.1795 -1.0 2074136 Maybridge1_008439 CSC(=S)NNC(=O)c1cc(C)on1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H14 compound treatment 0.9779 -0.0221 -0.43 -0.4291 -1.0 2074137 Maybridge1_008440 Clc1cccc(Cl)c1OCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H15 compound treatment 0.9681 -0.0319 -0.62 -0.6201 -1.0 2074138 Maybridge1_008441 NC(=S)COc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H16 compound treatment 0.9771 -0.0229 -0.44 -0.4438 -1.0 2074139 Maybridge1_008442 CC(C)Nc1ccc(Cl)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H17 compound treatment 0.9688 -0.0312 -0.61 -0.6054 -1.0 2074140 Maybridge1_008443 CCCCCCCCCCCc1nnc(S)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H18 compound treatment 0.9673 -0.0327 -0.63 -0.6348 -1.0 2074141 Maybridge1_008444 CC(C)n1c(S)nc2cc(Cl)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H19 compound treatment 0.9666 -0.0334 -0.65 -0.6495 -1.0 2074142 Maybridge1_008445 FC(F)(F)c1ccc(cc1)n2cnnc2S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H20 compound treatment 1.0104 0.0104 0.2 0.2024 1.0 1544875 Maybridge1_008446 CCOC(=O)c1sc(nc1OCc2ccc(Cl)cc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H21 compound treatment 0.9552 -0.0448 -0.87 -0.8698 -1.0 2074143 Maybridge1_008447 Cc1nn(C)c(C(=O)N)c1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H22 compound treatment 1.021 0.021 0.41 0.408 1.0 2074144 Maybridge1_008448 CC(=O)c1ccc(Oc2ncc(s2)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H23 mock treatment 0.9961 -0.00395 -0.08 -0.0766 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 H24 mock treatment 1.0308 0.0308 0.6 0.599 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I01 compound treatment 1.1004 0.1 1.95 1.9502 1.0 2074145 Maybridge1_008449 CN(C)c1ccc(cc1)C2CC(=O)C=C(C2)NCCSCc3c(C)cc(C)cc3C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I02 compound treatment 0.9537 -0.0463 -0.9 -0.8991 -1.0 2074146 Maybridge1_008450 CC(C)(C)c1cc(cc(c1O)C(C)(C)C)c2csc(n2)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I03 compound treatment 0.9847 -0.0153 -0.3 -0.297 -1.0 1236791 Maybridge1_008451 OC(=O)c1ccccc1NCc2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I04 compound treatment 0.9688 -0.0312 -0.61 -0.6054 -1.0 2074147 Maybridge1_008452 Cc1c(sc2ccc(Cl)cc12)c3csc(n3)c4ccc(cc4)C5SCCS5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I05 compound treatment 0.9991 -9.22E-4 -0.02 -0.0179 -1.0 2074148 Maybridge1_008453 CCOC(=O)C(CC(=O)c1ccc(Cl)cc1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I06 compound treatment 0.9605 -0.0395 -0.77 -0.767 -1.0 1154021 Maybridge1_008454 Cc1onc(c1c2nc(no2)c3ccccn3)c4c(F)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I07 compound treatment 0.993 -0.00697 -0.14 -0.1354 -1.0 1043838 Maybridge1_008455 Cc1cc(C)c(C(=O)N)c(N)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I08 compound treatment 0.9703 -0.0297 -0.58 -0.576 -1.0 2074149 Maybridge1_008456 CCn1nc(C)c(Br)c1c2nc(CS(=O)(=O)c3ccsc3)no2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I09 compound treatment 1.0286 0.0286 0.55 0.5549 1.0 2074150 Maybridge1_008457 OC(=O)c1cc(oc1C(F)(F)F)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I10 compound treatment 0.9953 -0.0047 -0.09 -0.0913 -1.0 1308808 Maybridge1_008458 Clc1ccc(cc1)c2cc(NC(=O)C3CCC3)n(n2)c4ccc(I)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I11 compound treatment 1.0346 0.0346 0.67 0.6724 1.0 1394972 Maybridge1_008459 Cc1c(cc(c2ccccc2)n1c3ccccc3)C(=O)Nc4cc(C)cc(C)c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I12 compound treatment 0.9802 -0.0198 -0.39 -0.3851 -1.0 2074151 Maybridge1_008460 Nc1cc(nn1c2cc(cc(c2)C(F)(F)F)C(F)(F)F)c3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I13 compound treatment 0.993 -0.00697 -0.14 -0.1354 -1.0 2074152 Maybridge1_008461 Cc1c(sc2ccccc12)c3csc(n3)c4ccc(cc4)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I14 compound treatment 0.9522 -0.0478 -0.93 -0.9285 -1.0 2074153 Maybridge1_008462 Cc1oc(cc1C(=O)Nc2cccc(c2)C(F)(F)F)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I15 compound treatment 1.0339 0.0339 0.66 0.6577 1.0 2071433 Maybridge1_008463 [O-][N+](=O)c1ccc(cc1)c2csc(n2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I16 compound treatment 0.9582 -0.0418 -0.81 -0.811 -1.0 2074154 Maybridge1_008464 FC(F)(F)c1ccc(SCc2noc(COc3ccc(Cl)cc3Cl)n2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I17 compound treatment 0.9809 -0.0191 -0.37 -0.3704 -1.0 2074155 Maybridge1_008465 [O-][N+](=O)c1ccc(cc1)c2csc(n2)c3ccc(Oc4ccc(cn4)C(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I18 compound treatment 0.9915 -0.00848 -0.16 -0.1648 -1.0 2074156 Maybridge1_008466 Cc1oc(C)c(c1C(=O)O)S(=O)(=O)NCc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I19 compound treatment 0.959 -0.041 -0.8 -0.7963 -1.0 2074157 Maybridge1_008467 Cc1onc(c1c2csc(n2)c3ccc(Oc4ccc(cn4)C(F)(F)F)cc3)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I20 compound treatment 0.9824 -0.0176 -0.34 -0.341 -1.0 1653730 Maybridge1_008468 CC(C)N(C(C)C)C(=O)c1c(C)onc1c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I21 compound treatment 0.9734 -0.0266 -0.52 -0.5173 -1.0 2074158 Maybridge1_008469 COC(=O)CSCCc1nc(cs1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I22 compound treatment 0.9726 -0.0274 -0.53 -0.532 -1.0 2074159 Maybridge1_008470 COc1ccc(cc1)c2noc(CSc3nnc(n3C)C(F)(F)F)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I23 mock treatment 0.9673 -0.0327 -0.63 -0.6348 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 I24 mock treatment 1.015 0.015 0.29 0.2905 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J01 compound treatment 0.987 -0.013 -0.25 -0.2529 -1.0 2074160 Maybridge1_008471 CCOC(=O)c1nc(no1)c2ccc(cc2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J02 compound treatment 1.077 0.077 1.49 1.4949 1.0 1725199 Maybridge1_008472 Cc1c(C)n(Cc2c(Cl)cccc2Cl)c(N)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J03 compound treatment 0.9673 -0.0327 -0.63 -0.6348 -1.0 1061396 Maybridge1_008473 CCOC(=O)NNC(=S)Nc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J04 compound treatment 0.9945 -0.00546 -0.11 -0.106 -1.0 2074161 Maybridge1_008474 Cc1cc(Oc2ccc(cc2[N+](=O)[O-])/C(=N/O)/N)cc(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J05 compound treatment 0.9885 -0.0115 -0.22 -0.2235 -1.0 2074162 Maybridge1_008475 Nc1n[nH]c(SCc2c(Cl)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J06 compound treatment 1.0066 0.00664 0.13 0.129 1.0 2074163 Maybridge1_008476 CCOC(=O)c1csc(COc2cc(Cl)cc(Cl)c2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J07 compound treatment 0.9885 -0.0115 -0.22 -0.2235 -1.0 2074164 Maybridge1_008477 Cn1c(SCC#N)nnc1c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J08 compound treatment 1.1715 0.172 3.33 3.3308 1.0 1508250 Maybridge1_008478 Cc1c(C)n(Cc2ccccc2)c(N)c1S(=O)(=O)c3ccccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J09 compound treatment 0.9923 -0.00773 -0.15 -0.1501 -1.0 2074165 Maybridge1_008479 CCCCCc1ccc(cc1)c2nnc(S)[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J10 compound treatment 0.9968 -0.00319 -0.06 -0.062 -1.0 2074166 Maybridge1_008480 c1csc(c1)c2nn[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J11 compound treatment 0.9998 -1.65E-4 0.0 -0.0032 -1.0 2074167 Maybridge1_008481 CCOC(=O)c1sc(nc1C)c2cccc(c2)n3cccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J12 compound treatment 0.993 -0.00697 -0.14 -0.1354 -1.0 2074168 Maybridge1_008482 Cn1c(Cc2ccsc2)nnc1SCC(=O)Nc3cc(Cl)cc(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J13 compound treatment 0.9371 -0.0629 -1.22 -1.2223 -1.0 2074169 Maybridge1_008483 CCOC(=O)c1cc(N)n(n1)c2nc3cc(Cl)ccc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J14 compound treatment 1.0013 0.00135 0.03 0.0262 1.0 2074170 Maybridge1_008484 Cc1cc(OCC#N)cc(C)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J15 compound treatment 0.9628 -0.0372 -0.72 -0.7229 -1.0 2074171 Maybridge1_008485 NC(=S)COc1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J16 compound treatment 1.0006 5.91E-4 0.01 0.0115 1.0 2074172 Maybridge1_008486 CCOC(=O)c1sc(nc1O)c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J17 compound treatment 0.9295 -0.0705 -1.37 -1.3691 -1.0 2074173 Maybridge1_008487 Fc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J18 compound treatment 0.9333 -0.0667 -1.3 -1.2957 -1.0 1448201 Maybridge1_008488 CCn1c(SCC(=O)O)nc2cc(Cl)ccc12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J19 compound treatment 0.9605 -0.0395 -0.77 -0.767 -1.0 2074174 Maybridge1_008489 NC(=N)COc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J20 compound treatment 0.9787 -0.0213 -0.41 -0.4145 -1.0 1650911 Maybridge1_008490 CCOC(=O)c1sc(nc1OCc2ccccc2Cl)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J21 compound treatment 1.0255 0.0255 0.5 0.4962 1.0 1423671 Maybridge1_008491 NC(=S)CS(=O)(=O)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J22 compound treatment 1.0248 0.0248 0.48 0.4815 1.0 2074175 Maybridge1_008492 CCn1nc(C)c([N+](=O)[O-])c1C(=O)Nc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J23 mock treatment 0.9658 -0.0342 -0.66 -0.6641 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 J24 mock treatment 1.0134 0.0134 0.26 0.2612 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K01 compound treatment 1.0528 0.0528 1.02 1.0249 1.0 2074176 Maybridge1_008493 CS(=O)(=O)/C(=C/c1sccc1Cl)/C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K02 compound treatment 1.0051 0.00513 0.1 0.0996 1.0 2074177 Maybridge1_008494 FC(F)(F)c1ccc(cc1)c2nc(cs2)c3ccc4OCCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K03 compound treatment 0.9945 -0.00546 -0.11 -0.106 -1.0 2074178 Maybridge1_008495 COC(=O)c1cc(C)[nH]c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K04 compound treatment 1.0059 0.00588 0.11 0.1143 1.0 1396826 Maybridge1_008496 CC(C)(C)c1cc(cc(c1O)C(C)(C)C)c2csc(CC#N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K05 compound treatment 1.0066 0.00664 0.13 0.129 1.0 2074179 Maybridge1_008497 OC(=O)c1cc(oc1C(F)(F)F)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K06 compound treatment 0.9961 -0.00395 -0.08 -0.0766 -1.0 2074180 Maybridge1_008498 Cc1nc(cs1)c2ccc3c(c2)C(C)(C)CCC3(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K07 compound treatment 1.0369 0.0369 0.72 0.7165 1.0 2074181 Maybridge1_008499 CC(=O)c1cc(oc1C)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K08 compound treatment 0.9824 -0.0176 -0.34 -0.341 -1.0 1204325 Maybridge1_008500 Fc1ccc(c2nc(CS(=O)(=O)c3ccsc3)no2)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K09 compound treatment 0.993 -0.00697 -0.14 -0.1354 -1.0 1432393 Maybridge1_008501 Cc1cc(C(=O)O)c(C)n1Cc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K10 compound treatment 1.0172 0.0172 0.33 0.3346 1.0 1530866 Maybridge1_008502 Fc1cccc(c1)S(=O)(=O)Nc2cc(nn2c3ccc(I)cc3)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K11 compound treatment 1.0165 0.0165 0.32 0.3199 1.0 2074182 Maybridge1_008503 CC(C)(C)c1ccc(cc1)c2nc(cs2)c3ccc(F)c(F)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K12 compound treatment 1.0112 0.0112 0.22 0.2171 1.0 2074183 Maybridge1_008504 Cc1n(CCSCc2c(Cl)cccc2Cl)c(c3ccccc3)c4cn[nH]c(=O)c14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K13 compound treatment 1.0029 0.00286 0.06 0.0555 1.0 2074184 Maybridge1_008505 Cc1c(sc2ccc(Cl)cc12)c3csc(n3)c4ccc(cc4)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K14 compound treatment 0.9991 -9.22E-4 -0.02 -0.0179 -1.0 2074185 Maybridge1_008506 Cc1oc(cc1C(=O)N2CCN(CC2)c3ccc(cn3)C(F)(F)F)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K15 compound treatment 0.962 -0.038 -0.74 -0.7376 -1.0 2074186 Maybridge1_008507 CC(C)OC(=O)Cc1csc(n1)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K16 compound treatment 0.9719 -0.0281 -0.55 -0.5466 -1.0 2074187 Maybridge1_008508 CN(NC(=O)c1ccc(F)cc1F)c2ccc(cn2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K17 compound treatment 0.9968 -0.00319 -0.06 -0.062 -1.0 2074188 Maybridge1_008509 Cc1c(sc2ccccc12)c3csc(n3)c4ccc(Oc5ccc(cn5)C(F)(F)F)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K18 compound treatment 0.9809 -0.0191 -0.37 -0.3704 -1.0 1247083 Maybridge1_008510 Cc1oc(cc1C(=O)O)S(=O)(=O)N2CCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K19 compound treatment 0.9983 -0.00168 -0.03 -0.0326 -1.0 2074189 Maybridge1_008511 FC(F)(F)c1ccc(cc1)c2csc(n2)c3ccc(Oc4ccc(cn4)C(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K20 compound treatment 0.9862 -0.0138 -0.27 -0.2676 -1.0 2074190 Maybridge1_008512 CC(C)(C)c1ccc(cc1)c2nc(S)n[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K21 compound treatment 0.9802 -0.0198 -0.39 -0.3851 -1.0 1153384 Maybridge1_008513 COc1ccc(OCc2nc(cs2)c3ccc(C)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K22 compound treatment 0.959 -0.041 -0.8 -0.7963 -1.0 1473078 Maybridge1_008514 CC(C)(C)c1ccc(cc1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K23 mock treatment 1.0074 0.0074 0.14 0.1437 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 K24 mock treatment 1.0452 0.0452 0.88 0.878 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L01 compound treatment 0.9787 -0.0213 -0.41 -0.4145 -1.0 2074191 Maybridge1_008515 CCOC(=O)c1nc(no1)c2cccc(C)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L02 compound treatment 0.9923 -0.00773 -0.15 -0.1501 -1.0 2074192 Maybridge1_008516 N/C(=N\O)/c1ccc(Oc2ccc(F)cc2F)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L03 compound treatment 0.9908 -0.00924 -0.18 -0.1795 -1.0 2074193 Maybridge1_008517 Oc1nnc(SCC=C)n1c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L04 compound treatment 1.0066 0.00664 0.13 0.129 1.0 2074194 Maybridge1_008518 Cn1cnnc1Sc2ccc(cn2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L05 compound treatment 0.956 -0.044 -0.86 -0.8551 -1.0 2074195 Maybridge1_008519 CN(C)/C=N/Nc1ccc(cc1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L06 compound treatment 1.0051 0.00513 0.1 0.0996 1.0 2074196 Maybridge1_008520 OC(=O)c1csc(COc2cc(Cl)cc(Cl)c2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L07 compound treatment 1.0384 0.0384 0.75 0.7458 1.0 2074197 Maybridge1_008521 Cn1c(SC/C(=N/O)/N)nnc1c2ccc(cc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L08 compound treatment 1.0225 0.0225 0.44 0.4374 1.0 1412794 Maybridge1_008522 Cc1c(C)n(Cc2cccc(Cl)c2)c(N)c1S(=O)(=O)c3ccccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L09 compound treatment 0.959 -0.041 -0.8 -0.7963 -1.0 1120732 Maybridge1_008523 Nc1c(cnn1c2cc(Cl)cc(Cl)c2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L10 compound treatment 1.0286 0.0286 0.55 0.5549 1.0 2074198 Maybridge1_008524 Cc1nc(cs1)c2nnc(S)n2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L11 compound treatment 0.965 -0.035 -0.68 -0.6788 -1.0 2074199 Maybridge1_008525 NC(=O)c1ccc(Oc2ccc(Cl)cc2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L12 compound treatment 0.9711 -0.0289 -0.56 -0.5613 -1.0 2074200 Maybridge1_008526 NC(=S)N/N=C/c1ccc(C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L13 compound treatment 0.987 -0.013 -0.25 -0.2529 -1.0 2074201 Maybridge1_008527 CCOC(=O)c1cc(C)nn1C(=O)c2ccc(C)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L14 compound treatment 0.9779 -0.0221 -0.43 -0.4291 -1.0 2074202 Maybridge1_008528 N/C(=N\O)/COc1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L15 compound treatment 1.0044 0.00437 0.08 0.0849 1.0 2074203 Maybridge1_008529 NC(=S)COc1cccc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L16 compound treatment 0.9726 -0.0274 -0.53 -0.532 -1.0 1055257 Maybridge1_008530 CCNc1ccc(Cl)cc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L17 compound treatment 1.0127 0.0127 0.25 0.2465 1.0 2074204 Maybridge1_008531 CC(C)c1ccc(NC(=S)NC(=O)c2ccc(cc2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L18 compound treatment 0.9938 -0.00622 -0.12 -0.1207 -1.0 2074205 Maybridge1_008532 CC(=O)c1sc(COc2ccccc2Cl)nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L19 compound treatment 1.0301 0.0301 0.58 0.5843 1.0 1210214 Maybridge1_008533 Cc1nc(C)c(s1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L20 compound treatment 1.0165 0.0165 0.32 0.3199 1.0 2074206 Maybridge1_008534 CCn1nc(C)cc1c2nnc(S)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L21 compound treatment 0.9968 -0.00319 -0.06 -0.062 -1.0 2074207 Maybridge1_008535 Cc1nc(C)c(s1)c2nnc(S)n2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L22 compound treatment 0.9567 -0.0433 -0.84 -0.8404 -1.0 2074208 Maybridge1_008536 FC(F)(F)c1cc(nc(SCc2csc(n2)c3cccs3)c1C#N)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L23 mock treatment 0.9454 -0.0546 -1.06 -1.0607 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 L24 mock treatment 1.0142 0.0142 0.28 0.2758 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M01 compound treatment 1.0785 0.0785 1.52 1.5243 1.0 2074209 Maybridge1_008537 Cc1onc(c1c2nc(CSc3ccc(cn3)C(F)(F)F)no2)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M02 compound treatment 1.0066 0.00664 0.13 0.129 1.0 2074210 Maybridge1_008538 Cc1ccc(c2csc(n2)c3ccc(cc3)C(F)(F)F)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M03 compound treatment 1.0112 0.0112 0.22 0.2171 1.0 2074211 Maybridge1_008539 COC(=O)c1cc(C)n(C)c1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M04 compound treatment 1.1496 0.15 2.9 2.9049 1.0 2074212 Maybridge1_008540 Cc1ccc(cc1C)c2csc(CC#N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M05 compound treatment 1.0354 0.0354 0.69 0.6871 1.0 2074213 Maybridge1_008541 Cc1cc(C(=O)CC#N)c(C)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M06 compound treatment 0.99 -0.01 -0.19 -0.1941 -1.0 1948412 Maybridge1_008542 CCCc1ccc(cc1)c2nc(no2)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M07 compound treatment 1.0354 0.0354 0.69 0.6871 1.0 2074214 Maybridge1_008543 NC(=S)c1ccc2OCCc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M08 compound treatment 1.0127 0.0127 0.25 0.2465 1.0 2074215 Maybridge1_008544 COc1ccc(Br)c(c1)c2nc(no2)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M09 compound treatment 0.9666 -0.0334 -0.65 -0.6495 -1.0 1385796 Maybridge1_008545 Cc1cc(C(=O)O)c(C)n1Cc2ccncc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M10 compound treatment 0.9567 -0.0433 -0.84 -0.8404 -1.0 2074216 Maybridge1_008546 Cc1oc(cc1C(=O)Nc2cc(nn2c3ccc(I)cc3)c4cccs4)c5ccc(Cl)cc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M11 compound treatment 0.9529 -0.0471 -0.91 -0.9138 -1.0 2074217 Maybridge1_008547 CC(C)(C)c1ccc(cc1)c2nc(cs2)c3ccc(Cl)c(Cl)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M12 compound treatment 0.9492 -0.0508 -0.99 -0.9873 -1.0 2074218 Maybridge1_008548 Cc1n(CCSCc2c(Cl)cccc2Cl)c(c3ccccc3)c4cnn(C)c(=O)c14 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M13 compound treatment 0.9885 -0.0115 -0.22 -0.2235 -1.0 2074219 Maybridge1_008549 CC(C)(C)c1ccc(cc1)c2nc(cs2)c3cccc(F)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M14 compound treatment 0.9877 -0.0123 -0.24 -0.2382 -1.0 1458102 Maybridge1_008550 Cc1oc(cc1C(=O)Nc2ccccc2)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M15 compound treatment 0.9711 -0.0289 -0.56 -0.5613 -1.0 2074220 Maybridge1_008551 Cc1nc(cs1)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M16 compound treatment 0.9424 -0.0576 -1.12 -1.1195 -1.0 1610243 Maybridge1_008552 Cc1oc(cc1C(=O)O)S(=O)(=O)N2CCOCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M17 compound treatment 0.9809 -0.0191 -0.37 -0.3704 -1.0 2074221 Maybridge1_008553 Cc1c(sc2ccc(Cl)cc12)c3csc(n3)c4ccc(Oc5ccc(cn5)C(F)(F)F)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M18 compound treatment 0.9567 -0.0433 -0.84 -0.8404 -1.0 1589369 Maybridge1_008554 CSc1ccc(cc1)n2c(C)c(cc2c3ccccc3)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M19 compound treatment 1.0127 0.0127 0.25 0.2465 1.0 2074222 Maybridge1_008555 CC(C)(C)c1cc(cc(c1O)C(C)(C)C)c2csc(n2)c3ccc(Oc4ccc(cn4)C(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M20 compound treatment 0.9847 -0.0153 -0.3 -0.297 -1.0 1539870 Maybridge1_008556 CCCOc1c(Cl)cc(cc1Cl)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M21 compound treatment 0.9991 -9.22E-4 -0.02 -0.0179 -1.0 2074223 Maybridge1_008557 COc1ccc(OCc2nc(cs2)c3ccc(cc3)[N+](=O)[O-])cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M22 compound treatment 0.9953 -0.0047 -0.09 -0.0913 -1.0 2074224 Maybridge1_008558 CC(C)(C)c1ccc(cc1)c2nnc(S)n2c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M23 mock treatment 1.0354 0.0354 0.69 0.6871 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 M24 mock treatment 0.9771 -0.0229 -0.44 -0.4438 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N01 compound treatment 0.9983 -0.00168 -0.03 -0.0326 -1.0 2074225 Maybridge1_008559 CCOC(=O)NNC(=S)NC1CCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N02 compound treatment 0.9295 -0.0705 -1.37 -1.3691 -1.0 2074226 Maybridge1_008560 Oc1nnc(S)n1CC=C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N03 compound treatment 1.0255 0.0255 0.5 0.4962 1.0 2074227 Maybridge1_008561 CC(C)(C)c1ccc(cc1)c2nnc(S)n2Cc3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N04 compound treatment 1.0134 0.0134 0.26 0.2612 1.0 2074228 Maybridge1_008562 Fc1ccc(CS(=O)(=O)CC#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N05 compound treatment 0.9998 -1.65E-4 0.0 -0.0032 -1.0 2074229 Maybridge1_008563 CN(C)/C=N/NC(=O)c1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N06 compound treatment 1.0059 0.00588 0.11 0.1143 1.0 2074230 Maybridge1_008564 Oc1nnc(Sc2ccc(cc2[N+](=O)[O-])C(F)(F)F)n1c3ccccc3C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N07 compound treatment 1.021 0.021 0.41 0.408 1.0 2074231 Maybridge1_008565 Cn1c(SC/C(=N/OC(=O)c2ccc(Cl)cc2)/N)nnc1c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N08 compound treatment 1.0921 0.0921 1.79 1.7886 1.0 2074232 Maybridge1_008566 Cc1c(C)n(Cc2ccc(cc2)C(F)(F)F)c(N)c1S(=O)(=O)c3ccccn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N09 compound treatment 0.962 -0.038 -0.74 -0.7376 -1.0 2074233 Maybridge1_008567 CC(C)c1ccc(cc1)n2c(S)nnc2c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N10 compound treatment 1.018 0.018 0.35 0.3493 1.0 2074234 Maybridge1_008568 Cc1nc(cs1)c2nnc(Sc3ccc(cc3[N+](=O)[O-])C(F)(F)F)n2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N11 compound treatment 0.9983 -0.00168 -0.03 -0.0326 -1.0 2074235 Maybridge1_008569 Clc1ccc2sc(Oc3ccc(C#N)cc3)nc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N12 compound treatment 0.9174 -0.0826 -1.6 -1.6041 -1.0 2074236 Maybridge1_008570 NC(=S)N/N=C/c1ccccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N13 compound treatment 0.9794 -0.0206 -0.4 -0.3998 -1.0 2074237 Maybridge1_008571 Cc1cccc(c1)c2noc(NC(=O)O/N=C/c3ccccc3)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N14 compound treatment 1.0165 0.0165 0.32 0.3199 1.0 2074238 Maybridge1_008572 CCOC(=O)c1sc(nc1O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N15 compound treatment 0.9809 -0.0191 -0.37 -0.3704 -1.0 1287595 Maybridge1_008573 COc1ccc(OCC(=S)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N16 compound treatment 0.9824 -0.0176 -0.34 -0.341 -1.0 2074239 Maybridge1_008574 Sc1nnc(Cc2ccsc2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N17 compound treatment 0.9855 -0.0145 -0.28 -0.2823 -1.0 2074240 Maybridge1_008575 CCCCCCCCCCCc1nnc(SCc2ccc(Cl)cc2)n1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N18 compound treatment 0.9908 -0.00924 -0.18 -0.1795 -1.0 2074241 Maybridge1_008576 CCOC(=O)c1sc(nc1C)n2cccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N19 compound treatment 0.987 -0.013 -0.25 -0.2529 -1.0 2074242 Maybridge1_008577 [O-][N+](=O)c1cnc(Sc2nnc([nH]2)c3cccs3)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N20 compound treatment 1.0255 0.0255 0.5 0.4962 1.0 2074243 Maybridge1_008578 CCn1nc(C)c(Br)c1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N21 compound treatment 0.9688 -0.0312 -0.61 -0.6054 -1.0 2074244 Maybridge1_008579 CCn1nc(C)cc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N22 compound treatment 1.015 0.015 0.29 0.2905 1.0 2074245 Maybridge1_008580 Clc1ccc(cc1)c2nnc(Cc3cc(Br)sc3Br)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N23 mock treatment 0.9582 -0.0418 -0.81 -0.811 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 N24 mock treatment 1.0195 0.0195 0.38 0.3787 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O01 compound treatment 0.9945 -0.00546 -0.11 -0.106 -1.0 1165825 Maybridge1_008581 Cc1ccc(CN2CC(CC2=O)C(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O02 compound treatment 0.9484 -0.0516 -1.0 -1.002 -1.0 2074246 Maybridge1_008582 [O-][N+](=O)c1ccc(cc1)c2csc(n2)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O03 compound treatment 0.9991 -9.22E-4 -0.02 -0.0179 -1.0 2074247 Maybridge1_008583 COC(=O)c1c(C)[nH]c(C)c1C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O04 compound treatment 1.0036 0.00362 0.07 0.0702 1.0 1864077 Maybridge1_008584 [O-][N+](=O)c1ccc(cc1)c2csc(CC#N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O05 compound treatment 1.0021 0.0021 0.04 0.0408 1.0 2074248 Maybridge1_008585 Cc1oc(cc1C(=O)O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O06 compound treatment 0.987 -0.013 -0.25 -0.2529 -1.0 1293522 Maybridge1_008586 COc1ccc(cc1OC)c2nc(no2)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O07 compound treatment 1.0082 0.00815 0.16 0.1583 1.0 2074249 Maybridge1_008587 Cc1oc(cc1COC(=O)Nc2ccc(Cl)cc2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O08 compound treatment 0.9938 -0.00622 -0.12 -0.1207 -1.0 2074250 Maybridge1_008588 CCn1nc(C)c(Br)c1c2nc(no2)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O09 compound treatment 1.0006 5.91E-4 0.01 0.0115 1.0 1169901 Maybridge1_008589 Cc1c(cc(c2ccccc2)n1c3ccccc3)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O10 compound treatment 1.0059 0.00588 0.11 0.1143 1.0 2074251 Maybridge1_008590 FC(F)(F)c1cc(cc(c1)C(F)(F)F)n2nc(cc2NC(=O)C3CCC3)c4ccco4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O11 compound treatment 1.0059 0.00588 0.11 0.1143 1.0 2074252 Maybridge1_008591 CC(C)(C)c1ccc(cc1)c2nc(cs2)c3cc(c(O)c(c3)C(C)(C)C)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O12 compound treatment 0.9923 -0.00773 -0.15 -0.1501 -1.0 2074253 Maybridge1_008592 Cc1oc(cc1C(=O)N2CCN(CC2)c3ncccc3C(F)(F)F)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O13 compound treatment 1.0119 0.0119 0.23 0.2318 1.0 2074254 Maybridge1_008593 COC(=O)CSCCc1nc(cs1)c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O14 compound treatment 1.0082 0.00815 0.16 0.1583 1.0 2074255 Maybridge1_008594 Cc1oc(cc1C(=O)Nc2ccc(cc2)[N+](=O)[O-])C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O15 compound treatment 0.956 -0.044 -0.86 -0.8551 -1.0 2074256 Maybridge1_008595 FC(F)(F)c1ccc(Oc2ccc(cc2)c3nc(cs3)c4ccc(Cl)c(Cl)c4)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O16 compound treatment 0.9386 -0.0614 -1.19 -1.1929 -1.0 1232555 Maybridge1_008596 Cc1oc(cc1C(=O)O)S(=O)(=O)N2CCCCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O17 compound treatment 1.0059 0.00588 0.11 0.1143 1.0 1122089 Maybridge1_008597 CC(C)(C)c1ccc(cc1)c2nc(cs2)c3ccc(C#N)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O18 compound treatment 1.1367 0.137 2.66 2.6552 1.0 2074257 Maybridge1_008598 Nc1sccc1c2nc3ccccc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O19 compound treatment 0.9794 -0.0206 -0.4 -0.3998 -1.0 1195213 Maybridge1_008599 COc1ccc(OCc2nc(cs2)c3ccc(Cl)c(Cl)c3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O20 compound treatment 1.0059 0.00588 0.11 0.1143 1.0 2074258 Maybridge1_008600 COc1c(Br)cc(C#N)cc1Br 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O21 compound treatment 1.0566 0.0566 1.1 1.0983 1.0 1708870 Maybridge1_008601 COc1ccc(OCc2nc(cs2)c3sc4ccccc4c3C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O22 compound treatment 1.0195 0.0195 0.38 0.3787 1.0 2074259 Maybridge1_008602 Sc1nnc([nH]1)c2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O23 mock treatment 0.9787 -0.0213 -0.41 -0.4145 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 O24 mock treatment 0.9764 -0.0236 -0.46 -0.4585 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P01 compound treatment 1.0059 0.00588 0.11 0.1143 1.0 2074260 Maybridge1_008603 COCc1cc(O)nc(Cc2c(Cl)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P02 compound treatment 1.0339 0.0339 0.66 0.6577 1.0 2074261 Maybridge1_008604 CCCCCn1c(O)nnc1S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P03 compound treatment 1.0104 0.0104 0.2 0.2024 1.0 2074262 Maybridge1_008605 CC(C)(C)c1ccc(cc1)n2c(S)nnc2c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P04 compound treatment 1.0422 0.0422 0.82 0.8193 1.0 2074263 Maybridge1_008606 CCOC(=O)c1csc(n1)c2cccc(Cl)c2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P05 compound treatment 0.9855 -0.0145 -0.28 -0.2823 -1.0 2074264 Maybridge1_008607 CN(C)/C=N/NS(=O)(=O)c1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P06 compound treatment 1.0308 0.0308 0.6 0.599 1.0 2074265 Maybridge1_008608 CCCCCn1c(O)nnc1SCC(=O)Nc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P07 compound treatment 0.9741 -0.0259 -0.5 -0.5026 -1.0 2074266 Maybridge1_008609 Cn1c(SC/C(=N/OC(=O)c2cccs2)/N)nnc1c3ccc(cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P08 compound treatment 1.0112 0.0112 0.22 0.2171 1.0 2074267 Maybridge1_008610 CCOC(=O)c1csc(n1)c2ccc(F)cc2F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P09 compound treatment 0.9877 -0.0123 -0.24 -0.2382 -1.0 2074268 Maybridge1_008611 [O-][N+](=O)c1cc(C#N)ccc1Oc2cc(Cl)cc(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P10 compound treatment 0.9877 -0.0123 -0.24 -0.2382 -1.0 2074269 Maybridge1_008612 NNC(=O)Cc1csc(n1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P11 compound treatment 0.9915 -0.00848 -0.16 -0.1648 -1.0 2074270 Maybridge1_008613 NC(=O)c1ccc(Oc2cc(Cl)cc(Cl)c2)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P12 compound treatment 0.9787 -0.0213 -0.41 -0.4145 -1.0 2074271 Maybridge1_008614 NC(=S)N/N=C/c1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P13 compound treatment 0.993 -0.00697 -0.14 -0.1354 -1.0 2074272 Maybridge1_008615 Cc1cc(no1)C(=O)N/N=C/C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P14 compound treatment 1.1488 0.149 2.89 2.8902 1.0 2074273 Maybridge1_008616 CCOC(=O)c1sc(nc1O)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P15 compound treatment 0.9892 -0.0108 -0.21 -0.2088 -1.0 2074274 Maybridge1_008617 Clc1ccc(cc1)C(=O)Oc2ccc(cc2)C3=NCCS3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P16 compound treatment 0.9726 -0.0274 -0.53 -0.532 -1.0 2074275 Maybridge1_008618 CCn1nc(C)cc1c2nnc(S)n2c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P17 compound treatment 0.9923 -0.00773 -0.15 -0.1501 -1.0 2074276 Maybridge1_008619 Fc1ccc(NC(=O)NC(=O)c2ccc(cc2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P18 compound treatment 1.0051 0.00513 0.1 0.0996 1.0 1280867 Maybridge1_008620 O=c1oc2ccccc2n1CCC#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P19 compound treatment 0.9885 -0.0115 -0.22 -0.2235 -1.0 2074277 Maybridge1_008621 Cn1c(O)nnc1Sc2ncc(s2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P20 compound treatment 0.9885 -0.0115 -0.22 -0.2235 -1.0 2074278 Maybridge1_008622 Cc1cc(no1)C(=O)NNC(=O)c2c(C)onc2c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P21 compound treatment 1.0233 0.0233 0.45 0.4521 1.0 2074279 Maybridge1_008623 CCOC(=O)c1sc(nc1O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P22 compound treatment 1.0263 0.0263 0.51 0.5108 1.0 2074280 Maybridge1_008624 FC(F)(F)c1ccc(Oc2ccc(C#N)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P23 mock treatment 0.9522 -0.0478 -0.93 -0.9285 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.565 P24 mock treatment 1.0407 0.0407 0.79 0.7899 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A01 compound treatment 1.2076 0.208 4.03 4.0322 1.0 2074281 Maybridge1_008625 Cc1nc(no1)c2ccc(Oc3ccc(cn3)C(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A02 compound treatment 1.0556 0.0556 1.08 1.0792 1.0 2074282 Maybridge1_008626 O/N=C/c1cccc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A03 compound treatment 1.0356 0.0356 0.69 0.6921 1.0 2074283 Maybridge1_008627 Cc1cc(C(=O)O)n(n1)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A04 compound treatment 1.0452 0.0452 0.88 0.8785 1.0 2074284 Maybridge1_008628 COC(C)(OC)c1ccc(C#N)c(S)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A05 compound treatment 1.0519 0.0519 1.01 1.0075 1.0 2074285 Maybridge1_008629 COC(=O)c1c(C)n[nH]c1c2cc(C)on2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A06 compound treatment 1.0593 0.0593 1.15 1.1508 1.0 2074286 Maybridge1_008630 CC(C)(C)c1ccc(OCC(=N)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A07 compound treatment 0.998 -0.00201 -0.04 -0.039 -1.0 2074287 Maybridge1_008631 CC(=O)c1csc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A08 compound treatment 1.0098 0.0098 0.19 0.1904 1.0 2074288 Maybridge1_008632 NC(=O)COc1cccc(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A09 compound treatment 1.0216 0.0216 0.42 0.4197 1.0 2074289 Maybridge1_008633 CC(=O)c1csc(n1)c2ccc(OC(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A10 compound treatment 0.9803 -0.0197 -0.38 -0.383 -1.0 2074290 Maybridge1_008634 Cc1ccc(Nc2nc(cs2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A11 compound treatment 1.0069 0.00685 0.13 0.133 1.0 2074291 Maybridge1_008635 FC(F)(F)Oc1ccc(cc1)c2nnc(S)n2c3ccccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A12 compound treatment 1.0128 0.0128 0.25 0.2477 1.0 1044931 Maybridge1_008636 COc1ncccc1[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A13 compound treatment 1.029 0.029 0.56 0.5631 1.0 2074292 Maybridge1_008637 Cc1nc(nc(O)c1Oc2ccc(Cl)cc2Cl)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A14 compound treatment 0.9913 -0.00865 -0.17 -0.168 -1.0 1194534 Maybridge1_008638 Cc1nn(CCC#N)c(C)c1Oc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A15 compound treatment 1.0113 0.0113 0.22 0.2191 1.0 2074293 Maybridge1_008639 COC(OC)c1ccnc(SCC(=O)Nc2cc(Cl)cc(Cl)c2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A16 compound treatment 0.998 -0.00201 -0.04 -0.039 -1.0 2074294 Maybridge1_008640 FC(F)(F)c1ccc(=O)n(CCC#N)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A17 compound treatment 1.1966 0.197 3.82 3.8171 1.0 1461755 Maybridge1_008641 CC(=O)Nc1nc(C)c(Oc2ccc(C)cc2)c(O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A18 compound treatment 0.9928 -0.00717 -0.14 -0.1393 -1.0 1022739 Maybridge1_008642 NC(=S)Nc1ccc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A19 compound treatment 1.0652 0.0652 1.27 1.2655 1.0 2074295 Maybridge1_008643 CC(=O)c1cc(no1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A20 compound treatment 1.0172 0.0172 0.33 0.3337 1.0 2074296 Maybridge1_008644 OC(=O)c1cc(Cl)cnc1O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A21 compound treatment 1.0305 0.0305 0.59 0.5918 1.0 2074297 Maybridge1_008645 Clc1ccc(c2cc(on2)c3csc(N/N=C/c4ccccc4)n3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A22 compound treatment 1.0585 0.0585 1.14 1.1365 1.0 2074298 Maybridge1_008646 SC1=NNC(S1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A23 mock treatment 0.9965 -0.00348 -0.07 -0.0676 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 A24 mock treatment 0.9773 -0.0227 -0.44 -0.4404 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B01 compound treatment 1.0962 0.0962 1.87 1.8676 1.0 2074299 Maybridge1_008647 Cc1ccc(CN2C(=O)CNC2=S)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B02 compound treatment 0.9847 -0.0153 -0.3 -0.297 -1.0 2074300 Maybridge1_008648 Cc1cccc(Cn2nc(cc2c3nnc(S)o3)C(C)(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B03 compound treatment 1.046 0.046 0.89 0.8928 1.0 2074301 Maybridge1_008649 NNC(=S)Nc1ccc(cc1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B04 compound treatment 1.0386 0.0386 0.75 0.7495 1.0 2074302 Maybridge1_008650 COc1ccc(OCCNC(=O)c2ccc(OC(F)(F)F)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B05 compound treatment 1.0415 0.0415 0.81 0.8068 1.0 1735075 Maybridge1_008651 Cc1nnc(S)n1c2ccc(OCc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B06 compound treatment 1.0164 0.0164 0.32 0.3194 1.0 2074303 Maybridge1_008652 N#Cc1ccc(/C=N/Nc2nc(cs2)c3ccc4OCCOc4c3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B07 compound treatment 1.0002 2.08E-4 0.0 0.004 1.0 2074304 Maybridge1_008653 CCOC(=O)N/N=C(/CN1C(=O)c2ccccc2C1=O)\c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B08 compound treatment 1.0179 0.0179 0.35 0.3481 1.0 1466613 Maybridge1_008654 O=S(=O)(Cc1ccco1)Cc2nc(cs2)c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B09 compound treatment 1.0327 0.0327 0.63 0.6348 1.0 2074305 Maybridge1_008655 CCCn1c(S)nnc1Cc2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B10 compound treatment 1.0128 0.0128 0.25 0.2477 1.0 2074306 Maybridge1_008656 Cc1onc(c1c2csc(n2)c3cccc(c3)C(F)(F)F)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B11 compound treatment 1.0083 0.00833 0.16 0.1617 1.0 2074307 Maybridge1_008657 CC(=O)N[C@@H](Cc1ccc(OC(F)(F)F)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B12 compound treatment 1.0002 2.08E-4 0.0 0.004 1.0 2074308 Maybridge1_008658 OC(=O)C(Cc1ccc(cc1)[N+](=O)[O-])NS(=O)(=O)c2ccc(OC(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B13 compound treatment 0.9847 -0.0153 -0.3 -0.297 -1.0 2074309 Maybridge1_008659 O=C(CSc1nncn1c2ccc(OCc3ccccc3)cc2)Nc4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B14 compound treatment 0.9987 -0.00127 -0.02 -0.0246 -1.0 1112632 Maybridge1_008660 COc1ccccc1NC(=O)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B15 compound treatment 0.9832 -0.0168 -0.33 -0.3257 -1.0 2074310 Maybridge1_008661 Fc1cccc(c1)C(=O)CSc2nnc(c3ccco3)n2c4ccc5OCCOc5c4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B16 compound treatment 1.0128 0.0128 0.25 0.2477 1.0 1682013 Maybridge1_008662 Clc1cccc(C(=O)Nc2cccnc2)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B17 compound treatment 1.0253 0.0253 0.49 0.4914 1.0 2074311 Maybridge1_008663 FC(F)(F)Oc1ccc(cc1)S(=O)(=O)N2CCCN(CC2)c3nc4ccc(Cl)cc4s3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B18 compound treatment 0.9877 -0.0123 -0.24 -0.2397 -1.0 2074312 Maybridge1_008664 COc1ccc(NC(=O)c2c(C)onc2c3c(Cl)cccc3Cl)cn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B19 compound treatment 0.9987 -0.00127 -0.02 -0.0246 -1.0 2074313 Maybridge1_008665 CCOC(=O)c1cc(nn1Cc2c(C)cc(C)cc2C)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B20 compound treatment 1.0172 0.0172 0.33 0.3337 1.0 1143232 Maybridge1_008666 Cc1cc(nn1C(C)(C)C)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B21 compound treatment 0.9958 -0.00422 -0.08 -0.082 -1.0 2074314 Maybridge1_008667 N/C(=N\OC(=O)Nc1cccc2ccccc12)/Cc3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B22 compound treatment 0.9729 -0.0271 -0.53 -0.5264 -1.0 1640080 Maybridge1_008668 CCOc1cc(N2CCOCC2)c(OCC)cc1NC(=O)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B23 mock treatment 1.0024 0.00242 0.05 0.047 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 B24 mock treatment 0.9987 -0.00127 -0.02 -0.0246 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C01 compound treatment 1.0593 0.0593 1.15 1.1508 1.0 2074315 Maybridge1_008669 CCOC(=O)c1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C02 compound treatment 1.0342 0.0342 0.66 0.6634 1.0 2074316 Maybridge1_008670 Nc1nccc(n1)c2cc(no2)c3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C03 compound treatment 1.0423 0.0423 0.82 0.8211 1.0 2074317 Maybridge1_008671 Cn1nc(cc1C(=O)O)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C04 compound treatment 1.057 0.057 1.11 1.1078 1.0 2074318 Maybridge1_008672 CC(=O)c1ccc(C#N)c(S)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C05 compound treatment 1.046 0.046 0.89 0.8928 1.0 1913710 Maybridge1_008673 NC(=S)N/N=C/c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C06 compound treatment 1.0024 0.00242 0.05 0.047 1.0 1103895 Maybridge1_008674 NC(=N)COc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C07 compound treatment 1.0482 0.0482 0.94 0.9358 1.0 2074319 Maybridge1_008675 FC(F)(F)Oc1ccccc1C(=O)NNC(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C08 compound treatment 1.0032 0.00316 0.06 0.0614 1.0 1561598 Maybridge1_008676 COc1ccc(cn1)C(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C09 compound treatment 1.0113 0.0113 0.22 0.2191 1.0 1335819 Maybridge1_008677 Cc1nc(cs1)c2nc(C)nc(N)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C10 compound treatment 1.0069 0.00685 0.13 0.133 1.0 2074320 Maybridge1_008678 Cc1ccc(cn1)C(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C11 compound treatment 0.9854 -0.0146 -0.28 -0.2827 -1.0 2074321 Maybridge1_008679 FC(F)(F)c1cnc(S)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C12 compound treatment 1.0098 0.0098 0.19 0.1904 1.0 2074322 Maybridge1_008680 FC(F)(F)c1cccn(CCC#N)c1=O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C13 compound treatment 1.0334 0.0334 0.65 0.6491 1.0 2074323 Maybridge1_008681 CN(C)/C=C(/Sc1nnc(n1C)C(F)(F)F)\C(=O)c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C14 compound treatment 1.0216 0.0216 0.42 0.4197 1.0 1953832 Maybridge1_008682 NC(=N)c1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C15 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 2074324 Maybridge1_008683 COC(OC)c1ccc(C#N)c(S)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C16 compound treatment 0.9862 -0.0138 -0.27 -0.2683 -1.0 1049916 Maybridge1_008684 CC(=O)Nc1ccccc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C17 compound treatment 1.0017 0.00168 0.03 0.0327 1.0 1288517 Maybridge1_008685 CC(=O)Nc1nc(C)c(Oc2ccccc2)c(O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C18 compound treatment 0.9958 -0.00422 -0.08 -0.082 -1.0 1008101 Maybridge1_008686 Cc1ccccc1NC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C19 compound treatment 1.0356 0.0356 0.69 0.6921 1.0 2074325 Maybridge1_008687 C/C(=N\NS(=O)(=O)c1ccc(Cl)cc1)/c2cc(no2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C20 compound treatment 0.9869 -0.0131 -0.25 -0.254 -1.0 1499311 Maybridge1_008688 Clc1cncc(Cl)c1N2CCN(CC2)C(=O)Nc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C21 compound treatment 1.0238 0.0238 0.46 0.4628 1.0 2074326 Maybridge1_008689 CC(=O)c1c(C)onc1c2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C22 compound treatment 1.015 0.015 0.29 0.2907 1.0 2074327 Maybridge1_008690 Cn1cc(Cl)c(n1)C2NN=C(S)S2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C23 mock treatment 1.0032 0.00316 0.06 0.0614 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 C24 mock treatment 0.9729 -0.0271 -0.53 -0.5264 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D01 compound treatment 1.0179 0.0179 0.35 0.3481 1.0 2074328 Maybridge1_008691 NNC(=O)c1ccc(F)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D02 compound treatment 1.046 0.046 0.89 0.8928 1.0 2074329 Maybridge1_008692 Cn1c(S)nnc1c2cc(nn2Cc3ccc(Cl)cc3Cl)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D03 compound treatment 1.0002 2.08E-4 0.0 0.004 1.0 2074330 Maybridge1_008693 FC(F)(F)c1ccccc1n2cnnc2S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D04 compound treatment 1.0474 0.0474 0.92 0.9215 1.0 2074331 Maybridge1_008694 COc1ccc(OCCNC(=O)c2c(C)noc2c3c(F)cccc3Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D05 compound treatment 1.012 0.012 0.23 0.2334 1.0 2074332 Maybridge1_008695 Sc1nnc(c2ccco2)n1c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D06 compound treatment 0.9899 -0.0101 -0.2 -0.1967 -1.0 1495996 Maybridge1_008696 O=S(=O)(Cc1nc(cs1)c2ccc3OCCOc3c2)c4ccccn4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D07 compound treatment 0.9869 -0.0131 -0.25 -0.254 -1.0 1628175 Maybridge1_008697 O=C1N(C(=O)c2ccccc12)c3snnc3c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D08 compound treatment 1.026 0.026 0.51 0.5058 1.0 1217127 Maybridge1_008698 Clc1ccc(OCc2nc(cs2)c3ccc4OCCOc4c3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D09 compound treatment 1.0179 0.0179 0.35 0.3481 1.0 2074333 Maybridge1_008699 Sc1nnc(Cc2ccc(Cl)c(Cl)c2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D10 compound treatment 1.0179 0.0179 0.35 0.3481 1.0 1380282 Maybridge1_008700 COc1ccccc1OCc2nc(cs2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D11 compound treatment 1.0246 0.0246 0.48 0.4771 1.0 1589372 Maybridge1_008701 CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D12 compound treatment 1.0157 0.0157 0.31 0.3051 1.0 1638560 Maybridge1_008702 Cc1onc(c1C(=O)N2CCN(CC2)c3ccc(C#N)cc3)c4c(Cl)cccc4Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D13 compound treatment 0.9707 -0.0293 -0.57 -0.5694 -1.0 2074334 Maybridge1_008703 Clc1cc(Cl)cc(NC(=O)CSc2nncn2c3ccc(OCc4ccccc4)cc3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D14 compound treatment 1.029 0.029 0.56 0.5631 1.0 1929843 Maybridge1_008704 Clc1cccc(c1)C(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D15 compound treatment 1.0319 0.0319 0.62 0.6204 1.0 2074335 Maybridge1_008705 O=C(CSc1nnc(c2ccco2)n1c3ccc4OCCOc4c3)c5ccccc5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D16 compound treatment 1.0009 9.46E-4 0.02 0.0184 1.0 2074336 Maybridge1_008706 Fc1cccc(F)c1C(=O)Nc2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D17 compound treatment 1.0076 0.00759 0.15 0.1474 1.0 2074337 Maybridge1_008707 Cc1onc(c1C(=O)N2C[C@H]3CCCC[C@H]3C[C@H]2C(=O)NC(C)(C)C)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D18 compound treatment 0.9803 -0.0197 -0.38 -0.383 -1.0 2074338 Maybridge1_008708 COc1ccc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)cn1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D19 compound treatment 0.9943 -0.0057 -0.11 -0.1106 -1.0 1317425 Maybridge1_008709 Cc1cccc(Cn2nc(cc2C(=O)O)C(C)(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D20 compound treatment 1.0216 0.0216 0.42 0.4197 1.0 1638488 Maybridge1_008710 CC(C)(C)NC(=S)NC1CCN(Cc2ccccc2)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D21 compound treatment 0.9736 -0.0264 -0.51 -0.512 -1.0 2074339 Maybridge1_008711 N/C(=N\OC(=O)Nc1cc(Cl)cc(Cl)c1)/Cc2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D22 compound treatment 0.953 -0.047 -0.91 -0.9134 -1.0 1409426 Maybridge1_008712 CN1CCN(CC1)c2ccc(NC(=O)c3ccc(F)cc3F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D23 mock treatment 0.9832 -0.0168 -0.33 -0.3257 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 D24 mock treatment 1.0474 0.0474 0.92 0.9215 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E01 compound treatment 1.1021 0.102 1.98 1.9823 1.0 2074340 Maybridge1_008713 NC(=S)c1ccc(Oc2ccc(cn2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E02 compound treatment 1.0445 0.0445 0.86 0.8641 1.0 2074341 Maybridge1_008714 CC(=O)c1cc(no1)c2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E03 compound treatment 1.0511 0.0511 0.99 0.9931 1.0 2074342 Maybridge1_008715 FC(F)(F)c1ccc(nc1)n2cncn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E04 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2074343 Maybridge1_008716 Cc1nnsc1c2c(C(=O)O)c(C)nn2c3ccc(OC(F)(F)F)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E05 compound treatment 0.9825 -0.0175 -0.34 -0.34 -1.0 2074344 Maybridge1_008717 NC(=S)N/N=C/c1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E06 compound treatment 0.9818 -0.0182 -0.35 -0.3543 -1.0 2074345 Maybridge1_008718 Cc1c(sc2nc(nn12)C(F)(F)F)c3ccn[nH]3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E07 compound treatment 0.9862 -0.0138 -0.27 -0.2683 -1.0 2074346 Maybridge1_008719 FC(F)(F)Oc1ccccc1c2nnc(o2)c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E08 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 2074347 Maybridge1_008720 FC(F)(F)c1ccncc1c2nc(cs2)c3ccc(C#N)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E09 compound treatment 1.0046 0.00464 0.09 0.09 1.0 2074348 Maybridge1_008721 CC(=O)c1csc(n1)c2csc(C)n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E10 compound treatment 0.9559 -0.0441 -0.86 -0.8561 -1.0 1208553 Maybridge1_008722 NC(=S)c1ccc(Oc2ccc(Cl)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E11 compound treatment 1.0172 0.0172 0.33 0.3337 1.0 2074349 Maybridge1_008723 N/C(=N\O)/CSc1ncccc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E12 compound treatment 0.9958 -0.00422 -0.08 -0.082 -1.0 2074350 Maybridge1_008724 NC(=N)CSc1ccc(Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E13 compound treatment 1.0113 0.0113 0.22 0.2191 1.0 2074351 Maybridge1_008725 Cc1n[nH]cc1Sc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E14 compound treatment 1.0046 0.00464 0.09 0.09 1.0 1037237 Maybridge1_008726 CCOC(=O)C(Nc1ccc(Cl)cc1)C(=O)OCC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E15 compound treatment 1.0105 0.0105 0.2 0.2047 1.0 1002860 Maybridge1_008727 NC(=O)COc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E16 compound treatment 1.0017 0.00168 0.03 0.0327 1.0 1033719 Maybridge1_008728 CC(=O)Nc1ccccc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E17 compound treatment 1.0283 0.0283 0.55 0.5488 1.0 2074352 Maybridge1_008729 Cc1nc(N)ncc1Sc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E18 compound treatment 1.0312 0.0312 0.61 0.6061 1.0 2074353 Maybridge1_008730 Cc1onc(c1C(=O)NC(=N)c2ccccc2)c3c(Cl)cccc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E19 compound treatment 1.0319 0.0319 0.62 0.6204 1.0 2074354 Maybridge1_008731 O/N=C/c1ccc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E20 compound treatment 1.0105 0.0105 0.2 0.2047 1.0 1047541 Maybridge1_008732 NNC(=S)NC1CCCCC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E21 compound treatment 0.9936 -0.00644 -0.12 -0.125 -1.0 1091162 Maybridge1_008733 CC(=O)c1c(C)onc1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E22 compound treatment 0.9736 -0.0264 -0.51 -0.512 -1.0 2074355 Maybridge1_008734 NNC(=S)NCc1ccco1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E23 mock treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 E24 mock treatment 1.0216 0.0216 0.42 0.4197 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F01 compound treatment 1.0666 0.0666 1.29 1.2942 1.0 1016959 Maybridge1_008735 NC(=S)c1ccc2ccccc2c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F02 compound treatment 1.0895 0.0895 1.74 1.7386 1.0 2074356 Maybridge1_008736 Cc1ccc(cc1)S(=O)(=O)NC(=O)NNC(=O)c2cc(nn2Cc3ccc(F)cc3)C(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F03 compound treatment 1.0364 0.0364 0.71 0.7064 1.0 2074357 Maybridge1_008737 Cc1n[nH]c(C)c1Sc2nc3ccccc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F04 compound treatment 1.0327 0.0327 0.63 0.6348 1.0 2074358 Maybridge1_008738 COc1ccc(OCCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F05 compound treatment 1.0224 0.0224 0.43 0.4341 1.0 2074359 Maybridge1_008739 CCOC(=O)C(C(=O)OCC)c1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F06 compound treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 1189493 Maybridge1_008740 Cc1ccc(cc1F)c2nc(cs2)c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F07 compound treatment 1.0024 0.00242 0.05 0.047 1.0 1724587 Maybridge1_008741 Nc1snnc1c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F08 compound treatment 1.0319 0.0319 0.62 0.6204 1.0 2074360 Maybridge1_008742 CC(C)(C)c1ccc(cc1)c2nnc(SCc3ccc(OC(F)(F)F)cc3)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F09 compound treatment 1.0356 0.0356 0.69 0.6921 1.0 2074361 Maybridge1_008743 CC(=O)c1c(C)onc1c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F10 compound treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 2074362 Maybridge1_008744 O/N=C/c1c(F)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F11 compound treatment 1.0187 0.0187 0.36 0.3624 1.0 1291550 Maybridge1_008745 CC(C)Oc1ccc(C[C@H](NC(=O)C)C(=O)O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F12 compound treatment 1.0069 0.00685 0.13 0.133 1.0 1334012 Maybridge1_008746 Fc1ccc(C(=O)N2CCN(CC2)c3ccc(C#N)cc3)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F13 compound treatment 1.0083 0.00833 0.16 0.1617 1.0 2074363 Maybridge1_008747 FC(F)(F)c1ccc(cc1)C(=O)CSc2nncn2c3ccc(OCc4ccccc4)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F14 compound treatment 1.0275 0.0275 0.53 0.5344 1.0 1460178 Maybridge1_008748 COc1ccc(NC(=O)Cc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F15 compound treatment 0.9832 -0.0168 -0.33 -0.3257 -1.0 2074364 Maybridge1_008749 Clc1cc(Cl)cc(NC(=O)CSc2nnc(c3ccco3)n2c4ccc5OCCOc5c4)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F16 compound treatment 1.0002 2.08E-4 0.0 0.004 1.0 1728052 Maybridge1_008750 COc1cccc(NC(=O)c2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F17 compound treatment 1.0268 0.0268 0.52 0.5201 1.0 2074365 Maybridge1_008751 Cc1nnsc1C(=O)N2C[C@@H]3CCCC[C@@H]3C[C@@H]2C(=O)NC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F18 compound treatment 0.9936 -0.00644 -0.12 -0.125 -1.0 1246370 Maybridge1_008752 CC(C)(C)c1ccc(NC2CCN(Cc3ccccc3)CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F19 compound treatment 1.0194 0.0194 0.38 0.3767 1.0 1396461 Maybridge1_008753 CC(C)(C)c1cc(C(=O)O)n(Cc2ccc(Cl)cc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F20 compound treatment 1.0032 0.00316 0.06 0.0614 1.0 2074366 Maybridge1_008754 Cn1cc(cc1C(=O)O)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F21 compound treatment 0.9729 -0.0271 -0.53 -0.5264 -1.0 2074367 Maybridge1_008755 CC(C)(C)c1cc(C(=O)NNC(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)n(Cc3ccc(F)cc3)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F22 compound treatment 0.998 -0.00201 -0.04 -0.039 -1.0 1444849 Maybridge1_008756 CCOc1cc(N2CCOCC2)c(OCC)cc1NS(=O)(=O)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F23 mock treatment 1.0009 9.46E-4 0.02 0.0184 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 F24 mock treatment 1.0128 0.0128 0.25 0.2477 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G01 compound treatment 1.1072 0.107 2.08 2.0826 1.0 2074368 Maybridge1_008757 CC(C)(C)c1csc(n1)c2ccc(Oc3ccc(cn3)C(F)(F)F)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G02 compound treatment 1.0534 0.0534 1.04 1.0362 1.0 2074369 Maybridge1_008758 Nc1nccc(n1)c2cc(no2)c3cccc(c3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G03 compound treatment 1.0076 0.00759 0.15 0.1474 1.0 1505963 Maybridge1_008759 CC(C)(C)c1cc(C(=O)N)n(Cc2ccccc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G04 compound treatment 0.9803 -0.0197 -0.38 -0.383 -1.0 2074370 Maybridge1_008760 Nc1cc(O)nc(n1)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G05 compound treatment 1.0113 0.0113 0.22 0.2191 1.0 2074371 Maybridge1_008761 COC(=O)c1c(C)noc1c2snnc2C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G06 compound treatment 1.0091 0.00907 0.18 0.1761 1.0 2074372 Maybridge1_008762 CC(=O)c1c(C)onc1c2cccc(Cl)c2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G07 compound treatment 1.0327 0.0327 0.63 0.6348 1.0 2074373 Maybridge1_008763 NNC(=O)c1ccc(OC(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G08 compound treatment 0.9818 -0.0182 -0.35 -0.3543 -1.0 2074374 Maybridge1_008764 Clc1ccc(Oc2ccc(C#N)cn2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G09 compound treatment 1.0246 0.0246 0.48 0.4771 1.0 2074375 Maybridge1_008765 COC(=O)c1noc(C)c1c2cc[nH]n2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G10 compound treatment 0.9611 -0.0389 -0.76 -0.7557 -1.0 2074376 Maybridge1_008766 NC(=S)c1ccc(OCC(F)(F)F)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G11 compound treatment 1.0327 0.0327 0.63 0.6348 1.0 1445942 Maybridge1_008767 CC(C)(C)c1cc(C(=O)NN)n(Cc2ccc(F)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G12 compound treatment 0.9795 -0.0205 -0.4 -0.3973 -1.0 1298876 Maybridge1_008768 CCOC(=O)N1CCN(CC1)C2c3ccccc3-c4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G13 compound treatment 1.0009 9.46E-4 0.02 0.0184 1.0 2074377 Maybridge1_008769 Clc1ccc(Sc2c[nH]nc2c3ccc(Cl)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G14 compound treatment 0.9943 -0.0057 -0.11 -0.1106 -1.0 2074378 Maybridge1_008770 COC(=O)c1cc(C)nc(O)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G15 compound treatment 1.0334 0.0334 0.65 0.6491 1.0 2074379 Maybridge1_008771 Cc1onc2c(=O)n(C)nc(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G16 compound treatment 0.9936 -0.00644 -0.12 -0.125 -1.0 2074380 Maybridge1_008772 CCOC(=O)c1cc(C#N)c(O)nc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G17 compound treatment 0.9973 -0.00275 -0.05 -0.0533 -1.0 2074381 Maybridge1_008773 CCOC(=O)c1nc(sc1c2cc[nH]n2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G18 compound treatment 0.9854 -0.0146 -0.28 -0.2827 -1.0 2074382 Maybridge1_008774 NC(=S)Nc1ccccc1F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G19 compound treatment 1.0098 0.0098 0.19 0.1904 1.0 2074383 Maybridge1_008775 CC(=O)c1cc(no1)c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G20 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 1671789 Maybridge1_008776 Clc1ccc2nc(sc2c1)N3CCNCC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G21 compound treatment 0.9936 -0.00644 -0.12 -0.125 -1.0 2074384 Maybridge1_008777 Cc1onc(c1c2ccn[nH]2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G22 compound treatment 1.0711 0.0711 1.38 1.3802 1.0 2074385 Maybridge1_008778 Nc1ccccc1Sc2ncc(s2)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G23 mock treatment 1.0091 0.00907 0.18 0.1761 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 G24 mock treatment 1.0091 0.00907 0.18 0.1761 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H01 compound treatment 1.0755 0.0755 1.47 1.4662 1.0 2074386 Maybridge1_008779 CCC(C)Cn1c(O)nnc1S 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H02 compound treatment 1.0091 0.00907 0.18 0.1761 1.0 1214172 Maybridge1_008780 CCOC(=O)CSc1nnc(c2cc(nn2Cc3cccc(C)c3)C(C)(C)C)n1C4CCCCC4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H03 compound treatment 1.0689 0.0689 1.34 1.3372 1.0 2074387 Maybridge1_008781 Cc1n[nH]c(C)c1Sc2ccc(Cl)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H04 compound treatment 1.0209 0.0209 0.41 0.4054 1.0 2074388 Maybridge1_008782 COc1ccc(OCCNC(=O)c2cccs2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H05 compound treatment 1.0504 0.0504 0.98 0.9788 1.0 2074389 Maybridge1_008783 Clc1ccc(cc1)C(=O)CSc2nnc(c3ccco3)n2c4ccc(OCc5ccccc5)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H06 compound treatment 1.0201 0.0201 0.39 0.3911 1.0 2074390 Maybridge1_008784 FC(F)(F)c1ccc(Oc2ccc(cc2)c3nc(cs3)c4ccc5OCCOc5c4)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H07 compound treatment 1.0275 0.0275 0.53 0.5344 1.0 2074391 Maybridge1_008785 FC(F)(F)c1cc(Cc2nnn[nH]2)cc(c1)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H08 compound treatment 1.0511 0.0511 0.99 0.9931 1.0 2074392 Maybridge1_008786 COc1ccc(OCCNC(=O)c2ccccc2C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H09 compound treatment 0.9677 -0.0323 -0.63 -0.6267 -1.0 2074393 Maybridge1_008787 COc1cccc(c1)C2(C)C(C#N)C(=O)NC(=O)C2C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H10 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2074394 Maybridge1_008788 FC(F)(F)Oc1ccc(cc1)C(=O)N2CCN(CC2)c3ccc(C#N)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H11 compound treatment 0.9648 -0.0352 -0.68 -0.684 -1.0 1183230 Maybridge1_008789 COc1ccccc1OCC(=O)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H12 compound treatment 0.9795 -0.0205 -0.4 -0.3973 -1.0 1718196 Maybridge1_008790 O=C(N1CCN(CC1)c2ccc(C#N)cc2)c3cccs3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H13 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2074395 Maybridge1_008791 CC1=N/C(=C\c2ccc(Br)cc2)/C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H14 compound treatment 0.9899 -0.0101 -0.2 -0.1967 -1.0 2074396 Maybridge1_008792 Clc1ccc(NC(=O)Cc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H15 compound treatment 1.0024 0.00242 0.05 0.047 1.0 2074397 Maybridge1_008793 FC(F)(F)c1ccc(NC(=O)CSc2nnc(c3ccco3)n2c4ccc5OCCOc5c4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H16 compound treatment 0.998 -0.00201 -0.04 -0.039 -1.0 1779629 Maybridge1_008794 [O-][N+](=O)c1cccc(NC(=O)c2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H17 compound treatment 0.9847 -0.0153 -0.3 -0.297 -1.0 1298245 Maybridge1_008795 Clc1cc(Cl)cc(NC(=O)N2CCCN(CC2)c3ccc(C#N)cn3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H18 compound treatment 1.0556 0.0556 1.08 1.0792 1.0 1464949 Maybridge1_008796 COc1ccc(NC2CCN(Cc3ccccc3)CC2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H19 compound treatment 1.0009 9.46E-4 0.02 0.0184 1.0 1155555 Maybridge1_008797 CC(C)(C)c1cc(C(=O)O)n(Cc2ccc(F)cc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H20 compound treatment 1.0024 0.00242 0.05 0.047 1.0 1709464 Maybridge1_008798 Cn1cc(NC(=O)OC(C)(C)C)cc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H21 compound treatment 0.984 -0.016 -0.31 -0.3113 -1.0 2074398 Maybridge1_008799 CC(C)(C)c1cc(c2nnc(S)n2c3ccccc3)n(Cc4ccc(Cl)cc4Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H22 compound treatment 0.9965 -0.00348 -0.07 -0.0676 -1.0 1672 Maybridge1_008800 OC(=O)CCc1nc(c(o1)c2ccccc2)c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H23 mock treatment 0.9751 -0.0249 -0.48 -0.4834 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 H24 mock treatment 0.9958 -0.00422 -0.08 -0.082 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I01 compound treatment 1.0703 0.0703 1.37 1.3659 1.0 2074399 Maybridge1_008801 Cc1nc(sc1C(=O)O)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I02 compound treatment 1.2335 0.233 4.53 4.5339 1.0 2074400 Maybridge1_008802 CCO/C(=C(\C#N)/C(=S)N)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I03 compound treatment 1.0283 0.0283 0.55 0.5488 1.0 2074401 Maybridge1_008803 COC(=O)c1c(C)noc1c2cc(C)on2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I04 compound treatment 0.998 -0.00201 -0.04 -0.039 -1.0 2074402 Maybridge1_008804 CCOC(=O)c1cnc(nc1O)c2ccccn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I05 compound treatment 1.0054 0.00537 0.1 0.1044 1.0 2074403 Maybridge1_008805 NC(=S)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I06 compound treatment 1.0319 0.0319 0.62 0.6204 1.0 2074404 Maybridge1_008806 COC(OC)c1nc(SCc2c(Cl)cccc2Cl)ncc1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I07 compound treatment 1.0061 0.00611 0.12 0.1187 1.0 2074405 Maybridge1_008807 NNC(=O)c1ccccc1OC(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I08 compound treatment 0.9788 -0.0212 -0.41 -0.4117 -1.0 2074406 Maybridge1_008808 N/C(=N\O)/c1ccc(Oc2ccc(Cl)cc2)nc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I09 compound treatment 1.0091 0.00907 0.18 0.1761 1.0 2074407 Maybridge1_008809 CC(=O)c1csc(n1)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I10 compound treatment 0.9862 -0.0138 -0.27 -0.2683 -1.0 2074408 Maybridge1_008810 CSC(=C(C#N)C#N)/N=C(/N)\C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I11 compound treatment 1.0216 0.0216 0.42 0.4197 1.0 2074409 Maybridge1_008811 CCOC(=O)c1cc(n[nH]1)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I12 compound treatment 0.9869 -0.0131 -0.25 -0.254 -1.0 1415037 Maybridge1_008812 C1CN(CCN1)C2c3ccccc3-c4ccccc24 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I13 compound treatment 1.0334 0.0334 0.65 0.6491 1.0 2074410 Maybridge1_008813 Cn1ccnc1Sc2cnc(S)nc2c3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I14 compound treatment 1.0187 0.0187 0.36 0.3624 1.0 1116774 Maybridge1_008814 OC(c1ccccc1)(c2ccccc2)c3ccncc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I15 compound treatment 0.9818 -0.0182 -0.35 -0.3543 -1.0 2074411 Maybridge1_008815 CCOC(=O)c1cc(on1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I16 compound treatment 0.9758 -0.0242 -0.47 -0.469 -1.0 2074412 Maybridge1_008816 Cc1nc(nc(Sc2nnc([nH]2)c3cc(Cl)cc(Cl)c3)c1C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I17 compound treatment 1.0393 0.0393 0.76 0.7638 1.0 2074413 Maybridge1_008817 CS(=O)(=O)CC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I18 compound treatment 1.0194 0.0194 0.38 0.3767 1.0 2074414 Maybridge1_008818 NC(=S)Nc1cc(ccc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I19 compound treatment 1.0135 0.0135 0.26 0.2621 1.0 1073042 Maybridge1_008819 COC(OC)c1cc(O)nc(S)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I20 compound treatment 1.0194 0.0194 0.38 0.3767 1.0 2074415 Maybridge1_008820 FC(F)(F)Oc1ccccc1S(=O)(=O)N2CCN(CC2)c3nc4ccc(Cl)cc4s3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I21 compound treatment 1.0371 0.0371 0.72 0.7208 1.0 1639470 Maybridge1_008821 CC(C)NC(=O)n1nccc1c2c(C)onc2c3ccc(Cl)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I22 compound treatment 1.012 0.012 0.23 0.2334 1.0 2074416 Maybridge1_008822 COc1cc(OC)nc(n1)S(=O)(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I23 mock treatment 0.9707 -0.0293 -0.57 -0.5694 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 I24 mock treatment 0.9773 -0.0227 -0.44 -0.4404 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J01 compound treatment 1.0593 0.0593 1.15 1.1508 1.0 2074417 Maybridge1_008823 CCOC(=O)c1cc(C)nn1Cc2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J02 compound treatment 1.0371 0.0371 0.72 0.7208 1.0 1159897 Maybridge1_008824 Cc1cccc(Cn2nc(cc2c3nnc(SCC(=O)O)n3C4CCCCC4)C(C)(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J03 compound treatment 1.0511 0.0511 0.99 0.9931 1.0 2074418 Maybridge1_008825 CCOC(=O)c1sc2nc(ccc2c1N)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J04 compound treatment 1.0224 0.0224 0.43 0.4341 1.0 2074419 Maybridge1_008826 OCCCCNC(=O)OCC1c2ccccc2-c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J05 compound treatment 1.0371 0.0371 0.72 0.7208 1.0 2074420 Maybridge1_008827 N/C(=N\O)/Cc1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J06 compound treatment 1.029 0.029 0.56 0.5631 1.0 2074421 Maybridge1_008828 FC(F)(F)c1ccc(cc1)c2nc(cs2)c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J07 compound treatment 1.0379 0.0379 0.74 0.7351 1.0 2074422 Maybridge1_008829 CCOC(=O)c1ccc(Oc2ccc(Cl)cc2Cl)c(c1)[N+](=O)[O-] 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J08 compound treatment 1.0164 0.0164 0.32 0.3194 1.0 2074423 Maybridge1_008830 C1COc2cc(ccc2O1)c3csc(N/N=C/c4cccs4)n3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J09 compound treatment 1.0201 0.0201 0.39 0.3911 1.0 2074424 Maybridge1_008831 CC(=O)c1cc(no1)c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J10 compound treatment 1.0039 0.0039 0.08 0.0757 1.0 1537006 Maybridge1_008832 Cc1onc(c1C(=O)N2CCN(CC2)c3nc(ns3)c4cccs4)c5c(Cl)cccc5Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J11 compound treatment 0.9832 -0.0168 -0.33 -0.3257 -1.0 2074425 Maybridge1_008833 CC(C)c1ccc(NC(=O)CSc2nncn2c3ccc4OCCOc4c3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J12 compound treatment 1.0172 0.0172 0.33 0.3337 1.0 1574772 Maybridge1_008834 O=C(N1CCN(CC1)c2nc(ns2)c3cccs3)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J13 compound treatment 0.9899 -0.0101 -0.2 -0.1967 -1.0 2074426 Maybridge1_008835 CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C(=O)COc3ccc(Cl)cc3Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J14 compound treatment 0.9936 -0.00644 -0.12 -0.125 -1.0 1110808 Maybridge1_008836 COc1ccc(NC(=O)c2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J15 compound treatment 1.0002 2.08E-4 0.0 0.004 1.0 2074427 Maybridge1_008837 Cc1nnc(SCc2c(Cl)cccc2Cl)n1c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J16 compound treatment 1.0238 0.0238 0.46 0.4628 1.0 1427190 Maybridge1_008838 Fc1cccc(F)c1C(=O)Nc2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J17 compound treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 1528180 Maybridge1_008839 Fc1ccc(NC(=O)N2CCCN(CC2)c3ccc(C#N)cn3)c(F)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J18 compound treatment 1.0091 0.00907 0.18 0.1761 1.0 2074428 Maybridge1_008840 CC(C)(C)OC(=O)N1Cc2ccccc2C[C@H]1C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J19 compound treatment 0.9685 -0.0315 -0.61 -0.6124 -1.0 1249554 Maybridge1_008841 Cc1cc(C)c(Cn2nc(cc2C(=O)O)C(C)(C)C)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J20 compound treatment 1.0157 0.0157 0.31 0.3051 1.0 2074429 Maybridge1_008842 [O-][N+](=O)c1ccc(cc1)N2CCN(Cc3ccccc3)CC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J21 compound treatment 0.9928 -0.00717 -0.14 -0.1393 -1.0 1524382 Maybridge1_008843 Cc1cccc(Cn2nc(cc2c3nnc(S)n3C4CCCCC4)C(C)(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J22 compound treatment 0.9544 -0.0456 -0.88 -0.8847 -1.0 1377203 Maybridge1_008844 Nc1cc(F)ccc1n2ccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J23 mock treatment 1.0069 0.00685 0.13 0.133 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 J24 mock treatment 1.0142 0.0142 0.28 0.2764 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K01 compound treatment 1.0504 0.0504 0.98 0.9788 1.0 2074430 Maybridge1_008845 Cc1nc(sc1C(=O)NN)c2ccc(cc2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K02 compound treatment 1.0164 0.0164 0.32 0.3194 1.0 1601358 Maybridge1_008846 Cc1noc(N)c1C(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K03 compound treatment 1.0253 0.0253 0.49 0.4914 1.0 2074431 Maybridge1_008847 COC(=O)c1c(C)noc1c2ccno2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K04 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 2074432 Maybridge1_008848 O/N=C/c1ccc(OC(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K05 compound treatment 1.0039 0.0039 0.08 0.0757 1.0 2074433 Maybridge1_008849 NNC(=O)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K06 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 2074434 Maybridge1_008850 Cc1nc(COc2ccccc2)nc(O)c1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K07 compound treatment 1.0046 0.00464 0.09 0.09 1.0 2074435 Maybridge1_008851 CC(=O)c1csc(CS(=O)(=O)c2ccccn2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K08 compound treatment 1.0105 0.0105 0.2 0.2047 1.0 2074436 Maybridge1_008852 O/N=C/c1c(Cl)cccc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K09 compound treatment 1.0069 0.00685 0.13 0.133 1.0 2074437 Maybridge1_008853 COC(=O)c1noc(C)c1/C(=N/O)/C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K10 compound treatment 0.9795 -0.0205 -0.4 -0.3973 -1.0 2074438 Maybridge1_008854 CNC(=S)NNC(=O)c1ccc(Cl)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K11 compound treatment 1.0216 0.0216 0.42 0.4197 1.0 2074439 Maybridge1_008855 CNc1ncc(cc1[N+](=O)[O-])C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K12 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 2074440 Maybridge1_008856 NC(=S)CCn1cccc(c1=O)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K13 compound treatment 1.0098 0.0098 0.19 0.1904 1.0 1465283 Maybridge1_008857 Cc1ccc(Oc2c(C)[nH]c(=S)[nH]c2=O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K14 compound treatment 1.0054 0.00537 0.1 0.1044 1.0 2074441 Maybridge1_008858 c1ccc-2c(c1)C(c3ccccc32)c4ccncc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K15 compound treatment 0.995 -0.00496 -0.1 -0.0963 -1.0 2074442 Maybridge1_008859 FC(F)(F)C(=O)/C(=N\Nc1ccc(Cl)cc1Cl)/C(=O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K16 compound treatment 1.0157 0.0157 0.31 0.3051 1.0 2074443 Maybridge1_008860 CCOC(=O)c1sc2nc(c(cc2c1N)C(=O)OCC)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K17 compound treatment 0.9825 -0.0175 -0.34 -0.34 -1.0 2074444 Maybridge1_008861 CC(C)(C)S(=O)(=O)CC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K18 compound treatment 1.0039 0.0039 0.08 0.0757 1.0 1459332 Maybridge1_008862 O=c1oc2ccccc2n1Cc3cccc(C#N)c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K19 compound treatment 0.9862 -0.0138 -0.27 -0.2683 -1.0 2074445 Maybridge1_008863 O/N=C/c1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K20 compound treatment 0.9478 -0.0522 -1.01 -1.0138 -1.0 2074446 Maybridge1_008864 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCN(CC2)c3nc4ccc(Cl)cc4s3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K21 compound treatment 1.0283 0.0283 0.55 0.5488 1.0 2074447 Maybridge1_008865 CC(=O)c1c(C)onc1c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K22 compound treatment 0.9758 -0.0242 -0.47 -0.469 -1.0 2074448 Maybridge1_008866 COc1ccc(cc1[N+](=O)[O-])C(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K23 mock treatment 1.015 0.015 0.29 0.2907 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 K24 mock treatment 1.0024 0.00242 0.05 0.047 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L01 compound treatment 1.0423 0.0423 0.82 0.8211 1.0 2074449 Maybridge1_008867 CCOC(=O)c1cc(C)n(Cc2c(Cl)cccc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L02 compound treatment 1.0275 0.0275 0.53 0.5344 1.0 2074450 Maybridge1_008868 COc1ccc(OCCNC(=O)c2c(C)onc2c3c(Cl)cccc3Cl)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L03 compound treatment 1.046 0.046 0.89 0.8928 1.0 1382829 Maybridge1_008869 O=c1[nH]c(ccc1C#N)c2ccco2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L04 compound treatment 1.0135 0.0135 0.26 0.2621 1.0 2074451 Maybridge1_008870 OCCCCCCNC(=O)OCC1c2ccccc2-c3ccccc13 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L05 compound treatment 1.0083 0.00833 0.16 0.1617 1.0 2074452 Maybridge1_008871 NNS(=O)(=O)c1ccc(Cl)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L06 compound treatment 1.0238 0.0238 0.46 0.4628 1.0 2074453 Maybridge1_008872 Cc1onc(c1c2nc(cs2)c3ccc4OCCOc4c3)c5c(Cl)cccc5Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L07 compound treatment 1.0024 0.00242 0.05 0.047 1.0 1925488 Maybridge1_008873 CC(C)(C)c1ccc(cc1)c2nnc(S)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L08 compound treatment 1.0408 0.0408 0.79 0.7925 1.0 1408544 Maybridge1_008874 Clc1ccc(cc1)S(=O)(=O)Cc2nc(cs2)c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L09 compound treatment 0.964 -0.036 -0.7 -0.6984 -1.0 1239086 Maybridge1_008875 COc1ccc(OCC(=O)N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L10 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2074454 Maybridge1_008876 FC(F)(F)Oc1ccc(cc1)C(=O)N2CCN(CC2)c3nc(ns3)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L11 compound treatment 0.9722 -0.0278 -0.54 -0.5407 -1.0 2074455 Maybridge1_008877 FC(F)(F)c1cccc(NC(=O)CSc2nncn2c3ccc4OCCOc4c3)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L12 compound treatment 1.0024 0.00242 0.05 0.047 1.0 1175090 Maybridge1_008878 Cc1cccc(Cn2nc(cc2c3nnc(SCC(=O)c4ccccc4)o3)C(C)(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L13 compound treatment 0.9781 -0.0219 -0.43 -0.426 -1.0 2074456 Maybridge1_008879 CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C(=O)c3ccc(cc3)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L14 compound treatment 0.9744 -0.0256 -0.5 -0.4977 -1.0 2074457 Maybridge1_008880 FC(F)(F)c1cccc(c1)C(=O)Nc2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L15 compound treatment 1.0113 0.0113 0.22 0.2191 1.0 2074458 Maybridge1_008881 Cc1nnc(SCC(=O)c2ccc(Cl)cc2)n1c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L16 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 1026880 Maybridge1_008882 Clc1cccc(NC(=O)c2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L17 compound treatment 1.0113 0.0113 0.22 0.2191 1.0 1374727 Maybridge1_008883 Cc1ccccc1NC(=O)N2CCCN(CC2)c3ccc(C#N)cn3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L18 compound treatment 1.0209 0.0209 0.41 0.4054 1.0 2074459 Maybridge1_008884 CCOC(=O)N1CCN(CC1)c2nc(c(cc2C#N)C(=O)OCC)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L19 compound treatment 0.9906 -0.00939 -0.18 -0.1823 -1.0 1563500 Maybridge1_008885 Cc1cccc(Cn2nc(cc2C(=O)NN)C(C)(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L20 compound treatment 1.0039 0.0039 0.08 0.0757 1.0 1602761 Maybridge1_008886 CCOc1cc(N2CCOCC2)c(OCC)cc1NC(=O)c3ccc(C)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L21 compound treatment 0.9773 -0.0227 -0.44 -0.4404 -1.0 2074460 Maybridge1_008887 Cc1cc(Br)ccc1NC(=O)OC(C)(C)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L22 compound treatment 1.0091 0.00907 0.18 0.1761 1.0 1564357 Maybridge1_008888 Cc1ccc(cc1)S(=O)(=O)n2ccc3cc(N)ccc23 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L23 mock treatment 1.0009 9.46E-4 0.02 0.0184 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 L24 mock treatment 1.0364 0.0364 0.71 0.7064 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M01 compound treatment 1.0408 0.0408 0.79 0.7925 1.0 1296479 Maybridge1_008889 CC(C)(C)c1cc(C(=O)O)n(Cc2ccccc2)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M02 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2074461 Maybridge1_008890 CCOC(=O)c1cc(C)n(C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M03 compound treatment 1.0393 0.0393 0.76 0.7638 1.0 2074462 Maybridge1_008891 CSc1nn(CO)c(=S)s1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M04 compound treatment 1.0297 0.0297 0.58 0.5774 1.0 2074463 Maybridge1_008892 NC(=S)c1ncc(cc1Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M05 compound treatment 1.0128 0.0128 0.25 0.2477 1.0 2074464 Maybridge1_008893 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)c2nnc(S)o2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M06 compound treatment 0.9877 -0.0123 -0.24 -0.2397 -1.0 2074465 Maybridge1_008894 COc1ccc(OCc2nc(C)c(Cl)c(O)n2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M07 compound treatment 0.9832 -0.0168 -0.33 -0.3257 -1.0 2074466 Maybridge1_008895 CC(=O)c1csc(Nc2c(C)cc(C)cc2C)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M08 compound treatment 0.9795 -0.0205 -0.4 -0.3973 -1.0 2074467 Maybridge1_008896 NC(=N)CSc1ccccc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M09 compound treatment 1.0135 0.0135 0.26 0.2621 1.0 2074468 Maybridge1_008897 C/C(=N\NC(=S)N)/c1csc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M10 compound treatment 1.0172 0.0172 0.33 0.3337 1.0 2074469 Maybridge1_008898 Sc1nnc(c2ccc(Cl)cc2Cl)n1Cc3ccco3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M11 compound treatment 1.0216 0.0216 0.42 0.4197 1.0 2074470 Maybridge1_008899 CCOC(=O)CSc1nc2cc(cnc2n1C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M12 compound treatment 0.9773 -0.0227 -0.44 -0.4404 -1.0 2074471 Maybridge1_008900 COC(=O)c1c(C)onc1c2c(Cl)cccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M13 compound treatment 1.0128 0.0128 0.25 0.2477 1.0 2074472 Maybridge1_008901 CCn1nc(cc1C(=O)O)c2cccs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M14 compound treatment 0.9736 -0.0264 -0.51 -0.512 -1.0 2074473 Maybridge1_008902 Nc1cc(ccc1N2CCC(CC2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M15 compound treatment 1.0172 0.0172 0.33 0.3337 1.0 2074474 Maybridge1_008903 COC(OC)c1ccnc(SCc2ccc(Cl)cc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M16 compound treatment 0.9699 -0.0301 -0.58 -0.5837 -1.0 2074475 Maybridge1_008904 CCOC(=O)c1cc(C#N)c(Sc2ccccc2N)nc1C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M17 compound treatment 0.9869 -0.0131 -0.25 -0.254 -1.0 2074476 Maybridge1_008905 CC(=O)c1csc(n1)c2cc(C)on2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M18 compound treatment 0.9633 -0.0367 -0.71 -0.7127 -1.0 2074477 Maybridge1_008906 NNC(=O)c1sccc1OCc2ncc(cc2Cl)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M19 compound treatment 0.9611 -0.0389 -0.76 -0.7557 -1.0 2074478 Maybridge1_008907 COC(OC)c1nc(S)c(C#N)cc1C(=O)OC 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M20 compound treatment 0.9714 -0.0286 -0.56 -0.555 -1.0 1394218 Maybridge1_008908 CS(=O)(=O)N1CCN(CC1)c2nc3ccc(Cl)cc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M21 compound treatment 0.998 -0.00201 -0.04 -0.039 -1.0 1657037 Maybridge1_008909 Cc1onc(c1c2csc(n2)c3ccc(cc3)C(C)(C)C)c4ccccc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M22 compound treatment 0.984 -0.016 -0.31 -0.3113 -1.0 2074479 Maybridge1_008910 Cc1ccc(cc1F)/C(=N/O)/N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M23 mock treatment 0.9899 -0.0101 -0.2 -0.1967 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 M24 mock treatment 0.964 -0.036 -0.7 -0.6984 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N01 compound treatment 1.043 0.043 0.84 0.8355 1.0 2074480 Maybridge1_008911 CC(=O)c1csc(n1)c2ccc(C)c(F)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N02 compound treatment 1.0172 0.0172 0.33 0.3337 1.0 2074481 Maybridge1_008912 FC(F)(F)c1ccc(cc1)c2nc(CSCc3csc(n3)c4ccc(cc4)C(F)(F)F)cs2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N03 compound treatment 1.0076 0.00759 0.15 0.1474 1.0 1713251 Maybridge1_008913 Sc1n[nH]c(=O)n1c2ccc(OCc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N04 compound treatment 1.0297 0.0297 0.58 0.5774 1.0 1634679 Maybridge1_008914 N#CCc1nc(cs1)c2ccc3OCCOc3c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N05 compound treatment 1.0268 0.0268 0.52 0.5201 1.0 1435896 Maybridge1_008915 NNC(=S)Nc1ccc(OCc2ccccc2)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N06 compound treatment 1.0179 0.0179 0.35 0.3481 1.0 1721437 Maybridge1_008916 C1COc2cc(ccc2O1)c3csc(n3)c4cccs4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N07 compound treatment 1.012 0.012 0.23 0.2334 1.0 2074482 Maybridge1_008917 NC(=S)Cc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N08 compound treatment 1.0246 0.0246 0.48 0.4771 1.0 2074483 Maybridge1_008918 Cc1cc(C)c(Cn2nc(cc2C(=O)Nc3cccc(c3)C(F)(F)F)C(C)(C)C)c(C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N09 compound treatment 1.0275 0.0275 0.53 0.5344 1.0 2074484 Maybridge1_008919 CC1=N/C(=C\c2cc(Cl)ccc2O)/C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N10 compound treatment 1.0246 0.0246 0.48 0.4771 1.0 2074485 Maybridge1_008920 FC(F)(F)c1ccc(cc1)c2nc(cs2)C3(CC4CC5CC(C4)C3)C5 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N11 compound treatment 1.0024 0.00242 0.05 0.047 1.0 1585407 Maybridge1_008921 CC(C)(C)c1ccc(CSc2nncn2c3ccc(OCc4ccccc4)cc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N12 compound treatment 1.0209 0.0209 0.41 0.4054 1.0 2074486 Maybridge1_008922 Clc1cc(Cl)cc(NC(=O)c2ccccc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N13 compound treatment 1.0083 0.00833 0.16 0.1617 1.0 2074487 Maybridge1_008923 Cc1ccc(CSc2nnc(c3ccco3)n2c4ccc5OCCOc5c4)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N14 compound treatment 1.0194 0.0194 0.38 0.3767 1.0 1098613 Maybridge1_008924 COc1ccc(cc1)C(=O)Nc2cccnc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N15 compound treatment 1.0069 0.00685 0.13 0.133 1.0 2074488 Maybridge1_008925 Cc1nnc(SCC(=O)c2ccccc2)n1c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N16 compound treatment 0.9758 -0.0242 -0.47 -0.469 -1.0 1065431 Maybridge1_008926 FC(F)(F)c1cccc(NC(=O)c2cccnc2)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N17 compound treatment 0.981 -0.019 -0.37 -0.3687 -1.0 1283307 Maybridge1_008927 CNC(=S)N1CCCN(CC1)c2ccc(C#N)cn2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N18 compound treatment 0.9832 -0.0168 -0.33 -0.3257 -1.0 2074489 Maybridge1_008928 CCOC(=O)N1CCN(CC1)c2cc(cc(n2)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N19 compound treatment 1.0002 2.08E-4 0.0 0.004 1.0 1566014 Maybridge1_008929 CC(C)(C)c1cc(C(=O)NN)n(Cc2ccc(Cl)cc2Cl)n1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N20 compound treatment 0.9928 -0.00717 -0.14 -0.1393 -1.0 1239894 Maybridge1_008930 Cc1ccc(cc1)C(=O)Nc2ccc(cc2)N3CCN(Cc4ccccc4)CC3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N21 compound treatment 0.9648 -0.0352 -0.68 -0.684 -1.0 1359647 Maybridge1_008931 CC(=O)N[C@@H](Cc1cccs1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N22 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 1032778 Maybridge1_008932 CC(=O)c1cccc(OCC(=O)O)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N23 mock treatment 0.9995 -5.31E-4 -0.01 -0.0103 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 N24 mock treatment 1.0216 0.0216 0.42 0.4197 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O01 compound treatment 1.074 0.074 1.44 1.4375 1.0 2074490 Maybridge1_008933 OC(=O)c1ccc(Oc2cc(Cl)cc(Cl)c2)o1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O02 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 1397180 Maybridge1_008934 Cc1c(sc2nc(nc(C)c12)c3ccccc3)C(=O)c4ccc(Cl)cc4 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O03 compound treatment 1.0452 0.0452 0.88 0.8785 1.0 2074491 Maybridge1_008935 CN(C)/C=C(\C#N)/c1ccc(Oc2ccc(cn2)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O04 compound treatment 1.0246 0.0246 0.48 0.4771 1.0 2074492 Maybridge1_008936 C/C(=N\O)/c1sc2nc(nn2c1C)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O05 compound treatment 0.9973 -0.00275 -0.05 -0.0533 -1.0 2074493 Maybridge1_008937 Cc1onc2c(=O)[nH]nc(C)c12 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O06 compound treatment 1.0076 0.00759 0.15 0.1474 1.0 2074494 Maybridge1_008938 FC(F)(F)c1ccc(nc1)c2nnn[nH]2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O07 compound treatment 1.0224 0.0224 0.43 0.4341 1.0 2074495 Maybridge1_008939 C/C(=N\O)/c1csc(n1)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O08 compound treatment 1.0142 0.0142 0.28 0.2764 1.0 2074496 Maybridge1_008940 CSc1nc(COc2ccccc2Cl)nc(N)c1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O09 compound treatment 1.0305 0.0305 0.59 0.5918 1.0 2074497 Maybridge1_008941 Cc1nc(sc1C(=O)O)c2ccccc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O10 compound treatment 0.9677 -0.0323 -0.63 -0.6267 -1.0 2074498 Maybridge1_008942 Cn1c(S)nnc1c2ccc(Cl)cc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O11 compound treatment 1.0157 0.0157 0.31 0.3051 1.0 2074499 Maybridge1_008943 Cc1ccc(Oc2c(C)nc(nc2O)c3ccccc3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O12 compound treatment 0.9973 -0.00275 -0.05 -0.0533 -1.0 2074500 Maybridge1_008944 CC(=O)C(Sc1ccc(Cl)cc1)C(=O)C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O13 compound treatment 1.0069 0.00685 0.13 0.133 1.0 2074501 Maybridge1_008945 CCOC(=O)c1cc(C#N)c(S)nc1C 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O14 compound treatment 0.9936 -0.00644 -0.12 -0.125 -1.0 2074502 Maybridge1_008946 CC(=O)Nc1ccc(Br)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O15 compound treatment 0.9899 -0.0101 -0.2 -0.1967 -1.0 1127840 Maybridge1_008947 Cc1ccc(Oc2c(C)nc(N)nc2O)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O16 compound treatment 0.9766 -0.0234 -0.45 -0.4547 -1.0 1116550 Maybridge1_008948 COc1ccccc1NC(=S)N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O17 compound treatment 1.0201 0.0201 0.39 0.3911 1.0 2074503 Maybridge1_008949 Cc1cc(/C=N/NS(=O)(=O)c2ccc(F)c(Cl)c2)no1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O18 compound treatment 0.9958 -0.00422 -0.08 -0.082 -1.0 2074504 Maybridge1_008950 CC(C)(C)NC(=O)O/N=C(\N)/c1ccc(NS(=O)(=O)C)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O19 compound treatment 0.9995 -5.31E-4 -0.01 -0.0103 -1.0 2074505 Maybridge1_008951 CC(=O)c1cc(no1)c2ccc(Cl)c(Cl)c2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O20 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 1450208 Maybridge1_008952 CC(C)(C)NC(=O)N1CCN(CC1)c2nc3ccc(Cl)cc3s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O21 compound treatment 0.9891 -0.0109 -0.21 -0.211 -1.0 2074506 Maybridge1_008953 N/C(=N\O)/c1ccc(OCc2ncc(cc2Cl)C(F)(F)F)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O22 compound treatment 0.95 -0.05 -0.97 -0.9707 -1.0 2074507 Maybridge1_008954 FC(F)(F)COc1ncccc1C#N 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O23 mock treatment 1.0135 0.0135 0.26 0.2621 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 O24 mock treatment 1.0002 2.08E-4 0.0 0.004 1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P01 compound treatment 1.0098 0.0098 0.19 0.1904 1.0 1049753 Maybridge1_008955 CC(=O)Nc1ccc(C#N)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P02 compound treatment 1.0681 0.0681 1.32 1.3229 1.0 2074508 Maybridge1_008956 Cc1cccc(Cn2nc(cc2c3nnc(SCc4c(F)cccc4Cl)n3C5CCCCC5)C(C)(C)C)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P03 compound treatment 1.063 0.063 1.22 1.2225 1.0 2074509 Maybridge1_008957 CCOC(=O)c1cc(C#N)c(nc1C(F)(F)F)N2CCCNCC2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P04 compound treatment 1.0674 0.0674 1.31 1.3085 1.0 2074510 Maybridge1_008958 FC(F)(F)Oc1ccc(cc1)c2nc(cs2)c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P05 compound treatment 1.0009 9.46E-4 0.02 0.0184 1.0 1439285 Maybridge1_008959 Sc1nncn1c2ccc(OCc3ccccc3)cc2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P06 compound treatment 1.0474 0.0474 0.92 0.9215 1.0 1609883 Maybridge1_008960 CCOC(=O)C1CCN(Cc2c(F)cccc2Cl)CC1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P07 compound treatment 1.015 0.015 0.29 0.2907 1.0 2074511 Maybridge1_008961 N/C(=N\O)/Cc1cc(cc(c1)C(F)(F)F)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P08 compound treatment 1.0061 0.00611 0.12 0.1187 1.0 1299675 Maybridge1_008962 COc1ccc(OCc2nc(cs2)c3ccc4OCCOc4c3)cc1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P09 compound treatment 1.0452 0.0452 0.88 0.8785 1.0 2074512 Maybridge1_008963 CC1=N/C(=C\c2cc(Cl)cc(Br)c2O)/C(=O)O1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P10 compound treatment 1.0128 0.0128 0.25 0.2477 1.0 2074513 Maybridge1_008964 Cc1cc(c(Cl)cc1Cl)S(=O)(=O)NC(Cc2ccc(cc2)[N+](=O)[O-])C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P11 compound treatment 1.0445 0.0445 0.86 0.8641 1.0 2074514 Maybridge1_008965 Fc1cccc(Cl)c1CSc2nncn2c3ccc(OCc4ccccc4)cc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P12 compound treatment 1.0482 0.0482 0.94 0.9358 1.0 2074515 Maybridge1_008966 Clc1ccc(NC(=O)c2ccccc2)cc1Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P13 compound treatment 1.0098 0.0098 0.19 0.1904 1.0 2074516 Maybridge1_008967 Clc1ccc(CSc2nnc(c3ccco3)n2c4ccc5OCCOc5c4)c(Cl)c1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P14 compound treatment 1.0231 0.0231 0.45 0.4484 1.0 1008239 Maybridge1_008968 Clc1ccccc1NC(=O)c2ccccc2Cl 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P15 compound treatment 0.9781 -0.0219 -0.43 -0.426 -1.0 2074517 Maybridge1_008969 Cc1nnc(SCC(=O)Nc2ccccc2Cl)n1c3ccc4OCCOc4c3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P16 compound treatment 1.0201 0.0201 0.39 0.3911 1.0 1927016 Maybridge1_008970 COc1ccccc1C(=O)Nc2cccc(c2)C(F)(F)F 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P17 compound treatment 0.9773 -0.0227 -0.44 -0.4404 -1.0 2074518 Maybridge1_008971 CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NN 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P18 compound treatment 0.9987 -0.00127 -0.02 -0.0246 -1.0 2074519 Maybridge1_008972 OC[C@@H]1Cc2ccccc2CN1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P19 compound treatment 0.9633 -0.0367 -0.71 -0.7127 -1.0 2074520 Maybridge1_008973 CCCCNC(=O)O/N=C(\N)/Cc1cccs1 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P20 compound treatment 0.9862 -0.0138 -0.27 -0.2683 -1.0 1681940 Maybridge1_008974 CCOc1cc(N2CCOCC2)c(OCC)cc1NC(=O)Cc3ccccc3 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P21 compound treatment 0.9913 -0.00865 -0.17 -0.168 -1.0 1218670 Maybridge1_008975 CC(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)O 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P22 compound treatment 0.9758 -0.0242 -0.47 -0.469 -1.0 2074521 Maybridge1_008976 COc1ccccc1NS(=O)(=O)c2ccc(Cl)s2 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P23 mock treatment 0.9722 -0.0278 -0.54 -0.5407 -1.0 295.0483 user{AvgPol(mP,17h)}(295.0483) GlycanaseActivity 295.0483.566 P24 mock treatment 1.0187 0.0187 0.36 0.3624 1.0